data_1fsp_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1fsp _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.424 ' HB3' HD22 ' A' ' 121' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.52 ' O ' ' CB ' ' A' ' 48' ' ' PRO . 0.4 OUTLIER -103.69 118.12 35.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.201 -0.937 . . . . 0.0 109.502 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.466 HG21 ' N ' ' A' ' 7' ' ' LEU . 13.8 mt -116.31 153.16 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.174 -0.954 . . . . 0.0 109.422 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.519 ' CD2' HG22 ' A' ' 42' ' ' ILE . 1.9 tm? -131.42 110.83 11.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.195 -0.94 . . . . 0.0 109.516 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.561 ' CG2' ' NH1' ' A' ' 16' ' ' ARG . 3.4 mt -90.07 108.11 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -0.879 . . . . 0.0 109.324 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.523 ' CG2' ' HB3' ' A' ' 39' ' ' ALA . 2.8 t -98.36 117.42 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.221 -0.924 . . . . 0.0 109.654 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.585 ' CB ' ' CZ ' ' A' ' 16' ' ' ARG . 24.9 t0 -175.17 154.94 1.85 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.337 -0.852 . . . . 0.0 109.421 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.444 ' CG ' ' N ' ' A' ' 12' ' ' GLN . 5.3 p-10 -105.95 -46.12 4.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.165 -0.96 . . . . 0.0 109.501 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.447 ' HG2' ' OD2' ' A' ' 10' ' ' ASP . 13.6 pt20 -50.04 127.51 16.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.241 -0.912 . . . . 0.0 109.527 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.487 ' CE2' HD13 ' A' ' 17' ' ' ILE . 8.2 t80 -80.86 157.95 25.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.257 -0.902 . . . . 0.0 109.645 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 116.31 -69.32 0.28 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.568 ' CG2' ' NH2' ' A' ' 16' ' ' ARG . 5.8 mt -64.02 -25.43 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.32 -1.106 . . . . 0.0 109.173 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.585 ' CZ ' ' CB ' ' A' ' 10' ' ' ASP . 3.7 mmp_? -65.34 -24.75 67.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.886 . . . . 0.0 109.403 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.487 HD13 ' CE2' ' A' ' 13' ' ' TYR . 6.1 mt -89.95 -24.9 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.343 -0.848 . . . . 0.0 109.387 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.505 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 49.3 mt -74.24 -50.83 17.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.312 -0.868 . . . . 0.0 109.499 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.509 ' O ' ' CD2' ' A' ' 23' ' ' PHE . 7.2 mt -69.16 -20.1 64.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 109.408 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 39.1 t30 -77.02 -58.95 2.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.26 -0.9 . . . . 0.0 109.491 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.418 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 14.0 mt-10 -59.58 -47.89 83.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.917 . . . . 0.0 109.5 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.505 ' CG2' ' O ' ' A' ' 18' ' ' LEU . 22.2 t -57.21 -57.32 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.229 -0.92 . . . . 0.0 109.442 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.518 ' CB ' HG22 ' A' ' 30' ' ' THR . 24.0 m-85 -71.81 -4.26 26.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.164 -0.96 . . . . 0.0 109.599 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.418 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 0.5 OUTLIER -82.21 -55.67 4.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -0.899 . . . . 0.0 109.463 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.407 ' O ' ' C ' ' A' ' 26' ' ' GLU . 1.8 mptt -73.87 -46.11 46.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.278 -0.889 . . . . 0.0 109.474 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.565 ' HB3' ' CD1' ' A' ' 28' ' ' TYR . 4.6 tt0 -44.05 -35.26 2.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.16 -0.963 . . . . 0.0 109.476 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.539 ' C ' ' CD1' ' A' ' 28' ' ' TYR . . . 114.57 55.03 0.39 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.57 ' CZ ' ' HG ' ' A' ' 121' ' ' LEU . 32.8 m-85 -143.22 135.03 26.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -1.152 . . . . 0.0 109.475 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -94.42 81.04 3.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.27 -0.894 . . . . 0.0 109.387 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.518 HG22 ' CB ' ' A' ' 23' ' ' PHE . 5.9 p -89.97 154.43 19.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.895 . . . . 0.0 109.556 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.515 ' HB2' ' CD2' ' A' ' 7' ' ' LEU . 6.8 m-85 -118.05 -171.5 2.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.299 -0.876 . . . . 0.0 109.341 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -130.5 146.94 52.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.897 . . . . 0.0 109.505 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -153.94 -172.56 4.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -0.92 . . . . 0.0 109.472 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.78 -88.01 0.1 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.219 -0.926 . . . . 0.0 109.495 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.516 ' ND2' ' HB2' ' A' ' 37' ' ' LEU . 21.5 p-10 -65.98 139.17 58.21 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.271 -0.893 . . . . 0.0 109.474 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.415 ' HA3' ' CD1' ' A' ' 65' ' ' ILE . . . -43.89 -34.53 2.98 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.516 ' HB2' ' ND2' ' A' ' 35' ' ' ASN . 3.2 mp -51.03 -53.15 36.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.195 -1.179 . . . . 0.0 109.44 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.506 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 2.7 tp60 -60.93 -51.31 69.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.246 -0.908 . . . . 0.0 109.436 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.525 ' O ' ' CG2' ' A' ' 43' ' ' VAL . . . -43.82 -39.67 3.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.251 -0.905 . . . . 0.0 109.558 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.403 HD22 ' HE1' ' A' ' 69' ' ' MET . 65.5 mt -71.95 -42.69 66.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.302 -0.873 . . . . 0.0 109.519 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -53.67 -57.81 9.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.255 -0.903 . . . . 0.0 109.491 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.519 HG22 ' CD2' ' A' ' 7' ' ' LEU . 2.0 mp -62.1 -33.16 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.145 -0.972 . . . . 0.0 109.478 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' A' ' 39' ' ' ALA . 48.1 t -66.35 -24.02 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -0.858 . . . . 0.0 109.467 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.4 m -90.07 -30.58 17.61 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.262 -0.899 . . . . 0.0 109.533 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.463 ' HG2' ' HA ' ' A' ' 42' ' ' ILE . 0.0 OUTLIER -90.06 -7.86 52.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.313 -0.867 . . . . 0.0 109.54 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.479 ' OE2' ' CE2' ' A' ' 31' ' ' PHE . 14.8 mt-10 -132.48 -36.75 1.09 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.925 . . . . 0.0 109.47 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 43' ' ' VAL . 0.8 OUTLIER 55.84 65.01 4.76 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.276 -0.89 . . . . 0.0 109.444 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.52 ' CB ' ' O ' ' A' ' 5' ' ' LYS . 35.4 Cg_endo -77.91 154.08 29.6 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.683 2.256 . . . . 0.0 110.394 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 3.5 m-20 -92.64 -13.33 29.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.259 -0.9 . . . . 0.0 109.462 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.424 ' HB3' HG22 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -120.73 116.87 26.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.213 -0.93 . . . . 0.0 109.46 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.513 HG13 ' CE ' ' A' ' 69' ' ' MET . 43.6 t -122.0 123.31 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 0.0 109.496 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.88 120.86 40.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.254 -0.903 . . . . 0.0 109.44 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.46 ' CD2' ' HG ' ' A' ' 66' ' ' LEU . 1.3 mp -108.61 122.21 46.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.256 -0.903 . . . . 0.0 109.506 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.431 ' OD2' ' OD1' ' A' ' 10' ' ' ASP . 33.3 t0 -97.26 111.33 23.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.361 -0.837 . . . . 0.0 109.427 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.433 ' HE1' HG23 ' A' ' 80' ' ' ILE . 18.8 mmt -75.03 -0.64 19.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.917 . . . . 0.0 109.576 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.4 mmmt -90.04 15.45 10.08 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.213 -0.93 . . . . 0.0 109.536 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.443 HG21 ' HD2' ' A' ' 58' ' ' PRO . 48.3 mt -76.53 132.45 72.43 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.941 . . . . 0.0 109.339 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.443 ' HD2' HG21 ' A' ' 57' ' ' ILE . 36.2 Cg_endo -78.93 74.74 5.39 Favored 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.478 2.119 . . . . 0.0 110.4 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -170.73 -63.94 0.04 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.509 ' N ' ' SD ' ' A' ' 60' ' ' MET . 0.1 OUTLIER -153.49 176.3 12.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -1.172 . . . . 0.0 109.566 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -90.08 135.59 33.56 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.197 -0.94 . . . . 0.0 109.487 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.416 ' O ' ' C ' ' A' ' 63' ' ' ILE . . . -72.43 -8.74 71.87 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.416 ' C ' ' O ' ' A' ' 62' ' ' GLY . 18.8 mm -44.02 -50.24 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.23 -1.159 . . . . 0.0 109.43 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.448 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 20.8 mm-40 -63.89 -43.94 94.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.214 -0.929 . . . . 0.0 109.405 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.456 ' HB ' HD22 ' A' ' 53' ' ' LEU . 78.3 mt -46.96 -50.9 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.315 -0.865 . . . . 0.0 109.444 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.584 ' CD2' ' CG1' ' A' ' 78' ' ' VAL . 61.8 mt -56.0 -53.51 56.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 109.416 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.473 ' O ' ' CG2' ' A' ' 71' ' ' VAL . 0.1 OUTLIER -44.13 -38.77 3.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.445 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -71.99 -41.03 68.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.32 -0.863 . . . . 0.0 109.495 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.513 ' CE ' HG13 ' A' ' 51' ' ' VAL . 1.2 mtt -58.52 -62.06 2.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.21 -0.931 . . . . 0.0 109.466 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.464 ' HD2' ' HA ' ' A' ' 67' ' ' LYS . 0.3 OUTLIER -52.13 -47.9 65.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.496 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.473 ' CG2' ' O ' ' A' ' 67' ' ' LYS . 53.9 t -48.43 -39.33 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.196 -0.94 . . . . 0.0 109.473 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 98.2 mt -70.38 -48.63 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 109.425 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.458 ' O ' HG23 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -152.97 111.98 3.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.22 -0.925 . . . . 0.0 109.5 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.54 -15.11 35.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.2 -0.938 . . . . 0.0 109.47 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -91.98 41.22 1.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.311 -0.868 . . . . 0.0 109.476 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.458 HG23 ' O ' ' A' ' 73' ' ' ASP . 2.2 tt -118.08 113.01 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.168 -0.958 . . . . 0.0 109.492 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.515 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -77.04 112.78 14.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.302 -0.874 . . . . 0.0 109.472 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.584 ' CG1' ' CD2' ' A' ' 66' ' ' LEU . 85.3 t -122.6 113.02 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.906 . . . . 0.0 109.491 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.52 ' CG2' ' N ' ' A' ' 80' ' ' ILE . 69.9 mt -89.93 165.73 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.237 -0.915 . . . . 0.0 109.52 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.57 HG13 ' CG ' ' A' ' 101' ' ' HIS . 0.1 OUTLIER -128.74 171.58 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.303 -0.873 . . . . 0.0 109.485 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.481 ' N ' ' CD2' ' A' ' 101' ' ' HIS . 22.5 mtm -146.74 107.73 4.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.877 . . . . 0.0 109.419 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.63 ' CG2' ' CE1' ' A' ' 101' ' ' HIS . 5.2 t -149.92 -161.85 1.43 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.245 -0.909 . . . . 0.0 109.465 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 82' ' ' THR . . . . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.221 -0.924 . . . . 0.0 109.509 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.52 ' CD1' ' CG2' ' A' ' 82' ' ' THR . 16.8 mt . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.448 ' O ' ' HG2' ' A' ' 94' ' ' LYS . 1.2 tt0 -63.3 -43.53 97.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.249 -0.907 . . . . 0.0 109.488 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.44 ' O ' HD21 ' A' ' 96' ' ' LEU . 3.9 mt-10 -76.19 -36.72 58.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.263 -0.898 . . . . 0.0 109.441 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.452 ' OG ' HD12 ' A' ' 80' ' ' ILE . 13.5 t -44.05 -61.91 1.31 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 109.425 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.52 ' HA ' ' CB ' ' A' ' 98' ' ' ALA . 0.1 OUTLIER -51.04 -48.6 61.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.296 -0.878 . . . . 0.0 109.537 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -44.1 -42.96 6.6 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.919 . . . . 0.0 109.424 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.534 ' N ' ' CD2' ' A' ' 96' ' ' LEU . 3.6 mm? -70.74 -54.06 13.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.212 -0.93 . . . . 0.0 109.512 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 177.27 63.65 0.06 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.52 ' CB ' ' HA ' ' A' ' 94' ' ' LYS . . . -146.94 107.64 4.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -1.153 . . . . 0.0 109.424 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.515 ' CD1' ' HB3' ' A' ' 77' ' ' ARG . 94.6 mt -44.09 -84.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.24 -0.912 . . . . 0.0 109.418 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.458 ' O ' HG21 ' A' ' 79' ' ' ILE . 11.4 t -127.83 178.74 5.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.462 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.63 ' CE1' ' CG2' ' A' ' 82' ' ' THR . 4.8 t-160 -130.65 96.76 4.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.262 -0.899 . . . . 0.0 109.573 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.409 ' CD2' HG22 ' A' ' 79' ' ' ILE . 79.7 m-85 -64.92 -166.79 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.255 -0.903 . . . . 0.0 109.319 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 82' ' ' THR . . . -161.14 -166.7 1.62 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.258 -0.901 . . . . 0.0 109.386 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.513 ' CG ' ' HA ' ' A' ' 105' ' ' PRO . 11.8 tttm -139.12 141.43 29.71 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.214 -0.929 . . . . 0.0 109.379 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.513 ' HA ' ' CG ' ' A' ' 104' ' ' LYS . 35.9 Cg_endo -77.95 139.88 58.93 Favored 'Cis proline' 0 C--N 1.311 -1.445 0 C-N-CA 123.415 -1.494 . . . . 0.0 110.417 -0.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.42 ' C ' ' CD1' ' A' ' 106' ' ' PHE . 13.2 p90 -106.42 175.93 5.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.872 . . . . 0.0 109.523 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.451 ' O ' HG12 ' A' ' 111' ' ' ILE . 41.4 t0 -113.29 127.71 56.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.174 -0.954 . . . . 0.0 109.427 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.458 HG21 HG12 ' A' ' 22' ' ' VAL . 15.2 mm -55.15 -18.7 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.273 -0.892 . . . . 0.0 109.52 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.421 ' OD2' ' OD2' ' A' ' 107' ' ' ASP . 15.9 m-20 -76.33 -46.98 25.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.19 -0.944 . . . . 0.0 109.402 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.55 -27.08 65.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.261 -0.899 . . . . 0.0 109.427 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 107' ' ' ASP . 15.9 mm -75.01 -52.48 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.223 -0.923 . . . . 0.0 109.493 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -67.36 -20.52 65.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.272 -0.892 . . . . 0.0 109.528 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -76.92 -51.43 11.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 109.553 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.5 -49.85 71.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.188 -0.945 . . . . 0.0 109.576 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.0 t -57.22 -49.9 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.263 -0.898 . . . . 0.0 109.487 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -27.82 69.0 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.222 -0.924 . . . . 0.0 109.565 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.07 -18.21 40.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 109.438 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -90.03 -70.9 0.64 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.244 -0.91 . . . . 0.0 109.436 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.512 ' CD1' ' HD2' ' A' ' 120' ' ' PRO . 5.5 tp -90.0 139.58 27.43 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.239 -0.913 . . . . 0.0 109.291 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.512 ' HD2' ' CD1' ' A' ' 119' ' ' LEU . 35.3 Cg_endo -78.25 138.67 16.15 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.571 2.181 . . . . 0.0 110.345 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.57 ' HG ' ' CZ ' ' A' ' 28' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.202 -0.936 . . . . 0.0 109.487 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.438 ' O ' ' CB ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -120.23 119.73 34.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.307 -0.87 . . . . 0.0 109.417 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.521 ' HB ' ' CG2' ' A' ' 30' ' ' THR . 15.0 mt -109.41 168.15 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.263 -0.898 . . . . 0.0 109.501 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.515 HD11 ' N ' ' A' ' 8' ' ' ILE . 0.4 OUTLIER -134.96 142.09 46.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.333 -0.854 . . . . 0.0 109.467 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.515 ' N ' HD11 ' A' ' 7' ' ' LEU . 2.9 mt -133.5 99.28 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.352 -0.843 . . . . 0.0 109.278 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.466 HG13 HD13 ' A' ' 57' ' ' ILE . 2.9 t -89.79 114.18 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.264 -0.898 . . . . 0.0 109.562 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.513 ' N ' ' OD1' ' A' ' 10' ' ' ASP . 0.4 OUTLIER -169.18 174.92 5.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.295 -0.878 . . . . 0.0 109.362 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.437 ' CG ' ' HD2' ' A' ' 58' ' ' PRO . 6.1 p-10 -142.54 -45.76 0.32 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.16 -0.963 . . . . 0.0 109.449 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.435 ' N ' ' CG ' ' A' ' 11' ' ' ASP . 5.5 tp60 -44.0 106.91 0.08 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.304 -0.872 . . . . 0.0 109.493 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.616 ' CE1' ' CD1' ' A' ' 17' ' ' ILE . 38.9 t80 -43.23 124.35 3.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.374 -0.829 . . . . 0.0 109.431 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 141.31 -75.98 0.32 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.498 HD12 ' CE ' ' A' ' 104' ' ' LYS . 1.7 mt -58.66 -32.42 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -1.169 . . . . 0.0 108.878 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.519 ' NH1' ' O ' ' A' ' 33' ' ' ALA . 9.1 mmm180 -60.34 -33.19 72.05 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.336 -0.852 . . . . 0.0 109.459 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.616 ' CD1' ' CE1' ' A' ' 13' ' ' TYR . 2.6 mt -90.7 -65.59 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.332 -0.855 . . . . 0.0 109.895 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.516 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 4.3 mt -42.45 -63.0 0.84 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.133 -0.979 . . . . 0.0 110.198 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.491 ' CD2' HG22 ' A' ' 8' ' ' ILE . 1.8 tp -51.98 -35.14 45.39 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.085 -1.009 . . . . 0.0 109.802 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.505 ' OD1' ' ND2' ' A' ' 24' ' ' ASN . 33.0 t30 -64.89 -70.43 0.23 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.211 -0.931 . . . . 0.0 110.163 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.46 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 1.0 OUTLIER -55.82 -16.49 4.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.143 -0.973 . . . . 0.0 110.152 -179.418 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.516 ' CG2' ' O ' ' A' ' 18' ' ' LEU . 53.5 t -75.57 -61.13 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.12 -0.987 . . . . 0.0 109.422 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.573 ' CZ ' HG23 ' A' ' 115' ' ' VAL . 17.0 m-85 -73.28 -8.51 56.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.272 -0.892 . . . . 0.0 109.407 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.505 ' ND2' ' OD1' ' A' ' 20' ' ' ASN . 1.3 m-80 -83.72 -54.84 4.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.914 . . . . 0.0 109.44 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.466 ' HG3' ' N ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -66.27 -22.08 66.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.244 -0.91 . . . . 0.0 109.406 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.466 ' N ' ' HG3' ' A' ' 25' ' ' LYS . 0.3 OUTLIER -78.83 -23.78 44.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.33 -0.856 . . . . 0.0 109.476 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.566 ' O ' ' CG ' ' A' ' 28' ' ' TYR . . . 110.48 64.33 0.52 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.566 ' CG ' ' O ' ' A' ' 27' ' ' GLY . 66.4 m-85 -158.88 135.26 9.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.202 -1.176 . . . . 0.0 109.607 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -89.91 85.01 6.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.254 -0.904 . . . . 0.0 108.959 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.548 ' CG2' ' CB ' ' A' ' 23' ' ' PHE . 5.2 p -89.87 137.8 32.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.276 -0.89 . . . . 0.0 109.895 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.514 ' HB2' ' CD2' ' A' ' 7' ' ' LEU . 14.5 m-85 -102.01 165.1 11.35 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.391 -0.818 . . . . 0.0 108.889 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.451 ' HG2' ' O ' ' A' ' 32' ' ' GLN . 0.2 OUTLIER -125.15 134.42 52.43 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.092 -1.005 . . . . 0.0 109.854 -179.757 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.527 ' HB3' ' CB ' ' A' ' 38' ' ' GLN . . . -140.35 -161.01 1.14 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.251 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.459 ' HB1' ' O ' ' A' ' 33' ' ' ALA . . . 171.23 -42.39 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.167 -0.958 . . . . 0.0 109.651 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -74.15 -1.33 19.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.208 -0.932 . . . . 0.0 109.611 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.19 -46.11 3.62 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.511 ' N ' HD21 ' A' ' 37' ' ' LEU . 3.4 mm? -63.15 -28.08 69.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.318 -1.107 . . . . 0.0 109.419 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.527 ' CB ' ' HB3' ' A' ' 33' ' ' ALA . 18.4 mm-40 -82.05 -36.14 28.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.284 -0.885 . . . . 0.0 109.375 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.81 -40.56 95.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.444 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.413 ' O ' ' C ' ' A' ' 41' ' ' ASP . 3.3 mt -78.32 -57.74 3.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.273 -0.892 . . . . 0.0 109.453 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 40' ' ' LEU . 5.9 t70 -44.45 -42.14 6.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.271 -0.893 . . . . 0.0 109.474 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.517 ' CD1' ' O ' ' A' ' 38' ' ' GLN . 15.3 mt -69.61 -47.0 73.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.279 -0.888 . . . . 0.0 109.357 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.527 ' HA ' ' CD ' ' A' ' 48' ' ' PRO . 73.2 t -55.73 -21.14 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.259 -0.901 . . . . 0.0 109.425 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.6 m -90.16 -33.66 16.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.283 -0.885 . . . . 0.0 109.446 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.456 ' HG2' ' HA ' ' A' ' 42' ' ' ILE . 0.0 OUTLIER -89.94 0.65 56.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 109.714 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.449 ' HG2' ' HD2' ' A' ' 45' ' ' LYS . 11.3 mm-40 -137.75 -38.6 0.58 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.157 -0.964 . . . . 0.0 109.442 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.504 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 2.6 mtt180 59.15 62.13 4.22 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.894 . . . . 0.0 109.519 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.527 ' CD ' ' HA ' ' A' ' 43' ' ' VAL . 35.4 Cg_endo -77.87 151.89 28.17 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.691 2.261 . . . . 0.0 110.407 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 1.2 m-20 -93.31 -11.98 31.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.209 -0.932 . . . . 0.0 109.513 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.461 HD22 ' HB2' ' A' ' 119' ' ' LEU . 4.3 mm? -118.8 125.7 50.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.199 -0.938 . . . . 0.0 109.476 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.526 ' CG1' ' HE2' ' A' ' 69' ' ' MET . 3.5 t -132.23 119.8 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.233 -0.917 . . . . 0.0 109.563 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.463 HD13 ' O ' ' A' ' 7' ' ' LEU . 1.1 mt -92.51 102.74 15.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.306 -0.871 . . . . 0.0 109.345 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.525 ' CD2' ' HG ' ' A' ' 66' ' ' LEU . 1.0 OUTLIER -89.91 128.49 36.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.176 -0.952 . . . . 0.0 109.643 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.459 ' HB2' ' HE3' ' A' ' 81' ' ' MET . 30.5 t0 -120.53 108.64 14.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.338 -0.851 . . . . 0.0 109.356 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.521 ' CG ' HG22 ' A' ' 82' ' ' THR . 12.7 mmt -71.78 -3.99 25.22 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.188 -0.945 . . . . 0.0 109.568 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.449 ' HB2' ' OD2' ' A' ' 54' ' ' ASP . 4.3 mttt -75.52 -7.87 55.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 109.625 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.511 ' CG2' ' SD ' ' A' ' 60' ' ' MET . 56.9 mt -57.06 116.52 13.7 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.095 -1.003 . . . . 0.0 109.318 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.437 ' HD2' ' CG ' ' A' ' 11' ' ' ASP . 35.6 Cg_endo -78.21 92.03 1.16 Allowed 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.297 1.998 . . . . 0.0 110.414 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 161.42 -23.5 0.23 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.511 ' SD ' ' CG2' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -170.48 161.19 7.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -1.172 . . . . 0.0 109.594 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -90.25 136.43 33.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.212 -0.93 . . . . 0.0 109.38 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.462 ' HA2' HG13 ' A' ' 65' ' ' ILE . . . -74.79 -8.91 82.72 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 30.6 mm -53.94 -55.22 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -1.149 . . . . 0.0 109.425 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 65' ' ' ILE . 24.9 mm-40 -53.14 -45.0 68.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.237 -0.914 . . . . 0.0 109.466 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.462 HG13 ' HA2' ' A' ' 62' ' ' GLY . 9.4 mt -44.81 -50.52 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.263 -0.898 . . . . 0.0 109.461 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.525 ' HG ' ' CD2' ' A' ' 53' ' ' LEU . 22.0 mt -54.66 -53.19 58.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.311 -0.868 . . . . 0.0 109.497 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 66' ' ' LEU . 4.7 mttt -43.65 -51.05 7.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.313 -0.867 . . . . 0.0 109.618 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.451 ' O ' HG13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -59.76 -41.2 90.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.162 -0.961 . . . . 0.0 109.486 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.526 ' HE2' ' CG1' ' A' ' 51' ' ' VAL . 4.6 mtt -60.32 -24.39 64.97 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.239 -0.913 . . . . 0.0 109.442 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 66' ' ' LEU . 1.8 mmpt? -80.03 -44.08 20.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.186 -0.946 . . . . 0.0 109.344 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.6 t -64.38 -24.47 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.217 -0.927 . . . . 0.0 109.451 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 68' ' ' ARG . 57.9 mt -90.05 -66.42 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.456 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -123.59 139.09 54.36 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.229 -0.919 . . . . 0.0 109.506 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -90.02 -25.05 21.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.274 -0.891 . . . . 0.0 109.455 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 49.2 m-20 -105.77 51.02 0.76 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.199 -0.938 . . . . 0.0 109.498 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.436 HG21 ' O ' ' A' ' 76' ' ' ILE . 3.0 tp -98.89 113.82 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.262 -0.899 . . . . 0.0 109.433 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.525 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 3.7 mtt180 -75.91 118.05 18.28 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.197 -0.939 . . . . 0.0 109.459 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.519 ' CG2' ' HB ' ' A' ' 51' ' ' VAL . 79.1 t -129.77 115.82 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.279 -0.888 . . . . 0.0 109.544 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 70.9 mt -89.87 125.69 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.281 -0.887 . . . . 0.0 109.396 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.577 HD11 ' CE1' ' A' ' 101' ' ' HIS . 0.6 OUTLIER -89.82 162.17 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.193 -0.942 . . . . 0.0 109.422 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.459 ' HE3' ' HB2' ' A' ' 54' ' ' ASP . 16.6 mtm -135.43 47.27 2.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.297 -0.877 . . . . 0.0 109.425 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.521 HG22 ' CG ' ' A' ' 55' ' ' MET . 9.9 t -159.71 66.64 0.38 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.31 -0.869 . . . . 0.0 109.469 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.446 ' HB1' ' HB1' ' A' ' 103' ' ' ALA . . . . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.241 -0.912 . . . . 0.0 109.437 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.594 ' CD1' ' N ' ' A' ' 90' ' ' ILE . 1.2 mp . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -47.65 -44.78 27.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.912 . . . . 0.0 109.411 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.453 ' HG3' ' N ' ' A' ' 93' ' ' SER . 19.3 pt-20 -70.2 -32.63 70.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -0.877 . . . . 0.0 109.429 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.514 ' O ' ' CB ' ' A' ' 98' ' ' ALA . 59.6 p -63.38 -30.59 71.69 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.236 -0.915 . . . . 0.0 109.471 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.5 OUTLIER -69.68 -71.84 0.22 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.911 . . . . 0.0 109.524 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.458 ' CG ' ' N ' ' A' ' 96' ' ' LEU . 9.4 pt-20 -43.81 -46.64 7.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.218 -0.926 . . . . 0.0 109.437 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.458 ' N ' ' CG ' ' A' ' 95' ' ' GLU . 24.5 mt -51.67 -57.33 9.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.181 -0.949 . . . . 0.0 109.441 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 165.53 44.89 0.02 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.514 ' CB ' ' O ' ' A' ' 93' ' ' SER . . . -113.92 98.6 7.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -1.115 . . . . 0.0 109.457 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.525 ' CD1' ' HB3' ' A' ' 77' ' ' ARG . 23.9 mt -46.63 -46.73 19.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.284 -0.885 . . . . 0.0 109.446 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.416 ' O ' HG21 ' A' ' 100' ' ' THR . 10.7 t -154.44 143.02 20.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.221 -0.924 . . . . 0.0 109.52 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.577 ' CE1' HD11 ' A' ' 80' ' ' ILE . 3.6 t-160 -107.93 87.71 2.56 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.252 -0.905 . . . . 0.0 109.487 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.508 ' O ' ' N ' ' A' ' 82' ' ' THR . 6.0 m-30 -80.55 179.12 7.9 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 0.0 109.57 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.446 ' HB1' ' HB1' ' A' ' 83' ' ' ALA . . . -137.82 -148.68 0.28 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.292 -0.88 . . . . 0.0 109.343 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.498 ' CE ' HD12 ' A' ' 15' ' ' ILE . 0.7 OUTLIER -137.85 145.75 49.65 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.291 -0.881 . . . . 0.0 109.452 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.458 ' HA ' ' HG3' ' A' ' 104' ' ' LYS . 35.3 Cg_endo -77.91 -176.69 19.21 Favored 'Cis proline' 0 C--N 1.308 -1.565 0 C-N-CA 123.289 -1.546 . . . . 0.0 110.333 0.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 106' ' ' PHE . 2.8 p90 -146.92 -163.69 1.82 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.281 -0.887 . . . . 0.0 109.494 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -135.46 132.55 37.54 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.273 -0.892 . . . . 0.0 109.503 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 14.4 mm -59.22 -21.59 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -0.926 . . . . 0.0 109.45 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.456 ' O ' ' HG2' ' A' ' 112' ' ' ARG . 34.8 m-20 -73.74 -44.73 55.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.34 -0.85 . . . . 0.0 109.474 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -64.68 -34.87 79.31 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.2 -0.938 . . . . 0.0 109.425 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.7 mm -66.33 -59.59 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.204 -0.935 . . . . 0.0 109.492 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.456 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 23.2 ptt180 -53.4 -32.05 47.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 109.529 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.44 ' OD2' ' O ' ' A' ' 109' ' ' ASP . 17.7 m-20 -64.64 -55.79 17.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.332 -0.855 . . . . 0.0 109.5 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.567 ' O ' ' CD2' ' A' ' 118' ' ' TYR . . . -55.33 -35.68 65.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.208 -0.933 . . . . 0.0 109.474 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.573 HG23 ' CZ ' ' A' ' 23' ' ' PHE . 77.9 t -72.08 -28.9 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.282 -0.886 . . . . 0.0 109.434 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.46 ' HE2' ' OE2' ' A' ' 26' ' ' GLU . 5.4 mmtm -72.12 -32.24 66.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.303 -0.873 . . . . 0.0 109.433 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -86.74 -24.44 25.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.926 . . . . 0.0 109.459 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.567 ' CD2' ' O ' ' A' ' 114' ' ' ALA . 18.6 m-85 -90.13 -66.18 0.95 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.226 -0.921 . . . . 0.0 109.48 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.461 ' HB2' HD22 ' A' ' 50' ' ' LEU . 31.5 tp -90.13 112.47 52.65 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.287 -0.883 . . . . 0.0 109.477 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 118' ' ' TYR . 35.3 Cg_endo -78.19 148.01 23.9 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.408 2.072 . . . . 0.0 110.314 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.542 HD11 ' CE2' ' A' ' 28' ' ' TYR . 1.2 tp . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.282 -0.886 . . . . 0.0 109.405 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.464 ' N ' ' OE1' ' A' ' 4' ' ' GLU . 1.5 mp0 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.497 ' CB ' ' HA ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -141.75 131.69 24.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.23 -0.918 . . . . 0.0 109.457 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.46 ' HB ' ' HA ' ' A' ' 30' ' ' THR . 91.5 mt -149.97 153.45 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.265 -0.897 . . . . 0.0 109.499 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.516 ' CD2' ' HB2' ' A' ' 31' ' ' PHE . 1.8 tm? -130.64 112.0 12.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.238 -0.914 . . . . 0.0 109.447 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.434 HD12 ' HB2' ' A' ' 19' ' ' LEU . 5.0 mt -89.98 106.33 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.278 -0.889 . . . . 0.0 109.545 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.482 ' CG2' HD11 ' A' ' 7' ' ' LEU . 3.1 t -95.02 113.32 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.219 -0.925 . . . . 0.0 109.5 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.503 ' O ' ' NH1' ' A' ' 16' ' ' ARG . 0.4 OUTLIER -162.93 150.44 13.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 0.0 109.415 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.457 ' OD2' ' HD2' ' A' ' 58' ' ' PRO . 7.4 p-10 -113.37 -37.28 4.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.244 -0.91 . . . . 0.0 109.454 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.405 ' O ' ' C ' ' A' ' 13' ' ' TYR . 20.1 tt0 -70.05 104.57 2.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.24 -0.913 . . . . 0.0 109.484 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.565 ' CZ ' HG13 ' A' ' 17' ' ' ILE . 26.2 t80 -44.13 149.93 0.32 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.294 -0.879 . . . . 0.0 109.496 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.61 -73.78 0.42 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.461 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 36.6 mt -61.21 -23.63 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -1.142 . . . . 0.0 109.365 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.503 ' NH1' ' O ' ' A' ' 10' ' ' ASP . 7.4 mmm-85 -69.75 -30.08 67.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.338 -0.851 . . . . 0.0 109.399 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.565 HG13 ' CZ ' ' A' ' 13' ' ' TYR . 9.2 mm -90.19 -25.18 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.376 -0.828 . . . . 0.0 109.534 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.522 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 1.3 mp -74.05 -53.21 10.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.209 -0.932 . . . . 0.0 109.567 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.495 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 12.3 mt -71.39 -17.11 62.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -0.918 . . . . 0.0 109.535 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.459 ' O ' ' ND2' ' A' ' 24' ' ' ASN . 47.9 t30 -79.77 -51.01 9.72 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.207 -0.933 . . . . 0.0 109.498 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -68.07 -40.06 82.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.211 -0.931 . . . . 0.0 109.463 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.526 HG23 ' CG2' ' A' ' 108' ' ' ILE . 15.1 t -67.18 -57.5 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.915 . . . . 0.0 109.403 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.56 ' CZ ' HG23 ' A' ' 115' ' ' VAL . 18.7 m-85 -65.46 -17.67 64.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.24 -0.912 . . . . 0.0 109.457 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.459 ' ND2' ' O ' ' A' ' 20' ' ' ASN . 0.7 OUTLIER -68.75 -63.14 1.12 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.427 179.936 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.58 -10.52 58.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.906 . . . . 0.0 109.402 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.453 ' HB2' ' HA ' ' A' ' 23' ' ' PHE . 1.7 mm-40 -76.34 -31.75 58.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.234 -0.917 . . . . 0.0 109.517 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.419 ' O ' ' HG2' ' A' ' 4' ' ' GLU . . . 107.2 33.38 3.21 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.64 ' CZ ' ' CD1' ' A' ' 121' ' ' LEU . 84.8 m-85 -123.51 139.34 54.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -1.164 . . . . 0.0 109.468 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -91.57 82.34 5.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.279 -0.888 . . . . 0.0 109.473 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.526 HG22 ' CB ' ' A' ' 23' ' ' PHE . 5.8 p -89.96 152.33 21.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.182 -0.949 . . . . 0.0 109.517 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.516 ' HB2' ' CD2' ' A' ' 7' ' ' LEU . 16.6 m-85 -119.51 -168.98 1.68 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.203 -0.935 . . . . 0.0 109.473 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -128.99 142.27 50.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.221 -0.925 . . . . 0.0 109.432 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.487 ' CB ' HD13 ' A' ' 7' ' ' LEU . . . -154.95 109.62 3.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.33 -0.856 . . . . 0.0 109.487 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.46 ' O ' HD11 ' A' ' 57' ' ' ILE . . . -69.45 -70.29 0.29 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.199 -0.938 . . . . 0.0 109.454 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.45 ' HA ' ' HE2' ' A' ' 60' ' ' MET . 22.5 p30 -77.56 178.03 7.58 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 0.0 109.514 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 37' ' ' LEU . . . -83.44 -41.97 8.13 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.418 ' C ' ' O ' ' A' ' 36' ' ' GLY . 0.3 OUTLIER -44.06 -56.53 3.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.192 -1.181 . . . . 0.0 109.453 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.474 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 7.5 tp-100 -57.17 -48.48 78.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 109.372 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.409 ' HB3' HG23 ' A' ' 9' ' ' VAL . . . -46.0 -68.21 0.21 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.278 -0.889 . . . . 0.0 109.464 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.404 ' HA ' HG22 ' A' ' 43' ' ' VAL . 2.2 mt -44.28 -41.06 5.67 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.288 -0.882 . . . . 0.0 109.529 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.64 -54.88 27.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.206 -0.934 . . . . 0.0 109.526 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.442 HG22 HD21 ' A' ' 7' ' ' LEU . 2.0 mp -63.87 -21.32 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.274 -0.891 . . . . 0.0 109.486 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.527 ' HA ' ' CD ' ' A' ' 48' ' ' PRO . 16.8 t -80.05 -22.11 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -0.903 . . . . 0.0 109.478 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.1 m -90.1 -28.53 18.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.915 . . . . 0.0 109.39 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -89.88 -27.76 19.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 0.0 109.448 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -113.83 -36.91 4.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.265 -0.897 . . . . 0.0 109.382 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 60.3 mtm180 57.54 69.16 1.68 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.896 . . . . 0.0 109.553 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.527 ' CD ' ' HA ' ' A' ' 43' ' ' VAL . 35.4 Cg_endo -77.91 176.03 10.49 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.685 2.257 . . . . 0.0 110.412 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 58.9 m-20 -114.7 -9.93 12.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.225 -0.922 . . . . 0.0 109.489 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.453 ' HB2' HG12 ' A' ' 6' ' ' ILE . 3.4 mm? -124.63 112.96 17.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 109.52 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.532 ' CG1' ' CE ' ' A' ' 69' ' ' MET . 24.7 t -114.0 119.2 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.171 -0.956 . . . . 0.0 109.422 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.417 HD11 ' HA ' ' A' ' 8' ' ' ILE . 1.3 mt -89.99 100.77 13.52 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.884 . . . . 0.0 109.456 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.1 mp -91.57 129.06 37.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.896 . . . . 0.0 109.516 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.455 ' OD2' ' OD1' ' A' ' 10' ' ' ASP . 57.0 t0 -117.94 103.59 10.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 109.42 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.449 ' HB2' HG23 ' A' ' 82' ' ' THR . 9.3 mmt -58.65 -15.72 12.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.319 -0.863 . . . . 0.0 109.504 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.467 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.1 OUTLIER -55.72 -35.69 66.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 109.414 179.959 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.535 HG22 HD11 ' A' ' 57' ' ' ILE . 46.0 mt -43.13 103.28 0.31 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.342 -0.849 . . . . 0.0 109.507 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 56' ' ' LYS . 35.4 Cg_endo -77.77 4.53 5.98 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.421 2.081 . . . . 0.0 110.415 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.94 -43.37 7.2 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.524 ' CE ' HG22 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -153.38 170.95 19.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -1.133 . . . . 0.0 109.452 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -88.97 134.27 34.03 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.215 -0.928 . . . . 0.0 109.474 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.4 ' HA2' HG12 ' A' ' 65' ' ' ILE . . . -81.73 -0.39 89.27 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.5 mm -61.4 -42.14 92.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.288 -1.125 . . . . 0.0 109.456 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -68.74 -18.91 64.31 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.405 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.428 HG21 ' HE1' ' A' ' 69' ' ' MET . 24.8 mm -69.94 -51.38 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.283 -0.886 . . . . 0.0 109.446 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.457 ' O ' ' HE3' ' A' ' 70' ' ' LYS . 29.8 mt -53.87 -30.65 46.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.291 -0.881 . . . . 0.0 109.441 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.459 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 0.6 OUTLIER -71.72 -63.25 1.16 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.233 -0.917 . . . . 0.0 109.5 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.461 ' O ' HG12 ' A' ' 72' ' ' ILE . 1.9 mtt85 -52.81 -20.67 3.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.216 -0.927 . . . . 0.0 109.41 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.532 ' CE ' ' CG1' ' A' ' 51' ' ' VAL . 1.3 mmt -75.39 -58.47 3.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.207 -0.933 . . . . 0.0 109.457 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 15.3 ptpt -62.35 -15.51 48.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.238 -0.914 . . . . 0.0 109.425 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 44.9 t -83.91 -42.69 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -0.881 . . . . 0.0 109.508 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 68' ' ' ARG . 19.0 mm -72.41 -56.27 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.274 -0.891 . . . . 0.0 109.506 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -129.72 132.55 46.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.204 -0.935 . . . . 0.0 109.493 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.61 15.38 9.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.241 -0.912 . . . . 0.0 109.513 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -129.99 37.05 3.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.322 -0.862 . . . . 0.0 109.44 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.516 HG13 ' N ' ' A' ' 77' ' ' ARG . 0.2 OUTLIER -112.34 142.32 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.279 -0.888 . . . . 0.0 109.373 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.522 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 37.9 mtt85 -103.87 158.55 16.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.291 -0.881 . . . . 0.0 109.436 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.46 ' CG2' ' C ' ' A' ' 77' ' ' ARG . 1.8 t -153.12 112.21 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.219 -0.925 . . . . 0.0 109.538 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.527 ' CG2' HG21 ' A' ' 100' ' ' THR . 95.7 mt -92.16 159.64 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.292 -0.88 . . . . 0.0 109.424 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.569 ' HB ' ' CG ' ' A' ' 101' ' ' HIS . 0.4 OUTLIER -114.64 119.11 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.212 -0.93 . . . . 0.0 109.414 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.449 ' HE2' HG22 ' A' ' 15' ' ' ILE . 4.6 mtm -101.0 68.42 1.26 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.191 -0.943 . . . . 0.0 109.515 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.449 HG23 ' HB2' ' A' ' 55' ' ' MET . 6.2 t 179.43 48.56 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.258 -0.901 . . . . 0.0 109.439 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.564 ' N ' ' NE2' ' A' ' 101' ' ' HIS . . . . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.261 -0.899 . . . . 0.0 109.512 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.576 HG12 ' CE1' ' A' ' 101' ' ' HIS . 48.0 mt . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.269 0.557 . . . . 0.0 109.529 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -47.6 -39.87 17.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.276 -0.89 . . . . 0.0 109.478 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.519 ' O ' ' CD1' ' A' ' 96' ' ' LEU . 0.2 OUTLIER -78.32 -33.37 49.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.24 -0.912 . . . . 0.0 109.522 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.48 ' O ' ' CB ' ' A' ' 98' ' ' ALA . 0.5 OUTLIER -59.89 -16.18 27.32 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.277 -0.889 . . . . 0.0 109.478 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.06 -76.68 0.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 0.0 109.456 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.444 ' HG3' ' N ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -58.09 -23.99 56.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.919 . . . . 0.0 109.507 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.519 ' CD1' ' O ' ' A' ' 92' ' ' GLU . 8.4 mt -67.6 -42.66 82.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.303 -0.873 . . . . 0.0 109.453 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 154.51 53.1 0.01 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.48 ' CB ' ' O ' ' A' ' 93' ' ' SER . . . -138.7 102.76 4.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.303 -1.116 . . . . 0.0 109.466 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.565 HD11 ' CD1' ' A' ' 118' ' ' TYR . 21.0 mt -45.48 -65.52 0.53 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.211 -0.931 . . . . 0.0 109.392 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.567 HG22 ' CE1' ' A' ' 102' ' ' PHE . 11.6 t -140.55 -174.91 4.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.294 -0.879 . . . . 0.0 109.457 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.576 ' CE1' HG12 ' A' ' 90' ' ' ILE . 3.3 t-160 -140.99 92.4 2.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.348 -0.845 . . . . 0.0 109.39 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.567 ' CE1' HG22 ' A' ' 100' ' ' THR . 60.0 m-85 -77.99 152.66 32.99 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.21 -0.931 . . . . 0.0 109.434 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.484 ' HB3' ' N ' ' A' ' 83' ' ' ALA . . . -140.25 -160.67 1.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.875 . . . . 0.0 109.462 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.527 ' CG ' ' HA ' ' A' ' 105' ' ' PRO . 9.5 tttm -89.37 141.83 29.25 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.231 -0.918 . . . . 0.0 109.31 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.527 ' HA ' ' CG ' ' A' ' 104' ' ' LYS . 36.0 Cg_endo -78.11 -176.51 18.85 Favored 'Cis proline' 0 C--N 1.31 -1.492 0 C-N-CA 123.406 -1.498 . . . . 0.0 110.486 -0.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.635 ' CE2' ' CD1' ' A' ' 111' ' ' ILE . 0.2 OUTLIER -114.75 106.3 14.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.196 -0.94 . . . . 0.0 109.524 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.46 ' O ' HG12 ' A' ' 111' ' ' ILE . 38.8 t0 -89.94 105.18 17.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -0.896 . . . . 0.0 109.318 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.526 ' CG2' HG23 ' A' ' 22' ' ' VAL . 13.6 mm -45.84 -25.02 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.195 -0.941 . . . . 0.0 109.61 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.456 ' HB2' ' OD2' ' A' ' 107' ' ' ASP . 79.1 m-20 -72.81 -46.37 53.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.127 -0.983 . . . . 0.0 109.518 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.5 -24.38 63.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.252 -0.905 . . . . 0.0 109.486 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.635 ' CD1' ' CE2' ' A' ' 106' ' ' PHE . 12.7 mm -75.23 -56.4 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.273 -0.892 . . . . 0.0 109.428 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.442 ' O ' ' HG3' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -60.22 -32.86 71.52 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.296 -0.877 . . . . 0.0 109.497 179.906 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -64.99 -55.0 21.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.33 -0.856 . . . . 0.0 109.447 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.571 ' O ' ' CD2' ' A' ' 118' ' ' TYR . . . -54.84 -42.56 72.12 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.197 -0.939 . . . . 0.0 109.474 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.56 HG23 ' CZ ' ' A' ' 23' ' ' PHE . 55.8 t -66.84 -28.58 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.19 -0.944 . . . . 0.0 109.442 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 0.5 OUTLIER -68.94 -48.94 62.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.272 -0.892 . . . . 0.0 109.457 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.13 -31.92 73.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.922 . . . . 0.0 109.54 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.571 ' CD2' ' O ' ' A' ' 114' ' ' ALA . 22.5 m-85 -73.64 -72.98 0.23 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.316 -0.865 . . . . 0.0 109.524 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.49 ' CD2' ' HD2' ' A' ' 120' ' ' PRO . 5.5 tt -88.08 137.84 31.1 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.26 -0.9 . . . . 0.0 109.251 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.49 ' HD2' ' CD2' ' A' ' 119' ' ' LEU . 35.9 Cg_endo -78.37 145.77 21.52 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.482 2.121 . . . . 0.0 110.427 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.64 ' CD1' ' CZ ' ' A' ' 28' ' ' TYR . 1.6 mt . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.892 . . . . 0.0 109.436 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.45 ' HB3' ' HB3' ' A' ' 48' ' ' PRO . 23.2 mttt -125.81 143.77 50.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 0.0 109.461 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.508 HG23 ' N ' ' A' ' 7' ' ' LEU . 70.0 mt -150.06 162.5 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -0.918 . . . . 0.0 109.464 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.508 ' N ' HG23 ' A' ' 6' ' ' ILE . 0.5 OUTLIER -131.81 122.62 26.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.163 -0.96 . . . . 0.0 109.404 -179.931 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.464 ' HA ' HD11 ' A' ' 52' ' ' LEU . 3.7 mt -100.75 109.06 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.238 -0.914 . . . . 0.0 109.426 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.513 HG13 ' CD1' ' A' ' 57' ' ' ILE . 2.6 t -103.95 95.87 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.3 -0.875 . . . . 0.0 109.41 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.463 ' O ' ' HD3' ' A' ' 16' ' ' ARG . 1.6 t70 -158.67 85.88 0.84 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 0.0 109.476 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.508 ' O ' ' N ' ' A' ' 13' ' ' TYR . 7.3 p-10 -51.25 -41.31 60.29 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.211 -0.931 . . . . 0.0 109.428 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.486 ' NE2' ' CD1' ' A' ' 15' ' ' ILE . 2.5 tt0 -44.11 95.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -0.896 . . . . 0.0 109.465 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.632 ' CE1' ' CD1' ' A' ' 17' ' ' ILE . 47.8 t80 -45.07 120.81 2.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.319 -0.863 . . . . 0.0 109.427 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.433 ' O ' HD21 ' A' ' 18' ' ' LEU . . . 144.97 -54.12 0.56 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.498 ' N ' ' CD1' ' A' ' 15' ' ' ILE . 1.8 mp -72.45 -50.17 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -1.162 . . . . 0.0 109.333 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.521 ' O ' ' CB ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -47.41 -31.59 4.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.229 -0.919 . . . . 0.0 109.5 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.632 ' CD1' ' CE1' ' A' ' 13' ' ' TYR . 1.7 mt -90.27 -29.14 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.222 -0.924 . . . . 0.0 109.497 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.521 ' CD1' HD13 ' A' ' 108' ' ' ILE . 0.4 OUTLIER -66.41 -62.33 1.52 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.203 -0.936 . . . . 0.0 109.498 -179.868 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.559 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 7.5 mt -68.1 -15.55 63.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.919 . . . . 0.0 109.044 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.521 ' CB ' ' O ' ' A' ' 16' ' ' ARG . 0.7 OUTLIER -72.07 -47.88 48.3 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.462 -0.774 . . . . 0.0 109.258 179.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.455 ' OE2' ' OD1' ' A' ' 20' ' ' ASN . 1.0 OUTLIER -73.27 -49.27 28.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.31 -0.869 . . . . 0.0 109.547 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.484 HG23 ' CG2' ' A' ' 108' ' ' ILE . 29.2 t -56.17 -47.81 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.272 -0.892 . . . . 0.0 109.542 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.559 ' CE2' ' HB3' ' A' ' 19' ' ' LEU . 19.7 m-85 -79.96 -13.63 59.2 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.186 -0.946 . . . . 0.0 109.559 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.489 ' ND2' ' O ' ' A' ' 20' ' ' ASN . 0.5 OUTLIER -71.71 -47.4 54.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -0.925 . . . . 0.0 109.368 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.5 tptt -85.0 -29.5 24.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -0.921 . . . . 0.0 109.39 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.421 ' HB3' ' CE2' ' A' ' 28' ' ' TYR . 0.2 OUTLIER -55.34 -43.17 74.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.251 -0.906 . . . . 0.0 109.459 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.52 44.14 0.4 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.421 ' CE2' ' HB3' ' A' ' 26' ' ' GLU . 96.6 m-85 -134.47 137.73 44.17 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.249 -1.148 . . . . 0.0 109.48 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -90.03 82.02 6.16 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 109.292 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.493 HG22 ' CB ' ' A' ' 23' ' ' PHE . 5.7 p -89.82 148.89 22.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.246 -0.909 . . . . 0.0 109.577 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.574 ' CZ ' ' OE1' ' A' ' 46' ' ' GLU . 5.8 m-85 -113.34 -171.13 1.82 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.237 -0.914 . . . . 0.0 109.44 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.403 ' NE2' ' HB3' ' A' ' 16' ' ' ARG . 37.7 mt-30 -124.16 150.58 44.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.255 -0.903 . . . . 0.0 109.608 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.447 ' O ' ' HB1' ' A' ' 34' ' ' ALA . . . -175.45 174.14 2.36 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.289 -0.882 . . . . 0.0 109.375 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.464 ' HA ' HD12 ' A' ' 57' ' ' ILE . . . 178.61 -31.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.298 -0.876 . . . . 0.0 109.555 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.502 ' OD1' ' CB ' ' A' ' 37' ' ' LEU . 8.0 p30 -74.14 -3.2 28.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.18 -0.95 . . . . 0.0 109.606 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.03 -45.08 3.46 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.502 ' CB ' ' OD1' ' A' ' 35' ' ' ASN . 0.2 OUTLIER -57.82 -50.0 74.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.286 -1.126 . . . . 0.0 109.519 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.521 ' O ' ' CG1' ' A' ' 42' ' ' ILE . 8.3 mt-30 -65.42 -23.97 67.08 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.178 -0.951 . . . . 0.0 109.519 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.59 -52.93 32.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.231 -0.918 . . . . 0.0 109.507 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.507 ' CD2' ' HB3' ' A' ' 68' ' ' ARG . 16.0 mt -70.79 -58.41 3.65 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.178 -0.952 . . . . 0.0 109.602 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -46.91 -49.23 20.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.292 -0.88 . . . . 0.0 109.628 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.521 ' CG1' ' O ' ' A' ' 38' ' ' GLN . 89.3 mt -62.55 -35.15 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.908 . . . . 0.0 109.446 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 49.0 t -75.22 -14.72 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.276 -0.89 . . . . 0.0 109.52 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.7 m -90.2 -28.87 18.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.186 -0.946 . . . . 0.0 109.561 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.1 mttm -85.96 -41.51 14.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.224 -0.923 . . . . 0.0 109.687 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.574 ' OE1' ' CZ ' ' A' ' 31' ' ' PHE . 4.8 mt-10 -102.08 -37.88 7.98 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.194 -0.941 . . . . 0.0 109.601 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 5.7 mtt180 61.31 67.26 1.43 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.279 -0.888 . . . . 0.0 109.499 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.45 ' HB3' ' HB3' ' A' ' 5' ' ' LYS . 35.4 Cg_endo -77.78 165.67 26.38 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.647 2.231 . . . . 0.0 110.427 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.512 ' O ' ' CD2' ' A' ' 50' ' ' LEU . 8.3 m-20 -107.62 11.08 28.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.337 -0.852 . . . . 0.0 109.548 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.512 ' CD2' ' O ' ' A' ' 49' ' ' ASP . 1.3 mm? -140.37 128.69 22.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 109.506 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.429 HG22 ' CG1' ' A' ' 76' ' ' ILE . 3.9 t -129.42 151.1 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.25 -0.906 . . . . 0.0 109.509 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.464 HD11 ' HA ' ' A' ' 8' ' ' ILE . 1.3 mt -121.14 97.65 5.62 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.197 -0.939 . . . . 0.0 109.364 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.521 ' CD2' ' HG ' ' A' ' 66' ' ' LEU . 2.0 mp -89.92 128.45 36.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.316 -0.865 . . . . 0.0 109.647 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.463 ' O ' HG13 ' A' ' 57' ' ' ILE . 44.3 t0 -119.44 115.38 23.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.285 -0.884 . . . . 0.0 109.405 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.541 ' CG ' ' CG2' ' A' ' 82' ' ' THR . 17.1 mmt -67.72 -8.05 32.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.259 -0.901 . . . . 0.0 109.577 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.44 ' HB2' ' OD2' ' A' ' 54' ' ' ASP . 16.7 mmtp -76.66 1.14 17.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -0.896 . . . . 0.0 109.633 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.52 HG23 ' CE ' ' A' ' 60' ' ' MET . 34.0 mt -75.32 118.27 69.47 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.11 -0.994 . . . . 0.0 109.382 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.424 ' HD2' ' CG ' ' A' ' 11' ' ' ASP . 35.7 Cg_endo -77.97 143.34 20.5 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.395 2.063 . . . . 0.0 110.469 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 121.66 -54.44 0.68 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.52 ' CE ' HG23 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -155.56 175.18 14.22 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.183 -1.187 . . . . 0.0 109.509 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -89.9 169.09 11.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.265 -0.897 . . . . 0.0 109.477 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.521 ' HA2' ' CD1' ' A' ' 65' ' ' ILE . . . -97.79 -7.02 56.92 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.2 mm -54.28 -64.82 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.155 -1.203 . . . . 0.0 109.495 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -47.92 -35.7 11.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.237 -0.914 . . . . 0.0 109.467 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.521 ' CD1' ' HA2' ' A' ' 62' ' ' GLY . 16.0 mt -53.97 -57.19 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.226 -0.921 . . . . 0.0 109.506 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.521 ' HG ' ' CD2' ' A' ' 53' ' ' LEU . 31.3 mt -52.51 -26.21 12.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.27 -0.894 . . . . 0.0 109.634 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.523 ' O ' ' CG2' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -73.76 -37.37 65.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.211 -0.93 . . . . 0.0 109.793 -179.801 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.507 ' HB3' ' CD2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -73.15 -50.73 21.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.19 -0.944 . . . . 0.0 109.731 -179.792 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.499 ' SD ' ' CD2' ' A' ' 66' ' ' LEU . 3.9 ptp -64.43 -35.81 82.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.198 -0.939 . . . . 0.0 109.759 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.49 ' HG3' ' N ' ' A' ' 71' ' ' VAL . 15.1 ptpt -71.4 -34.8 70.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.206 -0.934 . . . . 0.0 109.437 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.523 ' CG2' ' O ' ' A' ' 67' ' ' LYS . 71.7 t -70.12 -31.02 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.193 -0.942 . . . . 0.0 109.493 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 68' ' ' ARG . 10.4 mt -90.0 -17.85 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.214 -0.929 . . . . 0.0 109.468 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -166.46 122.9 1.27 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.299 -0.876 . . . . 0.0 109.448 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -89.9 -11.51 41.63 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.187 -0.945 . . . . 0.0 109.439 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -92.97 44.49 1.15 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.302 -0.874 . . . . 0.0 109.5 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.458 HG22 ' O ' ' A' ' 76' ' ' ILE . 0.5 OUTLIER -121.89 120.03 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 109.44 -179.947 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.526 ' CD ' HD12 ' A' ' 99' ' ' LEU . 9.8 mtt180 -84.65 143.3 29.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.346 -0.846 . . . . 0.0 109.518 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.519 ' CG1' HD23 ' A' ' 53' ' ' LEU . 53.5 t -138.2 124.77 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.235 -0.915 . . . . 0.0 109.534 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 70.6 mt -101.74 156.62 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.224 -0.923 . . . . 0.0 109.4 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.575 ' HB ' ' CG ' ' A' ' 101' ' ' HIS . 0.6 OUTLIER -114.94 115.25 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -0.929 . . . . 0.0 109.39 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.498 ' SD ' ' CZ ' ' A' ' 106' ' ' PHE . 4.3 mtm -95.97 58.75 1.92 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.226 -0.921 . . . . 0.0 109.506 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.541 ' CG2' ' CG ' ' A' ' 55' ' ' MET . 12.5 t -169.04 49.28 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.239 -0.913 . . . . 0.0 109.479 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.543 ' N ' ' NE2' ' A' ' 101' ' ' HIS . . . . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.22 -0.925 . . . . 0.0 109.502 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.565 HD12 ' CE1' ' A' ' 101' ' ' HIS . 48.8 mt . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -53.87 -39.57 65.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.34 -0.85 . . . . 0.0 109.494 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.452 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 1.1 tp10 -78.96 -24.78 43.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.295 -0.878 . . . . 0.0 109.432 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.458 ' O ' ' HB1' ' A' ' 98' ' ' ALA . 3.7 m -72.22 -28.34 63.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.298 -0.876 . . . . 0.0 109.474 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.452 ' HA ' ' HB2' ' A' ' 98' ' ' ALA . 5.8 mtpp -68.2 -67.42 0.47 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.268 -0.895 . . . . 0.0 109.464 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 94' ' ' LYS . 1.7 pt-20 -44.08 -26.74 0.32 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.355 -0.841 . . . . 0.0 109.554 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 92' ' ' GLU . 65.9 mt -73.82 -52.36 13.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.33 -0.856 . . . . 0.0 109.533 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 169.18 36.1 0.02 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 78' ' ' VAL . . . -104.39 103.35 13.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.247 -1.149 . . . . 0.0 109.437 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.577 HD11 ' CG ' ' A' ' 118' ' ' TYR . 17.0 mt -53.08 -55.42 24.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.237 -0.914 . . . . 0.0 109.472 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.559 HG22 ' CE1' ' A' ' 102' ' ' PHE . 7.0 t -149.25 177.65 9.46 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.288 -0.883 . . . . 0.0 109.469 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.575 ' CG ' ' HB ' ' A' ' 80' ' ' ILE . 3.4 t-160 -132.1 90.14 2.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 0.0 109.431 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.559 ' CE1' HG22 ' A' ' 100' ' ' THR . 43.0 m-85 -77.57 160.75 28.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.221 -0.924 . . . . 0.0 109.485 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.524 ' HB1' ' CB ' ' A' ' 83' ' ' ALA . . . -145.44 -148.62 0.25 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.315 -0.865 . . . . 0.0 109.334 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.03 146.65 32.95 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.205 -0.934 . . . . 0.0 109.447 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.85 173.8 55.36 Favored 'Cis proline' 0 C--N 1.31 -1.466 0 C-N-CA 123.229 -1.571 . . . . 0.0 110.365 0.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.638 ' CZ ' ' CD1' ' A' ' 111' ' ' ILE . 0.3 OUTLIER -102.84 104.58 14.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.317 -0.864 . . . . 0.0 109.531 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.461 ' O ' HG12 ' A' ' 111' ' ' ILE . 63.3 t0 -89.95 109.74 20.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.278 -0.889 . . . . 0.0 109.331 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.521 HD13 ' CD1' ' A' ' 18' ' ' LEU . 14.8 mm -47.92 -23.65 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 109.55 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.429 ' O ' ' OD2' ' A' ' 113' ' ' ASP . 37.3 m-20 -76.39 -43.37 40.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.212 -0.93 . . . . 0.0 109.516 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.4 ' HB2' ' HB3' ' A' ' 107' ' ' ASP . 1.4 tt0 -69.64 -25.76 64.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.282 -0.886 . . . . 0.0 109.491 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.638 ' CD1' ' CZ ' ' A' ' 106' ' ' PHE . 13.4 mm -75.35 -57.9 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.211 -0.931 . . . . 0.0 109.493 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.464 ' HG2' ' O ' ' A' ' 108' ' ' ILE . 1.4 ptt85 -61.27 -28.07 68.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.302 -0.874 . . . . 0.0 109.585 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.429 ' OD2' ' O ' ' A' ' 109' ' ' ASP . 53.6 m-20 -68.28 -56.27 9.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.242 -0.911 . . . . 0.0 109.416 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.34 -53.69 54.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.213 -0.93 . . . . 0.0 109.531 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.1 t -52.68 -39.92 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.232 -0.918 . . . . 0.0 109.502 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 0.6 OUTLIER -65.22 -33.56 76.29 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.327 -0.858 . . . . 0.0 109.554 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.23 -20.56 51.51 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.22 -0.925 . . . . 0.0 109.487 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.577 ' CG ' HD11 ' A' ' 99' ' ' LEU . 38.2 m-85 -89.68 -71.22 0.62 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.249 -0.907 . . . . 0.0 109.471 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.436 ' HB2' HD22 ' A' ' 50' ' ' LEU . 49.2 tp -90.05 112.49 52.68 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.248 -0.908 . . . . 0.0 109.37 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 118' ' ' TYR . 35.6 Cg_endo -77.9 132.63 11.93 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.34 2.027 . . . . 0.0 110.424 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.428 HD22 ' HA ' ' A' ' 121' ' ' LEU . 4.1 mt . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.292 -0.88 . . . . 0.0 109.455 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.515 ' HG3' ' CD2' ' A' ' 119' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.458 ' HB3' ' HB3' ' A' ' 48' ' ' PRO . 3.9 mtpt -94.52 139.16 31.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.22 -0.925 . . . . 0.0 109.466 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.575 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 84.4 mt -150.07 153.73 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.252 -0.905 . . . . 0.0 109.498 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.582 ' CD1' ' CG2' ' A' ' 42' ' ' ILE . 0.6 OUTLIER -136.48 150.5 48.72 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.283 -0.885 . . . . 0.0 109.438 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.523 HG12 ' CD1' ' A' ' 52' ' ' LEU . 7.8 mt -129.43 122.05 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -0.892 . . . . 0.0 109.407 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 3.3 t -106.42 122.21 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.253 -0.904 . . . . 0.0 109.58 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.454 ' O ' HD12 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -145.86 -151.71 0.39 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.246 -0.909 . . . . 0.0 109.408 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.441 ' HB3' HG12 ' A' ' 57' ' ' ILE . 6.3 p-10 -161.65 -46.69 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.267 -0.895 . . . . 0.0 109.449 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.4 tp60 -82.71 116.6 22.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.316 -0.865 . . . . 0.0 109.486 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.575 ' CZ ' HG13 ' A' ' 17' ' ' ILE . 8.5 t80 -43.91 143.33 1.11 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.243 -0.91 . . . . 0.0 109.434 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.476 ' N ' ' CD1' ' A' ' 13' ' ' TYR . . . 126.96 -46.48 1.08 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.526 HG21 ' CD1' ' A' ' 19' ' ' LEU . 2.2 mt -84.69 -45.86 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.293 -1.122 . . . . 0.0 109.35 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.575 ' NH2' ' CB ' ' A' ' 34' ' ' ALA . 1.5 mtp180 -58.25 -29.44 65.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.308 -0.87 . . . . 0.0 109.395 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.575 HG13 ' CZ ' ' A' ' 13' ' ' TYR . 3.1 mm -90.47 -59.56 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -0.894 . . . . 0.0 109.657 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 14' ' ' GLY . 87.0 mt -46.74 -58.48 3.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.91 . . . . 0.0 109.806 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.526 ' CD1' HG21 ' A' ' 15' ' ' ILE . 6.3 mp -55.02 -32.49 61.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.188 -0.945 . . . . 0.0 109.689 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.508 ' OD1' ' ND2' ' A' ' 24' ' ' ASN . 17.6 t30 -65.69 -70.82 0.22 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.913 . . . . 0.0 109.723 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.458 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 0.1 OUTLIER -43.28 -40.24 3.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.185 -0.947 . . . . 0.0 109.745 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.412 HG23 HG22 ' A' ' 108' ' ' ILE . 59.8 t -57.58 -58.41 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.913 . . . . 0.0 109.51 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.577 ' CB ' ' CG2' ' A' ' 30' ' ' THR . 38.0 m-85 -76.18 0.67 18.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.165 -0.959 . . . . 0.0 109.633 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.508 ' ND2' ' OD1' ' A' ' 20' ' ' ASN . 0.4 OUTLIER -89.01 -38.88 14.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.078 -1.014 . . . . 0.0 109.535 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.8 tptt -85.55 -44.13 12.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 109.42 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.461 ' HB3' ' CD2' ' A' ' 28' ' ' TYR . 0.4 OUTLIER -55.07 -21.4 12.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.179 -0.95 . . . . 0.0 109.391 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.473 ' O ' ' CG ' ' A' ' 28' ' ' TYR . . . 101.38 72.26 0.96 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.574 ' CE1' HD12 ' A' ' 121' ' ' LEU . 97.9 m-85 -156.66 134.29 10.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.293 -1.122 . . . . 0.0 109.58 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -90.96 82.81 5.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.342 -0.849 . . . . 0.0 109.182 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.577 ' CG2' ' CB ' ' A' ' 23' ' ' PHE . 7.4 p -89.9 173.22 8.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -0.897 . . . . 0.0 109.657 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.575 ' CD2' ' O ' ' A' ' 6' ' ' ILE . 11.7 m-85 -130.21 170.06 14.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.317 -0.864 . . . . 0.0 109.394 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.423 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 0.5 OUTLIER -131.41 135.82 47.5 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.2 -0.938 . . . . 0.0 109.682 -179.874 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.52 ' HB2' ' NE2' ' A' ' 38' ' ' GLN . . . -155.91 130.56 9.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.393 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.575 ' CB ' ' NH2' ' A' ' 16' ' ' ARG . . . -82.32 -70.71 0.53 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.156 -0.965 . . . . 0.0 109.483 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.469 ' OD1' ' N ' ' A' ' 35' ' ' ASN . 18.8 p-10 -60.54 170.94 1.23 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.223 -0.923 . . . . 0.0 109.577 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -97.84 -17.73 29.53 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.9 tt -73.99 -43.59 57.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.314 -1.109 . . . . 0.0 109.401 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.52 ' NE2' ' HB2' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -77.59 -35.04 53.35 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.19 -0.944 . . . . 0.0 108.893 179.77 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.466 ' HB3' ' HB2' ' A' ' 33' ' ' ALA . . . -62.57 -46.34 88.79 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.278 -0.889 . . . . 0.0 108.626 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.448 HD13 HG22 ' A' ' 65' ' ' ILE . 7.2 mt -61.54 -45.36 94.51 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -49.68 -43.76 47.5 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.203 -0.936 . . . . 0.0 108.856 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.582 ' CG2' ' CD1' ' A' ' 7' ' ' LEU . 64.0 mt -64.57 -36.23 76.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.336 -0.853 . . . . 0.0 108.881 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 69.0 t -74.5 -11.87 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.251 -0.905 . . . . 0.0 109.188 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 82.9 m -90.38 -31.5 16.84 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.201 -0.937 . . . . 0.0 109.412 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.22 -53.2 4.67 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.32 -0.862 . . . . 0.0 109.867 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.571 ' O ' ' C ' ' A' ' 47' ' ' ARG . 0.4 OUTLIER -97.17 26.93 4.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.183 -0.948 . . . . 0.0 109.627 -179.667 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.571 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -9.69 78.55 0.03 OUTLIER Pre-proline 0 N--CA 1.504 2.266 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.534 ' N ' ' O ' ' A' ' 46' ' ' GLU . 34.3 Cg_endo -75.88 162.66 34.56 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.684 2.256 . . . . 0.0 110.284 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 4.6 m-20 -92.49 -14.12 28.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 109.657 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.51 ' CB ' HG12 ' A' ' 6' ' ' ILE . 4.5 tp -114.16 126.33 54.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.215 -0.928 . . . . 0.0 109.554 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.497 ' CG1' ' HE2' ' A' ' 69' ' ' MET . 6.0 t -136.83 123.83 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.284 -0.885 . . . . 0.0 109.378 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.523 ' CD1' HG12 ' A' ' 8' ' ' ILE . 1.1 mt -103.11 134.78 45.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.212 -0.93 . . . . 0.0 109.584 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.485 ' CD2' ' HG ' ' A' ' 66' ' ' LEU . 1.4 mp -124.4 135.13 53.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.264 -0.898 . . . . 0.0 109.466 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.464 ' O ' HG13 ' A' ' 57' ' ' ILE . 31.1 t0 -123.61 103.96 8.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.215 -0.928 . . . . 0.0 109.484 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.519 ' CG ' HG23 ' A' ' 82' ' ' THR . 19.2 mmt -62.69 -19.06 63.5 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.17 -0.957 . . . . 0.0 109.463 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.464 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 1.1 mmmp? -54.89 -25.19 27.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 0.0 109.45 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 54' ' ' ASP . 9.8 mt -43.06 103.21 0.3 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.27 -0.893 . . . . 0.0 109.501 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 56' ' ' LYS . 35.2 Cg_endo -77.52 97.73 1.16 Allowed 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.437 2.092 . . . . 0.0 110.464 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 155.62 -20.43 0.53 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.432 ' HE1' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -166.59 150.93 7.43 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.278 -1.131 . . . . 0.0 109.475 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.408 ' O ' ' SD ' ' A' ' 60' ' ' MET . 1.1 m-20 -85.04 144.0 28.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.186 -0.946 . . . . 0.0 109.57 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -96.56 12.48 66.22 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.2 mm -69.36 -39.43 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.245 -1.15 . . . . 0.0 109.451 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -68.11 -34.65 76.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.262 -0.899 . . . . 0.0 109.494 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.448 HG22 HD13 ' A' ' 40' ' ' LEU . 9.3 mt -54.14 -63.95 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.923 . . . . 0.0 109.492 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.485 ' HG ' ' CD2' ' A' ' 53' ' ' LEU . 21.0 mt -46.63 -49.97 18.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.203 -0.936 . . . . 0.0 109.429 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 66' ' ' LEU . 2.5 ttmm -44.09 -50.51 8.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.182 -0.949 . . . . 0.0 109.508 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.443 ' O ' HG13 ' A' ' 72' ' ' ILE . 2.4 mpt_? -60.62 -39.25 87.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.926 . . . . 0.0 109.457 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.497 ' HE2' ' CG1' ' A' ' 51' ' ' VAL . 0.7 OUTLIER -61.79 -23.74 66.41 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -0.894 . . . . 0.0 109.438 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.518 ' CE ' ' HB3' ' A' ' 96' ' ' LEU . 21.8 mmtm -81.15 -45.29 16.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.3 -0.875 . . . . 0.0 109.473 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.6 t -65.1 -22.64 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.278 -0.889 . . . . 0.0 109.473 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 68' ' ' ARG . 78.8 mt -88.71 -41.89 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.258 -0.901 . . . . 0.0 109.415 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.82 130.95 11.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.19 -0.944 . . . . 0.0 109.469 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -90.02 -12.55 38.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.2 -0.937 . . . . 0.0 109.465 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.405 ' OD1' ' N ' ' A' ' 75' ' ' ASN . 1.8 m120 -116.58 55.5 0.82 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.409 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.0 tp -110.93 145.78 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.328 -0.858 . . . . 0.0 109.411 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.516 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 2.3 mtm180 -89.19 115.02 26.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.195 -0.941 . . . . 0.0 109.483 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.465 ' N ' HD13 ' A' ' 99' ' ' LEU . 16.9 t -131.1 115.83 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.221 -0.925 . . . . 0.0 109.531 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.429 HG12 HG21 ' A' ' 100' ' ' THR . 43.9 mt -100.38 132.59 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.309 -0.87 . . . . 0.0 109.445 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.572 HD11 ' CE1' ' A' ' 101' ' ' HIS . 1.0 OUTLIER -89.88 172.97 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.177 -0.952 . . . . 0.0 109.364 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.461 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 13.7 mtm -147.46 52.18 1.06 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.161 -0.962 . . . . 0.0 109.565 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.519 HG23 ' CG ' ' A' ' 55' ' ' MET . 14.7 t -162.68 40.66 0.11 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.185 -0.947 . . . . 0.0 109.519 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.633 ' CB ' ' CD2' ' A' ' 101' ' ' HIS . . . . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.278 -0.889 . . . . 0.0 109.483 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.422 ' O ' ' HB2' ' A' ' 93' ' ' SER . 57.9 mt . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.436 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 1.1 tp60 -44.32 -62.95 0.99 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -0.897 . . . . 0.0 109.452 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.458 ' O ' HD21 ' A' ' 96' ' ' LEU . 0.3 OUTLIER -60.84 -38.62 86.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.916 . . . . 0.0 109.512 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.456 ' HB3' ' HB3' ' A' ' 98' ' ' ALA . 0.6 OUTLIER -44.0 -26.67 0.3 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.209 -0.932 . . . . 0.0 109.429 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 91' ' ' GLN . 0.0 OUTLIER -53.08 -62.12 1.86 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.175 -0.953 . . . . 0.0 109.457 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.474 ' HG3' ' CD2' ' A' ' 96' ' ' LEU . 1.2 pt-20 -63.19 -35.02 78.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.187 -0.946 . . . . 0.0 109.509 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.528 ' N ' ' CD2' ' A' ' 96' ' ' LEU . 3.7 mm? -61.33 -24.84 66.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.221 -0.924 . . . . 0.0 109.511 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 130.13 42.33 0.22 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.456 ' HB3' ' HB3' ' A' ' 93' ' ' SER . . . -113.44 110.65 20.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -1.149 . . . . 0.0 109.466 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.534 ' HB3' ' CZ ' ' A' ' 118' ' ' TYR . 3.6 mt -73.25 -72.25 0.27 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.186 -0.946 . . . . 0.0 109.577 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.48 HG22 ' CE2' ' A' ' 102' ' ' PHE . 12.7 t -130.46 147.51 52.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.225 -0.922 . . . . 0.0 109.495 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.633 ' CD2' ' CB ' ' A' ' 83' ' ' ALA . 3.6 t-160 -111.21 89.54 3.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.295 -0.878 . . . . 0.0 109.339 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.483 ' O ' ' N ' ' A' ' 82' ' ' THR . 35.5 m-85 -68.96 153.34 43.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.226 -0.921 . . . . 0.0 109.531 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.462 ' CB ' ' C ' ' A' ' 83' ' ' ALA . . . -139.52 151.97 46.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.239 -0.913 . . . . 0.0 109.472 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.53 ' CG ' ' HA ' ' A' ' 105' ' ' PRO . 36.1 tttm -85.3 141.63 37.21 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 0.0 109.353 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.53 ' HA ' ' CG ' ' A' ' 104' ' ' LYS . 35.8 Cg_endo -77.96 137.39 46.59 Favored 'Cis proline' 0 C--N 1.31 -1.456 0 C-N-CA 123.39 -1.504 . . . . 0.0 110.367 0.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -114.54 -170.01 1.65 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.238 -0.914 . . . . 0.0 109.489 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -130.05 121.08 25.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.0 109.413 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.412 HG22 HG23 ' A' ' 22' ' ' VAL . 20.5 mm -50.11 -30.44 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.207 -0.933 . . . . 0.0 109.52 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.403 ' HA ' ' HD3' ' A' ' 112' ' ' ARG . 33.4 m-20 -66.6 -42.4 86.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.216 -0.928 . . . . 0.0 109.433 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.413 ' HB3' ' CE1' ' A' ' 102' ' ' PHE . 4.0 mt-10 -65.69 -35.18 80.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.289 -0.882 . . . . 0.0 109.467 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.479 HD11 ' CD2' ' A' ' 102' ' ' PHE . 22.1 mm -64.9 -60.36 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.295 -0.878 . . . . 0.0 109.496 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.403 ' HD3' ' HA ' ' A' ' 109' ' ' ASP . 1.1 ptm180 -56.81 -30.38 63.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 0.0 109.482 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -62.99 -54.92 30.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -0.895 . . . . 0.0 109.477 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.562 ' O ' ' CD2' ' A' ' 118' ' ' TYR . . . -60.01 -32.84 71.25 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.163 -0.96 . . . . 0.0 109.474 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.436 HG23 ' CZ ' ' A' ' 23' ' ' PHE . 58.2 t -67.42 -35.0 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.23 -0.919 . . . . 0.0 109.473 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.407 ' HE2' ' OE2' ' A' ' 26' ' ' GLU . 1.9 mttt -75.48 -30.05 59.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.279 -0.888 . . . . 0.0 109.499 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.68 -34.08 62.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.219 -0.926 . . . . 0.0 109.46 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.562 ' CD2' ' O ' ' A' ' 114' ' ' ALA . 46.6 m-85 -89.92 -65.59 1.0 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.294 -0.879 . . . . 0.0 109.466 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.515 ' CD2' ' HG3' ' A' ' 4' ' ' GLU . 2.8 tt -90.01 112.42 52.24 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.285 -0.884 . . . . 0.0 109.475 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 118' ' ' TYR . 35.7 Cg_endo -78.06 164.06 27.56 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.362 2.042 . . . . 0.0 110.396 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.574 HD12 ' CE1' ' A' ' 28' ' ' TYR . 1.3 tp . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.301 -0.875 . . . . 0.0 109.48 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.509 ' CG ' ' HA ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -114.12 132.57 56.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.246 -0.909 . . . . 0.0 109.447 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.438 HG21 ' HB3' ' A' ' 50' ' ' LEU . 52.5 mt -145.35 164.7 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.237 -0.915 . . . . 0.0 109.509 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.511 ' CD2' ' HB2' ' A' ' 31' ' ' PHE . 1.0 OUTLIER -131.08 128.55 40.44 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.241 -0.912 . . . . 0.0 109.451 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.5 ' N ' HD12 ' A' ' 7' ' ' LEU . 12.1 mt -115.46 108.44 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.186 -0.946 . . . . 0.0 109.464 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.479 HG21 ' CB ' ' A' ' 33' ' ' ALA . 17.5 t -92.44 128.63 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.919 . . . . 0.0 109.529 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.519 ' O ' ' CD ' ' A' ' 16' ' ' ARG . 2.1 t70 -174.94 123.43 0.24 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 109.44 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.527 ' HB3' ' CB ' ' A' ' 34' ' ' ALA . 2.6 p30 -114.68 81.43 1.56 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.318 -0.864 . . . . 0.0 109.601 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.512 ' HG2' ' N ' ' A' ' 13' ' ' TYR . 7.5 tt0 -175.99 -104.51 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.207 -0.933 . . . . 0.0 109.411 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.512 ' N ' ' HG2' ' A' ' 12' ' ' GLN . 37.4 t80 -179.54 120.47 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.85 -1.156 . . . . 0.0 109.543 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 18' ' ' LEU . . . 135.73 -50.44 0.85 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.466 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 2.0 mp -81.28 -54.44 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.179 -1.189 . . . . 0.0 109.658 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.519 ' CD ' ' O ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -50.33 -29.75 10.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.165 -0.959 . . . . 0.0 109.757 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.461 ' O ' ' HB3' ' A' ' 20' ' ' ASN . 2.6 mm -90.2 -64.76 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.183 -0.948 . . . . 0.0 109.887 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.513 HD11 ' N ' ' A' ' 18' ' ' LEU . 6.9 mp -48.55 -60.46 2.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.229 -0.92 . . . . 0.0 109.801 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.469 HD22 HD23 ' A' ' 52' ' ' LEU . 0.5 OUTLIER -53.87 -28.85 38.63 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 0.0 109.64 -179.773 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.504 ' OD1' ' ND2' ' A' ' 24' ' ' ASN . 28.4 t30 -69.2 -71.88 0.21 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.903 . . . . 0.0 109.665 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.455 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 2.5 tt0 -43.06 -38.04 2.19 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.317 -0.864 . . . . 0.0 109.71 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.516 HG23 ' CG2' ' A' ' 108' ' ' ILE . 19.0 t -61.77 -55.63 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.243 -0.911 . . . . 0.0 109.553 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.526 ' CB ' HG22 ' A' ' 30' ' ' THR . 23.6 m-85 -77.7 1.94 18.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 109.566 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.504 ' ND2' ' OD1' ' A' ' 20' ' ' ASN . 0.6 OUTLIER -90.06 -48.96 6.86 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.189 -0.944 . . . . 0.0 109.474 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.26 -46.13 24.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 109.544 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.505 ' HB3' ' CE1' ' A' ' 28' ' ' TYR . 1.8 tt0 -52.07 -22.65 4.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.2 -0.937 . . . . 0.0 109.469 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.436 ' C ' ' CD1' ' A' ' 28' ' ' TYR . . . 100.09 72.78 1.02 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.577 ' CE2' ' HG ' ' A' ' 121' ' ' LEU . 96.2 m-85 -154.55 134.62 13.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -1.17 . . . . 0.0 109.473 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 4' ' ' GLU . 12.4 mm100 -94.16 83.08 4.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 109.217 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.526 HG22 ' CB ' ' A' ' 23' ' ' PHE . 5.7 p -89.95 154.71 19.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.895 . . . . 0.0 109.604 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.511 ' HB2' ' CD2' ' A' ' 7' ' ' LEU . 38.6 m-85 -113.53 -171.25 1.85 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.274 -0.891 . . . . 0.0 109.283 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.419 ' OE1' ' HG2' ' A' ' 16' ' ' ARG . 11.8 mt-30 -124.44 154.78 39.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 109.552 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.522 ' O ' ' CB ' ' A' ' 34' ' ' ALA . . . -152.62 -165.37 2.18 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.297 -0.877 . . . . 0.0 109.392 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.527 ' CB ' ' HB3' ' A' ' 11' ' ' ASP . . . 164.34 -62.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.905 . . . . 0.0 109.597 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -71.15 -4.64 26.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.185 -0.947 . . . . 0.0 109.577 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 37' ' ' LEU . . . 86.29 -63.28 4.2 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 36' ' ' GLY . 1.0 OUTLIER -44.54 -32.28 1.38 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.207 -1.172 . . . . 0.0 109.405 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.513 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 1.4 tp60 -70.22 -60.32 2.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.498 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.444 ' O ' ' CG2' ' A' ' 43' ' ' VAL . . . -44.02 -45.22 7.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.224 -0.923 . . . . 0.0 109.482 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.7 mt -61.55 -44.06 97.72 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -0.871 . . . . 0.0 109.45 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -55.64 -57.57 11.42 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.287 -0.883 . . . . 0.0 109.488 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.449 ' HB ' HD22 ' A' ' 7' ' ' LEU . 2.5 mp -61.4 -20.83 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.285 -0.884 . . . . 0.0 109.482 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.517 ' HA ' ' CD ' ' A' ' 48' ' ' PRO . 53.5 t -79.63 -26.65 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 109.495 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 85.5 m -89.99 -24.21 21.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -0.901 . . . . 0.0 109.448 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.8 mtpt -89.97 -27.32 19.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.225 -0.922 . . . . 0.0 109.554 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -119.3 -34.37 3.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.206 -0.934 . . . . 0.0 109.506 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 33.2 mtm180 58.18 71.07 1.09 Allowed Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.173 -0.954 . . . . 0.0 109.476 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.517 ' CD ' ' HA ' ' A' ' 43' ' ' VAL . 35.3 Cg_endo -78.07 157.69 30.43 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.599 2.199 . . . . 0.0 110.328 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.453 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 0.4 OUTLIER -94.08 -9.61 36.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.194 -0.941 . . . . 0.0 109.512 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.438 ' HB3' HG21 ' A' ' 6' ' ' ILE . 6.5 tp -123.29 114.81 20.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.906 . . . . 0.0 109.504 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.437 ' HB ' HG23 ' A' ' 78' ' ' VAL . 1.7 t -121.21 111.41 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.263 -0.898 . . . . 0.0 109.443 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.469 HD23 HD22 ' A' ' 19' ' ' LEU . 0.7 OUTLIER -89.97 109.62 20.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.291 -0.881 . . . . 0.0 109.406 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.516 ' CD2' HG12 ' A' ' 78' ' ' VAL . 3.0 mm? -95.28 136.15 35.98 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.201 -0.937 . . . . 0.0 109.489 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.461 ' O ' HG13 ' A' ' 57' ' ' ILE . 30.2 t0 -113.9 117.7 32.12 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.31 -0.869 . . . . 0.0 109.446 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.512 ' CG ' HG22 ' A' ' 82' ' ' THR . 18.0 mmt -77.58 -7.99 57.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.175 -0.953 . . . . 0.0 109.489 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 57' ' ' ILE . 4.6 mtpm? -68.7 -15.56 63.56 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.308 -0.87 . . . . 0.0 109.527 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.505 ' CG2' ' OD2' ' A' ' 11' ' ' ASP . 80.5 mt -43.87 113.78 1.63 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.256 -0.902 . . . . 0.0 109.37 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.424 ' HD2' ' CG ' ' A' ' 11' ' ' ASP . 36.0 Cg_endo -78.67 6.0 5.19 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.337 2.025 . . . . 0.0 110.509 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.97 -43.97 4.28 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.489 ' CE ' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -169.58 -171.66 1.27 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.291 -1.123 . . . . 0.0 109.447 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -89.56 132.72 34.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.902 . . . . 0.0 109.431 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.36 10.89 60.07 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 25.5 mm -61.84 -38.44 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.197 -1.178 . . . . 0.0 109.487 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -68.7 -25.63 64.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.279 -0.888 . . . . 0.0 109.506 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.42 HG23 ' HE1' ' A' ' 69' ' ' MET . 70.9 mt -68.1 -64.92 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.184 -0.947 . . . . 0.0 109.505 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.513 ' CD2' HG12 ' A' ' 78' ' ' VAL . 2.4 mt -44.15 -34.45 1.84 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 0.0 109.531 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.518 ' O ' ' CG ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -64.02 -59.33 4.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -0.91 . . . . 0.0 109.465 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.0 mtt180 -49.57 -30.46 8.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.345 -0.847 . . . . 0.0 109.473 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.42 ' HE1' HG23 ' A' ' 65' ' ' ILE . 0.8 OUTLIER -67.01 -60.73 2.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.874 . . . . 0.0 109.466 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.518 ' CG ' ' O ' ' A' ' 67' ' ' LYS . 16.4 ptpt -51.39 -31.43 22.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.186 -0.946 . . . . 0.0 109.455 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 49.9 t -66.57 -44.99 89.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.19 -0.944 . . . . 0.0 109.493 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.2 mt -70.23 -65.11 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.218 -0.926 . . . . 0.0 109.535 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -113.7 130.84 56.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.227 -0.921 . . . . 0.0 109.429 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -87.11 -22.4 25.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.952 . . . . 0.0 109.411 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.2 p30 -105.55 45.26 0.98 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -0.886 . . . . 0.0 109.438 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.459 ' CD1' ' O ' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -104.15 128.08 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.283 -0.886 . . . . 0.0 109.452 179.964 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.519 ' CB ' HD12 ' A' ' 99' ' ' LEU . 3.4 mpt_? -78.11 143.13 37.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.259 -0.901 . . . . 0.0 109.48 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.516 HG12 ' CD2' ' A' ' 53' ' ' LEU . 55.5 t -144.57 144.94 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.326 -0.859 . . . . 0.0 109.568 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.519 ' CG2' ' O ' ' A' ' 100' ' ' THR . 18.3 mt -128.95 139.02 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.292 -0.88 . . . . 0.0 109.393 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.579 ' HB ' ' CE1' ' A' ' 101' ' ' HIS . 0.3 OUTLIER -102.6 130.64 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.161 -0.962 . . . . 0.0 109.337 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.454 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -102.69 51.99 0.8 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.29 -0.881 . . . . 0.0 109.532 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.512 HG22 ' CG ' ' A' ' 55' ' ' MET . 10.6 t -161.7 44.05 0.16 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.945 . . . . 0.0 109.565 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.626 ' N ' ' CD2' ' A' ' 101' ' ' HIS . . . . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.935 . . . . 0.0 109.412 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.633 ' CD1' ' CE1' ' A' ' 101' ' ' HIS . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.818 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.414 ' C ' ' O ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -45.02 -38.82 5.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.169 -0.957 . . . . 0.0 109.528 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -88.07 -40.8 13.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.203 -0.936 . . . . 0.0 109.541 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.506 ' HA ' ' CD1' ' A' ' 96' ' ' LEU . 2.9 m -53.05 -20.14 3.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 0.0 109.5 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -58.23 -53.8 54.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.186 -0.946 . . . . 0.0 109.477 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -76.78 -10.2 59.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.911 . . . . 0.0 109.481 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.506 ' CD1' ' HA ' ' A' ' 93' ' ' SER . 66.9 mt -75.4 -46.68 31.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.269 -0.895 . . . . 0.0 109.494 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 178.1 33.23 0.05 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -118.94 123.05 43.67 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.26 -1.141 . . . . 0.0 109.505 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.519 HD12 ' CB ' ' A' ' 77' ' ' ARG . 0.4 OUTLIER -90.08 -60.04 2.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 109.475 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.519 ' O ' ' CG2' ' A' ' 79' ' ' ILE . 21.2 m -117.79 138.13 52.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.213 -0.929 . . . . 0.0 109.582 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.633 ' CE1' ' CD1' ' A' ' 90' ' ' ILE . 3.9 t-160 -119.48 84.41 2.2 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.853 . . . . 0.0 109.254 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.608 ' CD2' ' CD1' ' A' ' 111' ' ' ILE . 22.5 m-85 -72.89 158.27 35.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.0 109.575 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.522 ' HB1' ' CB ' ' A' ' 83' ' ' ALA . . . -127.25 -148.73 0.39 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.241 -0.912 . . . . 0.0 109.368 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.447 ' HG3' ' HA ' ' A' ' 105' ' ' PRO . 2.0 tttm -128.17 131.89 24.04 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.258 -0.901 . . . . 0.0 109.369 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.447 ' HA ' ' HG3' ' A' ' 104' ' ' LYS . 35.5 Cg_endo -77.75 -162.4 2.95 Favored 'Cis proline' 0 C--N 1.311 -1.423 0 C-N-CA 123.51 -1.454 . . . . 0.0 110.355 -0.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 106' ' ' PHE . 3.0 p90 -153.95 165.1 37.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.921 . . . . 0.0 109.477 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.454 ' O ' HG12 ' A' ' 111' ' ' ILE . 19.6 t0 -108.17 128.94 55.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.274 -0.891 . . . . 0.0 109.45 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.516 ' CG2' HG23 ' A' ' 22' ' ' VAL . 14.6 mm -61.53 -18.11 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.267 -0.896 . . . . 0.0 109.474 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.417 ' O ' ' HB2' ' A' ' 113' ' ' ASP . 33.1 m-20 -78.06 -37.72 46.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.162 -0.961 . . . . 0.0 109.435 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.422 ' HG2' ' CZ ' ' A' ' 102' ' ' PHE . 1.4 tt0 -72.53 -24.37 61.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.252 -0.905 . . . . 0.0 109.435 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.608 ' CD1' ' CD2' ' A' ' 102' ' ' PHE . 12.8 mm -79.58 -52.62 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -0.893 . . . . 0.0 109.48 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.442 ' HG2' ' O ' ' A' ' 108' ' ' ILE . 2.7 ptt85 -69.47 -24.43 63.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.178 -0.951 . . . . 0.0 109.473 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 109' ' ' ASP . 68.9 m-20 -75.93 -51.24 12.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 0.0 109.516 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.426 ' O ' ' CD2' ' A' ' 118' ' ' TYR . . . -61.64 -46.96 87.54 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.303 -0.873 . . . . 0.0 109.601 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 68.0 t -58.42 -47.39 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.151 -0.968 . . . . 0.0 109.524 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.94 -30.48 70.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 109.493 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -83.17 -16.8 45.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.9 . . . . 0.0 109.426 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.434 ' OH ' ' OG1' ' A' ' 100' ' ' THR . 17.5 m-85 -90.02 -72.86 0.54 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.348 -0.845 . . . . 0.0 109.531 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.516 ' CD1' ' HD2' ' A' ' 120' ' ' PRO . 6.1 tp -90.12 139.11 27.16 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.89 . . . . 0.0 109.533 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.516 ' HD2' ' CD1' ' A' ' 119' ' ' LEU . 35.6 Cg_endo -78.78 132.63 10.9 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.495 2.13 . . . . 0.0 110.409 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.577 ' HG ' ' CE2' ' A' ' 28' ' ' TYR . 1.9 tm? . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.254 -0.904 . . . . 0.0 109.489 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.492 ' HG3' ' CD2' ' A' ' 119' ' ' LEU . 5.4 mm-40 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.26 0.552 . . . . 0.0 109.544 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.464 ' CB ' ' HB3' ' A' ' 48' ' ' PRO . 3.2 mtmm -89.99 157.28 17.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.908 . . . . 0.0 109.482 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.509 HG21 ' N ' ' A' ' 7' ' ' LEU . 55.3 mt -150.08 158.12 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -0.907 . . . . 0.0 109.453 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.517 ' CD2' ' HB2' ' A' ' 31' ' ' PHE . 1.0 OUTLIER -131.04 109.0 10.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.323 -0.861 . . . . 0.0 109.365 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.519 ' CD1' ' HB3' ' A' ' 19' ' ' LEU . 13.2 mt -89.91 113.47 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.235 -0.915 . . . . 0.0 109.444 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.511 ' CG1' HD13 ' A' ' 57' ' ' ILE . 37.1 t -109.39 97.99 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.221 -0.924 . . . . 0.0 109.392 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 11' ' ' ASP . 2.2 t0 -152.7 88.13 1.33 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.905 . . . . 0.0 109.509 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.459 ' OD1' ' HA ' ' A' ' 57' ' ' ILE . 7.3 p-10 -44.29 -43.32 7.31 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.5 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -55.97 134.94 52.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.298 -0.876 . . . . 0.0 109.56 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.574 ' CE2' HG13 ' A' ' 17' ' ' ILE . 7.6 t80 -73.71 174.0 9.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.272 -0.892 . . . . 0.0 109.535 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.29 -38.52 3.2 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.525 HG21 ' CD1' ' A' ' 19' ' ' LEU . 2.3 mp -84.64 -48.39 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.332 -1.099 . . . . 0.0 109.443 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.441 ' O ' ' HB2' ' A' ' 20' ' ' ASN . 2.5 mtp180 -59.88 -26.79 66.15 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.255 -0.903 . . . . 0.0 109.584 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.574 HG13 ' CE2' ' A' ' 13' ' ' TYR . 3.7 mm -90.22 -57.16 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.25 -0.906 . . . . 0.0 109.74 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.459 ' O ' HG21 ' A' ' 22' ' ' VAL . 79.6 mt -54.18 -59.37 4.75 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -0.92 . . . . 0.0 109.706 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.525 ' CD1' HG21 ' A' ' 15' ' ' ILE . 4.5 mp -56.7 -19.31 15.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.243 -0.911 . . . . 0.0 109.602 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.452 ' HB3' ' O ' ' A' ' 17' ' ' ILE . 25.9 t30 -78.2 -72.45 0.37 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.884 . . . . 0.0 109.637 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -48.29 -28.31 3.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -0.913 . . . . 0.0 109.554 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.525 ' CG2' HG23 ' A' ' 108' ' ' ILE . 63.7 t -70.61 -57.26 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.221 -0.925 . . . . 0.0 109.543 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.519 ' CB ' HG22 ' A' ' 30' ' ' THR . 15.5 m-85 -72.63 -3.09 22.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.276 -0.89 . . . . 0.0 109.585 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -80.08 -51.56 8.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.155 -0.966 . . . . 0.0 109.416 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.13 -22.01 53.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.292 -0.88 . . . . 0.0 109.451 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.511 ' O ' ' CD2' ' A' ' 121' ' ' LEU . 2.2 mt-10 -71.36 -33.47 69.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.233 -0.917 . . . . 0.0 109.464 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 110.02 61.93 0.51 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.519 ' OH ' ' CB ' ' A' ' 121' ' ' LEU . 98.8 m-85 -151.63 134.95 16.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.294 -1.121 . . . . 0.0 109.539 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -89.92 83.04 6.12 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.226 -0.922 . . . . 0.0 109.137 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.519 HG22 ' CB ' ' A' ' 23' ' ' PHE . 5.6 p -89.91 151.08 21.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.296 -0.877 . . . . 0.0 109.607 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.517 ' HB2' ' CD2' ' A' ' 7' ' ' LEU . 11.8 m-85 -115.85 -170.41 1.78 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.286 -0.884 . . . . 0.0 109.297 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -127.5 149.79 49.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.13 -0.981 . . . . 0.0 109.504 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.46 ' HB1' HD13 ' A' ' 7' ' ' LEU . . . -164.56 171.97 13.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.288 -0.882 . . . . 0.0 109.381 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.456 ' O ' HD12 ' A' ' 57' ' ' ILE . . . -172.65 -34.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -0.908 . . . . 0.0 109.536 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.421 ' OD1' ' HB2' ' A' ' 37' ' ' LEU . 3.1 p30 -81.89 -2.72 52.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.187 -0.946 . . . . 0.0 109.625 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.19 -45.69 3.55 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.452 ' N ' HD13 ' A' ' 37' ' ' LEU . 9.1 mp -58.2 -34.59 70.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.242 -1.152 . . . . 0.0 109.483 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.523 ' O ' ' CD1' ' A' ' 42' ' ' ILE . 18.8 mm-40 -76.08 -28.53 57.61 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.199 -0.938 . . . . 0.0 109.467 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.13 -55.32 11.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.324 -0.86 . . . . 0.0 109.485 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.502 HD23 ' CB ' ' A' ' 68' ' ' ARG . 13.1 mt -65.54 -51.46 59.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.246 -0.909 . . . . 0.0 109.496 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -48.99 -54.32 16.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.287 -0.883 . . . . 0.0 109.452 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.523 ' CD1' ' O ' ' A' ' 38' ' ' GLN . 15.7 mt -60.06 -30.17 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.235 -0.915 . . . . 0.0 109.43 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.464 ' HA ' ' CD ' ' A' ' 48' ' ' PRO . 70.2 t -70.36 -26.92 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.94 . . . . 0.0 109.461 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.1 m -89.86 -19.4 24.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.158 -0.964 . . . . 0.0 109.437 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.6 mmtt -90.02 -24.35 21.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.353 -0.842 . . . . 0.0 109.517 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' A' ' 47' ' ' ARG . 38.9 mm-40 -125.39 -32.93 2.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.171 -0.955 . . . . 0.0 109.524 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 1.4 mtt180 60.48 66.85 1.74 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 109.527 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.488 ' O ' ' CD1' ' A' ' 76' ' ' ILE . 35.6 Cg_endo -77.85 175.34 11.32 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.668 2.245 . . . . 0.0 110.474 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 0.9 OUTLIER -116.82 -9.32 11.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.276 -0.89 . . . . 0.0 109.511 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.552 ' CD2' ' CG2' ' A' ' 115' ' ' VAL . 7.2 tp -128.07 120.02 26.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.28 -0.888 . . . . 0.0 109.538 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.477 ' CG1' ' HB3' ' A' ' 7' ' ' LEU . 39.1 t -133.16 124.49 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 0.0 109.692 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.467 ' CD1' HG12 ' A' ' 8' ' ' ILE . 1.1 mp -89.94 112.78 24.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.341 -0.849 . . . . 0.0 109.355 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.467 ' CD2' ' HG ' ' A' ' 66' ' ' LEU . 1.1 mp -97.5 120.01 37.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.149 -0.969 . . . . 0.0 109.626 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.45 ' HA ' ' HG3' ' A' ' 81' ' ' MET . 26.5 t0 -105.77 101.78 11.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.264 -0.897 . . . . 0.0 109.273 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.513 ' CG ' HG22 ' A' ' 82' ' ' THR . 3.3 mmt -61.82 -13.35 23.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -0.919 . . . . 0.0 109.464 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.469 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 43.4 mttp -57.96 -25.94 61.64 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.214 -0.929 . . . . 0.0 109.486 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.517 ' CG2' ' HB3' ' A' ' 60' ' ' MET . 87.5 mt -42.08 102.25 0.27 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.342 -0.849 . . . . 0.0 109.582 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 56' ' ' LYS . 36.0 Cg_endo -78.33 102.2 1.54 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.377 2.052 . . . . 0.0 110.476 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 125.77 -20.19 6.47 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.517 ' HB3' ' CG2' ' A' ' 57' ' ' ILE . 11.2 tmm? -129.53 132.54 46.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -1.167 . . . . 0.0 109.521 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.431 ' O ' ' SD ' ' A' ' 60' ' ' MET . 74.1 m-20 -89.14 129.82 35.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.203 -0.936 . . . . 0.0 109.497 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.462 ' HA2' HG13 ' A' ' 65' ' ' ILE . . . -87.35 9.82 71.64 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 25.3 mm -76.15 -49.63 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.19 -1.182 . . . . 0.0 109.479 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -62.29 -25.31 67.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 109.388 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.482 HG21 ' CE ' ' A' ' 69' ' ' MET . 7.9 mt -62.83 -65.26 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.311 -0.868 . . . . 0.0 109.45 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.467 ' HG ' ' CD2' ' A' ' 53' ' ' LEU . 22.0 mt -46.57 -40.96 13.69 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.189 -0.944 . . . . 0.0 109.437 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.457 ' HA ' ' HG3' ' A' ' 70' ' ' LYS . 2.0 tttt -53.8 -53.7 48.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.934 . . . . 0.0 109.399 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.502 ' CB ' HD23 ' A' ' 40' ' ' LEU . 1.9 mtt85 -60.72 -24.99 66.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.258 -0.901 . . . . 0.0 109.396 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.482 ' CE ' HG21 ' A' ' 65' ' ' ILE . 2.2 mtt -78.36 -25.33 46.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.355 -0.841 . . . . 0.0 109.49 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' A' ' 66' ' ' LEU . 0.8 OUTLIER -82.91 -28.84 29.67 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 0.0 109.263 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.45 HG21 ' O ' ' A' ' 67' ' ' LYS . 2.6 t -90.07 -22.31 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.262 -0.899 . . . . 0.0 109.493 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.498 HG21 HD11 ' A' ' 72' ' ' ILE . 25.1 mm -90.1 -50.16 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.255 -0.903 . . . . 0.0 109.51 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.451 ' O ' ' O ' ' A' ' 69' ' ' MET . 1.0 OUTLIER -137.81 121.45 17.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -0.922 . . . . 0.0 109.509 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.79 7.76 19.59 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.223 -0.923 . . . . 0.0 109.515 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.476 ' C ' ' ND2' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -122.22 -9.11 8.66 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.246 -0.909 . . . . 0.0 108.984 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.488 ' CD1' ' O ' ' A' ' 48' ' ' PRO . 2.4 tp -57.86 106.85 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -0.934 . . . . 0.0 109.52 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.527 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 44.6 mtt180 -75.52 131.7 40.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.329 -0.857 . . . . 0.0 109.357 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.451 HG13 HD23 ' A' ' 66' ' ' LEU . 23.6 t -134.54 126.75 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 109.709 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.517 HG22 ' CG2' ' A' ' 100' ' ' THR . 80.0 mt -103.81 128.48 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.168 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.568 ' HB ' ' CG ' ' A' ' 101' ' ' HIS . 0.1 OUTLIER -89.84 153.54 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.174 -0.953 . . . . 0.0 109.427 -179.799 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.45 ' HG3' ' HA ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -132.39 69.0 1.48 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.321 -0.862 . . . . 0.0 109.522 179.899 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.521 HG21 ' NE2' ' A' ' 101' ' ' HIS . 12.8 t -170.67 28.16 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.213 -0.93 . . . . 0.0 109.583 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.517 ' CB ' ' HB1' ' A' ' 103' ' ' ALA . . . . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.236 -0.915 . . . . 0.0 109.516 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.508 HG13 ' ND1' ' A' ' 101' ' ' HIS . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.704 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.79 -43.77 94.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.309 -0.87 . . . . 0.0 109.604 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.461 ' O ' HD22 ' A' ' 96' ' ' LEU . 1.1 tp10 -90.13 -20.71 22.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.188 -0.945 . . . . 0.0 109.813 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.498 ' HB3' ' CB ' ' A' ' 98' ' ' ALA . 0.4 OUTLIER -42.39 -26.86 0.12 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.187 -0.945 . . . . 0.0 109.899 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 92' ' ' GLU . 0.3 OUTLIER -52.58 -76.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -0.906 . . . . 0.0 109.899 -179.776 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.427 ' HG3' ' CD2' ' A' ' 96' ' ' LEU . 2.5 pt-20 -64.91 -38.02 89.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.231 -0.918 . . . . 0.0 109.825 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.522 ' N ' ' CD2' ' A' ' 96' ' ' LEU . 3.3 mm? -55.19 -25.17 30.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.919 . . . . 0.0 109.594 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 132.8 68.27 0.08 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.498 ' CB ' ' HB3' ' A' ' 93' ' ' SER . . . -153.12 98.96 2.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.251 -1.146 . . . . 0.0 109.444 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.527 ' CD1' ' HB3' ' A' ' 77' ' ' ARG . 21.1 mt -43.94 -67.13 0.3 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.295 -0.878 . . . . 0.0 109.346 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.565 HG22 ' CE1' ' A' ' 102' ' ' PHE . 14.2 t -146.68 152.43 38.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.33 -0.856 . . . . 0.0 109.44 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.568 ' CG ' ' HB ' ' A' ' 80' ' ' ILE . 3.6 t-160 -113.68 87.29 2.58 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 109.346 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.565 ' CE1' HG22 ' A' ' 100' ' ' THR . 13.3 m-30 -71.56 159.92 33.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.226 -0.921 . . . . 0.0 109.569 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.517 ' HB1' ' CB ' ' A' ' 83' ' ' ALA . . . -131.35 -148.88 0.37 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.284 -0.885 . . . . 0.0 109.342 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.1 mtpt -91.74 146.42 33.03 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.254 -0.904 . . . . 0.0 109.466 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.5 -169.56 7.96 Favored 'Cis proline' 0 C--N 1.308 -1.565 0 C-N-CA 123.236 -1.568 . . . . 0.0 110.435 -0.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.627 ' CZ ' ' CG1' ' A' ' 111' ' ' ILE . 11.0 t80 -127.48 92.64 3.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.312 -0.868 . . . . 0.0 109.264 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.445 ' O ' HD11 ' A' ' 111' ' ' ILE . 16.3 t70 -89.83 127.83 36.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.282 -0.886 . . . . 0.0 109.511 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.525 HG23 ' CG2' ' A' ' 22' ' ' VAL . 13.7 mm -51.53 -22.16 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.225 -0.922 . . . . 0.0 109.356 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 109' ' ' ASP . 4.3 m-20 -72.64 -42.33 64.52 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.295 -0.878 . . . . 0.0 109.499 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.422 ' HG2' ' CE2' ' A' ' 102' ' ' PHE . 17.4 tt0 -62.51 -29.82 70.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.264 -0.898 . . . . 0.0 109.473 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.627 ' CG1' ' CZ ' ' A' ' 106' ' ' PHE . 1.4 mp -76.49 -56.13 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 109.327 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.426 ' HG2' ' HA ' ' A' ' 109' ' ' ASP . 30.4 ptt180 -60.79 -19.61 59.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.921 . . . . 0.0 109.435 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -81.61 -51.14 8.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 109.396 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.452 ' O ' ' CD2' ' A' ' 118' ' ' TYR . . . -55.58 -47.42 76.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.263 -0.898 . . . . 0.0 109.368 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.552 ' CG2' ' CD2' ' A' ' 50' ' ' LEU . 47.2 t -65.97 -47.64 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.314 -0.867 . . . . 0.0 109.419 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.81 -19.29 59.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 109.418 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -89.48 -27.25 20.46 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.251 -0.905 . . . . 0.0 109.345 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.452 ' CD2' ' O ' ' A' ' 114' ' ' ALA . 42.3 m-85 -88.07 -69.64 0.68 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.296 -0.878 . . . . 0.0 109.47 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.492 ' CD2' ' HG3' ' A' ' 4' ' ' GLU . 2.4 tt -90.19 127.92 51.47 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.235 -0.915 . . . . 0.0 109.435 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.451 ' O ' HD22 ' A' ' 119' ' ' LEU . 35.9 Cg_endo -78.49 142.42 18.5 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.414 2.076 . . . . 0.0 110.368 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.519 ' CB ' ' OH ' ' A' ' 28' ' ' TYR . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.479 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.524 ' CG ' ' HA ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -146.24 126.19 13.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.208 -0.932 . . . . 0.0 109.491 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.523 ' HB ' ' CG2' ' A' ' 30' ' ' THR . 4.1 mt -109.2 162.48 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.188 -0.945 . . . . 0.0 109.415 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.526 ' CD1' HG23 ' A' ' 9' ' ' VAL . 2.0 tm? -136.41 108.16 7.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.199 -0.938 . . . . 0.0 109.587 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.0 mt -90.01 103.41 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.219 -0.926 . . . . 0.0 109.138 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.526 HG23 ' CD1' ' A' ' 7' ' ' LEU . 2.7 t -89.99 95.12 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.172 -0.955 . . . . 0.0 109.801 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.483 ' OD1' ' CE ' ' A' ' 81' ' ' MET . 4.8 m-20 -145.22 155.36 43.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.272 -0.893 . . . . 0.0 109.402 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.464 ' OD2' ' CD ' ' A' ' 58' ' ' PRO . 7.1 p-10 -114.35 -29.75 6.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.339 -0.851 . . . . 0.0 109.41 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.515 ' HB3' ' NH2' ' A' ' 16' ' ' ARG . 1.4 tt0 -67.83 -148.04 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.349 -0.844 . . . . 0.0 109.514 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.614 ' CD1' ' N ' ' A' ' 14' ' ' GLY . 40.5 t80 -148.66 166.43 28.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.295 -0.878 . . . . 0.0 109.347 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.614 ' N ' ' CD1' ' A' ' 13' ' ' TYR . . . 102.24 -84.25 0.49 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.477 ' O ' ' N ' ' A' ' 17' ' ' ILE . 1.5 mt -51.08 -68.03 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.315 -1.109 . . . . 0.0 109.151 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.515 ' NH2' ' HB3' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -39.75 -27.57 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.616 -0.677 . . . . 0.0 110.217 -179.708 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.576 HG13 ' CZ ' ' A' ' 13' ' ' TYR . 9.9 mm -78.81 -46.77 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.091 -1.005 . . . . 0.0 109.841 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.525 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 3.8 mp -65.47 -54.8 23.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.18 -0.95 . . . . 0.0 109.654 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.461 ' CD1' HG21 ' A' ' 15' ' ' ILE . 8.6 mp -59.13 -18.88 39.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.276 -0.89 . . . . 0.0 109.3 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 31.1 t30 -77.94 -65.64 0.94 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.436 -0.79 . . . . 0.0 109.546 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -68.07 -7.79 32.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 109.719 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' A' ' 18' ' ' LEU . 43.7 t -88.16 -57.77 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.19 -0.944 . . . . 0.0 109.458 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.584 ' CB ' ' CG2' ' A' ' 30' ' ' THR . 18.0 m-85 -63.35 -28.84 70.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -0.91 . . . . 0.0 109.465 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -64.56 -60.04 3.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.274 -0.891 . . . . 0.0 109.44 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -57.03 -54.95 40.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.27 -0.894 . . . . 0.0 109.491 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.446 ' HB3' ' CD1' ' A' ' 28' ' ' TYR . 1.1 tt0 -44.48 -26.39 0.35 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.253 -0.904 . . . . 0.0 109.442 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.455 ' C ' ' CD1' ' A' ' 28' ' ' TYR . . . 113.21 55.71 0.43 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.458 ' HB2' ' O ' ' A' ' 23' ' ' PHE . 78.4 m-85 -147.68 135.91 21.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.259 -1.142 . . . . 0.0 109.475 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -89.85 82.23 6.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.272 -0.893 . . . . 0.0 109.358 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.584 ' CG2' ' CB ' ' A' ' 23' ' ' PHE . 6.0 p -89.96 146.76 24.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.324 -0.86 . . . . 0.0 109.605 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.554 ' CZ ' ' OE1' ' A' ' 46' ' ' GLU . 18.7 m-85 -116.15 -178.71 3.47 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.321 -0.862 . . . . 0.0 109.343 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -122.14 136.18 54.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 0.0 109.553 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' A' ' 10' ' ' ASP . . . -141.94 -175.82 4.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.257 -0.902 . . . . 0.0 109.425 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.57 -83.46 0.09 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.18 -0.95 . . . . 0.0 109.499 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.419 ' OD1' ' HB2' ' A' ' 38' ' ' GLN . 20.7 p-10 -63.21 137.22 58.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.303 -0.873 . . . . 0.0 109.476 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.405 ' HA2' HD12 ' A' ' 65' ' ' ILE . . . -45.29 -31.12 3.11 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.74 -49.87 76.05 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.214 -1.168 . . . . 0.0 109.477 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.517 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 6.6 tp-100 -61.96 -52.15 65.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 109.431 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.523 ' O ' ' CG2' ' A' ' 43' ' ' VAL . . . -44.69 -51.54 9.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.195 -0.94 . . . . 0.0 109.572 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.6 mt -60.25 -37.47 80.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.206 -0.934 . . . . 0.0 109.59 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.24 -59.46 5.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.139 -0.976 . . . . 0.0 109.527 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.519 ' CG2' HD22 ' A' ' 7' ' ' LEU . 5.1 mt -62.07 -19.85 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.207 -0.933 . . . . 0.0 109.577 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.523 ' CG2' ' O ' ' A' ' 39' ' ' ALA . 90.8 t -81.37 -24.9 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.188 -0.945 . . . . 0.0 109.491 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.5 m -90.13 -27.48 19.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 109.511 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.465 ' N ' ' CD ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -90.08 -30.89 17.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.247 -0.908 . . . . 0.0 109.527 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.554 ' OE1' ' CZ ' ' A' ' 31' ' ' PHE . 8.1 mm-40 -110.62 -35.26 6.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.916 . . . . 0.0 109.463 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 6.5 mtt85 56.33 69.89 1.65 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.478 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.524 ' HA ' ' CG ' ' A' ' 5' ' ' LYS . 35.4 Cg_endo -77.7 154.72 30.83 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.694 2.263 . . . . 0.0 110.416 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.523 ' HA ' ' CD1' ' A' ' 76' ' ' ILE . 4.0 t0 -92.77 -13.04 29.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.268 -0.895 . . . . 0.0 109.475 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.5 ' N ' HD21 ' A' ' 50' ' ' LEU . 4.3 mm? -122.54 111.98 17.46 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.222 -0.923 . . . . 0.0 109.453 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.521 HG13 ' CE ' ' A' ' 69' ' ' MET . 2.1 t -113.68 131.05 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.198 -0.939 . . . . 0.0 109.528 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.454 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 1.6 mp -108.95 117.98 35.6 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.245 -0.909 . . . . 0.0 109.48 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.54 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 2.3 mm? -103.19 130.74 50.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.268 -0.895 . . . . 0.0 109.518 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.457 ' HB2' ' OD2' ' A' ' 10' ' ' ASP . 19.6 t0 -111.11 97.81 7.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -0.872 . . . . 0.0 109.437 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.525 ' CG ' HG23 ' A' ' 82' ' ' THR . 12.6 mmt -64.76 -10.82 30.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 0.0 109.396 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -72.71 -2.96 22.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.155 -0.965 . . . . 0.0 109.668 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.44 HG12 ' OD1' ' A' ' 11' ' ' ASP . 55.3 mt -62.24 132.4 93.95 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.128 -0.983 . . . . 0.0 109.32 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.464 ' CD ' ' OD2' ' A' ' 11' ' ' ASP . 36.3 Cg_endo -78.88 112.0 3.04 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.494 2.129 . . . . 0.0 110.412 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 146.07 -76.49 0.27 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.421 ' SD ' ' C ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -130.47 170.14 14.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.207 -1.172 . . . . 0.0 109.501 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -90.09 139.54 30.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.355 -0.84 . . . . 0.0 109.499 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 63' ' ' ILE . . . -73.0 -10.11 77.16 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.459 ' HA ' ' HE3' ' A' ' 55' ' ' MET . 18.1 mm -44.14 -47.41 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.212 -1.169 . . . . 0.0 109.585 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.463 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 4.8 mt-10 -63.36 -39.52 94.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.235 -0.916 . . . . 0.0 109.533 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.466 HG23 HD13 ' A' ' 53' ' ' LEU . 65.6 mt -51.37 -64.49 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.262 -0.899 . . . . 0.0 109.415 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.459 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 7.1 mt -44.12 -49.01 9.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 109.391 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.06 -47.95 44.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.184 -0.948 . . . . 0.0 109.353 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.463 ' HG2' ' O ' ' A' ' 64' ' ' GLU . 9.7 mmt180 -57.15 -44.07 83.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -0.888 . . . . 0.0 109.415 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.521 ' CE ' HG13 ' A' ' 51' ' ' VAL . 3.6 mtt -60.04 -27.27 66.79 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 0.0 109.417 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 66' ' ' LEU . 0.7 OUTLIER -78.05 -31.7 50.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.238 -0.914 . . . . 0.0 109.368 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.6 t -77.9 -24.53 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.264 -0.898 . . . . 0.0 109.519 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.469 HG22 HD11 ' A' ' 72' ' ' ILE . 48.9 mt -87.42 -59.65 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -0.917 . . . . 0.0 109.406 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.462 ' O ' HG21 ' A' ' 76' ' ' ILE . 39.8 m-20 -130.52 133.56 46.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.19 -0.944 . . . . 0.0 109.482 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -90.16 -26.08 20.35 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.218 -0.926 . . . . 0.0 109.033 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 44.4 p-10 -96.51 46.85 1.06 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.262 -0.899 . . . . 0.0 109.472 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.523 ' CD1' ' HA ' ' A' ' 49' ' ' ASP . 2.9 tp -117.59 112.83 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.228 -0.92 . . . . 0.0 109.436 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.522 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 8.7 mpt_? -63.36 134.99 56.68 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.269 -0.894 . . . . 0.0 109.509 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.514 ' CG2' ' O ' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -138.66 108.84 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.247 -0.908 . . . . 0.0 109.6 -179.925 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.465 ' CG1' ' HB2' ' A' ' 99' ' ' LEU . 67.5 mt -96.77 145.68 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.211 -0.931 . . . . 0.0 109.371 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.581 HD11 ' CE1' ' A' ' 101' ' ' HIS . 0.4 OUTLIER -103.17 168.66 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.171 -0.956 . . . . 0.0 109.375 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.483 ' CE ' ' OD1' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -142.53 69.54 1.32 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.281 -0.887 . . . . 0.0 109.432 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.525 HG23 ' CG ' ' A' ' 55' ' ' MET . 9.0 t 178.79 55.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.348 -0.845 . . . . 0.0 109.429 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.512 ' CB ' ' HB1' ' A' ' 103' ' ' ALA . . . . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.901 . . . . 0.0 109.511 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.591 ' CD1' ' N ' ' A' ' 90' ' ' ILE . 1.2 mp . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.46 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -51.19 -27.76 9.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.216 -0.927 . . . . 0.0 109.41 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.497 ' HA ' ' CG ' ' A' ' 95' ' ' GLU . 6.9 mt-10 -89.89 -28.67 19.07 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.302 -0.874 . . . . 0.0 109.456 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.486 ' HB3' ' CD1' ' A' ' 80' ' ' ILE . 1.7 m -64.8 -40.17 94.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.308 -0.87 . . . . 0.0 109.447 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.451 ' HA ' ' HB1' ' A' ' 98' ' ' ALA . 20.3 mttt -70.12 -63.34 1.1 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.204 -0.935 . . . . 0.0 109.548 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.497 ' CG ' ' HA ' ' A' ' 92' ' ' GLU . 0.1 OUTLIER -47.15 -27.75 1.55 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.195 -0.94 . . . . 0.0 109.469 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.444 ' HG ' ' OE2' ' A' ' 95' ' ' GLU . 22.0 mt -77.8 -41.24 37.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.889 . . . . 0.0 109.439 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.514 ' O ' ' CG2' ' A' ' 78' ' ' VAL . . . 161.4 61.49 0.02 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 78' ' ' VAL . . . -151.03 116.52 5.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.295 -1.12 . . . . 0.0 109.448 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.522 ' CD1' ' HB3' ' A' ' 77' ' ' ARG . 20.3 mt -44.11 -84.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.188 -0.945 . . . . 0.0 109.436 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.622 ' CG2' ' CE1' ' A' ' 102' ' ' PHE . 12.6 t -129.83 151.87 49.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.301 -0.874 . . . . 0.0 109.456 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.581 ' CE1' HD11 ' A' ' 80' ' ' ILE . 2.9 t60 -101.56 96.29 7.02 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.272 -0.892 . . . . 0.0 109.503 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.622 ' CE1' ' CG2' ' A' ' 100' ' ' THR . 43.6 m-85 -72.22 168.32 18.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.202 -0.936 . . . . 0.0 109.404 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.512 ' HB1' ' CB ' ' A' ' 83' ' ' ALA . . . -145.68 -148.34 0.24 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.194 -0.941 . . . . 0.0 109.413 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.81 146.93 25.55 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.919 . . . . 0.0 109.534 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.99 168.01 76.98 Favored 'Cis proline' 0 C--N 1.308 -1.57 0 C-N-CA 123.233 -1.57 . . . . 0.0 110.393 0.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -142.33 -164.41 1.81 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 0.0 109.499 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -136.81 127.4 26.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.251 -0.906 . . . . 0.0 109.397 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.494 ' CG1' HD21 ' A' ' 18' ' ' LEU . 19.0 mm -54.11 -20.57 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -0.912 . . . . 0.0 109.468 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -74.61 -41.48 60.36 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.246 -0.909 . . . . 0.0 109.475 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -71.87 -31.6 66.62 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.228 -0.92 . . . . 0.0 109.539 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.461 HD12 ' CE2' ' A' ' 102' ' ' PHE . 17.8 mm -68.82 -58.0 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.339 -0.851 . . . . 0.0 109.516 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' A' ' 108' ' ' ILE . 8.2 ptt85 -60.14 -36.47 77.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.227 -0.921 . . . . 0.0 109.535 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -59.69 -54.08 50.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.253 -0.904 . . . . 0.0 109.434 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.526 ' O ' ' CD2' ' A' ' 118' ' ' TYR . . . -57.09 -42.1 80.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.234 -0.917 . . . . 0.0 109.387 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.9 t -65.63 -25.11 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.278 -0.889 . . . . 0.0 109.48 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.53 -45.05 61.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.283 -0.886 . . . . 0.0 109.459 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.38 -42.79 95.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.186 -0.946 . . . . 0.0 109.543 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.526 ' CD2' ' O ' ' A' ' 114' ' ' ALA . 52.7 m-85 -64.98 -70.04 0.26 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.214 -0.929 . . . . 0.0 109.518 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 18.0 tp -90.08 112.37 52.05 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.347 -0.846 . . . . 0.0 109.437 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 118' ' ' TYR . 35.7 Cg_endo -77.96 136.03 14.5 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.39 2.06 . . . . 0.0 110.42 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.7 tp . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.31 -0.869 . . . . 0.0 109.449 -179.957 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.444 ' HG2' HD11 ' A' ' 121' ' ' LEU . 1.4 mt-10 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.48 ' CB ' ' HB3' ' A' ' 48' ' ' PRO . 1.4 mptp? -120.83 159.7 24.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.254 -0.904 . . . . 0.0 109.484 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.524 ' HB ' ' CG2' ' A' ' 30' ' ' THR . 14.3 mt -149.98 158.79 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.23 -0.919 . . . . 0.0 109.487 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.52 ' CD2' ' HB2' ' A' ' 31' ' ' PHE . 1.8 tm? -133.2 106.84 7.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.207 -0.933 . . . . 0.0 109.401 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.45 HD12 ' HB3' ' A' ' 19' ' ' LEU . 6.0 mt -89.88 112.06 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.204 -0.935 . . . . 0.0 109.382 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.472 HG23 ' CD1' ' A' ' 53' ' ' LEU . 32.3 t -93.97 79.86 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.283 -0.886 . . . . 0.0 109.565 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.466 ' HB3' ' HD3' ' A' ' 16' ' ' ARG . 17.7 t70 -126.32 133.16 51.45 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.262 -0.899 . . . . 0.0 109.494 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.49 ' CG ' ' CD ' ' A' ' 58' ' ' PRO . 5.4 p-10 -99.65 -45.86 5.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.127 -0.983 . . . . 0.0 109.507 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.435 ' N ' ' CG ' ' A' ' 11' ' ' ASP . 1.0 OUTLIER -68.94 112.49 5.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -0.909 . . . . 0.0 109.444 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.42 ' C ' ' O ' ' A' ' 12' ' ' GLN . 1.8 t80 -43.79 159.02 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.24 -0.912 . . . . 0.0 109.529 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.83 -67.65 0.25 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.519 HG22 ' CD1' ' A' ' 19' ' ' LEU . 2.7 mt -65.31 -11.47 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.191 -1.182 . . . . 0.0 109.346 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.466 ' HD3' ' HB3' ' A' ' 10' ' ' ASP . 0.6 OUTLIER -84.24 -26.77 28.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.21 -0.931 . . . . 0.0 109.263 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.3 mm -90.7 -37.95 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.26 -0.9 . . . . 0.0 109.79 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.94 -58.19 5.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 0.0 109.7 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.519 ' CD1' HG22 ' A' ' 15' ' ' ILE . 7.9 mp -62.95 -22.13 66.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.167 -0.958 . . . . 0.0 109.394 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 8.8 t30 -71.21 -66.83 0.57 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.368 -0.833 . . . . 0.0 109.488 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.457 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 2.1 mt-10 -53.27 -33.3 52.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -0.885 . . . . 0.0 109.58 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.465 HG23 ' CG2' ' A' ' 108' ' ' ILE . 74.7 t -63.41 -60.07 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.251 -0.906 . . . . 0.0 109.512 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.465 ' O ' ' HB2' ' A' ' 28' ' ' TYR . 21.6 m-85 -78.03 1.77 19.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.944 . . . . 0.0 109.582 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 20' ' ' ASN . 1.0 OUTLIER -90.07 -43.13 10.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.192 -0.943 . . . . 0.0 109.491 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -76.09 -35.95 59.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.232 -0.917 . . . . 0.0 109.477 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.499 ' HB3' ' CE1' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -65.79 -27.53 68.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -0.914 . . . . 0.0 109.489 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.535 ' C ' ' CD1' ' A' ' 28' ' ' TYR . . . 106.77 73.01 0.83 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.535 ' CD1' ' C ' ' A' ' 27' ' ' GLY . 79.3 m-85 -151.17 134.71 16.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.225 -1.162 . . . . 0.0 109.539 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -93.99 83.84 4.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.228 -0.92 . . . . 0.0 109.265 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.524 ' CG2' ' HB ' ' A' ' 6' ' ' ILE . 5.8 p -89.87 161.59 15.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.187 -0.946 . . . . 0.0 109.562 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.52 ' HB2' ' CD2' ' A' ' 7' ' ' LEU . 25.6 m-85 -121.66 -168.65 1.73 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -0.899 . . . . 0.0 109.331 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.454 ' HB3' ' CZ ' ' A' ' 16' ' ' ARG . 6.9 mp0 -123.92 150.79 44.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.185 -0.947 . . . . 0.0 109.533 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.476 ' CB ' HD13 ' A' ' 7' ' ' LEU . . . -162.24 173.16 14.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.22 -0.925 . . . . 0.0 109.38 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.477 ' HB3' ' CA ' ' A' ' 11' ' ' ASP . . . -174.77 -47.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.253 -0.905 . . . . 0.0 109.541 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.45 ' OD1' ' HB2' ' A' ' 38' ' ' GLN . 19.1 p30 -70.17 -5.66 28.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.245 -0.909 . . . . 0.0 109.585 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.98 -58.77 4.77 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.531 ' CD1' ' N ' ' A' ' 38' ' ' GLN . 4.2 pp -52.39 -40.24 61.84 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.271 -1.135 . . . . 0.0 109.476 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.531 ' N ' ' CD1' ' A' ' 37' ' ' LEU . 1.8 tp60 -66.36 -33.34 75.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.325 -0.859 . . . . 0.0 109.358 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.439 ' HB3' HG21 ' A' ' 9' ' ' VAL . . . -64.53 -62.56 1.51 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.211 -0.931 . . . . 0.0 109.407 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.521 HD21 ' CD1' ' A' ' 72' ' ' ILE . 13.4 mt -54.35 -35.92 63.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -0.899 . . . . 0.0 109.445 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -57.54 -53.29 59.85 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.222 -0.924 . . . . 0.0 109.387 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.52 ' CD1' ' O ' ' A' ' 38' ' ' GLN . 1.8 mp -64.91 -20.72 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.275 -0.891 . . . . 0.0 109.387 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.526 ' HA ' ' CD ' ' A' ' 48' ' ' PRO . 21.6 t -81.51 -23.28 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.25 -0.906 . . . . 0.0 109.49 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.5 m -90.01 -28.54 19.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.321 -0.862 . . . . 0.0 109.533 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.6 mttm -87.44 -37.9 16.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.279 -0.888 . . . . 0.0 109.517 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.437 ' HG3' HG22 ' A' ' 42' ' ' ILE . 1.3 mm-40 -101.28 -39.6 7.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.261 -0.9 . . . . 0.0 109.466 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 0.9 OUTLIER 63.26 67.07 1.08 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.42 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.526 ' CD ' ' HA ' ' A' ' 43' ' ' VAL . 35.4 Cg_endo -77.51 -161.03 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.633 2.222 . . . . 0.0 110.469 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.52 ' O ' ' CD2' ' A' ' 50' ' ' LEU . 27.4 t70 -135.24 9.38 3.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 0.0 109.537 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.52 ' CD2' ' O ' ' A' ' 49' ' ' ASP . 0.4 OUTLIER -146.58 107.72 4.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.226 -0.921 . . . . 0.0 109.557 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.497 HG13 ' CE ' ' A' ' 69' ' ' MET . 1.7 t -113.47 109.49 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 109.382 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.461 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 1.3 mp -90.58 127.98 36.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.239 -0.913 . . . . 0.0 109.512 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.577 ' CD2' ' CG1' ' A' ' 78' ' ' VAL . 2.6 mm? -113.42 146.11 40.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.233 -0.917 . . . . 0.0 109.429 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.465 ' O ' HG13 ' A' ' 57' ' ' ILE . 12.5 t70 -118.76 111.48 18.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.34 -0.85 . . . . 0.0 109.371 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.447 ' CG ' HG23 ' A' ' 82' ' ' THR . 15.5 mmt -70.6 -5.02 26.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.219 -0.926 . . . . 0.0 109.594 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.454 ' HG3' ' OG1' ' A' ' 82' ' ' THR . 24.1 mttt -90.08 14.33 12.65 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.141 -0.975 . . . . 0.0 109.67 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.466 HG22 ' HD2' ' A' ' 58' ' ' PRO . 83.4 mt -76.57 139.63 67.43 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.187 -0.945 . . . . 0.0 109.301 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.49 ' CD ' ' CG ' ' A' ' 11' ' ' ASP . 35.8 Cg_endo -78.18 -37.75 0.72 Allowed 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.504 2.136 . . . . 0.0 110.443 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.447 ' O ' ' HB3' ' A' ' 60' ' ' MET . . . -43.71 -43.66 6.62 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.505 ' N ' ' SD ' ' A' ' 60' ' ' MET . 0.0 OUTLIER 178.4 -167.95 0.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -1.141 . . . . 0.0 109.361 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -87.77 120.34 28.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.436 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.445 ' HA2' HG13 ' A' ' 65' ' ' ILE . . . -58.14 -16.07 24.88 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.41 ' C ' ' O ' ' A' ' 62' ' ' GLY . 25.9 mm -44.09 -50.34 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -1.141 . . . . 0.0 109.465 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' A' ' 68' ' ' ARG . 6.4 mt-10 -64.56 -38.89 92.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.885 . . . . 0.0 109.425 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.463 ' O ' ' HB2' ' A' ' 68' ' ' ARG . 30.4 mt -53.24 -60.63 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 0.0 109.497 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.526 ' CD2' HG13 ' A' ' 78' ' ' VAL . 2.8 mt -50.25 -62.04 1.82 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.905 . . . . 0.0 109.71 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.45 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -41.45 -33.48 0.43 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.358 -0.839 . . . . 0.0 109.68 -179.895 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.465 ' O ' ' N ' ' A' ' 70' ' ' LYS . 24.8 mtt-85 -72.3 -63.04 1.23 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.211 -0.931 . . . . 0.0 109.391 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.519 ' SD ' ' CD2' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -40.6 -28.21 0.07 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.508 -0.745 . . . . 0.0 109.537 -179.385 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.581 ' N ' ' CD ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -78.07 -60.4 2.39 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.057 -1.027 . . . . 0.0 109.098 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 67' ' ' LYS . 3.4 t -43.44 -26.77 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.449 -0.782 . . . . 0.0 109.592 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.521 ' CD1' HD21 ' A' ' 40' ' ' LEU . 71.7 mt -85.31 -54.2 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.251 -0.906 . . . . 0.0 109.41 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.461 ' O ' HG23 ' A' ' 76' ' ' ILE . 1.4 m-20 -136.78 124.68 22.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.334 -0.854 . . . . 0.0 109.322 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -83.09 -9.23 59.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.213 -0.929 . . . . 0.0 109.51 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 -107.06 50.75 0.76 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.918 . . . . 0.0 109.522 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.474 ' CG1' HG22 ' A' ' 51' ' ' VAL . 3.2 tp -125.4 105.22 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.221 -0.925 . . . . 0.0 109.519 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.525 ' CG ' HD12 ' A' ' 99' ' ' LEU . 75.0 mtt85 -55.19 155.5 4.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 109.473 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.577 ' CG1' ' CD2' ' A' ' 53' ' ' LEU . 3.2 t -142.78 138.82 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.272 -0.893 . . . . 0.0 109.606 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.504 ' CG1' HD13 ' A' ' 50' ' ' LEU . 9.0 mm -121.39 123.6 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.238 -0.914 . . . . 0.0 109.229 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.566 ' HB ' ' CD2' ' A' ' 101' ' ' HIS . 0.7 OUTLIER -89.71 144.35 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.143 -0.973 . . . . 0.0 109.429 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.454 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 5.0 mtm -124.77 57.45 1.27 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.212 -0.93 . . . . 0.0 109.51 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.512 ' N ' ' O ' ' A' ' 102' ' ' PHE . 10.7 t -169.38 47.48 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.279 -0.888 . . . . 0.0 109.57 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.575 ' N ' ' CB ' ' A' ' 103' ' ' ALA . . . . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.245 -0.909 . . . . 0.0 109.522 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.541 HG12 ' CE1' ' A' ' 101' ' ' HIS . 15.5 mt . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.49 -32.47 71.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.311 -0.868 . . . . 0.0 109.499 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -89.8 -31.02 17.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.287 -0.883 . . . . 0.0 109.467 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.68 -51.44 69.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.265 -0.897 . . . . 0.0 109.479 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 95' ' ' GLU . 14.3 tttm -52.78 -57.95 8.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.0 109.465 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 94' ' ' LYS . 59.3 mt-10 -44.06 -50.54 8.39 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.232 -0.917 . . . . 0.0 109.49 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.9 mt -53.0 -48.25 67.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.307 -0.871 . . . . 0.0 109.457 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 154.46 42.65 0.02 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -99.48 118.11 35.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.19 -1.182 . . . . 0.0 109.487 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.573 HD11 ' CD1' ' A' ' 118' ' ' TYR . 21.9 mt -55.24 -81.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.477 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.573 ' OG1' ' CE1' ' A' ' 102' ' ' PHE . 0.1 OUTLIER -126.27 175.65 7.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.208 -0.933 . . . . 0.0 109.477 -179.956 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.566 ' CD2' ' HB ' ' A' ' 80' ' ' ILE . 4.7 t-160 -146.03 97.19 2.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 109.256 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.573 ' CE1' ' OG1' ' A' ' 100' ' ' THR . 18.4 m-30 -108.81 159.55 16.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.182 -0.949 . . . . 0.0 109.597 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.575 ' CB ' ' N ' ' A' ' 83' ' ' ALA . . . -128.73 168.39 15.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.319 -0.863 . . . . 0.0 109.343 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.468 ' C ' ' CD ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -90.97 144.85 30.68 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.186 -0.946 . . . . 0.0 109.48 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.09 130.2 20.42 Favored 'Cis proline' 0 C--N 1.309 -1.547 0 C-N-CA 123.353 -1.52 . . . . 0.0 110.36 0.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.483 ' CE1' HD12 ' A' ' 108' ' ' ILE . 0.7 OUTLIER -102.22 -174.51 2.59 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.282 -0.886 . . . . 0.0 109.448 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.411 ' O ' ' C ' ' A' ' 108' ' ' ILE . 46.5 t0 -111.97 100.35 8.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.305 -0.872 . . . . 0.0 109.489 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.483 HD12 ' CE1' ' A' ' 106' ' ' PHE . 12.5 mm -44.51 -31.21 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.381 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -63.77 -51.07 66.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.225 -0.922 . . . . 0.0 109.392 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' A' ' 113' ' ' ASP . 7.5 tt0 -57.07 -47.11 81.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.17 -0.956 . . . . 0.0 109.375 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.5 mm -51.82 -60.14 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.365 -0.834 . . . . 0.0 109.453 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.465 ' O ' ' HG3' ' A' ' 116' ' ' LYS . 98.8 mtt180 -49.54 -34.26 16.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.918 . . . . 0.0 109.51 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 110' ' ' GLU . 19.3 m-20 -67.29 -74.61 0.11 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 109.642 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.427 ' O ' ' C ' ' A' ' 115' ' ' VAL . . . -47.56 -63.43 1.05 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.239 -0.913 . . . . 0.0 109.622 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.427 ' C ' ' O ' ' A' ' 114' ' ' ALA . 49.4 t -42.49 -57.44 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.365 -0.835 . . . . 0.0 109.846 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 0.0 OUTLIER -45.78 -44.77 14.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.175 -0.953 . . . . 0.0 109.621 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 4.5 tptp -62.05 -39.9 93.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 109.703 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.573 ' CD1' HD11 ' A' ' 99' ' ' LEU . 48.7 m-85 -67.44 -69.77 0.29 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.168 -0.958 . . . . 0.0 109.654 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.483 ' CD1' ' C ' ' A' ' 119' ' ' LEU . 1.3 tm? -90.07 112.46 52.51 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.185 -0.947 . . . . 0.0 109.482 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 118' ' ' TYR . 36.1 Cg_endo -78.25 141.95 18.69 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.322 2.015 . . . . 0.0 110.418 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.452 ' HB2' ' OH ' ' A' ' 28' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.171 -0.956 . . . . 0.0 109.485 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 121.308 0.575 . . . . 0.0 109.992 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.485 ' CG ' ' HA ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -108.85 147.47 32.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.245 -0.909 . . . . 0.0 109.465 179.885 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.498 ' CG2' ' N ' ' A' ' 7' ' ' LEU . 16.3 mt -149.7 165.15 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.229 -0.919 . . . . 0.0 109.519 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.516 ' CD2' ' HB2' ' A' ' 31' ' ' PHE . 2.2 tm? -131.67 133.41 44.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.302 -0.874 . . . . 0.0 109.457 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.514 ' N ' HD12 ' A' ' 7' ' ' LEU . 12.4 mt -117.86 101.75 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.191 -0.943 . . . . 0.0 109.348 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.459 HG21 ' CD1' ' A' ' 7' ' ' LEU . 4.9 t -89.97 125.58 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.928 . . . . 0.0 109.522 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.465 ' O ' ' HB3' ' A' ' 34' ' ' ALA . 12.7 t70 -174.41 145.61 0.99 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.261 -0.9 . . . . 0.0 109.512 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.461 ' OD2' ' HD2' ' A' ' 58' ' ' PRO . 8.0 p-10 -117.95 -31.9 4.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.218 -0.926 . . . . 0.0 109.391 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.4 ' O ' ' C ' ' A' ' 13' ' ' TYR . 21.8 tm0? -69.73 104.64 2.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.334 -0.854 . . . . 0.0 109.589 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.628 ' CE2' ' CD1' ' A' ' 17' ' ' ILE . 6.7 t80 -43.63 123.13 2.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.337 -0.852 . . . . 0.0 109.569 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.77 -47.43 0.79 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.462 HD11 ' OD1' ' A' ' 10' ' ' ASP . 5.0 mt -80.1 -59.25 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -1.153 . . . . 0.0 109.486 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.481 ' HG2' ' CG ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -43.36 -26.69 0.21 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.235 -0.916 . . . . 0.0 109.714 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.628 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 2.4 mt -90.07 -64.33 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.19 -0.943 . . . . 0.0 109.697 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.422 ' O ' HG21 ' A' ' 22' ' ' VAL . 9.6 mt -47.59 -61.08 2.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.157 -0.964 . . . . 0.0 109.749 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.457 HD22 HD23 ' A' ' 52' ' ' LEU . 1.4 mp -52.76 -30.88 35.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -0.932 . . . . 0.0 109.575 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.467 ' HB3' ' O ' ' A' ' 17' ' ' ILE . 28.7 t30 -67.72 -72.42 0.17 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.223 -0.923 . . . . 0.0 109.716 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 20' ' ' ASN . 0.6 OUTLIER -43.72 -31.21 0.75 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 109.604 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.422 HG21 ' O ' ' A' ' 18' ' ' LEU . 67.4 t -66.77 -52.15 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.294 -0.879 . . . . 0.0 109.486 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.523 ' CB ' HG22 ' A' ' 30' ' ' THR . 22.9 m-85 -79.92 -0.47 35.15 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.187 -0.946 . . . . 0.0 109.62 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.422 ' ND2' ' OD1' ' A' ' 20' ' ' ASN . 0.7 OUTLIER -88.4 -48.15 7.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.145 -0.972 . . . . 0.0 109.462 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.54 -10.54 59.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.466 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.504 ' HB3' ' CE1' ' A' ' 28' ' ' TYR . 1.7 tt0 -89.43 -26.29 21.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.304 -0.872 . . . . 0.0 109.457 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.533 ' C ' ' CD1' ' A' ' 28' ' ' TYR . . . 105.91 67.73 0.69 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.629 ' CE2' ' CD2' ' A' ' 121' ' ' LEU . 90.2 m-85 -154.68 134.87 13.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.203 -1.175 . . . . 0.0 109.443 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -91.51 81.86 5.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.891 . . . . 0.0 109.326 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.523 HG22 ' CB ' ' A' ' 23' ' ' PHE . 5.7 p -89.92 146.37 24.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.311 -0.868 . . . . 0.0 109.608 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.516 ' HB2' ' CD2' ' A' ' 7' ' ' LEU . 57.6 m-85 -106.96 -173.34 2.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.256 -0.902 . . . . 0.0 109.231 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.481 ' CG ' ' HG2' ' A' ' 16' ' ' ARG . 78.8 mt-30 -131.04 151.58 51.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.182 -0.949 . . . . 0.0 109.676 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.52 ' O ' ' CB ' ' A' ' 34' ' ' ALA . . . -160.68 -163.47 1.07 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.302 -0.874 . . . . 0.0 109.291 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' A' ' 33' ' ' ALA . . . 164.41 -44.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.922 . . . . 0.0 109.591 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.453 ' OD1' ' HB2' ' A' ' 38' ' ' GLN . 45.7 p-10 -67.07 -8.51 31.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.22 -0.925 . . . . 0.0 109.569 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.447 ' HA2' HD12 ' A' ' 65' ' ' ILE . . . 87.49 -68.01 3.18 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 36' ' ' GLY . 0.2 OUTLIER -45.06 -53.49 7.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.254 -1.145 . . . . 0.0 109.378 179.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.495 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 2.8 tp60 -48.99 -55.87 10.63 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.209 -0.932 . . . . 0.0 109.473 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 38' ' ' GLN . . . -43.85 -50.12 8.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.283 -0.885 . . . . 0.0 109.455 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.405 HD23 ' CB ' ' A' ' 68' ' ' ARG . 96.5 mt -55.63 -43.03 75.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.253 -0.904 . . . . 0.0 109.452 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 8.3 m-20 -62.55 -28.71 70.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.295 -0.878 . . . . 0.0 109.373 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.507 HG22 ' CD2' ' A' ' 7' ' ' LEU . 20.6 mm -75.92 -29.9 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.222 -0.924 . . . . 0.0 109.477 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.525 ' O ' ' CG ' ' A' ' 47' ' ' ARG . 68.3 t -80.93 -25.24 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.272 -0.892 . . . . 0.0 109.417 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.439 ' HA ' ' HD2' ' A' ' 47' ' ' ARG . 4.1 m -87.14 -30.69 20.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.276 -0.89 . . . . 0.0 109.515 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 1.1 mtpt -89.99 -25.68 20.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.386 -0.821 . . . . 0.0 109.532 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -123.53 -31.59 3.48 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.206 -0.934 . . . . 0.0 109.56 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.525 ' CG ' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER 47.27 71.53 1.56 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.929 . . . . 0.0 109.481 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.522 ' CD ' ' HA ' ' A' ' 43' ' ' VAL . 34.5 Cg_endo -77.78 -178.54 4.68 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 122.683 2.255 . . . . 0.0 110.616 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.454 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 3.3 p30 -110.44 -20.02 12.74 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.412 -0.805 . . . . 0.0 109.185 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.518 HD23 ' CG2' ' A' ' 115' ' ' VAL . 7.4 tp -115.18 122.24 45.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.307 -0.871 . . . . 0.0 109.554 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.526 HG12 ' CE ' ' A' ' 69' ' ' MET . 1.8 t -126.08 115.47 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.29 -0.881 . . . . 0.0 109.508 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.466 HD11 ' HA ' ' A' ' 8' ' ' ILE . 1.0 OUTLIER -89.98 108.31 19.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.235 -0.915 . . . . 0.0 109.433 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.506 HD12 ' CE ' ' A' ' 69' ' ' MET . 1.1 tp -97.69 119.13 35.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.16 -0.963 . . . . 0.0 109.429 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.512 ' HB2' ' CE ' ' A' ' 81' ' ' MET . 40.7 t0 -100.62 104.1 15.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 109.423 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.456 ' HB2' ' HB ' ' A' ' 82' ' ' THR . 2.8 mmt -65.26 -10.42 31.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.306 -0.871 . . . . 0.0 109.452 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.467 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 3.3 mmtp -66.04 -24.72 66.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.209 -0.932 . . . . 0.0 109.459 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.518 HG22 HD11 ' A' ' 57' ' ' ILE . 48.9 mt -43.12 103.12 0.3 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.368 -0.832 . . . . 0.0 109.533 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 56' ' ' LYS . 35.3 Cg_endo -77.94 119.73 4.82 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.396 2.064 . . . . 0.0 110.388 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 108.55 5.83 31.49 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.517 ' CE ' HD11 ' A' ' 57' ' ' ILE . 24.9 ttp -165.13 127.33 2.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -1.161 . . . . 0.0 109.408 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -89.71 120.13 30.72 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -0.908 . . . . 0.0 109.423 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.461 ' HA2' HG13 ' A' ' 65' ' ' ILE . . . -67.87 -7.83 50.75 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.407 ' HA ' HD11 ' A' ' 63' ' ' ILE . 16.5 mm -53.08 -40.12 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.184 -1.186 . . . . 0.0 109.507 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -68.68 -44.1 74.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.216 -0.927 . . . . 0.0 109.418 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.47 ' CG2' ' HE1' ' A' ' 69' ' ' MET . 11.4 mt -46.4 -51.86 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.258 -0.901 . . . . 0.0 109.491 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.524 ' O ' ' CE ' ' A' ' 70' ' ' LYS . 55.2 mt -56.56 -41.06 76.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.289 -0.882 . . . . 0.0 109.428 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 1.3 tttm -54.73 -41.01 69.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.226 -0.921 . . . . 0.0 109.493 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.405 ' CB ' HD23 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -77.07 -21.19 54.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 109.441 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.526 ' CE ' HG12 ' A' ' 51' ' ' VAL . 14.3 mtt -72.13 -40.08 68.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.261 -0.9 . . . . 0.0 109.439 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.524 ' CE ' ' O ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -79.72 -37.63 35.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.272 -0.892 . . . . 0.0 109.522 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 97.5 t -65.46 -32.67 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.22 -0.925 . . . . 0.0 109.445 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.426 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 45.0 mm -89.65 -27.29 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.227 -0.921 . . . . 0.0 109.453 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.456 ' O ' ' O ' ' A' ' 69' ' ' MET . 15.7 m-20 -163.42 130.26 3.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.267 -0.895 . . . . 0.0 109.471 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -89.98 -10.88 43.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.229 -0.919 . . . . 0.0 109.48 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -106.94 50.23 0.78 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.288 -0.882 . . . . 0.0 109.445 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.456 HG22 ' HB3' ' A' ' 69' ' ' MET . 0.8 OUTLIER -117.94 122.98 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.269 -0.894 . . . . 0.0 109.519 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.464 ' HA ' HD13 ' A' ' 99' ' ' LEU . 10.4 mtt180 -79.31 141.66 36.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.209 -0.932 . . . . 0.0 109.426 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.456 HG11 ' O ' ' A' ' 51' ' ' VAL . 2.7 t -147.74 119.06 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.886 . . . . 0.0 109.603 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.434 HG21 ' O ' ' A' ' 100' ' ' THR . 23.5 mt -89.87 170.6 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 0.0 109.297 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.88 126.86 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.198 -0.938 . . . . 0.0 109.435 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.512 ' CE ' ' HB2' ' A' ' 54' ' ' ASP . 20.7 mtm -110.01 84.22 1.89 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 109.181 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.527 ' O ' ' CB ' ' A' ' 103' ' ' ALA . 4.7 t -149.67 -146.99 0.21 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.214 -0.929 . . . . 0.0 109.497 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.522 ' N ' ' CG2' ' A' ' 82' ' ' THR . . . . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.407 -0.808 . . . . 0.0 109.918 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.5 mt . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.81 -38.31 21.73 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.286 -0.884 . . . . 0.0 109.492 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.46 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 0.6 OUTLIER -90.03 -38.03 13.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.936 . . . . 0.0 109.514 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.473 ' O ' ' CB ' ' A' ' 98' ' ' ALA . 14.2 m -63.19 -12.15 26.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.254 -0.904 . . . . 0.0 109.554 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -71.96 -71.6 0.27 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.275 -0.89 . . . . 0.0 109.464 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -66.45 -13.22 60.48 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.35 -0.844 . . . . 0.0 109.422 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.504 ' HB3' ' NZ ' ' A' ' 70' ' ' LYS . 32.9 mt -74.55 -50.57 17.54 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.185 -0.947 . . . . 0.0 109.38 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 172.99 45.78 0.05 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.473 ' CB ' ' O ' ' A' ' 93' ' ' SER . . . -132.06 146.38 52.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -1.156 . . . . 0.0 109.411 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.464 HD13 ' HA ' ' A' ' 77' ' ' ARG . 0.4 OUTLIER -128.04 -60.32 1.15 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.336 -0.852 . . . . 0.0 109.489 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.574 HG22 ' CE2' ' A' ' 102' ' ' PHE . 17.1 m -102.97 148.96 25.02 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.263 -0.898 . . . . 0.0 109.571 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.52 ' NE2' HG21 ' A' ' 82' ' ' THR . 2.8 t-160 -144.84 93.77 2.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.892 . . . . 0.0 109.347 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.574 ' CE2' HG22 ' A' ' 100' ' ' THR . 18.7 m-30 -111.9 161.61 16.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.896 . . . . 0.0 109.587 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 82' ' ' THR . . . -113.51 -159.99 0.71 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.309 -0.87 . . . . 0.0 109.443 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.508 ' CG ' ' HA ' ' A' ' 105' ' ' PRO . 3.7 mttt -100.37 152.55 37.86 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.232 -0.918 . . . . 0.0 109.498 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.583 ' O ' ' CG ' ' A' ' 106' ' ' PHE . 37.1 Cg_endo -81.62 28.15 4.52 Favored 'Cis proline' 0 C--N 1.309 -1.506 0 C-N-CA 123.371 -1.512 . . . . 0.0 111.126 -0.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.583 ' CG ' ' O ' ' A' ' 105' ' ' PRO . 52.1 p90 41.46 -164.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.37 -0.831 . . . . 0.0 109.844 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.455 ' O ' HG12 ' A' ' 111' ' ' ILE . 30.5 t0 -150.1 118.7 6.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.87 . . . . 0.0 109.461 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.42 ' O ' ' HG2' ' A' ' 112' ' ' ARG . 12.7 mm -54.12 -19.73 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.25 -0.906 . . . . 0.0 109.393 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -75.75 -57.27 3.98 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.192 -0.942 . . . . 0.0 109.427 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -59.66 -24.18 63.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.179 -0.951 . . . . 0.0 109.491 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.455 HG12 ' O ' ' A' ' 107' ' ' ASP . 22.9 mm -74.12 -56.29 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.305 -0.872 . . . . 0.0 109.46 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 108' ' ' ILE . 2.5 ptt180 -60.04 -23.62 63.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.202 -0.936 . . . . 0.0 109.533 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -76.1 -63.25 1.36 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.32 -0.863 . . . . 0.0 109.482 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.507 ' O ' ' CD2' ' A' ' 118' ' ' TYR . . . -51.07 -31.87 20.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.244 -0.91 . . . . 0.0 109.381 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.518 ' CG2' HD23 ' A' ' 50' ' ' LEU . 72.6 t -75.44 -36.32 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.232 -0.918 . . . . 0.0 109.411 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.407 ' HE2' ' HB3' ' A' ' 116' ' ' LYS . 0.4 OUTLIER -69.44 -21.1 63.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.233 -0.917 . . . . 0.0 109.465 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -89.48 -40.06 12.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.211 -0.931 . . . . 0.0 109.52 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.507 ' CD2' ' O ' ' A' ' 114' ' ' ALA . 26.2 m-85 -76.13 -63.3 1.35 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 0.0 109.487 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.477 ' C ' ' CD2' ' A' ' 119' ' ' LEU . 4.1 tt -90.19 112.42 52.46 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 0.0 109.445 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.465 ' O ' HD21 ' A' ' 121' ' ' LEU . 35.9 Cg_endo -78.07 151.51 27.18 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.429 2.086 . . . . 0.0 110.402 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.629 ' CD2' ' CE2' ' A' ' 28' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.275 -0.891 . . . . 0.0 109.491 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.542 ' CD ' ' N ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -136.76 154.51 50.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.244 -0.91 . . . . 0.0 109.51 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.458 HG21 ' O ' ' A' ' 50' ' ' LEU . 4.3 mt -150.09 159.54 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.228 -0.92 . . . . 0.0 109.379 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.514 ' CD2' ' HB2' ' A' ' 31' ' ' PHE . 2.8 tm? -132.22 107.62 8.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.256 -0.903 . . . . 0.0 109.382 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.447 HD12 ' HB3' ' A' ' 19' ' ' LEU . 4.2 mt -94.81 110.51 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 0.0 109.451 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.511 HG23 ' CB ' ' A' ' 33' ' ' ALA . 61.1 t -95.46 109.49 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.231 -0.918 . . . . 0.0 109.44 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.514 ' CB ' ' HD2' ' A' ' 16' ' ' ARG . 4.2 m-20 -148.96 110.39 4.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.253 -0.904 . . . . 0.0 109.469 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.458 ' OD2' ' HD2' ' A' ' 58' ' ' PRO . 5.5 p-10 -76.38 -33.55 58.89 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 109.43 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.448 ' O ' ' O ' ' A' ' 13' ' ' TYR . 27.1 tt0 -78.77 104.24 9.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.25 -0.906 . . . . 0.0 109.5 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.638 ' CE2' ' CD1' ' A' ' 17' ' ' ILE . 2.6 t80 -44.56 168.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.205 -0.935 . . . . 0.0 109.509 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.77 -66.16 0.33 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.524 HG22 ' CD1' ' A' ' 19' ' ' LEU . 2.3 mt -63.4 -63.41 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.301 -1.117 . . . . 0.0 109.275 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.526 ' HB2' ' CG ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -42.23 -26.69 0.11 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.354 -0.841 . . . . 0.0 109.95 -179.804 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.638 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 20.6 mt -79.22 -59.63 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.106 -0.996 . . . . 0.0 109.761 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.523 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 11.0 mp -53.28 -57.13 11.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.925 . . . . 0.0 109.721 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.524 ' CD1' HG22 ' A' ' 15' ' ' ILE . 7.3 mp -57.18 -22.51 41.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.235 -0.915 . . . . 0.0 109.578 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 23.6 t30 -75.84 -72.38 0.32 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.308 -0.87 . . . . 0.0 109.549 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -52.91 -19.96 2.97 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.343 -0.848 . . . . 0.0 109.642 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.527 ' CG1' ' HD3' ' A' ' 112' ' ' ARG . 77.2 t -77.85 -58.77 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.187 -0.945 . . . . 0.0 109.39 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.527 ' CB ' HG22 ' A' ' 30' ' ' THR . 13.8 m-85 -66.68 -11.18 53.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.192 -0.943 . . . . 0.0 109.349 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.446 ' OD1' ' O ' ' A' ' 20' ' ' ASN . 21.7 m120 -73.31 -61.2 1.91 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.282 -0.886 . . . . 0.0 109.404 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -18.78 63.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.236 -0.915 . . . . 0.0 109.265 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.517 ' HB3' ' CD2' ' A' ' 28' ' ' TYR . 2.7 mt-10 -75.52 -34.18 60.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.299 -0.876 . . . . 0.0 109.41 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.2 46.51 0.75 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.561 ' CZ ' HD13 ' A' ' 121' ' ' LEU . 94.1 m-85 -139.0 134.56 33.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.269 -1.136 . . . . 0.0 109.529 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -91.01 83.63 5.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.099 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.527 HG22 ' CB ' ' A' ' 23' ' ' PHE . 5.7 p -89.74 150.56 22.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.939 . . . . 0.0 109.616 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.558 ' CZ ' ' OE2' ' A' ' 46' ' ' GLU . 17.8 m-85 -111.95 -168.38 1.31 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.302 -0.874 . . . . 0.0 109.264 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.526 ' CG ' ' HB2' ' A' ' 16' ' ' ARG . 0.6 OUTLIER -132.26 150.05 52.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.178 -0.951 . . . . 0.0 109.687 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.511 ' CB ' HG23 ' A' ' 9' ' ' VAL . . . -146.38 -174.4 4.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.229 -0.919 . . . . 0.0 109.349 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.441 ' O ' ' HE2' ' A' ' 60' ' ' MET . . . -175.98 -57.02 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.176 -0.952 . . . . 0.0 109.619 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -81.18 0.21 37.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 109.591 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.17 -53.78 4.65 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -45.08 -59.06 2.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -1.148 . . . . 0.0 109.549 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.439 ' O ' HD11 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -51.96 -38.17 55.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 0.0 109.496 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.45 ' O ' ' HB ' ' A' ' 43' ' ' VAL . . . -60.16 -38.44 83.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.904 . . . . 0.0 109.551 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.534 ' HA ' ' CG1' ' A' ' 43' ' ' VAL . 35.4 mt -76.25 -20.93 56.94 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.391 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.506 ' O ' ' CG ' ' A' ' 45' ' ' LYS . 0.8 OUTLIER -75.38 -40.23 58.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.132 -0.98 . . . . 0.0 109.041 179.705 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.46 HG12 ' CD2' ' A' ' 31' ' ' PHE . 1.8 mp -83.86 -24.76 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.337 -0.852 . . . . 0.0 109.245 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.534 ' CG1' ' HA ' ' A' ' 40' ' ' LEU . 1.5 p -72.63 -38.88 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.265 -0.897 . . . . 0.0 109.236 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.457 ' O ' HG21 ' A' ' 44' ' ' THR . 7.8 m -90.03 -22.86 21.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.361 -0.837 . . . . 0.0 109.438 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.506 ' CG ' ' O ' ' A' ' 41' ' ' ASP . 58.3 mttt -75.32 -54.42 7.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.21 -0.931 . . . . 0.0 109.618 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.558 ' OE2' ' CZ ' ' A' ' 31' ' ' PHE . 0.6 OUTLIER -91.34 -29.83 16.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.9 . . . . 0.0 109.632 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.515 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 0.0 OUTLIER 71.24 61.64 0.43 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.267 -0.896 . . . . 0.0 109.472 -179.975 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.525 ' HA ' ' CG ' ' A' ' 5' ' ' LYS . 35.4 Cg_endo -77.95 155.49 30.22 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.63 2.22 . . . . 0.0 110.462 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 0.3 OUTLIER -101.51 -9.02 21.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.26 -0.9 . . . . 0.0 109.477 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.458 ' O ' HG21 ' A' ' 6' ' ' ILE . 9.1 tp -124.79 116.51 22.41 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.203 -0.935 . . . . 0.0 109.517 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 43.3 t -128.38 118.08 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.176 -0.953 . . . . 0.0 109.472 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.4 HD11 HG21 ' A' ' 8' ' ' ILE . 0.7 OUTLIER -89.95 119.09 30.02 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.196 -0.94 . . . . 0.0 109.45 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.522 ' CD2' ' HG ' ' A' ' 66' ' ' LEU . 1.2 mp -104.1 138.24 40.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.32 -0.863 . . . . 0.0 109.446 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.437 ' O ' HG13 ' A' ' 57' ' ' ILE . 26.3 t70 -114.5 110.81 20.4 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.22 -0.925 . . . . 0.0 109.516 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.441 ' HB2' HG23 ' A' ' 82' ' ' THR . 24.5 mmt -73.34 -2.42 22.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.206 -0.934 . . . . 0.0 109.608 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.463 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 16.2 mmtt -85.35 13.16 6.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.156 -0.965 . . . . 0.0 109.552 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.521 ' CG2' ' CE ' ' A' ' 60' ' ' MET . 40.2 mt -78.48 114.29 41.75 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.27 -0.894 . . . . 0.0 109.417 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 56' ' ' LYS . 35.7 Cg_endo -78.23 107.02 2.24 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.376 2.051 . . . . 0.0 110.375 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 155.13 -44.0 0.56 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.521 ' CE ' ' CG2' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -158.99 163.46 36.44 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.168 -1.196 . . . . 0.0 109.427 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -89.88 144.83 25.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.209 -0.932 . . . . 0.0 109.559 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.458 ' O ' ' HB ' ' A' ' 65' ' ' ILE . . . -87.2 -1.22 84.44 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.8 mm -52.69 -52.83 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.201 -1.176 . . . . 0.0 109.464 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -61.22 -27.08 68.18 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.186 -0.946 . . . . 0.0 109.365 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.458 ' HB ' ' O ' ' A' ' 62' ' ' GLY . 19.4 mt -63.23 -66.7 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.316 -0.865 . . . . 0.0 109.456 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.522 ' HG ' ' CD2' ' A' ' 53' ' ' LEU . 16.4 mt -46.05 -25.56 0.59 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.91 . . . . 0.0 109.448 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.451 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 2.4 tmtp? -68.49 -60.26 2.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -0.895 . . . . 0.0 109.503 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.48 -29.04 61.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.263 -0.898 . . . . 0.0 109.428 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.436 ' SD ' HG23 ' A' ' 43' ' ' VAL . 3.1 mmt -64.78 -62.53 1.51 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.186 -0.946 . . . . 0.0 109.433 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 16.9 ptpt -51.84 -39.14 58.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.305 -0.872 . . . . 0.0 109.425 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 86.4 t -58.6 -40.6 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.189 -0.945 . . . . 0.0 109.473 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.41 ' O ' ' OD1' ' A' ' 73' ' ' ASP . 15.6 mt -73.77 -25.94 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.211 -0.931 . . . . 0.0 109.433 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.421 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 0.1 OUTLIER -173.22 140.35 0.86 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 109.497 -180.0 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -89.76 -17.9 27.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.272 -0.893 . . . . 0.0 109.441 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -86.0 11.1 12.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.258 -0.901 . . . . 0.0 109.434 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.503 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 2.1 tp -82.39 106.15 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.226 -0.921 . . . . 0.0 109.471 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.524 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 0.4 OUTLIER -77.3 154.16 33.15 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.29 -0.881 . . . . 0.0 109.514 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.511 HG23 ' CD2' ' A' ' 66' ' ' LEU . 43.0 t -147.03 121.65 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 109.545 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.443 HD12 ' HB2' ' A' ' 99' ' ' LEU . 3.6 mm -97.21 122.58 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.229 -0.919 . . . . 0.0 109.444 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.576 ' HB ' ' CG ' ' A' ' 101' ' ' HIS . 0.3 OUTLIER -90.05 126.2 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.279 -0.888 . . . . 0.0 109.293 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.561 ' SD ' ' CZ ' ' A' ' 106' ' ' PHE . 2.2 mtm -101.28 54.38 0.83 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.131 -0.981 . . . . 0.0 109.565 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 102' ' ' PHE . 14.8 t -168.64 56.25 0.05 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.3 -0.875 . . . . 0.0 109.444 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.527 ' HA ' ' CD2' ' A' ' 101' ' ' HIS . . . . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.879 . . . . 0.0 109.549 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.632 ' CD1' ' CE1' ' A' ' 101' ' ' HIS . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.723 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -58.3 -39.61 79.78 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.32 -0.863 . . . . 0.0 109.615 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -89.81 -16.22 30.64 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 109.547 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.461 ' HB2' ' HA ' ' A' ' 90' ' ' ILE . 0.6 OUTLIER -55.85 -19.0 10.11 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.26 -0.9 . . . . 0.0 109.51 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.2 mmmt -48.43 -61.32 2.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.261 -0.899 . . . . 0.0 109.495 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.408 ' O ' ' C ' ' A' ' 96' ' ' LEU . 4.9 mt-10 -65.42 -41.88 93.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.256 -0.903 . . . . 0.0 109.509 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.423 ' CD1' ' HA ' ' A' ' 93' ' ' SER . 81.6 mt -44.19 -38.86 4.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.226 -0.921 . . . . 0.0 109.457 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 143.61 40.08 0.06 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -102.91 99.06 8.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.222 -1.163 . . . . 0.0 109.486 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.561 HD21 ' CD1' ' A' ' 118' ' ' TYR . 16.9 mt -51.72 -68.03 0.2 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.255 -0.903 . . . . 0.0 109.498 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.526 ' CG2' ' N ' ' A' ' 101' ' ' HIS . 17.1 m -135.81 165.84 24.69 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.207 -0.933 . . . . 0.0 109.551 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.632 ' CE1' ' CD1' ' A' ' 90' ' ' ILE . 4.1 t60 -130.26 84.27 2.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.367 -0.833 . . . . 0.0 109.359 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.568 ' CE1' ' CG ' ' A' ' 110' ' ' GLU . 9.3 m-85 -70.28 157.19 38.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.215 -0.928 . . . . 0.0 109.485 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.512 ' HB1' ' CB ' ' A' ' 83' ' ' ALA . . . -132.46 -148.67 0.35 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 0.0 109.476 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.47 ' HB2' ' HA ' ' A' ' 105' ' ' PRO . 2.0 pttp -96.78 157.26 35.47 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.901 . . . . 0.0 109.494 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.47 ' HA ' ' HB2' ' A' ' 104' ' ' LYS . 36.3 Cg_endo -79.76 11.2 23.9 Favored 'Cis proline' 0 C--N 1.309 -1.518 0 C-N-CA 123.285 -1.548 . . . . 0.0 110.802 -0.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.631 ' CE1' ' CD1' ' A' ' 111' ' ' ILE . 11.4 t80 70.93 96.59 0.07 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.212 -0.93 . . . . 0.0 109.437 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.462 ' O ' HG12 ' A' ' 111' ' ' ILE . 21.3 t0 -89.88 118.32 29.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 0.0 109.385 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.44 ' O ' ' HG3' ' A' ' 112' ' ' ARG . 13.4 mm -51.24 -39.1 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.168 -0.958 . . . . 0.0 109.339 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.433 ' HB2' ' OD2' ' A' ' 107' ' ' ASP . 3.2 m-20 -63.05 -37.33 86.75 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.288 -0.882 . . . . 0.0 109.373 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.568 ' CG ' ' CE1' ' A' ' 102' ' ' PHE . 3.0 tp10 -69.08 -33.5 73.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.292 -0.88 . . . . 0.0 109.257 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.631 ' CD1' ' CE1' ' A' ' 106' ' ' PHE . 10.5 mm -66.35 -54.96 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.3 -0.875 . . . . 0.0 109.272 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.527 ' HD3' ' CG1' ' A' ' 22' ' ' VAL . 3.9 mtm180 -57.46 -33.6 68.13 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.311 -0.868 . . . . 0.0 109.486 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -62.66 -62.09 1.97 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.234 -0.916 . . . . 0.0 109.768 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.425 ' O ' ' C ' ' A' ' 115' ' ' VAL . . . -58.56 -62.99 1.45 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.166 -0.958 . . . . 0.0 109.734 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.425 ' C ' ' O ' ' A' ' 114' ' ' ALA . 55.8 t -42.77 -39.09 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.357 -0.839 . . . . 0.0 109.867 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 1.4 mttt -63.48 -58.95 5.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.218 -0.926 . . . . 0.0 109.668 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -49.64 -60.03 3.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.2 -0.938 . . . . 0.0 109.603 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.561 ' CD1' HD21 ' A' ' 99' ' ' LEU . 65.6 m-85 -54.81 -73.91 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.237 -0.915 . . . . 0.0 109.601 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.8 tt -90.15 112.47 52.66 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.926 . . . . 0.0 109.538 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 118' ' ' TYR . 35.6 Cg_endo -78.44 -159.39 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.389 2.059 . . . . 0.0 110.27 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.561 HD13 ' CZ ' ' A' ' 28' ' ' TYR . 1.3 mt . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.939 . . . . 0.0 109.439 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.458 ' HB2' ' HA ' ' A' ' 48' ' ' PRO . 10.6 mttm -105.58 135.76 46.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.298 -0.876 . . . . 0.0 109.497 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.533 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 68.9 mt -150.12 146.17 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.252 -0.905 . . . . 0.0 109.468 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.57 ' CD1' ' CG2' ' A' ' 42' ' ' ILE . 0.9 OUTLIER -124.8 133.07 53.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.263 -0.898 . . . . 0.0 109.405 179.905 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.487 HD11 HG22 ' A' ' 8' ' ' ILE . 14.1 mt -102.71 113.72 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.184 -0.948 . . . . 0.0 109.503 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.46 HG23 HD22 ' A' ' 7' ' ' LEU . 13.7 t -105.77 94.48 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.17 -0.957 . . . . 0.0 109.444 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.516 ' O ' ' CD ' ' A' ' 16' ' ' ARG . 31.2 t70 -145.86 116.96 7.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.911 . . . . 0.0 109.473 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.524 ' OD2' ' CD ' ' A' ' 58' ' ' PRO . 5.8 p-10 -77.98 -46.03 22.21 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -0.902 . . . . 0.0 109.482 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.477 ' CG ' ' O ' ' A' ' 12' ' ' GLN . 3.2 pt20 -56.27 101.09 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.292 -0.88 . . . . 0.0 109.474 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.635 ' CE2' ' CD1' ' A' ' 17' ' ' ILE . 2.7 t80 -45.83 141.94 2.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.307 -0.871 . . . . 0.0 109.499 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 132.25 -53.08 0.81 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.414 ' O ' ' C ' ' A' ' 16' ' ' ARG . 2.7 mp -75.34 -53.41 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.255 -1.144 . . . . 0.0 109.445 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.516 ' CD ' ' O ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -43.89 -26.53 0.27 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.258 -0.901 . . . . 0.0 109.614 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.635 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 2.3 mt -90.12 -60.39 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.211 -0.93 . . . . 0.0 109.886 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.457 ' O ' HG21 ' A' ' 22' ' ' VAL . 0.9 OUTLIER -50.4 -60.55 2.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.149 -0.969 . . . . 0.0 109.892 -179.697 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.572 ' HG ' ' CE2' ' A' ' 23' ' ' PHE . 1.5 tp -56.3 -24.23 42.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.304 -0.872 . . . . 0.0 109.873 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.469 ' HB3' ' O ' ' A' ' 17' ' ' ILE . 25.4 t30 -71.85 -69.83 0.37 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.123 -0.986 . . . . 0.0 109.81 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.465 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 0.7 OUTLIER -47.6 -41.47 21.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.29 -0.881 . . . . 0.0 109.706 -179.787 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.513 ' CG2' HG22 ' A' ' 108' ' ' ILE . 40.4 t -56.33 -60.52 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.244 -0.91 . . . . 0.0 109.606 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.573 ' CD2' HG23 ' A' ' 30' ' ' THR . 22.0 m-85 -69.41 -6.19 28.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 0.0 109.612 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 0.7 OUTLIER -77.39 -54.83 5.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.21 -0.931 . . . . 0.0 109.286 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt -78.31 -12.2 59.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.317 -0.865 . . . . 0.0 109.289 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.42 ' HB2' ' HA ' ' A' ' 23' ' ' PHE . 3.1 mm-40 -77.09 -43.58 33.77 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.249 -0.907 . . . . 0.0 109.461 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.69 50.67 0.32 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.635 ' CZ ' ' CD1' ' A' ' 121' ' ' LEU . 98.7 m-85 -140.81 140.47 34.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.229 -1.159 . . . . 0.0 109.527 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -90.02 82.87 6.08 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.229 -0.92 . . . . 0.0 109.291 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.573 HG23 ' CD2' ' A' ' 23' ' ' PHE . 5.8 p -89.91 153.8 20.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 109.55 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.533 ' CD2' ' O ' ' A' ' 6' ' ' ILE . 7.9 m-85 -120.99 -158.25 0.75 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -0.893 . . . . 0.0 109.338 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.463 ' HG2' ' CG ' ' A' ' 16' ' ' ARG . 73.9 mt-30 -144.05 157.86 44.07 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.208 -0.932 . . . . 0.0 109.663 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -170.99 161.34 6.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.876 . . . . 0.0 109.235 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.437 ' O ' HD11 ' A' ' 57' ' ' ILE . . . -127.55 -57.9 1.27 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.197 -0.939 . . . . 0.0 109.713 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.521 ' OD1' ' CB ' ' A' ' 37' ' ' LEU . 4.1 p30 -90.4 136.47 33.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.209 -0.932 . . . . 0.0 109.483 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.522 ' HA3' ' CD1' ' A' ' 65' ' ' ILE . . . -45.1 -29.11 2.13 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.521 ' CB ' ' OD1' ' A' ' 35' ' ' ASN . 0.2 OUTLIER -47.7 -53.61 14.55 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.326 -1.102 . . . . 0.0 109.382 179.853 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.459 ' O ' ' C ' ' A' ' 39' ' ' ALA . 11.4 mt-30 -62.3 -51.07 69.16 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.245 -0.909 . . . . 0.0 109.393 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.523 ' O ' ' CG2' ' A' ' 43' ' ' VAL . . . -39.92 -37.99 0.64 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.443 -0.786 . . . . 0.0 109.804 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.46 ' O ' ' OG1' ' A' ' 44' ' ' THR . 12.7 mt -77.5 -45.05 26.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.0 109.61 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -56.26 -62.01 2.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.206 -0.934 . . . . 0.0 109.626 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.57 ' CG2' ' CD1' ' A' ' 7' ' ' LEU . 10.4 mt -56.67 -51.72 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.894 . . . . 0.0 109.753 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.526 ' HA ' ' CD ' ' A' ' 48' ' ' PRO . 45.0 t -54.06 -22.67 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.166 -0.959 . . . . 0.0 109.704 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.46 ' OG1' ' O ' ' A' ' 40' ' ' LEU . 23.0 m -89.95 -28.39 19.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.182 -0.949 . . . . 0.0 109.837 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.425 ' C ' ' HG2' ' A' ' 46' ' ' GLU . 4.1 mmmt -90.2 -6.59 55.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.208 -0.932 . . . . 0.0 109.59 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.528 ' OE1' ' CZ ' ' A' ' 31' ' ' PHE . 2.5 mt-10 -137.26 -36.2 0.66 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.242 -0.911 . . . . 0.0 109.451 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.439 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 75.3 mtm-85 58.56 65.01 3.2 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.321 -0.862 . . . . 0.0 109.462 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.526 ' CD ' ' HA ' ' A' ' 43' ' ' VAL . 35.2 Cg_endo -77.02 159.4 34.0 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.578 2.185 . . . . 0.0 110.437 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 89.1 m-20 -96.3 -5.45 40.09 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.274 -0.891 . . . . 0.0 109.656 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.458 HD21 HD12 ' A' ' 6' ' ' ILE . 5.2 tp -129.39 123.55 31.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.169 -0.957 . . . . 0.0 109.593 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.524 ' CG1' ' HE2' ' A' ' 69' ' ' MET . 22.0 t -132.09 118.81 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.351 -0.843 . . . . 0.0 109.537 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.475 HD23 ' CD2' ' A' ' 19' ' ' LEU . 1.2 mp -90.05 113.35 25.04 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -0.912 . . . . 0.0 109.42 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.516 ' CD2' ' HG ' ' A' ' 66' ' ' LEU . 1.2 mp -104.79 130.88 52.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.375 -0.828 . . . . 0.0 109.585 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.476 ' HA ' ' HG3' ' A' ' 81' ' ' MET . 32.8 t70 -108.58 105.72 15.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.288 -0.882 . . . . 0.0 109.244 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.517 ' HG3' ' CG2' ' A' ' 82' ' ' THR . 7.5 mtp -71.64 -4.12 25.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -0.916 . . . . 0.0 109.534 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.403 ' HE3' ' O ' ' A' ' 81' ' ' MET . 8.1 mttp -86.07 15.08 5.38 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.116 -0.99 . . . . 0.0 109.508 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.462 ' HA ' ' OD1' ' A' ' 11' ' ' ASP . 53.8 mt -74.13 132.65 79.26 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.188 -0.945 . . . . 0.0 109.41 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.524 ' CD ' ' OD2' ' A' ' 11' ' ' ASP . 36.7 Cg_endo -80.54 41.9 1.23 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.624 2.216 . . . . 0.0 110.7 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -133.57 -56.72 0.07 OUTLIER Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.505 ' N ' ' SD ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -156.96 -178.54 7.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.311 -1.111 . . . . 0.0 109.532 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -90.08 142.36 27.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.266 -0.896 . . . . 0.0 109.505 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.456 ' HA2' HG13 ' A' ' 65' ' ' ILE . . . -77.63 -9.42 86.89 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.411 ' CD1' ' HE2' ' A' ' 55' ' ' MET . 17.6 mm -51.11 -55.72 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -1.16 . . . . 0.0 109.394 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -55.84 -39.24 71.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.259 -0.9 . . . . 0.0 109.479 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.522 ' CD1' ' HA3' ' A' ' 36' ' ' GLY . 13.8 mt -53.4 -69.46 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.201 -0.937 . . . . 0.0 109.463 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.516 ' HG ' ' CD2' ' A' ' 53' ' ' LEU . 93.1 mt -43.62 -48.37 7.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.158 -0.963 . . . . 0.0 109.68 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.462 ' O ' HG22 ' A' ' 71' ' ' VAL . 2.1 mmtt -43.17 -58.11 2.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 109.704 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.451 ' O ' HG13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -61.6 -32.59 72.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.171 -0.956 . . . . 0.0 109.588 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.524 ' HE2' ' CG1' ' A' ' 51' ' ' VAL . 78.7 mtp -66.0 -23.66 66.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.321 -0.862 . . . . 0.0 109.591 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -84.0 -41.98 16.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.225 -0.922 . . . . 0.0 108.942 179.904 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 67' ' ' LYS . 2.5 t -62.09 -31.99 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.486 -0.759 . . . . 0.0 109.522 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 68' ' ' ARG . 11.3 mt -84.01 -39.86 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.232 -0.918 . . . . 0.0 109.447 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.448 ' O ' HG23 ' A' ' 76' ' ' ILE . 0.5 OUTLIER -143.13 132.75 23.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.289 -0.882 . . . . 0.0 109.379 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -90.01 -23.58 21.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.272 -0.892 . . . . 0.0 109.527 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -99.41 47.97 0.95 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.289 -0.882 . . . . 0.0 109.467 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.45 HG21 ' O ' ' A' ' 76' ' ' ILE . 1.1 tt -107.68 134.54 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.262 -0.899 . . . . 0.0 109.478 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.528 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 0.5 OUTLIER -104.03 141.2 36.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.241 -0.912 . . . . 0.0 109.466 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.516 HG13 ' CD2' ' A' ' 66' ' ' LEU . 82.4 t -139.37 118.76 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -0.906 . . . . 0.0 109.557 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.51 HD11 ' CG2' ' A' ' 100' ' ' THR . 5.1 mm -89.96 122.4 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.287 -0.883 . . . . 0.0 109.162 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.579 ' HB ' ' CG ' ' A' ' 101' ' ' HIS . 0.1 OUTLIER -89.87 143.29 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.174 -0.954 . . . . 0.0 109.375 -179.876 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.476 ' HG3' ' HA ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -117.68 71.17 0.81 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.185 -0.947 . . . . 0.0 109.255 179.79 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.517 ' CG2' ' HG3' ' A' ' 55' ' ' MET . 13.4 t -176.15 31.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.346 -0.846 . . . . 0.0 109.536 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.618 ' N ' ' CD2' ' A' ' 101' ' ' HIS . . . . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.206 -0.934 . . . . 0.0 109.499 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.568 HD11 ' CE1' ' A' ' 101' ' ' HIS . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -55.68 -40.37 72.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 0.0 109.493 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.433 ' O ' ' C ' ' A' ' 93' ' ' SER . 29.9 mm-40 -90.06 -38.48 13.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.209 -0.932 . . . . 0.0 109.649 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.461 ' O ' ' HB2' ' A' ' 96' ' ' LEU . 1.2 m -43.34 -39.36 3.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.306 -0.871 . . . . 0.0 109.551 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 93' ' ' SER . 6.6 mttp -44.3 -55.62 4.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 109.387 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -58.71 -43.56 90.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.243 -0.911 . . . . 0.0 109.463 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 93' ' ' SER . 79.0 mt -47.2 -63.87 0.93 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.325 -0.859 . . . . 0.0 109.474 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 179.93 36.64 0.07 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -99.85 99.66 10.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -1.15 . . . . 0.0 109.503 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.563 HD11 ' CG ' ' A' ' 118' ' ' TYR . 16.7 mt -48.87 -62.74 1.36 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.323 -0.861 . . . . 0.0 109.516 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.51 ' CG2' HD11 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -144.39 176.42 9.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.154 -0.966 . . . . 0.0 109.577 -179.925 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.618 ' CD2' ' N ' ' A' ' 83' ' ' ALA . 3.5 t-160 -141.51 94.01 2.64 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.343 -0.848 . . . . 0.0 109.235 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.556 ' CD2' HD12 ' A' ' 111' ' ' ILE . 7.9 m-85 -82.12 160.9 23.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.265 -0.897 . . . . 0.0 109.696 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.51 ' HB1' ' CB ' ' A' ' 83' ' ' ALA . . . -140.43 -148.58 0.25 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.236 -0.915 . . . . 0.0 109.281 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.55 145.48 30.54 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.164 -0.96 . . . . 0.0 109.302 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.0 151.96 91.4 Favored 'Cis proline' 0 C--N 1.309 -1.551 0 C-N-CA 123.289 -1.546 . . . . 0.0 110.437 -0.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.619 ' CZ ' ' CD1' ' A' ' 111' ' ' ILE . 0.5 OUTLIER -83.05 103.89 12.84 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -0.893 . . . . 0.0 109.457 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.46 ' O ' HG12 ' A' ' 111' ' ' ILE . 48.2 t0 -89.84 103.0 15.69 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.106 -0.996 . . . . 0.0 109.401 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.513 HG22 ' CG2' ' A' ' 22' ' ' VAL . 19.8 mm -43.31 -26.95 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.31 -0.869 . . . . 0.0 109.698 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.44 -47.96 44.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.897 . . . . 0.0 109.576 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.457 ' HG3' ' OD2' ' A' ' 107' ' ' ASP . 41.5 mt-10 -66.91 -22.94 65.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 109.332 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.619 ' CD1' ' CZ ' ' A' ' 106' ' ' PHE . 16.2 mm -75.43 -56.4 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.34 -0.85 . . . . 0.0 109.293 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 108' ' ' ILE . 0.6 OUTLIER -63.83 -22.17 66.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.269 -0.894 . . . . 0.0 109.477 179.948 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -73.84 -51.46 16.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.94 . . . . 0.0 109.497 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.404 ' HB1' ' CZ ' ' A' ' 102' ' ' PHE . . . -63.35 -55.77 21.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.3 -0.875 . . . . 0.0 109.458 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.0 t -50.17 -52.28 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 109.537 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 6.5 mmmt -54.76 -39.56 68.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.19 -0.944 . . . . 0.0 109.48 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 7.0 tttm -58.22 -40.97 83.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.445 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.563 ' CG ' HD11 ' A' ' 99' ' ' LEU . 56.3 m-85 -81.89 -73.32 0.39 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.887 . . . . 0.0 109.476 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.443 HD13 ' HD2' ' A' ' 120' ' ' PRO . 39.7 tp -78.57 114.43 43.21 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.299 -0.875 . . . . 0.0 109.392 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 118' ' ' TYR . 35.9 Cg_endo -78.08 176.1 10.37 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.424 2.083 . . . . 0.0 110.408 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.635 ' CD1' ' CZ ' ' A' ' 28' ' ' TYR . 1.2 mt . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.313 -0.867 . . . . 0.0 109.516 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.291 0.567 . . . . 0.0 109.507 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.469 ' HB2' ' HA ' ' A' ' 48' ' ' PRO . 11.2 mttp -110.22 154.42 23.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.932 . . . . 0.0 109.378 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.463 HG12 ' HB3' ' A' ' 50' ' ' LEU . 70.7 mt -150.11 149.19 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.282 -0.886 . . . . 0.0 109.467 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.528 ' CD2' ' HB2' ' A' ' 31' ' ' PHE . 0.8 OUTLIER -125.98 125.04 42.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.325 -0.859 . . . . 0.0 109.363 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.525 HD12 ' CB ' ' A' ' 19' ' ' LEU . 10.1 mt -103.95 103.12 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.229 -0.92 . . . . 0.0 109.579 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 2.6 t -102.74 84.8 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.319 -0.863 . . . . 0.0 109.333 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.524 ' O ' ' CD1' ' A' ' 57' ' ' ILE . 40.1 p-10 -88.61 -149.44 0.18 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.33 -0.856 . . . . 0.0 109.502 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.517 ' CB ' ' HA ' ' A' ' 57' ' ' ILE . 1.0 OUTLIER -121.92 -31.39 3.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.309 -0.87 . . . . 0.0 109.519 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.45 ' O ' ' OD2' ' A' ' 10' ' ' ASP . 0.8 OUTLIER -146.75 153.95 40.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.27 -0.894 . . . . 0.0 109.483 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.635 ' CZ ' ' CD1' ' A' ' 17' ' ' ILE . 6.3 t80 -43.88 141.77 1.52 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 109.499 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.458 ' O ' HD11 ' A' ' 18' ' ' LEU . . . 137.34 -70.13 0.49 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.522 HG21 ' CD1' ' A' ' 19' ' ' LEU . 2.6 mt -62.86 -29.54 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.18 -1.188 . . . . 0.0 109.382 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.529 ' HB3' ' CG ' ' A' ' 32' ' ' GLN . 3.9 mpp_? -70.69 -21.81 62.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.273 -0.892 . . . . 0.0 109.566 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.635 ' CD1' ' CZ ' ' A' ' 13' ' ' TYR . 6.9 mt -90.14 -57.22 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.217 -0.927 . . . . 0.0 109.661 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.458 HD11 ' O ' ' A' ' 14' ' ' GLY . 7.1 mp -54.7 -58.91 5.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.24 -0.913 . . . . 0.0 109.683 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.525 ' CB ' HD12 ' A' ' 8' ' ' ILE . 6.2 mp -57.52 -23.75 52.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.216 -0.927 . . . . 0.0 109.643 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 16.5 t30 -71.44 -70.63 0.31 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.238 -0.914 . . . . 0.0 109.592 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.464 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 13.5 tp10 -46.92 -43.46 18.98 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -0.91 . . . . 0.0 109.623 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.524 ' CG1' ' HB3' ' A' ' 112' ' ' ARG . 22.7 t -54.33 -60.99 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 109.637 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.588 ' CE1' ' HA ' ' A' ' 112' ' ' ARG . 38.8 m-85 -71.25 -4.18 24.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.209 -0.932 . . . . 0.0 109.718 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.464 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 0.8 OUTLIER -80.02 -44.56 19.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.179 -0.95 . . . . 0.0 109.437 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.4 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 25.1 tttt -80.99 -18.01 48.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.301 -0.874 . . . . 0.0 109.464 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.51 ' HB3' ' CE1' ' A' ' 28' ' ' TYR . 2.2 tt0 -77.72 -37.46 49.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.215 -0.928 . . . . 0.0 109.449 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.522 ' C ' ' CD1' ' A' ' 28' ' ' TYR . . . 115.71 62.79 0.36 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.566 ' CE2' HD22 ' A' ' 121' ' ' LEU . 70.1 m-85 -149.67 134.55 17.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.177 -1.19 . . . . 0.0 109.518 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 -90.35 83.32 5.93 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.249 -0.907 . . . . 0.0 109.113 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.453 ' HA ' ' HB ' ' A' ' 6' ' ' ILE . 5.7 p -89.89 172.13 9.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.318 -0.864 . . . . 0.0 109.637 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.528 ' HB2' ' CD2' ' A' ' 7' ' ' LEU . 19.3 m-85 -134.6 -178.51 5.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.868 . . . . 0.0 109.352 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.529 ' CG ' ' HB3' ' A' ' 16' ' ' ARG . 27.4 mp0 -120.71 149.04 43.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.213 -0.93 . . . . 0.0 109.637 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.468 ' CB ' ' HB1' ' A' ' 39' ' ' ALA . . . -177.37 175.03 1.52 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.393 -0.817 . . . . 0.0 109.474 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 10' ' ' ASP . . . -178.74 -58.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 109.663 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.412 ' C ' ' O ' ' A' ' 34' ' ' ALA . 3.9 p30 -43.6 -27.15 0.27 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.258 -0.901 . . . . 0.0 109.578 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 34' ' ' ALA . . . 97.84 -39.14 2.85 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.575 ' CD1' ' N ' ' A' ' 38' ' ' GLN . 3.8 pp -70.08 -45.52 66.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.213 -1.169 . . . . 0.0 109.609 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.575 ' N ' ' CD1' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -79.39 -30.58 42.52 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.222 -0.924 . . . . 0.0 108.912 179.868 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.468 ' HB1' ' CB ' ' A' ' 33' ' ' ALA . . . -62.41 -48.41 79.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.254 -0.904 . . . . 0.0 108.934 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.458 HD23 HG21 ' A' ' 65' ' ' ILE . 3.7 mt -66.28 -48.59 69.94 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.333 -0.854 . . . . 0.0 109.046 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.419 ' C ' ' O ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -45.41 -40.08 7.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.337 -0.852 . . . . 0.0 109.009 179.659 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.444 ' HA ' ' HG2' ' A' ' 45' ' ' LYS . 5.3 mt -68.04 -48.43 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.334 -0.854 . . . . 0.0 109.19 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.518 ' HA ' ' CD ' ' A' ' 48' ' ' PRO . 46.1 t -55.41 -19.15 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.222 -0.924 . . . . 0.0 109.406 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.8 m -90.23 -35.05 15.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.171 -0.956 . . . . 0.0 109.514 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.444 ' HG2' ' HA ' ' A' ' 42' ' ' ILE . 0.0 OUTLIER -86.32 -5.25 59.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.187 -0.945 . . . . 0.0 109.684 -179.848 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.411 ' OE2' ' CZ ' ' A' ' 31' ' ' PHE . 5.1 mm-40 -134.5 -37.8 0.84 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.144 -0.973 . . . . 0.0 109.309 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.427 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 12.1 mtm-85 57.84 65.89 3.11 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.385 -0.822 . . . . 0.0 109.643 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.518 ' CD ' ' HA ' ' A' ' 43' ' ' VAL . 35.3 Cg_endo -77.3 162.77 30.82 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.541 2.161 . . . . 0.0 110.416 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 6.7 t0 -97.03 -13.38 22.3 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.135 -0.978 . . . . 0.0 109.57 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.519 ' CD2' HG11 ' A' ' 115' ' ' VAL . 7.0 tp -117.92 123.47 45.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.188 -0.945 . . . . 0.0 109.588 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.6 t -129.08 137.62 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -0.924 . . . . 0.0 109.403 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.467 HD11 ' HA ' ' A' ' 8' ' ' ILE . 1.1 mt -112.4 103.68 11.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 109.427 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.464 ' CD2' HD22 ' A' ' 66' ' ' LEU . 1.4 mp -97.47 124.6 41.75 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.304 -0.873 . . . . 0.0 109.582 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.459 ' O ' HG13 ' A' ' 57' ' ' ILE . 21.0 t70 -107.51 120.58 42.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.263 -0.898 . . . . 0.0 109.341 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.51 ' CG ' HG22 ' A' ' 82' ' ' THR . 25.6 mmt -75.15 -13.96 60.51 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.172 -0.955 . . . . 0.0 109.638 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.453 ' O ' ' HB3' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -89.57 46.49 1.37 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.201 -0.937 . . . . 0.0 109.52 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.524 ' CD1' ' O ' ' A' ' 10' ' ' ASP . 81.3 mt -110.99 130.21 23.17 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.177 -0.952 . . . . 0.0 109.457 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.453 ' HD3' ' HB2' ' A' ' 11' ' ' ASP . 36.1 Cg_endo -78.52 130.65 10.01 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.426 2.084 . . . . 0.0 110.372 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 123.81 -50.53 0.85 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.22 163.74 30.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.173 -1.192 . . . . 0.0 109.533 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -89.98 156.81 18.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 109.462 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.461 ' O ' HD22 ' A' ' 53' ' ' LEU . . . -89.92 -6.24 69.87 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 17.9 mm -54.92 -60.02 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.171 -1.194 . . . . 0.0 109.502 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.8 -38.14 54.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.174 -0.954 . . . . 0.0 109.432 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.458 HG21 HD23 ' A' ' 40' ' ' LEU . 15.9 mt -52.51 -57.11 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -0.889 . . . . 0.0 109.446 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.464 HD22 ' CD2' ' A' ' 53' ' ' LEU . 26.1 mt -46.33 -56.01 6.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.197 -0.939 . . . . 0.0 109.462 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 66' ' ' LEU . 5.3 mttt -44.09 -47.3 8.88 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -0.918 . . . . 0.0 109.431 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.449 ' O ' HG13 ' A' ' 72' ' ' ILE . 5.3 mtt180 -58.08 -43.24 86.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.263 -0.898 . . . . 0.0 109.461 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 4.1 mtt -64.07 -23.38 67.3 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.208 -0.933 . . . . 0.0 109.466 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 66' ' ' LEU . 0.5 OUTLIER -79.16 -33.91 43.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.226 -0.921 . . . . 0.0 109.479 179.95 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.4 t -79.39 -21.39 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.281 -0.887 . . . . 0.0 109.495 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 68' ' ' ARG . 66.2 mt -90.04 -60.07 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.284 -0.885 . . . . 0.0 109.395 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.53 133.09 36.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.234 -0.916 . . . . 0.0 109.492 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -90.04 -11.92 40.05 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.265 -0.897 . . . . 0.0 109.16 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -107.46 51.81 0.73 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.145 -0.972 . . . . 0.0 109.443 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.452 HG22 ' O ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -119.14 113.11 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.267 -0.896 . . . . 0.0 109.545 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.519 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 0.8 OUTLIER -68.59 124.91 24.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.246 -0.909 . . . . 0.0 109.44 179.893 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 17.6 t -134.24 108.22 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 0.0 109.704 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.434 HG21 ' N ' ' A' ' 80' ' ' ILE . 91.0 mt -90.26 148.4 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.218 -0.926 . . . . 0.0 109.36 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.579 ' HB ' ' CE1' ' A' ' 101' ' ' HIS . 0.0 OUTLIER -107.8 161.03 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.176 -0.952 . . . . 0.0 109.426 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.518 ' SD ' ' CZ ' ' A' ' 106' ' ' PHE . 8.6 mtm -137.77 89.69 2.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.239 -0.913 . . . . 0.0 109.725 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.597 ' CG2' ' CE1' ' A' ' 101' ' ' HIS . 14.3 t 177.8 37.2 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.271 -0.893 . . . . 0.0 109.369 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.519 ' CB ' ' HB1' ' A' ' 103' ' ' ALA . . . . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.308 -0.87 . . . . 0.0 109.556 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.458 ' HA ' ' HB2' ' A' ' 93' ' ' SER . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -56.58 -40.93 76.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.269 -0.895 . . . . 0.0 109.558 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.446 ' O ' HD11 ' A' ' 96' ' ' LEU . 8.2 mt-10 -90.08 -37.16 14.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.205 -0.934 . . . . 0.0 109.657 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.516 ' HA ' ' CD1' ' A' ' 96' ' ' LEU . 1.1 m -43.73 -43.06 5.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.301 -0.874 . . . . 0.0 109.613 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -43.64 -54.15 5.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.22 -0.925 . . . . 0.0 109.54 -179.915 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 96' ' ' LEU . 1.3 mm-40 -59.94 -48.52 81.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.257 -0.902 . . . . 0.0 109.521 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.516 ' CD1' ' HA ' ' A' ' 93' ' ' SER . 2.1 mp -43.62 -60.81 1.61 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.317 -0.864 . . . . 0.0 109.577 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 172.89 45.46 0.04 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.409 ' O ' ' HD2' ' A' ' 94' ' ' LYS . . . -120.93 110.18 15.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.317 -1.108 . . . . 0.0 109.423 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.519 ' CD1' ' HB3' ' A' ' 77' ' ' ARG . 1.7 mt -57.77 -71.48 0.1 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.203 -0.935 . . . . 0.0 109.534 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.417 HG21 HG22 ' A' ' 79' ' ' ILE . 14.8 t -130.34 162.45 29.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -0.928 . . . . 0.0 109.545 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.597 ' CE1' ' CG2' ' A' ' 82' ' ' THR . 5.1 t-160 -126.66 101.18 6.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.271 -0.893 . . . . 0.0 109.442 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -76.95 -176.1 3.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.319 -0.863 . . . . 0.0 109.519 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.519 ' HB1' ' CB ' ' A' ' 83' ' ' ALA . . . -168.38 172.91 8.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.343 -0.848 . . . . 0.0 109.454 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.503 ' HA ' ' N ' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -64.72 151.12 93.16 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.239 -0.913 . . . . 0.0 109.534 179.884 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.21 118.28 5.67 Favored 'Cis proline' 0 C--N 1.308 -1.574 0 C-N-CA 123.22 -1.575 . . . . 0.0 110.471 -0.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.637 ' CZ ' ' CD1' ' A' ' 111' ' ' ILE . 0.3 OUTLIER -55.18 106.08 0.21 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.213 -0.929 . . . . 0.0 109.406 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.481 ' O ' HG12 ' A' ' 111' ' ' ILE . 46.0 t0 -89.88 110.43 21.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 109.326 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.424 HG21 ' O ' ' A' ' 108' ' ' ILE . 15.5 mm -48.23 -22.44 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.248 -0.908 . . . . 0.0 109.777 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.21 -43.72 50.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.106 -0.997 . . . . 0.0 109.458 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -70.02 -27.11 64.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.297 -0.877 . . . . 0.0 109.514 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.637 ' CD1' ' CZ ' ' A' ' 106' ' ' PHE . 20.2 mm -76.03 -57.57 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.247 -0.908 . . . . 0.0 109.273 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.588 ' HA ' ' CE1' ' A' ' 23' ' ' PHE . 14.0 ptt180 -55.67 -32.26 63.08 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.396 -0.815 . . . . 0.0 109.985 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.507 ' HA ' ' HG2' ' A' ' 116' ' ' LYS . 10.8 m-20 -79.6 -65.86 0.95 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -0.935 . . . . 0.0 110.237 -179.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 113' ' ' ASP . . . -42.53 -35.77 1.16 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.207 -0.933 . . . . 0.0 109.876 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.576 ' HB ' ' CZ ' ' A' ' 23' ' ' PHE . 38.2 t -77.68 -40.43 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.356 -0.84 . . . . 0.0 109.737 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.508 ' HG3' ' N ' ' A' ' 117' ' ' LYS . 0.0 OUTLIER -60.45 -23.87 64.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.131 -0.981 . . . . 0.0 109.332 -179.789 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.508 ' N ' ' HG3' ' A' ' 116' ' ' LYS . 9.5 ttmt -85.03 -51.63 6.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.303 -0.873 . . . . 0.0 109.387 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.454 ' O ' ' HD3' ' A' ' 120' ' ' PRO . 27.1 m-85 -54.03 -64.86 0.69 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.266 -0.896 . . . . 0.0 109.353 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.458 HD13 ' HD2' ' A' ' 120' ' ' PRO . 37.5 tp -90.28 112.34 52.13 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.291 -0.881 . . . . 0.0 109.386 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.458 ' HD2' HD13 ' A' ' 119' ' ' LEU . 35.6 Cg_endo -78.27 -164.3 0.27 Allowed 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.326 2.017 . . . . 0.0 110.393 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.566 HD22 ' CE2' ' A' ' 28' ' ' TYR . 81.2 mt . . . . . 0 N--CA 1.489 1.512 0 O-C-N 121.276 -0.89 . . . . 0.0 109.378 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.508 ' CB ' ' HA ' ' A' ' 48' ' ' PRO . 6.4 mtmt -96.13 139.52 32.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -0.872 . . . . 0.0 109.414 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.574 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 80.5 mt -150.05 155.21 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.253 -0.904 . . . . 0.0 109.473 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.564 ' CD1' ' CG2' ' A' ' 42' ' ' ILE . 0.6 OUTLIER -140.56 127.69 20.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 109.367 179.949 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.458 HD11 ' HB2' ' A' ' 19' ' ' LEU . 9.2 mt -92.35 120.95 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -0.917 . . . . 0.0 109.518 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 t -103.01 102.81 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -0.954 . . . . 0.0 109.464 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.455 ' O ' ' NH1' ' A' ' 16' ' ' ARG . 7.3 t0 -162.17 134.98 5.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.158 -0.964 . . . . 0.0 109.434 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.462 ' OD2' ' HD2' ' A' ' 58' ' ' PRO . 8.6 p-10 -99.21 -34.22 10.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.294 -0.879 . . . . 0.0 109.444 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.417 ' O ' ' C ' ' A' ' 13' ' ' TYR . 0.5 OUTLIER -73.1 107.22 5.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.329 -0.857 . . . . 0.0 109.478 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.569 ' CZ ' HG13 ' A' ' 17' ' ' ILE . 20.5 t80 -43.07 153.06 0.1 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.351 -0.843 . . . . 0.0 109.603 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.403 ' N ' ' CD1' ' A' ' 13' ' ' TYR . . . 124.62 -74.43 0.4 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.515 ' CD1' ' OD2' ' A' ' 54' ' ' ASP . 6.6 mt -63.16 -16.92 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.24 -1.153 . . . . 0.0 109.403 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.455 ' NH1' ' O ' ' A' ' 10' ' ' ASP . 14.6 mmm-85 -77.26 -26.88 52.93 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 109.341 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.569 HG13 ' CZ ' ' A' ' 13' ' ' TYR . 9.6 mm -90.07 -39.78 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -0.903 . . . . 0.0 109.604 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.463 ' O ' HG21 ' A' ' 22' ' ' VAL . 2.1 mp -64.22 -58.22 7.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.25 -0.906 . . . . 0.0 109.613 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.501 ' CD1' HG21 ' A' ' 15' ' ' ILE . 44.0 mt -58.45 -20.95 49.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.282 -0.886 . . . . 0.0 109.482 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.509 ' OD1' ' ND2' ' A' ' 24' ' ' ASN . 27.6 t30 -75.72 -70.71 0.42 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -0.911 . . . . 0.0 109.568 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.46 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 17.8 tt0 -46.41 -42.51 15.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.243 -0.911 . . . . 0.0 109.614 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.463 HG21 ' O ' ' A' ' 18' ' ' LEU . 64.6 t -58.99 -56.01 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.143 -0.973 . . . . 0.0 109.615 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.483 ' CB ' ' CG2' ' A' ' 30' ' ' THR . 29.8 m-85 -78.14 3.05 16.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.178 -0.951 . . . . 0.0 109.707 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.509 ' ND2' ' OD1' ' A' ' 20' ' ' ASN . 0.5 OUTLIER -90.07 -46.73 8.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.229 -0.92 . . . . 0.0 109.486 179.884 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.1 -19.72 36.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.216 -0.928 . . . . 0.0 109.456 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.473 ' HB3' ' CD1' ' A' ' 28' ' ' TYR . 0.5 OUTLIER -78.33 -31.06 48.51 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.3 -0.875 . . . . 0.0 109.456 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.477 ' O ' ' CD1' ' A' ' 28' ' ' TYR . . . 102.5 77.94 1.26 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.559 ' CE1' HD13 ' A' ' 121' ' ' LEU . 91.5 m-85 -155.57 143.12 19.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.151 -1.205 . . . . 0.0 109.511 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -90.04 81.19 6.25 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.174 -0.954 . . . . 0.0 109.382 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.483 ' CG2' ' CB ' ' A' ' 23' ' ' PHE . 6.1 p -89.91 147.27 23.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.248 -0.907 . . . . 0.0 109.534 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.574 ' CD2' ' O ' ' A' ' 6' ' ' ILE . 12.0 m-85 -111.06 -166.19 1.05 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 0.0 109.487 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -143.61 139.98 29.92 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.341 -0.85 . . . . 0.0 109.484 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -153.49 -176.03 5.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.266 -0.896 . . . . 0.0 109.401 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.521 ' O ' ' CD1' ' A' ' 57' ' ' ILE . . . -145.01 -61.88 0.35 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.218 -0.926 . . . . 0.0 109.519 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.468 ' HA ' ' HE2' ' A' ' 60' ' ' MET . 1.6 p-10 -90.22 144.5 25.8 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 0.0 109.427 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.526 ' HA3' ' CD1' ' A' ' 65' ' ' ILE . . . -48.08 -37.66 16.93 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.79 -46.49 64.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -1.172 . . . . 0.0 109.54 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.516 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 6.7 tp-100 -64.84 -31.8 73.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.91 . . . . 0.0 109.541 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.522 ' O ' ' CG2' ' A' ' 43' ' ' VAL . . . -66.47 -37.32 84.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.923 . . . . 0.0 109.526 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.8 mt -73.75 -38.97 64.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.883 . . . . 0.0 109.564 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.35 -54.75 39.75 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.258 -0.901 . . . . 0.0 109.48 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.564 ' CG2' ' CD1' ' A' ' 7' ' ' LEU . 23.9 mt -62.93 -31.76 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.268 -0.895 . . . . 0.0 109.473 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 39' ' ' ALA . 42.7 t -69.73 -28.13 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 109.365 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.0 m -90.23 -15.75 30.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.278 -0.888 . . . . 0.0 109.512 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.65 -60.48 1.95 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.918 . . . . 0.0 109.73 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 47' ' ' ARG . 1.8 mm-40 -89.78 -30.69 17.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.152 -0.967 . . . . 0.0 109.645 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 13.2 mtm180 65.89 68.41 0.66 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.934 . . . . 0.0 109.577 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.518 ' CD ' ' HA ' ' A' ' 43' ' ' VAL . 35.3 Cg_endo -77.82 -167.01 0.43 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.625 2.217 . . . . 0.0 110.354 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 75' ' ' ASN . 5.0 t70 -142.1 11.16 1.97 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.272 -0.892 . . . . 0.0 109.465 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.439 ' HB3' HG12 ' A' ' 6' ' ' ILE . 4.9 tp -146.79 111.55 5.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -0.926 . . . . 0.0 109.517 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.479 ' CB ' ' HE2' ' A' ' 69' ' ' MET . 3.4 t -109.63 137.66 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.232 -0.917 . . . . 0.0 109.32 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.454 ' HB2' ' HA ' ' A' ' 8' ' ' ILE . 1.1 mt -104.51 97.65 7.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.655 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 1.0 OUTLIER -93.37 119.3 32.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.257 -0.902 . . . . 0.0 109.36 179.825 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.524 ' CA ' ' HE1' ' A' ' 81' ' ' MET . 21.0 t0 -99.28 -4.8 31.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.116 -0.99 . . . . 0.0 109.684 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.523 ' HG3' ' CG2' ' A' ' 82' ' ' THR . 0.0 OUTLIER 53.44 17.14 1.03 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.385 -0.822 . . . . 0.0 109.783 -179.854 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 57' ' ' ILE . 13.2 mmtm -91.03 -39.87 11.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.04 -1.037 . . . . 0.0 109.338 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.522 HG23 ' CE ' ' A' ' 60' ' ' MET . 4.3 mt -42.65 111.64 1.02 Allowed Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.377 -0.827 . . . . 0.0 109.495 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.462 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 35.0 Cg_endo -77.01 165.21 28.66 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.403 2.068 . . . . 0.0 110.387 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.77 -43.03 1.87 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.522 ' CE ' HG23 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -158.18 158.85 35.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.361 -1.082 . . . . 0.0 109.321 179.899 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -88.72 151.97 22.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.114 -0.991 . . . . 0.0 109.464 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.41 ' HA2' HG12 ' A' ' 65' ' ' ILE . . . -90.18 4.35 82.8 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.525 ' HA ' ' CD2' ' A' ' 66' ' ' LEU . 19.4 mm -59.72 -51.03 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.157 -1.202 . . . . 0.0 109.397 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -52.46 -23.67 6.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.19 -0.944 . . . . 0.0 109.401 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.526 ' CD1' ' HA3' ' A' ' 36' ' ' GLY . 8.7 mm -71.55 -65.05 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.32 -0.862 . . . . 0.0 109.449 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.525 ' CD2' ' HA ' ' A' ' 63' ' ' ILE . 1.6 pp -47.51 -28.62 2.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -0.889 . . . . 0.0 109.226 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.508 ' N ' ' HG ' ' A' ' 66' ' ' LEU . 12.8 tptt -67.45 -59.17 3.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 0.0 109.254 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.51 ' O ' ' CD1' ' A' ' 72' ' ' ILE . 10.7 mtt-85 -51.63 -26.67 9.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.264 -0.897 . . . . 0.0 109.319 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.479 ' HE2' ' CB ' ' A' ' 51' ' ' VAL . 1.4 mtt -73.9 -39.62 63.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.303 -0.873 . . . . 0.0 109.458 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.529 ' CD ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -69.34 -24.51 63.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.251 -0.905 . . . . 0.0 109.284 179.944 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.464 HG21 ' O ' ' A' ' 67' ' ' LYS . 2.6 t -90.1 -25.45 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.323 -0.86 . . . . 0.0 109.513 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.51 ' CD1' ' O ' ' A' ' 68' ' ' ARG . 28.2 mt -89.16 -16.92 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.308 -0.87 . . . . 0.0 109.422 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.453 ' O ' HG23 ' A' ' 76' ' ' ILE . 0.4 OUTLIER -170.71 116.59 0.48 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.259 -0.901 . . . . 0.0 109.481 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -74.93 -22.14 58.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.204 -0.935 . . . . 0.0 109.453 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.436 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 69.2 m-80 -89.7 43.09 1.13 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 109.489 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.478 HG13 ' N ' ' A' ' 77' ' ' ARG . 0.5 OUTLIER -117.26 146.8 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.342 -0.849 . . . . 0.0 109.554 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.517 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 46.0 mtt180 -115.27 162.31 17.27 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.299 -0.875 . . . . 0.0 109.516 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.515 ' CG2' ' O ' ' A' ' 77' ' ' ARG . 69.7 t -159.72 111.97 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.261 -0.899 . . . . 0.0 109.549 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.5 ' CG2' HG21 ' A' ' 100' ' ' THR . 9.1 mm -93.32 133.57 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.2 -0.938 . . . . 0.0 109.392 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.57 HG23 ' CE1' ' A' ' 101' ' ' HIS . 0.5 OUTLIER -95.43 171.98 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.19 -0.944 . . . . 0.0 109.395 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.568 ' HB3' ' CE1' ' A' ' 106' ' ' PHE . 39.4 mtm -146.84 62.49 1.19 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.24 -0.913 . . . . 0.0 109.459 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.523 ' CG2' ' HG3' ' A' ' 55' ' ' MET . 11.2 t -170.89 32.51 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 109.488 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.586 ' N ' ' CD2' ' A' ' 101' ' ' HIS . . . . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.261 -0.9 . . . . 0.0 109.464 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.634 ' CD1' ' CE1' ' A' ' 101' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.809 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.439 ' HA ' ' OE1' ' A' ' 91' ' ' GLN . 21.8 tp60 -53.33 -36.32 61.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.214 -0.929 . . . . 0.0 109.513 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.421 ' O ' HD11 ' A' ' 96' ' ' LEU . 8.0 mt-10 -90.09 -17.21 28.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.199 -0.938 . . . . 0.0 109.481 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.466 ' HB3' ' HB3' ' A' ' 98' ' ' ALA . 0.4 OUTLIER -57.82 -17.55 16.74 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.289 -0.882 . . . . 0.0 109.504 179.974 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.27 -66.76 0.49 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.268 -0.895 . . . . 0.0 109.507 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -56.77 -32.67 65.85 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.218 -0.926 . . . . 0.0 109.552 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.454 HD11 ' HA ' ' A' ' 93' ' ' SER . 2.1 mt -64.76 -33.33 75.71 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.299 -0.876 . . . . 0.0 109.47 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.529 ' HA3' ' CD ' ' A' ' 70' ' ' LYS . . . 140.7 40.4 0.08 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.466 ' HB3' ' HB3' ' A' ' 93' ' ' SER . . . -112.66 102.64 10.69 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.222 -1.164 . . . . 0.0 109.397 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.568 HD11 ' CG ' ' A' ' 118' ' ' TYR . 17.3 mt -43.74 -83.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.294 -0.879 . . . . 0.0 109.42 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.5 HG21 ' CG2' ' A' ' 79' ' ' ILE . 1.8 t -131.34 171.45 13.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.255 -0.903 . . . . 0.0 109.426 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.634 ' CE1' ' CD1' ' A' ' 90' ' ' ILE . 4.0 t60 -130.41 93.36 3.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.208 -0.933 . . . . 0.0 109.336 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.632 ' CE1' ' CG ' ' A' ' 110' ' ' GLU . 9.0 m-85 -72.72 155.64 39.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -0.918 . . . . 0.0 109.597 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.523 ' HB1' ' CB ' ' A' ' 83' ' ' ALA . . . -124.07 -148.56 0.4 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.313 -0.867 . . . . 0.0 109.467 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.443 ' HB2' ' HA ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -101.32 160.54 26.3 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 109.565 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.498 ' O ' ' CB ' ' A' ' 106' ' ' PHE . 36.4 Cg_endo -79.44 11.64 21.61 Favored 'Cis proline' 0 C--N 1.31 -1.489 0 C-N-CA 123.296 -1.543 . . . . 0.0 110.893 0.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.626 ' CZ ' ' CD1' ' A' ' 111' ' ' ILE . 2.2 t80 76.06 99.4 0.07 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.233 -0.917 . . . . 0.0 109.627 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.465 ' O ' HG12 ' A' ' 111' ' ' ILE . 15.2 t0 -89.96 114.32 26.12 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.221 -0.924 . . . . 0.0 109.309 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.46 HG22 HG23 ' A' ' 22' ' ' VAL . 13.7 mm -46.86 -40.08 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.239 -0.913 . . . . 0.0 109.468 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.449 ' HB2' ' OD2' ' A' ' 107' ' ' ASP . 99.6 m-20 -62.05 -42.12 98.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.902 . . . . 0.0 109.528 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.632 ' CG ' ' CE1' ' A' ' 102' ' ' PHE . 5.5 tp10 -67.23 -28.72 68.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.903 . . . . 0.0 109.513 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.626 ' CD1' ' CZ ' ' A' ' 106' ' ' PHE . 23.5 mm -69.35 -60.2 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.294 -0.879 . . . . 0.0 109.477 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.449 ' HG2' ' O ' ' A' ' 108' ' ' ILE . 0.0 OUTLIER -64.3 -19.91 65.73 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.554 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.427 ' CG ' ' O ' ' A' ' 109' ' ' ASP . 61.1 m-20 -72.47 -53.83 11.02 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.264 -0.897 . . . . 0.0 109.469 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.568 ' O ' ' CD2' ' A' ' 118' ' ' TYR . . . -61.8 -54.38 43.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 0.0 109.461 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.7 t -52.17 -52.35 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.177 -0.952 . . . . 0.0 109.496 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.67 -35.55 55.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.252 -0.905 . . . . 0.0 109.426 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.67 -34.72 74.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.304 -0.872 . . . . 0.0 109.472 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.568 ' CG ' HD11 ' A' ' 99' ' ' LEU . 58.2 m-85 -88.69 -74.19 0.47 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -0.898 . . . . 0.0 109.532 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.3 tt -90.11 112.46 52.58 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.287 -0.883 . . . . 0.0 109.443 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 118' ' ' TYR . 35.3 Cg_endo -77.88 -166.18 0.38 Allowed 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.381 2.054 . . . . 0.0 110.375 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.559 HD13 ' CE1' ' A' ' 28' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 0.0 109.424 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.573 ' OE2' ' CD2' ' A' ' 28' ' ' TYR . 51.8 tt0 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.45 ' HB2' ' HA ' ' A' ' 48' ' ' PRO . 3.0 mttt -109.58 156.14 20.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.331 -0.856 . . . . 0.0 109.482 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.452 HG12 ' HB2' ' A' ' 50' ' ' LEU . 63.0 mt -150.05 153.02 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.892 . . . . 0.0 109.453 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.523 HD13 ' CB ' ' A' ' 33' ' ' ALA . 1.8 tm? -132.11 113.97 13.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.289 -0.882 . . . . 0.0 109.482 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.519 HG12 ' CD1' ' A' ' 52' ' ' LEU . 4.4 mt -89.89 105.85 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 109.351 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.527 ' CG2' HD13 ' A' ' 53' ' ' LEU . 2.6 t -89.9 71.72 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.209 -0.932 . . . . 0.0 109.513 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.503 ' O ' ' NH1' ' A' ' 16' ' ' ARG . 1.5 t70 -126.09 146.27 49.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.216 -0.928 . . . . 0.0 109.399 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.482 ' HB3' ' CB ' ' A' ' 34' ' ' ALA . 6.5 p-10 -116.81 -37.07 3.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.315 -0.865 . . . . 0.0 109.473 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.515 ' CG ' ' O ' ' A' ' 12' ' ' GLN . 7.6 pt20 -61.38 102.14 0.21 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.2 -0.937 . . . . 0.0 109.489 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.638 ' CZ ' ' CD1' ' A' ' 17' ' ' ILE . 58.5 t80 -43.28 112.22 0.35 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.875 . . . . 0.0 109.596 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 159.28 -69.32 0.25 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.427 ' HB ' ' OD2' ' A' ' 10' ' ' ASP . 1.7 mp -62.78 -20.83 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.125 -1.221 . . . . 0.0 108.777 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.527 ' O ' ' CB ' ' A' ' 20' ' ' ASN . 7.4 mmm-85 -69.4 -29.98 67.85 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.386 -0.822 . . . . 0.0 109.331 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.638 ' CD1' ' CZ ' ' A' ' 13' ' ' TYR . 3.8 mt -90.34 -37.08 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.362 -0.836 . . . . 0.0 109.765 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.522 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 0.4 OUTLIER -69.14 -58.16 4.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.005 -1.059 . . . . 0.0 109.246 -179.906 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.454 ' HB3' HD12 ' A' ' 8' ' ' ILE . 1.3 tp -62.56 -20.54 64.78 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.304 -0.873 . . . . 0.0 108.663 179.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 16' ' ' ARG . 0.5 OUTLIER -71.44 -73.25 0.19 Allowed 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.455 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 0.3 OUTLIER -52.43 -30.82 31.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.29 -0.881 . . . . 0.0 109.807 -179.589 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 18' ' ' LEU . 96.8 t -64.75 -61.94 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.194 -0.941 . . . . 0.0 109.548 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.57 ' CB ' ' CG2' ' A' ' 30' ' ' THR . 16.4 m-85 -72.5 -3.8 26.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 109.544 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.455 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 0.7 OUTLIER -82.99 -52.61 6.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.146 -0.971 . . . . 0.0 109.38 179.809 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.3 mmtt -73.57 -19.09 60.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.121 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.493 ' HB3' ' CD1' ' A' ' 28' ' ' TYR . 0.4 OUTLIER -71.39 -49.19 44.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.369 -0.832 . . . . 0.0 109.372 179.885 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.465 ' O ' ' OE2' ' A' ' 4' ' ' GLU . . . 124.95 46.62 0.24 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.592 ' CZ ' ' CD1' ' A' ' 121' ' ' LEU . 97.7 m-85 -132.72 146.69 52.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.315 -1.109 . . . . 0.0 109.574 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.0 mm100 -89.87 85.32 6.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.297 -0.877 . . . . 0.0 108.798 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.57 ' CG2' ' CB ' ' A' ' 23' ' ' PHE . 5.6 p -89.63 137.51 32.27 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.239 -0.913 . . . . 0.0 109.791 -179.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.519 ' HB2' ' CD2' ' A' ' 7' ' ' LEU . 11.5 m-85 -109.15 -171.63 1.88 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.379 -0.826 . . . . 0.0 109.238 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -121.71 154.09 37.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.151 -0.968 . . . . 0.0 109.681 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.523 ' CB ' HD13 ' A' ' 7' ' ' LEU . . . -172.48 174.34 3.83 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.272 -0.892 . . . . 0.0 109.355 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.482 ' CB ' ' HB3' ' A' ' 11' ' ' ASP . . . 170.96 -50.38 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.296 -0.878 . . . . 0.0 109.558 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.457 ' OD1' ' HB2' ' A' ' 38' ' ' GLN . 8.3 p-10 -67.29 -8.36 31.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.2 -0.938 . . . . 0.0 109.553 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 37' ' ' LEU . . . 96.53 -70.62 0.84 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -44.69 -32.98 1.67 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.166 -1.196 . . . . 0.0 109.437 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.518 ' O ' ' CD1' ' A' ' 42' ' ' ILE . 1.1 tp60 -71.52 -44.11 65.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.242 -0.911 . . . . 0.0 109.461 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 33' ' ' ALA . . . -65.57 -63.09 1.18 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.247 -0.908 . . . . 0.0 109.437 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.8 mt -51.39 -33.58 30.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.3 -0.875 . . . . 0.0 109.557 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 37' ' ' LEU . 59.8 t0 -62.76 -51.94 65.17 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.268 -0.895 . . . . 0.0 109.453 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.518 ' CD1' ' O ' ' A' ' 38' ' ' GLN . 2.0 mp -70.64 -14.48 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.214 -0.929 . . . . 0.0 109.49 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.526 ' HA ' ' CD ' ' A' ' 48' ' ' PRO . 50.8 t -84.56 -29.21 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.324 -0.86 . . . . 0.0 109.424 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.44 ' O ' HG21 ' A' ' 44' ' ' THR . 20.7 m -90.06 -25.11 20.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.155 -0.966 . . . . 0.0 109.407 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.512 ' HD2' ' N ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -89.97 -33.19 16.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.267 -0.896 . . . . 0.0 109.463 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -110.32 -36.7 5.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.215 -0.928 . . . . 0.0 109.458 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.46 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER 59.82 69.51 1.23 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.291 -0.881 . . . . 0.0 109.478 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.526 ' CD ' ' HA ' ' A' ' 43' ' ' VAL . 34.7 Cg_endo -77.95 -179.58 5.58 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.747 2.298 . . . . 0.0 110.661 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.435 ' OD2' HD21 ' A' ' 50' ' ' LEU . 1.1 p-10 -119.71 -16.84 8.73 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.47 -0.769 . . . . 0.0 109.33 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.452 ' HB2' HG12 ' A' ' 6' ' ' ILE . 1.8 mm? -114.16 121.12 42.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.322 -0.861 . . . . 0.0 109.695 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.52 ' HB ' ' CG1' ' A' ' 78' ' ' VAL . 2.7 t -116.51 147.04 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.236 -0.915 . . . . 0.0 109.253 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.519 ' CD1' HG12 ' A' ' 8' ' ' ILE . 1.6 mt -122.19 87.9 2.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.146 -0.971 . . . . 0.0 109.609 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.527 HD13 ' CG2' ' A' ' 9' ' ' VAL . 1.2 mp -91.7 122.58 34.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.282 -0.886 . . . . 0.0 109.268 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 81' ' ' MET . 30.3 t0 -107.4 -2.87 20.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.201 -0.937 . . . . 0.0 109.754 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.513 ' HB2' ' CG2' ' A' ' 82' ' ' THR . 4.7 mmt 47.29 22.08 0.24 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.339 -0.851 . . . . 0.0 109.879 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.458 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 1.4 mttt -90.77 -31.66 16.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.005 -1.059 . . . . 0.0 109.28 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.461 ' HA ' ' OD1' ' A' ' 11' ' ' ASP . 2.5 mp -41.88 102.17 0.26 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.501 -0.749 . . . . 0.0 109.682 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.468 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 35.0 Cg_endo -77.48 121.21 5.51 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.455 2.104 . . . . 0.0 110.351 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 121.81 -27.31 6.25 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.458 ' HE1' ' O ' ' A' ' 60' ' ' MET . 1.3 ttp -139.84 135.36 32.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.282 -1.128 . . . . 0.0 109.398 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -89.83 137.34 32.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.243 -0.911 . . . . 0.0 109.457 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.465 ' HA2' HG13 ' A' ' 65' ' ' ILE . . . -90.49 8.74 79.33 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 23.9 mm -58.0 -43.59 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.25 -1.147 . . . . 0.0 109.49 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.517 ' O ' ' CG ' ' A' ' 68' ' ' ARG . 49.4 mm-40 -72.99 -16.72 61.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.9 . . . . 0.0 109.456 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.5 ' CG2' ' HE2' ' A' ' 69' ' ' MET . 48.8 mt -72.33 -53.5 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.256 -0.903 . . . . 0.0 109.461 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.517 ' HG ' ' CD2' ' A' ' 53' ' ' LEU . 12.1 mt -47.3 -57.02 5.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.911 . . . . 0.0 109.554 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.514 ' O ' ' CG2' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -56.62 -42.46 78.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.197 -0.94 . . . . 0.0 109.664 -179.855 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.517 ' CG ' ' O ' ' A' ' 64' ' ' GLU . 2.2 mmt180 -57.47 -29.93 64.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.949 . . . . 0.0 109.553 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.5 ' HE2' ' CG2' ' A' ' 65' ' ' ILE . 3.9 mtt -75.21 -56.37 4.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.271 -0.893 . . . . 0.0 109.489 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.443 ' HG2' ' HA ' ' A' ' 67' ' ' LYS . 6.5 ptpt -55.85 -19.65 12.52 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.183 -0.948 . . . . 0.0 109.462 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.514 ' CG2' ' O ' ' A' ' 67' ' ' LYS . 39.9 t -82.14 -46.64 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.266 -0.896 . . . . 0.0 109.456 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 67.6 mt -63.56 -56.09 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.33 -0.856 . . . . 0.0 109.507 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -135.86 142.74 44.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.325 -0.859 . . . . 0.0 109.46 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -89.42 -10.6 45.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.244 -0.91 . . . . 0.0 109.49 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -102.1 38.52 1.64 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.24 -0.913 . . . . 0.0 109.421 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.453 HD11 ' O ' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -113.55 91.65 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 109.417 -180.0 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.517 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -63.16 154.77 30.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.225 -0.922 . . . . 0.0 109.478 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.52 ' CG1' ' HB ' ' A' ' 51' ' ' VAL . 3.1 t -138.29 158.84 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.205 -0.935 . . . . 0.0 109.448 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.488 HD11 HG22 ' A' ' 79' ' ' ILE . 3.6 mm -136.81 125.74 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 109.454 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.575 ' HB ' ' CG ' ' A' ' 101' ' ' HIS . 0.7 OUTLIER -98.3 136.85 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.241 -0.912 . . . . 0.0 109.296 179.992 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.46 ' O ' ' OD1' ' A' ' 54' ' ' ASP . 16.9 mtm -122.16 49.03 1.63 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.489 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.513 ' CG2' ' HB2' ' A' ' 55' ' ' MET . 8.9 t -159.04 52.0 0.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 109.478 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.527 ' CB ' ' HB3' ' A' ' 103' ' ' ALA . . . . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.211 -0.93 . . . . 0.0 109.448 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.569 HD12 ' CE1' ' A' ' 101' ' ' HIS . 21.0 mt . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.26 0.552 . . . . 0.0 109.54 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.28 -41.84 76.5 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.315 -0.866 . . . . 0.0 109.481 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 93' ' ' SER . 2.1 tp10 -89.94 -48.22 7.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.191 -0.943 . . . . 0.0 109.496 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 92' ' ' GLU . 11.5 t -44.21 -26.58 0.33 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.929 . . . . 0.0 109.487 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.06 -82.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.901 . . . . 0.0 109.481 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.425 ' O ' ' C ' ' A' ' 96' ' ' LEU . 9.4 pt-20 -44.1 -40.86 5.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.883 . . . . 0.0 109.446 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.425 ' C ' ' O ' ' A' ' 95' ' ' GLU . 24.5 mt -44.09 -59.64 2.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -0.885 . . . . 0.0 109.47 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 163.87 47.54 0.02 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 99' ' ' LEU . . . -111.24 105.54 14.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -1.151 . . . . 0.0 109.471 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.636 ' CD2' ' CE1' ' A' ' 118' ' ' TYR . 20.4 mt -44.25 -63.45 0.88 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.256 -0.903 . . . . 0.0 109.426 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.46 ' O ' HG13 ' A' ' 80' ' ' ILE . 14.5 t -146.44 -176.86 5.34 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.305 -0.872 . . . . 0.0 109.424 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.575 ' CG ' ' HB ' ' A' ' 80' ' ' ILE . 2.9 t-160 -148.77 68.54 1.07 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -0.886 . . . . 0.0 109.376 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.51 ' O ' ' N ' ' A' ' 82' ' ' THR . 18.4 m-85 -65.39 160.68 21.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.214 -0.929 . . . . 0.0 109.447 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.527 ' HB3' ' CB ' ' A' ' 83' ' ' ALA . . . -126.72 -174.35 3.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.332 -0.855 . . . . 0.0 109.396 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.7 pttt -102.34 144.92 29.56 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.257 -0.902 . . . . 0.0 109.36 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.79 133.9 32.21 Favored 'Cis proline' 0 C--N 1.31 -1.457 0 C-N-CA 123.303 -1.54 . . . . 0.0 110.407 -0.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -99.65 -176.64 3.33 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.159 -0.963 . . . . 0.0 109.488 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -127.94 123.32 34.6 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.213 -0.929 . . . . 0.0 109.464 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.454 HG22 HG22 ' A' ' 22' ' ' VAL . 16.2 mm -56.63 -22.42 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.232 -0.918 . . . . 0.0 109.476 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.423 ' O ' ' CG ' ' A' ' 113' ' ' ASP . 11.9 m-20 -72.66 -41.22 65.64 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.221 -0.924 . . . . 0.0 109.539 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.15 -31.38 70.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.203 -0.936 . . . . 0.0 109.461 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.413 HD13 HG22 ' A' ' 111' ' ' ILE . 23.0 mm -69.34 -59.16 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.31 -0.869 . . . . 0.0 109.438 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.405 ' O ' ' HG3' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -62.51 -22.84 66.59 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.2 -0.938 . . . . 0.0 109.467 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.423 ' CG ' ' O ' ' A' ' 109' ' ' ASP . 57.1 m-20 -70.79 -52.28 21.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.895 . . . . 0.0 109.412 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.407 ' O ' ' C ' ' A' ' 115' ' ' VAL . . . -66.1 -61.04 2.25 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.494 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.407 ' C ' ' O ' ' A' ' 114' ' ' ALA . 50.3 t -44.25 -47.94 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.246 -0.909 . . . . 0.0 109.437 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.405 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 0.0 OUTLIER -59.07 -43.71 91.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.287 -0.883 . . . . 0.0 109.475 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.47 -23.98 64.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.301 -0.875 . . . . 0.0 109.513 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.636 ' CE1' ' CD2' ' A' ' 99' ' ' LEU . 67.4 m-85 -80.87 -69.88 0.57 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.886 . . . . 0.0 109.516 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.459 HD22 ' HG3' ' A' ' 4' ' ' GLU . 38.3 tp -90.12 112.47 52.63 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.379 -0.826 . . . . 0.0 109.466 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.463 ' O ' HD22 ' A' ' 121' ' ' LEU . 35.8 Cg_endo -78.12 152.95 28.12 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.327 2.018 . . . . 0.0 110.381 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.592 ' CD1' ' CZ ' ' A' ' 28' ' ' TYR . 26.1 mt . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.247 -0.908 . . . . 0.0 109.467 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.518 ' CB ' ' HA ' ' A' ' 48' ' ' PRO . 42.7 mttm -127.71 138.53 52.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.318 -0.864 . . . . 0.0 109.444 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.496 ' CD1' ' HB3' ' A' ' 28' ' ' TYR . 74.3 mt -144.33 155.0 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.188 -0.945 . . . . 0.0 109.417 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.521 ' CD2' ' HB2' ' A' ' 31' ' ' PHE . 0.2 OUTLIER -132.26 119.39 20.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.214 -0.929 . . . . 0.0 109.556 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.471 HD12 ' CB ' ' A' ' 19' ' ' LEU . 14.1 mt -99.78 102.21 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.248 -0.908 . . . . 0.0 109.447 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.524 ' CG2' HD13 ' A' ' 53' ' ' LEU . 4.9 t -90.02 91.55 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 109.546 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.52 ' O ' ' CD ' ' A' ' 16' ' ' ARG . 4.9 t70 -147.42 138.36 23.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.329 -0.857 . . . . 0.0 109.33 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.524 ' HB3' ' CB ' ' A' ' 34' ' ' ALA . 8.9 p-10 -106.96 -35.81 6.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.891 . . . . 0.0 109.495 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.408 ' O ' ' C ' ' A' ' 13' ' ' TYR . 21.6 tt0 -67.35 106.32 2.04 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.271 -0.893 . . . . 0.0 109.374 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.531 ' CE2' HG13 ' A' ' 17' ' ' ILE . 30.4 t80 -43.32 149.34 0.25 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.357 -0.839 . . . . 0.0 109.6 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.79 -50.79 0.81 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.51 HG22 ' CD1' ' A' ' 19' ' ' LEU . 2.5 mt -80.69 -36.07 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.204 -1.174 . . . . 0.0 109.435 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.524 ' O ' ' CB ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -63.21 -30.1 71.31 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.129 -0.982 . . . . 0.0 109.433 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.531 HG13 ' CE2' ' A' ' 13' ' ' TYR . 2.3 mm -90.84 -31.5 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.292 -0.88 . . . . 0.0 109.831 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.436 ' O ' HG21 ' A' ' 22' ' ' VAL . 8.3 mt -68.8 -60.23 2.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.103 -0.998 . . . . 0.0 109.351 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.51 ' CD1' HG22 ' A' ' 15' ' ' ILE . 7.3 mp -65.86 -18.03 65.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.318 -0.864 . . . . 0.0 108.789 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 16' ' ' ARG . 0.7 OUTLIER -70.2 -66.33 0.61 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.818 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.46 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 1.1 mm-40 -53.81 -44.2 69.98 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.337 -0.852 . . . . 0.0 109.575 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.526 HG22 ' CG2' ' A' ' 108' ' ' ILE . 46.8 t -54.6 -63.06 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.164 -0.96 . . . . 0.0 109.499 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.525 ' CB ' HG22 ' A' ' 30' ' ' THR . 25.8 m-85 -64.79 -10.62 29.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 0.0 109.54 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.46 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 0.5 OUTLIER -74.26 -60.23 2.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.256 -0.902 . . . . 0.0 109.477 179.919 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -67.59 -25.03 65.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.254 -0.903 . . . . 0.0 109.394 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.478 ' HB3' ' CD2' ' A' ' 28' ' ' TYR . 1.8 mt-10 -69.27 -34.77 75.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.442 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.479 ' O ' ' CG ' ' A' ' 28' ' ' TYR . . . 102.78 73.1 0.96 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.496 ' HB3' ' CD1' ' A' ' 6' ' ' ILE . 93.9 m-85 -156.71 144.45 19.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.213 -1.169 . . . . 0.0 109.576 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -89.85 83.24 6.17 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.246 -0.909 . . . . 0.0 109.252 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.525 HG22 ' CB ' ' A' ' 23' ' ' PHE . 5.8 p -89.93 137.95 31.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.28 -0.887 . . . . 0.0 109.566 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.521 ' HB2' ' CD2' ' A' ' 7' ' ' LEU . 42.4 m-85 -105.03 -172.08 2.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 109.345 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.474 ' HG2' ' CG ' ' A' ' 16' ' ' ARG . 54.4 mt-30 -136.88 147.09 46.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.143 -0.973 . . . . 0.0 109.548 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.5 ' O ' ' CB ' ' A' ' 34' ' ' ALA . . . -164.91 -161.94 0.59 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.239 -0.913 . . . . 0.0 109.368 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.524 ' CB ' ' HB3' ' A' ' 11' ' ' ASP . . . 163.65 -53.72 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.281 -0.887 . . . . 0.0 109.352 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.472 ' HA ' ' HE2' ' A' ' 60' ' ' MET . 22.3 p-10 -60.13 -14.63 18.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.308 -0.87 . . . . 0.0 109.462 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.467 ' HA3' HD12 ' A' ' 65' ' ' ILE . . . 95.79 -45.39 1.99 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 mt -67.68 -30.84 70.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.257 -1.143 . . . . 0.0 109.496 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -72.32 -43.72 63.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.235 -0.916 . . . . 0.0 109.461 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.36 -55.97 20.18 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.267 -0.896 . . . . 0.0 109.417 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.4 mt -51.98 -44.43 64.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.286 -0.884 . . . . 0.0 109.478 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.99 -49.73 72.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.277 -0.889 . . . . 0.0 109.465 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.448 HG23 ' CG ' ' A' ' 31' ' ' PHE . 3.1 mt -66.7 -19.48 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -0.897 . . . . 0.0 109.469 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.507 ' HA ' ' CD ' ' A' ' 48' ' ' PRO . 89.3 t -78.54 -32.35 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -0.892 . . . . 0.0 109.451 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.441 ' O ' HG21 ' A' ' 44' ' ' THR . 26.3 m -89.96 -19.44 24.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.205 -0.935 . . . . 0.0 109.494 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.01 -32.33 16.81 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.239 -0.913 . . . . 0.0 109.547 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.408 ' HA ' ' OE1' ' A' ' 46' ' ' GLU . 15.0 mm-40 -117.52 -33.36 4.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.281 -0.887 . . . . 0.0 109.569 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.451 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 4.4 ttp180 61.27 73.0 0.63 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.191 -0.943 . . . . 0.0 109.424 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.518 ' HA ' ' CB ' ' A' ' 5' ' ' LYS . 35.3 Cg_endo -78.12 -176.87 3.48 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.577 2.184 . . . . 0.0 110.405 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -127.44 -3.62 6.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.229 -0.919 . . . . 0.0 109.583 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.0 tp -136.93 125.17 23.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.203 -0.936 . . . . 0.0 109.52 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.49 HG13 ' N ' ' A' ' 52' ' ' LEU . 73.3 t -115.74 166.21 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.324 -0.86 . . . . 0.0 109.442 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.49 ' N ' HG13 ' A' ' 51' ' ' VAL . 1.1 mt -138.42 91.09 2.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.91 . . . . 0.0 109.585 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.524 HD13 ' CG2' ' A' ' 9' ' ' VAL . 3.1 mp -89.93 124.03 34.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.2 -0.938 . . . . 0.0 109.512 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.518 ' HB2' ' CE ' ' A' ' 81' ' ' MET . 28.1 t0 -100.06 -7.36 25.06 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.246 -0.909 . . . . 0.0 109.743 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 7.8 mmt 51.37 18.7 0.67 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.389 -0.819 . . . . 0.0 109.817 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.416 ' HG3' ' OD2' ' A' ' 54' ' ' ASP . 51.3 mmtt -90.95 -37.67 13.36 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.057 -1.027 . . . . 0.0 109.42 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.532 ' CG2' ' CE ' ' A' ' 60' ' ' MET . 2.9 mt -42.82 114.41 1.51 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.388 -0.82 . . . . 0.0 109.593 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.459 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 34.9 Cg_endo -77.14 152.87 31.58 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.394 2.062 . . . . 0.0 110.27 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 108.87 -43.69 1.65 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.532 ' CE ' ' CG2' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -153.98 159.72 41.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.343 -1.092 . . . . 0.0 109.286 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -90.02 164.84 14.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.23 -0.919 . . . . 0.0 109.538 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.453 ' HA2' HG12 ' A' ' 65' ' ' ILE . . . -89.66 -9.0 66.99 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 20.5 mm -46.85 -44.54 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.215 -1.168 . . . . 0.0 109.337 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -58.35 -42.01 85.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.336 -0.852 . . . . 0.0 109.338 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.467 HD12 ' HA3' ' A' ' 36' ' ' GLY . 15.6 mm -49.86 -50.26 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -0.926 . . . . 0.0 109.391 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.586 ' CD2' ' CG1' ' A' ' 78' ' ' VAL . 96.1 mt -58.36 -49.1 78.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.207 -0.933 . . . . 0.0 109.372 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 66' ' ' LEU . 12.5 mttp -44.28 -47.95 9.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.262 -0.899 . . . . 0.0 109.411 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.453 ' O ' HG12 ' A' ' 72' ' ' ILE . 1.9 mpt_? -66.1 -37.14 85.02 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.222 -0.924 . . . . 0.0 109.464 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.438 ' HG3' ' HA ' ' A' ' 66' ' ' LEU . 1.2 mmt -62.44 -22.91 66.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.251 -0.906 . . . . 0.0 109.438 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.462 ' HG2' ' O ' ' A' ' 66' ' ' LEU . 13.5 mmtt -84.92 -43.76 13.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.228 -0.92 . . . . 0.0 109.43 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.6 t -63.87 -27.69 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.327 -0.858 . . . . 0.0 109.465 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.453 HG12 ' O ' ' A' ' 68' ' ' ARG . 28.6 mm -89.95 -56.37 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.246 -0.909 . . . . 0.0 109.486 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.438 ' O ' ' O ' ' A' ' 69' ' ' MET . 2.6 m-20 -126.25 134.64 51.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.305 -0.872 . . . . 0.0 109.471 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -89.18 -15.97 32.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.268 -0.895 . . . . 0.0 109.482 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -114.76 55.49 0.75 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.176 -0.952 . . . . 0.0 109.46 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.446 HG21 ' O ' ' A' ' 76' ' ' ILE . 0.8 OUTLIER -110.94 118.0 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.305 -0.872 . . . . 0.0 109.481 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.519 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 0.4 OUTLIER -75.68 144.13 41.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.894 . . . . 0.0 109.48 -179.999 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.586 ' CG1' ' CD2' ' A' ' 66' ' ' LEU . 13.6 t -143.93 107.95 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.343 -0.848 . . . . 0.0 109.495 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.449 HG22 ' O ' ' A' ' 100' ' ' THR . 68.0 mt -90.28 139.32 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.247 -0.908 . . . . 0.0 109.425 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.579 HG13 ' CG ' ' A' ' 101' ' ' HIS . 0.0 OUTLIER -108.36 167.02 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.278 -0.889 . . . . 0.0 109.297 179.915 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.518 ' CE ' ' HB2' ' A' ' 54' ' ' ASP . 7.2 mtm -146.59 95.0 2.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.154 -0.967 . . . . 0.0 109.588 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.586 ' CG2' ' CE1' ' A' ' 101' ' ' HIS . 11.6 t 177.8 38.37 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.213 -0.929 . . . . 0.0 109.35 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.48 0 O-C-N 121.352 -0.842 . . . . 0.0 109.477 -179.977 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.47 ' HA ' ' HB2' ' A' ' 93' ' ' SER . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -61.06 -49.35 77.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -0.882 . . . . 0.0 109.4 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.442 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -77.54 -22.41 51.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.897 . . . . 0.0 109.295 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.47 ' HB2' ' HA ' ' A' ' 90' ' ' ILE . 0.6 OUTLIER -59.86 -68.8 0.25 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.258 -0.901 . . . . 0.0 109.358 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.52 ' HA ' ' CB ' ' A' ' 98' ' ' ALA . 24.0 tptt -44.04 -53.58 6.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.332 -0.855 . . . . 0.0 109.312 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 94' ' ' LYS . 36.3 tp10 -43.46 -51.5 6.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.365 -0.835 . . . . 0.0 109.461 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 92' ' ' GLU . 23.8 mt -58.11 -50.9 71.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.262 -0.899 . . . . 0.0 109.522 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 163.25 41.15 0.02 OUTLIER Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.52 ' CB ' ' HA ' ' A' ' 94' ' ' LYS . . . -93.52 107.23 19.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.295 -1.121 . . . . 0.0 109.368 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.519 ' CD1' ' HB3' ' A' ' 77' ' ' ARG . 22.0 mt -44.03 -87.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.261 -0.899 . . . . 0.0 109.518 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.449 ' O ' HG22 ' A' ' 79' ' ' ILE . 4.0 t -127.95 160.93 30.35 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.918 . . . . 0.0 109.517 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.586 ' CE1' ' CG2' ' A' ' 82' ' ' THR . 6.3 t-160 -125.21 95.32 4.44 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.255 -0.903 . . . . 0.0 109.581 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.606 ' CD2' ' CD1' ' A' ' 111' ' ' ILE . 18.8 m-85 -69.51 -168.45 0.17 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.29 -0.881 . . . . 0.0 109.419 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.462 ' O ' ' HB3' ' A' ' 106' ' ' PHE . . . -162.81 -165.85 1.21 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.201 -0.937 . . . . 0.0 109.402 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.514 ' HG3' ' CE1' ' A' ' 106' ' ' PHE . 16.9 mtpt -129.2 145.37 56.44 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.225 -0.922 . . . . 0.0 109.459 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.9 151.66 91.38 Favored 'Cis proline' 0 C--N 1.31 -1.476 0 C-N-CA 123.302 -1.541 . . . . 0.0 110.381 -0.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.547 ' CD1' ' N ' ' A' ' 106' ' ' PHE . 4.9 p90 -133.63 169.32 17.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.183 -0.948 . . . . 0.0 109.486 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.408 ' HB3' ' OE1' ' A' ' 110' ' ' GLU . 42.7 t0 -103.16 116.71 33.0 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.208 -0.933 . . . . 0.0 109.501 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.526 ' CG2' HG22 ' A' ' 22' ' ' VAL . 12.9 mm -50.23 -29.72 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.279 -0.888 . . . . 0.0 109.38 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.46 ' HA ' ' HD3' ' A' ' 112' ' ' ARG . 52.0 m-20 -66.26 -44.0 84.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.204 -0.935 . . . . 0.0 109.383 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 113' ' ' ASP . 2.2 mp0 -64.46 -46.92 81.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 109.505 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.606 ' CD1' ' CD2' ' A' ' 102' ' ' PHE . 22.6 mm -52.27 -62.28 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.317 -0.864 . . . . 0.0 109.533 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 108' ' ' ILE . 0.6 OUTLIER -52.23 -38.45 58.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.55 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 110' ' ' GLU . 88.3 m-20 -53.52 -63.21 1.22 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 109.494 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.428 ' HA ' ' HG3' ' A' ' 117' ' ' LYS . . . -52.08 -55.67 19.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.912 . . . . 0.0 109.518 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.41 ' C ' ' O ' ' A' ' 114' ' ' ALA . 50.7 t -43.96 -35.04 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.261 -0.899 . . . . 0.0 109.477 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.444 ' HE3' ' OE2' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -73.93 -42.2 60.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.282 -0.886 . . . . 0.0 109.467 179.952 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.428 ' HG3' ' HA ' ' A' ' 114' ' ' ALA . 4.0 mttt -62.4 -21.57 65.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 109.449 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.46 ' O ' ' HD3' ' A' ' 120' ' ' PRO . 61.2 m-85 -88.55 -70.8 0.62 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.287 -0.883 . . . . 0.0 109.499 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 21.1 tp -90.04 112.48 52.61 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.365 -0.835 . . . . 0.0 109.448 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 118' ' ' TYR . 35.5 Cg_endo -78.04 133.0 12.02 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.393 2.062 . . . . 0.0 110.382 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 121' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 109.427 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.514 ' OE1' ' CD2' ' A' ' 121' ' ' LEU . 3.9 mt-10 . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.503 ' O ' ' CB ' ' A' ' 48' ' ' PRO . 0.8 OUTLIER -134.42 134.46 41.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.287 -0.883 . . . . 0.0 109.426 179.934 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.525 ' HB ' ' CG2' ' A' ' 30' ' ' THR . 98.0 mt -128.85 161.27 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.3 -0.875 . . . . 0.0 109.486 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.526 ' CD2' ' HB2' ' A' ' 31' ' ' PHE . 2.1 tm? -132.51 114.97 14.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.551 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.528 ' CG2' ' OD2' ' A' ' 10' ' ' ASP . 3.2 mt -104.36 105.03 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.924 . . . . 0.0 109.552 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.493 HG21 ' CD1' ' A' ' 7' ' ' LEU . 35.9 t -90.49 90.0 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.874 . . . . 0.0 109.464 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.528 ' OD2' ' CG2' ' A' ' 8' ' ' ILE . 69.1 m-20 -127.37 128.79 46.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.202 -0.936 . . . . 0.0 109.434 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.469 ' OD2' ' HD2' ' A' ' 58' ' ' PRO . 6.7 p-10 -100.21 -23.69 14.76 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.289 -0.882 . . . . 0.0 109.241 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.421 ' O ' ' C ' ' A' ' 13' ' ' TYR . 9.7 tp-100 -84.41 105.78 15.5 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.362 -0.836 . . . . 0.0 109.558 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.642 ' CE2' ' CD1' ' A' ' 17' ' ' ILE . 1.5 t80 -42.53 155.37 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.402 -0.811 . . . . 0.0 109.325 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.516 ' N ' ' CD1' ' A' ' 13' ' ' TYR . . . 109.33 -55.53 0.5 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.516 HG22 ' CD1' ' A' ' 19' ' ' LEU . 2.1 mt -76.13 -60.28 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.329 -1.101 . . . . 0.0 109.268 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.466 ' HD2' ' O ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -41.16 -30.91 0.17 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.48 -0.762 . . . . 0.0 110.042 -179.869 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.642 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 1.3 mt -90.42 -35.66 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.135 -0.978 . . . . 0.0 109.973 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.459 HD13 HD13 ' A' ' 108' ' ' ILE . 0.4 OUTLIER -65.44 -59.81 3.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.239 -0.913 . . . . 0.0 109.758 -179.625 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.516 ' CD1' HG22 ' A' ' 15' ' ' ILE . 7.2 mp -64.32 -20.97 66.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.198 -0.939 . . . . 0.0 109.639 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 10.9 t30 -70.65 -62.56 1.34 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 109.514 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.45 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 34.9 mt-10 -56.46 -44.37 80.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.265 -0.897 . . . . 0.0 109.55 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.443 HG23 HG22 ' A' ' 108' ' ' ILE . 41.2 t -55.13 -61.73 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.236 -0.915 . . . . 0.0 109.491 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.522 ' CB ' HG22 ' A' ' 30' ' ' THR . 20.9 m-85 -65.56 -11.5 44.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.348 -0.845 . . . . 0.0 109.479 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 0.5 OUTLIER -73.52 -60.07 2.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.335 -0.853 . . . . 0.0 109.483 179.937 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.1 tttp -74.07 -11.3 60.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.453 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.462 ' HB2' ' HA ' ' A' ' 23' ' ' PHE . 0.7 OUTLIER -76.14 -31.57 58.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -0.935 . . . . 0.0 109.49 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.88 41.89 0.82 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.521 ' CE1' HD22 ' A' ' 121' ' ' LEU . 85.2 m-85 -141.56 134.93 29.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.256 -1.144 . . . . 0.0 109.592 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -93.96 82.21 4.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.234 -0.916 . . . . 0.0 109.07 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.525 ' CG2' ' HB ' ' A' ' 6' ' ' ILE . 5.5 p -89.79 149.07 22.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.27 -0.894 . . . . 0.0 109.881 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.538 ' CZ ' ' OE2' ' A' ' 46' ' ' GLU . 31.6 m-85 -109.01 -167.23 1.19 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 109.052 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 15.5 mp0 -133.19 157.09 46.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.161 -0.962 . . . . 0.0 109.821 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.437 ' HB1' ' HA ' ' A' ' 9' ' ' VAL . . . -157.77 176.94 11.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.414 -0.804 . . . . 0.0 109.283 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.437 ' HB3' ' HA ' ' A' ' 11' ' ' ASP . . . -173.35 -44.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.125 -0.985 . . . . 0.0 109.693 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.418 ' C ' ' SD ' ' A' ' 60' ' ' MET . 2.4 p30 -82.25 -1.8 50.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.214 -0.929 . . . . 0.0 109.607 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.449 ' HA3' ' SD ' ' A' ' 60' ' ' MET . . . 85.7 -48.69 4.03 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.457 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 1.1 mp -52.54 -44.79 66.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -1.149 . . . . 0.0 109.511 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.521 ' O ' ' CD1' ' A' ' 42' ' ' ILE . 1.0 OUTLIER -68.19 -27.71 66.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.217 -0.927 . . . . 0.0 109.481 179.939 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.4 ' O ' HG22 ' A' ' 43' ' ' VAL . . . -71.56 -69.45 0.38 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.202 -0.936 . . . . 0.0 109.548 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -51.77 -47.17 64.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.228 -0.92 . . . . 0.0 109.6 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 37' ' ' LEU . 16.0 t0 -54.08 -52.59 60.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.308 -0.87 . . . . 0.0 109.55 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.521 ' CD1' ' O ' ' A' ' 38' ' ' GLN . 20.4 mt -61.7 -22.92 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.257 -0.902 . . . . 0.0 109.424 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 54.1 t -78.29 -25.28 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.182 -0.949 . . . . 0.0 109.457 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.1 m -90.13 -25.29 20.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.308 -0.87 . . . . 0.0 109.525 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.513 ' CD ' ' HA ' ' A' ' 42' ' ' ILE . 3.8 ptmt -90.07 -27.13 19.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.574 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.538 ' OE2' ' CZ ' ' A' ' 31' ' ' PHE . 3.2 mt-10 -118.6 -26.66 6.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.23 -0.919 . . . . 0.0 109.471 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.476 ' CG ' ' C ' ' A' ' 46' ' ' GLU . 7.4 ptm180 38.55 72.12 0.98 Allowed Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.598 -0.689 . . . . 0.0 109.969 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.503 ' CB ' ' O ' ' A' ' 5' ' ' LYS . 34.7 Cg_endo -77.19 -171.51 1.18 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.619 2.213 . . . . 0.0 110.343 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 5.7 m-20 -117.6 -8.3 10.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.139 -0.975 . . . . 0.0 109.556 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.418 ' HB3' HG12 ' A' ' 6' ' ' ILE . 7.2 tp -131.57 117.34 18.6 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.286 -0.884 . . . . 0.0 109.54 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.584 ' CG1' ' CE ' ' A' ' 69' ' ' MET . 2.9 t -121.35 158.75 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.233 -0.917 . . . . 0.0 109.408 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.2 mp -135.3 115.68 13.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -0.935 . . . . 0.0 109.516 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.575 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.8 OUTLIER -102.19 126.45 49.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.355 -0.841 . . . . 0.0 109.419 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 81' ' ' MET . 31.9 t0 -106.49 106.6 17.19 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.917 . . . . 0.0 109.466 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.458 ' HB2' HG22 ' A' ' 82' ' ' THR . 16.0 mmt -59.78 -14.95 16.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.332 -0.855 . . . . 0.0 109.462 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.477 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 4.2 mmpt? -52.88 -37.18 60.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 109.502 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.526 ' CG2' ' HB3' ' A' ' 60' ' ' MET . 43.8 mt -41.14 101.15 0.24 Allowed Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.443 -0.786 . . . . 0.0 109.691 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 56' ' ' LYS . 36.2 Cg_endo -79.15 -29.53 3.14 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.512 2.141 . . . . 0.0 110.51 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -84.45 -3.91 88.19 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.526 ' HB3' ' CG2' ' A' ' 57' ' ' ILE . 10.3 ttp -156.96 141.03 16.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.103 -1.234 . . . . 0.0 109.607 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.474 ' N ' ' HG2' ' A' ' 60' ' ' MET . 15.3 m-20 -89.99 126.82 35.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.31 -0.869 . . . . 0.0 109.431 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.509 ' HA2' ' CG1' ' A' ' 65' ' ' ILE . . . -82.96 9.16 60.92 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 13.0 mm -70.8 -44.69 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.249 -1.148 . . . . 0.0 109.396 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -71.91 -12.89 61.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -0.905 . . . . 0.0 109.404 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.523 ' O ' ' CG ' ' A' ' 69' ' ' MET . 13.6 mm -73.49 -58.36 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.189 -0.944 . . . . 0.0 109.49 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.446 HD23 ' O ' ' A' ' 97' ' ' GLY . 6.3 mt -53.25 -28.42 27.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -0.916 . . . . 0.0 109.465 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.505 ' O ' ' CG ' ' A' ' 70' ' ' LYS . 5.7 mmtm -72.65 -70.28 0.36 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.189 -0.945 . . . . 0.0 109.451 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.459 ' O ' HG12 ' A' ' 72' ' ' ILE . 0.6 OUTLIER -45.25 -25.83 0.42 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.265 -0.897 . . . . 0.0 109.418 -179.938 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.584 ' CE ' ' CG1' ' A' ' 51' ' ' VAL . 2.9 mmm -72.78 -48.9 34.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.187 -0.946 . . . . 0.0 109.456 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.505 ' CG ' ' O ' ' A' ' 67' ' ' LYS . 16.3 ptpt -63.18 -21.77 66.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.262 -0.899 . . . . 0.0 109.51 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.1 t -80.1 -45.62 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.251 -0.905 . . . . 0.0 109.517 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.459 HG12 ' O ' ' A' ' 68' ' ' ARG . 24.1 mm -76.21 -14.64 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.215 -0.928 . . . . 0.0 109.525 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -170.06 117.62 0.56 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.221 -0.924 . . . . 0.0 109.514 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.422 ' HG3' ' N ' ' A' ' 75' ' ' ASN . 0.1 OUTLIER -90.13 -18.83 25.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.186 -0.946 . . . . 0.0 109.417 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.422 ' N ' ' HG3' ' A' ' 74' ' ' GLU . 17.3 m120 -101.2 48.85 0.88 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.295 -0.878 . . . . 0.0 109.456 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.458 HD13 ' O ' ' A' ' 48' ' ' PRO . 0.3 OUTLIER -121.9 116.96 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.275 -0.891 . . . . 0.0 109.518 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.525 ' CA ' HD12 ' A' ' 99' ' ' LEU . 7.7 mtt85 -54.02 130.73 38.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 109.417 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -132.08 117.86 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.213 -0.929 . . . . 0.0 109.63 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.46 HG21 ' O ' ' A' ' 100' ' ' THR . 66.9 mt -114.69 144.05 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.261 -0.899 . . . . 0.0 109.394 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.58 ' CD1' ' ND1' ' A' ' 101' ' ' HIS . 0.1 OUTLIER -108.63 158.88 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.235 -0.916 . . . . 0.0 109.418 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.463 ' O ' ' HB ' ' A' ' 82' ' ' THR . 14.2 mtm -136.83 91.92 2.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.135 -0.978 . . . . 0.0 109.644 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.573 HG21 ' CE1' ' A' ' 101' ' ' HIS . 11.4 t 176.69 38.65 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.377 -0.827 . . . . 0.0 109.331 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.517 ' CB ' ' HB1' ' A' ' 103' ' ' ALA . . . . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.338 -0.851 . . . . 0.0 109.571 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.448 ' HA ' ' HB2' ' A' ' 93' ' ' SER . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.785 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.71 -38.25 14.81 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.193 -0.942 . . . . 0.0 109.452 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.14 -44.82 9.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.915 . . . . 0.0 109.639 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.517 ' HA ' ' CD1' ' A' ' 96' ' ' LEU . 2.7 m -45.05 -26.88 0.49 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.171 -0.955 . . . . 0.0 109.69 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.64 -63.45 1.29 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.18 -0.95 . . . . 0.0 109.518 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.408 ' HG3' ' N ' ' A' ' 96' ' ' LEU . 7.1 pt-20 -61.45 -27.03 68.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.277 -0.89 . . . . 0.0 109.512 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.517 ' CD1' ' HA ' ' A' ' 93' ' ' SER . 36.2 mt -67.49 -33.73 75.71 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.205 -0.935 . . . . 0.0 109.5 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.526 ' O ' ' CG2' ' A' ' 78' ' ' VAL . . . 156.16 69.9 0.01 OUTLIER Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' A' ' 78' ' ' VAL . . . -158.01 110.03 2.31 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.273 -1.133 . . . . 0.0 109.382 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.525 HD12 ' CA ' ' A' ' 77' ' ' ARG . 0.4 OUTLIER -60.24 -67.58 0.38 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.289 -0.882 . . . . 0.0 109.436 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.46 ' O ' HG21 ' A' ' 79' ' ' ILE . 10.7 t -131.66 160.39 35.56 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.214 -0.928 . . . . 0.0 109.406 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.58 ' ND1' ' CD1' ' A' ' 80' ' ' ILE . 5.4 t-160 -124.92 94.79 4.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -0.892 . . . . 0.0 109.458 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -63.62 -179.0 0.32 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.238 -0.914 . . . . 0.0 109.5 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.517 ' HB1' ' CB ' ' A' ' 83' ' ' ALA . . . -171.08 -157.94 0.14 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.291 -0.881 . . . . 0.0 109.337 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.419 ' HG3' ' HA ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -98.9 143.03 25.63 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.188 -0.945 . . . . 0.0 109.454 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.419 ' HA ' ' HG3' ' A' ' 104' ' ' LYS . 35.6 Cg_endo -77.98 164.75 84.92 Favored 'Cis proline' 0 C--N 1.31 -1.487 0 C-N-CA 123.277 -1.551 . . . . 0.0 110.37 -0.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.624 ' CE2' ' CD1' ' A' ' 111' ' ' ILE . 0.2 OUTLIER -96.18 107.68 20.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.29 -0.881 . . . . 0.0 109.502 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.458 ' O ' HG12 ' A' ' 111' ' ' ILE . 23.1 t0 -89.83 103.87 16.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.258 -0.901 . . . . 0.0 109.384 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.461 ' O ' ' HG2' ' A' ' 112' ' ' ARG . 15.8 mm -46.21 -24.35 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 109.863 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.456 ' O ' ' OD2' ' A' ' 113' ' ' ASP . 22.4 m-20 -73.6 -45.22 54.39 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.203 -0.936 . . . . 0.0 109.789 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.92 -24.37 61.62 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.112 -0.993 . . . . 0.0 109.706 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.624 ' CD1' ' CE2' ' A' ' 106' ' ' PHE . 10.6 mm -76.26 -53.08 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.218 -0.926 . . . . 0.0 109.438 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 108' ' ' ILE . 0.9 OUTLIER -64.24 -37.39 87.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.319 -0.863 . . . . 0.0 109.588 -179.867 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.456 ' OD2' ' O ' ' A' ' 109' ' ' ASP . 16.6 m-20 -63.65 -60.13 3.72 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.203 -0.936 . . . . 0.0 109.6 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -46.58 -51.06 16.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.925 . . . . 0.0 109.618 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.422 HG22 ' CZ ' ' A' ' 23' ' ' PHE . 47.9 t -52.57 -49.98 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.889 . . . . 0.0 109.597 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 0.4 OUTLIER -58.42 -29.68 66.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.902 . . . . 0.0 109.553 -179.867 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.7 tttm -76.89 -27.36 54.94 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.201 -0.937 . . . . 0.0 109.42 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.486 ' O ' ' HD3' ' A' ' 120' ' ' PRO . 40.3 m-85 -90.05 -75.07 0.46 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.254 -0.904 . . . . 0.0 109.497 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.462 HD22 ' O ' ' A' ' 120' ' ' PRO . 5.3 tt -90.54 111.87 49.89 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.261 -0.899 . . . . 0.0 109.627 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' A' ' 118' ' ' TYR . 36.2 Cg_endo -79.53 154.83 24.26 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.442 2.094 . . . . 0.0 110.355 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.521 HD22 ' CE1' ' A' ' 28' ' ' TYR . 21.4 mt . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.298 -0.876 . . . . 0.0 109.205 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.52 ' OE2' ' CD2' ' A' ' 121' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.526 ' CB ' ' HA ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -127.53 111.15 13.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.294 -0.879 . . . . 0.0 109.454 179.958 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.519 HD11 HG22 ' A' ' 6' ' ' ILE . 16.2 mt -126.93 158.29 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.255 -0.903 . . . . 0.0 109.496 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.522 ' CD2' ' HB2' ' A' ' 31' ' ' PHE . 2.6 tm? -132.51 128.97 38.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.231 -0.918 . . . . 0.0 109.469 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.487 ' N ' HD12 ' A' ' 7' ' ' LEU . 9.1 mt -106.44 104.64 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.239 -0.913 . . . . 0.0 109.466 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.461 ' HB ' ' O ' ' A' ' 52' ' ' LEU . 3.9 t -89.97 70.78 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.292 -0.88 . . . . 0.0 109.463 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.515 ' O ' ' CD ' ' A' ' 16' ' ' ARG . 0.4 OUTLIER -123.22 148.94 45.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.892 . . . . 0.0 109.502 179.935 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.45 ' OD1' ' HA ' ' A' ' 57' ' ' ILE . 5.5 p-10 -115.8 -40.16 3.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.248 -0.907 . . . . 0.0 109.457 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.94 111.93 2.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.0 109.505 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.572 ' CZ ' HG13 ' A' ' 17' ' ' ILE . 46.6 t80 -49.26 128.84 17.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.212 -0.93 . . . . 0.0 109.477 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 138.23 -43.93 1.15 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.521 HG21 ' CD1' ' A' ' 19' ' ' LEU . 6.4 mt -84.26 -39.74 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -1.135 . . . . 0.0 109.392 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.515 ' CD ' ' O ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -65.93 -26.57 67.66 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.207 -0.933 . . . . 0.0 109.453 -179.964 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.572 HG13 ' CZ ' ' A' ' 13' ' ' TYR . 4.8 mm -90.65 -42.61 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.261 -0.9 . . . . 0.0 109.787 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.2 mt -64.65 -57.76 8.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.145 -0.972 . . . . 0.0 109.852 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.521 ' CD1' HG21 ' A' ' 15' ' ' ILE . 7.9 mp -60.23 -26.37 66.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.243 -0.91 . . . . 0.0 109.743 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 30.2 t30 -67.87 -55.2 13.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 109.59 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.466 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 33.4 mt-10 -59.74 -44.71 93.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.265 -0.897 . . . . 0.0 109.723 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.532 ' CG1' ' CG ' ' A' ' 112' ' ' ARG . 13.7 t -55.92 -62.22 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 109.729 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.427 ' HA ' ' HB2' ' A' ' 26' ' ' GLU . 17.0 m-85 -68.4 -10.16 53.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.915 . . . . 0.0 109.592 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.466 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 0.4 OUTLIER -70.84 -52.06 22.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.191 -0.943 . . . . 0.0 109.386 179.863 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -74.55 -11.71 60.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.238 -0.914 . . . . 0.0 109.311 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.536 ' HB3' ' CD2' ' A' ' 28' ' ' TYR . 3.5 mt-10 -78.61 -33.61 47.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.294 -0.879 . . . . 0.0 109.474 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.462 ' O ' ' CG ' ' A' ' 4' ' ' GLU . . . 105.56 54.08 0.75 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.625 ' CZ ' ' CD1' ' A' ' 121' ' ' LEU . 88.5 m-85 -138.07 143.53 40.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.168 -1.195 . . . . 0.0 109.525 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.433 ' HB2' ' O ' ' A' ' 4' ' ' GLU . 92.8 mm-40 -94.23 81.51 4.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.91 . . . . 0.0 109.394 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.442 HG23 HD13 ' A' ' 6' ' ' ILE . 5.8 p -89.88 148.34 23.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.906 . . . . 0.0 109.53 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.522 ' HB2' ' CD2' ' A' ' 7' ' ' LEU . 8.5 m-85 -114.84 -172.74 2.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.274 -0.892 . . . . 0.0 109.409 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -123.28 151.35 42.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.282 -0.886 . . . . 0.0 109.529 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.453 ' HB3' ' HB3' ' A' ' 38' ' ' GLN . . . -174.48 172.4 3.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.313 -0.867 . . . . 0.0 109.414 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.463 ' O ' HD11 ' A' ' 57' ' ' ILE . . . 177.67 -31.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.182 -0.949 . . . . 0.0 109.533 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -74.77 -0.91 19.79 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.171 -0.955 . . . . 0.0 109.619 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.447 ' O ' ' HB1' ' A' ' 39' ' ' ALA . . . 85.05 -45.2 3.48 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.29 -54.79 31.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.158 -1.201 . . . . 0.0 109.514 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.491 ' HG2' ' CD1' ' A' ' 42' ' ' ILE . 0.0 OUTLIER -71.24 -15.37 62.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.911 . . . . 0.0 109.617 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.522 ' O ' ' CG2' ' A' ' 43' ' ' VAL . . . -70.6 -60.66 2.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.205 -0.935 . . . . 0.0 109.536 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.496 ' CD2' ' HB3' ' A' ' 68' ' ' ARG . 0.7 OUTLIER -69.85 -38.66 76.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.247 -0.908 . . . . 0.0 109.55 -179.974 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.439 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 14.8 m-20 -61.43 -60.79 3.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.332 -0.855 . . . . 0.0 109.547 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.521 HG22 ' CD2' ' A' ' 7' ' ' LEU . 41.5 mt -56.97 -31.05 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.248 -0.908 . . . . 0.0 109.513 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 39' ' ' ALA . 44.0 t -68.84 -31.69 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.204 -0.935 . . . . 0.0 109.485 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 79.8 m -90.02 -14.5 33.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.214 -0.929 . . . . 0.0 109.474 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 3.7 mmtt -84.61 -58.48 2.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.891 . . . . 0.0 109.545 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 47' ' ' ARG . 2.4 mm-40 -89.97 -25.38 20.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 109.628 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.498 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 6.5 mmm180 63.48 62.8 1.61 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.182 -0.949 . . . . 0.0 109.436 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.526 ' HA ' ' CB ' ' A' ' 5' ' ' LYS . 35.3 Cg_endo -77.69 158.18 31.84 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.603 2.202 . . . . 0.0 110.49 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -100.04 -10.9 21.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.246 -0.909 . . . . 0.0 109.508 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.513 ' CD2' ' HB2' ' A' ' 119' ' ' LEU . 1.7 mm? -116.62 122.89 45.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.221 -0.924 . . . . 0.0 109.499 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.465 HG13 ' HE2' ' A' ' 69' ' ' MET . 9.0 t -123.91 113.06 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.902 . . . . 0.0 109.529 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.461 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 1.0 OUTLIER -90.75 120.31 31.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.883 . . . . 0.0 109.419 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.457 HD12 ' HE2' ' A' ' 69' ' ' MET . 1.1 tp -110.75 121.98 46.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.337 -0.852 . . . . 0.0 109.534 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.461 ' OD2' ' HB2' ' A' ' 56' ' ' LYS . 8.9 t0 -104.45 109.14 20.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 0.0 109.366 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.458 ' HB2' ' HB ' ' A' ' 82' ' ' THR . 6.6 mmt -67.18 -9.59 41.7 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.144 -0.972 . . . . 0.0 109.512 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.461 ' HB2' ' OD2' ' A' ' 54' ' ' ASP . 6.3 mmtt -74.92 -19.13 60.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 0.0 109.383 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.463 HD11 ' O ' ' A' ' 34' ' ' ALA . 81.0 mt -43.11 103.15 0.3 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.324 -0.86 . . . . 0.0 109.519 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 56' ' ' LYS . 35.5 Cg_endo -77.55 108.76 2.64 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.412 2.075 . . . . 0.0 110.421 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 128.93 -33.76 3.0 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.431 ' HE2' ' O ' ' A' ' 61' ' ' ASP . 0.6 OUTLIER -138.82 133.34 31.94 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.276 -1.132 . . . . 0.0 109.458 -179.962 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.431 ' O ' ' HE2' ' A' ' 60' ' ' MET . 4.3 m-20 -83.52 157.94 22.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.161 -0.962 . . . . 0.0 109.477 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.51 ' HA2' ' CD1' ' A' ' 65' ' ' ILE . . . -102.89 9.17 55.0 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.406 HD11 ' HA ' ' A' ' 63' ' ' ILE . 15.7 mm -70.37 -57.68 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -1.191 . . . . 0.0 109.447 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -58.59 -29.13 66.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 0.0 109.432 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.51 ' CD1' ' HA2' ' A' ' 62' ' ' GLY . 10.1 mt -59.23 -52.15 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.277 -0.889 . . . . 0.0 109.412 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.459 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 25.8 mt -53.87 -51.5 63.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.357 -0.84 . . . . 0.0 109.486 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.408 ' O ' HG21 ' A' ' 71' ' ' VAL . 1.3 tttt -46.81 -49.39 20.03 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.262 -0.899 . . . . 0.0 109.483 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.496 ' HB3' ' CD2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -57.93 -38.54 76.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.278 -0.889 . . . . 0.0 109.463 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.465 ' HE2' HG13 ' A' ' 51' ' ' VAL . 7.0 mtt -67.94 -25.31 65.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 0.0 109.465 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 66' ' ' LEU . 0.8 OUTLIER -78.88 -30.32 44.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.271 -0.893 . . . . 0.0 109.452 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.408 HG21 ' O ' ' A' ' 67' ' ' LYS . 3.6 t -84.9 -20.85 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.274 -0.891 . . . . 0.0 109.435 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 68' ' ' ARG . 91.4 mt -89.92 -34.97 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -0.879 . . . . 0.0 109.432 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -166.31 134.05 2.77 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.261 -0.899 . . . . 0.0 109.433 -179.927 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -89.72 -10.48 45.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.514 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -103.23 12.45 35.6 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.226 -0.921 . . . . 0.0 109.552 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.461 HG22 ' O ' ' A' ' 76' ' ' ILE . 1.0 OUTLIER -78.62 115.26 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.262 -0.899 . . . . 0.0 109.496 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.519 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 59.0 mtt85 -69.85 126.97 31.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 109.513 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 98' ' ' ALA . 2.9 t -133.23 110.44 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.269 -0.894 . . . . 0.0 109.458 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.506 HG23 ' N ' ' A' ' 80' ' ' ILE . 75.5 mt -92.59 165.02 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 109.384 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.576 ' CD1' ' ND1' ' A' ' 101' ' ' HIS . 0.3 OUTLIER -128.42 152.76 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.162 -0.962 . . . . 0.0 109.528 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.451 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 16.9 mtm -136.93 98.37 3.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.286 -0.884 . . . . 0.0 109.361 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.56 ' CG2' ' N ' ' A' ' 83' ' ' ALA . 4.4 t -166.37 -147.23 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.153 -0.967 . . . . 0.0 109.64 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.56 ' N ' ' CG2' ' A' ' 82' ' ' THR . . . . . . . . 0 N--CA 1.488 1.468 0 O-C-N 121.464 -0.772 . . . . 0.0 110.052 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.571 ' CD1' ' ND1' ' A' ' 101' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.789 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.418 ' N ' HG12 ' A' ' 90' ' ' ILE . 10.6 tt0 -47.66 -58.36 4.38 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.253 -0.905 . . . . 0.0 109.5 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.41 ' O ' ' C ' ' A' ' 93' ' ' SER . 11.2 tm-20 -58.81 -42.71 89.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.259 -0.901 . . . . 0.0 109.488 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.414 ' HA ' ' CD1' ' A' ' 96' ' ' LEU . 0.2 OUTLIER -43.76 -30.77 0.69 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 0.0 109.457 179.987 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.463 ' HG2' ' O ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -55.64 -54.6 42.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 109.469 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -51.06 -47.17 61.85 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.281 -0.887 . . . . 0.0 109.502 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.414 ' CD1' ' HA ' ' A' ' 93' ' ' SER . 0.7 OUTLIER -49.37 -58.36 5.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.212 -0.93 . . . . 0.0 109.488 179.946 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 169.62 64.89 0.04 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.463 ' O ' ' HG2' ' A' ' 94' ' ' LYS . . . -134.78 118.58 17.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.257 -1.143 . . . . 0.0 109.485 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.519 ' CD1' ' HB3' ' A' ' 77' ' ' ARG . 0.5 OUTLIER -71.11 -71.16 0.27 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.188 -0.945 . . . . 0.0 109.426 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.453 ' O ' HG21 ' A' ' 79' ' ' ILE . 14.5 t -122.24 173.16 7.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.247 -0.908 . . . . 0.0 109.453 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.576 ' ND1' ' CD1' ' A' ' 80' ' ' ILE . 5.4 t-160 -139.88 90.89 2.42 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.224 -0.923 . . . . 0.0 109.582 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.629 ' CD2' ' CD1' ' A' ' 111' ' ' ILE . 38.2 m-85 -73.21 -168.31 0.5 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.303 -0.873 . . . . 0.0 109.42 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 82' ' ' THR . . . -168.94 -147.39 0.07 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.224 -0.923 . . . . 0.0 109.294 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 7.6 ptmt -137.2 135.87 20.14 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.139 -0.976 . . . . 0.0 109.4 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.86 138.61 52.7 Favored 'Cis proline' 0 C--N 1.31 -1.459 0 C-N-CA 123.437 -1.485 . . . . 0.0 110.281 0.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.458 ' HB3' ' O ' ' A' ' 103' ' ' ALA . 26.9 p90 -99.43 172.45 7.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.28 -0.888 . . . . 0.0 109.656 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -114.81 111.96 22.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.271 -0.893 . . . . 0.0 109.348 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.453 HG23 HG23 ' A' ' 22' ' ' VAL . 10.7 mm -54.74 -18.76 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 109.38 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -72.96 -46.98 49.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 109.167 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -67.0 -33.73 76.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.302 -0.874 . . . . 0.0 109.215 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.629 ' CD1' ' CD2' ' A' ' 102' ' ' PHE . 16.7 mm -71.45 -35.19 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.322 -0.861 . . . . 0.0 109.116 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.532 ' CG ' ' CG1' ' A' ' 22' ' ' VAL . 5.3 mtp85 -63.69 -50.58 68.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.334 -0.854 . . . . 0.0 109.513 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 114' ' ' ALA . 61.8 m-20 -67.15 -62.54 1.38 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.223 -0.923 . . . . 0.0 109.766 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.56 ' O ' ' CD2' ' A' ' 118' ' ' TYR . . . -43.82 -39.77 4.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.113 -0.992 . . . . 0.0 109.684 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.482 ' CG2' ' O ' ' A' ' 111' ' ' ILE . 41.2 t -66.6 -42.97 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.909 . . . . 0.0 109.614 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 4.2 mtpp -61.81 -59.41 5.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 0.0 109.558 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -47.18 -56.31 6.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.197 -0.939 . . . . 0.0 109.566 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.56 ' CD2' ' O ' ' A' ' 114' ' ' ALA . 17.8 m-30 -51.96 -72.2 0.06 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.284 -0.885 . . . . 0.0 109.524 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.513 ' HB2' ' CD2' ' A' ' 50' ' ' LEU . 1.9 tp -90.19 112.49 52.86 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.324 -0.86 . . . . 0.0 109.534 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 118' ' ' TYR . 35.7 Cg_endo -78.16 152.94 27.96 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.318 2.012 . . . . 0.0 110.408 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.625 ' CD1' ' CZ ' ' A' ' 28' ' ' TYR . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 109.439 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.49 ' HG3' ' CD1' ' A' ' 121' ' ' LEU . 16.8 mm-40 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.452 ' O ' HG12 ' A' ' 6' ' ' ILE . 1.2 mtmp? -138.15 144.11 40.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.256 -0.902 . . . . 0.0 109.442 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.496 HD13 ' CG2' ' A' ' 30' ' ' THR . 3.5 mt -150.04 159.4 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.194 -0.941 . . . . 0.0 109.516 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.525 HD22 ' CG2' ' A' ' 42' ' ' ILE . 0.7 OUTLIER -131.18 128.14 39.39 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.333 -0.854 . . . . 0.0 109.492 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.513 ' N ' HD12 ' A' ' 7' ' ' LEU . 7.7 mt -109.68 106.81 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.287 -0.883 . . . . 0.0 109.494 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.505 HG11 ' N ' ' A' ' 34' ' ' ALA . 2.6 t -104.46 89.01 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.32 -0.862 . . . . 0.0 109.473 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.516 ' CB ' ' HD2' ' A' ' 16' ' ' ARG . 2.2 t70 -87.51 -155.98 0.32 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.202 -0.936 . . . . 0.0 109.392 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.508 ' CB ' ' HA ' ' A' ' 57' ' ' ILE . 0.7 OUTLIER -109.6 -45.52 3.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.91 . . . . 0.0 109.564 -179.977 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.507 ' HG2' ' N ' ' A' ' 13' ' ' TYR . 7.4 tt0 -132.52 -90.13 0.41 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.17 -0.956 . . . . 0.0 109.482 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.635 ' CE2' ' CD1' ' A' ' 17' ' ' ILE . 2.8 t80 -149.83 167.92 25.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.302 -0.874 . . . . 0.0 109.489 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.01 -66.75 0.24 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.461 HD12 ' OD1' ' A' ' 10' ' ' ASP . 9.8 mt -68.04 -28.01 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.254 -1.145 . . . . 0.0 109.48 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.516 ' HD2' ' CB ' ' A' ' 10' ' ' ASP . 0.3 OUTLIER -66.51 -25.87 66.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.302 -0.874 . . . . 0.0 109.444 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.635 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 4.5 mt -90.04 -51.85 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.221 -0.925 . . . . 0.0 109.533 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.436 ' O ' HG21 ' A' ' 22' ' ' VAL . 4.8 mp -59.29 -58.04 10.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.241 -0.912 . . . . 0.0 109.554 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.456 ' HB3' HD12 ' A' ' 8' ' ' ILE . 1.9 tp -56.6 -22.54 34.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.891 . . . . 0.0 109.464 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.424 ' O ' ' C ' ' A' ' 21' ' ' GLU . 28.1 t30 -74.87 -72.77 0.27 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.244 -0.91 . . . . 0.0 109.528 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 20' ' ' ASN . 17.4 tt0 -44.12 -35.52 2.21 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -0.895 . . . . 0.0 109.488 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.474 HG12 ' CG2' ' A' ' 108' ' ' ILE . 58.3 t -62.84 -56.99 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.903 . . . . 0.0 109.461 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.526 ' CB ' HG22 ' A' ' 30' ' ' THR . 18.8 m-85 -73.28 -2.49 22.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.342 -0.849 . . . . 0.0 109.618 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.413 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 0.7 OUTLIER -85.65 -55.14 4.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.145 -0.972 . . . . 0.0 109.45 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.8 mttt -69.54 -19.81 63.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.311 -0.868 . . . . 0.0 109.457 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.475 ' HB3' ' CD2' ' A' ' 28' ' ' TYR . 1.4 tt0 -78.55 -30.97 47.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.258 -0.901 . . . . 0.0 109.45 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.443 ' O ' ' CG ' ' A' ' 28' ' ' TYR . . . 110.07 64.48 0.53 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.475 ' CD2' ' HB3' ' A' ' 26' ' ' GLU . 93.7 m-85 -154.76 134.73 13.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.225 -1.162 . . . . 0.0 109.503 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 22.5 mm-40 -91.67 81.8 5.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.286 -0.884 . . . . 0.0 109.409 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.526 HG22 ' CB ' ' A' ' 23' ' ' PHE . 5.9 p -89.88 152.58 21.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.275 -0.89 . . . . 0.0 109.56 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.521 ' HB2' ' CD2' ' A' ' 7' ' ' LEU . 58.8 m-85 -116.48 -170.23 1.78 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.301 -0.875 . . . . 0.0 109.402 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.405 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 22.1 mp0 -124.17 161.26 26.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.241 -0.912 . . . . 0.0 109.547 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.448 ' HB1' HD13 ' A' ' 7' ' ' LEU . . . 178.49 177.52 0.44 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 109.437 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.505 ' N ' HG11 ' A' ' 9' ' ' VAL . . . 178.73 -41.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.217 -0.927 . . . . 0.0 109.466 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.41 ' OD1' ' CB ' ' A' ' 38' ' ' GLN . 30.9 p-10 -65.18 -10.58 32.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.923 . . . . 0.0 109.459 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.416 ' O ' ' C ' ' A' ' 37' ' ' LEU . . . 87.9 -71.42 2.58 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.464 ' O ' ' HB2' ' A' ' 40' ' ' LEU . 1.9 tt -44.46 -42.21 6.89 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -1.147 . . . . 0.0 109.395 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.513 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 6.6 tp-100 -58.72 -53.87 53.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.264 -0.898 . . . . 0.0 109.504 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.462 ' HB3' HG21 ' A' ' 9' ' ' VAL . . . -55.69 -24.16 32.81 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.15 -0.969 . . . . 0.0 109.493 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 37' ' ' LEU . 54.9 mt -73.06 -45.46 57.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.91 . . . . 0.0 109.517 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 42' ' ' ILE . 1.7 p30 -64.81 -43.02 94.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.182 -0.949 . . . . 0.0 109.449 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.525 ' CG2' HD22 ' A' ' 7' ' ' LEU . 7.2 mt -64.23 -34.77 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.21 -0.931 . . . . 0.0 109.268 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.522 ' HA ' ' CD ' ' A' ' 48' ' ' PRO . 54.2 t -74.32 -24.03 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.891 . . . . 0.0 109.453 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.2 m -89.7 -18.72 25.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.228 -0.92 . . . . 0.0 109.532 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.95 -55.65 3.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.285 -0.884 . . . . 0.0 109.483 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.438 ' O ' ' CB ' ' A' ' 47' ' ' ARG . 1.1 mt-10 -89.98 -39.04 13.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.268 -0.895 . . . . 0.0 109.458 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER 71.28 65.91 0.39 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.23 -0.919 . . . . 0.0 109.498 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.522 ' CD ' ' HA ' ' A' ' 43' ' ' VAL . 35.5 Cg_endo -78.14 167.99 22.52 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.589 2.192 . . . . 0.0 110.421 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -109.43 -9.91 14.92 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.218 -0.926 . . . . 0.0 109.533 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -117.84 121.51 40.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -0.937 . . . . 0.0 109.543 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 72.9 t -127.33 140.93 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.257 -0.902 . . . . 0.0 109.471 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.463 HD11 ' O ' ' A' ' 7' ' ' LEU . 1.1 mp -115.27 112.17 22.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.309 -0.87 . . . . 0.0 109.423 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.517 ' CD2' ' HG ' ' A' ' 66' ' ' LEU . 1.7 mp -102.59 132.02 48.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.282 -0.886 . . . . 0.0 109.517 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.46 ' O ' HG13 ' A' ' 57' ' ' ILE . 17.7 t70 -112.76 130.14 56.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.319 -0.863 . . . . 0.0 109.453 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.497 ' CG ' HG23 ' A' ' 82' ' ' THR . 9.6 mmt -86.84 -6.98 58.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.322 -0.861 . . . . 0.0 109.555 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt -86.58 15.02 5.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.166 -0.959 . . . . 0.0 109.498 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.508 ' HA ' ' CB ' ' A' ' 11' ' ' ASP . 41.7 mt -80.97 138.78 49.57 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.128 -0.983 . . . . 0.0 109.309 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.465 ' HD2' HG21 ' A' ' 57' ' ' ILE . 36.2 Cg_endo -78.54 -36.15 0.96 Allowed 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.488 2.126 . . . . 0.0 110.549 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 58' ' ' PRO . . . -42.41 -53.79 4.91 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.502 ' N ' ' SD ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -169.47 -150.3 0.08 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.136 -1.214 . . . . 0.0 109.558 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.497 ' N ' ' HG2' ' A' ' 60' ' ' MET . 36.9 m-20 -90.19 -97.28 0.11 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.291 -0.881 . . . . 0.0 109.481 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.465 ' HA2' HG13 ' A' ' 65' ' ' ILE . . . 147.42 -14.76 1.44 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 14.4 mm -57.0 -18.72 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.314 -1.109 . . . . 0.0 109.238 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -87.47 -33.52 18.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.313 -0.867 . . . . 0.0 109.24 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.465 HG13 ' HA2' ' A' ' 62' ' ' GLY . 17.2 mt -56.15 -54.58 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.338 -0.851 . . . . 0.0 109.319 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.518 HD23 ' CG1' ' A' ' 78' ' ' VAL . 23.0 mt -51.02 -44.49 61.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 109.31 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.463 ' O ' HG21 ' A' ' 71' ' ' VAL . 3.2 tttp -52.38 -50.32 62.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.326 -0.859 . . . . 0.0 109.411 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.46 ' O ' HG13 ' A' ' 72' ' ' ILE . 0.3 OUTLIER -59.28 -31.5 69.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.286 -0.884 . . . . 0.0 109.431 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.418 ' HE2' ' CG1' ' A' ' 51' ' ' VAL . 2.7 mtt -74.47 -24.92 59.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.278 -0.889 . . . . 0.0 109.435 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -79.95 -28.93 39.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.379 -0.826 . . . . 0.0 109.264 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.463 HG21 ' O ' ' A' ' 67' ' ' LYS . 2.7 t -90.08 -22.04 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.306 -0.871 . . . . 0.0 109.549 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 68' ' ' ARG . 53.3 mt -87.43 -44.56 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -0.909 . . . . 0.0 109.459 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.442 ' O ' HG23 ' A' ' 76' ' ' ILE . 73.0 m-20 -150.49 122.69 8.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.331 -0.856 . . . . 0.0 109.404 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -81.99 -9.62 59.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.277 -0.889 . . . . 0.0 109.522 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -103.37 49.87 0.82 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.233 -0.917 . . . . 0.0 109.493 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.505 ' CD1' ' O ' ' A' ' 48' ' ' PRO . 1.1 tp -129.94 112.62 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.466 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.517 ' CD ' HD13 ' A' ' 99' ' ' LEU . 1.6 mtt180 -79.85 154.19 28.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 0.0 109.468 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.518 ' CG1' HD23 ' A' ' 66' ' ' LEU . 4.8 t -150.02 108.44 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.913 . . . . 0.0 109.572 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.585 ' CG2' ' CG2' ' A' ' 100' ' ' THR . 72.5 mt -90.5 140.81 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.247 -0.908 . . . . 0.0 109.449 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.581 ' HB ' ' CE1' ' A' ' 101' ' ' HIS . 0.0 OUTLIER -94.44 152.32 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.271 -0.893 . . . . 0.0 109.198 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.452 ' O ' ' HB ' ' A' ' 82' ' ' THR . 14.0 mtm -124.53 73.16 1.24 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.183 -0.948 . . . . 0.0 109.373 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.516 HG21 ' NE2' ' A' ' 101' ' ' HIS . 9.6 t 177.29 56.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.31 -0.869 . . . . 0.0 109.397 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.418 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.281 -0.887 . . . . 0.0 109.528 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.627 ' CD1' ' CE1' ' A' ' 101' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.795 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -51.35 -37.15 46.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.255 -0.903 . . . . 0.0 109.5 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 93' ' ' SER . 1.4 mt-10 -90.15 -36.28 14.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.226 -0.921 . . . . 0.0 109.625 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.469 ' HB2' ' HA ' ' A' ' 90' ' ' ILE . 0.4 OUTLIER -43.55 -44.92 6.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.312 -0.868 . . . . 0.0 109.649 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 93' ' ' SER . 2.5 ttpt -44.02 -51.79 7.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.282 -0.886 . . . . 0.0 109.445 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -59.5 -40.99 88.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 0.0 109.431 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.509 ' N ' ' CD2' ' A' ' 96' ' ' LEU . 4.2 mm? -53.31 -64.99 0.64 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.296 -0.878 . . . . 0.0 109.49 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -176.08 40.98 0.11 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.42 ' O ' ' C ' ' A' ' 99' ' ' LEU . . . -110.77 101.33 9.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -1.164 . . . . 0.0 109.49 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.517 HD13 ' CD ' ' A' ' 77' ' ' ARG . 18.6 mt -44.1 -68.32 0.21 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 109.47 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.585 ' CG2' ' CG2' ' A' ' 79' ' ' ILE . 15.1 t -134.9 -177.6 4.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.284 -0.885 . . . . 0.0 109.437 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.627 ' CE1' ' CD1' ' A' ' 90' ' ' ILE . 3.2 t-160 -140.48 88.35 2.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 109.339 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.562 ' CE2' HG22 ' A' ' 79' ' ' ILE . 65.5 m-85 -58.99 -164.35 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.236 -0.915 . . . . 0.0 109.579 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.418 ' CB ' ' HB1' ' A' ' 83' ' ' ALA . . . -177.27 155.31 1.12 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.199 -0.938 . . . . 0.0 109.361 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.507 ' HA ' ' N ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -93.41 142.14 24.84 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.211 -0.931 . . . . 0.0 109.387 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.91 117.1 4.9 Favored 'Cis proline' 0 C--N 1.31 -1.479 0 C-N-CA 123.335 -1.527 . . . . 0.0 110.353 -0.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.507 ' N ' ' HA ' ' A' ' 104' ' ' LYS . 11.1 p90 -79.84 169.6 17.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.248 -0.908 . . . . 0.0 109.574 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.454 ' O ' HG12 ' A' ' 111' ' ' ILE . 36.0 t0 -119.77 121.73 39.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.347 -0.846 . . . . 0.0 109.473 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.474 ' CG2' HG12 ' A' ' 22' ' ' VAL . 14.5 mm -54.63 -21.28 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -0.897 . . . . 0.0 109.509 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -76.24 -37.52 57.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.235 -0.916 . . . . 0.0 109.518 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -77.57 -25.31 49.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.184 -0.947 . . . . 0.0 109.436 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.524 HD11 ' CZ ' ' A' ' 102' ' ' PHE . 19.2 mm -75.73 -45.85 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.313 -0.867 . . . . 0.0 109.516 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.447 ' HB2' ' OE1' ' A' ' 26' ' ' GLU . 7.6 ptt85 -72.51 -41.88 65.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.472 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -61.16 -53.43 57.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.928 . . . . 0.0 109.538 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.472 ' HA ' ' HG2' ' A' ' 117' ' ' LYS . . . -59.18 -45.06 92.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.292 -0.88 . . . . 0.0 109.47 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 111' ' ' ILE . 54.7 t -60.48 -25.19 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.191 -0.943 . . . . 0.0 109.396 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -76.89 -45.66 27.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.179 -0.95 . . . . 0.0 109.451 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.514 ' HG3' ' N ' ' A' ' 118' ' ' TYR . 0.0 OUTLIER -63.49 -27.08 69.03 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 109.481 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.514 ' N ' ' HG3' ' A' ' 117' ' ' LYS . 38.9 m-85 -84.51 -72.84 0.45 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.24 -0.912 . . . . 0.0 109.423 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.8 tp -90.06 112.58 53.18 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.341 -0.849 . . . . 0.0 109.422 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 118' ' ' TYR . 35.6 Cg_endo -77.79 132.76 12.15 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.33 2.02 . . . . 0.0 110.418 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.49 ' CD1' ' HG3' ' A' ' 4' ' ' GLU . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.327 -0.858 . . . . 0.0 109.47 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.567 ' OE1' ' CD2' ' A' ' 28' ' ' TYR . 1.6 mm-40 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.496 ' CB ' ' HA ' ' A' ' 48' ' ' PRO . 42.3 mttt -121.96 120.52 34.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -0.916 . . . . 0.0 109.485 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.477 HG21 ' N ' ' A' ' 7' ' ' LEU . 49.1 mt -148.51 150.93 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.157 -0.964 . . . . 0.0 109.483 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.515 HD11 ' CG2' ' A' ' 42' ' ' ILE . 0.6 OUTLIER -133.56 127.83 33.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.183 -0.948 . . . . 0.0 109.432 -179.999 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.461 HD12 ' HB3' ' A' ' 19' ' ' LEU . 8.4 mt -101.02 109.54 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.244 -0.91 . . . . 0.0 109.522 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.45 HG22 HD12 ' A' ' 53' ' ' LEU . 17.0 t -96.27 91.33 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.23 -0.919 . . . . 0.0 109.427 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.518 ' O ' ' CD ' ' A' ' 16' ' ' ARG . 16.7 t70 -145.27 146.01 31.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.264 -0.898 . . . . 0.0 109.45 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.456 ' OD2' ' HD2' ' A' ' 58' ' ' PRO . 9.1 p-10 -109.88 -37.75 5.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.185 -0.947 . . . . 0.0 109.501 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.414 ' O ' ' C ' ' A' ' 13' ' ' TYR . 1.8 tp60 -63.01 104.84 0.6 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.232 -0.918 . . . . 0.0 109.448 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.568 ' CZ ' HG13 ' A' ' 17' ' ' ILE . 9.2 t80 -44.73 132.3 6.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.243 -0.911 . . . . 0.0 109.447 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 18' ' ' LEU . . . 138.72 -47.11 0.94 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.526 HG21 ' CD1' ' A' ' 19' ' ' LEU . 4.5 mt -82.85 -43.62 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.174 -1.192 . . . . 0.0 109.491 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.518 ' CD ' ' O ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -63.0 -24.05 67.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.89 . . . . 0.0 109.505 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.568 HG13 ' CZ ' ' A' ' 13' ' ' TYR . 5.3 mm -90.1 -55.41 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.212 -0.93 . . . . 0.0 109.598 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' A' ' 14' ' ' GLY . 0.3 OUTLIER -56.61 -58.57 7.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 109.573 -179.853 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.526 ' CD1' HG21 ' A' ' 15' ' ' ILE . 5.0 mp -57.86 -21.23 41.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.905 . . . . 0.0 109.552 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 12.7 t30 -74.16 -71.11 0.35 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.316 -0.865 . . . . 0.0 109.469 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.451 ' N ' ' OE1' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -45.57 -44.18 12.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 0.0 109.522 -179.897 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.521 HG22 ' CD1' ' A' ' 108' ' ' ILE . 48.2 t -58.93 -53.18 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.218 -0.926 . . . . 0.0 109.431 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.568 ' CZ ' HG22 ' A' ' 115' ' ' VAL . 21.8 m-85 -78.13 2.33 18.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.372 -0.83 . . . . 0.0 109.622 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.457 ' ND2' ' OD1' ' A' ' 20' ' ' ASN . 0.6 OUTLIER -90.02 -50.32 6.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.139 -0.975 . . . . 0.0 109.532 179.896 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.5 tttp -79.57 -44.68 20.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.178 -0.951 . . . . 0.0 109.49 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.528 ' HB3' ' CD1' ' A' ' 28' ' ' TYR . 0.9 OUTLIER -49.09 -34.29 13.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 109.453 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.526 ' C ' ' CD1' ' A' ' 28' ' ' TYR . . . 110.26 66.26 0.55 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.577 ' CE2' HD23 ' A' ' 121' ' ' LEU . 70.1 m-85 -148.64 135.62 20.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.333 -1.099 . . . . 0.0 109.5 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 4' ' ' GLU . 5.6 mm100 -92.39 83.02 4.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.306 -0.871 . . . . 0.0 109.266 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.52 HG23 ' CD2' ' A' ' 23' ' ' PHE . 5.7 p -89.98 158.63 17.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.914 . . . . 0.0 109.571 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.549 ' CD2' HG23 ' A' ' 42' ' ' ILE . 8.8 m-85 -118.18 -163.56 0.95 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.289 -0.882 . . . . 0.0 109.465 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -144.52 147.89 33.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.166 -0.959 . . . . 0.0 109.519 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -168.36 -176.24 2.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.903 . . . . 0.0 109.417 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.459 ' O ' ' HE2' ' A' ' 60' ' ' MET . . . 177.98 -31.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.214 -0.929 . . . . 0.0 109.498 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -76.42 -8.06 56.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.259 -0.9 . . . . 0.0 109.514 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.462 ' HA2' HD12 ' A' ' 65' ' ' ILE . . . 86.13 -47.44 3.77 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.447 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -59.16 -43.26 92.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -1.113 . . . . 0.0 109.435 -179.983 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.525 ' O ' ' CD1' ' A' ' 42' ' ' ILE . 18.8 mm-40 -69.1 -24.31 64.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.324 -0.86 . . . . 0.0 109.436 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.441 ' HA ' HD23 ' A' ' 7' ' ' LEU . . . -70.98 -57.85 4.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -0.882 . . . . 0.0 109.515 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.407 HD23 ' HB3' ' A' ' 68' ' ' ARG . 12.7 mt -64.02 -31.41 72.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.188 -0.945 . . . . 0.0 109.531 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 37' ' ' LEU . 3.9 t0 -64.87 -49.88 68.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.27 -0.894 . . . . 0.0 109.459 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.549 HG23 ' CD2' ' A' ' 31' ' ' PHE . 3.6 mt -70.21 -20.17 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.25 -0.906 . . . . 0.0 109.477 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.501 ' HA ' ' CD ' ' A' ' 48' ' ' PRO . 55.5 t -77.67 -34.33 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.911 . . . . 0.0 109.489 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.416 ' O ' HG21 ' A' ' 44' ' ' THR . 18.3 m -90.02 -16.03 30.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.182 -0.949 . . . . 0.0 109.483 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.27 -51.44 5.76 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.252 -0.905 . . . . 0.0 109.552 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 47' ' ' ARG . 0.9 OUTLIER -92.88 -26.03 17.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.236 -0.915 . . . . 0.0 109.518 -179.925 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.482 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 12.8 mtm180 61.02 63.16 2.6 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.254 -0.903 . . . . 0.0 109.452 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.519 ' O ' ' CD1' ' A' ' 76' ' ' ILE . 35.2 Cg_endo -77.81 -178.32 4.52 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.594 2.196 . . . . 0.0 110.388 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.457 ' O ' HD23 ' A' ' 50' ' ' LEU . 55.5 m-20 -128.06 -2.76 5.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.302 -0.874 . . . . 0.0 109.673 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.457 HD23 ' O ' ' A' ' 49' ' ' ASP . 3.8 mm? -131.49 106.06 7.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.176 -0.952 . . . . 0.0 109.502 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.496 ' O ' ' CG1' ' A' ' 78' ' ' VAL . 1.5 t -115.88 121.41 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.9 . . . . 0.0 109.45 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.444 ' HB3' ' CE ' ' A' ' 81' ' ' MET . 1.1 mp -94.99 110.53 22.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.262 -0.899 . . . . 0.0 109.437 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.581 ' CD2' ' CG1' ' A' ' 78' ' ' VAL . 2.9 mm? -104.41 133.11 49.84 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.189 -0.944 . . . . 0.0 109.547 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -118.0 129.35 55.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.908 . . . . 0.0 109.488 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.494 ' CG ' HG23 ' A' ' 82' ' ' THR . 27.7 mmt -78.75 3.35 16.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 109.562 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.458 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 2.0 mmmm -78.16 -28.19 48.23 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.149 -0.969 . . . . 0.0 109.424 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.574 ' CG2' ' CE ' ' A' ' 60' ' ' MET . 44.3 mt -43.06 103.15 0.3 Allowed Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.392 -0.818 . . . . 0.0 109.552 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 56' ' ' LYS . 35.3 Cg_endo -77.76 71.74 6.41 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.497 2.131 . . . . 0.0 110.387 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -164.4 -47.67 0.02 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.574 ' CE ' ' CG2' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -153.21 135.09 14.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.262 -1.14 . . . . 0.0 109.454 179.897 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -56.65 136.47 54.78 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.205 -0.934 . . . . 0.0 109.482 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.46 ' HA2' HG13 ' A' ' 65' ' ' ILE . . . -83.69 9.69 61.67 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 38.7 mm -67.62 -45.05 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.191 -1.182 . . . . 0.0 109.475 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -66.83 -25.48 66.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.235 -0.915 . . . . 0.0 109.449 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.462 HD12 ' HA2' ' A' ' 36' ' ' GLY . 7.2 mt -69.81 -68.24 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.34 -0.85 . . . . 0.0 109.434 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.513 ' CD2' HG13 ' A' ' 78' ' ' VAL . 3.1 mt -50.35 -39.37 46.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.267 -0.896 . . . . 0.0 109.528 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.7 ttpp -60.68 -39.41 88.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -0.876 . . . . 0.0 109.505 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.407 ' HB3' HD23 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -68.25 -58.28 4.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.234 -0.916 . . . . 0.0 109.515 -179.894 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.454 ' SD ' HD22 ' A' ' 66' ' ' LEU . 2.2 ptp -60.71 -13.72 16.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.267 -0.896 . . . . 0.0 109.548 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.449 ' HB3' ' O ' ' A' ' 66' ' ' LEU . 0.6 OUTLIER -89.72 -31.58 17.39 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.836 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.42 ' O ' HG11 ' A' ' 71' ' ' VAL . 52.8 t -75.09 -28.97 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 109.195 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.5 mt -90.05 -44.52 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.363 -0.836 . . . . 0.0 109.419 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.524 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 15.0 t0 -132.05 116.78 17.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.16 -0.962 . . . . 0.0 109.427 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.01 -40.45 12.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.248 -0.908 . . . . 0.0 109.544 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -61.23 -13.87 21.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.281 -0.887 . . . . 0.0 109.46 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.524 ' CG2' ' O ' ' A' ' 73' ' ' ASP . 1.0 OUTLIER -60.51 112.03 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.2 -0.937 . . . . 0.0 109.525 179.922 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.455 ' HD3' ' HB3' ' A' ' 118' ' ' TYR . 5.0 mtt85 -71.19 142.43 50.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.213 -0.929 . . . . 0.0 109.436 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.581 ' CG1' ' CD2' ' A' ' 53' ' ' LEU . 15.9 t -145.05 150.58 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.237 -0.915 . . . . 0.0 109.631 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.461 HG22 ' O ' ' A' ' 100' ' ' THR . 11.1 mt -134.19 141.33 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.266 -0.896 . . . . 0.0 109.433 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.578 ' HB ' ' CE1' ' A' ' 101' ' ' HIS . 0.1 OUTLIER -96.74 141.77 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.172 -0.955 . . . . 0.0 109.206 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.452 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 2.8 mtm -113.88 59.85 0.67 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.145 -0.972 . . . . 0.0 109.508 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.494 HG23 ' CG ' ' A' ' 55' ' ' MET . 14.2 t -172.43 43.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.176 -0.952 . . . . 0.0 109.521 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.566 ' N ' ' NE2' ' A' ' 101' ' ' HIS . . . . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.266 -0.896 . . . . 0.0 109.526 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.622 ' CD1' ' CE1' ' A' ' 101' ' ' HIS . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.714 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.78 -38.26 15.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.315 -0.865 . . . . 0.0 109.573 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -90.02 -40.73 12.13 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.227 -0.92 . . . . 0.0 109.619 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.534 ' O ' ' CA ' ' A' ' 97' ' ' GLY . 9.9 m -58.73 -15.22 11.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.202 -0.936 . . . . 0.0 109.644 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.534 ' HA ' ' CB ' ' A' ' 98' ' ' ALA . 1.7 ttpt -88.89 -45.86 9.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.155 -0.966 . . . . 0.0 109.506 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.488 ' C ' ' CD2' ' A' ' 96' ' ' LEU . 10.0 mm-40 -47.62 -44.24 26.52 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.515 -0.741 . . . . 0.0 110.542 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.502 ' N ' HD21 ' A' ' 96' ' ' LEU . 3.3 mm? -132.38 5.51 4.07 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.93 -1.106 . . . . 0.0 110.704 -179.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.534 ' CA ' ' O ' ' A' ' 93' ' ' SER . . . -124.39 -14.19 3.68 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.473 -1.346 . . . . 0.0 109.99 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.534 ' CB ' ' HA ' ' A' ' 94' ' ' LYS . . . -149.84 98.03 2.68 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.166 -1.196 . . . . 0.0 109.615 -179.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.437 HD13 ' CA ' ' A' ' 77' ' ' ARG . 0.7 OUTLIER -48.79 -61.1 2.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.235 -0.915 . . . . 0.0 109.478 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.461 ' O ' HG22 ' A' ' 79' ' ' ILE . 16.7 m -113.53 157.68 21.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 109.476 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.622 ' CE1' ' CD1' ' A' ' 90' ' ' ILE . 3.4 t-160 -135.52 85.5 2.17 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.325 -0.859 . . . . 0.0 109.331 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.553 ' CE1' ' HG2' ' A' ' 110' ' ' GLU . 11.7 m-85 -73.13 158.27 35.62 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.198 -0.939 . . . . 0.0 109.575 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.51 ' HB3' ' N ' ' A' ' 83' ' ' ALA . . . -144.61 151.99 39.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.348 -0.845 . . . . 0.0 109.424 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.456 ' HG3' ' HA ' ' A' ' 105' ' ' PRO . 0.6 OUTLIER -45.1 137.04 4.84 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.235 -0.916 . . . . 0.0 109.304 -179.937 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' A' ' 103' ' ' ALA . 35.7 Cg_endo -77.78 -172.6 11.47 Favored 'Cis proline' 0 C--N 1.312 -1.363 0 C-N-CA 123.365 -1.514 . . . . 0.0 110.403 -0.03 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.636 ' CZ ' ' CD1' ' A' ' 111' ' ' ILE . 0.4 OUTLIER -118.66 111.52 18.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.212 -0.93 . . . . 0.0 109.492 -179.96 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.464 ' O ' HG12 ' A' ' 111' ' ' ILE . 22.1 t0 -89.94 105.79 18.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.262 -0.899 . . . . 0.0 109.36 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.521 ' CD1' HG22 ' A' ' 22' ' ' VAL . 13.7 mm -45.92 -24.63 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.226 -0.921 . . . . 0.0 109.772 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.408 ' O ' ' HG2' ' A' ' 112' ' ' ARG . 9.6 m-20 -69.75 -47.55 62.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.904 . . . . 0.0 109.542 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.553 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 0.9 OUTLIER -69.19 -30.23 68.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -0.901 . . . . 0.0 109.475 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.636 ' CD1' ' CZ ' ' A' ' 106' ' ' PHE . 14.7 mm -68.01 -46.31 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.234 -0.916 . . . . 0.0 109.399 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.46 ' O ' ' HG3' ' A' ' 116' ' ' LYS . 3.2 ptt180 -74.06 -20.76 60.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.354 -0.841 . . . . 0.0 109.572 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -73.54 -51.38 17.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.157 -0.965 . . . . 0.0 109.495 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.544 ' O ' ' CD2' ' A' ' 118' ' ' TYR . . . -70.06 -31.63 69.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 109.535 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.568 HG22 ' CZ ' ' A' ' 23' ' ' PHE . 72.4 t -74.95 -31.45 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -0.923 . . . . 0.0 109.57 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 0.1 OUTLIER -74.55 -42.55 58.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.21 -0.931 . . . . 0.0 109.583 179.957 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.443 ' HE2' ' HA ' ' A' ' 117' ' ' LYS . 0.0 OUTLIER -64.15 -50.42 68.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.921 . . . . 0.0 109.519 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.544 ' CD2' ' O ' ' A' ' 114' ' ' ALA . 14.8 m-85 -65.62 -63.71 1.03 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.207 -0.933 . . . . 0.0 109.486 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.455 HD21 ' CD2' ' A' ' 121' ' ' LEU . 2.9 tt -87.91 113.2 53.62 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.161 -0.962 . . . . 0.0 109.405 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 118' ' ' TYR . 35.7 Cg_endo -77.87 139.93 17.92 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.353 2.035 . . . . 0.0 110.401 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.577 HD23 ' CE2' ' A' ' 28' ' ' TYR . 2.8 mm? . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.251 -0.906 . . . . 0.0 109.51 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.434 ' O ' ' CB ' ' A' ' 2' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.434 ' CB ' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER 169.07 37.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.224 -0.923 . . . . 0.0 109.45 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.403 ' CG ' ' O ' ' A' ' 2' ' ' MET . 4.2 m120 -170.5 164.4 8.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.24 -0.913 . . . . 0.0 109.549 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.424 ' HB3' HD22 ' A' ' 121' ' ' LEU . 0.1 OUTLIER -166.15 68.68 0.12 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.144 -0.972 . . . . 0.0 109.489 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.52 ' O ' ' CB ' ' A' ' 48' ' ' PRO . 0.4 OUTLIER -103.69 118.12 35.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.201 -0.937 . . . . 0.0 109.502 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.466 HG21 ' N ' ' A' ' 7' ' ' LEU . 13.8 mt -116.31 153.16 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.174 -0.954 . . . . 0.0 109.422 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.519 ' CD2' HG22 ' A' ' 42' ' ' ILE . 1.9 tm? -131.42 110.83 11.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.195 -0.94 . . . . 0.0 109.516 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.561 ' CG2' ' NH1' ' A' ' 16' ' ' ARG . 3.4 mt -90.07 108.11 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -0.879 . . . . 0.0 109.324 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.523 ' CG2' ' HB3' ' A' ' 39' ' ' ALA . 2.8 t -98.36 117.42 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.221 -0.924 . . . . 0.0 109.654 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.585 ' CB ' ' CZ ' ' A' ' 16' ' ' ARG . 24.9 t0 -175.17 154.94 1.85 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.337 -0.852 . . . . 0.0 109.421 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.444 ' CG ' ' N ' ' A' ' 12' ' ' GLN . 5.3 p-10 -105.95 -46.12 4.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.165 -0.96 . . . . 0.0 109.501 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.447 ' HG2' ' OD2' ' A' ' 10' ' ' ASP . 13.6 pt20 -50.04 127.51 16.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.241 -0.912 . . . . 0.0 109.527 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.487 ' CE2' HD13 ' A' ' 17' ' ' ILE . 8.2 t80 -80.86 157.95 25.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.257 -0.902 . . . . 0.0 109.645 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 116.31 -69.32 0.28 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.568 ' CG2' ' NH2' ' A' ' 16' ' ' ARG . 5.8 mt -64.02 -25.43 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.32 -1.106 . . . . 0.0 109.173 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.585 ' CZ ' ' CB ' ' A' ' 10' ' ' ASP . 3.7 mmp_? -65.34 -24.75 67.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.886 . . . . 0.0 109.403 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.487 HD13 ' CE2' ' A' ' 13' ' ' TYR . 6.1 mt -89.95 -24.9 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.343 -0.848 . . . . 0.0 109.387 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.505 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 49.3 mt -74.24 -50.83 17.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.312 -0.868 . . . . 0.0 109.499 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.509 ' O ' ' CD2' ' A' ' 23' ' ' PHE . 7.2 mt -69.16 -20.1 64.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 109.408 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 39.1 t30 -77.02 -58.95 2.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.26 -0.9 . . . . 0.0 109.491 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.418 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 14.0 mt-10 -59.58 -47.89 83.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.917 . . . . 0.0 109.5 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.505 ' CG2' ' O ' ' A' ' 18' ' ' LEU . 22.2 t -57.21 -57.32 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.229 -0.92 . . . . 0.0 109.442 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.518 ' CB ' HG22 ' A' ' 30' ' ' THR . 24.0 m-85 -71.81 -4.26 26.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.164 -0.96 . . . . 0.0 109.599 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.418 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 0.5 OUTLIER -82.21 -55.67 4.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -0.899 . . . . 0.0 109.463 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.407 ' O ' ' C ' ' A' ' 26' ' ' GLU . 1.8 mptt -73.87 -46.11 46.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.278 -0.889 . . . . 0.0 109.474 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.565 ' HB3' ' CD1' ' A' ' 28' ' ' TYR . 4.6 tt0 -44.05 -35.26 2.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.16 -0.963 . . . . 0.0 109.476 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.539 ' C ' ' CD1' ' A' ' 28' ' ' TYR . . . 114.57 55.03 0.39 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.57 ' CZ ' ' HG ' ' A' ' 121' ' ' LEU . 32.8 m-85 -143.22 135.03 26.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -1.152 . . . . 0.0 109.475 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -94.42 81.04 3.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.27 -0.894 . . . . 0.0 109.387 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.518 HG22 ' CB ' ' A' ' 23' ' ' PHE . 5.9 p -89.97 154.43 19.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.895 . . . . 0.0 109.556 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.515 ' HB2' ' CD2' ' A' ' 7' ' ' LEU . 6.8 m-85 -118.05 -171.5 2.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.299 -0.876 . . . . 0.0 109.341 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -130.5 146.94 52.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.897 . . . . 0.0 109.505 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -153.94 -172.56 4.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -0.92 . . . . 0.0 109.472 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.78 -88.01 0.1 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.219 -0.926 . . . . 0.0 109.495 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.516 ' ND2' ' HB2' ' A' ' 37' ' ' LEU . 21.5 p-10 -65.98 139.17 58.21 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.271 -0.893 . . . . 0.0 109.474 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.415 ' HA3' ' CD1' ' A' ' 65' ' ' ILE . . . -43.89 -34.53 2.98 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.516 ' HB2' ' ND2' ' A' ' 35' ' ' ASN . 3.2 mp -51.03 -53.15 36.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.195 -1.179 . . . . 0.0 109.44 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.506 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 2.7 tp60 -60.93 -51.31 69.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.246 -0.908 . . . . 0.0 109.436 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.525 ' O ' ' CG2' ' A' ' 43' ' ' VAL . . . -43.82 -39.67 3.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.251 -0.905 . . . . 0.0 109.558 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.403 HD22 ' HE1' ' A' ' 69' ' ' MET . 65.5 mt -71.95 -42.69 66.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.302 -0.873 . . . . 0.0 109.519 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -53.67 -57.81 9.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.255 -0.903 . . . . 0.0 109.491 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.519 HG22 ' CD2' ' A' ' 7' ' ' LEU . 2.0 mp -62.1 -33.16 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.145 -0.972 . . . . 0.0 109.478 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' A' ' 39' ' ' ALA . 48.1 t -66.35 -24.02 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -0.858 . . . . 0.0 109.467 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.4 m -90.07 -30.58 17.61 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.262 -0.899 . . . . 0.0 109.533 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.463 ' HG2' ' HA ' ' A' ' 42' ' ' ILE . 0.0 OUTLIER -90.06 -7.86 52.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.313 -0.867 . . . . 0.0 109.54 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.479 ' OE2' ' CE2' ' A' ' 31' ' ' PHE . 14.8 mt-10 -132.48 -36.75 1.09 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.925 . . . . 0.0 109.47 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 43' ' ' VAL . 0.8 OUTLIER 55.84 65.01 4.76 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.276 -0.89 . . . . 0.0 109.444 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.52 ' CB ' ' O ' ' A' ' 5' ' ' LYS . 35.4 Cg_endo -77.91 154.08 29.6 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.683 2.256 . . . . 0.0 110.394 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 3.5 m-20 -92.64 -13.33 29.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.259 -0.9 . . . . 0.0 109.462 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.424 ' HB3' HG22 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -120.73 116.87 26.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.213 -0.93 . . . . 0.0 109.46 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.513 HG13 ' CE ' ' A' ' 69' ' ' MET . 43.6 t -122.0 123.31 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 0.0 109.496 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.88 120.86 40.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.254 -0.903 . . . . 0.0 109.44 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.46 ' CD2' ' HG ' ' A' ' 66' ' ' LEU . 1.3 mp -108.61 122.21 46.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.256 -0.903 . . . . 0.0 109.506 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.431 ' OD2' ' OD1' ' A' ' 10' ' ' ASP . 33.3 t0 -97.26 111.33 23.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.361 -0.837 . . . . 0.0 109.427 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.433 ' HE1' HG23 ' A' ' 80' ' ' ILE . 18.8 mmt -75.03 -0.64 19.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.917 . . . . 0.0 109.576 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.4 mmmt -90.04 15.45 10.08 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.213 -0.93 . . . . 0.0 109.536 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.443 HG21 ' HD2' ' A' ' 58' ' ' PRO . 48.3 mt -76.53 132.45 72.43 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.941 . . . . 0.0 109.339 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.443 ' HD2' HG21 ' A' ' 57' ' ' ILE . 36.2 Cg_endo -78.93 74.74 5.39 Favored 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.478 2.119 . . . . 0.0 110.4 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -170.73 -63.94 0.04 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.509 ' N ' ' SD ' ' A' ' 60' ' ' MET . 0.1 OUTLIER -153.49 176.3 12.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -1.172 . . . . 0.0 109.566 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -90.08 135.59 33.56 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.197 -0.94 . . . . 0.0 109.487 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.416 ' O ' ' C ' ' A' ' 63' ' ' ILE . . . -72.43 -8.74 71.87 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.444 HG22 ' SD ' ' A' ' 89' ' ' MET . 18.8 mm -44.02 -50.24 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.23 -1.159 . . . . 0.0 109.43 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.448 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 20.8 mm-40 -63.89 -43.94 94.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.214 -0.929 . . . . 0.0 109.405 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.456 ' HB ' HD22 ' A' ' 53' ' ' LEU . 78.3 mt -46.96 -50.9 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.315 -0.865 . . . . 0.0 109.444 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.584 ' CD2' ' CG1' ' A' ' 78' ' ' VAL . 61.8 mt -56.0 -53.51 56.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 109.416 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.473 ' O ' ' CG2' ' A' ' 71' ' ' VAL . 0.1 OUTLIER -44.13 -38.77 3.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.445 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -71.99 -41.03 68.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.32 -0.863 . . . . 0.0 109.495 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.513 ' CE ' HG13 ' A' ' 51' ' ' VAL . 1.2 mtt -58.52 -62.06 2.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.21 -0.931 . . . . 0.0 109.466 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.464 ' HD2' ' HA ' ' A' ' 67' ' ' LYS . 0.3 OUTLIER -52.13 -47.9 65.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.496 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.473 ' CG2' ' O ' ' A' ' 67' ' ' LYS . 53.9 t -48.43 -39.33 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.196 -0.94 . . . . 0.0 109.473 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 98.2 mt -70.38 -48.63 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 109.425 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.458 ' O ' HG23 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -152.97 111.98 3.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.22 -0.925 . . . . 0.0 109.5 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.54 -15.11 35.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.2 -0.938 . . . . 0.0 109.47 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -91.98 41.22 1.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.311 -0.868 . . . . 0.0 109.476 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.458 HG23 ' O ' ' A' ' 73' ' ' ASP . 2.2 tt -118.08 113.01 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.168 -0.958 . . . . 0.0 109.492 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.515 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -77.04 112.78 14.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.302 -0.874 . . . . 0.0 109.472 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.584 ' CG1' ' CD2' ' A' ' 66' ' ' LEU . 85.3 t -122.6 113.02 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.906 . . . . 0.0 109.491 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.52 ' CG2' ' N ' ' A' ' 80' ' ' ILE . 69.9 mt -89.93 165.73 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.237 -0.915 . . . . 0.0 109.52 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.57 HG13 ' CG ' ' A' ' 101' ' ' HIS . 0.1 OUTLIER -128.74 171.58 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.303 -0.873 . . . . 0.0 109.485 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.481 ' N ' ' CD2' ' A' ' 101' ' ' HIS . 22.5 mtm -146.74 107.73 4.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.877 . . . . 0.0 109.419 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.63 ' CG2' ' CE1' ' A' ' 101' ' ' HIS . 5.2 t -149.92 -161.85 1.43 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.245 -0.909 . . . . 0.0 109.465 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.429 ' HB2' ' HG2' ' A' ' 86' ' ' GLU . . . -43.81 138.13 2.83 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.221 -0.924 . . . . 0.0 109.509 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.575 ' CD2' ' HB2' ' A' ' 103' ' ' ALA . 0.2 OUTLIER -90.06 27.16 1.67 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.2 -0.937 . . . . 0.0 109.49 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' A' ' 87' ' ' LEU . . . -152.21 -86.21 0.05 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.429 ' HG2' ' HB2' ' A' ' 83' ' ' ALA . 7.8 pt-20 -43.94 98.12 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.216 -1.167 . . . . 0.0 109.478 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 85' ' ' GLY . 4.1 mp -73.16 90.14 1.55 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.353 -0.842 . . . . 0.0 109.459 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.518 ' O ' ' CB ' ' A' ' 89' ' ' MET . 13.8 t70 -98.13 88.19 4.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.233 -0.917 . . . . 0.0 109.433 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.518 ' CB ' ' O ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER 75.62 17.39 2.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.246 -0.909 . . . . 0.0 109.434 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.52 ' CD1' ' CG2' ' A' ' 82' ' ' THR . 16.8 mt -89.61 -41.25 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.291 -0.881 . . . . 0.0 109.492 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.448 ' O ' ' HG2' ' A' ' 94' ' ' LYS . 1.2 tt0 -63.3 -43.53 97.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.249 -0.907 . . . . 0.0 109.488 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.44 ' O ' HD21 ' A' ' 96' ' ' LEU . 3.9 mt-10 -76.19 -36.72 58.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.263 -0.898 . . . . 0.0 109.441 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.452 ' OG ' HD12 ' A' ' 80' ' ' ILE . 13.5 t -44.05 -61.91 1.31 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 109.425 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.52 ' HA ' ' CB ' ' A' ' 98' ' ' ALA . 0.1 OUTLIER -51.04 -48.6 61.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.296 -0.878 . . . . 0.0 109.537 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -44.1 -42.96 6.6 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.919 . . . . 0.0 109.424 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.534 ' N ' ' CD2' ' A' ' 96' ' ' LEU . 3.6 mm? -70.74 -54.06 13.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.212 -0.93 . . . . 0.0 109.512 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 177.27 63.65 0.06 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.52 ' CB ' ' HA ' ' A' ' 94' ' ' LYS . . . -146.94 107.64 4.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -1.153 . . . . 0.0 109.424 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.515 ' CD1' ' HB3' ' A' ' 77' ' ' ARG . 94.6 mt -44.09 -84.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.24 -0.912 . . . . 0.0 109.418 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.458 ' O ' HG21 ' A' ' 79' ' ' ILE . 11.4 t -127.83 178.74 5.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.462 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.63 ' CE1' ' CG2' ' A' ' 82' ' ' THR . 4.8 t-160 -130.65 96.76 4.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.262 -0.899 . . . . 0.0 109.573 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.409 ' CD2' HG22 ' A' ' 79' ' ' ILE . 79.7 m-85 -64.92 -166.79 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.255 -0.903 . . . . 0.0 109.319 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.575 ' HB2' ' CD2' ' A' ' 84' ' ' TYR . . . -161.14 -166.7 1.62 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.258 -0.901 . . . . 0.0 109.386 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.513 ' CG ' ' HA ' ' A' ' 105' ' ' PRO . 11.8 tttm -139.12 141.43 29.71 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.214 -0.929 . . . . 0.0 109.379 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.513 ' HA ' ' CG ' ' A' ' 104' ' ' LYS . 35.9 Cg_endo -77.95 139.88 58.93 Favored 'Cis proline' 0 C--N 1.311 -1.445 0 C-N-CA 123.415 -1.494 . . . . 0.0 110.417 -0.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.42 ' C ' ' CD1' ' A' ' 106' ' ' PHE . 13.2 p90 -106.42 175.93 5.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.872 . . . . 0.0 109.523 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.451 ' O ' HG12 ' A' ' 111' ' ' ILE . 41.4 t0 -113.29 127.71 56.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.174 -0.954 . . . . 0.0 109.427 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.458 HG21 HG12 ' A' ' 22' ' ' VAL . 15.2 mm -55.15 -18.7 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.273 -0.892 . . . . 0.0 109.52 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.421 ' OD2' ' OD2' ' A' ' 107' ' ' ASP . 15.9 m-20 -76.33 -46.98 25.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.19 -0.944 . . . . 0.0 109.402 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.55 -27.08 65.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.261 -0.899 . . . . 0.0 109.427 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 107' ' ' ASP . 15.9 mm -75.01 -52.48 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.223 -0.923 . . . . 0.0 109.493 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -67.36 -20.52 65.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.272 -0.892 . . . . 0.0 109.528 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -76.92 -51.43 11.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 109.553 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.5 -49.85 71.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.188 -0.945 . . . . 0.0 109.576 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.0 t -57.22 -49.9 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.263 -0.898 . . . . 0.0 109.487 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -27.82 69.0 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.222 -0.924 . . . . 0.0 109.565 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.07 -18.21 40.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 109.438 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -90.03 -70.9 0.64 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.244 -0.91 . . . . 0.0 109.436 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.512 ' CD1' ' HD2' ' A' ' 120' ' ' PRO . 5.5 tp -90.0 139.58 27.43 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.239 -0.913 . . . . 0.0 109.291 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.512 ' HD2' ' CD1' ' A' ' 119' ' ' LEU . 35.3 Cg_endo -78.25 138.67 16.15 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.571 2.181 . . . . 0.0 110.345 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.57 ' HG ' ' CZ ' ' A' ' 28' ' ' TYR . 0.2 OUTLIER -144.78 155.32 43.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.202 -0.936 . . . . 0.0 109.487 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.0 mtmm -47.51 121.88 4.31 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.249 -0.907 . . . . 0.0 109.472 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' A' ' 124' ' ' ASN . 1.6 t -139.78 161.34 37.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.226 -0.922 . . . . 0.0 109.462 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 123' ' ' SER . 25.3 m120 . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.506 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.414 ' O ' ' CG ' ' A' ' 2' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.276 0.56 . . . . 0.0 109.494 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.446 ' O ' ' HB2' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -178.88 -35.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.264 -0.898 . . . . 0.0 109.447 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 2' ' ' MET . 26.4 m-20 68.07 -166.16 0.2 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.285 -0.884 . . . . 0.0 109.497 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.426 ' HG2' ' C ' ' A' ' 3' ' ' ASN . 18.0 mm-40 61.11 92.44 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.438 ' O ' ' CB ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -120.23 119.73 34.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.307 -0.87 . . . . 0.0 109.417 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.521 ' HB ' ' CG2' ' A' ' 30' ' ' THR . 15.0 mt -109.41 168.15 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.263 -0.898 . . . . 0.0 109.501 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.515 HD11 ' N ' ' A' ' 8' ' ' ILE . 0.4 OUTLIER -134.96 142.09 46.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.333 -0.854 . . . . 0.0 109.467 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.515 ' N ' HD11 ' A' ' 7' ' ' LEU . 2.9 mt -133.5 99.28 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.352 -0.843 . . . . 0.0 109.278 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.466 HG13 HD13 ' A' ' 57' ' ' ILE . 2.9 t -89.79 114.18 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.264 -0.898 . . . . 0.0 109.562 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.513 ' N ' ' OD1' ' A' ' 10' ' ' ASP . 0.4 OUTLIER -169.18 174.92 5.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.295 -0.878 . . . . 0.0 109.362 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.437 ' CG ' ' HD2' ' A' ' 58' ' ' PRO . 6.1 p-10 -142.54 -45.76 0.32 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.16 -0.963 . . . . 0.0 109.449 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.435 ' N ' ' CG ' ' A' ' 11' ' ' ASP . 5.5 tp60 -44.0 106.91 0.08 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.304 -0.872 . . . . 0.0 109.493 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.616 ' CE1' ' CD1' ' A' ' 17' ' ' ILE . 38.9 t80 -43.23 124.35 3.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.374 -0.829 . . . . 0.0 109.431 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 141.31 -75.98 0.32 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.498 HD12 ' CE ' ' A' ' 104' ' ' LYS . 1.7 mt -58.66 -32.42 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -1.169 . . . . 0.0 108.878 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.519 ' NH1' ' O ' ' A' ' 33' ' ' ALA . 9.1 mmm180 -60.34 -33.19 72.05 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.336 -0.852 . . . . 0.0 109.459 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.616 ' CD1' ' CE1' ' A' ' 13' ' ' TYR . 2.6 mt -90.7 -65.59 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.332 -0.855 . . . . 0.0 109.895 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.516 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 4.3 mt -42.45 -63.0 0.84 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.133 -0.979 . . . . 0.0 110.198 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.491 ' CD2' HG22 ' A' ' 8' ' ' ILE . 1.8 tp -51.98 -35.14 45.39 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.085 -1.009 . . . . 0.0 109.802 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.505 ' OD1' ' ND2' ' A' ' 24' ' ' ASN . 33.0 t30 -64.89 -70.43 0.23 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.211 -0.931 . . . . 0.0 110.163 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.46 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 1.0 OUTLIER -55.82 -16.49 4.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.143 -0.973 . . . . 0.0 110.152 -179.418 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.516 ' CG2' ' O ' ' A' ' 18' ' ' LEU . 53.5 t -75.57 -61.13 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.12 -0.987 . . . . 0.0 109.422 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.573 ' CZ ' HG23 ' A' ' 115' ' ' VAL . 17.0 m-85 -73.28 -8.51 56.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.272 -0.892 . . . . 0.0 109.407 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.505 ' ND2' ' OD1' ' A' ' 20' ' ' ASN . 1.3 m-80 -83.72 -54.84 4.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.914 . . . . 0.0 109.44 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.466 ' HG3' ' N ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -66.27 -22.08 66.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.244 -0.91 . . . . 0.0 109.406 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.466 ' N ' ' HG3' ' A' ' 25' ' ' LYS . 0.3 OUTLIER -78.83 -23.78 44.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.33 -0.856 . . . . 0.0 109.476 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.566 ' O ' ' CG ' ' A' ' 28' ' ' TYR . . . 110.48 64.33 0.52 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.566 ' CG ' ' O ' ' A' ' 27' ' ' GLY . 66.4 m-85 -158.88 135.26 9.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.202 -1.176 . . . . 0.0 109.607 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -89.91 85.01 6.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.254 -0.904 . . . . 0.0 108.959 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.548 ' CG2' ' CB ' ' A' ' 23' ' ' PHE . 5.2 p -89.87 137.8 32.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.276 -0.89 . . . . 0.0 109.895 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.514 ' HB2' ' CD2' ' A' ' 7' ' ' LEU . 14.5 m-85 -102.01 165.1 11.35 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.391 -0.818 . . . . 0.0 108.889 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.451 ' HG2' ' O ' ' A' ' 32' ' ' GLN . 0.2 OUTLIER -125.15 134.42 52.43 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.092 -1.005 . . . . 0.0 109.854 -179.757 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.527 ' HB3' ' CB ' ' A' ' 38' ' ' GLN . . . -140.35 -161.01 1.14 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.251 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.459 ' HB1' ' O ' ' A' ' 33' ' ' ALA . . . 171.23 -42.39 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.167 -0.958 . . . . 0.0 109.651 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -74.15 -1.33 19.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.208 -0.932 . . . . 0.0 109.611 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.19 -46.11 3.62 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.511 ' N ' HD21 ' A' ' 37' ' ' LEU . 3.4 mm? -63.15 -28.08 69.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.318 -1.107 . . . . 0.0 109.419 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.527 ' CB ' ' HB3' ' A' ' 33' ' ' ALA . 18.4 mm-40 -82.05 -36.14 28.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.284 -0.885 . . . . 0.0 109.375 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.81 -40.56 95.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.444 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.413 ' O ' ' C ' ' A' ' 41' ' ' ASP . 3.3 mt -78.32 -57.74 3.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.273 -0.892 . . . . 0.0 109.453 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 40' ' ' LEU . 5.9 t70 -44.45 -42.14 6.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.271 -0.893 . . . . 0.0 109.474 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.517 ' CD1' ' O ' ' A' ' 38' ' ' GLN . 15.3 mt -69.61 -47.0 73.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.279 -0.888 . . . . 0.0 109.357 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.527 ' HA ' ' CD ' ' A' ' 48' ' ' PRO . 73.2 t -55.73 -21.14 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.259 -0.901 . . . . 0.0 109.425 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.6 m -90.16 -33.66 16.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.283 -0.885 . . . . 0.0 109.446 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.456 ' HG2' ' HA ' ' A' ' 42' ' ' ILE . 0.0 OUTLIER -89.94 0.65 56.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 109.714 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.449 ' HG2' ' HD2' ' A' ' 45' ' ' LYS . 11.3 mm-40 -137.75 -38.6 0.58 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.157 -0.964 . . . . 0.0 109.442 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.504 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 2.6 mtt180 59.15 62.13 4.22 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.894 . . . . 0.0 109.519 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.527 ' CD ' ' HA ' ' A' ' 43' ' ' VAL . 35.4 Cg_endo -77.87 151.89 28.17 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.691 2.261 . . . . 0.0 110.407 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 1.2 m-20 -93.31 -11.98 31.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.209 -0.932 . . . . 0.0 109.513 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.461 HD22 ' HB2' ' A' ' 119' ' ' LEU . 4.3 mm? -118.8 125.7 50.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.199 -0.938 . . . . 0.0 109.476 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.526 ' CG1' ' HE2' ' A' ' 69' ' ' MET . 3.5 t -132.23 119.8 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.233 -0.917 . . . . 0.0 109.563 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.463 HD13 ' O ' ' A' ' 7' ' ' LEU . 1.1 mt -92.51 102.74 15.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.306 -0.871 . . . . 0.0 109.345 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.525 ' CD2' ' HG ' ' A' ' 66' ' ' LEU . 1.0 OUTLIER -89.91 128.49 36.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.176 -0.952 . . . . 0.0 109.643 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.459 ' HB2' ' HE3' ' A' ' 81' ' ' MET . 30.5 t0 -120.53 108.64 14.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.338 -0.851 . . . . 0.0 109.356 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.521 ' CG ' HG22 ' A' ' 82' ' ' THR . 12.7 mmt -71.78 -3.99 25.22 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.188 -0.945 . . . . 0.0 109.568 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.449 ' HB2' ' OD2' ' A' ' 54' ' ' ASP . 4.3 mttt -75.52 -7.87 55.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 109.625 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.511 ' CG2' ' SD ' ' A' ' 60' ' ' MET . 56.9 mt -57.06 116.52 13.7 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.095 -1.003 . . . . 0.0 109.318 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.437 ' HD2' ' CG ' ' A' ' 11' ' ' ASP . 35.6 Cg_endo -78.21 92.03 1.16 Allowed 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.297 1.998 . . . . 0.0 110.414 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 161.42 -23.5 0.23 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.511 ' SD ' ' CG2' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -170.48 161.19 7.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -1.172 . . . . 0.0 109.594 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -90.25 136.43 33.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.212 -0.93 . . . . 0.0 109.38 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.462 ' HA2' HG13 ' A' ' 65' ' ' ILE . . . -74.79 -8.91 82.72 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 30.6 mm -53.94 -55.22 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -1.149 . . . . 0.0 109.425 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 65' ' ' ILE . 24.9 mm-40 -53.14 -45.0 68.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.237 -0.914 . . . . 0.0 109.466 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.462 HG13 ' HA2' ' A' ' 62' ' ' GLY . 9.4 mt -44.81 -50.52 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.263 -0.898 . . . . 0.0 109.461 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.525 ' HG ' ' CD2' ' A' ' 53' ' ' LEU . 22.0 mt -54.66 -53.19 58.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.311 -0.868 . . . . 0.0 109.497 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 66' ' ' LEU . 4.7 mttt -43.65 -51.05 7.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.313 -0.867 . . . . 0.0 109.618 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.451 ' O ' HG13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -59.76 -41.2 90.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.162 -0.961 . . . . 0.0 109.486 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.526 ' HE2' ' CG1' ' A' ' 51' ' ' VAL . 4.6 mtt -60.32 -24.39 64.97 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.239 -0.913 . . . . 0.0 109.442 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 66' ' ' LEU . 1.8 mmpt? -80.03 -44.08 20.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.186 -0.946 . . . . 0.0 109.344 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.6 t -64.38 -24.47 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.217 -0.927 . . . . 0.0 109.451 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 68' ' ' ARG . 57.9 mt -90.05 -66.42 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.456 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -123.59 139.09 54.36 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.229 -0.919 . . . . 0.0 109.506 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -90.02 -25.05 21.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.274 -0.891 . . . . 0.0 109.455 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 49.2 m-20 -105.77 51.02 0.76 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.199 -0.938 . . . . 0.0 109.498 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.436 HG21 ' O ' ' A' ' 76' ' ' ILE . 3.0 tp -98.89 113.82 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.262 -0.899 . . . . 0.0 109.433 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.525 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 3.7 mtt180 -75.91 118.05 18.28 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.197 -0.939 . . . . 0.0 109.459 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.519 ' CG2' ' HB ' ' A' ' 51' ' ' VAL . 79.1 t -129.77 115.82 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.279 -0.888 . . . . 0.0 109.544 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 70.9 mt -89.87 125.69 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.281 -0.887 . . . . 0.0 109.396 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.577 HD11 ' CE1' ' A' ' 101' ' ' HIS . 0.6 OUTLIER -89.82 162.17 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.193 -0.942 . . . . 0.0 109.422 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.459 ' HE3' ' HB2' ' A' ' 54' ' ' ASP . 16.6 mtm -135.43 47.27 2.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.297 -0.877 . . . . 0.0 109.425 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.521 HG22 ' CG ' ' A' ' 55' ' ' MET . 9.9 t -159.71 66.64 0.38 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.31 -0.869 . . . . 0.0 109.469 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.446 ' HB1' ' HB1' ' A' ' 103' ' ' ALA . . . -80.53 -38.94 28.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.241 -0.912 . . . . 0.0 109.437 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.484 ' CD1' ' N ' ' A' ' 85' ' ' GLY . 6.4 t80 -74.23 135.03 42.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.238 -0.914 . . . . 0.0 109.483 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.484 ' N ' ' CD1' ' A' ' 84' ' ' TYR . . . 120.95 -52.74 0.72 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.41 ' O ' ' CD1' ' A' ' 90' ' ' ILE . 1.8 pm0 -149.72 95.22 2.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.304 -1.115 . . . . 0.0 109.472 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.45 ' HA ' HD11 ' A' ' 90' ' ' ILE . 0.3 OUTLIER -87.97 14.0 9.84 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.224 -0.923 . . . . 0.0 109.476 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -83.27 -21.6 33.25 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.233 -0.917 . . . . 0.0 109.514 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.524 ' CG ' ' OE2' ' A' ' 92' ' ' GLU . 0.5 OUTLIER -106.15 0.89 25.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 109.63 179.914 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.594 ' CD1' ' N ' ' A' ' 90' ' ' ILE . 1.2 mp -74.12 -61.26 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.234 -0.916 . . . . 0.0 109.122 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -47.65 -44.78 27.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.912 . . . . 0.0 109.411 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.524 ' OE2' ' CG ' ' A' ' 89' ' ' MET . 19.3 pt-20 -70.2 -32.63 70.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -0.877 . . . . 0.0 109.429 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.514 ' O ' ' CB ' ' A' ' 98' ' ' ALA . 59.6 p -63.38 -30.59 71.69 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.236 -0.915 . . . . 0.0 109.471 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.5 OUTLIER -69.68 -71.84 0.22 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.911 . . . . 0.0 109.524 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.458 ' CG ' ' N ' ' A' ' 96' ' ' LEU . 9.4 pt-20 -43.81 -46.64 7.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.218 -0.926 . . . . 0.0 109.437 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.458 ' N ' ' CG ' ' A' ' 95' ' ' GLU . 24.5 mt -51.67 -57.33 9.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.181 -0.949 . . . . 0.0 109.441 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 165.53 44.89 0.02 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.514 ' CB ' ' O ' ' A' ' 93' ' ' SER . . . -113.92 98.6 7.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -1.115 . . . . 0.0 109.457 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.525 ' CD1' ' HB3' ' A' ' 77' ' ' ARG . 23.9 mt -46.63 -46.73 19.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.284 -0.885 . . . . 0.0 109.446 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.416 ' O ' HG21 ' A' ' 100' ' ' THR . 10.7 t -154.44 143.02 20.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.221 -0.924 . . . . 0.0 109.52 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.577 ' CE1' HD11 ' A' ' 80' ' ' ILE . 3.6 t-160 -107.93 87.71 2.56 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.252 -0.905 . . . . 0.0 109.487 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.508 ' O ' ' N ' ' A' ' 82' ' ' THR . 6.0 m-30 -80.55 179.12 7.9 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 0.0 109.57 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.446 ' HB1' ' HB1' ' A' ' 83' ' ' ALA . . . -137.82 -148.68 0.28 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.292 -0.88 . . . . 0.0 109.343 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.498 ' CE ' HD12 ' A' ' 15' ' ' ILE . 0.7 OUTLIER -137.85 145.75 49.65 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.291 -0.881 . . . . 0.0 109.452 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.458 ' HA ' ' HG3' ' A' ' 104' ' ' LYS . 35.3 Cg_endo -77.91 -176.69 19.21 Favored 'Cis proline' 0 C--N 1.308 -1.565 0 C-N-CA 123.289 -1.546 . . . . 0.0 110.333 0.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 106' ' ' PHE . 2.8 p90 -146.92 -163.69 1.82 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.281 -0.887 . . . . 0.0 109.494 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -135.46 132.55 37.54 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.273 -0.892 . . . . 0.0 109.503 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 14.4 mm -59.22 -21.59 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -0.926 . . . . 0.0 109.45 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.456 ' O ' ' HG2' ' A' ' 112' ' ' ARG . 34.8 m-20 -73.74 -44.73 55.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.34 -0.85 . . . . 0.0 109.474 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -64.68 -34.87 79.31 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.2 -0.938 . . . . 0.0 109.425 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.7 mm -66.33 -59.59 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.204 -0.935 . . . . 0.0 109.492 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.456 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 23.2 ptt180 -53.4 -32.05 47.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 109.529 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.44 ' OD2' ' O ' ' A' ' 109' ' ' ASP . 17.7 m-20 -64.64 -55.79 17.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.332 -0.855 . . . . 0.0 109.5 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.567 ' O ' ' CD2' ' A' ' 118' ' ' TYR . . . -55.33 -35.68 65.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.208 -0.933 . . . . 0.0 109.474 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.573 HG23 ' CZ ' ' A' ' 23' ' ' PHE . 77.9 t -72.08 -28.9 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.282 -0.886 . . . . 0.0 109.434 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.46 ' HE2' ' OE2' ' A' ' 26' ' ' GLU . 5.4 mmtm -72.12 -32.24 66.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.303 -0.873 . . . . 0.0 109.433 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -86.74 -24.44 25.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.926 . . . . 0.0 109.459 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.567 ' CD2' ' O ' ' A' ' 114' ' ' ALA . 18.6 m-85 -90.13 -66.18 0.95 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.226 -0.921 . . . . 0.0 109.48 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.461 ' HB2' HD22 ' A' ' 50' ' ' LEU . 31.5 tp -90.13 112.47 52.65 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.287 -0.883 . . . . 0.0 109.477 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 118' ' ' TYR . 35.3 Cg_endo -78.19 148.01 23.9 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.408 2.072 . . . . 0.0 110.314 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.542 HD11 ' CE2' ' A' ' 28' ' ' TYR . 1.2 tp -154.45 151.45 28.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.282 -0.886 . . . . 0.0 109.405 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.73 77.9 5.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.281 -0.887 . . . . 0.0 109.486 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.502 ' O ' ' CB ' ' A' ' 124' ' ' ASN . 16.3 m -164.59 30.91 0.07 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.232 -0.918 . . . . 0.0 109.462 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 123' ' ' SER . 1.1 t30 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.453 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 5.6 mtt 58.09 82.85 0.12 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.271 -0.893 . . . . 0.0 109.5 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -126.01 68.53 1.19 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.248 -0.908 . . . . 0.0 109.462 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.464 ' N ' ' OE1' ' A' ' 4' ' ' GLU . 1.5 mp0 -81.0 124.09 28.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.898 . . . . 0.0 109.489 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.497 ' CB ' ' HA ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -141.75 131.69 24.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.23 -0.918 . . . . 0.0 109.457 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.46 ' HB ' ' HA ' ' A' ' 30' ' ' THR . 91.5 mt -149.97 153.45 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.265 -0.897 . . . . 0.0 109.499 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.516 ' CD2' ' HB2' ' A' ' 31' ' ' PHE . 1.8 tm? -130.64 112.0 12.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.238 -0.914 . . . . 0.0 109.447 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.434 HD12 ' HB2' ' A' ' 19' ' ' LEU . 5.0 mt -89.98 106.33 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.278 -0.889 . . . . 0.0 109.545 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.482 ' CG2' HD11 ' A' ' 7' ' ' LEU . 3.1 t -95.02 113.32 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.219 -0.925 . . . . 0.0 109.5 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.503 ' O ' ' NH1' ' A' ' 16' ' ' ARG . 0.4 OUTLIER -162.93 150.44 13.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 0.0 109.415 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.457 ' OD2' ' HD2' ' A' ' 58' ' ' PRO . 7.4 p-10 -113.37 -37.28 4.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.244 -0.91 . . . . 0.0 109.454 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.405 ' O ' ' C ' ' A' ' 13' ' ' TYR . 20.1 tt0 -70.05 104.57 2.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.24 -0.913 . . . . 0.0 109.484 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.565 ' CZ ' HG13 ' A' ' 17' ' ' ILE . 26.2 t80 -44.13 149.93 0.32 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.294 -0.879 . . . . 0.0 109.496 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.61 -73.78 0.42 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.461 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 36.6 mt -61.21 -23.63 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -1.142 . . . . 0.0 109.365 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.503 ' NH1' ' O ' ' A' ' 10' ' ' ASP . 7.4 mmm-85 -69.75 -30.08 67.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.338 -0.851 . . . . 0.0 109.399 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.565 HG13 ' CZ ' ' A' ' 13' ' ' TYR . 9.2 mm -90.19 -25.18 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.376 -0.828 . . . . 0.0 109.534 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.522 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 1.3 mp -74.05 -53.21 10.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.209 -0.932 . . . . 0.0 109.567 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.495 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 12.3 mt -71.39 -17.11 62.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -0.918 . . . . 0.0 109.535 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.459 ' O ' ' ND2' ' A' ' 24' ' ' ASN . 47.9 t30 -79.77 -51.01 9.72 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.207 -0.933 . . . . 0.0 109.498 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -68.07 -40.06 82.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.211 -0.931 . . . . 0.0 109.463 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.526 HG23 ' CG2' ' A' ' 108' ' ' ILE . 15.1 t -67.18 -57.5 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.915 . . . . 0.0 109.403 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.56 ' CZ ' HG23 ' A' ' 115' ' ' VAL . 18.7 m-85 -65.46 -17.67 64.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.24 -0.912 . . . . 0.0 109.457 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.459 ' ND2' ' O ' ' A' ' 20' ' ' ASN . 0.7 OUTLIER -68.75 -63.14 1.12 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.427 179.936 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.58 -10.52 58.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.906 . . . . 0.0 109.402 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.453 ' HB2' ' HA ' ' A' ' 23' ' ' PHE . 1.7 mm-40 -76.34 -31.75 58.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.234 -0.917 . . . . 0.0 109.517 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.419 ' O ' ' HG2' ' A' ' 4' ' ' GLU . . . 107.2 33.38 3.21 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.64 ' CZ ' ' CD1' ' A' ' 121' ' ' LEU . 84.8 m-85 -123.51 139.34 54.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -1.164 . . . . 0.0 109.468 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -91.57 82.34 5.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.279 -0.888 . . . . 0.0 109.473 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.526 HG22 ' CB ' ' A' ' 23' ' ' PHE . 5.8 p -89.96 152.33 21.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.182 -0.949 . . . . 0.0 109.517 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.516 ' HB2' ' CD2' ' A' ' 7' ' ' LEU . 16.6 m-85 -119.51 -168.98 1.68 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.203 -0.935 . . . . 0.0 109.473 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -128.99 142.27 50.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.221 -0.925 . . . . 0.0 109.432 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.487 ' CB ' HD13 ' A' ' 7' ' ' LEU . . . -154.95 109.62 3.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.33 -0.856 . . . . 0.0 109.487 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.46 ' O ' HD11 ' A' ' 57' ' ' ILE . . . -69.45 -70.29 0.29 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.199 -0.938 . . . . 0.0 109.454 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.45 ' HA ' ' HE2' ' A' ' 60' ' ' MET . 22.5 p30 -77.56 178.03 7.58 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 0.0 109.514 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 37' ' ' LEU . . . -83.44 -41.97 8.13 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.418 ' C ' ' O ' ' A' ' 36' ' ' GLY . 0.3 OUTLIER -44.06 -56.53 3.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.192 -1.181 . . . . 0.0 109.453 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.474 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 7.5 tp-100 -57.17 -48.48 78.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 109.372 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.409 ' HB3' HG23 ' A' ' 9' ' ' VAL . . . -46.0 -68.21 0.21 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.278 -0.889 . . . . 0.0 109.464 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.404 ' HA ' HG22 ' A' ' 43' ' ' VAL . 2.2 mt -44.28 -41.06 5.67 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.288 -0.882 . . . . 0.0 109.529 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.64 -54.88 27.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.206 -0.934 . . . . 0.0 109.526 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.442 HG22 HD21 ' A' ' 7' ' ' LEU . 2.0 mp -63.87 -21.32 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.274 -0.891 . . . . 0.0 109.486 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.527 ' HA ' ' CD ' ' A' ' 48' ' ' PRO . 16.8 t -80.05 -22.11 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -0.903 . . . . 0.0 109.478 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.1 m -90.1 -28.53 18.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.915 . . . . 0.0 109.39 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -89.88 -27.76 19.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 0.0 109.448 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -113.83 -36.91 4.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.265 -0.897 . . . . 0.0 109.382 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 60.3 mtm180 57.54 69.16 1.68 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.896 . . . . 0.0 109.553 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.527 ' CD ' ' HA ' ' A' ' 43' ' ' VAL . 35.4 Cg_endo -77.91 176.03 10.49 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.685 2.257 . . . . 0.0 110.412 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 58.9 m-20 -114.7 -9.93 12.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.225 -0.922 . . . . 0.0 109.489 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.453 ' HB2' HG12 ' A' ' 6' ' ' ILE . 3.4 mm? -124.63 112.96 17.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 109.52 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.532 ' CG1' ' CE ' ' A' ' 69' ' ' MET . 24.7 t -114.0 119.2 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.171 -0.956 . . . . 0.0 109.422 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.417 HD11 ' HA ' ' A' ' 8' ' ' ILE . 1.3 mt -89.99 100.77 13.52 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.884 . . . . 0.0 109.456 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.1 mp -91.57 129.06 37.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.896 . . . . 0.0 109.516 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.455 ' OD2' ' OD1' ' A' ' 10' ' ' ASP . 57.0 t0 -117.94 103.59 10.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 109.42 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.449 ' HB2' HG23 ' A' ' 82' ' ' THR . 9.3 mmt -58.65 -15.72 12.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.319 -0.863 . . . . 0.0 109.504 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.467 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.1 OUTLIER -55.72 -35.69 66.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 109.414 179.959 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.535 HG22 HD11 ' A' ' 57' ' ' ILE . 46.0 mt -43.13 103.28 0.31 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.342 -0.849 . . . . 0.0 109.507 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 56' ' ' LYS . 35.4 Cg_endo -77.77 4.53 5.98 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.421 2.081 . . . . 0.0 110.415 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.94 -43.37 7.2 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.524 ' CE ' HG22 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -153.38 170.95 19.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -1.133 . . . . 0.0 109.452 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -88.97 134.27 34.03 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.215 -0.928 . . . . 0.0 109.474 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.4 ' HA2' HG12 ' A' ' 65' ' ' ILE . . . -81.73 -0.39 89.27 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.5 mm -61.4 -42.14 92.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.288 -1.125 . . . . 0.0 109.456 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -68.74 -18.91 64.31 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.405 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.428 HG21 ' HE1' ' A' ' 69' ' ' MET . 24.8 mm -69.94 -51.38 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.283 -0.886 . . . . 0.0 109.446 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.457 ' O ' ' HE3' ' A' ' 70' ' ' LYS . 29.8 mt -53.87 -30.65 46.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.291 -0.881 . . . . 0.0 109.441 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.459 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 0.6 OUTLIER -71.72 -63.25 1.16 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.233 -0.917 . . . . 0.0 109.5 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.461 ' O ' HG12 ' A' ' 72' ' ' ILE . 1.9 mtt85 -52.81 -20.67 3.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.216 -0.927 . . . . 0.0 109.41 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.532 ' CE ' ' CG1' ' A' ' 51' ' ' VAL . 1.3 mmt -75.39 -58.47 3.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.207 -0.933 . . . . 0.0 109.457 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 15.3 ptpt -62.35 -15.51 48.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.238 -0.914 . . . . 0.0 109.425 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 44.9 t -83.91 -42.69 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -0.881 . . . . 0.0 109.508 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 68' ' ' ARG . 19.0 mm -72.41 -56.27 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.274 -0.891 . . . . 0.0 109.506 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -129.72 132.55 46.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.204 -0.935 . . . . 0.0 109.493 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.61 15.38 9.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.241 -0.912 . . . . 0.0 109.513 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -129.99 37.05 3.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.322 -0.862 . . . . 0.0 109.44 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.516 HG13 ' N ' ' A' ' 77' ' ' ARG . 0.2 OUTLIER -112.34 142.32 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.279 -0.888 . . . . 0.0 109.373 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.522 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 37.9 mtt85 -103.87 158.55 16.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.291 -0.881 . . . . 0.0 109.436 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.46 ' CG2' ' C ' ' A' ' 77' ' ' ARG . 1.8 t -153.12 112.21 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.219 -0.925 . . . . 0.0 109.538 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.527 ' CG2' HG21 ' A' ' 100' ' ' THR . 95.7 mt -92.16 159.64 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.292 -0.88 . . . . 0.0 109.424 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.569 ' HB ' ' CG ' ' A' ' 101' ' ' HIS . 0.4 OUTLIER -114.64 119.11 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.212 -0.93 . . . . 0.0 109.414 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.449 ' HE2' HG22 ' A' ' 15' ' ' ILE . 4.6 mtm -101.0 68.42 1.26 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.191 -0.943 . . . . 0.0 109.515 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.449 HG23 ' HB2' ' A' ' 55' ' ' MET . 6.2 t 179.43 48.56 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.258 -0.901 . . . . 0.0 109.439 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.564 ' N ' ' NE2' ' A' ' 101' ' ' HIS . . . -76.02 -9.38 58.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.261 -0.899 . . . . 0.0 109.512 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.421 ' N ' ' HB3' ' A' ' 103' ' ' ALA . 0.1 OUTLIER -87.46 93.0 9.28 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.297 -0.877 . . . . 0.0 109.521 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 159.44 -108.1 0.34 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -98.49 128.27 44.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.288 -1.125 . . . . 0.0 109.463 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.55 52.25 0.82 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.367 -0.833 . . . . 0.0 109.465 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -102.75 -22.8 13.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.237 -0.914 . . . . 0.0 109.476 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.458 ' O ' ' CB ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -116.87 15.2 15.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -0.908 . . . . 0.0 109.484 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.576 HG12 ' CE1' ' A' ' 101' ' ' HIS . 48.0 mt -89.72 -66.26 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.235 -0.916 . . . . 0.0 109.529 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -47.6 -39.87 17.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.276 -0.89 . . . . 0.0 109.478 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.519 ' O ' ' CD1' ' A' ' 96' ' ' LEU . 0.2 OUTLIER -78.32 -33.37 49.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.24 -0.912 . . . . 0.0 109.522 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.48 ' O ' ' CB ' ' A' ' 98' ' ' ALA . 0.5 OUTLIER -59.89 -16.18 27.32 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.277 -0.889 . . . . 0.0 109.478 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.06 -76.68 0.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 0.0 109.456 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.444 ' HG3' ' N ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -58.09 -23.99 56.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.919 . . . . 0.0 109.507 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.519 ' CD1' ' O ' ' A' ' 92' ' ' GLU . 8.4 mt -67.6 -42.66 82.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.303 -0.873 . . . . 0.0 109.453 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 154.51 53.1 0.01 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.48 ' CB ' ' O ' ' A' ' 93' ' ' SER . . . -138.7 102.76 4.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.303 -1.116 . . . . 0.0 109.466 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.565 HD11 ' CD1' ' A' ' 118' ' ' TYR . 21.0 mt -45.48 -65.52 0.53 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.211 -0.931 . . . . 0.0 109.392 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.567 HG22 ' CE1' ' A' ' 102' ' ' PHE . 11.6 t -140.55 -174.91 4.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.294 -0.879 . . . . 0.0 109.457 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.576 ' CE1' HG12 ' A' ' 90' ' ' ILE . 3.3 t-160 -140.99 92.4 2.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.348 -0.845 . . . . 0.0 109.39 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.567 ' CE1' HG22 ' A' ' 100' ' ' THR . 60.0 m-85 -77.99 152.66 32.99 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.21 -0.931 . . . . 0.0 109.434 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.484 ' HB3' ' N ' ' A' ' 83' ' ' ALA . . . -140.25 -160.67 1.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.875 . . . . 0.0 109.462 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.527 ' CG ' ' HA ' ' A' ' 105' ' ' PRO . 9.5 tttm -89.37 141.83 29.25 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.231 -0.918 . . . . 0.0 109.31 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.527 ' HA ' ' CG ' ' A' ' 104' ' ' LYS . 36.0 Cg_endo -78.11 -176.51 18.85 Favored 'Cis proline' 0 C--N 1.31 -1.492 0 C-N-CA 123.406 -1.498 . . . . 0.0 110.486 -0.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.635 ' CE2' ' CD1' ' A' ' 111' ' ' ILE . 0.2 OUTLIER -114.75 106.3 14.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.196 -0.94 . . . . 0.0 109.524 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.46 ' O ' HG12 ' A' ' 111' ' ' ILE . 38.8 t0 -89.94 105.18 17.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -0.896 . . . . 0.0 109.318 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.526 ' CG2' HG23 ' A' ' 22' ' ' VAL . 13.6 mm -45.84 -25.02 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.195 -0.941 . . . . 0.0 109.61 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.456 ' HB2' ' OD2' ' A' ' 107' ' ' ASP . 79.1 m-20 -72.81 -46.37 53.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.127 -0.983 . . . . 0.0 109.518 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.5 -24.38 63.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.252 -0.905 . . . . 0.0 109.486 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.635 ' CD1' ' CE2' ' A' ' 106' ' ' PHE . 12.7 mm -75.23 -56.4 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.273 -0.892 . . . . 0.0 109.428 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.442 ' O ' ' HG3' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -60.22 -32.86 71.52 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.296 -0.877 . . . . 0.0 109.497 179.906 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -64.99 -55.0 21.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.33 -0.856 . . . . 0.0 109.447 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.571 ' O ' ' CD2' ' A' ' 118' ' ' TYR . . . -54.84 -42.56 72.12 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.197 -0.939 . . . . 0.0 109.474 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.56 HG23 ' CZ ' ' A' ' 23' ' ' PHE . 55.8 t -66.84 -28.58 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.19 -0.944 . . . . 0.0 109.442 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 0.5 OUTLIER -68.94 -48.94 62.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.272 -0.892 . . . . 0.0 109.457 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.13 -31.92 73.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.922 . . . . 0.0 109.54 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.571 ' CD2' ' O ' ' A' ' 114' ' ' ALA . 22.5 m-85 -73.64 -72.98 0.23 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.316 -0.865 . . . . 0.0 109.524 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.49 ' CD2' ' HD2' ' A' ' 120' ' ' PRO . 5.5 tt -88.08 137.84 31.1 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.26 -0.9 . . . . 0.0 109.251 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.49 ' HD2' ' CD2' ' A' ' 119' ' ' LEU . 35.9 Cg_endo -78.37 145.77 21.52 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.482 2.121 . . . . 0.0 110.427 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.64 ' CD1' ' CZ ' ' A' ' 28' ' ' TYR . 1.6 mt -132.08 -161.43 1.13 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.892 . . . . 0.0 109.436 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -56.14 91.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.277 -0.889 . . . . 0.0 109.491 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.451 ' O ' ' CB ' ' A' ' 124' ' ' ASN . 45.0 m -72.03 86.21 1.02 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.3 -0.875 . . . . 0.0 109.479 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.451 ' CB ' ' O ' ' A' ' 123' ' ' SER . 1.6 p30 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.437 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 33.8 mtm -118.15 -85.35 0.65 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.229 -0.92 . . . . 0.0 109.444 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -101.34 134.77 43.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.24 -0.913 . . . . 0.0 109.521 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -173.76 66.75 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.246 -0.909 . . . . 0.0 109.458 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.45 ' HB3' ' HB3' ' A' ' 48' ' ' PRO . 23.2 mttt -125.81 143.77 50.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 0.0 109.461 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.508 HG23 ' N ' ' A' ' 7' ' ' LEU . 70.0 mt -150.06 162.5 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -0.918 . . . . 0.0 109.464 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.508 ' N ' HG23 ' A' ' 6' ' ' ILE . 0.5 OUTLIER -131.81 122.62 26.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.163 -0.96 . . . . 0.0 109.404 -179.931 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.464 ' HA ' HD11 ' A' ' 52' ' ' LEU . 3.7 mt -100.75 109.06 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.238 -0.914 . . . . 0.0 109.426 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.513 HG13 ' CD1' ' A' ' 57' ' ' ILE . 2.6 t -103.95 95.87 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.3 -0.875 . . . . 0.0 109.41 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.463 ' O ' ' HD3' ' A' ' 16' ' ' ARG . 1.6 t70 -158.67 85.88 0.84 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 0.0 109.476 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.508 ' O ' ' N ' ' A' ' 13' ' ' TYR . 7.3 p-10 -51.25 -41.31 60.29 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.211 -0.931 . . . . 0.0 109.428 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.486 ' NE2' ' CD1' ' A' ' 15' ' ' ILE . 2.5 tt0 -44.11 95.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -0.896 . . . . 0.0 109.465 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.632 ' CE1' ' CD1' ' A' ' 17' ' ' ILE . 47.8 t80 -45.07 120.81 2.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.319 -0.863 . . . . 0.0 109.427 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.433 ' O ' HD21 ' A' ' 18' ' ' LEU . . . 144.97 -54.12 0.56 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.498 ' N ' ' CD1' ' A' ' 15' ' ' ILE . 1.8 mp -72.45 -50.17 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -1.162 . . . . 0.0 109.333 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.521 ' O ' ' CB ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -47.41 -31.59 4.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.229 -0.919 . . . . 0.0 109.5 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.632 ' CD1' ' CE1' ' A' ' 13' ' ' TYR . 1.7 mt -90.27 -29.14 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.222 -0.924 . . . . 0.0 109.497 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.521 ' CD1' HD13 ' A' ' 108' ' ' ILE . 0.4 OUTLIER -66.41 -62.33 1.52 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.203 -0.936 . . . . 0.0 109.498 -179.868 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.559 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 7.5 mt -68.1 -15.55 63.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.919 . . . . 0.0 109.044 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.521 ' CB ' ' O ' ' A' ' 16' ' ' ARG . 0.7 OUTLIER -72.07 -47.88 48.3 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.462 -0.774 . . . . 0.0 109.258 179.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.455 ' OE2' ' OD1' ' A' ' 20' ' ' ASN . 1.0 OUTLIER -73.27 -49.27 28.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.31 -0.869 . . . . 0.0 109.547 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.484 HG23 ' CG2' ' A' ' 108' ' ' ILE . 29.2 t -56.17 -47.81 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.272 -0.892 . . . . 0.0 109.542 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.559 ' CE2' ' HB3' ' A' ' 19' ' ' LEU . 19.7 m-85 -79.96 -13.63 59.2 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.186 -0.946 . . . . 0.0 109.559 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.489 ' ND2' ' O ' ' A' ' 20' ' ' ASN . 0.5 OUTLIER -71.71 -47.4 54.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -0.925 . . . . 0.0 109.368 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.5 tptt -85.0 -29.5 24.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -0.921 . . . . 0.0 109.39 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.421 ' HB3' ' CE2' ' A' ' 28' ' ' TYR . 0.2 OUTLIER -55.34 -43.17 74.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.251 -0.906 . . . . 0.0 109.459 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.52 44.14 0.4 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.421 ' CE2' ' HB3' ' A' ' 26' ' ' GLU . 96.6 m-85 -134.47 137.73 44.17 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.249 -1.148 . . . . 0.0 109.48 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -90.03 82.02 6.16 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 109.292 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.493 HG22 ' CB ' ' A' ' 23' ' ' PHE . 5.7 p -89.82 148.89 22.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.246 -0.909 . . . . 0.0 109.577 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.574 ' CZ ' ' OE1' ' A' ' 46' ' ' GLU . 5.8 m-85 -113.34 -171.13 1.82 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.237 -0.914 . . . . 0.0 109.44 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.403 ' NE2' ' HB3' ' A' ' 16' ' ' ARG . 37.7 mt-30 -124.16 150.58 44.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.255 -0.903 . . . . 0.0 109.608 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.447 ' O ' ' HB1' ' A' ' 34' ' ' ALA . . . -175.45 174.14 2.36 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.289 -0.882 . . . . 0.0 109.375 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.464 ' HA ' HD12 ' A' ' 57' ' ' ILE . . . 178.61 -31.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.298 -0.876 . . . . 0.0 109.555 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.502 ' OD1' ' CB ' ' A' ' 37' ' ' LEU . 8.0 p30 -74.14 -3.2 28.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.18 -0.95 . . . . 0.0 109.606 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.03 -45.08 3.46 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.502 ' CB ' ' OD1' ' A' ' 35' ' ' ASN . 0.2 OUTLIER -57.82 -50.0 74.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.286 -1.126 . . . . 0.0 109.519 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.521 ' O ' ' CG1' ' A' ' 42' ' ' ILE . 8.3 mt-30 -65.42 -23.97 67.08 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.178 -0.951 . . . . 0.0 109.519 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.59 -52.93 32.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.231 -0.918 . . . . 0.0 109.507 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.507 ' CD2' ' HB3' ' A' ' 68' ' ' ARG . 16.0 mt -70.79 -58.41 3.65 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.178 -0.952 . . . . 0.0 109.602 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -46.91 -49.23 20.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.292 -0.88 . . . . 0.0 109.628 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.521 ' CG1' ' O ' ' A' ' 38' ' ' GLN . 89.3 mt -62.55 -35.15 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.908 . . . . 0.0 109.446 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 49.0 t -75.22 -14.72 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.276 -0.89 . . . . 0.0 109.52 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.7 m -90.2 -28.87 18.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.186 -0.946 . . . . 0.0 109.561 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.1 mttm -85.96 -41.51 14.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.224 -0.923 . . . . 0.0 109.687 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.574 ' OE1' ' CZ ' ' A' ' 31' ' ' PHE . 4.8 mt-10 -102.08 -37.88 7.98 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.194 -0.941 . . . . 0.0 109.601 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 5.7 mtt180 61.31 67.26 1.43 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.279 -0.888 . . . . 0.0 109.499 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.45 ' HB3' ' HB3' ' A' ' 5' ' ' LYS . 35.4 Cg_endo -77.78 165.67 26.38 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.647 2.231 . . . . 0.0 110.427 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.512 ' O ' ' CD2' ' A' ' 50' ' ' LEU . 8.3 m-20 -107.62 11.08 28.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.337 -0.852 . . . . 0.0 109.548 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.512 ' CD2' ' O ' ' A' ' 49' ' ' ASP . 1.3 mm? -140.37 128.69 22.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 109.506 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.429 HG22 ' CG1' ' A' ' 76' ' ' ILE . 3.9 t -129.42 151.1 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.25 -0.906 . . . . 0.0 109.509 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.464 HD11 ' HA ' ' A' ' 8' ' ' ILE . 1.3 mt -121.14 97.65 5.62 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.197 -0.939 . . . . 0.0 109.364 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.521 ' CD2' ' HG ' ' A' ' 66' ' ' LEU . 2.0 mp -89.92 128.45 36.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.316 -0.865 . . . . 0.0 109.647 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.463 ' O ' HG13 ' A' ' 57' ' ' ILE . 44.3 t0 -119.44 115.38 23.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.285 -0.884 . . . . 0.0 109.405 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.541 ' CG ' ' CG2' ' A' ' 82' ' ' THR . 17.1 mmt -67.72 -8.05 32.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.259 -0.901 . . . . 0.0 109.577 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.44 ' HB2' ' OD2' ' A' ' 54' ' ' ASP . 16.7 mmtp -76.66 1.14 17.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -0.896 . . . . 0.0 109.633 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.52 HG23 ' CE ' ' A' ' 60' ' ' MET . 34.0 mt -75.32 118.27 69.47 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.11 -0.994 . . . . 0.0 109.382 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.424 ' HD2' ' CG ' ' A' ' 11' ' ' ASP . 35.7 Cg_endo -77.97 143.34 20.5 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.395 2.063 . . . . 0.0 110.469 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 121.66 -54.44 0.68 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.52 ' CE ' HG23 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -155.56 175.18 14.22 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.183 -1.187 . . . . 0.0 109.509 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -89.9 169.09 11.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.265 -0.897 . . . . 0.0 109.477 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.521 ' HA2' ' CD1' ' A' ' 65' ' ' ILE . . . -97.79 -7.02 56.92 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.2 mm -54.28 -64.82 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.155 -1.203 . . . . 0.0 109.495 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -47.92 -35.7 11.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.237 -0.914 . . . . 0.0 109.467 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.521 ' CD1' ' HA2' ' A' ' 62' ' ' GLY . 16.0 mt -53.97 -57.19 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.226 -0.921 . . . . 0.0 109.506 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.521 ' HG ' ' CD2' ' A' ' 53' ' ' LEU . 31.3 mt -52.51 -26.21 12.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.27 -0.894 . . . . 0.0 109.634 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.523 ' O ' ' CG2' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -73.76 -37.37 65.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.211 -0.93 . . . . 0.0 109.793 -179.801 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.507 ' HB3' ' CD2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -73.15 -50.73 21.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.19 -0.944 . . . . 0.0 109.731 -179.792 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.499 ' SD ' ' CD2' ' A' ' 66' ' ' LEU . 3.9 ptp -64.43 -35.81 82.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.198 -0.939 . . . . 0.0 109.759 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.49 ' HG3' ' N ' ' A' ' 71' ' ' VAL . 15.1 ptpt -71.4 -34.8 70.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.206 -0.934 . . . . 0.0 109.437 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.523 ' CG2' ' O ' ' A' ' 67' ' ' LYS . 71.7 t -70.12 -31.02 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.193 -0.942 . . . . 0.0 109.493 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 68' ' ' ARG . 10.4 mt -90.0 -17.85 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.214 -0.929 . . . . 0.0 109.468 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -166.46 122.9 1.27 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.299 -0.876 . . . . 0.0 109.448 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -89.9 -11.51 41.63 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.187 -0.945 . . . . 0.0 109.439 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -92.97 44.49 1.15 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.302 -0.874 . . . . 0.0 109.5 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.458 HG22 ' O ' ' A' ' 76' ' ' ILE . 0.5 OUTLIER -121.89 120.03 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 109.44 -179.947 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.526 ' CD ' HD12 ' A' ' 99' ' ' LEU . 9.8 mtt180 -84.65 143.3 29.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.346 -0.846 . . . . 0.0 109.518 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.519 ' CG1' HD23 ' A' ' 53' ' ' LEU . 53.5 t -138.2 124.77 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.235 -0.915 . . . . 0.0 109.534 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 70.6 mt -101.74 156.62 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.224 -0.923 . . . . 0.0 109.4 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.575 ' HB ' ' CG ' ' A' ' 101' ' ' HIS . 0.6 OUTLIER -114.94 115.25 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -0.929 . . . . 0.0 109.39 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.498 ' SD ' ' CZ ' ' A' ' 106' ' ' PHE . 4.3 mtm -95.97 58.75 1.92 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.226 -0.921 . . . . 0.0 109.506 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.541 ' CG2' ' CG ' ' A' ' 55' ' ' MET . 12.5 t -169.04 49.28 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.239 -0.913 . . . . 0.0 109.479 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.543 ' N ' ' NE2' ' A' ' 101' ' ' HIS . . . -67.7 -65.67 0.66 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.22 -0.925 . . . . 0.0 109.502 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.413 ' C ' ' O ' ' A' ' 83' ' ' ALA . 0.5 OUTLIER -44.0 104.56 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 109.521 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 159.85 -89.83 0.11 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -124.27 116.18 22.24 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.227 -1.161 . . . . 0.0 109.502 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.14 78.35 2.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.209 -0.932 . . . . 0.0 109.484 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -136.5 -50.99 0.69 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.261 -0.899 . . . . 0.0 109.403 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 4.5 ptt? -87.83 0.17 56.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.282 -0.886 . . . . 0.0 109.617 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.565 HD12 ' CE1' ' A' ' 101' ' ' HIS . 48.8 mt -74.59 -56.2 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.176 -0.952 . . . . 0.0 109.534 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -53.87 -39.57 65.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.34 -0.85 . . . . 0.0 109.494 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.452 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 1.1 tp10 -78.96 -24.78 43.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.295 -0.878 . . . . 0.0 109.432 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.458 ' O ' ' HB1' ' A' ' 98' ' ' ALA . 3.7 m -72.22 -28.34 63.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.298 -0.876 . . . . 0.0 109.474 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.452 ' HA ' ' HB2' ' A' ' 98' ' ' ALA . 5.8 mtpp -68.2 -67.42 0.47 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.268 -0.895 . . . . 0.0 109.464 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 94' ' ' LYS . 1.7 pt-20 -44.08 -26.74 0.32 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.355 -0.841 . . . . 0.0 109.554 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 92' ' ' GLU . 65.9 mt -73.82 -52.36 13.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.33 -0.856 . . . . 0.0 109.533 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 169.18 36.1 0.02 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 78' ' ' VAL . . . -104.39 103.35 13.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.247 -1.149 . . . . 0.0 109.437 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.577 HD11 ' CG ' ' A' ' 118' ' ' TYR . 17.0 mt -53.08 -55.42 24.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.237 -0.914 . . . . 0.0 109.472 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.559 HG22 ' CE1' ' A' ' 102' ' ' PHE . 7.0 t -149.25 177.65 9.46 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.288 -0.883 . . . . 0.0 109.469 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.575 ' CG ' ' HB ' ' A' ' 80' ' ' ILE . 3.4 t-160 -132.1 90.14 2.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 0.0 109.431 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.559 ' CE1' HG22 ' A' ' 100' ' ' THR . 43.0 m-85 -77.57 160.75 28.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.221 -0.924 . . . . 0.0 109.485 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.524 ' HB1' ' CB ' ' A' ' 83' ' ' ALA . . . -145.44 -148.62 0.25 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.315 -0.865 . . . . 0.0 109.334 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.03 146.65 32.95 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.205 -0.934 . . . . 0.0 109.447 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.85 173.8 55.36 Favored 'Cis proline' 0 C--N 1.31 -1.466 0 C-N-CA 123.229 -1.571 . . . . 0.0 110.365 0.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.638 ' CZ ' ' CD1' ' A' ' 111' ' ' ILE . 0.3 OUTLIER -102.84 104.58 14.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.317 -0.864 . . . . 0.0 109.531 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.461 ' O ' HG12 ' A' ' 111' ' ' ILE . 63.3 t0 -89.95 109.74 20.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.278 -0.889 . . . . 0.0 109.331 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.521 HD13 ' CD1' ' A' ' 18' ' ' LEU . 14.8 mm -47.92 -23.65 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 109.55 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.429 ' O ' ' OD2' ' A' ' 113' ' ' ASP . 37.3 m-20 -76.39 -43.37 40.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.212 -0.93 . . . . 0.0 109.516 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.4 ' HB2' ' HB3' ' A' ' 107' ' ' ASP . 1.4 tt0 -69.64 -25.76 64.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.282 -0.886 . . . . 0.0 109.491 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.638 ' CD1' ' CZ ' ' A' ' 106' ' ' PHE . 13.4 mm -75.35 -57.9 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.211 -0.931 . . . . 0.0 109.493 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.464 ' HG2' ' O ' ' A' ' 108' ' ' ILE . 1.4 ptt85 -61.27 -28.07 68.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.302 -0.874 . . . . 0.0 109.585 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.429 ' OD2' ' O ' ' A' ' 109' ' ' ASP . 53.6 m-20 -68.28 -56.27 9.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.242 -0.911 . . . . 0.0 109.416 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.34 -53.69 54.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.213 -0.93 . . . . 0.0 109.531 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.1 t -52.68 -39.92 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.232 -0.918 . . . . 0.0 109.502 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 0.6 OUTLIER -65.22 -33.56 76.29 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.327 -0.858 . . . . 0.0 109.554 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.23 -20.56 51.51 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.22 -0.925 . . . . 0.0 109.487 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.577 ' CG ' HD11 ' A' ' 99' ' ' LEU . 38.2 m-85 -89.68 -71.22 0.62 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.249 -0.907 . . . . 0.0 109.471 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.436 ' HB2' HD22 ' A' ' 50' ' ' LEU . 49.2 tp -90.05 112.49 52.68 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.248 -0.908 . . . . 0.0 109.37 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 118' ' ' TYR . 35.6 Cg_endo -77.9 132.63 11.93 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.34 2.027 . . . . 0.0 110.424 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.428 HD22 ' HA ' ' A' ' 121' ' ' LEU . 4.1 mt -88.75 -164.02 1.07 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.292 -0.88 . . . . 0.0 109.455 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.508 ' HD2' ' N ' ' A' ' 123' ' ' SER . 5.8 tptm -93.08 127.14 38.51 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.216 -0.928 . . . . 0.0 108.853 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.508 ' N ' ' HD2' ' A' ' 122' ' ' LYS . 31.3 t 61.35 -89.36 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.314 -0.866 . . . . 0.0 109.459 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.9 m120 . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.508 -179.993 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 66.79 -86.89 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 0.0 109.418 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 67.08 145.79 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.198 -0.939 . . . . 0.0 109.425 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.515 ' HG3' ' CD2' ' A' ' 119' ' ' LEU . 0.4 OUTLIER 46.89 83.55 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.264 -0.898 . . . . 0.0 109.496 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.458 ' HB3' ' HB3' ' A' ' 48' ' ' PRO . 3.9 mtpt -94.52 139.16 31.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.22 -0.925 . . . . 0.0 109.466 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.575 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 84.4 mt -150.07 153.73 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.252 -0.905 . . . . 0.0 109.498 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.582 ' CD1' ' CG2' ' A' ' 42' ' ' ILE . 0.6 OUTLIER -136.48 150.5 48.72 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.283 -0.885 . . . . 0.0 109.438 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.523 HG12 ' CD1' ' A' ' 52' ' ' LEU . 7.8 mt -129.43 122.05 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -0.892 . . . . 0.0 109.407 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 3.3 t -106.42 122.21 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.253 -0.904 . . . . 0.0 109.58 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.454 ' O ' HD12 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -145.86 -151.71 0.39 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.246 -0.909 . . . . 0.0 109.408 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.441 ' HB3' HG12 ' A' ' 57' ' ' ILE . 6.3 p-10 -161.65 -46.69 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.267 -0.895 . . . . 0.0 109.449 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.4 tp60 -82.71 116.6 22.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.316 -0.865 . . . . 0.0 109.486 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.575 ' CZ ' HG13 ' A' ' 17' ' ' ILE . 8.5 t80 -43.91 143.33 1.11 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.243 -0.91 . . . . 0.0 109.434 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.476 ' N ' ' CD1' ' A' ' 13' ' ' TYR . . . 126.96 -46.48 1.08 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.526 HG21 ' CD1' ' A' ' 19' ' ' LEU . 2.2 mt -84.69 -45.86 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.293 -1.122 . . . . 0.0 109.35 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.575 ' NH2' ' CB ' ' A' ' 34' ' ' ALA . 1.5 mtp180 -58.25 -29.44 65.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.308 -0.87 . . . . 0.0 109.395 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.575 HG13 ' CZ ' ' A' ' 13' ' ' TYR . 3.1 mm -90.47 -59.56 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -0.894 . . . . 0.0 109.657 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 14' ' ' GLY . 87.0 mt -46.74 -58.48 3.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.91 . . . . 0.0 109.806 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.526 ' CD1' HG21 ' A' ' 15' ' ' ILE . 6.3 mp -55.02 -32.49 61.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.188 -0.945 . . . . 0.0 109.689 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.508 ' OD1' ' ND2' ' A' ' 24' ' ' ASN . 17.6 t30 -65.69 -70.82 0.22 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.913 . . . . 0.0 109.723 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.458 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 0.1 OUTLIER -43.28 -40.24 3.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.185 -0.947 . . . . 0.0 109.745 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.412 HG23 HG22 ' A' ' 108' ' ' ILE . 59.8 t -57.58 -58.41 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.913 . . . . 0.0 109.51 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.577 ' CB ' ' CG2' ' A' ' 30' ' ' THR . 38.0 m-85 -76.18 0.67 18.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.165 -0.959 . . . . 0.0 109.633 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.508 ' ND2' ' OD1' ' A' ' 20' ' ' ASN . 0.4 OUTLIER -89.01 -38.88 14.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.078 -1.014 . . . . 0.0 109.535 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.8 tptt -85.55 -44.13 12.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 109.42 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.461 ' HB3' ' CD2' ' A' ' 28' ' ' TYR . 0.4 OUTLIER -55.07 -21.4 12.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.179 -0.95 . . . . 0.0 109.391 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.473 ' O ' ' CG ' ' A' ' 28' ' ' TYR . . . 101.38 72.26 0.96 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.574 ' CE1' HD12 ' A' ' 121' ' ' LEU . 97.9 m-85 -156.66 134.29 10.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.293 -1.122 . . . . 0.0 109.58 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -90.96 82.81 5.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.342 -0.849 . . . . 0.0 109.182 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.577 ' CG2' ' CB ' ' A' ' 23' ' ' PHE . 7.4 p -89.9 173.22 8.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -0.897 . . . . 0.0 109.657 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.575 ' CD2' ' O ' ' A' ' 6' ' ' ILE . 11.7 m-85 -130.21 170.06 14.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.317 -0.864 . . . . 0.0 109.394 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.423 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 0.5 OUTLIER -131.41 135.82 47.5 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.2 -0.938 . . . . 0.0 109.682 -179.874 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.52 ' HB2' ' NE2' ' A' ' 38' ' ' GLN . . . -155.91 130.56 9.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.393 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.575 ' CB ' ' NH2' ' A' ' 16' ' ' ARG . . . -82.32 -70.71 0.53 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.156 -0.965 . . . . 0.0 109.483 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.469 ' OD1' ' N ' ' A' ' 35' ' ' ASN . 18.8 p-10 -60.54 170.94 1.23 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.223 -0.923 . . . . 0.0 109.577 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -97.84 -17.73 29.53 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.9 tt -73.99 -43.59 57.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.314 -1.109 . . . . 0.0 109.401 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.52 ' NE2' ' HB2' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -77.59 -35.04 53.35 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.19 -0.944 . . . . 0.0 108.893 179.77 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.466 ' HB3' ' HB2' ' A' ' 33' ' ' ALA . . . -62.57 -46.34 88.79 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.278 -0.889 . . . . 0.0 108.626 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.448 HD13 HG22 ' A' ' 65' ' ' ILE . 7.2 mt -61.54 -45.36 94.51 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -49.68 -43.76 47.5 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.203 -0.936 . . . . 0.0 108.856 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.582 ' CG2' ' CD1' ' A' ' 7' ' ' LEU . 64.0 mt -64.57 -36.23 76.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.336 -0.853 . . . . 0.0 108.881 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 69.0 t -74.5 -11.87 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.251 -0.905 . . . . 0.0 109.188 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 82.9 m -90.38 -31.5 16.84 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.201 -0.937 . . . . 0.0 109.412 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.22 -53.2 4.67 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.32 -0.862 . . . . 0.0 109.867 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.571 ' O ' ' C ' ' A' ' 47' ' ' ARG . 0.4 OUTLIER -97.17 26.93 4.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.183 -0.948 . . . . 0.0 109.627 -179.667 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.571 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -9.69 78.55 0.03 OUTLIER Pre-proline 0 N--CA 1.504 2.266 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.534 ' N ' ' O ' ' A' ' 46' ' ' GLU . 34.3 Cg_endo -75.88 162.66 34.56 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.684 2.256 . . . . 0.0 110.284 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 4.6 m-20 -92.49 -14.12 28.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 109.657 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.51 ' CB ' HG12 ' A' ' 6' ' ' ILE . 4.5 tp -114.16 126.33 54.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.215 -0.928 . . . . 0.0 109.554 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.497 ' CG1' ' HE2' ' A' ' 69' ' ' MET . 6.0 t -136.83 123.83 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.284 -0.885 . . . . 0.0 109.378 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.523 ' CD1' HG12 ' A' ' 8' ' ' ILE . 1.1 mt -103.11 134.78 45.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.212 -0.93 . . . . 0.0 109.584 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.485 ' CD2' ' HG ' ' A' ' 66' ' ' LEU . 1.4 mp -124.4 135.13 53.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.264 -0.898 . . . . 0.0 109.466 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.464 ' O ' HG13 ' A' ' 57' ' ' ILE . 31.1 t0 -123.61 103.96 8.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.215 -0.928 . . . . 0.0 109.484 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.519 ' CG ' HG23 ' A' ' 82' ' ' THR . 19.2 mmt -62.69 -19.06 63.5 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.17 -0.957 . . . . 0.0 109.463 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.464 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 1.1 mmmp? -54.89 -25.19 27.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 0.0 109.45 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 54' ' ' ASP . 9.8 mt -43.06 103.21 0.3 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.27 -0.893 . . . . 0.0 109.501 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 56' ' ' LYS . 35.2 Cg_endo -77.52 97.73 1.16 Allowed 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.437 2.092 . . . . 0.0 110.464 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 155.62 -20.43 0.53 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.432 ' HE1' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -166.59 150.93 7.43 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.278 -1.131 . . . . 0.0 109.475 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.408 ' O ' ' SD ' ' A' ' 60' ' ' MET . 1.1 m-20 -85.04 144.0 28.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.186 -0.946 . . . . 0.0 109.57 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -96.56 12.48 66.22 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.2 mm -69.36 -39.43 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.245 -1.15 . . . . 0.0 109.451 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -68.11 -34.65 76.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.262 -0.899 . . . . 0.0 109.494 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.448 HG22 HD13 ' A' ' 40' ' ' LEU . 9.3 mt -54.14 -63.95 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.923 . . . . 0.0 109.492 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.485 ' HG ' ' CD2' ' A' ' 53' ' ' LEU . 21.0 mt -46.63 -49.97 18.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.203 -0.936 . . . . 0.0 109.429 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 66' ' ' LEU . 2.5 ttmm -44.09 -50.51 8.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.182 -0.949 . . . . 0.0 109.508 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.443 ' O ' HG13 ' A' ' 72' ' ' ILE . 2.4 mpt_? -60.62 -39.25 87.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.926 . . . . 0.0 109.457 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.497 ' HE2' ' CG1' ' A' ' 51' ' ' VAL . 0.7 OUTLIER -61.79 -23.74 66.41 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -0.894 . . . . 0.0 109.438 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.518 ' CE ' ' HB3' ' A' ' 96' ' ' LEU . 21.8 mmtm -81.15 -45.29 16.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.3 -0.875 . . . . 0.0 109.473 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.6 t -65.1 -22.64 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.278 -0.889 . . . . 0.0 109.473 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 68' ' ' ARG . 78.8 mt -88.71 -41.89 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.258 -0.901 . . . . 0.0 109.415 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.82 130.95 11.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.19 -0.944 . . . . 0.0 109.469 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -90.02 -12.55 38.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.2 -0.937 . . . . 0.0 109.465 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.405 ' OD1' ' N ' ' A' ' 75' ' ' ASN . 1.8 m120 -116.58 55.5 0.82 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.409 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.0 tp -110.93 145.78 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.328 -0.858 . . . . 0.0 109.411 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.516 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 2.3 mtm180 -89.19 115.02 26.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.195 -0.941 . . . . 0.0 109.483 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.465 ' N ' HD13 ' A' ' 99' ' ' LEU . 16.9 t -131.1 115.83 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.221 -0.925 . . . . 0.0 109.531 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.429 HG12 HG21 ' A' ' 100' ' ' THR . 43.9 mt -100.38 132.59 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.309 -0.87 . . . . 0.0 109.445 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.572 HD11 ' CE1' ' A' ' 101' ' ' HIS . 1.0 OUTLIER -89.88 172.97 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.177 -0.952 . . . . 0.0 109.364 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.461 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 13.7 mtm -147.46 52.18 1.06 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.161 -0.962 . . . . 0.0 109.565 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.519 HG23 ' CG ' ' A' ' 55' ' ' MET . 14.7 t -162.68 40.66 0.11 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.185 -0.947 . . . . 0.0 109.519 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.633 ' CB ' ' CD2' ' A' ' 101' ' ' HIS . . . -90.15 40.79 1.02 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.278 -0.889 . . . . 0.0 109.483 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.561 ' CD1' ' O ' ' A' ' 104' ' ' LYS . 2.6 t80 -90.0 72.89 7.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.22 -0.925 . . . . 0.0 109.464 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.455 ' O ' HD21 ' A' ' 87' ' ' LEU . . . 83.29 -69.92 3.28 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 85' ' ' GLY . 1.7 pm0 -43.81 104.9 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.195 -1.179 . . . . 0.0 109.567 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.461 ' HA ' HD13 ' A' ' 90' ' ' ILE . 2.6 pt? -126.28 137.75 53.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.501 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -147.24 -78.21 0.16 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.163 -0.961 . . . . 0.0 109.443 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.468 ' O ' ' CB ' ' A' ' 93' ' ' SER . 6.5 mtt -102.98 37.75 1.89 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.279 -0.888 . . . . 0.0 109.446 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.461 HD13 ' HA ' ' A' ' 87' ' ' LEU . 57.9 mt -89.95 -60.71 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.257 -0.902 . . . . 0.0 109.462 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.436 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 1.1 tp60 -44.32 -62.95 0.99 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -0.897 . . . . 0.0 109.452 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.458 ' O ' HD21 ' A' ' 96' ' ' LEU . 0.3 OUTLIER -60.84 -38.62 86.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.916 . . . . 0.0 109.512 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 89' ' ' MET . 0.6 OUTLIER -44.0 -26.67 0.3 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.209 -0.932 . . . . 0.0 109.429 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 91' ' ' GLN . 0.0 OUTLIER -53.08 -62.12 1.86 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.175 -0.953 . . . . 0.0 109.457 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.474 ' HG3' ' CD2' ' A' ' 96' ' ' LEU . 1.2 pt-20 -63.19 -35.02 78.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.187 -0.946 . . . . 0.0 109.509 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.528 ' N ' ' CD2' ' A' ' 96' ' ' LEU . 3.7 mm? -61.33 -24.84 66.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.221 -0.924 . . . . 0.0 109.511 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 130.13 42.33 0.22 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.456 ' HB3' ' HB3' ' A' ' 93' ' ' SER . . . -113.44 110.65 20.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -1.149 . . . . 0.0 109.466 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.534 ' HB3' ' CZ ' ' A' ' 118' ' ' TYR . 3.6 mt -73.25 -72.25 0.27 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.186 -0.946 . . . . 0.0 109.577 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.48 HG22 ' CE2' ' A' ' 102' ' ' PHE . 12.7 t -130.46 147.51 52.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.225 -0.922 . . . . 0.0 109.495 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.633 ' CD2' ' CB ' ' A' ' 83' ' ' ALA . 3.6 t-160 -111.21 89.54 3.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.295 -0.878 . . . . 0.0 109.339 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.483 ' O ' ' N ' ' A' ' 82' ' ' THR . 35.5 m-85 -68.96 153.34 43.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.226 -0.921 . . . . 0.0 109.531 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.514 ' HB3' ' N ' ' A' ' 84' ' ' TYR . . . -139.52 151.97 46.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.239 -0.913 . . . . 0.0 109.472 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.561 ' O ' ' CD1' ' A' ' 84' ' ' TYR . 36.1 tttm -85.3 141.63 37.21 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 0.0 109.353 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.53 ' HA ' ' CG ' ' A' ' 104' ' ' LYS . 35.8 Cg_endo -77.96 137.39 46.59 Favored 'Cis proline' 0 C--N 1.31 -1.456 0 C-N-CA 123.39 -1.504 . . . . 0.0 110.367 0.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -114.54 -170.01 1.65 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.238 -0.914 . . . . 0.0 109.489 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -130.05 121.08 25.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.0 109.413 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.412 HG22 HG23 ' A' ' 22' ' ' VAL . 20.5 mm -50.11 -30.44 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.207 -0.933 . . . . 0.0 109.52 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.403 ' HA ' ' HD3' ' A' ' 112' ' ' ARG . 33.4 m-20 -66.6 -42.4 86.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.216 -0.928 . . . . 0.0 109.433 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.413 ' HB3' ' CE1' ' A' ' 102' ' ' PHE . 4.0 mt-10 -65.69 -35.18 80.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.289 -0.882 . . . . 0.0 109.467 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.479 HD11 ' CD2' ' A' ' 102' ' ' PHE . 22.1 mm -64.9 -60.36 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.295 -0.878 . . . . 0.0 109.496 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.403 ' HD3' ' HA ' ' A' ' 109' ' ' ASP . 1.1 ptm180 -56.81 -30.38 63.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 0.0 109.482 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -62.99 -54.92 30.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -0.895 . . . . 0.0 109.477 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.562 ' O ' ' CD2' ' A' ' 118' ' ' TYR . . . -60.01 -32.84 71.25 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.163 -0.96 . . . . 0.0 109.474 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.436 HG23 ' CZ ' ' A' ' 23' ' ' PHE . 58.2 t -67.42 -35.0 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.23 -0.919 . . . . 0.0 109.473 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.407 ' HE2' ' OE2' ' A' ' 26' ' ' GLU . 1.9 mttt -75.48 -30.05 59.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.279 -0.888 . . . . 0.0 109.499 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.68 -34.08 62.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.219 -0.926 . . . . 0.0 109.46 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.562 ' CD2' ' O ' ' A' ' 114' ' ' ALA . 46.6 m-85 -89.92 -65.59 1.0 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.294 -0.879 . . . . 0.0 109.466 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.515 ' CD2' ' HG3' ' A' ' 4' ' ' GLU . 2.8 tt -90.01 112.42 52.24 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.285 -0.884 . . . . 0.0 109.475 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 118' ' ' TYR . 35.7 Cg_endo -78.06 164.06 27.56 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.362 2.042 . . . . 0.0 110.396 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.574 HD12 ' CE1' ' A' ' 28' ' ' TYR . 1.3 tp -151.09 98.04 2.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.301 -0.875 . . . . 0.0 109.48 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -129.83 61.23 1.57 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.316 -0.865 . . . . 0.0 109.446 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.463 ' O ' ' CB ' ' A' ' 124' ' ' ASN . 0.8 OUTLIER -134.17 71.72 1.46 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.293 -0.88 . . . . 0.0 109.443 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 123' ' ' SER . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.041 -0.981 . . . . 0.0 109.439 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.421 ' CG ' ' O ' ' A' ' 1' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -109.04 66.25 0.63 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.295 -0.878 . . . . 0.0 109.477 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.452 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 8.2 m-20 -117.0 59.9 0.75 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 109.531 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 0.2 OUTLIER -44.03 119.51 1.78 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.215 -0.928 . . . . 0.0 109.454 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.509 ' CG ' ' HA ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -114.12 132.57 56.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.246 -0.909 . . . . 0.0 109.447 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.438 HG21 ' HB3' ' A' ' 50' ' ' LEU . 52.5 mt -145.35 164.7 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.237 -0.915 . . . . 0.0 109.509 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.511 ' CD2' ' HB2' ' A' ' 31' ' ' PHE . 1.0 OUTLIER -131.08 128.55 40.44 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.241 -0.912 . . . . 0.0 109.451 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.5 ' N ' HD12 ' A' ' 7' ' ' LEU . 12.1 mt -115.46 108.44 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.186 -0.946 . . . . 0.0 109.464 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.479 HG21 ' CB ' ' A' ' 33' ' ' ALA . 17.5 t -92.44 128.63 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.919 . . . . 0.0 109.529 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.519 ' O ' ' CD ' ' A' ' 16' ' ' ARG . 2.1 t70 -174.94 123.43 0.24 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 109.44 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.527 ' HB3' ' CB ' ' A' ' 34' ' ' ALA . 2.6 p30 -114.68 81.43 1.56 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.318 -0.864 . . . . 0.0 109.601 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.512 ' HG2' ' N ' ' A' ' 13' ' ' TYR . 7.5 tt0 -175.99 -104.51 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.207 -0.933 . . . . 0.0 109.411 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.512 ' N ' ' HG2' ' A' ' 12' ' ' GLN . 37.4 t80 -179.54 120.47 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.85 -1.156 . . . . 0.0 109.543 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 18' ' ' LEU . . . 135.73 -50.44 0.85 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.466 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 2.0 mp -81.28 -54.44 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.179 -1.189 . . . . 0.0 109.658 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.519 ' CD ' ' O ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -50.33 -29.75 10.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.165 -0.959 . . . . 0.0 109.757 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.461 ' O ' ' HB3' ' A' ' 20' ' ' ASN . 2.6 mm -90.2 -64.76 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.183 -0.948 . . . . 0.0 109.887 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.513 HD11 ' N ' ' A' ' 18' ' ' LEU . 6.9 mp -48.55 -60.46 2.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.229 -0.92 . . . . 0.0 109.801 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.469 HD22 HD23 ' A' ' 52' ' ' LEU . 0.5 OUTLIER -53.87 -28.85 38.63 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 0.0 109.64 -179.773 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.504 ' OD1' ' ND2' ' A' ' 24' ' ' ASN . 28.4 t30 -69.2 -71.88 0.21 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.903 . . . . 0.0 109.665 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.455 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 2.5 tt0 -43.06 -38.04 2.19 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.317 -0.864 . . . . 0.0 109.71 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.516 HG23 ' CG2' ' A' ' 108' ' ' ILE . 19.0 t -61.77 -55.63 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.243 -0.911 . . . . 0.0 109.553 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.526 ' CB ' HG22 ' A' ' 30' ' ' THR . 23.6 m-85 -77.7 1.94 18.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 109.566 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.504 ' ND2' ' OD1' ' A' ' 20' ' ' ASN . 0.6 OUTLIER -90.06 -48.96 6.86 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.189 -0.944 . . . . 0.0 109.474 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.26 -46.13 24.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 109.544 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.505 ' HB3' ' CE1' ' A' ' 28' ' ' TYR . 1.8 tt0 -52.07 -22.65 4.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.2 -0.937 . . . . 0.0 109.469 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.436 ' C ' ' CD1' ' A' ' 28' ' ' TYR . . . 100.09 72.78 1.02 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.577 ' CE2' ' HG ' ' A' ' 121' ' ' LEU . 96.2 m-85 -154.55 134.62 13.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -1.17 . . . . 0.0 109.473 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 4' ' ' GLU . 12.4 mm100 -94.16 83.08 4.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 109.217 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.526 HG22 ' CB ' ' A' ' 23' ' ' PHE . 5.7 p -89.95 154.71 19.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.895 . . . . 0.0 109.604 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.511 ' HB2' ' CD2' ' A' ' 7' ' ' LEU . 38.6 m-85 -113.53 -171.25 1.85 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.274 -0.891 . . . . 0.0 109.283 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.419 ' OE1' ' HG2' ' A' ' 16' ' ' ARG . 11.8 mt-30 -124.44 154.78 39.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 109.552 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.522 ' O ' ' CB ' ' A' ' 34' ' ' ALA . . . -152.62 -165.37 2.18 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.297 -0.877 . . . . 0.0 109.392 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.527 ' CB ' ' HB3' ' A' ' 11' ' ' ASP . . . 164.34 -62.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.905 . . . . 0.0 109.597 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -71.15 -4.64 26.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.185 -0.947 . . . . 0.0 109.577 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 37' ' ' LEU . . . 86.29 -63.28 4.2 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 36' ' ' GLY . 1.0 OUTLIER -44.54 -32.28 1.38 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.207 -1.172 . . . . 0.0 109.405 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.513 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 1.4 tp60 -70.22 -60.32 2.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.498 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.444 ' O ' ' CG2' ' A' ' 43' ' ' VAL . . . -44.02 -45.22 7.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.224 -0.923 . . . . 0.0 109.482 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.7 mt -61.55 -44.06 97.72 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -0.871 . . . . 0.0 109.45 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -55.64 -57.57 11.42 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.287 -0.883 . . . . 0.0 109.488 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.449 ' HB ' HD22 ' A' ' 7' ' ' LEU . 2.5 mp -61.4 -20.83 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.285 -0.884 . . . . 0.0 109.482 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.517 ' HA ' ' CD ' ' A' ' 48' ' ' PRO . 53.5 t -79.63 -26.65 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 109.495 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 85.5 m -89.99 -24.21 21.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -0.901 . . . . 0.0 109.448 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.8 mtpt -89.97 -27.32 19.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.225 -0.922 . . . . 0.0 109.554 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -119.3 -34.37 3.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.206 -0.934 . . . . 0.0 109.506 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 33.2 mtm180 58.18 71.07 1.09 Allowed Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.173 -0.954 . . . . 0.0 109.476 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.517 ' CD ' ' HA ' ' A' ' 43' ' ' VAL . 35.3 Cg_endo -78.07 157.69 30.43 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.599 2.199 . . . . 0.0 110.328 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.453 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 0.4 OUTLIER -94.08 -9.61 36.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.194 -0.941 . . . . 0.0 109.512 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.438 ' HB3' HG21 ' A' ' 6' ' ' ILE . 6.5 tp -123.29 114.81 20.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.906 . . . . 0.0 109.504 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.437 ' HB ' HG23 ' A' ' 78' ' ' VAL . 1.7 t -121.21 111.41 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.263 -0.898 . . . . 0.0 109.443 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.469 HD23 HD22 ' A' ' 19' ' ' LEU . 0.7 OUTLIER -89.97 109.62 20.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.291 -0.881 . . . . 0.0 109.406 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.516 ' CD2' HG12 ' A' ' 78' ' ' VAL . 3.0 mm? -95.28 136.15 35.98 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.201 -0.937 . . . . 0.0 109.489 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.461 ' O ' HG13 ' A' ' 57' ' ' ILE . 30.2 t0 -113.9 117.7 32.12 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.31 -0.869 . . . . 0.0 109.446 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.512 ' CG ' HG22 ' A' ' 82' ' ' THR . 18.0 mmt -77.58 -7.99 57.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.175 -0.953 . . . . 0.0 109.489 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 57' ' ' ILE . 4.6 mtpm? -68.7 -15.56 63.56 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.308 -0.87 . . . . 0.0 109.527 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.505 ' CG2' ' OD2' ' A' ' 11' ' ' ASP . 80.5 mt -43.87 113.78 1.63 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.256 -0.902 . . . . 0.0 109.37 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.424 ' HD2' ' CG ' ' A' ' 11' ' ' ASP . 36.0 Cg_endo -78.67 6.0 5.19 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.337 2.025 . . . . 0.0 110.509 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.97 -43.97 4.28 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.489 ' CE ' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -169.58 -171.66 1.27 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.291 -1.123 . . . . 0.0 109.447 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -89.56 132.72 34.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.902 . . . . 0.0 109.431 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.36 10.89 60.07 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 25.5 mm -61.84 -38.44 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.197 -1.178 . . . . 0.0 109.487 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -68.7 -25.63 64.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.279 -0.888 . . . . 0.0 109.506 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.42 HG23 ' HE1' ' A' ' 69' ' ' MET . 70.9 mt -68.1 -64.92 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.184 -0.947 . . . . 0.0 109.505 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.513 ' CD2' HG12 ' A' ' 78' ' ' VAL . 2.4 mt -44.15 -34.45 1.84 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 0.0 109.531 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.518 ' O ' ' CG ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -64.02 -59.33 4.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -0.91 . . . . 0.0 109.465 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.0 mtt180 -49.57 -30.46 8.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.345 -0.847 . . . . 0.0 109.473 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.42 ' HE1' HG23 ' A' ' 65' ' ' ILE . 0.8 OUTLIER -67.01 -60.73 2.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.874 . . . . 0.0 109.466 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.518 ' CG ' ' O ' ' A' ' 67' ' ' LYS . 16.4 ptpt -51.39 -31.43 22.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.186 -0.946 . . . . 0.0 109.455 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 49.9 t -66.57 -44.99 89.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.19 -0.944 . . . . 0.0 109.493 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.2 mt -70.23 -65.11 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.218 -0.926 . . . . 0.0 109.535 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -113.7 130.84 56.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.227 -0.921 . . . . 0.0 109.429 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -87.11 -22.4 25.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.952 . . . . 0.0 109.411 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.2 p30 -105.55 45.26 0.98 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -0.886 . . . . 0.0 109.438 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.459 ' CD1' ' O ' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -104.15 128.08 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.283 -0.886 . . . . 0.0 109.452 179.964 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.519 ' CB ' HD12 ' A' ' 99' ' ' LEU . 3.4 mpt_? -78.11 143.13 37.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.259 -0.901 . . . . 0.0 109.48 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.516 HG12 ' CD2' ' A' ' 53' ' ' LEU . 55.5 t -144.57 144.94 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.326 -0.859 . . . . 0.0 109.568 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.519 ' CG2' ' O ' ' A' ' 100' ' ' THR . 18.3 mt -128.95 139.02 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.292 -0.88 . . . . 0.0 109.393 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.579 ' HB ' ' CE1' ' A' ' 101' ' ' HIS . 0.3 OUTLIER -102.6 130.64 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.161 -0.962 . . . . 0.0 109.337 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.454 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -102.69 51.99 0.8 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.29 -0.881 . . . . 0.0 109.532 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.512 HG22 ' CG ' ' A' ' 55' ' ' MET . 10.6 t -161.7 44.05 0.16 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.945 . . . . 0.0 109.565 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.626 ' N ' ' CD2' ' A' ' 101' ' ' HIS . . . -49.92 -33.09 16.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.935 . . . . 0.0 109.412 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -84.55 -171.86 3.86 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.222 -0.924 . . . . 0.0 109.507 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.74 -75.97 1.09 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.25 131.86 4.51 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.253 -1.145 . . . . 0.0 109.501 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.54 ' HA ' ' CG2' ' A' ' 90' ' ' ILE . 0.2 OUTLIER -99.86 78.82 2.15 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.407 -0.808 . . . . 0.0 109.829 -179.554 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.41 -84.65 0.59 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.316 -0.865 . . . . 0.0 109.184 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.489 ' O ' ' CB ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -78.02 2.11 18.76 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.302 -0.874 . . . . 0.0 109.399 179.626 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.633 ' CD1' ' CE1' ' A' ' 101' ' ' HIS . 0.2 OUTLIER -90.39 -55.57 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.286 -0.884 . . . . 0.0 108.904 179.73 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.414 ' C ' ' O ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -45.02 -38.82 5.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.169 -0.957 . . . . 0.0 109.528 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -88.07 -40.8 13.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.203 -0.936 . . . . 0.0 109.541 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.506 ' HA ' ' CD1' ' A' ' 96' ' ' LEU . 2.9 m -53.05 -20.14 3.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 0.0 109.5 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -58.23 -53.8 54.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.186 -0.946 . . . . 0.0 109.477 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -76.78 -10.2 59.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.911 . . . . 0.0 109.481 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.506 ' CD1' ' HA ' ' A' ' 93' ' ' SER . 66.9 mt -75.4 -46.68 31.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.269 -0.895 . . . . 0.0 109.494 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 178.1 33.23 0.05 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -118.94 123.05 43.67 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.26 -1.141 . . . . 0.0 109.505 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.519 HD12 ' CB ' ' A' ' 77' ' ' ARG . 0.4 OUTLIER -90.08 -60.04 2.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 109.475 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.519 ' O ' ' CG2' ' A' ' 79' ' ' ILE . 21.2 m -117.79 138.13 52.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.213 -0.929 . . . . 0.0 109.582 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.633 ' CE1' ' CD1' ' A' ' 90' ' ' ILE . 3.9 t-160 -119.48 84.41 2.2 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.853 . . . . 0.0 109.254 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.608 ' CD2' ' CD1' ' A' ' 111' ' ' ILE . 22.5 m-85 -72.89 158.27 35.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.0 109.575 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.522 ' HB1' ' CB ' ' A' ' 83' ' ' ALA . . . -127.25 -148.73 0.39 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.241 -0.912 . . . . 0.0 109.368 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.447 ' HG3' ' HA ' ' A' ' 105' ' ' PRO . 2.0 tttm -128.17 131.89 24.04 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.258 -0.901 . . . . 0.0 109.369 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.447 ' HA ' ' HG3' ' A' ' 104' ' ' LYS . 35.5 Cg_endo -77.75 -162.4 2.95 Favored 'Cis proline' 0 C--N 1.311 -1.423 0 C-N-CA 123.51 -1.454 . . . . 0.0 110.355 -0.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 106' ' ' PHE . 3.0 p90 -153.95 165.1 37.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.921 . . . . 0.0 109.477 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.454 ' O ' HG12 ' A' ' 111' ' ' ILE . 19.6 t0 -108.17 128.94 55.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.274 -0.891 . . . . 0.0 109.45 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.516 ' CG2' HG23 ' A' ' 22' ' ' VAL . 14.6 mm -61.53 -18.11 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.267 -0.896 . . . . 0.0 109.474 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.417 ' O ' ' HB2' ' A' ' 113' ' ' ASP . 33.1 m-20 -78.06 -37.72 46.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.162 -0.961 . . . . 0.0 109.435 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.422 ' HG2' ' CZ ' ' A' ' 102' ' ' PHE . 1.4 tt0 -72.53 -24.37 61.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.252 -0.905 . . . . 0.0 109.435 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.608 ' CD1' ' CD2' ' A' ' 102' ' ' PHE . 12.8 mm -79.58 -52.62 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -0.893 . . . . 0.0 109.48 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.442 ' HG2' ' O ' ' A' ' 108' ' ' ILE . 2.7 ptt85 -69.47 -24.43 63.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.178 -0.951 . . . . 0.0 109.473 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 109' ' ' ASP . 68.9 m-20 -75.93 -51.24 12.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 0.0 109.516 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.426 ' O ' ' CD2' ' A' ' 118' ' ' TYR . . . -61.64 -46.96 87.54 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.303 -0.873 . . . . 0.0 109.601 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 68.0 t -58.42 -47.39 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.151 -0.968 . . . . 0.0 109.524 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.94 -30.48 70.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 109.493 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -83.17 -16.8 45.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.9 . . . . 0.0 109.426 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.434 ' OH ' ' OG1' ' A' ' 100' ' ' THR . 17.5 m-85 -90.02 -72.86 0.54 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.348 -0.845 . . . . 0.0 109.531 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.516 ' CD1' ' HD2' ' A' ' 120' ' ' PRO . 6.1 tp -90.12 139.11 27.16 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.89 . . . . 0.0 109.533 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.516 ' HD2' ' CD1' ' A' ' 119' ' ' LEU . 35.6 Cg_endo -78.78 132.63 10.9 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.495 2.13 . . . . 0.0 110.409 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.577 ' HG ' ' CE2' ' A' ' 28' ' ' TYR . 1.9 tm? -134.3 3.69 3.39 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.254 -0.904 . . . . 0.0 109.489 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.21 -168.57 0.65 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.079 -1.013 . . . . 0.0 109.496 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 98.8 p -81.56 150.15 28.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.247 -0.908 . . . . 0.0 109.522 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 34.1 p-10 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 117.913 -1.042 . . . . 0.0 109.44 -179.979 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.419 ' O ' ' O ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -73.67 151.26 40.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -0.926 . . . . 0.0 109.418 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.419 ' O ' ' O ' ' A' ' 2' ' ' MET . 4.6 p30 -47.77 172.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.295 -0.878 . . . . 0.0 109.449 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.492 ' HG3' ' CD2' ' A' ' 119' ' ' LEU . 5.4 mm-40 -136.1 114.66 11.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -0.884 . . . . 0.0 109.544 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.464 ' CB ' ' HB3' ' A' ' 48' ' ' PRO . 3.2 mtmm -89.99 157.28 17.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.908 . . . . 0.0 109.482 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.509 HG21 ' N ' ' A' ' 7' ' ' LEU . 55.3 mt -150.08 158.12 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -0.907 . . . . 0.0 109.453 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.517 ' CD2' ' HB2' ' A' ' 31' ' ' PHE . 1.0 OUTLIER -131.04 109.0 10.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.323 -0.861 . . . . 0.0 109.365 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.519 ' CD1' ' HB3' ' A' ' 19' ' ' LEU . 13.2 mt -89.91 113.47 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.235 -0.915 . . . . 0.0 109.444 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.511 ' CG1' HD13 ' A' ' 57' ' ' ILE . 37.1 t -109.39 97.99 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.221 -0.924 . . . . 0.0 109.392 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 11' ' ' ASP . 2.2 t0 -152.7 88.13 1.33 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.905 . . . . 0.0 109.509 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.459 ' OD1' ' HA ' ' A' ' 57' ' ' ILE . 7.3 p-10 -44.29 -43.32 7.31 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.5 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -55.97 134.94 52.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.298 -0.876 . . . . 0.0 109.56 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.574 ' CE2' HG13 ' A' ' 17' ' ' ILE . 7.6 t80 -73.71 174.0 9.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.272 -0.892 . . . . 0.0 109.535 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.29 -38.52 3.2 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.525 HG21 ' CD1' ' A' ' 19' ' ' LEU . 2.3 mp -84.64 -48.39 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.332 -1.099 . . . . 0.0 109.443 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.441 ' O ' ' HB2' ' A' ' 20' ' ' ASN . 2.5 mtp180 -59.88 -26.79 66.15 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.255 -0.903 . . . . 0.0 109.584 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.574 HG13 ' CE2' ' A' ' 13' ' ' TYR . 3.7 mm -90.22 -57.16 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.25 -0.906 . . . . 0.0 109.74 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.459 ' O ' HG21 ' A' ' 22' ' ' VAL . 79.6 mt -54.18 -59.37 4.75 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -0.92 . . . . 0.0 109.706 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.525 ' CD1' HG21 ' A' ' 15' ' ' ILE . 4.5 mp -56.7 -19.31 15.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.243 -0.911 . . . . 0.0 109.602 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.452 ' HB3' ' O ' ' A' ' 17' ' ' ILE . 25.9 t30 -78.2 -72.45 0.37 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.884 . . . . 0.0 109.637 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -48.29 -28.31 3.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -0.913 . . . . 0.0 109.554 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.525 ' CG2' HG23 ' A' ' 108' ' ' ILE . 63.7 t -70.61 -57.26 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.221 -0.925 . . . . 0.0 109.543 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.519 ' CB ' HG22 ' A' ' 30' ' ' THR . 15.5 m-85 -72.63 -3.09 22.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.276 -0.89 . . . . 0.0 109.585 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -80.08 -51.56 8.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.155 -0.966 . . . . 0.0 109.416 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.13 -22.01 53.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.292 -0.88 . . . . 0.0 109.451 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.511 ' O ' ' CD2' ' A' ' 121' ' ' LEU . 2.2 mt-10 -71.36 -33.47 69.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.233 -0.917 . . . . 0.0 109.464 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 110.02 61.93 0.51 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.519 ' OH ' ' CB ' ' A' ' 121' ' ' LEU . 98.8 m-85 -151.63 134.95 16.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.294 -1.121 . . . . 0.0 109.539 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -89.92 83.04 6.12 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.226 -0.922 . . . . 0.0 109.137 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.519 HG22 ' CB ' ' A' ' 23' ' ' PHE . 5.6 p -89.91 151.08 21.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.296 -0.877 . . . . 0.0 109.607 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.517 ' HB2' ' CD2' ' A' ' 7' ' ' LEU . 11.8 m-85 -115.85 -170.41 1.78 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.286 -0.884 . . . . 0.0 109.297 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -127.5 149.79 49.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.13 -0.981 . . . . 0.0 109.504 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.46 ' HB1' HD13 ' A' ' 7' ' ' LEU . . . -164.56 171.97 13.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.288 -0.882 . . . . 0.0 109.381 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.456 ' O ' HD12 ' A' ' 57' ' ' ILE . . . -172.65 -34.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -0.908 . . . . 0.0 109.536 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.421 ' OD1' ' HB2' ' A' ' 37' ' ' LEU . 3.1 p30 -81.89 -2.72 52.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.187 -0.946 . . . . 0.0 109.625 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.19 -45.69 3.55 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.452 ' N ' HD13 ' A' ' 37' ' ' LEU . 9.1 mp -58.2 -34.59 70.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.242 -1.152 . . . . 0.0 109.483 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.523 ' O ' ' CD1' ' A' ' 42' ' ' ILE . 18.8 mm-40 -76.08 -28.53 57.61 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.199 -0.938 . . . . 0.0 109.467 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.13 -55.32 11.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.324 -0.86 . . . . 0.0 109.485 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.502 HD23 ' CB ' ' A' ' 68' ' ' ARG . 13.1 mt -65.54 -51.46 59.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.246 -0.909 . . . . 0.0 109.496 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -48.99 -54.32 16.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.287 -0.883 . . . . 0.0 109.452 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.523 ' CD1' ' O ' ' A' ' 38' ' ' GLN . 15.7 mt -60.06 -30.17 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.235 -0.915 . . . . 0.0 109.43 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.464 ' HA ' ' CD ' ' A' ' 48' ' ' PRO . 70.2 t -70.36 -26.92 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.94 . . . . 0.0 109.461 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.1 m -89.86 -19.4 24.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.158 -0.964 . . . . 0.0 109.437 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.6 mmtt -90.02 -24.35 21.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.353 -0.842 . . . . 0.0 109.517 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' A' ' 47' ' ' ARG . 38.9 mm-40 -125.39 -32.93 2.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.171 -0.955 . . . . 0.0 109.524 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 1.4 mtt180 60.48 66.85 1.74 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 109.527 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.488 ' O ' ' CD1' ' A' ' 76' ' ' ILE . 35.6 Cg_endo -77.85 175.34 11.32 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.668 2.245 . . . . 0.0 110.474 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 0.9 OUTLIER -116.82 -9.32 11.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.276 -0.89 . . . . 0.0 109.511 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.552 ' CD2' ' CG2' ' A' ' 115' ' ' VAL . 7.2 tp -128.07 120.02 26.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.28 -0.888 . . . . 0.0 109.538 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.477 ' CG1' ' HB3' ' A' ' 7' ' ' LEU . 39.1 t -133.16 124.49 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 0.0 109.692 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.467 ' CD1' HG12 ' A' ' 8' ' ' ILE . 1.1 mp -89.94 112.78 24.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.341 -0.849 . . . . 0.0 109.355 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.467 ' CD2' ' HG ' ' A' ' 66' ' ' LEU . 1.1 mp -97.5 120.01 37.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.149 -0.969 . . . . 0.0 109.626 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.45 ' HA ' ' HG3' ' A' ' 81' ' ' MET . 26.5 t0 -105.77 101.78 11.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.264 -0.897 . . . . 0.0 109.273 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.513 ' CG ' HG22 ' A' ' 82' ' ' THR . 3.3 mmt -61.82 -13.35 23.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -0.919 . . . . 0.0 109.464 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.469 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 43.4 mttp -57.96 -25.94 61.64 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.214 -0.929 . . . . 0.0 109.486 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.517 ' CG2' ' HB3' ' A' ' 60' ' ' MET . 87.5 mt -42.08 102.25 0.27 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.342 -0.849 . . . . 0.0 109.582 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 56' ' ' LYS . 36.0 Cg_endo -78.33 102.2 1.54 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.377 2.052 . . . . 0.0 110.476 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 125.77 -20.19 6.47 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.517 ' HB3' ' CG2' ' A' ' 57' ' ' ILE . 11.2 tmm? -129.53 132.54 46.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -1.167 . . . . 0.0 109.521 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.431 ' O ' ' SD ' ' A' ' 60' ' ' MET . 74.1 m-20 -89.14 129.82 35.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.203 -0.936 . . . . 0.0 109.497 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.462 ' HA2' HG13 ' A' ' 65' ' ' ILE . . . -87.35 9.82 71.64 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.45 HD13 ' SD ' ' A' ' 89' ' ' MET . 25.3 mm -76.15 -49.63 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.19 -1.182 . . . . 0.0 109.479 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -62.29 -25.31 67.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 109.388 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.482 HG21 ' CE ' ' A' ' 69' ' ' MET . 7.9 mt -62.83 -65.26 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.311 -0.868 . . . . 0.0 109.45 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.467 ' HG ' ' CD2' ' A' ' 53' ' ' LEU . 22.0 mt -46.57 -40.96 13.69 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.189 -0.944 . . . . 0.0 109.437 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.457 ' HA ' ' HG3' ' A' ' 70' ' ' LYS . 2.0 tttt -53.8 -53.7 48.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.934 . . . . 0.0 109.399 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.502 ' CB ' HD23 ' A' ' 40' ' ' LEU . 1.9 mtt85 -60.72 -24.99 66.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.258 -0.901 . . . . 0.0 109.396 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.482 ' CE ' HG21 ' A' ' 65' ' ' ILE . 2.2 mtt -78.36 -25.33 46.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.355 -0.841 . . . . 0.0 109.49 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' A' ' 66' ' ' LEU . 0.8 OUTLIER -82.91 -28.84 29.67 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 0.0 109.263 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.45 HG21 ' O ' ' A' ' 67' ' ' LYS . 2.6 t -90.07 -22.31 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.262 -0.899 . . . . 0.0 109.493 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.498 HG21 HD11 ' A' ' 72' ' ' ILE . 25.1 mm -90.1 -50.16 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.255 -0.903 . . . . 0.0 109.51 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.451 ' O ' ' O ' ' A' ' 69' ' ' MET . 1.0 OUTLIER -137.81 121.45 17.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -0.922 . . . . 0.0 109.509 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.79 7.76 19.59 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.223 -0.923 . . . . 0.0 109.515 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.476 ' C ' ' ND2' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -122.22 -9.11 8.66 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.246 -0.909 . . . . 0.0 108.984 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.488 ' CD1' ' O ' ' A' ' 48' ' ' PRO . 2.4 tp -57.86 106.85 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -0.934 . . . . 0.0 109.52 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.527 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 44.6 mtt180 -75.52 131.7 40.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.329 -0.857 . . . . 0.0 109.357 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.451 HG13 HD23 ' A' ' 66' ' ' LEU . 23.6 t -134.54 126.75 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 109.709 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.517 HG22 ' CG2' ' A' ' 100' ' ' THR . 80.0 mt -103.81 128.48 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.168 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.568 ' HB ' ' CG ' ' A' ' 101' ' ' HIS . 0.1 OUTLIER -89.84 153.54 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.174 -0.953 . . . . 0.0 109.427 -179.799 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.45 ' HG3' ' HA ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -132.39 69.0 1.48 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.321 -0.862 . . . . 0.0 109.522 179.899 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.521 HG21 ' NE2' ' A' ' 101' ' ' HIS . 12.8 t -170.67 28.16 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.213 -0.93 . . . . 0.0 109.583 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.517 ' CB ' ' HB1' ' A' ' 103' ' ' ALA . . . -51.61 -21.1 2.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.236 -0.915 . . . . 0.0 109.516 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.59 70.98 10.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.47 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -166.11 -84.25 0.05 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -127.62 -177.52 4.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.224 -1.162 . . . . 0.0 109.501 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.542 ' HA ' ' CG2' ' A' ' 90' ' ' ILE . 2.4 mp -137.15 54.52 1.85 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -0.907 . . . . 0.0 109.4 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -103.96 -88.71 0.41 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.219 -0.926 . . . . 0.0 109.597 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.527 ' O ' ' CB ' ' A' ' 93' ' ' SER . 2.0 mpt? -73.56 -1.58 19.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.198 -0.939 . . . . 0.0 109.616 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.542 ' CG2' ' HA ' ' A' ' 87' ' ' LEU . 0.3 OUTLIER -89.91 -43.99 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.226 -0.921 . . . . 0.0 109.065 179.865 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.79 -43.77 94.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.309 -0.87 . . . . 0.0 109.604 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.461 ' O ' HD22 ' A' ' 96' ' ' LEU . 1.1 tp10 -90.13 -20.71 22.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.188 -0.945 . . . . 0.0 109.813 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.527 ' CB ' ' O ' ' A' ' 89' ' ' MET . 0.4 OUTLIER -42.39 -26.86 0.12 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.187 -0.945 . . . . 0.0 109.899 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 92' ' ' GLU . 0.3 OUTLIER -52.58 -76.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -0.906 . . . . 0.0 109.899 -179.776 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.427 ' HG3' ' CD2' ' A' ' 96' ' ' LEU . 2.5 pt-20 -64.91 -38.02 89.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.231 -0.918 . . . . 0.0 109.825 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.522 ' N ' ' CD2' ' A' ' 96' ' ' LEU . 3.3 mm? -55.19 -25.17 30.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.919 . . . . 0.0 109.594 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 132.8 68.27 0.08 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.498 ' CB ' ' HB3' ' A' ' 93' ' ' SER . . . -153.12 98.96 2.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.251 -1.146 . . . . 0.0 109.444 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.527 ' CD1' ' HB3' ' A' ' 77' ' ' ARG . 21.1 mt -43.94 -67.13 0.3 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.295 -0.878 . . . . 0.0 109.346 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.565 HG22 ' CE1' ' A' ' 102' ' ' PHE . 14.2 t -146.68 152.43 38.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.33 -0.856 . . . . 0.0 109.44 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.568 ' CG ' ' HB ' ' A' ' 80' ' ' ILE . 3.6 t-160 -113.68 87.29 2.58 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 109.346 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.565 ' CE1' HG22 ' A' ' 100' ' ' THR . 13.3 m-30 -71.56 159.92 33.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.226 -0.921 . . . . 0.0 109.569 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.517 ' HB1' ' CB ' ' A' ' 83' ' ' ALA . . . -131.35 -148.88 0.37 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.284 -0.885 . . . . 0.0 109.342 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.1 mtpt -91.74 146.42 33.03 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.254 -0.904 . . . . 0.0 109.466 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.5 -169.56 7.96 Favored 'Cis proline' 0 C--N 1.308 -1.565 0 C-N-CA 123.236 -1.568 . . . . 0.0 110.435 -0.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.627 ' CZ ' ' CG1' ' A' ' 111' ' ' ILE . 11.0 t80 -127.48 92.64 3.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.312 -0.868 . . . . 0.0 109.264 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.445 ' O ' HD11 ' A' ' 111' ' ' ILE . 16.3 t70 -89.83 127.83 36.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.282 -0.886 . . . . 0.0 109.511 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.525 HG23 ' CG2' ' A' ' 22' ' ' VAL . 13.7 mm -51.53 -22.16 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.225 -0.922 . . . . 0.0 109.356 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 109' ' ' ASP . 4.3 m-20 -72.64 -42.33 64.52 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.295 -0.878 . . . . 0.0 109.499 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.422 ' HG2' ' CE2' ' A' ' 102' ' ' PHE . 17.4 tt0 -62.51 -29.82 70.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.264 -0.898 . . . . 0.0 109.473 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.627 ' CG1' ' CZ ' ' A' ' 106' ' ' PHE . 1.4 mp -76.49 -56.13 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 109.327 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.426 ' HG2' ' HA ' ' A' ' 109' ' ' ASP . 30.4 ptt180 -60.79 -19.61 59.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.921 . . . . 0.0 109.435 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -81.61 -51.14 8.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 109.396 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.452 ' O ' ' CD2' ' A' ' 118' ' ' TYR . . . -55.58 -47.42 76.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.263 -0.898 . . . . 0.0 109.368 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.552 ' CG2' ' CD2' ' A' ' 50' ' ' LEU . 47.2 t -65.97 -47.64 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.314 -0.867 . . . . 0.0 109.419 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.81 -19.29 59.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 109.418 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -89.48 -27.25 20.46 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.251 -0.905 . . . . 0.0 109.345 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.452 ' CD2' ' O ' ' A' ' 114' ' ' ALA . 42.3 m-85 -88.07 -69.64 0.68 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.296 -0.878 . . . . 0.0 109.47 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.492 ' CD2' ' HG3' ' A' ' 4' ' ' GLU . 2.4 tt -90.19 127.92 51.47 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.235 -0.915 . . . . 0.0 109.435 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.451 ' O ' HD22 ' A' ' 119' ' ' LEU . 35.9 Cg_endo -78.49 142.42 18.5 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.414 2.076 . . . . 0.0 110.368 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.519 ' CB ' ' OH ' ' A' ' 28' ' ' TYR . 1.0 OUTLIER -161.57 108.63 1.41 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.479 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.76 71.17 1.18 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.279 -0.888 . . . . 0.0 109.463 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 124' ' ' ASN . 1.5 m -147.77 -67.35 0.25 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.926 . . . . 0.0 109.461 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.44 ' O ' ' O ' ' A' ' 123' ' ' SER . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.108 -0.949 . . . . 0.0 109.443 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mtm . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.504 ' O ' ' CG ' ' A' ' 2' ' ' MET . 0.0 OUTLIER -89.83 55.29 3.11 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.249 -0.907 . . . . 0.0 109.474 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -132.53 64.45 1.61 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.231 -0.918 . . . . 0.0 109.444 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -122.01 112.24 18.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.419 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.524 ' CG ' ' HA ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -146.24 126.19 13.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.208 -0.932 . . . . 0.0 109.491 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.523 ' HB ' ' CG2' ' A' ' 30' ' ' THR . 4.1 mt -109.2 162.48 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.188 -0.945 . . . . 0.0 109.415 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.526 ' CD1' HG23 ' A' ' 9' ' ' VAL . 2.0 tm? -136.41 108.16 7.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.199 -0.938 . . . . 0.0 109.587 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.0 mt -90.01 103.41 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.219 -0.926 . . . . 0.0 109.138 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.526 HG23 ' CD1' ' A' ' 7' ' ' LEU . 2.7 t -89.99 95.12 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.172 -0.955 . . . . 0.0 109.801 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.483 ' OD1' ' CE ' ' A' ' 81' ' ' MET . 4.8 m-20 -145.22 155.36 43.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.272 -0.893 . . . . 0.0 109.402 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.464 ' OD2' ' CD ' ' A' ' 58' ' ' PRO . 7.1 p-10 -114.35 -29.75 6.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.339 -0.851 . . . . 0.0 109.41 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.515 ' HB3' ' NH2' ' A' ' 16' ' ' ARG . 1.4 tt0 -67.83 -148.04 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.349 -0.844 . . . . 0.0 109.514 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.614 ' CD1' ' N ' ' A' ' 14' ' ' GLY . 40.5 t80 -148.66 166.43 28.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.295 -0.878 . . . . 0.0 109.347 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.614 ' N ' ' CD1' ' A' ' 13' ' ' TYR . . . 102.24 -84.25 0.49 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.477 ' O ' ' N ' ' A' ' 17' ' ' ILE . 1.5 mt -51.08 -68.03 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.315 -1.109 . . . . 0.0 109.151 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.515 ' NH2' ' HB3' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -39.75 -27.57 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.616 -0.677 . . . . 0.0 110.217 -179.708 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.576 HG13 ' CZ ' ' A' ' 13' ' ' TYR . 9.9 mm -78.81 -46.77 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.091 -1.005 . . . . 0.0 109.841 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.525 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 3.8 mp -65.47 -54.8 23.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.18 -0.95 . . . . 0.0 109.654 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.461 ' CD1' HG21 ' A' ' 15' ' ' ILE . 8.6 mp -59.13 -18.88 39.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.276 -0.89 . . . . 0.0 109.3 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 31.1 t30 -77.94 -65.64 0.94 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.436 -0.79 . . . . 0.0 109.546 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -68.07 -7.79 32.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 109.719 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' A' ' 18' ' ' LEU . 43.7 t -88.16 -57.77 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.19 -0.944 . . . . 0.0 109.458 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.584 ' CB ' ' CG2' ' A' ' 30' ' ' THR . 18.0 m-85 -63.35 -28.84 70.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -0.91 . . . . 0.0 109.465 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -64.56 -60.04 3.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.274 -0.891 . . . . 0.0 109.44 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -57.03 -54.95 40.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.27 -0.894 . . . . 0.0 109.491 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.446 ' HB3' ' CD1' ' A' ' 28' ' ' TYR . 1.1 tt0 -44.48 -26.39 0.35 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.253 -0.904 . . . . 0.0 109.442 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.455 ' C ' ' CD1' ' A' ' 28' ' ' TYR . . . 113.21 55.71 0.43 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.458 ' HB2' ' O ' ' A' ' 23' ' ' PHE . 78.4 m-85 -147.68 135.91 21.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.259 -1.142 . . . . 0.0 109.475 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -89.85 82.23 6.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.272 -0.893 . . . . 0.0 109.358 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.584 ' CG2' ' CB ' ' A' ' 23' ' ' PHE . 6.0 p -89.96 146.76 24.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.324 -0.86 . . . . 0.0 109.605 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.554 ' CZ ' ' OE1' ' A' ' 46' ' ' GLU . 18.7 m-85 -116.15 -178.71 3.47 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.321 -0.862 . . . . 0.0 109.343 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -122.14 136.18 54.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 0.0 109.553 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' A' ' 10' ' ' ASP . . . -141.94 -175.82 4.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.257 -0.902 . . . . 0.0 109.425 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.57 -83.46 0.09 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.18 -0.95 . . . . 0.0 109.499 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.419 ' OD1' ' HB2' ' A' ' 38' ' ' GLN . 20.7 p-10 -63.21 137.22 58.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.303 -0.873 . . . . 0.0 109.476 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.405 ' HA2' HD12 ' A' ' 65' ' ' ILE . . . -45.29 -31.12 3.11 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.74 -49.87 76.05 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.214 -1.168 . . . . 0.0 109.477 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.517 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 6.6 tp-100 -61.96 -52.15 65.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 109.431 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.523 ' O ' ' CG2' ' A' ' 43' ' ' VAL . . . -44.69 -51.54 9.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.195 -0.94 . . . . 0.0 109.572 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.6 mt -60.25 -37.47 80.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.206 -0.934 . . . . 0.0 109.59 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.24 -59.46 5.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.139 -0.976 . . . . 0.0 109.527 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.519 ' CG2' HD22 ' A' ' 7' ' ' LEU . 5.1 mt -62.07 -19.85 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.207 -0.933 . . . . 0.0 109.577 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.523 ' CG2' ' O ' ' A' ' 39' ' ' ALA . 90.8 t -81.37 -24.9 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.188 -0.945 . . . . 0.0 109.491 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.5 m -90.13 -27.48 19.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 109.511 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.465 ' N ' ' CD ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -90.08 -30.89 17.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.247 -0.908 . . . . 0.0 109.527 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.554 ' OE1' ' CZ ' ' A' ' 31' ' ' PHE . 8.1 mm-40 -110.62 -35.26 6.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.916 . . . . 0.0 109.463 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 6.5 mtt85 56.33 69.89 1.65 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.478 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.524 ' HA ' ' CG ' ' A' ' 5' ' ' LYS . 35.4 Cg_endo -77.7 154.72 30.83 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.694 2.263 . . . . 0.0 110.416 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.523 ' HA ' ' CD1' ' A' ' 76' ' ' ILE . 4.0 t0 -92.77 -13.04 29.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.268 -0.895 . . . . 0.0 109.475 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.5 ' N ' HD21 ' A' ' 50' ' ' LEU . 4.3 mm? -122.54 111.98 17.46 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.222 -0.923 . . . . 0.0 109.453 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.521 HG13 ' CE ' ' A' ' 69' ' ' MET . 2.1 t -113.68 131.05 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.198 -0.939 . . . . 0.0 109.528 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.454 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 1.6 mp -108.95 117.98 35.6 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.245 -0.909 . . . . 0.0 109.48 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.54 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 2.3 mm? -103.19 130.74 50.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.268 -0.895 . . . . 0.0 109.518 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.457 ' HB2' ' OD2' ' A' ' 10' ' ' ASP . 19.6 t0 -111.11 97.81 7.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -0.872 . . . . 0.0 109.437 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.525 ' CG ' HG23 ' A' ' 82' ' ' THR . 12.6 mmt -64.76 -10.82 30.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 0.0 109.396 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -72.71 -2.96 22.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.155 -0.965 . . . . 0.0 109.668 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.44 HG12 ' OD1' ' A' ' 11' ' ' ASP . 55.3 mt -62.24 132.4 93.95 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.128 -0.983 . . . . 0.0 109.32 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.464 ' CD ' ' OD2' ' A' ' 11' ' ' ASP . 36.3 Cg_endo -78.88 112.0 3.04 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.494 2.129 . . . . 0.0 110.412 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 146.07 -76.49 0.27 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.421 ' SD ' ' C ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -130.47 170.14 14.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.207 -1.172 . . . . 0.0 109.501 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -90.09 139.54 30.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.355 -0.84 . . . . 0.0 109.499 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 63' ' ' ILE . . . -73.0 -10.11 77.16 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.459 ' HA ' ' HE3' ' A' ' 55' ' ' MET . 18.1 mm -44.14 -47.41 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.212 -1.169 . . . . 0.0 109.585 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.463 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 4.8 mt-10 -63.36 -39.52 94.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.235 -0.916 . . . . 0.0 109.533 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.466 HG23 HD13 ' A' ' 53' ' ' LEU . 65.6 mt -51.37 -64.49 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.262 -0.899 . . . . 0.0 109.415 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.459 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 7.1 mt -44.12 -49.01 9.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 109.391 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.06 -47.95 44.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.184 -0.948 . . . . 0.0 109.353 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.463 ' HG2' ' O ' ' A' ' 64' ' ' GLU . 9.7 mmt180 -57.15 -44.07 83.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -0.888 . . . . 0.0 109.415 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.521 ' CE ' HG13 ' A' ' 51' ' ' VAL . 3.6 mtt -60.04 -27.27 66.79 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 0.0 109.417 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 66' ' ' LEU . 0.7 OUTLIER -78.05 -31.7 50.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.238 -0.914 . . . . 0.0 109.368 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.6 t -77.9 -24.53 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.264 -0.898 . . . . 0.0 109.519 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.469 HG22 HD11 ' A' ' 72' ' ' ILE . 48.9 mt -87.42 -59.65 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -0.917 . . . . 0.0 109.406 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.462 ' O ' HG21 ' A' ' 76' ' ' ILE . 39.8 m-20 -130.52 133.56 46.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.19 -0.944 . . . . 0.0 109.482 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -90.16 -26.08 20.35 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.218 -0.926 . . . . 0.0 109.033 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 44.4 p-10 -96.51 46.85 1.06 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.262 -0.899 . . . . 0.0 109.472 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.523 ' CD1' ' HA ' ' A' ' 49' ' ' ASP . 2.9 tp -117.59 112.83 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.228 -0.92 . . . . 0.0 109.436 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.522 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 8.7 mpt_? -63.36 134.99 56.68 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.269 -0.894 . . . . 0.0 109.509 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.514 ' CG2' ' O ' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -138.66 108.84 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.247 -0.908 . . . . 0.0 109.6 -179.925 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.465 ' CG1' ' HB2' ' A' ' 99' ' ' LEU . 67.5 mt -96.77 145.68 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.211 -0.931 . . . . 0.0 109.371 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.581 HD11 ' CE1' ' A' ' 101' ' ' HIS . 0.4 OUTLIER -103.17 168.66 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.171 -0.956 . . . . 0.0 109.375 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.483 ' CE ' ' OD1' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -142.53 69.54 1.32 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.281 -0.887 . . . . 0.0 109.432 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.525 HG23 ' CG ' ' A' ' 55' ' ' MET . 9.0 t 178.79 55.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.348 -0.845 . . . . 0.0 109.429 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.512 ' CB ' ' HB1' ' A' ' 103' ' ' ALA . . . -60.7 -43.05 98.26 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.901 . . . . 0.0 109.511 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.06 153.64 42.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.245 -0.909 . . . . 0.0 109.395 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.79 -90.43 1.08 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.484 ' O ' ' CD1' ' A' ' 90' ' ' ILE . 4.2 mm-40 -95.77 62.58 2.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.22 -1.165 . . . . 0.0 109.46 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.03 -8.68 39.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.215 -0.928 . . . . 0.0 109.508 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -82.67 8.48 11.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.259 -0.901 . . . . 0.0 109.436 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.457 ' O ' ' CB ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -133.48 9.9 4.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.233 -0.917 . . . . 0.0 109.5 179.974 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.591 ' CD1' ' N ' ' A' ' 90' ' ' ILE . 1.2 mp -83.89 -66.53 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.285 -0.884 . . . . 0.0 109.163 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.46 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -51.19 -27.76 9.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.216 -0.927 . . . . 0.0 109.41 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.497 ' HA ' ' CG ' ' A' ' 95' ' ' GLU . 6.9 mt-10 -89.89 -28.67 19.07 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.302 -0.874 . . . . 0.0 109.456 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.486 ' HB3' ' CD1' ' A' ' 80' ' ' ILE . 1.7 m -64.8 -40.17 94.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.308 -0.87 . . . . 0.0 109.447 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.451 ' HA ' ' HB1' ' A' ' 98' ' ' ALA . 20.3 mttt -70.12 -63.34 1.1 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.204 -0.935 . . . . 0.0 109.548 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.497 ' CG ' ' HA ' ' A' ' 92' ' ' GLU . 0.1 OUTLIER -47.15 -27.75 1.55 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.195 -0.94 . . . . 0.0 109.469 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.444 ' HG ' ' OE2' ' A' ' 95' ' ' GLU . 22.0 mt -77.8 -41.24 37.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.889 . . . . 0.0 109.439 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.514 ' O ' ' CG2' ' A' ' 78' ' ' VAL . . . 161.4 61.49 0.02 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 78' ' ' VAL . . . -151.03 116.52 5.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.295 -1.12 . . . . 0.0 109.448 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.522 ' CD1' ' HB3' ' A' ' 77' ' ' ARG . 20.3 mt -44.11 -84.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.188 -0.945 . . . . 0.0 109.436 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.622 ' CG2' ' CE1' ' A' ' 102' ' ' PHE . 12.6 t -129.83 151.87 49.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.301 -0.874 . . . . 0.0 109.456 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.581 ' CE1' HD11 ' A' ' 80' ' ' ILE . 2.9 t60 -101.56 96.29 7.02 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.272 -0.892 . . . . 0.0 109.503 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.622 ' CE1' ' CG2' ' A' ' 100' ' ' THR . 43.6 m-85 -72.22 168.32 18.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.202 -0.936 . . . . 0.0 109.404 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.512 ' HB1' ' CB ' ' A' ' 83' ' ' ALA . . . -145.68 -148.34 0.24 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.194 -0.941 . . . . 0.0 109.413 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.81 146.93 25.55 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.919 . . . . 0.0 109.534 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.99 168.01 76.98 Favored 'Cis proline' 0 C--N 1.308 -1.57 0 C-N-CA 123.233 -1.57 . . . . 0.0 110.393 0.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -142.33 -164.41 1.81 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 0.0 109.499 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -136.81 127.4 26.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.251 -0.906 . . . . 0.0 109.397 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.494 ' CG1' HD21 ' A' ' 18' ' ' LEU . 19.0 mm -54.11 -20.57 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -0.912 . . . . 0.0 109.468 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -74.61 -41.48 60.36 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.246 -0.909 . . . . 0.0 109.475 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -71.87 -31.6 66.62 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.228 -0.92 . . . . 0.0 109.539 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.461 HD12 ' CE2' ' A' ' 102' ' ' PHE . 17.8 mm -68.82 -58.0 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.339 -0.851 . . . . 0.0 109.516 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' A' ' 108' ' ' ILE . 8.2 ptt85 -60.14 -36.47 77.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.227 -0.921 . . . . 0.0 109.535 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -59.69 -54.08 50.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.253 -0.904 . . . . 0.0 109.434 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.526 ' O ' ' CD2' ' A' ' 118' ' ' TYR . . . -57.09 -42.1 80.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.234 -0.917 . . . . 0.0 109.387 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.9 t -65.63 -25.11 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.278 -0.889 . . . . 0.0 109.48 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.53 -45.05 61.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.283 -0.886 . . . . 0.0 109.459 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.38 -42.79 95.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.186 -0.946 . . . . 0.0 109.543 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.526 ' CD2' ' O ' ' A' ' 114' ' ' ALA . 52.7 m-85 -64.98 -70.04 0.26 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.214 -0.929 . . . . 0.0 109.518 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 18.0 tp -90.08 112.37 52.05 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.347 -0.846 . . . . 0.0 109.437 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 118' ' ' TYR . 35.7 Cg_endo -77.96 136.03 14.5 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.39 2.06 . . . . 0.0 110.42 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.7 tp -112.45 -149.86 0.45 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.31 -0.869 . . . . 0.0 109.449 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.6 mtmp? -89.04 50.63 1.98 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.245 -0.91 . . . . 0.0 109.462 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 87.0 p -174.5 -174.49 0.85 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.906 . . . . 0.0 109.49 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 118.037 -0.983 . . . . 0.0 109.408 -179.969 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 2.6 mtm -143.8 128.21 17.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 0.0 109.479 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -107.04 -148.98 0.42 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.21 -0.931 . . . . 0.0 109.478 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.444 ' HG2' HD11 ' A' ' 121' ' ' LEU . 1.4 mt-10 -115.76 96.73 5.75 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.312 -0.868 . . . . 0.0 109.433 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.48 ' CB ' ' HB3' ' A' ' 48' ' ' PRO . 1.4 mptp? -120.83 159.7 24.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.254 -0.904 . . . . 0.0 109.484 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.524 ' HB ' ' CG2' ' A' ' 30' ' ' THR . 14.3 mt -149.98 158.79 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.23 -0.919 . . . . 0.0 109.487 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.52 ' CD2' ' HB2' ' A' ' 31' ' ' PHE . 1.8 tm? -133.2 106.84 7.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.207 -0.933 . . . . 0.0 109.401 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.45 HD12 ' HB3' ' A' ' 19' ' ' LEU . 6.0 mt -89.88 112.06 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.204 -0.935 . . . . 0.0 109.382 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.472 HG23 ' CD1' ' A' ' 53' ' ' LEU . 32.3 t -93.97 79.86 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.283 -0.886 . . . . 0.0 109.565 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.466 ' HB3' ' HD3' ' A' ' 16' ' ' ARG . 17.7 t70 -126.32 133.16 51.45 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.262 -0.899 . . . . 0.0 109.494 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.49 ' CG ' ' CD ' ' A' ' 58' ' ' PRO . 5.4 p-10 -99.65 -45.86 5.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.127 -0.983 . . . . 0.0 109.507 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.435 ' N ' ' CG ' ' A' ' 11' ' ' ASP . 1.0 OUTLIER -68.94 112.49 5.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -0.909 . . . . 0.0 109.444 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.42 ' C ' ' O ' ' A' ' 12' ' ' GLN . 1.8 t80 -43.79 159.02 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.24 -0.912 . . . . 0.0 109.529 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.83 -67.65 0.25 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.519 HG22 ' CD1' ' A' ' 19' ' ' LEU . 2.7 mt -65.31 -11.47 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.191 -1.182 . . . . 0.0 109.346 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.466 ' HD3' ' HB3' ' A' ' 10' ' ' ASP . 0.6 OUTLIER -84.24 -26.77 28.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.21 -0.931 . . . . 0.0 109.263 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.3 mm -90.7 -37.95 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.26 -0.9 . . . . 0.0 109.79 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.94 -58.19 5.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 0.0 109.7 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.519 ' CD1' HG22 ' A' ' 15' ' ' ILE . 7.9 mp -62.95 -22.13 66.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.167 -0.958 . . . . 0.0 109.394 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 8.8 t30 -71.21 -66.83 0.57 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.368 -0.833 . . . . 0.0 109.488 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.457 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 2.1 mt-10 -53.27 -33.3 52.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -0.885 . . . . 0.0 109.58 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.465 HG23 ' CG2' ' A' ' 108' ' ' ILE . 74.7 t -63.41 -60.07 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.251 -0.906 . . . . 0.0 109.512 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.465 ' O ' ' HB2' ' A' ' 28' ' ' TYR . 21.6 m-85 -78.03 1.77 19.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.944 . . . . 0.0 109.582 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 20' ' ' ASN . 1.0 OUTLIER -90.07 -43.13 10.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.192 -0.943 . . . . 0.0 109.491 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -76.09 -35.95 59.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.232 -0.917 . . . . 0.0 109.477 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.499 ' HB3' ' CE1' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -65.79 -27.53 68.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -0.914 . . . . 0.0 109.489 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.535 ' C ' ' CD1' ' A' ' 28' ' ' TYR . . . 106.77 73.01 0.83 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.535 ' CD1' ' C ' ' A' ' 27' ' ' GLY . 79.3 m-85 -151.17 134.71 16.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.225 -1.162 . . . . 0.0 109.539 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -93.99 83.84 4.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.228 -0.92 . . . . 0.0 109.265 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.524 ' CG2' ' HB ' ' A' ' 6' ' ' ILE . 5.8 p -89.87 161.59 15.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.187 -0.946 . . . . 0.0 109.562 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.52 ' HB2' ' CD2' ' A' ' 7' ' ' LEU . 25.6 m-85 -121.66 -168.65 1.73 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -0.899 . . . . 0.0 109.331 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.454 ' HB3' ' CZ ' ' A' ' 16' ' ' ARG . 6.9 mp0 -123.92 150.79 44.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.185 -0.947 . . . . 0.0 109.533 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.476 ' CB ' HD13 ' A' ' 7' ' ' LEU . . . -162.24 173.16 14.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.22 -0.925 . . . . 0.0 109.38 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.477 ' HB3' ' CA ' ' A' ' 11' ' ' ASP . . . -174.77 -47.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.253 -0.905 . . . . 0.0 109.541 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.45 ' OD1' ' HB2' ' A' ' 38' ' ' GLN . 19.1 p30 -70.17 -5.66 28.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.245 -0.909 . . . . 0.0 109.585 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.98 -58.77 4.77 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.531 ' CD1' ' N ' ' A' ' 38' ' ' GLN . 4.2 pp -52.39 -40.24 61.84 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.271 -1.135 . . . . 0.0 109.476 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.531 ' N ' ' CD1' ' A' ' 37' ' ' LEU . 1.8 tp60 -66.36 -33.34 75.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.325 -0.859 . . . . 0.0 109.358 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.439 ' HB3' HG21 ' A' ' 9' ' ' VAL . . . -64.53 -62.56 1.51 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.211 -0.931 . . . . 0.0 109.407 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.521 HD21 ' CD1' ' A' ' 72' ' ' ILE . 13.4 mt -54.35 -35.92 63.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -0.899 . . . . 0.0 109.445 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -57.54 -53.29 59.85 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.222 -0.924 . . . . 0.0 109.387 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.52 ' CD1' ' O ' ' A' ' 38' ' ' GLN . 1.8 mp -64.91 -20.72 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.275 -0.891 . . . . 0.0 109.387 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.526 ' HA ' ' CD ' ' A' ' 48' ' ' PRO . 21.6 t -81.51 -23.28 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.25 -0.906 . . . . 0.0 109.49 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.5 m -90.01 -28.54 19.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.321 -0.862 . . . . 0.0 109.533 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.6 mttm -87.44 -37.9 16.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.279 -0.888 . . . . 0.0 109.517 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.437 ' HG3' HG22 ' A' ' 42' ' ' ILE . 1.3 mm-40 -101.28 -39.6 7.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.261 -0.9 . . . . 0.0 109.466 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 0.9 OUTLIER 63.26 67.07 1.08 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.42 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.526 ' CD ' ' HA ' ' A' ' 43' ' ' VAL . 35.4 Cg_endo -77.51 -161.03 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.633 2.222 . . . . 0.0 110.469 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.52 ' O ' ' CD2' ' A' ' 50' ' ' LEU . 27.4 t70 -135.24 9.38 3.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 0.0 109.537 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.52 ' CD2' ' O ' ' A' ' 49' ' ' ASP . 0.4 OUTLIER -146.58 107.72 4.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.226 -0.921 . . . . 0.0 109.557 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.497 HG13 ' CE ' ' A' ' 69' ' ' MET . 1.7 t -113.47 109.49 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 109.382 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.461 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 1.3 mp -90.58 127.98 36.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.239 -0.913 . . . . 0.0 109.512 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.577 ' CD2' ' CG1' ' A' ' 78' ' ' VAL . 2.6 mm? -113.42 146.11 40.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.233 -0.917 . . . . 0.0 109.429 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.465 ' O ' HG13 ' A' ' 57' ' ' ILE . 12.5 t70 -118.76 111.48 18.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.34 -0.85 . . . . 0.0 109.371 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.447 ' CG ' HG23 ' A' ' 82' ' ' THR . 15.5 mmt -70.6 -5.02 26.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.219 -0.926 . . . . 0.0 109.594 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.454 ' HG3' ' OG1' ' A' ' 82' ' ' THR . 24.1 mttt -90.08 14.33 12.65 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.141 -0.975 . . . . 0.0 109.67 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.466 HG22 ' HD2' ' A' ' 58' ' ' PRO . 83.4 mt -76.57 139.63 67.43 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.187 -0.945 . . . . 0.0 109.301 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.49 ' CD ' ' CG ' ' A' ' 11' ' ' ASP . 35.8 Cg_endo -78.18 -37.75 0.72 Allowed 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.504 2.136 . . . . 0.0 110.443 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.447 ' O ' ' HB3' ' A' ' 60' ' ' MET . . . -43.71 -43.66 6.62 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.505 ' N ' ' SD ' ' A' ' 60' ' ' MET . 0.0 OUTLIER 178.4 -167.95 0.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -1.141 . . . . 0.0 109.361 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -87.77 120.34 28.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.436 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.445 ' HA2' HG13 ' A' ' 65' ' ' ILE . . . -58.14 -16.07 24.88 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.41 ' C ' ' O ' ' A' ' 62' ' ' GLY . 25.9 mm -44.09 -50.34 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -1.141 . . . . 0.0 109.465 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' A' ' 68' ' ' ARG . 6.4 mt-10 -64.56 -38.89 92.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.885 . . . . 0.0 109.425 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.463 ' O ' ' HB2' ' A' ' 68' ' ' ARG . 30.4 mt -53.24 -60.63 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 0.0 109.497 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.526 ' CD2' HG13 ' A' ' 78' ' ' VAL . 2.8 mt -50.25 -62.04 1.82 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.905 . . . . 0.0 109.71 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.45 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -41.45 -33.48 0.43 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.358 -0.839 . . . . 0.0 109.68 -179.895 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.465 ' O ' ' N ' ' A' ' 70' ' ' LYS . 24.8 mtt-85 -72.3 -63.04 1.23 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.211 -0.931 . . . . 0.0 109.391 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.519 ' SD ' ' CD2' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -40.6 -28.21 0.07 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.508 -0.745 . . . . 0.0 109.537 -179.385 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.581 ' N ' ' CD ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -78.07 -60.4 2.39 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.057 -1.027 . . . . 0.0 109.098 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 67' ' ' LYS . 3.4 t -43.44 -26.77 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.449 -0.782 . . . . 0.0 109.592 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.521 ' CD1' HD21 ' A' ' 40' ' ' LEU . 71.7 mt -85.31 -54.2 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.251 -0.906 . . . . 0.0 109.41 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.461 ' O ' HG23 ' A' ' 76' ' ' ILE . 1.4 m-20 -136.78 124.68 22.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.334 -0.854 . . . . 0.0 109.322 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -83.09 -9.23 59.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.213 -0.929 . . . . 0.0 109.51 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 -107.06 50.75 0.76 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.918 . . . . 0.0 109.522 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.474 ' CG1' HG22 ' A' ' 51' ' ' VAL . 3.2 tp -125.4 105.22 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.221 -0.925 . . . . 0.0 109.519 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.525 ' CG ' HD12 ' A' ' 99' ' ' LEU . 75.0 mtt85 -55.19 155.5 4.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 109.473 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.577 ' CG1' ' CD2' ' A' ' 53' ' ' LEU . 3.2 t -142.78 138.82 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.272 -0.893 . . . . 0.0 109.606 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.504 ' CG1' HD13 ' A' ' 50' ' ' LEU . 9.0 mm -121.39 123.6 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.238 -0.914 . . . . 0.0 109.229 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.566 ' HB ' ' CD2' ' A' ' 101' ' ' HIS . 0.7 OUTLIER -89.71 144.35 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.143 -0.973 . . . . 0.0 109.429 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.454 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 5.0 mtm -124.77 57.45 1.27 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.212 -0.93 . . . . 0.0 109.51 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.512 ' N ' ' O ' ' A' ' 102' ' ' PHE . 10.7 t -169.38 47.48 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.279 -0.888 . . . . 0.0 109.57 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.575 ' N ' ' CB ' ' A' ' 103' ' ' ALA . . . -85.03 72.06 10.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.245 -0.909 . . . . 0.0 109.522 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -83.1 -157.27 0.22 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.228 -0.92 . . . . 0.0 109.453 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -66.85 -11.83 58.63 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' A' ' 86' ' ' GLU . 3.5 pt-20 -83.95 110.65 18.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.297 -1.119 . . . . 0.0 109.456 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.455 ' HG ' HD13 ' A' ' 90' ' ' ILE . 0.3 OUTLIER -123.66 53.93 1.33 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.275 -0.89 . . . . 0.0 109.481 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 89' ' ' MET . 3.5 p30 -103.53 -45.83 4.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.529 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.448 ' O ' ' HB2' ' A' ' 93' ' ' SER . 4.4 ptp -87.36 -7.46 57.72 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.334 -0.854 . . . . 0.0 109.546 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.541 HG12 ' CE1' ' A' ' 101' ' ' HIS . 15.5 mt -81.0 -41.41 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.906 . . . . 0.0 109.5 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.49 -32.47 71.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.311 -0.868 . . . . 0.0 109.499 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -89.8 -31.02 17.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.287 -0.883 . . . . 0.0 109.467 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 89' ' ' MET . 0.4 OUTLIER -59.68 -51.44 69.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.265 -0.897 . . . . 0.0 109.479 -179.945 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 95' ' ' GLU . 14.3 tttm -52.78 -57.95 8.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.0 109.465 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 94' ' ' LYS . 59.3 mt-10 -44.06 -50.54 8.39 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.232 -0.917 . . . . 0.0 109.49 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.9 mt -53.0 -48.25 67.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.307 -0.871 . . . . 0.0 109.457 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 154.46 42.65 0.02 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -99.48 118.11 35.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.19 -1.182 . . . . 0.0 109.487 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.573 HD11 ' CD1' ' A' ' 118' ' ' TYR . 21.9 mt -55.24 -81.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.477 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.573 ' OG1' ' CE1' ' A' ' 102' ' ' PHE . 0.1 OUTLIER -126.27 175.65 7.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.208 -0.933 . . . . 0.0 109.477 -179.956 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.566 ' CD2' ' HB ' ' A' ' 80' ' ' ILE . 4.7 t-160 -146.03 97.19 2.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 109.256 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.573 ' CE1' ' OG1' ' A' ' 100' ' ' THR . 18.4 m-30 -108.81 159.55 16.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.182 -0.949 . . . . 0.0 109.597 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.575 ' CB ' ' N ' ' A' ' 83' ' ' ALA . . . -128.73 168.39 15.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.319 -0.863 . . . . 0.0 109.343 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.468 ' C ' ' CD ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -90.97 144.85 30.68 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.186 -0.946 . . . . 0.0 109.48 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.09 130.2 20.42 Favored 'Cis proline' 0 C--N 1.309 -1.547 0 C-N-CA 123.353 -1.52 . . . . 0.0 110.36 0.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.483 ' CE1' HD12 ' A' ' 108' ' ' ILE . 0.7 OUTLIER -102.22 -174.51 2.59 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.282 -0.886 . . . . 0.0 109.448 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.411 ' O ' ' C ' ' A' ' 108' ' ' ILE . 46.5 t0 -111.97 100.35 8.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.305 -0.872 . . . . 0.0 109.489 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.483 HD12 ' CE1' ' A' ' 106' ' ' PHE . 12.5 mm -44.51 -31.21 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.381 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -63.77 -51.07 66.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.225 -0.922 . . . . 0.0 109.392 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' A' ' 113' ' ' ASP . 7.5 tt0 -57.07 -47.11 81.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.17 -0.956 . . . . 0.0 109.375 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.5 mm -51.82 -60.14 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.365 -0.834 . . . . 0.0 109.453 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.465 ' O ' ' HG3' ' A' ' 116' ' ' LYS . 98.8 mtt180 -49.54 -34.26 16.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.918 . . . . 0.0 109.51 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 110' ' ' GLU . 19.3 m-20 -67.29 -74.61 0.11 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 109.642 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.427 ' O ' ' C ' ' A' ' 115' ' ' VAL . . . -47.56 -63.43 1.05 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.239 -0.913 . . . . 0.0 109.622 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.427 ' C ' ' O ' ' A' ' 114' ' ' ALA . 49.4 t -42.49 -57.44 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.365 -0.835 . . . . 0.0 109.846 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 0.0 OUTLIER -45.78 -44.77 14.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.175 -0.953 . . . . 0.0 109.621 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 4.5 tptp -62.05 -39.9 93.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 109.703 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.573 ' CD1' HD11 ' A' ' 99' ' ' LEU . 48.7 m-85 -67.44 -69.77 0.29 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.168 -0.958 . . . . 0.0 109.654 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.483 ' CD1' ' C ' ' A' ' 119' ' ' LEU . 1.3 tm? -90.07 112.46 52.51 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.185 -0.947 . . . . 0.0 109.482 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 118' ' ' TYR . 36.1 Cg_endo -78.25 141.95 18.69 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.322 2.015 . . . . 0.0 110.418 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.452 ' HB2' ' OH ' ' A' ' 28' ' ' TYR . 0.3 OUTLIER -147.99 76.31 1.37 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.171 -0.956 . . . . 0.0 109.485 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.6 pttp -128.48 138.9 52.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 109.537 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 15.8 t 52.49 89.53 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.287 -0.883 . . . . 0.0 109.438 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.488 179.953 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 2.6 tpt -150.0 92.42 1.89 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.195 -0.941 . . . . 0.0 109.51 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.48 ' C ' ' CG ' ' A' ' 4' ' ' GLU . 1.2 p30 -158.43 -170.25 3.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.235 -0.915 . . . . 0.0 109.529 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.48 ' CG ' ' C ' ' A' ' 3' ' ' ASN . 4.2 pt-20 38.2 77.83 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.586 -0.696 . . . . 0.0 109.992 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.485 ' CG ' ' HA ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -108.85 147.47 32.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.245 -0.909 . . . . 0.0 109.465 179.885 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.498 ' CG2' ' N ' ' A' ' 7' ' ' LEU . 16.3 mt -149.7 165.15 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.229 -0.919 . . . . 0.0 109.519 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.516 ' CD2' ' HB2' ' A' ' 31' ' ' PHE . 2.2 tm? -131.67 133.41 44.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.302 -0.874 . . . . 0.0 109.457 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.514 ' N ' HD12 ' A' ' 7' ' ' LEU . 12.4 mt -117.86 101.75 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.191 -0.943 . . . . 0.0 109.348 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.459 HG21 ' CD1' ' A' ' 7' ' ' LEU . 4.9 t -89.97 125.58 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.928 . . . . 0.0 109.522 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.465 ' O ' ' HB3' ' A' ' 34' ' ' ALA . 12.7 t70 -174.41 145.61 0.99 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.261 -0.9 . . . . 0.0 109.512 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.461 ' OD2' ' HD2' ' A' ' 58' ' ' PRO . 8.0 p-10 -117.95 -31.9 4.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.218 -0.926 . . . . 0.0 109.391 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.4 ' O ' ' C ' ' A' ' 13' ' ' TYR . 21.8 tm0? -69.73 104.64 2.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.334 -0.854 . . . . 0.0 109.589 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.628 ' CE2' ' CD1' ' A' ' 17' ' ' ILE . 6.7 t80 -43.63 123.13 2.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.337 -0.852 . . . . 0.0 109.569 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.77 -47.43 0.79 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.462 HD11 ' OD1' ' A' ' 10' ' ' ASP . 5.0 mt -80.1 -59.25 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -1.153 . . . . 0.0 109.486 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.481 ' HG2' ' CG ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -43.36 -26.69 0.21 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.235 -0.916 . . . . 0.0 109.714 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.628 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 2.4 mt -90.07 -64.33 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.19 -0.943 . . . . 0.0 109.697 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.422 ' O ' HG21 ' A' ' 22' ' ' VAL . 9.6 mt -47.59 -61.08 2.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.157 -0.964 . . . . 0.0 109.749 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.457 HD22 HD23 ' A' ' 52' ' ' LEU . 1.4 mp -52.76 -30.88 35.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -0.932 . . . . 0.0 109.575 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.467 ' HB3' ' O ' ' A' ' 17' ' ' ILE . 28.7 t30 -67.72 -72.42 0.17 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.223 -0.923 . . . . 0.0 109.716 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 20' ' ' ASN . 0.6 OUTLIER -43.72 -31.21 0.75 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 109.604 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.422 HG21 ' O ' ' A' ' 18' ' ' LEU . 67.4 t -66.77 -52.15 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.294 -0.879 . . . . 0.0 109.486 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.523 ' CB ' HG22 ' A' ' 30' ' ' THR . 22.9 m-85 -79.92 -0.47 35.15 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.187 -0.946 . . . . 0.0 109.62 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.422 ' ND2' ' OD1' ' A' ' 20' ' ' ASN . 0.7 OUTLIER -88.4 -48.15 7.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.145 -0.972 . . . . 0.0 109.462 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.54 -10.54 59.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.466 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.504 ' HB3' ' CE1' ' A' ' 28' ' ' TYR . 1.7 tt0 -89.43 -26.29 21.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.304 -0.872 . . . . 0.0 109.457 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.533 ' C ' ' CD1' ' A' ' 28' ' ' TYR . . . 105.91 67.73 0.69 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.629 ' CE2' ' CD2' ' A' ' 121' ' ' LEU . 90.2 m-85 -154.68 134.87 13.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.203 -1.175 . . . . 0.0 109.443 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -91.51 81.86 5.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.891 . . . . 0.0 109.326 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.523 HG22 ' CB ' ' A' ' 23' ' ' PHE . 5.7 p -89.92 146.37 24.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.311 -0.868 . . . . 0.0 109.608 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.516 ' HB2' ' CD2' ' A' ' 7' ' ' LEU . 57.6 m-85 -106.96 -173.34 2.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.256 -0.902 . . . . 0.0 109.231 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.481 ' CG ' ' HG2' ' A' ' 16' ' ' ARG . 78.8 mt-30 -131.04 151.58 51.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.182 -0.949 . . . . 0.0 109.676 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.52 ' O ' ' CB ' ' A' ' 34' ' ' ALA . . . -160.68 -163.47 1.07 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.302 -0.874 . . . . 0.0 109.291 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' A' ' 33' ' ' ALA . . . 164.41 -44.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.922 . . . . 0.0 109.591 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.453 ' OD1' ' HB2' ' A' ' 38' ' ' GLN . 45.7 p-10 -67.07 -8.51 31.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.22 -0.925 . . . . 0.0 109.569 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.447 ' HA2' HD12 ' A' ' 65' ' ' ILE . . . 87.49 -68.01 3.18 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 36' ' ' GLY . 0.2 OUTLIER -45.06 -53.49 7.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.254 -1.145 . . . . 0.0 109.378 179.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.495 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 2.8 tp60 -48.99 -55.87 10.63 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.209 -0.932 . . . . 0.0 109.473 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 38' ' ' GLN . . . -43.85 -50.12 8.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.283 -0.885 . . . . 0.0 109.455 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.405 HD23 ' CB ' ' A' ' 68' ' ' ARG . 96.5 mt -55.63 -43.03 75.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.253 -0.904 . . . . 0.0 109.452 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 8.3 m-20 -62.55 -28.71 70.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.295 -0.878 . . . . 0.0 109.373 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.507 HG22 ' CD2' ' A' ' 7' ' ' LEU . 20.6 mm -75.92 -29.9 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.222 -0.924 . . . . 0.0 109.477 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.525 ' O ' ' CG ' ' A' ' 47' ' ' ARG . 68.3 t -80.93 -25.24 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.272 -0.892 . . . . 0.0 109.417 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.439 ' HA ' ' HD2' ' A' ' 47' ' ' ARG . 4.1 m -87.14 -30.69 20.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.276 -0.89 . . . . 0.0 109.515 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 1.1 mtpt -89.99 -25.68 20.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.386 -0.821 . . . . 0.0 109.532 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -123.53 -31.59 3.48 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.206 -0.934 . . . . 0.0 109.56 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.525 ' CG ' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER 47.27 71.53 1.56 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.929 . . . . 0.0 109.481 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.522 ' CD ' ' HA ' ' A' ' 43' ' ' VAL . 34.5 Cg_endo -77.78 -178.54 4.68 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 122.683 2.255 . . . . 0.0 110.616 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.454 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 3.3 p30 -110.44 -20.02 12.74 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.412 -0.805 . . . . 0.0 109.185 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.518 HD23 ' CG2' ' A' ' 115' ' ' VAL . 7.4 tp -115.18 122.24 45.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.307 -0.871 . . . . 0.0 109.554 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.526 HG12 ' CE ' ' A' ' 69' ' ' MET . 1.8 t -126.08 115.47 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.29 -0.881 . . . . 0.0 109.508 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.466 HD11 ' HA ' ' A' ' 8' ' ' ILE . 1.0 OUTLIER -89.98 108.31 19.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.235 -0.915 . . . . 0.0 109.433 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.506 HD12 ' CE ' ' A' ' 69' ' ' MET . 1.1 tp -97.69 119.13 35.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.16 -0.963 . . . . 0.0 109.429 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.512 ' HB2' ' CE ' ' A' ' 81' ' ' MET . 40.7 t0 -100.62 104.1 15.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 109.423 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.456 ' HB2' ' HB ' ' A' ' 82' ' ' THR . 2.8 mmt -65.26 -10.42 31.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.306 -0.871 . . . . 0.0 109.452 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.467 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 3.3 mmtp -66.04 -24.72 66.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.209 -0.932 . . . . 0.0 109.459 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.518 HG22 HD11 ' A' ' 57' ' ' ILE . 48.9 mt -43.12 103.12 0.3 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.368 -0.832 . . . . 0.0 109.533 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 56' ' ' LYS . 35.3 Cg_endo -77.94 119.73 4.82 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.396 2.064 . . . . 0.0 110.388 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 108.55 5.83 31.49 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.517 ' CE ' HD11 ' A' ' 57' ' ' ILE . 24.9 ttp -165.13 127.33 2.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -1.161 . . . . 0.0 109.408 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -89.71 120.13 30.72 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -0.908 . . . . 0.0 109.423 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.461 ' HA2' HG13 ' A' ' 65' ' ' ILE . . . -67.87 -7.83 50.75 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.407 ' HA ' HD11 ' A' ' 63' ' ' ILE . 16.5 mm -53.08 -40.12 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.184 -1.186 . . . . 0.0 109.507 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -68.68 -44.1 74.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.216 -0.927 . . . . 0.0 109.418 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.47 ' CG2' ' HE1' ' A' ' 69' ' ' MET . 11.4 mt -46.4 -51.86 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.258 -0.901 . . . . 0.0 109.491 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.524 ' O ' ' CE ' ' A' ' 70' ' ' LYS . 55.2 mt -56.56 -41.06 76.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.289 -0.882 . . . . 0.0 109.428 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 1.3 tttm -54.73 -41.01 69.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.226 -0.921 . . . . 0.0 109.493 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.405 ' CB ' HD23 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -77.07 -21.19 54.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 109.441 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.526 ' CE ' HG12 ' A' ' 51' ' ' VAL . 14.3 mtt -72.13 -40.08 68.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.261 -0.9 . . . . 0.0 109.439 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.524 ' CE ' ' O ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -79.72 -37.63 35.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.272 -0.892 . . . . 0.0 109.522 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 97.5 t -65.46 -32.67 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.22 -0.925 . . . . 0.0 109.445 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.426 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 45.0 mm -89.65 -27.29 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.227 -0.921 . . . . 0.0 109.453 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.456 ' O ' ' O ' ' A' ' 69' ' ' MET . 15.7 m-20 -163.42 130.26 3.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.267 -0.895 . . . . 0.0 109.471 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -89.98 -10.88 43.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.229 -0.919 . . . . 0.0 109.48 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -106.94 50.23 0.78 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.288 -0.882 . . . . 0.0 109.445 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.456 HG22 ' HB3' ' A' ' 69' ' ' MET . 0.8 OUTLIER -117.94 122.98 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.269 -0.894 . . . . 0.0 109.519 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.464 ' HA ' HD13 ' A' ' 99' ' ' LEU . 10.4 mtt180 -79.31 141.66 36.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.209 -0.932 . . . . 0.0 109.426 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.456 HG11 ' O ' ' A' ' 51' ' ' VAL . 2.7 t -147.74 119.06 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.886 . . . . 0.0 109.603 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.434 HG21 ' O ' ' A' ' 100' ' ' THR . 23.5 mt -89.87 170.6 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 0.0 109.297 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.88 126.86 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.198 -0.938 . . . . 0.0 109.435 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.512 ' CE ' ' HB2' ' A' ' 54' ' ' ASP . 20.7 mtm -110.01 84.22 1.89 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 109.181 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.527 ' O ' ' CB ' ' A' ' 103' ' ' ALA . 4.7 t -149.67 -146.99 0.21 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.214 -0.929 . . . . 0.0 109.497 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.527 ' CB ' ' HG3' ' A' ' 86' ' ' GLU . . . -40.94 153.52 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.407 -0.808 . . . . 0.0 109.918 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.431 ' O ' ' C ' ' A' ' 85' ' ' GLY . 3.4 t80 -68.58 85.58 0.3 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.879 . . . . 0.0 109.758 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 86' ' ' GLU . . . 42.13 34.44 1.48 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.527 ' HG3' ' CB ' ' A' ' 83' ' ' ALA . 52.4 mt-10 -62.02 -133.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.187 -1.184 . . . . 0.0 109.062 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.4 mt -135.07 53.22 2.0 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.764 -1.21 . . . . 0.0 109.693 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 89' ' ' MET . 66.4 t0 -104.99 73.14 1.04 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.23 -0.919 . . . . 0.0 109.344 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.471 ' O ' ' CB ' ' A' ' 93' ' ' SER . 0.0 OUTLIER 68.41 29.04 5.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.4 -179.846 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.466 HD11 ' O ' ' A' ' 86' ' ' GLU . 6.5 mt -90.06 -48.33 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.319 -0.863 . . . . 0.0 109.423 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.81 -38.31 21.73 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.286 -0.884 . . . . 0.0 109.492 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.46 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 0.6 OUTLIER -90.03 -38.03 13.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.936 . . . . 0.0 109.514 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.473 ' O ' ' CB ' ' A' ' 98' ' ' ALA . 14.2 m -63.19 -12.15 26.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.254 -0.904 . . . . 0.0 109.554 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -71.96 -71.6 0.27 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.275 -0.89 . . . . 0.0 109.464 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -66.45 -13.22 60.48 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.35 -0.844 . . . . 0.0 109.422 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.504 ' HB3' ' NZ ' ' A' ' 70' ' ' LYS . 32.9 mt -74.55 -50.57 17.54 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.185 -0.947 . . . . 0.0 109.38 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 172.99 45.78 0.05 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.473 ' CB ' ' O ' ' A' ' 93' ' ' SER . . . -132.06 146.38 52.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -1.156 . . . . 0.0 109.411 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.464 HD13 ' HA ' ' A' ' 77' ' ' ARG . 0.4 OUTLIER -128.04 -60.32 1.15 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.336 -0.852 . . . . 0.0 109.489 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.574 HG22 ' CE2' ' A' ' 102' ' ' PHE . 17.1 m -102.97 148.96 25.02 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.263 -0.898 . . . . 0.0 109.571 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.52 ' NE2' HG21 ' A' ' 82' ' ' THR . 2.8 t-160 -144.84 93.77 2.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.892 . . . . 0.0 109.347 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.574 ' CE2' HG22 ' A' ' 100' ' ' THR . 18.7 m-30 -111.9 161.61 16.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.896 . . . . 0.0 109.587 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 82' ' ' THR . . . -113.51 -159.99 0.71 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.309 -0.87 . . . . 0.0 109.443 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.508 ' CG ' ' HA ' ' A' ' 105' ' ' PRO . 3.7 mttt -100.37 152.55 37.86 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.232 -0.918 . . . . 0.0 109.498 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.583 ' O ' ' CG ' ' A' ' 106' ' ' PHE . 37.1 Cg_endo -81.62 28.15 4.52 Favored 'Cis proline' 0 C--N 1.309 -1.506 0 C-N-CA 123.371 -1.512 . . . . 0.0 111.126 -0.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.583 ' CG ' ' O ' ' A' ' 105' ' ' PRO . 52.1 p90 41.46 -164.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.37 -0.831 . . . . 0.0 109.844 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.455 ' O ' HG12 ' A' ' 111' ' ' ILE . 30.5 t0 -150.1 118.7 6.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.87 . . . . 0.0 109.461 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.42 ' O ' ' HG2' ' A' ' 112' ' ' ARG . 12.7 mm -54.12 -19.73 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.25 -0.906 . . . . 0.0 109.393 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -75.75 -57.27 3.98 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.192 -0.942 . . . . 0.0 109.427 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -59.66 -24.18 63.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.179 -0.951 . . . . 0.0 109.491 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.455 HG12 ' O ' ' A' ' 107' ' ' ASP . 22.9 mm -74.12 -56.29 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.305 -0.872 . . . . 0.0 109.46 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 108' ' ' ILE . 2.5 ptt180 -60.04 -23.62 63.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.202 -0.936 . . . . 0.0 109.533 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -76.1 -63.25 1.36 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.32 -0.863 . . . . 0.0 109.482 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.507 ' O ' ' CD2' ' A' ' 118' ' ' TYR . . . -51.07 -31.87 20.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.244 -0.91 . . . . 0.0 109.381 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.518 ' CG2' HD23 ' A' ' 50' ' ' LEU . 72.6 t -75.44 -36.32 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.232 -0.918 . . . . 0.0 109.411 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.407 ' HE2' ' HB3' ' A' ' 116' ' ' LYS . 0.4 OUTLIER -69.44 -21.1 63.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.233 -0.917 . . . . 0.0 109.465 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -89.48 -40.06 12.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.211 -0.931 . . . . 0.0 109.52 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.507 ' CD2' ' O ' ' A' ' 114' ' ' ALA . 26.2 m-85 -76.13 -63.3 1.35 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 0.0 109.487 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.477 ' C ' ' CD2' ' A' ' 119' ' ' LEU . 4.1 tt -90.19 112.42 52.46 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 0.0 109.445 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.465 ' O ' HD21 ' A' ' 121' ' ' LEU . 35.9 Cg_endo -78.07 151.51 27.18 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.429 2.086 . . . . 0.0 110.402 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.629 ' CD2' ' CE2' ' A' ' 28' ' ' TYR . 0.4 OUTLIER -136.25 22.18 3.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.275 -0.891 . . . . 0.0 109.491 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -82.45 160.38 22.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.27 -0.894 . . . . 0.0 109.477 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.6 m -139.56 137.62 35.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.911 . . . . 0.0 109.464 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.526 -179.982 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ttt . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 59.08 103.81 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.181 -0.949 . . . . 0.0 109.447 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.446 ' HB2' ' HE2' ' A' ' 5' ' ' LYS . 3.3 p30 -177.9 141.7 0.27 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.243 -0.91 . . . . 0.0 109.491 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -138.93 76.06 1.55 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.259 -0.9 . . . . 0.0 109.5 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.542 ' CD ' ' N ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -136.76 154.51 50.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.244 -0.91 . . . . 0.0 109.51 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.458 HG21 ' O ' ' A' ' 50' ' ' LEU . 4.3 mt -150.09 159.54 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.228 -0.92 . . . . 0.0 109.379 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.514 ' CD2' ' HB2' ' A' ' 31' ' ' PHE . 2.8 tm? -132.22 107.62 8.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.256 -0.903 . . . . 0.0 109.382 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.447 HD12 ' HB3' ' A' ' 19' ' ' LEU . 4.2 mt -94.81 110.51 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 0.0 109.451 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.511 HG23 ' CB ' ' A' ' 33' ' ' ALA . 61.1 t -95.46 109.49 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.231 -0.918 . . . . 0.0 109.44 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.514 ' CB ' ' HD2' ' A' ' 16' ' ' ARG . 4.2 m-20 -148.96 110.39 4.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.253 -0.904 . . . . 0.0 109.469 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.458 ' OD2' ' HD2' ' A' ' 58' ' ' PRO . 5.5 p-10 -76.38 -33.55 58.89 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 109.43 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.448 ' O ' ' O ' ' A' ' 13' ' ' TYR . 27.1 tt0 -78.77 104.24 9.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.25 -0.906 . . . . 0.0 109.5 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.638 ' CE2' ' CD1' ' A' ' 17' ' ' ILE . 2.6 t80 -44.56 168.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.205 -0.935 . . . . 0.0 109.509 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.77 -66.16 0.33 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.524 HG22 ' CD1' ' A' ' 19' ' ' LEU . 2.3 mt -63.4 -63.41 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.301 -1.117 . . . . 0.0 109.275 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.526 ' HB2' ' CG ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -42.23 -26.69 0.11 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.354 -0.841 . . . . 0.0 109.95 -179.804 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.638 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 20.6 mt -79.22 -59.63 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.106 -0.996 . . . . 0.0 109.761 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.523 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 11.0 mp -53.28 -57.13 11.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.925 . . . . 0.0 109.721 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.524 ' CD1' HG22 ' A' ' 15' ' ' ILE . 7.3 mp -57.18 -22.51 41.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.235 -0.915 . . . . 0.0 109.578 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 23.6 t30 -75.84 -72.38 0.32 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.308 -0.87 . . . . 0.0 109.549 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -52.91 -19.96 2.97 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.343 -0.848 . . . . 0.0 109.642 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.527 ' CG1' ' HD3' ' A' ' 112' ' ' ARG . 77.2 t -77.85 -58.77 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.187 -0.945 . . . . 0.0 109.39 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.527 ' CB ' HG22 ' A' ' 30' ' ' THR . 13.8 m-85 -66.68 -11.18 53.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.192 -0.943 . . . . 0.0 109.349 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.446 ' OD1' ' O ' ' A' ' 20' ' ' ASN . 21.7 m120 -73.31 -61.2 1.91 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.282 -0.886 . . . . 0.0 109.404 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -18.78 63.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.236 -0.915 . . . . 0.0 109.265 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.517 ' HB3' ' CD2' ' A' ' 28' ' ' TYR . 2.7 mt-10 -75.52 -34.18 60.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.299 -0.876 . . . . 0.0 109.41 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.2 46.51 0.75 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.561 ' CZ ' HD13 ' A' ' 121' ' ' LEU . 94.1 m-85 -139.0 134.56 33.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.269 -1.136 . . . . 0.0 109.529 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -91.01 83.63 5.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.099 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.527 HG22 ' CB ' ' A' ' 23' ' ' PHE . 5.7 p -89.74 150.56 22.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.939 . . . . 0.0 109.616 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.558 ' CZ ' ' OE2' ' A' ' 46' ' ' GLU . 17.8 m-85 -111.95 -168.38 1.31 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.302 -0.874 . . . . 0.0 109.264 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.526 ' CG ' ' HB2' ' A' ' 16' ' ' ARG . 0.6 OUTLIER -132.26 150.05 52.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.178 -0.951 . . . . 0.0 109.687 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.511 ' CB ' HG23 ' A' ' 9' ' ' VAL . . . -146.38 -174.4 4.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.229 -0.919 . . . . 0.0 109.349 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.441 ' O ' ' HE2' ' A' ' 60' ' ' MET . . . -175.98 -57.02 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.176 -0.952 . . . . 0.0 109.619 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -81.18 0.21 37.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 109.591 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.17 -53.78 4.65 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -45.08 -59.06 2.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -1.148 . . . . 0.0 109.549 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.439 ' O ' HD11 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -51.96 -38.17 55.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 0.0 109.496 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.45 ' O ' ' HB ' ' A' ' 43' ' ' VAL . . . -60.16 -38.44 83.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.904 . . . . 0.0 109.551 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.534 ' HA ' ' CG1' ' A' ' 43' ' ' VAL . 35.4 mt -76.25 -20.93 56.94 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.391 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.506 ' O ' ' CG ' ' A' ' 45' ' ' LYS . 0.8 OUTLIER -75.38 -40.23 58.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.132 -0.98 . . . . 0.0 109.041 179.705 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.46 HG12 ' CD2' ' A' ' 31' ' ' PHE . 1.8 mp -83.86 -24.76 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.337 -0.852 . . . . 0.0 109.245 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.534 ' CG1' ' HA ' ' A' ' 40' ' ' LEU . 1.5 p -72.63 -38.88 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.265 -0.897 . . . . 0.0 109.236 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.457 ' O ' HG21 ' A' ' 44' ' ' THR . 7.8 m -90.03 -22.86 21.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.361 -0.837 . . . . 0.0 109.438 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.506 ' CG ' ' O ' ' A' ' 41' ' ' ASP . 58.3 mttt -75.32 -54.42 7.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.21 -0.931 . . . . 0.0 109.618 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.558 ' OE2' ' CZ ' ' A' ' 31' ' ' PHE . 0.6 OUTLIER -91.34 -29.83 16.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.9 . . . . 0.0 109.632 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.515 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 0.0 OUTLIER 71.24 61.64 0.43 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.267 -0.896 . . . . 0.0 109.472 -179.975 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.525 ' HA ' ' CG ' ' A' ' 5' ' ' LYS . 35.4 Cg_endo -77.95 155.49 30.22 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.63 2.22 . . . . 0.0 110.462 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 0.3 OUTLIER -101.51 -9.02 21.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.26 -0.9 . . . . 0.0 109.477 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.458 ' O ' HG21 ' A' ' 6' ' ' ILE . 9.1 tp -124.79 116.51 22.41 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.203 -0.935 . . . . 0.0 109.517 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 43.3 t -128.38 118.08 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.176 -0.953 . . . . 0.0 109.472 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.4 HD11 HG21 ' A' ' 8' ' ' ILE . 0.7 OUTLIER -89.95 119.09 30.02 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.196 -0.94 . . . . 0.0 109.45 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.522 ' CD2' ' HG ' ' A' ' 66' ' ' LEU . 1.2 mp -104.1 138.24 40.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.32 -0.863 . . . . 0.0 109.446 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.437 ' O ' HG13 ' A' ' 57' ' ' ILE . 26.3 t70 -114.5 110.81 20.4 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.22 -0.925 . . . . 0.0 109.516 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.441 ' HB2' HG23 ' A' ' 82' ' ' THR . 24.5 mmt -73.34 -2.42 22.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.206 -0.934 . . . . 0.0 109.608 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.463 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 16.2 mmtt -85.35 13.16 6.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.156 -0.965 . . . . 0.0 109.552 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.521 ' CG2' ' CE ' ' A' ' 60' ' ' MET . 40.2 mt -78.48 114.29 41.75 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.27 -0.894 . . . . 0.0 109.417 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 56' ' ' LYS . 35.7 Cg_endo -78.23 107.02 2.24 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.376 2.051 . . . . 0.0 110.375 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 155.13 -44.0 0.56 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.521 ' CE ' ' CG2' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -158.99 163.46 36.44 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.168 -1.196 . . . . 0.0 109.427 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -89.88 144.83 25.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.209 -0.932 . . . . 0.0 109.559 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.458 ' O ' ' HB ' ' A' ' 65' ' ' ILE . . . -87.2 -1.22 84.44 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.511 HD13 ' CB ' ' A' ' 89' ' ' MET . 15.8 mm -52.69 -52.83 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.201 -1.176 . . . . 0.0 109.464 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -61.22 -27.08 68.18 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.186 -0.946 . . . . 0.0 109.365 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.458 ' HB ' ' O ' ' A' ' 62' ' ' GLY . 19.4 mt -63.23 -66.7 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.316 -0.865 . . . . 0.0 109.456 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.522 ' HG ' ' CD2' ' A' ' 53' ' ' LEU . 16.4 mt -46.05 -25.56 0.59 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.91 . . . . 0.0 109.448 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.451 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 2.4 tmtp? -68.49 -60.26 2.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -0.895 . . . . 0.0 109.503 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.48 -29.04 61.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.263 -0.898 . . . . 0.0 109.428 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.436 ' SD ' HG23 ' A' ' 43' ' ' VAL . 3.1 mmt -64.78 -62.53 1.51 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.186 -0.946 . . . . 0.0 109.433 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 16.9 ptpt -51.84 -39.14 58.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.305 -0.872 . . . . 0.0 109.425 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 86.4 t -58.6 -40.6 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.189 -0.945 . . . . 0.0 109.473 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.41 ' O ' ' OD1' ' A' ' 73' ' ' ASP . 15.6 mt -73.77 -25.94 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.211 -0.931 . . . . 0.0 109.433 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.421 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 0.1 OUTLIER -173.22 140.35 0.86 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 109.497 -180.0 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -89.76 -17.9 27.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.272 -0.893 . . . . 0.0 109.441 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -86.0 11.1 12.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.258 -0.901 . . . . 0.0 109.434 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.503 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 2.1 tp -82.39 106.15 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.226 -0.921 . . . . 0.0 109.471 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.524 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 0.4 OUTLIER -77.3 154.16 33.15 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.29 -0.881 . . . . 0.0 109.514 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.511 HG23 ' CD2' ' A' ' 66' ' ' LEU . 43.0 t -147.03 121.65 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 109.545 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.443 HD12 ' HB2' ' A' ' 99' ' ' LEU . 3.6 mm -97.21 122.58 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.229 -0.919 . . . . 0.0 109.444 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.576 ' HB ' ' CG ' ' A' ' 101' ' ' HIS . 0.3 OUTLIER -90.05 126.2 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.279 -0.888 . . . . 0.0 109.293 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.561 ' SD ' ' CZ ' ' A' ' 106' ' ' PHE . 2.2 mtm -101.28 54.38 0.83 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.131 -0.981 . . . . 0.0 109.565 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 102' ' ' PHE . 14.8 t -168.64 56.25 0.05 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.3 -0.875 . . . . 0.0 109.444 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.527 ' HA ' ' CD2' ' A' ' 101' ' ' HIS . . . -57.93 -43.19 86.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.879 . . . . 0.0 109.549 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.77 128.09 34.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.266 -0.896 . . . . 0.0 109.498 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 153.64 -81.17 0.18 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -140.14 165.14 28.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.205 -1.174 . . . . 0.0 109.468 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.541 ' HA ' ' CG2' ' A' ' 90' ' ' ILE . 4.1 mt -127.45 66.35 1.31 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.22 -0.925 . . . . 0.0 109.504 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.534 ' O ' ' CB ' ' A' ' 89' ' ' MET . 0.3 OUTLIER -120.68 101.32 7.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.286 -0.884 . . . . 0.0 109.18 179.881 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.534 ' CB ' ' O ' ' A' ' 88' ' ' ASP . 2.4 tmm? 78.97 -4.46 2.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.373 -0.829 . . . . 0.0 109.297 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.632 ' CD1' ' CE1' ' A' ' 101' ' ' HIS . 0.2 OUTLIER -90.85 -49.64 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.368 -0.832 . . . . 0.0 108.783 179.572 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -58.3 -39.61 79.78 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.32 -0.863 . . . . 0.0 109.615 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -89.81 -16.22 30.64 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 109.547 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 89' ' ' MET . 0.6 OUTLIER -55.85 -19.0 10.11 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.26 -0.9 . . . . 0.0 109.51 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.2 mmmt -48.43 -61.32 2.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.261 -0.899 . . . . 0.0 109.495 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.408 ' O ' ' C ' ' A' ' 96' ' ' LEU . 4.9 mt-10 -65.42 -41.88 93.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.256 -0.903 . . . . 0.0 109.509 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.501 ' CD1' ' SD ' ' A' ' 89' ' ' MET . 81.6 mt -44.19 -38.86 4.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.226 -0.921 . . . . 0.0 109.457 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 143.61 40.08 0.06 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -102.91 99.06 8.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.222 -1.163 . . . . 0.0 109.486 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.561 HD21 ' CD1' ' A' ' 118' ' ' TYR . 16.9 mt -51.72 -68.03 0.2 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.255 -0.903 . . . . 0.0 109.498 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.526 ' CG2' ' N ' ' A' ' 101' ' ' HIS . 17.1 m -135.81 165.84 24.69 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.207 -0.933 . . . . 0.0 109.551 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.632 ' CE1' ' CD1' ' A' ' 90' ' ' ILE . 4.1 t60 -130.26 84.27 2.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.367 -0.833 . . . . 0.0 109.359 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.568 ' CE1' ' CG ' ' A' ' 110' ' ' GLU . 9.3 m-85 -70.28 157.19 38.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.215 -0.928 . . . . 0.0 109.485 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.512 ' HB1' ' CB ' ' A' ' 83' ' ' ALA . . . -132.46 -148.67 0.35 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 0.0 109.476 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.47 ' HB2' ' HA ' ' A' ' 105' ' ' PRO . 2.0 pttp -96.78 157.26 35.47 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.901 . . . . 0.0 109.494 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.47 ' HA ' ' HB2' ' A' ' 104' ' ' LYS . 36.3 Cg_endo -79.76 11.2 23.9 Favored 'Cis proline' 0 C--N 1.309 -1.518 0 C-N-CA 123.285 -1.548 . . . . 0.0 110.802 -0.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.631 ' CE1' ' CD1' ' A' ' 111' ' ' ILE . 11.4 t80 70.93 96.59 0.07 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.212 -0.93 . . . . 0.0 109.437 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.462 ' O ' HG12 ' A' ' 111' ' ' ILE . 21.3 t0 -89.88 118.32 29.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 0.0 109.385 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.44 ' O ' ' HG3' ' A' ' 112' ' ' ARG . 13.4 mm -51.24 -39.1 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.168 -0.958 . . . . 0.0 109.339 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.433 ' HB2' ' OD2' ' A' ' 107' ' ' ASP . 3.2 m-20 -63.05 -37.33 86.75 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.288 -0.882 . . . . 0.0 109.373 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.568 ' CG ' ' CE1' ' A' ' 102' ' ' PHE . 3.0 tp10 -69.08 -33.5 73.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.292 -0.88 . . . . 0.0 109.257 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.631 ' CD1' ' CE1' ' A' ' 106' ' ' PHE . 10.5 mm -66.35 -54.96 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.3 -0.875 . . . . 0.0 109.272 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.527 ' HD3' ' CG1' ' A' ' 22' ' ' VAL . 3.9 mtm180 -57.46 -33.6 68.13 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.311 -0.868 . . . . 0.0 109.486 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -62.66 -62.09 1.97 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.234 -0.916 . . . . 0.0 109.768 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.425 ' O ' ' C ' ' A' ' 115' ' ' VAL . . . -58.56 -62.99 1.45 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.166 -0.958 . . . . 0.0 109.734 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.425 ' C ' ' O ' ' A' ' 114' ' ' ALA . 55.8 t -42.77 -39.09 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.357 -0.839 . . . . 0.0 109.867 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 1.4 mttt -63.48 -58.95 5.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.218 -0.926 . . . . 0.0 109.668 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -49.64 -60.03 3.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.2 -0.938 . . . . 0.0 109.603 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.561 ' CD1' HD21 ' A' ' 99' ' ' LEU . 65.6 m-85 -54.81 -73.91 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.237 -0.915 . . . . 0.0 109.601 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.8 tt -90.15 112.47 52.66 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.926 . . . . 0.0 109.538 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 118' ' ' TYR . 35.6 Cg_endo -78.44 -159.39 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.389 2.059 . . . . 0.0 110.27 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.561 HD13 ' CZ ' ' A' ' 28' ' ' TYR . 1.3 mt -153.11 -177.97 6.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.939 . . . . 0.0 109.439 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.428 ' O ' ' OG ' ' A' ' 123' ' ' SER . 0.0 OUTLIER -59.48 -75.64 0.05 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.146 -0.971 . . . . 0.0 109.438 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 122' ' ' LYS . 3.1 p 64.93 27.36 12.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.34 -0.85 . . . . 0.0 109.523 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 48.8 t30 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.49 -179.933 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 ttp . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.264 0.555 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.454 ' O ' ' OD1' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -166.84 131.38 2.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.229 -0.92 . . . . 0.0 109.464 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.454 ' OD1' ' O ' ' A' ' 2' ' ' MET . 5.3 m120 -149.05 106.5 3.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.886 . . . . 0.0 109.452 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -128.96 78.12 1.83 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.234 -0.916 . . . . 0.0 109.474 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.458 ' HB2' ' HA ' ' A' ' 48' ' ' PRO . 10.6 mttm -105.58 135.76 46.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.298 -0.876 . . . . 0.0 109.497 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.533 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 68.9 mt -150.12 146.17 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.252 -0.905 . . . . 0.0 109.468 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.57 ' CD1' ' CG2' ' A' ' 42' ' ' ILE . 0.9 OUTLIER -124.8 133.07 53.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.263 -0.898 . . . . 0.0 109.405 179.905 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.487 HD11 HG22 ' A' ' 8' ' ' ILE . 14.1 mt -102.71 113.72 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.184 -0.948 . . . . 0.0 109.503 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.46 HG23 HD22 ' A' ' 7' ' ' LEU . 13.7 t -105.77 94.48 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.17 -0.957 . . . . 0.0 109.444 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.516 ' O ' ' CD ' ' A' ' 16' ' ' ARG . 31.2 t70 -145.86 116.96 7.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.911 . . . . 0.0 109.473 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.524 ' OD2' ' CD ' ' A' ' 58' ' ' PRO . 5.8 p-10 -77.98 -46.03 22.21 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -0.902 . . . . 0.0 109.482 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.477 ' CG ' ' O ' ' A' ' 12' ' ' GLN . 3.2 pt20 -56.27 101.09 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.292 -0.88 . . . . 0.0 109.474 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.635 ' CE2' ' CD1' ' A' ' 17' ' ' ILE . 2.7 t80 -45.83 141.94 2.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.307 -0.871 . . . . 0.0 109.499 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 132.25 -53.08 0.81 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.414 ' O ' ' C ' ' A' ' 16' ' ' ARG . 2.7 mp -75.34 -53.41 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.255 -1.144 . . . . 0.0 109.445 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.516 ' CD ' ' O ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -43.89 -26.53 0.27 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.258 -0.901 . . . . 0.0 109.614 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.635 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 2.3 mt -90.12 -60.39 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.211 -0.93 . . . . 0.0 109.886 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.457 ' O ' HG21 ' A' ' 22' ' ' VAL . 0.9 OUTLIER -50.4 -60.55 2.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.149 -0.969 . . . . 0.0 109.892 -179.697 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.572 ' HG ' ' CE2' ' A' ' 23' ' ' PHE . 1.5 tp -56.3 -24.23 42.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.304 -0.872 . . . . 0.0 109.873 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.469 ' HB3' ' O ' ' A' ' 17' ' ' ILE . 25.4 t30 -71.85 -69.83 0.37 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.123 -0.986 . . . . 0.0 109.81 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.465 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 0.7 OUTLIER -47.6 -41.47 21.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.29 -0.881 . . . . 0.0 109.706 -179.787 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.513 ' CG2' HG22 ' A' ' 108' ' ' ILE . 40.4 t -56.33 -60.52 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.244 -0.91 . . . . 0.0 109.606 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.573 ' CD2' HG23 ' A' ' 30' ' ' THR . 22.0 m-85 -69.41 -6.19 28.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 0.0 109.612 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 0.7 OUTLIER -77.39 -54.83 5.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.21 -0.931 . . . . 0.0 109.286 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt -78.31 -12.2 59.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.317 -0.865 . . . . 0.0 109.289 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.42 ' HB2' ' HA ' ' A' ' 23' ' ' PHE . 3.1 mm-40 -77.09 -43.58 33.77 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.249 -0.907 . . . . 0.0 109.461 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.69 50.67 0.32 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.635 ' CZ ' ' CD1' ' A' ' 121' ' ' LEU . 98.7 m-85 -140.81 140.47 34.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.229 -1.159 . . . . 0.0 109.527 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -90.02 82.87 6.08 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.229 -0.92 . . . . 0.0 109.291 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.573 HG23 ' CD2' ' A' ' 23' ' ' PHE . 5.8 p -89.91 153.8 20.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 109.55 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.533 ' CD2' ' O ' ' A' ' 6' ' ' ILE . 7.9 m-85 -120.99 -158.25 0.75 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -0.893 . . . . 0.0 109.338 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.463 ' HG2' ' CG ' ' A' ' 16' ' ' ARG . 73.9 mt-30 -144.05 157.86 44.07 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.208 -0.932 . . . . 0.0 109.663 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -170.99 161.34 6.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.876 . . . . 0.0 109.235 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.437 ' O ' HD11 ' A' ' 57' ' ' ILE . . . -127.55 -57.9 1.27 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.197 -0.939 . . . . 0.0 109.713 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.521 ' OD1' ' CB ' ' A' ' 37' ' ' LEU . 4.1 p30 -90.4 136.47 33.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.209 -0.932 . . . . 0.0 109.483 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.522 ' HA3' ' CD1' ' A' ' 65' ' ' ILE . . . -45.1 -29.11 2.13 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.521 ' CB ' ' OD1' ' A' ' 35' ' ' ASN . 0.2 OUTLIER -47.7 -53.61 14.55 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.326 -1.102 . . . . 0.0 109.382 179.853 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.459 ' O ' ' C ' ' A' ' 39' ' ' ALA . 11.4 mt-30 -62.3 -51.07 69.16 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.245 -0.909 . . . . 0.0 109.393 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.523 ' O ' ' CG2' ' A' ' 43' ' ' VAL . . . -39.92 -37.99 0.64 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.443 -0.786 . . . . 0.0 109.804 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.46 ' O ' ' OG1' ' A' ' 44' ' ' THR . 12.7 mt -77.5 -45.05 26.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.0 109.61 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -56.26 -62.01 2.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.206 -0.934 . . . . 0.0 109.626 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.57 ' CG2' ' CD1' ' A' ' 7' ' ' LEU . 10.4 mt -56.67 -51.72 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.894 . . . . 0.0 109.753 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.526 ' HA ' ' CD ' ' A' ' 48' ' ' PRO . 45.0 t -54.06 -22.67 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.166 -0.959 . . . . 0.0 109.704 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.46 ' OG1' ' O ' ' A' ' 40' ' ' LEU . 23.0 m -89.95 -28.39 19.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.182 -0.949 . . . . 0.0 109.837 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.425 ' C ' ' HG2' ' A' ' 46' ' ' GLU . 4.1 mmmt -90.2 -6.59 55.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.208 -0.932 . . . . 0.0 109.59 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.528 ' OE1' ' CZ ' ' A' ' 31' ' ' PHE . 2.5 mt-10 -137.26 -36.2 0.66 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.242 -0.911 . . . . 0.0 109.451 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.439 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 75.3 mtm-85 58.56 65.01 3.2 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.321 -0.862 . . . . 0.0 109.462 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.526 ' CD ' ' HA ' ' A' ' 43' ' ' VAL . 35.2 Cg_endo -77.02 159.4 34.0 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.578 2.185 . . . . 0.0 110.437 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 89.1 m-20 -96.3 -5.45 40.09 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.274 -0.891 . . . . 0.0 109.656 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.458 HD21 HD12 ' A' ' 6' ' ' ILE . 5.2 tp -129.39 123.55 31.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.169 -0.957 . . . . 0.0 109.593 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.524 ' CG1' ' HE2' ' A' ' 69' ' ' MET . 22.0 t -132.09 118.81 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.351 -0.843 . . . . 0.0 109.537 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.475 HD23 ' CD2' ' A' ' 19' ' ' LEU . 1.2 mp -90.05 113.35 25.04 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -0.912 . . . . 0.0 109.42 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.516 ' CD2' ' HG ' ' A' ' 66' ' ' LEU . 1.2 mp -104.79 130.88 52.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.375 -0.828 . . . . 0.0 109.585 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.476 ' HA ' ' HG3' ' A' ' 81' ' ' MET . 32.8 t70 -108.58 105.72 15.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.288 -0.882 . . . . 0.0 109.244 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.517 ' HG3' ' CG2' ' A' ' 82' ' ' THR . 7.5 mtp -71.64 -4.12 25.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -0.916 . . . . 0.0 109.534 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.403 ' HE3' ' O ' ' A' ' 81' ' ' MET . 8.1 mttp -86.07 15.08 5.38 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.116 -0.99 . . . . 0.0 109.508 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.462 ' HA ' ' OD1' ' A' ' 11' ' ' ASP . 53.8 mt -74.13 132.65 79.26 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.188 -0.945 . . . . 0.0 109.41 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.524 ' CD ' ' OD2' ' A' ' 11' ' ' ASP . 36.7 Cg_endo -80.54 41.9 1.23 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.624 2.216 . . . . 0.0 110.7 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -133.57 -56.72 0.07 OUTLIER Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.505 ' N ' ' SD ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -156.96 -178.54 7.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.311 -1.111 . . . . 0.0 109.532 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -90.08 142.36 27.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.266 -0.896 . . . . 0.0 109.505 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.456 ' HA2' HG13 ' A' ' 65' ' ' ILE . . . -77.63 -9.42 86.89 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.432 HD13 ' HB2' ' A' ' 89' ' ' MET . 17.6 mm -51.11 -55.72 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -1.16 . . . . 0.0 109.394 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -55.84 -39.24 71.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.259 -0.9 . . . . 0.0 109.479 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.522 ' CD1' ' HA3' ' A' ' 36' ' ' GLY . 13.8 mt -53.4 -69.46 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.201 -0.937 . . . . 0.0 109.463 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.516 ' HG ' ' CD2' ' A' ' 53' ' ' LEU . 93.1 mt -43.62 -48.37 7.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.158 -0.963 . . . . 0.0 109.68 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.462 ' O ' HG22 ' A' ' 71' ' ' VAL . 2.1 mmtt -43.17 -58.11 2.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 109.704 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.451 ' O ' HG13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -61.6 -32.59 72.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.171 -0.956 . . . . 0.0 109.588 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.524 ' HE2' ' CG1' ' A' ' 51' ' ' VAL . 78.7 mtp -66.0 -23.66 66.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.321 -0.862 . . . . 0.0 109.591 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -84.0 -41.98 16.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.225 -0.922 . . . . 0.0 108.942 179.904 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 67' ' ' LYS . 2.5 t -62.09 -31.99 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.486 -0.759 . . . . 0.0 109.522 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 68' ' ' ARG . 11.3 mt -84.01 -39.86 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.232 -0.918 . . . . 0.0 109.447 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.448 ' O ' HG23 ' A' ' 76' ' ' ILE . 0.5 OUTLIER -143.13 132.75 23.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.289 -0.882 . . . . 0.0 109.379 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -90.01 -23.58 21.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.272 -0.892 . . . . 0.0 109.527 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -99.41 47.97 0.95 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.289 -0.882 . . . . 0.0 109.467 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.45 HG21 ' O ' ' A' ' 76' ' ' ILE . 1.1 tt -107.68 134.54 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.262 -0.899 . . . . 0.0 109.478 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.528 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 0.5 OUTLIER -104.03 141.2 36.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.241 -0.912 . . . . 0.0 109.466 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.516 HG13 ' CD2' ' A' ' 66' ' ' LEU . 82.4 t -139.37 118.76 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -0.906 . . . . 0.0 109.557 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.51 HD11 ' CG2' ' A' ' 100' ' ' THR . 5.1 mm -89.96 122.4 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.287 -0.883 . . . . 0.0 109.162 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.579 ' HB ' ' CG ' ' A' ' 101' ' ' HIS . 0.1 OUTLIER -89.87 143.29 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.174 -0.954 . . . . 0.0 109.375 -179.876 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.476 ' HG3' ' HA ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -117.68 71.17 0.81 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.185 -0.947 . . . . 0.0 109.255 179.79 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.517 ' CG2' ' HG3' ' A' ' 55' ' ' MET . 13.4 t -176.15 31.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.346 -0.846 . . . . 0.0 109.536 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.618 ' N ' ' CD2' ' A' ' 101' ' ' HIS . . . -44.67 -77.05 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.206 -0.934 . . . . 0.0 109.499 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.416 ' C ' ' O ' ' A' ' 83' ' ' ALA . 0.4 OUTLIER -44.14 107.07 0.08 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.272 -0.893 . . . . 0.0 109.462 -179.982 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 164.46 -107.76 0.31 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.437 ' O ' HG22 ' A' ' 90' ' ' ILE . 0.9 OUTLIER -115.86 137.72 51.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.25 -1.147 . . . . 0.0 109.5 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.541 ' HA ' ' CG2' ' A' ' 90' ' ' ILE . 1.2 mp -108.28 59.52 0.61 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.194 -0.941 . . . . 0.0 109.503 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -100.77 -92.83 0.29 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.881 . . . . 0.0 109.657 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.511 ' O ' ' CB ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -68.26 -7.53 31.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 0.0 109.547 179.869 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.568 HD11 ' CE1' ' A' ' 101' ' ' HIS . 0.4 OUTLIER -86.96 -42.43 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.19 -0.944 . . . . 0.0 109.066 179.858 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -55.68 -40.37 72.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 0.0 109.493 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.433 ' O ' ' C ' ' A' ' 93' ' ' SER . 29.9 mm-40 -90.06 -38.48 13.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.209 -0.932 . . . . 0.0 109.649 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.511 ' CB ' ' O ' ' A' ' 89' ' ' MET . 1.2 m -43.34 -39.36 3.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.306 -0.871 . . . . 0.0 109.551 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 93' ' ' SER . 6.6 mttp -44.3 -55.62 4.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 109.387 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -58.71 -43.56 90.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.243 -0.911 . . . . 0.0 109.463 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 93' ' ' SER . 79.0 mt -47.2 -63.87 0.93 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.325 -0.859 . . . . 0.0 109.474 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 179.93 36.64 0.07 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -99.85 99.66 10.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -1.15 . . . . 0.0 109.503 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.563 HD11 ' CG ' ' A' ' 118' ' ' TYR . 16.7 mt -48.87 -62.74 1.36 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.323 -0.861 . . . . 0.0 109.516 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.51 ' CG2' HD11 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -144.39 176.42 9.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.154 -0.966 . . . . 0.0 109.577 -179.925 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.618 ' CD2' ' N ' ' A' ' 83' ' ' ALA . 3.5 t-160 -141.51 94.01 2.64 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.343 -0.848 . . . . 0.0 109.235 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.556 ' CD2' HD12 ' A' ' 111' ' ' ILE . 7.9 m-85 -82.12 160.9 23.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.265 -0.897 . . . . 0.0 109.696 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.51 ' HB1' ' CB ' ' A' ' 83' ' ' ALA . . . -140.43 -148.58 0.25 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.236 -0.915 . . . . 0.0 109.281 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.55 145.48 30.54 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.164 -0.96 . . . . 0.0 109.302 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.0 151.96 91.4 Favored 'Cis proline' 0 C--N 1.309 -1.551 0 C-N-CA 123.289 -1.546 . . . . 0.0 110.437 -0.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.619 ' CZ ' ' CD1' ' A' ' 111' ' ' ILE . 0.5 OUTLIER -83.05 103.89 12.84 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -0.893 . . . . 0.0 109.457 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.46 ' O ' HG12 ' A' ' 111' ' ' ILE . 48.2 t0 -89.84 103.0 15.69 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.106 -0.996 . . . . 0.0 109.401 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.513 HG22 ' CG2' ' A' ' 22' ' ' VAL . 19.8 mm -43.31 -26.95 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.31 -0.869 . . . . 0.0 109.698 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.44 -47.96 44.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.897 . . . . 0.0 109.576 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.457 ' HG3' ' OD2' ' A' ' 107' ' ' ASP . 41.5 mt-10 -66.91 -22.94 65.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 109.332 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.619 ' CD1' ' CZ ' ' A' ' 106' ' ' PHE . 16.2 mm -75.43 -56.4 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.34 -0.85 . . . . 0.0 109.293 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 108' ' ' ILE . 0.6 OUTLIER -63.83 -22.17 66.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.269 -0.894 . . . . 0.0 109.477 179.948 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -73.84 -51.46 16.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.94 . . . . 0.0 109.497 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.404 ' HB1' ' CZ ' ' A' ' 102' ' ' PHE . . . -63.35 -55.77 21.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.3 -0.875 . . . . 0.0 109.458 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.0 t -50.17 -52.28 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 109.537 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 6.5 mmmt -54.76 -39.56 68.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.19 -0.944 . . . . 0.0 109.48 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 7.0 tttm -58.22 -40.97 83.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.445 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.563 ' CG ' HD11 ' A' ' 99' ' ' LEU . 56.3 m-85 -81.89 -73.32 0.39 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.887 . . . . 0.0 109.476 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.443 HD13 ' HD2' ' A' ' 120' ' ' PRO . 39.7 tp -78.57 114.43 43.21 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.299 -0.875 . . . . 0.0 109.392 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 118' ' ' TYR . 35.9 Cg_endo -78.08 176.1 10.37 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.424 2.083 . . . . 0.0 110.408 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.635 ' CD1' ' CZ ' ' A' ' 28' ' ' TYR . 1.2 mt -140.91 131.23 25.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.313 -0.867 . . . . 0.0 109.516 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.01 -22.68 27.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.219 -0.925 . . . . 0.0 109.519 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 64.09 98.21 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.24 -0.913 . . . . 0.0 109.466 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.429 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.407 ' HG2' ' HG3' ' A' ' 29' ' ' GLN . 10.3 mtm -119.84 -59.67 1.78 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 109.487 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 62.97 31.84 15.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.229 -0.92 . . . . 0.0 109.456 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 2' ' ' MET . 0.2 OUTLIER 178.46 81.92 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.243 -0.91 . . . . 0.0 109.507 179.983 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.469 ' HB2' ' HA ' ' A' ' 48' ' ' PRO . 11.2 mttp -110.22 154.42 23.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.932 . . . . 0.0 109.378 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.463 HG12 ' HB3' ' A' ' 50' ' ' LEU . 70.7 mt -150.11 149.19 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.282 -0.886 . . . . 0.0 109.467 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.528 ' CD2' ' HB2' ' A' ' 31' ' ' PHE . 0.8 OUTLIER -125.98 125.04 42.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.325 -0.859 . . . . 0.0 109.363 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.525 HD12 ' CB ' ' A' ' 19' ' ' LEU . 10.1 mt -103.95 103.12 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.229 -0.92 . . . . 0.0 109.579 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 2.6 t -102.74 84.8 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.319 -0.863 . . . . 0.0 109.333 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.524 ' O ' ' CD1' ' A' ' 57' ' ' ILE . 40.1 p-10 -88.61 -149.44 0.18 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.33 -0.856 . . . . 0.0 109.502 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.517 ' CB ' ' HA ' ' A' ' 57' ' ' ILE . 1.0 OUTLIER -121.92 -31.39 3.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.309 -0.87 . . . . 0.0 109.519 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.45 ' O ' ' OD2' ' A' ' 10' ' ' ASP . 0.8 OUTLIER -146.75 153.95 40.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.27 -0.894 . . . . 0.0 109.483 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.635 ' CZ ' ' CD1' ' A' ' 17' ' ' ILE . 6.3 t80 -43.88 141.77 1.52 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 109.499 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.458 ' O ' HD11 ' A' ' 18' ' ' LEU . . . 137.34 -70.13 0.49 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.522 HG21 ' CD1' ' A' ' 19' ' ' LEU . 2.6 mt -62.86 -29.54 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.18 -1.188 . . . . 0.0 109.382 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.529 ' HB3' ' CG ' ' A' ' 32' ' ' GLN . 3.9 mpp_? -70.69 -21.81 62.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.273 -0.892 . . . . 0.0 109.566 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.635 ' CD1' ' CZ ' ' A' ' 13' ' ' TYR . 6.9 mt -90.14 -57.22 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.217 -0.927 . . . . 0.0 109.661 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.458 HD11 ' O ' ' A' ' 14' ' ' GLY . 7.1 mp -54.7 -58.91 5.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.24 -0.913 . . . . 0.0 109.683 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.525 ' CB ' HD12 ' A' ' 8' ' ' ILE . 6.2 mp -57.52 -23.75 52.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.216 -0.927 . . . . 0.0 109.643 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 16.5 t30 -71.44 -70.63 0.31 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.238 -0.914 . . . . 0.0 109.592 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.464 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 13.5 tp10 -46.92 -43.46 18.98 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -0.91 . . . . 0.0 109.623 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.524 ' CG1' ' HB3' ' A' ' 112' ' ' ARG . 22.7 t -54.33 -60.99 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 109.637 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.588 ' CE1' ' HA ' ' A' ' 112' ' ' ARG . 38.8 m-85 -71.25 -4.18 24.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.209 -0.932 . . . . 0.0 109.718 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.464 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 0.8 OUTLIER -80.02 -44.56 19.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.179 -0.95 . . . . 0.0 109.437 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.4 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 25.1 tttt -80.99 -18.01 48.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.301 -0.874 . . . . 0.0 109.464 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.51 ' HB3' ' CE1' ' A' ' 28' ' ' TYR . 2.2 tt0 -77.72 -37.46 49.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.215 -0.928 . . . . 0.0 109.449 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.522 ' C ' ' CD1' ' A' ' 28' ' ' TYR . . . 115.71 62.79 0.36 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.566 ' CE2' HD22 ' A' ' 121' ' ' LEU . 70.1 m-85 -149.67 134.55 17.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.177 -1.19 . . . . 0.0 109.518 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.407 ' HG3' ' HG2' ' A' ' 2' ' ' MET . 3.1 mm100 -90.35 83.32 5.93 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.249 -0.907 . . . . 0.0 109.113 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.453 ' HA ' ' HB ' ' A' ' 6' ' ' ILE . 5.7 p -89.89 172.13 9.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.318 -0.864 . . . . 0.0 109.637 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.528 ' HB2' ' CD2' ' A' ' 7' ' ' LEU . 19.3 m-85 -134.6 -178.51 5.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.868 . . . . 0.0 109.352 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.529 ' CG ' ' HB3' ' A' ' 16' ' ' ARG . 27.4 mp0 -120.71 149.04 43.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.213 -0.93 . . . . 0.0 109.637 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.468 ' CB ' ' HB1' ' A' ' 39' ' ' ALA . . . -177.37 175.03 1.52 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.393 -0.817 . . . . 0.0 109.474 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 10' ' ' ASP . . . -178.74 -58.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 109.663 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.412 ' C ' ' O ' ' A' ' 34' ' ' ALA . 3.9 p30 -43.6 -27.15 0.27 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.258 -0.901 . . . . 0.0 109.578 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 34' ' ' ALA . . . 97.84 -39.14 2.85 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.575 ' CD1' ' N ' ' A' ' 38' ' ' GLN . 3.8 pp -70.08 -45.52 66.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.213 -1.169 . . . . 0.0 109.609 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.575 ' N ' ' CD1' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -79.39 -30.58 42.52 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.222 -0.924 . . . . 0.0 108.912 179.868 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.468 ' HB1' ' CB ' ' A' ' 33' ' ' ALA . . . -62.41 -48.41 79.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.254 -0.904 . . . . 0.0 108.934 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.458 HD23 HG21 ' A' ' 65' ' ' ILE . 3.7 mt -66.28 -48.59 69.94 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.333 -0.854 . . . . 0.0 109.046 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.419 ' C ' ' O ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -45.41 -40.08 7.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.337 -0.852 . . . . 0.0 109.009 179.659 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.444 ' HA ' ' HG2' ' A' ' 45' ' ' LYS . 5.3 mt -68.04 -48.43 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.334 -0.854 . . . . 0.0 109.19 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.518 ' HA ' ' CD ' ' A' ' 48' ' ' PRO . 46.1 t -55.41 -19.15 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.222 -0.924 . . . . 0.0 109.406 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.8 m -90.23 -35.05 15.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.171 -0.956 . . . . 0.0 109.514 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.444 ' HG2' ' HA ' ' A' ' 42' ' ' ILE . 0.0 OUTLIER -86.32 -5.25 59.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.187 -0.945 . . . . 0.0 109.684 -179.848 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.411 ' OE2' ' CZ ' ' A' ' 31' ' ' PHE . 5.1 mm-40 -134.5 -37.8 0.84 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.144 -0.973 . . . . 0.0 109.309 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.427 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 12.1 mtm-85 57.84 65.89 3.11 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.385 -0.822 . . . . 0.0 109.643 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.518 ' CD ' ' HA ' ' A' ' 43' ' ' VAL . 35.3 Cg_endo -77.3 162.77 30.82 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.541 2.161 . . . . 0.0 110.416 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 6.7 t0 -97.03 -13.38 22.3 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.135 -0.978 . . . . 0.0 109.57 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.519 ' CD2' HG11 ' A' ' 115' ' ' VAL . 7.0 tp -117.92 123.47 45.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.188 -0.945 . . . . 0.0 109.588 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.6 t -129.08 137.62 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -0.924 . . . . 0.0 109.403 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.467 HD11 ' HA ' ' A' ' 8' ' ' ILE . 1.1 mt -112.4 103.68 11.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 109.427 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.464 ' CD2' HD22 ' A' ' 66' ' ' LEU . 1.4 mp -97.47 124.6 41.75 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.304 -0.873 . . . . 0.0 109.582 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.459 ' O ' HG13 ' A' ' 57' ' ' ILE . 21.0 t70 -107.51 120.58 42.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.263 -0.898 . . . . 0.0 109.341 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.51 ' CG ' HG22 ' A' ' 82' ' ' THR . 25.6 mmt -75.15 -13.96 60.51 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.172 -0.955 . . . . 0.0 109.638 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.453 ' O ' ' HB3' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -89.57 46.49 1.37 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.201 -0.937 . . . . 0.0 109.52 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.524 ' CD1' ' O ' ' A' ' 10' ' ' ASP . 81.3 mt -110.99 130.21 23.17 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.177 -0.952 . . . . 0.0 109.457 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.453 ' HD3' ' HB2' ' A' ' 11' ' ' ASP . 36.1 Cg_endo -78.52 130.65 10.01 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.426 2.084 . . . . 0.0 110.372 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 123.81 -50.53 0.85 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.22 163.74 30.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.173 -1.192 . . . . 0.0 109.533 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -89.98 156.81 18.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 109.462 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.461 ' O ' HD22 ' A' ' 53' ' ' LEU . . . -89.92 -6.24 69.87 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.477 ' CD1' ' HG2' ' A' ' 89' ' ' MET . 17.9 mm -54.92 -60.02 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.171 -1.194 . . . . 0.0 109.502 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.8 -38.14 54.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.174 -0.954 . . . . 0.0 109.432 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.458 HG21 HD23 ' A' ' 40' ' ' LEU . 15.9 mt -52.51 -57.11 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -0.889 . . . . 0.0 109.446 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.464 HD22 ' CD2' ' A' ' 53' ' ' LEU . 26.1 mt -46.33 -56.01 6.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.197 -0.939 . . . . 0.0 109.462 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 66' ' ' LEU . 5.3 mttt -44.09 -47.3 8.88 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -0.918 . . . . 0.0 109.431 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.449 ' O ' HG13 ' A' ' 72' ' ' ILE . 5.3 mtt180 -58.08 -43.24 86.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.263 -0.898 . . . . 0.0 109.461 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 4.1 mtt -64.07 -23.38 67.3 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.208 -0.933 . . . . 0.0 109.466 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 66' ' ' LEU . 0.5 OUTLIER -79.16 -33.91 43.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.226 -0.921 . . . . 0.0 109.479 179.95 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.4 t -79.39 -21.39 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.281 -0.887 . . . . 0.0 109.495 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 68' ' ' ARG . 66.2 mt -90.04 -60.07 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.284 -0.885 . . . . 0.0 109.395 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.53 133.09 36.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.234 -0.916 . . . . 0.0 109.492 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -90.04 -11.92 40.05 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.265 -0.897 . . . . 0.0 109.16 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -107.46 51.81 0.73 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.145 -0.972 . . . . 0.0 109.443 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.452 HG22 ' O ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -119.14 113.11 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.267 -0.896 . . . . 0.0 109.545 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.519 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 0.8 OUTLIER -68.59 124.91 24.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.246 -0.909 . . . . 0.0 109.44 179.893 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 17.6 t -134.24 108.22 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 0.0 109.704 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.434 HG21 ' N ' ' A' ' 80' ' ' ILE . 91.0 mt -90.26 148.4 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.218 -0.926 . . . . 0.0 109.36 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.579 ' HB ' ' CE1' ' A' ' 101' ' ' HIS . 0.0 OUTLIER -107.8 161.03 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.176 -0.952 . . . . 0.0 109.426 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.518 ' SD ' ' CZ ' ' A' ' 106' ' ' PHE . 8.6 mtm -137.77 89.69 2.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.239 -0.913 . . . . 0.0 109.725 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.597 ' CG2' ' CE1' ' A' ' 101' ' ' HIS . 14.3 t 177.8 37.2 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.271 -0.893 . . . . 0.0 109.369 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.519 ' CB ' ' HB1' ' A' ' 103' ' ' ALA . . . -89.33 66.21 7.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.308 -0.87 . . . . 0.0 109.556 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.53 ' CG ' ' O ' ' A' ' 84' ' ' TYR . 10.5 t80 -89.92 23.31 2.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.232 -0.917 . . . . 0.0 109.465 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 119.3 -31.53 5.4 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.89 123.61 20.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -1.14 . . . . 0.0 109.522 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.541 ' HA ' ' CG2' ' A' ' 90' ' ' ILE . 6.7 mt -123.76 53.28 1.38 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.261 -0.899 . . . . 0.0 109.462 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -102.19 -90.94 0.34 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.258 -0.902 . . . . 0.0 109.643 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.521 ' O ' ' CB ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -61.73 -13.27 21.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.329 -0.857 . . . . 0.0 109.535 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.541 ' CG2' ' HA ' ' A' ' 87' ' ' LEU . 0.5 OUTLIER -86.62 -41.27 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.237 -0.914 . . . . 0.0 109.219 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.424 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 4.9 tt0 -56.58 -40.93 76.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.269 -0.895 . . . . 0.0 109.558 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.446 ' O ' HD11 ' A' ' 96' ' ' LEU . 8.2 mt-10 -90.08 -37.16 14.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.205 -0.934 . . . . 0.0 109.657 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 89' ' ' MET . 1.1 m -43.73 -43.06 5.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.301 -0.874 . . . . 0.0 109.613 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -43.64 -54.15 5.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.22 -0.925 . . . . 0.0 109.54 -179.915 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 96' ' ' LEU . 1.3 mm-40 -59.94 -48.52 81.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.257 -0.902 . . . . 0.0 109.521 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.516 ' CD1' ' HA ' ' A' ' 93' ' ' SER . 2.1 mp -43.62 -60.81 1.61 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.317 -0.864 . . . . 0.0 109.577 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 172.89 45.46 0.04 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.409 ' O ' ' HD2' ' A' ' 94' ' ' LYS . . . -120.93 110.18 15.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.317 -1.108 . . . . 0.0 109.423 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.519 ' CD1' ' HB3' ' A' ' 77' ' ' ARG . 1.7 mt -57.77 -71.48 0.1 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.203 -0.935 . . . . 0.0 109.534 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.417 HG21 HG22 ' A' ' 79' ' ' ILE . 14.8 t -130.34 162.45 29.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -0.928 . . . . 0.0 109.545 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.597 ' CE1' ' CG2' ' A' ' 82' ' ' THR . 5.1 t-160 -126.66 101.18 6.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.271 -0.893 . . . . 0.0 109.442 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -76.95 -176.1 3.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.319 -0.863 . . . . 0.0 109.519 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.519 ' HB1' ' CB ' ' A' ' 83' ' ' ALA . . . -168.38 172.91 8.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.343 -0.848 . . . . 0.0 109.454 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.503 ' HA ' ' N ' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -64.72 151.12 93.16 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.239 -0.913 . . . . 0.0 109.534 179.884 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.21 118.28 5.67 Favored 'Cis proline' 0 C--N 1.308 -1.574 0 C-N-CA 123.22 -1.575 . . . . 0.0 110.471 -0.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.637 ' CZ ' ' CD1' ' A' ' 111' ' ' ILE . 0.3 OUTLIER -55.18 106.08 0.21 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.213 -0.929 . . . . 0.0 109.406 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.481 ' O ' HG12 ' A' ' 111' ' ' ILE . 46.0 t0 -89.88 110.43 21.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 109.326 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.424 HG21 ' O ' ' A' ' 108' ' ' ILE . 15.5 mm -48.23 -22.44 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.248 -0.908 . . . . 0.0 109.777 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.21 -43.72 50.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.106 -0.997 . . . . 0.0 109.458 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -70.02 -27.11 64.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.297 -0.877 . . . . 0.0 109.514 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.637 ' CD1' ' CZ ' ' A' ' 106' ' ' PHE . 20.2 mm -76.03 -57.57 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.247 -0.908 . . . . 0.0 109.273 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.588 ' HA ' ' CE1' ' A' ' 23' ' ' PHE . 14.0 ptt180 -55.67 -32.26 63.08 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.396 -0.815 . . . . 0.0 109.985 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.507 ' HA ' ' HG2' ' A' ' 116' ' ' LYS . 10.8 m-20 -79.6 -65.86 0.95 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -0.935 . . . . 0.0 110.237 -179.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 113' ' ' ASP . . . -42.53 -35.77 1.16 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.207 -0.933 . . . . 0.0 109.876 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.576 ' HB ' ' CZ ' ' A' ' 23' ' ' PHE . 38.2 t -77.68 -40.43 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.356 -0.84 . . . . 0.0 109.737 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.508 ' HG3' ' N ' ' A' ' 117' ' ' LYS . 0.0 OUTLIER -60.45 -23.87 64.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.131 -0.981 . . . . 0.0 109.332 -179.789 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.508 ' N ' ' HG3' ' A' ' 116' ' ' LYS . 9.5 ttmt -85.03 -51.63 6.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.303 -0.873 . . . . 0.0 109.387 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.454 ' O ' ' HD3' ' A' ' 120' ' ' PRO . 27.1 m-85 -54.03 -64.86 0.69 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.266 -0.896 . . . . 0.0 109.353 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.458 HD13 ' HD2' ' A' ' 120' ' ' PRO . 37.5 tp -90.28 112.34 52.13 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.291 -0.881 . . . . 0.0 109.386 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.458 ' HD2' HD13 ' A' ' 119' ' ' LEU . 35.6 Cg_endo -78.27 -164.3 0.27 Allowed 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.326 2.017 . . . . 0.0 110.393 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.566 HD22 ' CE2' ' A' ' 28' ' ' TYR . 81.2 mt -146.39 -159.47 1.02 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.276 -0.89 . . . . 0.0 109.378 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.2 tttp -43.61 -46.79 7.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.216 -0.928 . . . . 0.0 109.507 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 10.4 t -99.16 155.25 17.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.279 -0.888 . . . . 0.0 109.478 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 117.93 -1.033 . . . . 0.0 109.437 -179.977 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.423 ' O ' ' CG ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER 65.07 147.47 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.896 . . . . 0.0 109.46 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.423 ' CG ' ' O ' ' A' ' 2' ' ' MET . 9.0 m120 -158.41 -148.71 0.2 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.299 -0.875 . . . . 0.0 109.462 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.411 ' CG ' ' C ' ' A' ' 3' ' ' ASN . 1.3 mt-10 68.25 52.74 0.63 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.199 -0.938 . . . . 0.0 109.47 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.508 ' CB ' ' HA ' ' A' ' 48' ' ' PRO . 6.4 mtmt -96.13 139.52 32.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -0.872 . . . . 0.0 109.414 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.574 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 80.5 mt -150.05 155.21 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.253 -0.904 . . . . 0.0 109.473 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.564 ' CD1' ' CG2' ' A' ' 42' ' ' ILE . 0.6 OUTLIER -140.56 127.69 20.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 109.367 179.949 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.458 HD11 ' HB2' ' A' ' 19' ' ' LEU . 9.2 mt -92.35 120.95 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -0.917 . . . . 0.0 109.518 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 t -103.01 102.81 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -0.954 . . . . 0.0 109.464 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.455 ' O ' ' NH1' ' A' ' 16' ' ' ARG . 7.3 t0 -162.17 134.98 5.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.158 -0.964 . . . . 0.0 109.434 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.462 ' OD2' ' HD2' ' A' ' 58' ' ' PRO . 8.6 p-10 -99.21 -34.22 10.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.294 -0.879 . . . . 0.0 109.444 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.417 ' O ' ' C ' ' A' ' 13' ' ' TYR . 0.5 OUTLIER -73.1 107.22 5.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.329 -0.857 . . . . 0.0 109.478 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.569 ' CZ ' HG13 ' A' ' 17' ' ' ILE . 20.5 t80 -43.07 153.06 0.1 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.351 -0.843 . . . . 0.0 109.603 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.403 ' N ' ' CD1' ' A' ' 13' ' ' TYR . . . 124.62 -74.43 0.4 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.515 ' CD1' ' OD2' ' A' ' 54' ' ' ASP . 6.6 mt -63.16 -16.92 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.24 -1.153 . . . . 0.0 109.403 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.455 ' NH1' ' O ' ' A' ' 10' ' ' ASP . 14.6 mmm-85 -77.26 -26.88 52.93 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 109.341 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.569 HG13 ' CZ ' ' A' ' 13' ' ' TYR . 9.6 mm -90.07 -39.78 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -0.903 . . . . 0.0 109.604 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.463 ' O ' HG21 ' A' ' 22' ' ' VAL . 2.1 mp -64.22 -58.22 7.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.25 -0.906 . . . . 0.0 109.613 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.501 ' CD1' HG21 ' A' ' 15' ' ' ILE . 44.0 mt -58.45 -20.95 49.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.282 -0.886 . . . . 0.0 109.482 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.509 ' OD1' ' ND2' ' A' ' 24' ' ' ASN . 27.6 t30 -75.72 -70.71 0.42 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -0.911 . . . . 0.0 109.568 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.46 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 17.8 tt0 -46.41 -42.51 15.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.243 -0.911 . . . . 0.0 109.614 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.463 HG21 ' O ' ' A' ' 18' ' ' LEU . 64.6 t -58.99 -56.01 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.143 -0.973 . . . . 0.0 109.615 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.483 ' CB ' ' CG2' ' A' ' 30' ' ' THR . 29.8 m-85 -78.14 3.05 16.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.178 -0.951 . . . . 0.0 109.707 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.509 ' ND2' ' OD1' ' A' ' 20' ' ' ASN . 0.5 OUTLIER -90.07 -46.73 8.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.229 -0.92 . . . . 0.0 109.486 179.884 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.1 -19.72 36.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.216 -0.928 . . . . 0.0 109.456 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.473 ' HB3' ' CD1' ' A' ' 28' ' ' TYR . 0.5 OUTLIER -78.33 -31.06 48.51 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.3 -0.875 . . . . 0.0 109.456 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.477 ' O ' ' CD1' ' A' ' 28' ' ' TYR . . . 102.5 77.94 1.26 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.559 ' CE1' HD13 ' A' ' 121' ' ' LEU . 91.5 m-85 -155.57 143.12 19.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.151 -1.205 . . . . 0.0 109.511 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -90.04 81.19 6.25 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.174 -0.954 . . . . 0.0 109.382 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.483 ' CG2' ' CB ' ' A' ' 23' ' ' PHE . 6.1 p -89.91 147.27 23.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.248 -0.907 . . . . 0.0 109.534 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.574 ' CD2' ' O ' ' A' ' 6' ' ' ILE . 12.0 m-85 -111.06 -166.19 1.05 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 0.0 109.487 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -143.61 139.98 29.92 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.341 -0.85 . . . . 0.0 109.484 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -153.49 -176.03 5.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.266 -0.896 . . . . 0.0 109.401 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.521 ' O ' ' CD1' ' A' ' 57' ' ' ILE . . . -145.01 -61.88 0.35 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.218 -0.926 . . . . 0.0 109.519 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.468 ' HA ' ' HE2' ' A' ' 60' ' ' MET . 1.6 p-10 -90.22 144.5 25.8 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 0.0 109.427 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.526 ' HA3' ' CD1' ' A' ' 65' ' ' ILE . . . -48.08 -37.66 16.93 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.79 -46.49 64.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -1.172 . . . . 0.0 109.54 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.516 ' NE2' ' HA ' ' A' ' 38' ' ' GLN . 6.7 tp-100 -64.84 -31.8 73.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.91 . . . . 0.0 109.541 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.522 ' O ' ' CG2' ' A' ' 43' ' ' VAL . . . -66.47 -37.32 84.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.923 . . . . 0.0 109.526 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.8 mt -73.75 -38.97 64.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.883 . . . . 0.0 109.564 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.35 -54.75 39.75 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.258 -0.901 . . . . 0.0 109.48 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.564 ' CG2' ' CD1' ' A' ' 7' ' ' LEU . 23.9 mt -62.93 -31.76 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.268 -0.895 . . . . 0.0 109.473 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 39' ' ' ALA . 42.7 t -69.73 -28.13 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 109.365 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.0 m -90.23 -15.75 30.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.278 -0.888 . . . . 0.0 109.512 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.65 -60.48 1.95 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.918 . . . . 0.0 109.73 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 47' ' ' ARG . 1.8 mm-40 -89.78 -30.69 17.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.152 -0.967 . . . . 0.0 109.645 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 13.2 mtm180 65.89 68.41 0.66 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.934 . . . . 0.0 109.577 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.518 ' CD ' ' HA ' ' A' ' 43' ' ' VAL . 35.3 Cg_endo -77.82 -167.01 0.43 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.625 2.217 . . . . 0.0 110.354 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 75' ' ' ASN . 5.0 t70 -142.1 11.16 1.97 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.272 -0.892 . . . . 0.0 109.465 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.439 ' HB3' HG12 ' A' ' 6' ' ' ILE . 4.9 tp -146.79 111.55 5.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -0.926 . . . . 0.0 109.517 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.479 ' CB ' ' HE2' ' A' ' 69' ' ' MET . 3.4 t -109.63 137.66 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.232 -0.917 . . . . 0.0 109.32 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.454 ' HB2' ' HA ' ' A' ' 8' ' ' ILE . 1.1 mt -104.51 97.65 7.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.655 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 1.0 OUTLIER -93.37 119.3 32.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.257 -0.902 . . . . 0.0 109.36 179.825 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.524 ' CA ' ' HE1' ' A' ' 81' ' ' MET . 21.0 t0 -99.28 -4.8 31.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.116 -0.99 . . . . 0.0 109.684 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.523 ' HG3' ' CG2' ' A' ' 82' ' ' THR . 0.0 OUTLIER 53.44 17.14 1.03 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.385 -0.822 . . . . 0.0 109.783 -179.854 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 57' ' ' ILE . 13.2 mmtm -91.03 -39.87 11.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.04 -1.037 . . . . 0.0 109.338 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.522 HG23 ' CE ' ' A' ' 60' ' ' MET . 4.3 mt -42.65 111.64 1.02 Allowed Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.377 -0.827 . . . . 0.0 109.495 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.462 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 35.0 Cg_endo -77.01 165.21 28.66 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.403 2.068 . . . . 0.0 110.387 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.77 -43.03 1.87 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.522 ' CE ' HG23 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -158.18 158.85 35.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.361 -1.082 . . . . 0.0 109.321 179.899 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -88.72 151.97 22.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.114 -0.991 . . . . 0.0 109.464 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.41 ' HA2' HG12 ' A' ' 65' ' ' ILE . . . -90.18 4.35 82.8 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.525 ' HA ' ' CD2' ' A' ' 66' ' ' LEU . 19.4 mm -59.72 -51.03 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.157 -1.202 . . . . 0.0 109.397 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -52.46 -23.67 6.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.19 -0.944 . . . . 0.0 109.401 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.526 ' CD1' ' HA3' ' A' ' 36' ' ' GLY . 8.7 mm -71.55 -65.05 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.32 -0.862 . . . . 0.0 109.449 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.525 ' CD2' ' HA ' ' A' ' 63' ' ' ILE . 1.6 pp -47.51 -28.62 2.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -0.889 . . . . 0.0 109.226 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.508 ' N ' ' HG ' ' A' ' 66' ' ' LEU . 12.8 tptt -67.45 -59.17 3.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 0.0 109.254 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.51 ' O ' ' CD1' ' A' ' 72' ' ' ILE . 10.7 mtt-85 -51.63 -26.67 9.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.264 -0.897 . . . . 0.0 109.319 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.479 ' HE2' ' CB ' ' A' ' 51' ' ' VAL . 1.4 mtt -73.9 -39.62 63.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.303 -0.873 . . . . 0.0 109.458 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.529 ' CD ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -69.34 -24.51 63.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.251 -0.905 . . . . 0.0 109.284 179.944 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.464 HG21 ' O ' ' A' ' 67' ' ' LYS . 2.6 t -90.1 -25.45 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.323 -0.86 . . . . 0.0 109.513 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.51 ' CD1' ' O ' ' A' ' 68' ' ' ARG . 28.2 mt -89.16 -16.92 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.308 -0.87 . . . . 0.0 109.422 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.453 ' O ' HG23 ' A' ' 76' ' ' ILE . 0.4 OUTLIER -170.71 116.59 0.48 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.259 -0.901 . . . . 0.0 109.481 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -74.93 -22.14 58.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.204 -0.935 . . . . 0.0 109.453 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.436 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 69.2 m-80 -89.7 43.09 1.13 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 109.489 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.478 HG13 ' N ' ' A' ' 77' ' ' ARG . 0.5 OUTLIER -117.26 146.8 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.342 -0.849 . . . . 0.0 109.554 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.517 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 46.0 mtt180 -115.27 162.31 17.27 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.299 -0.875 . . . . 0.0 109.516 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.515 ' CG2' ' O ' ' A' ' 77' ' ' ARG . 69.7 t -159.72 111.97 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.261 -0.899 . . . . 0.0 109.549 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.5 ' CG2' HG21 ' A' ' 100' ' ' THR . 9.1 mm -93.32 133.57 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.2 -0.938 . . . . 0.0 109.392 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.57 HG23 ' CE1' ' A' ' 101' ' ' HIS . 0.5 OUTLIER -95.43 171.98 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.19 -0.944 . . . . 0.0 109.395 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.568 ' HB3' ' CE1' ' A' ' 106' ' ' PHE . 39.4 mtm -146.84 62.49 1.19 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.24 -0.913 . . . . 0.0 109.459 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.523 ' CG2' ' HG3' ' A' ' 55' ' ' MET . 11.2 t -170.89 32.51 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 109.488 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.586 ' N ' ' CD2' ' A' ' 101' ' ' HIS . . . -46.48 -76.93 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.261 -0.9 . . . . 0.0 109.464 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -46.79 100.34 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.918 . . . . 0.0 109.431 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 83' ' ' ALA . . . 138.57 -77.27 0.33 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.443 ' OE1' ' SD ' ' A' ' 55' ' ' MET . 2.1 mt-10 -81.12 148.94 29.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -1.153 . . . . 0.0 109.547 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.537 ' HA ' ' CG2' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -160.45 22.53 0.15 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.283 -0.885 . . . . 0.0 109.453 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -94.28 -82.32 0.36 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.129 -0.982 . . . . 0.0 109.123 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.525 ' O ' ' CB ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -83.28 8.22 14.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.217 -0.927 . . . . 0.0 109.146 179.434 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.634 ' CD1' ' CE1' ' A' ' 101' ' ' HIS . 0.1 OUTLIER -90.73 -60.11 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.416 -0.802 . . . . 0.0 108.962 179.758 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.53 ' HB2' ' CD1' ' A' ' 87' ' ' LEU . 21.8 tp60 -53.33 -36.32 61.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.214 -0.929 . . . . 0.0 109.513 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.421 ' O ' HD11 ' A' ' 96' ' ' LEU . 8.0 mt-10 -90.09 -17.21 28.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.199 -0.938 . . . . 0.0 109.481 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.525 ' CB ' ' O ' ' A' ' 89' ' ' MET . 0.4 OUTLIER -57.82 -17.55 16.74 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.289 -0.882 . . . . 0.0 109.504 179.974 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.27 -66.76 0.49 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.268 -0.895 . . . . 0.0 109.507 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -56.77 -32.67 65.85 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.218 -0.926 . . . . 0.0 109.552 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.454 HD11 ' HA ' ' A' ' 93' ' ' SER . 2.1 mt -64.76 -33.33 75.71 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.299 -0.876 . . . . 0.0 109.47 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.529 ' HA3' ' CD ' ' A' ' 70' ' ' LYS . . . 140.7 40.4 0.08 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.466 ' HB3' ' HB3' ' A' ' 93' ' ' SER . . . -112.66 102.64 10.69 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.222 -1.164 . . . . 0.0 109.397 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.568 HD11 ' CG ' ' A' ' 118' ' ' TYR . 17.3 mt -43.74 -83.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.294 -0.879 . . . . 0.0 109.42 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.5 HG21 ' CG2' ' A' ' 79' ' ' ILE . 1.8 t -131.34 171.45 13.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.255 -0.903 . . . . 0.0 109.426 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.634 ' CE1' ' CD1' ' A' ' 90' ' ' ILE . 4.0 t60 -130.41 93.36 3.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.208 -0.933 . . . . 0.0 109.336 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.632 ' CE1' ' CG ' ' A' ' 110' ' ' GLU . 9.0 m-85 -72.72 155.64 39.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -0.918 . . . . 0.0 109.597 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.523 ' HB1' ' CB ' ' A' ' 83' ' ' ALA . . . -124.07 -148.56 0.4 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.313 -0.867 . . . . 0.0 109.467 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.443 ' HB2' ' HA ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -101.32 160.54 26.3 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 109.565 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.498 ' O ' ' CB ' ' A' ' 106' ' ' PHE . 36.4 Cg_endo -79.44 11.64 21.61 Favored 'Cis proline' 0 C--N 1.31 -1.489 0 C-N-CA 123.296 -1.543 . . . . 0.0 110.893 0.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.626 ' CZ ' ' CD1' ' A' ' 111' ' ' ILE . 2.2 t80 76.06 99.4 0.07 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.233 -0.917 . . . . 0.0 109.627 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.465 ' O ' HG12 ' A' ' 111' ' ' ILE . 15.2 t0 -89.96 114.32 26.12 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.221 -0.924 . . . . 0.0 109.309 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.46 HG22 HG23 ' A' ' 22' ' ' VAL . 13.7 mm -46.86 -40.08 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.239 -0.913 . . . . 0.0 109.468 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.449 ' HB2' ' OD2' ' A' ' 107' ' ' ASP . 99.6 m-20 -62.05 -42.12 98.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.902 . . . . 0.0 109.528 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.632 ' CG ' ' CE1' ' A' ' 102' ' ' PHE . 5.5 tp10 -67.23 -28.72 68.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.903 . . . . 0.0 109.513 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.626 ' CD1' ' CZ ' ' A' ' 106' ' ' PHE . 23.5 mm -69.35 -60.2 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.294 -0.879 . . . . 0.0 109.477 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.449 ' HG2' ' O ' ' A' ' 108' ' ' ILE . 0.0 OUTLIER -64.3 -19.91 65.73 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.554 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.427 ' CG ' ' O ' ' A' ' 109' ' ' ASP . 61.1 m-20 -72.47 -53.83 11.02 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.264 -0.897 . . . . 0.0 109.469 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.568 ' O ' ' CD2' ' A' ' 118' ' ' TYR . . . -61.8 -54.38 43.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 0.0 109.461 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.7 t -52.17 -52.35 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.177 -0.952 . . . . 0.0 109.496 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.67 -35.55 55.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.252 -0.905 . . . . 0.0 109.426 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.67 -34.72 74.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.304 -0.872 . . . . 0.0 109.472 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.568 ' CG ' HD11 ' A' ' 99' ' ' LEU . 58.2 m-85 -88.69 -74.19 0.47 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -0.898 . . . . 0.0 109.532 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.3 tt -90.11 112.46 52.58 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.287 -0.883 . . . . 0.0 109.443 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 118' ' ' TYR . 35.3 Cg_endo -77.88 -166.18 0.38 Allowed 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.381 2.054 . . . . 0.0 110.375 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.559 HD13 ' CE1' ' A' ' 28' ' ' TYR . 0.4 OUTLIER -125.33 11.35 8.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 0.0 109.424 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.0 mmmt -143.74 128.72 18.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.144 -0.972 . . . . 0.0 109.435 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 50.45 -149.45 0.28 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.491 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.455 -179.976 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 ttt . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER 45.5 77.56 0.08 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.265 -0.897 . . . . 0.0 109.443 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.45 ' O ' ' HB3' ' A' ' 4' ' ' GLU . 1.0 OUTLIER -170.06 158.82 7.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 109.464 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.573 ' OE2' ' CD2' ' A' ' 28' ' ' TYR . 51.8 tt0 67.39 64.01 0.43 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.169 -0.957 . . . . 0.0 109.487 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.45 ' HB2' ' HA ' ' A' ' 48' ' ' PRO . 3.0 mttt -109.58 156.14 20.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.331 -0.856 . . . . 0.0 109.482 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.452 HG12 ' HB2' ' A' ' 50' ' ' LEU . 63.0 mt -150.05 153.02 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.892 . . . . 0.0 109.453 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.523 HD13 ' CB ' ' A' ' 33' ' ' ALA . 1.8 tm? -132.11 113.97 13.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.289 -0.882 . . . . 0.0 109.482 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.519 HG12 ' CD1' ' A' ' 52' ' ' LEU . 4.4 mt -89.89 105.85 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 109.351 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.527 ' CG2' HD13 ' A' ' 53' ' ' LEU . 2.6 t -89.9 71.72 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.209 -0.932 . . . . 0.0 109.513 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.503 ' O ' ' NH1' ' A' ' 16' ' ' ARG . 1.5 t70 -126.09 146.27 49.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.216 -0.928 . . . . 0.0 109.399 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.482 ' HB3' ' CB ' ' A' ' 34' ' ' ALA . 6.5 p-10 -116.81 -37.07 3.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.315 -0.865 . . . . 0.0 109.473 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.515 ' CG ' ' O ' ' A' ' 12' ' ' GLN . 7.6 pt20 -61.38 102.14 0.21 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.2 -0.937 . . . . 0.0 109.489 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.638 ' CZ ' ' CD1' ' A' ' 17' ' ' ILE . 58.5 t80 -43.28 112.22 0.35 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.875 . . . . 0.0 109.596 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 159.28 -69.32 0.25 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.427 ' HB ' ' OD2' ' A' ' 10' ' ' ASP . 1.7 mp -62.78 -20.83 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.125 -1.221 . . . . 0.0 108.777 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.527 ' O ' ' CB ' ' A' ' 20' ' ' ASN . 7.4 mmm-85 -69.4 -29.98 67.85 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.386 -0.822 . . . . 0.0 109.331 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.638 ' CD1' ' CZ ' ' A' ' 13' ' ' TYR . 3.8 mt -90.34 -37.08 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.362 -0.836 . . . . 0.0 109.765 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.522 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 0.4 OUTLIER -69.14 -58.16 4.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.005 -1.059 . . . . 0.0 109.246 -179.906 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.454 ' HB3' HD12 ' A' ' 8' ' ' ILE . 1.3 tp -62.56 -20.54 64.78 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.304 -0.873 . . . . 0.0 108.663 179.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 16' ' ' ARG . 0.5 OUTLIER -71.44 -73.25 0.19 Allowed 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.455 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 0.3 OUTLIER -52.43 -30.82 31.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.29 -0.881 . . . . 0.0 109.807 -179.589 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 18' ' ' LEU . 96.8 t -64.75 -61.94 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.194 -0.941 . . . . 0.0 109.548 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.57 ' CB ' ' CG2' ' A' ' 30' ' ' THR . 16.4 m-85 -72.5 -3.8 26.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 109.544 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.455 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 0.7 OUTLIER -82.99 -52.61 6.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.146 -0.971 . . . . 0.0 109.38 179.809 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.3 mmtt -73.57 -19.09 60.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.121 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.493 ' HB3' ' CD1' ' A' ' 28' ' ' TYR . 0.4 OUTLIER -71.39 -49.19 44.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.369 -0.832 . . . . 0.0 109.372 179.885 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.465 ' O ' ' OE2' ' A' ' 4' ' ' GLU . . . 124.95 46.62 0.24 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.592 ' CZ ' ' CD1' ' A' ' 121' ' ' LEU . 97.7 m-85 -132.72 146.69 52.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.315 -1.109 . . . . 0.0 109.574 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.0 mm100 -89.87 85.32 6.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.297 -0.877 . . . . 0.0 108.798 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.57 ' CG2' ' CB ' ' A' ' 23' ' ' PHE . 5.6 p -89.63 137.51 32.27 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.239 -0.913 . . . . 0.0 109.791 -179.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.519 ' HB2' ' CD2' ' A' ' 7' ' ' LEU . 11.5 m-85 -109.15 -171.63 1.88 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.379 -0.826 . . . . 0.0 109.238 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -121.71 154.09 37.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.151 -0.968 . . . . 0.0 109.681 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.523 ' CB ' HD13 ' A' ' 7' ' ' LEU . . . -172.48 174.34 3.83 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.272 -0.892 . . . . 0.0 109.355 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.482 ' CB ' ' HB3' ' A' ' 11' ' ' ASP . . . 170.96 -50.38 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.296 -0.878 . . . . 0.0 109.558 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.457 ' OD1' ' HB2' ' A' ' 38' ' ' GLN . 8.3 p-10 -67.29 -8.36 31.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.2 -0.938 . . . . 0.0 109.553 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 37' ' ' LEU . . . 96.53 -70.62 0.84 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -44.69 -32.98 1.67 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.166 -1.196 . . . . 0.0 109.437 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.518 ' O ' ' CD1' ' A' ' 42' ' ' ILE . 1.1 tp60 -71.52 -44.11 65.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.242 -0.911 . . . . 0.0 109.461 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 33' ' ' ALA . . . -65.57 -63.09 1.18 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.247 -0.908 . . . . 0.0 109.437 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.8 mt -51.39 -33.58 30.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.3 -0.875 . . . . 0.0 109.557 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 37' ' ' LEU . 59.8 t0 -62.76 -51.94 65.17 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.268 -0.895 . . . . 0.0 109.453 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.518 ' CD1' ' O ' ' A' ' 38' ' ' GLN . 2.0 mp -70.64 -14.48 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.214 -0.929 . . . . 0.0 109.49 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.526 ' HA ' ' CD ' ' A' ' 48' ' ' PRO . 50.8 t -84.56 -29.21 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.324 -0.86 . . . . 0.0 109.424 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.44 ' O ' HG21 ' A' ' 44' ' ' THR . 20.7 m -90.06 -25.11 20.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.155 -0.966 . . . . 0.0 109.407 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.512 ' HD2' ' N ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -89.97 -33.19 16.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.267 -0.896 . . . . 0.0 109.463 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -110.32 -36.7 5.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.215 -0.928 . . . . 0.0 109.458 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.46 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER 59.82 69.51 1.23 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.291 -0.881 . . . . 0.0 109.478 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.526 ' CD ' ' HA ' ' A' ' 43' ' ' VAL . 34.7 Cg_endo -77.95 -179.58 5.58 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.747 2.298 . . . . 0.0 110.661 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.435 ' OD2' HD21 ' A' ' 50' ' ' LEU . 1.1 p-10 -119.71 -16.84 8.73 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.47 -0.769 . . . . 0.0 109.33 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.452 ' HB2' HG12 ' A' ' 6' ' ' ILE . 1.8 mm? -114.16 121.12 42.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.322 -0.861 . . . . 0.0 109.695 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.52 ' HB ' ' CG1' ' A' ' 78' ' ' VAL . 2.7 t -116.51 147.04 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.236 -0.915 . . . . 0.0 109.253 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.519 ' CD1' HG12 ' A' ' 8' ' ' ILE . 1.6 mt -122.19 87.9 2.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.146 -0.971 . . . . 0.0 109.609 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.527 HD13 ' CG2' ' A' ' 9' ' ' VAL . 1.2 mp -91.7 122.58 34.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.282 -0.886 . . . . 0.0 109.268 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 81' ' ' MET . 30.3 t0 -107.4 -2.87 20.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.201 -0.937 . . . . 0.0 109.754 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.513 ' HB2' ' CG2' ' A' ' 82' ' ' THR . 4.7 mmt 47.29 22.08 0.24 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.339 -0.851 . . . . 0.0 109.879 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.458 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 1.4 mttt -90.77 -31.66 16.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.005 -1.059 . . . . 0.0 109.28 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.461 ' HA ' ' OD1' ' A' ' 11' ' ' ASP . 2.5 mp -41.88 102.17 0.26 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.501 -0.749 . . . . 0.0 109.682 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.468 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 35.0 Cg_endo -77.48 121.21 5.51 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.455 2.104 . . . . 0.0 110.351 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 121.81 -27.31 6.25 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.458 ' HE1' ' O ' ' A' ' 60' ' ' MET . 1.3 ttp -139.84 135.36 32.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.282 -1.128 . . . . 0.0 109.398 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -89.83 137.34 32.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.243 -0.911 . . . . 0.0 109.457 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.465 ' HA2' HG13 ' A' ' 65' ' ' ILE . . . -90.49 8.74 79.33 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 23.9 mm -58.0 -43.59 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.25 -1.147 . . . . 0.0 109.49 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.517 ' O ' ' CG ' ' A' ' 68' ' ' ARG . 49.4 mm-40 -72.99 -16.72 61.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.9 . . . . 0.0 109.456 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.5 ' CG2' ' HE2' ' A' ' 69' ' ' MET . 48.8 mt -72.33 -53.5 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.256 -0.903 . . . . 0.0 109.461 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.517 ' HG ' ' CD2' ' A' ' 53' ' ' LEU . 12.1 mt -47.3 -57.02 5.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.911 . . . . 0.0 109.554 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.514 ' O ' ' CG2' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -56.62 -42.46 78.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.197 -0.94 . . . . 0.0 109.664 -179.855 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.517 ' CG ' ' O ' ' A' ' 64' ' ' GLU . 2.2 mmt180 -57.47 -29.93 64.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.949 . . . . 0.0 109.553 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.5 ' HE2' ' CG2' ' A' ' 65' ' ' ILE . 3.9 mtt -75.21 -56.37 4.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.271 -0.893 . . . . 0.0 109.489 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.443 ' HG2' ' HA ' ' A' ' 67' ' ' LYS . 6.5 ptpt -55.85 -19.65 12.52 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.183 -0.948 . . . . 0.0 109.462 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.514 ' CG2' ' O ' ' A' ' 67' ' ' LYS . 39.9 t -82.14 -46.64 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.266 -0.896 . . . . 0.0 109.456 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 67.6 mt -63.56 -56.09 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.33 -0.856 . . . . 0.0 109.507 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -135.86 142.74 44.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.325 -0.859 . . . . 0.0 109.46 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -89.42 -10.6 45.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.244 -0.91 . . . . 0.0 109.49 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -102.1 38.52 1.64 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.24 -0.913 . . . . 0.0 109.421 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.453 HD11 ' O ' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -113.55 91.65 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 109.417 -180.0 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.517 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -63.16 154.77 30.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.225 -0.922 . . . . 0.0 109.478 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.52 ' CG1' ' HB ' ' A' ' 51' ' ' VAL . 3.1 t -138.29 158.84 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.205 -0.935 . . . . 0.0 109.448 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.488 HD11 HG22 ' A' ' 79' ' ' ILE . 3.6 mm -136.81 125.74 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 109.454 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.575 ' HB ' ' CG ' ' A' ' 101' ' ' HIS . 0.7 OUTLIER -98.3 136.85 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.241 -0.912 . . . . 0.0 109.296 179.992 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.46 ' O ' ' OD1' ' A' ' 54' ' ' ASP . 16.9 mtm -122.16 49.03 1.63 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.489 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.513 ' CG2' ' HB2' ' A' ' 55' ' ' MET . 8.9 t -159.04 52.0 0.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 109.478 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.527 ' CB ' ' HB3' ' A' ' 103' ' ' ALA . . . -66.38 -20.99 66.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.211 -0.93 . . . . 0.0 109.448 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.421 ' HB2' ' HB2' ' A' ' 103' ' ' ALA . 0.2 OUTLIER -80.39 115.93 20.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.206 -0.934 . . . . 0.0 109.427 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 137.21 -138.22 9.58 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.64 142.93 32.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -1.164 . . . . 0.0 109.508 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 9.2 mt -132.34 52.9 2.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.241 -0.912 . . . . 0.0 109.557 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.01 3.74 4.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.901 . . . . 0.0 109.511 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.499 ' O ' ' CB ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -123.49 -8.91 8.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.148 -0.97 . . . . 0.0 109.564 179.957 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.569 HD12 ' CE1' ' A' ' 101' ' ' HIS . 21.0 mt -87.6 -36.61 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.172 -0.955 . . . . 0.0 109.54 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.28 -41.84 76.5 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.315 -0.866 . . . . 0.0 109.481 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 93' ' ' SER . 2.1 tp10 -89.94 -48.22 7.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.191 -0.943 . . . . 0.0 109.496 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 89' ' ' MET . 11.5 t -44.21 -26.58 0.33 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.929 . . . . 0.0 109.487 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.06 -82.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.901 . . . . 0.0 109.481 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.425 ' O ' ' C ' ' A' ' 96' ' ' LEU . 9.4 pt-20 -44.1 -40.86 5.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.883 . . . . 0.0 109.446 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.425 ' C ' ' O ' ' A' ' 95' ' ' GLU . 24.5 mt -44.09 -59.64 2.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -0.885 . . . . 0.0 109.47 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 163.87 47.54 0.02 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 99' ' ' LEU . . . -111.24 105.54 14.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -1.151 . . . . 0.0 109.471 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.636 ' CD2' ' CE1' ' A' ' 118' ' ' TYR . 20.4 mt -44.25 -63.45 0.88 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.256 -0.903 . . . . 0.0 109.426 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.46 ' O ' HG13 ' A' ' 80' ' ' ILE . 14.5 t -146.44 -176.86 5.34 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.305 -0.872 . . . . 0.0 109.424 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.575 ' CG ' ' HB ' ' A' ' 80' ' ' ILE . 2.9 t-160 -148.77 68.54 1.07 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -0.886 . . . . 0.0 109.376 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.51 ' O ' ' N ' ' A' ' 82' ' ' THR . 18.4 m-85 -65.39 160.68 21.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.214 -0.929 . . . . 0.0 109.447 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.527 ' HB3' ' CB ' ' A' ' 83' ' ' ALA . . . -126.72 -174.35 3.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.332 -0.855 . . . . 0.0 109.396 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.7 pttt -102.34 144.92 29.56 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.257 -0.902 . . . . 0.0 109.36 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.79 133.9 32.21 Favored 'Cis proline' 0 C--N 1.31 -1.457 0 C-N-CA 123.303 -1.54 . . . . 0.0 110.407 -0.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -99.65 -176.64 3.33 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.159 -0.963 . . . . 0.0 109.488 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -127.94 123.32 34.6 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.213 -0.929 . . . . 0.0 109.464 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.454 HG22 HG22 ' A' ' 22' ' ' VAL . 16.2 mm -56.63 -22.42 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.232 -0.918 . . . . 0.0 109.476 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.423 ' O ' ' CG ' ' A' ' 113' ' ' ASP . 11.9 m-20 -72.66 -41.22 65.64 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.221 -0.924 . . . . 0.0 109.539 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.15 -31.38 70.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.203 -0.936 . . . . 0.0 109.461 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.413 HD13 HG22 ' A' ' 111' ' ' ILE . 23.0 mm -69.34 -59.16 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.31 -0.869 . . . . 0.0 109.438 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.405 ' O ' ' HG3' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -62.51 -22.84 66.59 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.2 -0.938 . . . . 0.0 109.467 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.423 ' CG ' ' O ' ' A' ' 109' ' ' ASP . 57.1 m-20 -70.79 -52.28 21.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.895 . . . . 0.0 109.412 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.407 ' O ' ' C ' ' A' ' 115' ' ' VAL . . . -66.1 -61.04 2.25 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.494 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.407 ' C ' ' O ' ' A' ' 114' ' ' ALA . 50.3 t -44.25 -47.94 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.246 -0.909 . . . . 0.0 109.437 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.405 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 0.0 OUTLIER -59.07 -43.71 91.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.287 -0.883 . . . . 0.0 109.475 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.47 -23.98 64.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.301 -0.875 . . . . 0.0 109.513 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.636 ' CE1' ' CD2' ' A' ' 99' ' ' LEU . 67.4 m-85 -80.87 -69.88 0.57 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.886 . . . . 0.0 109.516 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.459 HD22 ' HG3' ' A' ' 4' ' ' GLU . 38.3 tp -90.12 112.47 52.63 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.379 -0.826 . . . . 0.0 109.466 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.463 ' O ' HD22 ' A' ' 121' ' ' LEU . 35.8 Cg_endo -78.12 152.95 28.12 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.327 2.018 . . . . 0.0 110.381 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.592 ' CD1' ' CZ ' ' A' ' 28' ' ' TYR . 26.1 mt -116.83 -162.5 0.86 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.247 -0.908 . . . . 0.0 109.467 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.28 -72.86 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.279 -0.888 . . . . 0.0 109.519 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 5.4 t 175.45 157.01 0.19 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -0.914 . . . . 0.0 109.433 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.458 -179.961 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 ttm . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 7.6 mtm -125.58 46.76 2.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.345 -0.847 . . . . 0.0 109.422 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -109.23 21.11 17.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.244 -0.91 . . . . 0.0 109.471 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -163.91 62.53 0.16 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.228 -0.92 . . . . 0.0 109.436 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.518 ' CB ' ' HA ' ' A' ' 48' ' ' PRO . 42.7 mttm -127.71 138.53 52.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.318 -0.864 . . . . 0.0 109.444 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.496 ' CD1' ' HB3' ' A' ' 28' ' ' TYR . 74.3 mt -144.33 155.0 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.188 -0.945 . . . . 0.0 109.417 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.521 ' CD2' ' HB2' ' A' ' 31' ' ' PHE . 0.2 OUTLIER -132.26 119.39 20.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.214 -0.929 . . . . 0.0 109.556 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.471 HD12 ' CB ' ' A' ' 19' ' ' LEU . 14.1 mt -99.78 102.21 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.248 -0.908 . . . . 0.0 109.447 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.524 ' CG2' HD13 ' A' ' 53' ' ' LEU . 4.9 t -90.02 91.55 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 109.546 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.52 ' O ' ' CD ' ' A' ' 16' ' ' ARG . 4.9 t70 -147.42 138.36 23.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.329 -0.857 . . . . 0.0 109.33 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.524 ' HB3' ' CB ' ' A' ' 34' ' ' ALA . 8.9 p-10 -106.96 -35.81 6.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.891 . . . . 0.0 109.495 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.408 ' O ' ' C ' ' A' ' 13' ' ' TYR . 21.6 tt0 -67.35 106.32 2.04 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.271 -0.893 . . . . 0.0 109.374 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.531 ' CE2' HG13 ' A' ' 17' ' ' ILE . 30.4 t80 -43.32 149.34 0.25 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.357 -0.839 . . . . 0.0 109.6 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.79 -50.79 0.81 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.51 HG22 ' CD1' ' A' ' 19' ' ' LEU . 2.5 mt -80.69 -36.07 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.204 -1.174 . . . . 0.0 109.435 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.524 ' O ' ' CB ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -63.21 -30.1 71.31 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.129 -0.982 . . . . 0.0 109.433 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.531 HG13 ' CE2' ' A' ' 13' ' ' TYR . 2.3 mm -90.84 -31.5 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.292 -0.88 . . . . 0.0 109.831 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.436 ' O ' HG21 ' A' ' 22' ' ' VAL . 8.3 mt -68.8 -60.23 2.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.103 -0.998 . . . . 0.0 109.351 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.51 ' CD1' HG22 ' A' ' 15' ' ' ILE . 7.3 mp -65.86 -18.03 65.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.318 -0.864 . . . . 0.0 108.789 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 16' ' ' ARG . 0.7 OUTLIER -70.2 -66.33 0.61 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.818 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.46 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 1.1 mm-40 -53.81 -44.2 69.98 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.337 -0.852 . . . . 0.0 109.575 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.526 HG22 ' CG2' ' A' ' 108' ' ' ILE . 46.8 t -54.6 -63.06 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.164 -0.96 . . . . 0.0 109.499 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.525 ' CB ' HG22 ' A' ' 30' ' ' THR . 25.8 m-85 -64.79 -10.62 29.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 0.0 109.54 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.46 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 0.5 OUTLIER -74.26 -60.23 2.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.256 -0.902 . . . . 0.0 109.477 179.919 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -67.59 -25.03 65.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.254 -0.903 . . . . 0.0 109.394 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.478 ' HB3' ' CD2' ' A' ' 28' ' ' TYR . 1.8 mt-10 -69.27 -34.77 75.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.442 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.479 ' O ' ' CG ' ' A' ' 28' ' ' TYR . . . 102.78 73.1 0.96 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.496 ' HB3' ' CD1' ' A' ' 6' ' ' ILE . 93.9 m-85 -156.71 144.45 19.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.213 -1.169 . . . . 0.0 109.576 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -89.85 83.24 6.17 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.246 -0.909 . . . . 0.0 109.252 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.525 HG22 ' CB ' ' A' ' 23' ' ' PHE . 5.8 p -89.93 137.95 31.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.28 -0.887 . . . . 0.0 109.566 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.521 ' HB2' ' CD2' ' A' ' 7' ' ' LEU . 42.4 m-85 -105.03 -172.08 2.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 109.345 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.474 ' HG2' ' CG ' ' A' ' 16' ' ' ARG . 54.4 mt-30 -136.88 147.09 46.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.143 -0.973 . . . . 0.0 109.548 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.5 ' O ' ' CB ' ' A' ' 34' ' ' ALA . . . -164.91 -161.94 0.59 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.239 -0.913 . . . . 0.0 109.368 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.524 ' CB ' ' HB3' ' A' ' 11' ' ' ASP . . . 163.65 -53.72 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.281 -0.887 . . . . 0.0 109.352 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.472 ' HA ' ' HE2' ' A' ' 60' ' ' MET . 22.3 p-10 -60.13 -14.63 18.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.308 -0.87 . . . . 0.0 109.462 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.467 ' HA3' HD12 ' A' ' 65' ' ' ILE . . . 95.79 -45.39 1.99 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 mt -67.68 -30.84 70.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.257 -1.143 . . . . 0.0 109.496 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -72.32 -43.72 63.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.235 -0.916 . . . . 0.0 109.461 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.36 -55.97 20.18 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.267 -0.896 . . . . 0.0 109.417 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.4 mt -51.98 -44.43 64.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.286 -0.884 . . . . 0.0 109.478 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.99 -49.73 72.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.277 -0.889 . . . . 0.0 109.465 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.448 HG23 ' CG ' ' A' ' 31' ' ' PHE . 3.1 mt -66.7 -19.48 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -0.897 . . . . 0.0 109.469 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.507 ' HA ' ' CD ' ' A' ' 48' ' ' PRO . 89.3 t -78.54 -32.35 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -0.892 . . . . 0.0 109.451 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.441 ' O ' HG21 ' A' ' 44' ' ' THR . 26.3 m -89.96 -19.44 24.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.205 -0.935 . . . . 0.0 109.494 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.01 -32.33 16.81 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.239 -0.913 . . . . 0.0 109.547 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.408 ' HA ' ' OE1' ' A' ' 46' ' ' GLU . 15.0 mm-40 -117.52 -33.36 4.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.281 -0.887 . . . . 0.0 109.569 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.451 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 4.4 ttp180 61.27 73.0 0.63 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.191 -0.943 . . . . 0.0 109.424 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.518 ' HA ' ' CB ' ' A' ' 5' ' ' LYS . 35.3 Cg_endo -78.12 -176.87 3.48 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.577 2.184 . . . . 0.0 110.405 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -127.44 -3.62 6.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.229 -0.919 . . . . 0.0 109.583 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.0 tp -136.93 125.17 23.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.203 -0.936 . . . . 0.0 109.52 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.49 HG13 ' N ' ' A' ' 52' ' ' LEU . 73.3 t -115.74 166.21 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.324 -0.86 . . . . 0.0 109.442 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.49 ' N ' HG13 ' A' ' 51' ' ' VAL . 1.1 mt -138.42 91.09 2.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.91 . . . . 0.0 109.585 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.524 HD13 ' CG2' ' A' ' 9' ' ' VAL . 3.1 mp -89.93 124.03 34.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.2 -0.938 . . . . 0.0 109.512 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.518 ' HB2' ' CE ' ' A' ' 81' ' ' MET . 28.1 t0 -100.06 -7.36 25.06 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.246 -0.909 . . . . 0.0 109.743 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.438 ' HG3' ' HE2' ' A' ' 89' ' ' MET . 7.8 mmt 51.37 18.7 0.67 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.389 -0.819 . . . . 0.0 109.817 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.416 ' HG3' ' OD2' ' A' ' 54' ' ' ASP . 51.3 mmtt -90.95 -37.67 13.36 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.057 -1.027 . . . . 0.0 109.42 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.532 ' CG2' ' CE ' ' A' ' 60' ' ' MET . 2.9 mt -42.82 114.41 1.51 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.388 -0.82 . . . . 0.0 109.593 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.459 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 34.9 Cg_endo -77.14 152.87 31.58 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.394 2.062 . . . . 0.0 110.27 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 108.87 -43.69 1.65 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.532 ' CE ' ' CG2' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -153.98 159.72 41.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.343 -1.092 . . . . 0.0 109.286 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -90.02 164.84 14.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.23 -0.919 . . . . 0.0 109.538 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.453 ' HA2' HG12 ' A' ' 65' ' ' ILE . . . -89.66 -9.0 66.99 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.427 HD13 ' HB2' ' A' ' 89' ' ' MET . 20.5 mm -46.85 -44.54 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.215 -1.168 . . . . 0.0 109.337 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -58.35 -42.01 85.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.336 -0.852 . . . . 0.0 109.338 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.467 HD12 ' HA3' ' A' ' 36' ' ' GLY . 15.6 mm -49.86 -50.26 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -0.926 . . . . 0.0 109.391 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.586 ' CD2' ' CG1' ' A' ' 78' ' ' VAL . 96.1 mt -58.36 -49.1 78.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.207 -0.933 . . . . 0.0 109.372 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 66' ' ' LEU . 12.5 mttp -44.28 -47.95 9.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.262 -0.899 . . . . 0.0 109.411 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.453 ' O ' HG12 ' A' ' 72' ' ' ILE . 1.9 mpt_? -66.1 -37.14 85.02 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.222 -0.924 . . . . 0.0 109.464 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.438 ' HG3' ' HA ' ' A' ' 66' ' ' LEU . 1.2 mmt -62.44 -22.91 66.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.251 -0.906 . . . . 0.0 109.438 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.462 ' HG2' ' O ' ' A' ' 66' ' ' LEU . 13.5 mmtt -84.92 -43.76 13.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.228 -0.92 . . . . 0.0 109.43 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.6 t -63.87 -27.69 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.327 -0.858 . . . . 0.0 109.465 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.453 HG12 ' O ' ' A' ' 68' ' ' ARG . 28.6 mm -89.95 -56.37 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.246 -0.909 . . . . 0.0 109.486 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.438 ' O ' ' O ' ' A' ' 69' ' ' MET . 2.6 m-20 -126.25 134.64 51.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.305 -0.872 . . . . 0.0 109.471 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -89.18 -15.97 32.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.268 -0.895 . . . . 0.0 109.482 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -114.76 55.49 0.75 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.176 -0.952 . . . . 0.0 109.46 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.446 HG21 ' O ' ' A' ' 76' ' ' ILE . 0.8 OUTLIER -110.94 118.0 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.305 -0.872 . . . . 0.0 109.481 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.519 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 0.4 OUTLIER -75.68 144.13 41.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.894 . . . . 0.0 109.48 -179.999 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.586 ' CG1' ' CD2' ' A' ' 66' ' ' LEU . 13.6 t -143.93 107.95 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.343 -0.848 . . . . 0.0 109.495 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.449 HG22 ' O ' ' A' ' 100' ' ' THR . 68.0 mt -90.28 139.32 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.247 -0.908 . . . . 0.0 109.425 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.579 HG13 ' CG ' ' A' ' 101' ' ' HIS . 0.0 OUTLIER -108.36 167.02 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.278 -0.889 . . . . 0.0 109.297 179.915 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.518 ' CE ' ' HB2' ' A' ' 54' ' ' ASP . 7.2 mtm -146.59 95.0 2.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.154 -0.967 . . . . 0.0 109.588 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.586 ' CG2' ' CE1' ' A' ' 101' ' ' HIS . 11.6 t 177.8 38.37 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.213 -0.929 . . . . 0.0 109.35 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.04 45.42 1.27 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.352 -0.842 . . . . 0.0 109.477 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.49 ' CE2' ' O ' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -84.55 12.22 7.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.265 -0.897 . . . . 0.0 109.415 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 133.55 73.43 0.09 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -179.0 135.63 0.13 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -1.166 . . . . 0.0 109.51 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.539 ' HA ' ' CG2' ' A' ' 90' ' ' ILE . 1.1 mt -133.92 46.01 2.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.355 -0.841 . . . . 0.0 109.4 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -103.65 -95.84 0.31 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.164 -0.96 . . . . 0.0 109.394 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.458 ' O ' ' HB2' ' A' ' 93' ' ' SER . 13.1 ptt? -52.74 -23.02 5.96 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.032 -1.043 . . . . 0.0 109.16 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.539 ' CG2' ' HA ' ' A' ' 87' ' ' LEU . 0.8 OUTLIER -77.93 -39.08 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.404 -0.81 . . . . 0.0 109.16 179.787 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 26.5 tp60 -61.06 -49.35 77.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -0.882 . . . . 0.0 109.4 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.442 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -77.54 -22.41 51.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.897 . . . . 0.0 109.295 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.47 ' HB2' ' HA ' ' A' ' 90' ' ' ILE . 0.6 OUTLIER -59.86 -68.8 0.25 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.258 -0.901 . . . . 0.0 109.358 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.52 ' HA ' ' CB ' ' A' ' 98' ' ' ALA . 24.0 tptt -44.04 -53.58 6.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.332 -0.855 . . . . 0.0 109.312 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 94' ' ' LYS . 36.3 tp10 -43.46 -51.5 6.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.365 -0.835 . . . . 0.0 109.461 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 92' ' ' GLU . 23.8 mt -58.11 -50.9 71.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.262 -0.899 . . . . 0.0 109.522 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 163.25 41.15 0.02 OUTLIER Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.52 ' CB ' ' HA ' ' A' ' 94' ' ' LYS . . . -93.52 107.23 19.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.295 -1.121 . . . . 0.0 109.368 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.519 ' CD1' ' HB3' ' A' ' 77' ' ' ARG . 22.0 mt -44.03 -87.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.261 -0.899 . . . . 0.0 109.518 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.449 ' O ' HG22 ' A' ' 79' ' ' ILE . 4.0 t -127.95 160.93 30.35 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.918 . . . . 0.0 109.517 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.586 ' CE1' ' CG2' ' A' ' 82' ' ' THR . 6.3 t-160 -125.21 95.32 4.44 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.255 -0.903 . . . . 0.0 109.581 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.606 ' CD2' ' CD1' ' A' ' 111' ' ' ILE . 18.8 m-85 -69.51 -168.45 0.17 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.29 -0.881 . . . . 0.0 109.419 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.462 ' O ' ' HB3' ' A' ' 106' ' ' PHE . . . -162.81 -165.85 1.21 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.201 -0.937 . . . . 0.0 109.402 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.514 ' HG3' ' CE1' ' A' ' 106' ' ' PHE . 16.9 mtpt -129.2 145.37 56.44 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.225 -0.922 . . . . 0.0 109.459 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.9 151.66 91.38 Favored 'Cis proline' 0 C--N 1.31 -1.476 0 C-N-CA 123.302 -1.541 . . . . 0.0 110.381 -0.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.547 ' CD1' ' N ' ' A' ' 106' ' ' PHE . 4.9 p90 -133.63 169.32 17.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.183 -0.948 . . . . 0.0 109.486 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.408 ' HB3' ' OE1' ' A' ' 110' ' ' GLU . 42.7 t0 -103.16 116.71 33.0 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.208 -0.933 . . . . 0.0 109.501 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.526 ' CG2' HG22 ' A' ' 22' ' ' VAL . 12.9 mm -50.23 -29.72 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.279 -0.888 . . . . 0.0 109.38 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.46 ' HA ' ' HD3' ' A' ' 112' ' ' ARG . 52.0 m-20 -66.26 -44.0 84.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.204 -0.935 . . . . 0.0 109.383 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 113' ' ' ASP . 2.2 mp0 -64.46 -46.92 81.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 109.505 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.606 ' CD1' ' CD2' ' A' ' 102' ' ' PHE . 22.6 mm -52.27 -62.28 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.317 -0.864 . . . . 0.0 109.533 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 108' ' ' ILE . 0.6 OUTLIER -52.23 -38.45 58.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.55 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 110' ' ' GLU . 88.3 m-20 -53.52 -63.21 1.22 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 109.494 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.428 ' HA ' ' HG3' ' A' ' 117' ' ' LYS . . . -52.08 -55.67 19.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.912 . . . . 0.0 109.518 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.41 ' C ' ' O ' ' A' ' 114' ' ' ALA . 50.7 t -43.96 -35.04 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.261 -0.899 . . . . 0.0 109.477 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.444 ' HE3' ' OE2' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -73.93 -42.2 60.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.282 -0.886 . . . . 0.0 109.467 179.952 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.428 ' HG3' ' HA ' ' A' ' 114' ' ' ALA . 4.0 mttt -62.4 -21.57 65.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 109.449 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.46 ' O ' ' HD3' ' A' ' 120' ' ' PRO . 61.2 m-85 -88.55 -70.8 0.62 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.287 -0.883 . . . . 0.0 109.499 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 21.1 tp -90.04 112.48 52.61 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.365 -0.835 . . . . 0.0 109.448 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 118' ' ' TYR . 35.5 Cg_endo -78.04 133.0 12.02 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.393 2.062 . . . . 0.0 110.382 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 121' ' ' LEU . 0.7 OUTLIER -135.66 13.91 3.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 109.427 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.67 145.85 14.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.285 -0.885 . . . . 0.0 109.439 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 2.3 t 67.69 109.01 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.44 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.514 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.287 0.565 . . . . 0.0 109.476 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 2.9 mtp -148.3 169.22 20.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.906 . . . . 0.0 109.435 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.523 ' HB3' ' CE ' ' A' ' 5' ' ' LYS . 1.1 t-20 -75.69 -148.87 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.199 -0.938 . . . . 0.0 109.455 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.514 ' OE1' ' CD2' ' A' ' 121' ' ' LEU . 3.9 mt-10 -130.64 106.56 8.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.226 -0.921 . . . . 0.0 109.497 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.523 ' CE ' ' HB3' ' A' ' 3' ' ' ASN . 0.8 OUTLIER -134.42 134.46 41.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.287 -0.883 . . . . 0.0 109.426 179.934 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.525 ' HB ' ' CG2' ' A' ' 30' ' ' THR . 98.0 mt -128.85 161.27 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.3 -0.875 . . . . 0.0 109.486 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.526 ' CD2' ' HB2' ' A' ' 31' ' ' PHE . 2.1 tm? -132.51 114.97 14.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.551 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.528 ' CG2' ' OD2' ' A' ' 10' ' ' ASP . 3.2 mt -104.36 105.03 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.924 . . . . 0.0 109.552 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.493 HG21 ' CD1' ' A' ' 7' ' ' LEU . 35.9 t -90.49 90.0 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.874 . . . . 0.0 109.464 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.528 ' OD2' ' CG2' ' A' ' 8' ' ' ILE . 69.1 m-20 -127.37 128.79 46.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.202 -0.936 . . . . 0.0 109.434 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.469 ' OD2' ' HD2' ' A' ' 58' ' ' PRO . 6.7 p-10 -100.21 -23.69 14.76 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.289 -0.882 . . . . 0.0 109.241 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.421 ' O ' ' C ' ' A' ' 13' ' ' TYR . 9.7 tp-100 -84.41 105.78 15.5 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.362 -0.836 . . . . 0.0 109.558 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.642 ' CE2' ' CD1' ' A' ' 17' ' ' ILE . 1.5 t80 -42.53 155.37 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.402 -0.811 . . . . 0.0 109.325 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.516 ' N ' ' CD1' ' A' ' 13' ' ' TYR . . . 109.33 -55.53 0.5 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.516 HG22 ' CD1' ' A' ' 19' ' ' LEU . 2.1 mt -76.13 -60.28 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.329 -1.101 . . . . 0.0 109.268 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.466 ' HD2' ' O ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -41.16 -30.91 0.17 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.48 -0.762 . . . . 0.0 110.042 -179.869 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.642 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 1.3 mt -90.42 -35.66 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.135 -0.978 . . . . 0.0 109.973 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.459 HD13 HD13 ' A' ' 108' ' ' ILE . 0.4 OUTLIER -65.44 -59.81 3.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.239 -0.913 . . . . 0.0 109.758 -179.625 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.516 ' CD1' HG22 ' A' ' 15' ' ' ILE . 7.2 mp -64.32 -20.97 66.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.198 -0.939 . . . . 0.0 109.639 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 10.9 t30 -70.65 -62.56 1.34 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 109.514 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.45 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 34.9 mt-10 -56.46 -44.37 80.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.265 -0.897 . . . . 0.0 109.55 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.443 HG23 HG22 ' A' ' 108' ' ' ILE . 41.2 t -55.13 -61.73 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.236 -0.915 . . . . 0.0 109.491 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.522 ' CB ' HG22 ' A' ' 30' ' ' THR . 20.9 m-85 -65.56 -11.5 44.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.348 -0.845 . . . . 0.0 109.479 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 0.5 OUTLIER -73.52 -60.07 2.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.335 -0.853 . . . . 0.0 109.483 179.937 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.1 tttp -74.07 -11.3 60.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.453 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.462 ' HB2' ' HA ' ' A' ' 23' ' ' PHE . 0.7 OUTLIER -76.14 -31.57 58.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -0.935 . . . . 0.0 109.49 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.88 41.89 0.82 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.521 ' CE1' HD22 ' A' ' 121' ' ' LEU . 85.2 m-85 -141.56 134.93 29.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.256 -1.144 . . . . 0.0 109.592 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -93.96 82.21 4.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.234 -0.916 . . . . 0.0 109.07 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.525 ' CG2' ' HB ' ' A' ' 6' ' ' ILE . 5.5 p -89.79 149.07 22.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.27 -0.894 . . . . 0.0 109.881 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.538 ' CZ ' ' OE2' ' A' ' 46' ' ' GLU . 31.6 m-85 -109.01 -167.23 1.19 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 109.052 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 15.5 mp0 -133.19 157.09 46.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.161 -0.962 . . . . 0.0 109.821 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.437 ' HB1' ' HA ' ' A' ' 9' ' ' VAL . . . -157.77 176.94 11.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.414 -0.804 . . . . 0.0 109.283 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.437 ' HB3' ' HA ' ' A' ' 11' ' ' ASP . . . -173.35 -44.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.125 -0.985 . . . . 0.0 109.693 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.418 ' C ' ' SD ' ' A' ' 60' ' ' MET . 2.4 p30 -82.25 -1.8 50.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.214 -0.929 . . . . 0.0 109.607 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.449 ' HA3' ' SD ' ' A' ' 60' ' ' MET . . . 85.7 -48.69 4.03 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.457 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 1.1 mp -52.54 -44.79 66.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -1.149 . . . . 0.0 109.511 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.521 ' O ' ' CD1' ' A' ' 42' ' ' ILE . 1.0 OUTLIER -68.19 -27.71 66.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.217 -0.927 . . . . 0.0 109.481 179.939 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.4 ' O ' HG22 ' A' ' 43' ' ' VAL . . . -71.56 -69.45 0.38 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.202 -0.936 . . . . 0.0 109.548 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -51.77 -47.17 64.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.228 -0.92 . . . . 0.0 109.6 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 37' ' ' LEU . 16.0 t0 -54.08 -52.59 60.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.308 -0.87 . . . . 0.0 109.55 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.521 ' CD1' ' O ' ' A' ' 38' ' ' GLN . 20.4 mt -61.7 -22.92 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.257 -0.902 . . . . 0.0 109.424 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 54.1 t -78.29 -25.28 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.182 -0.949 . . . . 0.0 109.457 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.1 m -90.13 -25.29 20.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.308 -0.87 . . . . 0.0 109.525 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.513 ' CD ' ' HA ' ' A' ' 42' ' ' ILE . 3.8 ptmt -90.07 -27.13 19.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.574 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.538 ' OE2' ' CZ ' ' A' ' 31' ' ' PHE . 3.2 mt-10 -118.6 -26.66 6.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.23 -0.919 . . . . 0.0 109.471 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.476 ' CG ' ' C ' ' A' ' 46' ' ' GLU . 7.4 ptm180 38.55 72.12 0.98 Allowed Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.598 -0.689 . . . . 0.0 109.969 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.503 ' CB ' ' O ' ' A' ' 5' ' ' LYS . 34.7 Cg_endo -77.19 -171.51 1.18 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.619 2.213 . . . . 0.0 110.343 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 5.7 m-20 -117.6 -8.3 10.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.139 -0.975 . . . . 0.0 109.556 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.418 ' HB3' HG12 ' A' ' 6' ' ' ILE . 7.2 tp -131.57 117.34 18.6 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.286 -0.884 . . . . 0.0 109.54 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.584 ' CG1' ' CE ' ' A' ' 69' ' ' MET . 2.9 t -121.35 158.75 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.233 -0.917 . . . . 0.0 109.408 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.2 mp -135.3 115.68 13.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -0.935 . . . . 0.0 109.516 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.575 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.8 OUTLIER -102.19 126.45 49.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.355 -0.841 . . . . 0.0 109.419 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 81' ' ' MET . 31.9 t0 -106.49 106.6 17.19 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.917 . . . . 0.0 109.466 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.458 ' HB2' HG22 ' A' ' 82' ' ' THR . 16.0 mmt -59.78 -14.95 16.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.332 -0.855 . . . . 0.0 109.462 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.477 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 4.2 mmpt? -52.88 -37.18 60.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 109.502 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.526 ' CG2' ' HB3' ' A' ' 60' ' ' MET . 43.8 mt -41.14 101.15 0.24 Allowed Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.443 -0.786 . . . . 0.0 109.691 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 56' ' ' LYS . 36.2 Cg_endo -79.15 -29.53 3.14 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.512 2.141 . . . . 0.0 110.51 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -84.45 -3.91 88.19 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.526 ' HB3' ' CG2' ' A' ' 57' ' ' ILE . 10.3 ttp -156.96 141.03 16.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.103 -1.234 . . . . 0.0 109.607 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.474 ' N ' ' HG2' ' A' ' 60' ' ' MET . 15.3 m-20 -89.99 126.82 35.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.31 -0.869 . . . . 0.0 109.431 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.509 ' HA2' ' CG1' ' A' ' 65' ' ' ILE . . . -82.96 9.16 60.92 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 13.0 mm -70.8 -44.69 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.249 -1.148 . . . . 0.0 109.396 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -71.91 -12.89 61.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -0.905 . . . . 0.0 109.404 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.523 ' O ' ' CG ' ' A' ' 69' ' ' MET . 13.6 mm -73.49 -58.36 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.189 -0.944 . . . . 0.0 109.49 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.446 HD23 ' O ' ' A' ' 97' ' ' GLY . 6.3 mt -53.25 -28.42 27.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -0.916 . . . . 0.0 109.465 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.505 ' O ' ' CG ' ' A' ' 70' ' ' LYS . 5.7 mmtm -72.65 -70.28 0.36 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.189 -0.945 . . . . 0.0 109.451 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.459 ' O ' HG12 ' A' ' 72' ' ' ILE . 0.6 OUTLIER -45.25 -25.83 0.42 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.265 -0.897 . . . . 0.0 109.418 -179.938 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.584 ' CE ' ' CG1' ' A' ' 51' ' ' VAL . 2.9 mmm -72.78 -48.9 34.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.187 -0.946 . . . . 0.0 109.456 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.505 ' CG ' ' O ' ' A' ' 67' ' ' LYS . 16.3 ptpt -63.18 -21.77 66.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.262 -0.899 . . . . 0.0 109.51 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.1 t -80.1 -45.62 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.251 -0.905 . . . . 0.0 109.517 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.459 HG12 ' O ' ' A' ' 68' ' ' ARG . 24.1 mm -76.21 -14.64 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.215 -0.928 . . . . 0.0 109.525 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -170.06 117.62 0.56 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.221 -0.924 . . . . 0.0 109.514 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.422 ' HG3' ' N ' ' A' ' 75' ' ' ASN . 0.1 OUTLIER -90.13 -18.83 25.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.186 -0.946 . . . . 0.0 109.417 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.422 ' N ' ' HG3' ' A' ' 74' ' ' GLU . 17.3 m120 -101.2 48.85 0.88 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.295 -0.878 . . . . 0.0 109.456 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.458 HD13 ' O ' ' A' ' 48' ' ' PRO . 0.3 OUTLIER -121.9 116.96 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.275 -0.891 . . . . 0.0 109.518 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.525 ' CA ' HD12 ' A' ' 99' ' ' LEU . 7.7 mtt85 -54.02 130.73 38.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 109.417 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -132.08 117.86 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.213 -0.929 . . . . 0.0 109.63 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.46 HG21 ' O ' ' A' ' 100' ' ' THR . 66.9 mt -114.69 144.05 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.261 -0.899 . . . . 0.0 109.394 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.58 ' CD1' ' ND1' ' A' ' 101' ' ' HIS . 0.1 OUTLIER -108.63 158.88 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.235 -0.916 . . . . 0.0 109.418 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.463 ' O ' ' HB ' ' A' ' 82' ' ' THR . 14.2 mtm -136.83 91.92 2.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.135 -0.978 . . . . 0.0 109.644 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.573 HG21 ' CE1' ' A' ' 101' ' ' HIS . 11.4 t 176.69 38.65 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.377 -0.827 . . . . 0.0 109.331 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.517 ' CB ' ' HB1' ' A' ' 103' ' ' ALA . . . -89.33 43.81 1.17 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.338 -0.851 . . . . 0.0 109.571 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -88.82 81.76 6.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.206 -0.934 . . . . 0.0 109.501 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 55.25 66.66 2.67 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.415 ' CD ' ' O ' ' A' ' 82' ' ' THR . 0.6 OUTLIER -174.18 87.23 0.05 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.247 -1.149 . . . . 0.0 109.504 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.534 ' HA ' ' CG2' ' A' ' 90' ' ' ILE . 7.4 mp -103.6 69.7 0.99 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 109.447 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 89' ' ' MET . 4.7 t70 -105.48 -87.52 0.45 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.906 . . . . 0.0 109.577 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.51 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 0.3 OUTLIER -78.95 3.97 15.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.252 -0.905 . . . . 0.0 109.523 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.534 ' CG2' ' HA ' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -90.41 -50.43 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.257 -0.902 . . . . 0.0 108.966 179.716 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.71 -38.25 14.81 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.193 -0.942 . . . . 0.0 109.452 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.14 -44.82 9.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.915 . . . . 0.0 109.639 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.517 ' HA ' ' CD1' ' A' ' 96' ' ' LEU . 2.7 m -45.05 -26.88 0.49 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.171 -0.955 . . . . 0.0 109.69 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.64 -63.45 1.29 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.18 -0.95 . . . . 0.0 109.518 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.408 ' HG3' ' N ' ' A' ' 96' ' ' LEU . 7.1 pt-20 -61.45 -27.03 68.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.277 -0.89 . . . . 0.0 109.512 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.517 ' CD1' ' HA ' ' A' ' 93' ' ' SER . 36.2 mt -67.49 -33.73 75.71 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.205 -0.935 . . . . 0.0 109.5 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.526 ' O ' ' CG2' ' A' ' 78' ' ' VAL . . . 156.16 69.9 0.01 OUTLIER Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' A' ' 78' ' ' VAL . . . -158.01 110.03 2.31 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.273 -1.133 . . . . 0.0 109.382 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.525 HD12 ' CA ' ' A' ' 77' ' ' ARG . 0.4 OUTLIER -60.24 -67.58 0.38 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.289 -0.882 . . . . 0.0 109.436 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.46 ' O ' HG21 ' A' ' 79' ' ' ILE . 10.7 t -131.66 160.39 35.56 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.214 -0.928 . . . . 0.0 109.406 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.58 ' ND1' ' CD1' ' A' ' 80' ' ' ILE . 5.4 t-160 -124.92 94.79 4.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -0.892 . . . . 0.0 109.458 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -63.62 -179.0 0.32 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.238 -0.914 . . . . 0.0 109.5 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.517 ' HB1' ' CB ' ' A' ' 83' ' ' ALA . . . -171.08 -157.94 0.14 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.291 -0.881 . . . . 0.0 109.337 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.419 ' HG3' ' HA ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -98.9 143.03 25.63 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.188 -0.945 . . . . 0.0 109.454 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.419 ' HA ' ' HG3' ' A' ' 104' ' ' LYS . 35.6 Cg_endo -77.98 164.75 84.92 Favored 'Cis proline' 0 C--N 1.31 -1.487 0 C-N-CA 123.277 -1.551 . . . . 0.0 110.37 -0.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.624 ' CE2' ' CD1' ' A' ' 111' ' ' ILE . 0.2 OUTLIER -96.18 107.68 20.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.29 -0.881 . . . . 0.0 109.502 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.458 ' O ' HG12 ' A' ' 111' ' ' ILE . 23.1 t0 -89.83 103.87 16.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.258 -0.901 . . . . 0.0 109.384 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.461 ' O ' ' HG2' ' A' ' 112' ' ' ARG . 15.8 mm -46.21 -24.35 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 109.863 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.456 ' O ' ' OD2' ' A' ' 113' ' ' ASP . 22.4 m-20 -73.6 -45.22 54.39 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.203 -0.936 . . . . 0.0 109.789 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.92 -24.37 61.62 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.112 -0.993 . . . . 0.0 109.706 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.624 ' CD1' ' CE2' ' A' ' 106' ' ' PHE . 10.6 mm -76.26 -53.08 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.218 -0.926 . . . . 0.0 109.438 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 108' ' ' ILE . 0.9 OUTLIER -64.24 -37.39 87.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.319 -0.863 . . . . 0.0 109.588 -179.867 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.456 ' OD2' ' O ' ' A' ' 109' ' ' ASP . 16.6 m-20 -63.65 -60.13 3.72 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.203 -0.936 . . . . 0.0 109.6 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -46.58 -51.06 16.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.925 . . . . 0.0 109.618 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.422 HG22 ' CZ ' ' A' ' 23' ' ' PHE . 47.9 t -52.57 -49.98 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.889 . . . . 0.0 109.597 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 0.4 OUTLIER -58.42 -29.68 66.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.902 . . . . 0.0 109.553 -179.867 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.7 tttm -76.89 -27.36 54.94 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.201 -0.937 . . . . 0.0 109.42 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.486 ' O ' ' HD3' ' A' ' 120' ' ' PRO . 40.3 m-85 -90.05 -75.07 0.46 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.254 -0.904 . . . . 0.0 109.497 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.462 HD22 ' O ' ' A' ' 120' ' ' PRO . 5.3 tt -90.54 111.87 49.89 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.261 -0.899 . . . . 0.0 109.627 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' A' ' 118' ' ' TYR . 36.2 Cg_endo -79.53 154.83 24.26 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.442 2.094 . . . . 0.0 110.355 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.521 HD22 ' CE1' ' A' ' 28' ' ' TYR . 21.4 mt -91.81 -115.61 0.08 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.298 -0.876 . . . . 0.0 109.205 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 123' ' ' SER . 0.0 OUTLIER -127.59 131.98 49.87 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.884 -1.135 . . . . 0.0 109.615 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 122' ' ' LYS . 0.0 OUTLIER 57.64 112.04 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 109.563 179.879 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.476 179.94 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.301 0.572 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.59 132.32 38.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.208 -0.933 . . . . 0.0 109.512 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.461 ' O ' ' OE2' ' A' ' 4' ' ' GLU . 1.2 p-10 -120.15 63.9 0.83 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.267 -0.896 . . . . 0.0 109.467 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.52 ' OE2' ' CD2' ' A' ' 121' ' ' LEU . 0.7 OUTLIER -138.37 55.19 1.75 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.188 -0.945 . . . . 0.0 109.445 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.526 ' CB ' ' HA ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -127.53 111.15 13.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.294 -0.879 . . . . 0.0 109.454 179.958 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.519 HD11 HG22 ' A' ' 6' ' ' ILE . 16.2 mt -126.93 158.29 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.255 -0.903 . . . . 0.0 109.496 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.522 ' CD2' ' HB2' ' A' ' 31' ' ' PHE . 2.6 tm? -132.51 128.97 38.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.231 -0.918 . . . . 0.0 109.469 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.487 ' N ' HD12 ' A' ' 7' ' ' LEU . 9.1 mt -106.44 104.64 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.239 -0.913 . . . . 0.0 109.466 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.461 ' HB ' ' O ' ' A' ' 52' ' ' LEU . 3.9 t -89.97 70.78 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.292 -0.88 . . . . 0.0 109.463 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.515 ' O ' ' CD ' ' A' ' 16' ' ' ARG . 0.4 OUTLIER -123.22 148.94 45.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.892 . . . . 0.0 109.502 179.935 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.45 ' OD1' ' HA ' ' A' ' 57' ' ' ILE . 5.5 p-10 -115.8 -40.16 3.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.248 -0.907 . . . . 0.0 109.457 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.94 111.93 2.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.0 109.505 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.572 ' CZ ' HG13 ' A' ' 17' ' ' ILE . 46.6 t80 -49.26 128.84 17.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.212 -0.93 . . . . 0.0 109.477 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 138.23 -43.93 1.15 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.521 HG21 ' CD1' ' A' ' 19' ' ' LEU . 6.4 mt -84.26 -39.74 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -1.135 . . . . 0.0 109.392 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.515 ' CD ' ' O ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -65.93 -26.57 67.66 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.207 -0.933 . . . . 0.0 109.453 -179.964 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.572 HG13 ' CZ ' ' A' ' 13' ' ' TYR . 4.8 mm -90.65 -42.61 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.261 -0.9 . . . . 0.0 109.787 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.2 mt -64.65 -57.76 8.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.145 -0.972 . . . . 0.0 109.852 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.521 ' CD1' HG21 ' A' ' 15' ' ' ILE . 7.9 mp -60.23 -26.37 66.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.243 -0.91 . . . . 0.0 109.743 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 30.2 t30 -67.87 -55.2 13.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 109.59 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.466 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 33.4 mt-10 -59.74 -44.71 93.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.265 -0.897 . . . . 0.0 109.723 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.532 ' CG1' ' CG ' ' A' ' 112' ' ' ARG . 13.7 t -55.92 -62.22 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 109.729 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.427 ' HA ' ' HB2' ' A' ' 26' ' ' GLU . 17.0 m-85 -68.4 -10.16 53.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.915 . . . . 0.0 109.592 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.466 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 0.4 OUTLIER -70.84 -52.06 22.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.191 -0.943 . . . . 0.0 109.386 179.863 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -74.55 -11.71 60.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.238 -0.914 . . . . 0.0 109.311 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.536 ' HB3' ' CD2' ' A' ' 28' ' ' TYR . 3.5 mt-10 -78.61 -33.61 47.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.294 -0.879 . . . . 0.0 109.474 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.462 ' O ' ' CG ' ' A' ' 4' ' ' GLU . . . 105.56 54.08 0.75 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.625 ' CZ ' ' CD1' ' A' ' 121' ' ' LEU . 88.5 m-85 -138.07 143.53 40.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.168 -1.195 . . . . 0.0 109.525 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.433 ' HB2' ' O ' ' A' ' 4' ' ' GLU . 92.8 mm-40 -94.23 81.51 4.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.91 . . . . 0.0 109.394 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.442 HG23 HD13 ' A' ' 6' ' ' ILE . 5.8 p -89.88 148.34 23.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.906 . . . . 0.0 109.53 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.522 ' HB2' ' CD2' ' A' ' 7' ' ' LEU . 8.5 m-85 -114.84 -172.74 2.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.274 -0.892 . . . . 0.0 109.409 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -123.28 151.35 42.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.282 -0.886 . . . . 0.0 109.529 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.453 ' HB3' ' HB3' ' A' ' 38' ' ' GLN . . . -174.48 172.4 3.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.313 -0.867 . . . . 0.0 109.414 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.463 ' O ' HD11 ' A' ' 57' ' ' ILE . . . 177.67 -31.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.182 -0.949 . . . . 0.0 109.533 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -74.77 -0.91 19.79 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.171 -0.955 . . . . 0.0 109.619 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.447 ' O ' ' HB1' ' A' ' 39' ' ' ALA . . . 85.05 -45.2 3.48 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.29 -54.79 31.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.158 -1.201 . . . . 0.0 109.514 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.491 ' HG2' ' CD1' ' A' ' 42' ' ' ILE . 0.0 OUTLIER -71.24 -15.37 62.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.911 . . . . 0.0 109.617 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.522 ' O ' ' CG2' ' A' ' 43' ' ' VAL . . . -70.6 -60.66 2.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.205 -0.935 . . . . 0.0 109.536 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.496 ' CD2' ' HB3' ' A' ' 68' ' ' ARG . 0.7 OUTLIER -69.85 -38.66 76.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.247 -0.908 . . . . 0.0 109.55 -179.974 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.439 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 14.8 m-20 -61.43 -60.79 3.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.332 -0.855 . . . . 0.0 109.547 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.521 HG22 ' CD2' ' A' ' 7' ' ' LEU . 41.5 mt -56.97 -31.05 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.248 -0.908 . . . . 0.0 109.513 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 39' ' ' ALA . 44.0 t -68.84 -31.69 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.204 -0.935 . . . . 0.0 109.485 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 79.8 m -90.02 -14.5 33.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.214 -0.929 . . . . 0.0 109.474 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 3.7 mmtt -84.61 -58.48 2.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.891 . . . . 0.0 109.545 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 47' ' ' ARG . 2.4 mm-40 -89.97 -25.38 20.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 109.628 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.498 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 6.5 mmm180 63.48 62.8 1.61 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.182 -0.949 . . . . 0.0 109.436 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.526 ' HA ' ' CB ' ' A' ' 5' ' ' LYS . 35.3 Cg_endo -77.69 158.18 31.84 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.603 2.202 . . . . 0.0 110.49 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -100.04 -10.9 21.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.246 -0.909 . . . . 0.0 109.508 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.513 ' CD2' ' HB2' ' A' ' 119' ' ' LEU . 1.7 mm? -116.62 122.89 45.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.221 -0.924 . . . . 0.0 109.499 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.465 HG13 ' HE2' ' A' ' 69' ' ' MET . 9.0 t -123.91 113.06 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.902 . . . . 0.0 109.529 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.461 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 1.0 OUTLIER -90.75 120.31 31.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.883 . . . . 0.0 109.419 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.457 HD12 ' HE2' ' A' ' 69' ' ' MET . 1.1 tp -110.75 121.98 46.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.337 -0.852 . . . . 0.0 109.534 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.461 ' OD2' ' HB2' ' A' ' 56' ' ' LYS . 8.9 t0 -104.45 109.14 20.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 0.0 109.366 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.458 ' HB2' ' HB ' ' A' ' 82' ' ' THR . 6.6 mmt -67.18 -9.59 41.7 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.144 -0.972 . . . . 0.0 109.512 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.461 ' HB2' ' OD2' ' A' ' 54' ' ' ASP . 6.3 mmtt -74.92 -19.13 60.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 0.0 109.383 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.463 HD11 ' O ' ' A' ' 34' ' ' ALA . 81.0 mt -43.11 103.15 0.3 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.324 -0.86 . . . . 0.0 109.519 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 56' ' ' LYS . 35.5 Cg_endo -77.55 108.76 2.64 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.412 2.075 . . . . 0.0 110.421 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 128.93 -33.76 3.0 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.431 ' HE2' ' O ' ' A' ' 61' ' ' ASP . 0.6 OUTLIER -138.82 133.34 31.94 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.276 -1.132 . . . . 0.0 109.458 -179.962 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.431 ' O ' ' HE2' ' A' ' 60' ' ' MET . 4.3 m-20 -83.52 157.94 22.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.161 -0.962 . . . . 0.0 109.477 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.51 ' HA2' ' CD1' ' A' ' 65' ' ' ILE . . . -102.89 9.17 55.0 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.406 HD11 ' HA ' ' A' ' 63' ' ' ILE . 15.7 mm -70.37 -57.68 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -1.191 . . . . 0.0 109.447 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -58.59 -29.13 66.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 0.0 109.432 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.51 ' CD1' ' HA2' ' A' ' 62' ' ' GLY . 10.1 mt -59.23 -52.15 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.277 -0.889 . . . . 0.0 109.412 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.459 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 25.8 mt -53.87 -51.5 63.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.357 -0.84 . . . . 0.0 109.486 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.408 ' O ' HG21 ' A' ' 71' ' ' VAL . 1.3 tttt -46.81 -49.39 20.03 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.262 -0.899 . . . . 0.0 109.483 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.496 ' HB3' ' CD2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -57.93 -38.54 76.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.278 -0.889 . . . . 0.0 109.463 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.465 ' HE2' HG13 ' A' ' 51' ' ' VAL . 7.0 mtt -67.94 -25.31 65.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 0.0 109.465 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 66' ' ' LEU . 0.8 OUTLIER -78.88 -30.32 44.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.271 -0.893 . . . . 0.0 109.452 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.408 HG21 ' O ' ' A' ' 67' ' ' LYS . 3.6 t -84.9 -20.85 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.274 -0.891 . . . . 0.0 109.435 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 68' ' ' ARG . 91.4 mt -89.92 -34.97 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -0.879 . . . . 0.0 109.432 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -166.31 134.05 2.77 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.261 -0.899 . . . . 0.0 109.433 -179.927 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -89.72 -10.48 45.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.514 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -103.23 12.45 35.6 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.226 -0.921 . . . . 0.0 109.552 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.461 HG22 ' O ' ' A' ' 76' ' ' ILE . 1.0 OUTLIER -78.62 115.26 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.262 -0.899 . . . . 0.0 109.496 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.519 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 59.0 mtt85 -69.85 126.97 31.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 109.513 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 98' ' ' ALA . 2.9 t -133.23 110.44 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.269 -0.894 . . . . 0.0 109.458 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.506 HG23 ' N ' ' A' ' 80' ' ' ILE . 75.5 mt -92.59 165.02 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 109.384 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.576 ' CD1' ' ND1' ' A' ' 101' ' ' HIS . 0.3 OUTLIER -128.42 152.76 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.162 -0.962 . . . . 0.0 109.528 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.451 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 16.9 mtm -136.93 98.37 3.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.286 -0.884 . . . . 0.0 109.361 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.56 ' CG2' ' N ' ' A' ' 83' ' ' ALA . 4.4 t -166.37 -147.23 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.153 -0.967 . . . . 0.0 109.64 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.56 ' N ' ' CG2' ' A' ' 82' ' ' THR . . . -40.93 108.19 0.09 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.464 -0.772 . . . . 0.0 110.052 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.559 ' CG ' ' O ' ' A' ' 84' ' ' TYR . 9.7 t80 -90.05 20.16 4.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 0.0 109.303 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 86' ' ' GLU . . . -136.08 -90.83 0.31 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 85' ' ' GLY . 10.2 pt-20 -45.03 148.67 0.53 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.156 -1.202 . . . . 0.0 109.143 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.518 ' CD2' ' HB2' ' A' ' 91' ' ' GLN . 3.3 mp -134.02 87.21 2.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.161 -0.962 . . . . 0.0 109.748 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -94.5 -43.62 8.25 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.229 -0.92 . . . . 0.0 109.259 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.7 ptp -136.18 6.07 3.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.321 -0.862 . . . . 0.0 109.491 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.571 ' CD1' ' ND1' ' A' ' 101' ' ' HIS . 0.0 OUTLIER -90.95 -53.3 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.188 -0.945 . . . . 0.0 108.719 179.639 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.518 ' HB2' ' CD2' ' A' ' 87' ' ' LEU . 10.6 tt0 -47.66 -58.36 4.38 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.253 -0.905 . . . . 0.0 109.5 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.41 ' O ' ' C ' ' A' ' 93' ' ' SER . 11.2 tm-20 -58.81 -42.71 89.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.259 -0.901 . . . . 0.0 109.488 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.414 ' HA ' ' CD1' ' A' ' 96' ' ' LEU . 0.2 OUTLIER -43.76 -30.77 0.69 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 0.0 109.457 179.987 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.463 ' HG2' ' O ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -55.64 -54.6 42.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 109.469 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -51.06 -47.17 61.85 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.281 -0.887 . . . . 0.0 109.502 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.414 ' CD1' ' HA ' ' A' ' 93' ' ' SER . 0.7 OUTLIER -49.37 -58.36 5.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.212 -0.93 . . . . 0.0 109.488 179.946 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 169.62 64.89 0.04 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.463 ' O ' ' HG2' ' A' ' 94' ' ' LYS . . . -134.78 118.58 17.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.257 -1.143 . . . . 0.0 109.485 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.519 ' CD1' ' HB3' ' A' ' 77' ' ' ARG . 0.5 OUTLIER -71.11 -71.16 0.27 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.188 -0.945 . . . . 0.0 109.426 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.453 ' O ' HG21 ' A' ' 79' ' ' ILE . 14.5 t -122.24 173.16 7.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.247 -0.908 . . . . 0.0 109.453 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.576 ' ND1' ' CD1' ' A' ' 80' ' ' ILE . 5.4 t-160 -139.88 90.89 2.42 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.224 -0.923 . . . . 0.0 109.582 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.629 ' CD2' ' CD1' ' A' ' 111' ' ' ILE . 38.2 m-85 -73.21 -168.31 0.5 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.303 -0.873 . . . . 0.0 109.42 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 82' ' ' THR . . . -168.94 -147.39 0.07 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.224 -0.923 . . . . 0.0 109.294 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 7.6 ptmt -137.2 135.87 20.14 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.139 -0.976 . . . . 0.0 109.4 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.86 138.61 52.7 Favored 'Cis proline' 0 C--N 1.31 -1.459 0 C-N-CA 123.437 -1.485 . . . . 0.0 110.281 0.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.458 ' HB3' ' O ' ' A' ' 103' ' ' ALA . 26.9 p90 -99.43 172.45 7.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.28 -0.888 . . . . 0.0 109.656 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -114.81 111.96 22.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.271 -0.893 . . . . 0.0 109.348 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.453 HG23 HG23 ' A' ' 22' ' ' VAL . 10.7 mm -54.74 -18.76 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 109.38 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -72.96 -46.98 49.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 109.167 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -67.0 -33.73 76.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.302 -0.874 . . . . 0.0 109.215 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.629 ' CD1' ' CD2' ' A' ' 102' ' ' PHE . 16.7 mm -71.45 -35.19 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.322 -0.861 . . . . 0.0 109.116 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.532 ' CG ' ' CG1' ' A' ' 22' ' ' VAL . 5.3 mtp85 -63.69 -50.58 68.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.334 -0.854 . . . . 0.0 109.513 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 114' ' ' ALA . 61.8 m-20 -67.15 -62.54 1.38 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.223 -0.923 . . . . 0.0 109.766 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.56 ' O ' ' CD2' ' A' ' 118' ' ' TYR . . . -43.82 -39.77 4.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.113 -0.992 . . . . 0.0 109.684 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.482 ' CG2' ' O ' ' A' ' 111' ' ' ILE . 41.2 t -66.6 -42.97 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.909 . . . . 0.0 109.614 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 4.2 mtpp -61.81 -59.41 5.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 0.0 109.558 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -47.18 -56.31 6.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.197 -0.939 . . . . 0.0 109.566 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.56 ' CD2' ' O ' ' A' ' 114' ' ' ALA . 17.8 m-30 -51.96 -72.2 0.06 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.284 -0.885 . . . . 0.0 109.524 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.513 ' HB2' ' CD2' ' A' ' 50' ' ' LEU . 1.9 tp -90.19 112.49 52.86 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.324 -0.86 . . . . 0.0 109.534 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 118' ' ' TYR . 35.7 Cg_endo -78.16 152.94 27.96 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.318 2.012 . . . . 0.0 110.408 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.625 ' CD1' ' CZ ' ' A' ' 28' ' ' TYR . 1.0 OUTLIER -115.43 79.93 1.36 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 109.439 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.1 mttm -55.8 165.65 0.86 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.282 -0.886 . . . . 0.0 109.463 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 4.2 t 59.86 -151.4 0.41 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.299 -0.876 . . . . 0.0 109.469 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 54.0 m-20 . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.557 179.982 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 mmt . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER 61.83 31.06 18.41 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.282 -0.886 . . . . 0.0 109.453 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -143.15 81.42 1.72 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.886 . . . . 0.0 109.396 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.49 ' HG3' ' CD1' ' A' ' 121' ' ' LEU . 16.8 mm-40 -113.36 124.63 52.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.267 -0.895 . . . . 0.0 109.456 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.452 ' O ' HG12 ' A' ' 6' ' ' ILE . 1.2 mtmp? -138.15 144.11 40.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.256 -0.902 . . . . 0.0 109.442 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.496 HD13 ' CG2' ' A' ' 30' ' ' THR . 3.5 mt -150.04 159.4 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.194 -0.941 . . . . 0.0 109.516 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.525 HD22 ' CG2' ' A' ' 42' ' ' ILE . 0.7 OUTLIER -131.18 128.14 39.39 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.333 -0.854 . . . . 0.0 109.492 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.513 ' N ' HD12 ' A' ' 7' ' ' LEU . 7.7 mt -109.68 106.81 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.287 -0.883 . . . . 0.0 109.494 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.505 HG11 ' N ' ' A' ' 34' ' ' ALA . 2.6 t -104.46 89.01 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.32 -0.862 . . . . 0.0 109.473 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.516 ' CB ' ' HD2' ' A' ' 16' ' ' ARG . 2.2 t70 -87.51 -155.98 0.32 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.202 -0.936 . . . . 0.0 109.392 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.508 ' CB ' ' HA ' ' A' ' 57' ' ' ILE . 0.7 OUTLIER -109.6 -45.52 3.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.91 . . . . 0.0 109.564 -179.977 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.507 ' HG2' ' N ' ' A' ' 13' ' ' TYR . 7.4 tt0 -132.52 -90.13 0.41 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.17 -0.956 . . . . 0.0 109.482 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.635 ' CE2' ' CD1' ' A' ' 17' ' ' ILE . 2.8 t80 -149.83 167.92 25.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.302 -0.874 . . . . 0.0 109.489 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.01 -66.75 0.24 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.461 HD12 ' OD1' ' A' ' 10' ' ' ASP . 9.8 mt -68.04 -28.01 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.254 -1.145 . . . . 0.0 109.48 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.516 ' HD2' ' CB ' ' A' ' 10' ' ' ASP . 0.3 OUTLIER -66.51 -25.87 66.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.302 -0.874 . . . . 0.0 109.444 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.635 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 4.5 mt -90.04 -51.85 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.221 -0.925 . . . . 0.0 109.533 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.436 ' O ' HG21 ' A' ' 22' ' ' VAL . 4.8 mp -59.29 -58.04 10.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.241 -0.912 . . . . 0.0 109.554 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.456 ' HB3' HD12 ' A' ' 8' ' ' ILE . 1.9 tp -56.6 -22.54 34.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.891 . . . . 0.0 109.464 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.424 ' O ' ' C ' ' A' ' 21' ' ' GLU . 28.1 t30 -74.87 -72.77 0.27 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.244 -0.91 . . . . 0.0 109.528 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 20' ' ' ASN . 17.4 tt0 -44.12 -35.52 2.21 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -0.895 . . . . 0.0 109.488 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.474 HG12 ' CG2' ' A' ' 108' ' ' ILE . 58.3 t -62.84 -56.99 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.903 . . . . 0.0 109.461 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.526 ' CB ' HG22 ' A' ' 30' ' ' THR . 18.8 m-85 -73.28 -2.49 22.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.342 -0.849 . . . . 0.0 109.618 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.413 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 0.7 OUTLIER -85.65 -55.14 4.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.145 -0.972 . . . . 0.0 109.45 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.8 mttt -69.54 -19.81 63.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.311 -0.868 . . . . 0.0 109.457 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.475 ' HB3' ' CD2' ' A' ' 28' ' ' TYR . 1.4 tt0 -78.55 -30.97 47.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.258 -0.901 . . . . 0.0 109.45 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.443 ' O ' ' CG ' ' A' ' 28' ' ' TYR . . . 110.07 64.48 0.53 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.475 ' CD2' ' HB3' ' A' ' 26' ' ' GLU . 93.7 m-85 -154.76 134.73 13.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.225 -1.162 . . . . 0.0 109.503 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 22.5 mm-40 -91.67 81.8 5.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.286 -0.884 . . . . 0.0 109.409 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.526 HG22 ' CB ' ' A' ' 23' ' ' PHE . 5.9 p -89.88 152.58 21.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.275 -0.89 . . . . 0.0 109.56 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.521 ' HB2' ' CD2' ' A' ' 7' ' ' LEU . 58.8 m-85 -116.48 -170.23 1.78 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.301 -0.875 . . . . 0.0 109.402 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.405 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 22.1 mp0 -124.17 161.26 26.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.241 -0.912 . . . . 0.0 109.547 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.448 ' HB1' HD13 ' A' ' 7' ' ' LEU . . . 178.49 177.52 0.44 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 109.437 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.505 ' N ' HG11 ' A' ' 9' ' ' VAL . . . 178.73 -41.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.217 -0.927 . . . . 0.0 109.466 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.41 ' OD1' ' CB ' ' A' ' 38' ' ' GLN . 30.9 p-10 -65.18 -10.58 32.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.923 . . . . 0.0 109.459 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.416 ' O ' ' C ' ' A' ' 37' ' ' LEU . . . 87.9 -71.42 2.58 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.464 ' O ' ' HB2' ' A' ' 40' ' ' LEU . 1.9 tt -44.46 -42.21 6.89 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -1.147 . . . . 0.0 109.395 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.513 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 6.6 tp-100 -58.72 -53.87 53.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.264 -0.898 . . . . 0.0 109.504 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.462 ' HB3' HG21 ' A' ' 9' ' ' VAL . . . -55.69 -24.16 32.81 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.15 -0.969 . . . . 0.0 109.493 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 37' ' ' LEU . 54.9 mt -73.06 -45.46 57.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.91 . . . . 0.0 109.517 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 42' ' ' ILE . 1.7 p30 -64.81 -43.02 94.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.182 -0.949 . . . . 0.0 109.449 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.525 ' CG2' HD22 ' A' ' 7' ' ' LEU . 7.2 mt -64.23 -34.77 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.21 -0.931 . . . . 0.0 109.268 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.522 ' HA ' ' CD ' ' A' ' 48' ' ' PRO . 54.2 t -74.32 -24.03 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.891 . . . . 0.0 109.453 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.2 m -89.7 -18.72 25.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.228 -0.92 . . . . 0.0 109.532 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.95 -55.65 3.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.285 -0.884 . . . . 0.0 109.483 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.438 ' O ' ' CB ' ' A' ' 47' ' ' ARG . 1.1 mt-10 -89.98 -39.04 13.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.268 -0.895 . . . . 0.0 109.458 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER 71.28 65.91 0.39 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.23 -0.919 . . . . 0.0 109.498 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.522 ' CD ' ' HA ' ' A' ' 43' ' ' VAL . 35.5 Cg_endo -78.14 167.99 22.52 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.589 2.192 . . . . 0.0 110.421 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -109.43 -9.91 14.92 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.218 -0.926 . . . . 0.0 109.533 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -117.84 121.51 40.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -0.937 . . . . 0.0 109.543 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 72.9 t -127.33 140.93 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.257 -0.902 . . . . 0.0 109.471 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.463 HD11 ' O ' ' A' ' 7' ' ' LEU . 1.1 mp -115.27 112.17 22.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.309 -0.87 . . . . 0.0 109.423 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.517 ' CD2' ' HG ' ' A' ' 66' ' ' LEU . 1.7 mp -102.59 132.02 48.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.282 -0.886 . . . . 0.0 109.517 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.46 ' O ' HG13 ' A' ' 57' ' ' ILE . 17.7 t70 -112.76 130.14 56.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.319 -0.863 . . . . 0.0 109.453 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.497 ' CG ' HG23 ' A' ' 82' ' ' THR . 9.6 mmt -86.84 -6.98 58.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.322 -0.861 . . . . 0.0 109.555 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt -86.58 15.02 5.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.166 -0.959 . . . . 0.0 109.498 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.508 ' HA ' ' CB ' ' A' ' 11' ' ' ASP . 41.7 mt -80.97 138.78 49.57 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.128 -0.983 . . . . 0.0 109.309 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.465 ' HD2' HG21 ' A' ' 57' ' ' ILE . 36.2 Cg_endo -78.54 -36.15 0.96 Allowed 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.488 2.126 . . . . 0.0 110.549 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 58' ' ' PRO . . . -42.41 -53.79 4.91 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.502 ' N ' ' SD ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -169.47 -150.3 0.08 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.136 -1.214 . . . . 0.0 109.558 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.497 ' N ' ' HG2' ' A' ' 60' ' ' MET . 36.9 m-20 -90.19 -97.28 0.11 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.291 -0.881 . . . . 0.0 109.481 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.465 ' HA2' HG13 ' A' ' 65' ' ' ILE . . . 147.42 -14.76 1.44 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.457 HD13 ' HB3' ' A' ' 89' ' ' MET . 14.4 mm -57.0 -18.72 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.314 -1.109 . . . . 0.0 109.238 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -87.47 -33.52 18.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.313 -0.867 . . . . 0.0 109.24 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.465 HG13 ' HA2' ' A' ' 62' ' ' GLY . 17.2 mt -56.15 -54.58 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.338 -0.851 . . . . 0.0 109.319 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.518 HD23 ' CG1' ' A' ' 78' ' ' VAL . 23.0 mt -51.02 -44.49 61.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 109.31 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.463 ' O ' HG21 ' A' ' 71' ' ' VAL . 3.2 tttp -52.38 -50.32 62.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.326 -0.859 . . . . 0.0 109.411 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.46 ' O ' HG13 ' A' ' 72' ' ' ILE . 0.3 OUTLIER -59.28 -31.5 69.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.286 -0.884 . . . . 0.0 109.431 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.418 ' HE2' ' CG1' ' A' ' 51' ' ' VAL . 2.7 mtt -74.47 -24.92 59.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.278 -0.889 . . . . 0.0 109.435 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -79.95 -28.93 39.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.379 -0.826 . . . . 0.0 109.264 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.463 HG21 ' O ' ' A' ' 67' ' ' LYS . 2.7 t -90.08 -22.04 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.306 -0.871 . . . . 0.0 109.549 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 68' ' ' ARG . 53.3 mt -87.43 -44.56 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -0.909 . . . . 0.0 109.459 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.442 ' O ' HG23 ' A' ' 76' ' ' ILE . 73.0 m-20 -150.49 122.69 8.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.331 -0.856 . . . . 0.0 109.404 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -81.99 -9.62 59.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.277 -0.889 . . . . 0.0 109.522 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -103.37 49.87 0.82 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.233 -0.917 . . . . 0.0 109.493 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.505 ' CD1' ' O ' ' A' ' 48' ' ' PRO . 1.1 tp -129.94 112.62 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.466 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.517 ' CD ' HD13 ' A' ' 99' ' ' LEU . 1.6 mtt180 -79.85 154.19 28.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 0.0 109.468 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.518 ' CG1' HD23 ' A' ' 66' ' ' LEU . 4.8 t -150.02 108.44 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.913 . . . . 0.0 109.572 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.585 ' CG2' ' CG2' ' A' ' 100' ' ' THR . 72.5 mt -90.5 140.81 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.247 -0.908 . . . . 0.0 109.449 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.581 ' HB ' ' CE1' ' A' ' 101' ' ' HIS . 0.0 OUTLIER -94.44 152.32 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.271 -0.893 . . . . 0.0 109.198 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.452 ' O ' ' HB ' ' A' ' 82' ' ' THR . 14.0 mtm -124.53 73.16 1.24 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.183 -0.948 . . . . 0.0 109.373 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.516 HG21 ' NE2' ' A' ' 101' ' ' HIS . 9.6 t 177.29 56.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.31 -0.869 . . . . 0.0 109.397 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.418 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -82.09 -15.39 53.62 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.281 -0.887 . . . . 0.0 109.528 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -89.98 84.31 6.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.211 -0.931 . . . . 0.0 109.525 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 142.23 -96.87 0.2 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.423 ' OE2' ' HB3' ' A' ' 55' ' ' MET . 0.4 OUTLIER -53.34 146.76 11.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.324 -1.104 . . . . 0.0 109.59 -179.94 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.538 ' HA ' ' CG2' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -160.11 23.01 0.17 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.281 -0.887 . . . . 0.0 109.431 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -96.75 -77.92 0.48 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.204 -0.935 . . . . 0.0 109.513 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.506 ' O ' ' CB ' ' A' ' 93' ' ' SER . 1.8 mmt -79.23 3.82 16.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.27 -0.894 . . . . 0.0 109.57 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.627 ' CD1' ' CE1' ' A' ' 101' ' ' HIS . 0.1 OUTLIER -90.47 -53.22 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.231 -0.918 . . . . 0.0 108.862 179.533 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -51.35 -37.15 46.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.255 -0.903 . . . . 0.0 109.5 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 93' ' ' SER . 1.4 mt-10 -90.15 -36.28 14.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.226 -0.921 . . . . 0.0 109.625 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.506 ' CB ' ' O ' ' A' ' 89' ' ' MET . 0.4 OUTLIER -43.55 -44.92 6.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.312 -0.868 . . . . 0.0 109.649 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 93' ' ' SER . 2.5 ttpt -44.02 -51.79 7.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.282 -0.886 . . . . 0.0 109.445 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -59.5 -40.99 88.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 0.0 109.431 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.509 ' N ' ' CD2' ' A' ' 96' ' ' LEU . 4.2 mm? -53.31 -64.99 0.64 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.296 -0.878 . . . . 0.0 109.49 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -176.08 40.98 0.11 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.42 ' O ' ' C ' ' A' ' 99' ' ' LEU . . . -110.77 101.33 9.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -1.164 . . . . 0.0 109.49 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.517 HD13 ' CD ' ' A' ' 77' ' ' ARG . 18.6 mt -44.1 -68.32 0.21 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 109.47 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.585 ' CG2' ' CG2' ' A' ' 79' ' ' ILE . 15.1 t -134.9 -177.6 4.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.284 -0.885 . . . . 0.0 109.437 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.627 ' CE1' ' CD1' ' A' ' 90' ' ' ILE . 3.2 t-160 -140.48 88.35 2.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 109.339 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.562 ' CE2' HG22 ' A' ' 79' ' ' ILE . 65.5 m-85 -58.99 -164.35 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.236 -0.915 . . . . 0.0 109.579 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.418 ' CB ' ' HB1' ' A' ' 83' ' ' ALA . . . -177.27 155.31 1.12 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.199 -0.938 . . . . 0.0 109.361 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.507 ' HA ' ' N ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -93.41 142.14 24.84 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.211 -0.931 . . . . 0.0 109.387 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.91 117.1 4.9 Favored 'Cis proline' 0 C--N 1.31 -1.479 0 C-N-CA 123.335 -1.527 . . . . 0.0 110.353 -0.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.507 ' N ' ' HA ' ' A' ' 104' ' ' LYS . 11.1 p90 -79.84 169.6 17.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.248 -0.908 . . . . 0.0 109.574 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.454 ' O ' HG12 ' A' ' 111' ' ' ILE . 36.0 t0 -119.77 121.73 39.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.347 -0.846 . . . . 0.0 109.473 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.474 ' CG2' HG12 ' A' ' 22' ' ' VAL . 14.5 mm -54.63 -21.28 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -0.897 . . . . 0.0 109.509 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -76.24 -37.52 57.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.235 -0.916 . . . . 0.0 109.518 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -77.57 -25.31 49.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.184 -0.947 . . . . 0.0 109.436 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.524 HD11 ' CZ ' ' A' ' 102' ' ' PHE . 19.2 mm -75.73 -45.85 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.313 -0.867 . . . . 0.0 109.516 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.447 ' HB2' ' OE1' ' A' ' 26' ' ' GLU . 7.6 ptt85 -72.51 -41.88 65.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.472 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -61.16 -53.43 57.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.928 . . . . 0.0 109.538 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.472 ' HA ' ' HG2' ' A' ' 117' ' ' LYS . . . -59.18 -45.06 92.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.292 -0.88 . . . . 0.0 109.47 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 111' ' ' ILE . 54.7 t -60.48 -25.19 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.191 -0.943 . . . . 0.0 109.396 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -76.89 -45.66 27.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.179 -0.95 . . . . 0.0 109.451 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.514 ' HG3' ' N ' ' A' ' 118' ' ' TYR . 0.0 OUTLIER -63.49 -27.08 69.03 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 109.481 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.514 ' N ' ' HG3' ' A' ' 117' ' ' LYS . 38.9 m-85 -84.51 -72.84 0.45 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.24 -0.912 . . . . 0.0 109.423 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.8 tp -90.06 112.58 53.18 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.341 -0.849 . . . . 0.0 109.422 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 118' ' ' TYR . 35.6 Cg_endo -77.79 132.76 12.15 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.33 2.02 . . . . 0.0 110.418 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.49 ' CD1' ' HG3' ' A' ' 4' ' ' GLU . 0.6 OUTLIER -133.54 12.15 4.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.327 -0.858 . . . . 0.0 109.47 -179.917 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.57 26.22 0.23 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.213 -0.929 . . . . 0.0 109.507 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -142.62 -77.22 0.25 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.198 -0.939 . . . . 0.0 109.529 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.453 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptp . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 28.7 mtp -63.4 -150.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.175 -0.953 . . . . 0.0 109.408 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.31 149.31 31.6 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.252 -0.905 . . . . 0.0 109.473 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.567 ' OE1' ' CD2' ' A' ' 28' ' ' TYR . 1.6 mm-40 -82.91 111.6 18.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.173 -0.954 . . . . 0.0 109.47 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.496 ' CB ' ' HA ' ' A' ' 48' ' ' PRO . 42.3 mttt -121.96 120.52 34.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -0.916 . . . . 0.0 109.485 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.477 HG21 ' N ' ' A' ' 7' ' ' LEU . 49.1 mt -148.51 150.93 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.157 -0.964 . . . . 0.0 109.483 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.515 HD11 ' CG2' ' A' ' 42' ' ' ILE . 0.6 OUTLIER -133.56 127.83 33.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.183 -0.948 . . . . 0.0 109.432 -179.999 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.461 HD12 ' HB3' ' A' ' 19' ' ' LEU . 8.4 mt -101.02 109.54 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.244 -0.91 . . . . 0.0 109.522 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.45 HG22 HD12 ' A' ' 53' ' ' LEU . 17.0 t -96.27 91.33 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.23 -0.919 . . . . 0.0 109.427 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.518 ' O ' ' CD ' ' A' ' 16' ' ' ARG . 16.7 t70 -145.27 146.01 31.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.264 -0.898 . . . . 0.0 109.45 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.456 ' OD2' ' HD2' ' A' ' 58' ' ' PRO . 9.1 p-10 -109.88 -37.75 5.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.185 -0.947 . . . . 0.0 109.501 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.414 ' O ' ' C ' ' A' ' 13' ' ' TYR . 1.8 tp60 -63.01 104.84 0.6 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.232 -0.918 . . . . 0.0 109.448 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.568 ' CZ ' HG13 ' A' ' 17' ' ' ILE . 9.2 t80 -44.73 132.3 6.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.243 -0.911 . . . . 0.0 109.447 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 18' ' ' LEU . . . 138.72 -47.11 0.94 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.526 HG21 ' CD1' ' A' ' 19' ' ' LEU . 4.5 mt -82.85 -43.62 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.174 -1.192 . . . . 0.0 109.491 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.518 ' CD ' ' O ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -63.0 -24.05 67.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.89 . . . . 0.0 109.505 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.568 HG13 ' CZ ' ' A' ' 13' ' ' TYR . 5.3 mm -90.1 -55.41 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.212 -0.93 . . . . 0.0 109.598 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' A' ' 14' ' ' GLY . 0.3 OUTLIER -56.61 -58.57 7.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 109.573 -179.853 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.526 ' CD1' HG21 ' A' ' 15' ' ' ILE . 5.0 mp -57.86 -21.23 41.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.905 . . . . 0.0 109.552 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 12.7 t30 -74.16 -71.11 0.35 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.316 -0.865 . . . . 0.0 109.469 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.451 ' N ' ' OE1' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -45.57 -44.18 12.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 0.0 109.522 -179.897 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.521 HG22 ' CD1' ' A' ' 108' ' ' ILE . 48.2 t -58.93 -53.18 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.218 -0.926 . . . . 0.0 109.431 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.568 ' CZ ' HG22 ' A' ' 115' ' ' VAL . 21.8 m-85 -78.13 2.33 18.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.372 -0.83 . . . . 0.0 109.622 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.457 ' ND2' ' OD1' ' A' ' 20' ' ' ASN . 0.6 OUTLIER -90.02 -50.32 6.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.139 -0.975 . . . . 0.0 109.532 179.896 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.5 tttp -79.57 -44.68 20.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.178 -0.951 . . . . 0.0 109.49 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.528 ' HB3' ' CD1' ' A' ' 28' ' ' TYR . 0.9 OUTLIER -49.09 -34.29 13.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 109.453 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.526 ' C ' ' CD1' ' A' ' 28' ' ' TYR . . . 110.26 66.26 0.55 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.577 ' CE2' HD23 ' A' ' 121' ' ' LEU . 70.1 m-85 -148.64 135.62 20.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.333 -1.099 . . . . 0.0 109.5 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 4' ' ' GLU . 5.6 mm100 -92.39 83.02 4.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.306 -0.871 . . . . 0.0 109.266 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.52 HG23 ' CD2' ' A' ' 23' ' ' PHE . 5.7 p -89.98 158.63 17.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.914 . . . . 0.0 109.571 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.549 ' CD2' HG23 ' A' ' 42' ' ' ILE . 8.8 m-85 -118.18 -163.56 0.95 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.289 -0.882 . . . . 0.0 109.465 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -144.52 147.89 33.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.166 -0.959 . . . . 0.0 109.519 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -168.36 -176.24 2.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.903 . . . . 0.0 109.417 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.459 ' O ' ' HE2' ' A' ' 60' ' ' MET . . . 177.98 -31.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.214 -0.929 . . . . 0.0 109.498 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -76.42 -8.06 56.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.259 -0.9 . . . . 0.0 109.514 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.462 ' HA2' HD12 ' A' ' 65' ' ' ILE . . . 86.13 -47.44 3.77 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.447 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -59.16 -43.26 92.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -1.113 . . . . 0.0 109.435 -179.983 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.525 ' O ' ' CD1' ' A' ' 42' ' ' ILE . 18.8 mm-40 -69.1 -24.31 64.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.324 -0.86 . . . . 0.0 109.436 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.441 ' HA ' HD23 ' A' ' 7' ' ' LEU . . . -70.98 -57.85 4.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -0.882 . . . . 0.0 109.515 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.407 HD23 ' HB3' ' A' ' 68' ' ' ARG . 12.7 mt -64.02 -31.41 72.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.188 -0.945 . . . . 0.0 109.531 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 37' ' ' LEU . 3.9 t0 -64.87 -49.88 68.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.27 -0.894 . . . . 0.0 109.459 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.549 HG23 ' CD2' ' A' ' 31' ' ' PHE . 3.6 mt -70.21 -20.17 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.25 -0.906 . . . . 0.0 109.477 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.501 ' HA ' ' CD ' ' A' ' 48' ' ' PRO . 55.5 t -77.67 -34.33 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.911 . . . . 0.0 109.489 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.416 ' O ' HG21 ' A' ' 44' ' ' THR . 18.3 m -90.02 -16.03 30.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.182 -0.949 . . . . 0.0 109.483 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.27 -51.44 5.76 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.252 -0.905 . . . . 0.0 109.552 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 47' ' ' ARG . 0.9 OUTLIER -92.88 -26.03 17.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.236 -0.915 . . . . 0.0 109.518 -179.925 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.482 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 12.8 mtm180 61.02 63.16 2.6 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.254 -0.903 . . . . 0.0 109.452 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.519 ' O ' ' CD1' ' A' ' 76' ' ' ILE . 35.2 Cg_endo -77.81 -178.32 4.52 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.594 2.196 . . . . 0.0 110.388 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.457 ' O ' HD23 ' A' ' 50' ' ' LEU . 55.5 m-20 -128.06 -2.76 5.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.302 -0.874 . . . . 0.0 109.673 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.457 HD23 ' O ' ' A' ' 49' ' ' ASP . 3.8 mm? -131.49 106.06 7.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.176 -0.952 . . . . 0.0 109.502 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.496 ' O ' ' CG1' ' A' ' 78' ' ' VAL . 1.5 t -115.88 121.41 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.9 . . . . 0.0 109.45 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.444 ' HB3' ' CE ' ' A' ' 81' ' ' MET . 1.1 mp -94.99 110.53 22.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.262 -0.899 . . . . 0.0 109.437 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.581 ' CD2' ' CG1' ' A' ' 78' ' ' VAL . 2.9 mm? -104.41 133.11 49.84 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.189 -0.944 . . . . 0.0 109.547 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -118.0 129.35 55.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.908 . . . . 0.0 109.488 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.494 ' CG ' HG23 ' A' ' 82' ' ' THR . 27.7 mmt -78.75 3.35 16.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 109.562 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.458 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 2.0 mmmm -78.16 -28.19 48.23 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.149 -0.969 . . . . 0.0 109.424 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.574 ' CG2' ' CE ' ' A' ' 60' ' ' MET . 44.3 mt -43.06 103.15 0.3 Allowed Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.392 -0.818 . . . . 0.0 109.552 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 56' ' ' LYS . 35.3 Cg_endo -77.76 71.74 6.41 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.497 2.131 . . . . 0.0 110.387 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -164.4 -47.67 0.02 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.574 ' CE ' ' CG2' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -153.21 135.09 14.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.262 -1.14 . . . . 0.0 109.454 179.897 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -56.65 136.47 54.78 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.205 -0.934 . . . . 0.0 109.482 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.46 ' HA2' HG13 ' A' ' 65' ' ' ILE . . . -83.69 9.69 61.67 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 38.7 mm -67.62 -45.05 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.191 -1.182 . . . . 0.0 109.475 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -66.83 -25.48 66.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.235 -0.915 . . . . 0.0 109.449 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.462 HD12 ' HA2' ' A' ' 36' ' ' GLY . 7.2 mt -69.81 -68.24 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.34 -0.85 . . . . 0.0 109.434 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.513 ' CD2' HG13 ' A' ' 78' ' ' VAL . 3.1 mt -50.35 -39.37 46.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.267 -0.896 . . . . 0.0 109.528 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.7 ttpp -60.68 -39.41 88.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -0.876 . . . . 0.0 109.505 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.407 ' HB3' HD23 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -68.25 -58.28 4.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.234 -0.916 . . . . 0.0 109.515 -179.894 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.454 ' SD ' HD22 ' A' ' 66' ' ' LEU . 2.2 ptp -60.71 -13.72 16.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.267 -0.896 . . . . 0.0 109.548 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.449 ' HB3' ' O ' ' A' ' 66' ' ' LEU . 0.6 OUTLIER -89.72 -31.58 17.39 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.836 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.42 ' O ' HG11 ' A' ' 71' ' ' VAL . 52.8 t -75.09 -28.97 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 109.195 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.5 mt -90.05 -44.52 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.363 -0.836 . . . . 0.0 109.419 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.524 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 15.0 t0 -132.05 116.78 17.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.16 -0.962 . . . . 0.0 109.427 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.01 -40.45 12.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.248 -0.908 . . . . 0.0 109.544 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -61.23 -13.87 21.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.281 -0.887 . . . . 0.0 109.46 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.524 ' CG2' ' O ' ' A' ' 73' ' ' ASP . 1.0 OUTLIER -60.51 112.03 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.2 -0.937 . . . . 0.0 109.525 179.922 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.455 ' HD3' ' HB3' ' A' ' 118' ' ' TYR . 5.0 mtt85 -71.19 142.43 50.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.213 -0.929 . . . . 0.0 109.436 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.581 ' CG1' ' CD2' ' A' ' 53' ' ' LEU . 15.9 t -145.05 150.58 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.237 -0.915 . . . . 0.0 109.631 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.461 HG22 ' O ' ' A' ' 100' ' ' THR . 11.1 mt -134.19 141.33 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.266 -0.896 . . . . 0.0 109.433 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.578 ' HB ' ' CE1' ' A' ' 101' ' ' HIS . 0.1 OUTLIER -96.74 141.77 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.172 -0.955 . . . . 0.0 109.206 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.452 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 2.8 mtm -113.88 59.85 0.67 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.145 -0.972 . . . . 0.0 109.508 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.494 HG23 ' CG ' ' A' ' 55' ' ' MET . 14.2 t -172.43 43.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.176 -0.952 . . . . 0.0 109.521 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.566 ' N ' ' NE2' ' A' ' 101' ' ' HIS . . . -52.99 -74.5 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.266 -0.896 . . . . 0.0 109.526 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -56.52 104.42 0.15 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 109.522 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 175.16 -72.12 0.09 OUTLIER Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.458 ' O ' HG22 ' A' ' 90' ' ' ILE . 3.9 pt-20 -155.51 140.46 17.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.182 -1.187 . . . . 0.0 109.477 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.564 ' CD2' ' N ' ' A' ' 87' ' ' LEU . 2.4 mm? -103.71 68.55 0.93 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.338 -0.851 . . . . 0.0 109.435 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.531 ' O ' ' CB ' ' A' ' 89' ' ' MET . 21.3 m-20 -121.36 101.11 7.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.274 -0.891 . . . . 0.0 109.359 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.531 ' CB ' ' O ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER 77.67 -2.4 2.54 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.369 -0.832 . . . . 0.0 109.341 -179.49 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.622 ' CD1' ' CE1' ' A' ' 101' ' ' HIS . 0.2 OUTLIER -90.86 -50.16 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.353 -0.842 . . . . 0.0 108.905 179.619 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.78 -38.26 15.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.315 -0.865 . . . . 0.0 109.573 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -90.02 -40.73 12.13 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.227 -0.92 . . . . 0.0 109.619 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.534 ' O ' ' CA ' ' A' ' 97' ' ' GLY . 9.9 m -58.73 -15.22 11.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.202 -0.936 . . . . 0.0 109.644 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.534 ' HA ' ' CB ' ' A' ' 98' ' ' ALA . 1.7 ttpt -88.89 -45.86 9.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.155 -0.966 . . . . 0.0 109.506 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.488 ' C ' ' CD2' ' A' ' 96' ' ' LEU . 10.0 mm-40 -47.62 -44.24 26.52 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.515 -0.741 . . . . 0.0 110.542 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.502 HD21 ' N ' ' A' ' 96' ' ' LEU . 3.3 mm? -132.38 5.51 4.07 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.93 -1.106 . . . . 0.0 110.704 -179.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.534 ' CA ' ' O ' ' A' ' 93' ' ' SER . . . -124.39 -14.19 3.68 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.473 -1.346 . . . . 0.0 109.99 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.534 ' CB ' ' HA ' ' A' ' 94' ' ' LYS . . . -149.84 98.03 2.68 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.166 -1.196 . . . . 0.0 109.615 -179.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.437 HD13 ' CA ' ' A' ' 77' ' ' ARG . 0.7 OUTLIER -48.79 -61.1 2.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.235 -0.915 . . . . 0.0 109.478 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.461 ' O ' HG22 ' A' ' 79' ' ' ILE . 16.7 m -113.53 157.68 21.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 109.476 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.622 ' CE1' ' CD1' ' A' ' 90' ' ' ILE . 3.4 t-160 -135.52 85.5 2.17 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.325 -0.859 . . . . 0.0 109.331 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.553 ' CE1' ' HG2' ' A' ' 110' ' ' GLU . 11.7 m-85 -73.13 158.27 35.62 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.198 -0.939 . . . . 0.0 109.575 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.51 ' HB3' ' N ' ' A' ' 83' ' ' ALA . . . -144.61 151.99 39.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.348 -0.845 . . . . 0.0 109.424 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.456 ' HG3' ' HA ' ' A' ' 105' ' ' PRO . 0.6 OUTLIER -45.1 137.04 4.84 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.235 -0.916 . . . . 0.0 109.304 -179.937 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' A' ' 103' ' ' ALA . 35.7 Cg_endo -77.78 -172.6 11.47 Favored 'Cis proline' 0 C--N 1.312 -1.363 0 C-N-CA 123.365 -1.514 . . . . 0.0 110.403 -0.03 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.636 ' CZ ' ' CD1' ' A' ' 111' ' ' ILE . 0.4 OUTLIER -118.66 111.52 18.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.212 -0.93 . . . . 0.0 109.492 -179.96 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.464 ' O ' HG12 ' A' ' 111' ' ' ILE . 22.1 t0 -89.94 105.79 18.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.262 -0.899 . . . . 0.0 109.36 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.521 ' CD1' HG22 ' A' ' 22' ' ' VAL . 13.7 mm -45.92 -24.63 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.226 -0.921 . . . . 0.0 109.772 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.408 ' O ' ' HG2' ' A' ' 112' ' ' ARG . 9.6 m-20 -69.75 -47.55 62.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.904 . . . . 0.0 109.542 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.553 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 0.9 OUTLIER -69.19 -30.23 68.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -0.901 . . . . 0.0 109.475 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.636 ' CD1' ' CZ ' ' A' ' 106' ' ' PHE . 14.7 mm -68.01 -46.31 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.234 -0.916 . . . . 0.0 109.399 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.46 ' O ' ' HG3' ' A' ' 116' ' ' LYS . 3.2 ptt180 -74.06 -20.76 60.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.354 -0.841 . . . . 0.0 109.572 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -73.54 -51.38 17.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.157 -0.965 . . . . 0.0 109.495 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.544 ' O ' ' CD2' ' A' ' 118' ' ' TYR . . . -70.06 -31.63 69.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 109.535 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.568 HG22 ' CZ ' ' A' ' 23' ' ' PHE . 72.4 t -74.95 -31.45 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -0.923 . . . . 0.0 109.57 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 0.1 OUTLIER -74.55 -42.55 58.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.21 -0.931 . . . . 0.0 109.583 179.957 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.443 ' HE2' ' HA ' ' A' ' 117' ' ' LYS . 0.0 OUTLIER -64.15 -50.42 68.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.921 . . . . 0.0 109.519 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.544 ' CD2' ' O ' ' A' ' 114' ' ' ALA . 14.8 m-85 -65.62 -63.71 1.03 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.207 -0.933 . . . . 0.0 109.486 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.455 HD21 ' CD2' ' A' ' 121' ' ' LEU . 2.9 tt -87.91 113.2 53.62 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.161 -0.962 . . . . 0.0 109.405 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 118' ' ' TYR . 35.7 Cg_endo -77.87 139.93 17.92 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.353 2.035 . . . . 0.0 110.401 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.577 HD23 ' CE2' ' A' ' 28' ' ' TYR . 2.8 mm? -113.33 -166.51 1.09 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.251 -0.906 . . . . 0.0 109.51 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 121' ' ' LEU . 13.2 mttt -43.4 125.83 4.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.388 -0.82 . . . . 0.0 109.556 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 28.1 t -48.07 102.69 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.889 . . . . 0.0 109.451 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.9 m120 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.39 179.914 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.665 ' HB3' HD21 ' A' ' 121' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.52 ' O ' ' CB ' ' A' ' 48' ' ' PRO . 0.4 OUTLIER -103.69 118.12 35.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.201 -0.937 . . . . 0.0 109.502 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.707 ' HB ' HG22 ' A' ' 30' ' ' THR . 13.8 mt -116.31 153.16 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.174 -0.954 . . . . 0.0 109.422 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.847 HD23 HG21 ' A' ' 42' ' ' ILE . 1.9 tm? -131.42 110.83 11.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.195 -0.94 . . . . 0.0 109.516 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.89 HG22 ' NH1' ' A' ' 16' ' ' ARG . 3.4 mt -90.07 108.11 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -0.879 . . . . 0.0 109.324 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.748 HG22 HD12 ' A' ' 7' ' ' LEU . 2.8 t -98.36 117.42 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.221 -0.924 . . . . 0.0 109.654 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.585 ' CB ' ' CZ ' ' A' ' 16' ' ' ARG . 24.9 t0 -175.17 154.94 1.85 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.337 -0.852 . . . . 0.0 109.421 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.463 ' CG ' ' HD2' ' A' ' 58' ' ' PRO . 5.3 p-10 -105.95 -46.12 4.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.165 -0.96 . . . . 0.0 109.501 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.46 ' HG2' ' OD2' ' A' ' 10' ' ' ASP . 19.1 pt20 -50.04 127.51 16.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.241 -0.912 . . . . 0.0 109.527 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.911 ' CE2' HD11 ' A' ' 17' ' ' ILE . 8.2 t80 -80.86 157.95 25.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.257 -0.902 . . . . 0.0 109.645 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 116.31 -69.32 0.28 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.568 ' CG2' ' NH2' ' A' ' 16' ' ' ARG . 5.8 mt -64.02 -25.43 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.32 -1.106 . . . . 0.0 109.173 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.89 ' NH1' HG22 ' A' ' 8' ' ' ILE . 3.7 mmp_? -65.34 -24.75 67.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.886 . . . . 0.0 109.403 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.911 HD11 ' CE2' ' A' ' 13' ' ' TYR . 6.1 mt -89.95 -24.9 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.343 -0.848 . . . . 0.0 109.387 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.842 ' O ' HG23 ' A' ' 22' ' ' VAL . 49.3 mt -74.24 -50.83 17.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.312 -0.868 . . . . 0.0 109.499 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.734 ' HB2' HD13 ' A' ' 8' ' ' ILE . 7.2 mt -69.16 -20.1 64.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 109.408 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -77.02 -58.95 2.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.26 -0.9 . . . . 0.0 109.491 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.439 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 14.0 mt-10 -59.58 -47.89 83.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.917 . . . . 0.0 109.5 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.842 HG23 ' O ' ' A' ' 18' ' ' LEU . 22.2 t -57.21 -57.32 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.229 -0.92 . . . . 0.0 109.442 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.509 ' CD2' ' O ' ' A' ' 19' ' ' LEU . 24.0 m-85 -71.81 -4.26 26.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.164 -0.96 . . . . 0.0 109.599 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.439 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 1.7 m-20 -82.21 -55.67 4.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -0.899 . . . . 0.0 109.463 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.407 ' O ' ' C ' ' A' ' 26' ' ' GLU . 1.8 mptt -73.87 -46.11 46.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.278 -0.889 . . . . 0.0 109.474 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.575 ' HB3' ' CD1' ' A' ' 28' ' ' TYR . 4.6 tt0 -44.05 -35.26 2.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.16 -0.963 . . . . 0.0 109.476 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.539 ' C ' ' CD1' ' A' ' 28' ' ' TYR . . . 114.57 55.03 0.39 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.577 ' CE2' ' HG ' ' A' ' 121' ' ' LEU . 32.8 m-85 -143.22 135.03 26.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -1.152 . . . . 0.0 109.475 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -94.42 81.04 3.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.27 -0.894 . . . . 0.0 109.387 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.707 HG22 ' HB ' ' A' ' 6' ' ' ILE . 5.9 p -89.97 154.43 19.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.895 . . . . 0.0 109.556 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.562 ' HB2' HD22 ' A' ' 7' ' ' LEU . 6.8 m-85 -118.05 -171.5 2.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.299 -0.876 . . . . 0.0 109.341 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -130.5 146.94 52.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.897 . . . . 0.0 109.505 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -153.94 -172.56 4.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -0.92 . . . . 0.0 109.472 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.78 -88.01 0.1 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.219 -0.926 . . . . 0.0 109.495 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.539 ' ND2' ' HB2' ' A' ' 37' ' ' LEU . 21.5 p-10 -65.98 139.17 58.21 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.271 -0.893 . . . . 0.0 109.474 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.44 ' HA3' ' CD1' ' A' ' 65' ' ' ILE . . . -43.89 -34.53 2.98 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.539 ' HB2' ' ND2' ' A' ' 35' ' ' ASN . 3.2 mp -51.03 -53.15 36.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.195 -1.179 . . . . 0.0 109.44 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.475 ' HB2' ' OD1' ' A' ' 35' ' ' ASN . 1.4 tp-100 -60.93 -51.31 69.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.246 -0.908 . . . . 0.0 109.436 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.847 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -43.82 -39.67 3.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.251 -0.905 . . . . 0.0 109.558 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 65.5 mt -71.95 -42.69 66.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.302 -0.873 . . . . 0.0 109.519 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -53.67 -57.81 9.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.255 -0.903 . . . . 0.0 109.491 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.847 HG21 HD23 ' A' ' 7' ' ' LEU . 2.0 mp -62.1 -33.16 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.145 -0.972 . . . . 0.0 109.478 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 39' ' ' ALA . 48.1 t -66.35 -24.02 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -0.858 . . . . 0.0 109.467 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.4 m -90.07 -30.58 17.61 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.262 -0.899 . . . . 0.0 109.533 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.496 ' HG2' ' HA ' ' A' ' 42' ' ' ILE . 0.0 OUTLIER -90.06 -7.86 52.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.313 -0.867 . . . . 0.0 109.54 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.484 ' HG3' ' CD ' ' A' ' 45' ' ' LYS . 14.8 mt-10 -132.48 -36.75 1.09 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.925 . . . . 0.0 109.47 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 43' ' ' VAL . 0.8 OUTLIER 55.84 65.01 4.76 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.276 -0.89 . . . . 0.0 109.444 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.52 ' CB ' ' O ' ' A' ' 5' ' ' LYS . 35.4 Cg_endo -77.91 154.08 29.6 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.683 2.256 . . . . 0.0 110.394 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 3.5 m-20 -92.64 -13.33 29.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.259 -0.9 . . . . 0.0 109.462 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.471 HD21 HG22 ' A' ' 115' ' ' VAL . 1.0 OUTLIER -120.73 116.87 26.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.213 -0.93 . . . . 0.0 109.46 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.677 ' HB ' HG13 ' A' ' 78' ' ' VAL . 43.6 t -122.0 123.31 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 0.0 109.496 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.88 120.86 40.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.254 -0.903 . . . . 0.0 109.44 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.765 HD21 ' HB ' ' A' ' 65' ' ' ILE . 1.3 mp -108.61 122.21 46.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.256 -0.903 . . . . 0.0 109.506 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.431 ' OD2' ' OD1' ' A' ' 10' ' ' ASP . 33.3 t0 -97.26 111.33 23.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.361 -0.837 . . . . 0.0 109.427 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 18.8 mmt -75.03 -0.64 19.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.917 . . . . 0.0 109.576 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.4 mmmt -90.04 15.45 10.08 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.213 -0.93 . . . . 0.0 109.536 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.454 ' HA ' ' OD1' ' A' ' 11' ' ' ASP . 48.3 mt -76.53 132.45 72.43 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.941 . . . . 0.0 109.339 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.463 ' HD2' ' CG ' ' A' ' 11' ' ' ASP . 36.2 Cg_endo -78.93 74.74 5.39 Favored 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.478 2.119 . . . . 0.0 110.4 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -170.73 -63.94 0.04 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.509 ' N ' ' SD ' ' A' ' 60' ' ' MET . 0.1 OUTLIER -153.49 176.3 12.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -1.172 . . . . 0.0 109.566 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -90.08 135.59 33.56 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.197 -0.94 . . . . 0.0 109.487 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.498 ' HA2' HD12 ' A' ' 65' ' ' ILE . . . -72.43 -8.74 71.87 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.443 ' HA ' HD13 ' A' ' 63' ' ' ILE . 18.8 mm -44.02 -50.24 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.23 -1.159 . . . . 0.0 109.43 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.452 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 20.8 mm-40 -63.89 -43.94 94.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.214 -0.929 . . . . 0.0 109.405 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.765 ' HB ' HD21 ' A' ' 53' ' ' LEU . 78.3 mt -46.96 -50.9 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.315 -0.865 . . . . 0.0 109.444 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.821 ' CD2' HG11 ' A' ' 78' ' ' VAL . 61.8 mt -56.0 -53.51 56.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 109.416 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.81 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.1 OUTLIER -44.13 -38.77 3.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.445 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.452 ' HG2' ' O ' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -71.99 -41.03 68.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.32 -0.863 . . . . 0.0 109.495 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.522 ' CE ' HG11 ' A' ' 51' ' ' VAL . 1.2 mtt -58.52 -62.06 2.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.21 -0.931 . . . . 0.0 109.466 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.485 ' HE2' ' O ' ' A' ' 66' ' ' LEU . 0.3 OUTLIER -52.13 -47.9 65.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.496 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' ' 67' ' ' LYS . 53.9 t -48.43 -39.33 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.196 -0.94 . . . . 0.0 109.473 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 98.2 mt -70.38 -48.63 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 109.425 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.701 ' O ' HG22 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -152.97 111.98 3.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.22 -0.925 . . . . 0.0 109.5 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.54 -15.11 35.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.2 -0.938 . . . . 0.0 109.47 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -91.98 41.22 1.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.311 -0.868 . . . . 0.0 109.476 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.701 HG22 ' O ' ' A' ' 73' ' ' ASP . 2.2 tt -118.08 113.01 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.168 -0.958 . . . . 0.0 109.492 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.638 ' HB3' HD11 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -77.04 112.78 14.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.302 -0.874 . . . . 0.0 109.472 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.821 HG11 ' CD2' ' A' ' 66' ' ' LEU . 85.3 t -122.6 113.02 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.906 . . . . 0.0 109.491 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.619 HD13 ' HE2' ' A' ' 102' ' ' PHE . 69.9 mt -89.93 165.73 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.237 -0.915 . . . . 0.0 109.52 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.697 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.1 OUTLIER -128.74 171.58 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.303 -0.873 . . . . 0.0 109.485 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.481 ' N ' ' CD2' ' A' ' 101' ' ' HIS . 22.5 mtm -146.74 107.73 4.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.877 . . . . 0.0 109.419 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.842 ' CG2' HD11 ' A' ' 90' ' ' ILE . 5.2 t -149.92 -161.85 1.43 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.245 -0.909 . . . . 0.0 109.465 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.5 ' N ' HG23 ' A' ' 82' ' ' THR . . . . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.221 -0.924 . . . . 0.0 109.509 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.842 HD11 ' CG2' ' A' ' 82' ' ' THR . 16.8 mt . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.466 ' O ' ' HG2' ' A' ' 94' ' ' LYS . 1.2 tt0 -63.3 -43.53 97.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.249 -0.907 . . . . 0.0 109.488 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.438 ' O ' HD23 ' A' ' 96' ' ' LEU . 3.9 mt-10 -76.19 -36.72 58.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.263 -0.898 . . . . 0.0 109.441 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 92' ' ' GLU . 13.5 t -44.05 -61.91 1.31 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 109.425 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.767 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 0.1 OUTLIER -51.04 -48.6 61.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.296 -0.878 . . . . 0.0 109.537 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -44.1 -42.96 6.6 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.919 . . . . 0.0 109.424 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.541 HD22 ' N ' ' A' ' 96' ' ' LEU . 3.6 mm? -70.74 -54.06 13.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.212 -0.93 . . . . 0.0 109.512 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 177.27 63.65 0.06 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.767 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -146.94 107.64 4.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -1.153 . . . . 0.0 109.424 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.638 HD11 ' HB3' ' A' ' 77' ' ' ARG . 94.6 mt -44.09 -84.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.24 -0.912 . . . . 0.0 109.418 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.423 ' O ' HG23 ' A' ' 79' ' ' ILE . 11.4 t -127.83 178.74 5.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.462 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.708 ' HD1' HG23 ' A' ' 90' ' ' ILE . 4.8 t-160 -130.65 96.76 4.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.262 -0.899 . . . . 0.0 109.573 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.619 ' HE2' HD13 ' A' ' 79' ' ' ILE . 79.7 m-85 -64.92 -166.79 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.255 -0.903 . . . . 0.0 109.319 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 82' ' ' THR . . . -161.14 -166.7 1.62 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.258 -0.901 . . . . 0.0 109.386 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.474 ' CG ' ' HA ' ' A' ' 105' ' ' PRO . 11.8 tttm -139.12 141.43 29.71 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.214 -0.929 . . . . 0.0 109.379 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.474 ' HA ' ' CG ' ' A' ' 104' ' ' LYS . 35.9 Cg_endo -77.95 139.88 58.93 Favored 'Cis proline' 0 C--N 1.311 -1.445 0 C-N-CA 123.415 -1.494 . . . . 0.0 110.417 -0.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.42 ' C ' ' CD1' ' A' ' 106' ' ' PHE . 13.2 p90 -106.42 175.93 5.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.872 . . . . 0.0 109.523 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.469 ' O ' HG12 ' A' ' 111' ' ' ILE . 41.4 t0 -113.29 127.71 56.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.174 -0.954 . . . . 0.0 109.427 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.469 ' HA ' HD13 ' A' ' 108' ' ' ILE . 15.2 mm -55.15 -18.7 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.273 -0.892 . . . . 0.0 109.52 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.421 ' OD2' ' OD2' ' A' ' 107' ' ' ASP . 15.9 m-20 -76.33 -46.98 25.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.19 -0.944 . . . . 0.0 109.402 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.55 -27.08 65.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.261 -0.899 . . . . 0.0 109.427 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.469 HG12 ' O ' ' A' ' 107' ' ' ASP . 15.9 mm -75.01 -52.48 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.223 -0.923 . . . . 0.0 109.493 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -67.36 -20.52 65.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.272 -0.892 . . . . 0.0 109.528 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -76.92 -51.43 11.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 109.553 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.433 ' HB3' ' HZ ' ' A' ' 102' ' ' PHE . . . -63.5 -49.85 71.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.188 -0.945 . . . . 0.0 109.576 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.471 HG22 HD21 ' A' ' 50' ' ' LEU . 54.0 t -57.22 -49.9 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.263 -0.898 . . . . 0.0 109.487 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -27.82 69.0 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.222 -0.924 . . . . 0.0 109.565 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.07 -18.21 40.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 109.438 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -90.03 -70.9 0.64 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.244 -0.91 . . . . 0.0 109.436 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.534 ' CD1' ' HD2' ' A' ' 120' ' ' PRO . 5.5 tp -90.0 139.58 27.43 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.239 -0.913 . . . . 0.0 109.291 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.624 ' O ' HD22 ' A' ' 121' ' ' LEU . 35.3 Cg_endo -78.25 138.67 16.15 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.571 2.181 . . . . 0.0 110.345 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.665 HD21 ' HB3' ' A' ' 4' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.202 -0.936 . . . . 0.0 109.487 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.438 ' O ' ' CB ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -120.23 119.73 34.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.307 -0.87 . . . . 0.0 109.417 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.877 ' HB ' HG22 ' A' ' 30' ' ' THR . 15.0 mt -109.41 168.15 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.263 -0.898 . . . . 0.0 109.501 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.976 ' O ' HD12 ' A' ' 52' ' ' LEU . 0.4 OUTLIER -134.96 142.09 46.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.333 -0.854 . . . . 0.0 109.467 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.908 ' N ' HD13 ' A' ' 7' ' ' LEU . 2.9 mt -133.5 99.28 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.352 -0.843 . . . . 0.0 109.278 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.652 HG12 HD11 ' A' ' 57' ' ' ILE . 2.9 t -89.79 114.18 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.264 -0.898 . . . . 0.0 109.562 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.809 ' O ' ' HB2' ' A' ' 34' ' ' ALA . 0.4 OUTLIER -169.18 174.92 5.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.295 -0.878 . . . . 0.0 109.362 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.462 ' CG ' ' HD2' ' A' ' 58' ' ' PRO . 6.1 p-10 -142.54 -45.76 0.32 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.16 -0.963 . . . . 0.0 109.449 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.435 ' N ' ' CG ' ' A' ' 11' ' ' ASP . 5.5 tp60 -44.0 106.91 0.08 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.304 -0.872 . . . . 0.0 109.493 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 1.05 ' CE1' HD11 ' A' ' 17' ' ' ILE . 38.9 t80 -43.23 124.35 3.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.374 -0.829 . . . . 0.0 109.431 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 141.31 -75.98 0.32 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.439 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 1.7 mt -58.66 -32.42 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -1.169 . . . . 0.0 108.878 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.519 ' NH1' ' O ' ' A' ' 33' ' ' ALA . 9.1 mmm180 -60.34 -33.19 72.05 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.336 -0.852 . . . . 0.0 109.459 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 1.05 HD11 ' CE1' ' A' ' 13' ' ' TYR . 2.6 mt -90.7 -65.59 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.332 -0.855 . . . . 0.0 109.895 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.895 ' O ' HG23 ' A' ' 22' ' ' VAL . 4.3 mt -42.45 -63.0 0.84 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.133 -0.979 . . . . 0.0 110.198 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.828 HD23 HG23 ' A' ' 8' ' ' ILE . 1.8 tp -51.98 -35.14 45.39 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.085 -1.009 . . . . 0.0 109.802 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.433 ' HB3' ' O ' ' A' ' 17' ' ' ILE . 33.0 t30 -64.89 -70.43 0.23 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.211 -0.931 . . . . 0.0 110.163 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.475 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 1.0 OUTLIER -55.82 -16.49 4.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.143 -0.973 . . . . 0.0 110.152 -179.418 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 18' ' ' LEU . 53.5 t -75.57 -61.13 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.12 -0.987 . . . . 0.0 109.422 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 1.006 ' CZ ' HG21 ' A' ' 115' ' ' VAL . 17.0 m-85 -73.28 -8.51 56.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.272 -0.892 . . . . 0.0 109.407 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -83.72 -54.84 4.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.914 . . . . 0.0 109.44 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -66.27 -22.08 66.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.244 -0.91 . . . . 0.0 109.406 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.478 ' OE2' ' HE2' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -78.83 -23.78 44.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.33 -0.856 . . . . 0.0 109.476 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.566 ' O ' ' CG ' ' A' ' 28' ' ' TYR . . . 110.48 64.33 0.52 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.939 ' CE2' HD13 ' A' ' 121' ' ' LEU . 66.4 m-85 -158.88 135.26 9.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.202 -1.176 . . . . 0.0 109.607 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -89.91 85.01 6.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.254 -0.904 . . . . 0.0 108.959 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.908 HG21 ' HB2' ' A' ' 23' ' ' PHE . 5.2 p -89.87 137.8 32.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.276 -0.89 . . . . 0.0 109.895 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.623 ' HB2' HD22 ' A' ' 7' ' ' LEU . 14.5 m-85 -102.01 165.1 11.35 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.391 -0.818 . . . . 0.0 108.889 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 32' ' ' GLN . 1.5 pt20 -125.15 134.42 52.43 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.092 -1.005 . . . . 0.0 109.854 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.593 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -140.35 -161.01 1.14 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.251 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.809 ' HB2' ' O ' ' A' ' 10' ' ' ASP . . . 171.23 -42.39 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.167 -0.958 . . . . 0.0 109.651 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.433 ' ND2' ' H ' ' A' ' 35' ' ' ASN . 1.9 p30 -74.15 -1.33 19.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.208 -0.932 . . . . 0.0 109.611 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.19 -46.11 3.62 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.15 -28.08 69.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.318 -1.107 . . . . 0.0 109.419 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.916 ' O ' HD12 ' A' ' 42' ' ' ILE . 13.3 mm100 -82.05 -36.14 28.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.284 -0.885 . . . . 0.0 109.375 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.785 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -64.81 -40.56 95.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.444 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.413 ' O ' ' C ' ' A' ' 41' ' ' ASP . 3.3 mt -78.32 -57.74 3.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.273 -0.892 . . . . 0.0 109.453 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 40' ' ' LEU . 5.9 t70 -44.45 -42.14 6.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.271 -0.893 . . . . 0.0 109.474 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.916 HD12 ' O ' ' A' ' 38' ' ' GLN . 15.3 mt -69.61 -47.0 73.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.279 -0.888 . . . . 0.0 109.357 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.785 HG23 ' O ' ' A' ' 39' ' ' ALA . 73.2 t -55.73 -21.14 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.259 -0.901 . . . . 0.0 109.425 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.6 m -90.16 -33.66 16.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.283 -0.885 . . . . 0.0 109.446 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.49 ' HG2' ' HA ' ' A' ' 42' ' ' ILE . 0.0 OUTLIER -89.94 0.65 56.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 109.714 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.469 ' HG2' ' HD2' ' A' ' 45' ' ' LYS . 11.3 mm-40 -137.75 -38.6 0.58 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.157 -0.964 . . . . 0.0 109.442 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.513 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 2.6 mtt180 59.15 62.13 4.22 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.894 . . . . 0.0 109.519 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.558 ' HD2' HG13 ' A' ' 43' ' ' VAL . 35.4 Cg_endo -77.87 151.89 28.17 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.691 2.261 . . . . 0.0 110.407 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.692 ' C ' HD22 ' A' ' 50' ' ' LEU . 1.2 m-20 -93.31 -11.98 31.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.209 -0.932 . . . . 0.0 109.513 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.692 HD22 ' C ' ' A' ' 49' ' ' ASP . 4.3 mm? -118.8 125.7 50.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.199 -0.938 . . . . 0.0 109.476 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.93 ' HB ' HG22 ' A' ' 78' ' ' VAL . 3.5 t -132.23 119.8 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.233 -0.917 . . . . 0.0 109.563 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.976 HD12 ' O ' ' A' ' 7' ' ' LEU . 1.1 mt -92.51 102.74 15.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.306 -0.871 . . . . 0.0 109.345 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.593 HD22 ' CD2' ' A' ' 66' ' ' LEU . 1.0 OUTLIER -89.91 128.49 36.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.176 -0.952 . . . . 0.0 109.643 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.538 ' HB2' ' HE2' ' A' ' 81' ' ' MET . 30.5 t0 -120.53 108.64 14.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.338 -0.851 . . . . 0.0 109.356 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.853 ' CG ' HG21 ' A' ' 82' ' ' THR . 12.7 mmt -71.78 -3.99 25.22 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.188 -0.945 . . . . 0.0 109.568 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.457 ' HB2' ' OD2' ' A' ' 54' ' ' ASP . 4.3 mttt -75.52 -7.87 55.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 109.625 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.652 HD11 HG12 ' A' ' 9' ' ' VAL . 56.9 mt -57.06 116.52 13.7 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.095 -1.003 . . . . 0.0 109.318 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.462 ' HD2' ' CG ' ' A' ' 11' ' ' ASP . 35.6 Cg_endo -78.21 92.03 1.16 Allowed 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.297 1.998 . . . . 0.0 110.414 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 161.42 -23.5 0.23 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.511 ' SD ' ' CG2' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -170.48 161.19 7.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -1.172 . . . . 0.0 109.594 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -90.25 136.43 33.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.212 -0.93 . . . . 0.0 109.38 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.454 ' HA2' HG13 ' A' ' 65' ' ' ILE . . . -74.79 -8.91 82.72 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 30.6 mm -53.94 -55.22 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -1.149 . . . . 0.0 109.425 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 65' ' ' ILE . 24.9 mm-40 -53.14 -45.0 68.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.237 -0.914 . . . . 0.0 109.466 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.492 ' HB ' HD21 ' A' ' 53' ' ' LEU . 9.4 mt -44.81 -50.52 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.263 -0.898 . . . . 0.0 109.461 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.593 ' CD2' HD22 ' A' ' 53' ' ' LEU . 22.0 mt -54.66 -53.19 58.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.311 -0.868 . . . . 0.0 109.497 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.449 ' O ' HG23 ' A' ' 71' ' ' VAL . 4.7 mttt -43.65 -51.05 7.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.313 -0.867 . . . . 0.0 109.618 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.449 ' O ' HG13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -59.76 -41.2 90.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.162 -0.961 . . . . 0.0 109.486 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.765 ' HE1' HG11 ' A' ' 51' ' ' VAL . 4.6 mtt -60.32 -24.39 64.97 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.239 -0.913 . . . . 0.0 109.442 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 66' ' ' LEU . 1.8 mmpt? -80.03 -44.08 20.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.186 -0.946 . . . . 0.0 109.344 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 67' ' ' LYS . 2.6 t -64.38 -24.47 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.217 -0.927 . . . . 0.0 109.451 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 68' ' ' ARG . 57.9 mt -90.05 -66.42 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.456 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -123.59 139.09 54.36 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.229 -0.919 . . . . 0.0 109.506 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -90.02 -25.05 21.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.274 -0.891 . . . . 0.0 109.455 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 49.2 m-20 -105.77 51.02 0.76 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.199 -0.938 . . . . 0.0 109.498 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.615 HG13 HG23 ' A' ' 78' ' ' VAL . 3.0 tp -98.89 113.82 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.262 -0.899 . . . . 0.0 109.433 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.527 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 3.7 mtt180 -75.91 118.05 18.28 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.197 -0.939 . . . . 0.0 109.459 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.93 HG22 ' HB ' ' A' ' 51' ' ' VAL . 79.1 t -129.77 115.82 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.279 -0.888 . . . . 0.0 109.544 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.48 HG12 HG22 ' A' ' 100' ' ' THR . 70.9 mt -89.87 125.69 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.281 -0.887 . . . . 0.0 109.396 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.967 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.6 OUTLIER -89.82 162.17 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.193 -0.942 . . . . 0.0 109.422 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.538 ' HE2' ' HB2' ' A' ' 54' ' ' ASP . 16.6 mtm -135.43 47.27 2.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.297 -0.877 . . . . 0.0 109.425 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.853 HG21 ' CG ' ' A' ' 55' ' ' MET . 9.9 t -159.71 66.64 0.38 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.31 -0.869 . . . . 0.0 109.469 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.562 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.241 -0.912 . . . . 0.0 109.437 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.594 ' CD1' ' N ' ' A' ' 90' ' ' ILE . 1.2 mp . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -47.65 -44.78 27.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.912 . . . . 0.0 109.411 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.47 ' HG3' ' N ' ' A' ' 93' ' ' SER . 19.3 pt-20 -70.2 -32.63 70.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -0.877 . . . . 0.0 109.429 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.821 ' HB2' HD11 ' A' ' 80' ' ' ILE . 59.6 p -63.38 -30.59 71.69 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.236 -0.915 . . . . 0.0 109.471 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.5 OUTLIER -69.68 -71.84 0.22 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.911 . . . . 0.0 109.524 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.458 ' CG ' ' N ' ' A' ' 96' ' ' LEU . 9.4 pt-20 -43.81 -46.64 7.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.218 -0.926 . . . . 0.0 109.437 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.473 ' HA ' HD23 ' A' ' 96' ' ' LEU . 24.5 mt -51.67 -57.33 9.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.181 -0.949 . . . . 0.0 109.441 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 165.53 44.89 0.02 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.514 ' CB ' ' O ' ' A' ' 93' ' ' SER . . . -113.92 98.6 7.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -1.115 . . . . 0.0 109.457 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.527 ' CD1' ' HB3' ' A' ' 77' ' ' ARG . 23.9 mt -46.63 -46.73 19.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.284 -0.885 . . . . 0.0 109.446 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.48 HG22 HG12 ' A' ' 79' ' ' ILE . 10.7 t -154.44 143.02 20.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.221 -0.924 . . . . 0.0 109.52 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.967 ' ND1' HD12 ' A' ' 80' ' ' ILE . 3.6 t-160 -107.93 87.71 2.56 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.252 -0.905 . . . . 0.0 109.487 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.508 ' O ' ' N ' ' A' ' 82' ' ' THR . 6.0 m-30 -80.55 179.12 7.9 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 0.0 109.57 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.562 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -137.82 -148.68 0.28 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.292 -0.88 . . . . 0.0 109.343 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.525 ' HG3' ' HA ' ' A' ' 105' ' ' PRO . 0.7 OUTLIER -137.85 145.75 49.65 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.291 -0.881 . . . . 0.0 109.452 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.525 ' HA ' ' HG3' ' A' ' 104' ' ' LYS . 35.3 Cg_endo -77.91 -176.69 19.21 Favored 'Cis proline' 0 C--N 1.308 -1.565 0 C-N-CA 123.289 -1.546 . . . . 0.0 110.333 0.039 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 106' ' ' PHE . 2.8 p90 -146.92 -163.69 1.82 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.281 -0.887 . . . . 0.0 109.494 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -135.46 132.55 37.54 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.273 -0.892 . . . . 0.0 109.503 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.434 ' HA ' HD13 ' A' ' 108' ' ' ILE . 14.4 mm -59.22 -21.59 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -0.926 . . . . 0.0 109.45 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.478 ' O ' ' HG2' ' A' ' 112' ' ' ARG . 34.8 m-20 -73.74 -44.73 55.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.34 -0.85 . . . . 0.0 109.474 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -64.68 -34.87 79.31 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.2 -0.938 . . . . 0.0 109.425 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.496 HG21 HD11 ' A' ' 19' ' ' LEU . 17.7 mm -66.33 -59.59 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.204 -0.935 . . . . 0.0 109.492 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 23.2 ptt180 -53.4 -32.05 47.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 109.529 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.44 ' OD2' ' O ' ' A' ' 109' ' ' ASP . 17.7 m-20 -64.64 -55.79 17.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.332 -0.855 . . . . 0.0 109.5 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.665 ' HB1' ' CE2' ' A' ' 118' ' ' TYR . . . -55.33 -35.68 65.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.208 -0.933 . . . . 0.0 109.474 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 1.006 HG21 ' CZ ' ' A' ' 23' ' ' PHE . 77.9 t -72.08 -28.9 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.282 -0.886 . . . . 0.0 109.434 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.478 ' HE2' ' OE2' ' A' ' 26' ' ' GLU . 5.4 mmtm -72.12 -32.24 66.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.303 -0.873 . . . . 0.0 109.433 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -86.74 -24.44 25.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.926 . . . . 0.0 109.459 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.665 ' CE2' ' HB1' ' A' ' 114' ' ' ALA . 18.6 m-85 -90.13 -66.18 0.95 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.226 -0.921 . . . . 0.0 109.48 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.757 HD12 ' HD2' ' A' ' 120' ' ' PRO . 31.5 tp -90.13 112.47 52.65 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.287 -0.883 . . . . 0.0 109.477 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.757 ' HD2' HD12 ' A' ' 119' ' ' LEU . 35.3 Cg_endo -78.19 148.01 23.9 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.408 2.072 . . . . 0.0 110.314 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.939 HD13 ' CE2' ' A' ' 28' ' ' TYR . 1.2 tp . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.282 -0.886 . . . . 0.0 109.405 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.464 ' N ' ' OE1' ' A' ' 4' ' ' GLU . 1.5 mp0 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.465 ' HB3' ' HB3' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -141.75 131.69 24.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.23 -0.918 . . . . 0.0 109.457 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.628 HD12 ' HB3' ' A' ' 28' ' ' TYR . 91.5 mt -149.97 153.45 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.265 -0.897 . . . . 0.0 109.499 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.803 HD23 HG21 ' A' ' 42' ' ' ILE . 1.8 tm? -130.64 112.0 12.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.238 -0.914 . . . . 0.0 109.447 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.796 HD13 ' HB2' ' A' ' 19' ' ' LEU . 5.0 mt -89.98 106.33 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.278 -0.889 . . . . 0.0 109.545 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.718 HG22 HD12 ' A' ' 7' ' ' LEU . 3.1 t -95.02 113.32 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.219 -0.925 . . . . 0.0 109.5 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.503 ' O ' ' NH1' ' A' ' 16' ' ' ARG . 0.4 OUTLIER -162.93 150.44 13.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 0.0 109.415 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.482 ' OD2' ' HD2' ' A' ' 58' ' ' PRO . 7.4 p-10 -113.37 -37.28 4.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.244 -0.91 . . . . 0.0 109.454 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.405 ' O ' ' C ' ' A' ' 13' ' ' TYR . 20.1 tt0 -70.05 104.57 2.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.24 -0.913 . . . . 0.0 109.484 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.587 ' CZ ' HG13 ' A' ' 17' ' ' ILE . 26.2 t80 -44.13 149.93 0.32 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.294 -0.879 . . . . 0.0 109.496 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.61 -73.78 0.42 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.468 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 36.6 mt -61.21 -23.63 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -1.142 . . . . 0.0 109.365 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.503 ' NH1' ' O ' ' A' ' 10' ' ' ASP . 7.4 mmm-85 -69.75 -30.08 67.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.338 -0.851 . . . . 0.0 109.399 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.587 HG13 ' CZ ' ' A' ' 13' ' ' TYR . 9.2 mm -90.19 -25.18 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.376 -0.828 . . . . 0.0 109.534 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.905 ' O ' HG23 ' A' ' 22' ' ' VAL . 1.3 mp -74.05 -53.21 10.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.209 -0.932 . . . . 0.0 109.567 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.796 ' HB2' HD13 ' A' ' 8' ' ' ILE . 12.3 mt -71.39 -17.11 62.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -0.918 . . . . 0.0 109.535 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 47.9 t30 -79.77 -51.01 9.72 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.207 -0.933 . . . . 0.0 109.498 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -68.07 -40.06 82.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.211 -0.931 . . . . 0.0 109.463 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.905 HG23 ' O ' ' A' ' 18' ' ' LEU . 15.1 t -67.18 -57.5 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.915 . . . . 0.0 109.403 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.73 ' CZ ' HG21 ' A' ' 115' ' ' VAL . 18.7 m-85 -65.46 -17.67 64.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.24 -0.912 . . . . 0.0 109.457 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.435 ' HB2' ' O ' ' A' ' 20' ' ' ASN . 1.9 m-20 -68.75 -63.14 1.12 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.427 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.58 -10.52 58.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.906 . . . . 0.0 109.402 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.474 ' HB2' ' HA ' ' A' ' 23' ' ' PHE . 1.7 mm-40 -76.34 -31.75 58.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.234 -0.917 . . . . 0.0 109.517 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.416 ' O ' ' HG2' ' A' ' 4' ' ' GLU . . . 107.2 33.38 3.21 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.702 ' HE1' HD22 ' A' ' 119' ' ' LEU . 84.8 m-85 -123.51 139.34 54.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -1.164 . . . . 0.0 109.468 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -91.57 82.34 5.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.279 -0.888 . . . . 0.0 109.473 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.574 HG22 HD12 ' A' ' 6' ' ' ILE . 5.8 p -89.96 152.33 21.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.182 -0.949 . . . . 0.0 109.517 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.574 ' HB2' HD22 ' A' ' 7' ' ' LEU . 16.6 m-85 -119.51 -168.98 1.68 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.203 -0.935 . . . . 0.0 109.473 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -128.99 142.27 50.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.221 -0.925 . . . . 0.0 109.432 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.59 ' CB ' HD11 ' A' ' 7' ' ' LEU . . . -154.95 109.62 3.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.33 -0.856 . . . . 0.0 109.487 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.566 ' O ' HD13 ' A' ' 57' ' ' ILE . . . -69.45 -70.29 0.29 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.199 -0.938 . . . . 0.0 109.454 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -77.56 178.03 7.58 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 0.0 109.514 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.51 ' HA3' HD11 ' A' ' 65' ' ' ILE . . . -83.44 -41.97 8.13 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.418 ' C ' ' O ' ' A' ' 36' ' ' GLY . 0.3 OUTLIER -44.06 -56.53 3.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.192 -1.181 . . . . 0.0 109.453 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.435 ' O ' HD12 ' A' ' 42' ' ' ILE . 44.7 tp60 -57.17 -48.48 78.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 109.372 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.602 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -46.0 -68.21 0.21 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.278 -0.889 . . . . 0.0 109.464 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' A' ' 39' ' ' ALA . 2.2 mt -44.28 -41.06 5.67 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.288 -0.882 . . . . 0.0 109.529 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.64 -54.88 27.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.206 -0.934 . . . . 0.0 109.526 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.803 HG21 HD23 ' A' ' 7' ' ' LEU . 2.0 mp -63.87 -21.32 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.274 -0.891 . . . . 0.0 109.486 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.813 HG13 ' HD2' ' A' ' 48' ' ' PRO . 16.8 t -80.05 -22.11 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -0.903 . . . . 0.0 109.478 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.1 m -90.1 -28.53 18.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.915 . . . . 0.0 109.39 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -89.88 -27.76 19.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 0.0 109.448 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -113.83 -36.91 4.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.265 -0.897 . . . . 0.0 109.382 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 60.3 mtm180 57.54 69.16 1.68 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.896 . . . . 0.0 109.553 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.813 ' HD2' HG13 ' A' ' 43' ' ' VAL . 35.4 Cg_endo -77.91 176.03 10.49 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.685 2.257 . . . . 0.0 110.412 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.628 ' O ' HD22 ' A' ' 50' ' ' LEU . 58.9 m-20 -114.7 -9.93 12.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.225 -0.922 . . . . 0.0 109.489 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.628 HD22 ' O ' ' A' ' 49' ' ' ASP . 3.4 mm? -124.63 112.96 17.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 109.52 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 1.037 HG11 ' CE ' ' A' ' 69' ' ' MET . 24.7 t -114.0 119.2 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.171 -0.956 . . . . 0.0 109.422 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.413 HD13 HG23 ' A' ' 8' ' ' ILE . 1.3 mt -89.99 100.77 13.52 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.884 . . . . 0.0 109.456 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.825 HD21 ' HB ' ' A' ' 65' ' ' ILE . 1.1 mp -91.57 129.06 37.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.896 . . . . 0.0 109.516 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.455 ' OD2' ' OD1' ' A' ' 10' ' ' ASP . 57.0 t0 -117.94 103.59 10.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 109.42 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.676 ' HB2' HG21 ' A' ' 82' ' ' THR . 9.3 mmt -58.65 -15.72 12.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.319 -0.863 . . . . 0.0 109.504 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.447 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.1 OUTLIER -55.72 -35.69 66.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 109.414 179.959 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.898 HG21 ' CE ' ' A' ' 60' ' ' MET . 46.0 mt -43.13 103.28 0.31 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.342 -0.849 . . . . 0.0 109.507 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.482 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 35.4 Cg_endo -77.77 4.53 5.98 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.421 2.081 . . . . 0.0 110.415 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.94 -43.37 7.2 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.898 ' CE ' HG21 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -153.38 170.95 19.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -1.133 . . . . 0.0 109.452 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -88.97 134.27 34.03 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.215 -0.928 . . . . 0.0 109.474 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.423 ' HA2' HG12 ' A' ' 65' ' ' ILE . . . -81.73 -0.39 89.27 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.5 mm -61.4 -42.14 92.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.288 -1.125 . . . . 0.0 109.456 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -68.74 -18.91 64.31 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.405 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.825 ' HB ' HD21 ' A' ' 53' ' ' LEU . 24.8 mm -69.94 -51.38 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.283 -0.886 . . . . 0.0 109.446 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.477 ' O ' ' HE3' ' A' ' 70' ' ' LYS . 29.8 mt -53.87 -30.65 46.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.291 -0.881 . . . . 0.0 109.441 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.768 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.6 OUTLIER -71.72 -63.25 1.16 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.233 -0.917 . . . . 0.0 109.5 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.468 ' O ' HG12 ' A' ' 72' ' ' ILE . 1.9 mtt85 -52.81 -20.67 3.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.216 -0.927 . . . . 0.0 109.41 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' MET . . . . . 1.037 ' CE ' HG11 ' A' ' 51' ' ' VAL . 1.3 mmt -75.39 -58.47 3.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.207 -0.933 . . . . 0.0 109.457 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 15.3 ptpt -62.35 -15.51 48.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.238 -0.914 . . . . 0.0 109.425 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.768 HG23 ' O ' ' A' ' 67' ' ' LYS . 44.9 t -83.91 -42.69 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -0.881 . . . . 0.0 109.508 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.468 HG12 ' O ' ' A' ' 68' ' ' ARG . 19.0 mm -72.41 -56.27 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.274 -0.891 . . . . 0.0 109.506 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -129.72 132.55 46.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.204 -0.935 . . . . 0.0 109.493 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.61 15.38 9.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.241 -0.912 . . . . 0.0 109.513 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -129.99 37.05 3.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.322 -0.862 . . . . 0.0 109.44 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.662 HD11 ' CG2' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -112.34 142.32 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.279 -0.888 . . . . 0.0 109.373 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.626 ' CG ' HD11 ' A' ' 99' ' ' LEU . 37.9 mtt85 -103.87 158.55 16.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.291 -0.881 . . . . 0.0 109.436 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.649 HG13 ' HB ' ' A' ' 51' ' ' VAL . 1.8 t -153.12 112.21 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.219 -0.925 . . . . 0.0 109.538 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.482 HG23 ' CG2' ' A' ' 100' ' ' THR . 95.7 mt -92.16 159.64 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.292 -0.88 . . . . 0.0 109.424 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.581 ' HB ' ' CG ' ' A' ' 101' ' ' HIS . 0.4 OUTLIER -114.64 119.11 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.212 -0.93 . . . . 0.0 109.414 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.402 ' O ' ' HB ' ' A' ' 82' ' ' THR . 4.6 mtm -101.0 68.42 1.26 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.191 -0.943 . . . . 0.0 109.515 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.676 HG21 ' HB2' ' A' ' 55' ' ' MET . 6.2 t 179.43 48.56 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.258 -0.901 . . . . 0.0 109.439 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.025 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.261 -0.899 . . . . 0.0 109.512 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.74 HG23 ' HD1' ' A' ' 101' ' ' HIS . 48.0 mt . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.269 0.557 . . . . 0.0 109.529 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -47.6 -39.87 17.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.276 -0.89 . . . . 0.0 109.478 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.925 ' C ' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -78.32 -33.37 49.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.24 -0.912 . . . . 0.0 109.522 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.504 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 0.5 OUTLIER -59.89 -16.18 27.32 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.277 -0.889 . . . . 0.0 109.478 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.06 -76.68 0.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 0.0 109.456 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.43 ' HG3' ' N ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -58.09 -23.99 56.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.919 . . . . 0.0 109.507 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.925 HD12 ' C ' ' A' ' 92' ' ' GLU . 8.4 mt -67.6 -42.66 82.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.303 -0.873 . . . . 0.0 109.453 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 154.51 53.1 0.01 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 93' ' ' SER . . . -138.7 102.76 4.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.303 -1.116 . . . . 0.0 109.466 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.66 HD13 ' CD1' ' A' ' 118' ' ' TYR . 21.0 mt -45.48 -65.52 0.53 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.211 -0.931 . . . . 0.0 109.392 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.745 HG21 ' CE1' ' A' ' 102' ' ' PHE . 11.6 t -140.55 -174.91 4.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.294 -0.879 . . . . 0.0 109.457 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.81 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 3.3 t-160 -140.99 92.4 2.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.348 -0.845 . . . . 0.0 109.39 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.745 ' CE1' HG21 ' A' ' 100' ' ' THR . 60.0 m-85 -77.99 152.66 32.99 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.21 -0.931 . . . . 0.0 109.434 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 1.025 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -140.25 -160.67 1.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.875 . . . . 0.0 109.462 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.475 ' CG ' ' HA ' ' A' ' 105' ' ' PRO . 9.5 tttm -89.37 141.83 29.25 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.231 -0.918 . . . . 0.0 109.31 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.475 ' HA ' ' CG ' ' A' ' 104' ' ' LYS . 36.0 Cg_endo -78.11 -176.51 18.85 Favored 'Cis proline' 0 C--N 1.31 -1.492 0 C-N-CA 123.406 -1.498 . . . . 0.0 110.486 -0.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.69 ' CE2' HD12 ' A' ' 111' ' ' ILE . 0.2 OUTLIER -114.75 106.3 14.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.196 -0.94 . . . . 0.0 109.524 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.478 ' O ' HG12 ' A' ' 111' ' ' ILE . 38.8 t0 -89.94 105.18 17.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -0.896 . . . . 0.0 109.318 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.812 HD12 HG21 ' A' ' 22' ' ' VAL . 13.6 mm -45.84 -25.02 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.195 -0.941 . . . . 0.0 109.61 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.469 ' HB2' ' OD2' ' A' ' 107' ' ' ASP . 79.1 m-20 -72.81 -46.37 53.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.127 -0.983 . . . . 0.0 109.518 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.5 -24.38 63.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.252 -0.905 . . . . 0.0 109.486 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.69 HD12 ' CE2' ' A' ' 106' ' ' PHE . 12.7 mm -75.23 -56.4 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.273 -0.892 . . . . 0.0 109.428 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.464 ' O ' ' HG3' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -60.22 -32.86 71.52 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.296 -0.877 . . . . 0.0 109.497 179.906 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -64.99 -55.0 21.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.33 -0.856 . . . . 0.0 109.447 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.63 ' HB2' ' HZ ' ' A' ' 102' ' ' PHE . . . -54.84 -42.56 72.12 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.197 -0.939 . . . . 0.0 109.474 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.73 HG21 ' CZ ' ' A' ' 23' ' ' PHE . 55.8 t -66.84 -28.58 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.19 -0.944 . . . . 0.0 109.442 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 0.5 OUTLIER -68.94 -48.94 62.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.272 -0.892 . . . . 0.0 109.457 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.13 -31.92 73.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.922 . . . . 0.0 109.54 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.66 ' CD1' HD13 ' A' ' 99' ' ' LEU . 22.5 m-85 -73.64 -72.98 0.23 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.316 -0.865 . . . . 0.0 109.524 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.702 HD22 ' HE1' ' A' ' 28' ' ' TYR . 5.5 tt -88.08 137.84 31.1 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.26 -0.9 . . . . 0.0 109.251 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.667 ' N ' HD23 ' A' ' 119' ' ' LEU . 35.9 Cg_endo -78.37 145.77 21.52 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.482 2.121 . . . . 0.0 110.427 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.64 ' CD1' ' CZ ' ' A' ' 28' ' ' TYR . 1.6 mt . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.892 . . . . 0.0 109.436 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 48' ' ' PRO . 23.2 mttt -125.81 143.77 50.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 0.0 109.461 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.547 ' HB ' HG22 ' A' ' 30' ' ' THR . 70.0 mt -150.06 162.5 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -0.918 . . . . 0.0 109.464 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.799 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.5 OUTLIER -131.81 122.62 26.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.163 -0.96 . . . . 0.0 109.404 -179.931 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.799 ' N ' HD13 ' A' ' 7' ' ' LEU . 3.7 mt -100.75 109.06 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.238 -0.914 . . . . 0.0 109.426 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.607 HG12 HD11 ' A' ' 57' ' ' ILE . 2.6 t -103.95 95.87 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.3 -0.875 . . . . 0.0 109.41 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.484 ' O ' ' HD3' ' A' ' 16' ' ' ARG . 1.6 t70 -158.67 85.88 0.84 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 0.0 109.476 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.599 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . 7.3 p-10 -51.25 -41.31 60.29 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.211 -0.931 . . . . 0.0 109.428 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.414 ' C ' ' O ' ' A' ' 11' ' ' ASP . 4.8 tt0 -44.11 95.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -0.896 . . . . 0.0 109.465 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 1.056 ' CE1' HD11 ' A' ' 17' ' ' ILE . 47.8 t80 -45.07 120.81 2.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.319 -0.863 . . . . 0.0 109.427 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 144.97 -54.12 0.56 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.671 ' N ' HD12 ' A' ' 15' ' ' ILE . 1.8 mp -72.45 -50.17 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -1.162 . . . . 0.0 109.333 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.521 ' O ' ' CB ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -47.41 -31.59 4.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.229 -0.919 . . . . 0.0 109.5 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 1.056 HD11 ' CE1' ' A' ' 13' ' ' TYR . 1.7 mt -90.27 -29.14 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.222 -0.924 . . . . 0.0 109.497 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.864 HD12 HD11 ' A' ' 108' ' ' ILE . 0.4 OUTLIER -66.41 -62.33 1.52 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.203 -0.936 . . . . 0.0 109.498 -179.868 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.696 ' HB2' HD13 ' A' ' 8' ' ' ILE . 7.5 mt -68.1 -15.55 63.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.919 . . . . 0.0 109.044 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.608 ' ND2' ' OE2' ' A' ' 21' ' ' GLU . 1.0 OUTLIER -72.07 -47.88 48.3 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.462 -0.774 . . . . 0.0 109.258 179.945 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.608 ' OE2' ' ND2' ' A' ' 20' ' ' ASN . 1.0 OUTLIER -73.27 -49.27 28.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.31 -0.869 . . . . 0.0 109.547 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.671 HG21 HG23 ' A' ' 108' ' ' ILE . 29.2 t -56.17 -47.81 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.272 -0.892 . . . . 0.0 109.542 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.57 ' CE2' ' HB3' ' A' ' 19' ' ' LEU . 19.7 m-85 -79.96 -13.63 59.2 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.186 -0.946 . . . . 0.0 109.559 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 20' ' ' ASN . 1.8 m-20 -71.71 -47.4 54.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -0.925 . . . . 0.0 109.368 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.5 tptt -85.0 -29.5 24.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -0.921 . . . . 0.0 109.39 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.432 ' HB3' ' CE2' ' A' ' 28' ' ' TYR . 0.2 OUTLIER -55.34 -43.17 74.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.251 -0.906 . . . . 0.0 109.459 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.52 44.14 0.4 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.432 ' CE2' ' HB3' ' A' ' 26' ' ' GLU . 96.6 m-85 -134.47 137.73 44.17 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.249 -1.148 . . . . 0.0 109.48 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -90.03 82.02 6.16 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 109.292 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.547 HG22 ' HB ' ' A' ' 6' ' ' ILE . 5.7 p -89.82 148.89 22.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.246 -0.909 . . . . 0.0 109.577 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.721 ' HB2' HD22 ' A' ' 7' ' ' LEU . 5.8 m-85 -113.34 -171.13 1.82 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.237 -0.914 . . . . 0.0 109.44 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -124.16 150.58 44.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.255 -0.903 . . . . 0.0 109.608 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.658 ' HB3' HD11 ' A' ' 7' ' ' LEU . . . -175.45 174.14 2.36 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.289 -0.882 . . . . 0.0 109.375 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.599 ' HB1' ' HB3' ' A' ' 11' ' ' ASP . . . 178.61 -31.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.298 -0.876 . . . . 0.0 109.555 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.502 ' OD1' ' CB ' ' A' ' 37' ' ' LEU . 8.0 p30 -74.14 -3.2 28.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.18 -0.95 . . . . 0.0 109.606 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.03 -45.08 3.46 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.502 ' CB ' ' OD1' ' A' ' 35' ' ' ASN . 0.2 OUTLIER -57.82 -50.0 74.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.286 -1.126 . . . . 0.0 109.519 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.588 ' O ' HD12 ' A' ' 42' ' ' ILE . 28.7 mt-30 -65.42 -23.97 67.08 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.178 -0.951 . . . . 0.0 109.519 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.599 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -67.59 -52.93 32.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.231 -0.918 . . . . 0.0 109.507 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.677 HD22 ' HB3' ' A' ' 68' ' ' ARG . 16.0 mt -70.79 -58.41 3.65 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.178 -0.952 . . . . 0.0 109.602 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -46.91 -49.23 20.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.292 -0.88 . . . . 0.0 109.628 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.601 HG21 ' CD2' ' A' ' 7' ' ' LEU . 89.3 mt -62.55 -35.15 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.908 . . . . 0.0 109.446 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 39' ' ' ALA . 49.0 t -75.22 -14.72 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.276 -0.89 . . . . 0.0 109.52 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.7 m -90.2 -28.87 18.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.186 -0.946 . . . . 0.0 109.561 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.1 mttm -85.96 -41.51 14.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.224 -0.923 . . . . 0.0 109.687 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.574 ' OE1' ' CZ ' ' A' ' 31' ' ' PHE . 4.8 mt-10 -102.08 -37.88 7.98 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.194 -0.941 . . . . 0.0 109.601 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.474 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 5.7 mtt180 61.31 67.26 1.43 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.279 -0.888 . . . . 0.0 109.499 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.502 ' HD2' HG13 ' A' ' 43' ' ' VAL . 35.4 Cg_endo -77.78 165.67 26.38 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.647 2.231 . . . . 0.0 110.427 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 1.02 ' O ' HD22 ' A' ' 50' ' ' LEU . 8.3 m-20 -107.62 11.08 28.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.337 -0.852 . . . . 0.0 109.548 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.02 HD22 ' O ' ' A' ' 49' ' ' ASP . 1.3 mm? -140.37 128.69 22.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 109.506 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.574 ' HB ' HG22 ' A' ' 78' ' ' VAL . 3.9 t -129.42 151.1 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.25 -0.906 . . . . 0.0 109.509 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.622 HD12 ' O ' ' A' ' 7' ' ' LEU . 1.3 mt -121.14 97.65 5.62 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.197 -0.939 . . . . 0.0 109.364 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.893 HD22 HG11 ' A' ' 78' ' ' VAL . 2.0 mp -89.92 128.45 36.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.316 -0.865 . . . . 0.0 109.647 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.455 ' O ' HG13 ' A' ' 57' ' ' ILE . 44.3 t0 -119.44 115.38 23.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.285 -0.884 . . . . 0.0 109.405 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.923 ' CG ' HG21 ' A' ' 82' ' ' THR . 17.1 mmt -67.72 -8.05 32.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.259 -0.901 . . . . 0.0 109.577 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.44 ' HB2' ' OD2' ' A' ' 54' ' ' ASP . 16.7 mmtp -76.66 1.14 17.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -0.896 . . . . 0.0 109.633 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.607 HD11 HG12 ' A' ' 9' ' ' VAL . 34.0 mt -75.32 118.27 69.47 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.11 -0.994 . . . . 0.0 109.382 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.452 ' HD2' ' CG ' ' A' ' 11' ' ' ASP . 35.7 Cg_endo -77.97 143.34 20.5 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.395 2.063 . . . . 0.0 110.469 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 121.66 -54.44 0.68 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.585 ' HE1' HG21 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -155.56 175.18 14.22 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.183 -1.187 . . . . 0.0 109.509 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -89.9 169.09 11.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.265 -0.897 . . . . 0.0 109.477 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.536 ' HA2' ' CD1' ' A' ' 65' ' ' ILE . . . -97.79 -7.02 56.92 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.4 ' HA ' HD13 ' A' ' 63' ' ' ILE . 31.2 mm -54.28 -64.82 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.155 -1.203 . . . . 0.0 109.495 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 67' ' ' LYS . 1.3 pt-20 -47.92 -35.7 11.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.237 -0.914 . . . . 0.0 109.467 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.536 ' CD1' ' HA2' ' A' ' 62' ' ' GLY . 16.0 mt -53.97 -57.19 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.226 -0.921 . . . . 0.0 109.506 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 1.039 HD21 HG11 ' A' ' 78' ' ' VAL . 31.3 mt -52.51 -26.21 12.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.27 -0.894 . . . . 0.0 109.634 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.886 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -73.76 -37.37 65.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.211 -0.93 . . . . 0.0 109.793 -179.801 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.677 ' HB3' HD22 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -73.15 -50.73 21.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.19 -0.944 . . . . 0.0 109.731 -179.792 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.831 ' SD ' HD23 ' A' ' 66' ' ' LEU . 3.9 ptp -64.43 -35.81 82.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.198 -0.939 . . . . 0.0 109.759 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.51 ' HG3' ' N ' ' A' ' 71' ' ' VAL . 15.1 ptpt -71.4 -34.8 70.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.206 -0.934 . . . . 0.0 109.437 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.886 HG23 ' O ' ' A' ' 67' ' ' LYS . 71.7 t -70.12 -31.02 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.193 -0.942 . . . . 0.0 109.493 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 68' ' ' ARG . 10.4 mt -90.0 -17.85 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.214 -0.929 . . . . 0.0 109.468 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -166.46 122.9 1.27 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.299 -0.876 . . . . 0.0 109.448 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -89.9 -11.51 41.63 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.187 -0.945 . . . . 0.0 109.439 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -92.97 44.49 1.15 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.302 -0.874 . . . . 0.0 109.5 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.552 ' O ' HG23 ' A' ' 76' ' ' ILE . 0.5 OUTLIER -121.89 120.03 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 109.44 -179.947 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.617 ' CG ' HD11 ' A' ' 99' ' ' LEU . 9.8 mtt180 -84.65 143.3 29.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.346 -0.846 . . . . 0.0 109.518 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 1.039 HG11 HD21 ' A' ' 66' ' ' LEU . 53.5 t -138.2 124.77 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.235 -0.915 . . . . 0.0 109.534 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.788 HG23 HG23 ' A' ' 100' ' ' THR . 70.6 mt -101.74 156.62 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.224 -0.923 . . . . 0.0 109.4 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.585 ' HB ' ' CG ' ' A' ' 101' ' ' HIS . 0.6 OUTLIER -114.94 115.25 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -0.929 . . . . 0.0 109.39 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.498 ' SD ' ' CZ ' ' A' ' 106' ' ' PHE . 4.3 mtm -95.97 58.75 1.92 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.226 -0.921 . . . . 0.0 109.506 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.923 HG21 ' CG ' ' A' ' 55' ' ' MET . 12.5 t -169.04 49.28 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.239 -0.913 . . . . 0.0 109.479 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.781 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.22 -0.925 . . . . 0.0 109.502 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.602 HG23 ' HD1' ' A' ' 101' ' ' HIS . 48.8 mt . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -53.87 -39.57 65.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.34 -0.85 . . . . 0.0 109.494 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.457 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 1.1 tp10 -78.96 -24.78 43.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.295 -0.878 . . . . 0.0 109.432 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.7 m -72.22 -28.34 63.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.298 -0.876 . . . . 0.0 109.474 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.796 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 5.8 mtpp -68.2 -67.42 0.47 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.268 -0.895 . . . . 0.0 109.464 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 94' ' ' LYS . 1.7 pt-20 -44.08 -26.74 0.32 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.355 -0.841 . . . . 0.0 109.554 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 92' ' ' GLU . 65.9 mt -73.82 -52.36 13.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.33 -0.856 . . . . 0.0 109.533 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 169.18 36.1 0.02 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.796 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -104.39 103.35 13.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.247 -1.149 . . . . 0.0 109.437 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.617 HD11 ' CG ' ' A' ' 77' ' ' ARG . 17.0 mt -53.08 -55.42 24.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.237 -0.914 . . . . 0.0 109.472 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.788 HG23 HG23 ' A' ' 79' ' ' ILE . 7.0 t -149.25 177.65 9.46 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.288 -0.883 . . . . 0.0 109.469 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.602 ' HD1' HG23 ' A' ' 90' ' ' ILE . 3.4 t-160 -132.1 90.14 2.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 0.0 109.431 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.747 ' HE1' HG21 ' A' ' 100' ' ' THR . 43.0 m-85 -77.57 160.75 28.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.221 -0.924 . . . . 0.0 109.485 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.781 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -145.44 -148.62 0.25 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.315 -0.865 . . . . 0.0 109.334 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.415 ' HD2' ' HA ' ' A' ' 105' ' ' PRO . 0.2 OUTLIER -104.03 146.65 32.95 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.205 -0.934 . . . . 0.0 109.447 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.415 ' HA ' ' HD2' ' A' ' 104' ' ' LYS . 35.5 Cg_endo -77.85 173.8 55.36 Favored 'Cis proline' 0 C--N 1.31 -1.466 0 C-N-CA 123.229 -1.571 . . . . 0.0 110.365 0.05 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.688 ' CZ ' HD12 ' A' ' 111' ' ' ILE . 0.3 OUTLIER -102.84 104.58 14.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.317 -0.864 . . . . 0.0 109.531 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.474 ' O ' HG12 ' A' ' 111' ' ' ILE . 63.3 t0 -89.95 109.74 20.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.278 -0.889 . . . . 0.0 109.331 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.864 HD11 HD12 ' A' ' 18' ' ' LEU . 14.8 mm -47.92 -23.65 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 109.55 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.429 ' O ' ' OD2' ' A' ' 113' ' ' ASP . 37.3 m-20 -76.39 -43.37 40.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.212 -0.93 . . . . 0.0 109.516 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.428 ' HB2' ' HB3' ' A' ' 107' ' ' ASP . 1.4 tt0 -69.64 -25.76 64.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.282 -0.886 . . . . 0.0 109.491 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.688 HD12 ' CZ ' ' A' ' 106' ' ' PHE . 13.4 mm -75.35 -57.9 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.211 -0.931 . . . . 0.0 109.493 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.476 ' O ' ' HG3' ' A' ' 116' ' ' LYS . 1.4 ptt85 -61.27 -28.07 68.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.302 -0.874 . . . . 0.0 109.585 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.429 ' OD2' ' O ' ' A' ' 109' ' ' ASP . 53.6 m-20 -68.28 -56.27 9.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.242 -0.911 . . . . 0.0 109.416 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.642 ' HB2' ' HZ ' ' A' ' 102' ' ' PHE . . . -56.34 -53.69 54.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.213 -0.93 . . . . 0.0 109.531 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.1 t -52.68 -39.92 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.232 -0.918 . . . . 0.0 109.502 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.476 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 0.6 OUTLIER -65.22 -33.56 76.29 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.327 -0.858 . . . . 0.0 109.554 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.23 -20.56 51.51 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.22 -0.925 . . . . 0.0 109.487 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.582 ' CG ' HD13 ' A' ' 99' ' ' LEU . 38.2 m-85 -89.68 -71.22 0.62 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.249 -0.907 . . . . 0.0 109.471 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.528 HD12 ' HD2' ' A' ' 120' ' ' PRO . 49.2 tp -90.05 112.49 52.68 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.248 -0.908 . . . . 0.0 109.37 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.528 ' HD2' HD12 ' A' ' 119' ' ' LEU . 35.6 Cg_endo -77.9 132.63 11.93 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.34 2.027 . . . . 0.0 110.424 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.509 ' HA ' HD23 ' A' ' 121' ' ' LEU . 4.1 mt . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.292 -0.88 . . . . 0.0 109.455 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 1.012 ' CG ' HD21 ' A' ' 119' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.49 ' HB3' ' HB3' ' A' ' 48' ' ' PRO . 3.9 mtpt -94.52 139.16 31.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.22 -0.925 . . . . 0.0 109.466 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.859 HG23 ' HB3' ' A' ' 50' ' ' LEU . 84.4 mt -150.07 153.73 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.252 -0.905 . . . . 0.0 109.498 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.738 HD12 ' HB2' ' A' ' 31' ' ' PHE . 0.6 OUTLIER -136.48 150.5 48.72 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.283 -0.885 . . . . 0.0 109.438 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.75 HD13 ' HB3' ' A' ' 19' ' ' LEU . 7.8 mt -129.43 122.05 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -0.892 . . . . 0.0 109.407 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 3.3 t -106.42 122.21 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.253 -0.904 . . . . 0.0 109.58 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.452 ' OD2' HD13 ' A' ' 15' ' ' ILE . 0.4 OUTLIER -145.86 -151.71 0.39 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.246 -0.909 . . . . 0.0 109.408 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.458 ' CG ' ' HD2' ' A' ' 58' ' ' PRO . 6.3 p-10 -161.65 -46.69 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.267 -0.895 . . . . 0.0 109.449 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.4 tp60 -82.71 116.6 22.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.316 -0.865 . . . . 0.0 109.486 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.594 ' CZ ' HG13 ' A' ' 17' ' ' ILE . 8.5 t80 -43.91 143.33 1.11 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.243 -0.91 . . . . 0.0 109.434 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.476 ' N ' ' CD1' ' A' ' 13' ' ' TYR . . . 126.96 -46.48 1.08 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.938 HG23 HD13 ' A' ' 19' ' ' LEU . 2.2 mt -84.69 -45.86 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.293 -1.122 . . . . 0.0 109.35 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 1.116 ' NH2' ' HB2' ' A' ' 34' ' ' ALA . 1.5 mtp180 -58.25 -29.44 65.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.308 -0.87 . . . . 0.0 109.395 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.594 HG13 ' CZ ' ' A' ' 13' ' ' TYR . 3.1 mm -90.47 -59.56 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -0.894 . . . . 0.0 109.657 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.763 ' O ' HG23 ' A' ' 22' ' ' VAL . 87.0 mt -46.74 -58.48 3.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.91 . . . . 0.0 109.806 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.938 HD13 HG23 ' A' ' 15' ' ' ILE . 6.3 mp -55.02 -32.49 61.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.188 -0.945 . . . . 0.0 109.689 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.464 ' HB3' ' O ' ' A' ' 17' ' ' ILE . 17.6 t30 -65.69 -70.82 0.22 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.913 . . . . 0.0 109.723 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.486 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 0.1 OUTLIER -43.28 -40.24 3.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.185 -0.947 . . . . 0.0 109.745 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.763 HG23 ' O ' ' A' ' 18' ' ' LEU . 59.8 t -57.58 -58.41 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.913 . . . . 0.0 109.51 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.781 ' CB ' HG21 ' A' ' 30' ' ' THR . 38.0 m-85 -76.18 0.67 18.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.165 -0.959 . . . . 0.0 109.633 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.486 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 0.7 OUTLIER -89.01 -38.88 14.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.078 -1.014 . . . . 0.0 109.535 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.8 tptt -85.55 -44.13 12.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 109.42 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.465 ' HB3' ' CD2' ' A' ' 28' ' ' TYR . 0.4 OUTLIER -55.07 -21.4 12.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.179 -0.95 . . . . 0.0 109.391 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.473 ' O ' ' CG ' ' A' ' 28' ' ' TYR . . . 101.38 72.26 0.96 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.889 ' CE1' HD13 ' A' ' 121' ' ' LEU . 97.9 m-85 -156.66 134.29 10.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.293 -1.122 . . . . 0.0 109.58 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -90.96 82.81 5.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.342 -0.849 . . . . 0.0 109.182 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.781 HG21 ' CB ' ' A' ' 23' ' ' PHE . 7.4 p -89.9 173.22 8.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -0.897 . . . . 0.0 109.657 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.738 ' HB2' HD12 ' A' ' 7' ' ' LEU . 11.7 m-85 -130.21 170.06 14.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.317 -0.864 . . . . 0.0 109.394 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.435 ' HG2' ' O ' ' A' ' 32' ' ' GLN . 3.3 pt20 -131.41 135.82 47.5 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.2 -0.938 . . . . 0.0 109.682 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.613 ' HB1' ' OE1' ' A' ' 38' ' ' GLN . . . -155.91 130.56 9.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.393 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 1.116 ' HB2' ' NH2' ' A' ' 16' ' ' ARG . . . -82.32 -70.71 0.53 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.156 -0.965 . . . . 0.0 109.483 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.478 ' OD1' ' HB3' ' A' ' 38' ' ' GLN . 18.8 p-10 -60.54 170.94 1.23 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.223 -0.923 . . . . 0.0 109.577 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.715 ' O ' HD12 ' A' ' 40' ' ' LEU . . . -97.84 -17.73 29.53 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.9 tt -73.99 -43.59 57.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.314 -1.109 . . . . 0.0 109.401 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.613 ' OE1' ' HB1' ' A' ' 33' ' ' ALA . 1.0 OUTLIER -77.59 -35.04 53.35 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.19 -0.944 . . . . 0.0 108.893 179.77 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.464 ' HB1' HG22 ' A' ' 9' ' ' VAL . . . -62.57 -46.34 88.79 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.278 -0.889 . . . . 0.0 108.626 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.771 HD11 HG23 ' A' ' 65' ' ' ILE . 7.2 mt -61.54 -45.36 94.51 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -49.68 -43.76 47.5 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.203 -0.936 . . . . 0.0 108.856 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.631 HG21 ' CD1' ' A' ' 7' ' ' LEU . 64.0 mt -64.57 -36.23 76.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.336 -0.853 . . . . 0.0 108.881 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 69.0 t -74.5 -11.87 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.251 -0.905 . . . . 0.0 109.188 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 82.9 m -90.38 -31.5 16.84 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.201 -0.937 . . . . 0.0 109.412 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.22 -53.2 4.67 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.32 -0.862 . . . . 0.0 109.867 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.571 ' O ' ' C ' ' A' ' 47' ' ' ARG . 0.4 OUTLIER -97.17 26.93 4.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.183 -0.948 . . . . 0.0 109.627 -179.667 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.571 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -9.69 78.55 0.03 OUTLIER Pre-proline 0 N--CA 1.504 2.266 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.534 ' N ' ' O ' ' A' ' 46' ' ' GLU . 34.3 Cg_endo -75.88 162.66 34.56 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.684 2.256 . . . . 0.0 110.284 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 4.6 m-20 -92.49 -14.12 28.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 109.657 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.859 ' HB3' HG23 ' A' ' 6' ' ' ILE . 4.5 tp -114.16 126.33 54.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.215 -0.928 . . . . 0.0 109.554 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.755 HG11 ' CE ' ' A' ' 69' ' ' MET . 6.0 t -136.83 123.83 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.284 -0.885 . . . . 0.0 109.378 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.738 HD12 ' O ' ' A' ' 7' ' ' LEU . 1.1 mt -103.11 134.78 45.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.212 -0.93 . . . . 0.0 109.584 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.577 HD21 ' HB ' ' A' ' 65' ' ' ILE . 1.4 mp -124.4 135.13 53.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.264 -0.898 . . . . 0.0 109.466 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.461 ' O ' HG13 ' A' ' 57' ' ' ILE . 31.1 t0 -123.61 103.96 8.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.215 -0.928 . . . . 0.0 109.484 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.77 ' HB2' HG21 ' A' ' 82' ' ' THR . 19.2 mmt -62.69 -19.06 63.5 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.17 -0.957 . . . . 0.0 109.463 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.44 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 1.1 mmmp? -54.89 -25.19 27.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 0.0 109.45 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 54' ' ' ASP . 9.8 mt -43.06 103.21 0.3 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.27 -0.893 . . . . 0.0 109.501 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.458 ' HD2' ' CG ' ' A' ' 11' ' ' ASP . 35.2 Cg_endo -77.52 97.73 1.16 Allowed 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.437 2.092 . . . . 0.0 110.464 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 155.62 -20.43 0.53 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.408 ' SD ' ' O ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -166.59 150.93 7.43 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.278 -1.131 . . . . 0.0 109.475 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.408 ' O ' ' SD ' ' A' ' 60' ' ' MET . 1.1 m-20 -85.04 144.0 28.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.186 -0.946 . . . . 0.0 109.57 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -96.56 12.48 66.22 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.2 mm -69.36 -39.43 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.245 -1.15 . . . . 0.0 109.451 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -68.11 -34.65 76.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.262 -0.899 . . . . 0.0 109.494 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.771 HG23 HD11 ' A' ' 40' ' ' LEU . 9.3 mt -54.14 -63.95 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.923 . . . . 0.0 109.492 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.538 HD21 HG11 ' A' ' 78' ' ' VAL . 21.0 mt -46.63 -49.97 18.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.203 -0.936 . . . . 0.0 109.429 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.432 ' O ' HG23 ' A' ' 71' ' ' VAL . 2.5 ttmm -44.09 -50.51 8.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.182 -0.949 . . . . 0.0 109.508 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.432 ' O ' HG13 ' A' ' 72' ' ' ILE . 2.4 mpt_? -60.62 -39.25 87.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.926 . . . . 0.0 109.457 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.755 ' CE ' HG11 ' A' ' 51' ' ' VAL . 0.7 OUTLIER -61.79 -23.74 66.41 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -0.894 . . . . 0.0 109.438 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.534 ' CE ' ' HB3' ' A' ' 96' ' ' LEU . 21.8 mmtm -81.15 -45.29 16.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.3 -0.875 . . . . 0.0 109.473 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 67' ' ' LYS . 2.6 t -65.1 -22.64 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.278 -0.889 . . . . 0.0 109.473 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 68' ' ' ARG . 78.8 mt -88.71 -41.89 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.258 -0.901 . . . . 0.0 109.415 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.82 130.95 11.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.19 -0.944 . . . . 0.0 109.469 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -90.02 -12.55 38.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.2 -0.937 . . . . 0.0 109.465 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.405 ' OD1' ' N ' ' A' ' 75' ' ' ASN . 1.8 m120 -116.58 55.5 0.82 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.409 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.0 tp -110.93 145.78 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.328 -0.858 . . . . 0.0 109.411 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.859 ' CB ' HD11 ' A' ' 99' ' ' LEU . 2.3 mtm180 -89.19 115.02 26.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.195 -0.941 . . . . 0.0 109.483 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.538 HG11 HD21 ' A' ' 66' ' ' LEU . 16.9 t -131.1 115.83 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.221 -0.925 . . . . 0.0 109.531 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.826 HG12 HG22 ' A' ' 100' ' ' THR . 43.9 mt -100.38 132.59 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.309 -0.87 . . . . 0.0 109.445 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.921 HD12 ' ND1' ' A' ' 101' ' ' HIS . 1.0 OUTLIER -89.88 172.97 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.177 -0.952 . . . . 0.0 109.364 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.467 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 13.7 mtm -147.46 52.18 1.06 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.161 -0.962 . . . . 0.0 109.565 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.77 HG21 ' HB2' ' A' ' 55' ' ' MET . 14.7 t -162.68 40.66 0.11 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.185 -0.947 . . . . 0.0 109.519 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.035 ' HB2' ' CD2' ' A' ' 101' ' ' HIS . . . . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.278 -0.889 . . . . 0.0 109.483 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.658 HG23 ' HD1' ' A' ' 101' ' ' HIS . 57.9 mt . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.449 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 1.1 tp60 -44.32 -62.95 0.99 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -0.897 . . . . 0.0 109.452 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.464 ' O ' HD23 ' A' ' 96' ' ' LEU . 0.3 OUTLIER -60.84 -38.62 86.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.916 . . . . 0.0 109.512 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.524 ' HB3' ' HB2' ' A' ' 98' ' ' ALA . 0.6 OUTLIER -44.0 -26.67 0.3 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.209 -0.932 . . . . 0.0 109.429 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 91' ' ' GLN . 0.0 OUTLIER -53.08 -62.12 1.86 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.175 -0.953 . . . . 0.0 109.457 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.474 ' HG3' ' CD2' ' A' ' 96' ' ' LEU . 1.2 pt-20 -63.19 -35.02 78.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.187 -0.946 . . . . 0.0 109.509 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.538 HD22 ' N ' ' A' ' 96' ' ' LEU . 3.7 mm? -61.33 -24.84 66.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.221 -0.924 . . . . 0.0 109.511 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 130.13 42.33 0.22 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.524 ' HB2' ' HB3' ' A' ' 93' ' ' SER . . . -113.44 110.65 20.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -1.149 . . . . 0.0 109.466 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.859 HD11 ' CB ' ' A' ' 77' ' ' ARG . 3.6 mt -73.25 -72.25 0.27 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.186 -0.946 . . . . 0.0 109.577 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.826 HG22 HG12 ' A' ' 79' ' ' ILE . 12.7 t -130.46 147.51 52.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.225 -0.922 . . . . 0.0 109.495 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 1.035 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 3.6 t-160 -111.21 89.54 3.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.295 -0.878 . . . . 0.0 109.339 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.664 ' CD2' HD13 ' A' ' 111' ' ' ILE . 35.5 m-85 -68.96 153.34 43.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.226 -0.921 . . . . 0.0 109.531 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.564 ' HB2' ' CA ' ' A' ' 83' ' ' ALA . . . -139.52 151.97 46.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.239 -0.913 . . . . 0.0 109.472 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.489 ' CG ' ' HA ' ' A' ' 105' ' ' PRO . 36.1 tttm -85.3 141.63 37.21 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 0.0 109.353 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.489 ' HA ' ' CG ' ' A' ' 104' ' ' LYS . 35.8 Cg_endo -77.96 137.39 46.59 Favored 'Cis proline' 0 C--N 1.31 -1.456 0 C-N-CA 123.39 -1.504 . . . . 0.0 110.367 0.006 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -114.54 -170.01 1.65 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.238 -0.914 . . . . 0.0 109.489 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -130.05 121.08 25.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.0 109.413 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.446 ' HA ' HD13 ' A' ' 108' ' ' ILE . 20.5 mm -50.11 -30.44 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.207 -0.933 . . . . 0.0 109.52 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.41 ' O ' ' HG2' ' A' ' 112' ' ' ARG . 33.4 m-20 -66.6 -42.4 86.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.216 -0.928 . . . . 0.0 109.433 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.429 ' HB3' ' CE1' ' A' ' 102' ' ' PHE . 4.0 mt-10 -65.69 -35.18 80.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.289 -0.882 . . . . 0.0 109.467 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.664 HD13 ' CD2' ' A' ' 102' ' ' PHE . 22.1 mm -64.9 -60.36 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.295 -0.878 . . . . 0.0 109.496 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 1.1 ptm180 -56.81 -30.38 63.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 0.0 109.482 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -62.99 -54.92 30.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -0.895 . . . . 0.0 109.477 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.562 ' O ' ' CD2' ' A' ' 118' ' ' TYR . . . -60.01 -32.84 71.25 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.163 -0.96 . . . . 0.0 109.474 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.804 HG22 HD21 ' A' ' 50' ' ' LEU . 58.2 t -67.42 -35.0 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.23 -0.919 . . . . 0.0 109.473 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.422 ' HE2' ' OE2' ' A' ' 26' ' ' GLU . 1.9 mttt -75.48 -30.05 59.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.279 -0.888 . . . . 0.0 109.499 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.68 -34.08 62.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.219 -0.926 . . . . 0.0 109.46 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.562 ' CD2' ' O ' ' A' ' 114' ' ' ALA . 46.6 m-85 -89.92 -65.59 1.0 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.294 -0.879 . . . . 0.0 109.466 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 1.012 HD21 ' CG ' ' A' ' 4' ' ' GLU . 2.8 tt -90.01 112.42 52.24 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.285 -0.884 . . . . 0.0 109.475 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 118' ' ' TYR . 35.7 Cg_endo -78.06 164.06 27.56 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.362 2.042 . . . . 0.0 110.396 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.889 HD13 ' CE1' ' A' ' 28' ' ' TYR . 1.3 tp . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.301 -0.875 . . . . 0.0 109.48 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.615 ' CD ' HD23 ' A' ' 121' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.49 ' CG ' ' HA ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -114.12 132.57 56.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.246 -0.909 . . . . 0.0 109.447 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.676 HG23 ' HB3' ' A' ' 50' ' ' LEU . 52.5 mt -145.35 164.7 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.237 -0.915 . . . . 0.0 109.509 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.926 HD13 ' N ' ' A' ' 8' ' ' ILE . 1.0 OUTLIER -131.08 128.55 40.44 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.241 -0.912 . . . . 0.0 109.451 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.926 ' N ' HD13 ' A' ' 7' ' ' LEU . 12.1 mt -115.46 108.44 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.186 -0.946 . . . . 0.0 109.464 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.83 ' HA ' ' HB3' ' A' ' 33' ' ' ALA . 17.5 t -92.44 128.63 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.919 . . . . 0.0 109.529 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.533 ' OD2' HD13 ' A' ' 15' ' ' ILE . 2.1 t70 -174.94 123.43 0.24 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 109.44 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.982 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . 2.6 p30 -114.68 81.43 1.56 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.318 -0.864 . . . . 0.0 109.601 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.5 ' HG2' ' N ' ' A' ' 13' ' ' TYR . 7.5 tt0 -175.99 -104.51 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.207 -0.933 . . . . 0.0 109.411 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.5 ' N ' ' HG2' ' A' ' 12' ' ' GLN . 37.4 t80 -179.54 120.47 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.85 -1.156 . . . . 0.0 109.543 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.485 ' O ' HD13 ' A' ' 18' ' ' LEU . . . 135.73 -50.44 0.85 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.634 HG23 HD13 ' A' ' 19' ' ' LEU . 2.0 mp -81.28 -54.44 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.179 -1.189 . . . . 0.0 109.658 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.519 ' CD ' ' O ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -50.33 -29.75 10.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.165 -0.959 . . . . 0.0 109.757 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.59 ' N ' HD13 ' A' ' 17' ' ' ILE . 2.6 mm -90.2 -64.76 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.183 -0.948 . . . . 0.0 109.887 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.945 ' O ' HG23 ' A' ' 22' ' ' VAL . 6.9 mp -48.55 -60.46 2.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.229 -0.92 . . . . 0.0 109.801 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.739 ' HB3' HD13 ' A' ' 8' ' ' ILE . 0.5 OUTLIER -53.87 -28.85 38.63 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 0.0 109.64 -179.773 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 28.4 t30 -69.2 -71.88 0.21 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.903 . . . . 0.0 109.665 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.478 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 2.5 tt0 -43.06 -38.04 2.19 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.317 -0.864 . . . . 0.0 109.71 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.945 HG23 ' O ' ' A' ' 18' ' ' LEU . 19.0 t -61.77 -55.63 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.243 -0.911 . . . . 0.0 109.553 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.646 ' CB ' HG21 ' A' ' 30' ' ' THR . 23.6 m-85 -77.7 1.94 18.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 109.566 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.478 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 1.5 m-20 -90.06 -48.96 6.86 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.189 -0.944 . . . . 0.0 109.474 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.26 -46.13 24.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 109.544 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.505 ' HB3' ' CD1' ' A' ' 28' ' ' TYR . 1.8 tt0 -52.07 -22.65 4.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.2 -0.937 . . . . 0.0 109.469 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.436 ' C ' ' CD1' ' A' ' 28' ' ' TYR . . . 100.09 72.78 1.02 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.59 ' CE2' ' HG ' ' A' ' 121' ' ' LEU . 96.2 m-85 -154.55 134.62 13.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -1.17 . . . . 0.0 109.473 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.448 ' HB2' ' O ' ' A' ' 4' ' ' GLU . 12.4 mm100 -94.16 83.08 4.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 109.217 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.646 HG21 ' CB ' ' A' ' 23' ' ' PHE . 5.7 p -89.95 154.71 19.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.895 . . . . 0.0 109.604 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.796 ' HB2' HD22 ' A' ' 7' ' ' LEU . 38.6 m-85 -113.53 -171.25 1.85 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.274 -0.891 . . . . 0.0 109.283 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.426 ' OE1' ' HG2' ' A' ' 16' ' ' ARG . 11.8 mt-30 -124.44 154.78 39.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 109.552 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.83 ' HB3' ' HA ' ' A' ' 9' ' ' VAL . . . -152.62 -165.37 2.18 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.297 -0.877 . . . . 0.0 109.392 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.982 ' HB1' ' HB3' ' A' ' 11' ' ' ASP . . . 164.34 -62.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.905 . . . . 0.0 109.597 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.43 ' H ' ' ND2' ' A' ' 35' ' ' ASN . 3.9 p30 -71.15 -4.64 26.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.185 -0.947 . . . . 0.0 109.577 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 37' ' ' LEU . . . 86.29 -63.28 4.2 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.46 ' HA ' HD13 ' A' ' 37' ' ' LEU . 1.0 OUTLIER -44.54 -32.28 1.38 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.207 -1.172 . . . . 0.0 109.405 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.407 ' O ' ' C ' ' A' ' 39' ' ' ALA . 1.0 OUTLIER -70.22 -60.32 2.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.498 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.837 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -44.02 -45.22 7.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.224 -0.923 . . . . 0.0 109.482 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.7 mt -61.55 -44.06 97.72 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -0.871 . . . . 0.0 109.45 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -55.64 -57.57 11.42 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.287 -0.883 . . . . 0.0 109.488 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.419 ' CG2' HD23 ' A' ' 7' ' ' LEU . 2.5 mp -61.4 -20.83 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.285 -0.884 . . . . 0.0 109.482 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.837 HG23 ' O ' ' A' ' 39' ' ' ALA . 53.5 t -79.63 -26.65 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 109.495 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 85.5 m -89.99 -24.21 21.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -0.901 . . . . 0.0 109.448 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.8 mtpt -89.97 -27.32 19.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.225 -0.922 . . . . 0.0 109.554 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -119.3 -34.37 3.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.206 -0.934 . . . . 0.0 109.506 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 33.2 mtm180 58.18 71.07 1.09 Allowed Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.173 -0.954 . . . . 0.0 109.476 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.526 ' CD ' ' HA ' ' A' ' 43' ' ' VAL . 35.3 Cg_endo -78.07 157.69 30.43 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.599 2.199 . . . . 0.0 110.328 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 0.4 OUTLIER -94.08 -9.61 36.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.194 -0.941 . . . . 0.0 109.512 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.676 ' HB3' HG23 ' A' ' 6' ' ' ILE . 6.5 tp -123.29 114.81 20.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.906 . . . . 0.0 109.504 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.851 HG11 ' SD ' ' A' ' 69' ' ' MET . 1.7 t -121.21 111.41 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.263 -0.898 . . . . 0.0 109.443 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.546 HD12 ' O ' ' A' ' 7' ' ' LEU . 0.7 OUTLIER -89.97 109.62 20.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.291 -0.881 . . . . 0.0 109.406 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.721 HD22 ' N ' ' A' ' 53' ' ' LEU . 3.0 mm? -95.28 136.15 35.98 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.201 -0.937 . . . . 0.0 109.489 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.45 ' O ' HG13 ' A' ' 57' ' ' ILE . 30.2 t0 -113.9 117.7 32.12 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.31 -0.869 . . . . 0.0 109.446 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.918 ' CG ' HG21 ' A' ' 82' ' ' THR . 18.0 mmt -77.58 -7.99 57.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.175 -0.953 . . . . 0.0 109.489 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 57' ' ' ILE . 4.6 mtpm? -68.7 -15.56 63.56 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.308 -0.87 . . . . 0.0 109.527 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.878 HG23 ' OD2' ' A' ' 11' ' ' ASP . 80.5 mt -43.87 113.78 1.63 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.256 -0.902 . . . . 0.0 109.37 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.453 ' HD2' ' CG ' ' A' ' 11' ' ' ASP . 36.0 Cg_endo -78.67 6.0 5.19 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.337 2.025 . . . . 0.0 110.509 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.659 ' H ' HG22 ' A' ' 57' ' ' ILE . . . -91.97 -43.97 4.28 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.528 ' CE ' HG21 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -169.58 -171.66 1.27 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.291 -1.123 . . . . 0.0 109.447 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -89.56 132.72 34.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.902 . . . . 0.0 109.431 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.36 10.89 60.07 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 25.5 mm -61.84 -38.44 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.197 -1.178 . . . . 0.0 109.487 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -68.7 -25.63 64.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.279 -0.888 . . . . 0.0 109.506 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.409 HG22 ' HE3' ' A' ' 69' ' ' MET . 70.9 mt -68.1 -64.92 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.184 -0.947 . . . . 0.0 109.505 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.966 HD21 HG11 ' A' ' 78' ' ' VAL . 2.4 mt -44.15 -34.45 1.84 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 0.0 109.531 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.518 ' O ' ' CG ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -64.02 -59.33 4.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -0.91 . . . . 0.0 109.465 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.0 mtt180 -49.57 -30.46 8.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.345 -0.847 . . . . 0.0 109.473 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.851 ' SD ' HG11 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -67.01 -60.73 2.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.874 . . . . 0.0 109.466 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.518 ' CG ' ' O ' ' A' ' 67' ' ' LYS . 16.4 ptpt -51.39 -31.43 22.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.186 -0.946 . . . . 0.0 109.455 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 49.9 t -66.57 -44.99 89.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.19 -0.944 . . . . 0.0 109.493 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.2 mt -70.23 -65.11 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.218 -0.926 . . . . 0.0 109.535 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -113.7 130.84 56.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.227 -0.921 . . . . 0.0 109.429 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -87.11 -22.4 25.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.952 . . . . 0.0 109.411 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.2 p30 -105.55 45.26 0.98 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -0.886 . . . . 0.0 109.438 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.467 HD12 ' O ' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -104.15 128.08 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.283 -0.886 . . . . 0.0 109.452 179.964 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.531 ' CA ' HD11 ' A' ' 99' ' ' LEU . 3.4 mpt_? -78.11 143.13 37.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.259 -0.901 . . . . 0.0 109.48 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.966 HG11 HD21 ' A' ' 66' ' ' LEU . 55.5 t -144.57 144.94 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.326 -0.859 . . . . 0.0 109.568 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.865 HG23 ' O ' ' A' ' 100' ' ' THR . 18.3 mt -128.95 139.02 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.292 -0.88 . . . . 0.0 109.393 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.904 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.3 OUTLIER -102.6 130.64 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.161 -0.962 . . . . 0.0 109.337 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.46 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -102.69 51.99 0.8 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.29 -0.881 . . . . 0.0 109.532 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.918 HG21 ' CG ' ' A' ' 55' ' ' MET . 10.6 t -161.7 44.05 0.16 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.945 . . . . 0.0 109.565 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.901 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.935 . . . . 0.0 109.412 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.933 HD12 ' CE1' ' A' ' 101' ' ' HIS . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.818 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.414 ' C ' ' O ' ' A' ' 90' ' ' ILE . 0.1 OUTLIER -45.02 -38.82 5.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.169 -0.957 . . . . 0.0 109.528 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -88.07 -40.8 13.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.203 -0.936 . . . . 0.0 109.541 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.834 ' HA ' HD12 ' A' ' 96' ' ' LEU . 2.9 m -53.05 -20.14 3.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 0.0 109.5 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.788 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 6.0 tttt -58.23 -53.8 54.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.186 -0.946 . . . . 0.0 109.477 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -76.78 -10.2 59.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.911 . . . . 0.0 109.481 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.834 HD12 ' HA ' ' A' ' 93' ' ' SER . 66.9 mt -75.4 -46.68 31.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.269 -0.895 . . . . 0.0 109.494 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 178.1 33.23 0.05 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.788 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -118.94 123.05 43.67 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.26 -1.141 . . . . 0.0 109.505 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.531 HD11 ' CA ' ' A' ' 77' ' ' ARG . 0.4 OUTLIER -90.08 -60.04 2.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 109.475 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.865 ' O ' HG23 ' A' ' 79' ' ' ILE . 21.2 m -117.79 138.13 52.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.213 -0.929 . . . . 0.0 109.582 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.933 ' CE1' HD12 ' A' ' 90' ' ' ILE . 3.9 t-160 -119.48 84.41 2.2 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.853 . . . . 0.0 109.254 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.849 ' CE2' HD13 ' A' ' 111' ' ' ILE . 22.5 m-85 -72.89 158.27 35.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.0 109.575 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.901 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -127.25 -148.73 0.39 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.241 -0.912 . . . . 0.0 109.368 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.0 tttm -128.17 131.89 24.04 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.258 -0.901 . . . . 0.0 109.369 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.75 -162.4 2.95 Favored 'Cis proline' 0 C--N 1.311 -1.423 0 C-N-CA 123.51 -1.454 . . . . 0.0 110.355 -0.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 106' ' ' PHE . 3.0 p90 -153.95 165.1 37.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.921 . . . . 0.0 109.477 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.473 ' O ' HG12 ' A' ' 111' ' ' ILE . 19.6 t0 -108.17 128.94 55.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.274 -0.891 . . . . 0.0 109.45 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.506 ' HA ' HD13 ' A' ' 108' ' ' ILE . 14.6 mm -61.53 -18.11 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.267 -0.896 . . . . 0.0 109.474 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 113' ' ' ASP . 33.1 m-20 -78.06 -37.72 46.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.162 -0.961 . . . . 0.0 109.435 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.419 ' HG2' ' CZ ' ' A' ' 102' ' ' PHE . 1.4 tt0 -72.53 -24.37 61.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.252 -0.905 . . . . 0.0 109.435 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.849 HD13 ' CE2' ' A' ' 102' ' ' PHE . 12.8 mm -79.58 -52.62 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -0.893 . . . . 0.0 109.48 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.434 ' HG2' ' O ' ' A' ' 108' ' ' ILE . 2.7 ptt85 -69.47 -24.43 63.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.178 -0.951 . . . . 0.0 109.473 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 109' ' ' ASP . 68.9 m-20 -75.93 -51.24 12.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 0.0 109.516 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.59 ' HB1' ' CE2' ' A' ' 118' ' ' TYR . . . -61.64 -46.96 87.54 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.303 -0.873 . . . . 0.0 109.601 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.671 HG22 HD21 ' A' ' 50' ' ' LEU . 68.0 t -58.42 -47.39 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.151 -0.968 . . . . 0.0 109.524 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.94 -30.48 70.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 109.493 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -83.17 -16.8 45.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.9 . . . . 0.0 109.426 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.59 ' CE2' ' HB1' ' A' ' 114' ' ' ALA . 17.5 m-85 -90.02 -72.86 0.54 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.348 -0.845 . . . . 0.0 109.531 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.527 ' CD1' ' HD2' ' A' ' 120' ' ' PRO . 6.1 tp -90.12 139.11 27.16 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.89 . . . . 0.0 109.533 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.527 ' HD2' ' CD1' ' A' ' 119' ' ' LEU . 35.6 Cg_endo -78.78 132.63 10.9 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.495 2.13 . . . . 0.0 110.409 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.963 HD13 ' O ' ' A' ' 121' ' ' LEU . 1.9 tm? . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.254 -0.904 . . . . 0.0 109.489 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.573 ' HG3' HD22 ' A' ' 119' ' ' LEU . 5.4 mm-40 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.26 0.552 . . . . 0.0 109.544 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.476 ' CB ' ' HB3' ' A' ' 48' ' ' PRO . 3.2 mtmm -89.99 157.28 17.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.908 . . . . 0.0 109.482 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.821 HD12 HG22 ' A' ' 30' ' ' THR . 55.3 mt -150.08 158.12 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -0.907 . . . . 0.0 109.453 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.989 ' HB3' HG13 ' A' ' 51' ' ' VAL . 1.0 OUTLIER -131.04 109.0 10.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.323 -0.861 . . . . 0.0 109.365 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.561 HD13 ' HB3' ' A' ' 19' ' ' LEU . 13.2 mt -89.91 113.47 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.235 -0.915 . . . . 0.0 109.444 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.947 HG12 HD11 ' A' ' 57' ' ' ILE . 37.1 t -109.39 97.99 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.221 -0.924 . . . . 0.0 109.392 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 11' ' ' ASP . 2.2 t0 -152.7 88.13 1.33 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.905 . . . . 0.0 109.509 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.528 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . 7.3 p-10 -44.29 -43.32 7.31 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.5 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -55.97 134.94 52.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.298 -0.876 . . . . 0.0 109.56 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.596 ' CE2' HG13 ' A' ' 17' ' ' ILE . 7.6 t80 -73.71 174.0 9.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.272 -0.892 . . . . 0.0 109.535 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.29 -38.52 3.2 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 1.052 HG23 HD13 ' A' ' 19' ' ' LEU . 2.3 mp -84.64 -48.39 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.332 -1.099 . . . . 0.0 109.443 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.464 ' O ' ' HB2' ' A' ' 20' ' ' ASN . 2.5 mtp180 -59.88 -26.79 66.15 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.255 -0.903 . . . . 0.0 109.584 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.596 HG13 ' CE2' ' A' ' 13' ' ' TYR . 3.7 mm -90.22 -57.16 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.25 -0.906 . . . . 0.0 109.74 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.818 ' O ' HG23 ' A' ' 22' ' ' VAL . 79.6 mt -54.18 -59.37 4.75 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -0.92 . . . . 0.0 109.706 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 1.052 HD13 HG23 ' A' ' 15' ' ' ILE . 4.5 mp -56.7 -19.31 15.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.243 -0.911 . . . . 0.0 109.602 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 25.9 t30 -78.2 -72.45 0.37 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.884 . . . . 0.0 109.637 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -48.29 -28.31 3.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -0.913 . . . . 0.0 109.554 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.843 HG21 ' CG2' ' A' ' 108' ' ' ILE . 63.7 t -70.61 -57.26 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.221 -0.925 . . . . 0.0 109.543 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.511 ' CZ ' HG22 ' A' ' 111' ' ' ILE . 15.5 m-85 -72.63 -3.09 22.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.276 -0.89 . . . . 0.0 109.585 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -80.08 -51.56 8.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.155 -0.966 . . . . 0.0 109.416 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.13 -22.01 53.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.292 -0.88 . . . . 0.0 109.451 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.511 ' O ' ' CD2' ' A' ' 121' ' ' LEU . 2.2 mt-10 -71.36 -33.47 69.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.233 -0.917 . . . . 0.0 109.464 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 110.02 61.93 0.51 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.616 ' CE2' HD22 ' A' ' 121' ' ' LEU . 98.8 m-85 -151.63 134.95 16.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.294 -1.121 . . . . 0.0 109.539 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -89.92 83.04 6.12 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.226 -0.922 . . . . 0.0 109.137 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.821 HG22 HD12 ' A' ' 6' ' ' ILE . 5.6 p -89.91 151.08 21.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.296 -0.877 . . . . 0.0 109.607 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.747 ' HB2' HD22 ' A' ' 7' ' ' LEU . 11.8 m-85 -115.85 -170.41 1.78 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.286 -0.884 . . . . 0.0 109.297 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -127.5 149.79 49.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.13 -0.981 . . . . 0.0 109.504 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.662 ' HB3' HG22 ' A' ' 9' ' ' VAL . . . -164.56 171.97 13.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.288 -0.882 . . . . 0.0 109.381 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.528 ' HB1' ' HB3' ' A' ' 11' ' ' ASP . . . -172.65 -34.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -0.908 . . . . 0.0 109.536 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.421 ' OD1' ' HB2' ' A' ' 37' ' ' LEU . 3.1 p30 -81.89 -2.72 52.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.187 -0.946 . . . . 0.0 109.625 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.19 -45.69 3.55 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.606 HD12 ' N ' ' A' ' 37' ' ' LEU . 9.1 mp -58.2 -34.59 70.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.242 -1.152 . . . . 0.0 109.483 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.932 ' O ' HD12 ' A' ' 42' ' ' ILE . 13.2 mm100 -76.08 -28.53 57.61 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.199 -0.938 . . . . 0.0 109.467 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.833 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -69.13 -55.32 11.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.324 -0.86 . . . . 0.0 109.485 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.461 HD13 ' HD2' ' A' ' 68' ' ' ARG . 13.1 mt -65.54 -51.46 59.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.246 -0.909 . . . . 0.0 109.496 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -48.99 -54.32 16.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.287 -0.883 . . . . 0.0 109.452 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.932 HD12 ' O ' ' A' ' 38' ' ' GLN . 15.7 mt -60.06 -30.17 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.235 -0.915 . . . . 0.0 109.43 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.833 HG23 ' O ' ' A' ' 39' ' ' ALA . 70.2 t -70.36 -26.92 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.94 . . . . 0.0 109.461 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.1 m -89.86 -19.4 24.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.158 -0.964 . . . . 0.0 109.437 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.6 mmtt -90.02 -24.35 21.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.353 -0.842 . . . . 0.0 109.517 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.454 ' HB3' ' HD3' ' A' ' 5' ' ' LYS . 38.9 mm-40 -125.39 -32.93 2.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.171 -0.955 . . . . 0.0 109.524 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 1.4 mtt180 60.48 66.85 1.74 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 109.527 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.547 ' O ' HD12 ' A' ' 76' ' ' ILE . 35.6 Cg_endo -77.85 175.34 11.32 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.668 2.245 . . . . 0.0 110.474 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 0.9 OUTLIER -116.82 -9.32 11.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.276 -0.89 . . . . 0.0 109.511 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.04 HD21 HG22 ' A' ' 115' ' ' VAL . 7.2 tp -128.07 120.02 26.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.28 -0.888 . . . . 0.0 109.538 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.989 HG13 ' HB3' ' A' ' 7' ' ' LEU . 39.1 t -133.16 124.49 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 0.0 109.692 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.475 ' CD1' HG12 ' A' ' 8' ' ' ILE . 1.1 mp -89.94 112.78 24.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.341 -0.849 . . . . 0.0 109.355 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.474 ' CD2' ' HG ' ' A' ' 66' ' ' LEU . 1.1 mp -97.5 120.01 37.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.149 -0.969 . . . . 0.0 109.626 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.456 ' HA ' ' HG3' ' A' ' 81' ' ' MET . 26.5 t0 -105.77 101.78 11.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.264 -0.897 . . . . 0.0 109.273 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.863 ' CG ' HG21 ' A' ' 82' ' ' THR . 3.3 mmt -61.82 -13.35 23.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -0.919 . . . . 0.0 109.464 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.444 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 43.4 mttp -57.96 -25.94 61.64 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.214 -0.929 . . . . 0.0 109.486 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.947 HD11 HG12 ' A' ' 9' ' ' VAL . 87.5 mt -42.08 102.25 0.27 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.342 -0.849 . . . . 0.0 109.582 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.472 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 36.0 Cg_endo -78.33 102.2 1.54 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.377 2.052 . . . . 0.0 110.476 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 125.77 -20.19 6.47 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.681 ' HB3' HG21 ' A' ' 57' ' ' ILE . 11.2 tmm? -129.53 132.54 46.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -1.167 . . . . 0.0 109.521 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.431 ' O ' ' SD ' ' A' ' 60' ' ' MET . 74.1 m-20 -89.14 129.82 35.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.203 -0.936 . . . . 0.0 109.497 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.443 ' HA2' HG13 ' A' ' 65' ' ' ILE . . . -87.35 9.82 71.64 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 25.3 mm -76.15 -49.63 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.19 -1.182 . . . . 0.0 109.479 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -62.29 -25.31 67.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 109.388 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.566 HG22 ' HE2' ' A' ' 69' ' ' MET . 7.9 mt -62.83 -65.26 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.311 -0.868 . . . . 0.0 109.45 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.632 HD21 HG11 ' A' ' 78' ' ' VAL . 22.0 mt -46.57 -40.96 13.69 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.189 -0.944 . . . . 0.0 109.437 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.553 ' O ' HG23 ' A' ' 71' ' ' VAL . 2.0 tttt -53.8 -53.7 48.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.934 . . . . 0.0 109.399 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.476 ' O ' HG12 ' A' ' 72' ' ' ILE . 1.9 mtt85 -60.72 -24.99 66.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.258 -0.901 . . . . 0.0 109.396 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.566 ' HE2' HG22 ' A' ' 65' ' ' ILE . 2.2 mtt -78.36 -25.33 46.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.355 -0.841 . . . . 0.0 109.49 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.485 ' HG2' ' O ' ' A' ' 66' ' ' LEU . 0.8 OUTLIER -82.91 -28.84 29.67 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 0.0 109.263 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 67' ' ' LYS . 2.6 t -90.07 -22.31 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.262 -0.899 . . . . 0.0 109.493 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.476 HG12 ' O ' ' A' ' 68' ' ' ARG . 25.1 mm -90.1 -50.16 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.255 -0.903 . . . . 0.0 109.51 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.622 ' O ' HG22 ' A' ' 76' ' ' ILE . 1.0 OUTLIER -137.81 121.45 17.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -0.922 . . . . 0.0 109.509 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.79 7.76 19.59 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.223 -0.923 . . . . 0.0 109.515 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -122.22 -9.11 8.66 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.246 -0.909 . . . . 0.0 108.984 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.626 ' O ' HG23 ' A' ' 76' ' ' ILE . 2.4 tp -57.86 106.85 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -0.934 . . . . 0.0 109.52 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.547 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 44.6 mtt180 -75.52 131.7 40.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.329 -0.857 . . . . 0.0 109.357 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.632 HG11 HD21 ' A' ' 66' ' ' LEU . 23.6 t -134.54 126.75 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 109.709 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.652 HG23 ' O ' ' A' ' 100' ' ' THR . 80.0 mt -103.81 128.48 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.168 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.895 HD12 ' HD1' ' A' ' 101' ' ' HIS . 0.1 OUTLIER -89.84 153.54 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.174 -0.953 . . . . 0.0 109.427 -179.799 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.456 ' HG3' ' HA ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -132.39 69.0 1.48 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.321 -0.862 . . . . 0.0 109.522 179.899 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.863 HG21 ' CG ' ' A' ' 55' ' ' MET . 12.8 t -170.67 28.16 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.213 -0.93 . . . . 0.0 109.583 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.025 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.236 -0.915 . . . . 0.0 109.516 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.512 HD12 ' HA ' ' A' ' 83' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.704 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.79 -43.77 94.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.309 -0.87 . . . . 0.0 109.604 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.48 ' HG2' HD21 ' A' ' 96' ' ' LEU . 1.1 tp10 -90.13 -20.71 22.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.188 -0.945 . . . . 0.0 109.813 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.496 ' HB3' ' CB ' ' A' ' 98' ' ' ALA . 0.4 OUTLIER -42.39 -26.86 0.12 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.187 -0.945 . . . . 0.0 109.899 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 92' ' ' GLU . 0.3 OUTLIER -52.58 -76.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -0.906 . . . . 0.0 109.899 -179.776 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.459 ' HG3' HD23 ' A' ' 96' ' ' LEU . 2.5 pt-20 -64.91 -38.02 89.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.231 -0.918 . . . . 0.0 109.825 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.522 ' N ' ' CD2' ' A' ' 96' ' ' LEU . 3.3 mm? -55.19 -25.17 30.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.919 . . . . 0.0 109.594 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 132.8 68.27 0.08 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.496 ' CB ' ' HB3' ' A' ' 93' ' ' SER . . . -153.12 98.96 2.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.251 -1.146 . . . . 0.0 109.444 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.547 ' CD1' ' HB3' ' A' ' 77' ' ' ARG . 21.1 mt -43.94 -67.13 0.3 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.295 -0.878 . . . . 0.0 109.346 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.652 ' O ' HG23 ' A' ' 79' ' ' ILE . 14.2 t -146.68 152.43 38.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.33 -0.856 . . . . 0.0 109.44 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.895 ' HD1' HD12 ' A' ' 80' ' ' ILE . 3.6 t-160 -113.68 87.29 2.58 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 109.346 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.552 ' CZ ' ' HB2' ' A' ' 114' ' ' ALA . 13.3 m-30 -71.56 159.92 33.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.226 -0.921 . . . . 0.0 109.569 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 1.025 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -131.35 -148.88 0.37 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.284 -0.885 . . . . 0.0 109.342 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.1 mtpt -91.74 146.42 33.03 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.254 -0.904 . . . . 0.0 109.466 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.5 -169.56 7.96 Favored 'Cis proline' 0 C--N 1.308 -1.565 0 C-N-CA 123.236 -1.568 . . . . 0.0 110.435 -0.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.627 ' CZ ' ' CG1' ' A' ' 111' ' ' ILE . 11.0 t80 -127.48 92.64 3.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.312 -0.868 . . . . 0.0 109.264 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.437 ' O ' HD13 ' A' ' 111' ' ' ILE . 16.3 t70 -89.83 127.83 36.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.282 -0.886 . . . . 0.0 109.511 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.843 ' CG2' HG21 ' A' ' 22' ' ' VAL . 13.7 mm -51.53 -22.16 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.225 -0.922 . . . . 0.0 109.356 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 109' ' ' ASP . 4.3 m-20 -72.64 -42.33 64.52 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.295 -0.878 . . . . 0.0 109.499 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.436 ' HG2' ' CE2' ' A' ' 102' ' ' PHE . 17.4 tt0 -62.51 -29.82 70.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.264 -0.898 . . . . 0.0 109.473 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.648 ' N ' HD12 ' A' ' 111' ' ' ILE . 1.4 mp -76.49 -56.13 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 109.327 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.432 ' HG2' ' HA ' ' A' ' 109' ' ' ASP . 30.4 ptt180 -60.79 -19.61 59.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.921 . . . . 0.0 109.435 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -81.61 -51.14 8.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 109.396 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 102' ' ' PHE . . . -55.58 -47.42 76.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.263 -0.898 . . . . 0.0 109.368 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 1.04 HG22 HD21 ' A' ' 50' ' ' LEU . 47.2 t -65.97 -47.64 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.314 -0.867 . . . . 0.0 109.419 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.81 -19.29 59.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 109.418 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -89.48 -27.25 20.46 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.251 -0.905 . . . . 0.0 109.345 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.452 ' CD2' ' O ' ' A' ' 114' ' ' ALA . 42.3 m-85 -88.07 -69.64 0.68 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.296 -0.878 . . . . 0.0 109.47 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.573 HD22 ' HG3' ' A' ' 4' ' ' GLU . 2.4 tt -90.19 127.92 51.47 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.235 -0.915 . . . . 0.0 109.435 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.474 ' HD2' ' HG ' ' A' ' 119' ' ' LEU . 35.9 Cg_endo -78.49 142.42 18.5 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.414 2.076 . . . . 0.0 110.368 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.616 HD22 ' CE2' ' A' ' 28' ' ' TYR . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.479 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.499 ' CG ' ' HA ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -146.24 126.19 13.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.208 -0.932 . . . . 0.0 109.491 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.712 ' HB ' HG22 ' A' ' 30' ' ' THR . 4.1 mt -109.2 162.48 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.188 -0.945 . . . . 0.0 109.415 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.755 HD12 HG22 ' A' ' 9' ' ' VAL . 2.0 tm? -136.41 108.16 7.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.199 -0.938 . . . . 0.0 109.587 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.51 ' N ' HD13 ' A' ' 7' ' ' LEU . 5.0 mt -90.01 103.41 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.219 -0.926 . . . . 0.0 109.138 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.755 HG22 HD12 ' A' ' 7' ' ' LEU . 2.7 t -89.99 95.12 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.172 -0.955 . . . . 0.0 109.801 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.497 ' HB3' ' HD2' ' A' ' 16' ' ' ARG . 4.8 m-20 -145.22 155.36 43.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.272 -0.893 . . . . 0.0 109.402 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.464 ' OD2' ' CD ' ' A' ' 58' ' ' PRO . 7.1 p-10 -114.35 -29.75 6.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.339 -0.851 . . . . 0.0 109.41 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.529 ' HB3' ' NH2' ' A' ' 16' ' ' ARG . 1.4 tt0 -67.83 -148.04 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.349 -0.844 . . . . 0.0 109.514 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.614 ' CD1' ' N ' ' A' ' 14' ' ' GLY . 40.5 t80 -148.66 166.43 28.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.295 -0.878 . . . . 0.0 109.347 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.614 ' N ' ' CD1' ' A' ' 13' ' ' TYR . . . 102.24 -84.25 0.49 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.638 HG23 HD13 ' A' ' 19' ' ' LEU . 1.5 mt -51.08 -68.03 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.315 -1.109 . . . . 0.0 109.151 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.529 ' NH2' ' HB3' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -39.75 -27.57 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.616 -0.677 . . . . 0.0 110.217 -179.708 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.582 HG13 ' CZ ' ' A' ' 13' ' ' TYR . 9.9 mm -78.81 -46.77 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.091 -1.005 . . . . 0.0 109.841 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.69 ' O ' HG23 ' A' ' 22' ' ' VAL . 3.8 mp -65.47 -54.8 23.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.18 -0.95 . . . . 0.0 109.654 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.638 HD13 HG23 ' A' ' 15' ' ' ILE . 8.6 mp -59.13 -18.88 39.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.276 -0.89 . . . . 0.0 109.3 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 31.1 t30 -77.94 -65.64 0.94 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.436 -0.79 . . . . 0.0 109.546 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -68.07 -7.79 32.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 109.719 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 18' ' ' LEU . 43.7 t -88.16 -57.77 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.19 -0.944 . . . . 0.0 109.458 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.87 ' HB2' HG21 ' A' ' 30' ' ' THR . 18.0 m-85 -63.35 -28.84 70.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -0.91 . . . . 0.0 109.465 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -64.56 -60.04 3.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.274 -0.891 . . . . 0.0 109.44 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -57.03 -54.95 40.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.27 -0.894 . . . . 0.0 109.491 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.45 ' HB3' ' CD1' ' A' ' 28' ' ' TYR . 1.1 tt0 -44.48 -26.39 0.35 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.253 -0.904 . . . . 0.0 109.442 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.466 ' HA3' HD21 ' A' ' 121' ' ' LEU . . . 113.21 55.71 0.43 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.602 ' CZ ' HD13 ' A' ' 121' ' ' LEU . 78.4 m-85 -147.68 135.91 21.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.259 -1.142 . . . . 0.0 109.475 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -89.85 82.23 6.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.272 -0.893 . . . . 0.0 109.358 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.87 HG21 ' HB2' ' A' ' 23' ' ' PHE . 6.0 p -89.96 146.76 24.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.324 -0.86 . . . . 0.0 109.605 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.554 ' CZ ' ' OE1' ' A' ' 46' ' ' GLU . 18.7 m-85 -116.15 -178.71 3.47 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.321 -0.862 . . . . 0.0 109.343 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -122.14 136.18 54.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 0.0 109.553 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' A' ' 10' ' ' ASP . . . -141.94 -175.82 4.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.257 -0.902 . . . . 0.0 109.425 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.57 -83.46 0.09 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.18 -0.95 . . . . 0.0 109.499 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.441 ' OD1' ' HB2' ' A' ' 38' ' ' GLN . 20.7 p-10 -63.21 137.22 58.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.303 -0.873 . . . . 0.0 109.476 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -45.29 -31.12 3.11 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.455 ' HA ' HD23 ' A' ' 37' ' ' LEU . 0.5 OUTLIER -59.74 -49.87 76.05 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.214 -1.168 . . . . 0.0 109.477 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.441 ' HB2' ' OD1' ' A' ' 35' ' ' ASN . 44.1 tp60 -61.96 -52.15 65.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 109.431 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.976 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -44.69 -51.54 9.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.195 -0.94 . . . . 0.0 109.572 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.491 HD21 ' HB2' ' A' ' 68' ' ' ARG . 20.6 mt -60.25 -37.47 80.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.206 -0.934 . . . . 0.0 109.59 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.24 -59.46 5.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.139 -0.976 . . . . 0.0 109.527 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.751 HG21 HD23 ' A' ' 7' ' ' LEU . 5.1 mt -62.07 -19.85 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.207 -0.933 . . . . 0.0 109.577 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.976 HG23 ' O ' ' A' ' 39' ' ' ALA . 90.8 t -81.37 -24.9 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.188 -0.945 . . . . 0.0 109.491 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.5 m -90.13 -27.48 19.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 109.511 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.474 ' HD2' ' N ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -90.08 -30.89 17.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.247 -0.908 . . . . 0.0 109.527 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.554 ' OE1' ' CZ ' ' A' ' 31' ' ' PHE . 8.1 mm-40 -110.62 -35.26 6.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.916 . . . . 0.0 109.463 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.468 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 6.5 mtt85 56.33 69.89 1.65 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.478 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.534 ' HD2' HG13 ' A' ' 43' ' ' VAL . 35.4 Cg_endo -77.7 154.72 30.83 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.694 2.263 . . . . 0.0 110.416 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.819 ' C ' HD22 ' A' ' 50' ' ' LEU . 4.0 t0 -92.77 -13.04 29.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.268 -0.895 . . . . 0.0 109.475 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.819 HD22 ' C ' ' A' ' 49' ' ' ASP . 4.3 mm? -122.54 111.98 17.46 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.222 -0.923 . . . . 0.0 109.453 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 1.006 ' HB ' HG12 ' A' ' 78' ' ' VAL . 2.1 t -113.68 131.05 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.198 -0.939 . . . . 0.0 109.528 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.462 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 1.6 mp -108.95 117.98 35.6 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.245 -0.909 . . . . 0.0 109.48 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.809 HD22 ' N ' ' A' ' 53' ' ' LEU . 2.3 mm? -103.19 130.74 50.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.268 -0.895 . . . . 0.0 109.518 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.465 ' HB2' ' OD2' ' A' ' 10' ' ' ASP . 19.6 t0 -111.11 97.81 7.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -0.872 . . . . 0.0 109.437 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.825 ' HB2' HG21 ' A' ' 82' ' ' THR . 12.6 mmt -64.76 -10.82 30.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 0.0 109.396 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -72.71 -2.96 22.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.155 -0.965 . . . . 0.0 109.668 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.45 HG12 ' OD1' ' A' ' 11' ' ' ASP . 55.3 mt -62.24 132.4 93.95 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.128 -0.983 . . . . 0.0 109.32 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.464 ' CD ' ' OD2' ' A' ' 11' ' ' ASP . 36.3 Cg_endo -78.88 112.0 3.04 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.494 2.129 . . . . 0.0 110.412 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 146.07 -76.49 0.27 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.421 ' SD ' ' C ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -130.47 170.14 14.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.207 -1.172 . . . . 0.0 109.501 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -90.09 139.54 30.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.355 -0.84 . . . . 0.0 109.499 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 63' ' ' ILE . . . -73.0 -10.11 77.16 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.456 ' CD1' ' HE3' ' A' ' 55' ' ' MET . 18.1 mm -44.14 -47.41 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.212 -1.169 . . . . 0.0 109.585 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.468 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 4.8 mt-10 -63.36 -39.52 94.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.235 -0.916 . . . . 0.0 109.533 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.414 ' O ' ' C ' ' A' ' 66' ' ' LEU . 65.6 mt -51.37 -64.49 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.262 -0.899 . . . . 0.0 109.415 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.858 HD21 ' HB ' ' A' ' 78' ' ' VAL . 7.1 mt -44.12 -49.01 9.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 109.391 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.603 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.1 OUTLIER -49.06 -47.95 44.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.184 -0.948 . . . . 0.0 109.353 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.491 ' HB2' HD21 ' A' ' 40' ' ' LEU . 9.7 mmt180 -57.15 -44.07 83.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -0.888 . . . . 0.0 109.415 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.887 ' CE ' HG11 ' A' ' 51' ' ' VAL . 3.6 mtt -60.04 -27.27 66.79 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 0.0 109.417 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 66' ' ' LEU . 0.7 OUTLIER -78.05 -31.7 50.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.238 -0.914 . . . . 0.0 109.368 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 67' ' ' LYS . 2.6 t -77.9 -24.53 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.264 -0.898 . . . . 0.0 109.519 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 68' ' ' ARG . 48.9 mt -87.42 -59.65 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -0.917 . . . . 0.0 109.406 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.504 ' O ' HG22 ' A' ' 76' ' ' ILE . 39.8 m-20 -130.52 133.56 46.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.19 -0.944 . . . . 0.0 109.482 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -90.16 -26.08 20.35 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.218 -0.926 . . . . 0.0 109.033 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 44.4 p-10 -96.51 46.85 1.06 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.262 -0.899 . . . . 0.0 109.472 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.53 ' CD1' ' HA ' ' A' ' 49' ' ' ASP . 2.9 tp -117.59 112.83 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.228 -0.92 . . . . 0.0 109.436 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.614 ' CG ' HD11 ' A' ' 99' ' ' LEU . 8.7 mpt_? -63.36 134.99 56.68 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.269 -0.894 . . . . 0.0 109.509 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 1.006 HG12 ' HB ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -138.66 108.84 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.247 -0.908 . . . . 0.0 109.6 -179.925 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.504 HG23 ' O ' ' A' ' 100' ' ' THR . 67.5 mt -96.77 145.68 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.211 -0.931 . . . . 0.0 109.371 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.967 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.4 OUTLIER -103.17 168.66 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.171 -0.956 . . . . 0.0 109.375 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.483 ' CE ' ' OD1' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -142.53 69.54 1.32 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.281 -0.887 . . . . 0.0 109.432 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.825 HG21 ' HB2' ' A' ' 55' ' ' MET . 9.0 t 178.79 55.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.348 -0.845 . . . . 0.0 109.429 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.072 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.901 . . . . 0.0 109.511 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.591 ' CD1' ' N ' ' A' ' 90' ' ' ILE . 1.2 mp . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.48 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -51.19 -27.76 9.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.216 -0.927 . . . . 0.0 109.41 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.503 ' HA ' ' CG ' ' A' ' 95' ' ' GLU . 6.9 mt-10 -89.89 -28.67 19.07 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.302 -0.874 . . . . 0.0 109.456 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.749 ' HB3' HD11 ' A' ' 80' ' ' ILE . 1.7 m -64.8 -40.17 94.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.308 -0.87 . . . . 0.0 109.447 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.687 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 20.3 mttt -70.12 -63.34 1.1 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.204 -0.935 . . . . 0.0 109.548 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.503 ' CG ' ' HA ' ' A' ' 92' ' ' GLU . 0.1 OUTLIER -47.15 -27.75 1.55 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.195 -0.94 . . . . 0.0 109.469 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.495 ' HA ' HD23 ' A' ' 96' ' ' LEU . 22.0 mt -77.8 -41.24 37.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.889 . . . . 0.0 109.439 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.514 ' O ' ' CG2' ' A' ' 78' ' ' VAL . . . 161.4 61.49 0.02 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.687 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -151.03 116.52 5.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.295 -1.12 . . . . 0.0 109.448 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.614 HD11 ' CG ' ' A' ' 77' ' ' ARG . 20.3 mt -44.11 -84.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.188 -0.945 . . . . 0.0 109.436 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.622 ' CG2' ' CE1' ' A' ' 102' ' ' PHE . 12.6 t -129.83 151.87 49.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.301 -0.874 . . . . 0.0 109.456 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.967 ' ND1' HD12 ' A' ' 80' ' ' ILE . 2.9 t60 -101.56 96.29 7.02 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.272 -0.892 . . . . 0.0 109.503 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.622 ' CE1' ' CG2' ' A' ' 100' ' ' THR . 43.6 m-85 -72.22 168.32 18.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.202 -0.936 . . . . 0.0 109.404 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 1.072 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -145.68 -148.34 0.24 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.194 -0.941 . . . . 0.0 109.413 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.81 146.93 25.55 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.919 . . . . 0.0 109.534 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.99 168.01 76.98 Favored 'Cis proline' 0 C--N 1.308 -1.57 0 C-N-CA 123.233 -1.57 . . . . 0.0 110.393 0.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -142.33 -164.41 1.81 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 0.0 109.499 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -136.81 127.4 26.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.251 -0.906 . . . . 0.0 109.397 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.673 HG13 HD23 ' A' ' 18' ' ' LEU . 19.0 mm -54.11 -20.57 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -0.912 . . . . 0.0 109.468 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -74.61 -41.48 60.36 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.246 -0.909 . . . . 0.0 109.475 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -71.87 -31.6 66.62 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.228 -0.92 . . . . 0.0 109.539 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.439 HD13 ' CE2' ' A' ' 102' ' ' PHE . 17.8 mm -68.82 -58.0 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.339 -0.851 . . . . 0.0 109.516 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.442 ' HG2' ' O ' ' A' ' 108' ' ' ILE . 8.2 ptt85 -60.14 -36.47 77.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.227 -0.921 . . . . 0.0 109.535 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -59.69 -54.08 50.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.253 -0.904 . . . . 0.0 109.434 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.526 ' O ' ' CD2' ' A' ' 118' ' ' TYR . . . -57.09 -42.1 80.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.234 -0.917 . . . . 0.0 109.387 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.741 HG21 ' CZ ' ' A' ' 23' ' ' PHE . 53.9 t -65.63 -25.11 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.278 -0.889 . . . . 0.0 109.48 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.53 -45.05 61.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.283 -0.886 . . . . 0.0 109.459 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.38 -42.79 95.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.186 -0.946 . . . . 0.0 109.543 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.526 ' CD2' ' O ' ' A' ' 114' ' ' ALA . 52.7 m-85 -64.98 -70.04 0.26 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.214 -0.929 . . . . 0.0 109.518 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.558 HD23 ' CE2' ' A' ' 28' ' ' TYR . 18.0 tp -90.08 112.37 52.05 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.347 -0.846 . . . . 0.0 109.437 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 118' ' ' TYR . 35.7 Cg_endo -77.96 136.03 14.5 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.39 2.06 . . . . 0.0 110.42 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.602 HD13 ' CZ ' ' A' ' 28' ' ' TYR . 5.7 tp . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.31 -0.869 . . . . 0.0 109.449 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.617 ' HG2' HD12 ' A' ' 121' ' ' LEU . 1.4 mt-10 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.494 ' CB ' ' HB3' ' A' ' 48' ' ' PRO . 1.4 mptp? -120.83 159.7 24.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.254 -0.904 . . . . 0.0 109.484 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.785 ' HB ' HG22 ' A' ' 30' ' ' THR . 14.3 mt -149.98 158.79 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.23 -0.919 . . . . 0.0 109.487 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.674 ' C ' HD13 ' A' ' 7' ' ' LEU . 1.8 tm? -133.2 106.84 7.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.207 -0.933 . . . . 0.0 109.401 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.488 ' N ' HD13 ' A' ' 7' ' ' LEU . 6.0 mt -89.88 112.06 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.204 -0.935 . . . . 0.0 109.382 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.686 HG21 ' CD1' ' A' ' 53' ' ' LEU . 32.3 t -93.97 79.86 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.283 -0.886 . . . . 0.0 109.565 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.481 ' OD2' ' HG2' ' A' ' 16' ' ' ARG . 17.7 t70 -126.32 133.16 51.45 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.262 -0.899 . . . . 0.0 109.494 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.643 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . 5.4 p-10 -99.65 -45.86 5.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.127 -0.983 . . . . 0.0 109.507 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.435 ' N ' ' CG ' ' A' ' 11' ' ' ASP . 1.0 OUTLIER -68.94 112.49 5.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -0.909 . . . . 0.0 109.444 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.42 ' C ' ' O ' ' A' ' 12' ' ' GLN . 1.8 t80 -43.79 159.02 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.24 -0.912 . . . . 0.0 109.529 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.83 -67.65 0.25 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.853 HG23 HD13 ' A' ' 19' ' ' LEU . 2.7 mt -65.31 -11.47 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.191 -1.182 . . . . 0.0 109.346 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.486 ' O ' ' HB2' ' A' ' 20' ' ' ASN . 0.6 OUTLIER -84.24 -26.77 28.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.21 -0.931 . . . . 0.0 109.263 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.3 mm -90.7 -37.95 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.26 -0.9 . . . . 0.0 109.79 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.659 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.9 OUTLIER -66.94 -58.19 5.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 0.0 109.7 -179.755 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.853 HD13 HG23 ' A' ' 15' ' ' ILE . 7.9 mp -62.95 -22.13 66.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.167 -0.958 . . . . 0.0 109.394 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 8.8 t30 -71.21 -66.83 0.57 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.368 -0.833 . . . . 0.0 109.488 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.484 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 2.1 mt-10 -53.27 -33.3 52.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -0.885 . . . . 0.0 109.58 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.731 HG13 ' HE ' ' A' ' 112' ' ' ARG . 74.7 t -63.41 -60.07 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.251 -0.906 . . . . 0.0 109.512 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.483 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 21.6 m-85 -78.03 1.77 19.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.944 . . . . 0.0 109.582 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.484 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 1.0 OUTLIER -90.07 -43.13 10.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.192 -0.943 . . . . 0.0 109.491 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -76.09 -35.95 59.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.232 -0.917 . . . . 0.0 109.477 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.492 ' HB3' ' CE1' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -65.79 -27.53 68.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -0.914 . . . . 0.0 109.489 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.535 ' C ' ' CD1' ' A' ' 28' ' ' TYR . . . 106.77 73.01 0.83 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.595 ' HE2' HD12 ' A' ' 119' ' ' LEU . 79.3 m-85 -151.17 134.71 16.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.225 -1.162 . . . . 0.0 109.539 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -93.99 83.84 4.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.228 -0.92 . . . . 0.0 109.265 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.785 HG22 ' HB ' ' A' ' 6' ' ' ILE . 5.8 p -89.87 161.59 15.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.187 -0.946 . . . . 0.0 109.562 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.616 ' HB2' HD22 ' A' ' 7' ' ' LEU . 25.6 m-85 -121.66 -168.65 1.73 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -0.899 . . . . 0.0 109.331 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 16' ' ' ARG . 6.9 mp0 -123.92 150.79 44.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.185 -0.947 . . . . 0.0 109.533 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.66 ' HB3' ' HA ' ' A' ' 9' ' ' VAL . . . -162.24 173.16 14.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.22 -0.925 . . . . 0.0 109.38 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.643 ' HB1' ' HB3' ' A' ' 11' ' ' ASP . . . -174.77 -47.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.253 -0.905 . . . . 0.0 109.541 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.499 ' ND2' HD11 ' A' ' 37' ' ' LEU . 19.1 p30 -70.17 -5.66 28.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.245 -0.909 . . . . 0.0 109.585 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.424 ' HA2' HD13 ' A' ' 65' ' ' ILE . . . 85.98 -58.77 4.77 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.836 HD12 ' N ' ' A' ' 38' ' ' GLN . 4.2 pp -52.39 -40.24 61.84 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.271 -1.135 . . . . 0.0 109.476 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 1.016 ' O ' HD12 ' A' ' 42' ' ' ILE . 1.1 tp-100 -66.36 -33.34 75.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.325 -0.859 . . . . 0.0 109.358 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.803 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -64.53 -62.56 1.51 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.211 -0.931 . . . . 0.0 109.407 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.744 HD22 HD12 ' A' ' 72' ' ' ILE . 13.4 mt -54.35 -35.92 63.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -0.899 . . . . 0.0 109.445 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -57.54 -53.29 59.85 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.222 -0.924 . . . . 0.0 109.387 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 1.016 HD12 ' O ' ' A' ' 38' ' ' GLN . 1.8 mp -64.91 -20.72 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.275 -0.891 . . . . 0.0 109.387 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.803 HG23 ' O ' ' A' ' 39' ' ' ALA . 21.6 t -81.51 -23.28 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.25 -0.906 . . . . 0.0 109.49 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.5 m -90.01 -28.54 19.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.321 -0.862 . . . . 0.0 109.533 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.6 mttm -87.44 -37.9 16.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.279 -0.888 . . . . 0.0 109.517 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.525 ' HG3' HG23 ' A' ' 42' ' ' ILE . 1.3 mm-40 -101.28 -39.6 7.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.261 -0.9 . . . . 0.0 109.466 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 0.9 OUTLIER 63.26 67.07 1.08 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.42 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.658 ' HD2' HG13 ' A' ' 43' ' ' VAL . 35.4 Cg_endo -77.51 -161.03 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.633 2.222 . . . . 0.0 110.469 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.978 ' O ' HD22 ' A' ' 50' ' ' LEU . 27.4 t70 -135.24 9.38 3.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 0.0 109.537 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.978 HD22 ' O ' ' A' ' 49' ' ' ASP . 0.4 OUTLIER -146.58 107.72 4.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.226 -0.921 . . . . 0.0 109.557 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.83 HG11 ' CE ' ' A' ' 69' ' ' MET . 1.7 t -113.47 109.49 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 109.382 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.685 HD23 ' HB ' ' A' ' 79' ' ' ILE . 1.3 mp -90.58 127.98 36.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.239 -0.913 . . . . 0.0 109.512 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.746 ' N ' HD22 ' A' ' 53' ' ' LEU . 2.6 mm? -113.42 146.11 40.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.233 -0.917 . . . . 0.0 109.429 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.455 ' O ' HG13 ' A' ' 57' ' ' ILE . 12.5 t70 -118.76 111.48 18.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.34 -0.85 . . . . 0.0 109.371 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.89 ' HB2' HG21 ' A' ' 82' ' ' THR . 15.5 mmt -70.6 -5.02 26.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.219 -0.926 . . . . 0.0 109.594 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.467 ' HG3' ' OG1' ' A' ' 82' ' ' THR . 24.1 mttt -90.08 14.33 12.65 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.141 -0.975 . . . . 0.0 109.67 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.645 HG23 ' HD2' ' A' ' 58' ' ' PRO . 83.4 mt -76.57 139.63 67.43 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.187 -0.945 . . . . 0.0 109.301 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.645 ' HD2' HG23 ' A' ' 57' ' ' ILE . 35.8 Cg_endo -78.18 -37.75 0.72 Allowed 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.504 2.136 . . . . 0.0 110.443 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.436 ' O ' ' HB3' ' A' ' 60' ' ' MET . . . -43.71 -43.66 6.62 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.505 ' N ' ' SD ' ' A' ' 60' ' ' MET . 0.0 OUTLIER 178.4 -167.95 0.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -1.141 . . . . 0.0 109.361 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -87.77 120.34 28.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.436 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.43 ' HA2' HG13 ' A' ' 65' ' ' ILE . . . -58.14 -16.07 24.88 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.41 ' C ' ' O ' ' A' ' 62' ' ' GLY . 25.9 mm -44.09 -50.34 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -1.141 . . . . 0.0 109.465 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 68' ' ' ARG . 6.4 mt-10 -64.56 -38.89 92.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.885 . . . . 0.0 109.425 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.494 HG22 ' SD ' ' A' ' 69' ' ' MET . 30.4 mt -53.24 -60.63 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 0.0 109.497 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 1.019 ' CD2' HG11 ' A' ' 78' ' ' VAL . 2.8 mt -50.25 -62.04 1.82 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.905 . . . . 0.0 109.71 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.83 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -41.45 -33.48 0.43 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.358 -0.839 . . . . 0.0 109.68 -179.895 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.555 ' HB2' HD11 ' A' ' 40' ' ' LEU . 24.8 mtt-85 -72.3 -63.04 1.23 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.211 -0.931 . . . . 0.0 109.391 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.83 ' CE ' HG11 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -40.6 -28.21 0.07 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.508 -0.745 . . . . 0.0 109.537 -179.385 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.601 ' NZ ' HD22 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -78.07 -60.4 2.39 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.057 -1.027 . . . . 0.0 109.098 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.83 HG23 ' O ' ' A' ' 67' ' ' LYS . 3.4 t -43.44 -26.77 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.449 -0.782 . . . . 0.0 109.592 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.744 HD12 HD22 ' A' ' 40' ' ' LEU . 71.7 mt -85.31 -54.2 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.251 -0.906 . . . . 0.0 109.41 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.531 ' OD1' HG22 ' A' ' 72' ' ' ILE . 1.4 m-20 -136.78 124.68 22.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.334 -0.854 . . . . 0.0 109.322 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -83.09 -9.23 59.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.213 -0.929 . . . . 0.0 109.51 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 -107.06 50.75 0.76 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.918 . . . . 0.0 109.522 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.602 ' O ' HG23 ' A' ' 76' ' ' ILE . 3.2 tp -125.4 105.22 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.221 -0.925 . . . . 0.0 109.519 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.655 ' CG ' HD11 ' A' ' 99' ' ' LEU . 75.0 mtt85 -55.19 155.5 4.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 109.473 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 1.019 HG11 ' CD2' ' A' ' 66' ' ' LEU . 3.2 t -142.78 138.82 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.272 -0.893 . . . . 0.0 109.606 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.685 ' HB ' HD23 ' A' ' 52' ' ' LEU . 9.0 mm -121.39 123.6 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.238 -0.914 . . . . 0.0 109.229 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.623 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.7 OUTLIER -89.71 144.35 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.143 -0.973 . . . . 0.0 109.429 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.458 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 5.0 mtm -124.77 57.45 1.27 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.212 -0.93 . . . . 0.0 109.51 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.89 HG21 ' HB2' ' A' ' 55' ' ' MET . 10.7 t -169.38 47.48 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.279 -0.888 . . . . 0.0 109.57 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.072 ' N ' ' HB2' ' A' ' 103' ' ' ALA . . . . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.245 -0.909 . . . . 0.0 109.522 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.608 HG23 ' HD1' ' A' ' 101' ' ' HIS . 15.5 mt . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.49 -32.47 71.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.311 -0.868 . . . . 0.0 109.499 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -89.8 -31.02 17.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.287 -0.883 . . . . 0.0 109.467 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.68 -51.44 69.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.265 -0.897 . . . . 0.0 109.479 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.631 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 14.3 tttm -52.78 -57.95 8.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.0 109.465 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 94' ' ' LYS . 59.3 mt-10 -44.06 -50.54 8.39 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.232 -0.917 . . . . 0.0 109.49 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.9 mt -53.0 -48.25 67.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.307 -0.871 . . . . 0.0 109.457 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 154.46 42.65 0.02 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.631 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -99.48 118.11 35.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.19 -1.182 . . . . 0.0 109.487 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.813 HD13 ' CD1' ' A' ' 118' ' ' TYR . 21.9 mt -55.24 -81.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.477 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.56 ' OG1' ' CE1' ' A' ' 102' ' ' PHE . 0.1 OUTLIER -126.27 175.65 7.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.208 -0.933 . . . . 0.0 109.477 -179.956 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.792 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 4.7 t-160 -146.03 97.19 2.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 109.256 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.56 ' CE1' ' OG1' ' A' ' 100' ' ' THR . 18.4 m-30 -108.81 159.55 16.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.182 -0.949 . . . . 0.0 109.597 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 1.072 ' HB2' ' N ' ' A' ' 83' ' ' ALA . . . -128.73 168.39 15.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.319 -0.863 . . . . 0.0 109.343 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.469 ' O ' ' HD2' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -90.97 144.85 30.68 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.186 -0.946 . . . . 0.0 109.48 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.09 130.2 20.42 Favored 'Cis proline' 0 C--N 1.309 -1.547 0 C-N-CA 123.353 -1.52 . . . . 0.0 110.36 0.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -102.22 -174.51 2.59 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.282 -0.886 . . . . 0.0 109.448 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.411 ' O ' ' C ' ' A' ' 108' ' ' ILE . 46.5 t0 -111.97 100.35 8.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.305 -0.872 . . . . 0.0 109.489 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.456 ' O ' ' HG3' ' A' ' 112' ' ' ARG . 12.5 mm -44.51 -31.21 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.381 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -63.77 -51.07 66.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.225 -0.922 . . . . 0.0 109.392 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 113' ' ' ASP . 7.5 tt0 -57.07 -47.11 81.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.17 -0.956 . . . . 0.0 109.375 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.5 mm -51.82 -60.14 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.365 -0.834 . . . . 0.0 109.453 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.731 ' HE ' HG13 ' A' ' 22' ' ' VAL . 98.8 mtt180 -49.54 -34.26 16.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.918 . . . . 0.0 109.51 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 110' ' ' GLU . 19.3 m-20 -67.29 -74.61 0.11 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 109.642 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.427 ' O ' ' C ' ' A' ' 115' ' ' VAL . . . -47.56 -63.43 1.05 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.239 -0.913 . . . . 0.0 109.622 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.427 ' C ' ' O ' ' A' ' 114' ' ' ALA . 49.4 t -42.49 -57.44 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.365 -0.835 . . . . 0.0 109.846 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 0.0 OUTLIER -45.78 -44.77 14.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.175 -0.953 . . . . 0.0 109.621 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 4.5 tptp -62.05 -39.9 93.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 109.703 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.813 ' CD1' HD13 ' A' ' 99' ' ' LEU . 48.7 m-85 -67.44 -69.77 0.29 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.168 -0.958 . . . . 0.0 109.654 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.64 ' C ' HD13 ' A' ' 119' ' ' LEU . 1.3 tm? -90.07 112.46 52.51 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.185 -0.947 . . . . 0.0 109.482 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.611 ' N ' HD13 ' A' ' 119' ' ' LEU . 36.1 Cg_endo -78.25 141.95 18.69 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.322 2.015 . . . . 0.0 110.418 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.617 HD12 ' HG2' ' A' ' 4' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.171 -0.956 . . . . 0.0 109.485 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 121.308 0.575 . . . . 0.0 109.992 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.468 ' CD ' ' N ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -108.85 147.47 32.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.245 -0.909 . . . . 0.0 109.465 179.885 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.599 HG22 ' N ' ' A' ' 7' ' ' LEU . 16.3 mt -149.7 165.15 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.229 -0.919 . . . . 0.0 109.519 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.979 HD13 ' N ' ' A' ' 8' ' ' ILE . 2.2 tm? -131.67 133.41 44.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.302 -0.874 . . . . 0.0 109.457 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.979 ' N ' HD13 ' A' ' 7' ' ' LEU . 12.4 mt -117.86 101.75 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.191 -0.943 . . . . 0.0 109.348 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.771 HG12 HD11 ' A' ' 57' ' ' ILE . 4.9 t -89.97 125.58 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.928 . . . . 0.0 109.522 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.6 ' O ' ' HB2' ' A' ' 34' ' ' ALA . 12.7 t70 -174.41 145.61 0.99 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.261 -0.9 . . . . 0.0 109.512 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.482 ' OD2' ' HD2' ' A' ' 58' ' ' PRO . 8.0 p-10 -117.95 -31.9 4.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.218 -0.926 . . . . 0.0 109.391 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.4 ' O ' ' C ' ' A' ' 13' ' ' TYR . 21.8 tm0? -69.73 104.64 2.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.334 -0.854 . . . . 0.0 109.589 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.922 ' CE2' HD11 ' A' ' 17' ' ' ILE . 6.7 t80 -43.63 123.13 2.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.337 -0.852 . . . . 0.0 109.569 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.77 -47.43 0.79 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.551 HD11 ' HE3' ' A' ' 104' ' ' LYS . 5.0 mt -80.1 -59.25 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -1.153 . . . . 0.0 109.486 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.504 ' HG2' ' CG ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -43.36 -26.69 0.21 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.235 -0.916 . . . . 0.0 109.714 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.922 HD11 ' CE2' ' A' ' 13' ' ' TYR . 2.4 mt -90.07 -64.33 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.19 -0.943 . . . . 0.0 109.697 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.806 ' O ' HG23 ' A' ' 22' ' ' VAL . 9.6 mt -47.59 -61.08 2.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.157 -0.964 . . . . 0.0 109.749 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.476 HD12 ' CD1' ' A' ' 108' ' ' ILE . 1.4 mp -52.76 -30.88 35.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -0.932 . . . . 0.0 109.575 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.476 ' HB3' ' O ' ' A' ' 17' ' ' ILE . 28.7 t30 -67.72 -72.42 0.17 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.223 -0.923 . . . . 0.0 109.716 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 20' ' ' ASN . 0.6 OUTLIER -43.72 -31.21 0.75 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 109.604 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 18' ' ' LEU . 67.4 t -66.77 -52.15 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.294 -0.879 . . . . 0.0 109.486 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.833 ' CZ ' HG21 ' A' ' 115' ' ' VAL . 22.9 m-85 -79.92 -0.47 35.15 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.187 -0.946 . . . . 0.0 109.62 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.421 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 2.0 m-20 -88.4 -48.15 7.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.145 -0.972 . . . . 0.0 109.462 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.54 -10.54 59.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.466 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.497 ' HB3' ' CD1' ' A' ' 28' ' ' TYR . 1.7 tt0 -89.43 -26.29 21.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.304 -0.872 . . . . 0.0 109.457 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.533 ' C ' ' CD1' ' A' ' 28' ' ' TYR . . . 105.91 67.73 0.69 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.695 ' HE2' HD23 ' A' ' 121' ' ' LEU . 90.2 m-85 -154.68 134.87 13.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.203 -1.175 . . . . 0.0 109.443 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -91.51 81.86 5.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.891 . . . . 0.0 109.326 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.479 HG21 ' CB ' ' A' ' 23' ' ' PHE . 5.7 p -89.92 146.37 24.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.311 -0.868 . . . . 0.0 109.608 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.658 ' HB2' HD22 ' A' ' 7' ' ' LEU . 57.6 m-85 -106.96 -173.34 2.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.256 -0.902 . . . . 0.0 109.231 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.504 ' CG ' ' HG2' ' A' ' 16' ' ' ARG . 78.8 mt-30 -131.04 151.58 51.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.182 -0.949 . . . . 0.0 109.676 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.691 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -160.68 -163.47 1.07 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.302 -0.874 . . . . 0.0 109.291 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.691 ' HB2' ' O ' ' A' ' 33' ' ' ALA . . . 164.41 -44.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.922 . . . . 0.0 109.591 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.472 ' OD1' ' HB2' ' A' ' 38' ' ' GLN . 45.7 p-10 -67.07 -8.51 31.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.22 -0.925 . . . . 0.0 109.569 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.432 ' HA3' ' SD ' ' A' ' 60' ' ' MET . . . 87.49 -68.01 3.18 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 36' ' ' GLY . 0.2 OUTLIER -45.06 -53.49 7.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.254 -1.145 . . . . 0.0 109.378 179.914 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.472 ' HB2' ' OD1' ' A' ' 35' ' ' ASN . 1.7 tp-100 -48.99 -55.87 10.63 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.209 -0.932 . . . . 0.0 109.473 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 38' ' ' GLN . . . -43.85 -50.12 8.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.283 -0.885 . . . . 0.0 109.455 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 96.5 mt -55.63 -43.03 75.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.253 -0.904 . . . . 0.0 109.452 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.456 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 8.3 m-20 -62.55 -28.71 70.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.295 -0.878 . . . . 0.0 109.373 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.959 HG21 HD23 ' A' ' 7' ' ' LEU . 20.6 mm -75.92 -29.9 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.222 -0.924 . . . . 0.0 109.477 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.531 ' HA ' ' CD ' ' A' ' 48' ' ' PRO . 68.3 t -80.93 -25.24 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.272 -0.892 . . . . 0.0 109.417 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.471 ' HA ' ' HD2' ' A' ' 47' ' ' ARG . 4.1 m -87.14 -30.69 20.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.276 -0.89 . . . . 0.0 109.515 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 1.1 mtpt -89.99 -25.68 20.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.386 -0.821 . . . . 0.0 109.532 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -123.53 -31.59 3.48 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.206 -0.934 . . . . 0.0 109.56 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.525 ' CG ' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER 47.27 71.53 1.56 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.929 . . . . 0.0 109.481 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.531 ' CD ' ' HA ' ' A' ' 43' ' ' VAL . 34.5 Cg_endo -77.78 -178.54 4.68 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 122.683 2.255 . . . . 0.0 110.616 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.55 ' OD1' HD12 ' A' ' 119' ' ' LEU . 3.3 p30 -110.44 -20.02 12.74 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.412 -0.805 . . . . 0.0 109.185 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.955 HD21 HG22 ' A' ' 115' ' ' VAL . 7.4 tp -115.18 122.24 45.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.307 -0.871 . . . . 0.0 109.554 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.884 HG11 ' HE1' ' A' ' 69' ' ' MET . 1.8 t -126.08 115.47 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.29 -0.881 . . . . 0.0 109.508 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.809 HD12 ' O ' ' A' ' 7' ' ' LEU . 1.0 OUTLIER -89.98 108.31 19.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.235 -0.915 . . . . 0.0 109.433 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.729 HD21 ' HB ' ' A' ' 65' ' ' ILE . 1.1 tp -97.69 119.13 35.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.16 -0.963 . . . . 0.0 109.429 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.508 ' HB2' ' CE ' ' A' ' 81' ' ' MET . 40.7 t0 -100.62 104.1 15.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 109.423 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.459 ' HB2' ' HB ' ' A' ' 82' ' ' THR . 2.8 mmt -65.26 -10.42 31.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.306 -0.871 . . . . 0.0 109.452 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.473 ' HB2' ' OD2' ' A' ' 54' ' ' ASP . 3.3 mmtp -66.04 -24.72 66.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.209 -0.932 . . . . 0.0 109.459 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.771 HD11 HG12 ' A' ' 9' ' ' VAL . 48.9 mt -43.12 103.12 0.3 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.368 -0.832 . . . . 0.0 109.533 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.482 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 35.3 Cg_endo -77.94 119.73 4.82 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.396 2.064 . . . . 0.0 110.388 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 108.55 5.83 31.49 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.448 ' HE2' HG21 ' A' ' 57' ' ' ILE . 24.9 ttp -165.13 127.33 2.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -1.161 . . . . 0.0 109.408 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -89.71 120.13 30.72 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -0.908 . . . . 0.0 109.423 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.455 ' HA2' HG13 ' A' ' 65' ' ' ILE . . . -67.87 -7.83 50.75 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.5 mm -53.08 -40.12 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.184 -1.186 . . . . 0.0 109.507 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -68.68 -44.1 74.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.216 -0.927 . . . . 0.0 109.418 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.729 ' HB ' HD21 ' A' ' 53' ' ' LEU . 11.4 mt -46.4 -51.86 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.258 -0.901 . . . . 0.0 109.491 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.724 ' CD2' HD22 ' A' ' 53' ' ' LEU . 55.2 mt -56.56 -41.06 76.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.289 -0.882 . . . . 0.0 109.428 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.567 ' O ' HG23 ' A' ' 71' ' ' VAL . 1.3 tttm -54.73 -41.01 69.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.226 -0.921 . . . . 0.0 109.493 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.07 -21.19 54.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 109.441 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.884 ' HE1' HG11 ' A' ' 51' ' ' VAL . 14.3 mtt -72.13 -40.08 68.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.261 -0.9 . . . . 0.0 109.439 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.524 ' CE ' ' O ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -79.72 -37.63 35.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.272 -0.892 . . . . 0.0 109.522 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 67' ' ' LYS . 97.5 t -65.46 -32.67 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.22 -0.925 . . . . 0.0 109.445 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.426 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 45.0 mm -89.65 -27.29 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.227 -0.921 . . . . 0.0 109.453 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.456 ' O ' ' O ' ' A' ' 69' ' ' MET . 15.7 m-20 -163.42 130.26 3.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.267 -0.895 . . . . 0.0 109.471 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -89.98 -10.88 43.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.229 -0.919 . . . . 0.0 109.48 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -106.94 50.23 0.78 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.288 -0.882 . . . . 0.0 109.445 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.468 ' O ' HG23 ' A' ' 76' ' ' ILE . 0.8 OUTLIER -117.94 122.98 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.269 -0.894 . . . . 0.0 109.519 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.5 ' HA ' HD11 ' A' ' 99' ' ' LEU . 10.4 mtt180 -79.31 141.66 36.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.209 -0.932 . . . . 0.0 109.426 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.671 HG13 ' HB ' ' A' ' 51' ' ' VAL . 2.7 t -147.74 119.06 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.886 . . . . 0.0 109.603 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.644 HG23 ' HB ' ' A' ' 100' ' ' THR . 23.5 mt -89.87 170.6 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 0.0 109.297 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.774 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.0 OUTLIER -134.88 126.86 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.198 -0.938 . . . . 0.0 109.435 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.508 ' CE ' ' HB2' ' A' ' 54' ' ' ASP . 20.7 mtm -110.01 84.22 1.89 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 109.181 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.85 HG22 ' NE2' ' A' ' 101' ' ' HIS . 4.7 t -149.67 -146.99 0.21 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.214 -0.929 . . . . 0.0 109.497 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.808 ' N ' HG23 ' A' ' 82' ' ' THR . . . . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.407 -0.808 . . . . 0.0 109.918 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.514 HG23 ' HD1' ' A' ' 101' ' ' HIS . 6.5 mt . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.81 -38.31 21.73 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.286 -0.884 . . . . 0.0 109.492 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.464 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 0.6 OUTLIER -90.03 -38.03 13.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.936 . . . . 0.0 109.514 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.473 ' O ' ' CB ' ' A' ' 98' ' ' ALA . 14.2 m -63.19 -12.15 26.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.254 -0.904 . . . . 0.0 109.554 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.411 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 1.2 tptp -71.96 -71.6 0.27 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.275 -0.89 . . . . 0.0 109.464 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -66.45 -13.22 60.48 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.35 -0.844 . . . . 0.0 109.422 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.512 ' HB3' ' NZ ' ' A' ' 70' ' ' LYS . 32.9 mt -74.55 -50.57 17.54 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.185 -0.947 . . . . 0.0 109.38 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 172.99 45.78 0.05 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.473 ' CB ' ' O ' ' A' ' 93' ' ' SER . . . -132.06 146.38 52.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -1.156 . . . . 0.0 109.411 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.5 HD11 ' HA ' ' A' ' 77' ' ' ARG . 0.4 OUTLIER -128.04 -60.32 1.15 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.336 -0.852 . . . . 0.0 109.489 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.691 HG23 ' CZ ' ' A' ' 102' ' ' PHE . 17.1 m -102.97 148.96 25.02 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.263 -0.898 . . . . 0.0 109.571 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.85 ' NE2' HG22 ' A' ' 82' ' ' THR . 2.8 t-160 -144.84 93.77 2.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.892 . . . . 0.0 109.347 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.691 ' CZ ' HG23 ' A' ' 100' ' ' THR . 18.7 m-30 -111.9 161.61 16.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.896 . . . . 0.0 109.587 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 82' ' ' THR . . . -113.51 -159.99 0.71 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.309 -0.87 . . . . 0.0 109.443 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.551 ' HE3' HD11 ' A' ' 15' ' ' ILE . 3.7 mttt -100.37 152.55 37.86 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.232 -0.918 . . . . 0.0 109.498 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.583 ' O ' ' CG ' ' A' ' 106' ' ' PHE . 37.1 Cg_endo -81.62 28.15 4.52 Favored 'Cis proline' 0 C--N 1.309 -1.506 0 C-N-CA 123.371 -1.512 . . . . 0.0 111.126 -0.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.583 ' CG ' ' O ' ' A' ' 105' ' ' PRO . 52.1 p90 41.46 -164.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.37 -0.831 . . . . 0.0 109.844 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.472 ' O ' HG12 ' A' ' 111' ' ' ILE . 30.5 t0 -150.1 118.7 6.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.87 . . . . 0.0 109.461 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.56 HG23 HG21 ' A' ' 22' ' ' VAL . 12.7 mm -54.12 -19.73 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.25 -0.906 . . . . 0.0 109.393 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -75.75 -57.27 3.98 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.192 -0.942 . . . . 0.0 109.427 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -59.66 -24.18 63.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.179 -0.951 . . . . 0.0 109.491 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.472 HG12 ' O ' ' A' ' 107' ' ' ASP . 22.9 mm -74.12 -56.29 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.305 -0.872 . . . . 0.0 109.46 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.414 ' HG2' ' O ' ' A' ' 108' ' ' ILE . 2.5 ptt180 -60.04 -23.62 63.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.202 -0.936 . . . . 0.0 109.533 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -76.1 -63.25 1.36 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.32 -0.863 . . . . 0.0 109.482 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.507 ' O ' ' CD2' ' A' ' 118' ' ' TYR . . . -51.07 -31.87 20.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.244 -0.91 . . . . 0.0 109.381 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.955 HG22 HD21 ' A' ' 50' ' ' LEU . 72.6 t -75.44 -36.32 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.232 -0.918 . . . . 0.0 109.411 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.409 ' HE2' ' HB3' ' A' ' 116' ' ' LYS . 0.4 OUTLIER -69.44 -21.1 63.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.233 -0.917 . . . . 0.0 109.465 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -89.48 -40.06 12.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.211 -0.931 . . . . 0.0 109.52 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.507 ' CD2' ' O ' ' A' ' 114' ' ' ALA . 26.2 m-85 -76.13 -63.3 1.35 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 0.0 109.487 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.653 HD23 ' C ' ' A' ' 119' ' ' LEU . 4.1 tt -90.19 112.42 52.46 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 0.0 109.445 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.609 ' N ' HD23 ' A' ' 119' ' ' LEU . 35.9 Cg_endo -78.07 151.51 27.18 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.429 2.086 . . . . 0.0 110.402 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.695 HD23 ' HE2' ' A' ' 28' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.275 -0.891 . . . . 0.0 109.491 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.542 ' CD ' ' N ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -136.76 154.51 50.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.244 -0.91 . . . . 0.0 109.51 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.767 HD12 HG22 ' A' ' 30' ' ' THR . 4.3 mt -150.09 159.54 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.228 -0.92 . . . . 0.0 109.379 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.721 ' C ' HD13 ' A' ' 7' ' ' LEU . 2.8 tm? -132.22 107.62 8.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.256 -0.903 . . . . 0.0 109.382 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.454 ' N ' HD13 ' A' ' 7' ' ' LEU . 4.2 mt -94.81 110.51 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 0.0 109.451 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.771 ' HA ' ' HB3' ' A' ' 33' ' ' ALA . 61.1 t -95.46 109.49 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.231 -0.918 . . . . 0.0 109.44 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.54 ' CB ' ' HD2' ' A' ' 16' ' ' ARG . 4.2 m-20 -148.96 110.39 4.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.253 -0.904 . . . . 0.0 109.469 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.479 ' OD2' ' HD2' ' A' ' 58' ' ' PRO . 5.5 p-10 -76.38 -33.55 58.89 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 109.43 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.448 ' O ' ' O ' ' A' ' 13' ' ' TYR . 27.1 tt0 -78.77 104.24 9.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.25 -0.906 . . . . 0.0 109.5 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 1.046 ' CE2' HD11 ' A' ' 17' ' ' ILE . 2.6 t80 -44.56 168.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.205 -0.935 . . . . 0.0 109.509 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.77 -66.16 0.33 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.772 HG23 HD13 ' A' ' 19' ' ' LEU . 2.3 mt -63.4 -63.41 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.301 -1.117 . . . . 0.0 109.275 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.551 ' HB2' ' CG ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -42.23 -26.69 0.11 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.354 -0.841 . . . . 0.0 109.95 -179.804 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 1.046 HD11 ' CE2' ' A' ' 13' ' ' TYR . 20.6 mt -79.22 -59.63 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.106 -0.996 . . . . 0.0 109.761 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.783 ' O ' HG23 ' A' ' 22' ' ' VAL . 11.0 mp -53.28 -57.13 11.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.925 . . . . 0.0 109.721 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.772 HD13 HG23 ' A' ' 15' ' ' ILE . 7.3 mp -57.18 -22.51 41.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.235 -0.915 . . . . 0.0 109.578 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 23.6 t30 -75.84 -72.38 0.32 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.308 -0.87 . . . . 0.0 109.549 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -52.91 -19.96 2.97 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.343 -0.848 . . . . 0.0 109.642 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.783 HG23 ' O ' ' A' ' 18' ' ' LEU . 77.2 t -77.85 -58.77 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.187 -0.945 . . . . 0.0 109.39 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.428 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 13.8 m-85 -66.68 -11.18 53.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.192 -0.943 . . . . 0.0 109.349 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.446 ' OD1' ' O ' ' A' ' 20' ' ' ASN . 21.7 m120 -73.31 -61.2 1.91 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.282 -0.886 . . . . 0.0 109.404 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -18.78 63.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.236 -0.915 . . . . 0.0 109.265 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.538 ' HB3' ' CD2' ' A' ' 28' ' ' TYR . 2.7 mt-10 -75.52 -34.18 60.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.299 -0.876 . . . . 0.0 109.41 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.2 46.51 0.75 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.549 ' OH ' HD12 ' A' ' 121' ' ' LEU . 94.1 m-85 -139.0 134.56 33.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.269 -1.136 . . . . 0.0 109.529 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -91.01 83.63 5.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.099 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.767 HG22 HD12 ' A' ' 6' ' ' ILE . 5.7 p -89.74 150.56 22.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.939 . . . . 0.0 109.616 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.558 ' CZ ' ' OE2' ' A' ' 46' ' ' GLU . 17.8 m-85 -111.95 -168.38 1.31 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.302 -0.874 . . . . 0.0 109.264 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.551 ' CG ' ' HB2' ' A' ' 16' ' ' ARG . 0.6 OUTLIER -132.26 150.05 52.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.178 -0.951 . . . . 0.0 109.687 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.771 ' HB3' ' HA ' ' A' ' 9' ' ' VAL . . . -146.38 -174.4 4.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.229 -0.919 . . . . 0.0 109.349 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.612 ' O ' HD13 ' A' ' 57' ' ' ILE . . . -175.98 -57.02 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.176 -0.952 . . . . 0.0 109.619 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -81.18 0.21 37.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 109.591 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.414 ' O ' ' HB3' ' A' ' 39' ' ' ALA . . . 86.17 -53.78 4.65 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.472 HD13 ' HA ' ' A' ' 37' ' ' LEU . 2.3 mm? -45.08 -59.06 2.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -1.148 . . . . 0.0 109.549 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.565 ' O ' HD12 ' A' ' 42' ' ' ILE . 6.3 tp60 -51.96 -38.17 55.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 0.0 109.496 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.464 ' O ' ' HB ' ' A' ' 43' ' ' VAL . . . -60.16 -38.44 83.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.904 . . . . 0.0 109.551 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.541 ' HA ' ' CG1' ' A' ' 43' ' ' VAL . 35.4 mt -76.25 -20.93 56.94 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.391 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.506 ' O ' ' CG ' ' A' ' 45' ' ' LYS . 0.8 OUTLIER -75.38 -40.23 58.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.132 -0.98 . . . . 0.0 109.041 179.705 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.565 HD12 ' O ' ' A' ' 38' ' ' GLN . 1.8 mp -83.86 -24.76 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.337 -0.852 . . . . 0.0 109.245 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.541 ' CG1' ' HA ' ' A' ' 40' ' ' LEU . 1.5 p -72.63 -38.88 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.265 -0.897 . . . . 0.0 109.236 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.434 ' N ' ' CG1' ' A' ' 43' ' ' VAL . 7.8 m -90.03 -22.86 21.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.361 -0.837 . . . . 0.0 109.438 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.506 ' CG ' ' O ' ' A' ' 41' ' ' ASP . 58.3 mttt -75.32 -54.42 7.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.21 -0.931 . . . . 0.0 109.618 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.558 ' OE2' ' CZ ' ' A' ' 31' ' ' PHE . 0.6 OUTLIER -91.34 -29.83 16.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.9 . . . . 0.0 109.632 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.527 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 0.0 OUTLIER 71.24 61.64 0.43 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.267 -0.896 . . . . 0.0 109.472 -179.975 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.535 ' CD ' ' HA ' ' A' ' 43' ' ' VAL . 35.4 Cg_endo -77.95 155.49 30.22 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.63 2.22 . . . . 0.0 110.462 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.451 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 0.3 OUTLIER -101.51 -9.02 21.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.26 -0.9 . . . . 0.0 109.477 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.686 HD21 HG22 ' A' ' 115' ' ' VAL . 9.1 tp -124.79 116.51 22.41 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.203 -0.935 . . . . 0.0 109.517 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.569 HG11 ' HE1' ' A' ' 69' ' ' MET . 43.3 t -128.38 118.08 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.176 -0.953 . . . . 0.0 109.472 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.535 HD23 ' HB ' ' A' ' 79' ' ' ILE . 0.7 OUTLIER -89.95 119.09 30.02 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.196 -0.94 . . . . 0.0 109.45 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.571 HD22 ' HG ' ' A' ' 66' ' ' LEU . 1.2 mp -104.1 138.24 40.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.32 -0.863 . . . . 0.0 109.446 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.43 ' O ' HG13 ' A' ' 57' ' ' ILE . 26.3 t70 -114.5 110.81 20.4 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.22 -0.925 . . . . 0.0 109.516 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.841 ' HB2' HG21 ' A' ' 82' ' ' THR . 24.5 mmt -73.34 -2.42 22.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.206 -0.934 . . . . 0.0 109.608 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.463 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 16.2 mmtt -85.35 13.16 6.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.156 -0.965 . . . . 0.0 109.552 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.924 HG21 ' HE1' ' A' ' 60' ' ' MET . 40.2 mt -78.48 114.29 41.75 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.27 -0.894 . . . . 0.0 109.417 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.479 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 35.7 Cg_endo -78.23 107.02 2.24 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.376 2.051 . . . . 0.0 110.375 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 155.13 -44.0 0.56 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.924 ' HE1' HG21 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -158.99 163.46 36.44 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.168 -1.196 . . . . 0.0 109.427 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -89.88 144.83 25.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.209 -0.932 . . . . 0.0 109.559 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.465 ' O ' ' HB ' ' A' ' 65' ' ' ILE . . . -87.2 -1.22 84.44 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.8 mm -52.69 -52.83 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.201 -1.176 . . . . 0.0 109.464 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -61.22 -27.08 68.18 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.186 -0.946 . . . . 0.0 109.365 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.465 ' HB ' ' O ' ' A' ' 62' ' ' GLY . 19.4 mt -63.23 -66.7 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.316 -0.865 . . . . 0.0 109.456 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.963 HD21 HG11 ' A' ' 78' ' ' VAL . 16.4 mt -46.05 -25.56 0.59 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.91 . . . . 0.0 109.448 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.475 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 2.4 tmtp? -68.49 -60.26 2.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -0.895 . . . . 0.0 109.503 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.48 -29.04 61.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.263 -0.898 . . . . 0.0 109.428 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.569 ' HE1' HG11 ' A' ' 51' ' ' VAL . 3.1 mmt -64.78 -62.53 1.51 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.186 -0.946 . . . . 0.0 109.433 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 16.9 ptpt -51.84 -39.14 58.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.305 -0.872 . . . . 0.0 109.425 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 67' ' ' LYS . 86.4 t -58.6 -40.6 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.189 -0.945 . . . . 0.0 109.473 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.41 ' O ' ' OD1' ' A' ' 73' ' ' ASP . 15.6 mt -73.77 -25.94 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.211 -0.931 . . . . 0.0 109.433 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.429 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 0.1 OUTLIER -173.22 140.35 0.86 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 109.497 -180.0 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -89.76 -17.9 27.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.272 -0.893 . . . . 0.0 109.441 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -86.0 11.1 12.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.258 -0.901 . . . . 0.0 109.434 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.742 ' O ' HG23 ' A' ' 76' ' ' ILE . 2.1 tp -82.39 106.15 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.226 -0.921 . . . . 0.0 109.471 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.532 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 0.4 OUTLIER -77.3 154.16 33.15 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.29 -0.881 . . . . 0.0 109.514 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.963 HG11 HD21 ' A' ' 66' ' ' LEU . 43.0 t -147.03 121.65 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 109.545 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.535 ' HB ' HD23 ' A' ' 52' ' ' LEU . 3.6 mm -97.21 122.58 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.229 -0.919 . . . . 0.0 109.444 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.916 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.3 OUTLIER -90.05 126.2 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.279 -0.888 . . . . 0.0 109.293 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.561 ' SD ' ' CZ ' ' A' ' 106' ' ' PHE . 2.2 mtm -101.28 54.38 0.83 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.131 -0.981 . . . . 0.0 109.565 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.841 HG21 ' HB2' ' A' ' 55' ' ' MET . 14.8 t -168.64 56.25 0.05 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.3 -0.875 . . . . 0.0 109.444 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.82 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.879 . . . . 0.0 109.549 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.632 ' CD1' ' CE1' ' A' ' 101' ' ' HIS . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.723 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -58.3 -39.61 79.78 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.32 -0.863 . . . . 0.0 109.615 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -89.81 -16.22 30.64 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 109.547 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.746 ' HA ' HD12 ' A' ' 96' ' ' LEU . 0.6 OUTLIER -55.85 -19.0 10.11 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.26 -0.9 . . . . 0.0 109.51 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.419 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 2.2 mmmt -48.43 -61.32 2.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.261 -0.899 . . . . 0.0 109.495 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.408 ' O ' ' C ' ' A' ' 96' ' ' LEU . 4.9 mt-10 -65.42 -41.88 93.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.256 -0.903 . . . . 0.0 109.509 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.746 HD12 ' HA ' ' A' ' 93' ' ' SER . 81.6 mt -44.19 -38.86 4.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.226 -0.921 . . . . 0.0 109.457 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 143.61 40.08 0.06 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.419 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -102.91 99.06 8.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.222 -1.163 . . . . 0.0 109.486 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.727 HD22 ' CD1' ' A' ' 118' ' ' TYR . 16.9 mt -51.72 -68.03 0.2 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.255 -0.903 . . . . 0.0 109.498 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.586 HG22 ' N ' ' A' ' 101' ' ' HIS . 17.1 m -135.81 165.84 24.69 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.207 -0.933 . . . . 0.0 109.551 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.916 ' ND1' HD12 ' A' ' 80' ' ' ILE . 4.1 t60 -130.26 84.27 2.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.367 -0.833 . . . . 0.0 109.359 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.575 ' CE2' ' HA ' ' A' ' 111' ' ' ILE . 9.3 m-85 -70.28 157.19 38.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.215 -0.928 . . . . 0.0 109.485 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.82 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -132.46 -148.67 0.35 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 0.0 109.476 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.446 ' HB2' ' HA ' ' A' ' 105' ' ' PRO . 2.0 pttp -96.78 157.26 35.47 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.901 . . . . 0.0 109.494 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.446 ' HA ' ' HB2' ' A' ' 104' ' ' LYS . 36.3 Cg_endo -79.76 11.2 23.9 Favored 'Cis proline' 0 C--N 1.309 -1.518 0 C-N-CA 123.285 -1.548 . . . . 0.0 110.802 -0.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.686 ' CE2' HD21 ' A' ' 19' ' ' LEU . 11.4 t80 70.93 96.59 0.07 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.212 -0.93 . . . . 0.0 109.437 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.466 ' O ' HG12 ' A' ' 111' ' ' ILE . 21.3 t0 -89.88 118.32 29.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 0.0 109.385 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.591 HG22 ' HE ' ' A' ' 112' ' ' ARG . 13.4 mm -51.24 -39.1 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.168 -0.958 . . . . 0.0 109.339 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.439 ' HB2' ' OD2' ' A' ' 107' ' ' ASP . 3.2 m-20 -63.05 -37.33 86.75 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.288 -0.882 . . . . 0.0 109.373 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.574 ' HG3' ' CE1' ' A' ' 102' ' ' PHE . 3.0 tp10 -69.08 -33.5 73.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.292 -0.88 . . . . 0.0 109.257 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.631 ' CD1' ' CE1' ' A' ' 106' ' ' PHE . 10.5 mm -66.35 -54.96 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.3 -0.875 . . . . 0.0 109.272 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.591 ' HE ' HG22 ' A' ' 108' ' ' ILE . 3.9 mtm180 -57.46 -33.6 68.13 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.311 -0.868 . . . . 0.0 109.486 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -62.66 -62.09 1.97 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.234 -0.916 . . . . 0.0 109.768 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.425 ' O ' ' C ' ' A' ' 115' ' ' VAL . . . -58.56 -62.99 1.45 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.166 -0.958 . . . . 0.0 109.734 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.686 HG22 HD21 ' A' ' 50' ' ' LEU . 55.8 t -42.77 -39.09 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.357 -0.839 . . . . 0.0 109.867 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 1.4 mttt -63.48 -58.95 5.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.218 -0.926 . . . . 0.0 109.668 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -49.64 -60.03 3.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.2 -0.938 . . . . 0.0 109.603 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.727 ' CD1' HD22 ' A' ' 99' ' ' LEU . 65.6 m-85 -54.81 -73.91 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.237 -0.915 . . . . 0.0 109.601 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.718 HD23 ' O ' ' A' ' 120' ' ' PRO . 5.8 tt -90.15 112.47 52.66 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.926 . . . . 0.0 109.538 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.718 ' O ' HD23 ' A' ' 119' ' ' LEU . 35.6 Cg_endo -78.44 -159.39 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.389 2.059 . . . . 0.0 110.27 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.549 HD12 ' OH ' ' A' ' 28' ' ' TYR . 1.3 mt . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.939 . . . . 0.0 109.439 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.474 ' HB2' ' HA ' ' A' ' 48' ' ' PRO . 10.6 mttm -105.58 135.76 46.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.298 -0.876 . . . . 0.0 109.497 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.533 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 68.9 mt -150.12 146.17 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.252 -0.905 . . . . 0.0 109.468 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 1.015 HD11 HD13 ' A' ' 42' ' ' ILE . 0.9 OUTLIER -124.8 133.07 53.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.263 -0.898 . . . . 0.0 109.405 179.905 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.618 HD13 ' HB3' ' A' ' 19' ' ' LEU . 14.1 mt -102.71 113.72 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.184 -0.948 . . . . 0.0 109.503 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.548 ' CG2' HD23 ' A' ' 7' ' ' LEU . 13.7 t -105.77 94.48 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.17 -0.957 . . . . 0.0 109.444 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.516 ' O ' ' CD ' ' A' ' 16' ' ' ARG . 31.2 t70 -145.86 116.96 7.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.911 . . . . 0.0 109.473 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.524 ' OD2' ' CD ' ' A' ' 58' ' ' PRO . 5.8 p-10 -77.98 -46.03 22.21 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -0.902 . . . . 0.0 109.482 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.477 ' CG ' ' O ' ' A' ' 12' ' ' GLN . 10.5 pt20 -56.27 101.09 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.292 -0.88 . . . . 0.0 109.474 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 1.15 ' CE2' HD11 ' A' ' 17' ' ' ILE . 2.7 t80 -45.83 141.94 2.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.307 -0.871 . . . . 0.0 109.499 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 132.25 -53.08 0.81 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.414 ' O ' ' C ' ' A' ' 16' ' ' ARG . 2.7 mp -75.34 -53.41 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.255 -1.144 . . . . 0.0 109.445 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.516 ' CD ' ' O ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -43.89 -26.53 0.27 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.258 -0.901 . . . . 0.0 109.614 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 1.15 HD11 ' CE2' ' A' ' 13' ' ' TYR . 2.3 mt -90.12 -60.39 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.211 -0.93 . . . . 0.0 109.886 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.824 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.9 OUTLIER -50.4 -60.55 2.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.149 -0.969 . . . . 0.0 109.892 -179.697 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.832 HD11 HG21 ' A' ' 111' ' ' ILE . 1.5 tp -56.3 -24.23 42.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.304 -0.872 . . . . 0.0 109.873 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 25.4 t30 -71.85 -69.83 0.37 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.123 -0.986 . . . . 0.0 109.81 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 0.7 OUTLIER -47.6 -41.47 21.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.29 -0.881 . . . . 0.0 109.706 -179.787 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.824 HG23 ' O ' ' A' ' 18' ' ' LEU . 40.4 t -56.33 -60.52 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.244 -0.91 . . . . 0.0 109.606 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.629 ' CB ' HG21 ' A' ' 30' ' ' THR . 22.0 m-85 -69.41 -6.19 28.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 0.0 109.612 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 3.0 m-20 -77.39 -54.83 5.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.21 -0.931 . . . . 0.0 109.286 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt -78.31 -12.2 59.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.317 -0.865 . . . . 0.0 109.289 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.446 ' HB2' ' HA ' ' A' ' 23' ' ' PHE . 3.1 mm-40 -77.09 -43.58 33.77 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.249 -0.907 . . . . 0.0 109.461 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.69 50.67 0.32 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.635 ' CZ ' ' CD1' ' A' ' 121' ' ' LEU . 98.7 m-85 -140.81 140.47 34.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.229 -1.159 . . . . 0.0 109.527 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -90.02 82.87 6.08 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.229 -0.92 . . . . 0.0 109.291 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.629 HG21 ' CB ' ' A' ' 23' ' ' PHE . 5.8 p -89.91 153.8 20.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 109.55 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.533 ' CD2' ' O ' ' A' ' 6' ' ' ILE . 7.9 m-85 -120.99 -158.25 0.75 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -0.893 . . . . 0.0 109.338 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.465 ' HG2' ' HG2' ' A' ' 16' ' ' ARG . 73.9 mt-30 -144.05 157.86 44.07 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.208 -0.932 . . . . 0.0 109.663 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.446 ' HB3' HG22 ' A' ' 9' ' ' VAL . . . -170.99 161.34 6.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.876 . . . . 0.0 109.235 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.608 ' O ' HD13 ' A' ' 57' ' ' ILE . . . -127.55 -57.9 1.27 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.197 -0.939 . . . . 0.0 109.713 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.521 ' OD1' ' CB ' ' A' ' 37' ' ' LEU . 4.1 p30 -90.4 136.47 33.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.209 -0.932 . . . . 0.0 109.483 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.55 ' HA3' ' CD1' ' A' ' 65' ' ' ILE . . . -45.1 -29.11 2.13 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.521 ' CB ' ' OD1' ' A' ' 35' ' ' ASN . 0.2 OUTLIER -47.7 -53.61 14.55 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.326 -1.102 . . . . 0.0 109.382 179.853 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.459 ' O ' ' C ' ' A' ' 39' ' ' ALA . 11.4 mt-30 -62.3 -51.07 69.16 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.245 -0.909 . . . . 0.0 109.393 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.562 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -39.92 -37.99 0.64 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.443 -0.786 . . . . 0.0 109.804 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.7 mt -77.5 -45.05 26.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.0 109.61 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -56.26 -62.01 2.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.206 -0.934 . . . . 0.0 109.626 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 1.015 HD13 HD11 ' A' ' 7' ' ' LEU . 10.4 mt -56.67 -51.72 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.894 . . . . 0.0 109.753 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 39' ' ' ALA . 45.0 t -54.06 -22.67 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.166 -0.959 . . . . 0.0 109.704 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.0 m -89.95 -28.39 19.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.182 -0.949 . . . . 0.0 109.837 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.435 ' C ' ' HG2' ' A' ' 46' ' ' GLU . 4.1 mmmt -90.2 -6.59 55.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.208 -0.932 . . . . 0.0 109.59 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.528 ' OE1' ' CZ ' ' A' ' 31' ' ' PHE . 2.5 mt-10 -137.26 -36.2 0.66 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.242 -0.911 . . . . 0.0 109.451 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.45 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 75.3 mtm-85 58.56 65.01 3.2 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.321 -0.862 . . . . 0.0 109.462 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.536 ' CD ' ' HA ' ' A' ' 43' ' ' VAL . 35.2 Cg_endo -77.02 159.4 34.0 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.578 2.185 . . . . 0.0 110.437 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 89.1 m-20 -96.3 -5.45 40.09 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.274 -0.891 . . . . 0.0 109.656 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.479 ' CD2' HG13 ' A' ' 115' ' ' VAL . 5.2 tp -129.39 123.55 31.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.169 -0.957 . . . . 0.0 109.593 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.7 ' HB ' HG22 ' A' ' 78' ' ' VAL . 22.0 t -132.09 118.81 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.351 -0.843 . . . . 0.0 109.537 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.652 HD12 ' O ' ' A' ' 7' ' ' LEU . 1.2 mp -90.05 113.35 25.04 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -0.912 . . . . 0.0 109.42 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.523 ' CD2' ' HG ' ' A' ' 66' ' ' LEU . 1.2 mp -104.79 130.88 52.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.375 -0.828 . . . . 0.0 109.585 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.487 ' HA ' ' HG3' ' A' ' 81' ' ' MET . 32.8 t70 -108.58 105.72 15.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.288 -0.882 . . . . 0.0 109.244 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.579 ' CG ' HG21 ' A' ' 82' ' ' THR . 7.5 mtp -71.64 -4.12 25.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -0.916 . . . . 0.0 109.534 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.402 ' HE3' ' CB ' ' A' ' 82' ' ' THR . 8.1 mttp -86.07 15.08 5.38 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.116 -0.99 . . . . 0.0 109.508 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.608 HD13 ' O ' ' A' ' 34' ' ' ALA . 53.8 mt -74.13 132.65 79.26 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.188 -0.945 . . . . 0.0 109.41 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.524 ' CD ' ' OD2' ' A' ' 11' ' ' ASP . 36.7 Cg_endo -80.54 41.9 1.23 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.624 2.216 . . . . 0.0 110.7 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -133.57 -56.72 0.07 OUTLIER Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.505 ' N ' ' SD ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -156.96 -178.54 7.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.311 -1.111 . . . . 0.0 109.532 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -90.08 142.36 27.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.266 -0.896 . . . . 0.0 109.505 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.442 ' HA2' HG13 ' A' ' 65' ' ' ILE . . . -77.63 -9.42 86.89 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.455 HD13 ' HA ' ' A' ' 63' ' ' ILE . 17.6 mm -51.11 -55.72 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -1.16 . . . . 0.0 109.394 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -55.84 -39.24 71.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.259 -0.9 . . . . 0.0 109.479 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.55 ' CD1' ' HA3' ' A' ' 36' ' ' GLY . 13.8 mt -53.4 -69.46 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.201 -0.937 . . . . 0.0 109.463 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 1.052 HD21 HG11 ' A' ' 78' ' ' VAL . 93.1 mt -43.62 -48.37 7.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.158 -0.963 . . . . 0.0 109.68 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.562 ' O ' HG23 ' A' ' 71' ' ' VAL . 2.1 mmtt -43.17 -58.11 2.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 109.704 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.44 ' O ' HG13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -61.6 -32.59 72.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.171 -0.956 . . . . 0.0 109.588 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.597 ' SD ' HD23 ' A' ' 66' ' ' LEU . 78.7 mtp -66.0 -23.66 66.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.321 -0.862 . . . . 0.0 109.591 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -84.0 -41.98 16.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.225 -0.922 . . . . 0.0 108.942 179.904 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 67' ' ' LYS . 2.5 t -62.09 -31.99 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.486 -0.759 . . . . 0.0 109.522 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 68' ' ' ARG . 11.3 mt -84.01 -39.86 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.232 -0.918 . . . . 0.0 109.447 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -143.13 132.75 23.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.289 -0.882 . . . . 0.0 109.379 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -90.01 -23.58 21.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.272 -0.892 . . . . 0.0 109.527 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -99.41 47.97 0.95 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.289 -0.882 . . . . 0.0 109.467 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.1 tt -107.68 134.54 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.262 -0.899 . . . . 0.0 109.478 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.536 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 0.5 OUTLIER -104.03 141.2 36.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.241 -0.912 . . . . 0.0 109.466 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 1.052 HG11 HD21 ' A' ' 66' ' ' LEU . 82.4 t -139.37 118.76 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -0.906 . . . . 0.0 109.557 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.933 HG23 HG23 ' A' ' 100' ' ' THR . 5.1 mm -89.96 122.4 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.287 -0.883 . . . . 0.0 109.162 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.862 HD12 ' HD1' ' A' ' 101' ' ' HIS . 0.1 OUTLIER -89.87 143.29 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.174 -0.954 . . . . 0.0 109.375 -179.876 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.487 ' HG3' ' HA ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -117.68 71.17 0.81 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.185 -0.947 . . . . 0.0 109.255 179.79 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.579 HG21 ' CG ' ' A' ' 55' ' ' MET . 13.4 t -176.15 31.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.346 -0.846 . . . . 0.0 109.536 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.79 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.206 -0.934 . . . . 0.0 109.499 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.938 HD12 ' CE1' ' A' ' 101' ' ' HIS . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -55.68 -40.37 72.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 0.0 109.493 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.433 ' O ' ' C ' ' A' ' 93' ' ' SER . 29.9 mm-40 -90.06 -38.48 13.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.209 -0.932 . . . . 0.0 109.649 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.764 ' HA ' HD12 ' A' ' 96' ' ' LEU . 1.2 m -43.34 -39.36 3.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.306 -0.871 . . . . 0.0 109.551 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.909 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 6.6 mttp -44.3 -55.62 4.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 109.387 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -58.71 -43.56 90.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.243 -0.911 . . . . 0.0 109.463 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.764 HD12 ' HA ' ' A' ' 93' ' ' SER . 79.0 mt -47.2 -63.87 0.93 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.325 -0.859 . . . . 0.0 109.474 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 179.93 36.64 0.07 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.909 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -99.85 99.66 10.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -1.15 . . . . 0.0 109.503 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.598 HD13 ' CG ' ' A' ' 118' ' ' TYR . 16.7 mt -48.87 -62.74 1.36 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.323 -0.861 . . . . 0.0 109.516 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.933 HG23 HG23 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -144.39 176.42 9.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.154 -0.966 . . . . 0.0 109.577 -179.925 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.938 ' CE1' HD12 ' A' ' 90' ' ' ILE . 3.5 t-160 -141.51 94.01 2.64 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.343 -0.848 . . . . 0.0 109.235 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.734 ' HZ ' ' HB2' ' A' ' 114' ' ' ALA . 7.9 m-85 -82.12 160.9 23.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.265 -0.897 . . . . 0.0 109.696 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.79 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -140.43 -148.58 0.25 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.236 -0.915 . . . . 0.0 109.281 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.55 145.48 30.54 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.164 -0.96 . . . . 0.0 109.302 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.0 151.96 91.4 Favored 'Cis proline' 0 C--N 1.309 -1.551 0 C-N-CA 123.289 -1.546 . . . . 0.0 110.437 -0.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.733 ' CZ ' HD12 ' A' ' 111' ' ' ILE . 0.5 OUTLIER -83.05 103.89 12.84 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -0.893 . . . . 0.0 109.457 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.473 ' O ' HG12 ' A' ' 111' ' ' ILE . 48.2 t0 -89.84 103.0 15.69 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.106 -0.996 . . . . 0.0 109.401 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.457 ' O ' ' HG2' ' A' ' 112' ' ' ARG . 19.8 mm -43.31 -26.95 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.31 -0.869 . . . . 0.0 109.698 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.44 -47.96 44.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.897 . . . . 0.0 109.576 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.472 ' HG3' ' OD2' ' A' ' 107' ' ' ASP . 41.5 mt-10 -66.91 -22.94 65.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 109.332 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.832 HG21 HD11 ' A' ' 19' ' ' LEU . 16.2 mm -75.43 -56.4 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.34 -0.85 . . . . 0.0 109.293 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 108' ' ' ILE . 0.6 OUTLIER -63.83 -22.17 66.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.269 -0.894 . . . . 0.0 109.477 179.948 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -73.84 -51.46 16.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.94 . . . . 0.0 109.497 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.734 ' HB2' ' HZ ' ' A' ' 102' ' ' PHE . . . -63.35 -55.77 21.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.3 -0.875 . . . . 0.0 109.458 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.479 HG13 ' CD2' ' A' ' 50' ' ' LEU . 54.0 t -50.17 -52.28 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 109.537 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 6.5 mmmt -54.76 -39.56 68.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.19 -0.944 . . . . 0.0 109.48 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 7.0 tttm -58.22 -40.97 83.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.445 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.598 ' CG ' HD13 ' A' ' 99' ' ' LEU . 56.3 m-85 -81.89 -73.32 0.39 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.887 . . . . 0.0 109.476 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.67 HD12 ' HD2' ' A' ' 120' ' ' PRO . 39.7 tp -78.57 114.43 43.21 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.299 -0.875 . . . . 0.0 109.392 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.67 ' HD2' HD12 ' A' ' 119' ' ' LEU . 35.9 Cg_endo -78.08 176.1 10.37 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.424 2.083 . . . . 0.0 110.408 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.635 ' CD1' ' CZ ' ' A' ' 28' ' ' TYR . 1.2 mt . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.313 -0.867 . . . . 0.0 109.516 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.422 ' HA ' HD21 ' A' ' 119' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.291 0.567 . . . . 0.0 109.507 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.439 ' HB2' ' HA ' ' A' ' 48' ' ' PRO . 11.2 mttp -110.22 154.42 23.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.932 . . . . 0.0 109.378 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.647 ' HB ' HG22 ' A' ' 30' ' ' THR . 70.7 mt -150.11 149.19 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.282 -0.886 . . . . 0.0 109.467 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.858 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.8 OUTLIER -125.98 125.04 42.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.325 -0.859 . . . . 0.0 109.363 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.858 ' N ' HD13 ' A' ' 7' ' ' LEU . 10.1 mt -103.95 103.12 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.229 -0.92 . . . . 0.0 109.579 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.727 ' CG2' HD12 ' A' ' 7' ' ' LEU . 2.6 t -102.74 84.8 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.319 -0.863 . . . . 0.0 109.333 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.524 ' O ' ' CD1' ' A' ' 57' ' ' ILE . 40.1 p-10 -88.61 -149.44 0.18 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.33 -0.856 . . . . 0.0 109.502 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.523 ' CB ' ' HA ' ' A' ' 57' ' ' ILE . 1.0 OUTLIER -121.92 -31.39 3.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.309 -0.87 . . . . 0.0 109.519 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.45 ' O ' ' OD2' ' A' ' 10' ' ' ASP . 1.9 tt0 -146.75 153.95 40.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.27 -0.894 . . . . 0.0 109.483 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 1.015 ' CE2' HD11 ' A' ' 17' ' ' ILE . 6.3 t80 -43.88 141.77 1.52 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 109.499 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 137.34 -70.13 0.49 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.978 HG23 HD13 ' A' ' 19' ' ' LEU . 2.6 mt -62.86 -29.54 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.18 -1.188 . . . . 0.0 109.382 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.524 ' HB3' ' CG ' ' A' ' 32' ' ' GLN . 3.9 mpp_? -70.69 -21.81 62.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.273 -0.892 . . . . 0.0 109.566 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 1.015 HD11 ' CE2' ' A' ' 13' ' ' TYR . 6.9 mt -90.14 -57.22 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.217 -0.927 . . . . 0.0 109.661 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.905 ' O ' HG23 ' A' ' 22' ' ' VAL . 7.1 mp -54.7 -58.91 5.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.24 -0.913 . . . . 0.0 109.683 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.978 HD13 HG23 ' A' ' 15' ' ' ILE . 6.2 mp -57.52 -23.75 52.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.216 -0.927 . . . . 0.0 109.643 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 16.5 t30 -71.44 -70.63 0.31 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.238 -0.914 . . . . 0.0 109.592 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.479 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 13.5 tp10 -46.92 -43.46 18.98 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -0.91 . . . . 0.0 109.623 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.905 HG23 ' O ' ' A' ' 18' ' ' LEU . 22.7 t -54.33 -60.99 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 109.637 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.603 ' CE1' ' HA ' ' A' ' 112' ' ' ARG . 38.8 m-85 -71.25 -4.18 24.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.209 -0.932 . . . . 0.0 109.718 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.479 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 7.1 m-20 -80.02 -44.56 19.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.179 -0.95 . . . . 0.0 109.437 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.415 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 25.1 tttt -80.99 -18.01 48.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.301 -0.874 . . . . 0.0 109.464 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.511 ' HB3' ' CD1' ' A' ' 28' ' ' TYR . 2.2 tt0 -77.72 -37.46 49.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.215 -0.928 . . . . 0.0 109.449 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.522 ' C ' ' CD1' ' A' ' 28' ' ' TYR . . . 115.71 62.79 0.36 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.954 ' CE2' HD21 ' A' ' 121' ' ' LEU . 70.1 m-85 -149.67 134.55 17.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.177 -1.19 . . . . 0.0 109.518 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.41 ' HG2' ' OE2' ' A' ' 4' ' ' GLU . 3.1 mm100 -90.35 83.32 5.93 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.249 -0.907 . . . . 0.0 109.113 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.647 HG22 ' HB ' ' A' ' 6' ' ' ILE . 5.7 p -89.89 172.13 9.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.318 -0.864 . . . . 0.0 109.637 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.799 ' HB2' HD22 ' A' ' 7' ' ' LEU . 19.3 m-85 -134.6 -178.51 5.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.868 . . . . 0.0 109.352 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.524 ' CG ' ' HB3' ' A' ' 16' ' ' ARG . 27.4 mp0 -120.71 149.04 43.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.213 -0.93 . . . . 0.0 109.637 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.832 ' HB1' ' HB2' ' A' ' 39' ' ' ALA . . . -177.37 175.03 1.52 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.393 -0.817 . . . . 0.0 109.474 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.502 ' HA ' HG12 ' A' ' 9' ' ' VAL . . . -178.74 -58.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 109.663 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.412 ' C ' ' O ' ' A' ' 34' ' ' ALA . 3.9 p30 -43.6 -27.15 0.27 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.258 -0.901 . . . . 0.0 109.578 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.542 ' O ' HD12 ' A' ' 40' ' ' LEU . . . 97.84 -39.14 2.85 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.9 HD12 ' N ' ' A' ' 38' ' ' GLN . 3.8 pp -70.08 -45.52 66.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.213 -1.169 . . . . 0.0 109.609 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.9 ' N ' HD12 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -79.39 -30.58 42.52 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.222 -0.924 . . . . 0.0 108.912 179.868 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.832 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . . . -62.41 -48.41 79.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.254 -0.904 . . . . 0.0 108.934 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.828 HD11 HG23 ' A' ' 65' ' ' ILE . 3.7 mt -66.28 -48.59 69.94 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.333 -0.854 . . . . 0.0 109.046 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.419 ' C ' ' O ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -45.41 -40.08 7.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.337 -0.852 . . . . 0.0 109.009 179.659 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.642 HD12 ' O ' ' A' ' 38' ' ' GLN . 5.3 mt -68.04 -48.43 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.334 -0.854 . . . . 0.0 109.19 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.855 HG13 ' HD2' ' A' ' 48' ' ' PRO . 46.1 t -55.41 -19.15 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.222 -0.924 . . . . 0.0 109.406 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.8 m -90.23 -35.05 15.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.171 -0.956 . . . . 0.0 109.514 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.478 ' HG2' ' HA ' ' A' ' 42' ' ' ILE . 0.0 OUTLIER -86.32 -5.25 59.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.187 -0.945 . . . . 0.0 109.684 -179.848 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.422 ' CG ' ' HD2' ' A' ' 45' ' ' LYS . 5.1 mm-40 -134.5 -37.8 0.84 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.144 -0.973 . . . . 0.0 109.309 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.434 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 12.1 mtm-85 57.84 65.89 3.11 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.385 -0.822 . . . . 0.0 109.643 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.855 ' HD2' HG13 ' A' ' 43' ' ' VAL . 35.3 Cg_endo -77.3 162.77 30.82 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.541 2.161 . . . . 0.0 110.416 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.462 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 6.7 t0 -97.03 -13.38 22.3 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.135 -0.978 . . . . 0.0 109.57 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.8 ' CD2' HG13 ' A' ' 115' ' ' VAL . 7.0 tp -117.92 123.47 45.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.188 -0.945 . . . . 0.0 109.588 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.703 ' HB ' HG13 ' A' ' 78' ' ' VAL . 39.6 t -129.08 137.62 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -0.924 . . . . 0.0 109.403 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.668 HD12 ' O ' ' A' ' 7' ' ' LEU . 1.1 mt -112.4 103.68 11.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 109.427 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.711 HD21 ' HB ' ' A' ' 65' ' ' ILE . 1.4 mp -97.47 124.6 41.75 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.304 -0.873 . . . . 0.0 109.582 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.449 ' O ' HG13 ' A' ' 57' ' ' ILE . 21.0 t70 -107.51 120.58 42.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.263 -0.898 . . . . 0.0 109.341 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.846 ' CG ' HG21 ' A' ' 82' ' ' THR . 25.6 mmt -75.15 -13.96 60.51 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.172 -0.955 . . . . 0.0 109.638 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -89.57 46.49 1.37 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.201 -0.937 . . . . 0.0 109.52 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.524 ' CD1' ' O ' ' A' ' 10' ' ' ASP . 81.3 mt -110.99 130.21 23.17 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.177 -0.952 . . . . 0.0 109.457 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.505 ' HD3' ' HB2' ' A' ' 11' ' ' ASP . 36.1 Cg_endo -78.52 130.65 10.01 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.426 2.084 . . . . 0.0 110.372 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 123.81 -50.53 0.85 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.22 163.74 30.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.173 -1.192 . . . . 0.0 109.533 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -89.98 156.81 18.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 109.462 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.415 ' HA2' ' CD1' ' A' ' 65' ' ' ILE . . . -89.92 -6.24 69.87 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.419 ' HA ' HD13 ' A' ' 63' ' ' ILE . 17.9 mm -54.92 -60.02 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.171 -1.194 . . . . 0.0 109.502 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.8 -38.14 54.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.174 -0.954 . . . . 0.0 109.432 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.828 HG23 HD11 ' A' ' 40' ' ' LEU . 15.9 mt -52.51 -57.11 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -0.889 . . . . 0.0 109.446 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.611 ' CD2' HD22 ' A' ' 53' ' ' LEU . 26.1 mt -46.33 -56.01 6.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.197 -0.939 . . . . 0.0 109.462 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.451 ' O ' HG23 ' A' ' 71' ' ' VAL . 5.3 mttt -44.09 -47.3 8.88 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -0.918 . . . . 0.0 109.431 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.438 ' O ' HG13 ' A' ' 72' ' ' ILE . 5.3 mtt180 -58.08 -43.24 86.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.263 -0.898 . . . . 0.0 109.461 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.429 ' CE ' HG11 ' A' ' 51' ' ' VAL . 4.1 mtt -64.07 -23.38 67.3 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.208 -0.933 . . . . 0.0 109.466 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 66' ' ' LEU . 0.5 OUTLIER -79.16 -33.91 43.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.226 -0.921 . . . . 0.0 109.479 179.95 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 67' ' ' LYS . 5.4 t -79.39 -21.39 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.281 -0.887 . . . . 0.0 109.495 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 68' ' ' ARG . 66.2 mt -90.04 -60.07 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.284 -0.885 . . . . 0.0 109.395 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.53 133.09 36.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.234 -0.916 . . . . 0.0 109.492 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -90.04 -11.92 40.05 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.265 -0.897 . . . . 0.0 109.16 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -107.46 51.81 0.73 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.145 -0.972 . . . . 0.0 109.443 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.492 ' O ' HG23 ' A' ' 76' ' ' ILE . 0.3 OUTLIER -119.14 113.11 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.267 -0.896 . . . . 0.0 109.545 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.804 ' CB ' HD11 ' A' ' 99' ' ' LEU . 0.8 OUTLIER -68.59 124.91 24.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.246 -0.909 . . . . 0.0 109.44 179.893 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.703 HG13 ' HB ' ' A' ' 51' ' ' VAL . 17.6 t -134.24 108.22 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 0.0 109.704 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.735 HD11 ' CE2' ' A' ' 118' ' ' TYR . 91.0 mt -90.26 148.4 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.218 -0.926 . . . . 0.0 109.36 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 1.014 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.0 OUTLIER -107.8 161.03 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.176 -0.952 . . . . 0.0 109.426 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.518 ' SD ' ' CZ ' ' A' ' 106' ' ' PHE . 8.6 mtm -137.77 89.69 2.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.239 -0.913 . . . . 0.0 109.725 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.936 HG22 ' NE2' ' A' ' 101' ' ' HIS . 14.3 t 177.8 37.2 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.271 -0.893 . . . . 0.0 109.369 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.75 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.308 -0.87 . . . . 0.0 109.556 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.526 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -56.58 -40.93 76.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.269 -0.895 . . . . 0.0 109.558 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.417 ' O ' HD12 ' A' ' 96' ' ' LEU . 8.2 mt-10 -90.08 -37.16 14.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.205 -0.934 . . . . 0.0 109.657 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.868 ' HA ' HD13 ' A' ' 96' ' ' LEU . 1.1 m -43.73 -43.06 5.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.301 -0.874 . . . . 0.0 109.613 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.449 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -43.64 -54.15 5.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.22 -0.925 . . . . 0.0 109.54 -179.915 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 96' ' ' LEU . 1.3 mm-40 -59.94 -48.52 81.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.257 -0.902 . . . . 0.0 109.521 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.868 HD13 ' HA ' ' A' ' 93' ' ' SER . 2.1 mp -43.62 -60.81 1.61 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.317 -0.864 . . . . 0.0 109.577 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 172.89 45.46 0.04 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.449 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -120.93 110.18 15.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.317 -1.108 . . . . 0.0 109.423 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.804 HD11 ' CB ' ' A' ' 77' ' ' ARG . 1.7 mt -57.77 -71.48 0.1 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.203 -0.935 . . . . 0.0 109.534 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.485 ' O ' HG23 ' A' ' 79' ' ' ILE . 14.8 t -130.34 162.45 29.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -0.928 . . . . 0.0 109.545 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 1.014 ' ND1' HD12 ' A' ' 80' ' ' ILE . 5.1 t-160 -126.66 101.18 6.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.271 -0.893 . . . . 0.0 109.442 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -76.95 -176.1 3.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.319 -0.863 . . . . 0.0 109.519 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.75 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -168.38 172.91 8.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.343 -0.848 . . . . 0.0 109.454 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.513 ' HA ' ' N ' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -64.72 151.12 93.16 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.239 -0.913 . . . . 0.0 109.534 179.884 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.21 118.28 5.67 Favored 'Cis proline' 0 C--N 1.308 -1.574 0 C-N-CA 123.22 -1.575 . . . . 0.0 110.471 -0.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.741 ' CZ ' HD12 ' A' ' 111' ' ' ILE . 0.3 OUTLIER -55.18 106.08 0.21 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.213 -0.929 . . . . 0.0 109.406 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.495 ' O ' HG12 ' A' ' 111' ' ' ILE . 46.0 t0 -89.88 110.43 21.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 109.326 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.428 HD13 ' HA ' ' A' ' 108' ' ' ILE . 15.5 mm -48.23 -22.44 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.248 -0.908 . . . . 0.0 109.777 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.406 ' O ' ' HG2' ' A' ' 112' ' ' ARG . 0.9 OUTLIER -75.21 -43.72 50.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.106 -0.997 . . . . 0.0 109.458 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -70.02 -27.11 64.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.297 -0.877 . . . . 0.0 109.514 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.888 HG21 HD21 ' A' ' 19' ' ' LEU . 20.2 mm -76.03 -57.57 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.247 -0.908 . . . . 0.0 109.273 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.872 ' HB3' HG11 ' A' ' 22' ' ' VAL . 14.0 ptt180 -55.67 -32.26 63.08 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.396 -0.815 . . . . 0.0 109.985 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.542 ' HA ' ' HG2' ' A' ' 116' ' ' LYS . 10.8 m-20 -79.6 -65.86 0.95 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -0.935 . . . . 0.0 110.237 -179.354 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 113' ' ' ASP . . . -42.53 -35.77 1.16 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.207 -0.933 . . . . 0.0 109.876 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.8 HG13 ' CD2' ' A' ' 50' ' ' LEU . 38.2 t -77.68 -40.43 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.356 -0.84 . . . . 0.0 109.737 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.542 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -60.45 -23.87 64.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.131 -0.981 . . . . 0.0 109.332 -179.789 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.498 ' N ' ' HG3' ' A' ' 116' ' ' LYS . 9.5 ttmt -85.03 -51.63 6.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.303 -0.873 . . . . 0.0 109.387 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.735 ' CE2' HD11 ' A' ' 79' ' ' ILE . 27.1 m-85 -54.03 -64.86 0.69 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.266 -0.896 . . . . 0.0 109.353 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.885 HD12 ' HD2' ' A' ' 120' ' ' PRO . 37.5 tp -90.28 112.34 52.13 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.291 -0.881 . . . . 0.0 109.386 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.885 ' HD2' HD12 ' A' ' 119' ' ' LEU . 35.6 Cg_endo -78.27 -164.3 0.27 Allowed 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.326 2.017 . . . . 0.0 110.393 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.954 HD21 ' CE2' ' A' ' 28' ' ' TYR . 81.2 mt . . . . . 0 N--CA 1.489 1.512 0 O-C-N 121.276 -0.89 . . . . 0.0 109.378 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.521 ' OE2' HD23 ' A' ' 121' ' ' LEU . 1.3 mt-10 . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.503 ' HB2' ' HA ' ' A' ' 48' ' ' PRO . 6.4 mtmt -96.13 139.52 32.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -0.872 . . . . 0.0 109.414 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.574 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 80.5 mt -150.05 155.21 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.253 -0.904 . . . . 0.0 109.473 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.985 HD11 HD13 ' A' ' 42' ' ' ILE . 0.6 OUTLIER -140.56 127.69 20.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 109.367 179.949 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.709 HD13 ' HB2' ' A' ' 19' ' ' LEU . 9.2 mt -92.35 120.95 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -0.917 . . . . 0.0 109.518 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.475 HG22 HD23 ' A' ' 7' ' ' LEU . 2.7 t -103.01 102.81 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -0.954 . . . . 0.0 109.464 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.462 ' HB3' ' HD3' ' A' ' 16' ' ' ARG . 7.3 t0 -162.17 134.98 5.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.158 -0.964 . . . . 0.0 109.434 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.488 ' OD2' ' HD2' ' A' ' 58' ' ' PRO . 8.6 p-10 -99.21 -34.22 10.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.294 -0.879 . . . . 0.0 109.444 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.417 ' O ' ' C ' ' A' ' 13' ' ' TYR . 0.5 OUTLIER -73.1 107.22 5.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.329 -0.857 . . . . 0.0 109.478 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.595 ' CZ ' HG13 ' A' ' 17' ' ' ILE . 20.5 t80 -43.07 153.06 0.1 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.351 -0.843 . . . . 0.0 109.603 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.403 ' N ' ' CD1' ' A' ' 13' ' ' TYR . . . 124.62 -74.43 0.4 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.899 HD13 ' OD2' ' A' ' 54' ' ' ASP . 6.6 mt -63.16 -16.92 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.24 -1.153 . . . . 0.0 109.403 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.462 ' HD3' ' HB3' ' A' ' 10' ' ' ASP . 14.6 mmm-85 -77.26 -26.88 52.93 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 109.341 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.595 HG13 ' CZ ' ' A' ' 13' ' ' TYR . 9.6 mm -90.07 -39.78 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -0.903 . . . . 0.0 109.604 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.59 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.1 mp -64.22 -58.22 7.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.25 -0.906 . . . . 0.0 109.613 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.709 ' HB2' HD13 ' A' ' 8' ' ' ILE . 44.0 mt -58.45 -20.95 49.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.282 -0.886 . . . . 0.0 109.482 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -75.72 -70.71 0.42 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -0.911 . . . . 0.0 109.568 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.482 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 17.8 tt0 -46.41 -42.51 15.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.243 -0.911 . . . . 0.0 109.614 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.609 HG21 HG23 ' A' ' 108' ' ' ILE . 64.6 t -58.99 -56.01 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.143 -0.973 . . . . 0.0 109.615 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.757 ' CB ' HG21 ' A' ' 30' ' ' THR . 29.8 m-85 -78.14 3.05 16.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.178 -0.951 . . . . 0.0 109.707 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.482 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 1.5 m-20 -90.07 -46.73 8.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.229 -0.92 . . . . 0.0 109.486 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.1 -19.72 36.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.216 -0.928 . . . . 0.0 109.456 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.478 ' HB3' ' CD1' ' A' ' 28' ' ' TYR . 0.5 OUTLIER -78.33 -31.06 48.51 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.3 -0.875 . . . . 0.0 109.456 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.477 ' O ' ' CD1' ' A' ' 28' ' ' TYR . . . 102.5 77.94 1.26 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.558 ' CZ ' ' HG ' ' A' ' 121' ' ' LEU . 91.5 m-85 -155.57 143.12 19.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.151 -1.205 . . . . 0.0 109.511 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -90.04 81.19 6.25 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.174 -0.954 . . . . 0.0 109.382 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.757 HG21 ' CB ' ' A' ' 23' ' ' PHE . 6.1 p -89.91 147.27 23.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.248 -0.907 . . . . 0.0 109.534 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.63 ' HB2' HD12 ' A' ' 7' ' ' LEU . 12.0 m-85 -111.06 -166.19 1.05 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 0.0 109.487 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -143.61 139.98 29.92 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.341 -0.85 . . . . 0.0 109.484 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -153.49 -176.03 5.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.266 -0.896 . . . . 0.0 109.401 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.536 ' O ' HD13 ' A' ' 57' ' ' ILE . . . -145.01 -61.88 0.35 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.218 -0.926 . . . . 0.0 109.519 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.514 ' H ' ' ND2' ' A' ' 35' ' ' ASN . 0.5 OUTLIER -90.22 144.5 25.8 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 0.0 109.427 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.539 ' HA3' ' CD1' ' A' ' 65' ' ' ILE . . . -48.08 -37.66 16.93 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.403 ' HA ' HD13 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -51.79 -46.49 64.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -1.172 . . . . 0.0 109.54 -179.923 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 43.9 tp60 -64.84 -31.8 73.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.91 . . . . 0.0 109.541 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.785 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -66.47 -37.32 84.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.923 . . . . 0.0 109.526 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.708 HD21 ' HB2' ' A' ' 68' ' ' ARG . 13.8 mt -73.75 -38.97 64.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.883 . . . . 0.0 109.564 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.35 -54.75 39.75 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.258 -0.901 . . . . 0.0 109.48 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.985 HD13 HD11 ' A' ' 7' ' ' LEU . 23.9 mt -62.93 -31.76 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.268 -0.895 . . . . 0.0 109.473 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.785 HG23 ' O ' ' A' ' 39' ' ' ALA . 42.7 t -69.73 -28.13 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 109.365 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.0 m -90.23 -15.75 30.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.278 -0.888 . . . . 0.0 109.512 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.65 -60.48 1.95 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.918 . . . . 0.0 109.73 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 47' ' ' ARG . 1.8 mm-40 -89.78 -30.69 17.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.152 -0.967 . . . . 0.0 109.645 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 13.2 mtm180 65.89 68.41 0.66 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.934 . . . . 0.0 109.577 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.528 ' CD ' ' HA ' ' A' ' 43' ' ' VAL . 35.3 Cg_endo -77.82 -167.01 0.43 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.625 2.217 . . . . 0.0 110.354 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 75' ' ' ASN . 5.0 t70 -142.1 11.16 1.97 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.272 -0.892 . . . . 0.0 109.465 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.489 HD23 HG23 ' A' ' 6' ' ' ILE . 4.9 tp -146.79 111.55 5.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -0.926 . . . . 0.0 109.517 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.968 HG21 ' SD ' ' A' ' 69' ' ' MET . 3.4 t -109.63 137.66 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.232 -0.917 . . . . 0.0 109.32 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.552 HD12 ' O ' ' A' ' 7' ' ' LEU . 1.1 mt -104.51 97.65 7.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.655 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.468 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 1.0 OUTLIER -93.37 119.3 32.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.257 -0.902 . . . . 0.0 109.36 179.825 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.899 ' OD2' HD13 ' A' ' 15' ' ' ILE . 21.0 t0 -99.28 -4.8 31.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.116 -0.99 . . . . 0.0 109.684 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.512 ' HG3' ' CG2' ' A' ' 82' ' ' THR . 0.0 OUTLIER 53.44 17.14 1.03 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.385 -0.822 . . . . 0.0 109.783 -179.854 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 57' ' ' ILE . 13.2 mmtm -91.03 -39.87 11.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.04 -1.037 . . . . 0.0 109.338 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.755 HG21 ' HE3' ' A' ' 60' ' ' MET . 4.3 mt -42.65 111.64 1.02 Allowed Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.377 -0.827 . . . . 0.0 109.495 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.488 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 35.0 Cg_endo -77.01 165.21 28.66 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.403 2.068 . . . . 0.0 110.387 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.77 -43.03 1.87 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.755 ' HE3' HG21 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -158.18 158.85 35.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.361 -1.082 . . . . 0.0 109.321 179.899 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -88.72 151.97 22.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.114 -0.991 . . . . 0.0 109.464 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.439 ' HA2' HG12 ' A' ' 65' ' ' ILE . . . -90.18 4.35 82.8 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.644 ' HA ' HD23 ' A' ' 66' ' ' LEU . 19.4 mm -59.72 -51.03 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.157 -1.202 . . . . 0.0 109.397 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -52.46 -23.67 6.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.19 -0.944 . . . . 0.0 109.401 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.539 ' CD1' ' HA3' ' A' ' 36' ' ' GLY . 8.7 mm -71.55 -65.05 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.32 -0.862 . . . . 0.0 109.449 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.644 HD23 ' HA ' ' A' ' 63' ' ' ILE . 1.6 pp -47.51 -28.62 2.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -0.889 . . . . 0.0 109.226 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.552 ' O ' HG23 ' A' ' 71' ' ' VAL . 12.8 tptt -67.45 -59.17 3.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 0.0 109.254 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.708 ' HB2' HD21 ' A' ' 40' ' ' LEU . 10.7 mtt-85 -51.63 -26.67 9.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.264 -0.897 . . . . 0.0 109.319 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.968 ' SD ' HG21 ' A' ' 51' ' ' VAL . 1.4 mtt -73.9 -39.62 63.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.303 -0.873 . . . . 0.0 109.458 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.526 ' CD ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -69.34 -24.51 63.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.251 -0.905 . . . . 0.0 109.284 179.944 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 67' ' ' LYS . 2.6 t -90.1 -25.45 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.323 -0.86 . . . . 0.0 109.513 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.612 HD12 ' O ' ' A' ' 68' ' ' ARG . 28.2 mt -89.16 -16.92 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.308 -0.87 . . . . 0.0 109.422 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.618 ' O ' HG22 ' A' ' 76' ' ' ILE . 0.4 OUTLIER -170.71 116.59 0.48 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.259 -0.901 . . . . 0.0 109.481 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -74.93 -22.14 58.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.204 -0.935 . . . . 0.0 109.453 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.436 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 69.2 m-80 -89.7 43.09 1.13 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 109.489 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.618 HG22 ' O ' ' A' ' 73' ' ' ASP . 0.5 OUTLIER -117.26 146.8 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.342 -0.849 . . . . 0.0 109.554 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.58 ' O ' HG23 ' A' ' 78' ' ' VAL . 46.0 mtt180 -115.27 162.31 17.27 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.299 -0.875 . . . . 0.0 109.516 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 77' ' ' ARG . 69.7 t -159.72 111.97 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.261 -0.899 . . . . 0.0 109.549 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.85 HG23 HG23 ' A' ' 100' ' ' THR . 9.1 mm -93.32 133.57 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.2 -0.938 . . . . 0.0 109.392 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.902 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.5 OUTLIER -95.43 171.98 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.19 -0.944 . . . . 0.0 109.395 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.605 ' HE1' ' HB2' ' A' ' 54' ' ' ASP . 39.4 mtm -146.84 62.49 1.19 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.24 -0.913 . . . . 0.0 109.459 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.512 ' CG2' ' HG3' ' A' ' 55' ' ' MET . 11.2 t -170.89 32.51 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 109.488 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.033 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.261 -0.9 . . . . 0.0 109.464 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 1.146 HD12 ' CE1' ' A' ' 101' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.809 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.444 ' HA ' ' OE1' ' A' ' 91' ' ' GLN . 21.8 tp60 -53.33 -36.32 61.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.214 -0.929 . . . . 0.0 109.513 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.561 ' O ' HD12 ' A' ' 96' ' ' LEU . 8.0 mt-10 -90.09 -17.21 28.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.199 -0.938 . . . . 0.0 109.481 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.485 ' HB3' ' HB2' ' A' ' 98' ' ' ALA . 0.4 OUTLIER -57.82 -17.55 16.74 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.289 -0.882 . . . . 0.0 109.504 179.974 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.27 -66.76 0.49 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.268 -0.895 . . . . 0.0 109.507 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -56.77 -32.67 65.85 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.218 -0.926 . . . . 0.0 109.552 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.561 HD12 ' O ' ' A' ' 92' ' ' GLU . 2.1 mt -64.76 -33.33 75.71 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.299 -0.876 . . . . 0.0 109.47 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.526 ' HA3' ' CD ' ' A' ' 70' ' ' LYS . . . 140.7 40.4 0.08 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.485 ' HB2' ' HB3' ' A' ' 93' ' ' SER . . . -112.66 102.64 10.69 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.222 -1.164 . . . . 0.0 109.397 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.81 ' HB2' HD13 ' A' ' 79' ' ' ILE . 17.3 mt -43.74 -83.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.294 -0.879 . . . . 0.0 109.42 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.85 HG23 HG23 ' A' ' 79' ' ' ILE . 1.8 t -131.34 171.45 13.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.255 -0.903 . . . . 0.0 109.426 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 1.146 ' CE1' HD12 ' A' ' 90' ' ' ILE . 4.0 t60 -130.41 93.36 3.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.208 -0.933 . . . . 0.0 109.336 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.632 ' CE1' ' CG ' ' A' ' 110' ' ' GLU . 9.0 m-85 -72.72 155.64 39.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -0.918 . . . . 0.0 109.597 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 1.033 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -124.07 -148.56 0.4 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.313 -0.867 . . . . 0.0 109.467 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.43 ' HB2' ' HA ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -101.32 160.54 26.3 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 109.565 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.498 ' O ' ' CB ' ' A' ' 106' ' ' PHE . 36.4 Cg_endo -79.44 11.64 21.61 Favored 'Cis proline' 0 C--N 1.31 -1.489 0 C-N-CA 123.296 -1.543 . . . . 0.0 110.893 0.039 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.656 ' CZ ' HD12 ' A' ' 111' ' ' ILE . 2.2 t80 76.06 99.4 0.07 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.233 -0.917 . . . . 0.0 109.627 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.468 ' O ' HG12 ' A' ' 111' ' ' ILE . 15.2 t0 -89.96 114.32 26.12 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.221 -0.924 . . . . 0.0 109.309 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.609 HG23 HG21 ' A' ' 22' ' ' VAL . 13.7 mm -46.86 -40.08 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.239 -0.913 . . . . 0.0 109.468 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.457 ' HB2' ' OD2' ' A' ' 107' ' ' ASP . 99.6 m-20 -62.05 -42.12 98.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.902 . . . . 0.0 109.528 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.632 ' CG ' ' CE1' ' A' ' 102' ' ' PHE . 5.5 tp10 -67.23 -28.72 68.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.903 . . . . 0.0 109.513 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.656 HD12 ' CZ ' ' A' ' 106' ' ' PHE . 23.5 mm -69.35 -60.2 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.294 -0.879 . . . . 0.0 109.477 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.467 ' HG2' ' O ' ' A' ' 108' ' ' ILE . 0.0 OUTLIER -64.3 -19.91 65.73 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.554 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.427 ' CG ' ' O ' ' A' ' 109' ' ' ASP . 61.1 m-20 -72.47 -53.83 11.02 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.264 -0.897 . . . . 0.0 109.469 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.62 ' HB1' ' HE2' ' A' ' 118' ' ' TYR . . . -61.8 -54.38 43.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 0.0 109.461 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.7 t -52.17 -52.35 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.177 -0.952 . . . . 0.0 109.496 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.67 -35.55 55.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.252 -0.905 . . . . 0.0 109.426 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.67 -34.72 74.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.304 -0.872 . . . . 0.0 109.472 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.636 ' CG ' HD13 ' A' ' 99' ' ' LEU . 58.2 m-85 -88.69 -74.19 0.47 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -0.898 . . . . 0.0 109.532 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.765 HD23 ' O ' ' A' ' 120' ' ' PRO . 6.3 tt -90.11 112.46 52.58 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.287 -0.883 . . . . 0.0 109.443 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.765 ' O ' HD23 ' A' ' 119' ' ' LEU . 35.3 Cg_endo -77.88 -166.18 0.38 Allowed 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.381 2.054 . . . . 0.0 110.375 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.558 ' HG ' ' CZ ' ' A' ' 28' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 0.0 109.424 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.573 ' OE2' ' CD2' ' A' ' 28' ' ' TYR . 51.8 tt0 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.453 ' HB2' ' HB3' ' A' ' 48' ' ' PRO . 3.0 mttt -109.58 156.14 20.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.331 -0.856 . . . . 0.0 109.482 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.494 HG12 ' HB2' ' A' ' 50' ' ' LEU . 63.0 mt -150.05 153.02 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.892 . . . . 0.0 109.453 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.814 HD11 ' CB ' ' A' ' 33' ' ' ALA . 1.8 tm? -132.11 113.97 13.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.289 -0.882 . . . . 0.0 109.482 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.618 ' N ' HD13 ' A' ' 7' ' ' LEU . 4.4 mt -89.89 105.85 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 109.351 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.658 HG22 HD12 ' A' ' 7' ' ' LEU . 2.6 t -89.9 71.72 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.209 -0.932 . . . . 0.0 109.513 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.665 ' O ' ' HB2' ' A' ' 34' ' ' ALA . 1.5 t70 -126.09 146.27 49.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.216 -0.928 . . . . 0.0 109.399 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.943 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . 6.5 p-10 -116.81 -37.07 3.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.315 -0.865 . . . . 0.0 109.473 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.515 ' CG ' ' O ' ' A' ' 12' ' ' GLN . 7.6 pt20 -61.38 102.14 0.21 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.2 -0.937 . . . . 0.0 109.489 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 1.048 ' CE1' HD11 ' A' ' 17' ' ' ILE . 58.5 t80 -43.28 112.22 0.35 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.875 . . . . 0.0 109.596 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 159.28 -69.32 0.25 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.432 ' HB ' ' OD2' ' A' ' 10' ' ' ASP . 1.7 mp -62.78 -20.83 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.125 -1.221 . . . . 0.0 108.777 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.527 ' O ' ' CB ' ' A' ' 20' ' ' ASN . 7.4 mmm-85 -69.4 -29.98 67.85 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.386 -0.822 . . . . 0.0 109.331 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 1.048 HD11 ' CE1' ' A' ' 13' ' ' TYR . 3.8 mt -90.34 -37.08 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.362 -0.836 . . . . 0.0 109.765 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.84 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.4 OUTLIER -69.14 -58.16 4.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.005 -1.059 . . . . 0.0 109.246 -179.906 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.537 ' HA ' HD12 ' A' ' 19' ' ' LEU . 1.3 tp -62.56 -20.54 64.78 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.304 -0.873 . . . . 0.0 108.663 179.348 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 16' ' ' ARG . 0.5 OUTLIER -71.44 -73.25 0.19 Allowed 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.48 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 0.3 OUTLIER -52.43 -30.82 31.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.29 -0.881 . . . . 0.0 109.807 -179.589 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.84 HG23 ' O ' ' A' ' 18' ' ' LEU . 96.8 t -64.75 -61.94 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.194 -0.941 . . . . 0.0 109.548 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.877 ' HB2' HG21 ' A' ' 30' ' ' THR . 16.4 m-85 -72.5 -3.8 26.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 109.544 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.48 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 5.1 m-20 -82.99 -52.61 6.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.146 -0.971 . . . . 0.0 109.38 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.3 mmtt -73.57 -19.09 60.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.121 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.515 ' HB3' ' CD1' ' A' ' 28' ' ' TYR . 0.4 OUTLIER -71.39 -49.19 44.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.369 -0.832 . . . . 0.0 109.372 179.885 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.465 ' O ' ' OE2' ' A' ' 4' ' ' GLU . . . 124.95 46.62 0.24 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 1.074 ' CZ ' HD11 ' A' ' 121' ' ' LEU . 97.7 m-85 -132.72 146.69 52.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.315 -1.109 . . . . 0.0 109.574 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.0 mm100 -89.87 85.32 6.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.297 -0.877 . . . . 0.0 108.798 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.877 HG21 ' HB2' ' A' ' 23' ' ' PHE . 5.6 p -89.63 137.51 32.27 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.239 -0.913 . . . . 0.0 109.791 -179.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.616 ' HB2' HD22 ' A' ' 7' ' ' LEU . 11.5 m-85 -109.15 -171.63 1.88 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.379 -0.826 . . . . 0.0 109.238 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -121.71 154.09 37.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.151 -0.968 . . . . 0.0 109.681 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.814 ' CB ' HD11 ' A' ' 7' ' ' LEU . . . -172.48 174.34 3.83 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.272 -0.892 . . . . 0.0 109.355 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.943 ' HB1' ' HB3' ' A' ' 11' ' ' ASP . . . 170.96 -50.38 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.296 -0.878 . . . . 0.0 109.558 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.473 ' OD1' ' HB2' ' A' ' 38' ' ' GLN . 8.3 p-10 -67.29 -8.36 31.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.2 -0.938 . . . . 0.0 109.553 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 37' ' ' LEU . . . 96.53 -70.62 0.84 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.479 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -44.69 -32.98 1.67 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.166 -1.196 . . . . 0.0 109.437 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.998 ' O ' HD12 ' A' ' 42' ' ' ILE . 1.0 OUTLIER -71.52 -44.11 65.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.242 -0.911 . . . . 0.0 109.461 179.909 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.433 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . . . -65.57 -63.09 1.18 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.247 -0.908 . . . . 0.0 109.437 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.8 mt -51.39 -33.58 30.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.3 -0.875 . . . . 0.0 109.557 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 37' ' ' LEU . 59.8 t0 -62.76 -51.94 65.17 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.268 -0.895 . . . . 0.0 109.453 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.998 HD12 ' O ' ' A' ' 38' ' ' GLN . 2.0 mp -70.64 -14.48 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.214 -0.929 . . . . 0.0 109.49 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.536 ' HA ' ' CD ' ' A' ' 48' ' ' PRO . 50.8 t -84.56 -29.21 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.324 -0.86 . . . . 0.0 109.424 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.7 m -90.06 -25.11 20.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.155 -0.966 . . . . 0.0 109.407 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.51 ' HD2' ' N ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -89.97 -33.19 16.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.267 -0.896 . . . . 0.0 109.463 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -110.32 -36.7 5.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.215 -0.928 . . . . 0.0 109.458 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER 59.82 69.51 1.23 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.291 -0.881 . . . . 0.0 109.478 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.887 ' O ' HD12 ' A' ' 76' ' ' ILE . 34.7 Cg_endo -77.95 -179.58 5.58 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.747 2.298 . . . . 0.0 110.661 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -119.71 -16.84 8.73 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.47 -0.769 . . . . 0.0 109.33 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.494 ' HB2' HG12 ' A' ' 6' ' ' ILE . 1.8 mm? -114.16 121.12 42.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.322 -0.861 . . . . 0.0 109.695 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 1.015 ' HB ' HG13 ' A' ' 78' ' ' VAL . 2.7 t -116.51 147.04 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.236 -0.915 . . . . 0.0 109.253 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.524 ' CD1' HG12 ' A' ' 8' ' ' ILE . 1.6 mt -122.19 87.9 2.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.146 -0.971 . . . . 0.0 109.609 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.61 ' CD1' HG21 ' A' ' 9' ' ' VAL . 1.2 mp -91.7 122.58 34.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.282 -0.886 . . . . 0.0 109.268 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 81' ' ' MET . 30.3 t0 -107.4 -2.87 20.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.201 -0.937 . . . . 0.0 109.754 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.991 ' HB2' HG21 ' A' ' 82' ' ' THR . 4.7 mmt 47.29 22.08 0.24 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.339 -0.851 . . . . 0.0 109.879 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.442 ' HG3' ' CG ' ' A' ' 54' ' ' ASP . 1.4 mttt -90.77 -31.66 16.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.005 -1.059 . . . . 0.0 109.28 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.547 HG12 ' HB1' ' A' ' 34' ' ' ALA . 2.5 mp -41.88 102.17 0.26 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.501 -0.749 . . . . 0.0 109.682 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.497 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 35.0 Cg_endo -77.48 121.21 5.51 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.455 2.104 . . . . 0.0 110.351 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 121.81 -27.31 6.25 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.454 ' SD ' ' O ' ' A' ' 35' ' ' ASN . 1.3 ttp -139.84 135.36 32.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.282 -1.128 . . . . 0.0 109.398 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -89.83 137.34 32.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.243 -0.911 . . . . 0.0 109.457 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.46 ' HA2' HG13 ' A' ' 65' ' ' ILE . . . -90.49 8.74 79.33 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.437 ' HA ' HD13 ' A' ' 63' ' ' ILE . 23.9 mm -58.0 -43.59 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.25 -1.147 . . . . 0.0 109.49 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.517 ' O ' ' CG ' ' A' ' 68' ' ' ARG . 49.4 mm-40 -72.99 -16.72 61.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.9 . . . . 0.0 109.456 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.642 HG22 ' CE ' ' A' ' 69' ' ' MET . 48.8 mt -72.33 -53.5 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.256 -0.903 . . . . 0.0 109.461 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.736 HD21 HG11 ' A' ' 78' ' ' VAL . 12.1 mt -47.3 -57.02 5.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.911 . . . . 0.0 109.554 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 1.011 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -56.62 -42.46 78.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.197 -0.94 . . . . 0.0 109.664 -179.855 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.517 ' CG ' ' O ' ' A' ' 64' ' ' GLU . 2.2 mmt180 -57.47 -29.93 64.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.949 . . . . 0.0 109.553 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.679 ' SD ' HG11 ' A' ' 51' ' ' VAL . 3.9 mtt -75.21 -56.37 4.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.271 -0.893 . . . . 0.0 109.489 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.525 ' NZ ' HD13 ' A' ' 96' ' ' LEU . 6.5 ptpt -55.85 -19.65 12.52 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.183 -0.948 . . . . 0.0 109.462 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 1.011 HG23 ' O ' ' A' ' 67' ' ' LYS . 39.9 t -82.14 -46.64 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.266 -0.896 . . . . 0.0 109.456 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 67.6 mt -63.56 -56.09 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.33 -0.856 . . . . 0.0 109.507 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -135.86 142.74 44.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.325 -0.859 . . . . 0.0 109.46 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -89.42 -10.6 45.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.244 -0.91 . . . . 0.0 109.49 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -102.1 38.52 1.64 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.24 -0.913 . . . . 0.0 109.421 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.887 HD12 ' O ' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -113.55 91.65 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 109.417 -180.0 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.565 ' HB3' HD11 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -63.16 154.77 30.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.225 -0.922 . . . . 0.0 109.478 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 1.015 HG13 ' HB ' ' A' ' 51' ' ' VAL . 3.1 t -138.29 158.84 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.205 -0.935 . . . . 0.0 109.448 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.816 HD11 HD12 ' A' ' 99' ' ' LEU . 3.6 mm -136.81 125.74 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 109.454 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.582 ' HB ' ' CG ' ' A' ' 101' ' ' HIS . 0.7 OUTLIER -98.3 136.85 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.241 -0.912 . . . . 0.0 109.296 179.992 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.46 ' O ' ' OD1' ' A' ' 54' ' ' ASP . 16.9 mtm -122.16 49.03 1.63 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.489 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.991 HG21 ' HB2' ' A' ' 55' ' ' MET . 8.9 t -159.04 52.0 0.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 109.478 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.839 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.211 -0.93 . . . . 0.0 109.448 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.637 HG23 ' HD1' ' A' ' 101' ' ' HIS . 21.0 mt . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.26 0.552 . . . . 0.0 109.54 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.28 -41.84 76.5 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.315 -0.866 . . . . 0.0 109.481 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 93' ' ' SER . 2.1 tp10 -89.94 -48.22 7.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.191 -0.943 . . . . 0.0 109.496 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.626 ' HA ' HD12 ' A' ' 96' ' ' LEU . 11.5 t -44.21 -26.58 0.33 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.929 . . . . 0.0 109.487 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.06 -82.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.901 . . . . 0.0 109.481 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.425 ' O ' ' C ' ' A' ' 96' ' ' LEU . 9.4 pt-20 -44.1 -40.86 5.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.883 . . . . 0.0 109.446 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.626 HD12 ' HA ' ' A' ' 93' ' ' SER . 24.5 mt -44.09 -59.64 2.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -0.885 . . . . 0.0 109.47 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 163.87 47.54 0.02 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 99' ' ' LEU . . . -111.24 105.54 14.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -1.151 . . . . 0.0 109.471 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.905 HD22 ' CE1' ' A' ' 118' ' ' TYR . 20.4 mt -44.25 -63.45 0.88 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.256 -0.903 . . . . 0.0 109.426 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.729 HG22 HG23 ' A' ' 79' ' ' ILE . 14.5 t -146.44 -176.86 5.34 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.305 -0.872 . . . . 0.0 109.424 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.655 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 2.9 t-160 -148.77 68.54 1.07 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -0.886 . . . . 0.0 109.376 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.513 ' CZ ' HG21 ' A' ' 100' ' ' THR . 18.4 m-85 -65.39 160.68 21.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.214 -0.929 . . . . 0.0 109.447 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.839 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -126.72 -174.35 3.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.332 -0.855 . . . . 0.0 109.396 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.403 ' HA ' ' C ' ' A' ' 105' ' ' PRO . 3.7 pttt -102.34 144.92 29.56 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.257 -0.902 . . . . 0.0 109.36 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.403 ' C ' ' HA ' ' A' ' 104' ' ' LYS . 35.6 Cg_endo -77.79 133.9 32.21 Favored 'Cis proline' 0 C--N 1.31 -1.457 0 C-N-CA 123.303 -1.54 . . . . 0.0 110.407 -0.078 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -99.65 -176.64 3.33 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.159 -0.963 . . . . 0.0 109.488 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -127.94 123.32 34.6 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.213 -0.929 . . . . 0.0 109.464 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.77 HG21 HG21 ' A' ' 22' ' ' VAL . 16.2 mm -56.63 -22.42 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.232 -0.918 . . . . 0.0 109.476 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.423 ' O ' ' CG ' ' A' ' 113' ' ' ASP . 11.9 m-20 -72.66 -41.22 65.64 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.221 -0.924 . . . . 0.0 109.539 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.15 -31.38 70.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.203 -0.936 . . . . 0.0 109.461 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 23.0 mm -69.34 -59.16 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.31 -0.869 . . . . 0.0 109.438 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.418 ' O ' ' HG3' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -62.51 -22.84 66.59 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.2 -0.938 . . . . 0.0 109.467 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.423 ' CG ' ' O ' ' A' ' 109' ' ' ASP . 57.1 m-20 -70.79 -52.28 21.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.895 . . . . 0.0 109.412 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.407 ' O ' ' C ' ' A' ' 115' ' ' VAL . . . -66.1 -61.04 2.25 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.494 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.474 HG13 ' HG ' ' A' ' 50' ' ' LEU . 50.3 t -44.25 -47.94 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.246 -0.909 . . . . 0.0 109.437 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 0.0 OUTLIER -59.07 -43.71 91.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.287 -0.883 . . . . 0.0 109.475 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.47 -23.98 64.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.301 -0.875 . . . . 0.0 109.513 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.905 ' CE1' HD22 ' A' ' 99' ' ' LEU . 67.4 m-85 -80.87 -69.88 0.57 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.886 . . . . 0.0 109.516 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.443 HD12 ' HD2' ' A' ' 120' ' ' PRO . 38.3 tp -90.12 112.47 52.63 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.379 -0.826 . . . . 0.0 109.466 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.47 ' O ' HD23 ' A' ' 121' ' ' LEU . 35.8 Cg_endo -78.12 152.95 28.12 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.327 2.018 . . . . 0.0 110.381 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 1.074 HD11 ' CZ ' ' A' ' 28' ' ' TYR . 26.1 mt . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.247 -0.908 . . . . 0.0 109.467 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.511 ' HB2' ' HA ' ' A' ' 48' ' ' PRO . 42.7 mttm -127.71 138.53 52.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.318 -0.864 . . . . 0.0 109.444 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.653 HD12 ' HB3' ' A' ' 28' ' ' TYR . 74.3 mt -144.33 155.0 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.188 -0.945 . . . . 0.0 109.417 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.978 HD22 ' HB2' ' A' ' 31' ' ' PHE . 0.2 OUTLIER -132.26 119.39 20.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.214 -0.929 . . . . 0.0 109.556 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.694 ' N ' HD13 ' A' ' 7' ' ' LEU . 14.1 mt -99.78 102.21 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.248 -0.908 . . . . 0.0 109.447 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.624 HG21 ' CD1' ' A' ' 53' ' ' LEU . 4.9 t -90.02 91.55 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 109.546 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.52 ' O ' ' CD ' ' A' ' 16' ' ' ARG . 4.9 t70 -147.42 138.36 23.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.329 -0.857 . . . . 0.0 109.33 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.921 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . 8.9 p-10 -106.96 -35.81 6.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.891 . . . . 0.0 109.495 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.408 ' O ' ' C ' ' A' ' 13' ' ' TYR . 21.6 tt0 -67.35 106.32 2.04 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.271 -0.893 . . . . 0.0 109.374 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.551 ' CE2' HG13 ' A' ' 17' ' ' ILE . 30.4 t80 -43.32 149.34 0.25 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.357 -0.839 . . . . 0.0 109.6 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.79 -50.79 0.81 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.831 HG23 HD13 ' A' ' 19' ' ' LEU . 2.5 mt -80.69 -36.07 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.204 -1.174 . . . . 0.0 109.435 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.524 ' O ' ' CB ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -63.21 -30.1 71.31 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.129 -0.982 . . . . 0.0 109.433 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.604 ' N ' HD13 ' A' ' 17' ' ' ILE . 2.3 mm -90.84 -31.5 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.292 -0.88 . . . . 0.0 109.831 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.719 ' O ' HG23 ' A' ' 22' ' ' VAL . 8.3 mt -68.8 -60.23 2.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.103 -0.998 . . . . 0.0 109.351 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.831 HD13 HG23 ' A' ' 15' ' ' ILE . 7.3 mp -65.86 -18.03 65.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.318 -0.864 . . . . 0.0 108.789 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 16' ' ' ARG . 0.7 OUTLIER -70.2 -66.33 0.61 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.818 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.478 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 1.1 mm-40 -53.81 -44.2 69.98 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.337 -0.852 . . . . 0.0 109.575 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.805 HG21 ' CG2' ' A' ' 108' ' ' ILE . 46.8 t -54.6 -63.06 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.164 -0.96 . . . . 0.0 109.499 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.776 ' CB ' HG21 ' A' ' 30' ' ' THR . 25.8 m-85 -64.79 -10.62 29.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 0.0 109.54 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.478 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 0.5 OUTLIER -74.26 -60.23 2.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.256 -0.902 . . . . 0.0 109.477 179.919 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -67.59 -25.03 65.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.254 -0.903 . . . . 0.0 109.394 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.494 ' HB3' ' CD2' ' A' ' 28' ' ' TYR . 1.8 mt-10 -69.27 -34.77 75.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.442 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.479 ' O ' ' CG ' ' A' ' 28' ' ' TYR . . . 102.78 73.1 0.96 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.653 ' HB3' HD12 ' A' ' 6' ' ' ILE . 93.9 m-85 -156.71 144.45 19.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.213 -1.169 . . . . 0.0 109.576 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -89.85 83.24 6.17 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.246 -0.909 . . . . 0.0 109.252 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.776 HG21 ' CB ' ' A' ' 23' ' ' PHE . 5.8 p -89.93 137.95 31.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.28 -0.887 . . . . 0.0 109.566 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.978 ' HB2' HD22 ' A' ' 7' ' ' LEU . 42.4 m-85 -105.03 -172.08 2.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 109.345 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.462 ' HG2' ' CG ' ' A' ' 16' ' ' ARG . 54.4 mt-30 -136.88 147.09 46.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.143 -0.973 . . . . 0.0 109.548 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.712 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -164.91 -161.94 0.59 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.239 -0.913 . . . . 0.0 109.368 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.921 ' HB1' ' HB3' ' A' ' 11' ' ' ASP . . . 163.65 -53.72 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.281 -0.887 . . . . 0.0 109.352 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.423 ' HA ' ' HE1' ' A' ' 60' ' ' MET . 22.3 p-10 -60.13 -14.63 18.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.308 -0.87 . . . . 0.0 109.462 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.579 ' HA3' HD11 ' A' ' 65' ' ' ILE . . . 95.79 -45.39 1.99 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 mt -67.68 -30.84 70.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.257 -1.143 . . . . 0.0 109.496 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.902 ' O ' HD12 ' A' ' 42' ' ' ILE . 44.5 tp60 -72.32 -43.72 63.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.235 -0.916 . . . . 0.0 109.461 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.629 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -63.36 -55.97 20.18 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.267 -0.896 . . . . 0.0 109.417 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.4 mt -51.98 -44.43 64.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.286 -0.884 . . . . 0.0 109.478 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.99 -49.73 72.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.277 -0.889 . . . . 0.0 109.465 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.902 HD12 ' O ' ' A' ' 38' ' ' GLN . 3.1 mt -66.7 -19.48 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -0.897 . . . . 0.0 109.469 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 39' ' ' ALA . 89.3 t -78.54 -32.35 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -0.892 . . . . 0.0 109.451 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 26.3 m -89.96 -19.44 24.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.205 -0.935 . . . . 0.0 109.494 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.01 -32.33 16.81 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.239 -0.913 . . . . 0.0 109.547 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.412 ' HA ' ' OE1' ' A' ' 46' ' ' GLU . 15.0 mm-40 -117.52 -33.36 4.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.281 -0.887 . . . . 0.0 109.569 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 4.4 ttp180 61.27 73.0 0.63 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.191 -0.943 . . . . 0.0 109.424 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.517 ' CD ' ' HA ' ' A' ' 43' ' ' VAL . 35.3 Cg_endo -78.12 -176.87 3.48 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.577 2.184 . . . . 0.0 110.405 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -127.44 -3.62 6.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.229 -0.919 . . . . 0.0 109.583 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.0 tp -136.93 125.17 23.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.203 -0.936 . . . . 0.0 109.52 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.766 HG21 ' SD ' ' A' ' 69' ' ' MET . 73.3 t -115.74 166.21 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.324 -0.86 . . . . 0.0 109.442 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.614 ' N ' HG12 ' A' ' 51' ' ' VAL . 1.1 mt -138.42 91.09 2.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.91 . . . . 0.0 109.585 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.624 ' CD1' HG21 ' A' ' 9' ' ' VAL . 3.1 mp -89.93 124.03 34.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.2 -0.938 . . . . 0.0 109.512 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.535 ' HB2' ' HE3' ' A' ' 81' ' ' MET . 28.1 t0 -100.06 -7.36 25.06 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.246 -0.909 . . . . 0.0 109.743 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 7.8 mmt 51.37 18.7 0.67 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.389 -0.819 . . . . 0.0 109.817 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.439 ' HG3' ' OD2' ' A' ' 54' ' ' ASP . 51.3 mmtt -90.95 -37.67 13.36 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.057 -1.027 . . . . 0.0 109.42 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.878 HG12 ' HB1' ' A' ' 34' ' ' ALA . 2.9 mt -42.82 114.41 1.51 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.388 -0.82 . . . . 0.0 109.593 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.489 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 34.9 Cg_endo -77.14 152.87 31.58 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.394 2.062 . . . . 0.0 110.27 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 108.87 -43.69 1.65 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.809 ' HE1' HG21 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -153.98 159.72 41.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.343 -1.092 . . . . 0.0 109.286 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -90.02 164.84 14.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.23 -0.919 . . . . 0.0 109.538 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.481 ' HA2' HG12 ' A' ' 65' ' ' ILE . . . -89.66 -9.0 66.99 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.491 HD13 ' HA ' ' A' ' 63' ' ' ILE . 20.5 mm -46.85 -44.54 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.215 -1.168 . . . . 0.0 109.337 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -58.35 -42.01 85.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.336 -0.852 . . . . 0.0 109.338 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.579 HD11 ' HA3' ' A' ' 36' ' ' GLY . 15.6 mm -49.86 -50.26 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -0.926 . . . . 0.0 109.391 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 1.067 ' CD2' HG11 ' A' ' 78' ' ' VAL . 96.1 mt -58.36 -49.1 78.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.207 -0.933 . . . . 0.0 109.372 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.618 ' O ' HG23 ' A' ' 71' ' ' VAL . 12.5 mttp -44.28 -47.95 9.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.262 -0.899 . . . . 0.0 109.411 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.462 ' O ' HG12 ' A' ' 72' ' ' ILE . 1.9 mpt_? -66.1 -37.14 85.02 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.222 -0.924 . . . . 0.0 109.464 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.766 ' SD ' HG21 ' A' ' 51' ' ' VAL . 1.2 mmt -62.44 -22.91 66.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.251 -0.906 . . . . 0.0 109.438 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 66' ' ' LEU . 13.5 mmtt -84.92 -43.76 13.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.228 -0.92 . . . . 0.0 109.43 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 67' ' ' LYS . 2.6 t -63.87 -27.69 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.327 -0.858 . . . . 0.0 109.465 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.462 HG12 ' O ' ' A' ' 68' ' ' ARG . 28.6 mm -89.95 -56.37 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.246 -0.909 . . . . 0.0 109.486 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.438 ' O ' ' O ' ' A' ' 69' ' ' MET . 2.6 m-20 -126.25 134.64 51.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.305 -0.872 . . . . 0.0 109.471 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -89.18 -15.97 32.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.268 -0.895 . . . . 0.0 109.482 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -114.76 55.49 0.75 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.176 -0.952 . . . . 0.0 109.46 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.423 ' O ' HG23 ' A' ' 76' ' ' ILE . 0.8 OUTLIER -110.94 118.0 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.305 -0.872 . . . . 0.0 109.481 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.527 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 0.4 OUTLIER -75.68 144.13 41.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.894 . . . . 0.0 109.48 -179.999 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 1.067 HG11 ' CD2' ' A' ' 66' ' ' LEU . 13.6 t -143.93 107.95 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.343 -0.848 . . . . 0.0 109.495 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.529 HG23 ' O ' ' A' ' 100' ' ' THR . 68.0 mt -90.28 139.32 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.247 -0.908 . . . . 0.0 109.425 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.814 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.0 OUTLIER -108.36 167.02 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.278 -0.889 . . . . 0.0 109.297 179.915 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.535 ' HE3' ' HB2' ' A' ' 54' ' ' ASP . 7.2 mtm -146.59 95.0 2.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.154 -0.967 . . . . 0.0 109.588 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.975 HG22 ' NE2' ' A' ' 101' ' ' HIS . 11.6 t 177.8 38.37 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.213 -0.929 . . . . 0.0 109.35 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.7 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . . . . . . 0 N--CA 1.489 1.48 0 O-C-N 121.352 -0.842 . . . . 0.0 109.477 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.49 ' HA ' ' HB2' ' A' ' 93' ' ' SER . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -61.06 -49.35 77.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -0.882 . . . . 0.0 109.4 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.448 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -77.54 -22.41 51.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.897 . . . . 0.0 109.295 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.49 ' HB2' ' HA ' ' A' ' 90' ' ' ILE . 0.6 OUTLIER -59.86 -68.8 0.25 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.258 -0.901 . . . . 0.0 109.358 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.854 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 24.0 tptt -44.04 -53.58 6.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.332 -0.855 . . . . 0.0 109.312 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 94' ' ' LYS . 36.3 tp10 -43.46 -51.5 6.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.365 -0.835 . . . . 0.0 109.461 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 92' ' ' GLU . 23.8 mt -58.11 -50.9 71.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.262 -0.899 . . . . 0.0 109.522 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 163.25 41.15 0.02 OUTLIER Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.854 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -93.52 107.23 19.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.295 -1.121 . . . . 0.0 109.368 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.527 ' CD1' ' HB3' ' A' ' 77' ' ' ARG . 22.0 mt -44.03 -87.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.261 -0.899 . . . . 0.0 109.518 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.529 ' O ' HG23 ' A' ' 79' ' ' ILE . 4.0 t -127.95 160.93 30.35 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.918 . . . . 0.0 109.517 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.975 ' NE2' HG22 ' A' ' 82' ' ' THR . 6.3 t-160 -125.21 95.32 4.44 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.255 -0.903 . . . . 0.0 109.581 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.66 ' CD2' HD13 ' A' ' 111' ' ' ILE . 18.8 m-85 -69.51 -168.45 0.17 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.29 -0.881 . . . . 0.0 109.419 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.7 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -162.81 -165.85 1.21 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.201 -0.937 . . . . 0.0 109.402 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.538 ' HG3' ' CE1' ' A' ' 106' ' ' PHE . 16.9 mtpt -129.2 145.37 56.44 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.225 -0.922 . . . . 0.0 109.459 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.9 151.66 91.38 Favored 'Cis proline' 0 C--N 1.31 -1.476 0 C-N-CA 123.302 -1.541 . . . . 0.0 110.381 -0.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.547 ' CD1' ' N ' ' A' ' 106' ' ' PHE . 4.9 p90 -133.63 169.32 17.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.183 -0.948 . . . . 0.0 109.486 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.413 ' HB3' ' OE1' ' A' ' 110' ' ' GLU . 42.7 t0 -103.16 116.71 33.0 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.208 -0.933 . . . . 0.0 109.501 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.805 ' CG2' HG21 ' A' ' 22' ' ' VAL . 12.9 mm -50.23 -29.72 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.279 -0.888 . . . . 0.0 109.38 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.453 ' HA ' ' HD3' ' A' ' 112' ' ' ARG . 52.0 m-20 -66.26 -44.0 84.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.204 -0.935 . . . . 0.0 109.383 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 113' ' ' ASP . 2.2 mp0 -64.46 -46.92 81.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 109.505 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.66 HD13 ' CD2' ' A' ' 102' ' ' PHE . 22.6 mm -52.27 -62.28 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.317 -0.864 . . . . 0.0 109.533 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.456 ' HG2' ' O ' ' A' ' 108' ' ' ILE . 0.6 OUTLIER -52.23 -38.45 58.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.55 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 110' ' ' GLU . 88.3 m-20 -53.52 -63.21 1.22 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 109.494 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.44 ' HA ' ' HG3' ' A' ' 117' ' ' LYS . . . -52.08 -55.67 19.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.912 . . . . 0.0 109.518 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.41 ' C ' ' O ' ' A' ' 114' ' ' ALA . 50.7 t -43.96 -35.04 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.261 -0.899 . . . . 0.0 109.477 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.45 ' HE3' ' OE2' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -73.93 -42.2 60.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.282 -0.886 . . . . 0.0 109.467 179.952 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.44 ' HG3' ' HA ' ' A' ' 114' ' ' ALA . 4.0 mttt -62.4 -21.57 65.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 109.449 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.46 ' O ' ' HD3' ' A' ' 120' ' ' PRO . 61.2 m-85 -88.55 -70.8 0.62 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.287 -0.883 . . . . 0.0 109.499 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 21.1 tp -90.04 112.48 52.61 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.365 -0.835 . . . . 0.0 109.448 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 118' ' ' TYR . 35.5 Cg_endo -78.04 133.0 12.02 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.393 2.062 . . . . 0.0 110.382 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 121' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 109.427 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.732 ' OE1' HD23 ' A' ' 121' ' ' LEU . 3.9 mt-10 . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.503 ' O ' ' CB ' ' A' ' 48' ' ' PRO . 0.8 OUTLIER -134.42 134.46 41.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.287 -0.883 . . . . 0.0 109.426 179.934 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.824 ' HB ' HG22 ' A' ' 30' ' ' THR . 98.0 mt -128.85 161.27 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.3 -0.875 . . . . 0.0 109.486 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.768 ' HB3' HG13 ' A' ' 51' ' ' VAL . 2.1 tm? -132.51 114.97 14.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.551 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.838 HG22 ' OD2' ' A' ' 10' ' ' ASP . 3.2 mt -104.36 105.03 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.924 . . . . 0.0 109.552 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.773 ' HA ' ' HB3' ' A' ' 33' ' ' ALA . 35.9 t -90.49 90.0 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.874 . . . . 0.0 109.464 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.838 ' OD2' HG22 ' A' ' 8' ' ' ILE . 69.1 m-20 -127.37 128.79 46.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.202 -0.936 . . . . 0.0 109.434 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.5 ' OD2' ' HD2' ' A' ' 58' ' ' PRO . 6.7 p-10 -100.21 -23.69 14.76 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.289 -0.882 . . . . 0.0 109.241 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.421 ' O ' ' C ' ' A' ' 13' ' ' TYR . 9.7 tp-100 -84.41 105.78 15.5 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.362 -0.836 . . . . 0.0 109.558 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.677 ' CE2' HD11 ' A' ' 17' ' ' ILE . 1.5 t80 -42.53 155.37 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.402 -0.811 . . . . 0.0 109.325 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.516 ' N ' ' CD1' ' A' ' 13' ' ' TYR . . . 109.33 -55.53 0.5 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.904 HG23 HD13 ' A' ' 19' ' ' LEU . 2.1 mt -76.13 -60.28 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.329 -1.101 . . . . 0.0 109.268 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.472 ' HD2' ' O ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -41.16 -30.91 0.17 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.48 -0.762 . . . . 0.0 110.042 -179.869 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.677 HD11 ' CE2' ' A' ' 13' ' ' TYR . 1.3 mt -90.42 -35.66 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.135 -0.978 . . . . 0.0 109.973 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.783 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.4 OUTLIER -65.44 -59.81 3.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.239 -0.913 . . . . 0.0 109.758 -179.625 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.904 HD13 HG23 ' A' ' 15' ' ' ILE . 7.2 mp -64.32 -20.97 66.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.198 -0.939 . . . . 0.0 109.639 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.472 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 10.9 t30 -70.65 -62.56 1.34 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 109.514 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.461 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 34.9 mt-10 -56.46 -44.37 80.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.265 -0.897 . . . . 0.0 109.55 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.783 HG23 ' O ' ' A' ' 18' ' ' LEU . 41.2 t -55.13 -61.73 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.236 -0.915 . . . . 0.0 109.491 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.863 ' CZ ' HG21 ' A' ' 115' ' ' VAL . 20.9 m-85 -65.56 -11.5 44.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.348 -0.845 . . . . 0.0 109.479 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.461 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 1.7 m-20 -73.52 -60.07 2.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.335 -0.853 . . . . 0.0 109.483 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.1 tttp -74.07 -11.3 60.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.453 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.484 ' HB2' ' HA ' ' A' ' 23' ' ' PHE . 0.7 OUTLIER -76.14 -31.57 58.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -0.935 . . . . 0.0 109.49 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.88 41.89 0.82 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.485 ' HB3' HD12 ' A' ' 6' ' ' ILE . 85.2 m-85 -141.56 134.93 29.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.256 -1.144 . . . . 0.0 109.592 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -93.96 82.21 4.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.234 -0.916 . . . . 0.0 109.07 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.824 HG22 ' HB ' ' A' ' 6' ' ' ILE . 5.5 p -89.79 149.07 22.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.27 -0.894 . . . . 0.0 109.881 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.612 ' HB2' HD22 ' A' ' 7' ' ' LEU . 31.6 m-85 -109.01 -167.23 1.19 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 109.052 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.428 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 15.5 mp0 -133.19 157.09 46.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.161 -0.962 . . . . 0.0 109.821 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.773 ' HB3' ' HA ' ' A' ' 9' ' ' VAL . . . -157.77 176.94 11.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.414 -0.804 . . . . 0.0 109.283 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.522 ' O ' HD13 ' A' ' 57' ' ' ILE . . . -173.35 -44.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.125 -0.985 . . . . 0.0 109.693 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.418 ' C ' ' SD ' ' A' ' 60' ' ' MET . 2.4 p30 -82.25 -1.8 50.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.214 -0.929 . . . . 0.0 109.607 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.461 ' HA3' ' SD ' ' A' ' 60' ' ' MET . . . 85.7 -48.69 4.03 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.477 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 1.1 mp -52.54 -44.79 66.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -1.149 . . . . 0.0 109.511 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.851 ' O ' HD12 ' A' ' 42' ' ' ILE . 0.9 OUTLIER -68.19 -27.71 66.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.217 -0.927 . . . . 0.0 109.481 179.939 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.778 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -71.56 -69.45 0.38 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.202 -0.936 . . . . 0.0 109.548 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -51.77 -47.17 64.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.228 -0.92 . . . . 0.0 109.6 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.477 ' HB2' ' O ' ' A' ' 37' ' ' LEU . 16.0 t0 -54.08 -52.59 60.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.308 -0.87 . . . . 0.0 109.55 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.851 HD12 ' O ' ' A' ' 38' ' ' GLN . 20.4 mt -61.7 -22.92 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.257 -0.902 . . . . 0.0 109.424 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.778 HG23 ' O ' ' A' ' 39' ' ' ALA . 54.1 t -78.29 -25.28 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.182 -0.949 . . . . 0.0 109.457 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.1 m -90.13 -25.29 20.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.308 -0.87 . . . . 0.0 109.525 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.523 ' CD ' ' HA ' ' A' ' 42' ' ' ILE . 3.8 ptmt -90.07 -27.13 19.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.574 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.538 ' OE2' ' CZ ' ' A' ' 31' ' ' PHE . 3.2 mt-10 -118.6 -26.66 6.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.23 -0.919 . . . . 0.0 109.471 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.502 ' HG3' ' O ' ' A' ' 46' ' ' GLU . 7.4 ptm180 38.55 72.12 0.98 Allowed Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.598 -0.689 . . . . 0.0 109.969 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.503 ' CB ' ' O ' ' A' ' 5' ' ' LYS . 34.7 Cg_endo -77.19 -171.51 1.18 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.619 2.213 . . . . 0.0 110.343 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 5.7 m-20 -117.6 -8.3 10.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.139 -0.975 . . . . 0.0 109.556 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.456 HD21 HG22 ' A' ' 115' ' ' VAL . 7.2 tp -131.57 117.34 18.6 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.286 -0.884 . . . . 0.0 109.54 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 1.06 HG11 ' CE ' ' A' ' 69' ' ' MET . 2.9 t -121.35 158.75 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.233 -0.917 . . . . 0.0 109.408 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.2 mp -135.3 115.68 13.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -0.935 . . . . 0.0 109.516 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.857 HD22 ' N ' ' A' ' 53' ' ' LEU . 0.8 OUTLIER -102.19 126.45 49.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.355 -0.841 . . . . 0.0 109.419 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 81' ' ' MET . 31.9 t0 -106.49 106.6 17.19 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.917 . . . . 0.0 109.466 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.711 ' CG ' HG21 ' A' ' 82' ' ' THR . 16.0 mmt -59.78 -14.95 16.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.332 -0.855 . . . . 0.0 109.462 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.458 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 4.2 mmpt? -52.88 -37.18 60.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 109.502 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.751 ' CD1' ' HE1' ' A' ' 60' ' ' MET . 43.8 mt -41.14 101.15 0.24 Allowed Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.443 -0.786 . . . . 0.0 109.691 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.5 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 36.2 Cg_endo -79.15 -29.53 3.14 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.512 2.141 . . . . 0.0 110.51 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -84.45 -3.91 88.19 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.751 ' HE1' ' CD1' ' A' ' 57' ' ' ILE . 10.3 ttp -156.96 141.03 16.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.103 -1.234 . . . . 0.0 109.607 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.477 ' N ' ' HG2' ' A' ' 60' ' ' MET . 15.3 m-20 -89.99 126.82 35.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.31 -0.869 . . . . 0.0 109.431 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.518 ' HA2' ' CG1' ' A' ' 65' ' ' ILE . . . -82.96 9.16 60.92 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' ' 63' ' ' ILE . 13.0 mm -70.8 -44.69 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.249 -1.148 . . . . 0.0 109.396 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -71.91 -12.89 61.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -0.905 . . . . 0.0 109.404 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.523 ' O ' ' CG ' ' A' ' 69' ' ' MET . 13.6 mm -73.49 -58.36 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.189 -0.944 . . . . 0.0 109.49 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.751 HD21 ' HB ' ' A' ' 78' ' ' VAL . 6.3 mt -53.25 -28.42 27.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -0.916 . . . . 0.0 109.465 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.505 ' O ' ' CG ' ' A' ' 70' ' ' LYS . 5.7 mmtm -72.65 -70.28 0.36 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.189 -0.945 . . . . 0.0 109.451 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.467 ' O ' HG12 ' A' ' 72' ' ' ILE . 0.6 OUTLIER -45.25 -25.83 0.42 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.265 -0.897 . . . . 0.0 109.418 -179.938 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' MET . . . . . 1.06 ' CE ' HG11 ' A' ' 51' ' ' VAL . 2.9 mmm -72.78 -48.9 34.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.187 -0.946 . . . . 0.0 109.456 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.505 ' CG ' ' O ' ' A' ' 67' ' ' LYS . 16.3 ptpt -63.18 -21.77 66.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.262 -0.899 . . . . 0.0 109.51 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.1 t -80.1 -45.62 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.251 -0.905 . . . . 0.0 109.517 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 68' ' ' ARG . 24.1 mm -76.21 -14.64 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.215 -0.928 . . . . 0.0 109.525 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.402 ' O ' HG22 ' A' ' 76' ' ' ILE . 1.2 m-20 -170.06 117.62 0.56 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.221 -0.924 . . . . 0.0 109.514 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.418 ' HG3' ' N ' ' A' ' 75' ' ' ASN . 0.1 OUTLIER -90.13 -18.83 25.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.186 -0.946 . . . . 0.0 109.417 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.418 ' N ' ' HG3' ' A' ' 74' ' ' GLU . 17.3 m120 -101.2 48.85 0.88 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.295 -0.878 . . . . 0.0 109.456 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.485 ' O ' HG23 ' A' ' 76' ' ' ILE . 0.3 OUTLIER -121.9 116.96 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.275 -0.891 . . . . 0.0 109.518 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.536 ' CA ' HD11 ' A' ' 99' ' ' LEU . 7.7 mtt85 -54.02 130.73 38.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 109.417 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.751 ' HB ' HD21 ' A' ' 66' ' ' LEU . 0.2 OUTLIER -132.08 117.86 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.213 -0.929 . . . . 0.0 109.63 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.556 HG23 ' O ' ' A' ' 100' ' ' THR . 66.9 mt -114.69 144.05 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.261 -0.899 . . . . 0.0 109.394 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 1.017 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.1 OUTLIER -108.63 158.88 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.235 -0.916 . . . . 0.0 109.418 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.469 ' O ' ' HB ' ' A' ' 82' ' ' THR . 14.2 mtm -136.83 91.92 2.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.135 -0.978 . . . . 0.0 109.644 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.924 HG22 ' NE2' ' A' ' 101' ' ' HIS . 11.4 t 176.69 38.65 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.377 -0.827 . . . . 0.0 109.331 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.95 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.338 -0.851 . . . . 0.0 109.571 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.456 ' HA ' ' HB2' ' A' ' 93' ' ' SER . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.785 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.71 -38.25 14.81 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.193 -0.942 . . . . 0.0 109.452 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.14 -44.82 9.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.915 . . . . 0.0 109.639 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' SER . . . . . 1.006 ' HA ' HD12 ' A' ' 96' ' ' LEU . 2.7 m -45.05 -26.88 0.49 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.171 -0.955 . . . . 0.0 109.69 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.841 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 0.8 OUTLIER -60.64 -63.45 1.29 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.18 -0.95 . . . . 0.0 109.518 -179.93 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.414 ' HG3' ' N ' ' A' ' 96' ' ' LEU . 7.1 pt-20 -61.45 -27.03 68.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.277 -0.89 . . . . 0.0 109.512 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 1.006 HD12 ' HA ' ' A' ' 93' ' ' SER . 36.2 mt -67.49 -33.73 75.71 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.205 -0.935 . . . . 0.0 109.5 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.558 ' O ' HG21 ' A' ' 78' ' ' VAL . . . 156.16 69.9 0.01 OUTLIER Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.841 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -158.01 110.03 2.31 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.273 -1.133 . . . . 0.0 109.382 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.536 HD11 ' CA ' ' A' ' 77' ' ' ARG . 0.4 OUTLIER -60.24 -67.58 0.38 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.289 -0.882 . . . . 0.0 109.436 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.556 ' O ' HG23 ' A' ' 79' ' ' ILE . 10.7 t -131.66 160.39 35.56 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.214 -0.928 . . . . 0.0 109.406 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 1.017 ' ND1' HD12 ' A' ' 80' ' ' ILE . 5.4 t-160 -124.92 94.79 4.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -0.892 . . . . 0.0 109.458 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.412 ' HZ ' ' HB2' ' A' ' 114' ' ' ALA . 38.8 m-85 -63.62 -179.0 0.32 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.238 -0.914 . . . . 0.0 109.5 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.95 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -171.08 -157.94 0.14 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.291 -0.881 . . . . 0.0 109.337 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.448 ' HG3' ' HA ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -98.9 143.03 25.63 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.188 -0.945 . . . . 0.0 109.454 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.448 ' HA ' ' HG3' ' A' ' 104' ' ' LYS . 35.6 Cg_endo -77.98 164.75 84.92 Favored 'Cis proline' 0 C--N 1.31 -1.487 0 C-N-CA 123.277 -1.551 . . . . 0.0 110.37 -0.03 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.727 ' CE2' HD12 ' A' ' 111' ' ' ILE . 0.2 OUTLIER -96.18 107.68 20.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.29 -0.881 . . . . 0.0 109.502 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.478 ' O ' HG12 ' A' ' 111' ' ' ILE . 23.1 t0 -89.83 103.87 16.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.258 -0.901 . . . . 0.0 109.384 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.683 HD12 HG21 ' A' ' 22' ' ' VAL . 15.8 mm -46.21 -24.35 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 109.863 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.456 ' O ' ' OD2' ' A' ' 113' ' ' ASP . 22.4 m-20 -73.6 -45.22 54.39 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.203 -0.936 . . . . 0.0 109.789 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.92 -24.37 61.62 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.112 -0.993 . . . . 0.0 109.706 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.727 HD12 ' CE2' ' A' ' 106' ' ' PHE . 10.6 mm -76.26 -53.08 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.218 -0.926 . . . . 0.0 109.438 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.459 ' O ' ' HG3' ' A' ' 116' ' ' LYS . 0.9 OUTLIER -64.24 -37.39 87.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.319 -0.863 . . . . 0.0 109.588 -179.867 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.456 ' OD2' ' O ' ' A' ' 109' ' ' ASP . 16.6 m-20 -63.65 -60.13 3.72 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.203 -0.936 . . . . 0.0 109.6 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.412 ' HB2' ' HZ ' ' A' ' 102' ' ' PHE . . . -46.58 -51.06 16.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.925 . . . . 0.0 109.618 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.863 HG21 ' CZ ' ' A' ' 23' ' ' PHE . 47.9 t -52.57 -49.98 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.889 . . . . 0.0 109.597 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 0.4 OUTLIER -58.42 -29.68 66.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.902 . . . . 0.0 109.553 -179.867 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.7 tttm -76.89 -27.36 54.94 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.201 -0.937 . . . . 0.0 109.42 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.492 ' O ' ' HD3' ' A' ' 120' ' ' PRO . 40.3 m-85 -90.05 -75.07 0.46 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.254 -0.904 . . . . 0.0 109.497 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.417 HD23 ' O ' ' A' ' 120' ' ' PRO . 5.3 tt -90.54 111.87 49.89 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.261 -0.899 . . . . 0.0 109.627 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 118' ' ' TYR . 36.2 Cg_endo -79.53 154.83 24.26 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.442 2.094 . . . . 0.0 110.355 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.732 HD23 ' OE1' ' A' ' 4' ' ' GLU . 21.4 mt . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.298 -0.876 . . . . 0.0 109.205 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.522 ' CD ' HD21 ' A' ' 121' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.488 ' O ' ' CB ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -127.53 111.15 13.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.294 -0.879 . . . . 0.0 109.454 179.958 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.687 HD12 HG22 ' A' ' 30' ' ' THR . 16.2 mt -126.93 158.29 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.255 -0.903 . . . . 0.0 109.496 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.879 HD13 ' N ' ' A' ' 8' ' ' ILE . 2.6 tm? -132.51 128.97 38.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.231 -0.918 . . . . 0.0 109.469 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.879 ' N ' HD13 ' A' ' 7' ' ' LEU . 9.1 mt -106.44 104.64 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.239 -0.913 . . . . 0.0 109.466 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.494 ' CG2' HD12 ' A' ' 7' ' ' LEU . 3.9 t -89.97 70.78 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.292 -0.88 . . . . 0.0 109.463 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.561 ' O ' ' HB2' ' A' ' 34' ' ' ALA . 0.4 OUTLIER -123.22 148.94 45.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.892 . . . . 0.0 109.502 179.935 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.549 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . 5.5 p-10 -115.8 -40.16 3.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.248 -0.907 . . . . 0.0 109.457 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.94 111.93 2.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.0 109.505 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.581 ' CZ ' HG13 ' A' ' 17' ' ' ILE . 46.6 t80 -49.26 128.84 17.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.212 -0.93 . . . . 0.0 109.477 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.52 ' O ' HD12 ' A' ' 18' ' ' LEU . . . 138.23 -43.93 1.15 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.784 HG23 HD13 ' A' ' 19' ' ' LEU . 6.4 mt -84.26 -39.74 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -1.135 . . . . 0.0 109.392 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.515 ' CD ' ' O ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -65.93 -26.57 67.66 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.207 -0.933 . . . . 0.0 109.453 -179.964 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.581 HG13 ' CZ ' ' A' ' 13' ' ' TYR . 4.8 mm -90.65 -42.61 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.261 -0.9 . . . . 0.0 109.787 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.789 ' O ' HG23 ' A' ' 22' ' ' VAL . 55.2 mt -64.65 -57.76 8.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.145 -0.972 . . . . 0.0 109.852 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.784 HD13 HG23 ' A' ' 15' ' ' ILE . 7.9 mp -60.23 -26.37 66.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.243 -0.91 . . . . 0.0 109.743 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 30.2 t30 -67.87 -55.2 13.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 109.59 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.489 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 33.4 mt-10 -59.74 -44.71 93.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.265 -0.897 . . . . 0.0 109.723 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.789 HG23 ' O ' ' A' ' 18' ' ' LEU . 13.7 t -55.92 -62.22 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 109.729 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.759 ' CZ ' HG21 ' A' ' 115' ' ' VAL . 17.0 m-85 -68.4 -10.16 53.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.915 . . . . 0.0 109.592 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.489 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 1.7 m-20 -70.84 -52.06 22.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.191 -0.943 . . . . 0.0 109.386 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -74.55 -11.71 60.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.238 -0.914 . . . . 0.0 109.311 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.557 ' HB3' ' CD2' ' A' ' 28' ' ' TYR . 3.5 mt-10 -78.61 -33.61 47.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.294 -0.879 . . . . 0.0 109.474 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.476 ' O ' ' HG2' ' A' ' 4' ' ' GLU . . . 105.56 54.08 0.75 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.725 ' CE1' HD23 ' A' ' 119' ' ' LEU . 88.5 m-85 -138.07 143.53 40.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.168 -1.195 . . . . 0.0 109.525 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.425 ' HB2' ' O ' ' A' ' 4' ' ' GLU . 92.8 mm-40 -94.23 81.51 4.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.91 . . . . 0.0 109.394 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.687 HG22 HD12 ' A' ' 6' ' ' ILE . 5.8 p -89.88 148.34 23.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.906 . . . . 0.0 109.53 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.541 ' HB2' ' CD2' ' A' ' 7' ' ' LEU . 8.5 m-85 -114.84 -172.74 2.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.274 -0.892 . . . . 0.0 109.409 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -123.28 151.35 42.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.282 -0.886 . . . . 0.0 109.529 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.608 ' HB3' HD11 ' A' ' 7' ' ' LEU . . . -174.48 172.4 3.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.313 -0.867 . . . . 0.0 109.414 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.561 ' HB2' ' O ' ' A' ' 10' ' ' ASP . . . 177.67 -31.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.182 -0.949 . . . . 0.0 109.533 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.415 ' ND2' ' H ' ' A' ' 35' ' ' ASN . 2.6 p30 -74.77 -0.91 19.79 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.171 -0.955 . . . . 0.0 109.619 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.05 -45.2 3.48 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.29 -54.79 31.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.158 -1.201 . . . . 0.0 109.514 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.605 ' HG2' HD11 ' A' ' 42' ' ' ILE . 1.5 mt-30 -71.24 -15.37 62.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.911 . . . . 0.0 109.617 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.814 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -70.6 -60.66 2.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.205 -0.935 . . . . 0.0 109.536 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.511 ' CD2' ' HB3' ' A' ' 68' ' ' ARG . 0.7 OUTLIER -69.85 -38.66 76.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.247 -0.908 . . . . 0.0 109.55 -179.974 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.461 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 14.8 m-20 -61.43 -60.79 3.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.332 -0.855 . . . . 0.0 109.547 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.785 HG21 HD23 ' A' ' 7' ' ' LEU . 41.5 mt -56.97 -31.05 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.248 -0.908 . . . . 0.0 109.513 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.814 HG23 ' O ' ' A' ' 39' ' ' ALA . 44.0 t -68.84 -31.69 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.204 -0.935 . . . . 0.0 109.485 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 79.8 m -90.02 -14.5 33.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.214 -0.929 . . . . 0.0 109.474 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 3.7 mmtt -84.61 -58.48 2.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.891 . . . . 0.0 109.545 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 47' ' ' ARG . 2.4 mm-40 -89.97 -25.38 20.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 109.628 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.507 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 6.5 mmm180 63.48 62.8 1.61 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.182 -0.949 . . . . 0.0 109.436 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.507 ' HD3' ' N ' ' A' ' 47' ' ' ARG . 35.3 Cg_endo -77.69 158.18 31.84 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.603 2.202 . . . . 0.0 110.49 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.405 ' HB2' ' CD1' ' A' ' 119' ' ' LEU . 4.4 m-20 -100.04 -10.9 21.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.246 -0.909 . . . . 0.0 109.508 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.695 HD23 ' HB2' ' A' ' 119' ' ' LEU . 1.7 mm? -116.62 122.89 45.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.221 -0.924 . . . . 0.0 109.499 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.887 HG11 ' CE ' ' A' ' 69' ' ' MET . 9.0 t -123.91 113.06 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.902 . . . . 0.0 109.529 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.633 HD12 ' O ' ' A' ' 7' ' ' LEU . 1.0 OUTLIER -90.75 120.31 31.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.883 . . . . 0.0 109.419 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.673 HD21 ' HB ' ' A' ' 65' ' ' ILE . 1.1 tp -110.75 121.98 46.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.337 -0.852 . . . . 0.0 109.534 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.471 ' OD2' ' HB2' ' A' ' 56' ' ' LYS . 8.9 t0 -104.45 109.14 20.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 0.0 109.366 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.45 ' HB2' ' HB ' ' A' ' 82' ' ' THR . 6.6 mmt -67.18 -9.59 41.7 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.144 -0.972 . . . . 0.0 109.512 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.471 ' HB2' ' OD2' ' A' ' 54' ' ' ASP . 6.3 mmtt -74.92 -19.13 60.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 0.0 109.383 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.668 HG21 ' HE2' ' A' ' 60' ' ' MET . 81.0 mt -43.11 103.15 0.3 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.324 -0.86 . . . . 0.0 109.519 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.44 ' HD2' ' CG ' ' A' ' 11' ' ' ASP . 35.5 Cg_endo -77.55 108.76 2.64 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.412 2.075 . . . . 0.0 110.421 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 128.93 -33.76 3.0 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.668 ' HE2' HG21 ' A' ' 57' ' ' ILE . 0.6 OUTLIER -138.82 133.34 31.94 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.276 -1.132 . . . . 0.0 109.458 -179.962 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.418 ' O ' ' HE3' ' A' ' 60' ' ' MET . 4.3 m-20 -83.52 157.94 22.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.161 -0.962 . . . . 0.0 109.477 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.526 ' HA2' ' CD1' ' A' ' 65' ' ' ILE . . . -102.89 9.17 55.0 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.7 mm -70.37 -57.68 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -1.191 . . . . 0.0 109.447 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -58.59 -29.13 66.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 0.0 109.432 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.673 ' HB ' HD21 ' A' ' 53' ' ' LEU . 10.1 mt -59.23 -52.15 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.277 -0.889 . . . . 0.0 109.412 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.777 ' CD2' HG11 ' A' ' 78' ' ' VAL . 25.8 mt -53.87 -51.5 63.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.357 -0.84 . . . . 0.0 109.486 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.522 ' O ' HG23 ' A' ' 71' ' ' VAL . 1.3 tttt -46.81 -49.39 20.03 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.262 -0.899 . . . . 0.0 109.483 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.511 ' HB3' ' CD2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -57.93 -38.54 76.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.278 -0.889 . . . . 0.0 109.463 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.887 ' CE ' HG11 ' A' ' 51' ' ' VAL . 7.0 mtt -67.94 -25.31 65.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 0.0 109.465 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 66' ' ' LEU . 0.8 OUTLIER -78.88 -30.32 44.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.271 -0.893 . . . . 0.0 109.452 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 67' ' ' LYS . 3.6 t -84.9 -20.85 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.274 -0.891 . . . . 0.0 109.435 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 68' ' ' ARG . 91.4 mt -89.92 -34.97 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -0.879 . . . . 0.0 109.432 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -166.31 134.05 2.77 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.261 -0.899 . . . . 0.0 109.433 -179.927 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -89.72 -10.48 45.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.514 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -103.23 12.45 35.6 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.226 -0.921 . . . . 0.0 109.552 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.632 ' O ' HG23 ' A' ' 76' ' ' ILE . 1.0 OUTLIER -78.62 115.26 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.262 -0.899 . . . . 0.0 109.496 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.792 ' HB3' HD11 ' A' ' 99' ' ' LEU . 59.0 mtt85 -69.85 126.97 31.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 109.513 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.777 HG11 ' CD2' ' A' ' 66' ' ' LEU . 2.9 t -133.23 110.44 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.269 -0.894 . . . . 0.0 109.458 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.547 HG22 ' N ' ' A' ' 80' ' ' ILE . 75.5 mt -92.59 165.02 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 109.384 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 1.016 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.3 OUTLIER -128.42 152.76 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.162 -0.962 . . . . 0.0 109.528 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.46 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 16.9 mtm -136.93 98.37 3.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.286 -0.884 . . . . 0.0 109.361 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' THR . . . . . 1.077 HG22 ' NE2' ' A' ' 101' ' ' HIS . 4.4 t -166.37 -147.23 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.153 -0.967 . . . . 0.0 109.64 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.787 ' N ' HG23 ' A' ' 82' ' ' THR . . . . . . . . 0 N--CA 1.488 1.468 0 O-C-N 121.464 -0.772 . . . . 0.0 110.052 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.982 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.789 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.432 ' N ' HG12 ' A' ' 90' ' ' ILE . 10.6 tt0 -47.66 -58.36 4.38 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.253 -0.905 . . . . 0.0 109.5 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.41 ' O ' ' C ' ' A' ' 93' ' ' SER . 11.2 tm-20 -58.81 -42.71 89.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.259 -0.901 . . . . 0.0 109.488 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.553 ' HA ' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -43.76 -30.77 0.69 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 0.0 109.457 179.987 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.757 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -55.64 -54.6 42.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 109.469 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -51.06 -47.17 61.85 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.281 -0.887 . . . . 0.0 109.502 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.553 HD12 ' HA ' ' A' ' 93' ' ' SER . 0.7 OUTLIER -49.37 -58.36 5.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.212 -0.93 . . . . 0.0 109.488 179.946 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 169.62 64.89 0.04 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.757 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -134.78 118.58 17.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.257 -1.143 . . . . 0.0 109.485 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.792 HD11 ' HB3' ' A' ' 77' ' ' ARG . 0.5 OUTLIER -71.11 -71.16 0.27 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.188 -0.945 . . . . 0.0 109.426 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.463 HG23 HG23 ' A' ' 79' ' ' ILE . 14.5 t -122.24 173.16 7.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.247 -0.908 . . . . 0.0 109.453 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 1.077 ' NE2' HG22 ' A' ' 82' ' ' THR . 5.4 t-160 -139.88 90.89 2.42 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.224 -0.923 . . . . 0.0 109.582 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.848 ' CE2' HD13 ' A' ' 111' ' ' ILE . 38.2 m-85 -73.21 -168.31 0.5 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.303 -0.873 . . . . 0.0 109.42 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.589 ' HB2' ' O ' ' A' ' 82' ' ' THR . . . -168.94 -147.39 0.07 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.224 -0.923 . . . . 0.0 109.294 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 7.6 ptmt -137.2 135.87 20.14 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.139 -0.976 . . . . 0.0 109.4 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.86 138.61 52.7 Favored 'Cis proline' 0 C--N 1.31 -1.459 0 C-N-CA 123.437 -1.485 . . . . 0.0 110.281 0.009 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.448 ' HB3' ' O ' ' A' ' 103' ' ' ALA . 26.9 p90 -99.43 172.45 7.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.28 -0.888 . . . . 0.0 109.656 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -114.81 111.96 22.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.271 -0.893 . . . . 0.0 109.348 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.445 HD13 ' HA ' ' A' ' 108' ' ' ILE . 10.7 mm -54.74 -18.76 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 109.38 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -72.96 -46.98 49.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 109.167 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -67.0 -33.73 76.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.302 -0.874 . . . . 0.0 109.215 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.848 HD13 ' CE2' ' A' ' 102' ' ' PHE . 16.7 mm -71.45 -35.19 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.322 -0.861 . . . . 0.0 109.116 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.532 ' CG ' ' CG1' ' A' ' 22' ' ' VAL . 5.3 mtp85 -63.69 -50.58 68.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.334 -0.854 . . . . 0.0 109.513 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 114' ' ' ALA . 61.8 m-20 -67.15 -62.54 1.38 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.223 -0.923 . . . . 0.0 109.766 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.56 ' O ' ' CD2' ' A' ' 118' ' ' TYR . . . -43.82 -39.77 4.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.113 -0.992 . . . . 0.0 109.684 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.759 HG21 ' CZ ' ' A' ' 23' ' ' PHE . 41.2 t -66.6 -42.97 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.909 . . . . 0.0 109.614 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 4.2 mtpp -61.81 -59.41 5.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 0.0 109.558 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -47.18 -56.31 6.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.197 -0.939 . . . . 0.0 109.566 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.56 ' CD2' ' O ' ' A' ' 114' ' ' ALA . 17.8 m-30 -51.96 -72.2 0.06 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.284 -0.885 . . . . 0.0 109.524 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.725 HD23 ' CE1' ' A' ' 28' ' ' TYR . 1.9 tp -90.19 112.49 52.86 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.324 -0.86 . . . . 0.0 109.534 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 118' ' ' TYR . 35.7 Cg_endo -78.16 152.94 27.96 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.318 2.012 . . . . 0.0 110.408 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.633 HD12 ' OH ' ' A' ' 28' ' ' TYR . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 109.439 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.612 ' HG3' HD11 ' A' ' 121' ' ' LEU . 16.8 mm-40 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.47 ' O ' HG12 ' A' ' 6' ' ' ILE . 1.2 mtmp? -138.15 144.11 40.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.256 -0.902 . . . . 0.0 109.442 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.86 HD12 HG22 ' A' ' 30' ' ' THR . 3.5 mt -150.04 159.4 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.194 -0.941 . . . . 0.0 109.516 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.914 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.7 OUTLIER -131.18 128.14 39.39 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.333 -0.854 . . . . 0.0 109.492 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.914 ' N ' HD13 ' A' ' 7' ' ' LEU . 7.7 mt -109.68 106.81 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.287 -0.883 . . . . 0.0 109.494 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.666 HG12 ' HA ' ' A' ' 34' ' ' ALA . 2.6 t -104.46 89.01 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.32 -0.862 . . . . 0.0 109.473 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.54 ' CB ' ' HD2' ' A' ' 16' ' ' ARG . 2.2 t70 -87.51 -155.98 0.32 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.202 -0.936 . . . . 0.0 109.392 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.512 ' CB ' ' HA ' ' A' ' 57' ' ' ILE . 0.7 OUTLIER -109.6 -45.52 3.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.91 . . . . 0.0 109.564 -179.977 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.501 ' HG2' ' N ' ' A' ' 13' ' ' TYR . 45.8 tt0 -132.52 -90.13 0.41 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.17 -0.956 . . . . 0.0 109.482 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 1.147 ' CE2' HD11 ' A' ' 17' ' ' ILE . 2.8 t80 -149.83 167.92 25.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.302 -0.874 . . . . 0.0 109.489 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.01 -66.75 0.24 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.528 HD13 ' OD1' ' A' ' 10' ' ' ASP . 9.8 mt -68.04 -28.01 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.254 -1.145 . . . . 0.0 109.48 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.54 ' HD2' ' CB ' ' A' ' 10' ' ' ASP . 0.3 OUTLIER -66.51 -25.87 66.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.302 -0.874 . . . . 0.0 109.444 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 1.147 HD11 ' CE2' ' A' ' 13' ' ' TYR . 4.5 mt -90.04 -51.85 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.221 -0.925 . . . . 0.0 109.533 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.785 ' O ' HG23 ' A' ' 22' ' ' VAL . 4.8 mp -59.29 -58.04 10.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.241 -0.912 . . . . 0.0 109.554 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.728 ' HB3' HD13 ' A' ' 8' ' ' ILE . 1.9 tp -56.6 -22.54 34.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.891 . . . . 0.0 109.464 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 28.1 t30 -74.87 -72.77 0.27 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.244 -0.91 . . . . 0.0 109.528 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.427 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 17.4 tt0 -44.12 -35.52 2.21 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -0.895 . . . . 0.0 109.488 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.785 HG23 ' O ' ' A' ' 18' ' ' LEU . 58.3 t -62.84 -56.99 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.903 . . . . 0.0 109.461 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.545 ' CB ' HG21 ' A' ' 30' ' ' THR . 18.8 m-85 -73.28 -2.49 22.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.342 -0.849 . . . . 0.0 109.618 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.427 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 4.6 m-20 -85.65 -55.14 4.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.145 -0.972 . . . . 0.0 109.45 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.8 mttt -69.54 -19.81 63.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.311 -0.868 . . . . 0.0 109.457 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.487 ' HB3' ' CD2' ' A' ' 28' ' ' TYR . 1.4 tt0 -78.55 -30.97 47.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.258 -0.901 . . . . 0.0 109.45 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.443 ' O ' ' CG ' ' A' ' 28' ' ' TYR . . . 110.07 64.48 0.53 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.487 ' CD2' ' HB3' ' A' ' 26' ' ' GLU . 93.7 m-85 -154.76 134.73 13.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.225 -1.162 . . . . 0.0 109.503 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 22.5 mm-40 -91.67 81.8 5.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.286 -0.884 . . . . 0.0 109.409 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.86 HG22 HD12 ' A' ' 6' ' ' ILE . 5.9 p -89.88 152.58 21.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.275 -0.89 . . . . 0.0 109.56 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.837 ' HB2' HD22 ' A' ' 7' ' ' LEU . 58.8 m-85 -116.48 -170.23 1.78 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.301 -0.875 . . . . 0.0 109.402 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.427 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 22.1 mp0 -124.17 161.26 26.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.241 -0.912 . . . . 0.0 109.547 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.463 ' HB3' HG22 ' A' ' 9' ' ' VAL . . . 178.49 177.52 0.44 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 109.437 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.666 ' HA ' HG12 ' A' ' 9' ' ' VAL . . . 178.73 -41.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.217 -0.927 . . . . 0.0 109.466 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.41 ' OD1' ' CB ' ' A' ' 38' ' ' GLN . 30.9 p-10 -65.18 -10.58 32.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.923 . . . . 0.0 109.459 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.416 ' O ' ' C ' ' A' ' 37' ' ' LEU . . . 87.9 -71.42 2.58 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 40' ' ' LEU . 1.9 tt -44.46 -42.21 6.89 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -1.147 . . . . 0.0 109.395 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.471 ' HA ' ' OD2' ' A' ' 41' ' ' ASP . 44.5 tp60 -58.72 -53.87 53.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.264 -0.898 . . . . 0.0 109.504 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.597 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -55.69 -24.16 32.81 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.15 -0.969 . . . . 0.0 109.493 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 37' ' ' LEU . 54.9 mt -73.06 -45.46 57.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.91 . . . . 0.0 109.517 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 42' ' ' ILE . 1.7 p30 -64.81 -43.02 94.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.182 -0.949 . . . . 0.0 109.449 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.644 HG21 HD23 ' A' ' 7' ' ' LEU . 7.2 mt -64.23 -34.77 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.21 -0.931 . . . . 0.0 109.268 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 39' ' ' ALA . 54.2 t -74.32 -24.03 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.891 . . . . 0.0 109.453 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.2 m -89.7 -18.72 25.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.228 -0.92 . . . . 0.0 109.532 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.95 -55.65 3.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.285 -0.884 . . . . 0.0 109.483 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.438 ' O ' ' CB ' ' A' ' 47' ' ' ARG . 1.1 mt-10 -89.98 -39.04 13.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.268 -0.895 . . . . 0.0 109.458 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER 71.28 65.91 0.39 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.23 -0.919 . . . . 0.0 109.498 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.531 ' CD ' ' HA ' ' A' ' 43' ' ' VAL . 35.5 Cg_endo -78.14 167.99 22.52 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.589 2.192 . . . . 0.0 110.421 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.559 ' C ' HD22 ' A' ' 50' ' ' LEU . 29.0 t70 -109.43 -9.91 14.92 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.218 -0.926 . . . . 0.0 109.533 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.559 HD22 ' C ' ' A' ' 49' ' ' ASP . 3.8 mm? -117.84 121.51 40.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -0.937 . . . . 0.0 109.543 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.488 HG11 ' CE ' ' A' ' 69' ' ' MET . 72.9 t -127.33 140.93 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.257 -0.902 . . . . 0.0 109.471 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.648 HD12 ' O ' ' A' ' 7' ' ' LEU . 1.1 mp -115.27 112.17 22.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.309 -0.87 . . . . 0.0 109.423 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.632 HD22 ' CD2' ' A' ' 66' ' ' LEU . 1.7 mp -102.59 132.02 48.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.282 -0.886 . . . . 0.0 109.517 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.451 ' O ' HG13 ' A' ' 57' ' ' ILE . 17.7 t70 -112.76 130.14 56.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.319 -0.863 . . . . 0.0 109.453 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.729 ' HB2' HG21 ' A' ' 82' ' ' THR . 9.6 mmt -86.84 -6.98 58.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.322 -0.861 . . . . 0.0 109.555 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt -86.58 15.02 5.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.166 -0.959 . . . . 0.0 109.498 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.512 ' HA ' ' CB ' ' A' ' 11' ' ' ASP . 41.7 mt -80.97 138.78 49.57 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.128 -0.983 . . . . 0.0 109.309 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.493 ' HD3' ' HB2' ' A' ' 11' ' ' ASP . 36.2 Cg_endo -78.54 -36.15 0.96 Allowed 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.488 2.126 . . . . 0.0 110.549 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 58' ' ' PRO . . . -42.41 -53.79 4.91 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.502 ' N ' ' SD ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -169.47 -150.3 0.08 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.136 -1.214 . . . . 0.0 109.558 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.497 ' N ' ' HG2' ' A' ' 60' ' ' MET . 36.9 m-20 -90.19 -97.28 0.11 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.291 -0.881 . . . . 0.0 109.481 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.459 ' HA2' HG13 ' A' ' 65' ' ' ILE . . . 147.42 -14.76 1.44 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.466 HD13 ' HA ' ' A' ' 63' ' ' ILE . 14.4 mm -57.0 -18.72 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.314 -1.109 . . . . 0.0 109.238 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -87.47 -33.52 18.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.313 -0.867 . . . . 0.0 109.24 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.515 ' HB ' HD21 ' A' ' 53' ' ' LEU . 17.2 mt -56.15 -54.58 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.338 -0.851 . . . . 0.0 109.319 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.925 HD21 HG11 ' A' ' 78' ' ' VAL . 23.0 mt -51.02 -44.49 61.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 109.31 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.559 ' O ' HG23 ' A' ' 71' ' ' VAL . 3.2 tttp -52.38 -50.32 62.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.326 -0.859 . . . . 0.0 109.411 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.492 ' O ' HD12 ' A' ' 72' ' ' ILE . 0.3 OUTLIER -59.28 -31.5 69.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.286 -0.884 . . . . 0.0 109.431 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.488 ' CE ' HG11 ' A' ' 51' ' ' VAL . 2.7 mtt -74.47 -24.92 59.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.278 -0.889 . . . . 0.0 109.435 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -79.95 -28.93 39.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.379 -0.826 . . . . 0.0 109.264 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 67' ' ' LYS . 2.7 t -90.08 -22.04 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.306 -0.871 . . . . 0.0 109.549 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.492 HD12 ' O ' ' A' ' 68' ' ' ARG . 53.3 mt -87.43 -44.56 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -0.909 . . . . 0.0 109.459 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.507 ' O ' HG22 ' A' ' 76' ' ' ILE . 73.0 m-20 -150.49 122.69 8.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.331 -0.856 . . . . 0.0 109.404 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -81.99 -9.62 59.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.277 -0.889 . . . . 0.0 109.522 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -103.37 49.87 0.82 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.233 -0.917 . . . . 0.0 109.493 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.601 ' O ' HG23 ' A' ' 76' ' ' ILE . 1.1 tp -129.94 112.62 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.466 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.518 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 1.6 mtt180 -79.85 154.19 28.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 0.0 109.468 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.925 HG11 HD21 ' A' ' 66' ' ' LEU . 4.8 t -150.02 108.44 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.913 . . . . 0.0 109.572 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.692 HG23 HG23 ' A' ' 100' ' ' THR . 72.5 mt -90.5 140.81 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.247 -0.908 . . . . 0.0 109.449 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.898 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.0 OUTLIER -94.44 152.32 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.271 -0.893 . . . . 0.0 109.198 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.459 ' O ' ' HB ' ' A' ' 82' ' ' THR . 14.0 mtm -124.53 73.16 1.24 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.183 -0.948 . . . . 0.0 109.373 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.729 HG21 ' HB2' ' A' ' 55' ' ' MET . 9.6 t 177.29 56.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.31 -0.869 . . . . 0.0 109.397 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.88 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.281 -0.887 . . . . 0.0 109.528 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 1.068 HD12 ' CE1' ' A' ' 101' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.795 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -51.35 -37.15 46.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.255 -0.903 . . . . 0.0 109.5 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 93' ' ' SER . 1.4 mt-10 -90.15 -36.28 14.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.226 -0.921 . . . . 0.0 109.625 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.469 ' HB2' ' HA ' ' A' ' 90' ' ' ILE . 0.4 OUTLIER -43.55 -44.92 6.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.312 -0.868 . . . . 0.0 109.649 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.928 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 2.5 ttpt -44.02 -51.79 7.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.282 -0.886 . . . . 0.0 109.445 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -59.5 -40.99 88.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 0.0 109.431 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.562 HD22 ' N ' ' A' ' 96' ' ' LEU . 4.2 mm? -53.31 -64.99 0.64 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.296 -0.878 . . . . 0.0 109.49 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -176.08 40.98 0.11 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.928 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -110.77 101.33 9.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -1.164 . . . . 0.0 109.49 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.518 ' CD1' ' HB3' ' A' ' 77' ' ' ARG . 18.6 mt -44.1 -68.32 0.21 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 109.47 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.692 HG23 HG23 ' A' ' 79' ' ' ILE . 15.1 t -134.9 -177.6 4.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.284 -0.885 . . . . 0.0 109.437 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 1.068 ' CE1' HD12 ' A' ' 90' ' ' ILE . 3.2 t-160 -140.48 88.35 2.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 109.339 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.717 ' CE1' HD13 ' A' ' 111' ' ' ILE . 65.5 m-85 -58.99 -164.35 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.236 -0.915 . . . . 0.0 109.579 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.88 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -177.27 155.31 1.12 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.199 -0.938 . . . . 0.0 109.361 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.519 ' HA ' ' N ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -93.41 142.14 24.84 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.211 -0.931 . . . . 0.0 109.387 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.91 117.1 4.9 Favored 'Cis proline' 0 C--N 1.31 -1.479 0 C-N-CA 123.335 -1.527 . . . . 0.0 110.353 -0.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.519 ' N ' ' HA ' ' A' ' 104' ' ' LYS . 11.1 p90 -79.84 169.6 17.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.248 -0.908 . . . . 0.0 109.574 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.472 ' O ' HG12 ' A' ' 111' ' ' ILE . 36.0 t0 -119.77 121.73 39.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.347 -0.846 . . . . 0.0 109.473 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.463 HG23 HG11 ' A' ' 22' ' ' VAL . 14.5 mm -54.63 -21.28 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -0.897 . . . . 0.0 109.509 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -76.24 -37.52 57.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.235 -0.916 . . . . 0.0 109.518 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -77.57 -25.31 49.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.184 -0.947 . . . . 0.0 109.436 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.717 HD13 ' CE1' ' A' ' 102' ' ' PHE . 19.2 mm -75.73 -45.85 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.313 -0.867 . . . . 0.0 109.516 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.467 ' HB2' ' OE1' ' A' ' 26' ' ' GLU . 7.6 ptt85 -72.51 -41.88 65.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.472 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -61.16 -53.43 57.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.928 . . . . 0.0 109.538 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.486 ' O ' ' HG2' ' A' ' 117' ' ' LYS . . . -59.18 -45.06 92.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.292 -0.88 . . . . 0.0 109.47 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 111' ' ' ILE . 54.7 t -60.48 -25.19 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.191 -0.943 . . . . 0.0 109.396 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -76.89 -45.66 27.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.179 -0.95 . . . . 0.0 109.451 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.524 ' HG3' ' N ' ' A' ' 118' ' ' TYR . 0.0 OUTLIER -63.49 -27.08 69.03 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 109.481 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.524 ' N ' ' HG3' ' A' ' 117' ' ' LYS . 38.9 m-85 -84.51 -72.84 0.45 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.24 -0.912 . . . . 0.0 109.423 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.8 tp -90.06 112.58 53.18 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.341 -0.849 . . . . 0.0 109.422 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 118' ' ' TYR . 35.6 Cg_endo -77.79 132.76 12.15 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.33 2.02 . . . . 0.0 110.418 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.612 HD11 ' HG3' ' A' ' 4' ' ' GLU . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.327 -0.858 . . . . 0.0 109.47 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.567 ' OE1' ' CD2' ' A' ' 28' ' ' TYR . 1.6 mm-40 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.495 ' HB2' ' HA ' ' A' ' 48' ' ' PRO . 42.3 mttt -121.96 120.52 34.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -0.916 . . . . 0.0 109.485 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.475 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 49.1 mt -148.51 150.93 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.157 -0.964 . . . . 0.0 109.483 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.633 HD11 HD13 ' A' ' 42' ' ' ILE . 0.6 OUTLIER -133.56 127.83 33.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.183 -0.948 . . . . 0.0 109.432 -179.999 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.403 HD13 ' CB ' ' A' ' 19' ' ' LEU . 8.4 mt -101.02 109.54 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.244 -0.91 . . . . 0.0 109.522 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.651 HG12 HD11 ' A' ' 57' ' ' ILE . 17.0 t -96.27 91.33 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.23 -0.919 . . . . 0.0 109.427 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.518 ' O ' ' CD ' ' A' ' 16' ' ' ARG . 16.7 t70 -145.27 146.01 31.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.264 -0.898 . . . . 0.0 109.45 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.477 ' OD2' ' HD2' ' A' ' 58' ' ' PRO . 9.1 p-10 -109.88 -37.75 5.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.185 -0.947 . . . . 0.0 109.501 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.414 ' O ' ' C ' ' A' ' 13' ' ' TYR . 1.8 tp60 -63.01 104.84 0.6 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.232 -0.918 . . . . 0.0 109.448 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.583 ' CZ ' HG13 ' A' ' 17' ' ' ILE . 9.2 t80 -44.73 132.3 6.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.243 -0.911 . . . . 0.0 109.447 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 18' ' ' LEU . . . 138.72 -47.11 0.94 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 1.021 HG23 HD13 ' A' ' 19' ' ' LEU . 4.5 mt -82.85 -43.62 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.174 -1.192 . . . . 0.0 109.491 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.518 ' CD ' ' O ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -63.0 -24.05 67.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.89 . . . . 0.0 109.505 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.583 HG13 ' CZ ' ' A' ' 13' ' ' TYR . 5.3 mm -90.1 -55.41 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.212 -0.93 . . . . 0.0 109.598 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.591 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.3 OUTLIER -56.61 -58.57 7.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 109.573 -179.853 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 1.021 HD13 HG23 ' A' ' 15' ' ' ILE . 5.0 mp -57.86 -21.23 41.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.905 . . . . 0.0 109.552 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 12.7 t30 -74.16 -71.11 0.35 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.316 -0.865 . . . . 0.0 109.469 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.451 ' N ' ' OE1' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -45.57 -44.18 12.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 0.0 109.522 -179.897 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.902 HG21 HD12 ' A' ' 108' ' ' ILE . 48.2 t -58.93 -53.18 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.218 -0.926 . . . . 0.0 109.431 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.771 ' HZ ' HG22 ' A' ' 111' ' ' ILE . 21.8 m-85 -78.13 2.33 18.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.372 -0.83 . . . . 0.0 109.622 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.444 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 3.6 m-20 -90.02 -50.32 6.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.139 -0.975 . . . . 0.0 109.532 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.5 tttp -79.57 -44.68 20.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.178 -0.951 . . . . 0.0 109.49 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.534 ' HB3' ' CD1' ' A' ' 28' ' ' TYR . 0.9 OUTLIER -49.09 -34.29 13.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 109.453 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.526 ' C ' ' CD1' ' A' ' 28' ' ' TYR . . . 110.26 66.26 0.55 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.751 ' CE2' HD21 ' A' ' 121' ' ' LEU . 70.1 m-85 -148.64 135.62 20.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.333 -1.099 . . . . 0.0 109.5 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.465 ' HG2' ' HB2' ' A' ' 4' ' ' GLU . 5.6 mm100 -92.39 83.02 4.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.306 -0.871 . . . . 0.0 109.266 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.671 HG21 ' CB ' ' A' ' 23' ' ' PHE . 5.7 p -89.98 158.63 17.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.914 . . . . 0.0 109.571 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.577 ' HB2' HD12 ' A' ' 7' ' ' LEU . 8.8 m-85 -118.18 -163.56 0.95 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.289 -0.882 . . . . 0.0 109.465 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -144.52 147.89 33.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.166 -0.959 . . . . 0.0 109.519 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -168.36 -176.24 2.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.903 . . . . 0.0 109.417 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.464 ' O ' ' HE1' ' A' ' 60' ' ' MET . . . 177.98 -31.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.214 -0.929 . . . . 0.0 109.498 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -76.42 -8.06 56.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.259 -0.9 . . . . 0.0 109.514 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.13 -47.44 3.77 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.463 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -59.16 -43.26 92.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -1.113 . . . . 0.0 109.435 -179.983 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 1.062 ' O ' HD12 ' A' ' 42' ' ' ILE . 11.6 mm100 -69.1 -24.31 64.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.324 -0.86 . . . . 0.0 109.436 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.669 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -70.98 -57.85 4.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -0.882 . . . . 0.0 109.515 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.427 HD22 ' HB3' ' A' ' 68' ' ' ARG . 12.7 mt -64.02 -31.41 72.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.188 -0.945 . . . . 0.0 109.531 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 37' ' ' LEU . 3.9 t0 -64.87 -49.88 68.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.27 -0.894 . . . . 0.0 109.459 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 1.062 HD12 ' O ' ' A' ' 38' ' ' GLN . 3.6 mt -70.21 -20.17 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.25 -0.906 . . . . 0.0 109.477 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 39' ' ' ALA . 55.5 t -77.67 -34.33 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.911 . . . . 0.0 109.489 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.3 m -90.02 -16.03 30.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.182 -0.949 . . . . 0.0 109.483 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.27 -51.44 5.76 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.252 -0.905 . . . . 0.0 109.552 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.478 ' HG3' HG23 ' A' ' 42' ' ' ILE . 0.9 OUTLIER -92.88 -26.03 17.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.236 -0.915 . . . . 0.0 109.518 -179.925 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.492 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 12.8 mtm180 61.02 63.16 2.6 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.254 -0.903 . . . . 0.0 109.452 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.594 ' O ' HD12 ' A' ' 76' ' ' ILE . 35.2 Cg_endo -77.81 -178.32 4.52 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.594 2.196 . . . . 0.0 110.388 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.862 ' O ' HD22 ' A' ' 50' ' ' LEU . 55.5 m-20 -128.06 -2.76 5.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.302 -0.874 . . . . 0.0 109.673 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.862 HD22 ' O ' ' A' ' 49' ' ' ASP . 3.8 mm? -131.49 106.06 7.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.176 -0.952 . . . . 0.0 109.502 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.853 HG11 ' CE ' ' A' ' 69' ' ' MET . 1.5 t -115.88 121.41 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.9 . . . . 0.0 109.45 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.468 ' HB3' ' CE ' ' A' ' 81' ' ' MET . 1.1 mp -94.99 110.53 22.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.262 -0.899 . . . . 0.0 109.437 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.814 HD23 ' CG1' ' A' ' 78' ' ' VAL . 2.9 mm? -104.41 133.11 49.84 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.189 -0.944 . . . . 0.0 109.547 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -118.0 129.35 55.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.908 . . . . 0.0 109.488 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.624 ' HB2' HG21 ' A' ' 82' ' ' THR . 27.7 mmt -78.75 3.35 16.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 109.562 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.434 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 2.0 mmmm -78.16 -28.19 48.23 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.149 -0.969 . . . . 0.0 109.424 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.839 HG21 ' CE ' ' A' ' 60' ' ' MET . 44.3 mt -43.06 103.15 0.3 Allowed Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.392 -0.818 . . . . 0.0 109.552 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.477 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 35.3 Cg_endo -77.76 71.74 6.41 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.497 2.131 . . . . 0.0 110.387 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -164.4 -47.67 0.02 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.839 ' CE ' HG21 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -153.21 135.09 14.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.262 -1.14 . . . . 0.0 109.454 179.897 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -56.65 136.47 54.78 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.205 -0.934 . . . . 0.0 109.482 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.452 ' HA2' HG13 ' A' ' 65' ' ' ILE . . . -83.69 9.69 61.67 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.442 HD13 ' HA ' ' A' ' 63' ' ' ILE . 38.7 mm -67.62 -45.05 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.191 -1.182 . . . . 0.0 109.475 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -66.83 -25.48 66.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.235 -0.915 . . . . 0.0 109.449 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.452 HG13 ' HA2' ' A' ' 62' ' ' GLY . 7.2 mt -69.81 -68.24 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.34 -0.85 . . . . 0.0 109.434 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 1.045 HD21 HG11 ' A' ' 78' ' ' VAL . 3.1 mt -50.35 -39.37 46.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.267 -0.896 . . . . 0.0 109.528 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.505 ' O ' HG23 ' A' ' 71' ' ' VAL . 1.7 ttpp -60.68 -39.41 88.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -0.876 . . . . 0.0 109.505 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.427 ' HB3' HD22 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -68.25 -58.28 4.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.234 -0.916 . . . . 0.0 109.515 -179.894 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.853 ' CE ' HG11 ' A' ' 51' ' ' VAL . 2.2 ptp -60.71 -13.72 16.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.267 -0.896 . . . . 0.0 109.548 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 66' ' ' LEU . 0.6 OUTLIER -89.72 -31.58 17.39 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.836 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 67' ' ' LYS . 52.8 t -75.09 -28.97 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 109.195 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.5 mt -90.05 -44.52 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.363 -0.836 . . . . 0.0 109.419 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.758 ' O ' HG22 ' A' ' 76' ' ' ILE . 15.0 t0 -132.05 116.78 17.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.16 -0.962 . . . . 0.0 109.427 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.01 -40.45 12.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.248 -0.908 . . . . 0.0 109.544 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -61.23 -13.87 21.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.281 -0.887 . . . . 0.0 109.46 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.758 HG22 ' O ' ' A' ' 73' ' ' ASP . 1.0 OUTLIER -60.51 112.03 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.2 -0.937 . . . . 0.0 109.525 179.922 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.485 ' CB ' HD11 ' A' ' 99' ' ' LEU . 5.0 mtt85 -71.19 142.43 50.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.213 -0.929 . . . . 0.0 109.436 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 1.045 HG11 HD21 ' A' ' 66' ' ' LEU . 15.9 t -145.05 150.58 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.237 -0.915 . . . . 0.0 109.631 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.667 HG23 ' O ' ' A' ' 100' ' ' THR . 11.1 mt -134.19 141.33 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.266 -0.896 . . . . 0.0 109.433 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.885 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.1 OUTLIER -96.74 141.77 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.172 -0.955 . . . . 0.0 109.206 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.468 ' CE ' ' HB3' ' A' ' 52' ' ' LEU . 2.8 mtm -113.88 59.85 0.67 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.145 -0.972 . . . . 0.0 109.508 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.624 HG21 ' HB2' ' A' ' 55' ' ' MET . 14.2 t -172.43 43.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.176 -0.952 . . . . 0.0 109.521 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.732 ' N ' ' HB2' ' A' ' 103' ' ' ALA . . . . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.266 -0.896 . . . . 0.0 109.526 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.656 HD12 ' CE1' ' A' ' 101' ' ' HIS . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.714 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.78 -38.26 15.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.315 -0.865 . . . . 0.0 109.573 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -90.02 -40.73 12.13 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.227 -0.92 . . . . 0.0 109.619 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.534 ' O ' ' CA ' ' A' ' 97' ' ' GLY . 9.9 m -58.73 -15.22 11.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.202 -0.936 . . . . 0.0 109.644 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.872 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 1.7 ttpt -88.89 -45.86 9.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.155 -0.966 . . . . 0.0 109.506 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.993 ' C ' HD22 ' A' ' 96' ' ' LEU . 10.0 mm-40 -47.62 -44.24 26.52 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.515 -0.741 . . . . 0.0 110.542 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.993 HD22 ' C ' ' A' ' 95' ' ' GLU . 3.3 mm? -132.38 5.51 4.07 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.93 -1.106 . . . . 0.0 110.704 -179.048 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.534 ' CA ' ' O ' ' A' ' 93' ' ' SER . . . -124.39 -14.19 3.68 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.473 -1.346 . . . . 0.0 109.99 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.872 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -149.84 98.03 2.68 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.166 -1.196 . . . . 0.0 109.615 -179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.485 HD11 ' CB ' ' A' ' 77' ' ' ARG . 0.7 OUTLIER -48.79 -61.1 2.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.235 -0.915 . . . . 0.0 109.478 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.667 ' O ' HG23 ' A' ' 79' ' ' ILE . 16.7 m -113.53 157.68 21.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 109.476 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.885 ' ND1' HD12 ' A' ' 80' ' ' ILE . 3.4 t-160 -135.52 85.5 2.17 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.325 -0.859 . . . . 0.0 109.331 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.54 ' CE1' ' HG2' ' A' ' 110' ' ' GLU . 11.7 m-85 -73.13 158.27 35.62 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.198 -0.939 . . . . 0.0 109.575 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.732 ' HB2' ' N ' ' A' ' 83' ' ' ALA . . . -144.61 151.99 39.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.348 -0.845 . . . . 0.0 109.424 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 103' ' ' ALA . 0.6 OUTLIER -45.1 137.04 4.84 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.235 -0.916 . . . . 0.0 109.304 -179.937 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' A' ' 103' ' ' ALA . 35.7 Cg_endo -77.78 -172.6 11.47 Favored 'Cis proline' 0 C--N 1.312 -1.363 0 C-N-CA 123.365 -1.514 . . . . 0.0 110.403 -0.03 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.759 ' HE2' HD21 ' A' ' 19' ' ' LEU . 0.4 OUTLIER -118.66 111.52 18.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.212 -0.93 . . . . 0.0 109.492 -179.96 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.468 ' O ' HG12 ' A' ' 111' ' ' ILE . 22.1 t0 -89.94 105.79 18.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.262 -0.899 . . . . 0.0 109.36 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.902 HD12 HG21 ' A' ' 22' ' ' VAL . 13.7 mm -45.92 -24.63 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.226 -0.921 . . . . 0.0 109.772 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.431 ' O ' ' HG2' ' A' ' 112' ' ' ARG . 9.6 m-20 -69.75 -47.55 62.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.904 . . . . 0.0 109.542 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.54 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 0.9 OUTLIER -69.19 -30.23 68.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -0.901 . . . . 0.0 109.475 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.771 HG22 ' HZ ' ' A' ' 23' ' ' PHE . 14.7 mm -68.01 -46.31 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.234 -0.916 . . . . 0.0 109.399 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.472 ' O ' ' HG3' ' A' ' 116' ' ' LYS . 3.2 ptt180 -74.06 -20.76 60.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.354 -0.841 . . . . 0.0 109.572 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -73.54 -51.38 17.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.157 -0.965 . . . . 0.0 109.495 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.544 ' O ' ' CD2' ' A' ' 118' ' ' TYR . . . -70.06 -31.63 69.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 109.535 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.569 HG21 ' CZ ' ' A' ' 23' ' ' PHE . 72.4 t -74.95 -31.45 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -0.923 . . . . 0.0 109.57 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 0.1 OUTLIER -74.55 -42.55 58.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.21 -0.931 . . . . 0.0 109.583 179.957 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.454 ' HE2' ' HA ' ' A' ' 117' ' ' LYS . 0.0 OUTLIER -64.15 -50.42 68.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.921 . . . . 0.0 109.519 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.544 ' CD2' ' O ' ' A' ' 114' ' ' ALA . 14.8 m-85 -65.62 -63.71 1.03 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.207 -0.933 . . . . 0.0 109.486 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.52 HD21 ' OE2' ' A' ' 4' ' ' GLU . 2.9 tt -87.91 113.2 53.62 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.161 -0.962 . . . . 0.0 109.405 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 118' ' ' TYR . 35.7 Cg_endo -77.87 139.93 17.92 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.353 2.035 . . . . 0.0 110.401 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.751 HD21 ' CE2' ' A' ' 28' ' ' TYR . 2.8 mm? . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.251 -0.906 . . . . 0.0 109.51 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.434 ' O ' ' CB ' ' A' ' 2' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.434 ' CB ' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER 169.07 37.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.224 -0.923 . . . . 0.0 109.45 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.403 ' CG ' ' O ' ' A' ' 2' ' ' MET . 4.2 m120 -170.5 164.4 8.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.24 -0.913 . . . . 0.0 109.549 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.665 ' HB3' HD21 ' A' ' 121' ' ' LEU . 0.1 OUTLIER -166.15 68.68 0.12 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.144 -0.972 . . . . 0.0 109.489 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.52 ' O ' ' CB ' ' A' ' 48' ' ' PRO . 0.4 OUTLIER -103.69 118.12 35.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.201 -0.937 . . . . 0.0 109.502 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.707 ' HB ' HG22 ' A' ' 30' ' ' THR . 13.8 mt -116.31 153.16 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.174 -0.954 . . . . 0.0 109.422 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.847 HD23 HG21 ' A' ' 42' ' ' ILE . 1.9 tm? -131.42 110.83 11.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.195 -0.94 . . . . 0.0 109.516 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.89 HG22 ' NH1' ' A' ' 16' ' ' ARG . 3.4 mt -90.07 108.11 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -0.879 . . . . 0.0 109.324 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.748 HG22 HD12 ' A' ' 7' ' ' LEU . 2.8 t -98.36 117.42 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.221 -0.924 . . . . 0.0 109.654 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.585 ' CB ' ' CZ ' ' A' ' 16' ' ' ARG . 24.9 t0 -175.17 154.94 1.85 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.337 -0.852 . . . . 0.0 109.421 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.463 ' CG ' ' HD2' ' A' ' 58' ' ' PRO . 5.3 p-10 -105.95 -46.12 4.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.165 -0.96 . . . . 0.0 109.501 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.46 ' HG2' ' OD2' ' A' ' 10' ' ' ASP . 19.1 pt20 -50.04 127.51 16.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.241 -0.912 . . . . 0.0 109.527 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.911 ' CE2' HD11 ' A' ' 17' ' ' ILE . 8.2 t80 -80.86 157.95 25.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.257 -0.902 . . . . 0.0 109.645 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 116.31 -69.32 0.28 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.568 ' CG2' ' NH2' ' A' ' 16' ' ' ARG . 5.8 mt -64.02 -25.43 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.32 -1.106 . . . . 0.0 109.173 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.89 ' NH1' HG22 ' A' ' 8' ' ' ILE . 3.7 mmp_? -65.34 -24.75 67.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.886 . . . . 0.0 109.403 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.911 HD11 ' CE2' ' A' ' 13' ' ' TYR . 6.1 mt -89.95 -24.9 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.343 -0.848 . . . . 0.0 109.387 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.842 ' O ' HG23 ' A' ' 22' ' ' VAL . 49.3 mt -74.24 -50.83 17.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.312 -0.868 . . . . 0.0 109.499 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.734 ' HB2' HD13 ' A' ' 8' ' ' ILE . 7.2 mt -69.16 -20.1 64.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 109.408 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -77.02 -58.95 2.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.26 -0.9 . . . . 0.0 109.491 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.439 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 14.0 mt-10 -59.58 -47.89 83.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.917 . . . . 0.0 109.5 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.842 HG23 ' O ' ' A' ' 18' ' ' LEU . 22.2 t -57.21 -57.32 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.229 -0.92 . . . . 0.0 109.442 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.509 ' CD2' ' O ' ' A' ' 19' ' ' LEU . 24.0 m-85 -71.81 -4.26 26.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.164 -0.96 . . . . 0.0 109.599 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.439 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 1.7 m-20 -82.21 -55.67 4.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -0.899 . . . . 0.0 109.463 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.407 ' O ' ' C ' ' A' ' 26' ' ' GLU . 1.8 mptt -73.87 -46.11 46.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.278 -0.889 . . . . 0.0 109.474 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.575 ' HB3' ' CD1' ' A' ' 28' ' ' TYR . 4.6 tt0 -44.05 -35.26 2.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.16 -0.963 . . . . 0.0 109.476 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.539 ' C ' ' CD1' ' A' ' 28' ' ' TYR . . . 114.57 55.03 0.39 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.577 ' CE2' ' HG ' ' A' ' 121' ' ' LEU . 32.8 m-85 -143.22 135.03 26.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -1.152 . . . . 0.0 109.475 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -94.42 81.04 3.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.27 -0.894 . . . . 0.0 109.387 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.707 HG22 ' HB ' ' A' ' 6' ' ' ILE . 5.9 p -89.97 154.43 19.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.895 . . . . 0.0 109.556 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.562 ' HB2' HD22 ' A' ' 7' ' ' LEU . 6.8 m-85 -118.05 -171.5 2.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.299 -0.876 . . . . 0.0 109.341 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -130.5 146.94 52.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.897 . . . . 0.0 109.505 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -153.94 -172.56 4.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -0.92 . . . . 0.0 109.472 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.78 -88.01 0.1 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.219 -0.926 . . . . 0.0 109.495 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.539 ' ND2' ' HB2' ' A' ' 37' ' ' LEU . 21.5 p-10 -65.98 139.17 58.21 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.271 -0.893 . . . . 0.0 109.474 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.44 ' HA3' ' CD1' ' A' ' 65' ' ' ILE . . . -43.89 -34.53 2.98 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.539 ' HB2' ' ND2' ' A' ' 35' ' ' ASN . 3.2 mp -51.03 -53.15 36.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.195 -1.179 . . . . 0.0 109.44 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.475 ' HB2' ' OD1' ' A' ' 35' ' ' ASN . 1.4 tp-100 -60.93 -51.31 69.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.246 -0.908 . . . . 0.0 109.436 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.847 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -43.82 -39.67 3.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.251 -0.905 . . . . 0.0 109.558 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 65.5 mt -71.95 -42.69 66.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.302 -0.873 . . . . 0.0 109.519 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -53.67 -57.81 9.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.255 -0.903 . . . . 0.0 109.491 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.847 HG21 HD23 ' A' ' 7' ' ' LEU . 2.0 mp -62.1 -33.16 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.145 -0.972 . . . . 0.0 109.478 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 39' ' ' ALA . 48.1 t -66.35 -24.02 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -0.858 . . . . 0.0 109.467 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.4 m -90.07 -30.58 17.61 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.262 -0.899 . . . . 0.0 109.533 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.496 ' HG2' ' HA ' ' A' ' 42' ' ' ILE . 0.0 OUTLIER -90.06 -7.86 52.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.313 -0.867 . . . . 0.0 109.54 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.484 ' HG3' ' CD ' ' A' ' 45' ' ' LYS . 14.8 mt-10 -132.48 -36.75 1.09 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.925 . . . . 0.0 109.47 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 43' ' ' VAL . 0.8 OUTLIER 55.84 65.01 4.76 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.276 -0.89 . . . . 0.0 109.444 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.52 ' CB ' ' O ' ' A' ' 5' ' ' LYS . 35.4 Cg_endo -77.91 154.08 29.6 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.683 2.256 . . . . 0.0 110.394 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 3.5 m-20 -92.64 -13.33 29.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.259 -0.9 . . . . 0.0 109.462 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.471 HD21 HG22 ' A' ' 115' ' ' VAL . 1.0 OUTLIER -120.73 116.87 26.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.213 -0.93 . . . . 0.0 109.46 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.677 ' HB ' HG13 ' A' ' 78' ' ' VAL . 43.6 t -122.0 123.31 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 0.0 109.496 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.88 120.86 40.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.254 -0.903 . . . . 0.0 109.44 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.765 HD21 ' HB ' ' A' ' 65' ' ' ILE . 1.3 mp -108.61 122.21 46.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.256 -0.903 . . . . 0.0 109.506 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.431 ' OD2' ' OD1' ' A' ' 10' ' ' ASP . 33.3 t0 -97.26 111.33 23.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.361 -0.837 . . . . 0.0 109.427 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 18.8 mmt -75.03 -0.64 19.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.917 . . . . 0.0 109.576 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.4 mmmt -90.04 15.45 10.08 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.213 -0.93 . . . . 0.0 109.536 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.454 ' HA ' ' OD1' ' A' ' 11' ' ' ASP . 48.3 mt -76.53 132.45 72.43 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.941 . . . . 0.0 109.339 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.463 ' HD2' ' CG ' ' A' ' 11' ' ' ASP . 36.2 Cg_endo -78.93 74.74 5.39 Favored 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.478 2.119 . . . . 0.0 110.4 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -170.73 -63.94 0.04 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.509 ' N ' ' SD ' ' A' ' 60' ' ' MET . 0.1 OUTLIER -153.49 176.3 12.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -1.172 . . . . 0.0 109.566 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -90.08 135.59 33.56 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.197 -0.94 . . . . 0.0 109.487 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.498 ' HA2' HD12 ' A' ' 65' ' ' ILE . . . -72.43 -8.74 71.87 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.443 ' HA ' HD13 ' A' ' 63' ' ' ILE . 18.8 mm -44.02 -50.24 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.23 -1.159 . . . . 0.0 109.43 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.452 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 20.8 mm-40 -63.89 -43.94 94.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.214 -0.929 . . . . 0.0 109.405 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.765 ' HB ' HD21 ' A' ' 53' ' ' LEU . 78.3 mt -46.96 -50.9 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.315 -0.865 . . . . 0.0 109.444 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.821 ' CD2' HG11 ' A' ' 78' ' ' VAL . 61.8 mt -56.0 -53.51 56.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 109.416 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.81 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.1 OUTLIER -44.13 -38.77 3.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.445 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.452 ' HG2' ' O ' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -71.99 -41.03 68.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.32 -0.863 . . . . 0.0 109.495 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.522 ' CE ' HG11 ' A' ' 51' ' ' VAL . 1.2 mtt -58.52 -62.06 2.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.21 -0.931 . . . . 0.0 109.466 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.485 ' HE2' ' O ' ' A' ' 66' ' ' LEU . 0.3 OUTLIER -52.13 -47.9 65.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.496 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' ' 67' ' ' LYS . 53.9 t -48.43 -39.33 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.196 -0.94 . . . . 0.0 109.473 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 98.2 mt -70.38 -48.63 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 109.425 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.701 ' O ' HG22 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -152.97 111.98 3.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.22 -0.925 . . . . 0.0 109.5 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.54 -15.11 35.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.2 -0.938 . . . . 0.0 109.47 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -91.98 41.22 1.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.311 -0.868 . . . . 0.0 109.476 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.701 HG22 ' O ' ' A' ' 73' ' ' ASP . 2.2 tt -118.08 113.01 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.168 -0.958 . . . . 0.0 109.492 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.638 ' HB3' HD11 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -77.04 112.78 14.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.302 -0.874 . . . . 0.0 109.472 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.821 HG11 ' CD2' ' A' ' 66' ' ' LEU . 85.3 t -122.6 113.02 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.906 . . . . 0.0 109.491 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.619 HD13 ' HE2' ' A' ' 102' ' ' PHE . 69.9 mt -89.93 165.73 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.237 -0.915 . . . . 0.0 109.52 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.697 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.1 OUTLIER -128.74 171.58 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.303 -0.873 . . . . 0.0 109.485 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.481 ' N ' ' CD2' ' A' ' 101' ' ' HIS . 22.5 mtm -146.74 107.73 4.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.877 . . . . 0.0 109.419 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.842 ' CG2' HD11 ' A' ' 90' ' ' ILE . 5.2 t -149.92 -161.85 1.43 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.245 -0.909 . . . . 0.0 109.465 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.5 ' N ' HG23 ' A' ' 82' ' ' THR . . . -43.81 138.13 2.83 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.221 -0.924 . . . . 0.0 109.509 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.599 ' CD2' ' HB3' ' A' ' 103' ' ' ALA . 0.2 OUTLIER -90.06 27.16 1.67 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.2 -0.937 . . . . 0.0 109.49 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.922 ' O ' HD12 ' A' ' 87' ' ' LEU . . . -152.21 -86.21 0.05 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -43.94 98.12 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.216 -1.167 . . . . 0.0 109.478 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.922 HD12 ' O ' ' A' ' 85' ' ' GLY . 4.1 mp -73.16 90.14 1.55 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.353 -0.842 . . . . 0.0 109.459 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.518 ' O ' ' CB ' ' A' ' 89' ' ' MET . 13.8 t70 -98.13 88.19 4.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.233 -0.917 . . . . 0.0 109.433 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.518 ' CB ' ' O ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER 75.62 17.39 2.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.246 -0.909 . . . . 0.0 109.434 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.842 HD11 ' CG2' ' A' ' 82' ' ' THR . 16.8 mt -89.61 -41.25 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.291 -0.881 . . . . 0.0 109.492 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.466 ' O ' ' HG2' ' A' ' 94' ' ' LYS . 1.2 tt0 -63.3 -43.53 97.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.249 -0.907 . . . . 0.0 109.488 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.438 ' O ' HD23 ' A' ' 96' ' ' LEU . 3.9 mt-10 -76.19 -36.72 58.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.263 -0.898 . . . . 0.0 109.441 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 92' ' ' GLU . 13.5 t -44.05 -61.91 1.31 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 109.425 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.767 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 0.1 OUTLIER -51.04 -48.6 61.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.296 -0.878 . . . . 0.0 109.537 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -44.1 -42.96 6.6 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.919 . . . . 0.0 109.424 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.541 HD22 ' N ' ' A' ' 96' ' ' LEU . 3.6 mm? -70.74 -54.06 13.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.212 -0.93 . . . . 0.0 109.512 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 177.27 63.65 0.06 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.767 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -146.94 107.64 4.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -1.153 . . . . 0.0 109.424 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.638 HD11 ' HB3' ' A' ' 77' ' ' ARG . 94.6 mt -44.09 -84.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.24 -0.912 . . . . 0.0 109.418 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.423 ' O ' HG23 ' A' ' 79' ' ' ILE . 11.4 t -127.83 178.74 5.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.462 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.708 ' HD1' HG23 ' A' ' 90' ' ' ILE . 4.8 t-160 -130.65 96.76 4.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.262 -0.899 . . . . 0.0 109.573 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.619 ' HE2' HD13 ' A' ' 79' ' ' ILE . 79.7 m-85 -64.92 -166.79 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.255 -0.903 . . . . 0.0 109.319 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.599 ' HB3' ' CD2' ' A' ' 84' ' ' TYR . . . -161.14 -166.7 1.62 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.258 -0.901 . . . . 0.0 109.386 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.474 ' CG ' ' HA ' ' A' ' 105' ' ' PRO . 11.8 tttm -139.12 141.43 29.71 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.214 -0.929 . . . . 0.0 109.379 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.474 ' HA ' ' CG ' ' A' ' 104' ' ' LYS . 35.9 Cg_endo -77.95 139.88 58.93 Favored 'Cis proline' 0 C--N 1.311 -1.445 0 C-N-CA 123.415 -1.494 . . . . 0.0 110.417 -0.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.42 ' C ' ' CD1' ' A' ' 106' ' ' PHE . 13.2 p90 -106.42 175.93 5.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.872 . . . . 0.0 109.523 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.469 ' O ' HG12 ' A' ' 111' ' ' ILE . 41.4 t0 -113.29 127.71 56.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.174 -0.954 . . . . 0.0 109.427 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.469 ' HA ' HD13 ' A' ' 108' ' ' ILE . 15.2 mm -55.15 -18.7 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.273 -0.892 . . . . 0.0 109.52 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.421 ' OD2' ' OD2' ' A' ' 107' ' ' ASP . 15.9 m-20 -76.33 -46.98 25.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.19 -0.944 . . . . 0.0 109.402 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.55 -27.08 65.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.261 -0.899 . . . . 0.0 109.427 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.469 HG12 ' O ' ' A' ' 107' ' ' ASP . 15.9 mm -75.01 -52.48 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.223 -0.923 . . . . 0.0 109.493 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -67.36 -20.52 65.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.272 -0.892 . . . . 0.0 109.528 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -76.92 -51.43 11.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 109.553 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.433 ' HB3' ' HZ ' ' A' ' 102' ' ' PHE . . . -63.5 -49.85 71.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.188 -0.945 . . . . 0.0 109.576 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.471 HG22 HD21 ' A' ' 50' ' ' LEU . 54.0 t -57.22 -49.9 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.263 -0.898 . . . . 0.0 109.487 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -27.82 69.0 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.222 -0.924 . . . . 0.0 109.565 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.07 -18.21 40.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 109.438 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -90.03 -70.9 0.64 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.244 -0.91 . . . . 0.0 109.436 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.534 ' CD1' ' HD2' ' A' ' 120' ' ' PRO . 5.5 tp -90.0 139.58 27.43 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.239 -0.913 . . . . 0.0 109.291 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.624 ' O ' HD22 ' A' ' 121' ' ' LEU . 35.3 Cg_endo -78.25 138.67 16.15 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.571 2.181 . . . . 0.0 110.345 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.665 HD21 ' HB3' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -144.78 155.32 43.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.202 -0.936 . . . . 0.0 109.487 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.41 ' H ' HD13 ' A' ' 121' ' ' LEU . 16.0 mtmm -47.51 121.88 4.31 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.249 -0.907 . . . . 0.0 109.472 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.434 ' O ' ' HB2' ' A' ' 124' ' ' ASN . 1.6 t -139.78 161.34 37.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.226 -0.922 . . . . 0.0 109.462 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 123' ' ' SER . 25.3 m120 . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.506 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.414 ' O ' ' CG ' ' A' ' 2' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.276 0.56 . . . . 0.0 109.494 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.431 ' O ' ' HB2' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -178.88 -35.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.264 -0.898 . . . . 0.0 109.447 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.431 ' HB2' ' O ' ' A' ' 2' ' ' MET . 26.4 m-20 68.07 -166.16 0.2 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.285 -0.884 . . . . 0.0 109.497 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.423 ' HG2' ' C ' ' A' ' 3' ' ' ASN . 18.0 mm-40 61.11 92.44 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.438 ' O ' ' CB ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -120.23 119.73 34.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.307 -0.87 . . . . 0.0 109.417 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.877 ' HB ' HG22 ' A' ' 30' ' ' THR . 15.0 mt -109.41 168.15 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.263 -0.898 . . . . 0.0 109.501 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.976 ' O ' HD12 ' A' ' 52' ' ' LEU . 0.4 OUTLIER -134.96 142.09 46.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.333 -0.854 . . . . 0.0 109.467 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.908 ' N ' HD13 ' A' ' 7' ' ' LEU . 2.9 mt -133.5 99.28 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.352 -0.843 . . . . 0.0 109.278 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.652 HG12 HD11 ' A' ' 57' ' ' ILE . 2.9 t -89.79 114.18 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.264 -0.898 . . . . 0.0 109.562 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.809 ' O ' ' HB2' ' A' ' 34' ' ' ALA . 0.4 OUTLIER -169.18 174.92 5.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.295 -0.878 . . . . 0.0 109.362 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.462 ' CG ' ' HD2' ' A' ' 58' ' ' PRO . 6.1 p-10 -142.54 -45.76 0.32 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.16 -0.963 . . . . 0.0 109.449 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.435 ' N ' ' CG ' ' A' ' 11' ' ' ASP . 5.5 tp60 -44.0 106.91 0.08 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.304 -0.872 . . . . 0.0 109.493 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 1.05 ' CE1' HD11 ' A' ' 17' ' ' ILE . 38.9 t80 -43.23 124.35 3.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.374 -0.829 . . . . 0.0 109.431 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 141.31 -75.98 0.32 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.439 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 1.7 mt -58.66 -32.42 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -1.169 . . . . 0.0 108.878 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.519 ' NH1' ' O ' ' A' ' 33' ' ' ALA . 9.1 mmm180 -60.34 -33.19 72.05 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.336 -0.852 . . . . 0.0 109.459 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 1.05 HD11 ' CE1' ' A' ' 13' ' ' TYR . 2.6 mt -90.7 -65.59 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.332 -0.855 . . . . 0.0 109.895 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.895 ' O ' HG23 ' A' ' 22' ' ' VAL . 4.3 mt -42.45 -63.0 0.84 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.133 -0.979 . . . . 0.0 110.198 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.828 HD23 HG23 ' A' ' 8' ' ' ILE . 1.8 tp -51.98 -35.14 45.39 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.085 -1.009 . . . . 0.0 109.802 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.433 ' HB3' ' O ' ' A' ' 17' ' ' ILE . 33.0 t30 -64.89 -70.43 0.23 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.211 -0.931 . . . . 0.0 110.163 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.475 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 1.0 OUTLIER -55.82 -16.49 4.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.143 -0.973 . . . . 0.0 110.152 -179.418 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 18' ' ' LEU . 53.5 t -75.57 -61.13 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.12 -0.987 . . . . 0.0 109.422 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 1.006 ' CZ ' HG21 ' A' ' 115' ' ' VAL . 17.0 m-85 -73.28 -8.51 56.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.272 -0.892 . . . . 0.0 109.407 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -83.72 -54.84 4.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.914 . . . . 0.0 109.44 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -66.27 -22.08 66.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.244 -0.91 . . . . 0.0 109.406 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.478 ' OE2' ' HE2' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -78.83 -23.78 44.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.33 -0.856 . . . . 0.0 109.476 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.566 ' O ' ' CG ' ' A' ' 28' ' ' TYR . . . 110.48 64.33 0.52 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.939 ' CE2' HD13 ' A' ' 121' ' ' LEU . 66.4 m-85 -158.88 135.26 9.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.202 -1.176 . . . . 0.0 109.607 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -89.91 85.01 6.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.254 -0.904 . . . . 0.0 108.959 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.908 HG21 ' HB2' ' A' ' 23' ' ' PHE . 5.2 p -89.87 137.8 32.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.276 -0.89 . . . . 0.0 109.895 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.623 ' HB2' HD22 ' A' ' 7' ' ' LEU . 14.5 m-85 -102.01 165.1 11.35 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.391 -0.818 . . . . 0.0 108.889 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 32' ' ' GLN . 1.5 pt20 -125.15 134.42 52.43 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.092 -1.005 . . . . 0.0 109.854 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.593 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -140.35 -161.01 1.14 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.251 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.809 ' HB2' ' O ' ' A' ' 10' ' ' ASP . . . 171.23 -42.39 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.167 -0.958 . . . . 0.0 109.651 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.433 ' ND2' ' H ' ' A' ' 35' ' ' ASN . 1.9 p30 -74.15 -1.33 19.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.208 -0.932 . . . . 0.0 109.611 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.19 -46.11 3.62 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.15 -28.08 69.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.318 -1.107 . . . . 0.0 109.419 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.916 ' O ' HD12 ' A' ' 42' ' ' ILE . 13.3 mm100 -82.05 -36.14 28.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.284 -0.885 . . . . 0.0 109.375 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.785 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -64.81 -40.56 95.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.444 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.413 ' O ' ' C ' ' A' ' 41' ' ' ASP . 3.3 mt -78.32 -57.74 3.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.273 -0.892 . . . . 0.0 109.453 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 40' ' ' LEU . 5.9 t70 -44.45 -42.14 6.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.271 -0.893 . . . . 0.0 109.474 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.916 HD12 ' O ' ' A' ' 38' ' ' GLN . 15.3 mt -69.61 -47.0 73.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.279 -0.888 . . . . 0.0 109.357 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.785 HG23 ' O ' ' A' ' 39' ' ' ALA . 73.2 t -55.73 -21.14 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.259 -0.901 . . . . 0.0 109.425 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.6 m -90.16 -33.66 16.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.283 -0.885 . . . . 0.0 109.446 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.49 ' HG2' ' HA ' ' A' ' 42' ' ' ILE . 0.0 OUTLIER -89.94 0.65 56.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 109.714 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.469 ' HG2' ' HD2' ' A' ' 45' ' ' LYS . 11.3 mm-40 -137.75 -38.6 0.58 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.157 -0.964 . . . . 0.0 109.442 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.513 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 2.6 mtt180 59.15 62.13 4.22 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.894 . . . . 0.0 109.519 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.558 ' HD2' HG13 ' A' ' 43' ' ' VAL . 35.4 Cg_endo -77.87 151.89 28.17 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.691 2.261 . . . . 0.0 110.407 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.692 ' C ' HD22 ' A' ' 50' ' ' LEU . 1.2 m-20 -93.31 -11.98 31.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.209 -0.932 . . . . 0.0 109.513 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.692 HD22 ' C ' ' A' ' 49' ' ' ASP . 4.3 mm? -118.8 125.7 50.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.199 -0.938 . . . . 0.0 109.476 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.93 ' HB ' HG22 ' A' ' 78' ' ' VAL . 3.5 t -132.23 119.8 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.233 -0.917 . . . . 0.0 109.563 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.976 HD12 ' O ' ' A' ' 7' ' ' LEU . 1.1 mt -92.51 102.74 15.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.306 -0.871 . . . . 0.0 109.345 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.593 HD22 ' CD2' ' A' ' 66' ' ' LEU . 1.0 OUTLIER -89.91 128.49 36.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.176 -0.952 . . . . 0.0 109.643 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.538 ' HB2' ' HE2' ' A' ' 81' ' ' MET . 30.5 t0 -120.53 108.64 14.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.338 -0.851 . . . . 0.0 109.356 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.853 ' CG ' HG21 ' A' ' 82' ' ' THR . 12.7 mmt -71.78 -3.99 25.22 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.188 -0.945 . . . . 0.0 109.568 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.457 ' HB2' ' OD2' ' A' ' 54' ' ' ASP . 4.3 mttt -75.52 -7.87 55.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 109.625 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.652 HD11 HG12 ' A' ' 9' ' ' VAL . 56.9 mt -57.06 116.52 13.7 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.095 -1.003 . . . . 0.0 109.318 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.462 ' HD2' ' CG ' ' A' ' 11' ' ' ASP . 35.6 Cg_endo -78.21 92.03 1.16 Allowed 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.297 1.998 . . . . 0.0 110.414 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 161.42 -23.5 0.23 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.511 ' SD ' ' CG2' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -170.48 161.19 7.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -1.172 . . . . 0.0 109.594 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -90.25 136.43 33.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.212 -0.93 . . . . 0.0 109.38 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.454 ' HA2' HG13 ' A' ' 65' ' ' ILE . . . -74.79 -8.91 82.72 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 30.6 mm -53.94 -55.22 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -1.149 . . . . 0.0 109.425 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 65' ' ' ILE . 24.9 mm-40 -53.14 -45.0 68.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.237 -0.914 . . . . 0.0 109.466 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.492 ' HB ' HD21 ' A' ' 53' ' ' LEU . 9.4 mt -44.81 -50.52 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.263 -0.898 . . . . 0.0 109.461 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.593 ' CD2' HD22 ' A' ' 53' ' ' LEU . 22.0 mt -54.66 -53.19 58.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.311 -0.868 . . . . 0.0 109.497 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.449 ' O ' HG23 ' A' ' 71' ' ' VAL . 4.7 mttt -43.65 -51.05 7.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.313 -0.867 . . . . 0.0 109.618 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.449 ' O ' HG13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -59.76 -41.2 90.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.162 -0.961 . . . . 0.0 109.486 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.765 ' HE1' HG11 ' A' ' 51' ' ' VAL . 4.6 mtt -60.32 -24.39 64.97 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.239 -0.913 . . . . 0.0 109.442 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 66' ' ' LEU . 1.8 mmpt? -80.03 -44.08 20.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.186 -0.946 . . . . 0.0 109.344 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 67' ' ' LYS . 2.6 t -64.38 -24.47 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.217 -0.927 . . . . 0.0 109.451 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 68' ' ' ARG . 57.9 mt -90.05 -66.42 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.456 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -123.59 139.09 54.36 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.229 -0.919 . . . . 0.0 109.506 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -90.02 -25.05 21.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.274 -0.891 . . . . 0.0 109.455 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 49.2 m-20 -105.77 51.02 0.76 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.199 -0.938 . . . . 0.0 109.498 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.615 HG13 HG23 ' A' ' 78' ' ' VAL . 3.0 tp -98.89 113.82 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.262 -0.899 . . . . 0.0 109.433 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.527 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 3.7 mtt180 -75.91 118.05 18.28 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.197 -0.939 . . . . 0.0 109.459 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.93 HG22 ' HB ' ' A' ' 51' ' ' VAL . 79.1 t -129.77 115.82 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.279 -0.888 . . . . 0.0 109.544 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.48 HG12 HG22 ' A' ' 100' ' ' THR . 70.9 mt -89.87 125.69 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.281 -0.887 . . . . 0.0 109.396 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.967 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.6 OUTLIER -89.82 162.17 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.193 -0.942 . . . . 0.0 109.422 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.538 ' HE2' ' HB2' ' A' ' 54' ' ' ASP . 16.6 mtm -135.43 47.27 2.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.297 -0.877 . . . . 0.0 109.425 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.853 HG21 ' CG ' ' A' ' 55' ' ' MET . 9.9 t -159.71 66.64 0.38 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.31 -0.869 . . . . 0.0 109.469 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.562 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . -80.53 -38.94 28.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.241 -0.912 . . . . 0.0 109.437 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.484 ' CD1' ' N ' ' A' ' 85' ' ' GLY . 6.4 t80 -74.23 135.03 42.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.238 -0.914 . . . . 0.0 109.483 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.484 ' N ' ' CD1' ' A' ' 84' ' ' TYR . . . 120.95 -52.74 0.72 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.451 ' O ' HD13 ' A' ' 90' ' ' ILE . 1.8 pm0 -149.72 95.22 2.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.304 -1.115 . . . . 0.0 109.472 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.588 ' HA ' HD13 ' A' ' 90' ' ' ILE . 0.3 OUTLIER -87.97 14.0 9.84 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.224 -0.923 . . . . 0.0 109.476 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -83.27 -21.6 33.25 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.233 -0.917 . . . . 0.0 109.514 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.524 ' CG ' ' OE2' ' A' ' 92' ' ' GLU . 0.5 OUTLIER -106.15 0.89 25.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 109.63 179.914 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.594 ' CD1' ' N ' ' A' ' 90' ' ' ILE . 1.2 mp -74.12 -61.26 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.234 -0.916 . . . . 0.0 109.122 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -47.65 -44.78 27.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.912 . . . . 0.0 109.411 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.524 ' OE2' ' CG ' ' A' ' 89' ' ' MET . 19.3 pt-20 -70.2 -32.63 70.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -0.877 . . . . 0.0 109.429 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.821 ' HB2' HD11 ' A' ' 80' ' ' ILE . 59.6 p -63.38 -30.59 71.69 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.236 -0.915 . . . . 0.0 109.471 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.5 OUTLIER -69.68 -71.84 0.22 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.911 . . . . 0.0 109.524 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.458 ' CG ' ' N ' ' A' ' 96' ' ' LEU . 9.4 pt-20 -43.81 -46.64 7.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.218 -0.926 . . . . 0.0 109.437 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.473 ' HA ' HD23 ' A' ' 96' ' ' LEU . 24.5 mt -51.67 -57.33 9.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.181 -0.949 . . . . 0.0 109.441 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 165.53 44.89 0.02 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.514 ' CB ' ' O ' ' A' ' 93' ' ' SER . . . -113.92 98.6 7.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -1.115 . . . . 0.0 109.457 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.527 ' CD1' ' HB3' ' A' ' 77' ' ' ARG . 23.9 mt -46.63 -46.73 19.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.284 -0.885 . . . . 0.0 109.446 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.48 HG22 HG12 ' A' ' 79' ' ' ILE . 10.7 t -154.44 143.02 20.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.221 -0.924 . . . . 0.0 109.52 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.967 ' ND1' HD12 ' A' ' 80' ' ' ILE . 3.6 t-160 -107.93 87.71 2.56 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.252 -0.905 . . . . 0.0 109.487 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.508 ' O ' ' N ' ' A' ' 82' ' ' THR . 6.0 m-30 -80.55 179.12 7.9 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 0.0 109.57 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.562 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -137.82 -148.68 0.28 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.292 -0.88 . . . . 0.0 109.343 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.525 ' HG3' ' HA ' ' A' ' 105' ' ' PRO . 0.7 OUTLIER -137.85 145.75 49.65 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.291 -0.881 . . . . 0.0 109.452 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.525 ' HA ' ' HG3' ' A' ' 104' ' ' LYS . 35.3 Cg_endo -77.91 -176.69 19.21 Favored 'Cis proline' 0 C--N 1.308 -1.565 0 C-N-CA 123.289 -1.546 . . . . 0.0 110.333 0.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 106' ' ' PHE . 2.8 p90 -146.92 -163.69 1.82 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.281 -0.887 . . . . 0.0 109.494 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -135.46 132.55 37.54 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.273 -0.892 . . . . 0.0 109.503 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.434 ' HA ' HD13 ' A' ' 108' ' ' ILE . 14.4 mm -59.22 -21.59 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -0.926 . . . . 0.0 109.45 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.478 ' O ' ' HG2' ' A' ' 112' ' ' ARG . 34.8 m-20 -73.74 -44.73 55.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.34 -0.85 . . . . 0.0 109.474 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -64.68 -34.87 79.31 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.2 -0.938 . . . . 0.0 109.425 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.496 HG21 HD11 ' A' ' 19' ' ' LEU . 17.7 mm -66.33 -59.59 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.204 -0.935 . . . . 0.0 109.492 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 23.2 ptt180 -53.4 -32.05 47.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 109.529 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.44 ' OD2' ' O ' ' A' ' 109' ' ' ASP . 17.7 m-20 -64.64 -55.79 17.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.332 -0.855 . . . . 0.0 109.5 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.665 ' HB1' ' CE2' ' A' ' 118' ' ' TYR . . . -55.33 -35.68 65.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.208 -0.933 . . . . 0.0 109.474 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 1.006 HG21 ' CZ ' ' A' ' 23' ' ' PHE . 77.9 t -72.08 -28.9 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.282 -0.886 . . . . 0.0 109.434 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.478 ' HE2' ' OE2' ' A' ' 26' ' ' GLU . 5.4 mmtm -72.12 -32.24 66.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.303 -0.873 . . . . 0.0 109.433 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -86.74 -24.44 25.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.926 . . . . 0.0 109.459 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.665 ' CE2' ' HB1' ' A' ' 114' ' ' ALA . 18.6 m-85 -90.13 -66.18 0.95 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.226 -0.921 . . . . 0.0 109.48 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.757 HD12 ' HD2' ' A' ' 120' ' ' PRO . 31.5 tp -90.13 112.47 52.65 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.287 -0.883 . . . . 0.0 109.477 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.757 ' HD2' HD12 ' A' ' 119' ' ' LEU . 35.3 Cg_endo -78.19 148.01 23.9 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.408 2.072 . . . . 0.0 110.314 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.939 HD13 ' CE2' ' A' ' 28' ' ' TYR . 1.2 tp -154.45 151.45 28.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.282 -0.886 . . . . 0.0 109.405 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.73 77.9 5.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.281 -0.887 . . . . 0.0 109.486 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.502 ' O ' ' CB ' ' A' ' 124' ' ' ASN . 16.3 m -164.59 30.91 0.07 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.232 -0.918 . . . . 0.0 109.462 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 123' ' ' SER . 1.1 t30 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.453 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 5.6 mtt 58.09 82.85 0.12 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.271 -0.893 . . . . 0.0 109.5 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -126.01 68.53 1.19 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.248 -0.908 . . . . 0.0 109.462 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.464 ' N ' ' OE1' ' A' ' 4' ' ' GLU . 1.5 mp0 -81.0 124.09 28.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.898 . . . . 0.0 109.489 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.465 ' HB3' ' HB3' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -141.75 131.69 24.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.23 -0.918 . . . . 0.0 109.457 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.628 HD12 ' HB3' ' A' ' 28' ' ' TYR . 91.5 mt -149.97 153.45 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.265 -0.897 . . . . 0.0 109.499 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.803 HD23 HG21 ' A' ' 42' ' ' ILE . 1.8 tm? -130.64 112.0 12.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.238 -0.914 . . . . 0.0 109.447 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.796 HD13 ' HB2' ' A' ' 19' ' ' LEU . 5.0 mt -89.98 106.33 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.278 -0.889 . . . . 0.0 109.545 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.718 HG22 HD12 ' A' ' 7' ' ' LEU . 3.1 t -95.02 113.32 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.219 -0.925 . . . . 0.0 109.5 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.503 ' O ' ' NH1' ' A' ' 16' ' ' ARG . 0.4 OUTLIER -162.93 150.44 13.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 0.0 109.415 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.482 ' OD2' ' HD2' ' A' ' 58' ' ' PRO . 7.4 p-10 -113.37 -37.28 4.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.244 -0.91 . . . . 0.0 109.454 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.405 ' O ' ' C ' ' A' ' 13' ' ' TYR . 20.1 tt0 -70.05 104.57 2.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.24 -0.913 . . . . 0.0 109.484 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.587 ' CZ ' HG13 ' A' ' 17' ' ' ILE . 26.2 t80 -44.13 149.93 0.32 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.294 -0.879 . . . . 0.0 109.496 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.61 -73.78 0.42 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.468 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 36.6 mt -61.21 -23.63 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -1.142 . . . . 0.0 109.365 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.503 ' NH1' ' O ' ' A' ' 10' ' ' ASP . 7.4 mmm-85 -69.75 -30.08 67.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.338 -0.851 . . . . 0.0 109.399 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.587 HG13 ' CZ ' ' A' ' 13' ' ' TYR . 9.2 mm -90.19 -25.18 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.376 -0.828 . . . . 0.0 109.534 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.905 ' O ' HG23 ' A' ' 22' ' ' VAL . 1.3 mp -74.05 -53.21 10.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.209 -0.932 . . . . 0.0 109.567 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.796 ' HB2' HD13 ' A' ' 8' ' ' ILE . 12.3 mt -71.39 -17.11 62.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -0.918 . . . . 0.0 109.535 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 47.9 t30 -79.77 -51.01 9.72 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.207 -0.933 . . . . 0.0 109.498 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -68.07 -40.06 82.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.211 -0.931 . . . . 0.0 109.463 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.905 HG23 ' O ' ' A' ' 18' ' ' LEU . 15.1 t -67.18 -57.5 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.915 . . . . 0.0 109.403 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.73 ' CZ ' HG21 ' A' ' 115' ' ' VAL . 18.7 m-85 -65.46 -17.67 64.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.24 -0.912 . . . . 0.0 109.457 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.435 ' HB2' ' O ' ' A' ' 20' ' ' ASN . 1.9 m-20 -68.75 -63.14 1.12 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.427 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.58 -10.52 58.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.906 . . . . 0.0 109.402 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.474 ' HB2' ' HA ' ' A' ' 23' ' ' PHE . 1.7 mm-40 -76.34 -31.75 58.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.234 -0.917 . . . . 0.0 109.517 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.416 ' O ' ' HG2' ' A' ' 4' ' ' GLU . . . 107.2 33.38 3.21 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.702 ' HE1' HD22 ' A' ' 119' ' ' LEU . 84.8 m-85 -123.51 139.34 54.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -1.164 . . . . 0.0 109.468 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -91.57 82.34 5.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.279 -0.888 . . . . 0.0 109.473 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.574 HG22 HD12 ' A' ' 6' ' ' ILE . 5.8 p -89.96 152.33 21.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.182 -0.949 . . . . 0.0 109.517 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.574 ' HB2' HD22 ' A' ' 7' ' ' LEU . 16.6 m-85 -119.51 -168.98 1.68 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.203 -0.935 . . . . 0.0 109.473 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -128.99 142.27 50.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.221 -0.925 . . . . 0.0 109.432 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.59 ' CB ' HD11 ' A' ' 7' ' ' LEU . . . -154.95 109.62 3.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.33 -0.856 . . . . 0.0 109.487 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.566 ' O ' HD13 ' A' ' 57' ' ' ILE . . . -69.45 -70.29 0.29 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.199 -0.938 . . . . 0.0 109.454 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -77.56 178.03 7.58 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 0.0 109.514 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.51 ' HA3' HD11 ' A' ' 65' ' ' ILE . . . -83.44 -41.97 8.13 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.418 ' C ' ' O ' ' A' ' 36' ' ' GLY . 0.3 OUTLIER -44.06 -56.53 3.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.192 -1.181 . . . . 0.0 109.453 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.435 ' O ' HD12 ' A' ' 42' ' ' ILE . 44.7 tp60 -57.17 -48.48 78.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 109.372 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.602 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -46.0 -68.21 0.21 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.278 -0.889 . . . . 0.0 109.464 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' A' ' 39' ' ' ALA . 2.2 mt -44.28 -41.06 5.67 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.288 -0.882 . . . . 0.0 109.529 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.64 -54.88 27.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.206 -0.934 . . . . 0.0 109.526 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.803 HG21 HD23 ' A' ' 7' ' ' LEU . 2.0 mp -63.87 -21.32 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.274 -0.891 . . . . 0.0 109.486 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.813 HG13 ' HD2' ' A' ' 48' ' ' PRO . 16.8 t -80.05 -22.11 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -0.903 . . . . 0.0 109.478 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.1 m -90.1 -28.53 18.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.915 . . . . 0.0 109.39 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -89.88 -27.76 19.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 0.0 109.448 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -113.83 -36.91 4.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.265 -0.897 . . . . 0.0 109.382 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 60.3 mtm180 57.54 69.16 1.68 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.896 . . . . 0.0 109.553 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.813 ' HD2' HG13 ' A' ' 43' ' ' VAL . 35.4 Cg_endo -77.91 176.03 10.49 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.685 2.257 . . . . 0.0 110.412 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.628 ' O ' HD22 ' A' ' 50' ' ' LEU . 58.9 m-20 -114.7 -9.93 12.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.225 -0.922 . . . . 0.0 109.489 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.628 HD22 ' O ' ' A' ' 49' ' ' ASP . 3.4 mm? -124.63 112.96 17.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 109.52 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 1.037 HG11 ' CE ' ' A' ' 69' ' ' MET . 24.7 t -114.0 119.2 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.171 -0.956 . . . . 0.0 109.422 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.413 HD13 HG23 ' A' ' 8' ' ' ILE . 1.3 mt -89.99 100.77 13.52 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.884 . . . . 0.0 109.456 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.825 HD21 ' HB ' ' A' ' 65' ' ' ILE . 1.1 mp -91.57 129.06 37.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.896 . . . . 0.0 109.516 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.455 ' OD2' ' OD1' ' A' ' 10' ' ' ASP . 57.0 t0 -117.94 103.59 10.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 109.42 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.676 ' HB2' HG21 ' A' ' 82' ' ' THR . 9.3 mmt -58.65 -15.72 12.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.319 -0.863 . . . . 0.0 109.504 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.447 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.1 OUTLIER -55.72 -35.69 66.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 109.414 179.959 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.898 HG21 ' CE ' ' A' ' 60' ' ' MET . 46.0 mt -43.13 103.28 0.31 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.342 -0.849 . . . . 0.0 109.507 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.482 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 35.4 Cg_endo -77.77 4.53 5.98 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.421 2.081 . . . . 0.0 110.415 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.94 -43.37 7.2 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.898 ' CE ' HG21 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -153.38 170.95 19.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -1.133 . . . . 0.0 109.452 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -88.97 134.27 34.03 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.215 -0.928 . . . . 0.0 109.474 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.423 ' HA2' HG12 ' A' ' 65' ' ' ILE . . . -81.73 -0.39 89.27 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.5 mm -61.4 -42.14 92.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.288 -1.125 . . . . 0.0 109.456 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -68.74 -18.91 64.31 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.405 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.825 ' HB ' HD21 ' A' ' 53' ' ' LEU . 24.8 mm -69.94 -51.38 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.283 -0.886 . . . . 0.0 109.446 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.477 ' O ' ' HE3' ' A' ' 70' ' ' LYS . 29.8 mt -53.87 -30.65 46.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.291 -0.881 . . . . 0.0 109.441 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.768 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.6 OUTLIER -71.72 -63.25 1.16 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.233 -0.917 . . . . 0.0 109.5 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.468 ' O ' HG12 ' A' ' 72' ' ' ILE . 1.9 mtt85 -52.81 -20.67 3.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.216 -0.927 . . . . 0.0 109.41 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' MET . . . . . 1.037 ' CE ' HG11 ' A' ' 51' ' ' VAL . 1.3 mmt -75.39 -58.47 3.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.207 -0.933 . . . . 0.0 109.457 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 15.3 ptpt -62.35 -15.51 48.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.238 -0.914 . . . . 0.0 109.425 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.768 HG23 ' O ' ' A' ' 67' ' ' LYS . 44.9 t -83.91 -42.69 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -0.881 . . . . 0.0 109.508 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.468 HG12 ' O ' ' A' ' 68' ' ' ARG . 19.0 mm -72.41 -56.27 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.274 -0.891 . . . . 0.0 109.506 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -129.72 132.55 46.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.204 -0.935 . . . . 0.0 109.493 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.61 15.38 9.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.241 -0.912 . . . . 0.0 109.513 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -129.99 37.05 3.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.322 -0.862 . . . . 0.0 109.44 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.662 HD11 ' CG2' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -112.34 142.32 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.279 -0.888 . . . . 0.0 109.373 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.626 ' CG ' HD11 ' A' ' 99' ' ' LEU . 37.9 mtt85 -103.87 158.55 16.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.291 -0.881 . . . . 0.0 109.436 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.649 HG13 ' HB ' ' A' ' 51' ' ' VAL . 1.8 t -153.12 112.21 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.219 -0.925 . . . . 0.0 109.538 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.482 HG23 ' CG2' ' A' ' 100' ' ' THR . 95.7 mt -92.16 159.64 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.292 -0.88 . . . . 0.0 109.424 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.581 ' HB ' ' CG ' ' A' ' 101' ' ' HIS . 0.4 OUTLIER -114.64 119.11 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.212 -0.93 . . . . 0.0 109.414 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.402 ' O ' ' HB ' ' A' ' 82' ' ' THR . 4.6 mtm -101.0 68.42 1.26 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.191 -0.943 . . . . 0.0 109.515 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.676 HG21 ' HB2' ' A' ' 55' ' ' MET . 6.2 t 179.43 48.56 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.258 -0.901 . . . . 0.0 109.439 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.025 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . -76.02 -9.38 58.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.261 -0.899 . . . . 0.0 109.512 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.46 93.0 9.28 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.297 -0.877 . . . . 0.0 109.521 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 159.44 -108.1 0.34 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -98.49 128.27 44.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.288 -1.125 . . . . 0.0 109.463 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.55 52.25 0.82 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.367 -0.833 . . . . 0.0 109.465 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -102.75 -22.8 13.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.237 -0.914 . . . . 0.0 109.476 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.458 ' O ' ' CB ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -116.87 15.2 15.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -0.908 . . . . 0.0 109.484 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.74 HG23 ' HD1' ' A' ' 101' ' ' HIS . 48.0 mt -89.72 -66.26 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.235 -0.916 . . . . 0.0 109.529 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -47.6 -39.87 17.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.276 -0.89 . . . . 0.0 109.478 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.925 ' C ' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -78.32 -33.37 49.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.24 -0.912 . . . . 0.0 109.522 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.504 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 0.5 OUTLIER -59.89 -16.18 27.32 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.277 -0.889 . . . . 0.0 109.478 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.06 -76.68 0.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 0.0 109.456 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.43 ' HG3' ' N ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -58.09 -23.99 56.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.919 . . . . 0.0 109.507 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.925 HD12 ' C ' ' A' ' 92' ' ' GLU . 8.4 mt -67.6 -42.66 82.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.303 -0.873 . . . . 0.0 109.453 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 154.51 53.1 0.01 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 93' ' ' SER . . . -138.7 102.76 4.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.303 -1.116 . . . . 0.0 109.466 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.66 HD13 ' CD1' ' A' ' 118' ' ' TYR . 21.0 mt -45.48 -65.52 0.53 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.211 -0.931 . . . . 0.0 109.392 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.745 HG21 ' CE1' ' A' ' 102' ' ' PHE . 11.6 t -140.55 -174.91 4.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.294 -0.879 . . . . 0.0 109.457 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.81 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 3.3 t-160 -140.99 92.4 2.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.348 -0.845 . . . . 0.0 109.39 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.745 ' CE1' HG21 ' A' ' 100' ' ' THR . 60.0 m-85 -77.99 152.66 32.99 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.21 -0.931 . . . . 0.0 109.434 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 1.025 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -140.25 -160.67 1.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.875 . . . . 0.0 109.462 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.475 ' CG ' ' HA ' ' A' ' 105' ' ' PRO . 9.5 tttm -89.37 141.83 29.25 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.231 -0.918 . . . . 0.0 109.31 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.475 ' HA ' ' CG ' ' A' ' 104' ' ' LYS . 36.0 Cg_endo -78.11 -176.51 18.85 Favored 'Cis proline' 0 C--N 1.31 -1.492 0 C-N-CA 123.406 -1.498 . . . . 0.0 110.486 -0.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.69 ' CE2' HD12 ' A' ' 111' ' ' ILE . 0.2 OUTLIER -114.75 106.3 14.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.196 -0.94 . . . . 0.0 109.524 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.478 ' O ' HG12 ' A' ' 111' ' ' ILE . 38.8 t0 -89.94 105.18 17.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -0.896 . . . . 0.0 109.318 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.812 HD12 HG21 ' A' ' 22' ' ' VAL . 13.6 mm -45.84 -25.02 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.195 -0.941 . . . . 0.0 109.61 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.469 ' HB2' ' OD2' ' A' ' 107' ' ' ASP . 79.1 m-20 -72.81 -46.37 53.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.127 -0.983 . . . . 0.0 109.518 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.5 -24.38 63.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.252 -0.905 . . . . 0.0 109.486 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.69 HD12 ' CE2' ' A' ' 106' ' ' PHE . 12.7 mm -75.23 -56.4 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.273 -0.892 . . . . 0.0 109.428 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.464 ' O ' ' HG3' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -60.22 -32.86 71.52 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.296 -0.877 . . . . 0.0 109.497 179.906 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -64.99 -55.0 21.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.33 -0.856 . . . . 0.0 109.447 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.63 ' HB2' ' HZ ' ' A' ' 102' ' ' PHE . . . -54.84 -42.56 72.12 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.197 -0.939 . . . . 0.0 109.474 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.73 HG21 ' CZ ' ' A' ' 23' ' ' PHE . 55.8 t -66.84 -28.58 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.19 -0.944 . . . . 0.0 109.442 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 0.5 OUTLIER -68.94 -48.94 62.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.272 -0.892 . . . . 0.0 109.457 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.13 -31.92 73.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.922 . . . . 0.0 109.54 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.66 ' CD1' HD13 ' A' ' 99' ' ' LEU . 22.5 m-85 -73.64 -72.98 0.23 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.316 -0.865 . . . . 0.0 109.524 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.702 HD22 ' HE1' ' A' ' 28' ' ' TYR . 5.5 tt -88.08 137.84 31.1 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.26 -0.9 . . . . 0.0 109.251 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.667 ' N ' HD23 ' A' ' 119' ' ' LEU . 35.9 Cg_endo -78.37 145.77 21.52 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.482 2.121 . . . . 0.0 110.427 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.64 ' CD1' ' CZ ' ' A' ' 28' ' ' TYR . 1.6 mt -132.08 -161.43 1.13 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.892 . . . . 0.0 109.436 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -56.14 91.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.277 -0.889 . . . . 0.0 109.491 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.451 ' O ' ' CB ' ' A' ' 124' ' ' ASN . 45.0 m -72.03 86.21 1.02 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.3 -0.875 . . . . 0.0 109.479 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.451 ' CB ' ' O ' ' A' ' 123' ' ' SER . 1.6 p30 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.437 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 33.8 mtm -118.15 -85.35 0.65 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.229 -0.92 . . . . 0.0 109.444 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -101.34 134.77 43.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.24 -0.913 . . . . 0.0 109.521 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -173.76 66.75 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.246 -0.909 . . . . 0.0 109.458 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 48' ' ' PRO . 23.2 mttt -125.81 143.77 50.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 0.0 109.461 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.547 ' HB ' HG22 ' A' ' 30' ' ' THR . 70.0 mt -150.06 162.5 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -0.918 . . . . 0.0 109.464 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.799 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.5 OUTLIER -131.81 122.62 26.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.163 -0.96 . . . . 0.0 109.404 -179.931 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.799 ' N ' HD13 ' A' ' 7' ' ' LEU . 3.7 mt -100.75 109.06 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.238 -0.914 . . . . 0.0 109.426 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.607 HG12 HD11 ' A' ' 57' ' ' ILE . 2.6 t -103.95 95.87 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.3 -0.875 . . . . 0.0 109.41 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.484 ' O ' ' HD3' ' A' ' 16' ' ' ARG . 1.6 t70 -158.67 85.88 0.84 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 0.0 109.476 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.599 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . 7.3 p-10 -51.25 -41.31 60.29 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.211 -0.931 . . . . 0.0 109.428 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.414 ' C ' ' O ' ' A' ' 11' ' ' ASP . 4.8 tt0 -44.11 95.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -0.896 . . . . 0.0 109.465 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 1.056 ' CE1' HD11 ' A' ' 17' ' ' ILE . 47.8 t80 -45.07 120.81 2.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.319 -0.863 . . . . 0.0 109.427 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 144.97 -54.12 0.56 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.671 ' N ' HD12 ' A' ' 15' ' ' ILE . 1.8 mp -72.45 -50.17 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -1.162 . . . . 0.0 109.333 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.521 ' O ' ' CB ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -47.41 -31.59 4.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.229 -0.919 . . . . 0.0 109.5 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 1.056 HD11 ' CE1' ' A' ' 13' ' ' TYR . 1.7 mt -90.27 -29.14 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.222 -0.924 . . . . 0.0 109.497 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.864 HD12 HD11 ' A' ' 108' ' ' ILE . 0.4 OUTLIER -66.41 -62.33 1.52 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.203 -0.936 . . . . 0.0 109.498 -179.868 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.696 ' HB2' HD13 ' A' ' 8' ' ' ILE . 7.5 mt -68.1 -15.55 63.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.919 . . . . 0.0 109.044 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.608 ' ND2' ' OE2' ' A' ' 21' ' ' GLU . 1.0 OUTLIER -72.07 -47.88 48.3 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.462 -0.774 . . . . 0.0 109.258 179.945 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.608 ' OE2' ' ND2' ' A' ' 20' ' ' ASN . 1.0 OUTLIER -73.27 -49.27 28.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.31 -0.869 . . . . 0.0 109.547 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.671 HG21 HG23 ' A' ' 108' ' ' ILE . 29.2 t -56.17 -47.81 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.272 -0.892 . . . . 0.0 109.542 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.57 ' CE2' ' HB3' ' A' ' 19' ' ' LEU . 19.7 m-85 -79.96 -13.63 59.2 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.186 -0.946 . . . . 0.0 109.559 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 20' ' ' ASN . 1.8 m-20 -71.71 -47.4 54.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -0.925 . . . . 0.0 109.368 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.5 tptt -85.0 -29.5 24.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -0.921 . . . . 0.0 109.39 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.432 ' HB3' ' CE2' ' A' ' 28' ' ' TYR . 0.2 OUTLIER -55.34 -43.17 74.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.251 -0.906 . . . . 0.0 109.459 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.52 44.14 0.4 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.432 ' CE2' ' HB3' ' A' ' 26' ' ' GLU . 96.6 m-85 -134.47 137.73 44.17 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.249 -1.148 . . . . 0.0 109.48 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -90.03 82.02 6.16 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 109.292 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.547 HG22 ' HB ' ' A' ' 6' ' ' ILE . 5.7 p -89.82 148.89 22.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.246 -0.909 . . . . 0.0 109.577 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.721 ' HB2' HD22 ' A' ' 7' ' ' LEU . 5.8 m-85 -113.34 -171.13 1.82 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.237 -0.914 . . . . 0.0 109.44 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -124.16 150.58 44.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.255 -0.903 . . . . 0.0 109.608 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.658 ' HB3' HD11 ' A' ' 7' ' ' LEU . . . -175.45 174.14 2.36 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.289 -0.882 . . . . 0.0 109.375 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.599 ' HB1' ' HB3' ' A' ' 11' ' ' ASP . . . 178.61 -31.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.298 -0.876 . . . . 0.0 109.555 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.502 ' OD1' ' CB ' ' A' ' 37' ' ' LEU . 8.0 p30 -74.14 -3.2 28.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.18 -0.95 . . . . 0.0 109.606 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.03 -45.08 3.46 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.502 ' CB ' ' OD1' ' A' ' 35' ' ' ASN . 0.2 OUTLIER -57.82 -50.0 74.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.286 -1.126 . . . . 0.0 109.519 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.588 ' O ' HD12 ' A' ' 42' ' ' ILE . 28.7 mt-30 -65.42 -23.97 67.08 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.178 -0.951 . . . . 0.0 109.519 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.599 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -67.59 -52.93 32.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.231 -0.918 . . . . 0.0 109.507 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.677 HD22 ' HB3' ' A' ' 68' ' ' ARG . 16.0 mt -70.79 -58.41 3.65 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.178 -0.952 . . . . 0.0 109.602 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -46.91 -49.23 20.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.292 -0.88 . . . . 0.0 109.628 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.601 HG21 ' CD2' ' A' ' 7' ' ' LEU . 89.3 mt -62.55 -35.15 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.908 . . . . 0.0 109.446 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 39' ' ' ALA . 49.0 t -75.22 -14.72 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.276 -0.89 . . . . 0.0 109.52 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.7 m -90.2 -28.87 18.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.186 -0.946 . . . . 0.0 109.561 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.1 mttm -85.96 -41.51 14.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.224 -0.923 . . . . 0.0 109.687 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.574 ' OE1' ' CZ ' ' A' ' 31' ' ' PHE . 4.8 mt-10 -102.08 -37.88 7.98 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.194 -0.941 . . . . 0.0 109.601 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.474 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 5.7 mtt180 61.31 67.26 1.43 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.279 -0.888 . . . . 0.0 109.499 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.502 ' HD2' HG13 ' A' ' 43' ' ' VAL . 35.4 Cg_endo -77.78 165.67 26.38 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.647 2.231 . . . . 0.0 110.427 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 1.02 ' O ' HD22 ' A' ' 50' ' ' LEU . 8.3 m-20 -107.62 11.08 28.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.337 -0.852 . . . . 0.0 109.548 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.02 HD22 ' O ' ' A' ' 49' ' ' ASP . 1.3 mm? -140.37 128.69 22.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 109.506 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.574 ' HB ' HG22 ' A' ' 78' ' ' VAL . 3.9 t -129.42 151.1 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.25 -0.906 . . . . 0.0 109.509 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.622 HD12 ' O ' ' A' ' 7' ' ' LEU . 1.3 mt -121.14 97.65 5.62 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.197 -0.939 . . . . 0.0 109.364 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.893 HD22 HG11 ' A' ' 78' ' ' VAL . 2.0 mp -89.92 128.45 36.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.316 -0.865 . . . . 0.0 109.647 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.455 ' O ' HG13 ' A' ' 57' ' ' ILE . 44.3 t0 -119.44 115.38 23.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.285 -0.884 . . . . 0.0 109.405 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.923 ' CG ' HG21 ' A' ' 82' ' ' THR . 17.1 mmt -67.72 -8.05 32.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.259 -0.901 . . . . 0.0 109.577 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.44 ' HB2' ' OD2' ' A' ' 54' ' ' ASP . 16.7 mmtp -76.66 1.14 17.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -0.896 . . . . 0.0 109.633 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.607 HD11 HG12 ' A' ' 9' ' ' VAL . 34.0 mt -75.32 118.27 69.47 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.11 -0.994 . . . . 0.0 109.382 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.452 ' HD2' ' CG ' ' A' ' 11' ' ' ASP . 35.7 Cg_endo -77.97 143.34 20.5 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.395 2.063 . . . . 0.0 110.469 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 121.66 -54.44 0.68 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.585 ' HE1' HG21 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -155.56 175.18 14.22 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.183 -1.187 . . . . 0.0 109.509 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -89.9 169.09 11.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.265 -0.897 . . . . 0.0 109.477 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.536 ' HA2' ' CD1' ' A' ' 65' ' ' ILE . . . -97.79 -7.02 56.92 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.4 ' HA ' HD13 ' A' ' 63' ' ' ILE . 31.2 mm -54.28 -64.82 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.155 -1.203 . . . . 0.0 109.495 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 67' ' ' LYS . 1.3 pt-20 -47.92 -35.7 11.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.237 -0.914 . . . . 0.0 109.467 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.536 ' CD1' ' HA2' ' A' ' 62' ' ' GLY . 16.0 mt -53.97 -57.19 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.226 -0.921 . . . . 0.0 109.506 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 1.039 HD21 HG11 ' A' ' 78' ' ' VAL . 31.3 mt -52.51 -26.21 12.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.27 -0.894 . . . . 0.0 109.634 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.886 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -73.76 -37.37 65.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.211 -0.93 . . . . 0.0 109.793 -179.801 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.677 ' HB3' HD22 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -73.15 -50.73 21.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.19 -0.944 . . . . 0.0 109.731 -179.792 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.831 ' SD ' HD23 ' A' ' 66' ' ' LEU . 3.9 ptp -64.43 -35.81 82.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.198 -0.939 . . . . 0.0 109.759 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.51 ' HG3' ' N ' ' A' ' 71' ' ' VAL . 15.1 ptpt -71.4 -34.8 70.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.206 -0.934 . . . . 0.0 109.437 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.886 HG23 ' O ' ' A' ' 67' ' ' LYS . 71.7 t -70.12 -31.02 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.193 -0.942 . . . . 0.0 109.493 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 68' ' ' ARG . 10.4 mt -90.0 -17.85 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.214 -0.929 . . . . 0.0 109.468 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -166.46 122.9 1.27 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.299 -0.876 . . . . 0.0 109.448 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -89.9 -11.51 41.63 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.187 -0.945 . . . . 0.0 109.439 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -92.97 44.49 1.15 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.302 -0.874 . . . . 0.0 109.5 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.552 ' O ' HG23 ' A' ' 76' ' ' ILE . 0.5 OUTLIER -121.89 120.03 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 109.44 -179.947 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.617 ' CG ' HD11 ' A' ' 99' ' ' LEU . 9.8 mtt180 -84.65 143.3 29.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.346 -0.846 . . . . 0.0 109.518 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 1.039 HG11 HD21 ' A' ' 66' ' ' LEU . 53.5 t -138.2 124.77 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.235 -0.915 . . . . 0.0 109.534 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.788 HG23 HG23 ' A' ' 100' ' ' THR . 70.6 mt -101.74 156.62 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.224 -0.923 . . . . 0.0 109.4 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.585 ' HB ' ' CG ' ' A' ' 101' ' ' HIS . 0.6 OUTLIER -114.94 115.25 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -0.929 . . . . 0.0 109.39 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.498 ' SD ' ' CZ ' ' A' ' 106' ' ' PHE . 4.3 mtm -95.97 58.75 1.92 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.226 -0.921 . . . . 0.0 109.506 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.923 HG21 ' CG ' ' A' ' 55' ' ' MET . 12.5 t -169.04 49.28 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.239 -0.913 . . . . 0.0 109.479 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.781 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . -67.7 -65.67 0.66 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.22 -0.925 . . . . 0.0 109.502 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.413 ' C ' ' O ' ' A' ' 83' ' ' ALA . 0.5 OUTLIER -44.0 104.56 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 109.521 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 159.85 -89.83 0.11 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -124.27 116.18 22.24 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.227 -1.161 . . . . 0.0 109.502 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.14 78.35 2.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.209 -0.932 . . . . 0.0 109.484 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -136.5 -50.99 0.69 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.261 -0.899 . . . . 0.0 109.403 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 4.5 ptt? -87.83 0.17 56.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.282 -0.886 . . . . 0.0 109.617 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.602 HG23 ' HD1' ' A' ' 101' ' ' HIS . 48.8 mt -74.59 -56.2 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.176 -0.952 . . . . 0.0 109.534 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -53.87 -39.57 65.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.34 -0.85 . . . . 0.0 109.494 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.457 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 1.1 tp10 -78.96 -24.78 43.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.295 -0.878 . . . . 0.0 109.432 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.7 m -72.22 -28.34 63.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.298 -0.876 . . . . 0.0 109.474 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.796 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 5.8 mtpp -68.2 -67.42 0.47 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.268 -0.895 . . . . 0.0 109.464 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 94' ' ' LYS . 1.7 pt-20 -44.08 -26.74 0.32 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.355 -0.841 . . . . 0.0 109.554 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 92' ' ' GLU . 65.9 mt -73.82 -52.36 13.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.33 -0.856 . . . . 0.0 109.533 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 169.18 36.1 0.02 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.796 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -104.39 103.35 13.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.247 -1.149 . . . . 0.0 109.437 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.617 HD11 ' CG ' ' A' ' 77' ' ' ARG . 17.0 mt -53.08 -55.42 24.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.237 -0.914 . . . . 0.0 109.472 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.788 HG23 HG23 ' A' ' 79' ' ' ILE . 7.0 t -149.25 177.65 9.46 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.288 -0.883 . . . . 0.0 109.469 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.602 ' HD1' HG23 ' A' ' 90' ' ' ILE . 3.4 t-160 -132.1 90.14 2.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 0.0 109.431 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.747 ' HE1' HG21 ' A' ' 100' ' ' THR . 43.0 m-85 -77.57 160.75 28.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.221 -0.924 . . . . 0.0 109.485 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.781 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -145.44 -148.62 0.25 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.315 -0.865 . . . . 0.0 109.334 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.415 ' HD2' ' HA ' ' A' ' 105' ' ' PRO . 0.2 OUTLIER -104.03 146.65 32.95 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.205 -0.934 . . . . 0.0 109.447 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.415 ' HA ' ' HD2' ' A' ' 104' ' ' LYS . 35.5 Cg_endo -77.85 173.8 55.36 Favored 'Cis proline' 0 C--N 1.31 -1.466 0 C-N-CA 123.229 -1.571 . . . . 0.0 110.365 0.05 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.688 ' CZ ' HD12 ' A' ' 111' ' ' ILE . 0.3 OUTLIER -102.84 104.58 14.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.317 -0.864 . . . . 0.0 109.531 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.474 ' O ' HG12 ' A' ' 111' ' ' ILE . 63.3 t0 -89.95 109.74 20.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.278 -0.889 . . . . 0.0 109.331 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.864 HD11 HD12 ' A' ' 18' ' ' LEU . 14.8 mm -47.92 -23.65 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 109.55 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.429 ' O ' ' OD2' ' A' ' 113' ' ' ASP . 37.3 m-20 -76.39 -43.37 40.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.212 -0.93 . . . . 0.0 109.516 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.428 ' HB2' ' HB3' ' A' ' 107' ' ' ASP . 1.4 tt0 -69.64 -25.76 64.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.282 -0.886 . . . . 0.0 109.491 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.688 HD12 ' CZ ' ' A' ' 106' ' ' PHE . 13.4 mm -75.35 -57.9 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.211 -0.931 . . . . 0.0 109.493 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.476 ' O ' ' HG3' ' A' ' 116' ' ' LYS . 1.4 ptt85 -61.27 -28.07 68.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.302 -0.874 . . . . 0.0 109.585 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.429 ' OD2' ' O ' ' A' ' 109' ' ' ASP . 53.6 m-20 -68.28 -56.27 9.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.242 -0.911 . . . . 0.0 109.416 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.642 ' HB2' ' HZ ' ' A' ' 102' ' ' PHE . . . -56.34 -53.69 54.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.213 -0.93 . . . . 0.0 109.531 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.1 t -52.68 -39.92 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.232 -0.918 . . . . 0.0 109.502 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.476 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 0.6 OUTLIER -65.22 -33.56 76.29 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.327 -0.858 . . . . 0.0 109.554 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.23 -20.56 51.51 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.22 -0.925 . . . . 0.0 109.487 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.582 ' CG ' HD13 ' A' ' 99' ' ' LEU . 38.2 m-85 -89.68 -71.22 0.62 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.249 -0.907 . . . . 0.0 109.471 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.528 HD12 ' HD2' ' A' ' 120' ' ' PRO . 49.2 tp -90.05 112.49 52.68 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.248 -0.908 . . . . 0.0 109.37 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.528 ' HD2' HD12 ' A' ' 119' ' ' LEU . 35.6 Cg_endo -77.9 132.63 11.93 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.34 2.027 . . . . 0.0 110.424 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.509 ' HA ' HD23 ' A' ' 121' ' ' LEU . 4.1 mt -88.75 -164.02 1.07 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.292 -0.88 . . . . 0.0 109.455 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.518 ' HD2' ' N ' ' A' ' 123' ' ' SER . 5.8 tptm -93.08 127.14 38.51 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.216 -0.928 . . . . 0.0 108.853 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.518 ' N ' ' HD2' ' A' ' 122' ' ' LYS . 31.3 t 61.35 -89.36 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.314 -0.866 . . . . 0.0 109.459 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.9 m120 . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.508 -179.993 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.404 ' O ' ' HB2' ' A' ' 2' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.404 ' HB2' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER 66.79 -86.89 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 0.0 109.418 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 67.08 145.79 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.198 -0.939 . . . . 0.0 109.425 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 1.012 ' CG ' HD21 ' A' ' 119' ' ' LEU . 0.4 OUTLIER 46.89 83.55 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.264 -0.898 . . . . 0.0 109.496 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.49 ' HB3' ' HB3' ' A' ' 48' ' ' PRO . 3.9 mtpt -94.52 139.16 31.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.22 -0.925 . . . . 0.0 109.466 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.859 HG23 ' HB3' ' A' ' 50' ' ' LEU . 84.4 mt -150.07 153.73 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.252 -0.905 . . . . 0.0 109.498 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.738 HD12 ' HB2' ' A' ' 31' ' ' PHE . 0.6 OUTLIER -136.48 150.5 48.72 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.283 -0.885 . . . . 0.0 109.438 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.75 HD13 ' HB3' ' A' ' 19' ' ' LEU . 7.8 mt -129.43 122.05 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -0.892 . . . . 0.0 109.407 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 3.3 t -106.42 122.21 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.253 -0.904 . . . . 0.0 109.58 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.452 ' OD2' HD13 ' A' ' 15' ' ' ILE . 0.4 OUTLIER -145.86 -151.71 0.39 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.246 -0.909 . . . . 0.0 109.408 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.458 ' CG ' ' HD2' ' A' ' 58' ' ' PRO . 6.3 p-10 -161.65 -46.69 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.267 -0.895 . . . . 0.0 109.449 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.4 tp60 -82.71 116.6 22.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.316 -0.865 . . . . 0.0 109.486 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.594 ' CZ ' HG13 ' A' ' 17' ' ' ILE . 8.5 t80 -43.91 143.33 1.11 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.243 -0.91 . . . . 0.0 109.434 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.476 ' N ' ' CD1' ' A' ' 13' ' ' TYR . . . 126.96 -46.48 1.08 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.938 HG23 HD13 ' A' ' 19' ' ' LEU . 2.2 mt -84.69 -45.86 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.293 -1.122 . . . . 0.0 109.35 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 1.116 ' NH2' ' HB2' ' A' ' 34' ' ' ALA . 1.5 mtp180 -58.25 -29.44 65.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.308 -0.87 . . . . 0.0 109.395 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.594 HG13 ' CZ ' ' A' ' 13' ' ' TYR . 3.1 mm -90.47 -59.56 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -0.894 . . . . 0.0 109.657 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.763 ' O ' HG23 ' A' ' 22' ' ' VAL . 87.0 mt -46.74 -58.48 3.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.91 . . . . 0.0 109.806 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.938 HD13 HG23 ' A' ' 15' ' ' ILE . 6.3 mp -55.02 -32.49 61.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.188 -0.945 . . . . 0.0 109.689 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.464 ' HB3' ' O ' ' A' ' 17' ' ' ILE . 17.6 t30 -65.69 -70.82 0.22 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.913 . . . . 0.0 109.723 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.486 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 0.1 OUTLIER -43.28 -40.24 3.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.185 -0.947 . . . . 0.0 109.745 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.763 HG23 ' O ' ' A' ' 18' ' ' LEU . 59.8 t -57.58 -58.41 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.913 . . . . 0.0 109.51 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.781 ' CB ' HG21 ' A' ' 30' ' ' THR . 38.0 m-85 -76.18 0.67 18.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.165 -0.959 . . . . 0.0 109.633 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.486 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 0.7 OUTLIER -89.01 -38.88 14.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.078 -1.014 . . . . 0.0 109.535 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.8 tptt -85.55 -44.13 12.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 109.42 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.465 ' HB3' ' CD2' ' A' ' 28' ' ' TYR . 0.4 OUTLIER -55.07 -21.4 12.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.179 -0.95 . . . . 0.0 109.391 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.473 ' O ' ' CG ' ' A' ' 28' ' ' TYR . . . 101.38 72.26 0.96 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.889 ' CE1' HD13 ' A' ' 121' ' ' LEU . 97.9 m-85 -156.66 134.29 10.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.293 -1.122 . . . . 0.0 109.58 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -90.96 82.81 5.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.342 -0.849 . . . . 0.0 109.182 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.781 HG21 ' CB ' ' A' ' 23' ' ' PHE . 7.4 p -89.9 173.22 8.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -0.897 . . . . 0.0 109.657 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.738 ' HB2' HD12 ' A' ' 7' ' ' LEU . 11.7 m-85 -130.21 170.06 14.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.317 -0.864 . . . . 0.0 109.394 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.435 ' HG2' ' O ' ' A' ' 32' ' ' GLN . 3.3 pt20 -131.41 135.82 47.5 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.2 -0.938 . . . . 0.0 109.682 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.613 ' HB1' ' OE1' ' A' ' 38' ' ' GLN . . . -155.91 130.56 9.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.393 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 1.116 ' HB2' ' NH2' ' A' ' 16' ' ' ARG . . . -82.32 -70.71 0.53 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.156 -0.965 . . . . 0.0 109.483 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.478 ' OD1' ' HB3' ' A' ' 38' ' ' GLN . 18.8 p-10 -60.54 170.94 1.23 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.223 -0.923 . . . . 0.0 109.577 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.715 ' O ' HD12 ' A' ' 40' ' ' LEU . . . -97.84 -17.73 29.53 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.9 tt -73.99 -43.59 57.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.314 -1.109 . . . . 0.0 109.401 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.613 ' OE1' ' HB1' ' A' ' 33' ' ' ALA . 1.0 OUTLIER -77.59 -35.04 53.35 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.19 -0.944 . . . . 0.0 108.893 179.77 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.464 ' HB1' HG22 ' A' ' 9' ' ' VAL . . . -62.57 -46.34 88.79 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.278 -0.889 . . . . 0.0 108.626 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.771 HD11 HG23 ' A' ' 65' ' ' ILE . 7.2 mt -61.54 -45.36 94.51 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -49.68 -43.76 47.5 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.203 -0.936 . . . . 0.0 108.856 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.631 HG21 ' CD1' ' A' ' 7' ' ' LEU . 64.0 mt -64.57 -36.23 76.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.336 -0.853 . . . . 0.0 108.881 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 69.0 t -74.5 -11.87 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.251 -0.905 . . . . 0.0 109.188 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 82.9 m -90.38 -31.5 16.84 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.201 -0.937 . . . . 0.0 109.412 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.22 -53.2 4.67 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.32 -0.862 . . . . 0.0 109.867 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.571 ' O ' ' C ' ' A' ' 47' ' ' ARG . 0.4 OUTLIER -97.17 26.93 4.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.183 -0.948 . . . . 0.0 109.627 -179.667 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.571 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -9.69 78.55 0.03 OUTLIER Pre-proline 0 N--CA 1.504 2.266 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.534 ' N ' ' O ' ' A' ' 46' ' ' GLU . 34.3 Cg_endo -75.88 162.66 34.56 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.684 2.256 . . . . 0.0 110.284 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 4.6 m-20 -92.49 -14.12 28.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 109.657 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.859 ' HB3' HG23 ' A' ' 6' ' ' ILE . 4.5 tp -114.16 126.33 54.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.215 -0.928 . . . . 0.0 109.554 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.755 HG11 ' CE ' ' A' ' 69' ' ' MET . 6.0 t -136.83 123.83 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.284 -0.885 . . . . 0.0 109.378 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.738 HD12 ' O ' ' A' ' 7' ' ' LEU . 1.1 mt -103.11 134.78 45.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.212 -0.93 . . . . 0.0 109.584 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.577 HD21 ' HB ' ' A' ' 65' ' ' ILE . 1.4 mp -124.4 135.13 53.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.264 -0.898 . . . . 0.0 109.466 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.461 ' O ' HG13 ' A' ' 57' ' ' ILE . 31.1 t0 -123.61 103.96 8.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.215 -0.928 . . . . 0.0 109.484 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.77 ' HB2' HG21 ' A' ' 82' ' ' THR . 19.2 mmt -62.69 -19.06 63.5 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.17 -0.957 . . . . 0.0 109.463 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.44 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 1.1 mmmp? -54.89 -25.19 27.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 0.0 109.45 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 54' ' ' ASP . 9.8 mt -43.06 103.21 0.3 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.27 -0.893 . . . . 0.0 109.501 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.458 ' HD2' ' CG ' ' A' ' 11' ' ' ASP . 35.2 Cg_endo -77.52 97.73 1.16 Allowed 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.437 2.092 . . . . 0.0 110.464 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 155.62 -20.43 0.53 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.408 ' SD ' ' O ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -166.59 150.93 7.43 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.278 -1.131 . . . . 0.0 109.475 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.408 ' O ' ' SD ' ' A' ' 60' ' ' MET . 1.1 m-20 -85.04 144.0 28.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.186 -0.946 . . . . 0.0 109.57 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -96.56 12.48 66.22 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.2 mm -69.36 -39.43 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.245 -1.15 . . . . 0.0 109.451 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -68.11 -34.65 76.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.262 -0.899 . . . . 0.0 109.494 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.771 HG23 HD11 ' A' ' 40' ' ' LEU . 9.3 mt -54.14 -63.95 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.923 . . . . 0.0 109.492 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.538 HD21 HG11 ' A' ' 78' ' ' VAL . 21.0 mt -46.63 -49.97 18.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.203 -0.936 . . . . 0.0 109.429 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.432 ' O ' HG23 ' A' ' 71' ' ' VAL . 2.5 ttmm -44.09 -50.51 8.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.182 -0.949 . . . . 0.0 109.508 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.432 ' O ' HG13 ' A' ' 72' ' ' ILE . 2.4 mpt_? -60.62 -39.25 87.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.926 . . . . 0.0 109.457 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.755 ' CE ' HG11 ' A' ' 51' ' ' VAL . 0.7 OUTLIER -61.79 -23.74 66.41 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -0.894 . . . . 0.0 109.438 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.534 ' CE ' ' HB3' ' A' ' 96' ' ' LEU . 21.8 mmtm -81.15 -45.29 16.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.3 -0.875 . . . . 0.0 109.473 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 67' ' ' LYS . 2.6 t -65.1 -22.64 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.278 -0.889 . . . . 0.0 109.473 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 68' ' ' ARG . 78.8 mt -88.71 -41.89 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.258 -0.901 . . . . 0.0 109.415 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.82 130.95 11.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.19 -0.944 . . . . 0.0 109.469 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -90.02 -12.55 38.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.2 -0.937 . . . . 0.0 109.465 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.405 ' OD1' ' N ' ' A' ' 75' ' ' ASN . 1.8 m120 -116.58 55.5 0.82 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.409 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.0 tp -110.93 145.78 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.328 -0.858 . . . . 0.0 109.411 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.859 ' CB ' HD11 ' A' ' 99' ' ' LEU . 2.3 mtm180 -89.19 115.02 26.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.195 -0.941 . . . . 0.0 109.483 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.538 HG11 HD21 ' A' ' 66' ' ' LEU . 16.9 t -131.1 115.83 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.221 -0.925 . . . . 0.0 109.531 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.826 HG12 HG22 ' A' ' 100' ' ' THR . 43.9 mt -100.38 132.59 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.309 -0.87 . . . . 0.0 109.445 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.921 HD12 ' ND1' ' A' ' 101' ' ' HIS . 1.0 OUTLIER -89.88 172.97 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.177 -0.952 . . . . 0.0 109.364 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.467 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 13.7 mtm -147.46 52.18 1.06 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.161 -0.962 . . . . 0.0 109.565 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.77 HG21 ' HB2' ' A' ' 55' ' ' MET . 14.7 t -162.68 40.66 0.11 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.185 -0.947 . . . . 0.0 109.519 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.035 ' HB2' ' CD2' ' A' ' 101' ' ' HIS . . . -90.15 40.79 1.02 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.278 -0.889 . . . . 0.0 109.483 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.561 ' CD1' ' O ' ' A' ' 104' ' ' LYS . 2.6 t80 -90.0 72.89 7.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.22 -0.925 . . . . 0.0 109.464 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.42 ' O ' ' C ' ' A' ' 86' ' ' GLU . . . 83.29 -69.92 3.28 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 85' ' ' GLY . 1.7 pm0 -43.81 104.9 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.195 -1.179 . . . . 0.0 109.567 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.844 ' H ' HD23 ' A' ' 87' ' ' LEU . 2.6 pt? -126.28 137.75 53.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.501 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -147.24 -78.21 0.16 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.163 -0.961 . . . . 0.0 109.443 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.468 ' O ' ' CB ' ' A' ' 93' ' ' SER . 6.5 mtt -102.98 37.75 1.89 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.279 -0.888 . . . . 0.0 109.446 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.658 HG23 ' HD1' ' A' ' 101' ' ' HIS . 57.9 mt -89.95 -60.71 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.257 -0.902 . . . . 0.0 109.462 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.449 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 1.1 tp60 -44.32 -62.95 0.99 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -0.897 . . . . 0.0 109.452 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.464 ' O ' HD23 ' A' ' 96' ' ' LEU . 0.3 OUTLIER -60.84 -38.62 86.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.916 . . . . 0.0 109.512 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.524 ' HB3' ' HB2' ' A' ' 98' ' ' ALA . 0.6 OUTLIER -44.0 -26.67 0.3 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.209 -0.932 . . . . 0.0 109.429 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 91' ' ' GLN . 0.0 OUTLIER -53.08 -62.12 1.86 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.175 -0.953 . . . . 0.0 109.457 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.474 ' HG3' ' CD2' ' A' ' 96' ' ' LEU . 1.2 pt-20 -63.19 -35.02 78.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.187 -0.946 . . . . 0.0 109.509 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.538 HD22 ' N ' ' A' ' 96' ' ' LEU . 3.7 mm? -61.33 -24.84 66.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.221 -0.924 . . . . 0.0 109.511 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 130.13 42.33 0.22 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.524 ' HB2' ' HB3' ' A' ' 93' ' ' SER . . . -113.44 110.65 20.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -1.149 . . . . 0.0 109.466 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.859 HD11 ' CB ' ' A' ' 77' ' ' ARG . 3.6 mt -73.25 -72.25 0.27 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.186 -0.946 . . . . 0.0 109.577 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.826 HG22 HG12 ' A' ' 79' ' ' ILE . 12.7 t -130.46 147.51 52.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.225 -0.922 . . . . 0.0 109.495 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 1.035 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 3.6 t-160 -111.21 89.54 3.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.295 -0.878 . . . . 0.0 109.339 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.664 ' CD2' HD13 ' A' ' 111' ' ' ILE . 35.5 m-85 -68.96 153.34 43.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.226 -0.921 . . . . 0.0 109.531 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.564 ' HB2' ' CA ' ' A' ' 83' ' ' ALA . . . -139.52 151.97 46.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.239 -0.913 . . . . 0.0 109.472 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.561 ' O ' ' CD1' ' A' ' 84' ' ' TYR . 36.1 tttm -85.3 141.63 37.21 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 0.0 109.353 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.489 ' HA ' ' CG ' ' A' ' 104' ' ' LYS . 35.8 Cg_endo -77.96 137.39 46.59 Favored 'Cis proline' 0 C--N 1.31 -1.456 0 C-N-CA 123.39 -1.504 . . . . 0.0 110.367 0.006 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -114.54 -170.01 1.65 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.238 -0.914 . . . . 0.0 109.489 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -130.05 121.08 25.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.0 109.413 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.446 ' HA ' HD13 ' A' ' 108' ' ' ILE . 20.5 mm -50.11 -30.44 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.207 -0.933 . . . . 0.0 109.52 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.41 ' O ' ' HG2' ' A' ' 112' ' ' ARG . 33.4 m-20 -66.6 -42.4 86.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.216 -0.928 . . . . 0.0 109.433 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.429 ' HB3' ' CE1' ' A' ' 102' ' ' PHE . 4.0 mt-10 -65.69 -35.18 80.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.289 -0.882 . . . . 0.0 109.467 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.664 HD13 ' CD2' ' A' ' 102' ' ' PHE . 22.1 mm -64.9 -60.36 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.295 -0.878 . . . . 0.0 109.496 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 1.1 ptm180 -56.81 -30.38 63.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 0.0 109.482 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -62.99 -54.92 30.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -0.895 . . . . 0.0 109.477 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.562 ' O ' ' CD2' ' A' ' 118' ' ' TYR . . . -60.01 -32.84 71.25 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.163 -0.96 . . . . 0.0 109.474 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.804 HG22 HD21 ' A' ' 50' ' ' LEU . 58.2 t -67.42 -35.0 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.23 -0.919 . . . . 0.0 109.473 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.422 ' HE2' ' OE2' ' A' ' 26' ' ' GLU . 1.9 mttt -75.48 -30.05 59.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.279 -0.888 . . . . 0.0 109.499 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.68 -34.08 62.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.219 -0.926 . . . . 0.0 109.46 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.562 ' CD2' ' O ' ' A' ' 114' ' ' ALA . 46.6 m-85 -89.92 -65.59 1.0 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.294 -0.879 . . . . 0.0 109.466 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 1.012 HD21 ' CG ' ' A' ' 4' ' ' GLU . 2.8 tt -90.01 112.42 52.24 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.285 -0.884 . . . . 0.0 109.475 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 118' ' ' TYR . 35.7 Cg_endo -78.06 164.06 27.56 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.362 2.042 . . . . 0.0 110.396 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.889 HD13 ' CE1' ' A' ' 28' ' ' TYR . 1.3 tp -151.09 98.04 2.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.301 -0.875 . . . . 0.0 109.48 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -129.83 61.23 1.57 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.316 -0.865 . . . . 0.0 109.446 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.463 ' O ' ' CB ' ' A' ' 124' ' ' ASN . 0.8 OUTLIER -134.17 71.72 1.46 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.293 -0.88 . . . . 0.0 109.443 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 123' ' ' SER . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.041 -0.981 . . . . 0.0 109.439 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.421 ' CG ' ' O ' ' A' ' 1' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -109.04 66.25 0.63 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.295 -0.878 . . . . 0.0 109.477 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.471 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 8.2 m-20 -117.0 59.9 0.75 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 109.531 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.615 ' CD ' HD23 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -44.03 119.51 1.78 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.215 -0.928 . . . . 0.0 109.454 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.49 ' CG ' ' HA ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -114.12 132.57 56.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.246 -0.909 . . . . 0.0 109.447 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.676 HG23 ' HB3' ' A' ' 50' ' ' LEU . 52.5 mt -145.35 164.7 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.237 -0.915 . . . . 0.0 109.509 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.926 HD13 ' N ' ' A' ' 8' ' ' ILE . 1.0 OUTLIER -131.08 128.55 40.44 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.241 -0.912 . . . . 0.0 109.451 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.926 ' N ' HD13 ' A' ' 7' ' ' LEU . 12.1 mt -115.46 108.44 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.186 -0.946 . . . . 0.0 109.464 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.83 ' HA ' ' HB3' ' A' ' 33' ' ' ALA . 17.5 t -92.44 128.63 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.919 . . . . 0.0 109.529 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.533 ' OD2' HD13 ' A' ' 15' ' ' ILE . 2.1 t70 -174.94 123.43 0.24 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 109.44 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.982 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . 2.6 p30 -114.68 81.43 1.56 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.318 -0.864 . . . . 0.0 109.601 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.5 ' HG2' ' N ' ' A' ' 13' ' ' TYR . 7.5 tt0 -175.99 -104.51 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.207 -0.933 . . . . 0.0 109.411 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.5 ' N ' ' HG2' ' A' ' 12' ' ' GLN . 37.4 t80 -179.54 120.47 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.85 -1.156 . . . . 0.0 109.543 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.485 ' O ' HD13 ' A' ' 18' ' ' LEU . . . 135.73 -50.44 0.85 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.634 HG23 HD13 ' A' ' 19' ' ' LEU . 2.0 mp -81.28 -54.44 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.179 -1.189 . . . . 0.0 109.658 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.519 ' CD ' ' O ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -50.33 -29.75 10.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.165 -0.959 . . . . 0.0 109.757 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.59 ' N ' HD13 ' A' ' 17' ' ' ILE . 2.6 mm -90.2 -64.76 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.183 -0.948 . . . . 0.0 109.887 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.945 ' O ' HG23 ' A' ' 22' ' ' VAL . 6.9 mp -48.55 -60.46 2.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.229 -0.92 . . . . 0.0 109.801 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.739 ' HB3' HD13 ' A' ' 8' ' ' ILE . 0.5 OUTLIER -53.87 -28.85 38.63 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 0.0 109.64 -179.773 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 28.4 t30 -69.2 -71.88 0.21 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.903 . . . . 0.0 109.665 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.478 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 2.5 tt0 -43.06 -38.04 2.19 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.317 -0.864 . . . . 0.0 109.71 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.945 HG23 ' O ' ' A' ' 18' ' ' LEU . 19.0 t -61.77 -55.63 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.243 -0.911 . . . . 0.0 109.553 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.646 ' CB ' HG21 ' A' ' 30' ' ' THR . 23.6 m-85 -77.7 1.94 18.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 109.566 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.478 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 1.5 m-20 -90.06 -48.96 6.86 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.189 -0.944 . . . . 0.0 109.474 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.26 -46.13 24.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 109.544 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.505 ' HB3' ' CD1' ' A' ' 28' ' ' TYR . 1.8 tt0 -52.07 -22.65 4.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.2 -0.937 . . . . 0.0 109.469 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.436 ' C ' ' CD1' ' A' ' 28' ' ' TYR . . . 100.09 72.78 1.02 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.59 ' CE2' ' HG ' ' A' ' 121' ' ' LEU . 96.2 m-85 -154.55 134.62 13.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -1.17 . . . . 0.0 109.473 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.448 ' HB2' ' O ' ' A' ' 4' ' ' GLU . 12.4 mm100 -94.16 83.08 4.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 109.217 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.646 HG21 ' CB ' ' A' ' 23' ' ' PHE . 5.7 p -89.95 154.71 19.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.895 . . . . 0.0 109.604 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.796 ' HB2' HD22 ' A' ' 7' ' ' LEU . 38.6 m-85 -113.53 -171.25 1.85 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.274 -0.891 . . . . 0.0 109.283 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.426 ' OE1' ' HG2' ' A' ' 16' ' ' ARG . 11.8 mt-30 -124.44 154.78 39.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 109.552 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.83 ' HB3' ' HA ' ' A' ' 9' ' ' VAL . . . -152.62 -165.37 2.18 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.297 -0.877 . . . . 0.0 109.392 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.982 ' HB1' ' HB3' ' A' ' 11' ' ' ASP . . . 164.34 -62.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.905 . . . . 0.0 109.597 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.43 ' H ' ' ND2' ' A' ' 35' ' ' ASN . 3.9 p30 -71.15 -4.64 26.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.185 -0.947 . . . . 0.0 109.577 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 37' ' ' LEU . . . 86.29 -63.28 4.2 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.46 ' HA ' HD13 ' A' ' 37' ' ' LEU . 1.0 OUTLIER -44.54 -32.28 1.38 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.207 -1.172 . . . . 0.0 109.405 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.407 ' O ' ' C ' ' A' ' 39' ' ' ALA . 1.0 OUTLIER -70.22 -60.32 2.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.498 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.837 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -44.02 -45.22 7.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.224 -0.923 . . . . 0.0 109.482 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.7 mt -61.55 -44.06 97.72 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -0.871 . . . . 0.0 109.45 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -55.64 -57.57 11.42 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.287 -0.883 . . . . 0.0 109.488 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.419 ' CG2' HD23 ' A' ' 7' ' ' LEU . 2.5 mp -61.4 -20.83 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.285 -0.884 . . . . 0.0 109.482 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.837 HG23 ' O ' ' A' ' 39' ' ' ALA . 53.5 t -79.63 -26.65 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 109.495 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 85.5 m -89.99 -24.21 21.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -0.901 . . . . 0.0 109.448 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.8 mtpt -89.97 -27.32 19.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.225 -0.922 . . . . 0.0 109.554 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -119.3 -34.37 3.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.206 -0.934 . . . . 0.0 109.506 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 33.2 mtm180 58.18 71.07 1.09 Allowed Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.173 -0.954 . . . . 0.0 109.476 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.526 ' CD ' ' HA ' ' A' ' 43' ' ' VAL . 35.3 Cg_endo -78.07 157.69 30.43 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.599 2.199 . . . . 0.0 110.328 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 0.4 OUTLIER -94.08 -9.61 36.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.194 -0.941 . . . . 0.0 109.512 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.676 ' HB3' HG23 ' A' ' 6' ' ' ILE . 6.5 tp -123.29 114.81 20.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.906 . . . . 0.0 109.504 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.851 HG11 ' SD ' ' A' ' 69' ' ' MET . 1.7 t -121.21 111.41 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.263 -0.898 . . . . 0.0 109.443 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.546 HD12 ' O ' ' A' ' 7' ' ' LEU . 0.7 OUTLIER -89.97 109.62 20.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.291 -0.881 . . . . 0.0 109.406 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.721 HD22 ' N ' ' A' ' 53' ' ' LEU . 3.0 mm? -95.28 136.15 35.98 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.201 -0.937 . . . . 0.0 109.489 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.45 ' O ' HG13 ' A' ' 57' ' ' ILE . 30.2 t0 -113.9 117.7 32.12 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.31 -0.869 . . . . 0.0 109.446 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.918 ' CG ' HG21 ' A' ' 82' ' ' THR . 18.0 mmt -77.58 -7.99 57.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.175 -0.953 . . . . 0.0 109.489 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 57' ' ' ILE . 4.6 mtpm? -68.7 -15.56 63.56 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.308 -0.87 . . . . 0.0 109.527 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.878 HG23 ' OD2' ' A' ' 11' ' ' ASP . 80.5 mt -43.87 113.78 1.63 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.256 -0.902 . . . . 0.0 109.37 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.453 ' HD2' ' CG ' ' A' ' 11' ' ' ASP . 36.0 Cg_endo -78.67 6.0 5.19 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.337 2.025 . . . . 0.0 110.509 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.659 ' H ' HG22 ' A' ' 57' ' ' ILE . . . -91.97 -43.97 4.28 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.528 ' CE ' HG21 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -169.58 -171.66 1.27 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.291 -1.123 . . . . 0.0 109.447 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -89.56 132.72 34.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.902 . . . . 0.0 109.431 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.36 10.89 60.07 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 25.5 mm -61.84 -38.44 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.197 -1.178 . . . . 0.0 109.487 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -68.7 -25.63 64.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.279 -0.888 . . . . 0.0 109.506 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.409 HG22 ' HE3' ' A' ' 69' ' ' MET . 70.9 mt -68.1 -64.92 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.184 -0.947 . . . . 0.0 109.505 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.966 HD21 HG11 ' A' ' 78' ' ' VAL . 2.4 mt -44.15 -34.45 1.84 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 0.0 109.531 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.518 ' O ' ' CG ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -64.02 -59.33 4.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -0.91 . . . . 0.0 109.465 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.0 mtt180 -49.57 -30.46 8.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.345 -0.847 . . . . 0.0 109.473 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.851 ' SD ' HG11 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -67.01 -60.73 2.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.874 . . . . 0.0 109.466 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.518 ' CG ' ' O ' ' A' ' 67' ' ' LYS . 16.4 ptpt -51.39 -31.43 22.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.186 -0.946 . . . . 0.0 109.455 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 49.9 t -66.57 -44.99 89.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.19 -0.944 . . . . 0.0 109.493 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.2 mt -70.23 -65.11 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.218 -0.926 . . . . 0.0 109.535 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -113.7 130.84 56.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.227 -0.921 . . . . 0.0 109.429 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -87.11 -22.4 25.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.952 . . . . 0.0 109.411 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.2 p30 -105.55 45.26 0.98 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -0.886 . . . . 0.0 109.438 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.467 HD12 ' O ' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -104.15 128.08 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.283 -0.886 . . . . 0.0 109.452 179.964 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.531 ' CA ' HD11 ' A' ' 99' ' ' LEU . 3.4 mpt_? -78.11 143.13 37.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.259 -0.901 . . . . 0.0 109.48 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.966 HG11 HD21 ' A' ' 66' ' ' LEU . 55.5 t -144.57 144.94 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.326 -0.859 . . . . 0.0 109.568 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.865 HG23 ' O ' ' A' ' 100' ' ' THR . 18.3 mt -128.95 139.02 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.292 -0.88 . . . . 0.0 109.393 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.904 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.3 OUTLIER -102.6 130.64 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.161 -0.962 . . . . 0.0 109.337 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.46 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -102.69 51.99 0.8 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.29 -0.881 . . . . 0.0 109.532 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.918 HG21 ' CG ' ' A' ' 55' ' ' MET . 10.6 t -161.7 44.05 0.16 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.945 . . . . 0.0 109.565 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.901 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . -49.92 -33.09 16.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.935 . . . . 0.0 109.412 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -84.55 -171.86 3.86 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.222 -0.924 . . . . 0.0 109.507 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.74 -75.97 1.09 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.25 131.86 4.51 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.253 -1.145 . . . . 0.0 109.501 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.556 ' HA ' ' CG2' ' A' ' 90' ' ' ILE . 0.2 OUTLIER -99.86 78.82 2.15 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.407 -0.808 . . . . 0.0 109.829 -179.554 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.41 -84.65 0.59 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.316 -0.865 . . . . 0.0 109.184 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.489 ' O ' ' CB ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -78.02 2.11 18.76 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.302 -0.874 . . . . 0.0 109.399 179.626 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.933 HD12 ' CE1' ' A' ' 101' ' ' HIS . 0.2 OUTLIER -90.39 -55.57 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.286 -0.884 . . . . 0.0 108.904 179.73 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.414 ' C ' ' O ' ' A' ' 90' ' ' ILE . 0.1 OUTLIER -45.02 -38.82 5.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.169 -0.957 . . . . 0.0 109.528 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -88.07 -40.8 13.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.203 -0.936 . . . . 0.0 109.541 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.834 ' HA ' HD12 ' A' ' 96' ' ' LEU . 2.9 m -53.05 -20.14 3.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 0.0 109.5 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.788 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 6.0 tttt -58.23 -53.8 54.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.186 -0.946 . . . . 0.0 109.477 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -76.78 -10.2 59.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.911 . . . . 0.0 109.481 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.834 HD12 ' HA ' ' A' ' 93' ' ' SER . 66.9 mt -75.4 -46.68 31.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.269 -0.895 . . . . 0.0 109.494 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 178.1 33.23 0.05 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.788 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -118.94 123.05 43.67 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.26 -1.141 . . . . 0.0 109.505 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.531 HD11 ' CA ' ' A' ' 77' ' ' ARG . 0.4 OUTLIER -90.08 -60.04 2.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 109.475 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.865 ' O ' HG23 ' A' ' 79' ' ' ILE . 21.2 m -117.79 138.13 52.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.213 -0.929 . . . . 0.0 109.582 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.933 ' CE1' HD12 ' A' ' 90' ' ' ILE . 3.9 t-160 -119.48 84.41 2.2 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.853 . . . . 0.0 109.254 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.849 ' CE2' HD13 ' A' ' 111' ' ' ILE . 22.5 m-85 -72.89 158.27 35.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.0 109.575 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.901 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -127.25 -148.73 0.39 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.241 -0.912 . . . . 0.0 109.368 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.0 tttm -128.17 131.89 24.04 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.258 -0.901 . . . . 0.0 109.369 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.75 -162.4 2.95 Favored 'Cis proline' 0 C--N 1.311 -1.423 0 C-N-CA 123.51 -1.454 . . . . 0.0 110.355 -0.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 106' ' ' PHE . 3.0 p90 -153.95 165.1 37.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.921 . . . . 0.0 109.477 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.473 ' O ' HG12 ' A' ' 111' ' ' ILE . 19.6 t0 -108.17 128.94 55.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.274 -0.891 . . . . 0.0 109.45 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.506 ' HA ' HD13 ' A' ' 108' ' ' ILE . 14.6 mm -61.53 -18.11 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.267 -0.896 . . . . 0.0 109.474 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 113' ' ' ASP . 33.1 m-20 -78.06 -37.72 46.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.162 -0.961 . . . . 0.0 109.435 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.419 ' HG2' ' CZ ' ' A' ' 102' ' ' PHE . 1.4 tt0 -72.53 -24.37 61.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.252 -0.905 . . . . 0.0 109.435 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.849 HD13 ' CE2' ' A' ' 102' ' ' PHE . 12.8 mm -79.58 -52.62 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -0.893 . . . . 0.0 109.48 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.434 ' HG2' ' O ' ' A' ' 108' ' ' ILE . 2.7 ptt85 -69.47 -24.43 63.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.178 -0.951 . . . . 0.0 109.473 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 109' ' ' ASP . 68.9 m-20 -75.93 -51.24 12.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 0.0 109.516 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.59 ' HB1' ' CE2' ' A' ' 118' ' ' TYR . . . -61.64 -46.96 87.54 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.303 -0.873 . . . . 0.0 109.601 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.671 HG22 HD21 ' A' ' 50' ' ' LEU . 68.0 t -58.42 -47.39 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.151 -0.968 . . . . 0.0 109.524 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.94 -30.48 70.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 109.493 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -83.17 -16.8 45.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.9 . . . . 0.0 109.426 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.59 ' CE2' ' HB1' ' A' ' 114' ' ' ALA . 17.5 m-85 -90.02 -72.86 0.54 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.348 -0.845 . . . . 0.0 109.531 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.527 ' CD1' ' HD2' ' A' ' 120' ' ' PRO . 6.1 tp -90.12 139.11 27.16 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.89 . . . . 0.0 109.533 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.527 ' HD2' ' CD1' ' A' ' 119' ' ' LEU . 35.6 Cg_endo -78.78 132.63 10.9 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.495 2.13 . . . . 0.0 110.409 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.963 HD13 ' O ' ' A' ' 121' ' ' LEU . 1.9 tm? -134.3 3.69 3.39 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.254 -0.904 . . . . 0.0 109.489 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.21 -168.57 0.65 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.079 -1.013 . . . . 0.0 109.496 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 98.8 p -81.56 150.15 28.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.247 -0.908 . . . . 0.0 109.522 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 34.1 p-10 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 117.913 -1.042 . . . . 0.0 109.44 -179.979 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.419 ' O ' ' O ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -73.67 151.26 40.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -0.926 . . . . 0.0 109.418 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.419 ' O ' ' O ' ' A' ' 2' ' ' MET . 4.6 p30 -47.77 172.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.295 -0.878 . . . . 0.0 109.449 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.573 ' HG3' HD22 ' A' ' 119' ' ' LEU . 5.4 mm-40 -136.1 114.66 11.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -0.884 . . . . 0.0 109.544 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.476 ' CB ' ' HB3' ' A' ' 48' ' ' PRO . 3.2 mtmm -89.99 157.28 17.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.908 . . . . 0.0 109.482 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.821 HD12 HG22 ' A' ' 30' ' ' THR . 55.3 mt -150.08 158.12 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -0.907 . . . . 0.0 109.453 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.989 ' HB3' HG13 ' A' ' 51' ' ' VAL . 1.0 OUTLIER -131.04 109.0 10.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.323 -0.861 . . . . 0.0 109.365 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.561 HD13 ' HB3' ' A' ' 19' ' ' LEU . 13.2 mt -89.91 113.47 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.235 -0.915 . . . . 0.0 109.444 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.947 HG12 HD11 ' A' ' 57' ' ' ILE . 37.1 t -109.39 97.99 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.221 -0.924 . . . . 0.0 109.392 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 11' ' ' ASP . 2.2 t0 -152.7 88.13 1.33 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.905 . . . . 0.0 109.509 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.528 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . 7.3 p-10 -44.29 -43.32 7.31 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.5 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -55.97 134.94 52.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.298 -0.876 . . . . 0.0 109.56 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.596 ' CE2' HG13 ' A' ' 17' ' ' ILE . 7.6 t80 -73.71 174.0 9.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.272 -0.892 . . . . 0.0 109.535 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.29 -38.52 3.2 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 1.052 HG23 HD13 ' A' ' 19' ' ' LEU . 2.3 mp -84.64 -48.39 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.332 -1.099 . . . . 0.0 109.443 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.464 ' O ' ' HB2' ' A' ' 20' ' ' ASN . 2.5 mtp180 -59.88 -26.79 66.15 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.255 -0.903 . . . . 0.0 109.584 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.596 HG13 ' CE2' ' A' ' 13' ' ' TYR . 3.7 mm -90.22 -57.16 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.25 -0.906 . . . . 0.0 109.74 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.818 ' O ' HG23 ' A' ' 22' ' ' VAL . 79.6 mt -54.18 -59.37 4.75 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -0.92 . . . . 0.0 109.706 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 1.052 HD13 HG23 ' A' ' 15' ' ' ILE . 4.5 mp -56.7 -19.31 15.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.243 -0.911 . . . . 0.0 109.602 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 25.9 t30 -78.2 -72.45 0.37 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.884 . . . . 0.0 109.637 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -48.29 -28.31 3.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -0.913 . . . . 0.0 109.554 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.843 HG21 ' CG2' ' A' ' 108' ' ' ILE . 63.7 t -70.61 -57.26 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.221 -0.925 . . . . 0.0 109.543 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.511 ' CZ ' HG22 ' A' ' 111' ' ' ILE . 15.5 m-85 -72.63 -3.09 22.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.276 -0.89 . . . . 0.0 109.585 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -80.08 -51.56 8.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.155 -0.966 . . . . 0.0 109.416 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.13 -22.01 53.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.292 -0.88 . . . . 0.0 109.451 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.511 ' O ' ' CD2' ' A' ' 121' ' ' LEU . 2.2 mt-10 -71.36 -33.47 69.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.233 -0.917 . . . . 0.0 109.464 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 110.02 61.93 0.51 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.616 ' CE2' HD22 ' A' ' 121' ' ' LEU . 98.8 m-85 -151.63 134.95 16.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.294 -1.121 . . . . 0.0 109.539 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -89.92 83.04 6.12 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.226 -0.922 . . . . 0.0 109.137 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.821 HG22 HD12 ' A' ' 6' ' ' ILE . 5.6 p -89.91 151.08 21.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.296 -0.877 . . . . 0.0 109.607 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.747 ' HB2' HD22 ' A' ' 7' ' ' LEU . 11.8 m-85 -115.85 -170.41 1.78 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.286 -0.884 . . . . 0.0 109.297 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -127.5 149.79 49.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.13 -0.981 . . . . 0.0 109.504 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.662 ' HB3' HG22 ' A' ' 9' ' ' VAL . . . -164.56 171.97 13.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.288 -0.882 . . . . 0.0 109.381 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.528 ' HB1' ' HB3' ' A' ' 11' ' ' ASP . . . -172.65 -34.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -0.908 . . . . 0.0 109.536 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.421 ' OD1' ' HB2' ' A' ' 37' ' ' LEU . 3.1 p30 -81.89 -2.72 52.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.187 -0.946 . . . . 0.0 109.625 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.19 -45.69 3.55 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.606 HD12 ' N ' ' A' ' 37' ' ' LEU . 9.1 mp -58.2 -34.59 70.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.242 -1.152 . . . . 0.0 109.483 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.932 ' O ' HD12 ' A' ' 42' ' ' ILE . 13.2 mm100 -76.08 -28.53 57.61 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.199 -0.938 . . . . 0.0 109.467 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.833 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -69.13 -55.32 11.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.324 -0.86 . . . . 0.0 109.485 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.461 HD13 ' HD2' ' A' ' 68' ' ' ARG . 13.1 mt -65.54 -51.46 59.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.246 -0.909 . . . . 0.0 109.496 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -48.99 -54.32 16.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.287 -0.883 . . . . 0.0 109.452 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.932 HD12 ' O ' ' A' ' 38' ' ' GLN . 15.7 mt -60.06 -30.17 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.235 -0.915 . . . . 0.0 109.43 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.833 HG23 ' O ' ' A' ' 39' ' ' ALA . 70.2 t -70.36 -26.92 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.94 . . . . 0.0 109.461 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.1 m -89.86 -19.4 24.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.158 -0.964 . . . . 0.0 109.437 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.6 mmtt -90.02 -24.35 21.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.353 -0.842 . . . . 0.0 109.517 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.454 ' HB3' ' HD3' ' A' ' 5' ' ' LYS . 38.9 mm-40 -125.39 -32.93 2.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.171 -0.955 . . . . 0.0 109.524 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 1.4 mtt180 60.48 66.85 1.74 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 109.527 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.547 ' O ' HD12 ' A' ' 76' ' ' ILE . 35.6 Cg_endo -77.85 175.34 11.32 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.668 2.245 . . . . 0.0 110.474 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 0.9 OUTLIER -116.82 -9.32 11.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.276 -0.89 . . . . 0.0 109.511 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.04 HD21 HG22 ' A' ' 115' ' ' VAL . 7.2 tp -128.07 120.02 26.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.28 -0.888 . . . . 0.0 109.538 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.989 HG13 ' HB3' ' A' ' 7' ' ' LEU . 39.1 t -133.16 124.49 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 0.0 109.692 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.475 ' CD1' HG12 ' A' ' 8' ' ' ILE . 1.1 mp -89.94 112.78 24.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.341 -0.849 . . . . 0.0 109.355 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.474 ' CD2' ' HG ' ' A' ' 66' ' ' LEU . 1.1 mp -97.5 120.01 37.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.149 -0.969 . . . . 0.0 109.626 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.456 ' HA ' ' HG3' ' A' ' 81' ' ' MET . 26.5 t0 -105.77 101.78 11.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.264 -0.897 . . . . 0.0 109.273 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.863 ' CG ' HG21 ' A' ' 82' ' ' THR . 3.3 mmt -61.82 -13.35 23.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -0.919 . . . . 0.0 109.464 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.444 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 43.4 mttp -57.96 -25.94 61.64 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.214 -0.929 . . . . 0.0 109.486 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.947 HD11 HG12 ' A' ' 9' ' ' VAL . 87.5 mt -42.08 102.25 0.27 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.342 -0.849 . . . . 0.0 109.582 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.472 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 36.0 Cg_endo -78.33 102.2 1.54 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.377 2.052 . . . . 0.0 110.476 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 125.77 -20.19 6.47 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.681 ' HB3' HG21 ' A' ' 57' ' ' ILE . 11.2 tmm? -129.53 132.54 46.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -1.167 . . . . 0.0 109.521 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.431 ' O ' ' SD ' ' A' ' 60' ' ' MET . 74.1 m-20 -89.14 129.82 35.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.203 -0.936 . . . . 0.0 109.497 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.443 ' HA2' HG13 ' A' ' 65' ' ' ILE . . . -87.35 9.82 71.64 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 25.3 mm -76.15 -49.63 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.19 -1.182 . . . . 0.0 109.479 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -62.29 -25.31 67.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 109.388 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.566 HG22 ' HE2' ' A' ' 69' ' ' MET . 7.9 mt -62.83 -65.26 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.311 -0.868 . . . . 0.0 109.45 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.632 HD21 HG11 ' A' ' 78' ' ' VAL . 22.0 mt -46.57 -40.96 13.69 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.189 -0.944 . . . . 0.0 109.437 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.553 ' O ' HG23 ' A' ' 71' ' ' VAL . 2.0 tttt -53.8 -53.7 48.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.934 . . . . 0.0 109.399 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.476 ' O ' HG12 ' A' ' 72' ' ' ILE . 1.9 mtt85 -60.72 -24.99 66.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.258 -0.901 . . . . 0.0 109.396 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.566 ' HE2' HG22 ' A' ' 65' ' ' ILE . 2.2 mtt -78.36 -25.33 46.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.355 -0.841 . . . . 0.0 109.49 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.485 ' HG2' ' O ' ' A' ' 66' ' ' LEU . 0.8 OUTLIER -82.91 -28.84 29.67 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 0.0 109.263 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 67' ' ' LYS . 2.6 t -90.07 -22.31 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.262 -0.899 . . . . 0.0 109.493 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.476 HG12 ' O ' ' A' ' 68' ' ' ARG . 25.1 mm -90.1 -50.16 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.255 -0.903 . . . . 0.0 109.51 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.622 ' O ' HG22 ' A' ' 76' ' ' ILE . 1.0 OUTLIER -137.81 121.45 17.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -0.922 . . . . 0.0 109.509 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.79 7.76 19.59 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.223 -0.923 . . . . 0.0 109.515 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -122.22 -9.11 8.66 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.246 -0.909 . . . . 0.0 108.984 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.626 ' O ' HG23 ' A' ' 76' ' ' ILE . 2.4 tp -57.86 106.85 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -0.934 . . . . 0.0 109.52 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.547 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 44.6 mtt180 -75.52 131.7 40.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.329 -0.857 . . . . 0.0 109.357 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.632 HG11 HD21 ' A' ' 66' ' ' LEU . 23.6 t -134.54 126.75 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 109.709 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.652 HG23 ' O ' ' A' ' 100' ' ' THR . 80.0 mt -103.81 128.48 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.168 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.895 HD12 ' HD1' ' A' ' 101' ' ' HIS . 0.1 OUTLIER -89.84 153.54 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.174 -0.953 . . . . 0.0 109.427 -179.799 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.456 ' HG3' ' HA ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -132.39 69.0 1.48 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.321 -0.862 . . . . 0.0 109.522 179.899 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.863 HG21 ' CG ' ' A' ' 55' ' ' MET . 12.8 t -170.67 28.16 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.213 -0.93 . . . . 0.0 109.583 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.025 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . -51.61 -21.1 2.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.236 -0.915 . . . . 0.0 109.516 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.59 70.98 10.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.47 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -166.11 -84.25 0.05 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -127.62 -177.52 4.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.224 -1.162 . . . . 0.0 109.501 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.571 ' HA ' HG23 ' A' ' 90' ' ' ILE . 2.4 mp -137.15 54.52 1.85 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -0.907 . . . . 0.0 109.4 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -103.96 -88.71 0.41 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.219 -0.926 . . . . 0.0 109.597 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.527 ' O ' ' CB ' ' A' ' 93' ' ' SER . 2.0 mpt? -73.56 -1.58 19.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.198 -0.939 . . . . 0.0 109.616 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.571 HG23 ' HA ' ' A' ' 87' ' ' LEU . 0.3 OUTLIER -89.91 -43.99 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.226 -0.921 . . . . 0.0 109.065 179.865 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.79 -43.77 94.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.309 -0.87 . . . . 0.0 109.604 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.48 ' HG2' HD21 ' A' ' 96' ' ' LEU . 1.1 tp10 -90.13 -20.71 22.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.188 -0.945 . . . . 0.0 109.813 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.527 ' CB ' ' O ' ' A' ' 89' ' ' MET . 0.4 OUTLIER -42.39 -26.86 0.12 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.187 -0.945 . . . . 0.0 109.899 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 92' ' ' GLU . 0.3 OUTLIER -52.58 -76.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -0.906 . . . . 0.0 109.899 -179.776 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.459 ' HG3' HD23 ' A' ' 96' ' ' LEU . 2.5 pt-20 -64.91 -38.02 89.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.231 -0.918 . . . . 0.0 109.825 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.522 ' N ' ' CD2' ' A' ' 96' ' ' LEU . 3.3 mm? -55.19 -25.17 30.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.919 . . . . 0.0 109.594 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 132.8 68.27 0.08 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.496 ' CB ' ' HB3' ' A' ' 93' ' ' SER . . . -153.12 98.96 2.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.251 -1.146 . . . . 0.0 109.444 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.547 ' CD1' ' HB3' ' A' ' 77' ' ' ARG . 21.1 mt -43.94 -67.13 0.3 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.295 -0.878 . . . . 0.0 109.346 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.652 ' O ' HG23 ' A' ' 79' ' ' ILE . 14.2 t -146.68 152.43 38.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.33 -0.856 . . . . 0.0 109.44 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.895 ' HD1' HD12 ' A' ' 80' ' ' ILE . 3.6 t-160 -113.68 87.29 2.58 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 109.346 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.552 ' CZ ' ' HB2' ' A' ' 114' ' ' ALA . 13.3 m-30 -71.56 159.92 33.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.226 -0.921 . . . . 0.0 109.569 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 1.025 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -131.35 -148.88 0.37 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.284 -0.885 . . . . 0.0 109.342 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.1 mtpt -91.74 146.42 33.03 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.254 -0.904 . . . . 0.0 109.466 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.5 -169.56 7.96 Favored 'Cis proline' 0 C--N 1.308 -1.565 0 C-N-CA 123.236 -1.568 . . . . 0.0 110.435 -0.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.627 ' CZ ' ' CG1' ' A' ' 111' ' ' ILE . 11.0 t80 -127.48 92.64 3.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.312 -0.868 . . . . 0.0 109.264 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.437 ' O ' HD13 ' A' ' 111' ' ' ILE . 16.3 t70 -89.83 127.83 36.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.282 -0.886 . . . . 0.0 109.511 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.843 ' CG2' HG21 ' A' ' 22' ' ' VAL . 13.7 mm -51.53 -22.16 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.225 -0.922 . . . . 0.0 109.356 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 109' ' ' ASP . 4.3 m-20 -72.64 -42.33 64.52 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.295 -0.878 . . . . 0.0 109.499 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.436 ' HG2' ' CE2' ' A' ' 102' ' ' PHE . 17.4 tt0 -62.51 -29.82 70.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.264 -0.898 . . . . 0.0 109.473 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.648 ' N ' HD12 ' A' ' 111' ' ' ILE . 1.4 mp -76.49 -56.13 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 109.327 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.432 ' HG2' ' HA ' ' A' ' 109' ' ' ASP . 30.4 ptt180 -60.79 -19.61 59.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.921 . . . . 0.0 109.435 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -81.61 -51.14 8.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 109.396 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 102' ' ' PHE . . . -55.58 -47.42 76.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.263 -0.898 . . . . 0.0 109.368 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 1.04 HG22 HD21 ' A' ' 50' ' ' LEU . 47.2 t -65.97 -47.64 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.314 -0.867 . . . . 0.0 109.419 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.81 -19.29 59.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 109.418 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -89.48 -27.25 20.46 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.251 -0.905 . . . . 0.0 109.345 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.452 ' CD2' ' O ' ' A' ' 114' ' ' ALA . 42.3 m-85 -88.07 -69.64 0.68 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.296 -0.878 . . . . 0.0 109.47 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.573 HD22 ' HG3' ' A' ' 4' ' ' GLU . 2.4 tt -90.19 127.92 51.47 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.235 -0.915 . . . . 0.0 109.435 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.474 ' HD2' ' HG ' ' A' ' 119' ' ' LEU . 35.9 Cg_endo -78.49 142.42 18.5 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.414 2.076 . . . . 0.0 110.368 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.616 HD22 ' CE2' ' A' ' 28' ' ' TYR . 1.0 OUTLIER -161.57 108.63 1.41 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.479 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.76 71.17 1.18 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.279 -0.888 . . . . 0.0 109.463 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 124' ' ' ASN . 1.5 m -147.77 -67.35 0.25 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.926 . . . . 0.0 109.461 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.44 ' O ' ' O ' ' A' ' 123' ' ' SER . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.108 -0.949 . . . . 0.0 109.443 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mtm . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.504 ' O ' ' CG ' ' A' ' 2' ' ' MET . 0.0 OUTLIER -89.83 55.29 3.11 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.249 -0.907 . . . . 0.0 109.474 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -132.53 64.45 1.61 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.231 -0.918 . . . . 0.0 109.444 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -122.01 112.24 18.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.419 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.499 ' CG ' ' HA ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -146.24 126.19 13.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.208 -0.932 . . . . 0.0 109.491 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.712 ' HB ' HG22 ' A' ' 30' ' ' THR . 4.1 mt -109.2 162.48 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.188 -0.945 . . . . 0.0 109.415 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.755 HD12 HG22 ' A' ' 9' ' ' VAL . 2.0 tm? -136.41 108.16 7.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.199 -0.938 . . . . 0.0 109.587 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.51 ' N ' HD13 ' A' ' 7' ' ' LEU . 5.0 mt -90.01 103.41 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.219 -0.926 . . . . 0.0 109.138 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.755 HG22 HD12 ' A' ' 7' ' ' LEU . 2.7 t -89.99 95.12 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.172 -0.955 . . . . 0.0 109.801 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.497 ' HB3' ' HD2' ' A' ' 16' ' ' ARG . 4.8 m-20 -145.22 155.36 43.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.272 -0.893 . . . . 0.0 109.402 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.464 ' OD2' ' CD ' ' A' ' 58' ' ' PRO . 7.1 p-10 -114.35 -29.75 6.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.339 -0.851 . . . . 0.0 109.41 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.529 ' HB3' ' NH2' ' A' ' 16' ' ' ARG . 1.4 tt0 -67.83 -148.04 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.349 -0.844 . . . . 0.0 109.514 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.614 ' CD1' ' N ' ' A' ' 14' ' ' GLY . 40.5 t80 -148.66 166.43 28.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.295 -0.878 . . . . 0.0 109.347 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.614 ' N ' ' CD1' ' A' ' 13' ' ' TYR . . . 102.24 -84.25 0.49 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.638 HG23 HD13 ' A' ' 19' ' ' LEU . 1.5 mt -51.08 -68.03 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.315 -1.109 . . . . 0.0 109.151 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.529 ' NH2' ' HB3' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -39.75 -27.57 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.616 -0.677 . . . . 0.0 110.217 -179.708 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.582 HG13 ' CZ ' ' A' ' 13' ' ' TYR . 9.9 mm -78.81 -46.77 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.091 -1.005 . . . . 0.0 109.841 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.69 ' O ' HG23 ' A' ' 22' ' ' VAL . 3.8 mp -65.47 -54.8 23.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.18 -0.95 . . . . 0.0 109.654 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.638 HD13 HG23 ' A' ' 15' ' ' ILE . 8.6 mp -59.13 -18.88 39.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.276 -0.89 . . . . 0.0 109.3 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 31.1 t30 -77.94 -65.64 0.94 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.436 -0.79 . . . . 0.0 109.546 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -68.07 -7.79 32.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 109.719 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 18' ' ' LEU . 43.7 t -88.16 -57.77 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.19 -0.944 . . . . 0.0 109.458 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.87 ' HB2' HG21 ' A' ' 30' ' ' THR . 18.0 m-85 -63.35 -28.84 70.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -0.91 . . . . 0.0 109.465 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -64.56 -60.04 3.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.274 -0.891 . . . . 0.0 109.44 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -57.03 -54.95 40.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.27 -0.894 . . . . 0.0 109.491 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.45 ' HB3' ' CD1' ' A' ' 28' ' ' TYR . 1.1 tt0 -44.48 -26.39 0.35 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.253 -0.904 . . . . 0.0 109.442 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.466 ' HA3' HD21 ' A' ' 121' ' ' LEU . . . 113.21 55.71 0.43 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.602 ' CZ ' HD13 ' A' ' 121' ' ' LEU . 78.4 m-85 -147.68 135.91 21.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.259 -1.142 . . . . 0.0 109.475 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -89.85 82.23 6.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.272 -0.893 . . . . 0.0 109.358 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.87 HG21 ' HB2' ' A' ' 23' ' ' PHE . 6.0 p -89.96 146.76 24.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.324 -0.86 . . . . 0.0 109.605 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.554 ' CZ ' ' OE1' ' A' ' 46' ' ' GLU . 18.7 m-85 -116.15 -178.71 3.47 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.321 -0.862 . . . . 0.0 109.343 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -122.14 136.18 54.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 0.0 109.553 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' A' ' 10' ' ' ASP . . . -141.94 -175.82 4.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.257 -0.902 . . . . 0.0 109.425 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.57 -83.46 0.09 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.18 -0.95 . . . . 0.0 109.499 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.441 ' OD1' ' HB2' ' A' ' 38' ' ' GLN . 20.7 p-10 -63.21 137.22 58.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.303 -0.873 . . . . 0.0 109.476 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -45.29 -31.12 3.11 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.455 ' HA ' HD23 ' A' ' 37' ' ' LEU . 0.5 OUTLIER -59.74 -49.87 76.05 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.214 -1.168 . . . . 0.0 109.477 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.441 ' HB2' ' OD1' ' A' ' 35' ' ' ASN . 44.1 tp60 -61.96 -52.15 65.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 109.431 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.976 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -44.69 -51.54 9.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.195 -0.94 . . . . 0.0 109.572 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.491 HD21 ' HB2' ' A' ' 68' ' ' ARG . 20.6 mt -60.25 -37.47 80.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.206 -0.934 . . . . 0.0 109.59 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.24 -59.46 5.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.139 -0.976 . . . . 0.0 109.527 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.751 HG21 HD23 ' A' ' 7' ' ' LEU . 5.1 mt -62.07 -19.85 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.207 -0.933 . . . . 0.0 109.577 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.976 HG23 ' O ' ' A' ' 39' ' ' ALA . 90.8 t -81.37 -24.9 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.188 -0.945 . . . . 0.0 109.491 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.5 m -90.13 -27.48 19.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 109.511 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.474 ' HD2' ' N ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -90.08 -30.89 17.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.247 -0.908 . . . . 0.0 109.527 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.554 ' OE1' ' CZ ' ' A' ' 31' ' ' PHE . 8.1 mm-40 -110.62 -35.26 6.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.916 . . . . 0.0 109.463 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.468 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 6.5 mtt85 56.33 69.89 1.65 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.478 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.534 ' HD2' HG13 ' A' ' 43' ' ' VAL . 35.4 Cg_endo -77.7 154.72 30.83 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.694 2.263 . . . . 0.0 110.416 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.819 ' C ' HD22 ' A' ' 50' ' ' LEU . 4.0 t0 -92.77 -13.04 29.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.268 -0.895 . . . . 0.0 109.475 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.819 HD22 ' C ' ' A' ' 49' ' ' ASP . 4.3 mm? -122.54 111.98 17.46 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.222 -0.923 . . . . 0.0 109.453 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 1.006 ' HB ' HG12 ' A' ' 78' ' ' VAL . 2.1 t -113.68 131.05 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.198 -0.939 . . . . 0.0 109.528 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.462 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 1.6 mp -108.95 117.98 35.6 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.245 -0.909 . . . . 0.0 109.48 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.809 HD22 ' N ' ' A' ' 53' ' ' LEU . 2.3 mm? -103.19 130.74 50.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.268 -0.895 . . . . 0.0 109.518 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.465 ' HB2' ' OD2' ' A' ' 10' ' ' ASP . 19.6 t0 -111.11 97.81 7.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -0.872 . . . . 0.0 109.437 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.825 ' HB2' HG21 ' A' ' 82' ' ' THR . 12.6 mmt -64.76 -10.82 30.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 0.0 109.396 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -72.71 -2.96 22.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.155 -0.965 . . . . 0.0 109.668 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.45 HG12 ' OD1' ' A' ' 11' ' ' ASP . 55.3 mt -62.24 132.4 93.95 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.128 -0.983 . . . . 0.0 109.32 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.464 ' CD ' ' OD2' ' A' ' 11' ' ' ASP . 36.3 Cg_endo -78.88 112.0 3.04 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.494 2.129 . . . . 0.0 110.412 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 146.07 -76.49 0.27 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.421 ' SD ' ' C ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -130.47 170.14 14.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.207 -1.172 . . . . 0.0 109.501 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -90.09 139.54 30.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.355 -0.84 . . . . 0.0 109.499 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 63' ' ' ILE . . . -73.0 -10.11 77.16 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.456 ' CD1' ' HE3' ' A' ' 55' ' ' MET . 18.1 mm -44.14 -47.41 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.212 -1.169 . . . . 0.0 109.585 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.468 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 4.8 mt-10 -63.36 -39.52 94.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.235 -0.916 . . . . 0.0 109.533 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.414 ' O ' ' C ' ' A' ' 66' ' ' LEU . 65.6 mt -51.37 -64.49 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.262 -0.899 . . . . 0.0 109.415 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.858 HD21 ' HB ' ' A' ' 78' ' ' VAL . 7.1 mt -44.12 -49.01 9.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 109.391 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.603 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.1 OUTLIER -49.06 -47.95 44.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.184 -0.948 . . . . 0.0 109.353 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.491 ' HB2' HD21 ' A' ' 40' ' ' LEU . 9.7 mmt180 -57.15 -44.07 83.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -0.888 . . . . 0.0 109.415 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.887 ' CE ' HG11 ' A' ' 51' ' ' VAL . 3.6 mtt -60.04 -27.27 66.79 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 0.0 109.417 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 66' ' ' LEU . 0.7 OUTLIER -78.05 -31.7 50.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.238 -0.914 . . . . 0.0 109.368 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 67' ' ' LYS . 2.6 t -77.9 -24.53 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.264 -0.898 . . . . 0.0 109.519 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 68' ' ' ARG . 48.9 mt -87.42 -59.65 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -0.917 . . . . 0.0 109.406 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.504 ' O ' HG22 ' A' ' 76' ' ' ILE . 39.8 m-20 -130.52 133.56 46.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.19 -0.944 . . . . 0.0 109.482 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -90.16 -26.08 20.35 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.218 -0.926 . . . . 0.0 109.033 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 44.4 p-10 -96.51 46.85 1.06 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.262 -0.899 . . . . 0.0 109.472 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.53 ' CD1' ' HA ' ' A' ' 49' ' ' ASP . 2.9 tp -117.59 112.83 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.228 -0.92 . . . . 0.0 109.436 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.614 ' CG ' HD11 ' A' ' 99' ' ' LEU . 8.7 mpt_? -63.36 134.99 56.68 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.269 -0.894 . . . . 0.0 109.509 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 1.006 HG12 ' HB ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -138.66 108.84 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.247 -0.908 . . . . 0.0 109.6 -179.925 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.504 HG23 ' O ' ' A' ' 100' ' ' THR . 67.5 mt -96.77 145.68 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.211 -0.931 . . . . 0.0 109.371 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.967 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.4 OUTLIER -103.17 168.66 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.171 -0.956 . . . . 0.0 109.375 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.483 ' CE ' ' OD1' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -142.53 69.54 1.32 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.281 -0.887 . . . . 0.0 109.432 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.825 HG21 ' HB2' ' A' ' 55' ' ' MET . 9.0 t 178.79 55.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.348 -0.845 . . . . 0.0 109.429 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.072 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . -60.7 -43.05 98.26 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.901 . . . . 0.0 109.511 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.06 153.64 42.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.245 -0.909 . . . . 0.0 109.395 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.79 -90.43 1.08 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.484 ' O ' ' CD1' ' A' ' 90' ' ' ILE . 4.2 mm-40 -95.77 62.58 2.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.22 -1.165 . . . . 0.0 109.46 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.545 ' HA ' HD13 ' A' ' 90' ' ' ILE . 0.4 OUTLIER -68.03 -8.68 39.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.215 -0.928 . . . . 0.0 109.508 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -82.67 8.48 11.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.259 -0.901 . . . . 0.0 109.436 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.457 ' O ' ' CB ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -133.48 9.9 4.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.233 -0.917 . . . . 0.0 109.5 179.974 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.591 ' CD1' ' N ' ' A' ' 90' ' ' ILE . 1.2 mp -83.89 -66.53 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.285 -0.884 . . . . 0.0 109.163 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.48 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -51.19 -27.76 9.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.216 -0.927 . . . . 0.0 109.41 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.503 ' HA ' ' CG ' ' A' ' 95' ' ' GLU . 6.9 mt-10 -89.89 -28.67 19.07 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.302 -0.874 . . . . 0.0 109.456 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.749 ' HB3' HD11 ' A' ' 80' ' ' ILE . 1.7 m -64.8 -40.17 94.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.308 -0.87 . . . . 0.0 109.447 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.687 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 20.3 mttt -70.12 -63.34 1.1 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.204 -0.935 . . . . 0.0 109.548 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.503 ' CG ' ' HA ' ' A' ' 92' ' ' GLU . 0.1 OUTLIER -47.15 -27.75 1.55 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.195 -0.94 . . . . 0.0 109.469 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.495 ' HA ' HD23 ' A' ' 96' ' ' LEU . 22.0 mt -77.8 -41.24 37.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.889 . . . . 0.0 109.439 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.514 ' O ' ' CG2' ' A' ' 78' ' ' VAL . . . 161.4 61.49 0.02 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.687 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -151.03 116.52 5.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.295 -1.12 . . . . 0.0 109.448 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.614 HD11 ' CG ' ' A' ' 77' ' ' ARG . 20.3 mt -44.11 -84.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.188 -0.945 . . . . 0.0 109.436 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.622 ' CG2' ' CE1' ' A' ' 102' ' ' PHE . 12.6 t -129.83 151.87 49.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.301 -0.874 . . . . 0.0 109.456 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.967 ' ND1' HD12 ' A' ' 80' ' ' ILE . 2.9 t60 -101.56 96.29 7.02 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.272 -0.892 . . . . 0.0 109.503 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.622 ' CE1' ' CG2' ' A' ' 100' ' ' THR . 43.6 m-85 -72.22 168.32 18.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.202 -0.936 . . . . 0.0 109.404 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 1.072 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -145.68 -148.34 0.24 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.194 -0.941 . . . . 0.0 109.413 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.81 146.93 25.55 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.919 . . . . 0.0 109.534 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.99 168.01 76.98 Favored 'Cis proline' 0 C--N 1.308 -1.57 0 C-N-CA 123.233 -1.57 . . . . 0.0 110.393 0.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -142.33 -164.41 1.81 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 0.0 109.499 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -136.81 127.4 26.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.251 -0.906 . . . . 0.0 109.397 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.673 HG13 HD23 ' A' ' 18' ' ' LEU . 19.0 mm -54.11 -20.57 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -0.912 . . . . 0.0 109.468 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -74.61 -41.48 60.36 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.246 -0.909 . . . . 0.0 109.475 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -71.87 -31.6 66.62 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.228 -0.92 . . . . 0.0 109.539 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.439 HD13 ' CE2' ' A' ' 102' ' ' PHE . 17.8 mm -68.82 -58.0 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.339 -0.851 . . . . 0.0 109.516 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.442 ' HG2' ' O ' ' A' ' 108' ' ' ILE . 8.2 ptt85 -60.14 -36.47 77.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.227 -0.921 . . . . 0.0 109.535 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -59.69 -54.08 50.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.253 -0.904 . . . . 0.0 109.434 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.526 ' O ' ' CD2' ' A' ' 118' ' ' TYR . . . -57.09 -42.1 80.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.234 -0.917 . . . . 0.0 109.387 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.741 HG21 ' CZ ' ' A' ' 23' ' ' PHE . 53.9 t -65.63 -25.11 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.278 -0.889 . . . . 0.0 109.48 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.53 -45.05 61.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.283 -0.886 . . . . 0.0 109.459 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.38 -42.79 95.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.186 -0.946 . . . . 0.0 109.543 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.526 ' CD2' ' O ' ' A' ' 114' ' ' ALA . 52.7 m-85 -64.98 -70.04 0.26 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.214 -0.929 . . . . 0.0 109.518 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.558 HD23 ' CE2' ' A' ' 28' ' ' TYR . 18.0 tp -90.08 112.37 52.05 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.347 -0.846 . . . . 0.0 109.437 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 118' ' ' TYR . 35.7 Cg_endo -77.96 136.03 14.5 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.39 2.06 . . . . 0.0 110.42 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.602 HD13 ' CZ ' ' A' ' 28' ' ' TYR . 5.7 tp -112.45 -149.86 0.45 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.31 -0.869 . . . . 0.0 109.449 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.6 mtmp? -89.04 50.63 1.98 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.245 -0.91 . . . . 0.0 109.462 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 87.0 p -174.5 -174.49 0.85 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.906 . . . . 0.0 109.49 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 118.037 -0.983 . . . . 0.0 109.408 -179.969 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 2.6 mtm -143.8 128.21 17.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 0.0 109.479 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -107.04 -148.98 0.42 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.21 -0.931 . . . . 0.0 109.478 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.617 ' HG2' HD12 ' A' ' 121' ' ' LEU . 1.4 mt-10 -115.76 96.73 5.75 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.312 -0.868 . . . . 0.0 109.433 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.494 ' CB ' ' HB3' ' A' ' 48' ' ' PRO . 1.4 mptp? -120.83 159.7 24.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.254 -0.904 . . . . 0.0 109.484 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.785 ' HB ' HG22 ' A' ' 30' ' ' THR . 14.3 mt -149.98 158.79 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.23 -0.919 . . . . 0.0 109.487 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.674 ' C ' HD13 ' A' ' 7' ' ' LEU . 1.8 tm? -133.2 106.84 7.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.207 -0.933 . . . . 0.0 109.401 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.488 ' N ' HD13 ' A' ' 7' ' ' LEU . 6.0 mt -89.88 112.06 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.204 -0.935 . . . . 0.0 109.382 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.686 HG21 ' CD1' ' A' ' 53' ' ' LEU . 32.3 t -93.97 79.86 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.283 -0.886 . . . . 0.0 109.565 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.481 ' OD2' ' HG2' ' A' ' 16' ' ' ARG . 17.7 t70 -126.32 133.16 51.45 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.262 -0.899 . . . . 0.0 109.494 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.643 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . 5.4 p-10 -99.65 -45.86 5.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.127 -0.983 . . . . 0.0 109.507 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.435 ' N ' ' CG ' ' A' ' 11' ' ' ASP . 1.0 OUTLIER -68.94 112.49 5.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -0.909 . . . . 0.0 109.444 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.42 ' C ' ' O ' ' A' ' 12' ' ' GLN . 1.8 t80 -43.79 159.02 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.24 -0.912 . . . . 0.0 109.529 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.83 -67.65 0.25 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.853 HG23 HD13 ' A' ' 19' ' ' LEU . 2.7 mt -65.31 -11.47 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.191 -1.182 . . . . 0.0 109.346 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.486 ' O ' ' HB2' ' A' ' 20' ' ' ASN . 0.6 OUTLIER -84.24 -26.77 28.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.21 -0.931 . . . . 0.0 109.263 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.3 mm -90.7 -37.95 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.26 -0.9 . . . . 0.0 109.79 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.659 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.9 OUTLIER -66.94 -58.19 5.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 0.0 109.7 -179.755 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.853 HD13 HG23 ' A' ' 15' ' ' ILE . 7.9 mp -62.95 -22.13 66.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.167 -0.958 . . . . 0.0 109.394 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 8.8 t30 -71.21 -66.83 0.57 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.368 -0.833 . . . . 0.0 109.488 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.484 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 2.1 mt-10 -53.27 -33.3 52.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -0.885 . . . . 0.0 109.58 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.731 HG13 ' HE ' ' A' ' 112' ' ' ARG . 74.7 t -63.41 -60.07 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.251 -0.906 . . . . 0.0 109.512 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.483 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 21.6 m-85 -78.03 1.77 19.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.944 . . . . 0.0 109.582 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.484 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 1.0 OUTLIER -90.07 -43.13 10.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.192 -0.943 . . . . 0.0 109.491 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -76.09 -35.95 59.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.232 -0.917 . . . . 0.0 109.477 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.492 ' HB3' ' CE1' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -65.79 -27.53 68.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -0.914 . . . . 0.0 109.489 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.535 ' C ' ' CD1' ' A' ' 28' ' ' TYR . . . 106.77 73.01 0.83 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.595 ' HE2' HD12 ' A' ' 119' ' ' LEU . 79.3 m-85 -151.17 134.71 16.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.225 -1.162 . . . . 0.0 109.539 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -93.99 83.84 4.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.228 -0.92 . . . . 0.0 109.265 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.785 HG22 ' HB ' ' A' ' 6' ' ' ILE . 5.8 p -89.87 161.59 15.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.187 -0.946 . . . . 0.0 109.562 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.616 ' HB2' HD22 ' A' ' 7' ' ' LEU . 25.6 m-85 -121.66 -168.65 1.73 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -0.899 . . . . 0.0 109.331 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 16' ' ' ARG . 6.9 mp0 -123.92 150.79 44.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.185 -0.947 . . . . 0.0 109.533 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.66 ' HB3' ' HA ' ' A' ' 9' ' ' VAL . . . -162.24 173.16 14.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.22 -0.925 . . . . 0.0 109.38 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.643 ' HB1' ' HB3' ' A' ' 11' ' ' ASP . . . -174.77 -47.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.253 -0.905 . . . . 0.0 109.541 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.499 ' ND2' HD11 ' A' ' 37' ' ' LEU . 19.1 p30 -70.17 -5.66 28.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.245 -0.909 . . . . 0.0 109.585 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.424 ' HA2' HD13 ' A' ' 65' ' ' ILE . . . 85.98 -58.77 4.77 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.836 HD12 ' N ' ' A' ' 38' ' ' GLN . 4.2 pp -52.39 -40.24 61.84 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.271 -1.135 . . . . 0.0 109.476 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 1.016 ' O ' HD12 ' A' ' 42' ' ' ILE . 1.1 tp-100 -66.36 -33.34 75.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.325 -0.859 . . . . 0.0 109.358 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.803 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -64.53 -62.56 1.51 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.211 -0.931 . . . . 0.0 109.407 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.744 HD22 HD12 ' A' ' 72' ' ' ILE . 13.4 mt -54.35 -35.92 63.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -0.899 . . . . 0.0 109.445 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -57.54 -53.29 59.85 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.222 -0.924 . . . . 0.0 109.387 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 1.016 HD12 ' O ' ' A' ' 38' ' ' GLN . 1.8 mp -64.91 -20.72 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.275 -0.891 . . . . 0.0 109.387 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.803 HG23 ' O ' ' A' ' 39' ' ' ALA . 21.6 t -81.51 -23.28 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.25 -0.906 . . . . 0.0 109.49 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.5 m -90.01 -28.54 19.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.321 -0.862 . . . . 0.0 109.533 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.6 mttm -87.44 -37.9 16.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.279 -0.888 . . . . 0.0 109.517 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.525 ' HG3' HG23 ' A' ' 42' ' ' ILE . 1.3 mm-40 -101.28 -39.6 7.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.261 -0.9 . . . . 0.0 109.466 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 0.9 OUTLIER 63.26 67.07 1.08 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.42 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.658 ' HD2' HG13 ' A' ' 43' ' ' VAL . 35.4 Cg_endo -77.51 -161.03 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.633 2.222 . . . . 0.0 110.469 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.978 ' O ' HD22 ' A' ' 50' ' ' LEU . 27.4 t70 -135.24 9.38 3.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 0.0 109.537 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.978 HD22 ' O ' ' A' ' 49' ' ' ASP . 0.4 OUTLIER -146.58 107.72 4.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.226 -0.921 . . . . 0.0 109.557 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.83 HG11 ' CE ' ' A' ' 69' ' ' MET . 1.7 t -113.47 109.49 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 109.382 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.685 HD23 ' HB ' ' A' ' 79' ' ' ILE . 1.3 mp -90.58 127.98 36.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.239 -0.913 . . . . 0.0 109.512 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.746 ' N ' HD22 ' A' ' 53' ' ' LEU . 2.6 mm? -113.42 146.11 40.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.233 -0.917 . . . . 0.0 109.429 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.455 ' O ' HG13 ' A' ' 57' ' ' ILE . 12.5 t70 -118.76 111.48 18.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.34 -0.85 . . . . 0.0 109.371 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.89 ' HB2' HG21 ' A' ' 82' ' ' THR . 15.5 mmt -70.6 -5.02 26.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.219 -0.926 . . . . 0.0 109.594 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.467 ' HG3' ' OG1' ' A' ' 82' ' ' THR . 24.1 mttt -90.08 14.33 12.65 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.141 -0.975 . . . . 0.0 109.67 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.645 HG23 ' HD2' ' A' ' 58' ' ' PRO . 83.4 mt -76.57 139.63 67.43 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.187 -0.945 . . . . 0.0 109.301 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.645 ' HD2' HG23 ' A' ' 57' ' ' ILE . 35.8 Cg_endo -78.18 -37.75 0.72 Allowed 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.504 2.136 . . . . 0.0 110.443 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.436 ' O ' ' HB3' ' A' ' 60' ' ' MET . . . -43.71 -43.66 6.62 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.505 ' N ' ' SD ' ' A' ' 60' ' ' MET . 0.0 OUTLIER 178.4 -167.95 0.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -1.141 . . . . 0.0 109.361 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -87.77 120.34 28.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.436 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.43 ' HA2' HG13 ' A' ' 65' ' ' ILE . . . -58.14 -16.07 24.88 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.41 ' C ' ' O ' ' A' ' 62' ' ' GLY . 25.9 mm -44.09 -50.34 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -1.141 . . . . 0.0 109.465 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 68' ' ' ARG . 6.4 mt-10 -64.56 -38.89 92.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.885 . . . . 0.0 109.425 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.494 HG22 ' SD ' ' A' ' 69' ' ' MET . 30.4 mt -53.24 -60.63 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 0.0 109.497 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 1.019 ' CD2' HG11 ' A' ' 78' ' ' VAL . 2.8 mt -50.25 -62.04 1.82 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.905 . . . . 0.0 109.71 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.83 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -41.45 -33.48 0.43 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.358 -0.839 . . . . 0.0 109.68 -179.895 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.555 ' HB2' HD11 ' A' ' 40' ' ' LEU . 24.8 mtt-85 -72.3 -63.04 1.23 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.211 -0.931 . . . . 0.0 109.391 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.83 ' CE ' HG11 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -40.6 -28.21 0.07 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.508 -0.745 . . . . 0.0 109.537 -179.385 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.601 ' NZ ' HD22 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -78.07 -60.4 2.39 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.057 -1.027 . . . . 0.0 109.098 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.83 HG23 ' O ' ' A' ' 67' ' ' LYS . 3.4 t -43.44 -26.77 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.449 -0.782 . . . . 0.0 109.592 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.744 HD12 HD22 ' A' ' 40' ' ' LEU . 71.7 mt -85.31 -54.2 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.251 -0.906 . . . . 0.0 109.41 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.531 ' OD1' HG22 ' A' ' 72' ' ' ILE . 1.4 m-20 -136.78 124.68 22.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.334 -0.854 . . . . 0.0 109.322 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -83.09 -9.23 59.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.213 -0.929 . . . . 0.0 109.51 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 -107.06 50.75 0.76 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.918 . . . . 0.0 109.522 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.602 ' O ' HG23 ' A' ' 76' ' ' ILE . 3.2 tp -125.4 105.22 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.221 -0.925 . . . . 0.0 109.519 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.655 ' CG ' HD11 ' A' ' 99' ' ' LEU . 75.0 mtt85 -55.19 155.5 4.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 109.473 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 1.019 HG11 ' CD2' ' A' ' 66' ' ' LEU . 3.2 t -142.78 138.82 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.272 -0.893 . . . . 0.0 109.606 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.685 ' HB ' HD23 ' A' ' 52' ' ' LEU . 9.0 mm -121.39 123.6 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.238 -0.914 . . . . 0.0 109.229 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.623 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.7 OUTLIER -89.71 144.35 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.143 -0.973 . . . . 0.0 109.429 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.458 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 5.0 mtm -124.77 57.45 1.27 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.212 -0.93 . . . . 0.0 109.51 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.89 HG21 ' HB2' ' A' ' 55' ' ' MET . 10.7 t -169.38 47.48 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.279 -0.888 . . . . 0.0 109.57 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.072 ' N ' ' HB2' ' A' ' 103' ' ' ALA . . . -85.03 72.06 10.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.245 -0.909 . . . . 0.0 109.522 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -83.1 -157.27 0.22 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.228 -0.92 . . . . 0.0 109.453 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -66.85 -11.83 58.63 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.419 ' O ' ' HG3' ' A' ' 86' ' ' GLU . 3.5 pt-20 -83.95 110.65 18.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.297 -1.119 . . . . 0.0 109.456 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.804 HD23 ' HB ' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -123.66 53.93 1.33 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.275 -0.89 . . . . 0.0 109.481 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 89' ' ' MET . 3.5 p30 -103.53 -45.83 4.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.529 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.441 ' O ' ' HB2' ' A' ' 93' ' ' SER . 4.4 ptp -87.36 -7.46 57.72 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.334 -0.854 . . . . 0.0 109.546 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.804 ' HB ' HD23 ' A' ' 87' ' ' LEU . 15.5 mt -81.0 -41.41 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.906 . . . . 0.0 109.5 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.49 -32.47 71.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.311 -0.868 . . . . 0.0 109.499 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.409 ' CD ' ' HA ' ' A' ' 89' ' ' MET . 5.8 pt-20 -89.8 -31.02 17.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.287 -0.883 . . . . 0.0 109.467 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 89' ' ' MET . 0.4 OUTLIER -59.68 -51.44 69.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.265 -0.897 . . . . 0.0 109.479 -179.945 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.631 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 14.3 tttm -52.78 -57.95 8.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.0 109.465 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 94' ' ' LYS . 59.3 mt-10 -44.06 -50.54 8.39 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.232 -0.917 . . . . 0.0 109.49 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.9 mt -53.0 -48.25 67.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.307 -0.871 . . . . 0.0 109.457 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 154.46 42.65 0.02 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.631 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -99.48 118.11 35.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.19 -1.182 . . . . 0.0 109.487 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.813 HD13 ' CD1' ' A' ' 118' ' ' TYR . 21.9 mt -55.24 -81.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.477 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.56 ' OG1' ' CE1' ' A' ' 102' ' ' PHE . 0.1 OUTLIER -126.27 175.65 7.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.208 -0.933 . . . . 0.0 109.477 -179.956 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.792 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 4.7 t-160 -146.03 97.19 2.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 109.256 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.56 ' CE1' ' OG1' ' A' ' 100' ' ' THR . 18.4 m-30 -108.81 159.55 16.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.182 -0.949 . . . . 0.0 109.597 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 1.072 ' HB2' ' N ' ' A' ' 83' ' ' ALA . . . -128.73 168.39 15.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.319 -0.863 . . . . 0.0 109.343 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.469 ' O ' ' HD2' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -90.97 144.85 30.68 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.186 -0.946 . . . . 0.0 109.48 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.09 130.2 20.42 Favored 'Cis proline' 0 C--N 1.309 -1.547 0 C-N-CA 123.353 -1.52 . . . . 0.0 110.36 0.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -102.22 -174.51 2.59 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.282 -0.886 . . . . 0.0 109.448 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.411 ' O ' ' C ' ' A' ' 108' ' ' ILE . 46.5 t0 -111.97 100.35 8.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.305 -0.872 . . . . 0.0 109.489 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.456 ' O ' ' HG3' ' A' ' 112' ' ' ARG . 12.5 mm -44.51 -31.21 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.381 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -63.77 -51.07 66.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.225 -0.922 . . . . 0.0 109.392 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 113' ' ' ASP . 7.5 tt0 -57.07 -47.11 81.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.17 -0.956 . . . . 0.0 109.375 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.5 mm -51.82 -60.14 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.365 -0.834 . . . . 0.0 109.453 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.731 ' HE ' HG13 ' A' ' 22' ' ' VAL . 98.8 mtt180 -49.54 -34.26 16.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.918 . . . . 0.0 109.51 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 110' ' ' GLU . 19.3 m-20 -67.29 -74.61 0.11 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 109.642 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.427 ' O ' ' C ' ' A' ' 115' ' ' VAL . . . -47.56 -63.43 1.05 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.239 -0.913 . . . . 0.0 109.622 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.427 ' C ' ' O ' ' A' ' 114' ' ' ALA . 49.4 t -42.49 -57.44 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.365 -0.835 . . . . 0.0 109.846 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 0.0 OUTLIER -45.78 -44.77 14.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.175 -0.953 . . . . 0.0 109.621 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 4.5 tptp -62.05 -39.9 93.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 109.703 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.813 ' CD1' HD13 ' A' ' 99' ' ' LEU . 48.7 m-85 -67.44 -69.77 0.29 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.168 -0.958 . . . . 0.0 109.654 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.64 ' C ' HD13 ' A' ' 119' ' ' LEU . 1.3 tm? -90.07 112.46 52.51 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.185 -0.947 . . . . 0.0 109.482 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.611 ' N ' HD13 ' A' ' 119' ' ' LEU . 36.1 Cg_endo -78.25 141.95 18.69 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.322 2.015 . . . . 0.0 110.418 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.617 HD12 ' HG2' ' A' ' 4' ' ' GLU . 0.3 OUTLIER -147.99 76.31 1.37 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.171 -0.956 . . . . 0.0 109.485 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.6 pttp -128.48 138.9 52.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 109.537 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 15.8 t 52.49 89.53 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.287 -0.883 . . . . 0.0 109.438 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.488 179.953 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 2.6 tpt -150.0 92.42 1.89 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.195 -0.941 . . . . 0.0 109.51 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.491 ' O ' ' HG3' ' A' ' 4' ' ' GLU . 1.2 p30 -158.43 -170.25 3.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.235 -0.915 . . . . 0.0 109.529 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 3' ' ' ASN . 4.2 pt-20 38.2 77.83 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.586 -0.696 . . . . 0.0 109.992 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.468 ' CD ' ' N ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -108.85 147.47 32.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.245 -0.909 . . . . 0.0 109.465 179.885 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.599 HG22 ' N ' ' A' ' 7' ' ' LEU . 16.3 mt -149.7 165.15 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.229 -0.919 . . . . 0.0 109.519 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.979 HD13 ' N ' ' A' ' 8' ' ' ILE . 2.2 tm? -131.67 133.41 44.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.302 -0.874 . . . . 0.0 109.457 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.979 ' N ' HD13 ' A' ' 7' ' ' LEU . 12.4 mt -117.86 101.75 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.191 -0.943 . . . . 0.0 109.348 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.771 HG12 HD11 ' A' ' 57' ' ' ILE . 4.9 t -89.97 125.58 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.928 . . . . 0.0 109.522 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.6 ' O ' ' HB2' ' A' ' 34' ' ' ALA . 12.7 t70 -174.41 145.61 0.99 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.261 -0.9 . . . . 0.0 109.512 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.482 ' OD2' ' HD2' ' A' ' 58' ' ' PRO . 8.0 p-10 -117.95 -31.9 4.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.218 -0.926 . . . . 0.0 109.391 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.4 ' O ' ' C ' ' A' ' 13' ' ' TYR . 21.8 tm0? -69.73 104.64 2.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.334 -0.854 . . . . 0.0 109.589 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.922 ' CE2' HD11 ' A' ' 17' ' ' ILE . 6.7 t80 -43.63 123.13 2.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.337 -0.852 . . . . 0.0 109.569 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.77 -47.43 0.79 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.551 HD11 ' HE3' ' A' ' 104' ' ' LYS . 5.0 mt -80.1 -59.25 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -1.153 . . . . 0.0 109.486 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.504 ' HG2' ' CG ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -43.36 -26.69 0.21 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.235 -0.916 . . . . 0.0 109.714 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.922 HD11 ' CE2' ' A' ' 13' ' ' TYR . 2.4 mt -90.07 -64.33 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.19 -0.943 . . . . 0.0 109.697 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.806 ' O ' HG23 ' A' ' 22' ' ' VAL . 9.6 mt -47.59 -61.08 2.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.157 -0.964 . . . . 0.0 109.749 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.476 HD12 ' CD1' ' A' ' 108' ' ' ILE . 1.4 mp -52.76 -30.88 35.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -0.932 . . . . 0.0 109.575 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.476 ' HB3' ' O ' ' A' ' 17' ' ' ILE . 28.7 t30 -67.72 -72.42 0.17 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.223 -0.923 . . . . 0.0 109.716 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 20' ' ' ASN . 0.6 OUTLIER -43.72 -31.21 0.75 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 109.604 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 18' ' ' LEU . 67.4 t -66.77 -52.15 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.294 -0.879 . . . . 0.0 109.486 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.833 ' CZ ' HG21 ' A' ' 115' ' ' VAL . 22.9 m-85 -79.92 -0.47 35.15 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.187 -0.946 . . . . 0.0 109.62 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.421 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 2.0 m-20 -88.4 -48.15 7.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.145 -0.972 . . . . 0.0 109.462 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.54 -10.54 59.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.466 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.497 ' HB3' ' CD1' ' A' ' 28' ' ' TYR . 1.7 tt0 -89.43 -26.29 21.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.304 -0.872 . . . . 0.0 109.457 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.533 ' C ' ' CD1' ' A' ' 28' ' ' TYR . . . 105.91 67.73 0.69 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.695 ' HE2' HD23 ' A' ' 121' ' ' LEU . 90.2 m-85 -154.68 134.87 13.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.203 -1.175 . . . . 0.0 109.443 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -91.51 81.86 5.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.891 . . . . 0.0 109.326 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.479 HG21 ' CB ' ' A' ' 23' ' ' PHE . 5.7 p -89.92 146.37 24.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.311 -0.868 . . . . 0.0 109.608 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.658 ' HB2' HD22 ' A' ' 7' ' ' LEU . 57.6 m-85 -106.96 -173.34 2.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.256 -0.902 . . . . 0.0 109.231 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.504 ' CG ' ' HG2' ' A' ' 16' ' ' ARG . 78.8 mt-30 -131.04 151.58 51.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.182 -0.949 . . . . 0.0 109.676 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.691 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -160.68 -163.47 1.07 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.302 -0.874 . . . . 0.0 109.291 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.691 ' HB2' ' O ' ' A' ' 33' ' ' ALA . . . 164.41 -44.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.922 . . . . 0.0 109.591 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.472 ' OD1' ' HB2' ' A' ' 38' ' ' GLN . 45.7 p-10 -67.07 -8.51 31.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.22 -0.925 . . . . 0.0 109.569 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.432 ' HA3' ' SD ' ' A' ' 60' ' ' MET . . . 87.49 -68.01 3.18 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 36' ' ' GLY . 0.2 OUTLIER -45.06 -53.49 7.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.254 -1.145 . . . . 0.0 109.378 179.914 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.472 ' HB2' ' OD1' ' A' ' 35' ' ' ASN . 1.7 tp-100 -48.99 -55.87 10.63 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.209 -0.932 . . . . 0.0 109.473 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 38' ' ' GLN . . . -43.85 -50.12 8.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.283 -0.885 . . . . 0.0 109.455 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 96.5 mt -55.63 -43.03 75.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.253 -0.904 . . . . 0.0 109.452 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.456 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 8.3 m-20 -62.55 -28.71 70.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.295 -0.878 . . . . 0.0 109.373 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.959 HG21 HD23 ' A' ' 7' ' ' LEU . 20.6 mm -75.92 -29.9 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.222 -0.924 . . . . 0.0 109.477 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.531 ' HA ' ' CD ' ' A' ' 48' ' ' PRO . 68.3 t -80.93 -25.24 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.272 -0.892 . . . . 0.0 109.417 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.471 ' HA ' ' HD2' ' A' ' 47' ' ' ARG . 4.1 m -87.14 -30.69 20.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.276 -0.89 . . . . 0.0 109.515 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 1.1 mtpt -89.99 -25.68 20.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.386 -0.821 . . . . 0.0 109.532 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -123.53 -31.59 3.48 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.206 -0.934 . . . . 0.0 109.56 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.525 ' CG ' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER 47.27 71.53 1.56 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.929 . . . . 0.0 109.481 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.531 ' CD ' ' HA ' ' A' ' 43' ' ' VAL . 34.5 Cg_endo -77.78 -178.54 4.68 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 122.683 2.255 . . . . 0.0 110.616 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.55 ' OD1' HD12 ' A' ' 119' ' ' LEU . 3.3 p30 -110.44 -20.02 12.74 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.412 -0.805 . . . . 0.0 109.185 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.955 HD21 HG22 ' A' ' 115' ' ' VAL . 7.4 tp -115.18 122.24 45.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.307 -0.871 . . . . 0.0 109.554 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.884 HG11 ' HE1' ' A' ' 69' ' ' MET . 1.8 t -126.08 115.47 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.29 -0.881 . . . . 0.0 109.508 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.809 HD12 ' O ' ' A' ' 7' ' ' LEU . 1.0 OUTLIER -89.98 108.31 19.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.235 -0.915 . . . . 0.0 109.433 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.729 HD21 ' HB ' ' A' ' 65' ' ' ILE . 1.1 tp -97.69 119.13 35.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.16 -0.963 . . . . 0.0 109.429 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.508 ' HB2' ' CE ' ' A' ' 81' ' ' MET . 40.7 t0 -100.62 104.1 15.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 109.423 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.459 ' HB2' ' HB ' ' A' ' 82' ' ' THR . 2.8 mmt -65.26 -10.42 31.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.306 -0.871 . . . . 0.0 109.452 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.473 ' HB2' ' OD2' ' A' ' 54' ' ' ASP . 3.3 mmtp -66.04 -24.72 66.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.209 -0.932 . . . . 0.0 109.459 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.771 HD11 HG12 ' A' ' 9' ' ' VAL . 48.9 mt -43.12 103.12 0.3 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.368 -0.832 . . . . 0.0 109.533 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.482 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 35.3 Cg_endo -77.94 119.73 4.82 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.396 2.064 . . . . 0.0 110.388 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 108.55 5.83 31.49 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.448 ' HE2' HG21 ' A' ' 57' ' ' ILE . 24.9 ttp -165.13 127.33 2.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -1.161 . . . . 0.0 109.408 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -89.71 120.13 30.72 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -0.908 . . . . 0.0 109.423 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.455 ' HA2' HG13 ' A' ' 65' ' ' ILE . . . -67.87 -7.83 50.75 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.5 mm -53.08 -40.12 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.184 -1.186 . . . . 0.0 109.507 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -68.68 -44.1 74.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.216 -0.927 . . . . 0.0 109.418 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.729 ' HB ' HD21 ' A' ' 53' ' ' LEU . 11.4 mt -46.4 -51.86 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.258 -0.901 . . . . 0.0 109.491 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.724 ' CD2' HD22 ' A' ' 53' ' ' LEU . 55.2 mt -56.56 -41.06 76.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.289 -0.882 . . . . 0.0 109.428 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.567 ' O ' HG23 ' A' ' 71' ' ' VAL . 1.3 tttm -54.73 -41.01 69.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.226 -0.921 . . . . 0.0 109.493 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.07 -21.19 54.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 109.441 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.884 ' HE1' HG11 ' A' ' 51' ' ' VAL . 14.3 mtt -72.13 -40.08 68.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.261 -0.9 . . . . 0.0 109.439 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.524 ' CE ' ' O ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -79.72 -37.63 35.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.272 -0.892 . . . . 0.0 109.522 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 67' ' ' LYS . 97.5 t -65.46 -32.67 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.22 -0.925 . . . . 0.0 109.445 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.426 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 45.0 mm -89.65 -27.29 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.227 -0.921 . . . . 0.0 109.453 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.456 ' O ' ' O ' ' A' ' 69' ' ' MET . 15.7 m-20 -163.42 130.26 3.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.267 -0.895 . . . . 0.0 109.471 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -89.98 -10.88 43.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.229 -0.919 . . . . 0.0 109.48 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -106.94 50.23 0.78 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.288 -0.882 . . . . 0.0 109.445 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.468 ' O ' HG23 ' A' ' 76' ' ' ILE . 0.8 OUTLIER -117.94 122.98 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.269 -0.894 . . . . 0.0 109.519 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.5 ' HA ' HD11 ' A' ' 99' ' ' LEU . 10.4 mtt180 -79.31 141.66 36.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.209 -0.932 . . . . 0.0 109.426 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.671 HG13 ' HB ' ' A' ' 51' ' ' VAL . 2.7 t -147.74 119.06 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.886 . . . . 0.0 109.603 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.644 HG23 ' HB ' ' A' ' 100' ' ' THR . 23.5 mt -89.87 170.6 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 0.0 109.297 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.774 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.0 OUTLIER -134.88 126.86 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.198 -0.938 . . . . 0.0 109.435 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.508 ' CE ' ' HB2' ' A' ' 54' ' ' ASP . 20.7 mtm -110.01 84.22 1.89 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 109.181 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.85 HG22 ' NE2' ' A' ' 101' ' ' HIS . 4.7 t -149.67 -146.99 0.21 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.214 -0.929 . . . . 0.0 109.497 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.847 ' HB1' ' HG3' ' A' ' 86' ' ' GLU . . . -40.94 153.52 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.407 -0.808 . . . . 0.0 109.918 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.431 ' O ' ' C ' ' A' ' 85' ' ' GLY . 3.4 t80 -68.58 85.58 0.3 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.879 . . . . 0.0 109.758 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 86' ' ' GLU . . . 42.13 34.44 1.48 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.847 ' HG3' ' HB1' ' A' ' 83' ' ' ALA . 52.4 mt-10 -62.02 -133.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.187 -1.184 . . . . 0.0 109.062 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.4 mt -135.07 53.22 2.0 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.764 -1.21 . . . . 0.0 109.693 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 89' ' ' MET . 66.4 t0 -104.99 73.14 1.04 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.23 -0.919 . . . . 0.0 109.344 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.471 ' O ' ' CB ' ' A' ' 93' ' ' SER . 0.0 OUTLIER 68.41 29.04 5.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.4 -179.846 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.832 HD12 ' O ' ' A' ' 86' ' ' GLU . 6.5 mt -90.06 -48.33 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.319 -0.863 . . . . 0.0 109.423 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.81 -38.31 21.73 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.286 -0.884 . . . . 0.0 109.492 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.464 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 0.6 OUTLIER -90.03 -38.03 13.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.936 . . . . 0.0 109.514 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.473 ' O ' ' CB ' ' A' ' 98' ' ' ALA . 14.2 m -63.19 -12.15 26.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.254 -0.904 . . . . 0.0 109.554 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.411 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 1.2 tptp -71.96 -71.6 0.27 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.275 -0.89 . . . . 0.0 109.464 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -66.45 -13.22 60.48 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.35 -0.844 . . . . 0.0 109.422 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.512 ' HB3' ' NZ ' ' A' ' 70' ' ' LYS . 32.9 mt -74.55 -50.57 17.54 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.185 -0.947 . . . . 0.0 109.38 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 172.99 45.78 0.05 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.473 ' CB ' ' O ' ' A' ' 93' ' ' SER . . . -132.06 146.38 52.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -1.156 . . . . 0.0 109.411 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.5 HD11 ' HA ' ' A' ' 77' ' ' ARG . 0.4 OUTLIER -128.04 -60.32 1.15 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.336 -0.852 . . . . 0.0 109.489 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.691 HG23 ' CZ ' ' A' ' 102' ' ' PHE . 17.1 m -102.97 148.96 25.02 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.263 -0.898 . . . . 0.0 109.571 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.85 ' NE2' HG22 ' A' ' 82' ' ' THR . 2.8 t-160 -144.84 93.77 2.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.892 . . . . 0.0 109.347 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.691 ' CZ ' HG23 ' A' ' 100' ' ' THR . 18.7 m-30 -111.9 161.61 16.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.896 . . . . 0.0 109.587 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 82' ' ' THR . . . -113.51 -159.99 0.71 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.309 -0.87 . . . . 0.0 109.443 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.551 ' HE3' HD11 ' A' ' 15' ' ' ILE . 3.7 mttt -100.37 152.55 37.86 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.232 -0.918 . . . . 0.0 109.498 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.583 ' O ' ' CG ' ' A' ' 106' ' ' PHE . 37.1 Cg_endo -81.62 28.15 4.52 Favored 'Cis proline' 0 C--N 1.309 -1.506 0 C-N-CA 123.371 -1.512 . . . . 0.0 111.126 -0.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.583 ' CG ' ' O ' ' A' ' 105' ' ' PRO . 52.1 p90 41.46 -164.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.37 -0.831 . . . . 0.0 109.844 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.472 ' O ' HG12 ' A' ' 111' ' ' ILE . 30.5 t0 -150.1 118.7 6.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.87 . . . . 0.0 109.461 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.56 HG23 HG21 ' A' ' 22' ' ' VAL . 12.7 mm -54.12 -19.73 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.25 -0.906 . . . . 0.0 109.393 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -75.75 -57.27 3.98 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.192 -0.942 . . . . 0.0 109.427 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -59.66 -24.18 63.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.179 -0.951 . . . . 0.0 109.491 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.472 HG12 ' O ' ' A' ' 107' ' ' ASP . 22.9 mm -74.12 -56.29 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.305 -0.872 . . . . 0.0 109.46 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.414 ' HG2' ' O ' ' A' ' 108' ' ' ILE . 2.5 ptt180 -60.04 -23.62 63.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.202 -0.936 . . . . 0.0 109.533 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -76.1 -63.25 1.36 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.32 -0.863 . . . . 0.0 109.482 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.507 ' O ' ' CD2' ' A' ' 118' ' ' TYR . . . -51.07 -31.87 20.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.244 -0.91 . . . . 0.0 109.381 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.955 HG22 HD21 ' A' ' 50' ' ' LEU . 72.6 t -75.44 -36.32 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.232 -0.918 . . . . 0.0 109.411 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.409 ' HE2' ' HB3' ' A' ' 116' ' ' LYS . 0.4 OUTLIER -69.44 -21.1 63.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.233 -0.917 . . . . 0.0 109.465 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -89.48 -40.06 12.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.211 -0.931 . . . . 0.0 109.52 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.507 ' CD2' ' O ' ' A' ' 114' ' ' ALA . 26.2 m-85 -76.13 -63.3 1.35 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 0.0 109.487 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.653 HD23 ' C ' ' A' ' 119' ' ' LEU . 4.1 tt -90.19 112.42 52.46 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 0.0 109.445 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.609 ' N ' HD23 ' A' ' 119' ' ' LEU . 35.9 Cg_endo -78.07 151.51 27.18 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.429 2.086 . . . . 0.0 110.402 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.695 HD23 ' HE2' ' A' ' 28' ' ' TYR . 0.4 OUTLIER -136.25 22.18 3.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.275 -0.891 . . . . 0.0 109.491 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -82.45 160.38 22.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.27 -0.894 . . . . 0.0 109.477 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.6 m -139.56 137.62 35.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.911 . . . . 0.0 109.464 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.526 -179.982 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ttt . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 59.08 103.81 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.181 -0.949 . . . . 0.0 109.447 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.453 ' HB2' ' HE2' ' A' ' 5' ' ' LYS . 4.0 p-10 -177.9 141.7 0.27 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.243 -0.91 . . . . 0.0 109.491 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -138.93 76.06 1.55 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.259 -0.9 . . . . 0.0 109.5 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.542 ' CD ' ' N ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -136.76 154.51 50.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.244 -0.91 . . . . 0.0 109.51 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.767 HD12 HG22 ' A' ' 30' ' ' THR . 4.3 mt -150.09 159.54 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.228 -0.92 . . . . 0.0 109.379 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.721 ' C ' HD13 ' A' ' 7' ' ' LEU . 2.8 tm? -132.22 107.62 8.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.256 -0.903 . . . . 0.0 109.382 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.454 ' N ' HD13 ' A' ' 7' ' ' LEU . 4.2 mt -94.81 110.51 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 0.0 109.451 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.771 ' HA ' ' HB3' ' A' ' 33' ' ' ALA . 61.1 t -95.46 109.49 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.231 -0.918 . . . . 0.0 109.44 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.54 ' CB ' ' HD2' ' A' ' 16' ' ' ARG . 4.2 m-20 -148.96 110.39 4.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.253 -0.904 . . . . 0.0 109.469 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.479 ' OD2' ' HD2' ' A' ' 58' ' ' PRO . 5.5 p-10 -76.38 -33.55 58.89 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 109.43 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.448 ' O ' ' O ' ' A' ' 13' ' ' TYR . 27.1 tt0 -78.77 104.24 9.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.25 -0.906 . . . . 0.0 109.5 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 1.046 ' CE2' HD11 ' A' ' 17' ' ' ILE . 2.6 t80 -44.56 168.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.205 -0.935 . . . . 0.0 109.509 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.77 -66.16 0.33 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.772 HG23 HD13 ' A' ' 19' ' ' LEU . 2.3 mt -63.4 -63.41 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.301 -1.117 . . . . 0.0 109.275 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.551 ' HB2' ' CG ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -42.23 -26.69 0.11 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.354 -0.841 . . . . 0.0 109.95 -179.804 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 1.046 HD11 ' CE2' ' A' ' 13' ' ' TYR . 20.6 mt -79.22 -59.63 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.106 -0.996 . . . . 0.0 109.761 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.783 ' O ' HG23 ' A' ' 22' ' ' VAL . 11.0 mp -53.28 -57.13 11.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.925 . . . . 0.0 109.721 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.772 HD13 HG23 ' A' ' 15' ' ' ILE . 7.3 mp -57.18 -22.51 41.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.235 -0.915 . . . . 0.0 109.578 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 23.6 t30 -75.84 -72.38 0.32 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.308 -0.87 . . . . 0.0 109.549 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -52.91 -19.96 2.97 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.343 -0.848 . . . . 0.0 109.642 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.783 HG23 ' O ' ' A' ' 18' ' ' LEU . 77.2 t -77.85 -58.77 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.187 -0.945 . . . . 0.0 109.39 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.428 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 13.8 m-85 -66.68 -11.18 53.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.192 -0.943 . . . . 0.0 109.349 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.446 ' OD1' ' O ' ' A' ' 20' ' ' ASN . 21.7 m120 -73.31 -61.2 1.91 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.282 -0.886 . . . . 0.0 109.404 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -18.78 63.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.236 -0.915 . . . . 0.0 109.265 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.538 ' HB3' ' CD2' ' A' ' 28' ' ' TYR . 2.7 mt-10 -75.52 -34.18 60.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.299 -0.876 . . . . 0.0 109.41 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.2 46.51 0.75 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.549 ' OH ' HD12 ' A' ' 121' ' ' LEU . 94.1 m-85 -139.0 134.56 33.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.269 -1.136 . . . . 0.0 109.529 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -91.01 83.63 5.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.099 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.767 HG22 HD12 ' A' ' 6' ' ' ILE . 5.7 p -89.74 150.56 22.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.939 . . . . 0.0 109.616 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.558 ' CZ ' ' OE2' ' A' ' 46' ' ' GLU . 17.8 m-85 -111.95 -168.38 1.31 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.302 -0.874 . . . . 0.0 109.264 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.551 ' CG ' ' HB2' ' A' ' 16' ' ' ARG . 0.6 OUTLIER -132.26 150.05 52.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.178 -0.951 . . . . 0.0 109.687 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.771 ' HB3' ' HA ' ' A' ' 9' ' ' VAL . . . -146.38 -174.4 4.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.229 -0.919 . . . . 0.0 109.349 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.612 ' O ' HD13 ' A' ' 57' ' ' ILE . . . -175.98 -57.02 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.176 -0.952 . . . . 0.0 109.619 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -81.18 0.21 37.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 109.591 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.414 ' O ' ' HB3' ' A' ' 39' ' ' ALA . . . 86.17 -53.78 4.65 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.472 HD13 ' HA ' ' A' ' 37' ' ' LEU . 2.3 mm? -45.08 -59.06 2.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -1.148 . . . . 0.0 109.549 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.565 ' O ' HD12 ' A' ' 42' ' ' ILE . 6.3 tp60 -51.96 -38.17 55.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 0.0 109.496 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.464 ' O ' ' HB ' ' A' ' 43' ' ' VAL . . . -60.16 -38.44 83.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.904 . . . . 0.0 109.551 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.541 ' HA ' ' CG1' ' A' ' 43' ' ' VAL . 35.4 mt -76.25 -20.93 56.94 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.391 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.506 ' O ' ' CG ' ' A' ' 45' ' ' LYS . 0.8 OUTLIER -75.38 -40.23 58.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.132 -0.98 . . . . 0.0 109.041 179.705 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.565 HD12 ' O ' ' A' ' 38' ' ' GLN . 1.8 mp -83.86 -24.76 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.337 -0.852 . . . . 0.0 109.245 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.541 ' CG1' ' HA ' ' A' ' 40' ' ' LEU . 1.5 p -72.63 -38.88 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.265 -0.897 . . . . 0.0 109.236 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.434 ' N ' ' CG1' ' A' ' 43' ' ' VAL . 7.8 m -90.03 -22.86 21.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.361 -0.837 . . . . 0.0 109.438 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.506 ' CG ' ' O ' ' A' ' 41' ' ' ASP . 58.3 mttt -75.32 -54.42 7.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.21 -0.931 . . . . 0.0 109.618 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.558 ' OE2' ' CZ ' ' A' ' 31' ' ' PHE . 0.6 OUTLIER -91.34 -29.83 16.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.9 . . . . 0.0 109.632 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.527 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 0.0 OUTLIER 71.24 61.64 0.43 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.267 -0.896 . . . . 0.0 109.472 -179.975 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.535 ' CD ' ' HA ' ' A' ' 43' ' ' VAL . 35.4 Cg_endo -77.95 155.49 30.22 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.63 2.22 . . . . 0.0 110.462 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.451 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 0.3 OUTLIER -101.51 -9.02 21.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.26 -0.9 . . . . 0.0 109.477 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.686 HD21 HG22 ' A' ' 115' ' ' VAL . 9.1 tp -124.79 116.51 22.41 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.203 -0.935 . . . . 0.0 109.517 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.569 HG11 ' HE1' ' A' ' 69' ' ' MET . 43.3 t -128.38 118.08 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.176 -0.953 . . . . 0.0 109.472 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.535 HD23 ' HB ' ' A' ' 79' ' ' ILE . 0.7 OUTLIER -89.95 119.09 30.02 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.196 -0.94 . . . . 0.0 109.45 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.571 HD22 ' HG ' ' A' ' 66' ' ' LEU . 1.2 mp -104.1 138.24 40.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.32 -0.863 . . . . 0.0 109.446 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.43 ' O ' HG13 ' A' ' 57' ' ' ILE . 26.3 t70 -114.5 110.81 20.4 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.22 -0.925 . . . . 0.0 109.516 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.841 ' HB2' HG21 ' A' ' 82' ' ' THR . 24.5 mmt -73.34 -2.42 22.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.206 -0.934 . . . . 0.0 109.608 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.463 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 16.2 mmtt -85.35 13.16 6.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.156 -0.965 . . . . 0.0 109.552 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.924 HG21 ' HE1' ' A' ' 60' ' ' MET . 40.2 mt -78.48 114.29 41.75 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.27 -0.894 . . . . 0.0 109.417 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.479 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 35.7 Cg_endo -78.23 107.02 2.24 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.376 2.051 . . . . 0.0 110.375 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 155.13 -44.0 0.56 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.924 ' HE1' HG21 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -158.99 163.46 36.44 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.168 -1.196 . . . . 0.0 109.427 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -89.88 144.83 25.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.209 -0.932 . . . . 0.0 109.559 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.465 ' O ' ' HB ' ' A' ' 65' ' ' ILE . . . -87.2 -1.22 84.44 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.545 HD11 ' O ' ' A' ' 88' ' ' ASP . 15.8 mm -52.69 -52.83 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.201 -1.176 . . . . 0.0 109.464 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -61.22 -27.08 68.18 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.186 -0.946 . . . . 0.0 109.365 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.465 ' HB ' ' O ' ' A' ' 62' ' ' GLY . 19.4 mt -63.23 -66.7 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.316 -0.865 . . . . 0.0 109.456 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.963 HD21 HG11 ' A' ' 78' ' ' VAL . 16.4 mt -46.05 -25.56 0.59 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.91 . . . . 0.0 109.448 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.475 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 2.4 tmtp? -68.49 -60.26 2.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -0.895 . . . . 0.0 109.503 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.48 -29.04 61.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.263 -0.898 . . . . 0.0 109.428 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.569 ' HE1' HG11 ' A' ' 51' ' ' VAL . 3.1 mmt -64.78 -62.53 1.51 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.186 -0.946 . . . . 0.0 109.433 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 16.9 ptpt -51.84 -39.14 58.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.305 -0.872 . . . . 0.0 109.425 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 67' ' ' LYS . 86.4 t -58.6 -40.6 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.189 -0.945 . . . . 0.0 109.473 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.41 ' O ' ' OD1' ' A' ' 73' ' ' ASP . 15.6 mt -73.77 -25.94 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.211 -0.931 . . . . 0.0 109.433 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.429 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 0.1 OUTLIER -173.22 140.35 0.86 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 109.497 -180.0 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -89.76 -17.9 27.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.272 -0.893 . . . . 0.0 109.441 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -86.0 11.1 12.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.258 -0.901 . . . . 0.0 109.434 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.742 ' O ' HG23 ' A' ' 76' ' ' ILE . 2.1 tp -82.39 106.15 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.226 -0.921 . . . . 0.0 109.471 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.532 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 0.4 OUTLIER -77.3 154.16 33.15 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.29 -0.881 . . . . 0.0 109.514 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.963 HG11 HD21 ' A' ' 66' ' ' LEU . 43.0 t -147.03 121.65 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 109.545 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.535 ' HB ' HD23 ' A' ' 52' ' ' LEU . 3.6 mm -97.21 122.58 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.229 -0.919 . . . . 0.0 109.444 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.916 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.3 OUTLIER -90.05 126.2 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.279 -0.888 . . . . 0.0 109.293 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.561 ' SD ' ' CZ ' ' A' ' 106' ' ' PHE . 2.2 mtm -101.28 54.38 0.83 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.131 -0.981 . . . . 0.0 109.565 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.841 HG21 ' HB2' ' A' ' 55' ' ' MET . 14.8 t -168.64 56.25 0.05 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.3 -0.875 . . . . 0.0 109.444 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.82 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . -57.93 -43.19 86.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.879 . . . . 0.0 109.549 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.77 128.09 34.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.266 -0.896 . . . . 0.0 109.498 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 153.64 -81.17 0.18 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -140.14 165.14 28.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.205 -1.174 . . . . 0.0 109.468 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.551 ' HA ' ' CG2' ' A' ' 90' ' ' ILE . 4.1 mt -127.45 66.35 1.31 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.22 -0.925 . . . . 0.0 109.504 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.545 ' O ' HD11 ' A' ' 63' ' ' ILE . 0.3 OUTLIER -120.68 101.32 7.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.286 -0.884 . . . . 0.0 109.18 179.881 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.534 ' CB ' ' O ' ' A' ' 88' ' ' ASP . 2.4 tmm? 78.97 -4.46 2.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.373 -0.829 . . . . 0.0 109.297 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.632 ' CD1' ' CE1' ' A' ' 101' ' ' HIS . 0.2 OUTLIER -90.85 -49.64 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.368 -0.832 . . . . 0.0 108.783 179.572 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -58.3 -39.61 79.78 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.32 -0.863 . . . . 0.0 109.615 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -89.81 -16.22 30.64 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 109.547 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.746 ' HA ' HD12 ' A' ' 96' ' ' LEU . 0.6 OUTLIER -55.85 -19.0 10.11 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.26 -0.9 . . . . 0.0 109.51 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.419 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 2.2 mmmt -48.43 -61.32 2.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.261 -0.899 . . . . 0.0 109.495 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.408 ' O ' ' C ' ' A' ' 96' ' ' LEU . 4.9 mt-10 -65.42 -41.88 93.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.256 -0.903 . . . . 0.0 109.509 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.746 HD12 ' HA ' ' A' ' 93' ' ' SER . 81.6 mt -44.19 -38.86 4.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.226 -0.921 . . . . 0.0 109.457 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 143.61 40.08 0.06 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.419 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -102.91 99.06 8.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.222 -1.163 . . . . 0.0 109.486 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.727 HD22 ' CD1' ' A' ' 118' ' ' TYR . 16.9 mt -51.72 -68.03 0.2 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.255 -0.903 . . . . 0.0 109.498 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.586 HG22 ' N ' ' A' ' 101' ' ' HIS . 17.1 m -135.81 165.84 24.69 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.207 -0.933 . . . . 0.0 109.551 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.916 ' ND1' HD12 ' A' ' 80' ' ' ILE . 4.1 t60 -130.26 84.27 2.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.367 -0.833 . . . . 0.0 109.359 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.575 ' CE2' ' HA ' ' A' ' 111' ' ' ILE . 9.3 m-85 -70.28 157.19 38.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.215 -0.928 . . . . 0.0 109.485 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.82 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -132.46 -148.67 0.35 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 0.0 109.476 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.446 ' HB2' ' HA ' ' A' ' 105' ' ' PRO . 2.0 pttp -96.78 157.26 35.47 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.901 . . . . 0.0 109.494 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.446 ' HA ' ' HB2' ' A' ' 104' ' ' LYS . 36.3 Cg_endo -79.76 11.2 23.9 Favored 'Cis proline' 0 C--N 1.309 -1.518 0 C-N-CA 123.285 -1.548 . . . . 0.0 110.802 -0.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.686 ' CE2' HD21 ' A' ' 19' ' ' LEU . 11.4 t80 70.93 96.59 0.07 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.212 -0.93 . . . . 0.0 109.437 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.466 ' O ' HG12 ' A' ' 111' ' ' ILE . 21.3 t0 -89.88 118.32 29.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 0.0 109.385 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.591 HG22 ' HE ' ' A' ' 112' ' ' ARG . 13.4 mm -51.24 -39.1 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.168 -0.958 . . . . 0.0 109.339 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.439 ' HB2' ' OD2' ' A' ' 107' ' ' ASP . 3.2 m-20 -63.05 -37.33 86.75 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.288 -0.882 . . . . 0.0 109.373 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.574 ' HG3' ' CE1' ' A' ' 102' ' ' PHE . 3.0 tp10 -69.08 -33.5 73.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.292 -0.88 . . . . 0.0 109.257 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.631 ' CD1' ' CE1' ' A' ' 106' ' ' PHE . 10.5 mm -66.35 -54.96 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.3 -0.875 . . . . 0.0 109.272 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.591 ' HE ' HG22 ' A' ' 108' ' ' ILE . 3.9 mtm180 -57.46 -33.6 68.13 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.311 -0.868 . . . . 0.0 109.486 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -62.66 -62.09 1.97 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.234 -0.916 . . . . 0.0 109.768 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.425 ' O ' ' C ' ' A' ' 115' ' ' VAL . . . -58.56 -62.99 1.45 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.166 -0.958 . . . . 0.0 109.734 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.686 HG22 HD21 ' A' ' 50' ' ' LEU . 55.8 t -42.77 -39.09 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.357 -0.839 . . . . 0.0 109.867 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 1.4 mttt -63.48 -58.95 5.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.218 -0.926 . . . . 0.0 109.668 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -49.64 -60.03 3.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.2 -0.938 . . . . 0.0 109.603 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.727 ' CD1' HD22 ' A' ' 99' ' ' LEU . 65.6 m-85 -54.81 -73.91 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.237 -0.915 . . . . 0.0 109.601 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.718 HD23 ' O ' ' A' ' 120' ' ' PRO . 5.8 tt -90.15 112.47 52.66 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.926 . . . . 0.0 109.538 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.718 ' O ' HD23 ' A' ' 119' ' ' LEU . 35.6 Cg_endo -78.44 -159.39 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.389 2.059 . . . . 0.0 110.27 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.549 HD12 ' OH ' ' A' ' 28' ' ' TYR . 1.3 mt -153.11 -177.97 6.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.939 . . . . 0.0 109.439 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.407 ' HE2' ' HB3' ' A' ' 124' ' ' ASN . 0.0 OUTLIER -59.48 -75.64 0.05 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.146 -0.971 . . . . 0.0 109.438 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.1 p 64.93 27.36 12.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.34 -0.85 . . . . 0.0 109.523 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.407 ' HB3' ' HE2' ' A' ' 122' ' ' LYS . 48.8 t30 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.49 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 ttp . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.264 0.555 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.454 ' O ' ' OD1' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -166.84 131.38 2.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.229 -0.92 . . . . 0.0 109.464 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.454 ' OD1' ' O ' ' A' ' 2' ' ' MET . 5.3 m120 -149.05 106.5 3.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.886 . . . . 0.0 109.452 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -128.96 78.12 1.83 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.234 -0.916 . . . . 0.0 109.474 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.474 ' HB2' ' HA ' ' A' ' 48' ' ' PRO . 10.6 mttm -105.58 135.76 46.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.298 -0.876 . . . . 0.0 109.497 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.533 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 68.9 mt -150.12 146.17 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.252 -0.905 . . . . 0.0 109.468 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 1.015 HD11 HD13 ' A' ' 42' ' ' ILE . 0.9 OUTLIER -124.8 133.07 53.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.263 -0.898 . . . . 0.0 109.405 179.905 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.618 HD13 ' HB3' ' A' ' 19' ' ' LEU . 14.1 mt -102.71 113.72 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.184 -0.948 . . . . 0.0 109.503 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.548 ' CG2' HD23 ' A' ' 7' ' ' LEU . 13.7 t -105.77 94.48 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.17 -0.957 . . . . 0.0 109.444 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.516 ' O ' ' CD ' ' A' ' 16' ' ' ARG . 31.2 t70 -145.86 116.96 7.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.911 . . . . 0.0 109.473 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.524 ' OD2' ' CD ' ' A' ' 58' ' ' PRO . 5.8 p-10 -77.98 -46.03 22.21 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -0.902 . . . . 0.0 109.482 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.477 ' CG ' ' O ' ' A' ' 12' ' ' GLN . 10.5 pt20 -56.27 101.09 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.292 -0.88 . . . . 0.0 109.474 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 1.15 ' CE2' HD11 ' A' ' 17' ' ' ILE . 2.7 t80 -45.83 141.94 2.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.307 -0.871 . . . . 0.0 109.499 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 132.25 -53.08 0.81 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.414 ' O ' ' C ' ' A' ' 16' ' ' ARG . 2.7 mp -75.34 -53.41 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.255 -1.144 . . . . 0.0 109.445 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.516 ' CD ' ' O ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -43.89 -26.53 0.27 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.258 -0.901 . . . . 0.0 109.614 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 1.15 HD11 ' CE2' ' A' ' 13' ' ' TYR . 2.3 mt -90.12 -60.39 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.211 -0.93 . . . . 0.0 109.886 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.824 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.9 OUTLIER -50.4 -60.55 2.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.149 -0.969 . . . . 0.0 109.892 -179.697 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.832 HD11 HG21 ' A' ' 111' ' ' ILE . 1.5 tp -56.3 -24.23 42.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.304 -0.872 . . . . 0.0 109.873 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 25.4 t30 -71.85 -69.83 0.37 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.123 -0.986 . . . . 0.0 109.81 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 0.7 OUTLIER -47.6 -41.47 21.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.29 -0.881 . . . . 0.0 109.706 -179.787 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.824 HG23 ' O ' ' A' ' 18' ' ' LEU . 40.4 t -56.33 -60.52 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.244 -0.91 . . . . 0.0 109.606 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.629 ' CB ' HG21 ' A' ' 30' ' ' THR . 22.0 m-85 -69.41 -6.19 28.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 0.0 109.612 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 3.0 m-20 -77.39 -54.83 5.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.21 -0.931 . . . . 0.0 109.286 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt -78.31 -12.2 59.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.317 -0.865 . . . . 0.0 109.289 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.446 ' HB2' ' HA ' ' A' ' 23' ' ' PHE . 3.1 mm-40 -77.09 -43.58 33.77 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.249 -0.907 . . . . 0.0 109.461 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.69 50.67 0.32 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.635 ' CZ ' ' CD1' ' A' ' 121' ' ' LEU . 98.7 m-85 -140.81 140.47 34.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.229 -1.159 . . . . 0.0 109.527 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -90.02 82.87 6.08 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.229 -0.92 . . . . 0.0 109.291 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.629 HG21 ' CB ' ' A' ' 23' ' ' PHE . 5.8 p -89.91 153.8 20.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 109.55 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.533 ' CD2' ' O ' ' A' ' 6' ' ' ILE . 7.9 m-85 -120.99 -158.25 0.75 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -0.893 . . . . 0.0 109.338 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.465 ' HG2' ' HG2' ' A' ' 16' ' ' ARG . 73.9 mt-30 -144.05 157.86 44.07 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.208 -0.932 . . . . 0.0 109.663 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.446 ' HB3' HG22 ' A' ' 9' ' ' VAL . . . -170.99 161.34 6.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.876 . . . . 0.0 109.235 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.608 ' O ' HD13 ' A' ' 57' ' ' ILE . . . -127.55 -57.9 1.27 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.197 -0.939 . . . . 0.0 109.713 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.521 ' OD1' ' CB ' ' A' ' 37' ' ' LEU . 4.1 p30 -90.4 136.47 33.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.209 -0.932 . . . . 0.0 109.483 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.55 ' HA3' ' CD1' ' A' ' 65' ' ' ILE . . . -45.1 -29.11 2.13 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.521 ' CB ' ' OD1' ' A' ' 35' ' ' ASN . 0.2 OUTLIER -47.7 -53.61 14.55 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.326 -1.102 . . . . 0.0 109.382 179.853 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.459 ' O ' ' C ' ' A' ' 39' ' ' ALA . 11.4 mt-30 -62.3 -51.07 69.16 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.245 -0.909 . . . . 0.0 109.393 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.562 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -39.92 -37.99 0.64 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.443 -0.786 . . . . 0.0 109.804 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.7 mt -77.5 -45.05 26.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.0 109.61 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -56.26 -62.01 2.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.206 -0.934 . . . . 0.0 109.626 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 1.015 HD13 HD11 ' A' ' 7' ' ' LEU . 10.4 mt -56.67 -51.72 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.894 . . . . 0.0 109.753 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 39' ' ' ALA . 45.0 t -54.06 -22.67 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.166 -0.959 . . . . 0.0 109.704 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.0 m -89.95 -28.39 19.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.182 -0.949 . . . . 0.0 109.837 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.435 ' C ' ' HG2' ' A' ' 46' ' ' GLU . 4.1 mmmt -90.2 -6.59 55.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.208 -0.932 . . . . 0.0 109.59 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.528 ' OE1' ' CZ ' ' A' ' 31' ' ' PHE . 2.5 mt-10 -137.26 -36.2 0.66 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.242 -0.911 . . . . 0.0 109.451 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.45 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 75.3 mtm-85 58.56 65.01 3.2 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.321 -0.862 . . . . 0.0 109.462 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.536 ' CD ' ' HA ' ' A' ' 43' ' ' VAL . 35.2 Cg_endo -77.02 159.4 34.0 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.578 2.185 . . . . 0.0 110.437 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 89.1 m-20 -96.3 -5.45 40.09 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.274 -0.891 . . . . 0.0 109.656 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.479 ' CD2' HG13 ' A' ' 115' ' ' VAL . 5.2 tp -129.39 123.55 31.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.169 -0.957 . . . . 0.0 109.593 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.7 ' HB ' HG22 ' A' ' 78' ' ' VAL . 22.0 t -132.09 118.81 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.351 -0.843 . . . . 0.0 109.537 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.652 HD12 ' O ' ' A' ' 7' ' ' LEU . 1.2 mp -90.05 113.35 25.04 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -0.912 . . . . 0.0 109.42 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.523 ' CD2' ' HG ' ' A' ' 66' ' ' LEU . 1.2 mp -104.79 130.88 52.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.375 -0.828 . . . . 0.0 109.585 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.487 ' HA ' ' HG3' ' A' ' 81' ' ' MET . 32.8 t70 -108.58 105.72 15.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.288 -0.882 . . . . 0.0 109.244 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.579 ' CG ' HG21 ' A' ' 82' ' ' THR . 7.5 mtp -71.64 -4.12 25.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -0.916 . . . . 0.0 109.534 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.402 ' HE3' ' CB ' ' A' ' 82' ' ' THR . 8.1 mttp -86.07 15.08 5.38 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.116 -0.99 . . . . 0.0 109.508 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.608 HD13 ' O ' ' A' ' 34' ' ' ALA . 53.8 mt -74.13 132.65 79.26 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.188 -0.945 . . . . 0.0 109.41 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.524 ' CD ' ' OD2' ' A' ' 11' ' ' ASP . 36.7 Cg_endo -80.54 41.9 1.23 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.624 2.216 . . . . 0.0 110.7 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -133.57 -56.72 0.07 OUTLIER Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.505 ' N ' ' SD ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -156.96 -178.54 7.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.311 -1.111 . . . . 0.0 109.532 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -90.08 142.36 27.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.266 -0.896 . . . . 0.0 109.505 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.442 ' HA2' HG13 ' A' ' 65' ' ' ILE . . . -77.63 -9.42 86.89 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.63 HD12 ' HB3' ' A' ' 89' ' ' MET . 17.6 mm -51.11 -55.72 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -1.16 . . . . 0.0 109.394 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -55.84 -39.24 71.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.259 -0.9 . . . . 0.0 109.479 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.55 ' CD1' ' HA3' ' A' ' 36' ' ' GLY . 13.8 mt -53.4 -69.46 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.201 -0.937 . . . . 0.0 109.463 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 1.052 HD21 HG11 ' A' ' 78' ' ' VAL . 93.1 mt -43.62 -48.37 7.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.158 -0.963 . . . . 0.0 109.68 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.562 ' O ' HG23 ' A' ' 71' ' ' VAL . 2.1 mmtt -43.17 -58.11 2.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 109.704 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.44 ' O ' HG13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -61.6 -32.59 72.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.171 -0.956 . . . . 0.0 109.588 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.597 ' SD ' HD23 ' A' ' 66' ' ' LEU . 78.7 mtp -66.0 -23.66 66.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.321 -0.862 . . . . 0.0 109.591 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -84.0 -41.98 16.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.225 -0.922 . . . . 0.0 108.942 179.904 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 67' ' ' LYS . 2.5 t -62.09 -31.99 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.486 -0.759 . . . . 0.0 109.522 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 68' ' ' ARG . 11.3 mt -84.01 -39.86 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.232 -0.918 . . . . 0.0 109.447 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -143.13 132.75 23.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.289 -0.882 . . . . 0.0 109.379 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -90.01 -23.58 21.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.272 -0.892 . . . . 0.0 109.527 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -99.41 47.97 0.95 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.289 -0.882 . . . . 0.0 109.467 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.1 tt -107.68 134.54 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.262 -0.899 . . . . 0.0 109.478 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.536 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 0.5 OUTLIER -104.03 141.2 36.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.241 -0.912 . . . . 0.0 109.466 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 1.052 HG11 HD21 ' A' ' 66' ' ' LEU . 82.4 t -139.37 118.76 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -0.906 . . . . 0.0 109.557 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.933 HG23 HG23 ' A' ' 100' ' ' THR . 5.1 mm -89.96 122.4 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.287 -0.883 . . . . 0.0 109.162 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.862 HD12 ' HD1' ' A' ' 101' ' ' HIS . 0.1 OUTLIER -89.87 143.29 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.174 -0.954 . . . . 0.0 109.375 -179.876 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.487 ' HG3' ' HA ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -117.68 71.17 0.81 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.185 -0.947 . . . . 0.0 109.255 179.79 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.579 HG21 ' CG ' ' A' ' 55' ' ' MET . 13.4 t -176.15 31.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.346 -0.846 . . . . 0.0 109.536 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.79 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . -44.67 -77.05 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.206 -0.934 . . . . 0.0 109.499 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.416 ' C ' ' O ' ' A' ' 83' ' ' ALA . 0.4 OUTLIER -44.14 107.07 0.08 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.272 -0.893 . . . . 0.0 109.462 -179.982 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 164.46 -107.76 0.31 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.505 ' O ' HG21 ' A' ' 90' ' ' ILE . 0.9 OUTLIER -115.86 137.72 51.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.25 -1.147 . . . . 0.0 109.5 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.613 ' HA ' HG23 ' A' ' 90' ' ' ILE . 1.2 mp -108.28 59.52 0.61 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.194 -0.941 . . . . 0.0 109.503 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -100.77 -92.83 0.29 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.881 . . . . 0.0 109.657 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.63 ' HB3' HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -68.26 -7.53 31.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 0.0 109.547 179.869 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.938 HD12 ' CE1' ' A' ' 101' ' ' HIS . 0.4 OUTLIER -86.96 -42.43 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.19 -0.944 . . . . 0.0 109.066 179.858 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -55.68 -40.37 72.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 0.0 109.493 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.433 ' O ' ' C ' ' A' ' 93' ' ' SER . 29.9 mm-40 -90.06 -38.48 13.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.209 -0.932 . . . . 0.0 109.649 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.764 ' HA ' HD12 ' A' ' 96' ' ' LEU . 1.2 m -43.34 -39.36 3.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.306 -0.871 . . . . 0.0 109.551 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.909 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 6.6 mttp -44.3 -55.62 4.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 109.387 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -58.71 -43.56 90.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.243 -0.911 . . . . 0.0 109.463 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.764 HD12 ' HA ' ' A' ' 93' ' ' SER . 79.0 mt -47.2 -63.87 0.93 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.325 -0.859 . . . . 0.0 109.474 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 179.93 36.64 0.07 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.909 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -99.85 99.66 10.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -1.15 . . . . 0.0 109.503 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.598 HD13 ' CG ' ' A' ' 118' ' ' TYR . 16.7 mt -48.87 -62.74 1.36 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.323 -0.861 . . . . 0.0 109.516 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.933 HG23 HG23 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -144.39 176.42 9.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.154 -0.966 . . . . 0.0 109.577 -179.925 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.938 ' CE1' HD12 ' A' ' 90' ' ' ILE . 3.5 t-160 -141.51 94.01 2.64 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.343 -0.848 . . . . 0.0 109.235 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.734 ' HZ ' ' HB2' ' A' ' 114' ' ' ALA . 7.9 m-85 -82.12 160.9 23.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.265 -0.897 . . . . 0.0 109.696 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.79 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -140.43 -148.58 0.25 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.236 -0.915 . . . . 0.0 109.281 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.55 145.48 30.54 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.164 -0.96 . . . . 0.0 109.302 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.0 151.96 91.4 Favored 'Cis proline' 0 C--N 1.309 -1.551 0 C-N-CA 123.289 -1.546 . . . . 0.0 110.437 -0.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.733 ' CZ ' HD12 ' A' ' 111' ' ' ILE . 0.5 OUTLIER -83.05 103.89 12.84 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -0.893 . . . . 0.0 109.457 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.473 ' O ' HG12 ' A' ' 111' ' ' ILE . 48.2 t0 -89.84 103.0 15.69 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.106 -0.996 . . . . 0.0 109.401 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.457 ' O ' ' HG2' ' A' ' 112' ' ' ARG . 19.8 mm -43.31 -26.95 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.31 -0.869 . . . . 0.0 109.698 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.44 -47.96 44.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.897 . . . . 0.0 109.576 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.472 ' HG3' ' OD2' ' A' ' 107' ' ' ASP . 41.5 mt-10 -66.91 -22.94 65.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 109.332 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.832 HG21 HD11 ' A' ' 19' ' ' LEU . 16.2 mm -75.43 -56.4 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.34 -0.85 . . . . 0.0 109.293 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 108' ' ' ILE . 0.6 OUTLIER -63.83 -22.17 66.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.269 -0.894 . . . . 0.0 109.477 179.948 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -73.84 -51.46 16.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.94 . . . . 0.0 109.497 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.734 ' HB2' ' HZ ' ' A' ' 102' ' ' PHE . . . -63.35 -55.77 21.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.3 -0.875 . . . . 0.0 109.458 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.479 HG13 ' CD2' ' A' ' 50' ' ' LEU . 54.0 t -50.17 -52.28 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 109.537 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 6.5 mmmt -54.76 -39.56 68.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.19 -0.944 . . . . 0.0 109.48 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 7.0 tttm -58.22 -40.97 83.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.445 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.598 ' CG ' HD13 ' A' ' 99' ' ' LEU . 56.3 m-85 -81.89 -73.32 0.39 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.887 . . . . 0.0 109.476 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.67 HD12 ' HD2' ' A' ' 120' ' ' PRO . 39.7 tp -78.57 114.43 43.21 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.299 -0.875 . . . . 0.0 109.392 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.67 ' HD2' HD12 ' A' ' 119' ' ' LEU . 35.9 Cg_endo -78.08 176.1 10.37 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.424 2.083 . . . . 0.0 110.408 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.635 ' CD1' ' CZ ' ' A' ' 28' ' ' TYR . 1.2 mt -140.91 131.23 25.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.313 -0.867 . . . . 0.0 109.516 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.01 -22.68 27.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.219 -0.925 . . . . 0.0 109.519 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 64.09 98.21 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.24 -0.913 . . . . 0.0 109.466 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.429 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.428 ' O ' ' HG2' ' A' ' 4' ' ' GLU . 10.3 mtm -119.84 -59.67 1.78 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 109.487 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 62.97 31.84 15.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.229 -0.92 . . . . 0.0 109.456 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 2' ' ' MET . 0.2 OUTLIER 178.46 81.92 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.243 -0.91 . . . . 0.0 109.507 179.983 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.439 ' HB2' ' HA ' ' A' ' 48' ' ' PRO . 11.2 mttp -110.22 154.42 23.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.932 . . . . 0.0 109.378 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.647 ' HB ' HG22 ' A' ' 30' ' ' THR . 70.7 mt -150.11 149.19 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.282 -0.886 . . . . 0.0 109.467 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.858 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.8 OUTLIER -125.98 125.04 42.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.325 -0.859 . . . . 0.0 109.363 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.858 ' N ' HD13 ' A' ' 7' ' ' LEU . 10.1 mt -103.95 103.12 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.229 -0.92 . . . . 0.0 109.579 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.727 ' CG2' HD12 ' A' ' 7' ' ' LEU . 2.6 t -102.74 84.8 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.319 -0.863 . . . . 0.0 109.333 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.524 ' O ' ' CD1' ' A' ' 57' ' ' ILE . 40.1 p-10 -88.61 -149.44 0.18 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.33 -0.856 . . . . 0.0 109.502 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.523 ' CB ' ' HA ' ' A' ' 57' ' ' ILE . 1.0 OUTLIER -121.92 -31.39 3.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.309 -0.87 . . . . 0.0 109.519 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.45 ' O ' ' OD2' ' A' ' 10' ' ' ASP . 1.9 tt0 -146.75 153.95 40.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.27 -0.894 . . . . 0.0 109.483 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 1.015 ' CE2' HD11 ' A' ' 17' ' ' ILE . 6.3 t80 -43.88 141.77 1.52 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 109.499 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 137.34 -70.13 0.49 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.978 HG23 HD13 ' A' ' 19' ' ' LEU . 2.6 mt -62.86 -29.54 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.18 -1.188 . . . . 0.0 109.382 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.524 ' HB3' ' CG ' ' A' ' 32' ' ' GLN . 3.9 mpp_? -70.69 -21.81 62.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.273 -0.892 . . . . 0.0 109.566 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 1.015 HD11 ' CE2' ' A' ' 13' ' ' TYR . 6.9 mt -90.14 -57.22 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.217 -0.927 . . . . 0.0 109.661 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.905 ' O ' HG23 ' A' ' 22' ' ' VAL . 7.1 mp -54.7 -58.91 5.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.24 -0.913 . . . . 0.0 109.683 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.978 HD13 HG23 ' A' ' 15' ' ' ILE . 6.2 mp -57.52 -23.75 52.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.216 -0.927 . . . . 0.0 109.643 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 16.5 t30 -71.44 -70.63 0.31 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.238 -0.914 . . . . 0.0 109.592 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.479 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 13.5 tp10 -46.92 -43.46 18.98 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -0.91 . . . . 0.0 109.623 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.905 HG23 ' O ' ' A' ' 18' ' ' LEU . 22.7 t -54.33 -60.99 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 109.637 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.603 ' CE1' ' HA ' ' A' ' 112' ' ' ARG . 38.8 m-85 -71.25 -4.18 24.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.209 -0.932 . . . . 0.0 109.718 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.479 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 7.1 m-20 -80.02 -44.56 19.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.179 -0.95 . . . . 0.0 109.437 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.415 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 25.1 tttt -80.99 -18.01 48.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.301 -0.874 . . . . 0.0 109.464 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.511 ' HB3' ' CD1' ' A' ' 28' ' ' TYR . 2.2 tt0 -77.72 -37.46 49.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.215 -0.928 . . . . 0.0 109.449 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.522 ' C ' ' CD1' ' A' ' 28' ' ' TYR . . . 115.71 62.79 0.36 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.954 ' CE2' HD21 ' A' ' 121' ' ' LEU . 70.1 m-85 -149.67 134.55 17.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.177 -1.19 . . . . 0.0 109.518 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.41 ' HG2' ' OE2' ' A' ' 4' ' ' GLU . 3.1 mm100 -90.35 83.32 5.93 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.249 -0.907 . . . . 0.0 109.113 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.647 HG22 ' HB ' ' A' ' 6' ' ' ILE . 5.7 p -89.89 172.13 9.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.318 -0.864 . . . . 0.0 109.637 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.799 ' HB2' HD22 ' A' ' 7' ' ' LEU . 19.3 m-85 -134.6 -178.51 5.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.868 . . . . 0.0 109.352 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.524 ' CG ' ' HB3' ' A' ' 16' ' ' ARG . 27.4 mp0 -120.71 149.04 43.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.213 -0.93 . . . . 0.0 109.637 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.832 ' HB1' ' HB2' ' A' ' 39' ' ' ALA . . . -177.37 175.03 1.52 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.393 -0.817 . . . . 0.0 109.474 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.502 ' HA ' HG12 ' A' ' 9' ' ' VAL . . . -178.74 -58.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 109.663 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.412 ' C ' ' O ' ' A' ' 34' ' ' ALA . 3.9 p30 -43.6 -27.15 0.27 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.258 -0.901 . . . . 0.0 109.578 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.542 ' O ' HD12 ' A' ' 40' ' ' LEU . . . 97.84 -39.14 2.85 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.9 HD12 ' N ' ' A' ' 38' ' ' GLN . 3.8 pp -70.08 -45.52 66.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.213 -1.169 . . . . 0.0 109.609 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.9 ' N ' HD12 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -79.39 -30.58 42.52 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.222 -0.924 . . . . 0.0 108.912 179.868 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.832 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . . . -62.41 -48.41 79.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.254 -0.904 . . . . 0.0 108.934 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.828 HD11 HG23 ' A' ' 65' ' ' ILE . 3.7 mt -66.28 -48.59 69.94 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.333 -0.854 . . . . 0.0 109.046 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.419 ' C ' ' O ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -45.41 -40.08 7.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.337 -0.852 . . . . 0.0 109.009 179.659 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.642 HD12 ' O ' ' A' ' 38' ' ' GLN . 5.3 mt -68.04 -48.43 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.334 -0.854 . . . . 0.0 109.19 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.855 HG13 ' HD2' ' A' ' 48' ' ' PRO . 46.1 t -55.41 -19.15 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.222 -0.924 . . . . 0.0 109.406 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.8 m -90.23 -35.05 15.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.171 -0.956 . . . . 0.0 109.514 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.478 ' HG2' ' HA ' ' A' ' 42' ' ' ILE . 0.0 OUTLIER -86.32 -5.25 59.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.187 -0.945 . . . . 0.0 109.684 -179.848 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.422 ' CG ' ' HD2' ' A' ' 45' ' ' LYS . 5.1 mm-40 -134.5 -37.8 0.84 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.144 -0.973 . . . . 0.0 109.309 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.434 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 12.1 mtm-85 57.84 65.89 3.11 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.385 -0.822 . . . . 0.0 109.643 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.855 ' HD2' HG13 ' A' ' 43' ' ' VAL . 35.3 Cg_endo -77.3 162.77 30.82 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.541 2.161 . . . . 0.0 110.416 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.462 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 6.7 t0 -97.03 -13.38 22.3 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.135 -0.978 . . . . 0.0 109.57 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.8 ' CD2' HG13 ' A' ' 115' ' ' VAL . 7.0 tp -117.92 123.47 45.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.188 -0.945 . . . . 0.0 109.588 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.703 ' HB ' HG13 ' A' ' 78' ' ' VAL . 39.6 t -129.08 137.62 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -0.924 . . . . 0.0 109.403 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.668 HD12 ' O ' ' A' ' 7' ' ' LEU . 1.1 mt -112.4 103.68 11.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 109.427 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.711 HD21 ' HB ' ' A' ' 65' ' ' ILE . 1.4 mp -97.47 124.6 41.75 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.304 -0.873 . . . . 0.0 109.582 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.449 ' O ' HG13 ' A' ' 57' ' ' ILE . 21.0 t70 -107.51 120.58 42.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.263 -0.898 . . . . 0.0 109.341 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.846 ' CG ' HG21 ' A' ' 82' ' ' THR . 25.6 mmt -75.15 -13.96 60.51 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.172 -0.955 . . . . 0.0 109.638 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -89.57 46.49 1.37 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.201 -0.937 . . . . 0.0 109.52 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.524 ' CD1' ' O ' ' A' ' 10' ' ' ASP . 81.3 mt -110.99 130.21 23.17 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.177 -0.952 . . . . 0.0 109.457 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.505 ' HD3' ' HB2' ' A' ' 11' ' ' ASP . 36.1 Cg_endo -78.52 130.65 10.01 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.426 2.084 . . . . 0.0 110.372 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 123.81 -50.53 0.85 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.22 163.74 30.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.173 -1.192 . . . . 0.0 109.533 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -89.98 156.81 18.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 109.462 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.415 ' HA2' ' CD1' ' A' ' 65' ' ' ILE . . . -89.92 -6.24 69.87 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.604 HD12 ' HG2' ' A' ' 89' ' ' MET . 17.9 mm -54.92 -60.02 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.171 -1.194 . . . . 0.0 109.502 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.8 -38.14 54.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.174 -0.954 . . . . 0.0 109.432 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.828 HG23 HD11 ' A' ' 40' ' ' LEU . 15.9 mt -52.51 -57.11 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -0.889 . . . . 0.0 109.446 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.611 ' CD2' HD22 ' A' ' 53' ' ' LEU . 26.1 mt -46.33 -56.01 6.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.197 -0.939 . . . . 0.0 109.462 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.451 ' O ' HG23 ' A' ' 71' ' ' VAL . 5.3 mttt -44.09 -47.3 8.88 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -0.918 . . . . 0.0 109.431 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.438 ' O ' HG13 ' A' ' 72' ' ' ILE . 5.3 mtt180 -58.08 -43.24 86.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.263 -0.898 . . . . 0.0 109.461 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.429 ' CE ' HG11 ' A' ' 51' ' ' VAL . 4.1 mtt -64.07 -23.38 67.3 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.208 -0.933 . . . . 0.0 109.466 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 66' ' ' LEU . 0.5 OUTLIER -79.16 -33.91 43.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.226 -0.921 . . . . 0.0 109.479 179.95 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 67' ' ' LYS . 5.4 t -79.39 -21.39 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.281 -0.887 . . . . 0.0 109.495 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 68' ' ' ARG . 66.2 mt -90.04 -60.07 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.284 -0.885 . . . . 0.0 109.395 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.53 133.09 36.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.234 -0.916 . . . . 0.0 109.492 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -90.04 -11.92 40.05 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.265 -0.897 . . . . 0.0 109.16 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -107.46 51.81 0.73 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.145 -0.972 . . . . 0.0 109.443 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.492 ' O ' HG23 ' A' ' 76' ' ' ILE . 0.3 OUTLIER -119.14 113.11 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.267 -0.896 . . . . 0.0 109.545 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.804 ' CB ' HD11 ' A' ' 99' ' ' LEU . 0.8 OUTLIER -68.59 124.91 24.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.246 -0.909 . . . . 0.0 109.44 179.893 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.703 HG13 ' HB ' ' A' ' 51' ' ' VAL . 17.6 t -134.24 108.22 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 0.0 109.704 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.735 HD11 ' CE2' ' A' ' 118' ' ' TYR . 91.0 mt -90.26 148.4 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.218 -0.926 . . . . 0.0 109.36 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 1.014 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.0 OUTLIER -107.8 161.03 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.176 -0.952 . . . . 0.0 109.426 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.518 ' SD ' ' CZ ' ' A' ' 106' ' ' PHE . 8.6 mtm -137.77 89.69 2.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.239 -0.913 . . . . 0.0 109.725 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.936 HG22 ' NE2' ' A' ' 101' ' ' HIS . 14.3 t 177.8 37.2 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.271 -0.893 . . . . 0.0 109.369 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.75 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . -89.33 66.21 7.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.308 -0.87 . . . . 0.0 109.556 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.53 ' O ' ' CG ' ' A' ' 84' ' ' TYR . 10.5 t80 -89.92 23.31 2.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.232 -0.917 . . . . 0.0 109.465 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 119.3 -31.53 5.4 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.4 ' O ' HG21 ' A' ' 90' ' ' ILE . 0.1 OUTLIER -66.89 123.61 20.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -1.14 . . . . 0.0 109.522 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.607 ' HA ' HG23 ' A' ' 90' ' ' ILE . 6.7 mt -123.76 53.28 1.38 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.261 -0.899 . . . . 0.0 109.462 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -102.19 -90.94 0.34 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.258 -0.902 . . . . 0.0 109.643 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.604 ' HG2' HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -61.73 -13.27 21.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.329 -0.857 . . . . 0.0 109.535 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.607 HG23 ' HA ' ' A' ' 87' ' ' LEU . 0.5 OUTLIER -86.62 -41.27 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.237 -0.914 . . . . 0.0 109.219 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.442 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 4.9 tt0 -56.58 -40.93 76.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.269 -0.895 . . . . 0.0 109.558 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.417 ' O ' ' C ' ' A' ' 93' ' ' SER . 8.2 mt-10 -90.08 -37.16 14.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.205 -0.934 . . . . 0.0 109.657 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.868 ' HA ' HD13 ' A' ' 96' ' ' LEU . 1.1 m -43.73 -43.06 5.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.301 -0.874 . . . . 0.0 109.613 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.449 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -43.64 -54.15 5.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.22 -0.925 . . . . 0.0 109.54 -179.915 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 96' ' ' LEU . 1.3 mm-40 -59.94 -48.52 81.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.257 -0.902 . . . . 0.0 109.521 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.868 HD13 ' HA ' ' A' ' 93' ' ' SER . 2.1 mp -43.62 -60.81 1.61 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.317 -0.864 . . . . 0.0 109.577 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 172.89 45.46 0.04 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.449 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -120.93 110.18 15.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.317 -1.108 . . . . 0.0 109.423 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.804 HD11 ' CB ' ' A' ' 77' ' ' ARG . 1.7 mt -57.77 -71.48 0.1 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.203 -0.935 . . . . 0.0 109.534 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.485 ' O ' HG23 ' A' ' 79' ' ' ILE . 14.8 t -130.34 162.45 29.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -0.928 . . . . 0.0 109.545 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 1.014 ' ND1' HD12 ' A' ' 80' ' ' ILE . 5.1 t-160 -126.66 101.18 6.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.271 -0.893 . . . . 0.0 109.442 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -76.95 -176.1 3.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.319 -0.863 . . . . 0.0 109.519 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.75 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -168.38 172.91 8.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.343 -0.848 . . . . 0.0 109.454 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.513 ' HA ' ' N ' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -64.72 151.12 93.16 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.239 -0.913 . . . . 0.0 109.534 179.884 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.21 118.28 5.67 Favored 'Cis proline' 0 C--N 1.308 -1.574 0 C-N-CA 123.22 -1.575 . . . . 0.0 110.471 -0.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.741 ' CZ ' HD12 ' A' ' 111' ' ' ILE . 0.3 OUTLIER -55.18 106.08 0.21 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.213 -0.929 . . . . 0.0 109.406 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.495 ' O ' HG12 ' A' ' 111' ' ' ILE . 46.0 t0 -89.88 110.43 21.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 109.326 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.428 HD13 ' HA ' ' A' ' 108' ' ' ILE . 15.5 mm -48.23 -22.44 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.248 -0.908 . . . . 0.0 109.777 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.406 ' O ' ' HG2' ' A' ' 112' ' ' ARG . 0.9 OUTLIER -75.21 -43.72 50.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.106 -0.997 . . . . 0.0 109.458 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -70.02 -27.11 64.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.297 -0.877 . . . . 0.0 109.514 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.888 HG21 HD21 ' A' ' 19' ' ' LEU . 20.2 mm -76.03 -57.57 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.247 -0.908 . . . . 0.0 109.273 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.872 ' HB3' HG11 ' A' ' 22' ' ' VAL . 14.0 ptt180 -55.67 -32.26 63.08 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.396 -0.815 . . . . 0.0 109.985 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.542 ' HA ' ' HG2' ' A' ' 116' ' ' LYS . 10.8 m-20 -79.6 -65.86 0.95 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -0.935 . . . . 0.0 110.237 -179.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 113' ' ' ASP . . . -42.53 -35.77 1.16 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.207 -0.933 . . . . 0.0 109.876 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.8 HG13 ' CD2' ' A' ' 50' ' ' LEU . 38.2 t -77.68 -40.43 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.356 -0.84 . . . . 0.0 109.737 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.542 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -60.45 -23.87 64.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.131 -0.981 . . . . 0.0 109.332 -179.789 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.498 ' N ' ' HG3' ' A' ' 116' ' ' LYS . 9.5 ttmt -85.03 -51.63 6.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.303 -0.873 . . . . 0.0 109.387 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.735 ' CE2' HD11 ' A' ' 79' ' ' ILE . 27.1 m-85 -54.03 -64.86 0.69 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.266 -0.896 . . . . 0.0 109.353 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.885 HD12 ' HD2' ' A' ' 120' ' ' PRO . 37.5 tp -90.28 112.34 52.13 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.291 -0.881 . . . . 0.0 109.386 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.885 ' HD2' HD12 ' A' ' 119' ' ' LEU . 35.6 Cg_endo -78.27 -164.3 0.27 Allowed 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.326 2.017 . . . . 0.0 110.393 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.954 HD21 ' CE2' ' A' ' 28' ' ' TYR . 81.2 mt -146.39 -159.47 1.02 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.276 -0.89 . . . . 0.0 109.378 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.2 tttp -43.61 -46.79 7.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.216 -0.928 . . . . 0.0 109.507 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 10.4 t -99.16 155.25 17.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.279 -0.888 . . . . 0.0 109.478 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 117.93 -1.033 . . . . 0.0 109.437 -179.977 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.423 ' O ' ' CG ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER 65.07 147.47 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.896 . . . . 0.0 109.46 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.423 ' CG ' ' O ' ' A' ' 2' ' ' MET . 9.0 m120 -158.41 -148.71 0.2 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.299 -0.875 . . . . 0.0 109.462 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.521 ' OE2' HD23 ' A' ' 121' ' ' LEU . 1.3 mt-10 68.25 52.74 0.63 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.199 -0.938 . . . . 0.0 109.47 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.503 ' HB2' ' HA ' ' A' ' 48' ' ' PRO . 6.4 mtmt -96.13 139.52 32.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -0.872 . . . . 0.0 109.414 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.574 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 80.5 mt -150.05 155.21 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.253 -0.904 . . . . 0.0 109.473 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.985 HD11 HD13 ' A' ' 42' ' ' ILE . 0.6 OUTLIER -140.56 127.69 20.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 109.367 179.949 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.709 HD13 ' HB2' ' A' ' 19' ' ' LEU . 9.2 mt -92.35 120.95 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -0.917 . . . . 0.0 109.518 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.475 HG22 HD23 ' A' ' 7' ' ' LEU . 2.7 t -103.01 102.81 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -0.954 . . . . 0.0 109.464 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.462 ' HB3' ' HD3' ' A' ' 16' ' ' ARG . 7.3 t0 -162.17 134.98 5.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.158 -0.964 . . . . 0.0 109.434 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.488 ' OD2' ' HD2' ' A' ' 58' ' ' PRO . 8.6 p-10 -99.21 -34.22 10.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.294 -0.879 . . . . 0.0 109.444 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.417 ' O ' ' C ' ' A' ' 13' ' ' TYR . 0.5 OUTLIER -73.1 107.22 5.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.329 -0.857 . . . . 0.0 109.478 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.595 ' CZ ' HG13 ' A' ' 17' ' ' ILE . 20.5 t80 -43.07 153.06 0.1 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.351 -0.843 . . . . 0.0 109.603 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.403 ' N ' ' CD1' ' A' ' 13' ' ' TYR . . . 124.62 -74.43 0.4 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.899 HD13 ' OD2' ' A' ' 54' ' ' ASP . 6.6 mt -63.16 -16.92 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.24 -1.153 . . . . 0.0 109.403 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.462 ' HD3' ' HB3' ' A' ' 10' ' ' ASP . 14.6 mmm-85 -77.26 -26.88 52.93 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 109.341 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.595 HG13 ' CZ ' ' A' ' 13' ' ' TYR . 9.6 mm -90.07 -39.78 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -0.903 . . . . 0.0 109.604 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.59 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.1 mp -64.22 -58.22 7.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.25 -0.906 . . . . 0.0 109.613 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.709 ' HB2' HD13 ' A' ' 8' ' ' ILE . 44.0 mt -58.45 -20.95 49.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.282 -0.886 . . . . 0.0 109.482 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -75.72 -70.71 0.42 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -0.911 . . . . 0.0 109.568 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.482 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 17.8 tt0 -46.41 -42.51 15.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.243 -0.911 . . . . 0.0 109.614 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.609 HG21 HG23 ' A' ' 108' ' ' ILE . 64.6 t -58.99 -56.01 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.143 -0.973 . . . . 0.0 109.615 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.757 ' CB ' HG21 ' A' ' 30' ' ' THR . 29.8 m-85 -78.14 3.05 16.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.178 -0.951 . . . . 0.0 109.707 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.482 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 1.5 m-20 -90.07 -46.73 8.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.229 -0.92 . . . . 0.0 109.486 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.1 -19.72 36.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.216 -0.928 . . . . 0.0 109.456 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.478 ' HB3' ' CD1' ' A' ' 28' ' ' TYR . 0.5 OUTLIER -78.33 -31.06 48.51 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.3 -0.875 . . . . 0.0 109.456 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.477 ' O ' ' CD1' ' A' ' 28' ' ' TYR . . . 102.5 77.94 1.26 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.558 ' CZ ' ' HG ' ' A' ' 121' ' ' LEU . 91.5 m-85 -155.57 143.12 19.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.151 -1.205 . . . . 0.0 109.511 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -90.04 81.19 6.25 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.174 -0.954 . . . . 0.0 109.382 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.757 HG21 ' CB ' ' A' ' 23' ' ' PHE . 6.1 p -89.91 147.27 23.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.248 -0.907 . . . . 0.0 109.534 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.63 ' HB2' HD12 ' A' ' 7' ' ' LEU . 12.0 m-85 -111.06 -166.19 1.05 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 0.0 109.487 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -143.61 139.98 29.92 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.341 -0.85 . . . . 0.0 109.484 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -153.49 -176.03 5.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.266 -0.896 . . . . 0.0 109.401 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.536 ' O ' HD13 ' A' ' 57' ' ' ILE . . . -145.01 -61.88 0.35 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.218 -0.926 . . . . 0.0 109.519 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.514 ' ND2' ' H ' ' A' ' 35' ' ' ASN . 0.5 OUTLIER -90.22 144.5 25.8 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 0.0 109.427 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.539 ' HA3' ' CD1' ' A' ' 65' ' ' ILE . . . -48.08 -37.66 16.93 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.403 ' HA ' HD13 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -51.79 -46.49 64.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -1.172 . . . . 0.0 109.54 -179.923 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 43.9 tp60 -64.84 -31.8 73.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.91 . . . . 0.0 109.541 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.785 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -66.47 -37.32 84.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.923 . . . . 0.0 109.526 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.708 HD21 ' HB2' ' A' ' 68' ' ' ARG . 13.8 mt -73.75 -38.97 64.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.883 . . . . 0.0 109.564 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.35 -54.75 39.75 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.258 -0.901 . . . . 0.0 109.48 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.985 HD13 HD11 ' A' ' 7' ' ' LEU . 23.9 mt -62.93 -31.76 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.268 -0.895 . . . . 0.0 109.473 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.785 HG23 ' O ' ' A' ' 39' ' ' ALA . 42.7 t -69.73 -28.13 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 109.365 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.0 m -90.23 -15.75 30.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.278 -0.888 . . . . 0.0 109.512 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.65 -60.48 1.95 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.918 . . . . 0.0 109.73 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 47' ' ' ARG . 1.8 mm-40 -89.78 -30.69 17.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.152 -0.967 . . . . 0.0 109.645 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 13.2 mtm180 65.89 68.41 0.66 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.934 . . . . 0.0 109.577 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.528 ' CD ' ' HA ' ' A' ' 43' ' ' VAL . 35.3 Cg_endo -77.82 -167.01 0.43 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.625 2.217 . . . . 0.0 110.354 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 75' ' ' ASN . 5.0 t70 -142.1 11.16 1.97 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.272 -0.892 . . . . 0.0 109.465 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.489 HD23 HG23 ' A' ' 6' ' ' ILE . 4.9 tp -146.79 111.55 5.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -0.926 . . . . 0.0 109.517 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.968 HG21 ' SD ' ' A' ' 69' ' ' MET . 3.4 t -109.63 137.66 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.232 -0.917 . . . . 0.0 109.32 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.552 HD12 ' O ' ' A' ' 7' ' ' LEU . 1.1 mt -104.51 97.65 7.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.655 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.468 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 1.0 OUTLIER -93.37 119.3 32.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.257 -0.902 . . . . 0.0 109.36 179.825 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.899 ' OD2' HD13 ' A' ' 15' ' ' ILE . 21.0 t0 -99.28 -4.8 31.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.116 -0.99 . . . . 0.0 109.684 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.512 ' HG3' ' CG2' ' A' ' 82' ' ' THR . 0.0 OUTLIER 53.44 17.14 1.03 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.385 -0.822 . . . . 0.0 109.783 -179.854 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 57' ' ' ILE . 13.2 mmtm -91.03 -39.87 11.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.04 -1.037 . . . . 0.0 109.338 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.755 HG21 ' HE3' ' A' ' 60' ' ' MET . 4.3 mt -42.65 111.64 1.02 Allowed Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.377 -0.827 . . . . 0.0 109.495 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.488 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 35.0 Cg_endo -77.01 165.21 28.66 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.403 2.068 . . . . 0.0 110.387 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.77 -43.03 1.87 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.755 ' HE3' HG21 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -158.18 158.85 35.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.361 -1.082 . . . . 0.0 109.321 179.899 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -88.72 151.97 22.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.114 -0.991 . . . . 0.0 109.464 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.439 ' HA2' HG12 ' A' ' 65' ' ' ILE . . . -90.18 4.35 82.8 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.644 ' HA ' HD23 ' A' ' 66' ' ' LEU . 19.4 mm -59.72 -51.03 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.157 -1.202 . . . . 0.0 109.397 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -52.46 -23.67 6.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.19 -0.944 . . . . 0.0 109.401 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.539 ' CD1' ' HA3' ' A' ' 36' ' ' GLY . 8.7 mm -71.55 -65.05 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.32 -0.862 . . . . 0.0 109.449 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.644 HD23 ' HA ' ' A' ' 63' ' ' ILE . 1.6 pp -47.51 -28.62 2.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -0.889 . . . . 0.0 109.226 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.552 ' O ' HG23 ' A' ' 71' ' ' VAL . 12.8 tptt -67.45 -59.17 3.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 0.0 109.254 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.708 ' HB2' HD21 ' A' ' 40' ' ' LEU . 10.7 mtt-85 -51.63 -26.67 9.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.264 -0.897 . . . . 0.0 109.319 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.968 ' SD ' HG21 ' A' ' 51' ' ' VAL . 1.4 mtt -73.9 -39.62 63.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.303 -0.873 . . . . 0.0 109.458 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.526 ' CD ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -69.34 -24.51 63.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.251 -0.905 . . . . 0.0 109.284 179.944 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 67' ' ' LYS . 2.6 t -90.1 -25.45 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.323 -0.86 . . . . 0.0 109.513 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.612 HD12 ' O ' ' A' ' 68' ' ' ARG . 28.2 mt -89.16 -16.92 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.308 -0.87 . . . . 0.0 109.422 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.618 ' O ' HG22 ' A' ' 76' ' ' ILE . 0.4 OUTLIER -170.71 116.59 0.48 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.259 -0.901 . . . . 0.0 109.481 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -74.93 -22.14 58.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.204 -0.935 . . . . 0.0 109.453 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.436 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 69.2 m-80 -89.7 43.09 1.13 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 109.489 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.618 HG22 ' O ' ' A' ' 73' ' ' ASP . 0.5 OUTLIER -117.26 146.8 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.342 -0.849 . . . . 0.0 109.554 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.58 ' O ' HG23 ' A' ' 78' ' ' VAL . 46.0 mtt180 -115.27 162.31 17.27 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.299 -0.875 . . . . 0.0 109.516 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 77' ' ' ARG . 69.7 t -159.72 111.97 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.261 -0.899 . . . . 0.0 109.549 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.85 HG23 HG23 ' A' ' 100' ' ' THR . 9.1 mm -93.32 133.57 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.2 -0.938 . . . . 0.0 109.392 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.902 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.5 OUTLIER -95.43 171.98 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.19 -0.944 . . . . 0.0 109.395 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.605 ' HE1' ' HB2' ' A' ' 54' ' ' ASP . 39.4 mtm -146.84 62.49 1.19 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.24 -0.913 . . . . 0.0 109.459 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.512 ' CG2' ' HG3' ' A' ' 55' ' ' MET . 11.2 t -170.89 32.51 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 109.488 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.033 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . -46.48 -76.93 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.261 -0.9 . . . . 0.0 109.464 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -46.79 100.34 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.918 . . . . 0.0 109.431 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 83' ' ' ALA . . . 138.57 -77.27 0.33 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.444 ' C ' HG21 ' A' ' 90' ' ' ILE . 2.1 mt-10 -81.12 148.94 29.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -1.153 . . . . 0.0 109.547 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.69 ' HA ' HG23 ' A' ' 90' ' ' ILE . 0.3 OUTLIER -160.45 22.53 0.15 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.283 -0.885 . . . . 0.0 109.453 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -94.28 -82.32 0.36 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.129 -0.982 . . . . 0.0 109.123 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.525 ' O ' ' CB ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -83.28 8.22 14.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.217 -0.927 . . . . 0.0 109.146 179.434 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 1.146 HD12 ' CE1' ' A' ' 101' ' ' HIS . 0.1 OUTLIER -90.73 -60.11 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.416 -0.802 . . . . 0.0 108.962 179.758 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.555 ' HB2' ' CD1' ' A' ' 87' ' ' LEU . 21.8 tp60 -53.33 -36.32 61.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.214 -0.929 . . . . 0.0 109.513 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.561 ' O ' HD12 ' A' ' 96' ' ' LEU . 8.0 mt-10 -90.09 -17.21 28.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.199 -0.938 . . . . 0.0 109.481 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.525 ' CB ' ' O ' ' A' ' 89' ' ' MET . 0.4 OUTLIER -57.82 -17.55 16.74 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.289 -0.882 . . . . 0.0 109.504 179.974 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.27 -66.76 0.49 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.268 -0.895 . . . . 0.0 109.507 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -56.77 -32.67 65.85 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.218 -0.926 . . . . 0.0 109.552 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.561 HD12 ' O ' ' A' ' 92' ' ' GLU . 2.1 mt -64.76 -33.33 75.71 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.299 -0.876 . . . . 0.0 109.47 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.526 ' HA3' ' CD ' ' A' ' 70' ' ' LYS . . . 140.7 40.4 0.08 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.485 ' HB2' ' HB3' ' A' ' 93' ' ' SER . . . -112.66 102.64 10.69 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.222 -1.164 . . . . 0.0 109.397 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.81 ' HB2' HD13 ' A' ' 79' ' ' ILE . 17.3 mt -43.74 -83.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.294 -0.879 . . . . 0.0 109.42 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.85 HG23 HG23 ' A' ' 79' ' ' ILE . 1.8 t -131.34 171.45 13.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.255 -0.903 . . . . 0.0 109.426 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 1.146 ' CE1' HD12 ' A' ' 90' ' ' ILE . 4.0 t60 -130.41 93.36 3.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.208 -0.933 . . . . 0.0 109.336 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.632 ' CE1' ' CG ' ' A' ' 110' ' ' GLU . 9.0 m-85 -72.72 155.64 39.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -0.918 . . . . 0.0 109.597 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 1.033 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -124.07 -148.56 0.4 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.313 -0.867 . . . . 0.0 109.467 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.43 ' HB2' ' HA ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -101.32 160.54 26.3 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 109.565 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.498 ' O ' ' CB ' ' A' ' 106' ' ' PHE . 36.4 Cg_endo -79.44 11.64 21.61 Favored 'Cis proline' 0 C--N 1.31 -1.489 0 C-N-CA 123.296 -1.543 . . . . 0.0 110.893 0.039 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.656 ' CZ ' HD12 ' A' ' 111' ' ' ILE . 2.2 t80 76.06 99.4 0.07 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.233 -0.917 . . . . 0.0 109.627 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.468 ' O ' HG12 ' A' ' 111' ' ' ILE . 15.2 t0 -89.96 114.32 26.12 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.221 -0.924 . . . . 0.0 109.309 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.609 HG23 HG21 ' A' ' 22' ' ' VAL . 13.7 mm -46.86 -40.08 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.239 -0.913 . . . . 0.0 109.468 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.457 ' HB2' ' OD2' ' A' ' 107' ' ' ASP . 99.6 m-20 -62.05 -42.12 98.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.902 . . . . 0.0 109.528 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.632 ' CG ' ' CE1' ' A' ' 102' ' ' PHE . 5.5 tp10 -67.23 -28.72 68.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.903 . . . . 0.0 109.513 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.656 HD12 ' CZ ' ' A' ' 106' ' ' PHE . 23.5 mm -69.35 -60.2 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.294 -0.879 . . . . 0.0 109.477 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.467 ' HG2' ' O ' ' A' ' 108' ' ' ILE . 0.0 OUTLIER -64.3 -19.91 65.73 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.554 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.427 ' CG ' ' O ' ' A' ' 109' ' ' ASP . 61.1 m-20 -72.47 -53.83 11.02 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.264 -0.897 . . . . 0.0 109.469 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.62 ' HB1' ' HE2' ' A' ' 118' ' ' TYR . . . -61.8 -54.38 43.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 0.0 109.461 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.7 t -52.17 -52.35 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.177 -0.952 . . . . 0.0 109.496 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.67 -35.55 55.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.252 -0.905 . . . . 0.0 109.426 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.67 -34.72 74.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.304 -0.872 . . . . 0.0 109.472 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.636 ' CG ' HD13 ' A' ' 99' ' ' LEU . 58.2 m-85 -88.69 -74.19 0.47 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -0.898 . . . . 0.0 109.532 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.765 HD23 ' O ' ' A' ' 120' ' ' PRO . 6.3 tt -90.11 112.46 52.58 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.287 -0.883 . . . . 0.0 109.443 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.765 ' O ' HD23 ' A' ' 119' ' ' LEU . 35.3 Cg_endo -77.88 -166.18 0.38 Allowed 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.381 2.054 . . . . 0.0 110.375 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.558 ' HG ' ' CZ ' ' A' ' 28' ' ' TYR . 0.4 OUTLIER -125.33 11.35 8.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 0.0 109.424 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.0 mmmt -143.74 128.72 18.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.144 -0.972 . . . . 0.0 109.435 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 50.45 -149.45 0.28 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.491 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.455 -179.976 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 ttt . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER 45.5 77.56 0.08 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.265 -0.897 . . . . 0.0 109.443 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.457 ' O ' ' HB3' ' A' ' 4' ' ' GLU . 1.0 OUTLIER -170.06 158.82 7.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 109.464 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.573 ' OE2' ' CD2' ' A' ' 28' ' ' TYR . 51.8 tt0 67.39 64.01 0.43 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.169 -0.957 . . . . 0.0 109.487 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.453 ' HB2' ' HB3' ' A' ' 48' ' ' PRO . 3.0 mttt -109.58 156.14 20.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.331 -0.856 . . . . 0.0 109.482 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.494 HG12 ' HB2' ' A' ' 50' ' ' LEU . 63.0 mt -150.05 153.02 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.892 . . . . 0.0 109.453 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.814 HD11 ' CB ' ' A' ' 33' ' ' ALA . 1.8 tm? -132.11 113.97 13.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.289 -0.882 . . . . 0.0 109.482 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.618 ' N ' HD13 ' A' ' 7' ' ' LEU . 4.4 mt -89.89 105.85 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 109.351 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.658 HG22 HD12 ' A' ' 7' ' ' LEU . 2.6 t -89.9 71.72 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.209 -0.932 . . . . 0.0 109.513 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.665 ' O ' ' HB2' ' A' ' 34' ' ' ALA . 1.5 t70 -126.09 146.27 49.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.216 -0.928 . . . . 0.0 109.399 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.943 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . 6.5 p-10 -116.81 -37.07 3.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.315 -0.865 . . . . 0.0 109.473 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.515 ' CG ' ' O ' ' A' ' 12' ' ' GLN . 7.6 pt20 -61.38 102.14 0.21 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.2 -0.937 . . . . 0.0 109.489 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 1.048 ' CE1' HD11 ' A' ' 17' ' ' ILE . 58.5 t80 -43.28 112.22 0.35 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.875 . . . . 0.0 109.596 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 159.28 -69.32 0.25 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.432 ' HB ' ' OD2' ' A' ' 10' ' ' ASP . 1.7 mp -62.78 -20.83 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.125 -1.221 . . . . 0.0 108.777 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.527 ' O ' ' CB ' ' A' ' 20' ' ' ASN . 7.4 mmm-85 -69.4 -29.98 67.85 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.386 -0.822 . . . . 0.0 109.331 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 1.048 HD11 ' CE1' ' A' ' 13' ' ' TYR . 3.8 mt -90.34 -37.08 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.362 -0.836 . . . . 0.0 109.765 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.84 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.4 OUTLIER -69.14 -58.16 4.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.005 -1.059 . . . . 0.0 109.246 -179.906 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.537 ' HA ' HD12 ' A' ' 19' ' ' LEU . 1.3 tp -62.56 -20.54 64.78 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.304 -0.873 . . . . 0.0 108.663 179.348 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 16' ' ' ARG . 0.5 OUTLIER -71.44 -73.25 0.19 Allowed 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.48 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 0.3 OUTLIER -52.43 -30.82 31.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.29 -0.881 . . . . 0.0 109.807 -179.589 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.84 HG23 ' O ' ' A' ' 18' ' ' LEU . 96.8 t -64.75 -61.94 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.194 -0.941 . . . . 0.0 109.548 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.877 ' HB2' HG21 ' A' ' 30' ' ' THR . 16.4 m-85 -72.5 -3.8 26.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 109.544 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.48 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 5.1 m-20 -82.99 -52.61 6.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.146 -0.971 . . . . 0.0 109.38 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.3 mmtt -73.57 -19.09 60.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.121 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.515 ' HB3' ' CD1' ' A' ' 28' ' ' TYR . 0.4 OUTLIER -71.39 -49.19 44.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.369 -0.832 . . . . 0.0 109.372 179.885 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.465 ' O ' ' OE2' ' A' ' 4' ' ' GLU . . . 124.95 46.62 0.24 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 1.074 ' CZ ' HD11 ' A' ' 121' ' ' LEU . 97.7 m-85 -132.72 146.69 52.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.315 -1.109 . . . . 0.0 109.574 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.0 mm100 -89.87 85.32 6.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.297 -0.877 . . . . 0.0 108.798 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.877 HG21 ' HB2' ' A' ' 23' ' ' PHE . 5.6 p -89.63 137.51 32.27 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.239 -0.913 . . . . 0.0 109.791 -179.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.616 ' HB2' HD22 ' A' ' 7' ' ' LEU . 11.5 m-85 -109.15 -171.63 1.88 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.379 -0.826 . . . . 0.0 109.238 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -121.71 154.09 37.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.151 -0.968 . . . . 0.0 109.681 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.814 ' CB ' HD11 ' A' ' 7' ' ' LEU . . . -172.48 174.34 3.83 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.272 -0.892 . . . . 0.0 109.355 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.943 ' HB1' ' HB3' ' A' ' 11' ' ' ASP . . . 170.96 -50.38 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.296 -0.878 . . . . 0.0 109.558 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.473 ' OD1' ' HB2' ' A' ' 38' ' ' GLN . 8.3 p-10 -67.29 -8.36 31.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.2 -0.938 . . . . 0.0 109.553 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 37' ' ' LEU . . . 96.53 -70.62 0.84 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.479 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -44.69 -32.98 1.67 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.166 -1.196 . . . . 0.0 109.437 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.998 ' O ' HD12 ' A' ' 42' ' ' ILE . 1.0 OUTLIER -71.52 -44.11 65.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.242 -0.911 . . . . 0.0 109.461 179.909 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.433 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . . . -65.57 -63.09 1.18 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.247 -0.908 . . . . 0.0 109.437 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.8 mt -51.39 -33.58 30.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.3 -0.875 . . . . 0.0 109.557 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 37' ' ' LEU . 59.8 t0 -62.76 -51.94 65.17 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.268 -0.895 . . . . 0.0 109.453 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.998 HD12 ' O ' ' A' ' 38' ' ' GLN . 2.0 mp -70.64 -14.48 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.214 -0.929 . . . . 0.0 109.49 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.536 ' HA ' ' CD ' ' A' ' 48' ' ' PRO . 50.8 t -84.56 -29.21 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.324 -0.86 . . . . 0.0 109.424 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.7 m -90.06 -25.11 20.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.155 -0.966 . . . . 0.0 109.407 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.51 ' HD2' ' N ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -89.97 -33.19 16.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.267 -0.896 . . . . 0.0 109.463 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -110.32 -36.7 5.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.215 -0.928 . . . . 0.0 109.458 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER 59.82 69.51 1.23 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.291 -0.881 . . . . 0.0 109.478 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.887 ' O ' HD12 ' A' ' 76' ' ' ILE . 34.7 Cg_endo -77.95 -179.58 5.58 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.747 2.298 . . . . 0.0 110.661 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -119.71 -16.84 8.73 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.47 -0.769 . . . . 0.0 109.33 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.494 ' HB2' HG12 ' A' ' 6' ' ' ILE . 1.8 mm? -114.16 121.12 42.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.322 -0.861 . . . . 0.0 109.695 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 1.015 ' HB ' HG13 ' A' ' 78' ' ' VAL . 2.7 t -116.51 147.04 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.236 -0.915 . . . . 0.0 109.253 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.524 ' CD1' HG12 ' A' ' 8' ' ' ILE . 1.6 mt -122.19 87.9 2.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.146 -0.971 . . . . 0.0 109.609 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.61 ' CD1' HG21 ' A' ' 9' ' ' VAL . 1.2 mp -91.7 122.58 34.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.282 -0.886 . . . . 0.0 109.268 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 81' ' ' MET . 30.3 t0 -107.4 -2.87 20.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.201 -0.937 . . . . 0.0 109.754 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.991 ' HB2' HG21 ' A' ' 82' ' ' THR . 4.7 mmt 47.29 22.08 0.24 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.339 -0.851 . . . . 0.0 109.879 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.442 ' HG3' ' CG ' ' A' ' 54' ' ' ASP . 1.4 mttt -90.77 -31.66 16.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.005 -1.059 . . . . 0.0 109.28 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.547 HG12 ' HB1' ' A' ' 34' ' ' ALA . 2.5 mp -41.88 102.17 0.26 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.501 -0.749 . . . . 0.0 109.682 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.497 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 35.0 Cg_endo -77.48 121.21 5.51 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.455 2.104 . . . . 0.0 110.351 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 121.81 -27.31 6.25 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.454 ' SD ' ' O ' ' A' ' 35' ' ' ASN . 1.3 ttp -139.84 135.36 32.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.282 -1.128 . . . . 0.0 109.398 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -89.83 137.34 32.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.243 -0.911 . . . . 0.0 109.457 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.46 ' HA2' HG13 ' A' ' 65' ' ' ILE . . . -90.49 8.74 79.33 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.54 HD11 ' CE ' ' A' ' 89' ' ' MET . 23.9 mm -58.0 -43.59 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.25 -1.147 . . . . 0.0 109.49 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.517 ' O ' ' CG ' ' A' ' 68' ' ' ARG . 49.4 mm-40 -72.99 -16.72 61.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.9 . . . . 0.0 109.456 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.642 HG22 ' CE ' ' A' ' 69' ' ' MET . 48.8 mt -72.33 -53.5 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.256 -0.903 . . . . 0.0 109.461 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.736 HD21 HG11 ' A' ' 78' ' ' VAL . 12.1 mt -47.3 -57.02 5.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.911 . . . . 0.0 109.554 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 1.011 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -56.62 -42.46 78.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.197 -0.94 . . . . 0.0 109.664 -179.855 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.517 ' CG ' ' O ' ' A' ' 64' ' ' GLU . 2.2 mmt180 -57.47 -29.93 64.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.949 . . . . 0.0 109.553 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.679 ' SD ' HG11 ' A' ' 51' ' ' VAL . 3.9 mtt -75.21 -56.37 4.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.271 -0.893 . . . . 0.0 109.489 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.525 ' NZ ' HD13 ' A' ' 96' ' ' LEU . 6.5 ptpt -55.85 -19.65 12.52 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.183 -0.948 . . . . 0.0 109.462 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 1.011 HG23 ' O ' ' A' ' 67' ' ' LYS . 39.9 t -82.14 -46.64 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.266 -0.896 . . . . 0.0 109.456 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 67.6 mt -63.56 -56.09 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.33 -0.856 . . . . 0.0 109.507 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -135.86 142.74 44.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.325 -0.859 . . . . 0.0 109.46 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -89.42 -10.6 45.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.244 -0.91 . . . . 0.0 109.49 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -102.1 38.52 1.64 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.24 -0.913 . . . . 0.0 109.421 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.887 HD12 ' O ' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -113.55 91.65 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 109.417 -180.0 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.565 ' HB3' HD11 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -63.16 154.77 30.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.225 -0.922 . . . . 0.0 109.478 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 1.015 HG13 ' HB ' ' A' ' 51' ' ' VAL . 3.1 t -138.29 158.84 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.205 -0.935 . . . . 0.0 109.448 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.816 HD11 HD12 ' A' ' 99' ' ' LEU . 3.6 mm -136.81 125.74 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 109.454 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.582 ' HB ' ' CG ' ' A' ' 101' ' ' HIS . 0.7 OUTLIER -98.3 136.85 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.241 -0.912 . . . . 0.0 109.296 179.992 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.46 ' O ' ' OD1' ' A' ' 54' ' ' ASP . 16.9 mtm -122.16 49.03 1.63 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.489 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.991 HG21 ' HB2' ' A' ' 55' ' ' MET . 8.9 t -159.04 52.0 0.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 109.478 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.839 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . -66.38 -20.99 66.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.211 -0.93 . . . . 0.0 109.448 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.462 ' HB2' ' HB1' ' A' ' 103' ' ' ALA . 0.2 OUTLIER -80.39 115.93 20.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.206 -0.934 . . . . 0.0 109.427 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 137.21 -138.22 9.58 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.418 ' HG3' ' SD ' ' A' ' 89' ' ' MET . 0.4 OUTLIER -55.64 142.93 32.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -1.164 . . . . 0.0 109.508 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 9.2 mt -132.34 52.9 2.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.241 -0.912 . . . . 0.0 109.557 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.01 3.74 4.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.901 . . . . 0.0 109.511 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.54 ' CE ' HD11 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -123.49 -8.91 8.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.148 -0.97 . . . . 0.0 109.564 179.957 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.637 HG23 ' HD1' ' A' ' 101' ' ' HIS . 21.0 mt -87.6 -36.61 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.172 -0.955 . . . . 0.0 109.54 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.28 -41.84 76.5 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.315 -0.866 . . . . 0.0 109.481 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 93' ' ' SER . 2.1 tp10 -89.94 -48.22 7.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.191 -0.943 . . . . 0.0 109.496 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.626 ' HA ' HD12 ' A' ' 96' ' ' LEU . 11.5 t -44.21 -26.58 0.33 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.929 . . . . 0.0 109.487 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.06 -82.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.901 . . . . 0.0 109.481 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.425 ' O ' ' C ' ' A' ' 96' ' ' LEU . 9.4 pt-20 -44.1 -40.86 5.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.883 . . . . 0.0 109.446 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.626 HD12 ' HA ' ' A' ' 93' ' ' SER . 24.5 mt -44.09 -59.64 2.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -0.885 . . . . 0.0 109.47 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 163.87 47.54 0.02 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 99' ' ' LEU . . . -111.24 105.54 14.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -1.151 . . . . 0.0 109.471 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.905 HD22 ' CE1' ' A' ' 118' ' ' TYR . 20.4 mt -44.25 -63.45 0.88 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.256 -0.903 . . . . 0.0 109.426 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.729 HG22 HG23 ' A' ' 79' ' ' ILE . 14.5 t -146.44 -176.86 5.34 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.305 -0.872 . . . . 0.0 109.424 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.655 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 2.9 t-160 -148.77 68.54 1.07 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -0.886 . . . . 0.0 109.376 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.513 ' CZ ' HG21 ' A' ' 100' ' ' THR . 18.4 m-85 -65.39 160.68 21.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.214 -0.929 . . . . 0.0 109.447 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.839 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -126.72 -174.35 3.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.332 -0.855 . . . . 0.0 109.396 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.403 ' HA ' ' C ' ' A' ' 105' ' ' PRO . 3.7 pttt -102.34 144.92 29.56 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.257 -0.902 . . . . 0.0 109.36 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.403 ' C ' ' HA ' ' A' ' 104' ' ' LYS . 35.6 Cg_endo -77.79 133.9 32.21 Favored 'Cis proline' 0 C--N 1.31 -1.457 0 C-N-CA 123.303 -1.54 . . . . 0.0 110.407 -0.078 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -99.65 -176.64 3.33 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.159 -0.963 . . . . 0.0 109.488 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -127.94 123.32 34.6 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.213 -0.929 . . . . 0.0 109.464 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.77 HG21 HG21 ' A' ' 22' ' ' VAL . 16.2 mm -56.63 -22.42 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.232 -0.918 . . . . 0.0 109.476 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.423 ' O ' ' CG ' ' A' ' 113' ' ' ASP . 11.9 m-20 -72.66 -41.22 65.64 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.221 -0.924 . . . . 0.0 109.539 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.15 -31.38 70.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.203 -0.936 . . . . 0.0 109.461 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 23.0 mm -69.34 -59.16 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.31 -0.869 . . . . 0.0 109.438 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.418 ' O ' ' HG3' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -62.51 -22.84 66.59 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.2 -0.938 . . . . 0.0 109.467 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.423 ' CG ' ' O ' ' A' ' 109' ' ' ASP . 57.1 m-20 -70.79 -52.28 21.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.895 . . . . 0.0 109.412 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.407 ' O ' ' C ' ' A' ' 115' ' ' VAL . . . -66.1 -61.04 2.25 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.494 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.474 HG13 ' HG ' ' A' ' 50' ' ' LEU . 50.3 t -44.25 -47.94 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.246 -0.909 . . . . 0.0 109.437 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 0.0 OUTLIER -59.07 -43.71 91.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.287 -0.883 . . . . 0.0 109.475 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.47 -23.98 64.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.301 -0.875 . . . . 0.0 109.513 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.905 ' CE1' HD22 ' A' ' 99' ' ' LEU . 67.4 m-85 -80.87 -69.88 0.57 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.886 . . . . 0.0 109.516 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.443 HD12 ' HD2' ' A' ' 120' ' ' PRO . 38.3 tp -90.12 112.47 52.63 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.379 -0.826 . . . . 0.0 109.466 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.47 ' O ' HD23 ' A' ' 121' ' ' LEU . 35.8 Cg_endo -78.12 152.95 28.12 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.327 2.018 . . . . 0.0 110.381 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 1.074 HD11 ' CZ ' ' A' ' 28' ' ' TYR . 26.1 mt -116.83 -162.5 0.86 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.247 -0.908 . . . . 0.0 109.467 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.28 -72.86 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.279 -0.888 . . . . 0.0 109.519 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 5.4 t 175.45 157.01 0.19 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -0.914 . . . . 0.0 109.433 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.458 -179.961 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 ttm . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 7.6 mtm -125.58 46.76 2.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.345 -0.847 . . . . 0.0 109.422 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -109.23 21.11 17.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.244 -0.91 . . . . 0.0 109.471 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -163.91 62.53 0.16 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.228 -0.92 . . . . 0.0 109.436 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.511 ' HB2' ' HA ' ' A' ' 48' ' ' PRO . 42.7 mttm -127.71 138.53 52.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.318 -0.864 . . . . 0.0 109.444 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.653 HD12 ' HB3' ' A' ' 28' ' ' TYR . 74.3 mt -144.33 155.0 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.188 -0.945 . . . . 0.0 109.417 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.978 HD22 ' HB2' ' A' ' 31' ' ' PHE . 0.2 OUTLIER -132.26 119.39 20.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.214 -0.929 . . . . 0.0 109.556 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.694 ' N ' HD13 ' A' ' 7' ' ' LEU . 14.1 mt -99.78 102.21 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.248 -0.908 . . . . 0.0 109.447 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.624 HG21 ' CD1' ' A' ' 53' ' ' LEU . 4.9 t -90.02 91.55 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 109.546 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.52 ' O ' ' CD ' ' A' ' 16' ' ' ARG . 4.9 t70 -147.42 138.36 23.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.329 -0.857 . . . . 0.0 109.33 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.921 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . 8.9 p-10 -106.96 -35.81 6.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.891 . . . . 0.0 109.495 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.408 ' O ' ' C ' ' A' ' 13' ' ' TYR . 21.6 tt0 -67.35 106.32 2.04 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.271 -0.893 . . . . 0.0 109.374 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.551 ' CE2' HG13 ' A' ' 17' ' ' ILE . 30.4 t80 -43.32 149.34 0.25 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.357 -0.839 . . . . 0.0 109.6 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.79 -50.79 0.81 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.831 HG23 HD13 ' A' ' 19' ' ' LEU . 2.5 mt -80.69 -36.07 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.204 -1.174 . . . . 0.0 109.435 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.524 ' O ' ' CB ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -63.21 -30.1 71.31 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.129 -0.982 . . . . 0.0 109.433 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.604 ' N ' HD13 ' A' ' 17' ' ' ILE . 2.3 mm -90.84 -31.5 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.292 -0.88 . . . . 0.0 109.831 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.719 ' O ' HG23 ' A' ' 22' ' ' VAL . 8.3 mt -68.8 -60.23 2.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.103 -0.998 . . . . 0.0 109.351 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.831 HD13 HG23 ' A' ' 15' ' ' ILE . 7.3 mp -65.86 -18.03 65.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.318 -0.864 . . . . 0.0 108.789 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 16' ' ' ARG . 0.7 OUTLIER -70.2 -66.33 0.61 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.818 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.478 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 1.1 mm-40 -53.81 -44.2 69.98 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.337 -0.852 . . . . 0.0 109.575 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.805 HG21 ' CG2' ' A' ' 108' ' ' ILE . 46.8 t -54.6 -63.06 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.164 -0.96 . . . . 0.0 109.499 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.776 ' CB ' HG21 ' A' ' 30' ' ' THR . 25.8 m-85 -64.79 -10.62 29.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 0.0 109.54 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.478 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 0.5 OUTLIER -74.26 -60.23 2.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.256 -0.902 . . . . 0.0 109.477 179.919 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -67.59 -25.03 65.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.254 -0.903 . . . . 0.0 109.394 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.494 ' HB3' ' CD2' ' A' ' 28' ' ' TYR . 1.8 mt-10 -69.27 -34.77 75.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.442 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.479 ' O ' ' CG ' ' A' ' 28' ' ' TYR . . . 102.78 73.1 0.96 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.653 ' HB3' HD12 ' A' ' 6' ' ' ILE . 93.9 m-85 -156.71 144.45 19.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.213 -1.169 . . . . 0.0 109.576 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -89.85 83.24 6.17 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.246 -0.909 . . . . 0.0 109.252 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.776 HG21 ' CB ' ' A' ' 23' ' ' PHE . 5.8 p -89.93 137.95 31.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.28 -0.887 . . . . 0.0 109.566 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.978 ' HB2' HD22 ' A' ' 7' ' ' LEU . 42.4 m-85 -105.03 -172.08 2.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 109.345 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.462 ' HG2' ' CG ' ' A' ' 16' ' ' ARG . 54.4 mt-30 -136.88 147.09 46.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.143 -0.973 . . . . 0.0 109.548 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.712 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -164.91 -161.94 0.59 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.239 -0.913 . . . . 0.0 109.368 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.921 ' HB1' ' HB3' ' A' ' 11' ' ' ASP . . . 163.65 -53.72 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.281 -0.887 . . . . 0.0 109.352 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.423 ' HA ' ' HE1' ' A' ' 60' ' ' MET . 22.3 p-10 -60.13 -14.63 18.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.308 -0.87 . . . . 0.0 109.462 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.579 ' HA3' HD11 ' A' ' 65' ' ' ILE . . . 95.79 -45.39 1.99 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 mt -67.68 -30.84 70.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.257 -1.143 . . . . 0.0 109.496 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.902 ' O ' HD12 ' A' ' 42' ' ' ILE . 44.5 tp60 -72.32 -43.72 63.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.235 -0.916 . . . . 0.0 109.461 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.629 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -63.36 -55.97 20.18 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.267 -0.896 . . . . 0.0 109.417 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.4 mt -51.98 -44.43 64.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.286 -0.884 . . . . 0.0 109.478 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.99 -49.73 72.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.277 -0.889 . . . . 0.0 109.465 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.902 HD12 ' O ' ' A' ' 38' ' ' GLN . 3.1 mt -66.7 -19.48 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -0.897 . . . . 0.0 109.469 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 39' ' ' ALA . 89.3 t -78.54 -32.35 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -0.892 . . . . 0.0 109.451 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 26.3 m -89.96 -19.44 24.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.205 -0.935 . . . . 0.0 109.494 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.01 -32.33 16.81 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.239 -0.913 . . . . 0.0 109.547 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.412 ' HA ' ' OE1' ' A' ' 46' ' ' GLU . 15.0 mm-40 -117.52 -33.36 4.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.281 -0.887 . . . . 0.0 109.569 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 4.4 ttp180 61.27 73.0 0.63 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.191 -0.943 . . . . 0.0 109.424 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.517 ' CD ' ' HA ' ' A' ' 43' ' ' VAL . 35.3 Cg_endo -78.12 -176.87 3.48 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.577 2.184 . . . . 0.0 110.405 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -127.44 -3.62 6.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.229 -0.919 . . . . 0.0 109.583 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.0 tp -136.93 125.17 23.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.203 -0.936 . . . . 0.0 109.52 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.766 HG21 ' SD ' ' A' ' 69' ' ' MET . 73.3 t -115.74 166.21 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.324 -0.86 . . . . 0.0 109.442 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.614 ' N ' HG12 ' A' ' 51' ' ' VAL . 1.1 mt -138.42 91.09 2.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.91 . . . . 0.0 109.585 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.624 ' CD1' HG21 ' A' ' 9' ' ' VAL . 3.1 mp -89.93 124.03 34.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.2 -0.938 . . . . 0.0 109.512 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.535 ' HB2' ' HE3' ' A' ' 81' ' ' MET . 28.1 t0 -100.06 -7.36 25.06 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.246 -0.909 . . . . 0.0 109.743 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 7.8 mmt 51.37 18.7 0.67 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.389 -0.819 . . . . 0.0 109.817 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.439 ' HG3' ' OD2' ' A' ' 54' ' ' ASP . 51.3 mmtt -90.95 -37.67 13.36 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.057 -1.027 . . . . 0.0 109.42 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.878 HG12 ' HB1' ' A' ' 34' ' ' ALA . 2.9 mt -42.82 114.41 1.51 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.388 -0.82 . . . . 0.0 109.593 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.489 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 34.9 Cg_endo -77.14 152.87 31.58 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.394 2.062 . . . . 0.0 110.27 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 108.87 -43.69 1.65 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.809 ' HE1' HG21 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -153.98 159.72 41.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.343 -1.092 . . . . 0.0 109.286 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -90.02 164.84 14.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.23 -0.919 . . . . 0.0 109.538 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.481 ' HA2' HG12 ' A' ' 65' ' ' ILE . . . -89.66 -9.0 66.99 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.883 HD11 ' HB2' ' A' ' 89' ' ' MET . 20.5 mm -46.85 -44.54 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.215 -1.168 . . . . 0.0 109.337 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -58.35 -42.01 85.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.336 -0.852 . . . . 0.0 109.338 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.579 HD11 ' HA3' ' A' ' 36' ' ' GLY . 15.6 mm -49.86 -50.26 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -0.926 . . . . 0.0 109.391 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 1.067 ' CD2' HG11 ' A' ' 78' ' ' VAL . 96.1 mt -58.36 -49.1 78.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.207 -0.933 . . . . 0.0 109.372 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.618 ' O ' HG23 ' A' ' 71' ' ' VAL . 12.5 mttp -44.28 -47.95 9.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.262 -0.899 . . . . 0.0 109.411 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.462 ' O ' HG12 ' A' ' 72' ' ' ILE . 1.9 mpt_? -66.1 -37.14 85.02 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.222 -0.924 . . . . 0.0 109.464 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.766 ' SD ' HG21 ' A' ' 51' ' ' VAL . 1.2 mmt -62.44 -22.91 66.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.251 -0.906 . . . . 0.0 109.438 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 66' ' ' LEU . 13.5 mmtt -84.92 -43.76 13.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.228 -0.92 . . . . 0.0 109.43 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 67' ' ' LYS . 2.6 t -63.87 -27.69 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.327 -0.858 . . . . 0.0 109.465 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.462 HG12 ' O ' ' A' ' 68' ' ' ARG . 28.6 mm -89.95 -56.37 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.246 -0.909 . . . . 0.0 109.486 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.438 ' O ' ' O ' ' A' ' 69' ' ' MET . 2.6 m-20 -126.25 134.64 51.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.305 -0.872 . . . . 0.0 109.471 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -89.18 -15.97 32.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.268 -0.895 . . . . 0.0 109.482 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -114.76 55.49 0.75 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.176 -0.952 . . . . 0.0 109.46 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.423 ' O ' HG23 ' A' ' 76' ' ' ILE . 0.8 OUTLIER -110.94 118.0 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.305 -0.872 . . . . 0.0 109.481 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.527 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 0.4 OUTLIER -75.68 144.13 41.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.894 . . . . 0.0 109.48 -179.999 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 1.067 HG11 ' CD2' ' A' ' 66' ' ' LEU . 13.6 t -143.93 107.95 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.343 -0.848 . . . . 0.0 109.495 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.529 HG23 ' O ' ' A' ' 100' ' ' THR . 68.0 mt -90.28 139.32 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.247 -0.908 . . . . 0.0 109.425 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.814 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.0 OUTLIER -108.36 167.02 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.278 -0.889 . . . . 0.0 109.297 179.915 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.535 ' HE3' ' HB2' ' A' ' 54' ' ' ASP . 7.2 mtm -146.59 95.0 2.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.154 -0.967 . . . . 0.0 109.588 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.975 HG22 ' NE2' ' A' ' 101' ' ' HIS . 11.6 t 177.8 38.37 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.213 -0.929 . . . . 0.0 109.35 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.7 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . -90.04 45.42 1.27 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.352 -0.842 . . . . 0.0 109.477 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.49 ' CE2' ' O ' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -84.55 12.22 7.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.265 -0.897 . . . . 0.0 109.415 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 133.55 73.43 0.09 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -179.0 135.63 0.13 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -1.166 . . . . 0.0 109.51 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.563 ' HA ' HG23 ' A' ' 90' ' ' ILE . 1.1 mt -133.92 46.01 2.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.355 -0.841 . . . . 0.0 109.4 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -103.65 -95.84 0.31 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.164 -0.96 . . . . 0.0 109.394 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.883 ' HB2' HD11 ' A' ' 63' ' ' ILE . 13.1 ptt? -52.74 -23.02 5.96 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.032 -1.043 . . . . 0.0 109.16 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.563 HG23 ' HA ' ' A' ' 87' ' ' LEU . 0.8 OUTLIER -77.93 -39.08 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.404 -0.81 . . . . 0.0 109.16 179.787 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.483 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 26.5 tp60 -61.06 -49.35 77.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -0.882 . . . . 0.0 109.4 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.448 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -77.54 -22.41 51.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.897 . . . . 0.0 109.295 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.49 ' HB2' ' HA ' ' A' ' 90' ' ' ILE . 0.6 OUTLIER -59.86 -68.8 0.25 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.258 -0.901 . . . . 0.0 109.358 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.854 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 24.0 tptt -44.04 -53.58 6.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.332 -0.855 . . . . 0.0 109.312 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 94' ' ' LYS . 36.3 tp10 -43.46 -51.5 6.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.365 -0.835 . . . . 0.0 109.461 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 92' ' ' GLU . 23.8 mt -58.11 -50.9 71.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.262 -0.899 . . . . 0.0 109.522 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 163.25 41.15 0.02 OUTLIER Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.854 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -93.52 107.23 19.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.295 -1.121 . . . . 0.0 109.368 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.527 ' CD1' ' HB3' ' A' ' 77' ' ' ARG . 22.0 mt -44.03 -87.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.261 -0.899 . . . . 0.0 109.518 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.529 ' O ' HG23 ' A' ' 79' ' ' ILE . 4.0 t -127.95 160.93 30.35 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.918 . . . . 0.0 109.517 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.975 ' NE2' HG22 ' A' ' 82' ' ' THR . 6.3 t-160 -125.21 95.32 4.44 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.255 -0.903 . . . . 0.0 109.581 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.66 ' CD2' HD13 ' A' ' 111' ' ' ILE . 18.8 m-85 -69.51 -168.45 0.17 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.29 -0.881 . . . . 0.0 109.419 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.7 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -162.81 -165.85 1.21 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.201 -0.937 . . . . 0.0 109.402 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.538 ' HG3' ' CE1' ' A' ' 106' ' ' PHE . 16.9 mtpt -129.2 145.37 56.44 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.225 -0.922 . . . . 0.0 109.459 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.9 151.66 91.38 Favored 'Cis proline' 0 C--N 1.31 -1.476 0 C-N-CA 123.302 -1.541 . . . . 0.0 110.381 -0.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.547 ' CD1' ' N ' ' A' ' 106' ' ' PHE . 4.9 p90 -133.63 169.32 17.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.183 -0.948 . . . . 0.0 109.486 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.413 ' HB3' ' OE1' ' A' ' 110' ' ' GLU . 42.7 t0 -103.16 116.71 33.0 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.208 -0.933 . . . . 0.0 109.501 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.805 ' CG2' HG21 ' A' ' 22' ' ' VAL . 12.9 mm -50.23 -29.72 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.279 -0.888 . . . . 0.0 109.38 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.453 ' HA ' ' HD3' ' A' ' 112' ' ' ARG . 52.0 m-20 -66.26 -44.0 84.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.204 -0.935 . . . . 0.0 109.383 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 113' ' ' ASP . 2.2 mp0 -64.46 -46.92 81.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 109.505 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.66 HD13 ' CD2' ' A' ' 102' ' ' PHE . 22.6 mm -52.27 -62.28 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.317 -0.864 . . . . 0.0 109.533 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.456 ' HG2' ' O ' ' A' ' 108' ' ' ILE . 0.6 OUTLIER -52.23 -38.45 58.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.55 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 110' ' ' GLU . 88.3 m-20 -53.52 -63.21 1.22 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 109.494 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.44 ' HA ' ' HG3' ' A' ' 117' ' ' LYS . . . -52.08 -55.67 19.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.912 . . . . 0.0 109.518 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.41 ' C ' ' O ' ' A' ' 114' ' ' ALA . 50.7 t -43.96 -35.04 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.261 -0.899 . . . . 0.0 109.477 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.45 ' HE3' ' OE2' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -73.93 -42.2 60.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.282 -0.886 . . . . 0.0 109.467 179.952 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.44 ' HG3' ' HA ' ' A' ' 114' ' ' ALA . 4.0 mttt -62.4 -21.57 65.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 109.449 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.46 ' O ' ' HD3' ' A' ' 120' ' ' PRO . 61.2 m-85 -88.55 -70.8 0.62 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.287 -0.883 . . . . 0.0 109.499 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 21.1 tp -90.04 112.48 52.61 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.365 -0.835 . . . . 0.0 109.448 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 118' ' ' TYR . 35.5 Cg_endo -78.04 133.0 12.02 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.393 2.062 . . . . 0.0 110.382 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 121' ' ' LEU . 0.7 OUTLIER -135.66 13.91 3.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 109.427 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.67 145.85 14.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.285 -0.885 . . . . 0.0 109.439 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 2.3 t 67.69 109.01 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.44 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 10.4 p30 . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.514 -179.975 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.287 0.565 . . . . 0.0 109.476 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 2.9 mtp -148.3 169.22 20.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.906 . . . . 0.0 109.435 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.543 ' HB3' ' CE ' ' A' ' 5' ' ' LYS . 1.1 t-20 -75.69 -148.87 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.199 -0.938 . . . . 0.0 109.455 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.732 ' OE1' HD23 ' A' ' 121' ' ' LEU . 3.9 mt-10 -130.64 106.56 8.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.226 -0.921 . . . . 0.0 109.497 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.543 ' CE ' ' HB3' ' A' ' 3' ' ' ASN . 0.8 OUTLIER -134.42 134.46 41.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.287 -0.883 . . . . 0.0 109.426 179.934 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.824 ' HB ' HG22 ' A' ' 30' ' ' THR . 98.0 mt -128.85 161.27 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.3 -0.875 . . . . 0.0 109.486 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.768 ' HB3' HG13 ' A' ' 51' ' ' VAL . 2.1 tm? -132.51 114.97 14.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.551 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.838 HG22 ' OD2' ' A' ' 10' ' ' ASP . 3.2 mt -104.36 105.03 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.924 . . . . 0.0 109.552 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.773 ' HA ' ' HB3' ' A' ' 33' ' ' ALA . 35.9 t -90.49 90.0 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.874 . . . . 0.0 109.464 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.838 ' OD2' HG22 ' A' ' 8' ' ' ILE . 69.1 m-20 -127.37 128.79 46.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.202 -0.936 . . . . 0.0 109.434 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.5 ' OD2' ' HD2' ' A' ' 58' ' ' PRO . 6.7 p-10 -100.21 -23.69 14.76 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.289 -0.882 . . . . 0.0 109.241 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.421 ' O ' ' C ' ' A' ' 13' ' ' TYR . 9.7 tp-100 -84.41 105.78 15.5 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.362 -0.836 . . . . 0.0 109.558 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.677 ' CE2' HD11 ' A' ' 17' ' ' ILE . 1.5 t80 -42.53 155.37 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.402 -0.811 . . . . 0.0 109.325 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.516 ' N ' ' CD1' ' A' ' 13' ' ' TYR . . . 109.33 -55.53 0.5 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.904 HG23 HD13 ' A' ' 19' ' ' LEU . 2.1 mt -76.13 -60.28 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.329 -1.101 . . . . 0.0 109.268 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.472 ' HD2' ' O ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -41.16 -30.91 0.17 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.48 -0.762 . . . . 0.0 110.042 -179.869 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.677 HD11 ' CE2' ' A' ' 13' ' ' TYR . 1.3 mt -90.42 -35.66 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.135 -0.978 . . . . 0.0 109.973 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.783 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.4 OUTLIER -65.44 -59.81 3.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.239 -0.913 . . . . 0.0 109.758 -179.625 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.904 HD13 HG23 ' A' ' 15' ' ' ILE . 7.2 mp -64.32 -20.97 66.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.198 -0.939 . . . . 0.0 109.639 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.472 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 10.9 t30 -70.65 -62.56 1.34 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 109.514 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.461 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 34.9 mt-10 -56.46 -44.37 80.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.265 -0.897 . . . . 0.0 109.55 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.783 HG23 ' O ' ' A' ' 18' ' ' LEU . 41.2 t -55.13 -61.73 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.236 -0.915 . . . . 0.0 109.491 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.863 ' CZ ' HG21 ' A' ' 115' ' ' VAL . 20.9 m-85 -65.56 -11.5 44.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.348 -0.845 . . . . 0.0 109.479 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.461 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 1.7 m-20 -73.52 -60.07 2.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.335 -0.853 . . . . 0.0 109.483 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.1 tttp -74.07 -11.3 60.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.453 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.484 ' HB2' ' HA ' ' A' ' 23' ' ' PHE . 0.7 OUTLIER -76.14 -31.57 58.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -0.935 . . . . 0.0 109.49 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.88 41.89 0.82 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.485 ' HB3' HD12 ' A' ' 6' ' ' ILE . 85.2 m-85 -141.56 134.93 29.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.256 -1.144 . . . . 0.0 109.592 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -93.96 82.21 4.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.234 -0.916 . . . . 0.0 109.07 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.824 HG22 ' HB ' ' A' ' 6' ' ' ILE . 5.5 p -89.79 149.07 22.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.27 -0.894 . . . . 0.0 109.881 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.612 ' HB2' HD22 ' A' ' 7' ' ' LEU . 31.6 m-85 -109.01 -167.23 1.19 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 109.052 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.428 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 15.5 mp0 -133.19 157.09 46.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.161 -0.962 . . . . 0.0 109.821 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.773 ' HB3' ' HA ' ' A' ' 9' ' ' VAL . . . -157.77 176.94 11.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.414 -0.804 . . . . 0.0 109.283 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.522 ' O ' HD13 ' A' ' 57' ' ' ILE . . . -173.35 -44.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.125 -0.985 . . . . 0.0 109.693 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.418 ' C ' ' SD ' ' A' ' 60' ' ' MET . 2.4 p30 -82.25 -1.8 50.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.214 -0.929 . . . . 0.0 109.607 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.461 ' HA3' ' SD ' ' A' ' 60' ' ' MET . . . 85.7 -48.69 4.03 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.477 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 1.1 mp -52.54 -44.79 66.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -1.149 . . . . 0.0 109.511 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.851 ' O ' HD12 ' A' ' 42' ' ' ILE . 0.9 OUTLIER -68.19 -27.71 66.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.217 -0.927 . . . . 0.0 109.481 179.939 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.778 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -71.56 -69.45 0.38 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.202 -0.936 . . . . 0.0 109.548 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -51.77 -47.17 64.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.228 -0.92 . . . . 0.0 109.6 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.477 ' HB2' ' O ' ' A' ' 37' ' ' LEU . 16.0 t0 -54.08 -52.59 60.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.308 -0.87 . . . . 0.0 109.55 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.851 HD12 ' O ' ' A' ' 38' ' ' GLN . 20.4 mt -61.7 -22.92 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.257 -0.902 . . . . 0.0 109.424 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.778 HG23 ' O ' ' A' ' 39' ' ' ALA . 54.1 t -78.29 -25.28 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.182 -0.949 . . . . 0.0 109.457 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.1 m -90.13 -25.29 20.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.308 -0.87 . . . . 0.0 109.525 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.523 ' CD ' ' HA ' ' A' ' 42' ' ' ILE . 3.8 ptmt -90.07 -27.13 19.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.574 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.538 ' OE2' ' CZ ' ' A' ' 31' ' ' PHE . 3.2 mt-10 -118.6 -26.66 6.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.23 -0.919 . . . . 0.0 109.471 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.502 ' HG3' ' O ' ' A' ' 46' ' ' GLU . 7.4 ptm180 38.55 72.12 0.98 Allowed Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.598 -0.689 . . . . 0.0 109.969 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.503 ' CB ' ' O ' ' A' ' 5' ' ' LYS . 34.7 Cg_endo -77.19 -171.51 1.18 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.619 2.213 . . . . 0.0 110.343 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 5.7 m-20 -117.6 -8.3 10.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.139 -0.975 . . . . 0.0 109.556 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.456 HD21 HG22 ' A' ' 115' ' ' VAL . 7.2 tp -131.57 117.34 18.6 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.286 -0.884 . . . . 0.0 109.54 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 1.06 HG11 ' CE ' ' A' ' 69' ' ' MET . 2.9 t -121.35 158.75 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.233 -0.917 . . . . 0.0 109.408 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.2 mp -135.3 115.68 13.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -0.935 . . . . 0.0 109.516 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.857 HD22 ' N ' ' A' ' 53' ' ' LEU . 0.8 OUTLIER -102.19 126.45 49.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.355 -0.841 . . . . 0.0 109.419 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 81' ' ' MET . 31.9 t0 -106.49 106.6 17.19 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.917 . . . . 0.0 109.466 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.711 ' CG ' HG21 ' A' ' 82' ' ' THR . 16.0 mmt -59.78 -14.95 16.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.332 -0.855 . . . . 0.0 109.462 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.458 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 4.2 mmpt? -52.88 -37.18 60.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 109.502 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.751 ' CD1' ' HE1' ' A' ' 60' ' ' MET . 43.8 mt -41.14 101.15 0.24 Allowed Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.443 -0.786 . . . . 0.0 109.691 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.5 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 36.2 Cg_endo -79.15 -29.53 3.14 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.512 2.141 . . . . 0.0 110.51 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -84.45 -3.91 88.19 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.751 ' HE1' ' CD1' ' A' ' 57' ' ' ILE . 10.3 ttp -156.96 141.03 16.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.103 -1.234 . . . . 0.0 109.607 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.477 ' N ' ' HG2' ' A' ' 60' ' ' MET . 15.3 m-20 -89.99 126.82 35.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.31 -0.869 . . . . 0.0 109.431 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.518 ' HA2' ' CG1' ' A' ' 65' ' ' ILE . . . -82.96 9.16 60.92 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' ' 63' ' ' ILE . 13.0 mm -70.8 -44.69 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.249 -1.148 . . . . 0.0 109.396 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -71.91 -12.89 61.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -0.905 . . . . 0.0 109.404 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.523 ' O ' ' CG ' ' A' ' 69' ' ' MET . 13.6 mm -73.49 -58.36 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.189 -0.944 . . . . 0.0 109.49 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.751 HD21 ' HB ' ' A' ' 78' ' ' VAL . 6.3 mt -53.25 -28.42 27.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -0.916 . . . . 0.0 109.465 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.505 ' O ' ' CG ' ' A' ' 70' ' ' LYS . 5.7 mmtm -72.65 -70.28 0.36 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.189 -0.945 . . . . 0.0 109.451 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.467 ' O ' HG12 ' A' ' 72' ' ' ILE . 0.6 OUTLIER -45.25 -25.83 0.42 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.265 -0.897 . . . . 0.0 109.418 -179.938 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' MET . . . . . 1.06 ' CE ' HG11 ' A' ' 51' ' ' VAL . 2.9 mmm -72.78 -48.9 34.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.187 -0.946 . . . . 0.0 109.456 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.505 ' CG ' ' O ' ' A' ' 67' ' ' LYS . 16.3 ptpt -63.18 -21.77 66.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.262 -0.899 . . . . 0.0 109.51 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.1 t -80.1 -45.62 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.251 -0.905 . . . . 0.0 109.517 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 68' ' ' ARG . 24.1 mm -76.21 -14.64 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.215 -0.928 . . . . 0.0 109.525 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.402 ' O ' HG22 ' A' ' 76' ' ' ILE . 1.2 m-20 -170.06 117.62 0.56 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.221 -0.924 . . . . 0.0 109.514 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.418 ' HG3' ' N ' ' A' ' 75' ' ' ASN . 0.1 OUTLIER -90.13 -18.83 25.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.186 -0.946 . . . . 0.0 109.417 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.418 ' N ' ' HG3' ' A' ' 74' ' ' GLU . 17.3 m120 -101.2 48.85 0.88 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.295 -0.878 . . . . 0.0 109.456 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.485 ' O ' HG23 ' A' ' 76' ' ' ILE . 0.3 OUTLIER -121.9 116.96 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.275 -0.891 . . . . 0.0 109.518 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.536 ' CA ' HD11 ' A' ' 99' ' ' LEU . 7.7 mtt85 -54.02 130.73 38.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 109.417 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.751 ' HB ' HD21 ' A' ' 66' ' ' LEU . 0.2 OUTLIER -132.08 117.86 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.213 -0.929 . . . . 0.0 109.63 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.556 HG23 ' O ' ' A' ' 100' ' ' THR . 66.9 mt -114.69 144.05 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.261 -0.899 . . . . 0.0 109.394 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 1.017 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.1 OUTLIER -108.63 158.88 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.235 -0.916 . . . . 0.0 109.418 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.469 ' O ' ' HB ' ' A' ' 82' ' ' THR . 14.2 mtm -136.83 91.92 2.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.135 -0.978 . . . . 0.0 109.644 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.924 HG22 ' NE2' ' A' ' 101' ' ' HIS . 11.4 t 176.69 38.65 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.377 -0.827 . . . . 0.0 109.331 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.95 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . -89.33 43.81 1.17 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.338 -0.851 . . . . 0.0 109.571 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -88.82 81.76 6.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.206 -0.934 . . . . 0.0 109.501 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 55.25 66.66 2.67 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.415 ' CD ' ' O ' ' A' ' 82' ' ' THR . 0.6 OUTLIER -174.18 87.23 0.05 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.247 -1.149 . . . . 0.0 109.504 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.542 ' HA ' ' CG2' ' A' ' 90' ' ' ILE . 7.4 mp -103.6 69.7 0.99 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 109.447 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 89' ' ' MET . 4.7 t70 -105.48 -87.52 0.45 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.906 . . . . 0.0 109.577 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.51 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 0.3 OUTLIER -78.95 3.97 15.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.252 -0.905 . . . . 0.0 109.523 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.542 ' CG2' ' HA ' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -90.41 -50.43 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.257 -0.902 . . . . 0.0 108.966 179.716 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.71 -38.25 14.81 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.193 -0.942 . . . . 0.0 109.452 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.14 -44.82 9.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.915 . . . . 0.0 109.639 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . 1.006 ' HA ' HD12 ' A' ' 96' ' ' LEU . 2.7 m -45.05 -26.88 0.49 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.171 -0.955 . . . . 0.0 109.69 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.841 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 0.8 OUTLIER -60.64 -63.45 1.29 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.18 -0.95 . . . . 0.0 109.518 -179.93 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.414 ' HG3' ' N ' ' A' ' 96' ' ' LEU . 7.1 pt-20 -61.45 -27.03 68.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.277 -0.89 . . . . 0.0 109.512 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 1.006 HD12 ' HA ' ' A' ' 93' ' ' SER . 36.2 mt -67.49 -33.73 75.71 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.205 -0.935 . . . . 0.0 109.5 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.558 ' O ' HG21 ' A' ' 78' ' ' VAL . . . 156.16 69.9 0.01 OUTLIER Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.841 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -158.01 110.03 2.31 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.273 -1.133 . . . . 0.0 109.382 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.536 HD11 ' CA ' ' A' ' 77' ' ' ARG . 0.4 OUTLIER -60.24 -67.58 0.38 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.289 -0.882 . . . . 0.0 109.436 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.556 ' O ' HG23 ' A' ' 79' ' ' ILE . 10.7 t -131.66 160.39 35.56 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.214 -0.928 . . . . 0.0 109.406 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 1.017 ' ND1' HD12 ' A' ' 80' ' ' ILE . 5.4 t-160 -124.92 94.79 4.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -0.892 . . . . 0.0 109.458 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.412 ' HZ ' ' HB2' ' A' ' 114' ' ' ALA . 38.8 m-85 -63.62 -179.0 0.32 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.238 -0.914 . . . . 0.0 109.5 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.95 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -171.08 -157.94 0.14 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.291 -0.881 . . . . 0.0 109.337 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.448 ' HG3' ' HA ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -98.9 143.03 25.63 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.188 -0.945 . . . . 0.0 109.454 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.448 ' HA ' ' HG3' ' A' ' 104' ' ' LYS . 35.6 Cg_endo -77.98 164.75 84.92 Favored 'Cis proline' 0 C--N 1.31 -1.487 0 C-N-CA 123.277 -1.551 . . . . 0.0 110.37 -0.03 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.727 ' CE2' HD12 ' A' ' 111' ' ' ILE . 0.2 OUTLIER -96.18 107.68 20.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.29 -0.881 . . . . 0.0 109.502 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.478 ' O ' HG12 ' A' ' 111' ' ' ILE . 23.1 t0 -89.83 103.87 16.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.258 -0.901 . . . . 0.0 109.384 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.683 HD12 HG21 ' A' ' 22' ' ' VAL . 15.8 mm -46.21 -24.35 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 109.863 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.456 ' O ' ' OD2' ' A' ' 113' ' ' ASP . 22.4 m-20 -73.6 -45.22 54.39 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.203 -0.936 . . . . 0.0 109.789 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.92 -24.37 61.62 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.112 -0.993 . . . . 0.0 109.706 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.727 HD12 ' CE2' ' A' ' 106' ' ' PHE . 10.6 mm -76.26 -53.08 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.218 -0.926 . . . . 0.0 109.438 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.459 ' O ' ' HG3' ' A' ' 116' ' ' LYS . 0.9 OUTLIER -64.24 -37.39 87.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.319 -0.863 . . . . 0.0 109.588 -179.867 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.456 ' OD2' ' O ' ' A' ' 109' ' ' ASP . 16.6 m-20 -63.65 -60.13 3.72 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.203 -0.936 . . . . 0.0 109.6 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.412 ' HB2' ' HZ ' ' A' ' 102' ' ' PHE . . . -46.58 -51.06 16.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.925 . . . . 0.0 109.618 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.863 HG21 ' CZ ' ' A' ' 23' ' ' PHE . 47.9 t -52.57 -49.98 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.889 . . . . 0.0 109.597 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 0.4 OUTLIER -58.42 -29.68 66.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.902 . . . . 0.0 109.553 -179.867 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.7 tttm -76.89 -27.36 54.94 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.201 -0.937 . . . . 0.0 109.42 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.492 ' O ' ' HD3' ' A' ' 120' ' ' PRO . 40.3 m-85 -90.05 -75.07 0.46 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.254 -0.904 . . . . 0.0 109.497 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.417 HD23 ' O ' ' A' ' 120' ' ' PRO . 5.3 tt -90.54 111.87 49.89 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.261 -0.899 . . . . 0.0 109.627 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 118' ' ' TYR . 36.2 Cg_endo -79.53 154.83 24.26 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.442 2.094 . . . . 0.0 110.355 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.732 HD23 ' OE1' ' A' ' 4' ' ' GLU . 21.4 mt -91.81 -115.61 0.08 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.298 -0.876 . . . . 0.0 109.205 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 123' ' ' SER . 0.0 OUTLIER -127.59 131.98 49.87 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.884 -1.135 . . . . 0.0 109.615 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 122' ' ' LYS . 0.0 OUTLIER 57.64 112.04 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 109.563 179.879 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.476 179.94 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.301 0.572 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.59 132.32 38.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.208 -0.933 . . . . 0.0 109.512 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.461 ' O ' ' OE2' ' A' ' 4' ' ' GLU . 1.2 p-10 -120.15 63.9 0.83 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.267 -0.896 . . . . 0.0 109.467 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.522 ' CD ' HD21 ' A' ' 121' ' ' LEU . 0.7 OUTLIER -138.37 55.19 1.75 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.188 -0.945 . . . . 0.0 109.445 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.488 ' O ' ' CB ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -127.53 111.15 13.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.294 -0.879 . . . . 0.0 109.454 179.958 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.687 HD12 HG22 ' A' ' 30' ' ' THR . 16.2 mt -126.93 158.29 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.255 -0.903 . . . . 0.0 109.496 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.879 HD13 ' N ' ' A' ' 8' ' ' ILE . 2.6 tm? -132.51 128.97 38.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.231 -0.918 . . . . 0.0 109.469 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.879 ' N ' HD13 ' A' ' 7' ' ' LEU . 9.1 mt -106.44 104.64 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.239 -0.913 . . . . 0.0 109.466 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.494 ' CG2' HD12 ' A' ' 7' ' ' LEU . 3.9 t -89.97 70.78 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.292 -0.88 . . . . 0.0 109.463 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.561 ' O ' ' HB2' ' A' ' 34' ' ' ALA . 0.4 OUTLIER -123.22 148.94 45.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.892 . . . . 0.0 109.502 179.935 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.549 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . 5.5 p-10 -115.8 -40.16 3.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.248 -0.907 . . . . 0.0 109.457 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.94 111.93 2.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.0 109.505 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.581 ' CZ ' HG13 ' A' ' 17' ' ' ILE . 46.6 t80 -49.26 128.84 17.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.212 -0.93 . . . . 0.0 109.477 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.52 ' O ' HD12 ' A' ' 18' ' ' LEU . . . 138.23 -43.93 1.15 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.784 HG23 HD13 ' A' ' 19' ' ' LEU . 6.4 mt -84.26 -39.74 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -1.135 . . . . 0.0 109.392 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.515 ' CD ' ' O ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -65.93 -26.57 67.66 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.207 -0.933 . . . . 0.0 109.453 -179.964 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.581 HG13 ' CZ ' ' A' ' 13' ' ' TYR . 4.8 mm -90.65 -42.61 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.261 -0.9 . . . . 0.0 109.787 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.789 ' O ' HG23 ' A' ' 22' ' ' VAL . 55.2 mt -64.65 -57.76 8.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.145 -0.972 . . . . 0.0 109.852 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.784 HD13 HG23 ' A' ' 15' ' ' ILE . 7.9 mp -60.23 -26.37 66.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.243 -0.91 . . . . 0.0 109.743 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 30.2 t30 -67.87 -55.2 13.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 109.59 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.489 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 33.4 mt-10 -59.74 -44.71 93.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.265 -0.897 . . . . 0.0 109.723 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.789 HG23 ' O ' ' A' ' 18' ' ' LEU . 13.7 t -55.92 -62.22 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 109.729 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.759 ' CZ ' HG21 ' A' ' 115' ' ' VAL . 17.0 m-85 -68.4 -10.16 53.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.915 . . . . 0.0 109.592 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.489 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 1.7 m-20 -70.84 -52.06 22.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.191 -0.943 . . . . 0.0 109.386 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -74.55 -11.71 60.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.238 -0.914 . . . . 0.0 109.311 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.557 ' HB3' ' CD2' ' A' ' 28' ' ' TYR . 3.5 mt-10 -78.61 -33.61 47.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.294 -0.879 . . . . 0.0 109.474 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.476 ' O ' ' HG2' ' A' ' 4' ' ' GLU . . . 105.56 54.08 0.75 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.725 ' CE1' HD23 ' A' ' 119' ' ' LEU . 88.5 m-85 -138.07 143.53 40.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.168 -1.195 . . . . 0.0 109.525 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.425 ' HB2' ' O ' ' A' ' 4' ' ' GLU . 92.8 mm-40 -94.23 81.51 4.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.91 . . . . 0.0 109.394 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.687 HG22 HD12 ' A' ' 6' ' ' ILE . 5.8 p -89.88 148.34 23.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.906 . . . . 0.0 109.53 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.541 ' HB2' ' CD2' ' A' ' 7' ' ' LEU . 8.5 m-85 -114.84 -172.74 2.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.274 -0.892 . . . . 0.0 109.409 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -123.28 151.35 42.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.282 -0.886 . . . . 0.0 109.529 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.608 ' HB3' HD11 ' A' ' 7' ' ' LEU . . . -174.48 172.4 3.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.313 -0.867 . . . . 0.0 109.414 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.561 ' HB2' ' O ' ' A' ' 10' ' ' ASP . . . 177.67 -31.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.182 -0.949 . . . . 0.0 109.533 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.415 ' ND2' ' H ' ' A' ' 35' ' ' ASN . 2.6 p30 -74.77 -0.91 19.79 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.171 -0.955 . . . . 0.0 109.619 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.05 -45.2 3.48 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.29 -54.79 31.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.158 -1.201 . . . . 0.0 109.514 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.605 ' HG2' HD11 ' A' ' 42' ' ' ILE . 1.5 mt-30 -71.24 -15.37 62.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.911 . . . . 0.0 109.617 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.814 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -70.6 -60.66 2.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.205 -0.935 . . . . 0.0 109.536 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.511 ' CD2' ' HB3' ' A' ' 68' ' ' ARG . 0.7 OUTLIER -69.85 -38.66 76.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.247 -0.908 . . . . 0.0 109.55 -179.974 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.461 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 14.8 m-20 -61.43 -60.79 3.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.332 -0.855 . . . . 0.0 109.547 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.785 HG21 HD23 ' A' ' 7' ' ' LEU . 41.5 mt -56.97 -31.05 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.248 -0.908 . . . . 0.0 109.513 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.814 HG23 ' O ' ' A' ' 39' ' ' ALA . 44.0 t -68.84 -31.69 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.204 -0.935 . . . . 0.0 109.485 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 79.8 m -90.02 -14.5 33.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.214 -0.929 . . . . 0.0 109.474 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 3.7 mmtt -84.61 -58.48 2.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.891 . . . . 0.0 109.545 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 47' ' ' ARG . 2.4 mm-40 -89.97 -25.38 20.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 109.628 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.507 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 6.5 mmm180 63.48 62.8 1.61 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.182 -0.949 . . . . 0.0 109.436 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.507 ' HD3' ' N ' ' A' ' 47' ' ' ARG . 35.3 Cg_endo -77.69 158.18 31.84 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.603 2.202 . . . . 0.0 110.49 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.405 ' HB2' ' CD1' ' A' ' 119' ' ' LEU . 4.4 m-20 -100.04 -10.9 21.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.246 -0.909 . . . . 0.0 109.508 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.695 HD23 ' HB2' ' A' ' 119' ' ' LEU . 1.7 mm? -116.62 122.89 45.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.221 -0.924 . . . . 0.0 109.499 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.887 HG11 ' CE ' ' A' ' 69' ' ' MET . 9.0 t -123.91 113.06 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.902 . . . . 0.0 109.529 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.633 HD12 ' O ' ' A' ' 7' ' ' LEU . 1.0 OUTLIER -90.75 120.31 31.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.883 . . . . 0.0 109.419 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.673 HD21 ' HB ' ' A' ' 65' ' ' ILE . 1.1 tp -110.75 121.98 46.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.337 -0.852 . . . . 0.0 109.534 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.471 ' OD2' ' HB2' ' A' ' 56' ' ' LYS . 8.9 t0 -104.45 109.14 20.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 0.0 109.366 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.45 ' HB2' ' HB ' ' A' ' 82' ' ' THR . 6.6 mmt -67.18 -9.59 41.7 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.144 -0.972 . . . . 0.0 109.512 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.471 ' HB2' ' OD2' ' A' ' 54' ' ' ASP . 6.3 mmtt -74.92 -19.13 60.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 0.0 109.383 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.668 HG21 ' HE2' ' A' ' 60' ' ' MET . 81.0 mt -43.11 103.15 0.3 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.324 -0.86 . . . . 0.0 109.519 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.44 ' HD2' ' CG ' ' A' ' 11' ' ' ASP . 35.5 Cg_endo -77.55 108.76 2.64 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.412 2.075 . . . . 0.0 110.421 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 128.93 -33.76 3.0 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.668 ' HE2' HG21 ' A' ' 57' ' ' ILE . 0.6 OUTLIER -138.82 133.34 31.94 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.276 -1.132 . . . . 0.0 109.458 -179.962 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.418 ' O ' ' HE3' ' A' ' 60' ' ' MET . 4.3 m-20 -83.52 157.94 22.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.161 -0.962 . . . . 0.0 109.477 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.526 ' HA2' ' CD1' ' A' ' 65' ' ' ILE . . . -102.89 9.17 55.0 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.7 mm -70.37 -57.68 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -1.191 . . . . 0.0 109.447 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -58.59 -29.13 66.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 0.0 109.432 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.673 ' HB ' HD21 ' A' ' 53' ' ' LEU . 10.1 mt -59.23 -52.15 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.277 -0.889 . . . . 0.0 109.412 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.777 ' CD2' HG11 ' A' ' 78' ' ' VAL . 25.8 mt -53.87 -51.5 63.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.357 -0.84 . . . . 0.0 109.486 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.522 ' O ' HG23 ' A' ' 71' ' ' VAL . 1.3 tttt -46.81 -49.39 20.03 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.262 -0.899 . . . . 0.0 109.483 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.511 ' HB3' ' CD2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -57.93 -38.54 76.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.278 -0.889 . . . . 0.0 109.463 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.887 ' CE ' HG11 ' A' ' 51' ' ' VAL . 7.0 mtt -67.94 -25.31 65.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 0.0 109.465 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 66' ' ' LEU . 0.8 OUTLIER -78.88 -30.32 44.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.271 -0.893 . . . . 0.0 109.452 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 67' ' ' LYS . 3.6 t -84.9 -20.85 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.274 -0.891 . . . . 0.0 109.435 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 68' ' ' ARG . 91.4 mt -89.92 -34.97 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -0.879 . . . . 0.0 109.432 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -166.31 134.05 2.77 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.261 -0.899 . . . . 0.0 109.433 -179.927 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -89.72 -10.48 45.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.514 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -103.23 12.45 35.6 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.226 -0.921 . . . . 0.0 109.552 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.632 ' O ' HG23 ' A' ' 76' ' ' ILE . 1.0 OUTLIER -78.62 115.26 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.262 -0.899 . . . . 0.0 109.496 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.792 ' HB3' HD11 ' A' ' 99' ' ' LEU . 59.0 mtt85 -69.85 126.97 31.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 109.513 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.777 HG11 ' CD2' ' A' ' 66' ' ' LEU . 2.9 t -133.23 110.44 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.269 -0.894 . . . . 0.0 109.458 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.547 HG22 ' N ' ' A' ' 80' ' ' ILE . 75.5 mt -92.59 165.02 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 109.384 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 1.016 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.3 OUTLIER -128.42 152.76 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.162 -0.962 . . . . 0.0 109.528 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.46 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 16.9 mtm -136.93 98.37 3.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.286 -0.884 . . . . 0.0 109.361 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' THR . . . . . 1.077 HG22 ' NE2' ' A' ' 101' ' ' HIS . 4.4 t -166.37 -147.23 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.153 -0.967 . . . . 0.0 109.64 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.787 ' N ' HG23 ' A' ' 82' ' ' THR . . . -40.93 108.19 0.09 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.464 -0.772 . . . . 0.0 110.052 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.559 ' CG ' ' O ' ' A' ' 84' ' ' TYR . 9.7 t80 -90.05 20.16 4.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 0.0 109.303 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 86' ' ' GLU . . . -136.08 -90.83 0.31 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.438 ' HG2' ' HB1' ' A' ' 83' ' ' ALA . 10.2 pt-20 -45.03 148.67 0.53 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.156 -1.202 . . . . 0.0 109.143 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.526 ' CD2' ' HB2' ' A' ' 91' ' ' GLN . 3.3 mp -134.02 87.21 2.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.161 -0.962 . . . . 0.0 109.748 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -94.5 -43.62 8.25 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.229 -0.92 . . . . 0.0 109.259 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.7 ptp -136.18 6.07 3.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.321 -0.862 . . . . 0.0 109.491 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.982 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.0 OUTLIER -90.95 -53.3 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.188 -0.945 . . . . 0.0 108.719 179.639 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.526 ' HB2' ' CD2' ' A' ' 87' ' ' LEU . 35.3 tt0 -47.66 -58.36 4.38 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.253 -0.905 . . . . 0.0 109.5 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.41 ' O ' ' C ' ' A' ' 93' ' ' SER . 11.2 tm-20 -58.81 -42.71 89.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.259 -0.901 . . . . 0.0 109.488 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.553 ' HA ' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -43.76 -30.77 0.69 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 0.0 109.457 179.987 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.757 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -55.64 -54.6 42.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 109.469 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -51.06 -47.17 61.85 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.281 -0.887 . . . . 0.0 109.502 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.553 HD12 ' HA ' ' A' ' 93' ' ' SER . 0.7 OUTLIER -49.37 -58.36 5.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.212 -0.93 . . . . 0.0 109.488 179.946 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 169.62 64.89 0.04 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.757 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -134.78 118.58 17.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.257 -1.143 . . . . 0.0 109.485 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.792 HD11 ' HB3' ' A' ' 77' ' ' ARG . 0.5 OUTLIER -71.11 -71.16 0.27 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.188 -0.945 . . . . 0.0 109.426 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.463 HG23 HG23 ' A' ' 79' ' ' ILE . 14.5 t -122.24 173.16 7.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.247 -0.908 . . . . 0.0 109.453 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 1.077 ' NE2' HG22 ' A' ' 82' ' ' THR . 5.4 t-160 -139.88 90.89 2.42 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.224 -0.923 . . . . 0.0 109.582 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.848 ' CE2' HD13 ' A' ' 111' ' ' ILE . 38.2 m-85 -73.21 -168.31 0.5 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.303 -0.873 . . . . 0.0 109.42 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.589 ' HB2' ' O ' ' A' ' 82' ' ' THR . . . -168.94 -147.39 0.07 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.224 -0.923 . . . . 0.0 109.294 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 7.6 ptmt -137.2 135.87 20.14 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.139 -0.976 . . . . 0.0 109.4 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.86 138.61 52.7 Favored 'Cis proline' 0 C--N 1.31 -1.459 0 C-N-CA 123.437 -1.485 . . . . 0.0 110.281 0.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.448 ' HB3' ' O ' ' A' ' 103' ' ' ALA . 26.9 p90 -99.43 172.45 7.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.28 -0.888 . . . . 0.0 109.656 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -114.81 111.96 22.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.271 -0.893 . . . . 0.0 109.348 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.445 HD13 ' HA ' ' A' ' 108' ' ' ILE . 10.7 mm -54.74 -18.76 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 109.38 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -72.96 -46.98 49.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 109.167 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -67.0 -33.73 76.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.302 -0.874 . . . . 0.0 109.215 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.848 HD13 ' CE2' ' A' ' 102' ' ' PHE . 16.7 mm -71.45 -35.19 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.322 -0.861 . . . . 0.0 109.116 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.532 ' CG ' ' CG1' ' A' ' 22' ' ' VAL . 5.3 mtp85 -63.69 -50.58 68.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.334 -0.854 . . . . 0.0 109.513 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 114' ' ' ALA . 61.8 m-20 -67.15 -62.54 1.38 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.223 -0.923 . . . . 0.0 109.766 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.56 ' O ' ' CD2' ' A' ' 118' ' ' TYR . . . -43.82 -39.77 4.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.113 -0.992 . . . . 0.0 109.684 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.759 HG21 ' CZ ' ' A' ' 23' ' ' PHE . 41.2 t -66.6 -42.97 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.909 . . . . 0.0 109.614 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 4.2 mtpp -61.81 -59.41 5.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 0.0 109.558 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -47.18 -56.31 6.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.197 -0.939 . . . . 0.0 109.566 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.56 ' CD2' ' O ' ' A' ' 114' ' ' ALA . 17.8 m-30 -51.96 -72.2 0.06 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.284 -0.885 . . . . 0.0 109.524 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.725 HD23 ' CE1' ' A' ' 28' ' ' TYR . 1.9 tp -90.19 112.49 52.86 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.324 -0.86 . . . . 0.0 109.534 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 118' ' ' TYR . 35.7 Cg_endo -78.16 152.94 27.96 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.318 2.012 . . . . 0.0 110.408 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.633 HD12 ' OH ' ' A' ' 28' ' ' TYR . 1.0 OUTLIER -115.43 79.93 1.36 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 109.439 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.1 mttm -55.8 165.65 0.86 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.282 -0.886 . . . . 0.0 109.463 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 4.2 t 59.86 -151.4 0.41 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.299 -0.876 . . . . 0.0 109.469 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 54.0 m-20 . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.557 179.982 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 mmt . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER 61.83 31.06 18.41 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.282 -0.886 . . . . 0.0 109.453 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -143.15 81.42 1.72 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.886 . . . . 0.0 109.396 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.612 ' HG3' HD11 ' A' ' 121' ' ' LEU . 16.8 mm-40 -113.36 124.63 52.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.267 -0.895 . . . . 0.0 109.456 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.47 ' O ' HG12 ' A' ' 6' ' ' ILE . 1.2 mtmp? -138.15 144.11 40.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.256 -0.902 . . . . 0.0 109.442 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.86 HD12 HG22 ' A' ' 30' ' ' THR . 3.5 mt -150.04 159.4 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.194 -0.941 . . . . 0.0 109.516 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.914 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.7 OUTLIER -131.18 128.14 39.39 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.333 -0.854 . . . . 0.0 109.492 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.914 ' N ' HD13 ' A' ' 7' ' ' LEU . 7.7 mt -109.68 106.81 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.287 -0.883 . . . . 0.0 109.494 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.666 HG12 ' HA ' ' A' ' 34' ' ' ALA . 2.6 t -104.46 89.01 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.32 -0.862 . . . . 0.0 109.473 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.54 ' CB ' ' HD2' ' A' ' 16' ' ' ARG . 2.2 t70 -87.51 -155.98 0.32 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.202 -0.936 . . . . 0.0 109.392 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.512 ' CB ' ' HA ' ' A' ' 57' ' ' ILE . 0.7 OUTLIER -109.6 -45.52 3.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.91 . . . . 0.0 109.564 -179.977 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.501 ' HG2' ' N ' ' A' ' 13' ' ' TYR . 45.8 tt0 -132.52 -90.13 0.41 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.17 -0.956 . . . . 0.0 109.482 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 1.147 ' CE2' HD11 ' A' ' 17' ' ' ILE . 2.8 t80 -149.83 167.92 25.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.302 -0.874 . . . . 0.0 109.489 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.01 -66.75 0.24 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.528 HD13 ' OD1' ' A' ' 10' ' ' ASP . 9.8 mt -68.04 -28.01 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.254 -1.145 . . . . 0.0 109.48 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.54 ' HD2' ' CB ' ' A' ' 10' ' ' ASP . 0.3 OUTLIER -66.51 -25.87 66.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.302 -0.874 . . . . 0.0 109.444 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 1.147 HD11 ' CE2' ' A' ' 13' ' ' TYR . 4.5 mt -90.04 -51.85 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.221 -0.925 . . . . 0.0 109.533 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.785 ' O ' HG23 ' A' ' 22' ' ' VAL . 4.8 mp -59.29 -58.04 10.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.241 -0.912 . . . . 0.0 109.554 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.728 ' HB3' HD13 ' A' ' 8' ' ' ILE . 1.9 tp -56.6 -22.54 34.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.891 . . . . 0.0 109.464 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 28.1 t30 -74.87 -72.77 0.27 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.244 -0.91 . . . . 0.0 109.528 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.427 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 17.4 tt0 -44.12 -35.52 2.21 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -0.895 . . . . 0.0 109.488 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.785 HG23 ' O ' ' A' ' 18' ' ' LEU . 58.3 t -62.84 -56.99 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.903 . . . . 0.0 109.461 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.545 ' CB ' HG21 ' A' ' 30' ' ' THR . 18.8 m-85 -73.28 -2.49 22.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.342 -0.849 . . . . 0.0 109.618 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.427 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 4.6 m-20 -85.65 -55.14 4.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.145 -0.972 . . . . 0.0 109.45 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.8 mttt -69.54 -19.81 63.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.311 -0.868 . . . . 0.0 109.457 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.487 ' HB3' ' CD2' ' A' ' 28' ' ' TYR . 1.4 tt0 -78.55 -30.97 47.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.258 -0.901 . . . . 0.0 109.45 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.443 ' O ' ' CG ' ' A' ' 28' ' ' TYR . . . 110.07 64.48 0.53 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.487 ' CD2' ' HB3' ' A' ' 26' ' ' GLU . 93.7 m-85 -154.76 134.73 13.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.225 -1.162 . . . . 0.0 109.503 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 22.5 mm-40 -91.67 81.8 5.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.286 -0.884 . . . . 0.0 109.409 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.86 HG22 HD12 ' A' ' 6' ' ' ILE . 5.9 p -89.88 152.58 21.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.275 -0.89 . . . . 0.0 109.56 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.837 ' HB2' HD22 ' A' ' 7' ' ' LEU . 58.8 m-85 -116.48 -170.23 1.78 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.301 -0.875 . . . . 0.0 109.402 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.427 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 22.1 mp0 -124.17 161.26 26.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.241 -0.912 . . . . 0.0 109.547 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.463 ' HB3' HG22 ' A' ' 9' ' ' VAL . . . 178.49 177.52 0.44 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 109.437 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.666 ' HA ' HG12 ' A' ' 9' ' ' VAL . . . 178.73 -41.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.217 -0.927 . . . . 0.0 109.466 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.41 ' OD1' ' CB ' ' A' ' 38' ' ' GLN . 30.9 p-10 -65.18 -10.58 32.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.923 . . . . 0.0 109.459 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.416 ' O ' ' C ' ' A' ' 37' ' ' LEU . . . 87.9 -71.42 2.58 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 40' ' ' LEU . 1.9 tt -44.46 -42.21 6.89 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -1.147 . . . . 0.0 109.395 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.471 ' HA ' ' OD2' ' A' ' 41' ' ' ASP . 44.5 tp60 -58.72 -53.87 53.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.264 -0.898 . . . . 0.0 109.504 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.597 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -55.69 -24.16 32.81 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.15 -0.969 . . . . 0.0 109.493 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 37' ' ' LEU . 54.9 mt -73.06 -45.46 57.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.91 . . . . 0.0 109.517 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 42' ' ' ILE . 1.7 p30 -64.81 -43.02 94.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.182 -0.949 . . . . 0.0 109.449 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.644 HG21 HD23 ' A' ' 7' ' ' LEU . 7.2 mt -64.23 -34.77 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.21 -0.931 . . . . 0.0 109.268 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 39' ' ' ALA . 54.2 t -74.32 -24.03 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.891 . . . . 0.0 109.453 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.2 m -89.7 -18.72 25.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.228 -0.92 . . . . 0.0 109.532 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.95 -55.65 3.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.285 -0.884 . . . . 0.0 109.483 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.438 ' O ' ' CB ' ' A' ' 47' ' ' ARG . 1.1 mt-10 -89.98 -39.04 13.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.268 -0.895 . . . . 0.0 109.458 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER 71.28 65.91 0.39 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.23 -0.919 . . . . 0.0 109.498 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.531 ' CD ' ' HA ' ' A' ' 43' ' ' VAL . 35.5 Cg_endo -78.14 167.99 22.52 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.589 2.192 . . . . 0.0 110.421 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.559 ' C ' HD22 ' A' ' 50' ' ' LEU . 29.0 t70 -109.43 -9.91 14.92 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.218 -0.926 . . . . 0.0 109.533 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.559 HD22 ' C ' ' A' ' 49' ' ' ASP . 3.8 mm? -117.84 121.51 40.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -0.937 . . . . 0.0 109.543 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.488 HG11 ' CE ' ' A' ' 69' ' ' MET . 72.9 t -127.33 140.93 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.257 -0.902 . . . . 0.0 109.471 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.648 HD12 ' O ' ' A' ' 7' ' ' LEU . 1.1 mp -115.27 112.17 22.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.309 -0.87 . . . . 0.0 109.423 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.632 HD22 ' CD2' ' A' ' 66' ' ' LEU . 1.7 mp -102.59 132.02 48.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.282 -0.886 . . . . 0.0 109.517 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.451 ' O ' HG13 ' A' ' 57' ' ' ILE . 17.7 t70 -112.76 130.14 56.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.319 -0.863 . . . . 0.0 109.453 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.729 ' HB2' HG21 ' A' ' 82' ' ' THR . 9.6 mmt -86.84 -6.98 58.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.322 -0.861 . . . . 0.0 109.555 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt -86.58 15.02 5.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.166 -0.959 . . . . 0.0 109.498 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.512 ' HA ' ' CB ' ' A' ' 11' ' ' ASP . 41.7 mt -80.97 138.78 49.57 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.128 -0.983 . . . . 0.0 109.309 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.493 ' HD3' ' HB2' ' A' ' 11' ' ' ASP . 36.2 Cg_endo -78.54 -36.15 0.96 Allowed 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.488 2.126 . . . . 0.0 110.549 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 58' ' ' PRO . . . -42.41 -53.79 4.91 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.502 ' N ' ' SD ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -169.47 -150.3 0.08 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.136 -1.214 . . . . 0.0 109.558 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.497 ' N ' ' HG2' ' A' ' 60' ' ' MET . 36.9 m-20 -90.19 -97.28 0.11 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.291 -0.881 . . . . 0.0 109.481 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.459 ' HA2' HG13 ' A' ' 65' ' ' ILE . . . 147.42 -14.76 1.44 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.466 HD13 ' HA ' ' A' ' 63' ' ' ILE . 14.4 mm -57.0 -18.72 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.314 -1.109 . . . . 0.0 109.238 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -87.47 -33.52 18.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.313 -0.867 . . . . 0.0 109.24 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.515 ' HB ' HD21 ' A' ' 53' ' ' LEU . 17.2 mt -56.15 -54.58 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.338 -0.851 . . . . 0.0 109.319 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.925 HD21 HG11 ' A' ' 78' ' ' VAL . 23.0 mt -51.02 -44.49 61.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 109.31 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.559 ' O ' HG23 ' A' ' 71' ' ' VAL . 3.2 tttp -52.38 -50.32 62.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.326 -0.859 . . . . 0.0 109.411 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.492 ' O ' HD12 ' A' ' 72' ' ' ILE . 0.3 OUTLIER -59.28 -31.5 69.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.286 -0.884 . . . . 0.0 109.431 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.488 ' CE ' HG11 ' A' ' 51' ' ' VAL . 2.7 mtt -74.47 -24.92 59.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.278 -0.889 . . . . 0.0 109.435 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -79.95 -28.93 39.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.379 -0.826 . . . . 0.0 109.264 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 67' ' ' LYS . 2.7 t -90.08 -22.04 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.306 -0.871 . . . . 0.0 109.549 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.492 HD12 ' O ' ' A' ' 68' ' ' ARG . 53.3 mt -87.43 -44.56 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -0.909 . . . . 0.0 109.459 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.507 ' O ' HG22 ' A' ' 76' ' ' ILE . 73.0 m-20 -150.49 122.69 8.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.331 -0.856 . . . . 0.0 109.404 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -81.99 -9.62 59.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.277 -0.889 . . . . 0.0 109.522 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -103.37 49.87 0.82 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.233 -0.917 . . . . 0.0 109.493 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.601 ' O ' HG23 ' A' ' 76' ' ' ILE . 1.1 tp -129.94 112.62 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.466 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.518 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 1.6 mtt180 -79.85 154.19 28.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 0.0 109.468 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.925 HG11 HD21 ' A' ' 66' ' ' LEU . 4.8 t -150.02 108.44 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.913 . . . . 0.0 109.572 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.692 HG23 HG23 ' A' ' 100' ' ' THR . 72.5 mt -90.5 140.81 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.247 -0.908 . . . . 0.0 109.449 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.898 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.0 OUTLIER -94.44 152.32 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.271 -0.893 . . . . 0.0 109.198 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.459 ' O ' ' HB ' ' A' ' 82' ' ' THR . 14.0 mtm -124.53 73.16 1.24 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.183 -0.948 . . . . 0.0 109.373 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.729 HG21 ' HB2' ' A' ' 55' ' ' MET . 9.6 t 177.29 56.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.31 -0.869 . . . . 0.0 109.397 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.88 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . -82.09 -15.39 53.62 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.281 -0.887 . . . . 0.0 109.528 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -89.98 84.31 6.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.211 -0.931 . . . . 0.0 109.525 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 142.23 -96.87 0.2 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.446 ' OE2' ' HB3' ' A' ' 55' ' ' MET . 0.4 OUTLIER -53.34 146.76 11.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.324 -1.104 . . . . 0.0 109.59 -179.94 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.624 ' HA ' HG23 ' A' ' 90' ' ' ILE . 0.3 OUTLIER -160.11 23.01 0.17 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.281 -0.887 . . . . 0.0 109.431 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -96.75 -77.92 0.48 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.204 -0.935 . . . . 0.0 109.513 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.506 ' O ' ' CB ' ' A' ' 93' ' ' SER . 1.8 mmt -79.23 3.82 16.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.27 -0.894 . . . . 0.0 109.57 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 1.068 HD12 ' CE1' ' A' ' 101' ' ' HIS . 0.1 OUTLIER -90.47 -53.22 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.231 -0.918 . . . . 0.0 108.862 179.533 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -51.35 -37.15 46.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.255 -0.903 . . . . 0.0 109.5 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 93' ' ' SER . 1.4 mt-10 -90.15 -36.28 14.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.226 -0.921 . . . . 0.0 109.625 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.506 ' CB ' ' O ' ' A' ' 89' ' ' MET . 0.4 OUTLIER -43.55 -44.92 6.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.312 -0.868 . . . . 0.0 109.649 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.928 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 2.5 ttpt -44.02 -51.79 7.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.282 -0.886 . . . . 0.0 109.445 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -59.5 -40.99 88.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 0.0 109.431 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.562 HD22 ' N ' ' A' ' 96' ' ' LEU . 4.2 mm? -53.31 -64.99 0.64 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.296 -0.878 . . . . 0.0 109.49 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -176.08 40.98 0.11 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.928 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -110.77 101.33 9.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -1.164 . . . . 0.0 109.49 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.518 ' CD1' ' HB3' ' A' ' 77' ' ' ARG . 18.6 mt -44.1 -68.32 0.21 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 109.47 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.692 HG23 HG23 ' A' ' 79' ' ' ILE . 15.1 t -134.9 -177.6 4.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.284 -0.885 . . . . 0.0 109.437 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 1.068 ' CE1' HD12 ' A' ' 90' ' ' ILE . 3.2 t-160 -140.48 88.35 2.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 109.339 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.717 ' CE1' HD13 ' A' ' 111' ' ' ILE . 65.5 m-85 -58.99 -164.35 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.236 -0.915 . . . . 0.0 109.579 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.88 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -177.27 155.31 1.12 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.199 -0.938 . . . . 0.0 109.361 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.519 ' HA ' ' N ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -93.41 142.14 24.84 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.211 -0.931 . . . . 0.0 109.387 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.91 117.1 4.9 Favored 'Cis proline' 0 C--N 1.31 -1.479 0 C-N-CA 123.335 -1.527 . . . . 0.0 110.353 -0.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.519 ' N ' ' HA ' ' A' ' 104' ' ' LYS . 11.1 p90 -79.84 169.6 17.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.248 -0.908 . . . . 0.0 109.574 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.472 ' O ' HG12 ' A' ' 111' ' ' ILE . 36.0 t0 -119.77 121.73 39.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.347 -0.846 . . . . 0.0 109.473 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.463 HG23 HG11 ' A' ' 22' ' ' VAL . 14.5 mm -54.63 -21.28 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -0.897 . . . . 0.0 109.509 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -76.24 -37.52 57.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.235 -0.916 . . . . 0.0 109.518 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -77.57 -25.31 49.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.184 -0.947 . . . . 0.0 109.436 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.717 HD13 ' CE1' ' A' ' 102' ' ' PHE . 19.2 mm -75.73 -45.85 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.313 -0.867 . . . . 0.0 109.516 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.467 ' HB2' ' OE1' ' A' ' 26' ' ' GLU . 7.6 ptt85 -72.51 -41.88 65.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.472 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -61.16 -53.43 57.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.928 . . . . 0.0 109.538 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.486 ' O ' ' HG2' ' A' ' 117' ' ' LYS . . . -59.18 -45.06 92.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.292 -0.88 . . . . 0.0 109.47 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 111' ' ' ILE . 54.7 t -60.48 -25.19 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.191 -0.943 . . . . 0.0 109.396 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -76.89 -45.66 27.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.179 -0.95 . . . . 0.0 109.451 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.524 ' HG3' ' N ' ' A' ' 118' ' ' TYR . 0.0 OUTLIER -63.49 -27.08 69.03 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 109.481 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.524 ' N ' ' HG3' ' A' ' 117' ' ' LYS . 38.9 m-85 -84.51 -72.84 0.45 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.24 -0.912 . . . . 0.0 109.423 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.8 tp -90.06 112.58 53.18 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.341 -0.849 . . . . 0.0 109.422 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 118' ' ' TYR . 35.6 Cg_endo -77.79 132.76 12.15 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.33 2.02 . . . . 0.0 110.418 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.612 HD11 ' HG3' ' A' ' 4' ' ' GLU . 0.6 OUTLIER -133.54 12.15 4.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.327 -0.858 . . . . 0.0 109.47 -179.917 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.57 26.22 0.23 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.213 -0.929 . . . . 0.0 109.507 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -142.62 -77.22 0.25 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.198 -0.939 . . . . 0.0 109.529 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.453 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptp . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 28.7 mtp -63.4 -150.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.175 -0.953 . . . . 0.0 109.408 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.31 149.31 31.6 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.252 -0.905 . . . . 0.0 109.473 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.567 ' OE1' ' CD2' ' A' ' 28' ' ' TYR . 1.6 mm-40 -82.91 111.6 18.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.173 -0.954 . . . . 0.0 109.47 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.495 ' HB2' ' HA ' ' A' ' 48' ' ' PRO . 42.3 mttt -121.96 120.52 34.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -0.916 . . . . 0.0 109.485 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.475 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 49.1 mt -148.51 150.93 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.157 -0.964 . . . . 0.0 109.483 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.633 HD11 HD13 ' A' ' 42' ' ' ILE . 0.6 OUTLIER -133.56 127.83 33.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.183 -0.948 . . . . 0.0 109.432 -179.999 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.403 HD13 ' CB ' ' A' ' 19' ' ' LEU . 8.4 mt -101.02 109.54 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.244 -0.91 . . . . 0.0 109.522 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.651 HG12 HD11 ' A' ' 57' ' ' ILE . 17.0 t -96.27 91.33 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.23 -0.919 . . . . 0.0 109.427 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.518 ' O ' ' CD ' ' A' ' 16' ' ' ARG . 16.7 t70 -145.27 146.01 31.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.264 -0.898 . . . . 0.0 109.45 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.477 ' OD2' ' HD2' ' A' ' 58' ' ' PRO . 9.1 p-10 -109.88 -37.75 5.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.185 -0.947 . . . . 0.0 109.501 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.414 ' O ' ' C ' ' A' ' 13' ' ' TYR . 1.8 tp60 -63.01 104.84 0.6 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.232 -0.918 . . . . 0.0 109.448 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.583 ' CZ ' HG13 ' A' ' 17' ' ' ILE . 9.2 t80 -44.73 132.3 6.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.243 -0.911 . . . . 0.0 109.447 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 18' ' ' LEU . . . 138.72 -47.11 0.94 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 1.021 HG23 HD13 ' A' ' 19' ' ' LEU . 4.5 mt -82.85 -43.62 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.174 -1.192 . . . . 0.0 109.491 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.518 ' CD ' ' O ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -63.0 -24.05 67.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.89 . . . . 0.0 109.505 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.583 HG13 ' CZ ' ' A' ' 13' ' ' TYR . 5.3 mm -90.1 -55.41 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.212 -0.93 . . . . 0.0 109.598 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.591 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.3 OUTLIER -56.61 -58.57 7.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 109.573 -179.853 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 1.021 HD13 HG23 ' A' ' 15' ' ' ILE . 5.0 mp -57.86 -21.23 41.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.905 . . . . 0.0 109.552 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 12.7 t30 -74.16 -71.11 0.35 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.316 -0.865 . . . . 0.0 109.469 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.451 ' N ' ' OE1' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -45.57 -44.18 12.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 0.0 109.522 -179.897 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.902 HG21 HD12 ' A' ' 108' ' ' ILE . 48.2 t -58.93 -53.18 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.218 -0.926 . . . . 0.0 109.431 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.771 ' HZ ' HG22 ' A' ' 111' ' ' ILE . 21.8 m-85 -78.13 2.33 18.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.372 -0.83 . . . . 0.0 109.622 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.444 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 3.6 m-20 -90.02 -50.32 6.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.139 -0.975 . . . . 0.0 109.532 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.5 tttp -79.57 -44.68 20.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.178 -0.951 . . . . 0.0 109.49 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.534 ' HB3' ' CD1' ' A' ' 28' ' ' TYR . 0.9 OUTLIER -49.09 -34.29 13.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 109.453 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.526 ' C ' ' CD1' ' A' ' 28' ' ' TYR . . . 110.26 66.26 0.55 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.751 ' CE2' HD21 ' A' ' 121' ' ' LEU . 70.1 m-85 -148.64 135.62 20.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.333 -1.099 . . . . 0.0 109.5 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.465 ' HG2' ' HB2' ' A' ' 4' ' ' GLU . 5.6 mm100 -92.39 83.02 4.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.306 -0.871 . . . . 0.0 109.266 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.671 HG21 ' CB ' ' A' ' 23' ' ' PHE . 5.7 p -89.98 158.63 17.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.914 . . . . 0.0 109.571 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.577 ' HB2' HD12 ' A' ' 7' ' ' LEU . 8.8 m-85 -118.18 -163.56 0.95 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.289 -0.882 . . . . 0.0 109.465 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -144.52 147.89 33.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.166 -0.959 . . . . 0.0 109.519 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -168.36 -176.24 2.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.903 . . . . 0.0 109.417 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.464 ' O ' ' HE1' ' A' ' 60' ' ' MET . . . 177.98 -31.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.214 -0.929 . . . . 0.0 109.498 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -76.42 -8.06 56.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.259 -0.9 . . . . 0.0 109.514 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.13 -47.44 3.77 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.463 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -59.16 -43.26 92.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -1.113 . . . . 0.0 109.435 -179.983 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 1.062 ' O ' HD12 ' A' ' 42' ' ' ILE . 11.6 mm100 -69.1 -24.31 64.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.324 -0.86 . . . . 0.0 109.436 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.669 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -70.98 -57.85 4.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -0.882 . . . . 0.0 109.515 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.427 HD22 ' HB3' ' A' ' 68' ' ' ARG . 12.7 mt -64.02 -31.41 72.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.188 -0.945 . . . . 0.0 109.531 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 37' ' ' LEU . 3.9 t0 -64.87 -49.88 68.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.27 -0.894 . . . . 0.0 109.459 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 1.062 HD12 ' O ' ' A' ' 38' ' ' GLN . 3.6 mt -70.21 -20.17 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.25 -0.906 . . . . 0.0 109.477 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 39' ' ' ALA . 55.5 t -77.67 -34.33 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.911 . . . . 0.0 109.489 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.3 m -90.02 -16.03 30.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.182 -0.949 . . . . 0.0 109.483 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.27 -51.44 5.76 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.252 -0.905 . . . . 0.0 109.552 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.478 ' HG3' HG23 ' A' ' 42' ' ' ILE . 0.9 OUTLIER -92.88 -26.03 17.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.236 -0.915 . . . . 0.0 109.518 -179.925 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.492 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 12.8 mtm180 61.02 63.16 2.6 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.254 -0.903 . . . . 0.0 109.452 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.594 ' O ' HD12 ' A' ' 76' ' ' ILE . 35.2 Cg_endo -77.81 -178.32 4.52 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.594 2.196 . . . . 0.0 110.388 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.862 ' O ' HD22 ' A' ' 50' ' ' LEU . 55.5 m-20 -128.06 -2.76 5.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.302 -0.874 . . . . 0.0 109.673 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.862 HD22 ' O ' ' A' ' 49' ' ' ASP . 3.8 mm? -131.49 106.06 7.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.176 -0.952 . . . . 0.0 109.502 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.853 HG11 ' CE ' ' A' ' 69' ' ' MET . 1.5 t -115.88 121.41 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.9 . . . . 0.0 109.45 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.468 ' HB3' ' CE ' ' A' ' 81' ' ' MET . 1.1 mp -94.99 110.53 22.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.262 -0.899 . . . . 0.0 109.437 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.814 HD23 ' CG1' ' A' ' 78' ' ' VAL . 2.9 mm? -104.41 133.11 49.84 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.189 -0.944 . . . . 0.0 109.547 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -118.0 129.35 55.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.908 . . . . 0.0 109.488 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.624 ' HB2' HG21 ' A' ' 82' ' ' THR . 27.7 mmt -78.75 3.35 16.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 109.562 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.434 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 2.0 mmmm -78.16 -28.19 48.23 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.149 -0.969 . . . . 0.0 109.424 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.839 HG21 ' CE ' ' A' ' 60' ' ' MET . 44.3 mt -43.06 103.15 0.3 Allowed Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.392 -0.818 . . . . 0.0 109.552 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.477 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 35.3 Cg_endo -77.76 71.74 6.41 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.497 2.131 . . . . 0.0 110.387 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -164.4 -47.67 0.02 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.839 ' CE ' HG21 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -153.21 135.09 14.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.262 -1.14 . . . . 0.0 109.454 179.897 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -56.65 136.47 54.78 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.205 -0.934 . . . . 0.0 109.482 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.452 ' HA2' HG13 ' A' ' 65' ' ' ILE . . . -83.69 9.69 61.67 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.586 HG23 ' SD ' ' A' ' 89' ' ' MET . 38.7 mm -67.62 -45.05 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.191 -1.182 . . . . 0.0 109.475 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -66.83 -25.48 66.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.235 -0.915 . . . . 0.0 109.449 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.452 HG13 ' HA2' ' A' ' 62' ' ' GLY . 7.2 mt -69.81 -68.24 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.34 -0.85 . . . . 0.0 109.434 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 1.045 HD21 HG11 ' A' ' 78' ' ' VAL . 3.1 mt -50.35 -39.37 46.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.267 -0.896 . . . . 0.0 109.528 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.505 ' O ' HG23 ' A' ' 71' ' ' VAL . 1.7 ttpp -60.68 -39.41 88.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -0.876 . . . . 0.0 109.505 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.427 ' HB3' HD22 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -68.25 -58.28 4.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.234 -0.916 . . . . 0.0 109.515 -179.894 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.853 ' CE ' HG11 ' A' ' 51' ' ' VAL . 2.2 ptp -60.71 -13.72 16.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.267 -0.896 . . . . 0.0 109.548 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 66' ' ' LEU . 0.6 OUTLIER -89.72 -31.58 17.39 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.836 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 67' ' ' LYS . 52.8 t -75.09 -28.97 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 109.195 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.5 mt -90.05 -44.52 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.363 -0.836 . . . . 0.0 109.419 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.758 ' O ' HG22 ' A' ' 76' ' ' ILE . 15.0 t0 -132.05 116.78 17.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.16 -0.962 . . . . 0.0 109.427 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.01 -40.45 12.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.248 -0.908 . . . . 0.0 109.544 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -61.23 -13.87 21.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.281 -0.887 . . . . 0.0 109.46 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.758 HG22 ' O ' ' A' ' 73' ' ' ASP . 1.0 OUTLIER -60.51 112.03 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.2 -0.937 . . . . 0.0 109.525 179.922 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.485 ' CB ' HD11 ' A' ' 99' ' ' LEU . 5.0 mtt85 -71.19 142.43 50.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.213 -0.929 . . . . 0.0 109.436 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 1.045 HG11 HD21 ' A' ' 66' ' ' LEU . 15.9 t -145.05 150.58 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.237 -0.915 . . . . 0.0 109.631 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.667 HG23 ' O ' ' A' ' 100' ' ' THR . 11.1 mt -134.19 141.33 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.266 -0.896 . . . . 0.0 109.433 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.885 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.1 OUTLIER -96.74 141.77 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.172 -0.955 . . . . 0.0 109.206 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.468 ' CE ' ' HB3' ' A' ' 52' ' ' LEU . 2.8 mtm -113.88 59.85 0.67 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.145 -0.972 . . . . 0.0 109.508 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.624 HG21 ' HB2' ' A' ' 55' ' ' MET . 14.2 t -172.43 43.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.176 -0.952 . . . . 0.0 109.521 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.732 ' N ' ' HB2' ' A' ' 103' ' ' ALA . . . -52.99 -74.5 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.266 -0.896 . . . . 0.0 109.526 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -56.52 104.42 0.15 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 109.522 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 175.16 -72.12 0.09 OUTLIER Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.482 ' O ' HG21 ' A' ' 90' ' ' ILE . 3.9 pt-20 -155.51 140.46 17.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.182 -1.187 . . . . 0.0 109.477 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.836 ' N ' HD22 ' A' ' 87' ' ' LEU . 2.4 mm? -103.71 68.55 0.93 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.338 -0.851 . . . . 0.0 109.435 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.531 ' O ' ' CB ' ' A' ' 89' ' ' MET . 21.3 m-20 -121.36 101.11 7.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.274 -0.891 . . . . 0.0 109.359 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.586 ' SD ' HG23 ' A' ' 63' ' ' ILE . 0.0 OUTLIER 77.67 -2.4 2.54 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.369 -0.832 . . . . 0.0 109.341 -179.49 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.656 HD12 ' CE1' ' A' ' 101' ' ' HIS . 0.2 OUTLIER -90.86 -50.16 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.353 -0.842 . . . . 0.0 108.905 179.619 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.78 -38.26 15.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.315 -0.865 . . . . 0.0 109.573 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -90.02 -40.73 12.13 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.227 -0.92 . . . . 0.0 109.619 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.534 ' O ' ' CA ' ' A' ' 97' ' ' GLY . 9.9 m -58.73 -15.22 11.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.202 -0.936 . . . . 0.0 109.644 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.872 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 1.7 ttpt -88.89 -45.86 9.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.155 -0.966 . . . . 0.0 109.506 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.993 ' C ' HD22 ' A' ' 96' ' ' LEU . 10.0 mm-40 -47.62 -44.24 26.52 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.515 -0.741 . . . . 0.0 110.542 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.993 HD22 ' C ' ' A' ' 95' ' ' GLU . 3.3 mm? -132.38 5.51 4.07 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.93 -1.106 . . . . 0.0 110.704 -179.048 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.534 ' CA ' ' O ' ' A' ' 93' ' ' SER . . . -124.39 -14.19 3.68 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.473 -1.346 . . . . 0.0 109.99 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.872 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -149.84 98.03 2.68 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.166 -1.196 . . . . 0.0 109.615 -179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.485 HD11 ' CB ' ' A' ' 77' ' ' ARG . 0.7 OUTLIER -48.79 -61.1 2.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.235 -0.915 . . . . 0.0 109.478 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.667 ' O ' HG23 ' A' ' 79' ' ' ILE . 16.7 m -113.53 157.68 21.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 109.476 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.885 ' ND1' HD12 ' A' ' 80' ' ' ILE . 3.4 t-160 -135.52 85.5 2.17 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.325 -0.859 . . . . 0.0 109.331 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.54 ' CE1' ' HG2' ' A' ' 110' ' ' GLU . 11.7 m-85 -73.13 158.27 35.62 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.198 -0.939 . . . . 0.0 109.575 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.732 ' HB2' ' N ' ' A' ' 83' ' ' ALA . . . -144.61 151.99 39.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.348 -0.845 . . . . 0.0 109.424 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 103' ' ' ALA . 0.6 OUTLIER -45.1 137.04 4.84 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.235 -0.916 . . . . 0.0 109.304 -179.937 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' A' ' 103' ' ' ALA . 35.7 Cg_endo -77.78 -172.6 11.47 Favored 'Cis proline' 0 C--N 1.312 -1.363 0 C-N-CA 123.365 -1.514 . . . . 0.0 110.403 -0.03 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.759 ' HE2' HD21 ' A' ' 19' ' ' LEU . 0.4 OUTLIER -118.66 111.52 18.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.212 -0.93 . . . . 0.0 109.492 -179.96 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.468 ' O ' HG12 ' A' ' 111' ' ' ILE . 22.1 t0 -89.94 105.79 18.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.262 -0.899 . . . . 0.0 109.36 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.902 HD12 HG21 ' A' ' 22' ' ' VAL . 13.7 mm -45.92 -24.63 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.226 -0.921 . . . . 0.0 109.772 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.431 ' O ' ' HG2' ' A' ' 112' ' ' ARG . 9.6 m-20 -69.75 -47.55 62.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.904 . . . . 0.0 109.542 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.54 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 0.9 OUTLIER -69.19 -30.23 68.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -0.901 . . . . 0.0 109.475 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.771 HG22 ' HZ ' ' A' ' 23' ' ' PHE . 14.7 mm -68.01 -46.31 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.234 -0.916 . . . . 0.0 109.399 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.472 ' O ' ' HG3' ' A' ' 116' ' ' LYS . 3.2 ptt180 -74.06 -20.76 60.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.354 -0.841 . . . . 0.0 109.572 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -73.54 -51.38 17.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.157 -0.965 . . . . 0.0 109.495 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.544 ' O ' ' CD2' ' A' ' 118' ' ' TYR . . . -70.06 -31.63 69.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 109.535 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.569 HG21 ' CZ ' ' A' ' 23' ' ' PHE . 72.4 t -74.95 -31.45 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -0.923 . . . . 0.0 109.57 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 0.1 OUTLIER -74.55 -42.55 58.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.21 -0.931 . . . . 0.0 109.583 179.957 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.454 ' HE2' ' HA ' ' A' ' 117' ' ' LYS . 0.0 OUTLIER -64.15 -50.42 68.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.921 . . . . 0.0 109.519 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.544 ' CD2' ' O ' ' A' ' 114' ' ' ALA . 14.8 m-85 -65.62 -63.71 1.03 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.207 -0.933 . . . . 0.0 109.486 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.52 HD21 ' OE2' ' A' ' 4' ' ' GLU . 2.9 tt -87.91 113.2 53.62 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.161 -0.962 . . . . 0.0 109.405 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 118' ' ' TYR . 35.7 Cg_endo -77.87 139.93 17.92 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.353 2.035 . . . . 0.0 110.401 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.751 HD21 ' CE2' ' A' ' 28' ' ' TYR . 2.8 mm? -113.33 -166.51 1.09 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.251 -0.906 . . . . 0.0 109.51 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 121' ' ' LEU . 13.2 mttt -43.4 125.83 4.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.388 -0.82 . . . . 0.0 109.556 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 28.1 t -48.07 102.69 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.889 . . . . 0.0 109.451 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.9 m120 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.39 179.914 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.665 ' HB3' HD21 ' A' ' 121' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.52 ' O ' ' CB ' ' A' ' 48' ' ' PRO . 0.4 OUTLIER -103.69 118.12 35.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.201 -0.937 . . . . 0.0 109.502 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.707 ' HB ' HG22 ' A' ' 30' ' ' THR . 13.8 mt -116.31 153.16 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.174 -0.954 . . . . 0.0 109.422 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.847 HD23 HG21 ' A' ' 42' ' ' ILE . 1.9 tm? -131.42 110.83 11.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.195 -0.94 . . . . 0.0 109.516 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.89 HG22 ' NH1' ' A' ' 16' ' ' ARG . 3.4 mt -90.07 108.11 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -0.879 . . . . 0.0 109.324 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.748 HG22 HD12 ' A' ' 7' ' ' LEU . 2.8 t -98.36 117.42 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.221 -0.924 . . . . 0.0 109.654 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.585 ' CB ' ' CZ ' ' A' ' 16' ' ' ARG . 24.9 t0 -175.17 154.94 1.85 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.337 -0.852 . . . . 0.0 109.421 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.463 ' CG ' ' HD2' ' A' ' 58' ' ' PRO . 5.3 p-10 -105.95 -46.12 4.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.165 -0.96 . . . . 0.0 109.501 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.46 ' HG2' ' OD2' ' A' ' 10' ' ' ASP . 13.6 pt20 -50.04 127.51 16.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.241 -0.912 . . . . 0.0 109.527 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.911 ' CE2' HD11 ' A' ' 17' ' ' ILE . 8.2 t80 -80.86 157.95 25.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.257 -0.902 . . . . 0.0 109.645 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 116.31 -69.32 0.28 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.568 ' CG2' ' NH2' ' A' ' 16' ' ' ARG . 5.8 mt -64.02 -25.43 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.32 -1.106 . . . . 0.0 109.173 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.89 ' NH1' HG22 ' A' ' 8' ' ' ILE . 3.7 mmp_? -65.34 -24.75 67.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.886 . . . . 0.0 109.403 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.911 HD11 ' CE2' ' A' ' 13' ' ' TYR . 6.1 mt -89.95 -24.9 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.343 -0.848 . . . . 0.0 109.387 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.842 ' O ' HG23 ' A' ' 22' ' ' VAL . 49.3 mt -74.24 -50.83 17.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.312 -0.868 . . . . 0.0 109.499 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.734 ' HB2' HD13 ' A' ' 8' ' ' ILE . 7.2 mt -69.16 -20.1 64.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 109.408 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -77.02 -58.95 2.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.26 -0.9 . . . . 0.0 109.491 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.439 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 14.0 mt-10 -59.58 -47.89 83.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.917 . . . . 0.0 109.5 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.842 HG23 ' O ' ' A' ' 18' ' ' LEU . 22.2 t -57.21 -57.32 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.229 -0.92 . . . . 0.0 109.442 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.509 ' CD2' ' O ' ' A' ' 19' ' ' LEU . 24.0 m-85 -71.81 -4.26 26.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.164 -0.96 . . . . 0.0 109.599 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.439 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 0.5 OUTLIER -82.21 -55.67 4.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -0.899 . . . . 0.0 109.463 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.407 ' O ' ' C ' ' A' ' 26' ' ' GLU . 1.8 mptt -73.87 -46.11 46.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.278 -0.889 . . . . 0.0 109.474 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.575 ' HB3' ' CD1' ' A' ' 28' ' ' TYR . 4.6 tt0 -44.05 -35.26 2.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.16 -0.963 . . . . 0.0 109.476 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.539 ' C ' ' CD1' ' A' ' 28' ' ' TYR . . . 114.57 55.03 0.39 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.577 ' CE2' ' HG ' ' A' ' 121' ' ' LEU . 32.8 m-85 -143.22 135.03 26.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -1.152 . . . . 0.0 109.475 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -94.42 81.04 3.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.27 -0.894 . . . . 0.0 109.387 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.707 HG22 ' HB ' ' A' ' 6' ' ' ILE . 5.9 p -89.97 154.43 19.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.895 . . . . 0.0 109.556 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.562 ' HB2' HD22 ' A' ' 7' ' ' LEU . 6.8 m-85 -118.05 -171.5 2.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.299 -0.876 . . . . 0.0 109.341 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -130.5 146.94 52.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.897 . . . . 0.0 109.505 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -153.94 -172.56 4.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -0.92 . . . . 0.0 109.472 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.78 -88.01 0.1 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.219 -0.926 . . . . 0.0 109.495 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.539 ' ND2' ' HB2' ' A' ' 37' ' ' LEU . 21.5 p-10 -65.98 139.17 58.21 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.271 -0.893 . . . . 0.0 109.474 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.44 ' HA3' ' CD1' ' A' ' 65' ' ' ILE . . . -43.89 -34.53 2.98 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.539 ' HB2' ' ND2' ' A' ' 35' ' ' ASN . 3.2 mp -51.03 -53.15 36.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.195 -1.179 . . . . 0.0 109.44 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.514 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 2.7 tp60 -60.93 -51.31 69.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.246 -0.908 . . . . 0.0 109.436 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.847 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -43.82 -39.67 3.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.251 -0.905 . . . . 0.0 109.558 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 65.5 mt -71.95 -42.69 66.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.302 -0.873 . . . . 0.0 109.519 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -53.67 -57.81 9.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.255 -0.903 . . . . 0.0 109.491 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.847 HG21 HD23 ' A' ' 7' ' ' LEU . 2.0 mp -62.1 -33.16 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.145 -0.972 . . . . 0.0 109.478 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 39' ' ' ALA . 48.1 t -66.35 -24.02 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -0.858 . . . . 0.0 109.467 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.4 m -90.07 -30.58 17.61 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.262 -0.899 . . . . 0.0 109.533 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.496 ' HG2' ' HA ' ' A' ' 42' ' ' ILE . 0.0 OUTLIER -90.06 -7.86 52.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.313 -0.867 . . . . 0.0 109.54 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.484 ' HG3' ' CD ' ' A' ' 45' ' ' LYS . 14.8 mt-10 -132.48 -36.75 1.09 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.925 . . . . 0.0 109.47 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 43' ' ' VAL . 0.8 OUTLIER 55.84 65.01 4.76 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.276 -0.89 . . . . 0.0 109.444 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.52 ' CB ' ' O ' ' A' ' 5' ' ' LYS . 35.4 Cg_endo -77.91 154.08 29.6 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.683 2.256 . . . . 0.0 110.394 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 3.5 m-20 -92.64 -13.33 29.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.259 -0.9 . . . . 0.0 109.462 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.471 HD21 HG22 ' A' ' 115' ' ' VAL . 1.0 OUTLIER -120.73 116.87 26.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.213 -0.93 . . . . 0.0 109.46 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.677 ' HB ' HG13 ' A' ' 78' ' ' VAL . 43.6 t -122.0 123.31 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 0.0 109.496 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.88 120.86 40.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.254 -0.903 . . . . 0.0 109.44 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.765 HD21 ' HB ' ' A' ' 65' ' ' ILE . 1.3 mp -108.61 122.21 46.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.256 -0.903 . . . . 0.0 109.506 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.431 ' OD2' ' OD1' ' A' ' 10' ' ' ASP . 33.3 t0 -97.26 111.33 23.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.361 -0.837 . . . . 0.0 109.427 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 18.8 mmt -75.03 -0.64 19.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.917 . . . . 0.0 109.576 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.4 mmmt -90.04 15.45 10.08 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.213 -0.93 . . . . 0.0 109.536 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.454 ' HA ' ' OD1' ' A' ' 11' ' ' ASP . 48.3 mt -76.53 132.45 72.43 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.941 . . . . 0.0 109.339 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.463 ' HD2' ' CG ' ' A' ' 11' ' ' ASP . 36.2 Cg_endo -78.93 74.74 5.39 Favored 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.478 2.119 . . . . 0.0 110.4 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -170.73 -63.94 0.04 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.509 ' N ' ' SD ' ' A' ' 60' ' ' MET . 0.1 OUTLIER -153.49 176.3 12.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -1.172 . . . . 0.0 109.566 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -90.08 135.59 33.56 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.197 -0.94 . . . . 0.0 109.487 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.498 ' HA2' HD12 ' A' ' 65' ' ' ILE . . . -72.43 -8.74 71.87 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.443 ' HA ' HD13 ' A' ' 63' ' ' ILE . 18.8 mm -44.02 -50.24 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.23 -1.159 . . . . 0.0 109.43 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.452 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 20.8 mm-40 -63.89 -43.94 94.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.214 -0.929 . . . . 0.0 109.405 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.765 ' HB ' HD21 ' A' ' 53' ' ' LEU . 78.3 mt -46.96 -50.9 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.315 -0.865 . . . . 0.0 109.444 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.821 ' CD2' HG11 ' A' ' 78' ' ' VAL . 61.8 mt -56.0 -53.51 56.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 109.416 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.81 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.1 OUTLIER -44.13 -38.77 3.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.445 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.452 ' HG2' ' O ' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -71.99 -41.03 68.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.32 -0.863 . . . . 0.0 109.495 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.522 ' CE ' HG11 ' A' ' 51' ' ' VAL . 1.2 mtt -58.52 -62.06 2.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.21 -0.931 . . . . 0.0 109.466 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.485 ' HE2' ' O ' ' A' ' 66' ' ' LEU . 0.3 OUTLIER -52.13 -47.9 65.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.496 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' ' 67' ' ' LYS . 53.9 t -48.43 -39.33 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.196 -0.94 . . . . 0.0 109.473 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 98.2 mt -70.38 -48.63 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 109.425 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.701 ' O ' HG22 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -152.97 111.98 3.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.22 -0.925 . . . . 0.0 109.5 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.54 -15.11 35.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.2 -0.938 . . . . 0.0 109.47 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -91.98 41.22 1.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.311 -0.868 . . . . 0.0 109.476 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.701 HG22 ' O ' ' A' ' 73' ' ' ASP . 2.2 tt -118.08 113.01 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.168 -0.958 . . . . 0.0 109.492 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.638 ' HB3' HD11 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -77.04 112.78 14.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.302 -0.874 . . . . 0.0 109.472 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.821 HG11 ' CD2' ' A' ' 66' ' ' LEU . 85.3 t -122.6 113.02 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.906 . . . . 0.0 109.491 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.619 HD13 ' HE2' ' A' ' 102' ' ' PHE . 69.9 mt -89.93 165.73 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.237 -0.915 . . . . 0.0 109.52 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.697 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.1 OUTLIER -128.74 171.58 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.303 -0.873 . . . . 0.0 109.485 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.481 ' N ' ' CD2' ' A' ' 101' ' ' HIS . 22.5 mtm -146.74 107.73 4.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.877 . . . . 0.0 109.419 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.842 ' CG2' HD11 ' A' ' 90' ' ' ILE . 5.2 t -149.92 -161.85 1.43 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.245 -0.909 . . . . 0.0 109.465 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.5 ' N ' HG23 ' A' ' 82' ' ' THR . . . . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.221 -0.924 . . . . 0.0 109.509 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.842 HD11 ' CG2' ' A' ' 82' ' ' THR . 16.8 mt . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.466 ' O ' ' HG2' ' A' ' 94' ' ' LYS . 1.2 tt0 -63.3 -43.53 97.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.249 -0.907 . . . . 0.0 109.488 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.438 ' O ' HD23 ' A' ' 96' ' ' LEU . 3.9 mt-10 -76.19 -36.72 58.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.263 -0.898 . . . . 0.0 109.441 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 92' ' ' GLU . 13.5 t -44.05 -61.91 1.31 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 109.425 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.767 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 0.1 OUTLIER -51.04 -48.6 61.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.296 -0.878 . . . . 0.0 109.537 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -44.1 -42.96 6.6 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.919 . . . . 0.0 109.424 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.541 HD22 ' N ' ' A' ' 96' ' ' LEU . 3.6 mm? -70.74 -54.06 13.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.212 -0.93 . . . . 0.0 109.512 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 177.27 63.65 0.06 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.767 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -146.94 107.64 4.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -1.153 . . . . 0.0 109.424 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.638 HD11 ' HB3' ' A' ' 77' ' ' ARG . 94.6 mt -44.09 -84.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.24 -0.912 . . . . 0.0 109.418 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.423 ' O ' HG23 ' A' ' 79' ' ' ILE . 11.4 t -127.83 178.74 5.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.462 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.708 ' HD1' HG23 ' A' ' 90' ' ' ILE . 4.8 t-160 -130.65 96.76 4.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.262 -0.899 . . . . 0.0 109.573 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.619 ' HE2' HD13 ' A' ' 79' ' ' ILE . 79.7 m-85 -64.92 -166.79 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.255 -0.903 . . . . 0.0 109.319 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 82' ' ' THR . . . -161.14 -166.7 1.62 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.258 -0.901 . . . . 0.0 109.386 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.474 ' CG ' ' HA ' ' A' ' 105' ' ' PRO . 11.8 tttm -139.12 141.43 29.71 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.214 -0.929 . . . . 0.0 109.379 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.474 ' HA ' ' CG ' ' A' ' 104' ' ' LYS . 35.9 Cg_endo -77.95 139.88 58.93 Favored 'Cis proline' 0 C--N 1.311 -1.445 0 C-N-CA 123.415 -1.494 . . . . 0.0 110.417 -0.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.42 ' C ' ' CD1' ' A' ' 106' ' ' PHE . 13.2 p90 -106.42 175.93 5.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.872 . . . . 0.0 109.523 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.469 ' O ' HG12 ' A' ' 111' ' ' ILE . 41.4 t0 -113.29 127.71 56.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.174 -0.954 . . . . 0.0 109.427 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.469 ' HA ' HD13 ' A' ' 108' ' ' ILE . 15.2 mm -55.15 -18.7 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.273 -0.892 . . . . 0.0 109.52 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.421 ' OD2' ' OD2' ' A' ' 107' ' ' ASP . 15.9 m-20 -76.33 -46.98 25.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.19 -0.944 . . . . 0.0 109.402 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.55 -27.08 65.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.261 -0.899 . . . . 0.0 109.427 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.469 HG12 ' O ' ' A' ' 107' ' ' ASP . 15.9 mm -75.01 -52.48 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.223 -0.923 . . . . 0.0 109.493 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -67.36 -20.52 65.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.272 -0.892 . . . . 0.0 109.528 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -76.92 -51.43 11.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 109.553 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.433 ' HB3' ' HZ ' ' A' ' 102' ' ' PHE . . . -63.5 -49.85 71.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.188 -0.945 . . . . 0.0 109.576 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.471 HG22 HD21 ' A' ' 50' ' ' LEU . 54.0 t -57.22 -49.9 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.263 -0.898 . . . . 0.0 109.487 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -27.82 69.0 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.222 -0.924 . . . . 0.0 109.565 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.07 -18.21 40.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 109.438 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -90.03 -70.9 0.64 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.244 -0.91 . . . . 0.0 109.436 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.534 ' CD1' ' HD2' ' A' ' 120' ' ' PRO . 5.5 tp -90.0 139.58 27.43 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.239 -0.913 . . . . 0.0 109.291 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.624 ' O ' HD22 ' A' ' 121' ' ' LEU . 35.3 Cg_endo -78.25 138.67 16.15 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.571 2.181 . . . . 0.0 110.345 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.665 HD21 ' HB3' ' A' ' 4' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.202 -0.936 . . . . 0.0 109.487 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.438 ' O ' ' CB ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -120.23 119.73 34.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.307 -0.87 . . . . 0.0 109.417 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.877 ' HB ' HG22 ' A' ' 30' ' ' THR . 15.0 mt -109.41 168.15 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.263 -0.898 . . . . 0.0 109.501 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.976 ' O ' HD12 ' A' ' 52' ' ' LEU . 0.4 OUTLIER -134.96 142.09 46.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.333 -0.854 . . . . 0.0 109.467 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.908 ' N ' HD13 ' A' ' 7' ' ' LEU . 2.9 mt -133.5 99.28 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.352 -0.843 . . . . 0.0 109.278 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.652 HG12 HD11 ' A' ' 57' ' ' ILE . 2.9 t -89.79 114.18 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.264 -0.898 . . . . 0.0 109.562 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.809 ' O ' ' HB2' ' A' ' 34' ' ' ALA . 0.4 OUTLIER -169.18 174.92 5.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.295 -0.878 . . . . 0.0 109.362 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.462 ' CG ' ' HD2' ' A' ' 58' ' ' PRO . 6.1 p-10 -142.54 -45.76 0.32 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.16 -0.963 . . . . 0.0 109.449 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.435 ' N ' ' CG ' ' A' ' 11' ' ' ASP . 5.5 tp60 -44.0 106.91 0.08 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.304 -0.872 . . . . 0.0 109.493 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 1.05 ' CE1' HD11 ' A' ' 17' ' ' ILE . 38.9 t80 -43.23 124.35 3.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.374 -0.829 . . . . 0.0 109.431 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 141.31 -75.98 0.32 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.439 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 1.7 mt -58.66 -32.42 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -1.169 . . . . 0.0 108.878 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.519 ' NH1' ' O ' ' A' ' 33' ' ' ALA . 9.1 mmm180 -60.34 -33.19 72.05 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.336 -0.852 . . . . 0.0 109.459 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 1.05 HD11 ' CE1' ' A' ' 13' ' ' TYR . 2.6 mt -90.7 -65.59 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.332 -0.855 . . . . 0.0 109.895 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.895 ' O ' HG23 ' A' ' 22' ' ' VAL . 4.3 mt -42.45 -63.0 0.84 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.133 -0.979 . . . . 0.0 110.198 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.828 HD23 HG23 ' A' ' 8' ' ' ILE . 1.8 tp -51.98 -35.14 45.39 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.085 -1.009 . . . . 0.0 109.802 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.505 ' OD1' ' ND2' ' A' ' 24' ' ' ASN . 33.0 t30 -64.89 -70.43 0.23 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.211 -0.931 . . . . 0.0 110.163 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.475 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 1.0 OUTLIER -55.82 -16.49 4.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.143 -0.973 . . . . 0.0 110.152 -179.418 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 18' ' ' LEU . 53.5 t -75.57 -61.13 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.12 -0.987 . . . . 0.0 109.422 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 1.006 ' CZ ' HG21 ' A' ' 115' ' ' VAL . 17.0 m-85 -73.28 -8.51 56.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.272 -0.892 . . . . 0.0 109.407 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.505 ' ND2' ' OD1' ' A' ' 20' ' ' ASN . 1.3 m-80 -83.72 -54.84 4.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.914 . . . . 0.0 109.44 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -66.27 -22.08 66.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.244 -0.91 . . . . 0.0 109.406 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.478 ' OE2' ' HE2' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -78.83 -23.78 44.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.33 -0.856 . . . . 0.0 109.476 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.566 ' O ' ' CG ' ' A' ' 28' ' ' TYR . . . 110.48 64.33 0.52 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.939 ' CE2' HD13 ' A' ' 121' ' ' LEU . 66.4 m-85 -158.88 135.26 9.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.202 -1.176 . . . . 0.0 109.607 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -89.91 85.01 6.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.254 -0.904 . . . . 0.0 108.959 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.908 HG21 ' HB2' ' A' ' 23' ' ' PHE . 5.2 p -89.87 137.8 32.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.276 -0.89 . . . . 0.0 109.895 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.623 ' HB2' HD22 ' A' ' 7' ' ' LEU . 14.5 m-85 -102.01 165.1 11.35 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.391 -0.818 . . . . 0.0 108.889 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 32' ' ' GLN . 0.2 OUTLIER -125.15 134.42 52.43 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.092 -1.005 . . . . 0.0 109.854 -179.757 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.593 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -140.35 -161.01 1.14 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.251 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.809 ' HB2' ' O ' ' A' ' 10' ' ' ASP . . . 171.23 -42.39 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.167 -0.958 . . . . 0.0 109.651 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.433 ' ND2' ' H ' ' A' ' 35' ' ' ASN . 1.9 p30 -74.15 -1.33 19.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.208 -0.932 . . . . 0.0 109.611 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.19 -46.11 3.62 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.15 -28.08 69.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.318 -1.107 . . . . 0.0 109.419 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.916 ' O ' HD12 ' A' ' 42' ' ' ILE . 18.4 mm-40 -82.05 -36.14 28.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.284 -0.885 . . . . 0.0 109.375 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.785 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -64.81 -40.56 95.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.444 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.413 ' O ' ' C ' ' A' ' 41' ' ' ASP . 3.3 mt -78.32 -57.74 3.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.273 -0.892 . . . . 0.0 109.453 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 40' ' ' LEU . 5.9 t70 -44.45 -42.14 6.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.271 -0.893 . . . . 0.0 109.474 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.916 HD12 ' O ' ' A' ' 38' ' ' GLN . 15.3 mt -69.61 -47.0 73.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.279 -0.888 . . . . 0.0 109.357 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.785 HG23 ' O ' ' A' ' 39' ' ' ALA . 73.2 t -55.73 -21.14 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.259 -0.901 . . . . 0.0 109.425 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.6 m -90.16 -33.66 16.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.283 -0.885 . . . . 0.0 109.446 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.49 ' HG2' ' HA ' ' A' ' 42' ' ' ILE . 0.0 OUTLIER -89.94 0.65 56.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 109.714 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.469 ' HG2' ' HD2' ' A' ' 45' ' ' LYS . 11.3 mm-40 -137.75 -38.6 0.58 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.157 -0.964 . . . . 0.0 109.442 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.513 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 2.6 mtt180 59.15 62.13 4.22 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.894 . . . . 0.0 109.519 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.558 ' HD2' HG13 ' A' ' 43' ' ' VAL . 35.4 Cg_endo -77.87 151.89 28.17 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.691 2.261 . . . . 0.0 110.407 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.692 ' C ' HD22 ' A' ' 50' ' ' LEU . 1.2 m-20 -93.31 -11.98 31.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.209 -0.932 . . . . 0.0 109.513 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.692 HD22 ' C ' ' A' ' 49' ' ' ASP . 4.3 mm? -118.8 125.7 50.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.199 -0.938 . . . . 0.0 109.476 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.93 ' HB ' HG22 ' A' ' 78' ' ' VAL . 3.5 t -132.23 119.8 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.233 -0.917 . . . . 0.0 109.563 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.976 HD12 ' O ' ' A' ' 7' ' ' LEU . 1.1 mt -92.51 102.74 15.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.306 -0.871 . . . . 0.0 109.345 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.593 HD22 ' CD2' ' A' ' 66' ' ' LEU . 1.0 OUTLIER -89.91 128.49 36.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.176 -0.952 . . . . 0.0 109.643 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.538 ' HB2' ' HE2' ' A' ' 81' ' ' MET . 30.5 t0 -120.53 108.64 14.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.338 -0.851 . . . . 0.0 109.356 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.853 ' CG ' HG21 ' A' ' 82' ' ' THR . 12.7 mmt -71.78 -3.99 25.22 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.188 -0.945 . . . . 0.0 109.568 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.457 ' HB2' ' OD2' ' A' ' 54' ' ' ASP . 4.3 mttt -75.52 -7.87 55.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 109.625 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.652 HD11 HG12 ' A' ' 9' ' ' VAL . 56.9 mt -57.06 116.52 13.7 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.095 -1.003 . . . . 0.0 109.318 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.462 ' HD2' ' CG ' ' A' ' 11' ' ' ASP . 35.6 Cg_endo -78.21 92.03 1.16 Allowed 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.297 1.998 . . . . 0.0 110.414 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 161.42 -23.5 0.23 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.511 ' SD ' ' CG2' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -170.48 161.19 7.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -1.172 . . . . 0.0 109.594 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -90.25 136.43 33.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.212 -0.93 . . . . 0.0 109.38 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.454 ' HA2' HG13 ' A' ' 65' ' ' ILE . . . -74.79 -8.91 82.72 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 30.6 mm -53.94 -55.22 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -1.149 . . . . 0.0 109.425 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 65' ' ' ILE . 24.9 mm-40 -53.14 -45.0 68.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.237 -0.914 . . . . 0.0 109.466 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.492 ' HB ' HD21 ' A' ' 53' ' ' LEU . 9.4 mt -44.81 -50.52 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.263 -0.898 . . . . 0.0 109.461 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.593 ' CD2' HD22 ' A' ' 53' ' ' LEU . 22.0 mt -54.66 -53.19 58.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.311 -0.868 . . . . 0.0 109.497 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.449 ' O ' HG23 ' A' ' 71' ' ' VAL . 4.7 mttt -43.65 -51.05 7.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.313 -0.867 . . . . 0.0 109.618 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.449 ' O ' HG13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -59.76 -41.2 90.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.162 -0.961 . . . . 0.0 109.486 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.765 ' HE1' HG11 ' A' ' 51' ' ' VAL . 4.6 mtt -60.32 -24.39 64.97 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.239 -0.913 . . . . 0.0 109.442 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 66' ' ' LEU . 1.8 mmpt? -80.03 -44.08 20.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.186 -0.946 . . . . 0.0 109.344 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 67' ' ' LYS . 2.6 t -64.38 -24.47 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.217 -0.927 . . . . 0.0 109.451 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 68' ' ' ARG . 57.9 mt -90.05 -66.42 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.456 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -123.59 139.09 54.36 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.229 -0.919 . . . . 0.0 109.506 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -90.02 -25.05 21.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.274 -0.891 . . . . 0.0 109.455 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 49.2 m-20 -105.77 51.02 0.76 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.199 -0.938 . . . . 0.0 109.498 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.615 HG13 HG23 ' A' ' 78' ' ' VAL . 3.0 tp -98.89 113.82 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.262 -0.899 . . . . 0.0 109.433 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.527 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 3.7 mtt180 -75.91 118.05 18.28 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.197 -0.939 . . . . 0.0 109.459 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.93 HG22 ' HB ' ' A' ' 51' ' ' VAL . 79.1 t -129.77 115.82 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.279 -0.888 . . . . 0.0 109.544 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.48 HG12 HG22 ' A' ' 100' ' ' THR . 70.9 mt -89.87 125.69 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.281 -0.887 . . . . 0.0 109.396 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.967 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.6 OUTLIER -89.82 162.17 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.193 -0.942 . . . . 0.0 109.422 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.538 ' HE2' ' HB2' ' A' ' 54' ' ' ASP . 16.6 mtm -135.43 47.27 2.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.297 -0.877 . . . . 0.0 109.425 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.853 HG21 ' CG ' ' A' ' 55' ' ' MET . 9.9 t -159.71 66.64 0.38 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.31 -0.869 . . . . 0.0 109.469 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.562 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.241 -0.912 . . . . 0.0 109.437 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.594 ' CD1' ' N ' ' A' ' 90' ' ' ILE . 1.2 mp . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -47.65 -44.78 27.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.912 . . . . 0.0 109.411 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.47 ' HG3' ' N ' ' A' ' 93' ' ' SER . 19.3 pt-20 -70.2 -32.63 70.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -0.877 . . . . 0.0 109.429 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.821 ' HB2' HD11 ' A' ' 80' ' ' ILE . 59.6 p -63.38 -30.59 71.69 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.236 -0.915 . . . . 0.0 109.471 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.5 OUTLIER -69.68 -71.84 0.22 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.911 . . . . 0.0 109.524 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.458 ' CG ' ' N ' ' A' ' 96' ' ' LEU . 9.4 pt-20 -43.81 -46.64 7.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.218 -0.926 . . . . 0.0 109.437 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.473 ' HA ' HD23 ' A' ' 96' ' ' LEU . 24.5 mt -51.67 -57.33 9.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.181 -0.949 . . . . 0.0 109.441 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 165.53 44.89 0.02 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.514 ' CB ' ' O ' ' A' ' 93' ' ' SER . . . -113.92 98.6 7.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -1.115 . . . . 0.0 109.457 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.527 ' CD1' ' HB3' ' A' ' 77' ' ' ARG . 23.9 mt -46.63 -46.73 19.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.284 -0.885 . . . . 0.0 109.446 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.48 HG22 HG12 ' A' ' 79' ' ' ILE . 10.7 t -154.44 143.02 20.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.221 -0.924 . . . . 0.0 109.52 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.967 ' ND1' HD12 ' A' ' 80' ' ' ILE . 3.6 t-160 -107.93 87.71 2.56 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.252 -0.905 . . . . 0.0 109.487 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.508 ' O ' ' N ' ' A' ' 82' ' ' THR . 6.0 m-30 -80.55 179.12 7.9 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 0.0 109.57 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.562 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -137.82 -148.68 0.28 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.292 -0.88 . . . . 0.0 109.343 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.525 ' HG3' ' HA ' ' A' ' 105' ' ' PRO . 0.7 OUTLIER -137.85 145.75 49.65 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.291 -0.881 . . . . 0.0 109.452 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.525 ' HA ' ' HG3' ' A' ' 104' ' ' LYS . 35.3 Cg_endo -77.91 -176.69 19.21 Favored 'Cis proline' 0 C--N 1.308 -1.565 0 C-N-CA 123.289 -1.546 . . . . 0.0 110.333 0.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 106' ' ' PHE . 2.8 p90 -146.92 -163.69 1.82 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.281 -0.887 . . . . 0.0 109.494 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -135.46 132.55 37.54 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.273 -0.892 . . . . 0.0 109.503 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.434 ' HA ' HD13 ' A' ' 108' ' ' ILE . 14.4 mm -59.22 -21.59 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -0.926 . . . . 0.0 109.45 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.478 ' O ' ' HG2' ' A' ' 112' ' ' ARG . 34.8 m-20 -73.74 -44.73 55.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.34 -0.85 . . . . 0.0 109.474 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -64.68 -34.87 79.31 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.2 -0.938 . . . . 0.0 109.425 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.496 HG21 HD11 ' A' ' 19' ' ' LEU . 17.7 mm -66.33 -59.59 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.204 -0.935 . . . . 0.0 109.492 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 23.2 ptt180 -53.4 -32.05 47.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 109.529 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.44 ' OD2' ' O ' ' A' ' 109' ' ' ASP . 17.7 m-20 -64.64 -55.79 17.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.332 -0.855 . . . . 0.0 109.5 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.665 ' HB1' ' CE2' ' A' ' 118' ' ' TYR . . . -55.33 -35.68 65.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.208 -0.933 . . . . 0.0 109.474 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 1.006 HG21 ' CZ ' ' A' ' 23' ' ' PHE . 77.9 t -72.08 -28.9 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.282 -0.886 . . . . 0.0 109.434 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.478 ' HE2' ' OE2' ' A' ' 26' ' ' GLU . 5.4 mmtm -72.12 -32.24 66.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.303 -0.873 . . . . 0.0 109.433 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -86.74 -24.44 25.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.926 . . . . 0.0 109.459 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.665 ' CE2' ' HB1' ' A' ' 114' ' ' ALA . 18.6 m-85 -90.13 -66.18 0.95 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.226 -0.921 . . . . 0.0 109.48 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.757 HD12 ' HD2' ' A' ' 120' ' ' PRO . 31.5 tp -90.13 112.47 52.65 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.287 -0.883 . . . . 0.0 109.477 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.757 ' HD2' HD12 ' A' ' 119' ' ' LEU . 35.3 Cg_endo -78.19 148.01 23.9 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.408 2.072 . . . . 0.0 110.314 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.939 HD13 ' CE2' ' A' ' 28' ' ' TYR . 1.2 tp . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.282 -0.886 . . . . 0.0 109.405 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.464 ' N ' ' OE1' ' A' ' 4' ' ' GLU . 1.5 mp0 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.465 ' HB3' ' HB3' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -141.75 131.69 24.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.23 -0.918 . . . . 0.0 109.457 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.628 HD12 ' HB3' ' A' ' 28' ' ' TYR . 91.5 mt -149.97 153.45 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.265 -0.897 . . . . 0.0 109.499 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.803 HD23 HG21 ' A' ' 42' ' ' ILE . 1.8 tm? -130.64 112.0 12.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.238 -0.914 . . . . 0.0 109.447 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.796 HD13 ' HB2' ' A' ' 19' ' ' LEU . 5.0 mt -89.98 106.33 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.278 -0.889 . . . . 0.0 109.545 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.718 HG22 HD12 ' A' ' 7' ' ' LEU . 3.1 t -95.02 113.32 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.219 -0.925 . . . . 0.0 109.5 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.503 ' O ' ' NH1' ' A' ' 16' ' ' ARG . 0.4 OUTLIER -162.93 150.44 13.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 0.0 109.415 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.482 ' OD2' ' HD2' ' A' ' 58' ' ' PRO . 7.4 p-10 -113.37 -37.28 4.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.244 -0.91 . . . . 0.0 109.454 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.405 ' O ' ' C ' ' A' ' 13' ' ' TYR . 20.1 tt0 -70.05 104.57 2.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.24 -0.913 . . . . 0.0 109.484 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.587 ' CZ ' HG13 ' A' ' 17' ' ' ILE . 26.2 t80 -44.13 149.93 0.32 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.294 -0.879 . . . . 0.0 109.496 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.61 -73.78 0.42 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.468 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 36.6 mt -61.21 -23.63 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -1.142 . . . . 0.0 109.365 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.503 ' NH1' ' O ' ' A' ' 10' ' ' ASP . 7.4 mmm-85 -69.75 -30.08 67.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.338 -0.851 . . . . 0.0 109.399 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.587 HG13 ' CZ ' ' A' ' 13' ' ' TYR . 9.2 mm -90.19 -25.18 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.376 -0.828 . . . . 0.0 109.534 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.905 ' O ' HG23 ' A' ' 22' ' ' VAL . 1.3 mp -74.05 -53.21 10.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.209 -0.932 . . . . 0.0 109.567 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.796 ' HB2' HD13 ' A' ' 8' ' ' ILE . 12.3 mt -71.39 -17.11 62.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -0.918 . . . . 0.0 109.535 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 47.9 t30 -79.77 -51.01 9.72 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.207 -0.933 . . . . 0.0 109.498 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -68.07 -40.06 82.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.211 -0.931 . . . . 0.0 109.463 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.905 HG23 ' O ' ' A' ' 18' ' ' LEU . 15.1 t -67.18 -57.5 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.915 . . . . 0.0 109.403 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.73 ' CZ ' HG21 ' A' ' 115' ' ' VAL . 18.7 m-85 -65.46 -17.67 64.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.24 -0.912 . . . . 0.0 109.457 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.459 ' ND2' ' O ' ' A' ' 20' ' ' ASN . 0.7 OUTLIER -68.75 -63.14 1.12 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.427 179.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.58 -10.52 58.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.906 . . . . 0.0 109.402 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.474 ' HB2' ' HA ' ' A' ' 23' ' ' PHE . 1.7 mm-40 -76.34 -31.75 58.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.234 -0.917 . . . . 0.0 109.517 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.416 ' O ' ' HG2' ' A' ' 4' ' ' GLU . . . 107.2 33.38 3.21 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.702 ' HE1' HD22 ' A' ' 119' ' ' LEU . 84.8 m-85 -123.51 139.34 54.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -1.164 . . . . 0.0 109.468 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -91.57 82.34 5.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.279 -0.888 . . . . 0.0 109.473 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.574 HG22 HD12 ' A' ' 6' ' ' ILE . 5.8 p -89.96 152.33 21.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.182 -0.949 . . . . 0.0 109.517 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.574 ' HB2' HD22 ' A' ' 7' ' ' LEU . 16.6 m-85 -119.51 -168.98 1.68 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.203 -0.935 . . . . 0.0 109.473 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -128.99 142.27 50.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.221 -0.925 . . . . 0.0 109.432 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.59 ' CB ' HD11 ' A' ' 7' ' ' LEU . . . -154.95 109.62 3.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.33 -0.856 . . . . 0.0 109.487 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.566 ' O ' HD13 ' A' ' 57' ' ' ILE . . . -69.45 -70.29 0.29 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.199 -0.938 . . . . 0.0 109.454 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -77.56 178.03 7.58 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 0.0 109.514 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.51 ' HA3' HD11 ' A' ' 65' ' ' ILE . . . -83.44 -41.97 8.13 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.418 ' C ' ' O ' ' A' ' 36' ' ' GLY . 0.3 OUTLIER -44.06 -56.53 3.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.192 -1.181 . . . . 0.0 109.453 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.48 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 7.5 tp-100 -57.17 -48.48 78.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 109.372 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.602 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -46.0 -68.21 0.21 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.278 -0.889 . . . . 0.0 109.464 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' A' ' 39' ' ' ALA . 2.2 mt -44.28 -41.06 5.67 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.288 -0.882 . . . . 0.0 109.529 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.64 -54.88 27.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.206 -0.934 . . . . 0.0 109.526 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.803 HG21 HD23 ' A' ' 7' ' ' LEU . 2.0 mp -63.87 -21.32 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.274 -0.891 . . . . 0.0 109.486 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.813 HG13 ' HD2' ' A' ' 48' ' ' PRO . 16.8 t -80.05 -22.11 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -0.903 . . . . 0.0 109.478 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.1 m -90.1 -28.53 18.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.915 . . . . 0.0 109.39 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -89.88 -27.76 19.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 0.0 109.448 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -113.83 -36.91 4.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.265 -0.897 . . . . 0.0 109.382 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 60.3 mtm180 57.54 69.16 1.68 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.896 . . . . 0.0 109.553 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.813 ' HD2' HG13 ' A' ' 43' ' ' VAL . 35.4 Cg_endo -77.91 176.03 10.49 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.685 2.257 . . . . 0.0 110.412 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.628 ' O ' HD22 ' A' ' 50' ' ' LEU . 58.9 m-20 -114.7 -9.93 12.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.225 -0.922 . . . . 0.0 109.489 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.628 HD22 ' O ' ' A' ' 49' ' ' ASP . 3.4 mm? -124.63 112.96 17.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 109.52 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 1.037 HG11 ' CE ' ' A' ' 69' ' ' MET . 24.7 t -114.0 119.2 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.171 -0.956 . . . . 0.0 109.422 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.413 HD13 HG23 ' A' ' 8' ' ' ILE . 1.3 mt -89.99 100.77 13.52 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.884 . . . . 0.0 109.456 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.825 HD21 ' HB ' ' A' ' 65' ' ' ILE . 1.1 mp -91.57 129.06 37.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.896 . . . . 0.0 109.516 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.455 ' OD2' ' OD1' ' A' ' 10' ' ' ASP . 57.0 t0 -117.94 103.59 10.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 109.42 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.676 ' HB2' HG21 ' A' ' 82' ' ' THR . 9.3 mmt -58.65 -15.72 12.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.319 -0.863 . . . . 0.0 109.504 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.447 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.1 OUTLIER -55.72 -35.69 66.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 109.414 179.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.898 HG21 ' CE ' ' A' ' 60' ' ' MET . 46.0 mt -43.13 103.28 0.31 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.342 -0.849 . . . . 0.0 109.507 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.482 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 35.4 Cg_endo -77.77 4.53 5.98 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.421 2.081 . . . . 0.0 110.415 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.94 -43.37 7.2 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.898 ' CE ' HG21 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -153.38 170.95 19.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -1.133 . . . . 0.0 109.452 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -88.97 134.27 34.03 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.215 -0.928 . . . . 0.0 109.474 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.423 ' HA2' HG12 ' A' ' 65' ' ' ILE . . . -81.73 -0.39 89.27 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.5 mm -61.4 -42.14 92.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.288 -1.125 . . . . 0.0 109.456 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -68.74 -18.91 64.31 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.405 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.825 ' HB ' HD21 ' A' ' 53' ' ' LEU . 24.8 mm -69.94 -51.38 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.283 -0.886 . . . . 0.0 109.446 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.477 ' O ' ' HE3' ' A' ' 70' ' ' LYS . 29.8 mt -53.87 -30.65 46.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.291 -0.881 . . . . 0.0 109.441 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.768 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.6 OUTLIER -71.72 -63.25 1.16 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.233 -0.917 . . . . 0.0 109.5 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.468 ' O ' HG12 ' A' ' 72' ' ' ILE . 1.9 mtt85 -52.81 -20.67 3.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.216 -0.927 . . . . 0.0 109.41 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 1.037 ' CE ' HG11 ' A' ' 51' ' ' VAL . 1.3 mmt -75.39 -58.47 3.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.207 -0.933 . . . . 0.0 109.457 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 15.3 ptpt -62.35 -15.51 48.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.238 -0.914 . . . . 0.0 109.425 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.768 HG23 ' O ' ' A' ' 67' ' ' LYS . 44.9 t -83.91 -42.69 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -0.881 . . . . 0.0 109.508 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.468 HG12 ' O ' ' A' ' 68' ' ' ARG . 19.0 mm -72.41 -56.27 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.274 -0.891 . . . . 0.0 109.506 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -129.72 132.55 46.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.204 -0.935 . . . . 0.0 109.493 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.61 15.38 9.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.241 -0.912 . . . . 0.0 109.513 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -129.99 37.05 3.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.322 -0.862 . . . . 0.0 109.44 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.662 HD11 ' CG2' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -112.34 142.32 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.279 -0.888 . . . . 0.0 109.373 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.626 ' CG ' HD11 ' A' ' 99' ' ' LEU . 37.9 mtt85 -103.87 158.55 16.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.291 -0.881 . . . . 0.0 109.436 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.649 HG13 ' HB ' ' A' ' 51' ' ' VAL . 1.8 t -153.12 112.21 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.219 -0.925 . . . . 0.0 109.538 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.482 HG23 ' CG2' ' A' ' 100' ' ' THR . 95.7 mt -92.16 159.64 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.292 -0.88 . . . . 0.0 109.424 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.581 ' HB ' ' CG ' ' A' ' 101' ' ' HIS . 0.4 OUTLIER -114.64 119.11 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.212 -0.93 . . . . 0.0 109.414 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.402 ' O ' ' HB ' ' A' ' 82' ' ' THR . 4.6 mtm -101.0 68.42 1.26 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.191 -0.943 . . . . 0.0 109.515 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.676 HG21 ' HB2' ' A' ' 55' ' ' MET . 6.2 t 179.43 48.56 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.258 -0.901 . . . . 0.0 109.439 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.025 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.261 -0.899 . . . . 0.0 109.512 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.74 HG23 ' HD1' ' A' ' 101' ' ' HIS . 48.0 mt . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.269 0.557 . . . . 0.0 109.529 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -47.6 -39.87 17.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.276 -0.89 . . . . 0.0 109.478 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.925 ' C ' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -78.32 -33.37 49.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.24 -0.912 . . . . 0.0 109.522 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.504 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 0.5 OUTLIER -59.89 -16.18 27.32 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.277 -0.889 . . . . 0.0 109.478 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.06 -76.68 0.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 0.0 109.456 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.43 ' HG3' ' N ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -58.09 -23.99 56.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.919 . . . . 0.0 109.507 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.925 HD12 ' C ' ' A' ' 92' ' ' GLU . 8.4 mt -67.6 -42.66 82.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.303 -0.873 . . . . 0.0 109.453 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 154.51 53.1 0.01 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 93' ' ' SER . . . -138.7 102.76 4.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.303 -1.116 . . . . 0.0 109.466 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.66 HD13 ' CD1' ' A' ' 118' ' ' TYR . 21.0 mt -45.48 -65.52 0.53 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.211 -0.931 . . . . 0.0 109.392 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.745 HG21 ' CE1' ' A' ' 102' ' ' PHE . 11.6 t -140.55 -174.91 4.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.294 -0.879 . . . . 0.0 109.457 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.81 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 3.3 t-160 -140.99 92.4 2.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.348 -0.845 . . . . 0.0 109.39 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.745 ' CE1' HG21 ' A' ' 100' ' ' THR . 60.0 m-85 -77.99 152.66 32.99 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.21 -0.931 . . . . 0.0 109.434 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 1.025 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -140.25 -160.67 1.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.875 . . . . 0.0 109.462 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.475 ' CG ' ' HA ' ' A' ' 105' ' ' PRO . 9.5 tttm -89.37 141.83 29.25 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.231 -0.918 . . . . 0.0 109.31 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.475 ' HA ' ' CG ' ' A' ' 104' ' ' LYS . 36.0 Cg_endo -78.11 -176.51 18.85 Favored 'Cis proline' 0 C--N 1.31 -1.492 0 C-N-CA 123.406 -1.498 . . . . 0.0 110.486 -0.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.69 ' CE2' HD12 ' A' ' 111' ' ' ILE . 0.2 OUTLIER -114.75 106.3 14.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.196 -0.94 . . . . 0.0 109.524 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.478 ' O ' HG12 ' A' ' 111' ' ' ILE . 38.8 t0 -89.94 105.18 17.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -0.896 . . . . 0.0 109.318 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.812 HD12 HG21 ' A' ' 22' ' ' VAL . 13.6 mm -45.84 -25.02 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.195 -0.941 . . . . 0.0 109.61 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.469 ' HB2' ' OD2' ' A' ' 107' ' ' ASP . 79.1 m-20 -72.81 -46.37 53.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.127 -0.983 . . . . 0.0 109.518 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.5 -24.38 63.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.252 -0.905 . . . . 0.0 109.486 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.69 HD12 ' CE2' ' A' ' 106' ' ' PHE . 12.7 mm -75.23 -56.4 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.273 -0.892 . . . . 0.0 109.428 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.464 ' O ' ' HG3' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -60.22 -32.86 71.52 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.296 -0.877 . . . . 0.0 109.497 179.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -64.99 -55.0 21.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.33 -0.856 . . . . 0.0 109.447 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.63 ' HB2' ' HZ ' ' A' ' 102' ' ' PHE . . . -54.84 -42.56 72.12 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.197 -0.939 . . . . 0.0 109.474 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.73 HG21 ' CZ ' ' A' ' 23' ' ' PHE . 55.8 t -66.84 -28.58 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.19 -0.944 . . . . 0.0 109.442 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 0.5 OUTLIER -68.94 -48.94 62.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.272 -0.892 . . . . 0.0 109.457 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.13 -31.92 73.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.922 . . . . 0.0 109.54 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.66 ' CD1' HD13 ' A' ' 99' ' ' LEU . 22.5 m-85 -73.64 -72.98 0.23 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.316 -0.865 . . . . 0.0 109.524 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.702 HD22 ' HE1' ' A' ' 28' ' ' TYR . 5.5 tt -88.08 137.84 31.1 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.26 -0.9 . . . . 0.0 109.251 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.667 ' N ' HD23 ' A' ' 119' ' ' LEU . 35.9 Cg_endo -78.37 145.77 21.52 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.482 2.121 . . . . 0.0 110.427 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.64 ' CD1' ' CZ ' ' A' ' 28' ' ' TYR . 1.6 mt . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.892 . . . . 0.0 109.436 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 48' ' ' PRO . 23.2 mttt -125.81 143.77 50.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 0.0 109.461 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.547 ' HB ' HG22 ' A' ' 30' ' ' THR . 70.0 mt -150.06 162.5 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -0.918 . . . . 0.0 109.464 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.799 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.5 OUTLIER -131.81 122.62 26.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.163 -0.96 . . . . 0.0 109.404 -179.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.799 ' N ' HD13 ' A' ' 7' ' ' LEU . 3.7 mt -100.75 109.06 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.238 -0.914 . . . . 0.0 109.426 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.607 HG12 HD11 ' A' ' 57' ' ' ILE . 2.6 t -103.95 95.87 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.3 -0.875 . . . . 0.0 109.41 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.484 ' O ' ' HD3' ' A' ' 16' ' ' ARG . 1.6 t70 -158.67 85.88 0.84 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 0.0 109.476 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.599 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . 7.3 p-10 -51.25 -41.31 60.29 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.211 -0.931 . . . . 0.0 109.428 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.486 ' NE2' ' CD1' ' A' ' 15' ' ' ILE . 2.5 tt0 -44.11 95.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -0.896 . . . . 0.0 109.465 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 1.056 ' CE1' HD11 ' A' ' 17' ' ' ILE . 47.8 t80 -45.07 120.81 2.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.319 -0.863 . . . . 0.0 109.427 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 144.97 -54.12 0.56 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.671 ' N ' HD12 ' A' ' 15' ' ' ILE . 1.8 mp -72.45 -50.17 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -1.162 . . . . 0.0 109.333 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.521 ' O ' ' CB ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -47.41 -31.59 4.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.229 -0.919 . . . . 0.0 109.5 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 1.056 HD11 ' CE1' ' A' ' 13' ' ' TYR . 1.7 mt -90.27 -29.14 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.222 -0.924 . . . . 0.0 109.497 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.864 HD12 HD11 ' A' ' 108' ' ' ILE . 0.4 OUTLIER -66.41 -62.33 1.52 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.203 -0.936 . . . . 0.0 109.498 -179.868 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.696 ' HB2' HD13 ' A' ' 8' ' ' ILE . 7.5 mt -68.1 -15.55 63.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.919 . . . . 0.0 109.044 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.521 ' CB ' ' O ' ' A' ' 16' ' ' ARG . 0.7 OUTLIER -72.07 -47.88 48.3 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.462 -0.774 . . . . 0.0 109.258 179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.469 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 1.0 OUTLIER -73.27 -49.27 28.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.31 -0.869 . . . . 0.0 109.547 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.671 HG21 HG23 ' A' ' 108' ' ' ILE . 29.2 t -56.17 -47.81 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.272 -0.892 . . . . 0.0 109.542 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.57 ' CE2' ' HB3' ' A' ' 19' ' ' LEU . 19.7 m-85 -79.96 -13.63 59.2 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.186 -0.946 . . . . 0.0 109.559 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.489 ' ND2' ' O ' ' A' ' 20' ' ' ASN . 0.5 OUTLIER -71.71 -47.4 54.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -0.925 . . . . 0.0 109.368 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.5 tptt -85.0 -29.5 24.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -0.921 . . . . 0.0 109.39 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.432 ' HB3' ' CE2' ' A' ' 28' ' ' TYR . 0.2 OUTLIER -55.34 -43.17 74.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.251 -0.906 . . . . 0.0 109.459 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.52 44.14 0.4 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.432 ' CE2' ' HB3' ' A' ' 26' ' ' GLU . 96.6 m-85 -134.47 137.73 44.17 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.249 -1.148 . . . . 0.0 109.48 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -90.03 82.02 6.16 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 109.292 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.547 HG22 ' HB ' ' A' ' 6' ' ' ILE . 5.7 p -89.82 148.89 22.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.246 -0.909 . . . . 0.0 109.577 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.721 ' HB2' HD22 ' A' ' 7' ' ' LEU . 5.8 m-85 -113.34 -171.13 1.82 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.237 -0.914 . . . . 0.0 109.44 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -124.16 150.58 44.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.255 -0.903 . . . . 0.0 109.608 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.658 ' HB3' HD11 ' A' ' 7' ' ' LEU . . . -175.45 174.14 2.36 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.289 -0.882 . . . . 0.0 109.375 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.599 ' HB1' ' HB3' ' A' ' 11' ' ' ASP . . . 178.61 -31.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.298 -0.876 . . . . 0.0 109.555 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.502 ' OD1' ' CB ' ' A' ' 37' ' ' LEU . 8.0 p30 -74.14 -3.2 28.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.18 -0.95 . . . . 0.0 109.606 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.03 -45.08 3.46 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.502 ' CB ' ' OD1' ' A' ' 35' ' ' ASN . 0.2 OUTLIER -57.82 -50.0 74.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.286 -1.126 . . . . 0.0 109.519 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.588 ' O ' HD12 ' A' ' 42' ' ' ILE . 8.3 mt-30 -65.42 -23.97 67.08 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.178 -0.951 . . . . 0.0 109.519 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.599 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -67.59 -52.93 32.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.231 -0.918 . . . . 0.0 109.507 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.677 HD22 ' HB3' ' A' ' 68' ' ' ARG . 16.0 mt -70.79 -58.41 3.65 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.178 -0.952 . . . . 0.0 109.602 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -46.91 -49.23 20.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.292 -0.88 . . . . 0.0 109.628 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.601 HG21 ' CD2' ' A' ' 7' ' ' LEU . 89.3 mt -62.55 -35.15 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.908 . . . . 0.0 109.446 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 39' ' ' ALA . 49.0 t -75.22 -14.72 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.276 -0.89 . . . . 0.0 109.52 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.7 m -90.2 -28.87 18.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.186 -0.946 . . . . 0.0 109.561 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.1 mttm -85.96 -41.51 14.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.224 -0.923 . . . . 0.0 109.687 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.574 ' OE1' ' CZ ' ' A' ' 31' ' ' PHE . 4.8 mt-10 -102.08 -37.88 7.98 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.194 -0.941 . . . . 0.0 109.601 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.474 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 5.7 mtt180 61.31 67.26 1.43 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.279 -0.888 . . . . 0.0 109.499 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.502 ' HD2' HG13 ' A' ' 43' ' ' VAL . 35.4 Cg_endo -77.78 165.67 26.38 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.647 2.231 . . . . 0.0 110.427 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 1.02 ' O ' HD22 ' A' ' 50' ' ' LEU . 8.3 m-20 -107.62 11.08 28.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.337 -0.852 . . . . 0.0 109.548 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.02 HD22 ' O ' ' A' ' 49' ' ' ASP . 1.3 mm? -140.37 128.69 22.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 109.506 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.574 ' HB ' HG22 ' A' ' 78' ' ' VAL . 3.9 t -129.42 151.1 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.25 -0.906 . . . . 0.0 109.509 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.622 HD12 ' O ' ' A' ' 7' ' ' LEU . 1.3 mt -121.14 97.65 5.62 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.197 -0.939 . . . . 0.0 109.364 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.893 HD22 HG11 ' A' ' 78' ' ' VAL . 2.0 mp -89.92 128.45 36.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.316 -0.865 . . . . 0.0 109.647 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.455 ' O ' HG13 ' A' ' 57' ' ' ILE . 44.3 t0 -119.44 115.38 23.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.285 -0.884 . . . . 0.0 109.405 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.923 ' CG ' HG21 ' A' ' 82' ' ' THR . 17.1 mmt -67.72 -8.05 32.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.259 -0.901 . . . . 0.0 109.577 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.44 ' HB2' ' OD2' ' A' ' 54' ' ' ASP . 16.7 mmtp -76.66 1.14 17.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -0.896 . . . . 0.0 109.633 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.607 HD11 HG12 ' A' ' 9' ' ' VAL . 34.0 mt -75.32 118.27 69.47 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.11 -0.994 . . . . 0.0 109.382 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.452 ' HD2' ' CG ' ' A' ' 11' ' ' ASP . 35.7 Cg_endo -77.97 143.34 20.5 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.395 2.063 . . . . 0.0 110.469 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 121.66 -54.44 0.68 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.585 ' HE1' HG21 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -155.56 175.18 14.22 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.183 -1.187 . . . . 0.0 109.509 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -89.9 169.09 11.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.265 -0.897 . . . . 0.0 109.477 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.536 ' HA2' ' CD1' ' A' ' 65' ' ' ILE . . . -97.79 -7.02 56.92 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.4 ' HA ' HD13 ' A' ' 63' ' ' ILE . 31.2 mm -54.28 -64.82 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.155 -1.203 . . . . 0.0 109.495 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 67' ' ' LYS . 1.3 pt-20 -47.92 -35.7 11.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.237 -0.914 . . . . 0.0 109.467 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.536 ' CD1' ' HA2' ' A' ' 62' ' ' GLY . 16.0 mt -53.97 -57.19 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.226 -0.921 . . . . 0.0 109.506 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 1.039 HD21 HG11 ' A' ' 78' ' ' VAL . 31.3 mt -52.51 -26.21 12.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.27 -0.894 . . . . 0.0 109.634 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.886 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -73.76 -37.37 65.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.211 -0.93 . . . . 0.0 109.793 -179.801 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.677 ' HB3' HD22 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -73.15 -50.73 21.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.19 -0.944 . . . . 0.0 109.731 -179.792 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.831 ' SD ' HD23 ' A' ' 66' ' ' LEU . 3.9 ptp -64.43 -35.81 82.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.198 -0.939 . . . . 0.0 109.759 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.51 ' HG3' ' N ' ' A' ' 71' ' ' VAL . 15.1 ptpt -71.4 -34.8 70.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.206 -0.934 . . . . 0.0 109.437 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.886 HG23 ' O ' ' A' ' 67' ' ' LYS . 71.7 t -70.12 -31.02 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.193 -0.942 . . . . 0.0 109.493 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 68' ' ' ARG . 10.4 mt -90.0 -17.85 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.214 -0.929 . . . . 0.0 109.468 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -166.46 122.9 1.27 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.299 -0.876 . . . . 0.0 109.448 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -89.9 -11.51 41.63 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.187 -0.945 . . . . 0.0 109.439 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -92.97 44.49 1.15 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.302 -0.874 . . . . 0.0 109.5 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.552 ' O ' HG23 ' A' ' 76' ' ' ILE . 0.5 OUTLIER -121.89 120.03 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 109.44 -179.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.617 ' CG ' HD11 ' A' ' 99' ' ' LEU . 9.8 mtt180 -84.65 143.3 29.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.346 -0.846 . . . . 0.0 109.518 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 1.039 HG11 HD21 ' A' ' 66' ' ' LEU . 53.5 t -138.2 124.77 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.235 -0.915 . . . . 0.0 109.534 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.788 HG23 HG23 ' A' ' 100' ' ' THR . 70.6 mt -101.74 156.62 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.224 -0.923 . . . . 0.0 109.4 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.585 ' HB ' ' CG ' ' A' ' 101' ' ' HIS . 0.6 OUTLIER -114.94 115.25 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -0.929 . . . . 0.0 109.39 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.498 ' SD ' ' CZ ' ' A' ' 106' ' ' PHE . 4.3 mtm -95.97 58.75 1.92 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.226 -0.921 . . . . 0.0 109.506 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.923 HG21 ' CG ' ' A' ' 55' ' ' MET . 12.5 t -169.04 49.28 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.239 -0.913 . . . . 0.0 109.479 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.781 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.22 -0.925 . . . . 0.0 109.502 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.602 HG23 ' HD1' ' A' ' 101' ' ' HIS . 48.8 mt . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -53.87 -39.57 65.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.34 -0.85 . . . . 0.0 109.494 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.457 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 1.1 tp10 -78.96 -24.78 43.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.295 -0.878 . . . . 0.0 109.432 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.7 m -72.22 -28.34 63.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.298 -0.876 . . . . 0.0 109.474 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.796 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 5.8 mtpp -68.2 -67.42 0.47 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.268 -0.895 . . . . 0.0 109.464 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 94' ' ' LYS . 1.7 pt-20 -44.08 -26.74 0.32 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.355 -0.841 . . . . 0.0 109.554 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 92' ' ' GLU . 65.9 mt -73.82 -52.36 13.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.33 -0.856 . . . . 0.0 109.533 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 169.18 36.1 0.02 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.796 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -104.39 103.35 13.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.247 -1.149 . . . . 0.0 109.437 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.617 HD11 ' CG ' ' A' ' 77' ' ' ARG . 17.0 mt -53.08 -55.42 24.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.237 -0.914 . . . . 0.0 109.472 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.788 HG23 HG23 ' A' ' 79' ' ' ILE . 7.0 t -149.25 177.65 9.46 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.288 -0.883 . . . . 0.0 109.469 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.602 ' HD1' HG23 ' A' ' 90' ' ' ILE . 3.4 t-160 -132.1 90.14 2.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 0.0 109.431 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.747 ' HE1' HG21 ' A' ' 100' ' ' THR . 43.0 m-85 -77.57 160.75 28.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.221 -0.924 . . . . 0.0 109.485 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.781 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -145.44 -148.62 0.25 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.315 -0.865 . . . . 0.0 109.334 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.415 ' HD2' ' HA ' ' A' ' 105' ' ' PRO . 0.2 OUTLIER -104.03 146.65 32.95 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.205 -0.934 . . . . 0.0 109.447 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.415 ' HA ' ' HD2' ' A' ' 104' ' ' LYS . 35.5 Cg_endo -77.85 173.8 55.36 Favored 'Cis proline' 0 C--N 1.31 -1.466 0 C-N-CA 123.229 -1.571 . . . . 0.0 110.365 0.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.688 ' CZ ' HD12 ' A' ' 111' ' ' ILE . 0.3 OUTLIER -102.84 104.58 14.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.317 -0.864 . . . . 0.0 109.531 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.474 ' O ' HG12 ' A' ' 111' ' ' ILE . 63.3 t0 -89.95 109.74 20.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.278 -0.889 . . . . 0.0 109.331 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.864 HD11 HD12 ' A' ' 18' ' ' LEU . 14.8 mm -47.92 -23.65 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 109.55 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.429 ' O ' ' OD2' ' A' ' 113' ' ' ASP . 37.3 m-20 -76.39 -43.37 40.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.212 -0.93 . . . . 0.0 109.516 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.428 ' HB2' ' HB3' ' A' ' 107' ' ' ASP . 1.4 tt0 -69.64 -25.76 64.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.282 -0.886 . . . . 0.0 109.491 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.688 HD12 ' CZ ' ' A' ' 106' ' ' PHE . 13.4 mm -75.35 -57.9 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.211 -0.931 . . . . 0.0 109.493 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.476 ' O ' ' HG3' ' A' ' 116' ' ' LYS . 1.4 ptt85 -61.27 -28.07 68.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.302 -0.874 . . . . 0.0 109.585 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.429 ' OD2' ' O ' ' A' ' 109' ' ' ASP . 53.6 m-20 -68.28 -56.27 9.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.242 -0.911 . . . . 0.0 109.416 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.642 ' HB2' ' HZ ' ' A' ' 102' ' ' PHE . . . -56.34 -53.69 54.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.213 -0.93 . . . . 0.0 109.531 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.1 t -52.68 -39.92 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.232 -0.918 . . . . 0.0 109.502 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.476 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 0.6 OUTLIER -65.22 -33.56 76.29 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.327 -0.858 . . . . 0.0 109.554 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.23 -20.56 51.51 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.22 -0.925 . . . . 0.0 109.487 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.582 ' CG ' HD13 ' A' ' 99' ' ' LEU . 38.2 m-85 -89.68 -71.22 0.62 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.249 -0.907 . . . . 0.0 109.471 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.528 HD12 ' HD2' ' A' ' 120' ' ' PRO . 49.2 tp -90.05 112.49 52.68 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.248 -0.908 . . . . 0.0 109.37 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.528 ' HD2' HD12 ' A' ' 119' ' ' LEU . 35.6 Cg_endo -77.9 132.63 11.93 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.34 2.027 . . . . 0.0 110.424 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.509 ' HA ' HD23 ' A' ' 121' ' ' LEU . 4.1 mt . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.292 -0.88 . . . . 0.0 109.455 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 1.012 ' CG ' HD21 ' A' ' 119' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.49 ' HB3' ' HB3' ' A' ' 48' ' ' PRO . 3.9 mtpt -94.52 139.16 31.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.22 -0.925 . . . . 0.0 109.466 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.859 HG23 ' HB3' ' A' ' 50' ' ' LEU . 84.4 mt -150.07 153.73 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.252 -0.905 . . . . 0.0 109.498 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.738 HD12 ' HB2' ' A' ' 31' ' ' PHE . 0.6 OUTLIER -136.48 150.5 48.72 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.283 -0.885 . . . . 0.0 109.438 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.75 HD13 ' HB3' ' A' ' 19' ' ' LEU . 7.8 mt -129.43 122.05 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -0.892 . . . . 0.0 109.407 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 3.3 t -106.42 122.21 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.253 -0.904 . . . . 0.0 109.58 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.452 ' OD2' HD13 ' A' ' 15' ' ' ILE . 0.4 OUTLIER -145.86 -151.71 0.39 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.246 -0.909 . . . . 0.0 109.408 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.458 ' CG ' ' HD2' ' A' ' 58' ' ' PRO . 6.3 p-10 -161.65 -46.69 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.267 -0.895 . . . . 0.0 109.449 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.4 tp60 -82.71 116.6 22.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.316 -0.865 . . . . 0.0 109.486 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.594 ' CZ ' HG13 ' A' ' 17' ' ' ILE . 8.5 t80 -43.91 143.33 1.11 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.243 -0.91 . . . . 0.0 109.434 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.476 ' N ' ' CD1' ' A' ' 13' ' ' TYR . . . 126.96 -46.48 1.08 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.938 HG23 HD13 ' A' ' 19' ' ' LEU . 2.2 mt -84.69 -45.86 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.293 -1.122 . . . . 0.0 109.35 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 1.116 ' NH2' ' HB2' ' A' ' 34' ' ' ALA . 1.5 mtp180 -58.25 -29.44 65.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.308 -0.87 . . . . 0.0 109.395 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.594 HG13 ' CZ ' ' A' ' 13' ' ' TYR . 3.1 mm -90.47 -59.56 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -0.894 . . . . 0.0 109.657 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.763 ' O ' HG23 ' A' ' 22' ' ' VAL . 87.0 mt -46.74 -58.48 3.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.91 . . . . 0.0 109.806 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.938 HD13 HG23 ' A' ' 15' ' ' ILE . 6.3 mp -55.02 -32.49 61.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.188 -0.945 . . . . 0.0 109.689 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.508 ' OD1' ' ND2' ' A' ' 24' ' ' ASN . 17.6 t30 -65.69 -70.82 0.22 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.913 . . . . 0.0 109.723 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.486 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 0.1 OUTLIER -43.28 -40.24 3.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.185 -0.947 . . . . 0.0 109.745 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.763 HG23 ' O ' ' A' ' 18' ' ' LEU . 59.8 t -57.58 -58.41 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.913 . . . . 0.0 109.51 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.781 ' CB ' HG21 ' A' ' 30' ' ' THR . 38.0 m-85 -76.18 0.67 18.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.165 -0.959 . . . . 0.0 109.633 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.508 ' ND2' ' OD1' ' A' ' 20' ' ' ASN . 0.4 OUTLIER -89.01 -38.88 14.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.078 -1.014 . . . . 0.0 109.535 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.8 tptt -85.55 -44.13 12.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 109.42 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.465 ' HB3' ' CD2' ' A' ' 28' ' ' TYR . 0.4 OUTLIER -55.07 -21.4 12.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.179 -0.95 . . . . 0.0 109.391 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.473 ' O ' ' CG ' ' A' ' 28' ' ' TYR . . . 101.38 72.26 0.96 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.889 ' CE1' HD13 ' A' ' 121' ' ' LEU . 97.9 m-85 -156.66 134.29 10.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.293 -1.122 . . . . 0.0 109.58 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -90.96 82.81 5.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.342 -0.849 . . . . 0.0 109.182 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.781 HG21 ' CB ' ' A' ' 23' ' ' PHE . 7.4 p -89.9 173.22 8.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -0.897 . . . . 0.0 109.657 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.738 ' HB2' HD12 ' A' ' 7' ' ' LEU . 11.7 m-85 -130.21 170.06 14.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.317 -0.864 . . . . 0.0 109.394 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.435 ' HG2' ' O ' ' A' ' 32' ' ' GLN . 0.5 OUTLIER -131.41 135.82 47.5 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.2 -0.938 . . . . 0.0 109.682 -179.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.754 ' HB1' ' NE2' ' A' ' 38' ' ' GLN . . . -155.91 130.56 9.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.393 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 1.116 ' HB2' ' NH2' ' A' ' 16' ' ' ARG . . . -82.32 -70.71 0.53 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.156 -0.965 . . . . 0.0 109.483 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.478 ' OD1' ' HB3' ' A' ' 38' ' ' GLN . 18.8 p-10 -60.54 170.94 1.23 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.223 -0.923 . . . . 0.0 109.577 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.715 ' O ' HD12 ' A' ' 40' ' ' LEU . . . -97.84 -17.73 29.53 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.9 tt -73.99 -43.59 57.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.314 -1.109 . . . . 0.0 109.401 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.754 ' NE2' ' HB1' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -77.59 -35.04 53.35 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.19 -0.944 . . . . 0.0 108.893 179.77 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.464 ' HB1' HG22 ' A' ' 9' ' ' VAL . . . -62.57 -46.34 88.79 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.278 -0.889 . . . . 0.0 108.626 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.771 HD11 HG23 ' A' ' 65' ' ' ILE . 7.2 mt -61.54 -45.36 94.51 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -49.68 -43.76 47.5 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.203 -0.936 . . . . 0.0 108.856 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.631 HG21 ' CD1' ' A' ' 7' ' ' LEU . 64.0 mt -64.57 -36.23 76.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.336 -0.853 . . . . 0.0 108.881 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 69.0 t -74.5 -11.87 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.251 -0.905 . . . . 0.0 109.188 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 82.9 m -90.38 -31.5 16.84 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.201 -0.937 . . . . 0.0 109.412 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.22 -53.2 4.67 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.32 -0.862 . . . . 0.0 109.867 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.571 ' O ' ' C ' ' A' ' 47' ' ' ARG . 0.4 OUTLIER -97.17 26.93 4.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.183 -0.948 . . . . 0.0 109.627 -179.667 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.571 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -9.69 78.55 0.03 OUTLIER Pre-proline 0 N--CA 1.504 2.266 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.534 ' N ' ' O ' ' A' ' 46' ' ' GLU . 34.3 Cg_endo -75.88 162.66 34.56 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.684 2.256 . . . . 0.0 110.284 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 4.6 m-20 -92.49 -14.12 28.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 109.657 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.859 ' HB3' HG23 ' A' ' 6' ' ' ILE . 4.5 tp -114.16 126.33 54.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.215 -0.928 . . . . 0.0 109.554 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.755 HG11 ' CE ' ' A' ' 69' ' ' MET . 6.0 t -136.83 123.83 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.284 -0.885 . . . . 0.0 109.378 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.738 HD12 ' O ' ' A' ' 7' ' ' LEU . 1.1 mt -103.11 134.78 45.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.212 -0.93 . . . . 0.0 109.584 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.577 HD21 ' HB ' ' A' ' 65' ' ' ILE . 1.4 mp -124.4 135.13 53.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.264 -0.898 . . . . 0.0 109.466 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.461 ' O ' HG13 ' A' ' 57' ' ' ILE . 31.1 t0 -123.61 103.96 8.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.215 -0.928 . . . . 0.0 109.484 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.77 ' HB2' HG21 ' A' ' 82' ' ' THR . 19.2 mmt -62.69 -19.06 63.5 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.17 -0.957 . . . . 0.0 109.463 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.44 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 1.1 mmmp? -54.89 -25.19 27.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 0.0 109.45 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 54' ' ' ASP . 9.8 mt -43.06 103.21 0.3 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.27 -0.893 . . . . 0.0 109.501 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.458 ' HD2' ' CG ' ' A' ' 11' ' ' ASP . 35.2 Cg_endo -77.52 97.73 1.16 Allowed 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.437 2.092 . . . . 0.0 110.464 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 155.62 -20.43 0.53 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.408 ' SD ' ' O ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -166.59 150.93 7.43 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.278 -1.131 . . . . 0.0 109.475 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.408 ' O ' ' SD ' ' A' ' 60' ' ' MET . 1.1 m-20 -85.04 144.0 28.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.186 -0.946 . . . . 0.0 109.57 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -96.56 12.48 66.22 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.2 mm -69.36 -39.43 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.245 -1.15 . . . . 0.0 109.451 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -68.11 -34.65 76.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.262 -0.899 . . . . 0.0 109.494 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.771 HG23 HD11 ' A' ' 40' ' ' LEU . 9.3 mt -54.14 -63.95 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.923 . . . . 0.0 109.492 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.538 HD21 HG11 ' A' ' 78' ' ' VAL . 21.0 mt -46.63 -49.97 18.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.203 -0.936 . . . . 0.0 109.429 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.432 ' O ' HG23 ' A' ' 71' ' ' VAL . 2.5 ttmm -44.09 -50.51 8.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.182 -0.949 . . . . 0.0 109.508 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.432 ' O ' HG13 ' A' ' 72' ' ' ILE . 2.4 mpt_? -60.62 -39.25 87.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.926 . . . . 0.0 109.457 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.755 ' CE ' HG11 ' A' ' 51' ' ' VAL . 0.7 OUTLIER -61.79 -23.74 66.41 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -0.894 . . . . 0.0 109.438 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.534 ' CE ' ' HB3' ' A' ' 96' ' ' LEU . 21.8 mmtm -81.15 -45.29 16.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.3 -0.875 . . . . 0.0 109.473 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 67' ' ' LYS . 2.6 t -65.1 -22.64 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.278 -0.889 . . . . 0.0 109.473 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 68' ' ' ARG . 78.8 mt -88.71 -41.89 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.258 -0.901 . . . . 0.0 109.415 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.82 130.95 11.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.19 -0.944 . . . . 0.0 109.469 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -90.02 -12.55 38.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.2 -0.937 . . . . 0.0 109.465 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.405 ' OD1' ' N ' ' A' ' 75' ' ' ASN . 1.8 m120 -116.58 55.5 0.82 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.409 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.0 tp -110.93 145.78 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.328 -0.858 . . . . 0.0 109.411 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.859 ' CB ' HD11 ' A' ' 99' ' ' LEU . 2.3 mtm180 -89.19 115.02 26.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.195 -0.941 . . . . 0.0 109.483 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.538 HG11 HD21 ' A' ' 66' ' ' LEU . 16.9 t -131.1 115.83 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.221 -0.925 . . . . 0.0 109.531 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.826 HG12 HG22 ' A' ' 100' ' ' THR . 43.9 mt -100.38 132.59 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.309 -0.87 . . . . 0.0 109.445 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.921 HD12 ' ND1' ' A' ' 101' ' ' HIS . 1.0 OUTLIER -89.88 172.97 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.177 -0.952 . . . . 0.0 109.364 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.467 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 13.7 mtm -147.46 52.18 1.06 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.161 -0.962 . . . . 0.0 109.565 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.77 HG21 ' HB2' ' A' ' 55' ' ' MET . 14.7 t -162.68 40.66 0.11 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.185 -0.947 . . . . 0.0 109.519 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.035 ' HB2' ' CD2' ' A' ' 101' ' ' HIS . . . . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.278 -0.889 . . . . 0.0 109.483 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.658 HG23 ' HD1' ' A' ' 101' ' ' HIS . 57.9 mt . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.449 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 1.1 tp60 -44.32 -62.95 0.99 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -0.897 . . . . 0.0 109.452 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.464 ' O ' HD23 ' A' ' 96' ' ' LEU . 0.3 OUTLIER -60.84 -38.62 86.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.916 . . . . 0.0 109.512 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.524 ' HB3' ' HB2' ' A' ' 98' ' ' ALA . 0.6 OUTLIER -44.0 -26.67 0.3 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.209 -0.932 . . . . 0.0 109.429 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 91' ' ' GLN . 0.0 OUTLIER -53.08 -62.12 1.86 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.175 -0.953 . . . . 0.0 109.457 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.474 ' HG3' ' CD2' ' A' ' 96' ' ' LEU . 1.2 pt-20 -63.19 -35.02 78.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.187 -0.946 . . . . 0.0 109.509 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.538 HD22 ' N ' ' A' ' 96' ' ' LEU . 3.7 mm? -61.33 -24.84 66.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.221 -0.924 . . . . 0.0 109.511 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 130.13 42.33 0.22 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.524 ' HB2' ' HB3' ' A' ' 93' ' ' SER . . . -113.44 110.65 20.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -1.149 . . . . 0.0 109.466 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.859 HD11 ' CB ' ' A' ' 77' ' ' ARG . 3.6 mt -73.25 -72.25 0.27 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.186 -0.946 . . . . 0.0 109.577 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.826 HG22 HG12 ' A' ' 79' ' ' ILE . 12.7 t -130.46 147.51 52.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.225 -0.922 . . . . 0.0 109.495 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 1.035 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 3.6 t-160 -111.21 89.54 3.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.295 -0.878 . . . . 0.0 109.339 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.664 ' CD2' HD13 ' A' ' 111' ' ' ILE . 35.5 m-85 -68.96 153.34 43.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.226 -0.921 . . . . 0.0 109.531 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.564 ' HB2' ' CA ' ' A' ' 83' ' ' ALA . . . -139.52 151.97 46.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.239 -0.913 . . . . 0.0 109.472 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.489 ' CG ' ' HA ' ' A' ' 105' ' ' PRO . 36.1 tttm -85.3 141.63 37.21 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 0.0 109.353 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.489 ' HA ' ' CG ' ' A' ' 104' ' ' LYS . 35.8 Cg_endo -77.96 137.39 46.59 Favored 'Cis proline' 0 C--N 1.31 -1.456 0 C-N-CA 123.39 -1.504 . . . . 0.0 110.367 0.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -114.54 -170.01 1.65 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.238 -0.914 . . . . 0.0 109.489 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -130.05 121.08 25.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.0 109.413 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.446 ' HA ' HD13 ' A' ' 108' ' ' ILE . 20.5 mm -50.11 -30.44 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.207 -0.933 . . . . 0.0 109.52 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.41 ' O ' ' HG2' ' A' ' 112' ' ' ARG . 33.4 m-20 -66.6 -42.4 86.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.216 -0.928 . . . . 0.0 109.433 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.429 ' HB3' ' CE1' ' A' ' 102' ' ' PHE . 4.0 mt-10 -65.69 -35.18 80.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.289 -0.882 . . . . 0.0 109.467 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.664 HD13 ' CD2' ' A' ' 102' ' ' PHE . 22.1 mm -64.9 -60.36 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.295 -0.878 . . . . 0.0 109.496 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 1.1 ptm180 -56.81 -30.38 63.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 0.0 109.482 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -62.99 -54.92 30.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -0.895 . . . . 0.0 109.477 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.562 ' O ' ' CD2' ' A' ' 118' ' ' TYR . . . -60.01 -32.84 71.25 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.163 -0.96 . . . . 0.0 109.474 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.804 HG22 HD21 ' A' ' 50' ' ' LEU . 58.2 t -67.42 -35.0 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.23 -0.919 . . . . 0.0 109.473 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.422 ' HE2' ' OE2' ' A' ' 26' ' ' GLU . 1.9 mttt -75.48 -30.05 59.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.279 -0.888 . . . . 0.0 109.499 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.68 -34.08 62.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.219 -0.926 . . . . 0.0 109.46 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.562 ' CD2' ' O ' ' A' ' 114' ' ' ALA . 46.6 m-85 -89.92 -65.59 1.0 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.294 -0.879 . . . . 0.0 109.466 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 1.012 HD21 ' CG ' ' A' ' 4' ' ' GLU . 2.8 tt -90.01 112.42 52.24 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.285 -0.884 . . . . 0.0 109.475 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 118' ' ' TYR . 35.7 Cg_endo -78.06 164.06 27.56 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.362 2.042 . . . . 0.0 110.396 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.889 HD13 ' CE1' ' A' ' 28' ' ' TYR . 1.3 tp . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.301 -0.875 . . . . 0.0 109.48 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.615 ' CD ' HD23 ' A' ' 121' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.49 ' CG ' ' HA ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -114.12 132.57 56.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.246 -0.909 . . . . 0.0 109.447 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.676 HG23 ' HB3' ' A' ' 50' ' ' LEU . 52.5 mt -145.35 164.7 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.237 -0.915 . . . . 0.0 109.509 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.926 HD13 ' N ' ' A' ' 8' ' ' ILE . 1.0 OUTLIER -131.08 128.55 40.44 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.241 -0.912 . . . . 0.0 109.451 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.926 ' N ' HD13 ' A' ' 7' ' ' LEU . 12.1 mt -115.46 108.44 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.186 -0.946 . . . . 0.0 109.464 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.83 ' HA ' ' HB3' ' A' ' 33' ' ' ALA . 17.5 t -92.44 128.63 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.919 . . . . 0.0 109.529 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.533 ' OD2' HD13 ' A' ' 15' ' ' ILE . 2.1 t70 -174.94 123.43 0.24 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 109.44 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.982 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . 2.6 p30 -114.68 81.43 1.56 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.318 -0.864 . . . . 0.0 109.601 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.5 ' HG2' ' N ' ' A' ' 13' ' ' TYR . 7.5 tt0 -175.99 -104.51 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.207 -0.933 . . . . 0.0 109.411 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.5 ' N ' ' HG2' ' A' ' 12' ' ' GLN . 37.4 t80 -179.54 120.47 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.85 -1.156 . . . . 0.0 109.543 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.485 ' O ' HD13 ' A' ' 18' ' ' LEU . . . 135.73 -50.44 0.85 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.634 HG23 HD13 ' A' ' 19' ' ' LEU . 2.0 mp -81.28 -54.44 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.179 -1.189 . . . . 0.0 109.658 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.519 ' CD ' ' O ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -50.33 -29.75 10.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.165 -0.959 . . . . 0.0 109.757 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.59 ' N ' HD13 ' A' ' 17' ' ' ILE . 2.6 mm -90.2 -64.76 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.183 -0.948 . . . . 0.0 109.887 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.945 ' O ' HG23 ' A' ' 22' ' ' VAL . 6.9 mp -48.55 -60.46 2.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.229 -0.92 . . . . 0.0 109.801 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.739 ' HB3' HD13 ' A' ' 8' ' ' ILE . 0.5 OUTLIER -53.87 -28.85 38.63 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 0.0 109.64 -179.773 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.504 ' OD1' ' ND2' ' A' ' 24' ' ' ASN . 28.4 t30 -69.2 -71.88 0.21 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.903 . . . . 0.0 109.665 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.478 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 2.5 tt0 -43.06 -38.04 2.19 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.317 -0.864 . . . . 0.0 109.71 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.945 HG23 ' O ' ' A' ' 18' ' ' LEU . 19.0 t -61.77 -55.63 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.243 -0.911 . . . . 0.0 109.553 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.646 ' CB ' HG21 ' A' ' 30' ' ' THR . 23.6 m-85 -77.7 1.94 18.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 109.566 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.504 ' ND2' ' OD1' ' A' ' 20' ' ' ASN . 0.6 OUTLIER -90.06 -48.96 6.86 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.189 -0.944 . . . . 0.0 109.474 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.26 -46.13 24.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 109.544 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.505 ' HB3' ' CD1' ' A' ' 28' ' ' TYR . 1.8 tt0 -52.07 -22.65 4.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.2 -0.937 . . . . 0.0 109.469 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.436 ' C ' ' CD1' ' A' ' 28' ' ' TYR . . . 100.09 72.78 1.02 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.59 ' CE2' ' HG ' ' A' ' 121' ' ' LEU . 96.2 m-85 -154.55 134.62 13.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -1.17 . . . . 0.0 109.473 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.448 ' HB2' ' O ' ' A' ' 4' ' ' GLU . 12.4 mm100 -94.16 83.08 4.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 109.217 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.646 HG21 ' CB ' ' A' ' 23' ' ' PHE . 5.7 p -89.95 154.71 19.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.895 . . . . 0.0 109.604 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.796 ' HB2' HD22 ' A' ' 7' ' ' LEU . 38.6 m-85 -113.53 -171.25 1.85 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.274 -0.891 . . . . 0.0 109.283 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.426 ' OE1' ' HG2' ' A' ' 16' ' ' ARG . 11.8 mt-30 -124.44 154.78 39.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 109.552 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.83 ' HB3' ' HA ' ' A' ' 9' ' ' VAL . . . -152.62 -165.37 2.18 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.297 -0.877 . . . . 0.0 109.392 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.982 ' HB1' ' HB3' ' A' ' 11' ' ' ASP . . . 164.34 -62.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.905 . . . . 0.0 109.597 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.43 ' H ' ' ND2' ' A' ' 35' ' ' ASN . 3.9 p30 -71.15 -4.64 26.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.185 -0.947 . . . . 0.0 109.577 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 37' ' ' LEU . . . 86.29 -63.28 4.2 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.46 ' HA ' HD13 ' A' ' 37' ' ' LEU . 1.0 OUTLIER -44.54 -32.28 1.38 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.207 -1.172 . . . . 0.0 109.405 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.521 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 1.4 tp60 -70.22 -60.32 2.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.498 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.837 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -44.02 -45.22 7.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.224 -0.923 . . . . 0.0 109.482 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.7 mt -61.55 -44.06 97.72 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -0.871 . . . . 0.0 109.45 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -55.64 -57.57 11.42 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.287 -0.883 . . . . 0.0 109.488 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.419 ' CG2' HD23 ' A' ' 7' ' ' LEU . 2.5 mp -61.4 -20.83 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.285 -0.884 . . . . 0.0 109.482 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.837 HG23 ' O ' ' A' ' 39' ' ' ALA . 53.5 t -79.63 -26.65 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 109.495 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 85.5 m -89.99 -24.21 21.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -0.901 . . . . 0.0 109.448 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.8 mtpt -89.97 -27.32 19.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.225 -0.922 . . . . 0.0 109.554 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -119.3 -34.37 3.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.206 -0.934 . . . . 0.0 109.506 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 33.2 mtm180 58.18 71.07 1.09 Allowed Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.173 -0.954 . . . . 0.0 109.476 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.526 ' CD ' ' HA ' ' A' ' 43' ' ' VAL . 35.3 Cg_endo -78.07 157.69 30.43 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.599 2.199 . . . . 0.0 110.328 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 0.4 OUTLIER -94.08 -9.61 36.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.194 -0.941 . . . . 0.0 109.512 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.676 ' HB3' HG23 ' A' ' 6' ' ' ILE . 6.5 tp -123.29 114.81 20.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.906 . . . . 0.0 109.504 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.851 HG11 ' SD ' ' A' ' 69' ' ' MET . 1.7 t -121.21 111.41 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.263 -0.898 . . . . 0.0 109.443 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.546 HD12 ' O ' ' A' ' 7' ' ' LEU . 0.7 OUTLIER -89.97 109.62 20.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.291 -0.881 . . . . 0.0 109.406 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.721 HD22 ' N ' ' A' ' 53' ' ' LEU . 3.0 mm? -95.28 136.15 35.98 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.201 -0.937 . . . . 0.0 109.489 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.45 ' O ' HG13 ' A' ' 57' ' ' ILE . 30.2 t0 -113.9 117.7 32.12 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.31 -0.869 . . . . 0.0 109.446 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.918 ' CG ' HG21 ' A' ' 82' ' ' THR . 18.0 mmt -77.58 -7.99 57.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.175 -0.953 . . . . 0.0 109.489 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 57' ' ' ILE . 4.6 mtpm? -68.7 -15.56 63.56 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.308 -0.87 . . . . 0.0 109.527 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.878 HG23 ' OD2' ' A' ' 11' ' ' ASP . 80.5 mt -43.87 113.78 1.63 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.256 -0.902 . . . . 0.0 109.37 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.453 ' HD2' ' CG ' ' A' ' 11' ' ' ASP . 36.0 Cg_endo -78.67 6.0 5.19 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.337 2.025 . . . . 0.0 110.509 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.659 ' H ' HG22 ' A' ' 57' ' ' ILE . . . -91.97 -43.97 4.28 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.528 ' CE ' HG21 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -169.58 -171.66 1.27 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.291 -1.123 . . . . 0.0 109.447 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -89.56 132.72 34.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.902 . . . . 0.0 109.431 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.36 10.89 60.07 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 25.5 mm -61.84 -38.44 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.197 -1.178 . . . . 0.0 109.487 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -68.7 -25.63 64.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.279 -0.888 . . . . 0.0 109.506 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.409 HG22 ' HE3' ' A' ' 69' ' ' MET . 70.9 mt -68.1 -64.92 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.184 -0.947 . . . . 0.0 109.505 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.966 HD21 HG11 ' A' ' 78' ' ' VAL . 2.4 mt -44.15 -34.45 1.84 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 0.0 109.531 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.518 ' O ' ' CG ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -64.02 -59.33 4.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -0.91 . . . . 0.0 109.465 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.0 mtt180 -49.57 -30.46 8.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.345 -0.847 . . . . 0.0 109.473 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.851 ' SD ' HG11 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -67.01 -60.73 2.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.874 . . . . 0.0 109.466 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.518 ' CG ' ' O ' ' A' ' 67' ' ' LYS . 16.4 ptpt -51.39 -31.43 22.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.186 -0.946 . . . . 0.0 109.455 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 49.9 t -66.57 -44.99 89.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.19 -0.944 . . . . 0.0 109.493 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.2 mt -70.23 -65.11 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.218 -0.926 . . . . 0.0 109.535 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -113.7 130.84 56.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.227 -0.921 . . . . 0.0 109.429 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -87.11 -22.4 25.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.952 . . . . 0.0 109.411 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.2 p30 -105.55 45.26 0.98 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -0.886 . . . . 0.0 109.438 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.467 HD12 ' O ' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -104.15 128.08 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.283 -0.886 . . . . 0.0 109.452 179.964 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.531 ' CA ' HD11 ' A' ' 99' ' ' LEU . 3.4 mpt_? -78.11 143.13 37.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.259 -0.901 . . . . 0.0 109.48 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.966 HG11 HD21 ' A' ' 66' ' ' LEU . 55.5 t -144.57 144.94 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.326 -0.859 . . . . 0.0 109.568 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.865 HG23 ' O ' ' A' ' 100' ' ' THR . 18.3 mt -128.95 139.02 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.292 -0.88 . . . . 0.0 109.393 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.904 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.3 OUTLIER -102.6 130.64 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.161 -0.962 . . . . 0.0 109.337 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.46 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -102.69 51.99 0.8 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.29 -0.881 . . . . 0.0 109.532 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.918 HG21 ' CG ' ' A' ' 55' ' ' MET . 10.6 t -161.7 44.05 0.16 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.945 . . . . 0.0 109.565 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.901 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.935 . . . . 0.0 109.412 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.933 HD12 ' CE1' ' A' ' 101' ' ' HIS . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.818 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.414 ' C ' ' O ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -45.02 -38.82 5.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.169 -0.957 . . . . 0.0 109.528 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -88.07 -40.8 13.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.203 -0.936 . . . . 0.0 109.541 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.834 ' HA ' HD12 ' A' ' 96' ' ' LEU . 2.9 m -53.05 -20.14 3.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 0.0 109.5 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.788 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 6.0 tttt -58.23 -53.8 54.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.186 -0.946 . . . . 0.0 109.477 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -76.78 -10.2 59.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.911 . . . . 0.0 109.481 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.834 HD12 ' HA ' ' A' ' 93' ' ' SER . 66.9 mt -75.4 -46.68 31.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.269 -0.895 . . . . 0.0 109.494 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 178.1 33.23 0.05 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.788 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -118.94 123.05 43.67 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.26 -1.141 . . . . 0.0 109.505 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.531 HD11 ' CA ' ' A' ' 77' ' ' ARG . 0.4 OUTLIER -90.08 -60.04 2.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 109.475 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.865 ' O ' HG23 ' A' ' 79' ' ' ILE . 21.2 m -117.79 138.13 52.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.213 -0.929 . . . . 0.0 109.582 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.933 ' CE1' HD12 ' A' ' 90' ' ' ILE . 3.9 t-160 -119.48 84.41 2.2 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.853 . . . . 0.0 109.254 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.849 ' CE2' HD13 ' A' ' 111' ' ' ILE . 22.5 m-85 -72.89 158.27 35.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.0 109.575 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.901 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -127.25 -148.73 0.39 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.241 -0.912 . . . . 0.0 109.368 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.0 tttm -128.17 131.89 24.04 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.258 -0.901 . . . . 0.0 109.369 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.75 -162.4 2.95 Favored 'Cis proline' 0 C--N 1.311 -1.423 0 C-N-CA 123.51 -1.454 . . . . 0.0 110.355 -0.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 106' ' ' PHE . 3.0 p90 -153.95 165.1 37.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.921 . . . . 0.0 109.477 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.473 ' O ' HG12 ' A' ' 111' ' ' ILE . 19.6 t0 -108.17 128.94 55.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.274 -0.891 . . . . 0.0 109.45 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.506 ' HA ' HD13 ' A' ' 108' ' ' ILE . 14.6 mm -61.53 -18.11 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.267 -0.896 . . . . 0.0 109.474 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 113' ' ' ASP . 33.1 m-20 -78.06 -37.72 46.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.162 -0.961 . . . . 0.0 109.435 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.419 ' HG2' ' CZ ' ' A' ' 102' ' ' PHE . 1.4 tt0 -72.53 -24.37 61.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.252 -0.905 . . . . 0.0 109.435 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.849 HD13 ' CE2' ' A' ' 102' ' ' PHE . 12.8 mm -79.58 -52.62 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -0.893 . . . . 0.0 109.48 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.434 ' HG2' ' O ' ' A' ' 108' ' ' ILE . 2.7 ptt85 -69.47 -24.43 63.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.178 -0.951 . . . . 0.0 109.473 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 109' ' ' ASP . 68.9 m-20 -75.93 -51.24 12.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 0.0 109.516 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.59 ' HB1' ' CE2' ' A' ' 118' ' ' TYR . . . -61.64 -46.96 87.54 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.303 -0.873 . . . . 0.0 109.601 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.671 HG22 HD21 ' A' ' 50' ' ' LEU . 68.0 t -58.42 -47.39 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.151 -0.968 . . . . 0.0 109.524 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.94 -30.48 70.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 109.493 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -83.17 -16.8 45.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.9 . . . . 0.0 109.426 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.59 ' CE2' ' HB1' ' A' ' 114' ' ' ALA . 17.5 m-85 -90.02 -72.86 0.54 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.348 -0.845 . . . . 0.0 109.531 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.527 ' CD1' ' HD2' ' A' ' 120' ' ' PRO . 6.1 tp -90.12 139.11 27.16 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.89 . . . . 0.0 109.533 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.527 ' HD2' ' CD1' ' A' ' 119' ' ' LEU . 35.6 Cg_endo -78.78 132.63 10.9 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.495 2.13 . . . . 0.0 110.409 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.963 HD13 ' O ' ' A' ' 121' ' ' LEU . 1.9 tm? . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.254 -0.904 . . . . 0.0 109.489 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.573 ' HG3' HD22 ' A' ' 119' ' ' LEU . 5.4 mm-40 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.26 0.552 . . . . 0.0 109.544 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.476 ' CB ' ' HB3' ' A' ' 48' ' ' PRO . 3.2 mtmm -89.99 157.28 17.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.908 . . . . 0.0 109.482 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.821 HD12 HG22 ' A' ' 30' ' ' THR . 55.3 mt -150.08 158.12 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -0.907 . . . . 0.0 109.453 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.989 ' HB3' HG13 ' A' ' 51' ' ' VAL . 1.0 OUTLIER -131.04 109.0 10.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.323 -0.861 . . . . 0.0 109.365 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.561 HD13 ' HB3' ' A' ' 19' ' ' LEU . 13.2 mt -89.91 113.47 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.235 -0.915 . . . . 0.0 109.444 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.947 HG12 HD11 ' A' ' 57' ' ' ILE . 37.1 t -109.39 97.99 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.221 -0.924 . . . . 0.0 109.392 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 11' ' ' ASP . 2.2 t0 -152.7 88.13 1.33 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.905 . . . . 0.0 109.509 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.528 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . 7.3 p-10 -44.29 -43.32 7.31 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.5 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -55.97 134.94 52.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.298 -0.876 . . . . 0.0 109.56 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.596 ' CE2' HG13 ' A' ' 17' ' ' ILE . 7.6 t80 -73.71 174.0 9.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.272 -0.892 . . . . 0.0 109.535 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.29 -38.52 3.2 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 1.052 HG23 HD13 ' A' ' 19' ' ' LEU . 2.3 mp -84.64 -48.39 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.332 -1.099 . . . . 0.0 109.443 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.464 ' O ' ' HB2' ' A' ' 20' ' ' ASN . 2.5 mtp180 -59.88 -26.79 66.15 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.255 -0.903 . . . . 0.0 109.584 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.596 HG13 ' CE2' ' A' ' 13' ' ' TYR . 3.7 mm -90.22 -57.16 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.25 -0.906 . . . . 0.0 109.74 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.818 ' O ' HG23 ' A' ' 22' ' ' VAL . 79.6 mt -54.18 -59.37 4.75 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -0.92 . . . . 0.0 109.706 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 1.052 HD13 HG23 ' A' ' 15' ' ' ILE . 4.5 mp -56.7 -19.31 15.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.243 -0.911 . . . . 0.0 109.602 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 25.9 t30 -78.2 -72.45 0.37 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.884 . . . . 0.0 109.637 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -48.29 -28.31 3.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -0.913 . . . . 0.0 109.554 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.843 HG21 ' CG2' ' A' ' 108' ' ' ILE . 63.7 t -70.61 -57.26 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.221 -0.925 . . . . 0.0 109.543 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.511 ' CZ ' HG22 ' A' ' 111' ' ' ILE . 15.5 m-85 -72.63 -3.09 22.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.276 -0.89 . . . . 0.0 109.585 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -80.08 -51.56 8.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.155 -0.966 . . . . 0.0 109.416 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.13 -22.01 53.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.292 -0.88 . . . . 0.0 109.451 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.511 ' O ' ' CD2' ' A' ' 121' ' ' LEU . 2.2 mt-10 -71.36 -33.47 69.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.233 -0.917 . . . . 0.0 109.464 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 110.02 61.93 0.51 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.616 ' CE2' HD22 ' A' ' 121' ' ' LEU . 98.8 m-85 -151.63 134.95 16.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.294 -1.121 . . . . 0.0 109.539 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -89.92 83.04 6.12 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.226 -0.922 . . . . 0.0 109.137 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.821 HG22 HD12 ' A' ' 6' ' ' ILE . 5.6 p -89.91 151.08 21.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.296 -0.877 . . . . 0.0 109.607 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.747 ' HB2' HD22 ' A' ' 7' ' ' LEU . 11.8 m-85 -115.85 -170.41 1.78 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.286 -0.884 . . . . 0.0 109.297 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -127.5 149.79 49.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.13 -0.981 . . . . 0.0 109.504 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.662 ' HB3' HG22 ' A' ' 9' ' ' VAL . . . -164.56 171.97 13.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.288 -0.882 . . . . 0.0 109.381 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.528 ' HB1' ' HB3' ' A' ' 11' ' ' ASP . . . -172.65 -34.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -0.908 . . . . 0.0 109.536 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.421 ' OD1' ' HB2' ' A' ' 37' ' ' LEU . 3.1 p30 -81.89 -2.72 52.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.187 -0.946 . . . . 0.0 109.625 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.19 -45.69 3.55 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.606 HD12 ' N ' ' A' ' 37' ' ' LEU . 9.1 mp -58.2 -34.59 70.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.242 -1.152 . . . . 0.0 109.483 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.932 ' O ' HD12 ' A' ' 42' ' ' ILE . 18.8 mm-40 -76.08 -28.53 57.61 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.199 -0.938 . . . . 0.0 109.467 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.833 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -69.13 -55.32 11.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.324 -0.86 . . . . 0.0 109.485 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.461 HD13 ' HD2' ' A' ' 68' ' ' ARG . 13.1 mt -65.54 -51.46 59.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.246 -0.909 . . . . 0.0 109.496 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -48.99 -54.32 16.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.287 -0.883 . . . . 0.0 109.452 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.932 HD12 ' O ' ' A' ' 38' ' ' GLN . 15.7 mt -60.06 -30.17 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.235 -0.915 . . . . 0.0 109.43 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.833 HG23 ' O ' ' A' ' 39' ' ' ALA . 70.2 t -70.36 -26.92 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.94 . . . . 0.0 109.461 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.1 m -89.86 -19.4 24.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.158 -0.964 . . . . 0.0 109.437 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.6 mmtt -90.02 -24.35 21.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.353 -0.842 . . . . 0.0 109.517 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.454 ' HB3' ' HD3' ' A' ' 5' ' ' LYS . 38.9 mm-40 -125.39 -32.93 2.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.171 -0.955 . . . . 0.0 109.524 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 1.4 mtt180 60.48 66.85 1.74 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 109.527 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.547 ' O ' HD12 ' A' ' 76' ' ' ILE . 35.6 Cg_endo -77.85 175.34 11.32 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.668 2.245 . . . . 0.0 110.474 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 0.9 OUTLIER -116.82 -9.32 11.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.276 -0.89 . . . . 0.0 109.511 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.04 HD21 HG22 ' A' ' 115' ' ' VAL . 7.2 tp -128.07 120.02 26.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.28 -0.888 . . . . 0.0 109.538 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.989 HG13 ' HB3' ' A' ' 7' ' ' LEU . 39.1 t -133.16 124.49 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 0.0 109.692 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.475 ' CD1' HG12 ' A' ' 8' ' ' ILE . 1.1 mp -89.94 112.78 24.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.341 -0.849 . . . . 0.0 109.355 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.474 ' CD2' ' HG ' ' A' ' 66' ' ' LEU . 1.1 mp -97.5 120.01 37.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.149 -0.969 . . . . 0.0 109.626 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.456 ' HA ' ' HG3' ' A' ' 81' ' ' MET . 26.5 t0 -105.77 101.78 11.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.264 -0.897 . . . . 0.0 109.273 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.863 ' CG ' HG21 ' A' ' 82' ' ' THR . 3.3 mmt -61.82 -13.35 23.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -0.919 . . . . 0.0 109.464 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.444 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 43.4 mttp -57.96 -25.94 61.64 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.214 -0.929 . . . . 0.0 109.486 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.947 HD11 HG12 ' A' ' 9' ' ' VAL . 87.5 mt -42.08 102.25 0.27 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.342 -0.849 . . . . 0.0 109.582 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.472 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 36.0 Cg_endo -78.33 102.2 1.54 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.377 2.052 . . . . 0.0 110.476 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 125.77 -20.19 6.47 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.681 ' HB3' HG21 ' A' ' 57' ' ' ILE . 11.2 tmm? -129.53 132.54 46.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -1.167 . . . . 0.0 109.521 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.431 ' O ' ' SD ' ' A' ' 60' ' ' MET . 74.1 m-20 -89.14 129.82 35.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.203 -0.936 . . . . 0.0 109.497 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.443 ' HA2' HG13 ' A' ' 65' ' ' ILE . . . -87.35 9.82 71.64 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 25.3 mm -76.15 -49.63 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.19 -1.182 . . . . 0.0 109.479 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -62.29 -25.31 67.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 109.388 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.566 HG22 ' HE2' ' A' ' 69' ' ' MET . 7.9 mt -62.83 -65.26 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.311 -0.868 . . . . 0.0 109.45 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.632 HD21 HG11 ' A' ' 78' ' ' VAL . 22.0 mt -46.57 -40.96 13.69 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.189 -0.944 . . . . 0.0 109.437 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.553 ' O ' HG23 ' A' ' 71' ' ' VAL . 2.0 tttt -53.8 -53.7 48.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.934 . . . . 0.0 109.399 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.476 ' O ' HG12 ' A' ' 72' ' ' ILE . 1.9 mtt85 -60.72 -24.99 66.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.258 -0.901 . . . . 0.0 109.396 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.566 ' HE2' HG22 ' A' ' 65' ' ' ILE . 2.2 mtt -78.36 -25.33 46.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.355 -0.841 . . . . 0.0 109.49 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.485 ' HG2' ' O ' ' A' ' 66' ' ' LEU . 0.8 OUTLIER -82.91 -28.84 29.67 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 0.0 109.263 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 67' ' ' LYS . 2.6 t -90.07 -22.31 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.262 -0.899 . . . . 0.0 109.493 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.476 HG12 ' O ' ' A' ' 68' ' ' ARG . 25.1 mm -90.1 -50.16 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.255 -0.903 . . . . 0.0 109.51 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.622 ' O ' HG22 ' A' ' 76' ' ' ILE . 1.0 OUTLIER -137.81 121.45 17.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -0.922 . . . . 0.0 109.509 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.79 7.76 19.59 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.223 -0.923 . . . . 0.0 109.515 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.476 ' C ' ' ND2' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -122.22 -9.11 8.66 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.246 -0.909 . . . . 0.0 108.984 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.626 ' O ' HG23 ' A' ' 76' ' ' ILE . 2.4 tp -57.86 106.85 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -0.934 . . . . 0.0 109.52 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.547 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 44.6 mtt180 -75.52 131.7 40.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.329 -0.857 . . . . 0.0 109.357 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.632 HG11 HD21 ' A' ' 66' ' ' LEU . 23.6 t -134.54 126.75 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 109.709 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.652 HG23 ' O ' ' A' ' 100' ' ' THR . 80.0 mt -103.81 128.48 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.168 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.895 HD12 ' HD1' ' A' ' 101' ' ' HIS . 0.1 OUTLIER -89.84 153.54 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.174 -0.953 . . . . 0.0 109.427 -179.799 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.456 ' HG3' ' HA ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -132.39 69.0 1.48 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.321 -0.862 . . . . 0.0 109.522 179.899 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.863 HG21 ' CG ' ' A' ' 55' ' ' MET . 12.8 t -170.67 28.16 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.213 -0.93 . . . . 0.0 109.583 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.025 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.236 -0.915 . . . . 0.0 109.516 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.512 HD12 ' HA ' ' A' ' 83' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.704 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.79 -43.77 94.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.309 -0.87 . . . . 0.0 109.604 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.48 ' HG2' HD21 ' A' ' 96' ' ' LEU . 1.1 tp10 -90.13 -20.71 22.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.188 -0.945 . . . . 0.0 109.813 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.496 ' HB3' ' CB ' ' A' ' 98' ' ' ALA . 0.4 OUTLIER -42.39 -26.86 0.12 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.187 -0.945 . . . . 0.0 109.899 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 92' ' ' GLU . 0.3 OUTLIER -52.58 -76.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -0.906 . . . . 0.0 109.899 -179.776 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.459 ' HG3' HD23 ' A' ' 96' ' ' LEU . 2.5 pt-20 -64.91 -38.02 89.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.231 -0.918 . . . . 0.0 109.825 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.522 ' N ' ' CD2' ' A' ' 96' ' ' LEU . 3.3 mm? -55.19 -25.17 30.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.919 . . . . 0.0 109.594 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 132.8 68.27 0.08 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.496 ' CB ' ' HB3' ' A' ' 93' ' ' SER . . . -153.12 98.96 2.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.251 -1.146 . . . . 0.0 109.444 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.547 ' CD1' ' HB3' ' A' ' 77' ' ' ARG . 21.1 mt -43.94 -67.13 0.3 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.295 -0.878 . . . . 0.0 109.346 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.652 ' O ' HG23 ' A' ' 79' ' ' ILE . 14.2 t -146.68 152.43 38.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.33 -0.856 . . . . 0.0 109.44 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.895 ' HD1' HD12 ' A' ' 80' ' ' ILE . 3.6 t-160 -113.68 87.29 2.58 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 109.346 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.552 ' CZ ' ' HB2' ' A' ' 114' ' ' ALA . 13.3 m-30 -71.56 159.92 33.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.226 -0.921 . . . . 0.0 109.569 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 1.025 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -131.35 -148.88 0.37 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.284 -0.885 . . . . 0.0 109.342 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.1 mtpt -91.74 146.42 33.03 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.254 -0.904 . . . . 0.0 109.466 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.5 -169.56 7.96 Favored 'Cis proline' 0 C--N 1.308 -1.565 0 C-N-CA 123.236 -1.568 . . . . 0.0 110.435 -0.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.627 ' CZ ' ' CG1' ' A' ' 111' ' ' ILE . 11.0 t80 -127.48 92.64 3.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.312 -0.868 . . . . 0.0 109.264 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.437 ' O ' HD13 ' A' ' 111' ' ' ILE . 16.3 t70 -89.83 127.83 36.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.282 -0.886 . . . . 0.0 109.511 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.843 ' CG2' HG21 ' A' ' 22' ' ' VAL . 13.7 mm -51.53 -22.16 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.225 -0.922 . . . . 0.0 109.356 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 109' ' ' ASP . 4.3 m-20 -72.64 -42.33 64.52 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.295 -0.878 . . . . 0.0 109.499 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.436 ' HG2' ' CE2' ' A' ' 102' ' ' PHE . 17.4 tt0 -62.51 -29.82 70.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.264 -0.898 . . . . 0.0 109.473 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.648 ' N ' HD12 ' A' ' 111' ' ' ILE . 1.4 mp -76.49 -56.13 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 109.327 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.432 ' HG2' ' HA ' ' A' ' 109' ' ' ASP . 30.4 ptt180 -60.79 -19.61 59.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.921 . . . . 0.0 109.435 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -81.61 -51.14 8.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 109.396 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 102' ' ' PHE . . . -55.58 -47.42 76.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.263 -0.898 . . . . 0.0 109.368 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 1.04 HG22 HD21 ' A' ' 50' ' ' LEU . 47.2 t -65.97 -47.64 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.314 -0.867 . . . . 0.0 109.419 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.81 -19.29 59.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 109.418 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -89.48 -27.25 20.46 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.251 -0.905 . . . . 0.0 109.345 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.452 ' CD2' ' O ' ' A' ' 114' ' ' ALA . 42.3 m-85 -88.07 -69.64 0.68 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.296 -0.878 . . . . 0.0 109.47 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.573 HD22 ' HG3' ' A' ' 4' ' ' GLU . 2.4 tt -90.19 127.92 51.47 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.235 -0.915 . . . . 0.0 109.435 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.474 ' HD2' ' HG ' ' A' ' 119' ' ' LEU . 35.9 Cg_endo -78.49 142.42 18.5 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.414 2.076 . . . . 0.0 110.368 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.616 HD22 ' CE2' ' A' ' 28' ' ' TYR . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.479 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.499 ' CG ' ' HA ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -146.24 126.19 13.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.208 -0.932 . . . . 0.0 109.491 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.712 ' HB ' HG22 ' A' ' 30' ' ' THR . 4.1 mt -109.2 162.48 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.188 -0.945 . . . . 0.0 109.415 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.755 HD12 HG22 ' A' ' 9' ' ' VAL . 2.0 tm? -136.41 108.16 7.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.199 -0.938 . . . . 0.0 109.587 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.51 ' N ' HD13 ' A' ' 7' ' ' LEU . 5.0 mt -90.01 103.41 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.219 -0.926 . . . . 0.0 109.138 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.755 HG22 HD12 ' A' ' 7' ' ' LEU . 2.7 t -89.99 95.12 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.172 -0.955 . . . . 0.0 109.801 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.497 ' HB3' ' HD2' ' A' ' 16' ' ' ARG . 4.8 m-20 -145.22 155.36 43.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.272 -0.893 . . . . 0.0 109.402 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.464 ' OD2' ' CD ' ' A' ' 58' ' ' PRO . 7.1 p-10 -114.35 -29.75 6.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.339 -0.851 . . . . 0.0 109.41 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.529 ' HB3' ' NH2' ' A' ' 16' ' ' ARG . 1.4 tt0 -67.83 -148.04 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.349 -0.844 . . . . 0.0 109.514 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.614 ' CD1' ' N ' ' A' ' 14' ' ' GLY . 40.5 t80 -148.66 166.43 28.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.295 -0.878 . . . . 0.0 109.347 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.614 ' N ' ' CD1' ' A' ' 13' ' ' TYR . . . 102.24 -84.25 0.49 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.638 HG23 HD13 ' A' ' 19' ' ' LEU . 1.5 mt -51.08 -68.03 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.315 -1.109 . . . . 0.0 109.151 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.529 ' NH2' ' HB3' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -39.75 -27.57 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.616 -0.677 . . . . 0.0 110.217 -179.708 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.582 HG13 ' CZ ' ' A' ' 13' ' ' TYR . 9.9 mm -78.81 -46.77 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.091 -1.005 . . . . 0.0 109.841 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.69 ' O ' HG23 ' A' ' 22' ' ' VAL . 3.8 mp -65.47 -54.8 23.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.18 -0.95 . . . . 0.0 109.654 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.638 HD13 HG23 ' A' ' 15' ' ' ILE . 8.6 mp -59.13 -18.88 39.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.276 -0.89 . . . . 0.0 109.3 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 31.1 t30 -77.94 -65.64 0.94 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.436 -0.79 . . . . 0.0 109.546 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -68.07 -7.79 32.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 109.719 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 18' ' ' LEU . 43.7 t -88.16 -57.77 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.19 -0.944 . . . . 0.0 109.458 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.87 ' HB2' HG21 ' A' ' 30' ' ' THR . 18.0 m-85 -63.35 -28.84 70.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -0.91 . . . . 0.0 109.465 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -64.56 -60.04 3.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.274 -0.891 . . . . 0.0 109.44 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -57.03 -54.95 40.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.27 -0.894 . . . . 0.0 109.491 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.45 ' HB3' ' CD1' ' A' ' 28' ' ' TYR . 1.1 tt0 -44.48 -26.39 0.35 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.253 -0.904 . . . . 0.0 109.442 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.466 ' HA3' HD21 ' A' ' 121' ' ' LEU . . . 113.21 55.71 0.43 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.602 ' CZ ' HD13 ' A' ' 121' ' ' LEU . 78.4 m-85 -147.68 135.91 21.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.259 -1.142 . . . . 0.0 109.475 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -89.85 82.23 6.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.272 -0.893 . . . . 0.0 109.358 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.87 HG21 ' HB2' ' A' ' 23' ' ' PHE . 6.0 p -89.96 146.76 24.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.324 -0.86 . . . . 0.0 109.605 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.554 ' CZ ' ' OE1' ' A' ' 46' ' ' GLU . 18.7 m-85 -116.15 -178.71 3.47 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.321 -0.862 . . . . 0.0 109.343 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -122.14 136.18 54.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 0.0 109.553 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' A' ' 10' ' ' ASP . . . -141.94 -175.82 4.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.257 -0.902 . . . . 0.0 109.425 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.57 -83.46 0.09 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.18 -0.95 . . . . 0.0 109.499 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.441 ' OD1' ' HB2' ' A' ' 38' ' ' GLN . 20.7 p-10 -63.21 137.22 58.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.303 -0.873 . . . . 0.0 109.476 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -45.29 -31.12 3.11 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.455 ' HA ' HD23 ' A' ' 37' ' ' LEU . 0.5 OUTLIER -59.74 -49.87 76.05 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.214 -1.168 . . . . 0.0 109.477 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.523 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 6.6 tp-100 -61.96 -52.15 65.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 109.431 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.976 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -44.69 -51.54 9.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.195 -0.94 . . . . 0.0 109.572 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.491 HD21 ' HB2' ' A' ' 68' ' ' ARG . 20.6 mt -60.25 -37.47 80.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.206 -0.934 . . . . 0.0 109.59 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.24 -59.46 5.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.139 -0.976 . . . . 0.0 109.527 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.751 HG21 HD23 ' A' ' 7' ' ' LEU . 5.1 mt -62.07 -19.85 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.207 -0.933 . . . . 0.0 109.577 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.976 HG23 ' O ' ' A' ' 39' ' ' ALA . 90.8 t -81.37 -24.9 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.188 -0.945 . . . . 0.0 109.491 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.5 m -90.13 -27.48 19.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 109.511 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.474 ' HD2' ' N ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -90.08 -30.89 17.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.247 -0.908 . . . . 0.0 109.527 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.554 ' OE1' ' CZ ' ' A' ' 31' ' ' PHE . 8.1 mm-40 -110.62 -35.26 6.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.916 . . . . 0.0 109.463 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.468 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 6.5 mtt85 56.33 69.89 1.65 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.478 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.534 ' HD2' HG13 ' A' ' 43' ' ' VAL . 35.4 Cg_endo -77.7 154.72 30.83 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.694 2.263 . . . . 0.0 110.416 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.819 ' C ' HD22 ' A' ' 50' ' ' LEU . 4.0 t0 -92.77 -13.04 29.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.268 -0.895 . . . . 0.0 109.475 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.819 HD22 ' C ' ' A' ' 49' ' ' ASP . 4.3 mm? -122.54 111.98 17.46 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.222 -0.923 . . . . 0.0 109.453 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 1.006 ' HB ' HG12 ' A' ' 78' ' ' VAL . 2.1 t -113.68 131.05 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.198 -0.939 . . . . 0.0 109.528 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.462 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 1.6 mp -108.95 117.98 35.6 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.245 -0.909 . . . . 0.0 109.48 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.809 HD22 ' N ' ' A' ' 53' ' ' LEU . 2.3 mm? -103.19 130.74 50.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.268 -0.895 . . . . 0.0 109.518 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.465 ' HB2' ' OD2' ' A' ' 10' ' ' ASP . 19.6 t0 -111.11 97.81 7.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -0.872 . . . . 0.0 109.437 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.825 ' HB2' HG21 ' A' ' 82' ' ' THR . 12.6 mmt -64.76 -10.82 30.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 0.0 109.396 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -72.71 -2.96 22.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.155 -0.965 . . . . 0.0 109.668 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.45 HG12 ' OD1' ' A' ' 11' ' ' ASP . 55.3 mt -62.24 132.4 93.95 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.128 -0.983 . . . . 0.0 109.32 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.464 ' CD ' ' OD2' ' A' ' 11' ' ' ASP . 36.3 Cg_endo -78.88 112.0 3.04 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.494 2.129 . . . . 0.0 110.412 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 146.07 -76.49 0.27 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.421 ' SD ' ' C ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -130.47 170.14 14.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.207 -1.172 . . . . 0.0 109.501 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -90.09 139.54 30.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.355 -0.84 . . . . 0.0 109.499 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 63' ' ' ILE . . . -73.0 -10.11 77.16 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.456 ' CD1' ' HE3' ' A' ' 55' ' ' MET . 18.1 mm -44.14 -47.41 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.212 -1.169 . . . . 0.0 109.585 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.468 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 4.8 mt-10 -63.36 -39.52 94.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.235 -0.916 . . . . 0.0 109.533 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.414 ' O ' ' C ' ' A' ' 66' ' ' LEU . 65.6 mt -51.37 -64.49 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.262 -0.899 . . . . 0.0 109.415 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.858 HD21 ' HB ' ' A' ' 78' ' ' VAL . 7.1 mt -44.12 -49.01 9.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 109.391 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.603 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.1 OUTLIER -49.06 -47.95 44.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.184 -0.948 . . . . 0.0 109.353 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.491 ' HB2' HD21 ' A' ' 40' ' ' LEU . 9.7 mmt180 -57.15 -44.07 83.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -0.888 . . . . 0.0 109.415 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.887 ' CE ' HG11 ' A' ' 51' ' ' VAL . 3.6 mtt -60.04 -27.27 66.79 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 0.0 109.417 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 66' ' ' LEU . 0.7 OUTLIER -78.05 -31.7 50.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.238 -0.914 . . . . 0.0 109.368 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 67' ' ' LYS . 2.6 t -77.9 -24.53 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.264 -0.898 . . . . 0.0 109.519 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 68' ' ' ARG . 48.9 mt -87.42 -59.65 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -0.917 . . . . 0.0 109.406 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.504 ' O ' HG22 ' A' ' 76' ' ' ILE . 39.8 m-20 -130.52 133.56 46.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.19 -0.944 . . . . 0.0 109.482 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -90.16 -26.08 20.35 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.218 -0.926 . . . . 0.0 109.033 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 44.4 p-10 -96.51 46.85 1.06 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.262 -0.899 . . . . 0.0 109.472 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.53 ' CD1' ' HA ' ' A' ' 49' ' ' ASP . 2.9 tp -117.59 112.83 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.228 -0.92 . . . . 0.0 109.436 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.614 ' CG ' HD11 ' A' ' 99' ' ' LEU . 8.7 mpt_? -63.36 134.99 56.68 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.269 -0.894 . . . . 0.0 109.509 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 1.006 HG12 ' HB ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -138.66 108.84 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.247 -0.908 . . . . 0.0 109.6 -179.925 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.504 HG23 ' O ' ' A' ' 100' ' ' THR . 67.5 mt -96.77 145.68 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.211 -0.931 . . . . 0.0 109.371 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.967 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.4 OUTLIER -103.17 168.66 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.171 -0.956 . . . . 0.0 109.375 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.483 ' CE ' ' OD1' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -142.53 69.54 1.32 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.281 -0.887 . . . . 0.0 109.432 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.825 HG21 ' HB2' ' A' ' 55' ' ' MET . 9.0 t 178.79 55.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.348 -0.845 . . . . 0.0 109.429 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.072 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.901 . . . . 0.0 109.511 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.591 ' CD1' ' N ' ' A' ' 90' ' ' ILE . 1.2 mp . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.48 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -51.19 -27.76 9.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.216 -0.927 . . . . 0.0 109.41 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.503 ' HA ' ' CG ' ' A' ' 95' ' ' GLU . 6.9 mt-10 -89.89 -28.67 19.07 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.302 -0.874 . . . . 0.0 109.456 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.749 ' HB3' HD11 ' A' ' 80' ' ' ILE . 1.7 m -64.8 -40.17 94.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.308 -0.87 . . . . 0.0 109.447 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.687 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 20.3 mttt -70.12 -63.34 1.1 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.204 -0.935 . . . . 0.0 109.548 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.503 ' CG ' ' HA ' ' A' ' 92' ' ' GLU . 0.1 OUTLIER -47.15 -27.75 1.55 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.195 -0.94 . . . . 0.0 109.469 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.495 ' HA ' HD23 ' A' ' 96' ' ' LEU . 22.0 mt -77.8 -41.24 37.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.889 . . . . 0.0 109.439 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.514 ' O ' ' CG2' ' A' ' 78' ' ' VAL . . . 161.4 61.49 0.02 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.687 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -151.03 116.52 5.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.295 -1.12 . . . . 0.0 109.448 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.614 HD11 ' CG ' ' A' ' 77' ' ' ARG . 20.3 mt -44.11 -84.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.188 -0.945 . . . . 0.0 109.436 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.622 ' CG2' ' CE1' ' A' ' 102' ' ' PHE . 12.6 t -129.83 151.87 49.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.301 -0.874 . . . . 0.0 109.456 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.967 ' ND1' HD12 ' A' ' 80' ' ' ILE . 2.9 t60 -101.56 96.29 7.02 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.272 -0.892 . . . . 0.0 109.503 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.622 ' CE1' ' CG2' ' A' ' 100' ' ' THR . 43.6 m-85 -72.22 168.32 18.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.202 -0.936 . . . . 0.0 109.404 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 1.072 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -145.68 -148.34 0.24 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.194 -0.941 . . . . 0.0 109.413 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.81 146.93 25.55 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.919 . . . . 0.0 109.534 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.99 168.01 76.98 Favored 'Cis proline' 0 C--N 1.308 -1.57 0 C-N-CA 123.233 -1.57 . . . . 0.0 110.393 0.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -142.33 -164.41 1.81 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 0.0 109.499 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -136.81 127.4 26.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.251 -0.906 . . . . 0.0 109.397 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.673 HG13 HD23 ' A' ' 18' ' ' LEU . 19.0 mm -54.11 -20.57 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -0.912 . . . . 0.0 109.468 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -74.61 -41.48 60.36 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.246 -0.909 . . . . 0.0 109.475 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -71.87 -31.6 66.62 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.228 -0.92 . . . . 0.0 109.539 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.439 HD13 ' CE2' ' A' ' 102' ' ' PHE . 17.8 mm -68.82 -58.0 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.339 -0.851 . . . . 0.0 109.516 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.442 ' HG2' ' O ' ' A' ' 108' ' ' ILE . 8.2 ptt85 -60.14 -36.47 77.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.227 -0.921 . . . . 0.0 109.535 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -59.69 -54.08 50.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.253 -0.904 . . . . 0.0 109.434 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.526 ' O ' ' CD2' ' A' ' 118' ' ' TYR . . . -57.09 -42.1 80.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.234 -0.917 . . . . 0.0 109.387 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.741 HG21 ' CZ ' ' A' ' 23' ' ' PHE . 53.9 t -65.63 -25.11 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.278 -0.889 . . . . 0.0 109.48 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.53 -45.05 61.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.283 -0.886 . . . . 0.0 109.459 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.38 -42.79 95.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.186 -0.946 . . . . 0.0 109.543 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.526 ' CD2' ' O ' ' A' ' 114' ' ' ALA . 52.7 m-85 -64.98 -70.04 0.26 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.214 -0.929 . . . . 0.0 109.518 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.558 HD23 ' CE2' ' A' ' 28' ' ' TYR . 18.0 tp -90.08 112.37 52.05 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.347 -0.846 . . . . 0.0 109.437 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 118' ' ' TYR . 35.7 Cg_endo -77.96 136.03 14.5 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.39 2.06 . . . . 0.0 110.42 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.602 HD13 ' CZ ' ' A' ' 28' ' ' TYR . 5.7 tp . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.31 -0.869 . . . . 0.0 109.449 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.617 ' HG2' HD12 ' A' ' 121' ' ' LEU . 1.4 mt-10 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.494 ' CB ' ' HB3' ' A' ' 48' ' ' PRO . 1.4 mptp? -120.83 159.7 24.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.254 -0.904 . . . . 0.0 109.484 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.785 ' HB ' HG22 ' A' ' 30' ' ' THR . 14.3 mt -149.98 158.79 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.23 -0.919 . . . . 0.0 109.487 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.674 ' C ' HD13 ' A' ' 7' ' ' LEU . 1.8 tm? -133.2 106.84 7.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.207 -0.933 . . . . 0.0 109.401 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.488 ' N ' HD13 ' A' ' 7' ' ' LEU . 6.0 mt -89.88 112.06 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.204 -0.935 . . . . 0.0 109.382 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.686 HG21 ' CD1' ' A' ' 53' ' ' LEU . 32.3 t -93.97 79.86 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.283 -0.886 . . . . 0.0 109.565 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.481 ' OD2' ' HG2' ' A' ' 16' ' ' ARG . 17.7 t70 -126.32 133.16 51.45 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.262 -0.899 . . . . 0.0 109.494 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.643 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . 5.4 p-10 -99.65 -45.86 5.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.127 -0.983 . . . . 0.0 109.507 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.435 ' N ' ' CG ' ' A' ' 11' ' ' ASP . 1.0 OUTLIER -68.94 112.49 5.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -0.909 . . . . 0.0 109.444 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.42 ' C ' ' O ' ' A' ' 12' ' ' GLN . 1.8 t80 -43.79 159.02 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.24 -0.912 . . . . 0.0 109.529 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.83 -67.65 0.25 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.853 HG23 HD13 ' A' ' 19' ' ' LEU . 2.7 mt -65.31 -11.47 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.191 -1.182 . . . . 0.0 109.346 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.486 ' O ' ' HB2' ' A' ' 20' ' ' ASN . 0.6 OUTLIER -84.24 -26.77 28.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.21 -0.931 . . . . 0.0 109.263 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.3 mm -90.7 -37.95 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.26 -0.9 . . . . 0.0 109.79 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.659 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.9 OUTLIER -66.94 -58.19 5.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 0.0 109.7 -179.755 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.853 HD13 HG23 ' A' ' 15' ' ' ILE . 7.9 mp -62.95 -22.13 66.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.167 -0.958 . . . . 0.0 109.394 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 8.8 t30 -71.21 -66.83 0.57 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.368 -0.833 . . . . 0.0 109.488 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.484 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 2.1 mt-10 -53.27 -33.3 52.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -0.885 . . . . 0.0 109.58 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.731 HG13 ' HE ' ' A' ' 112' ' ' ARG . 74.7 t -63.41 -60.07 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.251 -0.906 . . . . 0.0 109.512 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.483 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 21.6 m-85 -78.03 1.77 19.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.944 . . . . 0.0 109.582 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.484 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 1.0 OUTLIER -90.07 -43.13 10.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.192 -0.943 . . . . 0.0 109.491 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -76.09 -35.95 59.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.232 -0.917 . . . . 0.0 109.477 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.492 ' HB3' ' CE1' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -65.79 -27.53 68.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -0.914 . . . . 0.0 109.489 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.535 ' C ' ' CD1' ' A' ' 28' ' ' TYR . . . 106.77 73.01 0.83 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.595 ' HE2' HD12 ' A' ' 119' ' ' LEU . 79.3 m-85 -151.17 134.71 16.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.225 -1.162 . . . . 0.0 109.539 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -93.99 83.84 4.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.228 -0.92 . . . . 0.0 109.265 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.785 HG22 ' HB ' ' A' ' 6' ' ' ILE . 5.8 p -89.87 161.59 15.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.187 -0.946 . . . . 0.0 109.562 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.616 ' HB2' HD22 ' A' ' 7' ' ' LEU . 25.6 m-85 -121.66 -168.65 1.73 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -0.899 . . . . 0.0 109.331 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 16' ' ' ARG . 6.9 mp0 -123.92 150.79 44.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.185 -0.947 . . . . 0.0 109.533 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.66 ' HB3' ' HA ' ' A' ' 9' ' ' VAL . . . -162.24 173.16 14.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.22 -0.925 . . . . 0.0 109.38 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.643 ' HB1' ' HB3' ' A' ' 11' ' ' ASP . . . -174.77 -47.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.253 -0.905 . . . . 0.0 109.541 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.499 ' ND2' HD11 ' A' ' 37' ' ' LEU . 19.1 p30 -70.17 -5.66 28.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.245 -0.909 . . . . 0.0 109.585 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.424 ' HA2' HD13 ' A' ' 65' ' ' ILE . . . 85.98 -58.77 4.77 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.836 HD12 ' N ' ' A' ' 38' ' ' GLN . 4.2 pp -52.39 -40.24 61.84 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.271 -1.135 . . . . 0.0 109.476 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 1.016 ' O ' HD12 ' A' ' 42' ' ' ILE . 1.8 tp60 -66.36 -33.34 75.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.325 -0.859 . . . . 0.0 109.358 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.803 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -64.53 -62.56 1.51 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.211 -0.931 . . . . 0.0 109.407 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.744 HD22 HD12 ' A' ' 72' ' ' ILE . 13.4 mt -54.35 -35.92 63.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -0.899 . . . . 0.0 109.445 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -57.54 -53.29 59.85 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.222 -0.924 . . . . 0.0 109.387 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 1.016 HD12 ' O ' ' A' ' 38' ' ' GLN . 1.8 mp -64.91 -20.72 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.275 -0.891 . . . . 0.0 109.387 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.803 HG23 ' O ' ' A' ' 39' ' ' ALA . 21.6 t -81.51 -23.28 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.25 -0.906 . . . . 0.0 109.49 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.5 m -90.01 -28.54 19.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.321 -0.862 . . . . 0.0 109.533 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.6 mttm -87.44 -37.9 16.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.279 -0.888 . . . . 0.0 109.517 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.525 ' HG3' HG23 ' A' ' 42' ' ' ILE . 1.3 mm-40 -101.28 -39.6 7.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.261 -0.9 . . . . 0.0 109.466 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 0.9 OUTLIER 63.26 67.07 1.08 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.42 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.658 ' HD2' HG13 ' A' ' 43' ' ' VAL . 35.4 Cg_endo -77.51 -161.03 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.633 2.222 . . . . 0.0 110.469 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.978 ' O ' HD22 ' A' ' 50' ' ' LEU . 27.4 t70 -135.24 9.38 3.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 0.0 109.537 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.978 HD22 ' O ' ' A' ' 49' ' ' ASP . 0.4 OUTLIER -146.58 107.72 4.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.226 -0.921 . . . . 0.0 109.557 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.83 HG11 ' CE ' ' A' ' 69' ' ' MET . 1.7 t -113.47 109.49 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 109.382 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.685 HD23 ' HB ' ' A' ' 79' ' ' ILE . 1.3 mp -90.58 127.98 36.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.239 -0.913 . . . . 0.0 109.512 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.746 ' N ' HD22 ' A' ' 53' ' ' LEU . 2.6 mm? -113.42 146.11 40.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.233 -0.917 . . . . 0.0 109.429 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.455 ' O ' HG13 ' A' ' 57' ' ' ILE . 12.5 t70 -118.76 111.48 18.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.34 -0.85 . . . . 0.0 109.371 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.89 ' HB2' HG21 ' A' ' 82' ' ' THR . 15.5 mmt -70.6 -5.02 26.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.219 -0.926 . . . . 0.0 109.594 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.467 ' HG3' ' OG1' ' A' ' 82' ' ' THR . 24.1 mttt -90.08 14.33 12.65 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.141 -0.975 . . . . 0.0 109.67 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.645 HG23 ' HD2' ' A' ' 58' ' ' PRO . 83.4 mt -76.57 139.63 67.43 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.187 -0.945 . . . . 0.0 109.301 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.645 ' HD2' HG23 ' A' ' 57' ' ' ILE . 35.8 Cg_endo -78.18 -37.75 0.72 Allowed 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.504 2.136 . . . . 0.0 110.443 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.436 ' O ' ' HB3' ' A' ' 60' ' ' MET . . . -43.71 -43.66 6.62 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.505 ' N ' ' SD ' ' A' ' 60' ' ' MET . 0.0 OUTLIER 178.4 -167.95 0.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -1.141 . . . . 0.0 109.361 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -87.77 120.34 28.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.436 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.43 ' HA2' HG13 ' A' ' 65' ' ' ILE . . . -58.14 -16.07 24.88 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.41 ' C ' ' O ' ' A' ' 62' ' ' GLY . 25.9 mm -44.09 -50.34 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -1.141 . . . . 0.0 109.465 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 68' ' ' ARG . 6.4 mt-10 -64.56 -38.89 92.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.885 . . . . 0.0 109.425 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.494 HG22 ' SD ' ' A' ' 69' ' ' MET . 30.4 mt -53.24 -60.63 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 0.0 109.497 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 1.019 ' CD2' HG11 ' A' ' 78' ' ' VAL . 2.8 mt -50.25 -62.04 1.82 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.905 . . . . 0.0 109.71 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.83 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -41.45 -33.48 0.43 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.358 -0.839 . . . . 0.0 109.68 -179.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.555 ' HB2' HD11 ' A' ' 40' ' ' LEU . 24.8 mtt-85 -72.3 -63.04 1.23 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.211 -0.931 . . . . 0.0 109.391 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.83 ' CE ' HG11 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -40.6 -28.21 0.07 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.508 -0.745 . . . . 0.0 109.537 -179.385 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.601 ' NZ ' HD22 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -78.07 -60.4 2.39 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.057 -1.027 . . . . 0.0 109.098 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.83 HG23 ' O ' ' A' ' 67' ' ' LYS . 3.4 t -43.44 -26.77 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.449 -0.782 . . . . 0.0 109.592 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.744 HD12 HD22 ' A' ' 40' ' ' LEU . 71.7 mt -85.31 -54.2 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.251 -0.906 . . . . 0.0 109.41 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.531 ' OD1' HG22 ' A' ' 72' ' ' ILE . 1.4 m-20 -136.78 124.68 22.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.334 -0.854 . . . . 0.0 109.322 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -83.09 -9.23 59.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.213 -0.929 . . . . 0.0 109.51 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 -107.06 50.75 0.76 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.918 . . . . 0.0 109.522 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.602 ' O ' HG23 ' A' ' 76' ' ' ILE . 3.2 tp -125.4 105.22 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.221 -0.925 . . . . 0.0 109.519 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.655 ' CG ' HD11 ' A' ' 99' ' ' LEU . 75.0 mtt85 -55.19 155.5 4.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 109.473 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 1.019 HG11 ' CD2' ' A' ' 66' ' ' LEU . 3.2 t -142.78 138.82 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.272 -0.893 . . . . 0.0 109.606 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.685 ' HB ' HD23 ' A' ' 52' ' ' LEU . 9.0 mm -121.39 123.6 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.238 -0.914 . . . . 0.0 109.229 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.623 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.7 OUTLIER -89.71 144.35 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.143 -0.973 . . . . 0.0 109.429 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.458 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 5.0 mtm -124.77 57.45 1.27 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.212 -0.93 . . . . 0.0 109.51 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.89 HG21 ' HB2' ' A' ' 55' ' ' MET . 10.7 t -169.38 47.48 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.279 -0.888 . . . . 0.0 109.57 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.072 ' N ' ' HB2' ' A' ' 103' ' ' ALA . . . . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.245 -0.909 . . . . 0.0 109.522 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.608 HG23 ' HD1' ' A' ' 101' ' ' HIS . 15.5 mt . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.49 -32.47 71.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.311 -0.868 . . . . 0.0 109.499 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -89.8 -31.02 17.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.287 -0.883 . . . . 0.0 109.467 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.68 -51.44 69.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.265 -0.897 . . . . 0.0 109.479 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.631 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 14.3 tttm -52.78 -57.95 8.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.0 109.465 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 94' ' ' LYS . 59.3 mt-10 -44.06 -50.54 8.39 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.232 -0.917 . . . . 0.0 109.49 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.9 mt -53.0 -48.25 67.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.307 -0.871 . . . . 0.0 109.457 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 154.46 42.65 0.02 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.631 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -99.48 118.11 35.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.19 -1.182 . . . . 0.0 109.487 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.813 HD13 ' CD1' ' A' ' 118' ' ' TYR . 21.9 mt -55.24 -81.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.477 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.56 ' OG1' ' CE1' ' A' ' 102' ' ' PHE . 0.1 OUTLIER -126.27 175.65 7.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.208 -0.933 . . . . 0.0 109.477 -179.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.792 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 4.7 t-160 -146.03 97.19 2.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 109.256 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.56 ' CE1' ' OG1' ' A' ' 100' ' ' THR . 18.4 m-30 -108.81 159.55 16.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.182 -0.949 . . . . 0.0 109.597 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 1.072 ' HB2' ' N ' ' A' ' 83' ' ' ALA . . . -128.73 168.39 15.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.319 -0.863 . . . . 0.0 109.343 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.469 ' O ' ' HD2' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -90.97 144.85 30.68 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.186 -0.946 . . . . 0.0 109.48 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.09 130.2 20.42 Favored 'Cis proline' 0 C--N 1.309 -1.547 0 C-N-CA 123.353 -1.52 . . . . 0.0 110.36 0.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -102.22 -174.51 2.59 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.282 -0.886 . . . . 0.0 109.448 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.411 ' O ' ' C ' ' A' ' 108' ' ' ILE . 46.5 t0 -111.97 100.35 8.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.305 -0.872 . . . . 0.0 109.489 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.456 ' O ' ' HG3' ' A' ' 112' ' ' ARG . 12.5 mm -44.51 -31.21 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.381 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -63.77 -51.07 66.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.225 -0.922 . . . . 0.0 109.392 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 113' ' ' ASP . 7.5 tt0 -57.07 -47.11 81.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.17 -0.956 . . . . 0.0 109.375 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.5 mm -51.82 -60.14 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.365 -0.834 . . . . 0.0 109.453 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.731 ' HE ' HG13 ' A' ' 22' ' ' VAL . 98.8 mtt180 -49.54 -34.26 16.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.918 . . . . 0.0 109.51 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 110' ' ' GLU . 19.3 m-20 -67.29 -74.61 0.11 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 109.642 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.427 ' O ' ' C ' ' A' ' 115' ' ' VAL . . . -47.56 -63.43 1.05 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.239 -0.913 . . . . 0.0 109.622 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.427 ' C ' ' O ' ' A' ' 114' ' ' ALA . 49.4 t -42.49 -57.44 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.365 -0.835 . . . . 0.0 109.846 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 0.0 OUTLIER -45.78 -44.77 14.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.175 -0.953 . . . . 0.0 109.621 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 4.5 tptp -62.05 -39.9 93.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 109.703 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.813 ' CD1' HD13 ' A' ' 99' ' ' LEU . 48.7 m-85 -67.44 -69.77 0.29 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.168 -0.958 . . . . 0.0 109.654 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.64 ' C ' HD13 ' A' ' 119' ' ' LEU . 1.3 tm? -90.07 112.46 52.51 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.185 -0.947 . . . . 0.0 109.482 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.611 ' N ' HD13 ' A' ' 119' ' ' LEU . 36.1 Cg_endo -78.25 141.95 18.69 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.322 2.015 . . . . 0.0 110.418 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.617 HD12 ' HG2' ' A' ' 4' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.171 -0.956 . . . . 0.0 109.485 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 121.308 0.575 . . . . 0.0 109.992 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.468 ' CD ' ' N ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -108.85 147.47 32.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.245 -0.909 . . . . 0.0 109.465 179.885 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.599 HG22 ' N ' ' A' ' 7' ' ' LEU . 16.3 mt -149.7 165.15 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.229 -0.919 . . . . 0.0 109.519 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.979 HD13 ' N ' ' A' ' 8' ' ' ILE . 2.2 tm? -131.67 133.41 44.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.302 -0.874 . . . . 0.0 109.457 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.979 ' N ' HD13 ' A' ' 7' ' ' LEU . 12.4 mt -117.86 101.75 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.191 -0.943 . . . . 0.0 109.348 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.771 HG12 HD11 ' A' ' 57' ' ' ILE . 4.9 t -89.97 125.58 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.928 . . . . 0.0 109.522 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.6 ' O ' ' HB2' ' A' ' 34' ' ' ALA . 12.7 t70 -174.41 145.61 0.99 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.261 -0.9 . . . . 0.0 109.512 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.482 ' OD2' ' HD2' ' A' ' 58' ' ' PRO . 8.0 p-10 -117.95 -31.9 4.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.218 -0.926 . . . . 0.0 109.391 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.4 ' O ' ' C ' ' A' ' 13' ' ' TYR . 21.8 tm0? -69.73 104.64 2.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.334 -0.854 . . . . 0.0 109.589 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.922 ' CE2' HD11 ' A' ' 17' ' ' ILE . 6.7 t80 -43.63 123.13 2.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.337 -0.852 . . . . 0.0 109.569 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.77 -47.43 0.79 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.551 HD11 ' HE3' ' A' ' 104' ' ' LYS . 5.0 mt -80.1 -59.25 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -1.153 . . . . 0.0 109.486 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.504 ' HG2' ' CG ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -43.36 -26.69 0.21 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.235 -0.916 . . . . 0.0 109.714 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.922 HD11 ' CE2' ' A' ' 13' ' ' TYR . 2.4 mt -90.07 -64.33 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.19 -0.943 . . . . 0.0 109.697 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.806 ' O ' HG23 ' A' ' 22' ' ' VAL . 9.6 mt -47.59 -61.08 2.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.157 -0.964 . . . . 0.0 109.749 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.476 HD12 ' CD1' ' A' ' 108' ' ' ILE . 1.4 mp -52.76 -30.88 35.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -0.932 . . . . 0.0 109.575 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.476 ' HB3' ' O ' ' A' ' 17' ' ' ILE . 28.7 t30 -67.72 -72.42 0.17 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.223 -0.923 . . . . 0.0 109.716 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 20' ' ' ASN . 0.6 OUTLIER -43.72 -31.21 0.75 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 109.604 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 18' ' ' LEU . 67.4 t -66.77 -52.15 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.294 -0.879 . . . . 0.0 109.486 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.833 ' CZ ' HG21 ' A' ' 115' ' ' VAL . 22.9 m-85 -79.92 -0.47 35.15 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.187 -0.946 . . . . 0.0 109.62 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.422 ' ND2' ' OD1' ' A' ' 20' ' ' ASN . 0.7 OUTLIER -88.4 -48.15 7.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.145 -0.972 . . . . 0.0 109.462 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.54 -10.54 59.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.466 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.497 ' HB3' ' CD1' ' A' ' 28' ' ' TYR . 1.7 tt0 -89.43 -26.29 21.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.304 -0.872 . . . . 0.0 109.457 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.533 ' C ' ' CD1' ' A' ' 28' ' ' TYR . . . 105.91 67.73 0.69 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.695 ' HE2' HD23 ' A' ' 121' ' ' LEU . 90.2 m-85 -154.68 134.87 13.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.203 -1.175 . . . . 0.0 109.443 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -91.51 81.86 5.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.891 . . . . 0.0 109.326 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.479 HG21 ' CB ' ' A' ' 23' ' ' PHE . 5.7 p -89.92 146.37 24.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.311 -0.868 . . . . 0.0 109.608 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.658 ' HB2' HD22 ' A' ' 7' ' ' LEU . 57.6 m-85 -106.96 -173.34 2.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.256 -0.902 . . . . 0.0 109.231 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.504 ' CG ' ' HG2' ' A' ' 16' ' ' ARG . 78.8 mt-30 -131.04 151.58 51.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.182 -0.949 . . . . 0.0 109.676 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.691 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -160.68 -163.47 1.07 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.302 -0.874 . . . . 0.0 109.291 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.691 ' HB2' ' O ' ' A' ' 33' ' ' ALA . . . 164.41 -44.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.922 . . . . 0.0 109.591 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.472 ' OD1' ' HB2' ' A' ' 38' ' ' GLN . 45.7 p-10 -67.07 -8.51 31.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.22 -0.925 . . . . 0.0 109.569 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.432 ' HA3' ' SD ' ' A' ' 60' ' ' MET . . . 87.49 -68.01 3.18 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 36' ' ' GLY . 0.2 OUTLIER -45.06 -53.49 7.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.254 -1.145 . . . . 0.0 109.378 179.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.501 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 2.8 tp60 -48.99 -55.87 10.63 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.209 -0.932 . . . . 0.0 109.473 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 38' ' ' GLN . . . -43.85 -50.12 8.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.283 -0.885 . . . . 0.0 109.455 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 96.5 mt -55.63 -43.03 75.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.253 -0.904 . . . . 0.0 109.452 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.456 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 8.3 m-20 -62.55 -28.71 70.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.295 -0.878 . . . . 0.0 109.373 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.959 HG21 HD23 ' A' ' 7' ' ' LEU . 20.6 mm -75.92 -29.9 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.222 -0.924 . . . . 0.0 109.477 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.531 ' HA ' ' CD ' ' A' ' 48' ' ' PRO . 68.3 t -80.93 -25.24 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.272 -0.892 . . . . 0.0 109.417 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.471 ' HA ' ' HD2' ' A' ' 47' ' ' ARG . 4.1 m -87.14 -30.69 20.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.276 -0.89 . . . . 0.0 109.515 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 1.1 mtpt -89.99 -25.68 20.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.386 -0.821 . . . . 0.0 109.532 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -123.53 -31.59 3.48 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.206 -0.934 . . . . 0.0 109.56 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.525 ' CG ' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER 47.27 71.53 1.56 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.929 . . . . 0.0 109.481 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.531 ' CD ' ' HA ' ' A' ' 43' ' ' VAL . 34.5 Cg_endo -77.78 -178.54 4.68 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 122.683 2.255 . . . . 0.0 110.616 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.55 ' OD1' HD12 ' A' ' 119' ' ' LEU . 3.3 p30 -110.44 -20.02 12.74 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.412 -0.805 . . . . 0.0 109.185 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.955 HD21 HG22 ' A' ' 115' ' ' VAL . 7.4 tp -115.18 122.24 45.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.307 -0.871 . . . . 0.0 109.554 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.884 HG11 ' HE1' ' A' ' 69' ' ' MET . 1.8 t -126.08 115.47 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.29 -0.881 . . . . 0.0 109.508 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.809 HD12 ' O ' ' A' ' 7' ' ' LEU . 1.0 OUTLIER -89.98 108.31 19.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.235 -0.915 . . . . 0.0 109.433 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.729 HD21 ' HB ' ' A' ' 65' ' ' ILE . 1.1 tp -97.69 119.13 35.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.16 -0.963 . . . . 0.0 109.429 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.508 ' HB2' ' CE ' ' A' ' 81' ' ' MET . 40.7 t0 -100.62 104.1 15.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 109.423 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.459 ' HB2' ' HB ' ' A' ' 82' ' ' THR . 2.8 mmt -65.26 -10.42 31.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.306 -0.871 . . . . 0.0 109.452 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.473 ' HB2' ' OD2' ' A' ' 54' ' ' ASP . 3.3 mmtp -66.04 -24.72 66.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.209 -0.932 . . . . 0.0 109.459 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.771 HD11 HG12 ' A' ' 9' ' ' VAL . 48.9 mt -43.12 103.12 0.3 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.368 -0.832 . . . . 0.0 109.533 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.482 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 35.3 Cg_endo -77.94 119.73 4.82 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.396 2.064 . . . . 0.0 110.388 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 108.55 5.83 31.49 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.448 ' HE2' HG21 ' A' ' 57' ' ' ILE . 24.9 ttp -165.13 127.33 2.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -1.161 . . . . 0.0 109.408 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -89.71 120.13 30.72 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -0.908 . . . . 0.0 109.423 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.455 ' HA2' HG13 ' A' ' 65' ' ' ILE . . . -67.87 -7.83 50.75 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.5 mm -53.08 -40.12 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.184 -1.186 . . . . 0.0 109.507 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -68.68 -44.1 74.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.216 -0.927 . . . . 0.0 109.418 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.729 ' HB ' HD21 ' A' ' 53' ' ' LEU . 11.4 mt -46.4 -51.86 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.258 -0.901 . . . . 0.0 109.491 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.724 ' CD2' HD22 ' A' ' 53' ' ' LEU . 55.2 mt -56.56 -41.06 76.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.289 -0.882 . . . . 0.0 109.428 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.567 ' O ' HG23 ' A' ' 71' ' ' VAL . 1.3 tttm -54.73 -41.01 69.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.226 -0.921 . . . . 0.0 109.493 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.07 -21.19 54.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 109.441 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.884 ' HE1' HG11 ' A' ' 51' ' ' VAL . 14.3 mtt -72.13 -40.08 68.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.261 -0.9 . . . . 0.0 109.439 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.524 ' CE ' ' O ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -79.72 -37.63 35.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.272 -0.892 . . . . 0.0 109.522 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 67' ' ' LYS . 97.5 t -65.46 -32.67 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.22 -0.925 . . . . 0.0 109.445 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.426 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 45.0 mm -89.65 -27.29 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.227 -0.921 . . . . 0.0 109.453 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.456 ' O ' ' O ' ' A' ' 69' ' ' MET . 15.7 m-20 -163.42 130.26 3.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.267 -0.895 . . . . 0.0 109.471 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -89.98 -10.88 43.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.229 -0.919 . . . . 0.0 109.48 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -106.94 50.23 0.78 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.288 -0.882 . . . . 0.0 109.445 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.468 ' O ' HG23 ' A' ' 76' ' ' ILE . 0.8 OUTLIER -117.94 122.98 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.269 -0.894 . . . . 0.0 109.519 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.5 ' HA ' HD11 ' A' ' 99' ' ' LEU . 10.4 mtt180 -79.31 141.66 36.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.209 -0.932 . . . . 0.0 109.426 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.671 HG13 ' HB ' ' A' ' 51' ' ' VAL . 2.7 t -147.74 119.06 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.886 . . . . 0.0 109.603 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.644 HG23 ' HB ' ' A' ' 100' ' ' THR . 23.5 mt -89.87 170.6 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 0.0 109.297 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.774 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.0 OUTLIER -134.88 126.86 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.198 -0.938 . . . . 0.0 109.435 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.508 ' CE ' ' HB2' ' A' ' 54' ' ' ASP . 20.7 mtm -110.01 84.22 1.89 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 109.181 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.85 HG22 ' NE2' ' A' ' 101' ' ' HIS . 4.7 t -149.67 -146.99 0.21 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.214 -0.929 . . . . 0.0 109.497 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.808 ' N ' HG23 ' A' ' 82' ' ' THR . . . . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.407 -0.808 . . . . 0.0 109.918 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.514 HG23 ' HD1' ' A' ' 101' ' ' HIS . 6.5 mt . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.81 -38.31 21.73 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.286 -0.884 . . . . 0.0 109.492 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.464 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 0.6 OUTLIER -90.03 -38.03 13.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.936 . . . . 0.0 109.514 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.473 ' O ' ' CB ' ' A' ' 98' ' ' ALA . 14.2 m -63.19 -12.15 26.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.254 -0.904 . . . . 0.0 109.554 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.411 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 1.2 tptp -71.96 -71.6 0.27 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.275 -0.89 . . . . 0.0 109.464 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -66.45 -13.22 60.48 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.35 -0.844 . . . . 0.0 109.422 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.512 ' HB3' ' NZ ' ' A' ' 70' ' ' LYS . 32.9 mt -74.55 -50.57 17.54 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.185 -0.947 . . . . 0.0 109.38 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 172.99 45.78 0.05 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.473 ' CB ' ' O ' ' A' ' 93' ' ' SER . . . -132.06 146.38 52.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -1.156 . . . . 0.0 109.411 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.5 HD11 ' HA ' ' A' ' 77' ' ' ARG . 0.4 OUTLIER -128.04 -60.32 1.15 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.336 -0.852 . . . . 0.0 109.489 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.691 HG23 ' CZ ' ' A' ' 102' ' ' PHE . 17.1 m -102.97 148.96 25.02 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.263 -0.898 . . . . 0.0 109.571 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.85 ' NE2' HG22 ' A' ' 82' ' ' THR . 2.8 t-160 -144.84 93.77 2.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.892 . . . . 0.0 109.347 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.691 ' CZ ' HG23 ' A' ' 100' ' ' THR . 18.7 m-30 -111.9 161.61 16.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.896 . . . . 0.0 109.587 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 82' ' ' THR . . . -113.51 -159.99 0.71 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.309 -0.87 . . . . 0.0 109.443 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.551 ' HE3' HD11 ' A' ' 15' ' ' ILE . 3.7 mttt -100.37 152.55 37.86 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.232 -0.918 . . . . 0.0 109.498 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.583 ' O ' ' CG ' ' A' ' 106' ' ' PHE . 37.1 Cg_endo -81.62 28.15 4.52 Favored 'Cis proline' 0 C--N 1.309 -1.506 0 C-N-CA 123.371 -1.512 . . . . 0.0 111.126 -0.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.583 ' CG ' ' O ' ' A' ' 105' ' ' PRO . 52.1 p90 41.46 -164.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.37 -0.831 . . . . 0.0 109.844 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.472 ' O ' HG12 ' A' ' 111' ' ' ILE . 30.5 t0 -150.1 118.7 6.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.87 . . . . 0.0 109.461 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.56 HG23 HG21 ' A' ' 22' ' ' VAL . 12.7 mm -54.12 -19.73 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.25 -0.906 . . . . 0.0 109.393 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -75.75 -57.27 3.98 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.192 -0.942 . . . . 0.0 109.427 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -59.66 -24.18 63.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.179 -0.951 . . . . 0.0 109.491 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.472 HG12 ' O ' ' A' ' 107' ' ' ASP . 22.9 mm -74.12 -56.29 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.305 -0.872 . . . . 0.0 109.46 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.414 ' HG2' ' O ' ' A' ' 108' ' ' ILE . 2.5 ptt180 -60.04 -23.62 63.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.202 -0.936 . . . . 0.0 109.533 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -76.1 -63.25 1.36 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.32 -0.863 . . . . 0.0 109.482 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.507 ' O ' ' CD2' ' A' ' 118' ' ' TYR . . . -51.07 -31.87 20.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.244 -0.91 . . . . 0.0 109.381 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.955 HG22 HD21 ' A' ' 50' ' ' LEU . 72.6 t -75.44 -36.32 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.232 -0.918 . . . . 0.0 109.411 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.409 ' HE2' ' HB3' ' A' ' 116' ' ' LYS . 0.4 OUTLIER -69.44 -21.1 63.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.233 -0.917 . . . . 0.0 109.465 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -89.48 -40.06 12.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.211 -0.931 . . . . 0.0 109.52 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.507 ' CD2' ' O ' ' A' ' 114' ' ' ALA . 26.2 m-85 -76.13 -63.3 1.35 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 0.0 109.487 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.653 HD23 ' C ' ' A' ' 119' ' ' LEU . 4.1 tt -90.19 112.42 52.46 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 0.0 109.445 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.609 ' N ' HD23 ' A' ' 119' ' ' LEU . 35.9 Cg_endo -78.07 151.51 27.18 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.429 2.086 . . . . 0.0 110.402 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.695 HD23 ' HE2' ' A' ' 28' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.275 -0.891 . . . . 0.0 109.491 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.542 ' CD ' ' N ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -136.76 154.51 50.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.244 -0.91 . . . . 0.0 109.51 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.767 HD12 HG22 ' A' ' 30' ' ' THR . 4.3 mt -150.09 159.54 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.228 -0.92 . . . . 0.0 109.379 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.721 ' C ' HD13 ' A' ' 7' ' ' LEU . 2.8 tm? -132.22 107.62 8.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.256 -0.903 . . . . 0.0 109.382 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.454 ' N ' HD13 ' A' ' 7' ' ' LEU . 4.2 mt -94.81 110.51 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 0.0 109.451 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.771 ' HA ' ' HB3' ' A' ' 33' ' ' ALA . 61.1 t -95.46 109.49 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.231 -0.918 . . . . 0.0 109.44 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.54 ' CB ' ' HD2' ' A' ' 16' ' ' ARG . 4.2 m-20 -148.96 110.39 4.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.253 -0.904 . . . . 0.0 109.469 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.479 ' OD2' ' HD2' ' A' ' 58' ' ' PRO . 5.5 p-10 -76.38 -33.55 58.89 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 109.43 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.448 ' O ' ' O ' ' A' ' 13' ' ' TYR . 27.1 tt0 -78.77 104.24 9.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.25 -0.906 . . . . 0.0 109.5 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 1.046 ' CE2' HD11 ' A' ' 17' ' ' ILE . 2.6 t80 -44.56 168.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.205 -0.935 . . . . 0.0 109.509 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.77 -66.16 0.33 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.772 HG23 HD13 ' A' ' 19' ' ' LEU . 2.3 mt -63.4 -63.41 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.301 -1.117 . . . . 0.0 109.275 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.551 ' HB2' ' CG ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -42.23 -26.69 0.11 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.354 -0.841 . . . . 0.0 109.95 -179.804 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 1.046 HD11 ' CE2' ' A' ' 13' ' ' TYR . 20.6 mt -79.22 -59.63 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.106 -0.996 . . . . 0.0 109.761 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.783 ' O ' HG23 ' A' ' 22' ' ' VAL . 11.0 mp -53.28 -57.13 11.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.925 . . . . 0.0 109.721 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.772 HD13 HG23 ' A' ' 15' ' ' ILE . 7.3 mp -57.18 -22.51 41.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.235 -0.915 . . . . 0.0 109.578 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 23.6 t30 -75.84 -72.38 0.32 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.308 -0.87 . . . . 0.0 109.549 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -52.91 -19.96 2.97 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.343 -0.848 . . . . 0.0 109.642 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.783 HG23 ' O ' ' A' ' 18' ' ' LEU . 77.2 t -77.85 -58.77 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.187 -0.945 . . . . 0.0 109.39 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.428 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 13.8 m-85 -66.68 -11.18 53.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.192 -0.943 . . . . 0.0 109.349 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.446 ' OD1' ' O ' ' A' ' 20' ' ' ASN . 21.7 m120 -73.31 -61.2 1.91 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.282 -0.886 . . . . 0.0 109.404 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -18.78 63.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.236 -0.915 . . . . 0.0 109.265 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.538 ' HB3' ' CD2' ' A' ' 28' ' ' TYR . 2.7 mt-10 -75.52 -34.18 60.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.299 -0.876 . . . . 0.0 109.41 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.2 46.51 0.75 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.549 ' OH ' HD12 ' A' ' 121' ' ' LEU . 94.1 m-85 -139.0 134.56 33.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.269 -1.136 . . . . 0.0 109.529 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -91.01 83.63 5.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.099 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.767 HG22 HD12 ' A' ' 6' ' ' ILE . 5.7 p -89.74 150.56 22.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.939 . . . . 0.0 109.616 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.558 ' CZ ' ' OE2' ' A' ' 46' ' ' GLU . 17.8 m-85 -111.95 -168.38 1.31 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.302 -0.874 . . . . 0.0 109.264 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.551 ' CG ' ' HB2' ' A' ' 16' ' ' ARG . 0.6 OUTLIER -132.26 150.05 52.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.178 -0.951 . . . . 0.0 109.687 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.771 ' HB3' ' HA ' ' A' ' 9' ' ' VAL . . . -146.38 -174.4 4.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.229 -0.919 . . . . 0.0 109.349 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.612 ' O ' HD13 ' A' ' 57' ' ' ILE . . . -175.98 -57.02 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.176 -0.952 . . . . 0.0 109.619 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -81.18 0.21 37.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 109.591 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.414 ' O ' ' HB3' ' A' ' 39' ' ' ALA . . . 86.17 -53.78 4.65 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.472 HD13 ' HA ' ' A' ' 37' ' ' LEU . 2.3 mm? -45.08 -59.06 2.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -1.148 . . . . 0.0 109.549 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.565 ' O ' HD12 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -51.96 -38.17 55.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 0.0 109.496 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.464 ' O ' ' HB ' ' A' ' 43' ' ' VAL . . . -60.16 -38.44 83.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.904 . . . . 0.0 109.551 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.541 ' HA ' ' CG1' ' A' ' 43' ' ' VAL . 35.4 mt -76.25 -20.93 56.94 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.391 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.506 ' O ' ' CG ' ' A' ' 45' ' ' LYS . 0.8 OUTLIER -75.38 -40.23 58.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.132 -0.98 . . . . 0.0 109.041 179.705 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.565 HD12 ' O ' ' A' ' 38' ' ' GLN . 1.8 mp -83.86 -24.76 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.337 -0.852 . . . . 0.0 109.245 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.541 ' CG1' ' HA ' ' A' ' 40' ' ' LEU . 1.5 p -72.63 -38.88 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.265 -0.897 . . . . 0.0 109.236 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.434 ' N ' ' CG1' ' A' ' 43' ' ' VAL . 7.8 m -90.03 -22.86 21.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.361 -0.837 . . . . 0.0 109.438 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.506 ' CG ' ' O ' ' A' ' 41' ' ' ASP . 58.3 mttt -75.32 -54.42 7.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.21 -0.931 . . . . 0.0 109.618 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.558 ' OE2' ' CZ ' ' A' ' 31' ' ' PHE . 0.6 OUTLIER -91.34 -29.83 16.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.9 . . . . 0.0 109.632 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.527 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 0.0 OUTLIER 71.24 61.64 0.43 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.267 -0.896 . . . . 0.0 109.472 -179.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.535 ' CD ' ' HA ' ' A' ' 43' ' ' VAL . 35.4 Cg_endo -77.95 155.49 30.22 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.63 2.22 . . . . 0.0 110.462 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.451 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 0.3 OUTLIER -101.51 -9.02 21.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.26 -0.9 . . . . 0.0 109.477 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.686 HD21 HG22 ' A' ' 115' ' ' VAL . 9.1 tp -124.79 116.51 22.41 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.203 -0.935 . . . . 0.0 109.517 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.569 HG11 ' HE1' ' A' ' 69' ' ' MET . 43.3 t -128.38 118.08 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.176 -0.953 . . . . 0.0 109.472 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.535 HD23 ' HB ' ' A' ' 79' ' ' ILE . 0.7 OUTLIER -89.95 119.09 30.02 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.196 -0.94 . . . . 0.0 109.45 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.571 HD22 ' HG ' ' A' ' 66' ' ' LEU . 1.2 mp -104.1 138.24 40.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.32 -0.863 . . . . 0.0 109.446 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.43 ' O ' HG13 ' A' ' 57' ' ' ILE . 26.3 t70 -114.5 110.81 20.4 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.22 -0.925 . . . . 0.0 109.516 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.841 ' HB2' HG21 ' A' ' 82' ' ' THR . 24.5 mmt -73.34 -2.42 22.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.206 -0.934 . . . . 0.0 109.608 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.463 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 16.2 mmtt -85.35 13.16 6.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.156 -0.965 . . . . 0.0 109.552 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.924 HG21 ' HE1' ' A' ' 60' ' ' MET . 40.2 mt -78.48 114.29 41.75 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.27 -0.894 . . . . 0.0 109.417 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.479 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 35.7 Cg_endo -78.23 107.02 2.24 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.376 2.051 . . . . 0.0 110.375 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 155.13 -44.0 0.56 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.924 ' HE1' HG21 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -158.99 163.46 36.44 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.168 -1.196 . . . . 0.0 109.427 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -89.88 144.83 25.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.209 -0.932 . . . . 0.0 109.559 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.465 ' O ' ' HB ' ' A' ' 65' ' ' ILE . . . -87.2 -1.22 84.44 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.8 mm -52.69 -52.83 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.201 -1.176 . . . . 0.0 109.464 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -61.22 -27.08 68.18 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.186 -0.946 . . . . 0.0 109.365 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.465 ' HB ' ' O ' ' A' ' 62' ' ' GLY . 19.4 mt -63.23 -66.7 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.316 -0.865 . . . . 0.0 109.456 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.963 HD21 HG11 ' A' ' 78' ' ' VAL . 16.4 mt -46.05 -25.56 0.59 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.91 . . . . 0.0 109.448 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.475 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 2.4 tmtp? -68.49 -60.26 2.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -0.895 . . . . 0.0 109.503 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.48 -29.04 61.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.263 -0.898 . . . . 0.0 109.428 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.569 ' HE1' HG11 ' A' ' 51' ' ' VAL . 3.1 mmt -64.78 -62.53 1.51 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.186 -0.946 . . . . 0.0 109.433 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 16.9 ptpt -51.84 -39.14 58.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.305 -0.872 . . . . 0.0 109.425 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 67' ' ' LYS . 86.4 t -58.6 -40.6 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.189 -0.945 . . . . 0.0 109.473 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.41 ' O ' ' OD1' ' A' ' 73' ' ' ASP . 15.6 mt -73.77 -25.94 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.211 -0.931 . . . . 0.0 109.433 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.429 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 0.1 OUTLIER -173.22 140.35 0.86 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 109.497 -180.0 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -89.76 -17.9 27.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.272 -0.893 . . . . 0.0 109.441 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -86.0 11.1 12.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.258 -0.901 . . . . 0.0 109.434 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.742 ' O ' HG23 ' A' ' 76' ' ' ILE . 2.1 tp -82.39 106.15 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.226 -0.921 . . . . 0.0 109.471 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.532 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 0.4 OUTLIER -77.3 154.16 33.15 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.29 -0.881 . . . . 0.0 109.514 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.963 HG11 HD21 ' A' ' 66' ' ' LEU . 43.0 t -147.03 121.65 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 109.545 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.535 ' HB ' HD23 ' A' ' 52' ' ' LEU . 3.6 mm -97.21 122.58 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.229 -0.919 . . . . 0.0 109.444 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.916 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.3 OUTLIER -90.05 126.2 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.279 -0.888 . . . . 0.0 109.293 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.561 ' SD ' ' CZ ' ' A' ' 106' ' ' PHE . 2.2 mtm -101.28 54.38 0.83 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.131 -0.981 . . . . 0.0 109.565 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.841 HG21 ' HB2' ' A' ' 55' ' ' MET . 14.8 t -168.64 56.25 0.05 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.3 -0.875 . . . . 0.0 109.444 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.82 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.879 . . . . 0.0 109.549 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.632 ' CD1' ' CE1' ' A' ' 101' ' ' HIS . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.723 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -58.3 -39.61 79.78 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.32 -0.863 . . . . 0.0 109.615 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -89.81 -16.22 30.64 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 109.547 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.746 ' HA ' HD12 ' A' ' 96' ' ' LEU . 0.6 OUTLIER -55.85 -19.0 10.11 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.26 -0.9 . . . . 0.0 109.51 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.419 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 2.2 mmmt -48.43 -61.32 2.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.261 -0.899 . . . . 0.0 109.495 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.408 ' O ' ' C ' ' A' ' 96' ' ' LEU . 4.9 mt-10 -65.42 -41.88 93.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.256 -0.903 . . . . 0.0 109.509 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.746 HD12 ' HA ' ' A' ' 93' ' ' SER . 81.6 mt -44.19 -38.86 4.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.226 -0.921 . . . . 0.0 109.457 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 143.61 40.08 0.06 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.419 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -102.91 99.06 8.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.222 -1.163 . . . . 0.0 109.486 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.727 HD22 ' CD1' ' A' ' 118' ' ' TYR . 16.9 mt -51.72 -68.03 0.2 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.255 -0.903 . . . . 0.0 109.498 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.586 HG22 ' N ' ' A' ' 101' ' ' HIS . 17.1 m -135.81 165.84 24.69 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.207 -0.933 . . . . 0.0 109.551 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.916 ' ND1' HD12 ' A' ' 80' ' ' ILE . 4.1 t60 -130.26 84.27 2.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.367 -0.833 . . . . 0.0 109.359 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.575 ' CE2' ' HA ' ' A' ' 111' ' ' ILE . 9.3 m-85 -70.28 157.19 38.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.215 -0.928 . . . . 0.0 109.485 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.82 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -132.46 -148.67 0.35 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 0.0 109.476 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.446 ' HB2' ' HA ' ' A' ' 105' ' ' PRO . 2.0 pttp -96.78 157.26 35.47 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.901 . . . . 0.0 109.494 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.446 ' HA ' ' HB2' ' A' ' 104' ' ' LYS . 36.3 Cg_endo -79.76 11.2 23.9 Favored 'Cis proline' 0 C--N 1.309 -1.518 0 C-N-CA 123.285 -1.548 . . . . 0.0 110.802 -0.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.686 ' CE2' HD21 ' A' ' 19' ' ' LEU . 11.4 t80 70.93 96.59 0.07 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.212 -0.93 . . . . 0.0 109.437 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.466 ' O ' HG12 ' A' ' 111' ' ' ILE . 21.3 t0 -89.88 118.32 29.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 0.0 109.385 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.591 HG22 ' HE ' ' A' ' 112' ' ' ARG . 13.4 mm -51.24 -39.1 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.168 -0.958 . . . . 0.0 109.339 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.439 ' HB2' ' OD2' ' A' ' 107' ' ' ASP . 3.2 m-20 -63.05 -37.33 86.75 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.288 -0.882 . . . . 0.0 109.373 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.574 ' HG3' ' CE1' ' A' ' 102' ' ' PHE . 3.0 tp10 -69.08 -33.5 73.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.292 -0.88 . . . . 0.0 109.257 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.631 ' CD1' ' CE1' ' A' ' 106' ' ' PHE . 10.5 mm -66.35 -54.96 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.3 -0.875 . . . . 0.0 109.272 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.591 ' HE ' HG22 ' A' ' 108' ' ' ILE . 3.9 mtm180 -57.46 -33.6 68.13 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.311 -0.868 . . . . 0.0 109.486 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -62.66 -62.09 1.97 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.234 -0.916 . . . . 0.0 109.768 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.425 ' O ' ' C ' ' A' ' 115' ' ' VAL . . . -58.56 -62.99 1.45 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.166 -0.958 . . . . 0.0 109.734 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.686 HG22 HD21 ' A' ' 50' ' ' LEU . 55.8 t -42.77 -39.09 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.357 -0.839 . . . . 0.0 109.867 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 1.4 mttt -63.48 -58.95 5.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.218 -0.926 . . . . 0.0 109.668 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -49.64 -60.03 3.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.2 -0.938 . . . . 0.0 109.603 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.727 ' CD1' HD22 ' A' ' 99' ' ' LEU . 65.6 m-85 -54.81 -73.91 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.237 -0.915 . . . . 0.0 109.601 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.718 HD23 ' O ' ' A' ' 120' ' ' PRO . 5.8 tt -90.15 112.47 52.66 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.926 . . . . 0.0 109.538 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.718 ' O ' HD23 ' A' ' 119' ' ' LEU . 35.6 Cg_endo -78.44 -159.39 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.389 2.059 . . . . 0.0 110.27 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.549 HD12 ' OH ' ' A' ' 28' ' ' TYR . 1.3 mt . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.939 . . . . 0.0 109.439 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.474 ' HB2' ' HA ' ' A' ' 48' ' ' PRO . 10.6 mttm -105.58 135.76 46.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.298 -0.876 . . . . 0.0 109.497 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.533 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 68.9 mt -150.12 146.17 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.252 -0.905 . . . . 0.0 109.468 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 1.015 HD11 HD13 ' A' ' 42' ' ' ILE . 0.9 OUTLIER -124.8 133.07 53.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.263 -0.898 . . . . 0.0 109.405 179.905 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.618 HD13 ' HB3' ' A' ' 19' ' ' LEU . 14.1 mt -102.71 113.72 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.184 -0.948 . . . . 0.0 109.503 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.548 ' CG2' HD23 ' A' ' 7' ' ' LEU . 13.7 t -105.77 94.48 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.17 -0.957 . . . . 0.0 109.444 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.516 ' O ' ' CD ' ' A' ' 16' ' ' ARG . 31.2 t70 -145.86 116.96 7.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.911 . . . . 0.0 109.473 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.524 ' OD2' ' CD ' ' A' ' 58' ' ' PRO . 5.8 p-10 -77.98 -46.03 22.21 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -0.902 . . . . 0.0 109.482 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.477 ' CG ' ' O ' ' A' ' 12' ' ' GLN . 3.2 pt20 -56.27 101.09 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.292 -0.88 . . . . 0.0 109.474 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 1.15 ' CE2' HD11 ' A' ' 17' ' ' ILE . 2.7 t80 -45.83 141.94 2.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.307 -0.871 . . . . 0.0 109.499 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 132.25 -53.08 0.81 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.414 ' O ' ' C ' ' A' ' 16' ' ' ARG . 2.7 mp -75.34 -53.41 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.255 -1.144 . . . . 0.0 109.445 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.516 ' CD ' ' O ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -43.89 -26.53 0.27 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.258 -0.901 . . . . 0.0 109.614 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 1.15 HD11 ' CE2' ' A' ' 13' ' ' TYR . 2.3 mt -90.12 -60.39 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.211 -0.93 . . . . 0.0 109.886 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.824 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.9 OUTLIER -50.4 -60.55 2.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.149 -0.969 . . . . 0.0 109.892 -179.697 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.832 HD11 HG21 ' A' ' 111' ' ' ILE . 1.5 tp -56.3 -24.23 42.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.304 -0.872 . . . . 0.0 109.873 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 25.4 t30 -71.85 -69.83 0.37 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.123 -0.986 . . . . 0.0 109.81 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 0.7 OUTLIER -47.6 -41.47 21.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.29 -0.881 . . . . 0.0 109.706 -179.787 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.824 HG23 ' O ' ' A' ' 18' ' ' LEU . 40.4 t -56.33 -60.52 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.244 -0.91 . . . . 0.0 109.606 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.629 ' CB ' HG21 ' A' ' 30' ' ' THR . 22.0 m-85 -69.41 -6.19 28.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 0.0 109.612 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 0.7 OUTLIER -77.39 -54.83 5.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.21 -0.931 . . . . 0.0 109.286 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt -78.31 -12.2 59.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.317 -0.865 . . . . 0.0 109.289 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.446 ' HB2' ' HA ' ' A' ' 23' ' ' PHE . 3.1 mm-40 -77.09 -43.58 33.77 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.249 -0.907 . . . . 0.0 109.461 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.69 50.67 0.32 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.635 ' CZ ' ' CD1' ' A' ' 121' ' ' LEU . 98.7 m-85 -140.81 140.47 34.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.229 -1.159 . . . . 0.0 109.527 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -90.02 82.87 6.08 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.229 -0.92 . . . . 0.0 109.291 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.629 HG21 ' CB ' ' A' ' 23' ' ' PHE . 5.8 p -89.91 153.8 20.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 109.55 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.533 ' CD2' ' O ' ' A' ' 6' ' ' ILE . 7.9 m-85 -120.99 -158.25 0.75 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -0.893 . . . . 0.0 109.338 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.465 ' HG2' ' HG2' ' A' ' 16' ' ' ARG . 73.9 mt-30 -144.05 157.86 44.07 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.208 -0.932 . . . . 0.0 109.663 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.446 ' HB3' HG22 ' A' ' 9' ' ' VAL . . . -170.99 161.34 6.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.876 . . . . 0.0 109.235 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.608 ' O ' HD13 ' A' ' 57' ' ' ILE . . . -127.55 -57.9 1.27 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.197 -0.939 . . . . 0.0 109.713 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.521 ' OD1' ' CB ' ' A' ' 37' ' ' LEU . 4.1 p30 -90.4 136.47 33.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.209 -0.932 . . . . 0.0 109.483 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.55 ' HA3' ' CD1' ' A' ' 65' ' ' ILE . . . -45.1 -29.11 2.13 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.521 ' CB ' ' OD1' ' A' ' 35' ' ' ASN . 0.2 OUTLIER -47.7 -53.61 14.55 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.326 -1.102 . . . . 0.0 109.382 179.853 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.459 ' O ' ' C ' ' A' ' 39' ' ' ALA . 11.4 mt-30 -62.3 -51.07 69.16 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.245 -0.909 . . . . 0.0 109.393 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.562 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -39.92 -37.99 0.64 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.443 -0.786 . . . . 0.0 109.804 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.7 mt -77.5 -45.05 26.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.0 109.61 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -56.26 -62.01 2.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.206 -0.934 . . . . 0.0 109.626 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 1.015 HD13 HD11 ' A' ' 7' ' ' LEU . 10.4 mt -56.67 -51.72 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.894 . . . . 0.0 109.753 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 39' ' ' ALA . 45.0 t -54.06 -22.67 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.166 -0.959 . . . . 0.0 109.704 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.0 m -89.95 -28.39 19.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.182 -0.949 . . . . 0.0 109.837 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.435 ' C ' ' HG2' ' A' ' 46' ' ' GLU . 4.1 mmmt -90.2 -6.59 55.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.208 -0.932 . . . . 0.0 109.59 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.528 ' OE1' ' CZ ' ' A' ' 31' ' ' PHE . 2.5 mt-10 -137.26 -36.2 0.66 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.242 -0.911 . . . . 0.0 109.451 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.45 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 75.3 mtm-85 58.56 65.01 3.2 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.321 -0.862 . . . . 0.0 109.462 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.536 ' CD ' ' HA ' ' A' ' 43' ' ' VAL . 35.2 Cg_endo -77.02 159.4 34.0 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.578 2.185 . . . . 0.0 110.437 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 89.1 m-20 -96.3 -5.45 40.09 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.274 -0.891 . . . . 0.0 109.656 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.479 ' CD2' HG13 ' A' ' 115' ' ' VAL . 5.2 tp -129.39 123.55 31.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.169 -0.957 . . . . 0.0 109.593 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.7 ' HB ' HG22 ' A' ' 78' ' ' VAL . 22.0 t -132.09 118.81 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.351 -0.843 . . . . 0.0 109.537 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.652 HD12 ' O ' ' A' ' 7' ' ' LEU . 1.2 mp -90.05 113.35 25.04 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -0.912 . . . . 0.0 109.42 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.523 ' CD2' ' HG ' ' A' ' 66' ' ' LEU . 1.2 mp -104.79 130.88 52.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.375 -0.828 . . . . 0.0 109.585 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.487 ' HA ' ' HG3' ' A' ' 81' ' ' MET . 32.8 t70 -108.58 105.72 15.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.288 -0.882 . . . . 0.0 109.244 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.579 ' CG ' HG21 ' A' ' 82' ' ' THR . 7.5 mtp -71.64 -4.12 25.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -0.916 . . . . 0.0 109.534 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.402 ' HE3' ' CB ' ' A' ' 82' ' ' THR . 8.1 mttp -86.07 15.08 5.38 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.116 -0.99 . . . . 0.0 109.508 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.608 HD13 ' O ' ' A' ' 34' ' ' ALA . 53.8 mt -74.13 132.65 79.26 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.188 -0.945 . . . . 0.0 109.41 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.524 ' CD ' ' OD2' ' A' ' 11' ' ' ASP . 36.7 Cg_endo -80.54 41.9 1.23 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.624 2.216 . . . . 0.0 110.7 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -133.57 -56.72 0.07 OUTLIER Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.505 ' N ' ' SD ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -156.96 -178.54 7.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.311 -1.111 . . . . 0.0 109.532 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -90.08 142.36 27.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.266 -0.896 . . . . 0.0 109.505 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.442 ' HA2' HG13 ' A' ' 65' ' ' ILE . . . -77.63 -9.42 86.89 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.455 HD13 ' HA ' ' A' ' 63' ' ' ILE . 17.6 mm -51.11 -55.72 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -1.16 . . . . 0.0 109.394 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -55.84 -39.24 71.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.259 -0.9 . . . . 0.0 109.479 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.55 ' CD1' ' HA3' ' A' ' 36' ' ' GLY . 13.8 mt -53.4 -69.46 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.201 -0.937 . . . . 0.0 109.463 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 1.052 HD21 HG11 ' A' ' 78' ' ' VAL . 93.1 mt -43.62 -48.37 7.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.158 -0.963 . . . . 0.0 109.68 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.562 ' O ' HG23 ' A' ' 71' ' ' VAL . 2.1 mmtt -43.17 -58.11 2.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 109.704 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.44 ' O ' HG13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -61.6 -32.59 72.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.171 -0.956 . . . . 0.0 109.588 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.597 ' SD ' HD23 ' A' ' 66' ' ' LEU . 78.7 mtp -66.0 -23.66 66.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.321 -0.862 . . . . 0.0 109.591 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -84.0 -41.98 16.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.225 -0.922 . . . . 0.0 108.942 179.904 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 67' ' ' LYS . 2.5 t -62.09 -31.99 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.486 -0.759 . . . . 0.0 109.522 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 68' ' ' ARG . 11.3 mt -84.01 -39.86 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.232 -0.918 . . . . 0.0 109.447 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -143.13 132.75 23.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.289 -0.882 . . . . 0.0 109.379 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -90.01 -23.58 21.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.272 -0.892 . . . . 0.0 109.527 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -99.41 47.97 0.95 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.289 -0.882 . . . . 0.0 109.467 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.1 tt -107.68 134.54 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.262 -0.899 . . . . 0.0 109.478 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.536 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 0.5 OUTLIER -104.03 141.2 36.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.241 -0.912 . . . . 0.0 109.466 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 1.052 HG11 HD21 ' A' ' 66' ' ' LEU . 82.4 t -139.37 118.76 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -0.906 . . . . 0.0 109.557 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.933 HG23 HG23 ' A' ' 100' ' ' THR . 5.1 mm -89.96 122.4 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.287 -0.883 . . . . 0.0 109.162 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.862 HD12 ' HD1' ' A' ' 101' ' ' HIS . 0.1 OUTLIER -89.87 143.29 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.174 -0.954 . . . . 0.0 109.375 -179.876 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.487 ' HG3' ' HA ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -117.68 71.17 0.81 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.185 -0.947 . . . . 0.0 109.255 179.79 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.579 HG21 ' CG ' ' A' ' 55' ' ' MET . 13.4 t -176.15 31.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.346 -0.846 . . . . 0.0 109.536 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.79 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.206 -0.934 . . . . 0.0 109.499 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.938 HD12 ' CE1' ' A' ' 101' ' ' HIS . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -55.68 -40.37 72.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 0.0 109.493 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.433 ' O ' ' C ' ' A' ' 93' ' ' SER . 29.9 mm-40 -90.06 -38.48 13.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.209 -0.932 . . . . 0.0 109.649 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.764 ' HA ' HD12 ' A' ' 96' ' ' LEU . 1.2 m -43.34 -39.36 3.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.306 -0.871 . . . . 0.0 109.551 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.909 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 6.6 mttp -44.3 -55.62 4.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 109.387 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -58.71 -43.56 90.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.243 -0.911 . . . . 0.0 109.463 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.764 HD12 ' HA ' ' A' ' 93' ' ' SER . 79.0 mt -47.2 -63.87 0.93 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.325 -0.859 . . . . 0.0 109.474 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 179.93 36.64 0.07 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.909 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -99.85 99.66 10.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -1.15 . . . . 0.0 109.503 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.598 HD13 ' CG ' ' A' ' 118' ' ' TYR . 16.7 mt -48.87 -62.74 1.36 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.323 -0.861 . . . . 0.0 109.516 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.933 HG23 HG23 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -144.39 176.42 9.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.154 -0.966 . . . . 0.0 109.577 -179.925 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.938 ' CE1' HD12 ' A' ' 90' ' ' ILE . 3.5 t-160 -141.51 94.01 2.64 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.343 -0.848 . . . . 0.0 109.235 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.734 ' HZ ' ' HB2' ' A' ' 114' ' ' ALA . 7.9 m-85 -82.12 160.9 23.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.265 -0.897 . . . . 0.0 109.696 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.79 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -140.43 -148.58 0.25 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.236 -0.915 . . . . 0.0 109.281 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.55 145.48 30.54 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.164 -0.96 . . . . 0.0 109.302 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.0 151.96 91.4 Favored 'Cis proline' 0 C--N 1.309 -1.551 0 C-N-CA 123.289 -1.546 . . . . 0.0 110.437 -0.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.733 ' CZ ' HD12 ' A' ' 111' ' ' ILE . 0.5 OUTLIER -83.05 103.89 12.84 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -0.893 . . . . 0.0 109.457 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.473 ' O ' HG12 ' A' ' 111' ' ' ILE . 48.2 t0 -89.84 103.0 15.69 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.106 -0.996 . . . . 0.0 109.401 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.457 ' O ' ' HG2' ' A' ' 112' ' ' ARG . 19.8 mm -43.31 -26.95 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.31 -0.869 . . . . 0.0 109.698 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.44 -47.96 44.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.897 . . . . 0.0 109.576 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.472 ' HG3' ' OD2' ' A' ' 107' ' ' ASP . 41.5 mt-10 -66.91 -22.94 65.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 109.332 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.832 HG21 HD11 ' A' ' 19' ' ' LEU . 16.2 mm -75.43 -56.4 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.34 -0.85 . . . . 0.0 109.293 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 108' ' ' ILE . 0.6 OUTLIER -63.83 -22.17 66.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.269 -0.894 . . . . 0.0 109.477 179.948 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -73.84 -51.46 16.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.94 . . . . 0.0 109.497 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.734 ' HB2' ' HZ ' ' A' ' 102' ' ' PHE . . . -63.35 -55.77 21.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.3 -0.875 . . . . 0.0 109.458 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.479 HG13 ' CD2' ' A' ' 50' ' ' LEU . 54.0 t -50.17 -52.28 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 109.537 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 6.5 mmmt -54.76 -39.56 68.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.19 -0.944 . . . . 0.0 109.48 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 7.0 tttm -58.22 -40.97 83.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.445 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.598 ' CG ' HD13 ' A' ' 99' ' ' LEU . 56.3 m-85 -81.89 -73.32 0.39 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.887 . . . . 0.0 109.476 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.67 HD12 ' HD2' ' A' ' 120' ' ' PRO . 39.7 tp -78.57 114.43 43.21 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.299 -0.875 . . . . 0.0 109.392 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.67 ' HD2' HD12 ' A' ' 119' ' ' LEU . 35.9 Cg_endo -78.08 176.1 10.37 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.424 2.083 . . . . 0.0 110.408 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.635 ' CD1' ' CZ ' ' A' ' 28' ' ' TYR . 1.2 mt . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.313 -0.867 . . . . 0.0 109.516 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.422 ' HA ' HD21 ' A' ' 119' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.291 0.567 . . . . 0.0 109.507 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.439 ' HB2' ' HA ' ' A' ' 48' ' ' PRO . 11.2 mttp -110.22 154.42 23.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.932 . . . . 0.0 109.378 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.647 ' HB ' HG22 ' A' ' 30' ' ' THR . 70.7 mt -150.11 149.19 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.282 -0.886 . . . . 0.0 109.467 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.858 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.8 OUTLIER -125.98 125.04 42.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.325 -0.859 . . . . 0.0 109.363 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.858 ' N ' HD13 ' A' ' 7' ' ' LEU . 10.1 mt -103.95 103.12 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.229 -0.92 . . . . 0.0 109.579 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.727 ' CG2' HD12 ' A' ' 7' ' ' LEU . 2.6 t -102.74 84.8 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.319 -0.863 . . . . 0.0 109.333 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.524 ' O ' ' CD1' ' A' ' 57' ' ' ILE . 40.1 p-10 -88.61 -149.44 0.18 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.33 -0.856 . . . . 0.0 109.502 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.523 ' CB ' ' HA ' ' A' ' 57' ' ' ILE . 1.0 OUTLIER -121.92 -31.39 3.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.309 -0.87 . . . . 0.0 109.519 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.45 ' O ' ' OD2' ' A' ' 10' ' ' ASP . 0.8 OUTLIER -146.75 153.95 40.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.27 -0.894 . . . . 0.0 109.483 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 1.015 ' CE2' HD11 ' A' ' 17' ' ' ILE . 6.3 t80 -43.88 141.77 1.52 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 109.499 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 137.34 -70.13 0.49 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.978 HG23 HD13 ' A' ' 19' ' ' LEU . 2.6 mt -62.86 -29.54 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.18 -1.188 . . . . 0.0 109.382 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.524 ' HB3' ' CG ' ' A' ' 32' ' ' GLN . 3.9 mpp_? -70.69 -21.81 62.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.273 -0.892 . . . . 0.0 109.566 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 1.015 HD11 ' CE2' ' A' ' 13' ' ' TYR . 6.9 mt -90.14 -57.22 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.217 -0.927 . . . . 0.0 109.661 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.905 ' O ' HG23 ' A' ' 22' ' ' VAL . 7.1 mp -54.7 -58.91 5.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.24 -0.913 . . . . 0.0 109.683 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.978 HD13 HG23 ' A' ' 15' ' ' ILE . 6.2 mp -57.52 -23.75 52.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.216 -0.927 . . . . 0.0 109.643 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 16.5 t30 -71.44 -70.63 0.31 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.238 -0.914 . . . . 0.0 109.592 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.479 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 13.5 tp10 -46.92 -43.46 18.98 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -0.91 . . . . 0.0 109.623 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.905 HG23 ' O ' ' A' ' 18' ' ' LEU . 22.7 t -54.33 -60.99 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 109.637 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.603 ' CE1' ' HA ' ' A' ' 112' ' ' ARG . 38.8 m-85 -71.25 -4.18 24.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.209 -0.932 . . . . 0.0 109.718 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.479 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 0.8 OUTLIER -80.02 -44.56 19.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.179 -0.95 . . . . 0.0 109.437 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.415 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 25.1 tttt -80.99 -18.01 48.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.301 -0.874 . . . . 0.0 109.464 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.511 ' HB3' ' CD1' ' A' ' 28' ' ' TYR . 2.2 tt0 -77.72 -37.46 49.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.215 -0.928 . . . . 0.0 109.449 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.522 ' C ' ' CD1' ' A' ' 28' ' ' TYR . . . 115.71 62.79 0.36 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.954 ' CE2' HD21 ' A' ' 121' ' ' LEU . 70.1 m-85 -149.67 134.55 17.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.177 -1.19 . . . . 0.0 109.518 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.41 ' HG2' ' OE2' ' A' ' 4' ' ' GLU . 3.1 mm100 -90.35 83.32 5.93 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.249 -0.907 . . . . 0.0 109.113 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.647 HG22 ' HB ' ' A' ' 6' ' ' ILE . 5.7 p -89.89 172.13 9.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.318 -0.864 . . . . 0.0 109.637 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.799 ' HB2' HD22 ' A' ' 7' ' ' LEU . 19.3 m-85 -134.6 -178.51 5.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.868 . . . . 0.0 109.352 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.524 ' CG ' ' HB3' ' A' ' 16' ' ' ARG . 27.4 mp0 -120.71 149.04 43.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.213 -0.93 . . . . 0.0 109.637 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.832 ' HB1' ' HB2' ' A' ' 39' ' ' ALA . . . -177.37 175.03 1.52 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.393 -0.817 . . . . 0.0 109.474 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.502 ' HA ' HG12 ' A' ' 9' ' ' VAL . . . -178.74 -58.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 109.663 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.412 ' C ' ' O ' ' A' ' 34' ' ' ALA . 3.9 p30 -43.6 -27.15 0.27 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.258 -0.901 . . . . 0.0 109.578 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.542 ' O ' HD12 ' A' ' 40' ' ' LEU . . . 97.84 -39.14 2.85 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.9 HD12 ' N ' ' A' ' 38' ' ' GLN . 3.8 pp -70.08 -45.52 66.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.213 -1.169 . . . . 0.0 109.609 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.9 ' N ' HD12 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -79.39 -30.58 42.52 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.222 -0.924 . . . . 0.0 108.912 179.868 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.832 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . . . -62.41 -48.41 79.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.254 -0.904 . . . . 0.0 108.934 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.828 HD11 HG23 ' A' ' 65' ' ' ILE . 3.7 mt -66.28 -48.59 69.94 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.333 -0.854 . . . . 0.0 109.046 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.419 ' C ' ' O ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -45.41 -40.08 7.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.337 -0.852 . . . . 0.0 109.009 179.659 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.642 HD12 ' O ' ' A' ' 38' ' ' GLN . 5.3 mt -68.04 -48.43 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.334 -0.854 . . . . 0.0 109.19 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.855 HG13 ' HD2' ' A' ' 48' ' ' PRO . 46.1 t -55.41 -19.15 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.222 -0.924 . . . . 0.0 109.406 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.8 m -90.23 -35.05 15.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.171 -0.956 . . . . 0.0 109.514 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.478 ' HG2' ' HA ' ' A' ' 42' ' ' ILE . 0.0 OUTLIER -86.32 -5.25 59.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.187 -0.945 . . . . 0.0 109.684 -179.848 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.422 ' CG ' ' HD2' ' A' ' 45' ' ' LYS . 5.1 mm-40 -134.5 -37.8 0.84 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.144 -0.973 . . . . 0.0 109.309 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.434 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 12.1 mtm-85 57.84 65.89 3.11 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.385 -0.822 . . . . 0.0 109.643 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.855 ' HD2' HG13 ' A' ' 43' ' ' VAL . 35.3 Cg_endo -77.3 162.77 30.82 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.541 2.161 . . . . 0.0 110.416 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.462 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 6.7 t0 -97.03 -13.38 22.3 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.135 -0.978 . . . . 0.0 109.57 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.8 ' CD2' HG13 ' A' ' 115' ' ' VAL . 7.0 tp -117.92 123.47 45.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.188 -0.945 . . . . 0.0 109.588 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.703 ' HB ' HG13 ' A' ' 78' ' ' VAL . 39.6 t -129.08 137.62 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -0.924 . . . . 0.0 109.403 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.668 HD12 ' O ' ' A' ' 7' ' ' LEU . 1.1 mt -112.4 103.68 11.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 109.427 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.711 HD21 ' HB ' ' A' ' 65' ' ' ILE . 1.4 mp -97.47 124.6 41.75 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.304 -0.873 . . . . 0.0 109.582 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.449 ' O ' HG13 ' A' ' 57' ' ' ILE . 21.0 t70 -107.51 120.58 42.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.263 -0.898 . . . . 0.0 109.341 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.846 ' CG ' HG21 ' A' ' 82' ' ' THR . 25.6 mmt -75.15 -13.96 60.51 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.172 -0.955 . . . . 0.0 109.638 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -89.57 46.49 1.37 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.201 -0.937 . . . . 0.0 109.52 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.524 ' CD1' ' O ' ' A' ' 10' ' ' ASP . 81.3 mt -110.99 130.21 23.17 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.177 -0.952 . . . . 0.0 109.457 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.505 ' HD3' ' HB2' ' A' ' 11' ' ' ASP . 36.1 Cg_endo -78.52 130.65 10.01 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.426 2.084 . . . . 0.0 110.372 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 123.81 -50.53 0.85 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.22 163.74 30.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.173 -1.192 . . . . 0.0 109.533 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -89.98 156.81 18.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 109.462 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.415 ' HA2' ' CD1' ' A' ' 65' ' ' ILE . . . -89.92 -6.24 69.87 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.419 ' HA ' HD13 ' A' ' 63' ' ' ILE . 17.9 mm -54.92 -60.02 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.171 -1.194 . . . . 0.0 109.502 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.8 -38.14 54.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.174 -0.954 . . . . 0.0 109.432 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.828 HG23 HD11 ' A' ' 40' ' ' LEU . 15.9 mt -52.51 -57.11 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -0.889 . . . . 0.0 109.446 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.611 ' CD2' HD22 ' A' ' 53' ' ' LEU . 26.1 mt -46.33 -56.01 6.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.197 -0.939 . . . . 0.0 109.462 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.451 ' O ' HG23 ' A' ' 71' ' ' VAL . 5.3 mttt -44.09 -47.3 8.88 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -0.918 . . . . 0.0 109.431 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.438 ' O ' HG13 ' A' ' 72' ' ' ILE . 5.3 mtt180 -58.08 -43.24 86.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.263 -0.898 . . . . 0.0 109.461 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.429 ' CE ' HG11 ' A' ' 51' ' ' VAL . 4.1 mtt -64.07 -23.38 67.3 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.208 -0.933 . . . . 0.0 109.466 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 66' ' ' LEU . 0.5 OUTLIER -79.16 -33.91 43.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.226 -0.921 . . . . 0.0 109.479 179.95 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 67' ' ' LYS . 5.4 t -79.39 -21.39 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.281 -0.887 . . . . 0.0 109.495 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 68' ' ' ARG . 66.2 mt -90.04 -60.07 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.284 -0.885 . . . . 0.0 109.395 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.53 133.09 36.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.234 -0.916 . . . . 0.0 109.492 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -90.04 -11.92 40.05 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.265 -0.897 . . . . 0.0 109.16 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -107.46 51.81 0.73 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.145 -0.972 . . . . 0.0 109.443 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.492 ' O ' HG23 ' A' ' 76' ' ' ILE . 0.3 OUTLIER -119.14 113.11 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.267 -0.896 . . . . 0.0 109.545 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.804 ' CB ' HD11 ' A' ' 99' ' ' LEU . 0.8 OUTLIER -68.59 124.91 24.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.246 -0.909 . . . . 0.0 109.44 179.893 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.703 HG13 ' HB ' ' A' ' 51' ' ' VAL . 17.6 t -134.24 108.22 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 0.0 109.704 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.735 HD11 ' CE2' ' A' ' 118' ' ' TYR . 91.0 mt -90.26 148.4 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.218 -0.926 . . . . 0.0 109.36 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 1.014 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.0 OUTLIER -107.8 161.03 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.176 -0.952 . . . . 0.0 109.426 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.518 ' SD ' ' CZ ' ' A' ' 106' ' ' PHE . 8.6 mtm -137.77 89.69 2.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.239 -0.913 . . . . 0.0 109.725 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.936 HG22 ' NE2' ' A' ' 101' ' ' HIS . 14.3 t 177.8 37.2 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.271 -0.893 . . . . 0.0 109.369 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.75 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.308 -0.87 . . . . 0.0 109.556 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.526 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -56.58 -40.93 76.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.269 -0.895 . . . . 0.0 109.558 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.417 ' O ' HD12 ' A' ' 96' ' ' LEU . 8.2 mt-10 -90.08 -37.16 14.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.205 -0.934 . . . . 0.0 109.657 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.868 ' HA ' HD13 ' A' ' 96' ' ' LEU . 1.1 m -43.73 -43.06 5.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.301 -0.874 . . . . 0.0 109.613 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.449 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -43.64 -54.15 5.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.22 -0.925 . . . . 0.0 109.54 -179.915 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 96' ' ' LEU . 1.3 mm-40 -59.94 -48.52 81.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.257 -0.902 . . . . 0.0 109.521 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.868 HD13 ' HA ' ' A' ' 93' ' ' SER . 2.1 mp -43.62 -60.81 1.61 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.317 -0.864 . . . . 0.0 109.577 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 172.89 45.46 0.04 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.449 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -120.93 110.18 15.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.317 -1.108 . . . . 0.0 109.423 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.804 HD11 ' CB ' ' A' ' 77' ' ' ARG . 1.7 mt -57.77 -71.48 0.1 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.203 -0.935 . . . . 0.0 109.534 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.485 ' O ' HG23 ' A' ' 79' ' ' ILE . 14.8 t -130.34 162.45 29.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -0.928 . . . . 0.0 109.545 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 1.014 ' ND1' HD12 ' A' ' 80' ' ' ILE . 5.1 t-160 -126.66 101.18 6.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.271 -0.893 . . . . 0.0 109.442 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -76.95 -176.1 3.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.319 -0.863 . . . . 0.0 109.519 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.75 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -168.38 172.91 8.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.343 -0.848 . . . . 0.0 109.454 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.513 ' HA ' ' N ' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -64.72 151.12 93.16 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.239 -0.913 . . . . 0.0 109.534 179.884 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.21 118.28 5.67 Favored 'Cis proline' 0 C--N 1.308 -1.574 0 C-N-CA 123.22 -1.575 . . . . 0.0 110.471 -0.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.741 ' CZ ' HD12 ' A' ' 111' ' ' ILE . 0.3 OUTLIER -55.18 106.08 0.21 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.213 -0.929 . . . . 0.0 109.406 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.495 ' O ' HG12 ' A' ' 111' ' ' ILE . 46.0 t0 -89.88 110.43 21.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 109.326 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.428 HD13 ' HA ' ' A' ' 108' ' ' ILE . 15.5 mm -48.23 -22.44 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.248 -0.908 . . . . 0.0 109.777 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.406 ' O ' ' HG2' ' A' ' 112' ' ' ARG . 0.9 OUTLIER -75.21 -43.72 50.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.106 -0.997 . . . . 0.0 109.458 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -70.02 -27.11 64.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.297 -0.877 . . . . 0.0 109.514 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.888 HG21 HD21 ' A' ' 19' ' ' LEU . 20.2 mm -76.03 -57.57 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.247 -0.908 . . . . 0.0 109.273 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.872 ' HB3' HG11 ' A' ' 22' ' ' VAL . 14.0 ptt180 -55.67 -32.26 63.08 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.396 -0.815 . . . . 0.0 109.985 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.542 ' HA ' ' HG2' ' A' ' 116' ' ' LYS . 10.8 m-20 -79.6 -65.86 0.95 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -0.935 . . . . 0.0 110.237 -179.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 113' ' ' ASP . . . -42.53 -35.77 1.16 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.207 -0.933 . . . . 0.0 109.876 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.8 HG13 ' CD2' ' A' ' 50' ' ' LEU . 38.2 t -77.68 -40.43 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.356 -0.84 . . . . 0.0 109.737 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.542 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -60.45 -23.87 64.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.131 -0.981 . . . . 0.0 109.332 -179.789 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.498 ' N ' ' HG3' ' A' ' 116' ' ' LYS . 9.5 ttmt -85.03 -51.63 6.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.303 -0.873 . . . . 0.0 109.387 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.735 ' CE2' HD11 ' A' ' 79' ' ' ILE . 27.1 m-85 -54.03 -64.86 0.69 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.266 -0.896 . . . . 0.0 109.353 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.885 HD12 ' HD2' ' A' ' 120' ' ' PRO . 37.5 tp -90.28 112.34 52.13 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.291 -0.881 . . . . 0.0 109.386 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.885 ' HD2' HD12 ' A' ' 119' ' ' LEU . 35.6 Cg_endo -78.27 -164.3 0.27 Allowed 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.326 2.017 . . . . 0.0 110.393 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.954 HD21 ' CE2' ' A' ' 28' ' ' TYR . 81.2 mt . . . . . 0 N--CA 1.489 1.512 0 O-C-N 121.276 -0.89 . . . . 0.0 109.378 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.521 ' OE2' HD23 ' A' ' 121' ' ' LEU . 1.3 mt-10 . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.503 ' HB2' ' HA ' ' A' ' 48' ' ' PRO . 6.4 mtmt -96.13 139.52 32.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -0.872 . . . . 0.0 109.414 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.574 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 80.5 mt -150.05 155.21 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.253 -0.904 . . . . 0.0 109.473 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.985 HD11 HD13 ' A' ' 42' ' ' ILE . 0.6 OUTLIER -140.56 127.69 20.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 109.367 179.949 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.709 HD13 ' HB2' ' A' ' 19' ' ' LEU . 9.2 mt -92.35 120.95 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -0.917 . . . . 0.0 109.518 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.475 HG22 HD23 ' A' ' 7' ' ' LEU . 2.7 t -103.01 102.81 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -0.954 . . . . 0.0 109.464 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.462 ' HB3' ' HD3' ' A' ' 16' ' ' ARG . 7.3 t0 -162.17 134.98 5.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.158 -0.964 . . . . 0.0 109.434 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.488 ' OD2' ' HD2' ' A' ' 58' ' ' PRO . 8.6 p-10 -99.21 -34.22 10.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.294 -0.879 . . . . 0.0 109.444 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.417 ' O ' ' C ' ' A' ' 13' ' ' TYR . 0.5 OUTLIER -73.1 107.22 5.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.329 -0.857 . . . . 0.0 109.478 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.595 ' CZ ' HG13 ' A' ' 17' ' ' ILE . 20.5 t80 -43.07 153.06 0.1 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.351 -0.843 . . . . 0.0 109.603 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.403 ' N ' ' CD1' ' A' ' 13' ' ' TYR . . . 124.62 -74.43 0.4 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.899 HD13 ' OD2' ' A' ' 54' ' ' ASP . 6.6 mt -63.16 -16.92 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.24 -1.153 . . . . 0.0 109.403 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.462 ' HD3' ' HB3' ' A' ' 10' ' ' ASP . 14.6 mmm-85 -77.26 -26.88 52.93 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 109.341 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.595 HG13 ' CZ ' ' A' ' 13' ' ' TYR . 9.6 mm -90.07 -39.78 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -0.903 . . . . 0.0 109.604 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.59 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.1 mp -64.22 -58.22 7.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.25 -0.906 . . . . 0.0 109.613 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.709 ' HB2' HD13 ' A' ' 8' ' ' ILE . 44.0 mt -58.45 -20.95 49.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.282 -0.886 . . . . 0.0 109.482 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.509 ' OD1' ' ND2' ' A' ' 24' ' ' ASN . 27.6 t30 -75.72 -70.71 0.42 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -0.911 . . . . 0.0 109.568 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.482 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 17.8 tt0 -46.41 -42.51 15.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.243 -0.911 . . . . 0.0 109.614 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.609 HG21 HG23 ' A' ' 108' ' ' ILE . 64.6 t -58.99 -56.01 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.143 -0.973 . . . . 0.0 109.615 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.757 ' CB ' HG21 ' A' ' 30' ' ' THR . 29.8 m-85 -78.14 3.05 16.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.178 -0.951 . . . . 0.0 109.707 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.509 ' ND2' ' OD1' ' A' ' 20' ' ' ASN . 0.5 OUTLIER -90.07 -46.73 8.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.229 -0.92 . . . . 0.0 109.486 179.884 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.1 -19.72 36.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.216 -0.928 . . . . 0.0 109.456 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.478 ' HB3' ' CD1' ' A' ' 28' ' ' TYR . 0.5 OUTLIER -78.33 -31.06 48.51 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.3 -0.875 . . . . 0.0 109.456 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.477 ' O ' ' CD1' ' A' ' 28' ' ' TYR . . . 102.5 77.94 1.26 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.558 ' CZ ' ' HG ' ' A' ' 121' ' ' LEU . 91.5 m-85 -155.57 143.12 19.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.151 -1.205 . . . . 0.0 109.511 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -90.04 81.19 6.25 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.174 -0.954 . . . . 0.0 109.382 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.757 HG21 ' CB ' ' A' ' 23' ' ' PHE . 6.1 p -89.91 147.27 23.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.248 -0.907 . . . . 0.0 109.534 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.63 ' HB2' HD12 ' A' ' 7' ' ' LEU . 12.0 m-85 -111.06 -166.19 1.05 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 0.0 109.487 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -143.61 139.98 29.92 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.341 -0.85 . . . . 0.0 109.484 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -153.49 -176.03 5.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.266 -0.896 . . . . 0.0 109.401 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.536 ' O ' HD13 ' A' ' 57' ' ' ILE . . . -145.01 -61.88 0.35 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.218 -0.926 . . . . 0.0 109.519 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.442 ' HA ' ' HE3' ' A' ' 60' ' ' MET . 1.6 p-10 -90.22 144.5 25.8 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 0.0 109.427 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.539 ' HA3' ' CD1' ' A' ' 65' ' ' ILE . . . -48.08 -37.66 16.93 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.403 ' HA ' HD13 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -51.79 -46.49 64.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -1.172 . . . . 0.0 109.54 -179.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.52 ' NE2' ' HA ' ' A' ' 38' ' ' GLN . 6.7 tp-100 -64.84 -31.8 73.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.91 . . . . 0.0 109.541 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.785 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -66.47 -37.32 84.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.923 . . . . 0.0 109.526 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.708 HD21 ' HB2' ' A' ' 68' ' ' ARG . 13.8 mt -73.75 -38.97 64.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.883 . . . . 0.0 109.564 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.35 -54.75 39.75 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.258 -0.901 . . . . 0.0 109.48 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.985 HD13 HD11 ' A' ' 7' ' ' LEU . 23.9 mt -62.93 -31.76 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.268 -0.895 . . . . 0.0 109.473 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.785 HG23 ' O ' ' A' ' 39' ' ' ALA . 42.7 t -69.73 -28.13 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 109.365 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.0 m -90.23 -15.75 30.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.278 -0.888 . . . . 0.0 109.512 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.65 -60.48 1.95 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.918 . . . . 0.0 109.73 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 47' ' ' ARG . 1.8 mm-40 -89.78 -30.69 17.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.152 -0.967 . . . . 0.0 109.645 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 13.2 mtm180 65.89 68.41 0.66 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.934 . . . . 0.0 109.577 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.528 ' CD ' ' HA ' ' A' ' 43' ' ' VAL . 35.3 Cg_endo -77.82 -167.01 0.43 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.625 2.217 . . . . 0.0 110.354 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 75' ' ' ASN . 5.0 t70 -142.1 11.16 1.97 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.272 -0.892 . . . . 0.0 109.465 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.489 HD23 HG23 ' A' ' 6' ' ' ILE . 4.9 tp -146.79 111.55 5.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -0.926 . . . . 0.0 109.517 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.968 HG21 ' SD ' ' A' ' 69' ' ' MET . 3.4 t -109.63 137.66 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.232 -0.917 . . . . 0.0 109.32 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.552 HD12 ' O ' ' A' ' 7' ' ' LEU . 1.1 mt -104.51 97.65 7.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.655 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.468 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 1.0 OUTLIER -93.37 119.3 32.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.257 -0.902 . . . . 0.0 109.36 179.825 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.899 ' OD2' HD13 ' A' ' 15' ' ' ILE . 21.0 t0 -99.28 -4.8 31.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.116 -0.99 . . . . 0.0 109.684 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.512 ' HG3' ' CG2' ' A' ' 82' ' ' THR . 0.0 OUTLIER 53.44 17.14 1.03 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.385 -0.822 . . . . 0.0 109.783 -179.854 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 57' ' ' ILE . 13.2 mmtm -91.03 -39.87 11.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.04 -1.037 . . . . 0.0 109.338 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.755 HG21 ' HE3' ' A' ' 60' ' ' MET . 4.3 mt -42.65 111.64 1.02 Allowed Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.377 -0.827 . . . . 0.0 109.495 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.488 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 35.0 Cg_endo -77.01 165.21 28.66 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.403 2.068 . . . . 0.0 110.387 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.77 -43.03 1.87 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.755 ' HE3' HG21 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -158.18 158.85 35.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.361 -1.082 . . . . 0.0 109.321 179.899 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -88.72 151.97 22.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.114 -0.991 . . . . 0.0 109.464 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.439 ' HA2' HG12 ' A' ' 65' ' ' ILE . . . -90.18 4.35 82.8 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.644 ' HA ' HD23 ' A' ' 66' ' ' LEU . 19.4 mm -59.72 -51.03 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.157 -1.202 . . . . 0.0 109.397 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -52.46 -23.67 6.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.19 -0.944 . . . . 0.0 109.401 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.539 ' CD1' ' HA3' ' A' ' 36' ' ' GLY . 8.7 mm -71.55 -65.05 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.32 -0.862 . . . . 0.0 109.449 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.644 HD23 ' HA ' ' A' ' 63' ' ' ILE . 1.6 pp -47.51 -28.62 2.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -0.889 . . . . 0.0 109.226 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.552 ' O ' HG23 ' A' ' 71' ' ' VAL . 12.8 tptt -67.45 -59.17 3.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 0.0 109.254 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.708 ' HB2' HD21 ' A' ' 40' ' ' LEU . 10.7 mtt-85 -51.63 -26.67 9.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.264 -0.897 . . . . 0.0 109.319 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.968 ' SD ' HG21 ' A' ' 51' ' ' VAL . 1.4 mtt -73.9 -39.62 63.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.303 -0.873 . . . . 0.0 109.458 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.526 ' CD ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -69.34 -24.51 63.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.251 -0.905 . . . . 0.0 109.284 179.944 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 67' ' ' LYS . 2.6 t -90.1 -25.45 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.323 -0.86 . . . . 0.0 109.513 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.612 HD12 ' O ' ' A' ' 68' ' ' ARG . 28.2 mt -89.16 -16.92 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.308 -0.87 . . . . 0.0 109.422 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.618 ' O ' HG22 ' A' ' 76' ' ' ILE . 0.4 OUTLIER -170.71 116.59 0.48 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.259 -0.901 . . . . 0.0 109.481 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -74.93 -22.14 58.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.204 -0.935 . . . . 0.0 109.453 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.436 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 69.2 m-80 -89.7 43.09 1.13 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 109.489 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.618 HG22 ' O ' ' A' ' 73' ' ' ASP . 0.5 OUTLIER -117.26 146.8 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.342 -0.849 . . . . 0.0 109.554 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.58 ' O ' HG23 ' A' ' 78' ' ' VAL . 46.0 mtt180 -115.27 162.31 17.27 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.299 -0.875 . . . . 0.0 109.516 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 77' ' ' ARG . 69.7 t -159.72 111.97 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.261 -0.899 . . . . 0.0 109.549 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.85 HG23 HG23 ' A' ' 100' ' ' THR . 9.1 mm -93.32 133.57 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.2 -0.938 . . . . 0.0 109.392 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.902 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.5 OUTLIER -95.43 171.98 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.19 -0.944 . . . . 0.0 109.395 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.605 ' HE1' ' HB2' ' A' ' 54' ' ' ASP . 39.4 mtm -146.84 62.49 1.19 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.24 -0.913 . . . . 0.0 109.459 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.512 ' CG2' ' HG3' ' A' ' 55' ' ' MET . 11.2 t -170.89 32.51 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 109.488 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.033 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.261 -0.9 . . . . 0.0 109.464 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 1.146 HD12 ' CE1' ' A' ' 101' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.809 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.444 ' OE1' ' HA ' ' A' ' 91' ' ' GLN . 21.8 tp60 -53.33 -36.32 61.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.214 -0.929 . . . . 0.0 109.513 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.561 ' O ' HD12 ' A' ' 96' ' ' LEU . 8.0 mt-10 -90.09 -17.21 28.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.199 -0.938 . . . . 0.0 109.481 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.485 ' HB3' ' HB2' ' A' ' 98' ' ' ALA . 0.4 OUTLIER -57.82 -17.55 16.74 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.289 -0.882 . . . . 0.0 109.504 179.974 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.27 -66.76 0.49 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.268 -0.895 . . . . 0.0 109.507 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -56.77 -32.67 65.85 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.218 -0.926 . . . . 0.0 109.552 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.561 HD12 ' O ' ' A' ' 92' ' ' GLU . 2.1 mt -64.76 -33.33 75.71 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.299 -0.876 . . . . 0.0 109.47 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.526 ' HA3' ' CD ' ' A' ' 70' ' ' LYS . . . 140.7 40.4 0.08 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.485 ' HB2' ' HB3' ' A' ' 93' ' ' SER . . . -112.66 102.64 10.69 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.222 -1.164 . . . . 0.0 109.397 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.81 ' HB2' HD13 ' A' ' 79' ' ' ILE . 17.3 mt -43.74 -83.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.294 -0.879 . . . . 0.0 109.42 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.85 HG23 HG23 ' A' ' 79' ' ' ILE . 1.8 t -131.34 171.45 13.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.255 -0.903 . . . . 0.0 109.426 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 1.146 ' CE1' HD12 ' A' ' 90' ' ' ILE . 4.0 t60 -130.41 93.36 3.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.208 -0.933 . . . . 0.0 109.336 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.632 ' CE1' ' CG ' ' A' ' 110' ' ' GLU . 9.0 m-85 -72.72 155.64 39.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -0.918 . . . . 0.0 109.597 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 1.033 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -124.07 -148.56 0.4 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.313 -0.867 . . . . 0.0 109.467 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.43 ' HB2' ' HA ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -101.32 160.54 26.3 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 109.565 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.498 ' O ' ' CB ' ' A' ' 106' ' ' PHE . 36.4 Cg_endo -79.44 11.64 21.61 Favored 'Cis proline' 0 C--N 1.31 -1.489 0 C-N-CA 123.296 -1.543 . . . . 0.0 110.893 0.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.656 ' CZ ' HD12 ' A' ' 111' ' ' ILE . 2.2 t80 76.06 99.4 0.07 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.233 -0.917 . . . . 0.0 109.627 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.468 ' O ' HG12 ' A' ' 111' ' ' ILE . 15.2 t0 -89.96 114.32 26.12 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.221 -0.924 . . . . 0.0 109.309 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.609 HG23 HG21 ' A' ' 22' ' ' VAL . 13.7 mm -46.86 -40.08 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.239 -0.913 . . . . 0.0 109.468 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.457 ' HB2' ' OD2' ' A' ' 107' ' ' ASP . 99.6 m-20 -62.05 -42.12 98.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.902 . . . . 0.0 109.528 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.632 ' CG ' ' CE1' ' A' ' 102' ' ' PHE . 5.5 tp10 -67.23 -28.72 68.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.903 . . . . 0.0 109.513 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.656 HD12 ' CZ ' ' A' ' 106' ' ' PHE . 23.5 mm -69.35 -60.2 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.294 -0.879 . . . . 0.0 109.477 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.467 ' HG2' ' O ' ' A' ' 108' ' ' ILE . 0.0 OUTLIER -64.3 -19.91 65.73 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.554 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.427 ' CG ' ' O ' ' A' ' 109' ' ' ASP . 61.1 m-20 -72.47 -53.83 11.02 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.264 -0.897 . . . . 0.0 109.469 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.62 ' HB1' ' HE2' ' A' ' 118' ' ' TYR . . . -61.8 -54.38 43.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 0.0 109.461 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.7 t -52.17 -52.35 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.177 -0.952 . . . . 0.0 109.496 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.67 -35.55 55.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.252 -0.905 . . . . 0.0 109.426 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.67 -34.72 74.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.304 -0.872 . . . . 0.0 109.472 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.636 ' CG ' HD13 ' A' ' 99' ' ' LEU . 58.2 m-85 -88.69 -74.19 0.47 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -0.898 . . . . 0.0 109.532 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.765 HD23 ' O ' ' A' ' 120' ' ' PRO . 6.3 tt -90.11 112.46 52.58 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.287 -0.883 . . . . 0.0 109.443 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.765 ' O ' HD23 ' A' ' 119' ' ' LEU . 35.3 Cg_endo -77.88 -166.18 0.38 Allowed 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.381 2.054 . . . . 0.0 110.375 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.558 ' HG ' ' CZ ' ' A' ' 28' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 0.0 109.424 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.573 ' OE2' ' CD2' ' A' ' 28' ' ' TYR . 51.8 tt0 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.453 ' HB2' ' HB3' ' A' ' 48' ' ' PRO . 3.0 mttt -109.58 156.14 20.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.331 -0.856 . . . . 0.0 109.482 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.494 HG12 ' HB2' ' A' ' 50' ' ' LEU . 63.0 mt -150.05 153.02 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.892 . . . . 0.0 109.453 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.814 HD11 ' CB ' ' A' ' 33' ' ' ALA . 1.8 tm? -132.11 113.97 13.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.289 -0.882 . . . . 0.0 109.482 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.618 ' N ' HD13 ' A' ' 7' ' ' LEU . 4.4 mt -89.89 105.85 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 109.351 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.658 HG22 HD12 ' A' ' 7' ' ' LEU . 2.6 t -89.9 71.72 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.209 -0.932 . . . . 0.0 109.513 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.665 ' O ' ' HB2' ' A' ' 34' ' ' ALA . 1.5 t70 -126.09 146.27 49.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.216 -0.928 . . . . 0.0 109.399 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.943 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . 6.5 p-10 -116.81 -37.07 3.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.315 -0.865 . . . . 0.0 109.473 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.515 ' CG ' ' O ' ' A' ' 12' ' ' GLN . 7.6 pt20 -61.38 102.14 0.21 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.2 -0.937 . . . . 0.0 109.489 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 1.048 ' CE1' HD11 ' A' ' 17' ' ' ILE . 58.5 t80 -43.28 112.22 0.35 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.875 . . . . 0.0 109.596 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 159.28 -69.32 0.25 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.432 ' HB ' ' OD2' ' A' ' 10' ' ' ASP . 1.7 mp -62.78 -20.83 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.125 -1.221 . . . . 0.0 108.777 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.527 ' O ' ' CB ' ' A' ' 20' ' ' ASN . 7.4 mmm-85 -69.4 -29.98 67.85 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.386 -0.822 . . . . 0.0 109.331 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 1.048 HD11 ' CE1' ' A' ' 13' ' ' TYR . 3.8 mt -90.34 -37.08 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.362 -0.836 . . . . 0.0 109.765 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.84 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.4 OUTLIER -69.14 -58.16 4.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.005 -1.059 . . . . 0.0 109.246 -179.906 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.537 ' HA ' HD12 ' A' ' 19' ' ' LEU . 1.3 tp -62.56 -20.54 64.78 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.304 -0.873 . . . . 0.0 108.663 179.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 16' ' ' ARG . 0.5 OUTLIER -71.44 -73.25 0.19 Allowed 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.48 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 0.3 OUTLIER -52.43 -30.82 31.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.29 -0.881 . . . . 0.0 109.807 -179.589 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.84 HG23 ' O ' ' A' ' 18' ' ' LEU . 96.8 t -64.75 -61.94 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.194 -0.941 . . . . 0.0 109.548 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.877 ' HB2' HG21 ' A' ' 30' ' ' THR . 16.4 m-85 -72.5 -3.8 26.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 109.544 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.48 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 0.7 OUTLIER -82.99 -52.61 6.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.146 -0.971 . . . . 0.0 109.38 179.809 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.3 mmtt -73.57 -19.09 60.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.121 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.515 ' HB3' ' CD1' ' A' ' 28' ' ' TYR . 0.4 OUTLIER -71.39 -49.19 44.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.369 -0.832 . . . . 0.0 109.372 179.885 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.465 ' O ' ' OE2' ' A' ' 4' ' ' GLU . . . 124.95 46.62 0.24 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 1.074 ' CZ ' HD11 ' A' ' 121' ' ' LEU . 97.7 m-85 -132.72 146.69 52.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.315 -1.109 . . . . 0.0 109.574 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.0 mm100 -89.87 85.32 6.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.297 -0.877 . . . . 0.0 108.798 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.877 HG21 ' HB2' ' A' ' 23' ' ' PHE . 5.6 p -89.63 137.51 32.27 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.239 -0.913 . . . . 0.0 109.791 -179.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.616 ' HB2' HD22 ' A' ' 7' ' ' LEU . 11.5 m-85 -109.15 -171.63 1.88 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.379 -0.826 . . . . 0.0 109.238 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -121.71 154.09 37.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.151 -0.968 . . . . 0.0 109.681 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.814 ' CB ' HD11 ' A' ' 7' ' ' LEU . . . -172.48 174.34 3.83 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.272 -0.892 . . . . 0.0 109.355 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.943 ' HB1' ' HB3' ' A' ' 11' ' ' ASP . . . 170.96 -50.38 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.296 -0.878 . . . . 0.0 109.558 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.473 ' OD1' ' HB2' ' A' ' 38' ' ' GLN . 8.3 p-10 -67.29 -8.36 31.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.2 -0.938 . . . . 0.0 109.553 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 37' ' ' LEU . . . 96.53 -70.62 0.84 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.479 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -44.69 -32.98 1.67 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.166 -1.196 . . . . 0.0 109.437 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.998 ' O ' HD12 ' A' ' 42' ' ' ILE . 1.1 tp60 -71.52 -44.11 65.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.242 -0.911 . . . . 0.0 109.461 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.433 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . . . -65.57 -63.09 1.18 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.247 -0.908 . . . . 0.0 109.437 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.8 mt -51.39 -33.58 30.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.3 -0.875 . . . . 0.0 109.557 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 37' ' ' LEU . 59.8 t0 -62.76 -51.94 65.17 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.268 -0.895 . . . . 0.0 109.453 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.998 HD12 ' O ' ' A' ' 38' ' ' GLN . 2.0 mp -70.64 -14.48 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.214 -0.929 . . . . 0.0 109.49 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.536 ' HA ' ' CD ' ' A' ' 48' ' ' PRO . 50.8 t -84.56 -29.21 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.324 -0.86 . . . . 0.0 109.424 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.7 m -90.06 -25.11 20.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.155 -0.966 . . . . 0.0 109.407 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.51 ' HD2' ' N ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -89.97 -33.19 16.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.267 -0.896 . . . . 0.0 109.463 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -110.32 -36.7 5.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.215 -0.928 . . . . 0.0 109.458 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER 59.82 69.51 1.23 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.291 -0.881 . . . . 0.0 109.478 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.887 ' O ' HD12 ' A' ' 76' ' ' ILE . 34.7 Cg_endo -77.95 -179.58 5.58 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.747 2.298 . . . . 0.0 110.661 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -119.71 -16.84 8.73 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.47 -0.769 . . . . 0.0 109.33 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.494 ' HB2' HG12 ' A' ' 6' ' ' ILE . 1.8 mm? -114.16 121.12 42.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.322 -0.861 . . . . 0.0 109.695 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 1.015 ' HB ' HG13 ' A' ' 78' ' ' VAL . 2.7 t -116.51 147.04 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.236 -0.915 . . . . 0.0 109.253 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.524 ' CD1' HG12 ' A' ' 8' ' ' ILE . 1.6 mt -122.19 87.9 2.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.146 -0.971 . . . . 0.0 109.609 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.61 ' CD1' HG21 ' A' ' 9' ' ' VAL . 1.2 mp -91.7 122.58 34.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.282 -0.886 . . . . 0.0 109.268 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 81' ' ' MET . 30.3 t0 -107.4 -2.87 20.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.201 -0.937 . . . . 0.0 109.754 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.991 ' HB2' HG21 ' A' ' 82' ' ' THR . 4.7 mmt 47.29 22.08 0.24 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.339 -0.851 . . . . 0.0 109.879 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.442 ' HG3' ' CG ' ' A' ' 54' ' ' ASP . 1.4 mttt -90.77 -31.66 16.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.005 -1.059 . . . . 0.0 109.28 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.547 HG12 ' HB1' ' A' ' 34' ' ' ALA . 2.5 mp -41.88 102.17 0.26 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.501 -0.749 . . . . 0.0 109.682 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.497 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 35.0 Cg_endo -77.48 121.21 5.51 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.455 2.104 . . . . 0.0 110.351 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 121.81 -27.31 6.25 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.454 ' SD ' ' O ' ' A' ' 35' ' ' ASN . 1.3 ttp -139.84 135.36 32.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.282 -1.128 . . . . 0.0 109.398 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -89.83 137.34 32.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.243 -0.911 . . . . 0.0 109.457 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.46 ' HA2' HG13 ' A' ' 65' ' ' ILE . . . -90.49 8.74 79.33 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.437 ' HA ' HD13 ' A' ' 63' ' ' ILE . 23.9 mm -58.0 -43.59 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.25 -1.147 . . . . 0.0 109.49 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.517 ' O ' ' CG ' ' A' ' 68' ' ' ARG . 49.4 mm-40 -72.99 -16.72 61.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.9 . . . . 0.0 109.456 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.642 HG22 ' CE ' ' A' ' 69' ' ' MET . 48.8 mt -72.33 -53.5 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.256 -0.903 . . . . 0.0 109.461 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.736 HD21 HG11 ' A' ' 78' ' ' VAL . 12.1 mt -47.3 -57.02 5.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.911 . . . . 0.0 109.554 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 1.011 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -56.62 -42.46 78.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.197 -0.94 . . . . 0.0 109.664 -179.855 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.517 ' CG ' ' O ' ' A' ' 64' ' ' GLU . 2.2 mmt180 -57.47 -29.93 64.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.949 . . . . 0.0 109.553 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.679 ' SD ' HG11 ' A' ' 51' ' ' VAL . 3.9 mtt -75.21 -56.37 4.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.271 -0.893 . . . . 0.0 109.489 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.525 ' NZ ' HD13 ' A' ' 96' ' ' LEU . 6.5 ptpt -55.85 -19.65 12.52 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.183 -0.948 . . . . 0.0 109.462 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 1.011 HG23 ' O ' ' A' ' 67' ' ' LYS . 39.9 t -82.14 -46.64 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.266 -0.896 . . . . 0.0 109.456 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 67.6 mt -63.56 -56.09 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.33 -0.856 . . . . 0.0 109.507 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -135.86 142.74 44.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.325 -0.859 . . . . 0.0 109.46 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -89.42 -10.6 45.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.244 -0.91 . . . . 0.0 109.49 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -102.1 38.52 1.64 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.24 -0.913 . . . . 0.0 109.421 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.887 HD12 ' O ' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -113.55 91.65 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 109.417 -180.0 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.565 ' HB3' HD11 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -63.16 154.77 30.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.225 -0.922 . . . . 0.0 109.478 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 1.015 HG13 ' HB ' ' A' ' 51' ' ' VAL . 3.1 t -138.29 158.84 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.205 -0.935 . . . . 0.0 109.448 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.816 HD11 HD12 ' A' ' 99' ' ' LEU . 3.6 mm -136.81 125.74 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 109.454 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.582 ' HB ' ' CG ' ' A' ' 101' ' ' HIS . 0.7 OUTLIER -98.3 136.85 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.241 -0.912 . . . . 0.0 109.296 179.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.46 ' O ' ' OD1' ' A' ' 54' ' ' ASP . 16.9 mtm -122.16 49.03 1.63 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.489 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.991 HG21 ' HB2' ' A' ' 55' ' ' MET . 8.9 t -159.04 52.0 0.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 109.478 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.839 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.211 -0.93 . . . . 0.0 109.448 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.637 HG23 ' HD1' ' A' ' 101' ' ' HIS . 21.0 mt . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.26 0.552 . . . . 0.0 109.54 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.28 -41.84 76.5 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.315 -0.866 . . . . 0.0 109.481 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 93' ' ' SER . 2.1 tp10 -89.94 -48.22 7.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.191 -0.943 . . . . 0.0 109.496 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.626 ' HA ' HD12 ' A' ' 96' ' ' LEU . 11.5 t -44.21 -26.58 0.33 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.929 . . . . 0.0 109.487 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.06 -82.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.901 . . . . 0.0 109.481 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.425 ' O ' ' C ' ' A' ' 96' ' ' LEU . 9.4 pt-20 -44.1 -40.86 5.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.883 . . . . 0.0 109.446 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.626 HD12 ' HA ' ' A' ' 93' ' ' SER . 24.5 mt -44.09 -59.64 2.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -0.885 . . . . 0.0 109.47 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 163.87 47.54 0.02 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 99' ' ' LEU . . . -111.24 105.54 14.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -1.151 . . . . 0.0 109.471 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.905 HD22 ' CE1' ' A' ' 118' ' ' TYR . 20.4 mt -44.25 -63.45 0.88 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.256 -0.903 . . . . 0.0 109.426 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.729 HG22 HG23 ' A' ' 79' ' ' ILE . 14.5 t -146.44 -176.86 5.34 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.305 -0.872 . . . . 0.0 109.424 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.655 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 2.9 t-160 -148.77 68.54 1.07 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -0.886 . . . . 0.0 109.376 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.513 ' CZ ' HG21 ' A' ' 100' ' ' THR . 18.4 m-85 -65.39 160.68 21.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.214 -0.929 . . . . 0.0 109.447 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.839 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -126.72 -174.35 3.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.332 -0.855 . . . . 0.0 109.396 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.403 ' HA ' ' C ' ' A' ' 105' ' ' PRO . 3.7 pttt -102.34 144.92 29.56 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.257 -0.902 . . . . 0.0 109.36 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.403 ' C ' ' HA ' ' A' ' 104' ' ' LYS . 35.6 Cg_endo -77.79 133.9 32.21 Favored 'Cis proline' 0 C--N 1.31 -1.457 0 C-N-CA 123.303 -1.54 . . . . 0.0 110.407 -0.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -99.65 -176.64 3.33 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.159 -0.963 . . . . 0.0 109.488 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -127.94 123.32 34.6 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.213 -0.929 . . . . 0.0 109.464 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.77 HG21 HG21 ' A' ' 22' ' ' VAL . 16.2 mm -56.63 -22.42 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.232 -0.918 . . . . 0.0 109.476 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.423 ' O ' ' CG ' ' A' ' 113' ' ' ASP . 11.9 m-20 -72.66 -41.22 65.64 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.221 -0.924 . . . . 0.0 109.539 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.15 -31.38 70.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.203 -0.936 . . . . 0.0 109.461 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 23.0 mm -69.34 -59.16 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.31 -0.869 . . . . 0.0 109.438 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.418 ' O ' ' HG3' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -62.51 -22.84 66.59 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.2 -0.938 . . . . 0.0 109.467 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.423 ' CG ' ' O ' ' A' ' 109' ' ' ASP . 57.1 m-20 -70.79 -52.28 21.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.895 . . . . 0.0 109.412 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.407 ' O ' ' C ' ' A' ' 115' ' ' VAL . . . -66.1 -61.04 2.25 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.494 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.474 HG13 ' HG ' ' A' ' 50' ' ' LEU . 50.3 t -44.25 -47.94 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.246 -0.909 . . . . 0.0 109.437 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 0.0 OUTLIER -59.07 -43.71 91.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.287 -0.883 . . . . 0.0 109.475 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.47 -23.98 64.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.301 -0.875 . . . . 0.0 109.513 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.905 ' CE1' HD22 ' A' ' 99' ' ' LEU . 67.4 m-85 -80.87 -69.88 0.57 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.886 . . . . 0.0 109.516 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.443 HD12 ' HD2' ' A' ' 120' ' ' PRO . 38.3 tp -90.12 112.47 52.63 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.379 -0.826 . . . . 0.0 109.466 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.47 ' O ' HD23 ' A' ' 121' ' ' LEU . 35.8 Cg_endo -78.12 152.95 28.12 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.327 2.018 . . . . 0.0 110.381 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 1.074 HD11 ' CZ ' ' A' ' 28' ' ' TYR . 26.1 mt . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.247 -0.908 . . . . 0.0 109.467 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.511 ' HB2' ' HA ' ' A' ' 48' ' ' PRO . 42.7 mttm -127.71 138.53 52.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.318 -0.864 . . . . 0.0 109.444 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.653 HD12 ' HB3' ' A' ' 28' ' ' TYR . 74.3 mt -144.33 155.0 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.188 -0.945 . . . . 0.0 109.417 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.978 HD22 ' HB2' ' A' ' 31' ' ' PHE . 0.2 OUTLIER -132.26 119.39 20.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.214 -0.929 . . . . 0.0 109.556 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.694 ' N ' HD13 ' A' ' 7' ' ' LEU . 14.1 mt -99.78 102.21 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.248 -0.908 . . . . 0.0 109.447 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.624 HG21 ' CD1' ' A' ' 53' ' ' LEU . 4.9 t -90.02 91.55 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 109.546 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.52 ' O ' ' CD ' ' A' ' 16' ' ' ARG . 4.9 t70 -147.42 138.36 23.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.329 -0.857 . . . . 0.0 109.33 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.921 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . 8.9 p-10 -106.96 -35.81 6.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.891 . . . . 0.0 109.495 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.408 ' O ' ' C ' ' A' ' 13' ' ' TYR . 21.6 tt0 -67.35 106.32 2.04 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.271 -0.893 . . . . 0.0 109.374 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.551 ' CE2' HG13 ' A' ' 17' ' ' ILE . 30.4 t80 -43.32 149.34 0.25 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.357 -0.839 . . . . 0.0 109.6 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.79 -50.79 0.81 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.831 HG23 HD13 ' A' ' 19' ' ' LEU . 2.5 mt -80.69 -36.07 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.204 -1.174 . . . . 0.0 109.435 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.524 ' O ' ' CB ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -63.21 -30.1 71.31 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.129 -0.982 . . . . 0.0 109.433 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.604 ' N ' HD13 ' A' ' 17' ' ' ILE . 2.3 mm -90.84 -31.5 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.292 -0.88 . . . . 0.0 109.831 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.719 ' O ' HG23 ' A' ' 22' ' ' VAL . 8.3 mt -68.8 -60.23 2.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.103 -0.998 . . . . 0.0 109.351 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.831 HD13 HG23 ' A' ' 15' ' ' ILE . 7.3 mp -65.86 -18.03 65.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.318 -0.864 . . . . 0.0 108.789 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 16' ' ' ARG . 0.7 OUTLIER -70.2 -66.33 0.61 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.818 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.478 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 1.1 mm-40 -53.81 -44.2 69.98 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.337 -0.852 . . . . 0.0 109.575 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.805 HG21 ' CG2' ' A' ' 108' ' ' ILE . 46.8 t -54.6 -63.06 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.164 -0.96 . . . . 0.0 109.499 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.776 ' CB ' HG21 ' A' ' 30' ' ' THR . 25.8 m-85 -64.79 -10.62 29.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 0.0 109.54 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.478 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 0.5 OUTLIER -74.26 -60.23 2.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.256 -0.902 . . . . 0.0 109.477 179.919 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -67.59 -25.03 65.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.254 -0.903 . . . . 0.0 109.394 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.494 ' HB3' ' CD2' ' A' ' 28' ' ' TYR . 1.8 mt-10 -69.27 -34.77 75.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.442 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.479 ' O ' ' CG ' ' A' ' 28' ' ' TYR . . . 102.78 73.1 0.96 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.653 ' HB3' HD12 ' A' ' 6' ' ' ILE . 93.9 m-85 -156.71 144.45 19.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.213 -1.169 . . . . 0.0 109.576 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -89.85 83.24 6.17 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.246 -0.909 . . . . 0.0 109.252 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.776 HG21 ' CB ' ' A' ' 23' ' ' PHE . 5.8 p -89.93 137.95 31.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.28 -0.887 . . . . 0.0 109.566 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.978 ' HB2' HD22 ' A' ' 7' ' ' LEU . 42.4 m-85 -105.03 -172.08 2.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 109.345 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.462 ' HG2' ' CG ' ' A' ' 16' ' ' ARG . 54.4 mt-30 -136.88 147.09 46.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.143 -0.973 . . . . 0.0 109.548 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.712 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -164.91 -161.94 0.59 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.239 -0.913 . . . . 0.0 109.368 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.921 ' HB1' ' HB3' ' A' ' 11' ' ' ASP . . . 163.65 -53.72 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.281 -0.887 . . . . 0.0 109.352 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.423 ' HA ' ' HE1' ' A' ' 60' ' ' MET . 22.3 p-10 -60.13 -14.63 18.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.308 -0.87 . . . . 0.0 109.462 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.579 ' HA3' HD11 ' A' ' 65' ' ' ILE . . . 95.79 -45.39 1.99 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 mt -67.68 -30.84 70.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.257 -1.143 . . . . 0.0 109.496 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.902 ' O ' HD12 ' A' ' 42' ' ' ILE . 7.8 tp-100 -72.32 -43.72 63.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.235 -0.916 . . . . 0.0 109.461 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.629 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -63.36 -55.97 20.18 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.267 -0.896 . . . . 0.0 109.417 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.4 mt -51.98 -44.43 64.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.286 -0.884 . . . . 0.0 109.478 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.99 -49.73 72.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.277 -0.889 . . . . 0.0 109.465 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.902 HD12 ' O ' ' A' ' 38' ' ' GLN . 3.1 mt -66.7 -19.48 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -0.897 . . . . 0.0 109.469 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 39' ' ' ALA . 89.3 t -78.54 -32.35 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -0.892 . . . . 0.0 109.451 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 26.3 m -89.96 -19.44 24.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.205 -0.935 . . . . 0.0 109.494 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.01 -32.33 16.81 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.239 -0.913 . . . . 0.0 109.547 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.412 ' HA ' ' OE1' ' A' ' 46' ' ' GLU . 15.0 mm-40 -117.52 -33.36 4.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.281 -0.887 . . . . 0.0 109.569 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 4.4 ttp180 61.27 73.0 0.63 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.191 -0.943 . . . . 0.0 109.424 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.517 ' CD ' ' HA ' ' A' ' 43' ' ' VAL . 35.3 Cg_endo -78.12 -176.87 3.48 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.577 2.184 . . . . 0.0 110.405 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -127.44 -3.62 6.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.229 -0.919 . . . . 0.0 109.583 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.0 tp -136.93 125.17 23.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.203 -0.936 . . . . 0.0 109.52 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.766 HG21 ' SD ' ' A' ' 69' ' ' MET . 73.3 t -115.74 166.21 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.324 -0.86 . . . . 0.0 109.442 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.614 ' N ' HG12 ' A' ' 51' ' ' VAL . 1.1 mt -138.42 91.09 2.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.91 . . . . 0.0 109.585 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.624 ' CD1' HG21 ' A' ' 9' ' ' VAL . 3.1 mp -89.93 124.03 34.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.2 -0.938 . . . . 0.0 109.512 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.535 ' HB2' ' HE3' ' A' ' 81' ' ' MET . 28.1 t0 -100.06 -7.36 25.06 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.246 -0.909 . . . . 0.0 109.743 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 7.8 mmt 51.37 18.7 0.67 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.389 -0.819 . . . . 0.0 109.817 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.439 ' HG3' ' OD2' ' A' ' 54' ' ' ASP . 51.3 mmtt -90.95 -37.67 13.36 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.057 -1.027 . . . . 0.0 109.42 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.878 HG12 ' HB1' ' A' ' 34' ' ' ALA . 2.9 mt -42.82 114.41 1.51 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.388 -0.82 . . . . 0.0 109.593 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.489 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 34.9 Cg_endo -77.14 152.87 31.58 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.394 2.062 . . . . 0.0 110.27 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 108.87 -43.69 1.65 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.809 ' HE1' HG21 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -153.98 159.72 41.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.343 -1.092 . . . . 0.0 109.286 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -90.02 164.84 14.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.23 -0.919 . . . . 0.0 109.538 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.481 ' HA2' HG12 ' A' ' 65' ' ' ILE . . . -89.66 -9.0 66.99 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.491 HD13 ' HA ' ' A' ' 63' ' ' ILE . 20.5 mm -46.85 -44.54 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.215 -1.168 . . . . 0.0 109.337 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -58.35 -42.01 85.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.336 -0.852 . . . . 0.0 109.338 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.579 HD11 ' HA3' ' A' ' 36' ' ' GLY . 15.6 mm -49.86 -50.26 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -0.926 . . . . 0.0 109.391 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 1.067 ' CD2' HG11 ' A' ' 78' ' ' VAL . 96.1 mt -58.36 -49.1 78.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.207 -0.933 . . . . 0.0 109.372 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.618 ' O ' HG23 ' A' ' 71' ' ' VAL . 12.5 mttp -44.28 -47.95 9.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.262 -0.899 . . . . 0.0 109.411 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.462 ' O ' HG12 ' A' ' 72' ' ' ILE . 1.9 mpt_? -66.1 -37.14 85.02 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.222 -0.924 . . . . 0.0 109.464 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.766 ' SD ' HG21 ' A' ' 51' ' ' VAL . 1.2 mmt -62.44 -22.91 66.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.251 -0.906 . . . . 0.0 109.438 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 66' ' ' LEU . 13.5 mmtt -84.92 -43.76 13.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.228 -0.92 . . . . 0.0 109.43 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 67' ' ' LYS . 2.6 t -63.87 -27.69 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.327 -0.858 . . . . 0.0 109.465 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.462 HG12 ' O ' ' A' ' 68' ' ' ARG . 28.6 mm -89.95 -56.37 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.246 -0.909 . . . . 0.0 109.486 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.438 ' O ' ' O ' ' A' ' 69' ' ' MET . 2.6 m-20 -126.25 134.64 51.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.305 -0.872 . . . . 0.0 109.471 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -89.18 -15.97 32.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.268 -0.895 . . . . 0.0 109.482 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -114.76 55.49 0.75 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.176 -0.952 . . . . 0.0 109.46 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.423 ' O ' HG23 ' A' ' 76' ' ' ILE . 0.8 OUTLIER -110.94 118.0 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.305 -0.872 . . . . 0.0 109.481 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.527 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 0.4 OUTLIER -75.68 144.13 41.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.894 . . . . 0.0 109.48 -179.999 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 1.067 HG11 ' CD2' ' A' ' 66' ' ' LEU . 13.6 t -143.93 107.95 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.343 -0.848 . . . . 0.0 109.495 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.529 HG23 ' O ' ' A' ' 100' ' ' THR . 68.0 mt -90.28 139.32 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.247 -0.908 . . . . 0.0 109.425 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.814 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.0 OUTLIER -108.36 167.02 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.278 -0.889 . . . . 0.0 109.297 179.915 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.535 ' HE3' ' HB2' ' A' ' 54' ' ' ASP . 7.2 mtm -146.59 95.0 2.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.154 -0.967 . . . . 0.0 109.588 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.975 HG22 ' NE2' ' A' ' 101' ' ' HIS . 11.6 t 177.8 38.37 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.213 -0.929 . . . . 0.0 109.35 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.7 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . . . . . . 0 N--CA 1.489 1.48 0 O-C-N 121.352 -0.842 . . . . 0.0 109.477 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.49 ' HA ' ' HB2' ' A' ' 93' ' ' SER . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -61.06 -49.35 77.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -0.882 . . . . 0.0 109.4 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.448 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -77.54 -22.41 51.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.897 . . . . 0.0 109.295 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.49 ' HB2' ' HA ' ' A' ' 90' ' ' ILE . 0.6 OUTLIER -59.86 -68.8 0.25 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.258 -0.901 . . . . 0.0 109.358 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.854 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 24.0 tptt -44.04 -53.58 6.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.332 -0.855 . . . . 0.0 109.312 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 94' ' ' LYS . 36.3 tp10 -43.46 -51.5 6.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.365 -0.835 . . . . 0.0 109.461 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 92' ' ' GLU . 23.8 mt -58.11 -50.9 71.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.262 -0.899 . . . . 0.0 109.522 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 163.25 41.15 0.02 OUTLIER Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.854 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -93.52 107.23 19.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.295 -1.121 . . . . 0.0 109.368 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.527 ' CD1' ' HB3' ' A' ' 77' ' ' ARG . 22.0 mt -44.03 -87.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.261 -0.899 . . . . 0.0 109.518 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.529 ' O ' HG23 ' A' ' 79' ' ' ILE . 4.0 t -127.95 160.93 30.35 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.918 . . . . 0.0 109.517 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.975 ' NE2' HG22 ' A' ' 82' ' ' THR . 6.3 t-160 -125.21 95.32 4.44 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.255 -0.903 . . . . 0.0 109.581 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.66 ' CD2' HD13 ' A' ' 111' ' ' ILE . 18.8 m-85 -69.51 -168.45 0.17 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.29 -0.881 . . . . 0.0 109.419 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.7 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -162.81 -165.85 1.21 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.201 -0.937 . . . . 0.0 109.402 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.538 ' HG3' ' CE1' ' A' ' 106' ' ' PHE . 16.9 mtpt -129.2 145.37 56.44 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.225 -0.922 . . . . 0.0 109.459 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.9 151.66 91.38 Favored 'Cis proline' 0 C--N 1.31 -1.476 0 C-N-CA 123.302 -1.541 . . . . 0.0 110.381 -0.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.547 ' CD1' ' N ' ' A' ' 106' ' ' PHE . 4.9 p90 -133.63 169.32 17.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.183 -0.948 . . . . 0.0 109.486 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.413 ' HB3' ' OE1' ' A' ' 110' ' ' GLU . 42.7 t0 -103.16 116.71 33.0 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.208 -0.933 . . . . 0.0 109.501 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.805 ' CG2' HG21 ' A' ' 22' ' ' VAL . 12.9 mm -50.23 -29.72 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.279 -0.888 . . . . 0.0 109.38 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.453 ' HA ' ' HD3' ' A' ' 112' ' ' ARG . 52.0 m-20 -66.26 -44.0 84.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.204 -0.935 . . . . 0.0 109.383 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 113' ' ' ASP . 2.2 mp0 -64.46 -46.92 81.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 109.505 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.66 HD13 ' CD2' ' A' ' 102' ' ' PHE . 22.6 mm -52.27 -62.28 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.317 -0.864 . . . . 0.0 109.533 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.456 ' HG2' ' O ' ' A' ' 108' ' ' ILE . 0.6 OUTLIER -52.23 -38.45 58.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.55 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 110' ' ' GLU . 88.3 m-20 -53.52 -63.21 1.22 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 109.494 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.44 ' HA ' ' HG3' ' A' ' 117' ' ' LYS . . . -52.08 -55.67 19.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.912 . . . . 0.0 109.518 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.41 ' C ' ' O ' ' A' ' 114' ' ' ALA . 50.7 t -43.96 -35.04 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.261 -0.899 . . . . 0.0 109.477 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.45 ' HE3' ' OE2' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -73.93 -42.2 60.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.282 -0.886 . . . . 0.0 109.467 179.952 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.44 ' HG3' ' HA ' ' A' ' 114' ' ' ALA . 4.0 mttt -62.4 -21.57 65.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 109.449 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.46 ' O ' ' HD3' ' A' ' 120' ' ' PRO . 61.2 m-85 -88.55 -70.8 0.62 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.287 -0.883 . . . . 0.0 109.499 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 21.1 tp -90.04 112.48 52.61 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.365 -0.835 . . . . 0.0 109.448 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 118' ' ' TYR . 35.5 Cg_endo -78.04 133.0 12.02 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.393 2.062 . . . . 0.0 110.382 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 121' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 109.427 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.732 ' OE1' HD23 ' A' ' 121' ' ' LEU . 3.9 mt-10 . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.503 ' O ' ' CB ' ' A' ' 48' ' ' PRO . 0.8 OUTLIER -134.42 134.46 41.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.287 -0.883 . . . . 0.0 109.426 179.934 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.824 ' HB ' HG22 ' A' ' 30' ' ' THR . 98.0 mt -128.85 161.27 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.3 -0.875 . . . . 0.0 109.486 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.768 ' HB3' HG13 ' A' ' 51' ' ' VAL . 2.1 tm? -132.51 114.97 14.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.551 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.838 HG22 ' OD2' ' A' ' 10' ' ' ASP . 3.2 mt -104.36 105.03 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.924 . . . . 0.0 109.552 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.773 ' HA ' ' HB3' ' A' ' 33' ' ' ALA . 35.9 t -90.49 90.0 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.874 . . . . 0.0 109.464 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.838 ' OD2' HG22 ' A' ' 8' ' ' ILE . 69.1 m-20 -127.37 128.79 46.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.202 -0.936 . . . . 0.0 109.434 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.5 ' OD2' ' HD2' ' A' ' 58' ' ' PRO . 6.7 p-10 -100.21 -23.69 14.76 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.289 -0.882 . . . . 0.0 109.241 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.421 ' O ' ' C ' ' A' ' 13' ' ' TYR . 9.7 tp-100 -84.41 105.78 15.5 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.362 -0.836 . . . . 0.0 109.558 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.677 ' CE2' HD11 ' A' ' 17' ' ' ILE . 1.5 t80 -42.53 155.37 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.402 -0.811 . . . . 0.0 109.325 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.516 ' N ' ' CD1' ' A' ' 13' ' ' TYR . . . 109.33 -55.53 0.5 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.904 HG23 HD13 ' A' ' 19' ' ' LEU . 2.1 mt -76.13 -60.28 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.329 -1.101 . . . . 0.0 109.268 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.472 ' HD2' ' O ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -41.16 -30.91 0.17 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.48 -0.762 . . . . 0.0 110.042 -179.869 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.677 HD11 ' CE2' ' A' ' 13' ' ' TYR . 1.3 mt -90.42 -35.66 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.135 -0.978 . . . . 0.0 109.973 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.783 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.4 OUTLIER -65.44 -59.81 3.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.239 -0.913 . . . . 0.0 109.758 -179.625 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.904 HD13 HG23 ' A' ' 15' ' ' ILE . 7.2 mp -64.32 -20.97 66.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.198 -0.939 . . . . 0.0 109.639 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.472 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 10.9 t30 -70.65 -62.56 1.34 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 109.514 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.461 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 34.9 mt-10 -56.46 -44.37 80.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.265 -0.897 . . . . 0.0 109.55 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.783 HG23 ' O ' ' A' ' 18' ' ' LEU . 41.2 t -55.13 -61.73 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.236 -0.915 . . . . 0.0 109.491 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.863 ' CZ ' HG21 ' A' ' 115' ' ' VAL . 20.9 m-85 -65.56 -11.5 44.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.348 -0.845 . . . . 0.0 109.479 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.461 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 0.5 OUTLIER -73.52 -60.07 2.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.335 -0.853 . . . . 0.0 109.483 179.937 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.1 tttp -74.07 -11.3 60.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.453 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.484 ' HB2' ' HA ' ' A' ' 23' ' ' PHE . 0.7 OUTLIER -76.14 -31.57 58.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -0.935 . . . . 0.0 109.49 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.88 41.89 0.82 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.485 ' HB3' HD12 ' A' ' 6' ' ' ILE . 85.2 m-85 -141.56 134.93 29.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.256 -1.144 . . . . 0.0 109.592 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -93.96 82.21 4.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.234 -0.916 . . . . 0.0 109.07 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.824 HG22 ' HB ' ' A' ' 6' ' ' ILE . 5.5 p -89.79 149.07 22.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.27 -0.894 . . . . 0.0 109.881 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.612 ' HB2' HD22 ' A' ' 7' ' ' LEU . 31.6 m-85 -109.01 -167.23 1.19 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 109.052 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.428 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 15.5 mp0 -133.19 157.09 46.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.161 -0.962 . . . . 0.0 109.821 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.773 ' HB3' ' HA ' ' A' ' 9' ' ' VAL . . . -157.77 176.94 11.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.414 -0.804 . . . . 0.0 109.283 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.522 ' O ' HD13 ' A' ' 57' ' ' ILE . . . -173.35 -44.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.125 -0.985 . . . . 0.0 109.693 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.418 ' C ' ' SD ' ' A' ' 60' ' ' MET . 2.4 p30 -82.25 -1.8 50.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.214 -0.929 . . . . 0.0 109.607 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.461 ' HA3' ' SD ' ' A' ' 60' ' ' MET . . . 85.7 -48.69 4.03 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.477 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 1.1 mp -52.54 -44.79 66.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -1.149 . . . . 0.0 109.511 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.851 ' O ' HD12 ' A' ' 42' ' ' ILE . 1.0 OUTLIER -68.19 -27.71 66.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.217 -0.927 . . . . 0.0 109.481 179.939 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.778 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -71.56 -69.45 0.38 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.202 -0.936 . . . . 0.0 109.548 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -51.77 -47.17 64.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.228 -0.92 . . . . 0.0 109.6 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.477 ' HB2' ' O ' ' A' ' 37' ' ' LEU . 16.0 t0 -54.08 -52.59 60.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.308 -0.87 . . . . 0.0 109.55 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.851 HD12 ' O ' ' A' ' 38' ' ' GLN . 20.4 mt -61.7 -22.92 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.257 -0.902 . . . . 0.0 109.424 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.778 HG23 ' O ' ' A' ' 39' ' ' ALA . 54.1 t -78.29 -25.28 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.182 -0.949 . . . . 0.0 109.457 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.1 m -90.13 -25.29 20.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.308 -0.87 . . . . 0.0 109.525 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.523 ' CD ' ' HA ' ' A' ' 42' ' ' ILE . 3.8 ptmt -90.07 -27.13 19.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.574 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.538 ' OE2' ' CZ ' ' A' ' 31' ' ' PHE . 3.2 mt-10 -118.6 -26.66 6.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.23 -0.919 . . . . 0.0 109.471 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.502 ' HG3' ' O ' ' A' ' 46' ' ' GLU . 7.4 ptm180 38.55 72.12 0.98 Allowed Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.598 -0.689 . . . . 0.0 109.969 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.503 ' CB ' ' O ' ' A' ' 5' ' ' LYS . 34.7 Cg_endo -77.19 -171.51 1.18 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.619 2.213 . . . . 0.0 110.343 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 5.7 m-20 -117.6 -8.3 10.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.139 -0.975 . . . . 0.0 109.556 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.456 HD21 HG22 ' A' ' 115' ' ' VAL . 7.2 tp -131.57 117.34 18.6 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.286 -0.884 . . . . 0.0 109.54 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 1.06 HG11 ' CE ' ' A' ' 69' ' ' MET . 2.9 t -121.35 158.75 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.233 -0.917 . . . . 0.0 109.408 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.2 mp -135.3 115.68 13.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -0.935 . . . . 0.0 109.516 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.857 HD22 ' N ' ' A' ' 53' ' ' LEU . 0.8 OUTLIER -102.19 126.45 49.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.355 -0.841 . . . . 0.0 109.419 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 81' ' ' MET . 31.9 t0 -106.49 106.6 17.19 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.917 . . . . 0.0 109.466 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.711 ' CG ' HG21 ' A' ' 82' ' ' THR . 16.0 mmt -59.78 -14.95 16.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.332 -0.855 . . . . 0.0 109.462 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.458 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 4.2 mmpt? -52.88 -37.18 60.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 109.502 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.751 ' CD1' ' HE1' ' A' ' 60' ' ' MET . 43.8 mt -41.14 101.15 0.24 Allowed Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.443 -0.786 . . . . 0.0 109.691 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.5 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 36.2 Cg_endo -79.15 -29.53 3.14 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.512 2.141 . . . . 0.0 110.51 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -84.45 -3.91 88.19 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.751 ' HE1' ' CD1' ' A' ' 57' ' ' ILE . 10.3 ttp -156.96 141.03 16.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.103 -1.234 . . . . 0.0 109.607 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.477 ' N ' ' HG2' ' A' ' 60' ' ' MET . 15.3 m-20 -89.99 126.82 35.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.31 -0.869 . . . . 0.0 109.431 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.518 ' HA2' ' CG1' ' A' ' 65' ' ' ILE . . . -82.96 9.16 60.92 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' ' 63' ' ' ILE . 13.0 mm -70.8 -44.69 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.249 -1.148 . . . . 0.0 109.396 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -71.91 -12.89 61.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -0.905 . . . . 0.0 109.404 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.523 ' O ' ' CG ' ' A' ' 69' ' ' MET . 13.6 mm -73.49 -58.36 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.189 -0.944 . . . . 0.0 109.49 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.751 HD21 ' HB ' ' A' ' 78' ' ' VAL . 6.3 mt -53.25 -28.42 27.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -0.916 . . . . 0.0 109.465 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.505 ' O ' ' CG ' ' A' ' 70' ' ' LYS . 5.7 mmtm -72.65 -70.28 0.36 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.189 -0.945 . . . . 0.0 109.451 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.467 ' O ' HG12 ' A' ' 72' ' ' ILE . 0.6 OUTLIER -45.25 -25.83 0.42 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.265 -0.897 . . . . 0.0 109.418 -179.938 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 1.06 ' CE ' HG11 ' A' ' 51' ' ' VAL . 2.9 mmm -72.78 -48.9 34.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.187 -0.946 . . . . 0.0 109.456 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.505 ' CG ' ' O ' ' A' ' 67' ' ' LYS . 16.3 ptpt -63.18 -21.77 66.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.262 -0.899 . . . . 0.0 109.51 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.1 t -80.1 -45.62 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.251 -0.905 . . . . 0.0 109.517 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 68' ' ' ARG . 24.1 mm -76.21 -14.64 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.215 -0.928 . . . . 0.0 109.525 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.402 ' O ' HG22 ' A' ' 76' ' ' ILE . 1.2 m-20 -170.06 117.62 0.56 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.221 -0.924 . . . . 0.0 109.514 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.418 ' HG3' ' N ' ' A' ' 75' ' ' ASN . 0.1 OUTLIER -90.13 -18.83 25.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.186 -0.946 . . . . 0.0 109.417 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.418 ' N ' ' HG3' ' A' ' 74' ' ' GLU . 17.3 m120 -101.2 48.85 0.88 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.295 -0.878 . . . . 0.0 109.456 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.485 ' O ' HG23 ' A' ' 76' ' ' ILE . 0.3 OUTLIER -121.9 116.96 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.275 -0.891 . . . . 0.0 109.518 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.536 ' CA ' HD11 ' A' ' 99' ' ' LEU . 7.7 mtt85 -54.02 130.73 38.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 109.417 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.751 ' HB ' HD21 ' A' ' 66' ' ' LEU . 0.2 OUTLIER -132.08 117.86 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.213 -0.929 . . . . 0.0 109.63 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.556 HG23 ' O ' ' A' ' 100' ' ' THR . 66.9 mt -114.69 144.05 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.261 -0.899 . . . . 0.0 109.394 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 1.017 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.1 OUTLIER -108.63 158.88 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.235 -0.916 . . . . 0.0 109.418 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.469 ' O ' ' HB ' ' A' ' 82' ' ' THR . 14.2 mtm -136.83 91.92 2.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.135 -0.978 . . . . 0.0 109.644 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.924 HG22 ' NE2' ' A' ' 101' ' ' HIS . 11.4 t 176.69 38.65 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.377 -0.827 . . . . 0.0 109.331 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.95 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.338 -0.851 . . . . 0.0 109.571 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.456 ' HA ' ' HB2' ' A' ' 93' ' ' SER . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.785 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.71 -38.25 14.81 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.193 -0.942 . . . . 0.0 109.452 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.14 -44.82 9.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.915 . . . . 0.0 109.639 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 1.006 ' HA ' HD12 ' A' ' 96' ' ' LEU . 2.7 m -45.05 -26.88 0.49 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.171 -0.955 . . . . 0.0 109.69 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.841 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 0.8 OUTLIER -60.64 -63.45 1.29 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.18 -0.95 . . . . 0.0 109.518 -179.93 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.414 ' HG3' ' N ' ' A' ' 96' ' ' LEU . 7.1 pt-20 -61.45 -27.03 68.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.277 -0.89 . . . . 0.0 109.512 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 1.006 HD12 ' HA ' ' A' ' 93' ' ' SER . 36.2 mt -67.49 -33.73 75.71 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.205 -0.935 . . . . 0.0 109.5 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.558 ' O ' HG21 ' A' ' 78' ' ' VAL . . . 156.16 69.9 0.01 OUTLIER Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.841 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -158.01 110.03 2.31 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.273 -1.133 . . . . 0.0 109.382 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.536 HD11 ' CA ' ' A' ' 77' ' ' ARG . 0.4 OUTLIER -60.24 -67.58 0.38 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.289 -0.882 . . . . 0.0 109.436 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.556 ' O ' HG23 ' A' ' 79' ' ' ILE . 10.7 t -131.66 160.39 35.56 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.214 -0.928 . . . . 0.0 109.406 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 1.017 ' ND1' HD12 ' A' ' 80' ' ' ILE . 5.4 t-160 -124.92 94.79 4.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -0.892 . . . . 0.0 109.458 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.412 ' HZ ' ' HB2' ' A' ' 114' ' ' ALA . 38.8 m-85 -63.62 -179.0 0.32 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.238 -0.914 . . . . 0.0 109.5 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.95 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -171.08 -157.94 0.14 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.291 -0.881 . . . . 0.0 109.337 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.448 ' HG3' ' HA ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -98.9 143.03 25.63 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.188 -0.945 . . . . 0.0 109.454 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.448 ' HA ' ' HG3' ' A' ' 104' ' ' LYS . 35.6 Cg_endo -77.98 164.75 84.92 Favored 'Cis proline' 0 C--N 1.31 -1.487 0 C-N-CA 123.277 -1.551 . . . . 0.0 110.37 -0.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.727 ' CE2' HD12 ' A' ' 111' ' ' ILE . 0.2 OUTLIER -96.18 107.68 20.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.29 -0.881 . . . . 0.0 109.502 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.478 ' O ' HG12 ' A' ' 111' ' ' ILE . 23.1 t0 -89.83 103.87 16.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.258 -0.901 . . . . 0.0 109.384 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.683 HD12 HG21 ' A' ' 22' ' ' VAL . 15.8 mm -46.21 -24.35 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 109.863 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.456 ' O ' ' OD2' ' A' ' 113' ' ' ASP . 22.4 m-20 -73.6 -45.22 54.39 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.203 -0.936 . . . . 0.0 109.789 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.92 -24.37 61.62 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.112 -0.993 . . . . 0.0 109.706 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.727 HD12 ' CE2' ' A' ' 106' ' ' PHE . 10.6 mm -76.26 -53.08 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.218 -0.926 . . . . 0.0 109.438 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.459 ' O ' ' HG3' ' A' ' 116' ' ' LYS . 0.9 OUTLIER -64.24 -37.39 87.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.319 -0.863 . . . . 0.0 109.588 -179.867 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.456 ' OD2' ' O ' ' A' ' 109' ' ' ASP . 16.6 m-20 -63.65 -60.13 3.72 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.203 -0.936 . . . . 0.0 109.6 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.412 ' HB2' ' HZ ' ' A' ' 102' ' ' PHE . . . -46.58 -51.06 16.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.925 . . . . 0.0 109.618 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.863 HG21 ' CZ ' ' A' ' 23' ' ' PHE . 47.9 t -52.57 -49.98 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.889 . . . . 0.0 109.597 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 0.4 OUTLIER -58.42 -29.68 66.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.902 . . . . 0.0 109.553 -179.867 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.7 tttm -76.89 -27.36 54.94 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.201 -0.937 . . . . 0.0 109.42 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.492 ' O ' ' HD3' ' A' ' 120' ' ' PRO . 40.3 m-85 -90.05 -75.07 0.46 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.254 -0.904 . . . . 0.0 109.497 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.417 HD23 ' O ' ' A' ' 120' ' ' PRO . 5.3 tt -90.54 111.87 49.89 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.261 -0.899 . . . . 0.0 109.627 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 118' ' ' TYR . 36.2 Cg_endo -79.53 154.83 24.26 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.442 2.094 . . . . 0.0 110.355 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.732 HD23 ' OE1' ' A' ' 4' ' ' GLU . 21.4 mt . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.298 -0.876 . . . . 0.0 109.205 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.522 ' CD ' HD21 ' A' ' 121' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.488 ' O ' ' CB ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -127.53 111.15 13.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.294 -0.879 . . . . 0.0 109.454 179.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.687 HD12 HG22 ' A' ' 30' ' ' THR . 16.2 mt -126.93 158.29 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.255 -0.903 . . . . 0.0 109.496 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.879 HD13 ' N ' ' A' ' 8' ' ' ILE . 2.6 tm? -132.51 128.97 38.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.231 -0.918 . . . . 0.0 109.469 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.879 ' N ' HD13 ' A' ' 7' ' ' LEU . 9.1 mt -106.44 104.64 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.239 -0.913 . . . . 0.0 109.466 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.494 ' CG2' HD12 ' A' ' 7' ' ' LEU . 3.9 t -89.97 70.78 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.292 -0.88 . . . . 0.0 109.463 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.561 ' O ' ' HB2' ' A' ' 34' ' ' ALA . 0.4 OUTLIER -123.22 148.94 45.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.892 . . . . 0.0 109.502 179.935 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.549 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . 5.5 p-10 -115.8 -40.16 3.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.248 -0.907 . . . . 0.0 109.457 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.94 111.93 2.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.0 109.505 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.581 ' CZ ' HG13 ' A' ' 17' ' ' ILE . 46.6 t80 -49.26 128.84 17.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.212 -0.93 . . . . 0.0 109.477 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.52 ' O ' HD12 ' A' ' 18' ' ' LEU . . . 138.23 -43.93 1.15 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.784 HG23 HD13 ' A' ' 19' ' ' LEU . 6.4 mt -84.26 -39.74 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -1.135 . . . . 0.0 109.392 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.515 ' CD ' ' O ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -65.93 -26.57 67.66 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.207 -0.933 . . . . 0.0 109.453 -179.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.581 HG13 ' CZ ' ' A' ' 13' ' ' TYR . 4.8 mm -90.65 -42.61 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.261 -0.9 . . . . 0.0 109.787 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.789 ' O ' HG23 ' A' ' 22' ' ' VAL . 55.2 mt -64.65 -57.76 8.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.145 -0.972 . . . . 0.0 109.852 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.784 HD13 HG23 ' A' ' 15' ' ' ILE . 7.9 mp -60.23 -26.37 66.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.243 -0.91 . . . . 0.0 109.743 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 30.2 t30 -67.87 -55.2 13.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 109.59 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.489 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 33.4 mt-10 -59.74 -44.71 93.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.265 -0.897 . . . . 0.0 109.723 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.789 HG23 ' O ' ' A' ' 18' ' ' LEU . 13.7 t -55.92 -62.22 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 109.729 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.759 ' CZ ' HG21 ' A' ' 115' ' ' VAL . 17.0 m-85 -68.4 -10.16 53.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.915 . . . . 0.0 109.592 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.489 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 0.4 OUTLIER -70.84 -52.06 22.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.191 -0.943 . . . . 0.0 109.386 179.863 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -74.55 -11.71 60.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.238 -0.914 . . . . 0.0 109.311 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.557 ' HB3' ' CD2' ' A' ' 28' ' ' TYR . 3.5 mt-10 -78.61 -33.61 47.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.294 -0.879 . . . . 0.0 109.474 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.476 ' O ' ' HG2' ' A' ' 4' ' ' GLU . . . 105.56 54.08 0.75 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.725 ' CE1' HD23 ' A' ' 119' ' ' LEU . 88.5 m-85 -138.07 143.53 40.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.168 -1.195 . . . . 0.0 109.525 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.425 ' HB2' ' O ' ' A' ' 4' ' ' GLU . 92.8 mm-40 -94.23 81.51 4.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.91 . . . . 0.0 109.394 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.687 HG22 HD12 ' A' ' 6' ' ' ILE . 5.8 p -89.88 148.34 23.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.906 . . . . 0.0 109.53 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.541 ' HB2' ' CD2' ' A' ' 7' ' ' LEU . 8.5 m-85 -114.84 -172.74 2.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.274 -0.892 . . . . 0.0 109.409 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -123.28 151.35 42.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.282 -0.886 . . . . 0.0 109.529 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.608 ' HB3' HD11 ' A' ' 7' ' ' LEU . . . -174.48 172.4 3.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.313 -0.867 . . . . 0.0 109.414 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.561 ' HB2' ' O ' ' A' ' 10' ' ' ASP . . . 177.67 -31.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.182 -0.949 . . . . 0.0 109.533 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.415 ' ND2' ' H ' ' A' ' 35' ' ' ASN . 2.6 p30 -74.77 -0.91 19.79 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.171 -0.955 . . . . 0.0 109.619 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.05 -45.2 3.48 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.29 -54.79 31.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.158 -1.201 . . . . 0.0 109.514 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.605 ' HG2' HD11 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -71.24 -15.37 62.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.911 . . . . 0.0 109.617 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.814 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -70.6 -60.66 2.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.205 -0.935 . . . . 0.0 109.536 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.511 ' CD2' ' HB3' ' A' ' 68' ' ' ARG . 0.7 OUTLIER -69.85 -38.66 76.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.247 -0.908 . . . . 0.0 109.55 -179.974 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.461 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 14.8 m-20 -61.43 -60.79 3.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.332 -0.855 . . . . 0.0 109.547 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.785 HG21 HD23 ' A' ' 7' ' ' LEU . 41.5 mt -56.97 -31.05 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.248 -0.908 . . . . 0.0 109.513 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.814 HG23 ' O ' ' A' ' 39' ' ' ALA . 44.0 t -68.84 -31.69 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.204 -0.935 . . . . 0.0 109.485 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 79.8 m -90.02 -14.5 33.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.214 -0.929 . . . . 0.0 109.474 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 3.7 mmtt -84.61 -58.48 2.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.891 . . . . 0.0 109.545 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 47' ' ' ARG . 2.4 mm-40 -89.97 -25.38 20.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 109.628 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.507 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 6.5 mmm180 63.48 62.8 1.61 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.182 -0.949 . . . . 0.0 109.436 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.507 ' HD3' ' N ' ' A' ' 47' ' ' ARG . 35.3 Cg_endo -77.69 158.18 31.84 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.603 2.202 . . . . 0.0 110.49 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.405 ' HB2' ' CD1' ' A' ' 119' ' ' LEU . 4.4 m-20 -100.04 -10.9 21.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.246 -0.909 . . . . 0.0 109.508 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.695 HD23 ' HB2' ' A' ' 119' ' ' LEU . 1.7 mm? -116.62 122.89 45.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.221 -0.924 . . . . 0.0 109.499 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.887 HG11 ' CE ' ' A' ' 69' ' ' MET . 9.0 t -123.91 113.06 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.902 . . . . 0.0 109.529 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.633 HD12 ' O ' ' A' ' 7' ' ' LEU . 1.0 OUTLIER -90.75 120.31 31.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.883 . . . . 0.0 109.419 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.673 HD21 ' HB ' ' A' ' 65' ' ' ILE . 1.1 tp -110.75 121.98 46.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.337 -0.852 . . . . 0.0 109.534 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.471 ' OD2' ' HB2' ' A' ' 56' ' ' LYS . 8.9 t0 -104.45 109.14 20.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 0.0 109.366 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.45 ' HB2' ' HB ' ' A' ' 82' ' ' THR . 6.6 mmt -67.18 -9.59 41.7 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.144 -0.972 . . . . 0.0 109.512 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.471 ' HB2' ' OD2' ' A' ' 54' ' ' ASP . 6.3 mmtt -74.92 -19.13 60.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 0.0 109.383 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.668 HG21 ' HE2' ' A' ' 60' ' ' MET . 81.0 mt -43.11 103.15 0.3 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.324 -0.86 . . . . 0.0 109.519 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.44 ' HD2' ' CG ' ' A' ' 11' ' ' ASP . 35.5 Cg_endo -77.55 108.76 2.64 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.412 2.075 . . . . 0.0 110.421 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 128.93 -33.76 3.0 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.668 ' HE2' HG21 ' A' ' 57' ' ' ILE . 0.6 OUTLIER -138.82 133.34 31.94 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.276 -1.132 . . . . 0.0 109.458 -179.962 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.418 ' O ' ' HE3' ' A' ' 60' ' ' MET . 4.3 m-20 -83.52 157.94 22.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.161 -0.962 . . . . 0.0 109.477 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.526 ' HA2' ' CD1' ' A' ' 65' ' ' ILE . . . -102.89 9.17 55.0 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.7 mm -70.37 -57.68 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -1.191 . . . . 0.0 109.447 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -58.59 -29.13 66.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 0.0 109.432 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.673 ' HB ' HD21 ' A' ' 53' ' ' LEU . 10.1 mt -59.23 -52.15 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.277 -0.889 . . . . 0.0 109.412 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.777 ' CD2' HG11 ' A' ' 78' ' ' VAL . 25.8 mt -53.87 -51.5 63.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.357 -0.84 . . . . 0.0 109.486 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.522 ' O ' HG23 ' A' ' 71' ' ' VAL . 1.3 tttt -46.81 -49.39 20.03 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.262 -0.899 . . . . 0.0 109.483 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.511 ' HB3' ' CD2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -57.93 -38.54 76.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.278 -0.889 . . . . 0.0 109.463 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.887 ' CE ' HG11 ' A' ' 51' ' ' VAL . 7.0 mtt -67.94 -25.31 65.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 0.0 109.465 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 66' ' ' LEU . 0.8 OUTLIER -78.88 -30.32 44.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.271 -0.893 . . . . 0.0 109.452 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 67' ' ' LYS . 3.6 t -84.9 -20.85 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.274 -0.891 . . . . 0.0 109.435 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 68' ' ' ARG . 91.4 mt -89.92 -34.97 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -0.879 . . . . 0.0 109.432 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -166.31 134.05 2.77 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.261 -0.899 . . . . 0.0 109.433 -179.927 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -89.72 -10.48 45.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.514 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -103.23 12.45 35.6 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.226 -0.921 . . . . 0.0 109.552 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.632 ' O ' HG23 ' A' ' 76' ' ' ILE . 1.0 OUTLIER -78.62 115.26 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.262 -0.899 . . . . 0.0 109.496 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.792 ' HB3' HD11 ' A' ' 99' ' ' LEU . 59.0 mtt85 -69.85 126.97 31.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 109.513 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.777 HG11 ' CD2' ' A' ' 66' ' ' LEU . 2.9 t -133.23 110.44 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.269 -0.894 . . . . 0.0 109.458 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.547 HG22 ' N ' ' A' ' 80' ' ' ILE . 75.5 mt -92.59 165.02 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 109.384 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 1.016 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.3 OUTLIER -128.42 152.76 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.162 -0.962 . . . . 0.0 109.528 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.46 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 16.9 mtm -136.93 98.37 3.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.286 -0.884 . . . . 0.0 109.361 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 1.077 HG22 ' NE2' ' A' ' 101' ' ' HIS . 4.4 t -166.37 -147.23 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.153 -0.967 . . . . 0.0 109.64 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.787 ' N ' HG23 ' A' ' 82' ' ' THR . . . . . . . . 0 N--CA 1.488 1.468 0 O-C-N 121.464 -0.772 . . . . 0.0 110.052 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.982 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.789 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.432 ' N ' HG12 ' A' ' 90' ' ' ILE . 10.6 tt0 -47.66 -58.36 4.38 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.253 -0.905 . . . . 0.0 109.5 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.41 ' O ' ' C ' ' A' ' 93' ' ' SER . 11.2 tm-20 -58.81 -42.71 89.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.259 -0.901 . . . . 0.0 109.488 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.553 ' HA ' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -43.76 -30.77 0.69 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 0.0 109.457 179.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.757 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -55.64 -54.6 42.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 109.469 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -51.06 -47.17 61.85 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.281 -0.887 . . . . 0.0 109.502 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.553 HD12 ' HA ' ' A' ' 93' ' ' SER . 0.7 OUTLIER -49.37 -58.36 5.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.212 -0.93 . . . . 0.0 109.488 179.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 169.62 64.89 0.04 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.757 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -134.78 118.58 17.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.257 -1.143 . . . . 0.0 109.485 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.792 HD11 ' HB3' ' A' ' 77' ' ' ARG . 0.5 OUTLIER -71.11 -71.16 0.27 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.188 -0.945 . . . . 0.0 109.426 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.463 HG23 HG23 ' A' ' 79' ' ' ILE . 14.5 t -122.24 173.16 7.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.247 -0.908 . . . . 0.0 109.453 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 1.077 ' NE2' HG22 ' A' ' 82' ' ' THR . 5.4 t-160 -139.88 90.89 2.42 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.224 -0.923 . . . . 0.0 109.582 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.848 ' CE2' HD13 ' A' ' 111' ' ' ILE . 38.2 m-85 -73.21 -168.31 0.5 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.303 -0.873 . . . . 0.0 109.42 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.589 ' HB2' ' O ' ' A' ' 82' ' ' THR . . . -168.94 -147.39 0.07 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.224 -0.923 . . . . 0.0 109.294 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 7.6 ptmt -137.2 135.87 20.14 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.139 -0.976 . . . . 0.0 109.4 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.86 138.61 52.7 Favored 'Cis proline' 0 C--N 1.31 -1.459 0 C-N-CA 123.437 -1.485 . . . . 0.0 110.281 0.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.448 ' HB3' ' O ' ' A' ' 103' ' ' ALA . 26.9 p90 -99.43 172.45 7.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.28 -0.888 . . . . 0.0 109.656 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -114.81 111.96 22.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.271 -0.893 . . . . 0.0 109.348 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.445 HD13 ' HA ' ' A' ' 108' ' ' ILE . 10.7 mm -54.74 -18.76 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 109.38 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -72.96 -46.98 49.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 109.167 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -67.0 -33.73 76.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.302 -0.874 . . . . 0.0 109.215 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.848 HD13 ' CE2' ' A' ' 102' ' ' PHE . 16.7 mm -71.45 -35.19 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.322 -0.861 . . . . 0.0 109.116 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.532 ' CG ' ' CG1' ' A' ' 22' ' ' VAL . 5.3 mtp85 -63.69 -50.58 68.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.334 -0.854 . . . . 0.0 109.513 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 114' ' ' ALA . 61.8 m-20 -67.15 -62.54 1.38 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.223 -0.923 . . . . 0.0 109.766 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.56 ' O ' ' CD2' ' A' ' 118' ' ' TYR . . . -43.82 -39.77 4.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.113 -0.992 . . . . 0.0 109.684 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.759 HG21 ' CZ ' ' A' ' 23' ' ' PHE . 41.2 t -66.6 -42.97 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.909 . . . . 0.0 109.614 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 4.2 mtpp -61.81 -59.41 5.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 0.0 109.558 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -47.18 -56.31 6.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.197 -0.939 . . . . 0.0 109.566 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.56 ' CD2' ' O ' ' A' ' 114' ' ' ALA . 17.8 m-30 -51.96 -72.2 0.06 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.284 -0.885 . . . . 0.0 109.524 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.725 HD23 ' CE1' ' A' ' 28' ' ' TYR . 1.9 tp -90.19 112.49 52.86 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.324 -0.86 . . . . 0.0 109.534 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 118' ' ' TYR . 35.7 Cg_endo -78.16 152.94 27.96 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.318 2.012 . . . . 0.0 110.408 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.633 HD12 ' OH ' ' A' ' 28' ' ' TYR . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 109.439 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.612 ' HG3' HD11 ' A' ' 121' ' ' LEU . 16.8 mm-40 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.47 ' O ' HG12 ' A' ' 6' ' ' ILE . 1.2 mtmp? -138.15 144.11 40.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.256 -0.902 . . . . 0.0 109.442 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.86 HD12 HG22 ' A' ' 30' ' ' THR . 3.5 mt -150.04 159.4 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.194 -0.941 . . . . 0.0 109.516 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.914 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.7 OUTLIER -131.18 128.14 39.39 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.333 -0.854 . . . . 0.0 109.492 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.914 ' N ' HD13 ' A' ' 7' ' ' LEU . 7.7 mt -109.68 106.81 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.287 -0.883 . . . . 0.0 109.494 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.666 HG12 ' HA ' ' A' ' 34' ' ' ALA . 2.6 t -104.46 89.01 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.32 -0.862 . . . . 0.0 109.473 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.54 ' CB ' ' HD2' ' A' ' 16' ' ' ARG . 2.2 t70 -87.51 -155.98 0.32 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.202 -0.936 . . . . 0.0 109.392 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.512 ' CB ' ' HA ' ' A' ' 57' ' ' ILE . 0.7 OUTLIER -109.6 -45.52 3.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.91 . . . . 0.0 109.564 -179.977 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.501 ' HG2' ' N ' ' A' ' 13' ' ' TYR . 7.4 tt0 -132.52 -90.13 0.41 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.17 -0.956 . . . . 0.0 109.482 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 1.147 ' CE2' HD11 ' A' ' 17' ' ' ILE . 2.8 t80 -149.83 167.92 25.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.302 -0.874 . . . . 0.0 109.489 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.01 -66.75 0.24 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.528 HD13 ' OD1' ' A' ' 10' ' ' ASP . 9.8 mt -68.04 -28.01 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.254 -1.145 . . . . 0.0 109.48 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.54 ' HD2' ' CB ' ' A' ' 10' ' ' ASP . 0.3 OUTLIER -66.51 -25.87 66.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.302 -0.874 . . . . 0.0 109.444 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 1.147 HD11 ' CE2' ' A' ' 13' ' ' TYR . 4.5 mt -90.04 -51.85 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.221 -0.925 . . . . 0.0 109.533 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.785 ' O ' HG23 ' A' ' 22' ' ' VAL . 4.8 mp -59.29 -58.04 10.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.241 -0.912 . . . . 0.0 109.554 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.728 ' HB3' HD13 ' A' ' 8' ' ' ILE . 1.9 tp -56.6 -22.54 34.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.891 . . . . 0.0 109.464 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 28.1 t30 -74.87 -72.77 0.27 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.244 -0.91 . . . . 0.0 109.528 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.427 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 17.4 tt0 -44.12 -35.52 2.21 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -0.895 . . . . 0.0 109.488 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.785 HG23 ' O ' ' A' ' 18' ' ' LEU . 58.3 t -62.84 -56.99 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.903 . . . . 0.0 109.461 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.545 ' CB ' HG21 ' A' ' 30' ' ' THR . 18.8 m-85 -73.28 -2.49 22.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.342 -0.849 . . . . 0.0 109.618 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.427 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 0.7 OUTLIER -85.65 -55.14 4.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.145 -0.972 . . . . 0.0 109.45 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.8 mttt -69.54 -19.81 63.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.311 -0.868 . . . . 0.0 109.457 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.487 ' HB3' ' CD2' ' A' ' 28' ' ' TYR . 1.4 tt0 -78.55 -30.97 47.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.258 -0.901 . . . . 0.0 109.45 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.443 ' O ' ' CG ' ' A' ' 28' ' ' TYR . . . 110.07 64.48 0.53 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.487 ' CD2' ' HB3' ' A' ' 26' ' ' GLU . 93.7 m-85 -154.76 134.73 13.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.225 -1.162 . . . . 0.0 109.503 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 22.5 mm-40 -91.67 81.8 5.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.286 -0.884 . . . . 0.0 109.409 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.86 HG22 HD12 ' A' ' 6' ' ' ILE . 5.9 p -89.88 152.58 21.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.275 -0.89 . . . . 0.0 109.56 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.837 ' HB2' HD22 ' A' ' 7' ' ' LEU . 58.8 m-85 -116.48 -170.23 1.78 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.301 -0.875 . . . . 0.0 109.402 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.427 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 22.1 mp0 -124.17 161.26 26.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.241 -0.912 . . . . 0.0 109.547 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.463 ' HB3' HG22 ' A' ' 9' ' ' VAL . . . 178.49 177.52 0.44 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 109.437 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.666 ' HA ' HG12 ' A' ' 9' ' ' VAL . . . 178.73 -41.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.217 -0.927 . . . . 0.0 109.466 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.41 ' OD1' ' CB ' ' A' ' 38' ' ' GLN . 30.9 p-10 -65.18 -10.58 32.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.923 . . . . 0.0 109.459 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.416 ' O ' ' C ' ' A' ' 37' ' ' LEU . . . 87.9 -71.42 2.58 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 40' ' ' LEU . 1.9 tt -44.46 -42.21 6.89 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -1.147 . . . . 0.0 109.395 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.517 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 6.6 tp-100 -58.72 -53.87 53.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.264 -0.898 . . . . 0.0 109.504 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.597 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -55.69 -24.16 32.81 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.15 -0.969 . . . . 0.0 109.493 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 37' ' ' LEU . 54.9 mt -73.06 -45.46 57.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.91 . . . . 0.0 109.517 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 42' ' ' ILE . 1.7 p30 -64.81 -43.02 94.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.182 -0.949 . . . . 0.0 109.449 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.644 HG21 HD23 ' A' ' 7' ' ' LEU . 7.2 mt -64.23 -34.77 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.21 -0.931 . . . . 0.0 109.268 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 39' ' ' ALA . 54.2 t -74.32 -24.03 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.891 . . . . 0.0 109.453 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.2 m -89.7 -18.72 25.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.228 -0.92 . . . . 0.0 109.532 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.95 -55.65 3.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.285 -0.884 . . . . 0.0 109.483 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.438 ' O ' ' CB ' ' A' ' 47' ' ' ARG . 1.1 mt-10 -89.98 -39.04 13.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.268 -0.895 . . . . 0.0 109.458 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER 71.28 65.91 0.39 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.23 -0.919 . . . . 0.0 109.498 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.531 ' CD ' ' HA ' ' A' ' 43' ' ' VAL . 35.5 Cg_endo -78.14 167.99 22.52 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.589 2.192 . . . . 0.0 110.421 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.559 ' C ' HD22 ' A' ' 50' ' ' LEU . 29.0 t70 -109.43 -9.91 14.92 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.218 -0.926 . . . . 0.0 109.533 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.559 HD22 ' C ' ' A' ' 49' ' ' ASP . 3.8 mm? -117.84 121.51 40.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -0.937 . . . . 0.0 109.543 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.488 HG11 ' CE ' ' A' ' 69' ' ' MET . 72.9 t -127.33 140.93 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.257 -0.902 . . . . 0.0 109.471 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.648 HD12 ' O ' ' A' ' 7' ' ' LEU . 1.1 mp -115.27 112.17 22.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.309 -0.87 . . . . 0.0 109.423 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.632 HD22 ' CD2' ' A' ' 66' ' ' LEU . 1.7 mp -102.59 132.02 48.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.282 -0.886 . . . . 0.0 109.517 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.451 ' O ' HG13 ' A' ' 57' ' ' ILE . 17.7 t70 -112.76 130.14 56.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.319 -0.863 . . . . 0.0 109.453 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.729 ' HB2' HG21 ' A' ' 82' ' ' THR . 9.6 mmt -86.84 -6.98 58.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.322 -0.861 . . . . 0.0 109.555 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt -86.58 15.02 5.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.166 -0.959 . . . . 0.0 109.498 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.512 ' HA ' ' CB ' ' A' ' 11' ' ' ASP . 41.7 mt -80.97 138.78 49.57 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.128 -0.983 . . . . 0.0 109.309 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.493 ' HD3' ' HB2' ' A' ' 11' ' ' ASP . 36.2 Cg_endo -78.54 -36.15 0.96 Allowed 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.488 2.126 . . . . 0.0 110.549 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 58' ' ' PRO . . . -42.41 -53.79 4.91 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.502 ' N ' ' SD ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -169.47 -150.3 0.08 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.136 -1.214 . . . . 0.0 109.558 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.497 ' N ' ' HG2' ' A' ' 60' ' ' MET . 36.9 m-20 -90.19 -97.28 0.11 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.291 -0.881 . . . . 0.0 109.481 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.459 ' HA2' HG13 ' A' ' 65' ' ' ILE . . . 147.42 -14.76 1.44 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.466 HD13 ' HA ' ' A' ' 63' ' ' ILE . 14.4 mm -57.0 -18.72 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.314 -1.109 . . . . 0.0 109.238 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -87.47 -33.52 18.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.313 -0.867 . . . . 0.0 109.24 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.515 ' HB ' HD21 ' A' ' 53' ' ' LEU . 17.2 mt -56.15 -54.58 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.338 -0.851 . . . . 0.0 109.319 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.925 HD21 HG11 ' A' ' 78' ' ' VAL . 23.0 mt -51.02 -44.49 61.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 109.31 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.559 ' O ' HG23 ' A' ' 71' ' ' VAL . 3.2 tttp -52.38 -50.32 62.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.326 -0.859 . . . . 0.0 109.411 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.492 ' O ' HD12 ' A' ' 72' ' ' ILE . 0.3 OUTLIER -59.28 -31.5 69.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.286 -0.884 . . . . 0.0 109.431 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.488 ' CE ' HG11 ' A' ' 51' ' ' VAL . 2.7 mtt -74.47 -24.92 59.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.278 -0.889 . . . . 0.0 109.435 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -79.95 -28.93 39.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.379 -0.826 . . . . 0.0 109.264 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 67' ' ' LYS . 2.7 t -90.08 -22.04 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.306 -0.871 . . . . 0.0 109.549 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.492 HD12 ' O ' ' A' ' 68' ' ' ARG . 53.3 mt -87.43 -44.56 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -0.909 . . . . 0.0 109.459 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.507 ' O ' HG22 ' A' ' 76' ' ' ILE . 73.0 m-20 -150.49 122.69 8.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.331 -0.856 . . . . 0.0 109.404 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -81.99 -9.62 59.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.277 -0.889 . . . . 0.0 109.522 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -103.37 49.87 0.82 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.233 -0.917 . . . . 0.0 109.493 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.601 ' O ' HG23 ' A' ' 76' ' ' ILE . 1.1 tp -129.94 112.62 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.466 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.518 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 1.6 mtt180 -79.85 154.19 28.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 0.0 109.468 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.925 HG11 HD21 ' A' ' 66' ' ' LEU . 4.8 t -150.02 108.44 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.913 . . . . 0.0 109.572 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.692 HG23 HG23 ' A' ' 100' ' ' THR . 72.5 mt -90.5 140.81 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.247 -0.908 . . . . 0.0 109.449 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.898 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.0 OUTLIER -94.44 152.32 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.271 -0.893 . . . . 0.0 109.198 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.459 ' O ' ' HB ' ' A' ' 82' ' ' THR . 14.0 mtm -124.53 73.16 1.24 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.183 -0.948 . . . . 0.0 109.373 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.729 HG21 ' HB2' ' A' ' 55' ' ' MET . 9.6 t 177.29 56.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.31 -0.869 . . . . 0.0 109.397 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.88 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.281 -0.887 . . . . 0.0 109.528 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 1.068 HD12 ' CE1' ' A' ' 101' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.795 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -51.35 -37.15 46.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.255 -0.903 . . . . 0.0 109.5 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 93' ' ' SER . 1.4 mt-10 -90.15 -36.28 14.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.226 -0.921 . . . . 0.0 109.625 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.469 ' HB2' ' HA ' ' A' ' 90' ' ' ILE . 0.4 OUTLIER -43.55 -44.92 6.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.312 -0.868 . . . . 0.0 109.649 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.928 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 2.5 ttpt -44.02 -51.79 7.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.282 -0.886 . . . . 0.0 109.445 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -59.5 -40.99 88.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 0.0 109.431 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.562 HD22 ' N ' ' A' ' 96' ' ' LEU . 4.2 mm? -53.31 -64.99 0.64 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.296 -0.878 . . . . 0.0 109.49 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -176.08 40.98 0.11 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.928 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -110.77 101.33 9.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -1.164 . . . . 0.0 109.49 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.518 ' CD1' ' HB3' ' A' ' 77' ' ' ARG . 18.6 mt -44.1 -68.32 0.21 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 109.47 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.692 HG23 HG23 ' A' ' 79' ' ' ILE . 15.1 t -134.9 -177.6 4.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.284 -0.885 . . . . 0.0 109.437 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 1.068 ' CE1' HD12 ' A' ' 90' ' ' ILE . 3.2 t-160 -140.48 88.35 2.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 109.339 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.717 ' CE1' HD13 ' A' ' 111' ' ' ILE . 65.5 m-85 -58.99 -164.35 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.236 -0.915 . . . . 0.0 109.579 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.88 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -177.27 155.31 1.12 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.199 -0.938 . . . . 0.0 109.361 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.519 ' HA ' ' N ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -93.41 142.14 24.84 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.211 -0.931 . . . . 0.0 109.387 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.91 117.1 4.9 Favored 'Cis proline' 0 C--N 1.31 -1.479 0 C-N-CA 123.335 -1.527 . . . . 0.0 110.353 -0.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.519 ' N ' ' HA ' ' A' ' 104' ' ' LYS . 11.1 p90 -79.84 169.6 17.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.248 -0.908 . . . . 0.0 109.574 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.472 ' O ' HG12 ' A' ' 111' ' ' ILE . 36.0 t0 -119.77 121.73 39.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.347 -0.846 . . . . 0.0 109.473 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.463 HG23 HG11 ' A' ' 22' ' ' VAL . 14.5 mm -54.63 -21.28 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -0.897 . . . . 0.0 109.509 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -76.24 -37.52 57.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.235 -0.916 . . . . 0.0 109.518 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -77.57 -25.31 49.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.184 -0.947 . . . . 0.0 109.436 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.717 HD13 ' CE1' ' A' ' 102' ' ' PHE . 19.2 mm -75.73 -45.85 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.313 -0.867 . . . . 0.0 109.516 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.467 ' HB2' ' OE1' ' A' ' 26' ' ' GLU . 7.6 ptt85 -72.51 -41.88 65.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.472 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -61.16 -53.43 57.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.928 . . . . 0.0 109.538 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.486 ' O ' ' HG2' ' A' ' 117' ' ' LYS . . . -59.18 -45.06 92.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.292 -0.88 . . . . 0.0 109.47 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 111' ' ' ILE . 54.7 t -60.48 -25.19 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.191 -0.943 . . . . 0.0 109.396 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -76.89 -45.66 27.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.179 -0.95 . . . . 0.0 109.451 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.524 ' HG3' ' N ' ' A' ' 118' ' ' TYR . 0.0 OUTLIER -63.49 -27.08 69.03 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 109.481 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.524 ' N ' ' HG3' ' A' ' 117' ' ' LYS . 38.9 m-85 -84.51 -72.84 0.45 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.24 -0.912 . . . . 0.0 109.423 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.8 tp -90.06 112.58 53.18 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.341 -0.849 . . . . 0.0 109.422 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 118' ' ' TYR . 35.6 Cg_endo -77.79 132.76 12.15 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.33 2.02 . . . . 0.0 110.418 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.612 HD11 ' HG3' ' A' ' 4' ' ' GLU . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.327 -0.858 . . . . 0.0 109.47 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.567 ' OE1' ' CD2' ' A' ' 28' ' ' TYR . 1.6 mm-40 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.495 ' HB2' ' HA ' ' A' ' 48' ' ' PRO . 42.3 mttt -121.96 120.52 34.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -0.916 . . . . 0.0 109.485 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.475 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 49.1 mt -148.51 150.93 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.157 -0.964 . . . . 0.0 109.483 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.633 HD11 HD13 ' A' ' 42' ' ' ILE . 0.6 OUTLIER -133.56 127.83 33.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.183 -0.948 . . . . 0.0 109.432 -179.999 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.403 HD13 ' CB ' ' A' ' 19' ' ' LEU . 8.4 mt -101.02 109.54 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.244 -0.91 . . . . 0.0 109.522 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.651 HG12 HD11 ' A' ' 57' ' ' ILE . 17.0 t -96.27 91.33 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.23 -0.919 . . . . 0.0 109.427 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.518 ' O ' ' CD ' ' A' ' 16' ' ' ARG . 16.7 t70 -145.27 146.01 31.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.264 -0.898 . . . . 0.0 109.45 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.477 ' OD2' ' HD2' ' A' ' 58' ' ' PRO . 9.1 p-10 -109.88 -37.75 5.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.185 -0.947 . . . . 0.0 109.501 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.414 ' O ' ' C ' ' A' ' 13' ' ' TYR . 1.8 tp60 -63.01 104.84 0.6 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.232 -0.918 . . . . 0.0 109.448 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.583 ' CZ ' HG13 ' A' ' 17' ' ' ILE . 9.2 t80 -44.73 132.3 6.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.243 -0.911 . . . . 0.0 109.447 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 18' ' ' LEU . . . 138.72 -47.11 0.94 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 1.021 HG23 HD13 ' A' ' 19' ' ' LEU . 4.5 mt -82.85 -43.62 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.174 -1.192 . . . . 0.0 109.491 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.518 ' CD ' ' O ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -63.0 -24.05 67.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.89 . . . . 0.0 109.505 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.583 HG13 ' CZ ' ' A' ' 13' ' ' TYR . 5.3 mm -90.1 -55.41 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.212 -0.93 . . . . 0.0 109.598 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.591 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.3 OUTLIER -56.61 -58.57 7.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 109.573 -179.853 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 1.021 HD13 HG23 ' A' ' 15' ' ' ILE . 5.0 mp -57.86 -21.23 41.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.905 . . . . 0.0 109.552 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 12.7 t30 -74.16 -71.11 0.35 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.316 -0.865 . . . . 0.0 109.469 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.451 ' N ' ' OE1' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -45.57 -44.18 12.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 0.0 109.522 -179.897 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.902 HG21 HD12 ' A' ' 108' ' ' ILE . 48.2 t -58.93 -53.18 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.218 -0.926 . . . . 0.0 109.431 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.771 ' HZ ' HG22 ' A' ' 111' ' ' ILE . 21.8 m-85 -78.13 2.33 18.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.372 -0.83 . . . . 0.0 109.622 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.457 ' ND2' ' OD1' ' A' ' 20' ' ' ASN . 0.6 OUTLIER -90.02 -50.32 6.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.139 -0.975 . . . . 0.0 109.532 179.896 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.5 tttp -79.57 -44.68 20.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.178 -0.951 . . . . 0.0 109.49 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.534 ' HB3' ' CD1' ' A' ' 28' ' ' TYR . 0.9 OUTLIER -49.09 -34.29 13.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 109.453 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.526 ' C ' ' CD1' ' A' ' 28' ' ' TYR . . . 110.26 66.26 0.55 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.751 ' CE2' HD21 ' A' ' 121' ' ' LEU . 70.1 m-85 -148.64 135.62 20.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.333 -1.099 . . . . 0.0 109.5 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.465 ' HG2' ' HB2' ' A' ' 4' ' ' GLU . 5.6 mm100 -92.39 83.02 4.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.306 -0.871 . . . . 0.0 109.266 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.671 HG21 ' CB ' ' A' ' 23' ' ' PHE . 5.7 p -89.98 158.63 17.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.914 . . . . 0.0 109.571 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.577 ' HB2' HD12 ' A' ' 7' ' ' LEU . 8.8 m-85 -118.18 -163.56 0.95 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.289 -0.882 . . . . 0.0 109.465 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -144.52 147.89 33.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.166 -0.959 . . . . 0.0 109.519 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -168.36 -176.24 2.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.903 . . . . 0.0 109.417 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.464 ' O ' ' HE1' ' A' ' 60' ' ' MET . . . 177.98 -31.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.214 -0.929 . . . . 0.0 109.498 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -76.42 -8.06 56.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.259 -0.9 . . . . 0.0 109.514 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.13 -47.44 3.77 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.463 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -59.16 -43.26 92.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -1.113 . . . . 0.0 109.435 -179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 1.062 ' O ' HD12 ' A' ' 42' ' ' ILE . 18.8 mm-40 -69.1 -24.31 64.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.324 -0.86 . . . . 0.0 109.436 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.669 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -70.98 -57.85 4.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -0.882 . . . . 0.0 109.515 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.427 HD22 ' HB3' ' A' ' 68' ' ' ARG . 12.7 mt -64.02 -31.41 72.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.188 -0.945 . . . . 0.0 109.531 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 37' ' ' LEU . 3.9 t0 -64.87 -49.88 68.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.27 -0.894 . . . . 0.0 109.459 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 1.062 HD12 ' O ' ' A' ' 38' ' ' GLN . 3.6 mt -70.21 -20.17 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.25 -0.906 . . . . 0.0 109.477 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 39' ' ' ALA . 55.5 t -77.67 -34.33 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.911 . . . . 0.0 109.489 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.3 m -90.02 -16.03 30.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.182 -0.949 . . . . 0.0 109.483 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.27 -51.44 5.76 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.252 -0.905 . . . . 0.0 109.552 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.478 ' HG3' HG23 ' A' ' 42' ' ' ILE . 0.9 OUTLIER -92.88 -26.03 17.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.236 -0.915 . . . . 0.0 109.518 -179.925 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.492 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 12.8 mtm180 61.02 63.16 2.6 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.254 -0.903 . . . . 0.0 109.452 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.594 ' O ' HD12 ' A' ' 76' ' ' ILE . 35.2 Cg_endo -77.81 -178.32 4.52 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.594 2.196 . . . . 0.0 110.388 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.862 ' O ' HD22 ' A' ' 50' ' ' LEU . 55.5 m-20 -128.06 -2.76 5.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.302 -0.874 . . . . 0.0 109.673 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.862 HD22 ' O ' ' A' ' 49' ' ' ASP . 3.8 mm? -131.49 106.06 7.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.176 -0.952 . . . . 0.0 109.502 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.853 HG11 ' CE ' ' A' ' 69' ' ' MET . 1.5 t -115.88 121.41 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.9 . . . . 0.0 109.45 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.468 ' HB3' ' CE ' ' A' ' 81' ' ' MET . 1.1 mp -94.99 110.53 22.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.262 -0.899 . . . . 0.0 109.437 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.814 HD23 ' CG1' ' A' ' 78' ' ' VAL . 2.9 mm? -104.41 133.11 49.84 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.189 -0.944 . . . . 0.0 109.547 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -118.0 129.35 55.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.908 . . . . 0.0 109.488 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.624 ' HB2' HG21 ' A' ' 82' ' ' THR . 27.7 mmt -78.75 3.35 16.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 109.562 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.434 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 2.0 mmmm -78.16 -28.19 48.23 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.149 -0.969 . . . . 0.0 109.424 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.839 HG21 ' CE ' ' A' ' 60' ' ' MET . 44.3 mt -43.06 103.15 0.3 Allowed Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.392 -0.818 . . . . 0.0 109.552 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.477 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 35.3 Cg_endo -77.76 71.74 6.41 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.497 2.131 . . . . 0.0 110.387 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -164.4 -47.67 0.02 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.839 ' CE ' HG21 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -153.21 135.09 14.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.262 -1.14 . . . . 0.0 109.454 179.897 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -56.65 136.47 54.78 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.205 -0.934 . . . . 0.0 109.482 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.452 ' HA2' HG13 ' A' ' 65' ' ' ILE . . . -83.69 9.69 61.67 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.442 HD13 ' HA ' ' A' ' 63' ' ' ILE . 38.7 mm -67.62 -45.05 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.191 -1.182 . . . . 0.0 109.475 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -66.83 -25.48 66.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.235 -0.915 . . . . 0.0 109.449 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.452 HG13 ' HA2' ' A' ' 62' ' ' GLY . 7.2 mt -69.81 -68.24 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.34 -0.85 . . . . 0.0 109.434 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 1.045 HD21 HG11 ' A' ' 78' ' ' VAL . 3.1 mt -50.35 -39.37 46.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.267 -0.896 . . . . 0.0 109.528 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.505 ' O ' HG23 ' A' ' 71' ' ' VAL . 1.7 ttpp -60.68 -39.41 88.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -0.876 . . . . 0.0 109.505 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.427 ' HB3' HD22 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -68.25 -58.28 4.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.234 -0.916 . . . . 0.0 109.515 -179.894 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.853 ' CE ' HG11 ' A' ' 51' ' ' VAL . 2.2 ptp -60.71 -13.72 16.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.267 -0.896 . . . . 0.0 109.548 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 66' ' ' LEU . 0.6 OUTLIER -89.72 -31.58 17.39 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.836 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 67' ' ' LYS . 52.8 t -75.09 -28.97 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 109.195 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.5 mt -90.05 -44.52 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.363 -0.836 . . . . 0.0 109.419 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.758 ' O ' HG22 ' A' ' 76' ' ' ILE . 15.0 t0 -132.05 116.78 17.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.16 -0.962 . . . . 0.0 109.427 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.01 -40.45 12.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.248 -0.908 . . . . 0.0 109.544 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -61.23 -13.87 21.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.281 -0.887 . . . . 0.0 109.46 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.758 HG22 ' O ' ' A' ' 73' ' ' ASP . 1.0 OUTLIER -60.51 112.03 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.2 -0.937 . . . . 0.0 109.525 179.922 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.485 ' CB ' HD11 ' A' ' 99' ' ' LEU . 5.0 mtt85 -71.19 142.43 50.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.213 -0.929 . . . . 0.0 109.436 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 1.045 HG11 HD21 ' A' ' 66' ' ' LEU . 15.9 t -145.05 150.58 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.237 -0.915 . . . . 0.0 109.631 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.667 HG23 ' O ' ' A' ' 100' ' ' THR . 11.1 mt -134.19 141.33 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.266 -0.896 . . . . 0.0 109.433 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.885 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.1 OUTLIER -96.74 141.77 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.172 -0.955 . . . . 0.0 109.206 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.468 ' CE ' ' HB3' ' A' ' 52' ' ' LEU . 2.8 mtm -113.88 59.85 0.67 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.145 -0.972 . . . . 0.0 109.508 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.624 HG21 ' HB2' ' A' ' 55' ' ' MET . 14.2 t -172.43 43.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.176 -0.952 . . . . 0.0 109.521 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.732 ' N ' ' HB2' ' A' ' 103' ' ' ALA . . . . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.266 -0.896 . . . . 0.0 109.526 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.656 HD12 ' CE1' ' A' ' 101' ' ' HIS . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.714 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.78 -38.26 15.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.315 -0.865 . . . . 0.0 109.573 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -90.02 -40.73 12.13 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.227 -0.92 . . . . 0.0 109.619 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.534 ' O ' ' CA ' ' A' ' 97' ' ' GLY . 9.9 m -58.73 -15.22 11.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.202 -0.936 . . . . 0.0 109.644 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.872 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 1.7 ttpt -88.89 -45.86 9.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.155 -0.966 . . . . 0.0 109.506 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.993 ' C ' HD22 ' A' ' 96' ' ' LEU . 10.0 mm-40 -47.62 -44.24 26.52 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.515 -0.741 . . . . 0.0 110.542 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.993 HD22 ' C ' ' A' ' 95' ' ' GLU . 3.3 mm? -132.38 5.51 4.07 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.93 -1.106 . . . . 0.0 110.704 -179.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.534 ' CA ' ' O ' ' A' ' 93' ' ' SER . . . -124.39 -14.19 3.68 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.473 -1.346 . . . . 0.0 109.99 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.872 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -149.84 98.03 2.68 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.166 -1.196 . . . . 0.0 109.615 -179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.485 HD11 ' CB ' ' A' ' 77' ' ' ARG . 0.7 OUTLIER -48.79 -61.1 2.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.235 -0.915 . . . . 0.0 109.478 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.667 ' O ' HG23 ' A' ' 79' ' ' ILE . 16.7 m -113.53 157.68 21.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 109.476 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.885 ' ND1' HD12 ' A' ' 80' ' ' ILE . 3.4 t-160 -135.52 85.5 2.17 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.325 -0.859 . . . . 0.0 109.331 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.54 ' CE1' ' HG2' ' A' ' 110' ' ' GLU . 11.7 m-85 -73.13 158.27 35.62 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.198 -0.939 . . . . 0.0 109.575 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.732 ' HB2' ' N ' ' A' ' 83' ' ' ALA . . . -144.61 151.99 39.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.348 -0.845 . . . . 0.0 109.424 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 103' ' ' ALA . 0.6 OUTLIER -45.1 137.04 4.84 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.235 -0.916 . . . . 0.0 109.304 -179.937 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' A' ' 103' ' ' ALA . 35.7 Cg_endo -77.78 -172.6 11.47 Favored 'Cis proline' 0 C--N 1.312 -1.363 0 C-N-CA 123.365 -1.514 . . . . 0.0 110.403 -0.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.759 ' HE2' HD21 ' A' ' 19' ' ' LEU . 0.4 OUTLIER -118.66 111.52 18.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.212 -0.93 . . . . 0.0 109.492 -179.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.468 ' O ' HG12 ' A' ' 111' ' ' ILE . 22.1 t0 -89.94 105.79 18.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.262 -0.899 . . . . 0.0 109.36 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.902 HD12 HG21 ' A' ' 22' ' ' VAL . 13.7 mm -45.92 -24.63 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.226 -0.921 . . . . 0.0 109.772 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.431 ' O ' ' HG2' ' A' ' 112' ' ' ARG . 9.6 m-20 -69.75 -47.55 62.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.904 . . . . 0.0 109.542 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.54 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 0.9 OUTLIER -69.19 -30.23 68.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -0.901 . . . . 0.0 109.475 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.771 HG22 ' HZ ' ' A' ' 23' ' ' PHE . 14.7 mm -68.01 -46.31 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.234 -0.916 . . . . 0.0 109.399 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.472 ' O ' ' HG3' ' A' ' 116' ' ' LYS . 3.2 ptt180 -74.06 -20.76 60.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.354 -0.841 . . . . 0.0 109.572 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -73.54 -51.38 17.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.157 -0.965 . . . . 0.0 109.495 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.544 ' O ' ' CD2' ' A' ' 118' ' ' TYR . . . -70.06 -31.63 69.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 109.535 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.569 HG21 ' CZ ' ' A' ' 23' ' ' PHE . 72.4 t -74.95 -31.45 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -0.923 . . . . 0.0 109.57 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 0.1 OUTLIER -74.55 -42.55 58.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.21 -0.931 . . . . 0.0 109.583 179.957 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.454 ' HE2' ' HA ' ' A' ' 117' ' ' LYS . 0.0 OUTLIER -64.15 -50.42 68.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.921 . . . . 0.0 109.519 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.544 ' CD2' ' O ' ' A' ' 114' ' ' ALA . 14.8 m-85 -65.62 -63.71 1.03 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.207 -0.933 . . . . 0.0 109.486 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.52 HD21 ' OE2' ' A' ' 4' ' ' GLU . 2.9 tt -87.91 113.2 53.62 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.161 -0.962 . . . . 0.0 109.405 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 118' ' ' TYR . 35.7 Cg_endo -77.87 139.93 17.92 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.353 2.035 . . . . 0.0 110.401 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.751 HD21 ' CE2' ' A' ' 28' ' ' TYR . 2.8 mm? . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.251 -0.906 . . . . 0.0 109.51 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.434 ' O ' ' CB ' ' A' ' 2' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.434 ' CB ' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER 169.07 37.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.224 -0.923 . . . . 0.0 109.45 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.403 ' CG ' ' O ' ' A' ' 2' ' ' MET . 4.2 m120 -170.5 164.4 8.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.24 -0.913 . . . . 0.0 109.549 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.665 ' HB3' HD21 ' A' ' 121' ' ' LEU . 0.1 OUTLIER -166.15 68.68 0.12 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.144 -0.972 . . . . 0.0 109.489 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.52 ' O ' ' CB ' ' A' ' 48' ' ' PRO . 0.4 OUTLIER -103.69 118.12 35.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.201 -0.937 . . . . 0.0 109.502 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.707 ' HB ' HG22 ' A' ' 30' ' ' THR . 13.8 mt -116.31 153.16 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.174 -0.954 . . . . 0.0 109.422 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.847 HD23 HG21 ' A' ' 42' ' ' ILE . 1.9 tm? -131.42 110.83 11.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.195 -0.94 . . . . 0.0 109.516 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.89 HG22 ' NH1' ' A' ' 16' ' ' ARG . 3.4 mt -90.07 108.11 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -0.879 . . . . 0.0 109.324 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.748 HG22 HD12 ' A' ' 7' ' ' LEU . 2.8 t -98.36 117.42 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.221 -0.924 . . . . 0.0 109.654 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.585 ' CB ' ' CZ ' ' A' ' 16' ' ' ARG . 24.9 t0 -175.17 154.94 1.85 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.337 -0.852 . . . . 0.0 109.421 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.463 ' CG ' ' HD2' ' A' ' 58' ' ' PRO . 5.3 p-10 -105.95 -46.12 4.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.165 -0.96 . . . . 0.0 109.501 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.46 ' HG2' ' OD2' ' A' ' 10' ' ' ASP . 13.6 pt20 -50.04 127.51 16.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.241 -0.912 . . . . 0.0 109.527 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.911 ' CE2' HD11 ' A' ' 17' ' ' ILE . 8.2 t80 -80.86 157.95 25.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.257 -0.902 . . . . 0.0 109.645 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 116.31 -69.32 0.28 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.568 ' CG2' ' NH2' ' A' ' 16' ' ' ARG . 5.8 mt -64.02 -25.43 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.32 -1.106 . . . . 0.0 109.173 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.89 ' NH1' HG22 ' A' ' 8' ' ' ILE . 3.7 mmp_? -65.34 -24.75 67.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.886 . . . . 0.0 109.403 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.911 HD11 ' CE2' ' A' ' 13' ' ' TYR . 6.1 mt -89.95 -24.9 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.343 -0.848 . . . . 0.0 109.387 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.842 ' O ' HG23 ' A' ' 22' ' ' VAL . 49.3 mt -74.24 -50.83 17.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.312 -0.868 . . . . 0.0 109.499 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.734 ' HB2' HD13 ' A' ' 8' ' ' ILE . 7.2 mt -69.16 -20.1 64.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 109.408 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -77.02 -58.95 2.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.26 -0.9 . . . . 0.0 109.491 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.439 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 14.0 mt-10 -59.58 -47.89 83.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.917 . . . . 0.0 109.5 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.842 HG23 ' O ' ' A' ' 18' ' ' LEU . 22.2 t -57.21 -57.32 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.229 -0.92 . . . . 0.0 109.442 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.509 ' CD2' ' O ' ' A' ' 19' ' ' LEU . 24.0 m-85 -71.81 -4.26 26.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.164 -0.96 . . . . 0.0 109.599 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.439 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 0.5 OUTLIER -82.21 -55.67 4.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -0.899 . . . . 0.0 109.463 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.407 ' O ' ' C ' ' A' ' 26' ' ' GLU . 1.8 mptt -73.87 -46.11 46.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.278 -0.889 . . . . 0.0 109.474 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.575 ' HB3' ' CD1' ' A' ' 28' ' ' TYR . 4.6 tt0 -44.05 -35.26 2.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.16 -0.963 . . . . 0.0 109.476 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.539 ' C ' ' CD1' ' A' ' 28' ' ' TYR . . . 114.57 55.03 0.39 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.577 ' CE2' ' HG ' ' A' ' 121' ' ' LEU . 32.8 m-85 -143.22 135.03 26.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -1.152 . . . . 0.0 109.475 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -94.42 81.04 3.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.27 -0.894 . . . . 0.0 109.387 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.707 HG22 ' HB ' ' A' ' 6' ' ' ILE . 5.9 p -89.97 154.43 19.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.895 . . . . 0.0 109.556 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.562 ' HB2' HD22 ' A' ' 7' ' ' LEU . 6.8 m-85 -118.05 -171.5 2.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.299 -0.876 . . . . 0.0 109.341 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -130.5 146.94 52.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.897 . . . . 0.0 109.505 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -153.94 -172.56 4.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -0.92 . . . . 0.0 109.472 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.78 -88.01 0.1 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.219 -0.926 . . . . 0.0 109.495 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.539 ' ND2' ' HB2' ' A' ' 37' ' ' LEU . 21.5 p-10 -65.98 139.17 58.21 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.271 -0.893 . . . . 0.0 109.474 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.44 ' HA3' ' CD1' ' A' ' 65' ' ' ILE . . . -43.89 -34.53 2.98 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.539 ' HB2' ' ND2' ' A' ' 35' ' ' ASN . 3.2 mp -51.03 -53.15 36.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.195 -1.179 . . . . 0.0 109.44 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.514 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 2.7 tp60 -60.93 -51.31 69.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.246 -0.908 . . . . 0.0 109.436 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.847 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -43.82 -39.67 3.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.251 -0.905 . . . . 0.0 109.558 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 65.5 mt -71.95 -42.69 66.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.302 -0.873 . . . . 0.0 109.519 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -53.67 -57.81 9.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.255 -0.903 . . . . 0.0 109.491 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.847 HG21 HD23 ' A' ' 7' ' ' LEU . 2.0 mp -62.1 -33.16 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.145 -0.972 . . . . 0.0 109.478 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 39' ' ' ALA . 48.1 t -66.35 -24.02 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -0.858 . . . . 0.0 109.467 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.4 m -90.07 -30.58 17.61 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.262 -0.899 . . . . 0.0 109.533 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.496 ' HG2' ' HA ' ' A' ' 42' ' ' ILE . 0.0 OUTLIER -90.06 -7.86 52.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.313 -0.867 . . . . 0.0 109.54 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.484 ' HG3' ' CD ' ' A' ' 45' ' ' LYS . 14.8 mt-10 -132.48 -36.75 1.09 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.925 . . . . 0.0 109.47 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 43' ' ' VAL . 0.8 OUTLIER 55.84 65.01 4.76 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.276 -0.89 . . . . 0.0 109.444 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.52 ' CB ' ' O ' ' A' ' 5' ' ' LYS . 35.4 Cg_endo -77.91 154.08 29.6 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.683 2.256 . . . . 0.0 110.394 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 3.5 m-20 -92.64 -13.33 29.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.259 -0.9 . . . . 0.0 109.462 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.471 HD21 HG22 ' A' ' 115' ' ' VAL . 1.0 OUTLIER -120.73 116.87 26.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.213 -0.93 . . . . 0.0 109.46 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.677 ' HB ' HG13 ' A' ' 78' ' ' VAL . 43.6 t -122.0 123.31 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 0.0 109.496 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.88 120.86 40.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.254 -0.903 . . . . 0.0 109.44 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.765 HD21 ' HB ' ' A' ' 65' ' ' ILE . 1.3 mp -108.61 122.21 46.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.256 -0.903 . . . . 0.0 109.506 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.431 ' OD2' ' OD1' ' A' ' 10' ' ' ASP . 33.3 t0 -97.26 111.33 23.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.361 -0.837 . . . . 0.0 109.427 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 18.8 mmt -75.03 -0.64 19.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.917 . . . . 0.0 109.576 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.4 mmmt -90.04 15.45 10.08 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.213 -0.93 . . . . 0.0 109.536 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.454 ' HA ' ' OD1' ' A' ' 11' ' ' ASP . 48.3 mt -76.53 132.45 72.43 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.941 . . . . 0.0 109.339 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.463 ' HD2' ' CG ' ' A' ' 11' ' ' ASP . 36.2 Cg_endo -78.93 74.74 5.39 Favored 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.478 2.119 . . . . 0.0 110.4 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -170.73 -63.94 0.04 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.509 ' N ' ' SD ' ' A' ' 60' ' ' MET . 0.1 OUTLIER -153.49 176.3 12.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -1.172 . . . . 0.0 109.566 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -90.08 135.59 33.56 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.197 -0.94 . . . . 0.0 109.487 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.498 ' HA2' HD12 ' A' ' 65' ' ' ILE . . . -72.43 -8.74 71.87 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.443 ' HA ' HD13 ' A' ' 63' ' ' ILE . 18.8 mm -44.02 -50.24 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.23 -1.159 . . . . 0.0 109.43 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.452 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 20.8 mm-40 -63.89 -43.94 94.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.214 -0.929 . . . . 0.0 109.405 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.765 ' HB ' HD21 ' A' ' 53' ' ' LEU . 78.3 mt -46.96 -50.9 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.315 -0.865 . . . . 0.0 109.444 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.821 ' CD2' HG11 ' A' ' 78' ' ' VAL . 61.8 mt -56.0 -53.51 56.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 109.416 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.81 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.1 OUTLIER -44.13 -38.77 3.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.445 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.452 ' HG2' ' O ' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -71.99 -41.03 68.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.32 -0.863 . . . . 0.0 109.495 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.522 ' CE ' HG11 ' A' ' 51' ' ' VAL . 1.2 mtt -58.52 -62.06 2.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.21 -0.931 . . . . 0.0 109.466 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.485 ' HE2' ' O ' ' A' ' 66' ' ' LEU . 0.3 OUTLIER -52.13 -47.9 65.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.496 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' ' 67' ' ' LYS . 53.9 t -48.43 -39.33 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.196 -0.94 . . . . 0.0 109.473 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 98.2 mt -70.38 -48.63 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 109.425 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.701 ' O ' HG22 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -152.97 111.98 3.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.22 -0.925 . . . . 0.0 109.5 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.54 -15.11 35.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.2 -0.938 . . . . 0.0 109.47 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -91.98 41.22 1.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.311 -0.868 . . . . 0.0 109.476 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.701 HG22 ' O ' ' A' ' 73' ' ' ASP . 2.2 tt -118.08 113.01 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.168 -0.958 . . . . 0.0 109.492 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.638 ' HB3' HD11 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -77.04 112.78 14.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.302 -0.874 . . . . 0.0 109.472 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.821 HG11 ' CD2' ' A' ' 66' ' ' LEU . 85.3 t -122.6 113.02 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.906 . . . . 0.0 109.491 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.619 HD13 ' HE2' ' A' ' 102' ' ' PHE . 69.9 mt -89.93 165.73 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.237 -0.915 . . . . 0.0 109.52 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.697 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.1 OUTLIER -128.74 171.58 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.303 -0.873 . . . . 0.0 109.485 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.481 ' N ' ' CD2' ' A' ' 101' ' ' HIS . 22.5 mtm -146.74 107.73 4.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.877 . . . . 0.0 109.419 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.842 ' CG2' HD11 ' A' ' 90' ' ' ILE . 5.2 t -149.92 -161.85 1.43 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.245 -0.909 . . . . 0.0 109.465 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.5 ' N ' HG23 ' A' ' 82' ' ' THR . . . -43.81 138.13 2.83 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.221 -0.924 . . . . 0.0 109.509 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.599 ' CD2' ' HB3' ' A' ' 103' ' ' ALA . 0.2 OUTLIER -90.06 27.16 1.67 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.2 -0.937 . . . . 0.0 109.49 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.922 ' O ' HD12 ' A' ' 87' ' ' LEU . . . -152.21 -86.21 0.05 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -43.94 98.12 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.216 -1.167 . . . . 0.0 109.478 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.922 HD12 ' O ' ' A' ' 85' ' ' GLY . 4.1 mp -73.16 90.14 1.55 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.353 -0.842 . . . . 0.0 109.459 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.518 ' O ' ' CB ' ' A' ' 89' ' ' MET . 13.8 t70 -98.13 88.19 4.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.233 -0.917 . . . . 0.0 109.433 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.518 ' CB ' ' O ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER 75.62 17.39 2.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.246 -0.909 . . . . 0.0 109.434 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.842 HD11 ' CG2' ' A' ' 82' ' ' THR . 16.8 mt -89.61 -41.25 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.291 -0.881 . . . . 0.0 109.492 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.466 ' O ' ' HG2' ' A' ' 94' ' ' LYS . 1.2 tt0 -63.3 -43.53 97.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.249 -0.907 . . . . 0.0 109.488 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.438 ' O ' HD23 ' A' ' 96' ' ' LEU . 3.9 mt-10 -76.19 -36.72 58.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.263 -0.898 . . . . 0.0 109.441 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 92' ' ' GLU . 13.5 t -44.05 -61.91 1.31 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 109.425 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.767 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 0.1 OUTLIER -51.04 -48.6 61.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.296 -0.878 . . . . 0.0 109.537 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -44.1 -42.96 6.6 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.919 . . . . 0.0 109.424 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.541 HD22 ' N ' ' A' ' 96' ' ' LEU . 3.6 mm? -70.74 -54.06 13.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.212 -0.93 . . . . 0.0 109.512 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 177.27 63.65 0.06 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.767 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -146.94 107.64 4.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -1.153 . . . . 0.0 109.424 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.638 HD11 ' HB3' ' A' ' 77' ' ' ARG . 94.6 mt -44.09 -84.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.24 -0.912 . . . . 0.0 109.418 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.423 ' O ' HG23 ' A' ' 79' ' ' ILE . 11.4 t -127.83 178.74 5.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.462 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.708 ' HD1' HG23 ' A' ' 90' ' ' ILE . 4.8 t-160 -130.65 96.76 4.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.262 -0.899 . . . . 0.0 109.573 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.619 ' HE2' HD13 ' A' ' 79' ' ' ILE . 79.7 m-85 -64.92 -166.79 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.255 -0.903 . . . . 0.0 109.319 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.599 ' HB3' ' CD2' ' A' ' 84' ' ' TYR . . . -161.14 -166.7 1.62 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.258 -0.901 . . . . 0.0 109.386 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.474 ' CG ' ' HA ' ' A' ' 105' ' ' PRO . 11.8 tttm -139.12 141.43 29.71 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.214 -0.929 . . . . 0.0 109.379 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.474 ' HA ' ' CG ' ' A' ' 104' ' ' LYS . 35.9 Cg_endo -77.95 139.88 58.93 Favored 'Cis proline' 0 C--N 1.311 -1.445 0 C-N-CA 123.415 -1.494 . . . . 0.0 110.417 -0.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.42 ' C ' ' CD1' ' A' ' 106' ' ' PHE . 13.2 p90 -106.42 175.93 5.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.872 . . . . 0.0 109.523 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.469 ' O ' HG12 ' A' ' 111' ' ' ILE . 41.4 t0 -113.29 127.71 56.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.174 -0.954 . . . . 0.0 109.427 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.469 ' HA ' HD13 ' A' ' 108' ' ' ILE . 15.2 mm -55.15 -18.7 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.273 -0.892 . . . . 0.0 109.52 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.421 ' OD2' ' OD2' ' A' ' 107' ' ' ASP . 15.9 m-20 -76.33 -46.98 25.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.19 -0.944 . . . . 0.0 109.402 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.55 -27.08 65.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.261 -0.899 . . . . 0.0 109.427 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.469 HG12 ' O ' ' A' ' 107' ' ' ASP . 15.9 mm -75.01 -52.48 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.223 -0.923 . . . . 0.0 109.493 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -67.36 -20.52 65.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.272 -0.892 . . . . 0.0 109.528 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -76.92 -51.43 11.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 109.553 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.433 ' HB3' ' HZ ' ' A' ' 102' ' ' PHE . . . -63.5 -49.85 71.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.188 -0.945 . . . . 0.0 109.576 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.471 HG22 HD21 ' A' ' 50' ' ' LEU . 54.0 t -57.22 -49.9 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.263 -0.898 . . . . 0.0 109.487 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -27.82 69.0 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.222 -0.924 . . . . 0.0 109.565 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.07 -18.21 40.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 109.438 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -90.03 -70.9 0.64 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.244 -0.91 . . . . 0.0 109.436 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.534 ' CD1' ' HD2' ' A' ' 120' ' ' PRO . 5.5 tp -90.0 139.58 27.43 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.239 -0.913 . . . . 0.0 109.291 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.624 ' O ' HD22 ' A' ' 121' ' ' LEU . 35.3 Cg_endo -78.25 138.67 16.15 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.571 2.181 . . . . 0.0 110.345 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.665 HD21 ' HB3' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -144.78 155.32 43.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.202 -0.936 . . . . 0.0 109.487 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.41 ' H ' HD13 ' A' ' 121' ' ' LEU . 16.0 mtmm -47.51 121.88 4.31 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.249 -0.907 . . . . 0.0 109.472 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.434 ' O ' ' HB2' ' A' ' 124' ' ' ASN . 1.6 t -139.78 161.34 37.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.226 -0.922 . . . . 0.0 109.462 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 123' ' ' SER . 25.3 m120 . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.506 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.414 ' O ' ' CG ' ' A' ' 2' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.276 0.56 . . . . 0.0 109.494 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.431 ' O ' ' HB2' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -178.88 -35.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.264 -0.898 . . . . 0.0 109.447 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.431 ' HB2' ' O ' ' A' ' 2' ' ' MET . 26.4 m-20 68.07 -166.16 0.2 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.285 -0.884 . . . . 0.0 109.497 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.423 ' HG2' ' C ' ' A' ' 3' ' ' ASN . 18.0 mm-40 61.11 92.44 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.438 ' O ' ' CB ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -120.23 119.73 34.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.307 -0.87 . . . . 0.0 109.417 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.877 ' HB ' HG22 ' A' ' 30' ' ' THR . 15.0 mt -109.41 168.15 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.263 -0.898 . . . . 0.0 109.501 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.976 ' O ' HD12 ' A' ' 52' ' ' LEU . 0.4 OUTLIER -134.96 142.09 46.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.333 -0.854 . . . . 0.0 109.467 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.908 ' N ' HD13 ' A' ' 7' ' ' LEU . 2.9 mt -133.5 99.28 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.352 -0.843 . . . . 0.0 109.278 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.652 HG12 HD11 ' A' ' 57' ' ' ILE . 2.9 t -89.79 114.18 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.264 -0.898 . . . . 0.0 109.562 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.809 ' O ' ' HB2' ' A' ' 34' ' ' ALA . 0.4 OUTLIER -169.18 174.92 5.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.295 -0.878 . . . . 0.0 109.362 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.462 ' CG ' ' HD2' ' A' ' 58' ' ' PRO . 6.1 p-10 -142.54 -45.76 0.32 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.16 -0.963 . . . . 0.0 109.449 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.435 ' N ' ' CG ' ' A' ' 11' ' ' ASP . 5.5 tp60 -44.0 106.91 0.08 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.304 -0.872 . . . . 0.0 109.493 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 1.05 ' CE1' HD11 ' A' ' 17' ' ' ILE . 38.9 t80 -43.23 124.35 3.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.374 -0.829 . . . . 0.0 109.431 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 141.31 -75.98 0.32 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.439 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 1.7 mt -58.66 -32.42 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -1.169 . . . . 0.0 108.878 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.519 ' NH1' ' O ' ' A' ' 33' ' ' ALA . 9.1 mmm180 -60.34 -33.19 72.05 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.336 -0.852 . . . . 0.0 109.459 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 1.05 HD11 ' CE1' ' A' ' 13' ' ' TYR . 2.6 mt -90.7 -65.59 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.332 -0.855 . . . . 0.0 109.895 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.895 ' O ' HG23 ' A' ' 22' ' ' VAL . 4.3 mt -42.45 -63.0 0.84 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.133 -0.979 . . . . 0.0 110.198 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.828 HD23 HG23 ' A' ' 8' ' ' ILE . 1.8 tp -51.98 -35.14 45.39 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.085 -1.009 . . . . 0.0 109.802 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.505 ' OD1' ' ND2' ' A' ' 24' ' ' ASN . 33.0 t30 -64.89 -70.43 0.23 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.211 -0.931 . . . . 0.0 110.163 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.475 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 1.0 OUTLIER -55.82 -16.49 4.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.143 -0.973 . . . . 0.0 110.152 -179.418 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 18' ' ' LEU . 53.5 t -75.57 -61.13 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.12 -0.987 . . . . 0.0 109.422 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 1.006 ' CZ ' HG21 ' A' ' 115' ' ' VAL . 17.0 m-85 -73.28 -8.51 56.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.272 -0.892 . . . . 0.0 109.407 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.505 ' ND2' ' OD1' ' A' ' 20' ' ' ASN . 1.3 m-80 -83.72 -54.84 4.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.914 . . . . 0.0 109.44 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -66.27 -22.08 66.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.244 -0.91 . . . . 0.0 109.406 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.478 ' OE2' ' HE2' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -78.83 -23.78 44.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.33 -0.856 . . . . 0.0 109.476 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.566 ' O ' ' CG ' ' A' ' 28' ' ' TYR . . . 110.48 64.33 0.52 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.939 ' CE2' HD13 ' A' ' 121' ' ' LEU . 66.4 m-85 -158.88 135.26 9.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.202 -1.176 . . . . 0.0 109.607 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -89.91 85.01 6.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.254 -0.904 . . . . 0.0 108.959 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.908 HG21 ' HB2' ' A' ' 23' ' ' PHE . 5.2 p -89.87 137.8 32.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.276 -0.89 . . . . 0.0 109.895 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.623 ' HB2' HD22 ' A' ' 7' ' ' LEU . 14.5 m-85 -102.01 165.1 11.35 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.391 -0.818 . . . . 0.0 108.889 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 32' ' ' GLN . 0.2 OUTLIER -125.15 134.42 52.43 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.092 -1.005 . . . . 0.0 109.854 -179.757 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.593 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -140.35 -161.01 1.14 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.251 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.809 ' HB2' ' O ' ' A' ' 10' ' ' ASP . . . 171.23 -42.39 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.167 -0.958 . . . . 0.0 109.651 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.433 ' ND2' ' H ' ' A' ' 35' ' ' ASN . 1.9 p30 -74.15 -1.33 19.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.208 -0.932 . . . . 0.0 109.611 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.19 -46.11 3.62 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.15 -28.08 69.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.318 -1.107 . . . . 0.0 109.419 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.916 ' O ' HD12 ' A' ' 42' ' ' ILE . 18.4 mm-40 -82.05 -36.14 28.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.284 -0.885 . . . . 0.0 109.375 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.785 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -64.81 -40.56 95.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.444 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.413 ' O ' ' C ' ' A' ' 41' ' ' ASP . 3.3 mt -78.32 -57.74 3.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.273 -0.892 . . . . 0.0 109.453 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 40' ' ' LEU . 5.9 t70 -44.45 -42.14 6.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.271 -0.893 . . . . 0.0 109.474 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.916 HD12 ' O ' ' A' ' 38' ' ' GLN . 15.3 mt -69.61 -47.0 73.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.279 -0.888 . . . . 0.0 109.357 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.785 HG23 ' O ' ' A' ' 39' ' ' ALA . 73.2 t -55.73 -21.14 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.259 -0.901 . . . . 0.0 109.425 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.6 m -90.16 -33.66 16.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.283 -0.885 . . . . 0.0 109.446 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.49 ' HG2' ' HA ' ' A' ' 42' ' ' ILE . 0.0 OUTLIER -89.94 0.65 56.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 109.714 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.469 ' HG2' ' HD2' ' A' ' 45' ' ' LYS . 11.3 mm-40 -137.75 -38.6 0.58 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.157 -0.964 . . . . 0.0 109.442 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.513 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 2.6 mtt180 59.15 62.13 4.22 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.894 . . . . 0.0 109.519 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.558 ' HD2' HG13 ' A' ' 43' ' ' VAL . 35.4 Cg_endo -77.87 151.89 28.17 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.691 2.261 . . . . 0.0 110.407 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.692 ' C ' HD22 ' A' ' 50' ' ' LEU . 1.2 m-20 -93.31 -11.98 31.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.209 -0.932 . . . . 0.0 109.513 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.692 HD22 ' C ' ' A' ' 49' ' ' ASP . 4.3 mm? -118.8 125.7 50.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.199 -0.938 . . . . 0.0 109.476 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.93 ' HB ' HG22 ' A' ' 78' ' ' VAL . 3.5 t -132.23 119.8 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.233 -0.917 . . . . 0.0 109.563 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.976 HD12 ' O ' ' A' ' 7' ' ' LEU . 1.1 mt -92.51 102.74 15.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.306 -0.871 . . . . 0.0 109.345 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.593 HD22 ' CD2' ' A' ' 66' ' ' LEU . 1.0 OUTLIER -89.91 128.49 36.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.176 -0.952 . . . . 0.0 109.643 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.538 ' HB2' ' HE2' ' A' ' 81' ' ' MET . 30.5 t0 -120.53 108.64 14.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.338 -0.851 . . . . 0.0 109.356 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.853 ' CG ' HG21 ' A' ' 82' ' ' THR . 12.7 mmt -71.78 -3.99 25.22 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.188 -0.945 . . . . 0.0 109.568 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.457 ' HB2' ' OD2' ' A' ' 54' ' ' ASP . 4.3 mttt -75.52 -7.87 55.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 109.625 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.652 HD11 HG12 ' A' ' 9' ' ' VAL . 56.9 mt -57.06 116.52 13.7 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.095 -1.003 . . . . 0.0 109.318 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.462 ' HD2' ' CG ' ' A' ' 11' ' ' ASP . 35.6 Cg_endo -78.21 92.03 1.16 Allowed 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.297 1.998 . . . . 0.0 110.414 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 161.42 -23.5 0.23 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.511 ' SD ' ' CG2' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -170.48 161.19 7.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -1.172 . . . . 0.0 109.594 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -90.25 136.43 33.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.212 -0.93 . . . . 0.0 109.38 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.454 ' HA2' HG13 ' A' ' 65' ' ' ILE . . . -74.79 -8.91 82.72 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 30.6 mm -53.94 -55.22 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -1.149 . . . . 0.0 109.425 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 65' ' ' ILE . 24.9 mm-40 -53.14 -45.0 68.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.237 -0.914 . . . . 0.0 109.466 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.492 ' HB ' HD21 ' A' ' 53' ' ' LEU . 9.4 mt -44.81 -50.52 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.263 -0.898 . . . . 0.0 109.461 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.593 ' CD2' HD22 ' A' ' 53' ' ' LEU . 22.0 mt -54.66 -53.19 58.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.311 -0.868 . . . . 0.0 109.497 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.449 ' O ' HG23 ' A' ' 71' ' ' VAL . 4.7 mttt -43.65 -51.05 7.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.313 -0.867 . . . . 0.0 109.618 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.449 ' O ' HG13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -59.76 -41.2 90.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.162 -0.961 . . . . 0.0 109.486 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.765 ' HE1' HG11 ' A' ' 51' ' ' VAL . 4.6 mtt -60.32 -24.39 64.97 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.239 -0.913 . . . . 0.0 109.442 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 66' ' ' LEU . 1.8 mmpt? -80.03 -44.08 20.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.186 -0.946 . . . . 0.0 109.344 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 67' ' ' LYS . 2.6 t -64.38 -24.47 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.217 -0.927 . . . . 0.0 109.451 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 68' ' ' ARG . 57.9 mt -90.05 -66.42 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.456 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -123.59 139.09 54.36 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.229 -0.919 . . . . 0.0 109.506 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -90.02 -25.05 21.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.274 -0.891 . . . . 0.0 109.455 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 49.2 m-20 -105.77 51.02 0.76 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.199 -0.938 . . . . 0.0 109.498 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.615 HG13 HG23 ' A' ' 78' ' ' VAL . 3.0 tp -98.89 113.82 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.262 -0.899 . . . . 0.0 109.433 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.527 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 3.7 mtt180 -75.91 118.05 18.28 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.197 -0.939 . . . . 0.0 109.459 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.93 HG22 ' HB ' ' A' ' 51' ' ' VAL . 79.1 t -129.77 115.82 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.279 -0.888 . . . . 0.0 109.544 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.48 HG12 HG22 ' A' ' 100' ' ' THR . 70.9 mt -89.87 125.69 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.281 -0.887 . . . . 0.0 109.396 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.967 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.6 OUTLIER -89.82 162.17 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.193 -0.942 . . . . 0.0 109.422 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.538 ' HE2' ' HB2' ' A' ' 54' ' ' ASP . 16.6 mtm -135.43 47.27 2.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.297 -0.877 . . . . 0.0 109.425 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.853 HG21 ' CG ' ' A' ' 55' ' ' MET . 9.9 t -159.71 66.64 0.38 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.31 -0.869 . . . . 0.0 109.469 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.562 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . -80.53 -38.94 28.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.241 -0.912 . . . . 0.0 109.437 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.484 ' CD1' ' N ' ' A' ' 85' ' ' GLY . 6.4 t80 -74.23 135.03 42.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.238 -0.914 . . . . 0.0 109.483 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.484 ' N ' ' CD1' ' A' ' 84' ' ' TYR . . . 120.95 -52.74 0.72 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.451 ' O ' HD13 ' A' ' 90' ' ' ILE . 1.8 pm0 -149.72 95.22 2.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.304 -1.115 . . . . 0.0 109.472 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.588 ' HA ' HD13 ' A' ' 90' ' ' ILE . 0.3 OUTLIER -87.97 14.0 9.84 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.224 -0.923 . . . . 0.0 109.476 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -83.27 -21.6 33.25 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.233 -0.917 . . . . 0.0 109.514 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.524 ' CG ' ' OE2' ' A' ' 92' ' ' GLU . 0.5 OUTLIER -106.15 0.89 25.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 109.63 179.914 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.594 ' CD1' ' N ' ' A' ' 90' ' ' ILE . 1.2 mp -74.12 -61.26 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.234 -0.916 . . . . 0.0 109.122 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -47.65 -44.78 27.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.912 . . . . 0.0 109.411 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.524 ' OE2' ' CG ' ' A' ' 89' ' ' MET . 19.3 pt-20 -70.2 -32.63 70.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -0.877 . . . . 0.0 109.429 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.821 ' HB2' HD11 ' A' ' 80' ' ' ILE . 59.6 p -63.38 -30.59 71.69 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.236 -0.915 . . . . 0.0 109.471 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.5 OUTLIER -69.68 -71.84 0.22 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.911 . . . . 0.0 109.524 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.458 ' CG ' ' N ' ' A' ' 96' ' ' LEU . 9.4 pt-20 -43.81 -46.64 7.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.218 -0.926 . . . . 0.0 109.437 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.473 ' HA ' HD23 ' A' ' 96' ' ' LEU . 24.5 mt -51.67 -57.33 9.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.181 -0.949 . . . . 0.0 109.441 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 165.53 44.89 0.02 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.514 ' CB ' ' O ' ' A' ' 93' ' ' SER . . . -113.92 98.6 7.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -1.115 . . . . 0.0 109.457 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.527 ' CD1' ' HB3' ' A' ' 77' ' ' ARG . 23.9 mt -46.63 -46.73 19.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.284 -0.885 . . . . 0.0 109.446 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.48 HG22 HG12 ' A' ' 79' ' ' ILE . 10.7 t -154.44 143.02 20.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.221 -0.924 . . . . 0.0 109.52 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.967 ' ND1' HD12 ' A' ' 80' ' ' ILE . 3.6 t-160 -107.93 87.71 2.56 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.252 -0.905 . . . . 0.0 109.487 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.508 ' O ' ' N ' ' A' ' 82' ' ' THR . 6.0 m-30 -80.55 179.12 7.9 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 0.0 109.57 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.562 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -137.82 -148.68 0.28 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.292 -0.88 . . . . 0.0 109.343 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.525 ' HG3' ' HA ' ' A' ' 105' ' ' PRO . 0.7 OUTLIER -137.85 145.75 49.65 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.291 -0.881 . . . . 0.0 109.452 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.525 ' HA ' ' HG3' ' A' ' 104' ' ' LYS . 35.3 Cg_endo -77.91 -176.69 19.21 Favored 'Cis proline' 0 C--N 1.308 -1.565 0 C-N-CA 123.289 -1.546 . . . . 0.0 110.333 0.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 106' ' ' PHE . 2.8 p90 -146.92 -163.69 1.82 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.281 -0.887 . . . . 0.0 109.494 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -135.46 132.55 37.54 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.273 -0.892 . . . . 0.0 109.503 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.434 ' HA ' HD13 ' A' ' 108' ' ' ILE . 14.4 mm -59.22 -21.59 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -0.926 . . . . 0.0 109.45 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.478 ' O ' ' HG2' ' A' ' 112' ' ' ARG . 34.8 m-20 -73.74 -44.73 55.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.34 -0.85 . . . . 0.0 109.474 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -64.68 -34.87 79.31 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.2 -0.938 . . . . 0.0 109.425 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.496 HG21 HD11 ' A' ' 19' ' ' LEU . 17.7 mm -66.33 -59.59 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.204 -0.935 . . . . 0.0 109.492 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 23.2 ptt180 -53.4 -32.05 47.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 109.529 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.44 ' OD2' ' O ' ' A' ' 109' ' ' ASP . 17.7 m-20 -64.64 -55.79 17.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.332 -0.855 . . . . 0.0 109.5 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.665 ' HB1' ' CE2' ' A' ' 118' ' ' TYR . . . -55.33 -35.68 65.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.208 -0.933 . . . . 0.0 109.474 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 1.006 HG21 ' CZ ' ' A' ' 23' ' ' PHE . 77.9 t -72.08 -28.9 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.282 -0.886 . . . . 0.0 109.434 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.478 ' HE2' ' OE2' ' A' ' 26' ' ' GLU . 5.4 mmtm -72.12 -32.24 66.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.303 -0.873 . . . . 0.0 109.433 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -86.74 -24.44 25.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.926 . . . . 0.0 109.459 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.665 ' CE2' ' HB1' ' A' ' 114' ' ' ALA . 18.6 m-85 -90.13 -66.18 0.95 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.226 -0.921 . . . . 0.0 109.48 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.757 HD12 ' HD2' ' A' ' 120' ' ' PRO . 31.5 tp -90.13 112.47 52.65 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.287 -0.883 . . . . 0.0 109.477 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.757 ' HD2' HD12 ' A' ' 119' ' ' LEU . 35.3 Cg_endo -78.19 148.01 23.9 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.408 2.072 . . . . 0.0 110.314 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.939 HD13 ' CE2' ' A' ' 28' ' ' TYR . 1.2 tp -154.45 151.45 28.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.282 -0.886 . . . . 0.0 109.405 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.73 77.9 5.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.281 -0.887 . . . . 0.0 109.486 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.502 ' O ' ' CB ' ' A' ' 124' ' ' ASN . 16.3 m -164.59 30.91 0.07 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.232 -0.918 . . . . 0.0 109.462 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 123' ' ' SER . 1.1 t30 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.453 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 5.6 mtt 58.09 82.85 0.12 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.271 -0.893 . . . . 0.0 109.5 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -126.01 68.53 1.19 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.248 -0.908 . . . . 0.0 109.462 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.464 ' N ' ' OE1' ' A' ' 4' ' ' GLU . 1.5 mp0 -81.0 124.09 28.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.898 . . . . 0.0 109.489 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.465 ' HB3' ' HB3' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -141.75 131.69 24.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.23 -0.918 . . . . 0.0 109.457 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.628 HD12 ' HB3' ' A' ' 28' ' ' TYR . 91.5 mt -149.97 153.45 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.265 -0.897 . . . . 0.0 109.499 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.803 HD23 HG21 ' A' ' 42' ' ' ILE . 1.8 tm? -130.64 112.0 12.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.238 -0.914 . . . . 0.0 109.447 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.796 HD13 ' HB2' ' A' ' 19' ' ' LEU . 5.0 mt -89.98 106.33 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.278 -0.889 . . . . 0.0 109.545 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.718 HG22 HD12 ' A' ' 7' ' ' LEU . 3.1 t -95.02 113.32 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.219 -0.925 . . . . 0.0 109.5 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.503 ' O ' ' NH1' ' A' ' 16' ' ' ARG . 0.4 OUTLIER -162.93 150.44 13.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 0.0 109.415 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.482 ' OD2' ' HD2' ' A' ' 58' ' ' PRO . 7.4 p-10 -113.37 -37.28 4.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.244 -0.91 . . . . 0.0 109.454 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.405 ' O ' ' C ' ' A' ' 13' ' ' TYR . 20.1 tt0 -70.05 104.57 2.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.24 -0.913 . . . . 0.0 109.484 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.587 ' CZ ' HG13 ' A' ' 17' ' ' ILE . 26.2 t80 -44.13 149.93 0.32 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.294 -0.879 . . . . 0.0 109.496 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.61 -73.78 0.42 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.468 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 36.6 mt -61.21 -23.63 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -1.142 . . . . 0.0 109.365 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.503 ' NH1' ' O ' ' A' ' 10' ' ' ASP . 7.4 mmm-85 -69.75 -30.08 67.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.338 -0.851 . . . . 0.0 109.399 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.587 HG13 ' CZ ' ' A' ' 13' ' ' TYR . 9.2 mm -90.19 -25.18 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.376 -0.828 . . . . 0.0 109.534 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.905 ' O ' HG23 ' A' ' 22' ' ' VAL . 1.3 mp -74.05 -53.21 10.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.209 -0.932 . . . . 0.0 109.567 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.796 ' HB2' HD13 ' A' ' 8' ' ' ILE . 12.3 mt -71.39 -17.11 62.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -0.918 . . . . 0.0 109.535 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 47.9 t30 -79.77 -51.01 9.72 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.207 -0.933 . . . . 0.0 109.498 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -68.07 -40.06 82.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.211 -0.931 . . . . 0.0 109.463 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.905 HG23 ' O ' ' A' ' 18' ' ' LEU . 15.1 t -67.18 -57.5 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.915 . . . . 0.0 109.403 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.73 ' CZ ' HG21 ' A' ' 115' ' ' VAL . 18.7 m-85 -65.46 -17.67 64.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.24 -0.912 . . . . 0.0 109.457 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.459 ' ND2' ' O ' ' A' ' 20' ' ' ASN . 0.7 OUTLIER -68.75 -63.14 1.12 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.427 179.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.58 -10.52 58.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.906 . . . . 0.0 109.402 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.474 ' HB2' ' HA ' ' A' ' 23' ' ' PHE . 1.7 mm-40 -76.34 -31.75 58.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.234 -0.917 . . . . 0.0 109.517 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.416 ' O ' ' HG2' ' A' ' 4' ' ' GLU . . . 107.2 33.38 3.21 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.702 ' HE1' HD22 ' A' ' 119' ' ' LEU . 84.8 m-85 -123.51 139.34 54.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -1.164 . . . . 0.0 109.468 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -91.57 82.34 5.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.279 -0.888 . . . . 0.0 109.473 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.574 HG22 HD12 ' A' ' 6' ' ' ILE . 5.8 p -89.96 152.33 21.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.182 -0.949 . . . . 0.0 109.517 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.574 ' HB2' HD22 ' A' ' 7' ' ' LEU . 16.6 m-85 -119.51 -168.98 1.68 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.203 -0.935 . . . . 0.0 109.473 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -128.99 142.27 50.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.221 -0.925 . . . . 0.0 109.432 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.59 ' CB ' HD11 ' A' ' 7' ' ' LEU . . . -154.95 109.62 3.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.33 -0.856 . . . . 0.0 109.487 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.566 ' O ' HD13 ' A' ' 57' ' ' ILE . . . -69.45 -70.29 0.29 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.199 -0.938 . . . . 0.0 109.454 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -77.56 178.03 7.58 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 0.0 109.514 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.51 ' HA3' HD11 ' A' ' 65' ' ' ILE . . . -83.44 -41.97 8.13 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.418 ' C ' ' O ' ' A' ' 36' ' ' GLY . 0.3 OUTLIER -44.06 -56.53 3.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.192 -1.181 . . . . 0.0 109.453 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.48 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 7.5 tp-100 -57.17 -48.48 78.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 109.372 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.602 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -46.0 -68.21 0.21 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.278 -0.889 . . . . 0.0 109.464 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' A' ' 39' ' ' ALA . 2.2 mt -44.28 -41.06 5.67 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.288 -0.882 . . . . 0.0 109.529 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.64 -54.88 27.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.206 -0.934 . . . . 0.0 109.526 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.803 HG21 HD23 ' A' ' 7' ' ' LEU . 2.0 mp -63.87 -21.32 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.274 -0.891 . . . . 0.0 109.486 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.813 HG13 ' HD2' ' A' ' 48' ' ' PRO . 16.8 t -80.05 -22.11 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -0.903 . . . . 0.0 109.478 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.1 m -90.1 -28.53 18.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.915 . . . . 0.0 109.39 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -89.88 -27.76 19.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 0.0 109.448 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -113.83 -36.91 4.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.265 -0.897 . . . . 0.0 109.382 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 60.3 mtm180 57.54 69.16 1.68 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.896 . . . . 0.0 109.553 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.813 ' HD2' HG13 ' A' ' 43' ' ' VAL . 35.4 Cg_endo -77.91 176.03 10.49 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.685 2.257 . . . . 0.0 110.412 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.628 ' O ' HD22 ' A' ' 50' ' ' LEU . 58.9 m-20 -114.7 -9.93 12.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.225 -0.922 . . . . 0.0 109.489 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.628 HD22 ' O ' ' A' ' 49' ' ' ASP . 3.4 mm? -124.63 112.96 17.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 109.52 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 1.037 HG11 ' CE ' ' A' ' 69' ' ' MET . 24.7 t -114.0 119.2 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.171 -0.956 . . . . 0.0 109.422 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.413 HD13 HG23 ' A' ' 8' ' ' ILE . 1.3 mt -89.99 100.77 13.52 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.884 . . . . 0.0 109.456 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.825 HD21 ' HB ' ' A' ' 65' ' ' ILE . 1.1 mp -91.57 129.06 37.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.896 . . . . 0.0 109.516 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.455 ' OD2' ' OD1' ' A' ' 10' ' ' ASP . 57.0 t0 -117.94 103.59 10.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 109.42 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.676 ' HB2' HG21 ' A' ' 82' ' ' THR . 9.3 mmt -58.65 -15.72 12.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.319 -0.863 . . . . 0.0 109.504 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.447 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.1 OUTLIER -55.72 -35.69 66.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 109.414 179.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.898 HG21 ' CE ' ' A' ' 60' ' ' MET . 46.0 mt -43.13 103.28 0.31 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.342 -0.849 . . . . 0.0 109.507 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.482 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 35.4 Cg_endo -77.77 4.53 5.98 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.421 2.081 . . . . 0.0 110.415 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.94 -43.37 7.2 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.898 ' CE ' HG21 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -153.38 170.95 19.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -1.133 . . . . 0.0 109.452 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -88.97 134.27 34.03 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.215 -0.928 . . . . 0.0 109.474 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.423 ' HA2' HG12 ' A' ' 65' ' ' ILE . . . -81.73 -0.39 89.27 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.5 mm -61.4 -42.14 92.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.288 -1.125 . . . . 0.0 109.456 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -68.74 -18.91 64.31 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.405 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.825 ' HB ' HD21 ' A' ' 53' ' ' LEU . 24.8 mm -69.94 -51.38 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.283 -0.886 . . . . 0.0 109.446 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.477 ' O ' ' HE3' ' A' ' 70' ' ' LYS . 29.8 mt -53.87 -30.65 46.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.291 -0.881 . . . . 0.0 109.441 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.768 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.6 OUTLIER -71.72 -63.25 1.16 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.233 -0.917 . . . . 0.0 109.5 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.468 ' O ' HG12 ' A' ' 72' ' ' ILE . 1.9 mtt85 -52.81 -20.67 3.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.216 -0.927 . . . . 0.0 109.41 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 1.037 ' CE ' HG11 ' A' ' 51' ' ' VAL . 1.3 mmt -75.39 -58.47 3.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.207 -0.933 . . . . 0.0 109.457 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 15.3 ptpt -62.35 -15.51 48.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.238 -0.914 . . . . 0.0 109.425 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.768 HG23 ' O ' ' A' ' 67' ' ' LYS . 44.9 t -83.91 -42.69 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -0.881 . . . . 0.0 109.508 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.468 HG12 ' O ' ' A' ' 68' ' ' ARG . 19.0 mm -72.41 -56.27 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.274 -0.891 . . . . 0.0 109.506 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -129.72 132.55 46.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.204 -0.935 . . . . 0.0 109.493 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.61 15.38 9.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.241 -0.912 . . . . 0.0 109.513 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -129.99 37.05 3.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.322 -0.862 . . . . 0.0 109.44 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.662 HD11 ' CG2' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -112.34 142.32 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.279 -0.888 . . . . 0.0 109.373 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.626 ' CG ' HD11 ' A' ' 99' ' ' LEU . 37.9 mtt85 -103.87 158.55 16.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.291 -0.881 . . . . 0.0 109.436 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.649 HG13 ' HB ' ' A' ' 51' ' ' VAL . 1.8 t -153.12 112.21 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.219 -0.925 . . . . 0.0 109.538 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.482 HG23 ' CG2' ' A' ' 100' ' ' THR . 95.7 mt -92.16 159.64 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.292 -0.88 . . . . 0.0 109.424 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.581 ' HB ' ' CG ' ' A' ' 101' ' ' HIS . 0.4 OUTLIER -114.64 119.11 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.212 -0.93 . . . . 0.0 109.414 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.402 ' O ' ' HB ' ' A' ' 82' ' ' THR . 4.6 mtm -101.0 68.42 1.26 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.191 -0.943 . . . . 0.0 109.515 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.676 HG21 ' HB2' ' A' ' 55' ' ' MET . 6.2 t 179.43 48.56 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.258 -0.901 . . . . 0.0 109.439 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.025 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . -76.02 -9.38 58.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.261 -0.899 . . . . 0.0 109.512 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.46 93.0 9.28 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.297 -0.877 . . . . 0.0 109.521 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 159.44 -108.1 0.34 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -98.49 128.27 44.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.288 -1.125 . . . . 0.0 109.463 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.55 52.25 0.82 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.367 -0.833 . . . . 0.0 109.465 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -102.75 -22.8 13.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.237 -0.914 . . . . 0.0 109.476 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.458 ' O ' ' CB ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -116.87 15.2 15.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -0.908 . . . . 0.0 109.484 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.74 HG23 ' HD1' ' A' ' 101' ' ' HIS . 48.0 mt -89.72 -66.26 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.235 -0.916 . . . . 0.0 109.529 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -47.6 -39.87 17.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.276 -0.89 . . . . 0.0 109.478 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.925 ' C ' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -78.32 -33.37 49.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.24 -0.912 . . . . 0.0 109.522 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.504 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 0.5 OUTLIER -59.89 -16.18 27.32 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.277 -0.889 . . . . 0.0 109.478 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.06 -76.68 0.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 0.0 109.456 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.43 ' HG3' ' N ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -58.09 -23.99 56.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.919 . . . . 0.0 109.507 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.925 HD12 ' C ' ' A' ' 92' ' ' GLU . 8.4 mt -67.6 -42.66 82.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.303 -0.873 . . . . 0.0 109.453 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 154.51 53.1 0.01 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 93' ' ' SER . . . -138.7 102.76 4.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.303 -1.116 . . . . 0.0 109.466 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.66 HD13 ' CD1' ' A' ' 118' ' ' TYR . 21.0 mt -45.48 -65.52 0.53 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.211 -0.931 . . . . 0.0 109.392 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.745 HG21 ' CE1' ' A' ' 102' ' ' PHE . 11.6 t -140.55 -174.91 4.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.294 -0.879 . . . . 0.0 109.457 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.81 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 3.3 t-160 -140.99 92.4 2.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.348 -0.845 . . . . 0.0 109.39 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.745 ' CE1' HG21 ' A' ' 100' ' ' THR . 60.0 m-85 -77.99 152.66 32.99 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.21 -0.931 . . . . 0.0 109.434 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 1.025 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -140.25 -160.67 1.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.875 . . . . 0.0 109.462 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.475 ' CG ' ' HA ' ' A' ' 105' ' ' PRO . 9.5 tttm -89.37 141.83 29.25 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.231 -0.918 . . . . 0.0 109.31 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.475 ' HA ' ' CG ' ' A' ' 104' ' ' LYS . 36.0 Cg_endo -78.11 -176.51 18.85 Favored 'Cis proline' 0 C--N 1.31 -1.492 0 C-N-CA 123.406 -1.498 . . . . 0.0 110.486 -0.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.69 ' CE2' HD12 ' A' ' 111' ' ' ILE . 0.2 OUTLIER -114.75 106.3 14.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.196 -0.94 . . . . 0.0 109.524 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.478 ' O ' HG12 ' A' ' 111' ' ' ILE . 38.8 t0 -89.94 105.18 17.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -0.896 . . . . 0.0 109.318 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.812 HD12 HG21 ' A' ' 22' ' ' VAL . 13.6 mm -45.84 -25.02 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.195 -0.941 . . . . 0.0 109.61 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.469 ' HB2' ' OD2' ' A' ' 107' ' ' ASP . 79.1 m-20 -72.81 -46.37 53.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.127 -0.983 . . . . 0.0 109.518 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.5 -24.38 63.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.252 -0.905 . . . . 0.0 109.486 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.69 HD12 ' CE2' ' A' ' 106' ' ' PHE . 12.7 mm -75.23 -56.4 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.273 -0.892 . . . . 0.0 109.428 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.464 ' O ' ' HG3' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -60.22 -32.86 71.52 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.296 -0.877 . . . . 0.0 109.497 179.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -64.99 -55.0 21.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.33 -0.856 . . . . 0.0 109.447 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.63 ' HB2' ' HZ ' ' A' ' 102' ' ' PHE . . . -54.84 -42.56 72.12 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.197 -0.939 . . . . 0.0 109.474 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.73 HG21 ' CZ ' ' A' ' 23' ' ' PHE . 55.8 t -66.84 -28.58 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.19 -0.944 . . . . 0.0 109.442 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 0.5 OUTLIER -68.94 -48.94 62.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.272 -0.892 . . . . 0.0 109.457 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.13 -31.92 73.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.922 . . . . 0.0 109.54 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.66 ' CD1' HD13 ' A' ' 99' ' ' LEU . 22.5 m-85 -73.64 -72.98 0.23 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.316 -0.865 . . . . 0.0 109.524 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.702 HD22 ' HE1' ' A' ' 28' ' ' TYR . 5.5 tt -88.08 137.84 31.1 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.26 -0.9 . . . . 0.0 109.251 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.667 ' N ' HD23 ' A' ' 119' ' ' LEU . 35.9 Cg_endo -78.37 145.77 21.52 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.482 2.121 . . . . 0.0 110.427 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.64 ' CD1' ' CZ ' ' A' ' 28' ' ' TYR . 1.6 mt -132.08 -161.43 1.13 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.892 . . . . 0.0 109.436 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -56.14 91.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.277 -0.889 . . . . 0.0 109.491 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.451 ' O ' ' CB ' ' A' ' 124' ' ' ASN . 45.0 m -72.03 86.21 1.02 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.3 -0.875 . . . . 0.0 109.479 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.451 ' CB ' ' O ' ' A' ' 123' ' ' SER . 1.6 p30 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.437 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 33.8 mtm -118.15 -85.35 0.65 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.229 -0.92 . . . . 0.0 109.444 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -101.34 134.77 43.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.24 -0.913 . . . . 0.0 109.521 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -173.76 66.75 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.246 -0.909 . . . . 0.0 109.458 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 48' ' ' PRO . 23.2 mttt -125.81 143.77 50.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 0.0 109.461 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.547 ' HB ' HG22 ' A' ' 30' ' ' THR . 70.0 mt -150.06 162.5 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -0.918 . . . . 0.0 109.464 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.799 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.5 OUTLIER -131.81 122.62 26.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.163 -0.96 . . . . 0.0 109.404 -179.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.799 ' N ' HD13 ' A' ' 7' ' ' LEU . 3.7 mt -100.75 109.06 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.238 -0.914 . . . . 0.0 109.426 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.607 HG12 HD11 ' A' ' 57' ' ' ILE . 2.6 t -103.95 95.87 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.3 -0.875 . . . . 0.0 109.41 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.484 ' O ' ' HD3' ' A' ' 16' ' ' ARG . 1.6 t70 -158.67 85.88 0.84 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 0.0 109.476 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.599 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . 7.3 p-10 -51.25 -41.31 60.29 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.211 -0.931 . . . . 0.0 109.428 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.486 ' NE2' ' CD1' ' A' ' 15' ' ' ILE . 2.5 tt0 -44.11 95.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -0.896 . . . . 0.0 109.465 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 1.056 ' CE1' HD11 ' A' ' 17' ' ' ILE . 47.8 t80 -45.07 120.81 2.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.319 -0.863 . . . . 0.0 109.427 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 144.97 -54.12 0.56 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.671 HD12 ' N ' ' A' ' 15' ' ' ILE . 1.8 mp -72.45 -50.17 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -1.162 . . . . 0.0 109.333 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.521 ' O ' ' CB ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -47.41 -31.59 4.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.229 -0.919 . . . . 0.0 109.5 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 1.056 HD11 ' CE1' ' A' ' 13' ' ' TYR . 1.7 mt -90.27 -29.14 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.222 -0.924 . . . . 0.0 109.497 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.864 HD12 HD11 ' A' ' 108' ' ' ILE . 0.4 OUTLIER -66.41 -62.33 1.52 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.203 -0.936 . . . . 0.0 109.498 -179.868 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.696 ' HB2' HD13 ' A' ' 8' ' ' ILE . 7.5 mt -68.1 -15.55 63.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.919 . . . . 0.0 109.044 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.521 ' CB ' ' O ' ' A' ' 16' ' ' ARG . 0.7 OUTLIER -72.07 -47.88 48.3 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.462 -0.774 . . . . 0.0 109.258 179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.469 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 1.0 OUTLIER -73.27 -49.27 28.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.31 -0.869 . . . . 0.0 109.547 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.671 HG21 HG23 ' A' ' 108' ' ' ILE . 29.2 t -56.17 -47.81 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.272 -0.892 . . . . 0.0 109.542 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.57 ' CE2' ' HB3' ' A' ' 19' ' ' LEU . 19.7 m-85 -79.96 -13.63 59.2 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.186 -0.946 . . . . 0.0 109.559 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.489 ' ND2' ' O ' ' A' ' 20' ' ' ASN . 0.5 OUTLIER -71.71 -47.4 54.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -0.925 . . . . 0.0 109.368 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.5 tptt -85.0 -29.5 24.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -0.921 . . . . 0.0 109.39 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.432 ' HB3' ' CE2' ' A' ' 28' ' ' TYR . 0.2 OUTLIER -55.34 -43.17 74.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.251 -0.906 . . . . 0.0 109.459 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.52 44.14 0.4 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.432 ' CE2' ' HB3' ' A' ' 26' ' ' GLU . 96.6 m-85 -134.47 137.73 44.17 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.249 -1.148 . . . . 0.0 109.48 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -90.03 82.02 6.16 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 109.292 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.547 HG22 ' HB ' ' A' ' 6' ' ' ILE . 5.7 p -89.82 148.89 22.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.246 -0.909 . . . . 0.0 109.577 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.721 ' HB2' HD22 ' A' ' 7' ' ' LEU . 5.8 m-85 -113.34 -171.13 1.82 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.237 -0.914 . . . . 0.0 109.44 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -124.16 150.58 44.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.255 -0.903 . . . . 0.0 109.608 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.658 ' HB3' HD11 ' A' ' 7' ' ' LEU . . . -175.45 174.14 2.36 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.289 -0.882 . . . . 0.0 109.375 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.599 ' HB1' ' HB3' ' A' ' 11' ' ' ASP . . . 178.61 -31.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.298 -0.876 . . . . 0.0 109.555 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.502 ' OD1' ' CB ' ' A' ' 37' ' ' LEU . 8.0 p30 -74.14 -3.2 28.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.18 -0.95 . . . . 0.0 109.606 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.03 -45.08 3.46 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.502 ' CB ' ' OD1' ' A' ' 35' ' ' ASN . 0.2 OUTLIER -57.82 -50.0 74.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.286 -1.126 . . . . 0.0 109.519 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.588 ' O ' HD12 ' A' ' 42' ' ' ILE . 8.3 mt-30 -65.42 -23.97 67.08 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.178 -0.951 . . . . 0.0 109.519 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.599 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -67.59 -52.93 32.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.231 -0.918 . . . . 0.0 109.507 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.677 HD22 ' HB3' ' A' ' 68' ' ' ARG . 16.0 mt -70.79 -58.41 3.65 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.178 -0.952 . . . . 0.0 109.602 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -46.91 -49.23 20.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.292 -0.88 . . . . 0.0 109.628 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.601 HG21 ' CD2' ' A' ' 7' ' ' LEU . 89.3 mt -62.55 -35.15 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.908 . . . . 0.0 109.446 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 39' ' ' ALA . 49.0 t -75.22 -14.72 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.276 -0.89 . . . . 0.0 109.52 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.7 m -90.2 -28.87 18.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.186 -0.946 . . . . 0.0 109.561 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.1 mttm -85.96 -41.51 14.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.224 -0.923 . . . . 0.0 109.687 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.574 ' OE1' ' CZ ' ' A' ' 31' ' ' PHE . 4.8 mt-10 -102.08 -37.88 7.98 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.194 -0.941 . . . . 0.0 109.601 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.474 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 5.7 mtt180 61.31 67.26 1.43 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.279 -0.888 . . . . 0.0 109.499 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.502 ' HD2' HG13 ' A' ' 43' ' ' VAL . 35.4 Cg_endo -77.78 165.67 26.38 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.647 2.231 . . . . 0.0 110.427 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 1.02 ' O ' HD22 ' A' ' 50' ' ' LEU . 8.3 m-20 -107.62 11.08 28.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.337 -0.852 . . . . 0.0 109.548 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.02 HD22 ' O ' ' A' ' 49' ' ' ASP . 1.3 mm? -140.37 128.69 22.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 109.506 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.574 ' HB ' HG22 ' A' ' 78' ' ' VAL . 3.9 t -129.42 151.1 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.25 -0.906 . . . . 0.0 109.509 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.622 HD12 ' O ' ' A' ' 7' ' ' LEU . 1.3 mt -121.14 97.65 5.62 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.197 -0.939 . . . . 0.0 109.364 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.893 HD22 HG11 ' A' ' 78' ' ' VAL . 2.0 mp -89.92 128.45 36.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.316 -0.865 . . . . 0.0 109.647 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.455 ' O ' HG13 ' A' ' 57' ' ' ILE . 44.3 t0 -119.44 115.38 23.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.285 -0.884 . . . . 0.0 109.405 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.923 ' CG ' HG21 ' A' ' 82' ' ' THR . 17.1 mmt -67.72 -8.05 32.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.259 -0.901 . . . . 0.0 109.577 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.44 ' HB2' ' OD2' ' A' ' 54' ' ' ASP . 16.7 mmtp -76.66 1.14 17.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -0.896 . . . . 0.0 109.633 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.607 HD11 HG12 ' A' ' 9' ' ' VAL . 34.0 mt -75.32 118.27 69.47 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.11 -0.994 . . . . 0.0 109.382 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.452 ' HD2' ' CG ' ' A' ' 11' ' ' ASP . 35.7 Cg_endo -77.97 143.34 20.5 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.395 2.063 . . . . 0.0 110.469 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 121.66 -54.44 0.68 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.585 ' HE1' HG21 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -155.56 175.18 14.22 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.183 -1.187 . . . . 0.0 109.509 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -89.9 169.09 11.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.265 -0.897 . . . . 0.0 109.477 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.536 ' HA2' ' CD1' ' A' ' 65' ' ' ILE . . . -97.79 -7.02 56.92 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.4 ' HA ' HD13 ' A' ' 63' ' ' ILE . 31.2 mm -54.28 -64.82 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.155 -1.203 . . . . 0.0 109.495 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 67' ' ' LYS . 1.3 pt-20 -47.92 -35.7 11.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.237 -0.914 . . . . 0.0 109.467 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.536 ' CD1' ' HA2' ' A' ' 62' ' ' GLY . 16.0 mt -53.97 -57.19 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.226 -0.921 . . . . 0.0 109.506 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 1.039 HD21 HG11 ' A' ' 78' ' ' VAL . 31.3 mt -52.51 -26.21 12.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.27 -0.894 . . . . 0.0 109.634 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.886 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -73.76 -37.37 65.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.211 -0.93 . . . . 0.0 109.793 -179.801 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.677 ' HB3' HD22 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -73.15 -50.73 21.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.19 -0.944 . . . . 0.0 109.731 -179.792 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.831 ' SD ' HD23 ' A' ' 66' ' ' LEU . 3.9 ptp -64.43 -35.81 82.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.198 -0.939 . . . . 0.0 109.759 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.51 ' HG3' ' N ' ' A' ' 71' ' ' VAL . 15.1 ptpt -71.4 -34.8 70.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.206 -0.934 . . . . 0.0 109.437 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.886 HG23 ' O ' ' A' ' 67' ' ' LYS . 71.7 t -70.12 -31.02 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.193 -0.942 . . . . 0.0 109.493 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 68' ' ' ARG . 10.4 mt -90.0 -17.85 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.214 -0.929 . . . . 0.0 109.468 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -166.46 122.9 1.27 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.299 -0.876 . . . . 0.0 109.448 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -89.9 -11.51 41.63 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.187 -0.945 . . . . 0.0 109.439 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -92.97 44.49 1.15 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.302 -0.874 . . . . 0.0 109.5 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.552 ' O ' HG23 ' A' ' 76' ' ' ILE . 0.5 OUTLIER -121.89 120.03 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 109.44 -179.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.617 ' CG ' HD11 ' A' ' 99' ' ' LEU . 9.8 mtt180 -84.65 143.3 29.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.346 -0.846 . . . . 0.0 109.518 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 1.039 HG11 HD21 ' A' ' 66' ' ' LEU . 53.5 t -138.2 124.77 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.235 -0.915 . . . . 0.0 109.534 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.788 HG23 HG23 ' A' ' 100' ' ' THR . 70.6 mt -101.74 156.62 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.224 -0.923 . . . . 0.0 109.4 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.585 ' HB ' ' CG ' ' A' ' 101' ' ' HIS . 0.6 OUTLIER -114.94 115.25 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -0.929 . . . . 0.0 109.39 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.498 ' SD ' ' CZ ' ' A' ' 106' ' ' PHE . 4.3 mtm -95.97 58.75 1.92 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.226 -0.921 . . . . 0.0 109.506 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.923 HG21 ' CG ' ' A' ' 55' ' ' MET . 12.5 t -169.04 49.28 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.239 -0.913 . . . . 0.0 109.479 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.781 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . -67.7 -65.67 0.66 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.22 -0.925 . . . . 0.0 109.502 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.413 ' C ' ' O ' ' A' ' 83' ' ' ALA . 0.5 OUTLIER -44.0 104.56 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 109.521 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 159.85 -89.83 0.11 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -124.27 116.18 22.24 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.227 -1.161 . . . . 0.0 109.502 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.14 78.35 2.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.209 -0.932 . . . . 0.0 109.484 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -136.5 -50.99 0.69 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.261 -0.899 . . . . 0.0 109.403 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 4.5 ptt? -87.83 0.17 56.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.282 -0.886 . . . . 0.0 109.617 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.602 HG23 ' HD1' ' A' ' 101' ' ' HIS . 48.8 mt -74.59 -56.2 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.176 -0.952 . . . . 0.0 109.534 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -53.87 -39.57 65.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.34 -0.85 . . . . 0.0 109.494 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.457 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 1.1 tp10 -78.96 -24.78 43.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.295 -0.878 . . . . 0.0 109.432 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.7 m -72.22 -28.34 63.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.298 -0.876 . . . . 0.0 109.474 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.796 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 5.8 mtpp -68.2 -67.42 0.47 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.268 -0.895 . . . . 0.0 109.464 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 94' ' ' LYS . 1.7 pt-20 -44.08 -26.74 0.32 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.355 -0.841 . . . . 0.0 109.554 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 92' ' ' GLU . 65.9 mt -73.82 -52.36 13.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.33 -0.856 . . . . 0.0 109.533 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 169.18 36.1 0.02 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.796 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -104.39 103.35 13.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.247 -1.149 . . . . 0.0 109.437 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.617 HD11 ' CG ' ' A' ' 77' ' ' ARG . 17.0 mt -53.08 -55.42 24.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.237 -0.914 . . . . 0.0 109.472 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.788 HG23 HG23 ' A' ' 79' ' ' ILE . 7.0 t -149.25 177.65 9.46 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.288 -0.883 . . . . 0.0 109.469 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.602 ' HD1' HG23 ' A' ' 90' ' ' ILE . 3.4 t-160 -132.1 90.14 2.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 0.0 109.431 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.747 ' HE1' HG21 ' A' ' 100' ' ' THR . 43.0 m-85 -77.57 160.75 28.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.221 -0.924 . . . . 0.0 109.485 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.781 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -145.44 -148.62 0.25 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.315 -0.865 . . . . 0.0 109.334 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.415 ' HD2' ' HA ' ' A' ' 105' ' ' PRO . 0.2 OUTLIER -104.03 146.65 32.95 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.205 -0.934 . . . . 0.0 109.447 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.415 ' HA ' ' HD2' ' A' ' 104' ' ' LYS . 35.5 Cg_endo -77.85 173.8 55.36 Favored 'Cis proline' 0 C--N 1.31 -1.466 0 C-N-CA 123.229 -1.571 . . . . 0.0 110.365 0.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.688 ' CZ ' HD12 ' A' ' 111' ' ' ILE . 0.3 OUTLIER -102.84 104.58 14.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.317 -0.864 . . . . 0.0 109.531 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.474 ' O ' HG12 ' A' ' 111' ' ' ILE . 63.3 t0 -89.95 109.74 20.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.278 -0.889 . . . . 0.0 109.331 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.864 HD11 HD12 ' A' ' 18' ' ' LEU . 14.8 mm -47.92 -23.65 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 109.55 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.429 ' O ' ' OD2' ' A' ' 113' ' ' ASP . 37.3 m-20 -76.39 -43.37 40.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.212 -0.93 . . . . 0.0 109.516 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.428 ' HB2' ' HB3' ' A' ' 107' ' ' ASP . 1.4 tt0 -69.64 -25.76 64.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.282 -0.886 . . . . 0.0 109.491 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.688 HD12 ' CZ ' ' A' ' 106' ' ' PHE . 13.4 mm -75.35 -57.9 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.211 -0.931 . . . . 0.0 109.493 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.476 ' O ' ' HG3' ' A' ' 116' ' ' LYS . 1.4 ptt85 -61.27 -28.07 68.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.302 -0.874 . . . . 0.0 109.585 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.429 ' OD2' ' O ' ' A' ' 109' ' ' ASP . 53.6 m-20 -68.28 -56.27 9.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.242 -0.911 . . . . 0.0 109.416 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.642 ' HB2' ' HZ ' ' A' ' 102' ' ' PHE . . . -56.34 -53.69 54.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.213 -0.93 . . . . 0.0 109.531 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.1 t -52.68 -39.92 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.232 -0.918 . . . . 0.0 109.502 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.476 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 0.6 OUTLIER -65.22 -33.56 76.29 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.327 -0.858 . . . . 0.0 109.554 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.23 -20.56 51.51 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.22 -0.925 . . . . 0.0 109.487 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.582 ' CG ' HD13 ' A' ' 99' ' ' LEU . 38.2 m-85 -89.68 -71.22 0.62 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.249 -0.907 . . . . 0.0 109.471 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.528 HD12 ' HD2' ' A' ' 120' ' ' PRO . 49.2 tp -90.05 112.49 52.68 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.248 -0.908 . . . . 0.0 109.37 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.528 ' HD2' HD12 ' A' ' 119' ' ' LEU . 35.6 Cg_endo -77.9 132.63 11.93 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.34 2.027 . . . . 0.0 110.424 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.509 HD23 ' HA ' ' A' ' 121' ' ' LEU . 4.1 mt -88.75 -164.02 1.07 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.292 -0.88 . . . . 0.0 109.455 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.518 ' HD2' ' N ' ' A' ' 123' ' ' SER . 5.8 tptm -93.08 127.14 38.51 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.216 -0.928 . . . . 0.0 108.853 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.518 ' N ' ' HD2' ' A' ' 122' ' ' LYS . 31.3 t 61.35 -89.36 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.314 -0.866 . . . . 0.0 109.459 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.9 m120 . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.508 -179.993 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.404 ' O ' ' HB2' ' A' ' 2' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.404 ' HB2' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER 66.79 -86.89 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 0.0 109.418 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 67.08 145.79 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.198 -0.939 . . . . 0.0 109.425 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 1.012 ' CG ' HD21 ' A' ' 119' ' ' LEU . 0.4 OUTLIER 46.89 83.55 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.264 -0.898 . . . . 0.0 109.496 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.49 ' HB3' ' HB3' ' A' ' 48' ' ' PRO . 3.9 mtpt -94.52 139.16 31.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.22 -0.925 . . . . 0.0 109.466 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.859 HG23 ' HB3' ' A' ' 50' ' ' LEU . 84.4 mt -150.07 153.73 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.252 -0.905 . . . . 0.0 109.498 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.738 HD12 ' HB2' ' A' ' 31' ' ' PHE . 0.6 OUTLIER -136.48 150.5 48.72 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.283 -0.885 . . . . 0.0 109.438 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.75 HD13 ' HB3' ' A' ' 19' ' ' LEU . 7.8 mt -129.43 122.05 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -0.892 . . . . 0.0 109.407 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 3.3 t -106.42 122.21 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.253 -0.904 . . . . 0.0 109.58 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.452 ' OD2' HD13 ' A' ' 15' ' ' ILE . 0.4 OUTLIER -145.86 -151.71 0.39 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.246 -0.909 . . . . 0.0 109.408 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.458 ' CG ' ' HD2' ' A' ' 58' ' ' PRO . 6.3 p-10 -161.65 -46.69 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.267 -0.895 . . . . 0.0 109.449 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.4 tp60 -82.71 116.6 22.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.316 -0.865 . . . . 0.0 109.486 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.594 ' CZ ' HG13 ' A' ' 17' ' ' ILE . 8.5 t80 -43.91 143.33 1.11 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.243 -0.91 . . . . 0.0 109.434 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.476 ' N ' ' CD1' ' A' ' 13' ' ' TYR . . . 126.96 -46.48 1.08 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.938 HG23 HD13 ' A' ' 19' ' ' LEU . 2.2 mt -84.69 -45.86 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.293 -1.122 . . . . 0.0 109.35 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 1.116 ' NH2' ' HB2' ' A' ' 34' ' ' ALA . 1.5 mtp180 -58.25 -29.44 65.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.308 -0.87 . . . . 0.0 109.395 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.594 HG13 ' CZ ' ' A' ' 13' ' ' TYR . 3.1 mm -90.47 -59.56 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -0.894 . . . . 0.0 109.657 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.763 ' O ' HG23 ' A' ' 22' ' ' VAL . 87.0 mt -46.74 -58.48 3.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.91 . . . . 0.0 109.806 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.938 HD13 HG23 ' A' ' 15' ' ' ILE . 6.3 mp -55.02 -32.49 61.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.188 -0.945 . . . . 0.0 109.689 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.508 ' OD1' ' ND2' ' A' ' 24' ' ' ASN . 17.6 t30 -65.69 -70.82 0.22 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.913 . . . . 0.0 109.723 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.486 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 0.1 OUTLIER -43.28 -40.24 3.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.185 -0.947 . . . . 0.0 109.745 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.763 HG23 ' O ' ' A' ' 18' ' ' LEU . 59.8 t -57.58 -58.41 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.913 . . . . 0.0 109.51 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.781 ' CB ' HG21 ' A' ' 30' ' ' THR . 38.0 m-85 -76.18 0.67 18.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.165 -0.959 . . . . 0.0 109.633 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.508 ' ND2' ' OD1' ' A' ' 20' ' ' ASN . 0.4 OUTLIER -89.01 -38.88 14.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.078 -1.014 . . . . 0.0 109.535 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.8 tptt -85.55 -44.13 12.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 109.42 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.465 ' HB3' ' CD2' ' A' ' 28' ' ' TYR . 0.4 OUTLIER -55.07 -21.4 12.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.179 -0.95 . . . . 0.0 109.391 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.473 ' O ' ' CG ' ' A' ' 28' ' ' TYR . . . 101.38 72.26 0.96 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.889 ' CE1' HD13 ' A' ' 121' ' ' LEU . 97.9 m-85 -156.66 134.29 10.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.293 -1.122 . . . . 0.0 109.58 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -90.96 82.81 5.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.342 -0.849 . . . . 0.0 109.182 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.781 HG21 ' CB ' ' A' ' 23' ' ' PHE . 7.4 p -89.9 173.22 8.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -0.897 . . . . 0.0 109.657 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.738 ' HB2' HD12 ' A' ' 7' ' ' LEU . 11.7 m-85 -130.21 170.06 14.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.317 -0.864 . . . . 0.0 109.394 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.435 ' HG2' ' O ' ' A' ' 32' ' ' GLN . 0.5 OUTLIER -131.41 135.82 47.5 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.2 -0.938 . . . . 0.0 109.682 -179.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.754 ' HB1' ' NE2' ' A' ' 38' ' ' GLN . . . -155.91 130.56 9.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.393 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 1.116 ' HB2' ' NH2' ' A' ' 16' ' ' ARG . . . -82.32 -70.71 0.53 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.156 -0.965 . . . . 0.0 109.483 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.478 ' OD1' ' HB3' ' A' ' 38' ' ' GLN . 18.8 p-10 -60.54 170.94 1.23 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.223 -0.923 . . . . 0.0 109.577 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.715 ' O ' HD12 ' A' ' 40' ' ' LEU . . . -97.84 -17.73 29.53 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.9 tt -73.99 -43.59 57.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.314 -1.109 . . . . 0.0 109.401 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.754 ' NE2' ' HB1' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -77.59 -35.04 53.35 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.19 -0.944 . . . . 0.0 108.893 179.77 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.464 ' HB1' HG22 ' A' ' 9' ' ' VAL . . . -62.57 -46.34 88.79 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.278 -0.889 . . . . 0.0 108.626 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.771 HD11 HG23 ' A' ' 65' ' ' ILE . 7.2 mt -61.54 -45.36 94.51 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -49.68 -43.76 47.5 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.203 -0.936 . . . . 0.0 108.856 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.631 HG21 ' CD1' ' A' ' 7' ' ' LEU . 64.0 mt -64.57 -36.23 76.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.336 -0.853 . . . . 0.0 108.881 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 69.0 t -74.5 -11.87 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.251 -0.905 . . . . 0.0 109.188 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 82.9 m -90.38 -31.5 16.84 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.201 -0.937 . . . . 0.0 109.412 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.22 -53.2 4.67 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.32 -0.862 . . . . 0.0 109.867 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.571 ' O ' ' C ' ' A' ' 47' ' ' ARG . 0.4 OUTLIER -97.17 26.93 4.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.183 -0.948 . . . . 0.0 109.627 -179.667 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.571 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -9.69 78.55 0.03 OUTLIER Pre-proline 0 N--CA 1.504 2.266 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.534 ' N ' ' O ' ' A' ' 46' ' ' GLU . 34.3 Cg_endo -75.88 162.66 34.56 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.684 2.256 . . . . 0.0 110.284 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 4.6 m-20 -92.49 -14.12 28.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 109.657 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.859 ' HB3' HG23 ' A' ' 6' ' ' ILE . 4.5 tp -114.16 126.33 54.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.215 -0.928 . . . . 0.0 109.554 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.755 HG11 ' CE ' ' A' ' 69' ' ' MET . 6.0 t -136.83 123.83 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.284 -0.885 . . . . 0.0 109.378 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.738 HD12 ' O ' ' A' ' 7' ' ' LEU . 1.1 mt -103.11 134.78 45.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.212 -0.93 . . . . 0.0 109.584 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.577 HD21 ' HB ' ' A' ' 65' ' ' ILE . 1.4 mp -124.4 135.13 53.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.264 -0.898 . . . . 0.0 109.466 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.461 ' O ' HG13 ' A' ' 57' ' ' ILE . 31.1 t0 -123.61 103.96 8.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.215 -0.928 . . . . 0.0 109.484 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.77 ' HB2' HG21 ' A' ' 82' ' ' THR . 19.2 mmt -62.69 -19.06 63.5 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.17 -0.957 . . . . 0.0 109.463 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.44 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 1.1 mmmp? -54.89 -25.19 27.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 0.0 109.45 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 54' ' ' ASP . 9.8 mt -43.06 103.21 0.3 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.27 -0.893 . . . . 0.0 109.501 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.458 ' HD2' ' CG ' ' A' ' 11' ' ' ASP . 35.2 Cg_endo -77.52 97.73 1.16 Allowed 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.437 2.092 . . . . 0.0 110.464 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 155.62 -20.43 0.53 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.408 ' SD ' ' O ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -166.59 150.93 7.43 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.278 -1.131 . . . . 0.0 109.475 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.408 ' O ' ' SD ' ' A' ' 60' ' ' MET . 1.1 m-20 -85.04 144.0 28.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.186 -0.946 . . . . 0.0 109.57 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -96.56 12.48 66.22 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.2 mm -69.36 -39.43 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.245 -1.15 . . . . 0.0 109.451 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -68.11 -34.65 76.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.262 -0.899 . . . . 0.0 109.494 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.771 HG23 HD11 ' A' ' 40' ' ' LEU . 9.3 mt -54.14 -63.95 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.923 . . . . 0.0 109.492 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.538 HD21 HG11 ' A' ' 78' ' ' VAL . 21.0 mt -46.63 -49.97 18.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.203 -0.936 . . . . 0.0 109.429 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.432 ' O ' HG23 ' A' ' 71' ' ' VAL . 2.5 ttmm -44.09 -50.51 8.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.182 -0.949 . . . . 0.0 109.508 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.432 ' O ' HG13 ' A' ' 72' ' ' ILE . 2.4 mpt_? -60.62 -39.25 87.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.926 . . . . 0.0 109.457 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.755 ' CE ' HG11 ' A' ' 51' ' ' VAL . 0.7 OUTLIER -61.79 -23.74 66.41 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -0.894 . . . . 0.0 109.438 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.534 ' CE ' ' HB3' ' A' ' 96' ' ' LEU . 21.8 mmtm -81.15 -45.29 16.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.3 -0.875 . . . . 0.0 109.473 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 67' ' ' LYS . 2.6 t -65.1 -22.64 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.278 -0.889 . . . . 0.0 109.473 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 68' ' ' ARG . 78.8 mt -88.71 -41.89 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.258 -0.901 . . . . 0.0 109.415 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.82 130.95 11.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.19 -0.944 . . . . 0.0 109.469 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -90.02 -12.55 38.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.2 -0.937 . . . . 0.0 109.465 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.405 ' OD1' ' N ' ' A' ' 75' ' ' ASN . 1.8 m120 -116.58 55.5 0.82 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.409 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.0 tp -110.93 145.78 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.328 -0.858 . . . . 0.0 109.411 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.859 ' CB ' HD11 ' A' ' 99' ' ' LEU . 2.3 mtm180 -89.19 115.02 26.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.195 -0.941 . . . . 0.0 109.483 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.538 HG11 HD21 ' A' ' 66' ' ' LEU . 16.9 t -131.1 115.83 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.221 -0.925 . . . . 0.0 109.531 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.826 HG12 HG22 ' A' ' 100' ' ' THR . 43.9 mt -100.38 132.59 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.309 -0.87 . . . . 0.0 109.445 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.921 HD12 ' ND1' ' A' ' 101' ' ' HIS . 1.0 OUTLIER -89.88 172.97 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.177 -0.952 . . . . 0.0 109.364 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.467 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 13.7 mtm -147.46 52.18 1.06 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.161 -0.962 . . . . 0.0 109.565 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.77 HG21 ' HB2' ' A' ' 55' ' ' MET . 14.7 t -162.68 40.66 0.11 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.185 -0.947 . . . . 0.0 109.519 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.035 ' HB2' ' CD2' ' A' ' 101' ' ' HIS . . . -90.15 40.79 1.02 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.278 -0.889 . . . . 0.0 109.483 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.561 ' CD1' ' O ' ' A' ' 104' ' ' LYS . 2.6 t80 -90.0 72.89 7.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.22 -0.925 . . . . 0.0 109.464 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.42 ' O ' ' C ' ' A' ' 86' ' ' GLU . . . 83.29 -69.92 3.28 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 85' ' ' GLY . 1.7 pm0 -43.81 104.9 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.195 -1.179 . . . . 0.0 109.567 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.844 ' H ' HD23 ' A' ' 87' ' ' LEU . 2.6 pt? -126.28 137.75 53.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.501 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -147.24 -78.21 0.16 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.163 -0.961 . . . . 0.0 109.443 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.468 ' O ' ' CB ' ' A' ' 93' ' ' SER . 6.5 mtt -102.98 37.75 1.89 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.279 -0.888 . . . . 0.0 109.446 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.658 HG23 ' HD1' ' A' ' 101' ' ' HIS . 57.9 mt -89.95 -60.71 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.257 -0.902 . . . . 0.0 109.462 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.449 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 1.1 tp60 -44.32 -62.95 0.99 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -0.897 . . . . 0.0 109.452 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.464 ' O ' HD23 ' A' ' 96' ' ' LEU . 0.3 OUTLIER -60.84 -38.62 86.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.916 . . . . 0.0 109.512 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.524 ' HB3' ' HB2' ' A' ' 98' ' ' ALA . 0.6 OUTLIER -44.0 -26.67 0.3 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.209 -0.932 . . . . 0.0 109.429 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 91' ' ' GLN . 0.0 OUTLIER -53.08 -62.12 1.86 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.175 -0.953 . . . . 0.0 109.457 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.474 ' HG3' ' CD2' ' A' ' 96' ' ' LEU . 1.2 pt-20 -63.19 -35.02 78.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.187 -0.946 . . . . 0.0 109.509 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.538 HD22 ' N ' ' A' ' 96' ' ' LEU . 3.7 mm? -61.33 -24.84 66.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.221 -0.924 . . . . 0.0 109.511 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 130.13 42.33 0.22 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.524 ' HB2' ' HB3' ' A' ' 93' ' ' SER . . . -113.44 110.65 20.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -1.149 . . . . 0.0 109.466 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.859 HD11 ' CB ' ' A' ' 77' ' ' ARG . 3.6 mt -73.25 -72.25 0.27 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.186 -0.946 . . . . 0.0 109.577 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.826 HG22 HG12 ' A' ' 79' ' ' ILE . 12.7 t -130.46 147.51 52.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.225 -0.922 . . . . 0.0 109.495 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 1.035 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 3.6 t-160 -111.21 89.54 3.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.295 -0.878 . . . . 0.0 109.339 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.664 ' CD2' HD13 ' A' ' 111' ' ' ILE . 35.5 m-85 -68.96 153.34 43.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.226 -0.921 . . . . 0.0 109.531 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.564 ' HB2' ' CA ' ' A' ' 83' ' ' ALA . . . -139.52 151.97 46.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.239 -0.913 . . . . 0.0 109.472 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.561 ' O ' ' CD1' ' A' ' 84' ' ' TYR . 36.1 tttm -85.3 141.63 37.21 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 0.0 109.353 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.489 ' HA ' ' CG ' ' A' ' 104' ' ' LYS . 35.8 Cg_endo -77.96 137.39 46.59 Favored 'Cis proline' 0 C--N 1.31 -1.456 0 C-N-CA 123.39 -1.504 . . . . 0.0 110.367 0.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -114.54 -170.01 1.65 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.238 -0.914 . . . . 0.0 109.489 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -130.05 121.08 25.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.0 109.413 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.446 ' HA ' HD13 ' A' ' 108' ' ' ILE . 20.5 mm -50.11 -30.44 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.207 -0.933 . . . . 0.0 109.52 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.41 ' O ' ' HG2' ' A' ' 112' ' ' ARG . 33.4 m-20 -66.6 -42.4 86.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.216 -0.928 . . . . 0.0 109.433 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.429 ' HB3' ' CE1' ' A' ' 102' ' ' PHE . 4.0 mt-10 -65.69 -35.18 80.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.289 -0.882 . . . . 0.0 109.467 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.664 HD13 ' CD2' ' A' ' 102' ' ' PHE . 22.1 mm -64.9 -60.36 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.295 -0.878 . . . . 0.0 109.496 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 1.1 ptm180 -56.81 -30.38 63.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 0.0 109.482 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -62.99 -54.92 30.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -0.895 . . . . 0.0 109.477 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.562 ' O ' ' CD2' ' A' ' 118' ' ' TYR . . . -60.01 -32.84 71.25 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.163 -0.96 . . . . 0.0 109.474 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.804 HG22 HD21 ' A' ' 50' ' ' LEU . 58.2 t -67.42 -35.0 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.23 -0.919 . . . . 0.0 109.473 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.422 ' HE2' ' OE2' ' A' ' 26' ' ' GLU . 1.9 mttt -75.48 -30.05 59.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.279 -0.888 . . . . 0.0 109.499 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.68 -34.08 62.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.219 -0.926 . . . . 0.0 109.46 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.562 ' CD2' ' O ' ' A' ' 114' ' ' ALA . 46.6 m-85 -89.92 -65.59 1.0 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.294 -0.879 . . . . 0.0 109.466 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 1.012 HD21 ' CG ' ' A' ' 4' ' ' GLU . 2.8 tt -90.01 112.42 52.24 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.285 -0.884 . . . . 0.0 109.475 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 118' ' ' TYR . 35.7 Cg_endo -78.06 164.06 27.56 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.362 2.042 . . . . 0.0 110.396 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.889 HD13 ' CE1' ' A' ' 28' ' ' TYR . 1.3 tp -151.09 98.04 2.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.301 -0.875 . . . . 0.0 109.48 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -129.83 61.23 1.57 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.316 -0.865 . . . . 0.0 109.446 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.463 ' O ' ' CB ' ' A' ' 124' ' ' ASN . 0.8 OUTLIER -134.17 71.72 1.46 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.293 -0.88 . . . . 0.0 109.443 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 123' ' ' SER . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.041 -0.981 . . . . 0.0 109.439 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.421 ' CG ' ' O ' ' A' ' 1' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -109.04 66.25 0.63 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.295 -0.878 . . . . 0.0 109.477 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.471 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 8.2 m-20 -117.0 59.9 0.75 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 109.531 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.615 ' CD ' HD23 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -44.03 119.51 1.78 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.215 -0.928 . . . . 0.0 109.454 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.49 ' CG ' ' HA ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -114.12 132.57 56.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.246 -0.909 . . . . 0.0 109.447 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.676 HG23 ' HB3' ' A' ' 50' ' ' LEU . 52.5 mt -145.35 164.7 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.237 -0.915 . . . . 0.0 109.509 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.926 HD13 ' N ' ' A' ' 8' ' ' ILE . 1.0 OUTLIER -131.08 128.55 40.44 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.241 -0.912 . . . . 0.0 109.451 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.926 ' N ' HD13 ' A' ' 7' ' ' LEU . 12.1 mt -115.46 108.44 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.186 -0.946 . . . . 0.0 109.464 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.83 ' HA ' ' HB3' ' A' ' 33' ' ' ALA . 17.5 t -92.44 128.63 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.919 . . . . 0.0 109.529 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.533 ' OD2' HD13 ' A' ' 15' ' ' ILE . 2.1 t70 -174.94 123.43 0.24 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 109.44 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.982 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . 2.6 p30 -114.68 81.43 1.56 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.318 -0.864 . . . . 0.0 109.601 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.5 ' HG2' ' N ' ' A' ' 13' ' ' TYR . 7.5 tt0 -175.99 -104.51 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.207 -0.933 . . . . 0.0 109.411 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.5 ' N ' ' HG2' ' A' ' 12' ' ' GLN . 37.4 t80 -179.54 120.47 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.85 -1.156 . . . . 0.0 109.543 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.485 ' O ' HD13 ' A' ' 18' ' ' LEU . . . 135.73 -50.44 0.85 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.634 HG23 HD13 ' A' ' 19' ' ' LEU . 2.0 mp -81.28 -54.44 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.179 -1.189 . . . . 0.0 109.658 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.519 ' CD ' ' O ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -50.33 -29.75 10.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.165 -0.959 . . . . 0.0 109.757 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.59 ' N ' HD13 ' A' ' 17' ' ' ILE . 2.6 mm -90.2 -64.76 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.183 -0.948 . . . . 0.0 109.887 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.945 ' O ' HG23 ' A' ' 22' ' ' VAL . 6.9 mp -48.55 -60.46 2.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.229 -0.92 . . . . 0.0 109.801 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.739 ' HB3' HD13 ' A' ' 8' ' ' ILE . 0.5 OUTLIER -53.87 -28.85 38.63 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 0.0 109.64 -179.773 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.504 ' OD1' ' ND2' ' A' ' 24' ' ' ASN . 28.4 t30 -69.2 -71.88 0.21 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.903 . . . . 0.0 109.665 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.478 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 2.5 tt0 -43.06 -38.04 2.19 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.317 -0.864 . . . . 0.0 109.71 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.945 HG23 ' O ' ' A' ' 18' ' ' LEU . 19.0 t -61.77 -55.63 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.243 -0.911 . . . . 0.0 109.553 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.646 ' CB ' HG21 ' A' ' 30' ' ' THR . 23.6 m-85 -77.7 1.94 18.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 109.566 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.504 ' ND2' ' OD1' ' A' ' 20' ' ' ASN . 0.6 OUTLIER -90.06 -48.96 6.86 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.189 -0.944 . . . . 0.0 109.474 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.26 -46.13 24.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 109.544 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.505 ' HB3' ' CD1' ' A' ' 28' ' ' TYR . 1.8 tt0 -52.07 -22.65 4.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.2 -0.937 . . . . 0.0 109.469 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.436 ' C ' ' CD1' ' A' ' 28' ' ' TYR . . . 100.09 72.78 1.02 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.59 ' CE2' ' HG ' ' A' ' 121' ' ' LEU . 96.2 m-85 -154.55 134.62 13.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -1.17 . . . . 0.0 109.473 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.448 ' HB2' ' O ' ' A' ' 4' ' ' GLU . 12.4 mm100 -94.16 83.08 4.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 109.217 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.646 HG21 ' CB ' ' A' ' 23' ' ' PHE . 5.7 p -89.95 154.71 19.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.895 . . . . 0.0 109.604 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.796 ' HB2' HD22 ' A' ' 7' ' ' LEU . 38.6 m-85 -113.53 -171.25 1.85 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.274 -0.891 . . . . 0.0 109.283 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.426 ' OE1' ' HG2' ' A' ' 16' ' ' ARG . 11.8 mt-30 -124.44 154.78 39.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 109.552 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.83 ' HB3' ' HA ' ' A' ' 9' ' ' VAL . . . -152.62 -165.37 2.18 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.297 -0.877 . . . . 0.0 109.392 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.982 ' HB1' ' HB3' ' A' ' 11' ' ' ASP . . . 164.34 -62.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.905 . . . . 0.0 109.597 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.43 ' H ' ' ND2' ' A' ' 35' ' ' ASN . 3.9 p30 -71.15 -4.64 26.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.185 -0.947 . . . . 0.0 109.577 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 37' ' ' LEU . . . 86.29 -63.28 4.2 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.46 ' HA ' HD13 ' A' ' 37' ' ' LEU . 1.0 OUTLIER -44.54 -32.28 1.38 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.207 -1.172 . . . . 0.0 109.405 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.521 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 1.4 tp60 -70.22 -60.32 2.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.498 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.837 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -44.02 -45.22 7.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.224 -0.923 . . . . 0.0 109.482 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.7 mt -61.55 -44.06 97.72 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -0.871 . . . . 0.0 109.45 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -55.64 -57.57 11.42 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.287 -0.883 . . . . 0.0 109.488 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.419 ' CG2' HD23 ' A' ' 7' ' ' LEU . 2.5 mp -61.4 -20.83 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.285 -0.884 . . . . 0.0 109.482 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.837 HG23 ' O ' ' A' ' 39' ' ' ALA . 53.5 t -79.63 -26.65 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 109.495 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 85.5 m -89.99 -24.21 21.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -0.901 . . . . 0.0 109.448 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.8 mtpt -89.97 -27.32 19.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.225 -0.922 . . . . 0.0 109.554 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -119.3 -34.37 3.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.206 -0.934 . . . . 0.0 109.506 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 33.2 mtm180 58.18 71.07 1.09 Allowed Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.173 -0.954 . . . . 0.0 109.476 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.526 ' CD ' ' HA ' ' A' ' 43' ' ' VAL . 35.3 Cg_endo -78.07 157.69 30.43 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.599 2.199 . . . . 0.0 110.328 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 0.4 OUTLIER -94.08 -9.61 36.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.194 -0.941 . . . . 0.0 109.512 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.676 ' HB3' HG23 ' A' ' 6' ' ' ILE . 6.5 tp -123.29 114.81 20.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.906 . . . . 0.0 109.504 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.851 HG11 ' SD ' ' A' ' 69' ' ' MET . 1.7 t -121.21 111.41 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.263 -0.898 . . . . 0.0 109.443 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.546 HD12 ' O ' ' A' ' 7' ' ' LEU . 0.7 OUTLIER -89.97 109.62 20.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.291 -0.881 . . . . 0.0 109.406 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.721 HD22 ' N ' ' A' ' 53' ' ' LEU . 3.0 mm? -95.28 136.15 35.98 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.201 -0.937 . . . . 0.0 109.489 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.45 ' O ' HG13 ' A' ' 57' ' ' ILE . 30.2 t0 -113.9 117.7 32.12 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.31 -0.869 . . . . 0.0 109.446 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.918 ' CG ' HG21 ' A' ' 82' ' ' THR . 18.0 mmt -77.58 -7.99 57.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.175 -0.953 . . . . 0.0 109.489 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 57' ' ' ILE . 4.6 mtpm? -68.7 -15.56 63.56 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.308 -0.87 . . . . 0.0 109.527 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.878 HG23 ' OD2' ' A' ' 11' ' ' ASP . 80.5 mt -43.87 113.78 1.63 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.256 -0.902 . . . . 0.0 109.37 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.453 ' HD2' ' CG ' ' A' ' 11' ' ' ASP . 36.0 Cg_endo -78.67 6.0 5.19 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.337 2.025 . . . . 0.0 110.509 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.659 ' H ' HG22 ' A' ' 57' ' ' ILE . . . -91.97 -43.97 4.28 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.528 ' CE ' HG21 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -169.58 -171.66 1.27 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.291 -1.123 . . . . 0.0 109.447 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -89.56 132.72 34.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.902 . . . . 0.0 109.431 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.36 10.89 60.07 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 25.5 mm -61.84 -38.44 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.197 -1.178 . . . . 0.0 109.487 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -68.7 -25.63 64.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.279 -0.888 . . . . 0.0 109.506 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.409 HG22 ' HE3' ' A' ' 69' ' ' MET . 70.9 mt -68.1 -64.92 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.184 -0.947 . . . . 0.0 109.505 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.966 HD21 HG11 ' A' ' 78' ' ' VAL . 2.4 mt -44.15 -34.45 1.84 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 0.0 109.531 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.518 ' O ' ' CG ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -64.02 -59.33 4.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -0.91 . . . . 0.0 109.465 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.0 mtt180 -49.57 -30.46 8.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.345 -0.847 . . . . 0.0 109.473 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.851 ' SD ' HG11 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -67.01 -60.73 2.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.874 . . . . 0.0 109.466 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.518 ' CG ' ' O ' ' A' ' 67' ' ' LYS . 16.4 ptpt -51.39 -31.43 22.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.186 -0.946 . . . . 0.0 109.455 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 49.9 t -66.57 -44.99 89.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.19 -0.944 . . . . 0.0 109.493 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.2 mt -70.23 -65.11 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.218 -0.926 . . . . 0.0 109.535 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -113.7 130.84 56.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.227 -0.921 . . . . 0.0 109.429 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -87.11 -22.4 25.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.952 . . . . 0.0 109.411 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.2 p30 -105.55 45.26 0.98 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -0.886 . . . . 0.0 109.438 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.467 HD12 ' O ' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -104.15 128.08 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.283 -0.886 . . . . 0.0 109.452 179.964 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.531 ' CA ' HD11 ' A' ' 99' ' ' LEU . 3.4 mpt_? -78.11 143.13 37.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.259 -0.901 . . . . 0.0 109.48 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.966 HG11 HD21 ' A' ' 66' ' ' LEU . 55.5 t -144.57 144.94 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.326 -0.859 . . . . 0.0 109.568 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.865 HG23 ' O ' ' A' ' 100' ' ' THR . 18.3 mt -128.95 139.02 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.292 -0.88 . . . . 0.0 109.393 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.904 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.3 OUTLIER -102.6 130.64 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.161 -0.962 . . . . 0.0 109.337 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.46 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -102.69 51.99 0.8 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.29 -0.881 . . . . 0.0 109.532 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.918 HG21 ' CG ' ' A' ' 55' ' ' MET . 10.6 t -161.7 44.05 0.16 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.945 . . . . 0.0 109.565 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.901 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . -49.92 -33.09 16.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.935 . . . . 0.0 109.412 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -84.55 -171.86 3.86 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.222 -0.924 . . . . 0.0 109.507 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.74 -75.97 1.09 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.25 131.86 4.51 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.253 -1.145 . . . . 0.0 109.501 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.556 ' HA ' ' CG2' ' A' ' 90' ' ' ILE . 0.2 OUTLIER -99.86 78.82 2.15 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.407 -0.808 . . . . 0.0 109.829 -179.554 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.41 -84.65 0.59 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.316 -0.865 . . . . 0.0 109.184 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.489 ' O ' ' CB ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -78.02 2.11 18.76 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.302 -0.874 . . . . 0.0 109.399 179.626 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.933 HD12 ' CE1' ' A' ' 101' ' ' HIS . 0.2 OUTLIER -90.39 -55.57 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.286 -0.884 . . . . 0.0 108.904 179.73 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.414 ' C ' ' O ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -45.02 -38.82 5.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.169 -0.957 . . . . 0.0 109.528 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -88.07 -40.8 13.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.203 -0.936 . . . . 0.0 109.541 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.834 ' HA ' HD12 ' A' ' 96' ' ' LEU . 2.9 m -53.05 -20.14 3.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 0.0 109.5 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.788 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 6.0 tttt -58.23 -53.8 54.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.186 -0.946 . . . . 0.0 109.477 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -76.78 -10.2 59.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.911 . . . . 0.0 109.481 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.834 HD12 ' HA ' ' A' ' 93' ' ' SER . 66.9 mt -75.4 -46.68 31.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.269 -0.895 . . . . 0.0 109.494 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 178.1 33.23 0.05 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.788 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -118.94 123.05 43.67 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.26 -1.141 . . . . 0.0 109.505 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.531 HD11 ' CA ' ' A' ' 77' ' ' ARG . 0.4 OUTLIER -90.08 -60.04 2.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 109.475 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.865 ' O ' HG23 ' A' ' 79' ' ' ILE . 21.2 m -117.79 138.13 52.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.213 -0.929 . . . . 0.0 109.582 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.933 ' CE1' HD12 ' A' ' 90' ' ' ILE . 3.9 t-160 -119.48 84.41 2.2 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.853 . . . . 0.0 109.254 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.849 ' CE2' HD13 ' A' ' 111' ' ' ILE . 22.5 m-85 -72.89 158.27 35.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.0 109.575 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.901 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -127.25 -148.73 0.39 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.241 -0.912 . . . . 0.0 109.368 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.0 tttm -128.17 131.89 24.04 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.258 -0.901 . . . . 0.0 109.369 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.75 -162.4 2.95 Favored 'Cis proline' 0 C--N 1.311 -1.423 0 C-N-CA 123.51 -1.454 . . . . 0.0 110.355 -0.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 106' ' ' PHE . 3.0 p90 -153.95 165.1 37.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.921 . . . . 0.0 109.477 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.473 ' O ' HG12 ' A' ' 111' ' ' ILE . 19.6 t0 -108.17 128.94 55.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.274 -0.891 . . . . 0.0 109.45 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.506 ' HA ' HD13 ' A' ' 108' ' ' ILE . 14.6 mm -61.53 -18.11 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.267 -0.896 . . . . 0.0 109.474 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 113' ' ' ASP . 33.1 m-20 -78.06 -37.72 46.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.162 -0.961 . . . . 0.0 109.435 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.419 ' HG2' ' CZ ' ' A' ' 102' ' ' PHE . 1.4 tt0 -72.53 -24.37 61.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.252 -0.905 . . . . 0.0 109.435 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.849 HD13 ' CE2' ' A' ' 102' ' ' PHE . 12.8 mm -79.58 -52.62 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -0.893 . . . . 0.0 109.48 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.434 ' HG2' ' O ' ' A' ' 108' ' ' ILE . 2.7 ptt85 -69.47 -24.43 63.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.178 -0.951 . . . . 0.0 109.473 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 109' ' ' ASP . 68.9 m-20 -75.93 -51.24 12.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 0.0 109.516 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.59 ' HB1' ' CE2' ' A' ' 118' ' ' TYR . . . -61.64 -46.96 87.54 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.303 -0.873 . . . . 0.0 109.601 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.671 HG22 HD21 ' A' ' 50' ' ' LEU . 68.0 t -58.42 -47.39 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.151 -0.968 . . . . 0.0 109.524 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.94 -30.48 70.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 109.493 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -83.17 -16.8 45.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.9 . . . . 0.0 109.426 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.59 ' CE2' ' HB1' ' A' ' 114' ' ' ALA . 17.5 m-85 -90.02 -72.86 0.54 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.348 -0.845 . . . . 0.0 109.531 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.527 ' CD1' ' HD2' ' A' ' 120' ' ' PRO . 6.1 tp -90.12 139.11 27.16 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.89 . . . . 0.0 109.533 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.527 ' HD2' ' CD1' ' A' ' 119' ' ' LEU . 35.6 Cg_endo -78.78 132.63 10.9 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.495 2.13 . . . . 0.0 110.409 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.963 HD13 ' O ' ' A' ' 121' ' ' LEU . 1.9 tm? -134.3 3.69 3.39 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.254 -0.904 . . . . 0.0 109.489 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.21 -168.57 0.65 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.079 -1.013 . . . . 0.0 109.496 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 98.8 p -81.56 150.15 28.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.247 -0.908 . . . . 0.0 109.522 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 34.1 p-10 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 117.913 -1.042 . . . . 0.0 109.44 -179.979 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.419 ' O ' ' O ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -73.67 151.26 40.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -0.926 . . . . 0.0 109.418 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.419 ' O ' ' O ' ' A' ' 2' ' ' MET . 4.6 p30 -47.77 172.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.295 -0.878 . . . . 0.0 109.449 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.573 ' HG3' HD22 ' A' ' 119' ' ' LEU . 5.4 mm-40 -136.1 114.66 11.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -0.884 . . . . 0.0 109.544 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.476 ' CB ' ' HB3' ' A' ' 48' ' ' PRO . 3.2 mtmm -89.99 157.28 17.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.908 . . . . 0.0 109.482 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.821 HD12 HG22 ' A' ' 30' ' ' THR . 55.3 mt -150.08 158.12 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -0.907 . . . . 0.0 109.453 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.989 ' HB3' HG13 ' A' ' 51' ' ' VAL . 1.0 OUTLIER -131.04 109.0 10.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.323 -0.861 . . . . 0.0 109.365 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.561 HD13 ' HB3' ' A' ' 19' ' ' LEU . 13.2 mt -89.91 113.47 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.235 -0.915 . . . . 0.0 109.444 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.947 HG12 HD11 ' A' ' 57' ' ' ILE . 37.1 t -109.39 97.99 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.221 -0.924 . . . . 0.0 109.392 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 11' ' ' ASP . 2.2 t0 -152.7 88.13 1.33 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.905 . . . . 0.0 109.509 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.528 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . 7.3 p-10 -44.29 -43.32 7.31 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.5 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -55.97 134.94 52.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.298 -0.876 . . . . 0.0 109.56 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.596 ' CE2' HG13 ' A' ' 17' ' ' ILE . 7.6 t80 -73.71 174.0 9.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.272 -0.892 . . . . 0.0 109.535 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.29 -38.52 3.2 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 1.052 HG23 HD13 ' A' ' 19' ' ' LEU . 2.3 mp -84.64 -48.39 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.332 -1.099 . . . . 0.0 109.443 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.464 ' O ' ' HB2' ' A' ' 20' ' ' ASN . 2.5 mtp180 -59.88 -26.79 66.15 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.255 -0.903 . . . . 0.0 109.584 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.596 HG13 ' CE2' ' A' ' 13' ' ' TYR . 3.7 mm -90.22 -57.16 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.25 -0.906 . . . . 0.0 109.74 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.818 ' O ' HG23 ' A' ' 22' ' ' VAL . 79.6 mt -54.18 -59.37 4.75 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -0.92 . . . . 0.0 109.706 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 1.052 HD13 HG23 ' A' ' 15' ' ' ILE . 4.5 mp -56.7 -19.31 15.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.243 -0.911 . . . . 0.0 109.602 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 25.9 t30 -78.2 -72.45 0.37 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.884 . . . . 0.0 109.637 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -48.29 -28.31 3.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -0.913 . . . . 0.0 109.554 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.843 HG21 ' CG2' ' A' ' 108' ' ' ILE . 63.7 t -70.61 -57.26 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.221 -0.925 . . . . 0.0 109.543 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.511 ' CZ ' HG22 ' A' ' 111' ' ' ILE . 15.5 m-85 -72.63 -3.09 22.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.276 -0.89 . . . . 0.0 109.585 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -80.08 -51.56 8.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.155 -0.966 . . . . 0.0 109.416 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.13 -22.01 53.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.292 -0.88 . . . . 0.0 109.451 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.511 ' O ' ' CD2' ' A' ' 121' ' ' LEU . 2.2 mt-10 -71.36 -33.47 69.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.233 -0.917 . . . . 0.0 109.464 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 110.02 61.93 0.51 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.616 ' CE2' HD22 ' A' ' 121' ' ' LEU . 98.8 m-85 -151.63 134.95 16.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.294 -1.121 . . . . 0.0 109.539 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -89.92 83.04 6.12 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.226 -0.922 . . . . 0.0 109.137 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.821 HG22 HD12 ' A' ' 6' ' ' ILE . 5.6 p -89.91 151.08 21.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.296 -0.877 . . . . 0.0 109.607 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.747 ' HB2' HD22 ' A' ' 7' ' ' LEU . 11.8 m-85 -115.85 -170.41 1.78 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.286 -0.884 . . . . 0.0 109.297 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -127.5 149.79 49.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.13 -0.981 . . . . 0.0 109.504 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.662 ' HB3' HG22 ' A' ' 9' ' ' VAL . . . -164.56 171.97 13.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.288 -0.882 . . . . 0.0 109.381 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.528 ' HB1' ' HB3' ' A' ' 11' ' ' ASP . . . -172.65 -34.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -0.908 . . . . 0.0 109.536 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.421 ' OD1' ' HB2' ' A' ' 37' ' ' LEU . 3.1 p30 -81.89 -2.72 52.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.187 -0.946 . . . . 0.0 109.625 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.19 -45.69 3.55 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.606 HD12 ' N ' ' A' ' 37' ' ' LEU . 9.1 mp -58.2 -34.59 70.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.242 -1.152 . . . . 0.0 109.483 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.932 ' O ' HD12 ' A' ' 42' ' ' ILE . 18.8 mm-40 -76.08 -28.53 57.61 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.199 -0.938 . . . . 0.0 109.467 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.833 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -69.13 -55.32 11.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.324 -0.86 . . . . 0.0 109.485 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.461 HD13 ' HD2' ' A' ' 68' ' ' ARG . 13.1 mt -65.54 -51.46 59.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.246 -0.909 . . . . 0.0 109.496 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -48.99 -54.32 16.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.287 -0.883 . . . . 0.0 109.452 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.932 HD12 ' O ' ' A' ' 38' ' ' GLN . 15.7 mt -60.06 -30.17 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.235 -0.915 . . . . 0.0 109.43 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.833 HG23 ' O ' ' A' ' 39' ' ' ALA . 70.2 t -70.36 -26.92 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.94 . . . . 0.0 109.461 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.1 m -89.86 -19.4 24.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.158 -0.964 . . . . 0.0 109.437 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.6 mmtt -90.02 -24.35 21.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.353 -0.842 . . . . 0.0 109.517 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.454 ' HB3' ' HD3' ' A' ' 5' ' ' LYS . 38.9 mm-40 -125.39 -32.93 2.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.171 -0.955 . . . . 0.0 109.524 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 1.4 mtt180 60.48 66.85 1.74 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 109.527 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.547 ' O ' HD12 ' A' ' 76' ' ' ILE . 35.6 Cg_endo -77.85 175.34 11.32 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.668 2.245 . . . . 0.0 110.474 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 0.9 OUTLIER -116.82 -9.32 11.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.276 -0.89 . . . . 0.0 109.511 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.04 HD21 HG22 ' A' ' 115' ' ' VAL . 7.2 tp -128.07 120.02 26.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.28 -0.888 . . . . 0.0 109.538 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.989 HG13 ' HB3' ' A' ' 7' ' ' LEU . 39.1 t -133.16 124.49 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 0.0 109.692 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.475 ' CD1' HG12 ' A' ' 8' ' ' ILE . 1.1 mp -89.94 112.78 24.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.341 -0.849 . . . . 0.0 109.355 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.474 ' CD2' ' HG ' ' A' ' 66' ' ' LEU . 1.1 mp -97.5 120.01 37.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.149 -0.969 . . . . 0.0 109.626 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.456 ' HA ' ' HG3' ' A' ' 81' ' ' MET . 26.5 t0 -105.77 101.78 11.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.264 -0.897 . . . . 0.0 109.273 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.863 ' CG ' HG21 ' A' ' 82' ' ' THR . 3.3 mmt -61.82 -13.35 23.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -0.919 . . . . 0.0 109.464 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.444 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 43.4 mttp -57.96 -25.94 61.64 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.214 -0.929 . . . . 0.0 109.486 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.947 HD11 HG12 ' A' ' 9' ' ' VAL . 87.5 mt -42.08 102.25 0.27 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.342 -0.849 . . . . 0.0 109.582 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.472 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 36.0 Cg_endo -78.33 102.2 1.54 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.377 2.052 . . . . 0.0 110.476 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 125.77 -20.19 6.47 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.681 ' HB3' HG21 ' A' ' 57' ' ' ILE . 11.2 tmm? -129.53 132.54 46.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -1.167 . . . . 0.0 109.521 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.431 ' O ' ' SD ' ' A' ' 60' ' ' MET . 74.1 m-20 -89.14 129.82 35.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.203 -0.936 . . . . 0.0 109.497 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.443 ' HA2' HG13 ' A' ' 65' ' ' ILE . . . -87.35 9.82 71.64 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 25.3 mm -76.15 -49.63 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.19 -1.182 . . . . 0.0 109.479 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -62.29 -25.31 67.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 109.388 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.566 HG22 ' HE2' ' A' ' 69' ' ' MET . 7.9 mt -62.83 -65.26 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.311 -0.868 . . . . 0.0 109.45 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.632 HD21 HG11 ' A' ' 78' ' ' VAL . 22.0 mt -46.57 -40.96 13.69 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.189 -0.944 . . . . 0.0 109.437 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.553 ' O ' HG23 ' A' ' 71' ' ' VAL . 2.0 tttt -53.8 -53.7 48.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.934 . . . . 0.0 109.399 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.476 ' O ' HG12 ' A' ' 72' ' ' ILE . 1.9 mtt85 -60.72 -24.99 66.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.258 -0.901 . . . . 0.0 109.396 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.566 ' HE2' HG22 ' A' ' 65' ' ' ILE . 2.2 mtt -78.36 -25.33 46.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.355 -0.841 . . . . 0.0 109.49 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.485 ' HG2' ' O ' ' A' ' 66' ' ' LEU . 0.8 OUTLIER -82.91 -28.84 29.67 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 0.0 109.263 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 67' ' ' LYS . 2.6 t -90.07 -22.31 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.262 -0.899 . . . . 0.0 109.493 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.476 HG12 ' O ' ' A' ' 68' ' ' ARG . 25.1 mm -90.1 -50.16 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.255 -0.903 . . . . 0.0 109.51 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.622 ' O ' HG22 ' A' ' 76' ' ' ILE . 1.0 OUTLIER -137.81 121.45 17.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -0.922 . . . . 0.0 109.509 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.79 7.76 19.59 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.223 -0.923 . . . . 0.0 109.515 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.476 ' ND2' ' C ' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -122.22 -9.11 8.66 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.246 -0.909 . . . . 0.0 108.984 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.626 ' O ' HG23 ' A' ' 76' ' ' ILE . 2.4 tp -57.86 106.85 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -0.934 . . . . 0.0 109.52 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.547 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 44.6 mtt180 -75.52 131.7 40.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.329 -0.857 . . . . 0.0 109.357 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.632 HG11 HD21 ' A' ' 66' ' ' LEU . 23.6 t -134.54 126.75 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 109.709 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.652 HG23 ' O ' ' A' ' 100' ' ' THR . 80.0 mt -103.81 128.48 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.168 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.895 HD12 ' HD1' ' A' ' 101' ' ' HIS . 0.1 OUTLIER -89.84 153.54 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.174 -0.953 . . . . 0.0 109.427 -179.799 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.456 ' HG3' ' HA ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -132.39 69.0 1.48 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.321 -0.862 . . . . 0.0 109.522 179.899 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.863 HG21 ' CG ' ' A' ' 55' ' ' MET . 12.8 t -170.67 28.16 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.213 -0.93 . . . . 0.0 109.583 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.025 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . -51.61 -21.1 2.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.236 -0.915 . . . . 0.0 109.516 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.59 70.98 10.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.47 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -166.11 -84.25 0.05 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -127.62 -177.52 4.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.224 -1.162 . . . . 0.0 109.501 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.571 ' HA ' HG23 ' A' ' 90' ' ' ILE . 2.4 mp -137.15 54.52 1.85 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -0.907 . . . . 0.0 109.4 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -103.96 -88.71 0.41 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.219 -0.926 . . . . 0.0 109.597 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.527 ' O ' ' CB ' ' A' ' 93' ' ' SER . 2.0 mpt? -73.56 -1.58 19.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.198 -0.939 . . . . 0.0 109.616 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.571 HG23 ' HA ' ' A' ' 87' ' ' LEU . 0.3 OUTLIER -89.91 -43.99 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.226 -0.921 . . . . 0.0 109.065 179.865 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.79 -43.77 94.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.309 -0.87 . . . . 0.0 109.604 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.48 ' HG2' HD21 ' A' ' 96' ' ' LEU . 1.1 tp10 -90.13 -20.71 22.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.188 -0.945 . . . . 0.0 109.813 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.527 ' CB ' ' O ' ' A' ' 89' ' ' MET . 0.4 OUTLIER -42.39 -26.86 0.12 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.187 -0.945 . . . . 0.0 109.899 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 92' ' ' GLU . 0.3 OUTLIER -52.58 -76.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -0.906 . . . . 0.0 109.899 -179.776 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.459 ' HG3' HD23 ' A' ' 96' ' ' LEU . 2.5 pt-20 -64.91 -38.02 89.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.231 -0.918 . . . . 0.0 109.825 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.522 ' N ' ' CD2' ' A' ' 96' ' ' LEU . 3.3 mm? -55.19 -25.17 30.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.919 . . . . 0.0 109.594 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 132.8 68.27 0.08 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.496 ' CB ' ' HB3' ' A' ' 93' ' ' SER . . . -153.12 98.96 2.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.251 -1.146 . . . . 0.0 109.444 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.547 ' CD1' ' HB3' ' A' ' 77' ' ' ARG . 21.1 mt -43.94 -67.13 0.3 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.295 -0.878 . . . . 0.0 109.346 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.652 ' O ' HG23 ' A' ' 79' ' ' ILE . 14.2 t -146.68 152.43 38.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.33 -0.856 . . . . 0.0 109.44 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.895 ' HD1' HD12 ' A' ' 80' ' ' ILE . 3.6 t-160 -113.68 87.29 2.58 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 109.346 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.552 ' CZ ' ' HB2' ' A' ' 114' ' ' ALA . 13.3 m-30 -71.56 159.92 33.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.226 -0.921 . . . . 0.0 109.569 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 1.025 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -131.35 -148.88 0.37 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.284 -0.885 . . . . 0.0 109.342 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.1 mtpt -91.74 146.42 33.03 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.254 -0.904 . . . . 0.0 109.466 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.5 -169.56 7.96 Favored 'Cis proline' 0 C--N 1.308 -1.565 0 C-N-CA 123.236 -1.568 . . . . 0.0 110.435 -0.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.627 ' CZ ' ' CG1' ' A' ' 111' ' ' ILE . 11.0 t80 -127.48 92.64 3.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.312 -0.868 . . . . 0.0 109.264 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.437 ' O ' HD13 ' A' ' 111' ' ' ILE . 16.3 t70 -89.83 127.83 36.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.282 -0.886 . . . . 0.0 109.511 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.843 ' CG2' HG21 ' A' ' 22' ' ' VAL . 13.7 mm -51.53 -22.16 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.225 -0.922 . . . . 0.0 109.356 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 109' ' ' ASP . 4.3 m-20 -72.64 -42.33 64.52 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.295 -0.878 . . . . 0.0 109.499 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.436 ' HG2' ' CE2' ' A' ' 102' ' ' PHE . 17.4 tt0 -62.51 -29.82 70.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.264 -0.898 . . . . 0.0 109.473 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.648 ' N ' HD12 ' A' ' 111' ' ' ILE . 1.4 mp -76.49 -56.13 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 109.327 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.432 ' HG2' ' HA ' ' A' ' 109' ' ' ASP . 30.4 ptt180 -60.79 -19.61 59.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.921 . . . . 0.0 109.435 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -81.61 -51.14 8.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 109.396 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 102' ' ' PHE . . . -55.58 -47.42 76.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.263 -0.898 . . . . 0.0 109.368 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 1.04 HG22 HD21 ' A' ' 50' ' ' LEU . 47.2 t -65.97 -47.64 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.314 -0.867 . . . . 0.0 109.419 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.81 -19.29 59.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 109.418 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -89.48 -27.25 20.46 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.251 -0.905 . . . . 0.0 109.345 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.452 ' CD2' ' O ' ' A' ' 114' ' ' ALA . 42.3 m-85 -88.07 -69.64 0.68 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.296 -0.878 . . . . 0.0 109.47 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.573 HD22 ' HG3' ' A' ' 4' ' ' GLU . 2.4 tt -90.19 127.92 51.47 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.235 -0.915 . . . . 0.0 109.435 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.474 ' HD2' ' HG ' ' A' ' 119' ' ' LEU . 35.9 Cg_endo -78.49 142.42 18.5 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.414 2.076 . . . . 0.0 110.368 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.616 HD22 ' CE2' ' A' ' 28' ' ' TYR . 1.0 OUTLIER -161.57 108.63 1.41 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.479 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.76 71.17 1.18 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.279 -0.888 . . . . 0.0 109.463 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 124' ' ' ASN . 1.5 m -147.77 -67.35 0.25 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.926 . . . . 0.0 109.461 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.44 ' O ' ' O ' ' A' ' 123' ' ' SER . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.108 -0.949 . . . . 0.0 109.443 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mtm . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.504 ' O ' ' CG ' ' A' ' 2' ' ' MET . 0.0 OUTLIER -89.83 55.29 3.11 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.249 -0.907 . . . . 0.0 109.474 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -132.53 64.45 1.61 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.231 -0.918 . . . . 0.0 109.444 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -122.01 112.24 18.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.419 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.499 ' CG ' ' HA ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -146.24 126.19 13.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.208 -0.932 . . . . 0.0 109.491 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.712 ' HB ' HG22 ' A' ' 30' ' ' THR . 4.1 mt -109.2 162.48 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.188 -0.945 . . . . 0.0 109.415 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.755 HD12 HG22 ' A' ' 9' ' ' VAL . 2.0 tm? -136.41 108.16 7.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.199 -0.938 . . . . 0.0 109.587 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.51 ' N ' HD13 ' A' ' 7' ' ' LEU . 5.0 mt -90.01 103.41 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.219 -0.926 . . . . 0.0 109.138 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.755 HG22 HD12 ' A' ' 7' ' ' LEU . 2.7 t -89.99 95.12 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.172 -0.955 . . . . 0.0 109.801 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.497 ' HB3' ' HD2' ' A' ' 16' ' ' ARG . 4.8 m-20 -145.22 155.36 43.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.272 -0.893 . . . . 0.0 109.402 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.464 ' OD2' ' CD ' ' A' ' 58' ' ' PRO . 7.1 p-10 -114.35 -29.75 6.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.339 -0.851 . . . . 0.0 109.41 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.529 ' HB3' ' NH2' ' A' ' 16' ' ' ARG . 1.4 tt0 -67.83 -148.04 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.349 -0.844 . . . . 0.0 109.514 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.614 ' CD1' ' N ' ' A' ' 14' ' ' GLY . 40.5 t80 -148.66 166.43 28.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.295 -0.878 . . . . 0.0 109.347 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.614 ' N ' ' CD1' ' A' ' 13' ' ' TYR . . . 102.24 -84.25 0.49 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.638 HG23 HD13 ' A' ' 19' ' ' LEU . 1.5 mt -51.08 -68.03 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.315 -1.109 . . . . 0.0 109.151 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.529 ' NH2' ' HB3' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -39.75 -27.57 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.616 -0.677 . . . . 0.0 110.217 -179.708 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.582 HG13 ' CZ ' ' A' ' 13' ' ' TYR . 9.9 mm -78.81 -46.77 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.091 -1.005 . . . . 0.0 109.841 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.69 ' O ' HG23 ' A' ' 22' ' ' VAL . 3.8 mp -65.47 -54.8 23.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.18 -0.95 . . . . 0.0 109.654 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.638 HD13 HG23 ' A' ' 15' ' ' ILE . 8.6 mp -59.13 -18.88 39.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.276 -0.89 . . . . 0.0 109.3 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 31.1 t30 -77.94 -65.64 0.94 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.436 -0.79 . . . . 0.0 109.546 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -68.07 -7.79 32.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 109.719 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 18' ' ' LEU . 43.7 t -88.16 -57.77 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.19 -0.944 . . . . 0.0 109.458 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.87 ' HB2' HG21 ' A' ' 30' ' ' THR . 18.0 m-85 -63.35 -28.84 70.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -0.91 . . . . 0.0 109.465 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -64.56 -60.04 3.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.274 -0.891 . . . . 0.0 109.44 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -57.03 -54.95 40.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.27 -0.894 . . . . 0.0 109.491 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.45 ' HB3' ' CD1' ' A' ' 28' ' ' TYR . 1.1 tt0 -44.48 -26.39 0.35 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.253 -0.904 . . . . 0.0 109.442 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.466 ' HA3' HD21 ' A' ' 121' ' ' LEU . . . 113.21 55.71 0.43 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.602 ' CZ ' HD13 ' A' ' 121' ' ' LEU . 78.4 m-85 -147.68 135.91 21.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.259 -1.142 . . . . 0.0 109.475 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -89.85 82.23 6.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.272 -0.893 . . . . 0.0 109.358 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.87 HG21 ' HB2' ' A' ' 23' ' ' PHE . 6.0 p -89.96 146.76 24.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.324 -0.86 . . . . 0.0 109.605 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.554 ' CZ ' ' OE1' ' A' ' 46' ' ' GLU . 18.7 m-85 -116.15 -178.71 3.47 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.321 -0.862 . . . . 0.0 109.343 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -122.14 136.18 54.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 0.0 109.553 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' A' ' 10' ' ' ASP . . . -141.94 -175.82 4.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.257 -0.902 . . . . 0.0 109.425 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.57 -83.46 0.09 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.18 -0.95 . . . . 0.0 109.499 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.441 ' OD1' ' HB2' ' A' ' 38' ' ' GLN . 20.7 p-10 -63.21 137.22 58.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.303 -0.873 . . . . 0.0 109.476 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -45.29 -31.12 3.11 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.455 ' HA ' HD23 ' A' ' 37' ' ' LEU . 0.5 OUTLIER -59.74 -49.87 76.05 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.214 -1.168 . . . . 0.0 109.477 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.523 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 6.6 tp-100 -61.96 -52.15 65.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 109.431 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.976 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -44.69 -51.54 9.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.195 -0.94 . . . . 0.0 109.572 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.491 HD21 ' HB2' ' A' ' 68' ' ' ARG . 20.6 mt -60.25 -37.47 80.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.206 -0.934 . . . . 0.0 109.59 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.24 -59.46 5.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.139 -0.976 . . . . 0.0 109.527 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.751 HG21 HD23 ' A' ' 7' ' ' LEU . 5.1 mt -62.07 -19.85 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.207 -0.933 . . . . 0.0 109.577 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.976 HG23 ' O ' ' A' ' 39' ' ' ALA . 90.8 t -81.37 -24.9 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.188 -0.945 . . . . 0.0 109.491 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.5 m -90.13 -27.48 19.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 109.511 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.474 ' HD2' ' N ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -90.08 -30.89 17.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.247 -0.908 . . . . 0.0 109.527 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.554 ' OE1' ' CZ ' ' A' ' 31' ' ' PHE . 8.1 mm-40 -110.62 -35.26 6.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.916 . . . . 0.0 109.463 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.468 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 6.5 mtt85 56.33 69.89 1.65 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.478 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.534 ' HD2' HG13 ' A' ' 43' ' ' VAL . 35.4 Cg_endo -77.7 154.72 30.83 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.694 2.263 . . . . 0.0 110.416 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.819 ' C ' HD22 ' A' ' 50' ' ' LEU . 4.0 t0 -92.77 -13.04 29.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.268 -0.895 . . . . 0.0 109.475 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.819 HD22 ' C ' ' A' ' 49' ' ' ASP . 4.3 mm? -122.54 111.98 17.46 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.222 -0.923 . . . . 0.0 109.453 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 1.006 ' HB ' HG12 ' A' ' 78' ' ' VAL . 2.1 t -113.68 131.05 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.198 -0.939 . . . . 0.0 109.528 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.462 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 1.6 mp -108.95 117.98 35.6 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.245 -0.909 . . . . 0.0 109.48 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.809 HD22 ' N ' ' A' ' 53' ' ' LEU . 2.3 mm? -103.19 130.74 50.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.268 -0.895 . . . . 0.0 109.518 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.465 ' HB2' ' OD2' ' A' ' 10' ' ' ASP . 19.6 t0 -111.11 97.81 7.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -0.872 . . . . 0.0 109.437 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.825 ' HB2' HG21 ' A' ' 82' ' ' THR . 12.6 mmt -64.76 -10.82 30.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 0.0 109.396 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -72.71 -2.96 22.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.155 -0.965 . . . . 0.0 109.668 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.45 HG12 ' OD1' ' A' ' 11' ' ' ASP . 55.3 mt -62.24 132.4 93.95 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.128 -0.983 . . . . 0.0 109.32 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.464 ' CD ' ' OD2' ' A' ' 11' ' ' ASP . 36.3 Cg_endo -78.88 112.0 3.04 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.494 2.129 . . . . 0.0 110.412 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 146.07 -76.49 0.27 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.421 ' SD ' ' C ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -130.47 170.14 14.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.207 -1.172 . . . . 0.0 109.501 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -90.09 139.54 30.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.355 -0.84 . . . . 0.0 109.499 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 63' ' ' ILE . . . -73.0 -10.11 77.16 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.456 ' CD1' ' HE3' ' A' ' 55' ' ' MET . 18.1 mm -44.14 -47.41 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.212 -1.169 . . . . 0.0 109.585 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.468 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 4.8 mt-10 -63.36 -39.52 94.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.235 -0.916 . . . . 0.0 109.533 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.414 ' O ' ' C ' ' A' ' 66' ' ' LEU . 65.6 mt -51.37 -64.49 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.262 -0.899 . . . . 0.0 109.415 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.858 HD21 ' HB ' ' A' ' 78' ' ' VAL . 7.1 mt -44.12 -49.01 9.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 109.391 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.603 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.1 OUTLIER -49.06 -47.95 44.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.184 -0.948 . . . . 0.0 109.353 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.491 ' HB2' HD21 ' A' ' 40' ' ' LEU . 9.7 mmt180 -57.15 -44.07 83.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -0.888 . . . . 0.0 109.415 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.887 ' CE ' HG11 ' A' ' 51' ' ' VAL . 3.6 mtt -60.04 -27.27 66.79 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 0.0 109.417 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 66' ' ' LEU . 0.7 OUTLIER -78.05 -31.7 50.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.238 -0.914 . . . . 0.0 109.368 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 67' ' ' LYS . 2.6 t -77.9 -24.53 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.264 -0.898 . . . . 0.0 109.519 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 68' ' ' ARG . 48.9 mt -87.42 -59.65 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -0.917 . . . . 0.0 109.406 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.504 ' O ' HG22 ' A' ' 76' ' ' ILE . 39.8 m-20 -130.52 133.56 46.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.19 -0.944 . . . . 0.0 109.482 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -90.16 -26.08 20.35 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.218 -0.926 . . . . 0.0 109.033 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 44.4 p-10 -96.51 46.85 1.06 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.262 -0.899 . . . . 0.0 109.472 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.53 ' CD1' ' HA ' ' A' ' 49' ' ' ASP . 2.9 tp -117.59 112.83 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.228 -0.92 . . . . 0.0 109.436 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.614 ' CG ' HD11 ' A' ' 99' ' ' LEU . 8.7 mpt_? -63.36 134.99 56.68 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.269 -0.894 . . . . 0.0 109.509 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 1.006 HG12 ' HB ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -138.66 108.84 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.247 -0.908 . . . . 0.0 109.6 -179.925 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.504 HG23 ' O ' ' A' ' 100' ' ' THR . 67.5 mt -96.77 145.68 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.211 -0.931 . . . . 0.0 109.371 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.967 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.4 OUTLIER -103.17 168.66 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.171 -0.956 . . . . 0.0 109.375 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.483 ' CE ' ' OD1' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -142.53 69.54 1.32 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.281 -0.887 . . . . 0.0 109.432 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.825 HG21 ' HB2' ' A' ' 55' ' ' MET . 9.0 t 178.79 55.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.348 -0.845 . . . . 0.0 109.429 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.072 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . -60.7 -43.05 98.26 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.901 . . . . 0.0 109.511 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.06 153.64 42.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.245 -0.909 . . . . 0.0 109.395 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.79 -90.43 1.08 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.484 ' O ' ' CD1' ' A' ' 90' ' ' ILE . 4.2 mm-40 -95.77 62.58 2.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.22 -1.165 . . . . 0.0 109.46 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.545 ' HA ' HD13 ' A' ' 90' ' ' ILE . 0.4 OUTLIER -68.03 -8.68 39.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.215 -0.928 . . . . 0.0 109.508 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -82.67 8.48 11.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.259 -0.901 . . . . 0.0 109.436 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.457 ' O ' ' CB ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -133.48 9.9 4.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.233 -0.917 . . . . 0.0 109.5 179.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.591 ' CD1' ' N ' ' A' ' 90' ' ' ILE . 1.2 mp -83.89 -66.53 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.285 -0.884 . . . . 0.0 109.163 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.48 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -51.19 -27.76 9.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.216 -0.927 . . . . 0.0 109.41 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.503 ' HA ' ' CG ' ' A' ' 95' ' ' GLU . 6.9 mt-10 -89.89 -28.67 19.07 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.302 -0.874 . . . . 0.0 109.456 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.749 ' HB3' HD11 ' A' ' 80' ' ' ILE . 1.7 m -64.8 -40.17 94.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.308 -0.87 . . . . 0.0 109.447 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.687 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 20.3 mttt -70.12 -63.34 1.1 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.204 -0.935 . . . . 0.0 109.548 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.503 ' CG ' ' HA ' ' A' ' 92' ' ' GLU . 0.1 OUTLIER -47.15 -27.75 1.55 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.195 -0.94 . . . . 0.0 109.469 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.495 ' HA ' HD23 ' A' ' 96' ' ' LEU . 22.0 mt -77.8 -41.24 37.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.889 . . . . 0.0 109.439 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.514 ' O ' ' CG2' ' A' ' 78' ' ' VAL . . . 161.4 61.49 0.02 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.687 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -151.03 116.52 5.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.295 -1.12 . . . . 0.0 109.448 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.614 HD11 ' CG ' ' A' ' 77' ' ' ARG . 20.3 mt -44.11 -84.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.188 -0.945 . . . . 0.0 109.436 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.622 ' CG2' ' CE1' ' A' ' 102' ' ' PHE . 12.6 t -129.83 151.87 49.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.301 -0.874 . . . . 0.0 109.456 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.967 ' ND1' HD12 ' A' ' 80' ' ' ILE . 2.9 t60 -101.56 96.29 7.02 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.272 -0.892 . . . . 0.0 109.503 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.622 ' CE1' ' CG2' ' A' ' 100' ' ' THR . 43.6 m-85 -72.22 168.32 18.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.202 -0.936 . . . . 0.0 109.404 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 1.072 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -145.68 -148.34 0.24 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.194 -0.941 . . . . 0.0 109.413 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.81 146.93 25.55 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.919 . . . . 0.0 109.534 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.99 168.01 76.98 Favored 'Cis proline' 0 C--N 1.308 -1.57 0 C-N-CA 123.233 -1.57 . . . . 0.0 110.393 0.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -142.33 -164.41 1.81 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 0.0 109.499 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -136.81 127.4 26.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.251 -0.906 . . . . 0.0 109.397 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.673 HG13 HD23 ' A' ' 18' ' ' LEU . 19.0 mm -54.11 -20.57 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -0.912 . . . . 0.0 109.468 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -74.61 -41.48 60.36 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.246 -0.909 . . . . 0.0 109.475 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -71.87 -31.6 66.62 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.228 -0.92 . . . . 0.0 109.539 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.439 HD13 ' CE2' ' A' ' 102' ' ' PHE . 17.8 mm -68.82 -58.0 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.339 -0.851 . . . . 0.0 109.516 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.442 ' HG2' ' O ' ' A' ' 108' ' ' ILE . 8.2 ptt85 -60.14 -36.47 77.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.227 -0.921 . . . . 0.0 109.535 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -59.69 -54.08 50.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.253 -0.904 . . . . 0.0 109.434 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.526 ' O ' ' CD2' ' A' ' 118' ' ' TYR . . . -57.09 -42.1 80.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.234 -0.917 . . . . 0.0 109.387 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.741 HG21 ' CZ ' ' A' ' 23' ' ' PHE . 53.9 t -65.63 -25.11 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.278 -0.889 . . . . 0.0 109.48 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.53 -45.05 61.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.283 -0.886 . . . . 0.0 109.459 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.38 -42.79 95.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.186 -0.946 . . . . 0.0 109.543 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.526 ' CD2' ' O ' ' A' ' 114' ' ' ALA . 52.7 m-85 -64.98 -70.04 0.26 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.214 -0.929 . . . . 0.0 109.518 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.558 HD23 ' CE2' ' A' ' 28' ' ' TYR . 18.0 tp -90.08 112.37 52.05 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.347 -0.846 . . . . 0.0 109.437 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 118' ' ' TYR . 35.7 Cg_endo -77.96 136.03 14.5 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.39 2.06 . . . . 0.0 110.42 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.602 HD13 ' CZ ' ' A' ' 28' ' ' TYR . 5.7 tp -112.45 -149.86 0.45 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.31 -0.869 . . . . 0.0 109.449 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.6 mtmp? -89.04 50.63 1.98 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.245 -0.91 . . . . 0.0 109.462 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 87.0 p -174.5 -174.49 0.85 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.906 . . . . 0.0 109.49 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 118.037 -0.983 . . . . 0.0 109.408 -179.969 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 2.6 mtm -143.8 128.21 17.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 0.0 109.479 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -107.04 -148.98 0.42 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.21 -0.931 . . . . 0.0 109.478 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.617 ' HG2' HD12 ' A' ' 121' ' ' LEU . 1.4 mt-10 -115.76 96.73 5.75 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.312 -0.868 . . . . 0.0 109.433 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.494 ' CB ' ' HB3' ' A' ' 48' ' ' PRO . 1.4 mptp? -120.83 159.7 24.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.254 -0.904 . . . . 0.0 109.484 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.785 ' HB ' HG22 ' A' ' 30' ' ' THR . 14.3 mt -149.98 158.79 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.23 -0.919 . . . . 0.0 109.487 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.674 ' C ' HD13 ' A' ' 7' ' ' LEU . 1.8 tm? -133.2 106.84 7.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.207 -0.933 . . . . 0.0 109.401 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.488 ' N ' HD13 ' A' ' 7' ' ' LEU . 6.0 mt -89.88 112.06 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.204 -0.935 . . . . 0.0 109.382 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.686 HG21 ' CD1' ' A' ' 53' ' ' LEU . 32.3 t -93.97 79.86 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.283 -0.886 . . . . 0.0 109.565 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.481 ' OD2' ' HG2' ' A' ' 16' ' ' ARG . 17.7 t70 -126.32 133.16 51.45 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.262 -0.899 . . . . 0.0 109.494 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.643 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . 5.4 p-10 -99.65 -45.86 5.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.127 -0.983 . . . . 0.0 109.507 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.435 ' N ' ' CG ' ' A' ' 11' ' ' ASP . 1.0 OUTLIER -68.94 112.49 5.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -0.909 . . . . 0.0 109.444 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.42 ' C ' ' O ' ' A' ' 12' ' ' GLN . 1.8 t80 -43.79 159.02 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.24 -0.912 . . . . 0.0 109.529 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.83 -67.65 0.25 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.853 HG23 HD13 ' A' ' 19' ' ' LEU . 2.7 mt -65.31 -11.47 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.191 -1.182 . . . . 0.0 109.346 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.486 ' O ' ' HB2' ' A' ' 20' ' ' ASN . 0.6 OUTLIER -84.24 -26.77 28.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.21 -0.931 . . . . 0.0 109.263 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.3 mm -90.7 -37.95 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.26 -0.9 . . . . 0.0 109.79 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.659 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.9 OUTLIER -66.94 -58.19 5.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 0.0 109.7 -179.755 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.853 HD13 HG23 ' A' ' 15' ' ' ILE . 7.9 mp -62.95 -22.13 66.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.167 -0.958 . . . . 0.0 109.394 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 8.8 t30 -71.21 -66.83 0.57 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.368 -0.833 . . . . 0.0 109.488 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.484 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 2.1 mt-10 -53.27 -33.3 52.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -0.885 . . . . 0.0 109.58 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.731 HG13 ' HE ' ' A' ' 112' ' ' ARG . 74.7 t -63.41 -60.07 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.251 -0.906 . . . . 0.0 109.512 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.483 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 21.6 m-85 -78.03 1.77 19.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.944 . . . . 0.0 109.582 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.484 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 1.0 OUTLIER -90.07 -43.13 10.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.192 -0.943 . . . . 0.0 109.491 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -76.09 -35.95 59.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.232 -0.917 . . . . 0.0 109.477 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.492 ' HB3' ' CE1' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -65.79 -27.53 68.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -0.914 . . . . 0.0 109.489 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.535 ' C ' ' CD1' ' A' ' 28' ' ' TYR . . . 106.77 73.01 0.83 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.595 ' HE2' HD12 ' A' ' 119' ' ' LEU . 79.3 m-85 -151.17 134.71 16.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.225 -1.162 . . . . 0.0 109.539 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -93.99 83.84 4.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.228 -0.92 . . . . 0.0 109.265 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.785 HG22 ' HB ' ' A' ' 6' ' ' ILE . 5.8 p -89.87 161.59 15.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.187 -0.946 . . . . 0.0 109.562 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.616 ' HB2' HD22 ' A' ' 7' ' ' LEU . 25.6 m-85 -121.66 -168.65 1.73 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -0.899 . . . . 0.0 109.331 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 16' ' ' ARG . 6.9 mp0 -123.92 150.79 44.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.185 -0.947 . . . . 0.0 109.533 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.66 ' HB3' ' HA ' ' A' ' 9' ' ' VAL . . . -162.24 173.16 14.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.22 -0.925 . . . . 0.0 109.38 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.643 ' HB1' ' HB3' ' A' ' 11' ' ' ASP . . . -174.77 -47.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.253 -0.905 . . . . 0.0 109.541 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.499 ' ND2' HD11 ' A' ' 37' ' ' LEU . 19.1 p30 -70.17 -5.66 28.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.245 -0.909 . . . . 0.0 109.585 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.424 ' HA2' HD13 ' A' ' 65' ' ' ILE . . . 85.98 -58.77 4.77 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.836 HD12 ' N ' ' A' ' 38' ' ' GLN . 4.2 pp -52.39 -40.24 61.84 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.271 -1.135 . . . . 0.0 109.476 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 1.016 ' O ' HD12 ' A' ' 42' ' ' ILE . 1.8 tp60 -66.36 -33.34 75.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.325 -0.859 . . . . 0.0 109.358 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.803 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -64.53 -62.56 1.51 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.211 -0.931 . . . . 0.0 109.407 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.744 HD22 HD12 ' A' ' 72' ' ' ILE . 13.4 mt -54.35 -35.92 63.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -0.899 . . . . 0.0 109.445 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -57.54 -53.29 59.85 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.222 -0.924 . . . . 0.0 109.387 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 1.016 HD12 ' O ' ' A' ' 38' ' ' GLN . 1.8 mp -64.91 -20.72 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.275 -0.891 . . . . 0.0 109.387 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.803 HG23 ' O ' ' A' ' 39' ' ' ALA . 21.6 t -81.51 -23.28 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.25 -0.906 . . . . 0.0 109.49 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.5 m -90.01 -28.54 19.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.321 -0.862 . . . . 0.0 109.533 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.6 mttm -87.44 -37.9 16.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.279 -0.888 . . . . 0.0 109.517 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.525 ' HG3' HG23 ' A' ' 42' ' ' ILE . 1.3 mm-40 -101.28 -39.6 7.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.261 -0.9 . . . . 0.0 109.466 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 0.9 OUTLIER 63.26 67.07 1.08 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.42 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.658 ' HD2' HG13 ' A' ' 43' ' ' VAL . 35.4 Cg_endo -77.51 -161.03 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.633 2.222 . . . . 0.0 110.469 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.978 ' O ' HD22 ' A' ' 50' ' ' LEU . 27.4 t70 -135.24 9.38 3.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 0.0 109.537 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.978 HD22 ' O ' ' A' ' 49' ' ' ASP . 0.4 OUTLIER -146.58 107.72 4.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.226 -0.921 . . . . 0.0 109.557 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.83 HG11 ' CE ' ' A' ' 69' ' ' MET . 1.7 t -113.47 109.49 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 109.382 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.685 HD23 ' HB ' ' A' ' 79' ' ' ILE . 1.3 mp -90.58 127.98 36.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.239 -0.913 . . . . 0.0 109.512 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.746 ' N ' HD22 ' A' ' 53' ' ' LEU . 2.6 mm? -113.42 146.11 40.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.233 -0.917 . . . . 0.0 109.429 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.455 ' O ' HG13 ' A' ' 57' ' ' ILE . 12.5 t70 -118.76 111.48 18.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.34 -0.85 . . . . 0.0 109.371 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.89 ' HB2' HG21 ' A' ' 82' ' ' THR . 15.5 mmt -70.6 -5.02 26.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.219 -0.926 . . . . 0.0 109.594 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.467 ' HG3' ' OG1' ' A' ' 82' ' ' THR . 24.1 mttt -90.08 14.33 12.65 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.141 -0.975 . . . . 0.0 109.67 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.645 HG23 ' HD2' ' A' ' 58' ' ' PRO . 83.4 mt -76.57 139.63 67.43 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.187 -0.945 . . . . 0.0 109.301 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.645 ' HD2' HG23 ' A' ' 57' ' ' ILE . 35.8 Cg_endo -78.18 -37.75 0.72 Allowed 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.504 2.136 . . . . 0.0 110.443 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.436 ' O ' ' HB3' ' A' ' 60' ' ' MET . . . -43.71 -43.66 6.62 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.505 ' N ' ' SD ' ' A' ' 60' ' ' MET . 0.0 OUTLIER 178.4 -167.95 0.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -1.141 . . . . 0.0 109.361 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -87.77 120.34 28.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.436 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.43 ' HA2' HG13 ' A' ' 65' ' ' ILE . . . -58.14 -16.07 24.88 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.41 ' C ' ' O ' ' A' ' 62' ' ' GLY . 25.9 mm -44.09 -50.34 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -1.141 . . . . 0.0 109.465 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 68' ' ' ARG . 6.4 mt-10 -64.56 -38.89 92.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.885 . . . . 0.0 109.425 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.494 HG22 ' SD ' ' A' ' 69' ' ' MET . 30.4 mt -53.24 -60.63 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 0.0 109.497 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 1.019 ' CD2' HG11 ' A' ' 78' ' ' VAL . 2.8 mt -50.25 -62.04 1.82 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.905 . . . . 0.0 109.71 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.83 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -41.45 -33.48 0.43 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.358 -0.839 . . . . 0.0 109.68 -179.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.555 ' HB2' HD11 ' A' ' 40' ' ' LEU . 24.8 mtt-85 -72.3 -63.04 1.23 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.211 -0.931 . . . . 0.0 109.391 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.83 ' CE ' HG11 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -40.6 -28.21 0.07 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.508 -0.745 . . . . 0.0 109.537 -179.385 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.601 ' NZ ' HD22 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -78.07 -60.4 2.39 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.057 -1.027 . . . . 0.0 109.098 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.83 HG23 ' O ' ' A' ' 67' ' ' LYS . 3.4 t -43.44 -26.77 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.449 -0.782 . . . . 0.0 109.592 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.744 HD12 HD22 ' A' ' 40' ' ' LEU . 71.7 mt -85.31 -54.2 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.251 -0.906 . . . . 0.0 109.41 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.531 ' OD1' HG22 ' A' ' 72' ' ' ILE . 1.4 m-20 -136.78 124.68 22.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.334 -0.854 . . . . 0.0 109.322 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -83.09 -9.23 59.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.213 -0.929 . . . . 0.0 109.51 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 -107.06 50.75 0.76 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.918 . . . . 0.0 109.522 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.602 ' O ' HG23 ' A' ' 76' ' ' ILE . 3.2 tp -125.4 105.22 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.221 -0.925 . . . . 0.0 109.519 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.655 ' CG ' HD11 ' A' ' 99' ' ' LEU . 75.0 mtt85 -55.19 155.5 4.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 109.473 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 1.019 HG11 ' CD2' ' A' ' 66' ' ' LEU . 3.2 t -142.78 138.82 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.272 -0.893 . . . . 0.0 109.606 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.685 ' HB ' HD23 ' A' ' 52' ' ' LEU . 9.0 mm -121.39 123.6 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.238 -0.914 . . . . 0.0 109.229 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.623 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.7 OUTLIER -89.71 144.35 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.143 -0.973 . . . . 0.0 109.429 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.458 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 5.0 mtm -124.77 57.45 1.27 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.212 -0.93 . . . . 0.0 109.51 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.89 HG21 ' HB2' ' A' ' 55' ' ' MET . 10.7 t -169.38 47.48 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.279 -0.888 . . . . 0.0 109.57 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.072 ' N ' ' HB2' ' A' ' 103' ' ' ALA . . . -85.03 72.06 10.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.245 -0.909 . . . . 0.0 109.522 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -83.1 -157.27 0.22 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.228 -0.92 . . . . 0.0 109.453 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -66.85 -11.83 58.63 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.419 ' O ' ' HG3' ' A' ' 86' ' ' GLU . 3.5 pt-20 -83.95 110.65 18.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.297 -1.119 . . . . 0.0 109.456 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.804 HD23 ' HB ' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -123.66 53.93 1.33 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.275 -0.89 . . . . 0.0 109.481 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 89' ' ' MET . 3.5 p30 -103.53 -45.83 4.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.529 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.441 ' O ' ' HB2' ' A' ' 93' ' ' SER . 4.4 ptp -87.36 -7.46 57.72 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.334 -0.854 . . . . 0.0 109.546 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.804 ' HB ' HD23 ' A' ' 87' ' ' LEU . 15.5 mt -81.0 -41.41 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.906 . . . . 0.0 109.5 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.49 -32.47 71.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.311 -0.868 . . . . 0.0 109.499 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.409 ' CD ' ' HA ' ' A' ' 89' ' ' MET . 5.8 pt-20 -89.8 -31.02 17.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.287 -0.883 . . . . 0.0 109.467 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 89' ' ' MET . 0.4 OUTLIER -59.68 -51.44 69.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.265 -0.897 . . . . 0.0 109.479 -179.945 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.631 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 14.3 tttm -52.78 -57.95 8.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.0 109.465 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 94' ' ' LYS . 59.3 mt-10 -44.06 -50.54 8.39 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.232 -0.917 . . . . 0.0 109.49 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.9 mt -53.0 -48.25 67.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.307 -0.871 . . . . 0.0 109.457 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 154.46 42.65 0.02 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.631 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -99.48 118.11 35.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.19 -1.182 . . . . 0.0 109.487 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.813 HD13 ' CD1' ' A' ' 118' ' ' TYR . 21.9 mt -55.24 -81.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.477 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.56 ' OG1' ' CE1' ' A' ' 102' ' ' PHE . 0.1 OUTLIER -126.27 175.65 7.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.208 -0.933 . . . . 0.0 109.477 -179.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.792 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 4.7 t-160 -146.03 97.19 2.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 109.256 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.56 ' CE1' ' OG1' ' A' ' 100' ' ' THR . 18.4 m-30 -108.81 159.55 16.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.182 -0.949 . . . . 0.0 109.597 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 1.072 ' HB2' ' N ' ' A' ' 83' ' ' ALA . . . -128.73 168.39 15.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.319 -0.863 . . . . 0.0 109.343 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.469 ' O ' ' HD2' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -90.97 144.85 30.68 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.186 -0.946 . . . . 0.0 109.48 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.09 130.2 20.42 Favored 'Cis proline' 0 C--N 1.309 -1.547 0 C-N-CA 123.353 -1.52 . . . . 0.0 110.36 0.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -102.22 -174.51 2.59 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.282 -0.886 . . . . 0.0 109.448 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.411 ' O ' ' C ' ' A' ' 108' ' ' ILE . 46.5 t0 -111.97 100.35 8.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.305 -0.872 . . . . 0.0 109.489 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.456 ' O ' ' HG3' ' A' ' 112' ' ' ARG . 12.5 mm -44.51 -31.21 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.381 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -63.77 -51.07 66.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.225 -0.922 . . . . 0.0 109.392 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 113' ' ' ASP . 7.5 tt0 -57.07 -47.11 81.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.17 -0.956 . . . . 0.0 109.375 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.5 mm -51.82 -60.14 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.365 -0.834 . . . . 0.0 109.453 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.731 ' HE ' HG13 ' A' ' 22' ' ' VAL . 98.8 mtt180 -49.54 -34.26 16.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.918 . . . . 0.0 109.51 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 110' ' ' GLU . 19.3 m-20 -67.29 -74.61 0.11 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 109.642 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.427 ' O ' ' C ' ' A' ' 115' ' ' VAL . . . -47.56 -63.43 1.05 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.239 -0.913 . . . . 0.0 109.622 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.427 ' C ' ' O ' ' A' ' 114' ' ' ALA . 49.4 t -42.49 -57.44 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.365 -0.835 . . . . 0.0 109.846 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 0.0 OUTLIER -45.78 -44.77 14.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.175 -0.953 . . . . 0.0 109.621 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 4.5 tptp -62.05 -39.9 93.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 109.703 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.813 ' CD1' HD13 ' A' ' 99' ' ' LEU . 48.7 m-85 -67.44 -69.77 0.29 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.168 -0.958 . . . . 0.0 109.654 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.64 ' C ' HD13 ' A' ' 119' ' ' LEU . 1.3 tm? -90.07 112.46 52.51 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.185 -0.947 . . . . 0.0 109.482 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.611 ' N ' HD13 ' A' ' 119' ' ' LEU . 36.1 Cg_endo -78.25 141.95 18.69 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.322 2.015 . . . . 0.0 110.418 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.617 HD12 ' HG2' ' A' ' 4' ' ' GLU . 0.3 OUTLIER -147.99 76.31 1.37 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.171 -0.956 . . . . 0.0 109.485 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.6 pttp -128.48 138.9 52.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 109.537 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 15.8 t 52.49 89.53 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.287 -0.883 . . . . 0.0 109.438 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.488 179.953 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 2.6 tpt -150.0 92.42 1.89 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.195 -0.941 . . . . 0.0 109.51 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.491 ' O ' ' HG3' ' A' ' 4' ' ' GLU . 1.2 p30 -158.43 -170.25 3.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.235 -0.915 . . . . 0.0 109.529 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 3' ' ' ASN . 4.2 pt-20 38.2 77.83 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.586 -0.696 . . . . 0.0 109.992 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.468 ' CD ' ' N ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -108.85 147.47 32.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.245 -0.909 . . . . 0.0 109.465 179.885 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.599 HG22 ' N ' ' A' ' 7' ' ' LEU . 16.3 mt -149.7 165.15 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.229 -0.919 . . . . 0.0 109.519 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.979 HD13 ' N ' ' A' ' 8' ' ' ILE . 2.2 tm? -131.67 133.41 44.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.302 -0.874 . . . . 0.0 109.457 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.979 ' N ' HD13 ' A' ' 7' ' ' LEU . 12.4 mt -117.86 101.75 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.191 -0.943 . . . . 0.0 109.348 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.771 HG12 HD11 ' A' ' 57' ' ' ILE . 4.9 t -89.97 125.58 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.928 . . . . 0.0 109.522 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.6 ' O ' ' HB2' ' A' ' 34' ' ' ALA . 12.7 t70 -174.41 145.61 0.99 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.261 -0.9 . . . . 0.0 109.512 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.482 ' OD2' ' HD2' ' A' ' 58' ' ' PRO . 8.0 p-10 -117.95 -31.9 4.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.218 -0.926 . . . . 0.0 109.391 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.4 ' O ' ' C ' ' A' ' 13' ' ' TYR . 21.8 tm0? -69.73 104.64 2.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.334 -0.854 . . . . 0.0 109.589 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.922 ' CE2' HD11 ' A' ' 17' ' ' ILE . 6.7 t80 -43.63 123.13 2.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.337 -0.852 . . . . 0.0 109.569 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.77 -47.43 0.79 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.551 HD11 ' HE3' ' A' ' 104' ' ' LYS . 5.0 mt -80.1 -59.25 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -1.153 . . . . 0.0 109.486 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.504 ' HG2' ' CG ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -43.36 -26.69 0.21 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.235 -0.916 . . . . 0.0 109.714 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.922 HD11 ' CE2' ' A' ' 13' ' ' TYR . 2.4 mt -90.07 -64.33 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.19 -0.943 . . . . 0.0 109.697 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.806 ' O ' HG23 ' A' ' 22' ' ' VAL . 9.6 mt -47.59 -61.08 2.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.157 -0.964 . . . . 0.0 109.749 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.476 HD12 ' CD1' ' A' ' 108' ' ' ILE . 1.4 mp -52.76 -30.88 35.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -0.932 . . . . 0.0 109.575 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.476 ' HB3' ' O ' ' A' ' 17' ' ' ILE . 28.7 t30 -67.72 -72.42 0.17 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.223 -0.923 . . . . 0.0 109.716 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 20' ' ' ASN . 0.6 OUTLIER -43.72 -31.21 0.75 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 109.604 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 18' ' ' LEU . 67.4 t -66.77 -52.15 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.294 -0.879 . . . . 0.0 109.486 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.833 ' CZ ' HG21 ' A' ' 115' ' ' VAL . 22.9 m-85 -79.92 -0.47 35.15 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.187 -0.946 . . . . 0.0 109.62 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.422 ' ND2' ' OD1' ' A' ' 20' ' ' ASN . 0.7 OUTLIER -88.4 -48.15 7.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.145 -0.972 . . . . 0.0 109.462 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.54 -10.54 59.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.466 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.497 ' HB3' ' CD1' ' A' ' 28' ' ' TYR . 1.7 tt0 -89.43 -26.29 21.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.304 -0.872 . . . . 0.0 109.457 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.533 ' C ' ' CD1' ' A' ' 28' ' ' TYR . . . 105.91 67.73 0.69 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.695 ' HE2' HD23 ' A' ' 121' ' ' LEU . 90.2 m-85 -154.68 134.87 13.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.203 -1.175 . . . . 0.0 109.443 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -91.51 81.86 5.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.891 . . . . 0.0 109.326 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.479 HG21 ' CB ' ' A' ' 23' ' ' PHE . 5.7 p -89.92 146.37 24.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.311 -0.868 . . . . 0.0 109.608 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.658 ' HB2' HD22 ' A' ' 7' ' ' LEU . 57.6 m-85 -106.96 -173.34 2.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.256 -0.902 . . . . 0.0 109.231 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.504 ' CG ' ' HG2' ' A' ' 16' ' ' ARG . 78.8 mt-30 -131.04 151.58 51.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.182 -0.949 . . . . 0.0 109.676 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.691 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -160.68 -163.47 1.07 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.302 -0.874 . . . . 0.0 109.291 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.691 ' HB2' ' O ' ' A' ' 33' ' ' ALA . . . 164.41 -44.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.922 . . . . 0.0 109.591 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.472 ' OD1' ' HB2' ' A' ' 38' ' ' GLN . 45.7 p-10 -67.07 -8.51 31.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.22 -0.925 . . . . 0.0 109.569 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.432 ' HA3' ' SD ' ' A' ' 60' ' ' MET . . . 87.49 -68.01 3.18 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 36' ' ' GLY . 0.2 OUTLIER -45.06 -53.49 7.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.254 -1.145 . . . . 0.0 109.378 179.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.501 ' NE2' ' HA ' ' A' ' 38' ' ' GLN . 2.8 tp60 -48.99 -55.87 10.63 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.209 -0.932 . . . . 0.0 109.473 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 38' ' ' GLN . . . -43.85 -50.12 8.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.283 -0.885 . . . . 0.0 109.455 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 96.5 mt -55.63 -43.03 75.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.253 -0.904 . . . . 0.0 109.452 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.456 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 8.3 m-20 -62.55 -28.71 70.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.295 -0.878 . . . . 0.0 109.373 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.959 HG21 HD23 ' A' ' 7' ' ' LEU . 20.6 mm -75.92 -29.9 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.222 -0.924 . . . . 0.0 109.477 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.531 ' HA ' ' CD ' ' A' ' 48' ' ' PRO . 68.3 t -80.93 -25.24 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.272 -0.892 . . . . 0.0 109.417 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.471 ' HA ' ' HD2' ' A' ' 47' ' ' ARG . 4.1 m -87.14 -30.69 20.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.276 -0.89 . . . . 0.0 109.515 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 1.1 mtpt -89.99 -25.68 20.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.386 -0.821 . . . . 0.0 109.532 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -123.53 -31.59 3.48 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.206 -0.934 . . . . 0.0 109.56 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.525 ' CG ' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER 47.27 71.53 1.56 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.929 . . . . 0.0 109.481 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.531 ' CD ' ' HA ' ' A' ' 43' ' ' VAL . 34.5 Cg_endo -77.78 -178.54 4.68 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 122.683 2.255 . . . . 0.0 110.616 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.55 ' OD1' HD12 ' A' ' 119' ' ' LEU . 3.3 p30 -110.44 -20.02 12.74 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.412 -0.805 . . . . 0.0 109.185 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.955 HD21 HG22 ' A' ' 115' ' ' VAL . 7.4 tp -115.18 122.24 45.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.307 -0.871 . . . . 0.0 109.554 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.884 HG11 ' HE1' ' A' ' 69' ' ' MET . 1.8 t -126.08 115.47 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.29 -0.881 . . . . 0.0 109.508 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.809 HD12 ' O ' ' A' ' 7' ' ' LEU . 1.0 OUTLIER -89.98 108.31 19.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.235 -0.915 . . . . 0.0 109.433 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.729 HD21 ' HB ' ' A' ' 65' ' ' ILE . 1.1 tp -97.69 119.13 35.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.16 -0.963 . . . . 0.0 109.429 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.508 ' HB2' ' CE ' ' A' ' 81' ' ' MET . 40.7 t0 -100.62 104.1 15.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 109.423 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.459 ' HB2' ' HB ' ' A' ' 82' ' ' THR . 2.8 mmt -65.26 -10.42 31.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.306 -0.871 . . . . 0.0 109.452 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.473 ' HB2' ' OD2' ' A' ' 54' ' ' ASP . 3.3 mmtp -66.04 -24.72 66.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.209 -0.932 . . . . 0.0 109.459 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.771 HD11 HG12 ' A' ' 9' ' ' VAL . 48.9 mt -43.12 103.12 0.3 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.368 -0.832 . . . . 0.0 109.533 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.482 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 35.3 Cg_endo -77.94 119.73 4.82 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.396 2.064 . . . . 0.0 110.388 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 108.55 5.83 31.49 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.448 ' HE2' HG21 ' A' ' 57' ' ' ILE . 24.9 ttp -165.13 127.33 2.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -1.161 . . . . 0.0 109.408 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -89.71 120.13 30.72 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -0.908 . . . . 0.0 109.423 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.455 ' HA2' HG13 ' A' ' 65' ' ' ILE . . . -67.87 -7.83 50.75 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.5 mm -53.08 -40.12 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.184 -1.186 . . . . 0.0 109.507 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -68.68 -44.1 74.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.216 -0.927 . . . . 0.0 109.418 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.729 ' HB ' HD21 ' A' ' 53' ' ' LEU . 11.4 mt -46.4 -51.86 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.258 -0.901 . . . . 0.0 109.491 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.724 ' CD2' HD22 ' A' ' 53' ' ' LEU . 55.2 mt -56.56 -41.06 76.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.289 -0.882 . . . . 0.0 109.428 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.567 ' O ' HG23 ' A' ' 71' ' ' VAL . 1.3 tttm -54.73 -41.01 69.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.226 -0.921 . . . . 0.0 109.493 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.07 -21.19 54.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 109.441 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.884 ' HE1' HG11 ' A' ' 51' ' ' VAL . 14.3 mtt -72.13 -40.08 68.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.261 -0.9 . . . . 0.0 109.439 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.524 ' CE ' ' O ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -79.72 -37.63 35.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.272 -0.892 . . . . 0.0 109.522 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 67' ' ' LYS . 97.5 t -65.46 -32.67 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.22 -0.925 . . . . 0.0 109.445 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.426 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 45.0 mm -89.65 -27.29 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.227 -0.921 . . . . 0.0 109.453 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.456 ' O ' ' O ' ' A' ' 69' ' ' MET . 15.7 m-20 -163.42 130.26 3.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.267 -0.895 . . . . 0.0 109.471 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -89.98 -10.88 43.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.229 -0.919 . . . . 0.0 109.48 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -106.94 50.23 0.78 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.288 -0.882 . . . . 0.0 109.445 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.468 ' O ' HG23 ' A' ' 76' ' ' ILE . 0.8 OUTLIER -117.94 122.98 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.269 -0.894 . . . . 0.0 109.519 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.5 ' HA ' HD11 ' A' ' 99' ' ' LEU . 10.4 mtt180 -79.31 141.66 36.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.209 -0.932 . . . . 0.0 109.426 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.671 HG13 ' HB ' ' A' ' 51' ' ' VAL . 2.7 t -147.74 119.06 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.886 . . . . 0.0 109.603 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.644 HG23 ' HB ' ' A' ' 100' ' ' THR . 23.5 mt -89.87 170.6 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 0.0 109.297 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.774 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.0 OUTLIER -134.88 126.86 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.198 -0.938 . . . . 0.0 109.435 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.508 ' CE ' ' HB2' ' A' ' 54' ' ' ASP . 20.7 mtm -110.01 84.22 1.89 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 109.181 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.85 HG22 ' NE2' ' A' ' 101' ' ' HIS . 4.7 t -149.67 -146.99 0.21 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.214 -0.929 . . . . 0.0 109.497 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.847 ' HB1' ' HG3' ' A' ' 86' ' ' GLU . . . -40.94 153.52 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.407 -0.808 . . . . 0.0 109.918 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.431 ' O ' ' C ' ' A' ' 85' ' ' GLY . 3.4 t80 -68.58 85.58 0.3 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.879 . . . . 0.0 109.758 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 86' ' ' GLU . . . 42.13 34.44 1.48 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.847 ' HG3' ' HB1' ' A' ' 83' ' ' ALA . 52.4 mt-10 -62.02 -133.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.187 -1.184 . . . . 0.0 109.062 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.4 mt -135.07 53.22 2.0 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.764 -1.21 . . . . 0.0 109.693 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 89' ' ' MET . 66.4 t0 -104.99 73.14 1.04 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.23 -0.919 . . . . 0.0 109.344 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.471 ' O ' ' CB ' ' A' ' 93' ' ' SER . 0.0 OUTLIER 68.41 29.04 5.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.4 -179.846 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.832 HD12 ' O ' ' A' ' 86' ' ' GLU . 6.5 mt -90.06 -48.33 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.319 -0.863 . . . . 0.0 109.423 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.81 -38.31 21.73 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.286 -0.884 . . . . 0.0 109.492 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.464 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 0.6 OUTLIER -90.03 -38.03 13.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.936 . . . . 0.0 109.514 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.473 ' O ' ' CB ' ' A' ' 98' ' ' ALA . 14.2 m -63.19 -12.15 26.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.254 -0.904 . . . . 0.0 109.554 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.411 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 1.2 tptp -71.96 -71.6 0.27 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.275 -0.89 . . . . 0.0 109.464 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -66.45 -13.22 60.48 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.35 -0.844 . . . . 0.0 109.422 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.512 ' HB3' ' NZ ' ' A' ' 70' ' ' LYS . 32.9 mt -74.55 -50.57 17.54 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.185 -0.947 . . . . 0.0 109.38 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 172.99 45.78 0.05 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.473 ' CB ' ' O ' ' A' ' 93' ' ' SER . . . -132.06 146.38 52.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -1.156 . . . . 0.0 109.411 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.5 HD11 ' HA ' ' A' ' 77' ' ' ARG . 0.4 OUTLIER -128.04 -60.32 1.15 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.336 -0.852 . . . . 0.0 109.489 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.691 HG23 ' CZ ' ' A' ' 102' ' ' PHE . 17.1 m -102.97 148.96 25.02 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.263 -0.898 . . . . 0.0 109.571 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.85 ' NE2' HG22 ' A' ' 82' ' ' THR . 2.8 t-160 -144.84 93.77 2.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.892 . . . . 0.0 109.347 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.691 ' CZ ' HG23 ' A' ' 100' ' ' THR . 18.7 m-30 -111.9 161.61 16.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.896 . . . . 0.0 109.587 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 82' ' ' THR . . . -113.51 -159.99 0.71 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.309 -0.87 . . . . 0.0 109.443 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.551 ' HE3' HD11 ' A' ' 15' ' ' ILE . 3.7 mttt -100.37 152.55 37.86 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.232 -0.918 . . . . 0.0 109.498 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.583 ' O ' ' CG ' ' A' ' 106' ' ' PHE . 37.1 Cg_endo -81.62 28.15 4.52 Favored 'Cis proline' 0 C--N 1.309 -1.506 0 C-N-CA 123.371 -1.512 . . . . 0.0 111.126 -0.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.583 ' CG ' ' O ' ' A' ' 105' ' ' PRO . 52.1 p90 41.46 -164.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.37 -0.831 . . . . 0.0 109.844 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.472 ' O ' HG12 ' A' ' 111' ' ' ILE . 30.5 t0 -150.1 118.7 6.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.87 . . . . 0.0 109.461 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.56 HG23 HG21 ' A' ' 22' ' ' VAL . 12.7 mm -54.12 -19.73 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.25 -0.906 . . . . 0.0 109.393 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -75.75 -57.27 3.98 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.192 -0.942 . . . . 0.0 109.427 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -59.66 -24.18 63.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.179 -0.951 . . . . 0.0 109.491 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.472 HG12 ' O ' ' A' ' 107' ' ' ASP . 22.9 mm -74.12 -56.29 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.305 -0.872 . . . . 0.0 109.46 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.414 ' HG2' ' O ' ' A' ' 108' ' ' ILE . 2.5 ptt180 -60.04 -23.62 63.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.202 -0.936 . . . . 0.0 109.533 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -76.1 -63.25 1.36 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.32 -0.863 . . . . 0.0 109.482 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.507 ' O ' ' CD2' ' A' ' 118' ' ' TYR . . . -51.07 -31.87 20.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.244 -0.91 . . . . 0.0 109.381 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.955 HG22 HD21 ' A' ' 50' ' ' LEU . 72.6 t -75.44 -36.32 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.232 -0.918 . . . . 0.0 109.411 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.409 ' HE2' ' HB3' ' A' ' 116' ' ' LYS . 0.4 OUTLIER -69.44 -21.1 63.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.233 -0.917 . . . . 0.0 109.465 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -89.48 -40.06 12.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.211 -0.931 . . . . 0.0 109.52 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.507 ' CD2' ' O ' ' A' ' 114' ' ' ALA . 26.2 m-85 -76.13 -63.3 1.35 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 0.0 109.487 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.653 HD23 ' C ' ' A' ' 119' ' ' LEU . 4.1 tt -90.19 112.42 52.46 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 0.0 109.445 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.609 ' N ' HD23 ' A' ' 119' ' ' LEU . 35.9 Cg_endo -78.07 151.51 27.18 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.429 2.086 . . . . 0.0 110.402 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.695 HD23 ' HE2' ' A' ' 28' ' ' TYR . 0.4 OUTLIER -136.25 22.18 3.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.275 -0.891 . . . . 0.0 109.491 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -82.45 160.38 22.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.27 -0.894 . . . . 0.0 109.477 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.6 m -139.56 137.62 35.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.911 . . . . 0.0 109.464 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.526 -179.982 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ttt . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 59.08 103.81 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.181 -0.949 . . . . 0.0 109.447 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.453 ' HB2' ' HE2' ' A' ' 5' ' ' LYS . 3.3 p30 -177.9 141.7 0.27 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.243 -0.91 . . . . 0.0 109.491 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -138.93 76.06 1.55 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.259 -0.9 . . . . 0.0 109.5 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.542 ' CD ' ' N ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -136.76 154.51 50.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.244 -0.91 . . . . 0.0 109.51 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.767 HD12 HG22 ' A' ' 30' ' ' THR . 4.3 mt -150.09 159.54 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.228 -0.92 . . . . 0.0 109.379 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.721 ' C ' HD13 ' A' ' 7' ' ' LEU . 2.8 tm? -132.22 107.62 8.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.256 -0.903 . . . . 0.0 109.382 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.454 ' N ' HD13 ' A' ' 7' ' ' LEU . 4.2 mt -94.81 110.51 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 0.0 109.451 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.771 ' HA ' ' HB3' ' A' ' 33' ' ' ALA . 61.1 t -95.46 109.49 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.231 -0.918 . . . . 0.0 109.44 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.54 ' CB ' ' HD2' ' A' ' 16' ' ' ARG . 4.2 m-20 -148.96 110.39 4.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.253 -0.904 . . . . 0.0 109.469 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.479 ' OD2' ' HD2' ' A' ' 58' ' ' PRO . 5.5 p-10 -76.38 -33.55 58.89 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 109.43 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.448 ' O ' ' O ' ' A' ' 13' ' ' TYR . 27.1 tt0 -78.77 104.24 9.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.25 -0.906 . . . . 0.0 109.5 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 1.046 ' CE2' HD11 ' A' ' 17' ' ' ILE . 2.6 t80 -44.56 168.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.205 -0.935 . . . . 0.0 109.509 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.77 -66.16 0.33 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.772 HG23 HD13 ' A' ' 19' ' ' LEU . 2.3 mt -63.4 -63.41 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.301 -1.117 . . . . 0.0 109.275 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.551 ' HB2' ' CG ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -42.23 -26.69 0.11 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.354 -0.841 . . . . 0.0 109.95 -179.804 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 1.046 HD11 ' CE2' ' A' ' 13' ' ' TYR . 20.6 mt -79.22 -59.63 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.106 -0.996 . . . . 0.0 109.761 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.783 ' O ' HG23 ' A' ' 22' ' ' VAL . 11.0 mp -53.28 -57.13 11.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.925 . . . . 0.0 109.721 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.772 HD13 HG23 ' A' ' 15' ' ' ILE . 7.3 mp -57.18 -22.51 41.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.235 -0.915 . . . . 0.0 109.578 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 23.6 t30 -75.84 -72.38 0.32 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.308 -0.87 . . . . 0.0 109.549 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -52.91 -19.96 2.97 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.343 -0.848 . . . . 0.0 109.642 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.783 HG23 ' O ' ' A' ' 18' ' ' LEU . 77.2 t -77.85 -58.77 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.187 -0.945 . . . . 0.0 109.39 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.428 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 13.8 m-85 -66.68 -11.18 53.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.192 -0.943 . . . . 0.0 109.349 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.446 ' OD1' ' O ' ' A' ' 20' ' ' ASN . 21.7 m120 -73.31 -61.2 1.91 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.282 -0.886 . . . . 0.0 109.404 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -18.78 63.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.236 -0.915 . . . . 0.0 109.265 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.538 ' HB3' ' CD2' ' A' ' 28' ' ' TYR . 2.7 mt-10 -75.52 -34.18 60.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.299 -0.876 . . . . 0.0 109.41 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.2 46.51 0.75 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.549 ' OH ' HD12 ' A' ' 121' ' ' LEU . 94.1 m-85 -139.0 134.56 33.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.269 -1.136 . . . . 0.0 109.529 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -91.01 83.63 5.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.099 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.767 HG22 HD12 ' A' ' 6' ' ' ILE . 5.7 p -89.74 150.56 22.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.939 . . . . 0.0 109.616 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.558 ' CZ ' ' OE2' ' A' ' 46' ' ' GLU . 17.8 m-85 -111.95 -168.38 1.31 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.302 -0.874 . . . . 0.0 109.264 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.551 ' CG ' ' HB2' ' A' ' 16' ' ' ARG . 0.6 OUTLIER -132.26 150.05 52.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.178 -0.951 . . . . 0.0 109.687 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.771 ' HB3' ' HA ' ' A' ' 9' ' ' VAL . . . -146.38 -174.4 4.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.229 -0.919 . . . . 0.0 109.349 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.612 ' O ' HD13 ' A' ' 57' ' ' ILE . . . -175.98 -57.02 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.176 -0.952 . . . . 0.0 109.619 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -81.18 0.21 37.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 109.591 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.414 ' O ' ' HB3' ' A' ' 39' ' ' ALA . . . 86.17 -53.78 4.65 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.472 HD13 ' HA ' ' A' ' 37' ' ' LEU . 2.3 mm? -45.08 -59.06 2.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -1.148 . . . . 0.0 109.549 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.565 ' O ' HD12 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -51.96 -38.17 55.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 0.0 109.496 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.464 ' O ' ' HB ' ' A' ' 43' ' ' VAL . . . -60.16 -38.44 83.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.904 . . . . 0.0 109.551 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.541 ' HA ' ' CG1' ' A' ' 43' ' ' VAL . 35.4 mt -76.25 -20.93 56.94 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.391 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.506 ' O ' ' CG ' ' A' ' 45' ' ' LYS . 0.8 OUTLIER -75.38 -40.23 58.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.132 -0.98 . . . . 0.0 109.041 179.705 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.565 HD12 ' O ' ' A' ' 38' ' ' GLN . 1.8 mp -83.86 -24.76 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.337 -0.852 . . . . 0.0 109.245 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.541 ' CG1' ' HA ' ' A' ' 40' ' ' LEU . 1.5 p -72.63 -38.88 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.265 -0.897 . . . . 0.0 109.236 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.434 ' N ' ' CG1' ' A' ' 43' ' ' VAL . 7.8 m -90.03 -22.86 21.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.361 -0.837 . . . . 0.0 109.438 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.506 ' CG ' ' O ' ' A' ' 41' ' ' ASP . 58.3 mttt -75.32 -54.42 7.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.21 -0.931 . . . . 0.0 109.618 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.558 ' OE2' ' CZ ' ' A' ' 31' ' ' PHE . 0.6 OUTLIER -91.34 -29.83 16.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.9 . . . . 0.0 109.632 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.527 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 0.0 OUTLIER 71.24 61.64 0.43 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.267 -0.896 . . . . 0.0 109.472 -179.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.535 ' CD ' ' HA ' ' A' ' 43' ' ' VAL . 35.4 Cg_endo -77.95 155.49 30.22 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.63 2.22 . . . . 0.0 110.462 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.451 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 0.3 OUTLIER -101.51 -9.02 21.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.26 -0.9 . . . . 0.0 109.477 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.686 HD21 HG22 ' A' ' 115' ' ' VAL . 9.1 tp -124.79 116.51 22.41 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.203 -0.935 . . . . 0.0 109.517 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.569 HG11 ' HE1' ' A' ' 69' ' ' MET . 43.3 t -128.38 118.08 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.176 -0.953 . . . . 0.0 109.472 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.535 HD23 ' HB ' ' A' ' 79' ' ' ILE . 0.7 OUTLIER -89.95 119.09 30.02 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.196 -0.94 . . . . 0.0 109.45 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.571 HD22 ' HG ' ' A' ' 66' ' ' LEU . 1.2 mp -104.1 138.24 40.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.32 -0.863 . . . . 0.0 109.446 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.43 ' O ' HG13 ' A' ' 57' ' ' ILE . 26.3 t70 -114.5 110.81 20.4 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.22 -0.925 . . . . 0.0 109.516 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.841 ' HB2' HG21 ' A' ' 82' ' ' THR . 24.5 mmt -73.34 -2.42 22.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.206 -0.934 . . . . 0.0 109.608 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.463 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 16.2 mmtt -85.35 13.16 6.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.156 -0.965 . . . . 0.0 109.552 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.924 HG21 ' HE1' ' A' ' 60' ' ' MET . 40.2 mt -78.48 114.29 41.75 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.27 -0.894 . . . . 0.0 109.417 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.479 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 35.7 Cg_endo -78.23 107.02 2.24 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.376 2.051 . . . . 0.0 110.375 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 155.13 -44.0 0.56 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.924 ' HE1' HG21 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -158.99 163.46 36.44 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.168 -1.196 . . . . 0.0 109.427 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -89.88 144.83 25.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.209 -0.932 . . . . 0.0 109.559 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.465 ' O ' ' HB ' ' A' ' 65' ' ' ILE . . . -87.2 -1.22 84.44 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.545 HD11 ' O ' ' A' ' 88' ' ' ASP . 15.8 mm -52.69 -52.83 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.201 -1.176 . . . . 0.0 109.464 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -61.22 -27.08 68.18 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.186 -0.946 . . . . 0.0 109.365 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.465 ' HB ' ' O ' ' A' ' 62' ' ' GLY . 19.4 mt -63.23 -66.7 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.316 -0.865 . . . . 0.0 109.456 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.963 HD21 HG11 ' A' ' 78' ' ' VAL . 16.4 mt -46.05 -25.56 0.59 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.91 . . . . 0.0 109.448 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.475 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 2.4 tmtp? -68.49 -60.26 2.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -0.895 . . . . 0.0 109.503 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.48 -29.04 61.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.263 -0.898 . . . . 0.0 109.428 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.569 ' HE1' HG11 ' A' ' 51' ' ' VAL . 3.1 mmt -64.78 -62.53 1.51 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.186 -0.946 . . . . 0.0 109.433 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 16.9 ptpt -51.84 -39.14 58.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.305 -0.872 . . . . 0.0 109.425 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 67' ' ' LYS . 86.4 t -58.6 -40.6 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.189 -0.945 . . . . 0.0 109.473 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.41 ' O ' ' OD1' ' A' ' 73' ' ' ASP . 15.6 mt -73.77 -25.94 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.211 -0.931 . . . . 0.0 109.433 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.429 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 0.1 OUTLIER -173.22 140.35 0.86 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 109.497 -180.0 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -89.76 -17.9 27.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.272 -0.893 . . . . 0.0 109.441 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -86.0 11.1 12.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.258 -0.901 . . . . 0.0 109.434 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.742 ' O ' HG23 ' A' ' 76' ' ' ILE . 2.1 tp -82.39 106.15 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.226 -0.921 . . . . 0.0 109.471 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.532 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 0.4 OUTLIER -77.3 154.16 33.15 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.29 -0.881 . . . . 0.0 109.514 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.963 HG11 HD21 ' A' ' 66' ' ' LEU . 43.0 t -147.03 121.65 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 109.545 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.535 ' HB ' HD23 ' A' ' 52' ' ' LEU . 3.6 mm -97.21 122.58 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.229 -0.919 . . . . 0.0 109.444 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.916 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.3 OUTLIER -90.05 126.2 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.279 -0.888 . . . . 0.0 109.293 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.561 ' SD ' ' CZ ' ' A' ' 106' ' ' PHE . 2.2 mtm -101.28 54.38 0.83 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.131 -0.981 . . . . 0.0 109.565 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.841 HG21 ' HB2' ' A' ' 55' ' ' MET . 14.8 t -168.64 56.25 0.05 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.3 -0.875 . . . . 0.0 109.444 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.82 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . -57.93 -43.19 86.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.879 . . . . 0.0 109.549 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.77 128.09 34.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.266 -0.896 . . . . 0.0 109.498 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 153.64 -81.17 0.18 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -140.14 165.14 28.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.205 -1.174 . . . . 0.0 109.468 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.551 ' HA ' ' CG2' ' A' ' 90' ' ' ILE . 4.1 mt -127.45 66.35 1.31 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.22 -0.925 . . . . 0.0 109.504 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.545 ' O ' HD11 ' A' ' 63' ' ' ILE . 0.3 OUTLIER -120.68 101.32 7.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.286 -0.884 . . . . 0.0 109.18 179.881 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.534 ' CB ' ' O ' ' A' ' 88' ' ' ASP . 2.4 tmm? 78.97 -4.46 2.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.373 -0.829 . . . . 0.0 109.297 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.632 ' CD1' ' CE1' ' A' ' 101' ' ' HIS . 0.2 OUTLIER -90.85 -49.64 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.368 -0.832 . . . . 0.0 108.783 179.572 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -58.3 -39.61 79.78 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.32 -0.863 . . . . 0.0 109.615 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -89.81 -16.22 30.64 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 109.547 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.746 ' HA ' HD12 ' A' ' 96' ' ' LEU . 0.6 OUTLIER -55.85 -19.0 10.11 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.26 -0.9 . . . . 0.0 109.51 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.419 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 2.2 mmmt -48.43 -61.32 2.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.261 -0.899 . . . . 0.0 109.495 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.408 ' O ' ' C ' ' A' ' 96' ' ' LEU . 4.9 mt-10 -65.42 -41.88 93.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.256 -0.903 . . . . 0.0 109.509 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.746 HD12 ' HA ' ' A' ' 93' ' ' SER . 81.6 mt -44.19 -38.86 4.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.226 -0.921 . . . . 0.0 109.457 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 143.61 40.08 0.06 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.419 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -102.91 99.06 8.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.222 -1.163 . . . . 0.0 109.486 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.727 HD22 ' CD1' ' A' ' 118' ' ' TYR . 16.9 mt -51.72 -68.03 0.2 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.255 -0.903 . . . . 0.0 109.498 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.586 HG22 ' N ' ' A' ' 101' ' ' HIS . 17.1 m -135.81 165.84 24.69 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.207 -0.933 . . . . 0.0 109.551 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.916 ' ND1' HD12 ' A' ' 80' ' ' ILE . 4.1 t60 -130.26 84.27 2.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.367 -0.833 . . . . 0.0 109.359 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.575 ' CE2' ' HA ' ' A' ' 111' ' ' ILE . 9.3 m-85 -70.28 157.19 38.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.215 -0.928 . . . . 0.0 109.485 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.82 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -132.46 -148.67 0.35 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 0.0 109.476 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.446 ' HB2' ' HA ' ' A' ' 105' ' ' PRO . 2.0 pttp -96.78 157.26 35.47 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.901 . . . . 0.0 109.494 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.446 ' HA ' ' HB2' ' A' ' 104' ' ' LYS . 36.3 Cg_endo -79.76 11.2 23.9 Favored 'Cis proline' 0 C--N 1.309 -1.518 0 C-N-CA 123.285 -1.548 . . . . 0.0 110.802 -0.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.686 ' CE2' HD21 ' A' ' 19' ' ' LEU . 11.4 t80 70.93 96.59 0.07 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.212 -0.93 . . . . 0.0 109.437 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.466 ' O ' HG12 ' A' ' 111' ' ' ILE . 21.3 t0 -89.88 118.32 29.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 0.0 109.385 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.591 HG22 ' HE ' ' A' ' 112' ' ' ARG . 13.4 mm -51.24 -39.1 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.168 -0.958 . . . . 0.0 109.339 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.439 ' HB2' ' OD2' ' A' ' 107' ' ' ASP . 3.2 m-20 -63.05 -37.33 86.75 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.288 -0.882 . . . . 0.0 109.373 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.574 ' HG3' ' CE1' ' A' ' 102' ' ' PHE . 3.0 tp10 -69.08 -33.5 73.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.292 -0.88 . . . . 0.0 109.257 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.631 ' CD1' ' CE1' ' A' ' 106' ' ' PHE . 10.5 mm -66.35 -54.96 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.3 -0.875 . . . . 0.0 109.272 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.591 ' HE ' HG22 ' A' ' 108' ' ' ILE . 3.9 mtm180 -57.46 -33.6 68.13 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.311 -0.868 . . . . 0.0 109.486 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -62.66 -62.09 1.97 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.234 -0.916 . . . . 0.0 109.768 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.425 ' O ' ' C ' ' A' ' 115' ' ' VAL . . . -58.56 -62.99 1.45 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.166 -0.958 . . . . 0.0 109.734 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.686 HG22 HD21 ' A' ' 50' ' ' LEU . 55.8 t -42.77 -39.09 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.357 -0.839 . . . . 0.0 109.867 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 1.4 mttt -63.48 -58.95 5.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.218 -0.926 . . . . 0.0 109.668 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -49.64 -60.03 3.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.2 -0.938 . . . . 0.0 109.603 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.727 ' CD1' HD22 ' A' ' 99' ' ' LEU . 65.6 m-85 -54.81 -73.91 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.237 -0.915 . . . . 0.0 109.601 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.718 HD23 ' O ' ' A' ' 120' ' ' PRO . 5.8 tt -90.15 112.47 52.66 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.926 . . . . 0.0 109.538 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.718 ' O ' HD23 ' A' ' 119' ' ' LEU . 35.6 Cg_endo -78.44 -159.39 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.389 2.059 . . . . 0.0 110.27 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.549 HD12 ' OH ' ' A' ' 28' ' ' TYR . 1.3 mt -153.11 -177.97 6.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.939 . . . . 0.0 109.439 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.407 ' HE2' ' HB3' ' A' ' 124' ' ' ASN . 0.0 OUTLIER -59.48 -75.64 0.05 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.146 -0.971 . . . . 0.0 109.438 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.1 p 64.93 27.36 12.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.34 -0.85 . . . . 0.0 109.523 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.407 ' HB3' ' HE2' ' A' ' 122' ' ' LYS . 48.8 t30 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.49 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 ttp . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.264 0.555 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.454 ' O ' ' OD1' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -166.84 131.38 2.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.229 -0.92 . . . . 0.0 109.464 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.454 ' OD1' ' O ' ' A' ' 2' ' ' MET . 5.3 m120 -149.05 106.5 3.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.886 . . . . 0.0 109.452 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -128.96 78.12 1.83 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.234 -0.916 . . . . 0.0 109.474 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.474 ' HB2' ' HA ' ' A' ' 48' ' ' PRO . 10.6 mttm -105.58 135.76 46.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.298 -0.876 . . . . 0.0 109.497 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.533 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 68.9 mt -150.12 146.17 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.252 -0.905 . . . . 0.0 109.468 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 1.015 HD11 HD13 ' A' ' 42' ' ' ILE . 0.9 OUTLIER -124.8 133.07 53.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.263 -0.898 . . . . 0.0 109.405 179.905 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.618 HD13 ' HB3' ' A' ' 19' ' ' LEU . 14.1 mt -102.71 113.72 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.184 -0.948 . . . . 0.0 109.503 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.548 ' CG2' HD23 ' A' ' 7' ' ' LEU . 13.7 t -105.77 94.48 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.17 -0.957 . . . . 0.0 109.444 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.516 ' O ' ' CD ' ' A' ' 16' ' ' ARG . 31.2 t70 -145.86 116.96 7.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.911 . . . . 0.0 109.473 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.524 ' OD2' ' CD ' ' A' ' 58' ' ' PRO . 5.8 p-10 -77.98 -46.03 22.21 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -0.902 . . . . 0.0 109.482 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.477 ' CG ' ' O ' ' A' ' 12' ' ' GLN . 3.2 pt20 -56.27 101.09 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.292 -0.88 . . . . 0.0 109.474 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 1.15 ' CE2' HD11 ' A' ' 17' ' ' ILE . 2.7 t80 -45.83 141.94 2.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.307 -0.871 . . . . 0.0 109.499 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 132.25 -53.08 0.81 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.414 ' O ' ' C ' ' A' ' 16' ' ' ARG . 2.7 mp -75.34 -53.41 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.255 -1.144 . . . . 0.0 109.445 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.516 ' CD ' ' O ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -43.89 -26.53 0.27 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.258 -0.901 . . . . 0.0 109.614 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 1.15 HD11 ' CE2' ' A' ' 13' ' ' TYR . 2.3 mt -90.12 -60.39 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.211 -0.93 . . . . 0.0 109.886 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.824 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.9 OUTLIER -50.4 -60.55 2.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.149 -0.969 . . . . 0.0 109.892 -179.697 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.832 HD11 HG21 ' A' ' 111' ' ' ILE . 1.5 tp -56.3 -24.23 42.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.304 -0.872 . . . . 0.0 109.873 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 25.4 t30 -71.85 -69.83 0.37 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.123 -0.986 . . . . 0.0 109.81 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 0.7 OUTLIER -47.6 -41.47 21.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.29 -0.881 . . . . 0.0 109.706 -179.787 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.824 HG23 ' O ' ' A' ' 18' ' ' LEU . 40.4 t -56.33 -60.52 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.244 -0.91 . . . . 0.0 109.606 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.629 ' CB ' HG21 ' A' ' 30' ' ' THR . 22.0 m-85 -69.41 -6.19 28.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 0.0 109.612 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 0.7 OUTLIER -77.39 -54.83 5.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.21 -0.931 . . . . 0.0 109.286 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt -78.31 -12.2 59.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.317 -0.865 . . . . 0.0 109.289 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.446 ' HB2' ' HA ' ' A' ' 23' ' ' PHE . 3.1 mm-40 -77.09 -43.58 33.77 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.249 -0.907 . . . . 0.0 109.461 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.69 50.67 0.32 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.635 ' CZ ' ' CD1' ' A' ' 121' ' ' LEU . 98.7 m-85 -140.81 140.47 34.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.229 -1.159 . . . . 0.0 109.527 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -90.02 82.87 6.08 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.229 -0.92 . . . . 0.0 109.291 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.629 HG21 ' CB ' ' A' ' 23' ' ' PHE . 5.8 p -89.91 153.8 20.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 109.55 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.533 ' CD2' ' O ' ' A' ' 6' ' ' ILE . 7.9 m-85 -120.99 -158.25 0.75 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -0.893 . . . . 0.0 109.338 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.465 ' HG2' ' HG2' ' A' ' 16' ' ' ARG . 73.9 mt-30 -144.05 157.86 44.07 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.208 -0.932 . . . . 0.0 109.663 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.446 ' HB3' HG22 ' A' ' 9' ' ' VAL . . . -170.99 161.34 6.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.876 . . . . 0.0 109.235 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.608 ' O ' HD13 ' A' ' 57' ' ' ILE . . . -127.55 -57.9 1.27 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.197 -0.939 . . . . 0.0 109.713 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.521 ' OD1' ' CB ' ' A' ' 37' ' ' LEU . 4.1 p30 -90.4 136.47 33.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.209 -0.932 . . . . 0.0 109.483 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.55 ' HA3' ' CD1' ' A' ' 65' ' ' ILE . . . -45.1 -29.11 2.13 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.521 ' CB ' ' OD1' ' A' ' 35' ' ' ASN . 0.2 OUTLIER -47.7 -53.61 14.55 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.326 -1.102 . . . . 0.0 109.382 179.853 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.459 ' O ' ' C ' ' A' ' 39' ' ' ALA . 11.4 mt-30 -62.3 -51.07 69.16 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.245 -0.909 . . . . 0.0 109.393 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.562 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -39.92 -37.99 0.64 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.443 -0.786 . . . . 0.0 109.804 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.7 mt -77.5 -45.05 26.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.0 109.61 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -56.26 -62.01 2.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.206 -0.934 . . . . 0.0 109.626 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 1.015 HD13 HD11 ' A' ' 7' ' ' LEU . 10.4 mt -56.67 -51.72 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.894 . . . . 0.0 109.753 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 39' ' ' ALA . 45.0 t -54.06 -22.67 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.166 -0.959 . . . . 0.0 109.704 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.0 m -89.95 -28.39 19.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.182 -0.949 . . . . 0.0 109.837 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.435 ' C ' ' HG2' ' A' ' 46' ' ' GLU . 4.1 mmmt -90.2 -6.59 55.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.208 -0.932 . . . . 0.0 109.59 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.528 ' OE1' ' CZ ' ' A' ' 31' ' ' PHE . 2.5 mt-10 -137.26 -36.2 0.66 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.242 -0.911 . . . . 0.0 109.451 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.45 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 75.3 mtm-85 58.56 65.01 3.2 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.321 -0.862 . . . . 0.0 109.462 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.536 ' CD ' ' HA ' ' A' ' 43' ' ' VAL . 35.2 Cg_endo -77.02 159.4 34.0 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.578 2.185 . . . . 0.0 110.437 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 89.1 m-20 -96.3 -5.45 40.09 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.274 -0.891 . . . . 0.0 109.656 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.479 ' CD2' HG13 ' A' ' 115' ' ' VAL . 5.2 tp -129.39 123.55 31.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.169 -0.957 . . . . 0.0 109.593 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.7 ' HB ' HG22 ' A' ' 78' ' ' VAL . 22.0 t -132.09 118.81 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.351 -0.843 . . . . 0.0 109.537 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.652 HD12 ' O ' ' A' ' 7' ' ' LEU . 1.2 mp -90.05 113.35 25.04 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -0.912 . . . . 0.0 109.42 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.523 ' CD2' ' HG ' ' A' ' 66' ' ' LEU . 1.2 mp -104.79 130.88 52.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.375 -0.828 . . . . 0.0 109.585 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.487 ' HA ' ' HG3' ' A' ' 81' ' ' MET . 32.8 t70 -108.58 105.72 15.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.288 -0.882 . . . . 0.0 109.244 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.579 ' CG ' HG21 ' A' ' 82' ' ' THR . 7.5 mtp -71.64 -4.12 25.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -0.916 . . . . 0.0 109.534 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.402 ' HE3' ' CB ' ' A' ' 82' ' ' THR . 8.1 mttp -86.07 15.08 5.38 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.116 -0.99 . . . . 0.0 109.508 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.608 HD13 ' O ' ' A' ' 34' ' ' ALA . 53.8 mt -74.13 132.65 79.26 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.188 -0.945 . . . . 0.0 109.41 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.524 ' CD ' ' OD2' ' A' ' 11' ' ' ASP . 36.7 Cg_endo -80.54 41.9 1.23 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.624 2.216 . . . . 0.0 110.7 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -133.57 -56.72 0.07 OUTLIER Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.505 ' N ' ' SD ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -156.96 -178.54 7.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.311 -1.111 . . . . 0.0 109.532 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -90.08 142.36 27.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.266 -0.896 . . . . 0.0 109.505 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.442 ' HA2' HG13 ' A' ' 65' ' ' ILE . . . -77.63 -9.42 86.89 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.63 HD12 ' HB3' ' A' ' 89' ' ' MET . 17.6 mm -51.11 -55.72 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -1.16 . . . . 0.0 109.394 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -55.84 -39.24 71.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.259 -0.9 . . . . 0.0 109.479 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.55 ' CD1' ' HA3' ' A' ' 36' ' ' GLY . 13.8 mt -53.4 -69.46 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.201 -0.937 . . . . 0.0 109.463 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 1.052 HD21 HG11 ' A' ' 78' ' ' VAL . 93.1 mt -43.62 -48.37 7.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.158 -0.963 . . . . 0.0 109.68 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.562 ' O ' HG23 ' A' ' 71' ' ' VAL . 2.1 mmtt -43.17 -58.11 2.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 109.704 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.44 ' O ' HG13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -61.6 -32.59 72.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.171 -0.956 . . . . 0.0 109.588 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.597 ' SD ' HD23 ' A' ' 66' ' ' LEU . 78.7 mtp -66.0 -23.66 66.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.321 -0.862 . . . . 0.0 109.591 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -84.0 -41.98 16.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.225 -0.922 . . . . 0.0 108.942 179.904 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 67' ' ' LYS . 2.5 t -62.09 -31.99 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.486 -0.759 . . . . 0.0 109.522 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 68' ' ' ARG . 11.3 mt -84.01 -39.86 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.232 -0.918 . . . . 0.0 109.447 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -143.13 132.75 23.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.289 -0.882 . . . . 0.0 109.379 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -90.01 -23.58 21.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.272 -0.892 . . . . 0.0 109.527 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -99.41 47.97 0.95 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.289 -0.882 . . . . 0.0 109.467 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.1 tt -107.68 134.54 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.262 -0.899 . . . . 0.0 109.478 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.536 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 0.5 OUTLIER -104.03 141.2 36.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.241 -0.912 . . . . 0.0 109.466 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 1.052 HG11 HD21 ' A' ' 66' ' ' LEU . 82.4 t -139.37 118.76 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -0.906 . . . . 0.0 109.557 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.933 HG23 HG23 ' A' ' 100' ' ' THR . 5.1 mm -89.96 122.4 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.287 -0.883 . . . . 0.0 109.162 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.862 HD12 ' HD1' ' A' ' 101' ' ' HIS . 0.1 OUTLIER -89.87 143.29 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.174 -0.954 . . . . 0.0 109.375 -179.876 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.487 ' HG3' ' HA ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -117.68 71.17 0.81 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.185 -0.947 . . . . 0.0 109.255 179.79 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.579 HG21 ' CG ' ' A' ' 55' ' ' MET . 13.4 t -176.15 31.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.346 -0.846 . . . . 0.0 109.536 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.79 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . -44.67 -77.05 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.206 -0.934 . . . . 0.0 109.499 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.416 ' C ' ' O ' ' A' ' 83' ' ' ALA . 0.4 OUTLIER -44.14 107.07 0.08 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.272 -0.893 . . . . 0.0 109.462 -179.982 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 164.46 -107.76 0.31 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.505 ' O ' HG21 ' A' ' 90' ' ' ILE . 0.9 OUTLIER -115.86 137.72 51.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.25 -1.147 . . . . 0.0 109.5 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.613 ' HA ' HG23 ' A' ' 90' ' ' ILE . 1.2 mp -108.28 59.52 0.61 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.194 -0.941 . . . . 0.0 109.503 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -100.77 -92.83 0.29 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.881 . . . . 0.0 109.657 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.63 ' HB3' HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -68.26 -7.53 31.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 0.0 109.547 179.869 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.938 HD12 ' CE1' ' A' ' 101' ' ' HIS . 0.4 OUTLIER -86.96 -42.43 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.19 -0.944 . . . . 0.0 109.066 179.858 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -55.68 -40.37 72.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 0.0 109.493 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.433 ' O ' ' C ' ' A' ' 93' ' ' SER . 29.9 mm-40 -90.06 -38.48 13.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.209 -0.932 . . . . 0.0 109.649 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.764 ' HA ' HD12 ' A' ' 96' ' ' LEU . 1.2 m -43.34 -39.36 3.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.306 -0.871 . . . . 0.0 109.551 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.909 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 6.6 mttp -44.3 -55.62 4.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 109.387 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -58.71 -43.56 90.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.243 -0.911 . . . . 0.0 109.463 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.764 HD12 ' HA ' ' A' ' 93' ' ' SER . 79.0 mt -47.2 -63.87 0.93 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.325 -0.859 . . . . 0.0 109.474 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 179.93 36.64 0.07 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.909 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -99.85 99.66 10.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -1.15 . . . . 0.0 109.503 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.598 HD13 ' CG ' ' A' ' 118' ' ' TYR . 16.7 mt -48.87 -62.74 1.36 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.323 -0.861 . . . . 0.0 109.516 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.933 HG23 HG23 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -144.39 176.42 9.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.154 -0.966 . . . . 0.0 109.577 -179.925 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.938 ' CE1' HD12 ' A' ' 90' ' ' ILE . 3.5 t-160 -141.51 94.01 2.64 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.343 -0.848 . . . . 0.0 109.235 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.734 ' HZ ' ' HB2' ' A' ' 114' ' ' ALA . 7.9 m-85 -82.12 160.9 23.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.265 -0.897 . . . . 0.0 109.696 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.79 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -140.43 -148.58 0.25 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.236 -0.915 . . . . 0.0 109.281 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.55 145.48 30.54 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.164 -0.96 . . . . 0.0 109.302 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.0 151.96 91.4 Favored 'Cis proline' 0 C--N 1.309 -1.551 0 C-N-CA 123.289 -1.546 . . . . 0.0 110.437 -0.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.733 ' CZ ' HD12 ' A' ' 111' ' ' ILE . 0.5 OUTLIER -83.05 103.89 12.84 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -0.893 . . . . 0.0 109.457 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.473 ' O ' HG12 ' A' ' 111' ' ' ILE . 48.2 t0 -89.84 103.0 15.69 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.106 -0.996 . . . . 0.0 109.401 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.457 ' O ' ' HG2' ' A' ' 112' ' ' ARG . 19.8 mm -43.31 -26.95 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.31 -0.869 . . . . 0.0 109.698 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.44 -47.96 44.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.897 . . . . 0.0 109.576 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.472 ' HG3' ' OD2' ' A' ' 107' ' ' ASP . 41.5 mt-10 -66.91 -22.94 65.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 109.332 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.832 HG21 HD11 ' A' ' 19' ' ' LEU . 16.2 mm -75.43 -56.4 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.34 -0.85 . . . . 0.0 109.293 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 108' ' ' ILE . 0.6 OUTLIER -63.83 -22.17 66.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.269 -0.894 . . . . 0.0 109.477 179.948 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -73.84 -51.46 16.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.94 . . . . 0.0 109.497 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.734 ' HB2' ' HZ ' ' A' ' 102' ' ' PHE . . . -63.35 -55.77 21.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.3 -0.875 . . . . 0.0 109.458 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.479 HG13 ' CD2' ' A' ' 50' ' ' LEU . 54.0 t -50.17 -52.28 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 109.537 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 6.5 mmmt -54.76 -39.56 68.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.19 -0.944 . . . . 0.0 109.48 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 7.0 tttm -58.22 -40.97 83.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.445 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.598 ' CG ' HD13 ' A' ' 99' ' ' LEU . 56.3 m-85 -81.89 -73.32 0.39 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.887 . . . . 0.0 109.476 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.67 HD12 ' HD2' ' A' ' 120' ' ' PRO . 39.7 tp -78.57 114.43 43.21 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.299 -0.875 . . . . 0.0 109.392 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.67 ' HD2' HD12 ' A' ' 119' ' ' LEU . 35.9 Cg_endo -78.08 176.1 10.37 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.424 2.083 . . . . 0.0 110.408 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.635 ' CD1' ' CZ ' ' A' ' 28' ' ' TYR . 1.2 mt -140.91 131.23 25.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.313 -0.867 . . . . 0.0 109.516 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.01 -22.68 27.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.219 -0.925 . . . . 0.0 109.519 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 64.09 98.21 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.24 -0.913 . . . . 0.0 109.466 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.429 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.428 ' O ' ' HG2' ' A' ' 4' ' ' GLU . 10.3 mtm -119.84 -59.67 1.78 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 109.487 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 62.97 31.84 15.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.229 -0.92 . . . . 0.0 109.456 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 2' ' ' MET . 0.2 OUTLIER 178.46 81.92 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.243 -0.91 . . . . 0.0 109.507 179.983 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.439 ' HB2' ' HA ' ' A' ' 48' ' ' PRO . 11.2 mttp -110.22 154.42 23.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.932 . . . . 0.0 109.378 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.647 ' HB ' HG22 ' A' ' 30' ' ' THR . 70.7 mt -150.11 149.19 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.282 -0.886 . . . . 0.0 109.467 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.858 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.8 OUTLIER -125.98 125.04 42.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.325 -0.859 . . . . 0.0 109.363 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.858 ' N ' HD13 ' A' ' 7' ' ' LEU . 10.1 mt -103.95 103.12 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.229 -0.92 . . . . 0.0 109.579 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.727 ' CG2' HD12 ' A' ' 7' ' ' LEU . 2.6 t -102.74 84.8 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.319 -0.863 . . . . 0.0 109.333 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.524 ' O ' ' CD1' ' A' ' 57' ' ' ILE . 40.1 p-10 -88.61 -149.44 0.18 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.33 -0.856 . . . . 0.0 109.502 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.523 ' CB ' ' HA ' ' A' ' 57' ' ' ILE . 1.0 OUTLIER -121.92 -31.39 3.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.309 -0.87 . . . . 0.0 109.519 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.45 ' O ' ' OD2' ' A' ' 10' ' ' ASP . 0.8 OUTLIER -146.75 153.95 40.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.27 -0.894 . . . . 0.0 109.483 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 1.015 ' CE2' HD11 ' A' ' 17' ' ' ILE . 6.3 t80 -43.88 141.77 1.52 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 109.499 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 137.34 -70.13 0.49 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.978 HG23 HD13 ' A' ' 19' ' ' LEU . 2.6 mt -62.86 -29.54 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.18 -1.188 . . . . 0.0 109.382 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.524 ' HB3' ' CG ' ' A' ' 32' ' ' GLN . 3.9 mpp_? -70.69 -21.81 62.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.273 -0.892 . . . . 0.0 109.566 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 1.015 HD11 ' CE2' ' A' ' 13' ' ' TYR . 6.9 mt -90.14 -57.22 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.217 -0.927 . . . . 0.0 109.661 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.905 ' O ' HG23 ' A' ' 22' ' ' VAL . 7.1 mp -54.7 -58.91 5.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.24 -0.913 . . . . 0.0 109.683 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.978 HD13 HG23 ' A' ' 15' ' ' ILE . 6.2 mp -57.52 -23.75 52.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.216 -0.927 . . . . 0.0 109.643 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 16.5 t30 -71.44 -70.63 0.31 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.238 -0.914 . . . . 0.0 109.592 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.479 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 13.5 tp10 -46.92 -43.46 18.98 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -0.91 . . . . 0.0 109.623 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.905 HG23 ' O ' ' A' ' 18' ' ' LEU . 22.7 t -54.33 -60.99 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 109.637 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.603 ' CE1' ' HA ' ' A' ' 112' ' ' ARG . 38.8 m-85 -71.25 -4.18 24.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.209 -0.932 . . . . 0.0 109.718 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.479 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 0.8 OUTLIER -80.02 -44.56 19.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.179 -0.95 . . . . 0.0 109.437 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.415 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 25.1 tttt -80.99 -18.01 48.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.301 -0.874 . . . . 0.0 109.464 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.511 ' HB3' ' CD1' ' A' ' 28' ' ' TYR . 2.2 tt0 -77.72 -37.46 49.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.215 -0.928 . . . . 0.0 109.449 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.522 ' C ' ' CD1' ' A' ' 28' ' ' TYR . . . 115.71 62.79 0.36 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.954 ' CE2' HD21 ' A' ' 121' ' ' LEU . 70.1 m-85 -149.67 134.55 17.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.177 -1.19 . . . . 0.0 109.518 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.41 ' HG2' ' OE2' ' A' ' 4' ' ' GLU . 3.1 mm100 -90.35 83.32 5.93 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.249 -0.907 . . . . 0.0 109.113 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.647 HG22 ' HB ' ' A' ' 6' ' ' ILE . 5.7 p -89.89 172.13 9.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.318 -0.864 . . . . 0.0 109.637 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.799 ' HB2' HD22 ' A' ' 7' ' ' LEU . 19.3 m-85 -134.6 -178.51 5.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.868 . . . . 0.0 109.352 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.524 ' CG ' ' HB3' ' A' ' 16' ' ' ARG . 27.4 mp0 -120.71 149.04 43.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.213 -0.93 . . . . 0.0 109.637 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.832 ' HB1' ' HB2' ' A' ' 39' ' ' ALA . . . -177.37 175.03 1.52 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.393 -0.817 . . . . 0.0 109.474 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.502 ' HA ' HG12 ' A' ' 9' ' ' VAL . . . -178.74 -58.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 109.663 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.412 ' C ' ' O ' ' A' ' 34' ' ' ALA . 3.9 p30 -43.6 -27.15 0.27 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.258 -0.901 . . . . 0.0 109.578 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.542 ' O ' HD12 ' A' ' 40' ' ' LEU . . . 97.84 -39.14 2.85 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.9 HD12 ' N ' ' A' ' 38' ' ' GLN . 3.8 pp -70.08 -45.52 66.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.213 -1.169 . . . . 0.0 109.609 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.9 ' N ' HD12 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -79.39 -30.58 42.52 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.222 -0.924 . . . . 0.0 108.912 179.868 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.832 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . . . -62.41 -48.41 79.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.254 -0.904 . . . . 0.0 108.934 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.828 HD11 HG23 ' A' ' 65' ' ' ILE . 3.7 mt -66.28 -48.59 69.94 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.333 -0.854 . . . . 0.0 109.046 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.419 ' C ' ' O ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -45.41 -40.08 7.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.337 -0.852 . . . . 0.0 109.009 179.659 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.642 HD12 ' O ' ' A' ' 38' ' ' GLN . 5.3 mt -68.04 -48.43 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.334 -0.854 . . . . 0.0 109.19 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.855 HG13 ' HD2' ' A' ' 48' ' ' PRO . 46.1 t -55.41 -19.15 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.222 -0.924 . . . . 0.0 109.406 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.8 m -90.23 -35.05 15.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.171 -0.956 . . . . 0.0 109.514 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.478 ' HG2' ' HA ' ' A' ' 42' ' ' ILE . 0.0 OUTLIER -86.32 -5.25 59.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.187 -0.945 . . . . 0.0 109.684 -179.848 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.422 ' CG ' ' HD2' ' A' ' 45' ' ' LYS . 5.1 mm-40 -134.5 -37.8 0.84 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.144 -0.973 . . . . 0.0 109.309 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.434 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 12.1 mtm-85 57.84 65.89 3.11 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.385 -0.822 . . . . 0.0 109.643 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.855 ' HD2' HG13 ' A' ' 43' ' ' VAL . 35.3 Cg_endo -77.3 162.77 30.82 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.541 2.161 . . . . 0.0 110.416 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.462 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 6.7 t0 -97.03 -13.38 22.3 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.135 -0.978 . . . . 0.0 109.57 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.8 ' CD2' HG13 ' A' ' 115' ' ' VAL . 7.0 tp -117.92 123.47 45.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.188 -0.945 . . . . 0.0 109.588 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.703 ' HB ' HG13 ' A' ' 78' ' ' VAL . 39.6 t -129.08 137.62 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -0.924 . . . . 0.0 109.403 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.668 HD12 ' O ' ' A' ' 7' ' ' LEU . 1.1 mt -112.4 103.68 11.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 109.427 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.711 HD21 ' HB ' ' A' ' 65' ' ' ILE . 1.4 mp -97.47 124.6 41.75 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.304 -0.873 . . . . 0.0 109.582 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.449 ' O ' HG13 ' A' ' 57' ' ' ILE . 21.0 t70 -107.51 120.58 42.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.263 -0.898 . . . . 0.0 109.341 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.846 ' CG ' HG21 ' A' ' 82' ' ' THR . 25.6 mmt -75.15 -13.96 60.51 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.172 -0.955 . . . . 0.0 109.638 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -89.57 46.49 1.37 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.201 -0.937 . . . . 0.0 109.52 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.524 ' CD1' ' O ' ' A' ' 10' ' ' ASP . 81.3 mt -110.99 130.21 23.17 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.177 -0.952 . . . . 0.0 109.457 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.505 ' HD3' ' HB2' ' A' ' 11' ' ' ASP . 36.1 Cg_endo -78.52 130.65 10.01 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.426 2.084 . . . . 0.0 110.372 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 123.81 -50.53 0.85 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.22 163.74 30.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.173 -1.192 . . . . 0.0 109.533 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -89.98 156.81 18.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 109.462 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.415 ' HA2' ' CD1' ' A' ' 65' ' ' ILE . . . -89.92 -6.24 69.87 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.604 HD12 ' HG2' ' A' ' 89' ' ' MET . 17.9 mm -54.92 -60.02 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.171 -1.194 . . . . 0.0 109.502 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.8 -38.14 54.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.174 -0.954 . . . . 0.0 109.432 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.828 HG23 HD11 ' A' ' 40' ' ' LEU . 15.9 mt -52.51 -57.11 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -0.889 . . . . 0.0 109.446 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.611 ' CD2' HD22 ' A' ' 53' ' ' LEU . 26.1 mt -46.33 -56.01 6.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.197 -0.939 . . . . 0.0 109.462 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.451 ' O ' HG23 ' A' ' 71' ' ' VAL . 5.3 mttt -44.09 -47.3 8.88 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -0.918 . . . . 0.0 109.431 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.438 ' O ' HG13 ' A' ' 72' ' ' ILE . 5.3 mtt180 -58.08 -43.24 86.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.263 -0.898 . . . . 0.0 109.461 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.429 ' CE ' HG11 ' A' ' 51' ' ' VAL . 4.1 mtt -64.07 -23.38 67.3 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.208 -0.933 . . . . 0.0 109.466 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 66' ' ' LEU . 0.5 OUTLIER -79.16 -33.91 43.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.226 -0.921 . . . . 0.0 109.479 179.95 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 67' ' ' LYS . 5.4 t -79.39 -21.39 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.281 -0.887 . . . . 0.0 109.495 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 68' ' ' ARG . 66.2 mt -90.04 -60.07 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.284 -0.885 . . . . 0.0 109.395 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.53 133.09 36.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.234 -0.916 . . . . 0.0 109.492 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -90.04 -11.92 40.05 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.265 -0.897 . . . . 0.0 109.16 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -107.46 51.81 0.73 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.145 -0.972 . . . . 0.0 109.443 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.492 ' O ' HG23 ' A' ' 76' ' ' ILE . 0.3 OUTLIER -119.14 113.11 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.267 -0.896 . . . . 0.0 109.545 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.804 ' CB ' HD11 ' A' ' 99' ' ' LEU . 0.8 OUTLIER -68.59 124.91 24.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.246 -0.909 . . . . 0.0 109.44 179.893 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.703 HG13 ' HB ' ' A' ' 51' ' ' VAL . 17.6 t -134.24 108.22 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 0.0 109.704 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.735 HD11 ' CE2' ' A' ' 118' ' ' TYR . 91.0 mt -90.26 148.4 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.218 -0.926 . . . . 0.0 109.36 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 1.014 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.0 OUTLIER -107.8 161.03 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.176 -0.952 . . . . 0.0 109.426 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.518 ' SD ' ' CZ ' ' A' ' 106' ' ' PHE . 8.6 mtm -137.77 89.69 2.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.239 -0.913 . . . . 0.0 109.725 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.936 HG22 ' NE2' ' A' ' 101' ' ' HIS . 14.3 t 177.8 37.2 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.271 -0.893 . . . . 0.0 109.369 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.75 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . -89.33 66.21 7.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.308 -0.87 . . . . 0.0 109.556 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.53 ' O ' ' CG ' ' A' ' 84' ' ' TYR . 10.5 t80 -89.92 23.31 2.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.232 -0.917 . . . . 0.0 109.465 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 119.3 -31.53 5.4 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.4 ' O ' HG21 ' A' ' 90' ' ' ILE . 0.1 OUTLIER -66.89 123.61 20.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -1.14 . . . . 0.0 109.522 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.607 ' HA ' HG23 ' A' ' 90' ' ' ILE . 6.7 mt -123.76 53.28 1.38 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.261 -0.899 . . . . 0.0 109.462 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -102.19 -90.94 0.34 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.258 -0.902 . . . . 0.0 109.643 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.604 ' HG2' HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -61.73 -13.27 21.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.329 -0.857 . . . . 0.0 109.535 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.607 HG23 ' HA ' ' A' ' 87' ' ' LEU . 0.5 OUTLIER -86.62 -41.27 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.237 -0.914 . . . . 0.0 109.219 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.442 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 4.9 tt0 -56.58 -40.93 76.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.269 -0.895 . . . . 0.0 109.558 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.417 ' O ' ' C ' ' A' ' 93' ' ' SER . 8.2 mt-10 -90.08 -37.16 14.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.205 -0.934 . . . . 0.0 109.657 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.868 ' HA ' HD13 ' A' ' 96' ' ' LEU . 1.1 m -43.73 -43.06 5.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.301 -0.874 . . . . 0.0 109.613 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.449 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -43.64 -54.15 5.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.22 -0.925 . . . . 0.0 109.54 -179.915 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 96' ' ' LEU . 1.3 mm-40 -59.94 -48.52 81.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.257 -0.902 . . . . 0.0 109.521 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.868 HD13 ' HA ' ' A' ' 93' ' ' SER . 2.1 mp -43.62 -60.81 1.61 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.317 -0.864 . . . . 0.0 109.577 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 172.89 45.46 0.04 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.449 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -120.93 110.18 15.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.317 -1.108 . . . . 0.0 109.423 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.804 HD11 ' CB ' ' A' ' 77' ' ' ARG . 1.7 mt -57.77 -71.48 0.1 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.203 -0.935 . . . . 0.0 109.534 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.485 ' O ' HG23 ' A' ' 79' ' ' ILE . 14.8 t -130.34 162.45 29.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -0.928 . . . . 0.0 109.545 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 1.014 ' ND1' HD12 ' A' ' 80' ' ' ILE . 5.1 t-160 -126.66 101.18 6.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.271 -0.893 . . . . 0.0 109.442 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -76.95 -176.1 3.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.319 -0.863 . . . . 0.0 109.519 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.75 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -168.38 172.91 8.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.343 -0.848 . . . . 0.0 109.454 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.513 ' HA ' ' N ' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -64.72 151.12 93.16 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.239 -0.913 . . . . 0.0 109.534 179.884 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.21 118.28 5.67 Favored 'Cis proline' 0 C--N 1.308 -1.574 0 C-N-CA 123.22 -1.575 . . . . 0.0 110.471 -0.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.741 ' CZ ' HD12 ' A' ' 111' ' ' ILE . 0.3 OUTLIER -55.18 106.08 0.21 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.213 -0.929 . . . . 0.0 109.406 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.495 ' O ' HG12 ' A' ' 111' ' ' ILE . 46.0 t0 -89.88 110.43 21.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 109.326 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.428 HD13 ' HA ' ' A' ' 108' ' ' ILE . 15.5 mm -48.23 -22.44 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.248 -0.908 . . . . 0.0 109.777 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.406 ' O ' ' HG2' ' A' ' 112' ' ' ARG . 0.9 OUTLIER -75.21 -43.72 50.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.106 -0.997 . . . . 0.0 109.458 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -70.02 -27.11 64.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.297 -0.877 . . . . 0.0 109.514 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.888 HG21 HD21 ' A' ' 19' ' ' LEU . 20.2 mm -76.03 -57.57 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.247 -0.908 . . . . 0.0 109.273 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.872 ' HB3' HG11 ' A' ' 22' ' ' VAL . 14.0 ptt180 -55.67 -32.26 63.08 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.396 -0.815 . . . . 0.0 109.985 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.542 ' HA ' ' HG2' ' A' ' 116' ' ' LYS . 10.8 m-20 -79.6 -65.86 0.95 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -0.935 . . . . 0.0 110.237 -179.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 113' ' ' ASP . . . -42.53 -35.77 1.16 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.207 -0.933 . . . . 0.0 109.876 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.8 HG13 ' CD2' ' A' ' 50' ' ' LEU . 38.2 t -77.68 -40.43 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.356 -0.84 . . . . 0.0 109.737 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.542 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -60.45 -23.87 64.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.131 -0.981 . . . . 0.0 109.332 -179.789 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.498 ' N ' ' HG3' ' A' ' 116' ' ' LYS . 9.5 ttmt -85.03 -51.63 6.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.303 -0.873 . . . . 0.0 109.387 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.735 ' CE2' HD11 ' A' ' 79' ' ' ILE . 27.1 m-85 -54.03 -64.86 0.69 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.266 -0.896 . . . . 0.0 109.353 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.885 HD12 ' HD2' ' A' ' 120' ' ' PRO . 37.5 tp -90.28 112.34 52.13 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.291 -0.881 . . . . 0.0 109.386 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.885 ' HD2' HD12 ' A' ' 119' ' ' LEU . 35.6 Cg_endo -78.27 -164.3 0.27 Allowed 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.326 2.017 . . . . 0.0 110.393 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.954 HD21 ' CE2' ' A' ' 28' ' ' TYR . 81.2 mt -146.39 -159.47 1.02 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.276 -0.89 . . . . 0.0 109.378 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.2 tttp -43.61 -46.79 7.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.216 -0.928 . . . . 0.0 109.507 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 10.4 t -99.16 155.25 17.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.279 -0.888 . . . . 0.0 109.478 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 117.93 -1.033 . . . . 0.0 109.437 -179.977 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.423 ' O ' ' CG ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER 65.07 147.47 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.896 . . . . 0.0 109.46 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.423 ' CG ' ' O ' ' A' ' 2' ' ' MET . 9.0 m120 -158.41 -148.71 0.2 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.299 -0.875 . . . . 0.0 109.462 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.521 ' OE2' HD23 ' A' ' 121' ' ' LEU . 1.3 mt-10 68.25 52.74 0.63 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.199 -0.938 . . . . 0.0 109.47 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.503 ' HB2' ' HA ' ' A' ' 48' ' ' PRO . 6.4 mtmt -96.13 139.52 32.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -0.872 . . . . 0.0 109.414 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.574 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 80.5 mt -150.05 155.21 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.253 -0.904 . . . . 0.0 109.473 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.985 HD11 HD13 ' A' ' 42' ' ' ILE . 0.6 OUTLIER -140.56 127.69 20.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 109.367 179.949 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.709 HD13 ' HB2' ' A' ' 19' ' ' LEU . 9.2 mt -92.35 120.95 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -0.917 . . . . 0.0 109.518 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.475 HG22 HD23 ' A' ' 7' ' ' LEU . 2.7 t -103.01 102.81 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -0.954 . . . . 0.0 109.464 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.462 ' HB3' ' HD3' ' A' ' 16' ' ' ARG . 7.3 t0 -162.17 134.98 5.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.158 -0.964 . . . . 0.0 109.434 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.488 ' OD2' ' HD2' ' A' ' 58' ' ' PRO . 8.6 p-10 -99.21 -34.22 10.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.294 -0.879 . . . . 0.0 109.444 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.417 ' O ' ' C ' ' A' ' 13' ' ' TYR . 0.5 OUTLIER -73.1 107.22 5.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.329 -0.857 . . . . 0.0 109.478 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.595 ' CZ ' HG13 ' A' ' 17' ' ' ILE . 20.5 t80 -43.07 153.06 0.1 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.351 -0.843 . . . . 0.0 109.603 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.403 ' N ' ' CD1' ' A' ' 13' ' ' TYR . . . 124.62 -74.43 0.4 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.899 HD13 ' OD2' ' A' ' 54' ' ' ASP . 6.6 mt -63.16 -16.92 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.24 -1.153 . . . . 0.0 109.403 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.462 ' HD3' ' HB3' ' A' ' 10' ' ' ASP . 14.6 mmm-85 -77.26 -26.88 52.93 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 109.341 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.595 HG13 ' CZ ' ' A' ' 13' ' ' TYR . 9.6 mm -90.07 -39.78 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -0.903 . . . . 0.0 109.604 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.59 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.1 mp -64.22 -58.22 7.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.25 -0.906 . . . . 0.0 109.613 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.709 ' HB2' HD13 ' A' ' 8' ' ' ILE . 44.0 mt -58.45 -20.95 49.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.282 -0.886 . . . . 0.0 109.482 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.509 ' OD1' ' ND2' ' A' ' 24' ' ' ASN . 27.6 t30 -75.72 -70.71 0.42 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -0.911 . . . . 0.0 109.568 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.482 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 17.8 tt0 -46.41 -42.51 15.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.243 -0.911 . . . . 0.0 109.614 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.609 HG21 HG23 ' A' ' 108' ' ' ILE . 64.6 t -58.99 -56.01 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.143 -0.973 . . . . 0.0 109.615 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.757 ' CB ' HG21 ' A' ' 30' ' ' THR . 29.8 m-85 -78.14 3.05 16.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.178 -0.951 . . . . 0.0 109.707 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.509 ' ND2' ' OD1' ' A' ' 20' ' ' ASN . 0.5 OUTLIER -90.07 -46.73 8.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.229 -0.92 . . . . 0.0 109.486 179.884 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.1 -19.72 36.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.216 -0.928 . . . . 0.0 109.456 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.478 ' HB3' ' CD1' ' A' ' 28' ' ' TYR . 0.5 OUTLIER -78.33 -31.06 48.51 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.3 -0.875 . . . . 0.0 109.456 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.477 ' O ' ' CD1' ' A' ' 28' ' ' TYR . . . 102.5 77.94 1.26 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.558 ' CZ ' ' HG ' ' A' ' 121' ' ' LEU . 91.5 m-85 -155.57 143.12 19.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.151 -1.205 . . . . 0.0 109.511 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -90.04 81.19 6.25 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.174 -0.954 . . . . 0.0 109.382 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.757 HG21 ' CB ' ' A' ' 23' ' ' PHE . 6.1 p -89.91 147.27 23.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.248 -0.907 . . . . 0.0 109.534 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.63 ' HB2' HD12 ' A' ' 7' ' ' LEU . 12.0 m-85 -111.06 -166.19 1.05 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 0.0 109.487 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -143.61 139.98 29.92 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.341 -0.85 . . . . 0.0 109.484 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -153.49 -176.03 5.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.266 -0.896 . . . . 0.0 109.401 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.536 ' O ' HD13 ' A' ' 57' ' ' ILE . . . -145.01 -61.88 0.35 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.218 -0.926 . . . . 0.0 109.519 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.442 ' HA ' ' HE3' ' A' ' 60' ' ' MET . 1.6 p-10 -90.22 144.5 25.8 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 0.0 109.427 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.539 ' HA3' ' CD1' ' A' ' 65' ' ' ILE . . . -48.08 -37.66 16.93 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.403 ' HA ' HD13 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -51.79 -46.49 64.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -1.172 . . . . 0.0 109.54 -179.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.52 ' NE2' ' HA ' ' A' ' 38' ' ' GLN . 6.7 tp-100 -64.84 -31.8 73.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.91 . . . . 0.0 109.541 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.785 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -66.47 -37.32 84.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.923 . . . . 0.0 109.526 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.708 HD21 ' HB2' ' A' ' 68' ' ' ARG . 13.8 mt -73.75 -38.97 64.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.883 . . . . 0.0 109.564 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.35 -54.75 39.75 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.258 -0.901 . . . . 0.0 109.48 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.985 HD13 HD11 ' A' ' 7' ' ' LEU . 23.9 mt -62.93 -31.76 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.268 -0.895 . . . . 0.0 109.473 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.785 HG23 ' O ' ' A' ' 39' ' ' ALA . 42.7 t -69.73 -28.13 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 109.365 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.0 m -90.23 -15.75 30.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.278 -0.888 . . . . 0.0 109.512 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.65 -60.48 1.95 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.918 . . . . 0.0 109.73 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 47' ' ' ARG . 1.8 mm-40 -89.78 -30.69 17.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.152 -0.967 . . . . 0.0 109.645 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 13.2 mtm180 65.89 68.41 0.66 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.934 . . . . 0.0 109.577 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.528 ' CD ' ' HA ' ' A' ' 43' ' ' VAL . 35.3 Cg_endo -77.82 -167.01 0.43 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.625 2.217 . . . . 0.0 110.354 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 75' ' ' ASN . 5.0 t70 -142.1 11.16 1.97 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.272 -0.892 . . . . 0.0 109.465 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.489 HD23 HG23 ' A' ' 6' ' ' ILE . 4.9 tp -146.79 111.55 5.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -0.926 . . . . 0.0 109.517 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.968 HG21 ' SD ' ' A' ' 69' ' ' MET . 3.4 t -109.63 137.66 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.232 -0.917 . . . . 0.0 109.32 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.552 HD12 ' O ' ' A' ' 7' ' ' LEU . 1.1 mt -104.51 97.65 7.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.655 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.468 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 1.0 OUTLIER -93.37 119.3 32.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.257 -0.902 . . . . 0.0 109.36 179.825 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.899 ' OD2' HD13 ' A' ' 15' ' ' ILE . 21.0 t0 -99.28 -4.8 31.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.116 -0.99 . . . . 0.0 109.684 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.512 ' HG3' ' CG2' ' A' ' 82' ' ' THR . 0.0 OUTLIER 53.44 17.14 1.03 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.385 -0.822 . . . . 0.0 109.783 -179.854 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 57' ' ' ILE . 13.2 mmtm -91.03 -39.87 11.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.04 -1.037 . . . . 0.0 109.338 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.755 HG21 ' HE3' ' A' ' 60' ' ' MET . 4.3 mt -42.65 111.64 1.02 Allowed Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.377 -0.827 . . . . 0.0 109.495 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.488 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 35.0 Cg_endo -77.01 165.21 28.66 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.403 2.068 . . . . 0.0 110.387 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.77 -43.03 1.87 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.755 ' HE3' HG21 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -158.18 158.85 35.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.361 -1.082 . . . . 0.0 109.321 179.899 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -88.72 151.97 22.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.114 -0.991 . . . . 0.0 109.464 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.439 ' HA2' HG12 ' A' ' 65' ' ' ILE . . . -90.18 4.35 82.8 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.644 ' HA ' HD23 ' A' ' 66' ' ' LEU . 19.4 mm -59.72 -51.03 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.157 -1.202 . . . . 0.0 109.397 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -52.46 -23.67 6.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.19 -0.944 . . . . 0.0 109.401 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.539 ' CD1' ' HA3' ' A' ' 36' ' ' GLY . 8.7 mm -71.55 -65.05 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.32 -0.862 . . . . 0.0 109.449 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.644 HD23 ' HA ' ' A' ' 63' ' ' ILE . 1.6 pp -47.51 -28.62 2.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -0.889 . . . . 0.0 109.226 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.552 ' O ' HG23 ' A' ' 71' ' ' VAL . 12.8 tptt -67.45 -59.17 3.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 0.0 109.254 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.708 ' HB2' HD21 ' A' ' 40' ' ' LEU . 10.7 mtt-85 -51.63 -26.67 9.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.264 -0.897 . . . . 0.0 109.319 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.968 ' SD ' HG21 ' A' ' 51' ' ' VAL . 1.4 mtt -73.9 -39.62 63.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.303 -0.873 . . . . 0.0 109.458 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.526 ' CD ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -69.34 -24.51 63.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.251 -0.905 . . . . 0.0 109.284 179.944 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 67' ' ' LYS . 2.6 t -90.1 -25.45 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.323 -0.86 . . . . 0.0 109.513 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.612 HD12 ' O ' ' A' ' 68' ' ' ARG . 28.2 mt -89.16 -16.92 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.308 -0.87 . . . . 0.0 109.422 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.618 ' O ' HG22 ' A' ' 76' ' ' ILE . 0.4 OUTLIER -170.71 116.59 0.48 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.259 -0.901 . . . . 0.0 109.481 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -74.93 -22.14 58.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.204 -0.935 . . . . 0.0 109.453 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.436 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 69.2 m-80 -89.7 43.09 1.13 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 109.489 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.618 HG22 ' O ' ' A' ' 73' ' ' ASP . 0.5 OUTLIER -117.26 146.8 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.342 -0.849 . . . . 0.0 109.554 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.58 ' O ' HG23 ' A' ' 78' ' ' VAL . 46.0 mtt180 -115.27 162.31 17.27 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.299 -0.875 . . . . 0.0 109.516 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 77' ' ' ARG . 69.7 t -159.72 111.97 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.261 -0.899 . . . . 0.0 109.549 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.85 HG23 HG23 ' A' ' 100' ' ' THR . 9.1 mm -93.32 133.57 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.2 -0.938 . . . . 0.0 109.392 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.902 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.5 OUTLIER -95.43 171.98 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.19 -0.944 . . . . 0.0 109.395 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.605 ' HE1' ' HB2' ' A' ' 54' ' ' ASP . 39.4 mtm -146.84 62.49 1.19 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.24 -0.913 . . . . 0.0 109.459 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.512 ' CG2' ' HG3' ' A' ' 55' ' ' MET . 11.2 t -170.89 32.51 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 109.488 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.033 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . -46.48 -76.93 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.261 -0.9 . . . . 0.0 109.464 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -46.79 100.34 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.918 . . . . 0.0 109.431 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 83' ' ' ALA . . . 138.57 -77.27 0.33 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.444 ' C ' HG21 ' A' ' 90' ' ' ILE . 2.1 mt-10 -81.12 148.94 29.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -1.153 . . . . 0.0 109.547 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.69 ' HA ' HG23 ' A' ' 90' ' ' ILE . 0.3 OUTLIER -160.45 22.53 0.15 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.283 -0.885 . . . . 0.0 109.453 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -94.28 -82.32 0.36 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.129 -0.982 . . . . 0.0 109.123 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.525 ' O ' ' CB ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -83.28 8.22 14.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.217 -0.927 . . . . 0.0 109.146 179.434 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 1.146 HD12 ' CE1' ' A' ' 101' ' ' HIS . 0.1 OUTLIER -90.73 -60.11 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.416 -0.802 . . . . 0.0 108.962 179.758 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.555 ' HB2' ' CD1' ' A' ' 87' ' ' LEU . 21.8 tp60 -53.33 -36.32 61.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.214 -0.929 . . . . 0.0 109.513 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.561 ' O ' HD12 ' A' ' 96' ' ' LEU . 8.0 mt-10 -90.09 -17.21 28.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.199 -0.938 . . . . 0.0 109.481 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.525 ' CB ' ' O ' ' A' ' 89' ' ' MET . 0.4 OUTLIER -57.82 -17.55 16.74 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.289 -0.882 . . . . 0.0 109.504 179.974 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.27 -66.76 0.49 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.268 -0.895 . . . . 0.0 109.507 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -56.77 -32.67 65.85 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.218 -0.926 . . . . 0.0 109.552 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.561 HD12 ' O ' ' A' ' 92' ' ' GLU . 2.1 mt -64.76 -33.33 75.71 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.299 -0.876 . . . . 0.0 109.47 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.526 ' HA3' ' CD ' ' A' ' 70' ' ' LYS . . . 140.7 40.4 0.08 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.485 ' HB2' ' HB3' ' A' ' 93' ' ' SER . . . -112.66 102.64 10.69 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.222 -1.164 . . . . 0.0 109.397 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.81 ' HB2' HD13 ' A' ' 79' ' ' ILE . 17.3 mt -43.74 -83.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.294 -0.879 . . . . 0.0 109.42 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.85 HG23 HG23 ' A' ' 79' ' ' ILE . 1.8 t -131.34 171.45 13.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.255 -0.903 . . . . 0.0 109.426 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 1.146 ' CE1' HD12 ' A' ' 90' ' ' ILE . 4.0 t60 -130.41 93.36 3.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.208 -0.933 . . . . 0.0 109.336 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.632 ' CE1' ' CG ' ' A' ' 110' ' ' GLU . 9.0 m-85 -72.72 155.64 39.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -0.918 . . . . 0.0 109.597 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 1.033 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -124.07 -148.56 0.4 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.313 -0.867 . . . . 0.0 109.467 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.43 ' HB2' ' HA ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -101.32 160.54 26.3 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 109.565 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.498 ' O ' ' CB ' ' A' ' 106' ' ' PHE . 36.4 Cg_endo -79.44 11.64 21.61 Favored 'Cis proline' 0 C--N 1.31 -1.489 0 C-N-CA 123.296 -1.543 . . . . 0.0 110.893 0.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.656 ' CZ ' HD12 ' A' ' 111' ' ' ILE . 2.2 t80 76.06 99.4 0.07 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.233 -0.917 . . . . 0.0 109.627 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.468 ' O ' HG12 ' A' ' 111' ' ' ILE . 15.2 t0 -89.96 114.32 26.12 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.221 -0.924 . . . . 0.0 109.309 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.609 HG23 HG21 ' A' ' 22' ' ' VAL . 13.7 mm -46.86 -40.08 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.239 -0.913 . . . . 0.0 109.468 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.457 ' HB2' ' OD2' ' A' ' 107' ' ' ASP . 99.6 m-20 -62.05 -42.12 98.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.902 . . . . 0.0 109.528 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.632 ' CG ' ' CE1' ' A' ' 102' ' ' PHE . 5.5 tp10 -67.23 -28.72 68.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.903 . . . . 0.0 109.513 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.656 HD12 ' CZ ' ' A' ' 106' ' ' PHE . 23.5 mm -69.35 -60.2 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.294 -0.879 . . . . 0.0 109.477 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.467 ' HG2' ' O ' ' A' ' 108' ' ' ILE . 0.0 OUTLIER -64.3 -19.91 65.73 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.554 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.427 ' CG ' ' O ' ' A' ' 109' ' ' ASP . 61.1 m-20 -72.47 -53.83 11.02 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.264 -0.897 . . . . 0.0 109.469 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.62 ' HB1' ' HE2' ' A' ' 118' ' ' TYR . . . -61.8 -54.38 43.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 0.0 109.461 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.7 t -52.17 -52.35 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.177 -0.952 . . . . 0.0 109.496 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.67 -35.55 55.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.252 -0.905 . . . . 0.0 109.426 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.67 -34.72 74.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.304 -0.872 . . . . 0.0 109.472 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.636 ' CG ' HD13 ' A' ' 99' ' ' LEU . 58.2 m-85 -88.69 -74.19 0.47 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -0.898 . . . . 0.0 109.532 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.765 HD23 ' O ' ' A' ' 120' ' ' PRO . 6.3 tt -90.11 112.46 52.58 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.287 -0.883 . . . . 0.0 109.443 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.765 ' O ' HD23 ' A' ' 119' ' ' LEU . 35.3 Cg_endo -77.88 -166.18 0.38 Allowed 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.381 2.054 . . . . 0.0 110.375 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.558 ' HG ' ' CZ ' ' A' ' 28' ' ' TYR . 0.4 OUTLIER -125.33 11.35 8.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 0.0 109.424 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.0 mmmt -143.74 128.72 18.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.144 -0.972 . . . . 0.0 109.435 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 50.45 -149.45 0.28 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.491 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.455 -179.976 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 ttt . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER 45.5 77.56 0.08 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.265 -0.897 . . . . 0.0 109.443 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.457 ' O ' ' HB3' ' A' ' 4' ' ' GLU . 1.0 OUTLIER -170.06 158.82 7.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 109.464 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.573 ' OE2' ' CD2' ' A' ' 28' ' ' TYR . 51.8 tt0 67.39 64.01 0.43 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.169 -0.957 . . . . 0.0 109.487 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.453 ' HB2' ' HB3' ' A' ' 48' ' ' PRO . 3.0 mttt -109.58 156.14 20.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.331 -0.856 . . . . 0.0 109.482 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.494 HG12 ' HB2' ' A' ' 50' ' ' LEU . 63.0 mt -150.05 153.02 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.892 . . . . 0.0 109.453 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.814 HD11 ' CB ' ' A' ' 33' ' ' ALA . 1.8 tm? -132.11 113.97 13.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.289 -0.882 . . . . 0.0 109.482 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.618 ' N ' HD13 ' A' ' 7' ' ' LEU . 4.4 mt -89.89 105.85 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 109.351 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.658 HG22 HD12 ' A' ' 7' ' ' LEU . 2.6 t -89.9 71.72 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.209 -0.932 . . . . 0.0 109.513 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.665 ' O ' ' HB2' ' A' ' 34' ' ' ALA . 1.5 t70 -126.09 146.27 49.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.216 -0.928 . . . . 0.0 109.399 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.943 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . 6.5 p-10 -116.81 -37.07 3.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.315 -0.865 . . . . 0.0 109.473 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.515 ' CG ' ' O ' ' A' ' 12' ' ' GLN . 7.6 pt20 -61.38 102.14 0.21 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.2 -0.937 . . . . 0.0 109.489 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 1.048 ' CE1' HD11 ' A' ' 17' ' ' ILE . 58.5 t80 -43.28 112.22 0.35 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.875 . . . . 0.0 109.596 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 159.28 -69.32 0.25 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.432 ' HB ' ' OD2' ' A' ' 10' ' ' ASP . 1.7 mp -62.78 -20.83 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.125 -1.221 . . . . 0.0 108.777 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.527 ' O ' ' CB ' ' A' ' 20' ' ' ASN . 7.4 mmm-85 -69.4 -29.98 67.85 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.386 -0.822 . . . . 0.0 109.331 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 1.048 HD11 ' CE1' ' A' ' 13' ' ' TYR . 3.8 mt -90.34 -37.08 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.362 -0.836 . . . . 0.0 109.765 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.84 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.4 OUTLIER -69.14 -58.16 4.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.005 -1.059 . . . . 0.0 109.246 -179.906 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.537 ' HA ' HD12 ' A' ' 19' ' ' LEU . 1.3 tp -62.56 -20.54 64.78 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.304 -0.873 . . . . 0.0 108.663 179.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 16' ' ' ARG . 0.5 OUTLIER -71.44 -73.25 0.19 Allowed 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.48 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 0.3 OUTLIER -52.43 -30.82 31.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.29 -0.881 . . . . 0.0 109.807 -179.589 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.84 HG23 ' O ' ' A' ' 18' ' ' LEU . 96.8 t -64.75 -61.94 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.194 -0.941 . . . . 0.0 109.548 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.877 ' HB2' HG21 ' A' ' 30' ' ' THR . 16.4 m-85 -72.5 -3.8 26.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 109.544 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.48 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 0.7 OUTLIER -82.99 -52.61 6.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.146 -0.971 . . . . 0.0 109.38 179.809 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.3 mmtt -73.57 -19.09 60.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.121 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.515 ' HB3' ' CD1' ' A' ' 28' ' ' TYR . 0.4 OUTLIER -71.39 -49.19 44.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.369 -0.832 . . . . 0.0 109.372 179.885 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.465 ' O ' ' OE2' ' A' ' 4' ' ' GLU . . . 124.95 46.62 0.24 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 1.074 ' CZ ' HD11 ' A' ' 121' ' ' LEU . 97.7 m-85 -132.72 146.69 52.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.315 -1.109 . . . . 0.0 109.574 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.0 mm100 -89.87 85.32 6.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.297 -0.877 . . . . 0.0 108.798 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.877 HG21 ' HB2' ' A' ' 23' ' ' PHE . 5.6 p -89.63 137.51 32.27 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.239 -0.913 . . . . 0.0 109.791 -179.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.616 ' HB2' HD22 ' A' ' 7' ' ' LEU . 11.5 m-85 -109.15 -171.63 1.88 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.379 -0.826 . . . . 0.0 109.238 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -121.71 154.09 37.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.151 -0.968 . . . . 0.0 109.681 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.814 ' CB ' HD11 ' A' ' 7' ' ' LEU . . . -172.48 174.34 3.83 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.272 -0.892 . . . . 0.0 109.355 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.943 ' HB1' ' HB3' ' A' ' 11' ' ' ASP . . . 170.96 -50.38 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.296 -0.878 . . . . 0.0 109.558 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.473 ' OD1' ' HB2' ' A' ' 38' ' ' GLN . 8.3 p-10 -67.29 -8.36 31.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.2 -0.938 . . . . 0.0 109.553 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 37' ' ' LEU . . . 96.53 -70.62 0.84 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.479 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -44.69 -32.98 1.67 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.166 -1.196 . . . . 0.0 109.437 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.998 ' O ' HD12 ' A' ' 42' ' ' ILE . 1.1 tp60 -71.52 -44.11 65.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.242 -0.911 . . . . 0.0 109.461 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.433 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . . . -65.57 -63.09 1.18 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.247 -0.908 . . . . 0.0 109.437 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.8 mt -51.39 -33.58 30.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.3 -0.875 . . . . 0.0 109.557 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 37' ' ' LEU . 59.8 t0 -62.76 -51.94 65.17 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.268 -0.895 . . . . 0.0 109.453 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.998 HD12 ' O ' ' A' ' 38' ' ' GLN . 2.0 mp -70.64 -14.48 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.214 -0.929 . . . . 0.0 109.49 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.536 ' HA ' ' CD ' ' A' ' 48' ' ' PRO . 50.8 t -84.56 -29.21 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.324 -0.86 . . . . 0.0 109.424 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.7 m -90.06 -25.11 20.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.155 -0.966 . . . . 0.0 109.407 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.51 ' HD2' ' N ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -89.97 -33.19 16.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.267 -0.896 . . . . 0.0 109.463 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -110.32 -36.7 5.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.215 -0.928 . . . . 0.0 109.458 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER 59.82 69.51 1.23 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.291 -0.881 . . . . 0.0 109.478 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.887 ' O ' HD12 ' A' ' 76' ' ' ILE . 34.7 Cg_endo -77.95 -179.58 5.58 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.747 2.298 . . . . 0.0 110.661 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -119.71 -16.84 8.73 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.47 -0.769 . . . . 0.0 109.33 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.494 ' HB2' HG12 ' A' ' 6' ' ' ILE . 1.8 mm? -114.16 121.12 42.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.322 -0.861 . . . . 0.0 109.695 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 1.015 ' HB ' HG13 ' A' ' 78' ' ' VAL . 2.7 t -116.51 147.04 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.236 -0.915 . . . . 0.0 109.253 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.524 ' CD1' HG12 ' A' ' 8' ' ' ILE . 1.6 mt -122.19 87.9 2.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.146 -0.971 . . . . 0.0 109.609 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.61 ' CD1' HG21 ' A' ' 9' ' ' VAL . 1.2 mp -91.7 122.58 34.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.282 -0.886 . . . . 0.0 109.268 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 81' ' ' MET . 30.3 t0 -107.4 -2.87 20.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.201 -0.937 . . . . 0.0 109.754 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.991 ' HB2' HG21 ' A' ' 82' ' ' THR . 4.7 mmt 47.29 22.08 0.24 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.339 -0.851 . . . . 0.0 109.879 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.442 ' HG3' ' CG ' ' A' ' 54' ' ' ASP . 1.4 mttt -90.77 -31.66 16.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.005 -1.059 . . . . 0.0 109.28 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.547 HG12 ' HB1' ' A' ' 34' ' ' ALA . 2.5 mp -41.88 102.17 0.26 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.501 -0.749 . . . . 0.0 109.682 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.497 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 35.0 Cg_endo -77.48 121.21 5.51 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.455 2.104 . . . . 0.0 110.351 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 121.81 -27.31 6.25 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.454 ' SD ' ' O ' ' A' ' 35' ' ' ASN . 1.3 ttp -139.84 135.36 32.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.282 -1.128 . . . . 0.0 109.398 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -89.83 137.34 32.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.243 -0.911 . . . . 0.0 109.457 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.46 ' HA2' HG13 ' A' ' 65' ' ' ILE . . . -90.49 8.74 79.33 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.54 HD11 ' CE ' ' A' ' 89' ' ' MET . 23.9 mm -58.0 -43.59 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.25 -1.147 . . . . 0.0 109.49 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.517 ' O ' ' CG ' ' A' ' 68' ' ' ARG . 49.4 mm-40 -72.99 -16.72 61.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.9 . . . . 0.0 109.456 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.642 HG22 ' CE ' ' A' ' 69' ' ' MET . 48.8 mt -72.33 -53.5 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.256 -0.903 . . . . 0.0 109.461 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.736 HD21 HG11 ' A' ' 78' ' ' VAL . 12.1 mt -47.3 -57.02 5.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.911 . . . . 0.0 109.554 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 1.011 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -56.62 -42.46 78.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.197 -0.94 . . . . 0.0 109.664 -179.855 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.517 ' CG ' ' O ' ' A' ' 64' ' ' GLU . 2.2 mmt180 -57.47 -29.93 64.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.949 . . . . 0.0 109.553 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.679 ' SD ' HG11 ' A' ' 51' ' ' VAL . 3.9 mtt -75.21 -56.37 4.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.271 -0.893 . . . . 0.0 109.489 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.525 ' NZ ' HD13 ' A' ' 96' ' ' LEU . 6.5 ptpt -55.85 -19.65 12.52 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.183 -0.948 . . . . 0.0 109.462 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 1.011 HG23 ' O ' ' A' ' 67' ' ' LYS . 39.9 t -82.14 -46.64 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.266 -0.896 . . . . 0.0 109.456 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 67.6 mt -63.56 -56.09 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.33 -0.856 . . . . 0.0 109.507 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -135.86 142.74 44.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.325 -0.859 . . . . 0.0 109.46 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -89.42 -10.6 45.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.244 -0.91 . . . . 0.0 109.49 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -102.1 38.52 1.64 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.24 -0.913 . . . . 0.0 109.421 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.887 HD12 ' O ' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -113.55 91.65 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 109.417 -180.0 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.565 ' HB3' HD11 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -63.16 154.77 30.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.225 -0.922 . . . . 0.0 109.478 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 1.015 HG13 ' HB ' ' A' ' 51' ' ' VAL . 3.1 t -138.29 158.84 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.205 -0.935 . . . . 0.0 109.448 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.816 HD11 HD12 ' A' ' 99' ' ' LEU . 3.6 mm -136.81 125.74 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 109.454 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.582 ' HB ' ' CG ' ' A' ' 101' ' ' HIS . 0.7 OUTLIER -98.3 136.85 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.241 -0.912 . . . . 0.0 109.296 179.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.46 ' O ' ' OD1' ' A' ' 54' ' ' ASP . 16.9 mtm -122.16 49.03 1.63 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.489 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.991 HG21 ' HB2' ' A' ' 55' ' ' MET . 8.9 t -159.04 52.0 0.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 109.478 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.839 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . -66.38 -20.99 66.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.211 -0.93 . . . . 0.0 109.448 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.462 ' HB2' ' HB1' ' A' ' 103' ' ' ALA . 0.2 OUTLIER -80.39 115.93 20.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.206 -0.934 . . . . 0.0 109.427 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 137.21 -138.22 9.58 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.418 ' HG3' ' SD ' ' A' ' 89' ' ' MET . 0.4 OUTLIER -55.64 142.93 32.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -1.164 . . . . 0.0 109.508 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 9.2 mt -132.34 52.9 2.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.241 -0.912 . . . . 0.0 109.557 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.01 3.74 4.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.901 . . . . 0.0 109.511 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.54 ' CE ' HD11 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -123.49 -8.91 8.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.148 -0.97 . . . . 0.0 109.564 179.957 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.637 HG23 ' HD1' ' A' ' 101' ' ' HIS . 21.0 mt -87.6 -36.61 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.172 -0.955 . . . . 0.0 109.54 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.28 -41.84 76.5 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.315 -0.866 . . . . 0.0 109.481 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 93' ' ' SER . 2.1 tp10 -89.94 -48.22 7.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.191 -0.943 . . . . 0.0 109.496 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.626 ' HA ' HD12 ' A' ' 96' ' ' LEU . 11.5 t -44.21 -26.58 0.33 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.929 . . . . 0.0 109.487 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.06 -82.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.901 . . . . 0.0 109.481 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.425 ' O ' ' C ' ' A' ' 96' ' ' LEU . 9.4 pt-20 -44.1 -40.86 5.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.883 . . . . 0.0 109.446 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.626 HD12 ' HA ' ' A' ' 93' ' ' SER . 24.5 mt -44.09 -59.64 2.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -0.885 . . . . 0.0 109.47 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 163.87 47.54 0.02 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 99' ' ' LEU . . . -111.24 105.54 14.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -1.151 . . . . 0.0 109.471 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.905 HD22 ' CE1' ' A' ' 118' ' ' TYR . 20.4 mt -44.25 -63.45 0.88 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.256 -0.903 . . . . 0.0 109.426 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.729 HG22 HG23 ' A' ' 79' ' ' ILE . 14.5 t -146.44 -176.86 5.34 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.305 -0.872 . . . . 0.0 109.424 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.655 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 2.9 t-160 -148.77 68.54 1.07 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -0.886 . . . . 0.0 109.376 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.513 ' CZ ' HG21 ' A' ' 100' ' ' THR . 18.4 m-85 -65.39 160.68 21.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.214 -0.929 . . . . 0.0 109.447 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.839 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -126.72 -174.35 3.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.332 -0.855 . . . . 0.0 109.396 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.403 ' HA ' ' C ' ' A' ' 105' ' ' PRO . 3.7 pttt -102.34 144.92 29.56 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.257 -0.902 . . . . 0.0 109.36 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.403 ' C ' ' HA ' ' A' ' 104' ' ' LYS . 35.6 Cg_endo -77.79 133.9 32.21 Favored 'Cis proline' 0 C--N 1.31 -1.457 0 C-N-CA 123.303 -1.54 . . . . 0.0 110.407 -0.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -99.65 -176.64 3.33 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.159 -0.963 . . . . 0.0 109.488 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -127.94 123.32 34.6 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.213 -0.929 . . . . 0.0 109.464 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.77 HG21 HG21 ' A' ' 22' ' ' VAL . 16.2 mm -56.63 -22.42 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.232 -0.918 . . . . 0.0 109.476 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.423 ' O ' ' CG ' ' A' ' 113' ' ' ASP . 11.9 m-20 -72.66 -41.22 65.64 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.221 -0.924 . . . . 0.0 109.539 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.15 -31.38 70.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.203 -0.936 . . . . 0.0 109.461 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 23.0 mm -69.34 -59.16 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.31 -0.869 . . . . 0.0 109.438 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.418 ' O ' ' HG3' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -62.51 -22.84 66.59 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.2 -0.938 . . . . 0.0 109.467 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.423 ' CG ' ' O ' ' A' ' 109' ' ' ASP . 57.1 m-20 -70.79 -52.28 21.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.895 . . . . 0.0 109.412 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.407 ' O ' ' C ' ' A' ' 115' ' ' VAL . . . -66.1 -61.04 2.25 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.494 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.474 HG13 ' HG ' ' A' ' 50' ' ' LEU . 50.3 t -44.25 -47.94 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.246 -0.909 . . . . 0.0 109.437 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 0.0 OUTLIER -59.07 -43.71 91.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.287 -0.883 . . . . 0.0 109.475 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.47 -23.98 64.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.301 -0.875 . . . . 0.0 109.513 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.905 ' CE1' HD22 ' A' ' 99' ' ' LEU . 67.4 m-85 -80.87 -69.88 0.57 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.886 . . . . 0.0 109.516 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.443 HD12 ' HD2' ' A' ' 120' ' ' PRO . 38.3 tp -90.12 112.47 52.63 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.379 -0.826 . . . . 0.0 109.466 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.47 ' O ' HD23 ' A' ' 121' ' ' LEU . 35.8 Cg_endo -78.12 152.95 28.12 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.327 2.018 . . . . 0.0 110.381 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 1.074 HD11 ' CZ ' ' A' ' 28' ' ' TYR . 26.1 mt -116.83 -162.5 0.86 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.247 -0.908 . . . . 0.0 109.467 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.28 -72.86 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.279 -0.888 . . . . 0.0 109.519 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 5.4 t 175.45 157.01 0.19 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -0.914 . . . . 0.0 109.433 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.458 -179.961 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 ttm . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 7.6 mtm -125.58 46.76 2.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.345 -0.847 . . . . 0.0 109.422 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -109.23 21.11 17.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.244 -0.91 . . . . 0.0 109.471 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -163.91 62.53 0.16 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.228 -0.92 . . . . 0.0 109.436 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.511 ' HB2' ' HA ' ' A' ' 48' ' ' PRO . 42.7 mttm -127.71 138.53 52.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.318 -0.864 . . . . 0.0 109.444 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.653 HD12 ' HB3' ' A' ' 28' ' ' TYR . 74.3 mt -144.33 155.0 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.188 -0.945 . . . . 0.0 109.417 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.978 HD22 ' HB2' ' A' ' 31' ' ' PHE . 0.2 OUTLIER -132.26 119.39 20.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.214 -0.929 . . . . 0.0 109.556 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.694 ' N ' HD13 ' A' ' 7' ' ' LEU . 14.1 mt -99.78 102.21 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.248 -0.908 . . . . 0.0 109.447 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.624 HG21 ' CD1' ' A' ' 53' ' ' LEU . 4.9 t -90.02 91.55 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 109.546 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.52 ' O ' ' CD ' ' A' ' 16' ' ' ARG . 4.9 t70 -147.42 138.36 23.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.329 -0.857 . . . . 0.0 109.33 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.921 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . 8.9 p-10 -106.96 -35.81 6.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.891 . . . . 0.0 109.495 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.408 ' O ' ' C ' ' A' ' 13' ' ' TYR . 21.6 tt0 -67.35 106.32 2.04 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.271 -0.893 . . . . 0.0 109.374 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.551 ' CE2' HG13 ' A' ' 17' ' ' ILE . 30.4 t80 -43.32 149.34 0.25 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.357 -0.839 . . . . 0.0 109.6 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.79 -50.79 0.81 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.831 HG23 HD13 ' A' ' 19' ' ' LEU . 2.5 mt -80.69 -36.07 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.204 -1.174 . . . . 0.0 109.435 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.524 ' O ' ' CB ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -63.21 -30.1 71.31 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.129 -0.982 . . . . 0.0 109.433 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.604 ' N ' HD13 ' A' ' 17' ' ' ILE . 2.3 mm -90.84 -31.5 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.292 -0.88 . . . . 0.0 109.831 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.719 ' O ' HG23 ' A' ' 22' ' ' VAL . 8.3 mt -68.8 -60.23 2.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.103 -0.998 . . . . 0.0 109.351 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.831 HD13 HG23 ' A' ' 15' ' ' ILE . 7.3 mp -65.86 -18.03 65.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.318 -0.864 . . . . 0.0 108.789 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 16' ' ' ARG . 0.7 OUTLIER -70.2 -66.33 0.61 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.818 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.478 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 1.1 mm-40 -53.81 -44.2 69.98 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.337 -0.852 . . . . 0.0 109.575 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.805 HG21 ' CG2' ' A' ' 108' ' ' ILE . 46.8 t -54.6 -63.06 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.164 -0.96 . . . . 0.0 109.499 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.776 ' CB ' HG21 ' A' ' 30' ' ' THR . 25.8 m-85 -64.79 -10.62 29.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 0.0 109.54 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.478 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 0.5 OUTLIER -74.26 -60.23 2.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.256 -0.902 . . . . 0.0 109.477 179.919 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -67.59 -25.03 65.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.254 -0.903 . . . . 0.0 109.394 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.494 ' HB3' ' CD2' ' A' ' 28' ' ' TYR . 1.8 mt-10 -69.27 -34.77 75.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.442 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.479 ' O ' ' CG ' ' A' ' 28' ' ' TYR . . . 102.78 73.1 0.96 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.653 ' HB3' HD12 ' A' ' 6' ' ' ILE . 93.9 m-85 -156.71 144.45 19.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.213 -1.169 . . . . 0.0 109.576 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -89.85 83.24 6.17 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.246 -0.909 . . . . 0.0 109.252 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.776 HG21 ' CB ' ' A' ' 23' ' ' PHE . 5.8 p -89.93 137.95 31.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.28 -0.887 . . . . 0.0 109.566 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.978 ' HB2' HD22 ' A' ' 7' ' ' LEU . 42.4 m-85 -105.03 -172.08 2.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 109.345 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.462 ' HG2' ' CG ' ' A' ' 16' ' ' ARG . 54.4 mt-30 -136.88 147.09 46.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.143 -0.973 . . . . 0.0 109.548 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.712 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -164.91 -161.94 0.59 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.239 -0.913 . . . . 0.0 109.368 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.921 ' HB1' ' HB3' ' A' ' 11' ' ' ASP . . . 163.65 -53.72 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.281 -0.887 . . . . 0.0 109.352 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.423 ' HA ' ' HE1' ' A' ' 60' ' ' MET . 22.3 p-10 -60.13 -14.63 18.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.308 -0.87 . . . . 0.0 109.462 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.579 ' HA3' HD11 ' A' ' 65' ' ' ILE . . . 95.79 -45.39 1.99 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 mt -67.68 -30.84 70.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.257 -1.143 . . . . 0.0 109.496 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.902 ' O ' HD12 ' A' ' 42' ' ' ILE . 7.8 tp-100 -72.32 -43.72 63.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.235 -0.916 . . . . 0.0 109.461 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.629 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -63.36 -55.97 20.18 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.267 -0.896 . . . . 0.0 109.417 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.4 mt -51.98 -44.43 64.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.286 -0.884 . . . . 0.0 109.478 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.99 -49.73 72.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.277 -0.889 . . . . 0.0 109.465 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.902 HD12 ' O ' ' A' ' 38' ' ' GLN . 3.1 mt -66.7 -19.48 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -0.897 . . . . 0.0 109.469 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 39' ' ' ALA . 89.3 t -78.54 -32.35 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -0.892 . . . . 0.0 109.451 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 26.3 m -89.96 -19.44 24.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.205 -0.935 . . . . 0.0 109.494 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.01 -32.33 16.81 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.239 -0.913 . . . . 0.0 109.547 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.412 ' HA ' ' OE1' ' A' ' 46' ' ' GLU . 15.0 mm-40 -117.52 -33.36 4.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.281 -0.887 . . . . 0.0 109.569 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 4.4 ttp180 61.27 73.0 0.63 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.191 -0.943 . . . . 0.0 109.424 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.517 ' CD ' ' HA ' ' A' ' 43' ' ' VAL . 35.3 Cg_endo -78.12 -176.87 3.48 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.577 2.184 . . . . 0.0 110.405 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -127.44 -3.62 6.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.229 -0.919 . . . . 0.0 109.583 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.0 tp -136.93 125.17 23.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.203 -0.936 . . . . 0.0 109.52 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.766 HG21 ' SD ' ' A' ' 69' ' ' MET . 73.3 t -115.74 166.21 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.324 -0.86 . . . . 0.0 109.442 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.614 ' N ' HG12 ' A' ' 51' ' ' VAL . 1.1 mt -138.42 91.09 2.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.91 . . . . 0.0 109.585 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.624 ' CD1' HG21 ' A' ' 9' ' ' VAL . 3.1 mp -89.93 124.03 34.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.2 -0.938 . . . . 0.0 109.512 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.535 ' HB2' ' HE3' ' A' ' 81' ' ' MET . 28.1 t0 -100.06 -7.36 25.06 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.246 -0.909 . . . . 0.0 109.743 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 7.8 mmt 51.37 18.7 0.67 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.389 -0.819 . . . . 0.0 109.817 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.439 ' HG3' ' OD2' ' A' ' 54' ' ' ASP . 51.3 mmtt -90.95 -37.67 13.36 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.057 -1.027 . . . . 0.0 109.42 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.878 HG12 ' HB1' ' A' ' 34' ' ' ALA . 2.9 mt -42.82 114.41 1.51 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.388 -0.82 . . . . 0.0 109.593 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.489 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 34.9 Cg_endo -77.14 152.87 31.58 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.394 2.062 . . . . 0.0 110.27 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 108.87 -43.69 1.65 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.809 ' HE1' HG21 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -153.98 159.72 41.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.343 -1.092 . . . . 0.0 109.286 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -90.02 164.84 14.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.23 -0.919 . . . . 0.0 109.538 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.481 ' HA2' HG12 ' A' ' 65' ' ' ILE . . . -89.66 -9.0 66.99 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.883 HD11 ' HB2' ' A' ' 89' ' ' MET . 20.5 mm -46.85 -44.54 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.215 -1.168 . . . . 0.0 109.337 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -58.35 -42.01 85.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.336 -0.852 . . . . 0.0 109.338 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.579 HD11 ' HA3' ' A' ' 36' ' ' GLY . 15.6 mm -49.86 -50.26 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -0.926 . . . . 0.0 109.391 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 1.067 ' CD2' HG11 ' A' ' 78' ' ' VAL . 96.1 mt -58.36 -49.1 78.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.207 -0.933 . . . . 0.0 109.372 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.618 ' O ' HG23 ' A' ' 71' ' ' VAL . 12.5 mttp -44.28 -47.95 9.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.262 -0.899 . . . . 0.0 109.411 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.462 ' O ' HG12 ' A' ' 72' ' ' ILE . 1.9 mpt_? -66.1 -37.14 85.02 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.222 -0.924 . . . . 0.0 109.464 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.766 ' SD ' HG21 ' A' ' 51' ' ' VAL . 1.2 mmt -62.44 -22.91 66.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.251 -0.906 . . . . 0.0 109.438 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 66' ' ' LEU . 13.5 mmtt -84.92 -43.76 13.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.228 -0.92 . . . . 0.0 109.43 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 67' ' ' LYS . 2.6 t -63.87 -27.69 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.327 -0.858 . . . . 0.0 109.465 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.462 HG12 ' O ' ' A' ' 68' ' ' ARG . 28.6 mm -89.95 -56.37 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.246 -0.909 . . . . 0.0 109.486 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.438 ' O ' ' O ' ' A' ' 69' ' ' MET . 2.6 m-20 -126.25 134.64 51.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.305 -0.872 . . . . 0.0 109.471 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -89.18 -15.97 32.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.268 -0.895 . . . . 0.0 109.482 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -114.76 55.49 0.75 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.176 -0.952 . . . . 0.0 109.46 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.423 ' O ' HG23 ' A' ' 76' ' ' ILE . 0.8 OUTLIER -110.94 118.0 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.305 -0.872 . . . . 0.0 109.481 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.527 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 0.4 OUTLIER -75.68 144.13 41.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.894 . . . . 0.0 109.48 -179.999 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 1.067 HG11 ' CD2' ' A' ' 66' ' ' LEU . 13.6 t -143.93 107.95 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.343 -0.848 . . . . 0.0 109.495 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.529 HG23 ' O ' ' A' ' 100' ' ' THR . 68.0 mt -90.28 139.32 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.247 -0.908 . . . . 0.0 109.425 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.814 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.0 OUTLIER -108.36 167.02 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.278 -0.889 . . . . 0.0 109.297 179.915 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.535 ' HE3' ' HB2' ' A' ' 54' ' ' ASP . 7.2 mtm -146.59 95.0 2.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.154 -0.967 . . . . 0.0 109.588 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.975 HG22 ' NE2' ' A' ' 101' ' ' HIS . 11.6 t 177.8 38.37 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.213 -0.929 . . . . 0.0 109.35 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.7 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . -90.04 45.42 1.27 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.352 -0.842 . . . . 0.0 109.477 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.49 ' CE2' ' O ' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -84.55 12.22 7.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.265 -0.897 . . . . 0.0 109.415 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 133.55 73.43 0.09 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -179.0 135.63 0.13 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -1.166 . . . . 0.0 109.51 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.563 ' HA ' HG23 ' A' ' 90' ' ' ILE . 1.1 mt -133.92 46.01 2.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.355 -0.841 . . . . 0.0 109.4 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -103.65 -95.84 0.31 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.164 -0.96 . . . . 0.0 109.394 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.883 ' HB2' HD11 ' A' ' 63' ' ' ILE . 13.1 ptt? -52.74 -23.02 5.96 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.032 -1.043 . . . . 0.0 109.16 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.563 HG23 ' HA ' ' A' ' 87' ' ' LEU . 0.8 OUTLIER -77.93 -39.08 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.404 -0.81 . . . . 0.0 109.16 179.787 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.483 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 26.5 tp60 -61.06 -49.35 77.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -0.882 . . . . 0.0 109.4 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.448 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -77.54 -22.41 51.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.897 . . . . 0.0 109.295 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.49 ' HB2' ' HA ' ' A' ' 90' ' ' ILE . 0.6 OUTLIER -59.86 -68.8 0.25 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.258 -0.901 . . . . 0.0 109.358 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.854 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 24.0 tptt -44.04 -53.58 6.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.332 -0.855 . . . . 0.0 109.312 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 94' ' ' LYS . 36.3 tp10 -43.46 -51.5 6.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.365 -0.835 . . . . 0.0 109.461 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 92' ' ' GLU . 23.8 mt -58.11 -50.9 71.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.262 -0.899 . . . . 0.0 109.522 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 163.25 41.15 0.02 OUTLIER Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.854 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -93.52 107.23 19.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.295 -1.121 . . . . 0.0 109.368 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.527 ' CD1' ' HB3' ' A' ' 77' ' ' ARG . 22.0 mt -44.03 -87.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.261 -0.899 . . . . 0.0 109.518 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.529 ' O ' HG23 ' A' ' 79' ' ' ILE . 4.0 t -127.95 160.93 30.35 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.918 . . . . 0.0 109.517 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.975 ' NE2' HG22 ' A' ' 82' ' ' THR . 6.3 t-160 -125.21 95.32 4.44 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.255 -0.903 . . . . 0.0 109.581 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.66 ' CD2' HD13 ' A' ' 111' ' ' ILE . 18.8 m-85 -69.51 -168.45 0.17 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.29 -0.881 . . . . 0.0 109.419 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.7 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -162.81 -165.85 1.21 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.201 -0.937 . . . . 0.0 109.402 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.538 ' HG3' ' CE1' ' A' ' 106' ' ' PHE . 16.9 mtpt -129.2 145.37 56.44 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.225 -0.922 . . . . 0.0 109.459 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.9 151.66 91.38 Favored 'Cis proline' 0 C--N 1.31 -1.476 0 C-N-CA 123.302 -1.541 . . . . 0.0 110.381 -0.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.547 ' CD1' ' N ' ' A' ' 106' ' ' PHE . 4.9 p90 -133.63 169.32 17.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.183 -0.948 . . . . 0.0 109.486 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.413 ' HB3' ' OE1' ' A' ' 110' ' ' GLU . 42.7 t0 -103.16 116.71 33.0 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.208 -0.933 . . . . 0.0 109.501 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.805 ' CG2' HG21 ' A' ' 22' ' ' VAL . 12.9 mm -50.23 -29.72 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.279 -0.888 . . . . 0.0 109.38 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.453 ' HA ' ' HD3' ' A' ' 112' ' ' ARG . 52.0 m-20 -66.26 -44.0 84.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.204 -0.935 . . . . 0.0 109.383 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 113' ' ' ASP . 2.2 mp0 -64.46 -46.92 81.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 109.505 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.66 HD13 ' CD2' ' A' ' 102' ' ' PHE . 22.6 mm -52.27 -62.28 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.317 -0.864 . . . . 0.0 109.533 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.456 ' HG2' ' O ' ' A' ' 108' ' ' ILE . 0.6 OUTLIER -52.23 -38.45 58.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.55 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 110' ' ' GLU . 88.3 m-20 -53.52 -63.21 1.22 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 109.494 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.44 ' HA ' ' HG3' ' A' ' 117' ' ' LYS . . . -52.08 -55.67 19.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.912 . . . . 0.0 109.518 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.41 ' C ' ' O ' ' A' ' 114' ' ' ALA . 50.7 t -43.96 -35.04 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.261 -0.899 . . . . 0.0 109.477 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.45 ' HE3' ' OE2' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -73.93 -42.2 60.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.282 -0.886 . . . . 0.0 109.467 179.952 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.44 ' HG3' ' HA ' ' A' ' 114' ' ' ALA . 4.0 mttt -62.4 -21.57 65.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 109.449 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.46 ' O ' ' HD3' ' A' ' 120' ' ' PRO . 61.2 m-85 -88.55 -70.8 0.62 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.287 -0.883 . . . . 0.0 109.499 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 21.1 tp -90.04 112.48 52.61 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.365 -0.835 . . . . 0.0 109.448 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 118' ' ' TYR . 35.5 Cg_endo -78.04 133.0 12.02 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.393 2.062 . . . . 0.0 110.382 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 121' ' ' LEU . 0.7 OUTLIER -135.66 13.91 3.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 109.427 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.67 145.85 14.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.285 -0.885 . . . . 0.0 109.439 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 2.3 t 67.69 109.01 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.44 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.514 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.287 0.565 . . . . 0.0 109.476 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 2.9 mtp -148.3 169.22 20.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.906 . . . . 0.0 109.435 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.543 ' HB3' ' CE ' ' A' ' 5' ' ' LYS . 1.1 t-20 -75.69 -148.87 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.199 -0.938 . . . . 0.0 109.455 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.732 ' OE1' HD23 ' A' ' 121' ' ' LEU . 3.9 mt-10 -130.64 106.56 8.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.226 -0.921 . . . . 0.0 109.497 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.543 ' CE ' ' HB3' ' A' ' 3' ' ' ASN . 0.8 OUTLIER -134.42 134.46 41.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.287 -0.883 . . . . 0.0 109.426 179.934 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.824 ' HB ' HG22 ' A' ' 30' ' ' THR . 98.0 mt -128.85 161.27 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.3 -0.875 . . . . 0.0 109.486 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.768 ' HB3' HG13 ' A' ' 51' ' ' VAL . 2.1 tm? -132.51 114.97 14.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.551 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.838 HG22 ' OD2' ' A' ' 10' ' ' ASP . 3.2 mt -104.36 105.03 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.924 . . . . 0.0 109.552 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.773 ' HA ' ' HB3' ' A' ' 33' ' ' ALA . 35.9 t -90.49 90.0 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.874 . . . . 0.0 109.464 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.838 ' OD2' HG22 ' A' ' 8' ' ' ILE . 69.1 m-20 -127.37 128.79 46.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.202 -0.936 . . . . 0.0 109.434 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.5 ' OD2' ' HD2' ' A' ' 58' ' ' PRO . 6.7 p-10 -100.21 -23.69 14.76 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.289 -0.882 . . . . 0.0 109.241 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.421 ' O ' ' C ' ' A' ' 13' ' ' TYR . 9.7 tp-100 -84.41 105.78 15.5 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.362 -0.836 . . . . 0.0 109.558 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.677 ' CE2' HD11 ' A' ' 17' ' ' ILE . 1.5 t80 -42.53 155.37 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.402 -0.811 . . . . 0.0 109.325 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.516 ' N ' ' CD1' ' A' ' 13' ' ' TYR . . . 109.33 -55.53 0.5 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.904 HG23 HD13 ' A' ' 19' ' ' LEU . 2.1 mt -76.13 -60.28 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.329 -1.101 . . . . 0.0 109.268 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.472 ' HD2' ' O ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -41.16 -30.91 0.17 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.48 -0.762 . . . . 0.0 110.042 -179.869 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.677 HD11 ' CE2' ' A' ' 13' ' ' TYR . 1.3 mt -90.42 -35.66 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.135 -0.978 . . . . 0.0 109.973 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.783 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.4 OUTLIER -65.44 -59.81 3.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.239 -0.913 . . . . 0.0 109.758 -179.625 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.904 HD13 HG23 ' A' ' 15' ' ' ILE . 7.2 mp -64.32 -20.97 66.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.198 -0.939 . . . . 0.0 109.639 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.472 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 10.9 t30 -70.65 -62.56 1.34 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 109.514 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.461 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 34.9 mt-10 -56.46 -44.37 80.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.265 -0.897 . . . . 0.0 109.55 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.783 HG23 ' O ' ' A' ' 18' ' ' LEU . 41.2 t -55.13 -61.73 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.236 -0.915 . . . . 0.0 109.491 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.863 ' CZ ' HG21 ' A' ' 115' ' ' VAL . 20.9 m-85 -65.56 -11.5 44.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.348 -0.845 . . . . 0.0 109.479 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.461 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 0.5 OUTLIER -73.52 -60.07 2.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.335 -0.853 . . . . 0.0 109.483 179.937 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.1 tttp -74.07 -11.3 60.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.453 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.484 ' HB2' ' HA ' ' A' ' 23' ' ' PHE . 0.7 OUTLIER -76.14 -31.57 58.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -0.935 . . . . 0.0 109.49 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.88 41.89 0.82 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.485 ' HB3' HD12 ' A' ' 6' ' ' ILE . 85.2 m-85 -141.56 134.93 29.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.256 -1.144 . . . . 0.0 109.592 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -93.96 82.21 4.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.234 -0.916 . . . . 0.0 109.07 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.824 HG22 ' HB ' ' A' ' 6' ' ' ILE . 5.5 p -89.79 149.07 22.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.27 -0.894 . . . . 0.0 109.881 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.612 ' HB2' HD22 ' A' ' 7' ' ' LEU . 31.6 m-85 -109.01 -167.23 1.19 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 109.052 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.428 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 15.5 mp0 -133.19 157.09 46.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.161 -0.962 . . . . 0.0 109.821 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.773 ' HB3' ' HA ' ' A' ' 9' ' ' VAL . . . -157.77 176.94 11.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.414 -0.804 . . . . 0.0 109.283 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.522 ' O ' HD13 ' A' ' 57' ' ' ILE . . . -173.35 -44.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.125 -0.985 . . . . 0.0 109.693 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.418 ' C ' ' SD ' ' A' ' 60' ' ' MET . 2.4 p30 -82.25 -1.8 50.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.214 -0.929 . . . . 0.0 109.607 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.461 ' HA3' ' SD ' ' A' ' 60' ' ' MET . . . 85.7 -48.69 4.03 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.477 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 1.1 mp -52.54 -44.79 66.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -1.149 . . . . 0.0 109.511 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.851 ' O ' HD12 ' A' ' 42' ' ' ILE . 1.0 OUTLIER -68.19 -27.71 66.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.217 -0.927 . . . . 0.0 109.481 179.939 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.778 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -71.56 -69.45 0.38 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.202 -0.936 . . . . 0.0 109.548 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -51.77 -47.17 64.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.228 -0.92 . . . . 0.0 109.6 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.477 ' HB2' ' O ' ' A' ' 37' ' ' LEU . 16.0 t0 -54.08 -52.59 60.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.308 -0.87 . . . . 0.0 109.55 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.851 HD12 ' O ' ' A' ' 38' ' ' GLN . 20.4 mt -61.7 -22.92 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.257 -0.902 . . . . 0.0 109.424 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.778 HG23 ' O ' ' A' ' 39' ' ' ALA . 54.1 t -78.29 -25.28 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.182 -0.949 . . . . 0.0 109.457 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.1 m -90.13 -25.29 20.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.308 -0.87 . . . . 0.0 109.525 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.523 ' CD ' ' HA ' ' A' ' 42' ' ' ILE . 3.8 ptmt -90.07 -27.13 19.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.574 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.538 ' OE2' ' CZ ' ' A' ' 31' ' ' PHE . 3.2 mt-10 -118.6 -26.66 6.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.23 -0.919 . . . . 0.0 109.471 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.502 ' HG3' ' O ' ' A' ' 46' ' ' GLU . 7.4 ptm180 38.55 72.12 0.98 Allowed Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.598 -0.689 . . . . 0.0 109.969 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.503 ' CB ' ' O ' ' A' ' 5' ' ' LYS . 34.7 Cg_endo -77.19 -171.51 1.18 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.619 2.213 . . . . 0.0 110.343 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 5.7 m-20 -117.6 -8.3 10.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.139 -0.975 . . . . 0.0 109.556 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.456 HD21 HG22 ' A' ' 115' ' ' VAL . 7.2 tp -131.57 117.34 18.6 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.286 -0.884 . . . . 0.0 109.54 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 1.06 HG11 ' CE ' ' A' ' 69' ' ' MET . 2.9 t -121.35 158.75 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.233 -0.917 . . . . 0.0 109.408 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.2 mp -135.3 115.68 13.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -0.935 . . . . 0.0 109.516 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.857 HD22 ' N ' ' A' ' 53' ' ' LEU . 0.8 OUTLIER -102.19 126.45 49.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.355 -0.841 . . . . 0.0 109.419 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 81' ' ' MET . 31.9 t0 -106.49 106.6 17.19 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.917 . . . . 0.0 109.466 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.711 ' CG ' HG21 ' A' ' 82' ' ' THR . 16.0 mmt -59.78 -14.95 16.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.332 -0.855 . . . . 0.0 109.462 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.458 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 4.2 mmpt? -52.88 -37.18 60.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 109.502 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.751 ' CD1' ' HE1' ' A' ' 60' ' ' MET . 43.8 mt -41.14 101.15 0.24 Allowed Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.443 -0.786 . . . . 0.0 109.691 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.5 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 36.2 Cg_endo -79.15 -29.53 3.14 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.512 2.141 . . . . 0.0 110.51 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -84.45 -3.91 88.19 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.751 ' HE1' ' CD1' ' A' ' 57' ' ' ILE . 10.3 ttp -156.96 141.03 16.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.103 -1.234 . . . . 0.0 109.607 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.477 ' N ' ' HG2' ' A' ' 60' ' ' MET . 15.3 m-20 -89.99 126.82 35.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.31 -0.869 . . . . 0.0 109.431 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.518 ' HA2' ' CG1' ' A' ' 65' ' ' ILE . . . -82.96 9.16 60.92 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' ' 63' ' ' ILE . 13.0 mm -70.8 -44.69 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.249 -1.148 . . . . 0.0 109.396 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -71.91 -12.89 61.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -0.905 . . . . 0.0 109.404 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.523 ' O ' ' CG ' ' A' ' 69' ' ' MET . 13.6 mm -73.49 -58.36 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.189 -0.944 . . . . 0.0 109.49 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.751 HD21 ' HB ' ' A' ' 78' ' ' VAL . 6.3 mt -53.25 -28.42 27.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -0.916 . . . . 0.0 109.465 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.505 ' O ' ' CG ' ' A' ' 70' ' ' LYS . 5.7 mmtm -72.65 -70.28 0.36 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.189 -0.945 . . . . 0.0 109.451 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.467 ' O ' HG12 ' A' ' 72' ' ' ILE . 0.6 OUTLIER -45.25 -25.83 0.42 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.265 -0.897 . . . . 0.0 109.418 -179.938 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 1.06 ' CE ' HG11 ' A' ' 51' ' ' VAL . 2.9 mmm -72.78 -48.9 34.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.187 -0.946 . . . . 0.0 109.456 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.505 ' CG ' ' O ' ' A' ' 67' ' ' LYS . 16.3 ptpt -63.18 -21.77 66.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.262 -0.899 . . . . 0.0 109.51 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.1 t -80.1 -45.62 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.251 -0.905 . . . . 0.0 109.517 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 68' ' ' ARG . 24.1 mm -76.21 -14.64 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.215 -0.928 . . . . 0.0 109.525 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.402 ' O ' HG22 ' A' ' 76' ' ' ILE . 1.2 m-20 -170.06 117.62 0.56 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.221 -0.924 . . . . 0.0 109.514 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.418 ' HG3' ' N ' ' A' ' 75' ' ' ASN . 0.1 OUTLIER -90.13 -18.83 25.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.186 -0.946 . . . . 0.0 109.417 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.418 ' N ' ' HG3' ' A' ' 74' ' ' GLU . 17.3 m120 -101.2 48.85 0.88 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.295 -0.878 . . . . 0.0 109.456 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.485 ' O ' HG23 ' A' ' 76' ' ' ILE . 0.3 OUTLIER -121.9 116.96 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.275 -0.891 . . . . 0.0 109.518 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.536 ' CA ' HD11 ' A' ' 99' ' ' LEU . 7.7 mtt85 -54.02 130.73 38.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 109.417 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.751 ' HB ' HD21 ' A' ' 66' ' ' LEU . 0.2 OUTLIER -132.08 117.86 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.213 -0.929 . . . . 0.0 109.63 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.556 HG23 ' O ' ' A' ' 100' ' ' THR . 66.9 mt -114.69 144.05 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.261 -0.899 . . . . 0.0 109.394 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 1.017 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.1 OUTLIER -108.63 158.88 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.235 -0.916 . . . . 0.0 109.418 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.469 ' O ' ' HB ' ' A' ' 82' ' ' THR . 14.2 mtm -136.83 91.92 2.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.135 -0.978 . . . . 0.0 109.644 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.924 HG22 ' NE2' ' A' ' 101' ' ' HIS . 11.4 t 176.69 38.65 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.377 -0.827 . . . . 0.0 109.331 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.95 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . -89.33 43.81 1.17 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.338 -0.851 . . . . 0.0 109.571 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -88.82 81.76 6.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.206 -0.934 . . . . 0.0 109.501 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 55.25 66.66 2.67 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.415 ' CD ' ' O ' ' A' ' 82' ' ' THR . 0.6 OUTLIER -174.18 87.23 0.05 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.247 -1.149 . . . . 0.0 109.504 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.542 ' HA ' ' CG2' ' A' ' 90' ' ' ILE . 7.4 mp -103.6 69.7 0.99 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 109.447 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 89' ' ' MET . 4.7 t70 -105.48 -87.52 0.45 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.906 . . . . 0.0 109.577 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.51 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 0.3 OUTLIER -78.95 3.97 15.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.252 -0.905 . . . . 0.0 109.523 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.542 ' CG2' ' HA ' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -90.41 -50.43 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.257 -0.902 . . . . 0.0 108.966 179.716 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.71 -38.25 14.81 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.193 -0.942 . . . . 0.0 109.452 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.14 -44.82 9.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.915 . . . . 0.0 109.639 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 1.006 ' HA ' HD12 ' A' ' 96' ' ' LEU . 2.7 m -45.05 -26.88 0.49 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.171 -0.955 . . . . 0.0 109.69 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.841 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 0.8 OUTLIER -60.64 -63.45 1.29 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.18 -0.95 . . . . 0.0 109.518 -179.93 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.414 ' HG3' ' N ' ' A' ' 96' ' ' LEU . 7.1 pt-20 -61.45 -27.03 68.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.277 -0.89 . . . . 0.0 109.512 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 1.006 HD12 ' HA ' ' A' ' 93' ' ' SER . 36.2 mt -67.49 -33.73 75.71 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.205 -0.935 . . . . 0.0 109.5 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.558 ' O ' HG21 ' A' ' 78' ' ' VAL . . . 156.16 69.9 0.01 OUTLIER Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.841 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -158.01 110.03 2.31 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.273 -1.133 . . . . 0.0 109.382 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.536 HD11 ' CA ' ' A' ' 77' ' ' ARG . 0.4 OUTLIER -60.24 -67.58 0.38 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.289 -0.882 . . . . 0.0 109.436 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.556 ' O ' HG23 ' A' ' 79' ' ' ILE . 10.7 t -131.66 160.39 35.56 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.214 -0.928 . . . . 0.0 109.406 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 1.017 ' ND1' HD12 ' A' ' 80' ' ' ILE . 5.4 t-160 -124.92 94.79 4.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -0.892 . . . . 0.0 109.458 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.412 ' HZ ' ' HB2' ' A' ' 114' ' ' ALA . 38.8 m-85 -63.62 -179.0 0.32 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.238 -0.914 . . . . 0.0 109.5 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.95 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -171.08 -157.94 0.14 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.291 -0.881 . . . . 0.0 109.337 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.448 ' HG3' ' HA ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -98.9 143.03 25.63 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.188 -0.945 . . . . 0.0 109.454 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.448 ' HA ' ' HG3' ' A' ' 104' ' ' LYS . 35.6 Cg_endo -77.98 164.75 84.92 Favored 'Cis proline' 0 C--N 1.31 -1.487 0 C-N-CA 123.277 -1.551 . . . . 0.0 110.37 -0.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.727 ' CE2' HD12 ' A' ' 111' ' ' ILE . 0.2 OUTLIER -96.18 107.68 20.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.29 -0.881 . . . . 0.0 109.502 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.478 ' O ' HG12 ' A' ' 111' ' ' ILE . 23.1 t0 -89.83 103.87 16.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.258 -0.901 . . . . 0.0 109.384 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.683 HD12 HG21 ' A' ' 22' ' ' VAL . 15.8 mm -46.21 -24.35 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 109.863 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.456 ' O ' ' OD2' ' A' ' 113' ' ' ASP . 22.4 m-20 -73.6 -45.22 54.39 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.203 -0.936 . . . . 0.0 109.789 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.92 -24.37 61.62 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.112 -0.993 . . . . 0.0 109.706 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.727 HD12 ' CE2' ' A' ' 106' ' ' PHE . 10.6 mm -76.26 -53.08 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.218 -0.926 . . . . 0.0 109.438 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.459 ' O ' ' HG3' ' A' ' 116' ' ' LYS . 0.9 OUTLIER -64.24 -37.39 87.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.319 -0.863 . . . . 0.0 109.588 -179.867 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.456 ' OD2' ' O ' ' A' ' 109' ' ' ASP . 16.6 m-20 -63.65 -60.13 3.72 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.203 -0.936 . . . . 0.0 109.6 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.412 ' HB2' ' HZ ' ' A' ' 102' ' ' PHE . . . -46.58 -51.06 16.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.925 . . . . 0.0 109.618 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.863 HG21 ' CZ ' ' A' ' 23' ' ' PHE . 47.9 t -52.57 -49.98 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.889 . . . . 0.0 109.597 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 0.4 OUTLIER -58.42 -29.68 66.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.902 . . . . 0.0 109.553 -179.867 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.7 tttm -76.89 -27.36 54.94 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.201 -0.937 . . . . 0.0 109.42 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.492 ' O ' ' HD3' ' A' ' 120' ' ' PRO . 40.3 m-85 -90.05 -75.07 0.46 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.254 -0.904 . . . . 0.0 109.497 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.417 HD23 ' O ' ' A' ' 120' ' ' PRO . 5.3 tt -90.54 111.87 49.89 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.261 -0.899 . . . . 0.0 109.627 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 118' ' ' TYR . 36.2 Cg_endo -79.53 154.83 24.26 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.442 2.094 . . . . 0.0 110.355 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.732 HD23 ' OE1' ' A' ' 4' ' ' GLU . 21.4 mt -91.81 -115.61 0.08 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.298 -0.876 . . . . 0.0 109.205 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 123' ' ' SER . 0.0 OUTLIER -127.59 131.98 49.87 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.884 -1.135 . . . . 0.0 109.615 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 122' ' ' LYS . 0.0 OUTLIER 57.64 112.04 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 109.563 179.879 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.476 179.94 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.301 0.572 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.59 132.32 38.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.208 -0.933 . . . . 0.0 109.512 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.461 ' O ' ' OE2' ' A' ' 4' ' ' GLU . 1.2 p-10 -120.15 63.9 0.83 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.267 -0.896 . . . . 0.0 109.467 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.522 ' CD ' HD21 ' A' ' 121' ' ' LEU . 0.7 OUTLIER -138.37 55.19 1.75 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.188 -0.945 . . . . 0.0 109.445 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.488 ' O ' ' CB ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -127.53 111.15 13.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.294 -0.879 . . . . 0.0 109.454 179.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.687 HD12 HG22 ' A' ' 30' ' ' THR . 16.2 mt -126.93 158.29 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.255 -0.903 . . . . 0.0 109.496 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.879 HD13 ' N ' ' A' ' 8' ' ' ILE . 2.6 tm? -132.51 128.97 38.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.231 -0.918 . . . . 0.0 109.469 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.879 ' N ' HD13 ' A' ' 7' ' ' LEU . 9.1 mt -106.44 104.64 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.239 -0.913 . . . . 0.0 109.466 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.494 ' CG2' HD12 ' A' ' 7' ' ' LEU . 3.9 t -89.97 70.78 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.292 -0.88 . . . . 0.0 109.463 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.561 ' O ' ' HB2' ' A' ' 34' ' ' ALA . 0.4 OUTLIER -123.22 148.94 45.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.892 . . . . 0.0 109.502 179.935 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.549 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . 5.5 p-10 -115.8 -40.16 3.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.248 -0.907 . . . . 0.0 109.457 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.94 111.93 2.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.0 109.505 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.581 ' CZ ' HG13 ' A' ' 17' ' ' ILE . 46.6 t80 -49.26 128.84 17.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.212 -0.93 . . . . 0.0 109.477 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.52 ' O ' HD12 ' A' ' 18' ' ' LEU . . . 138.23 -43.93 1.15 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.784 HG23 HD13 ' A' ' 19' ' ' LEU . 6.4 mt -84.26 -39.74 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -1.135 . . . . 0.0 109.392 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.515 ' CD ' ' O ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -65.93 -26.57 67.66 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.207 -0.933 . . . . 0.0 109.453 -179.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.581 HG13 ' CZ ' ' A' ' 13' ' ' TYR . 4.8 mm -90.65 -42.61 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.261 -0.9 . . . . 0.0 109.787 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.789 ' O ' HG23 ' A' ' 22' ' ' VAL . 55.2 mt -64.65 -57.76 8.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.145 -0.972 . . . . 0.0 109.852 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.784 HD13 HG23 ' A' ' 15' ' ' ILE . 7.9 mp -60.23 -26.37 66.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.243 -0.91 . . . . 0.0 109.743 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 30.2 t30 -67.87 -55.2 13.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 109.59 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.489 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 33.4 mt-10 -59.74 -44.71 93.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.265 -0.897 . . . . 0.0 109.723 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.789 HG23 ' O ' ' A' ' 18' ' ' LEU . 13.7 t -55.92 -62.22 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 109.729 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.759 ' CZ ' HG21 ' A' ' 115' ' ' VAL . 17.0 m-85 -68.4 -10.16 53.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.915 . . . . 0.0 109.592 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.489 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 0.4 OUTLIER -70.84 -52.06 22.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.191 -0.943 . . . . 0.0 109.386 179.863 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -74.55 -11.71 60.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.238 -0.914 . . . . 0.0 109.311 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.557 ' HB3' ' CD2' ' A' ' 28' ' ' TYR . 3.5 mt-10 -78.61 -33.61 47.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.294 -0.879 . . . . 0.0 109.474 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.476 ' O ' ' HG2' ' A' ' 4' ' ' GLU . . . 105.56 54.08 0.75 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.725 ' CE1' HD23 ' A' ' 119' ' ' LEU . 88.5 m-85 -138.07 143.53 40.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.168 -1.195 . . . . 0.0 109.525 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.425 ' HB2' ' O ' ' A' ' 4' ' ' GLU . 92.8 mm-40 -94.23 81.51 4.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.91 . . . . 0.0 109.394 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.687 HG22 HD12 ' A' ' 6' ' ' ILE . 5.8 p -89.88 148.34 23.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.906 . . . . 0.0 109.53 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.541 ' HB2' ' CD2' ' A' ' 7' ' ' LEU . 8.5 m-85 -114.84 -172.74 2.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.274 -0.892 . . . . 0.0 109.409 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -123.28 151.35 42.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.282 -0.886 . . . . 0.0 109.529 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.608 ' HB3' HD11 ' A' ' 7' ' ' LEU . . . -174.48 172.4 3.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.313 -0.867 . . . . 0.0 109.414 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.561 ' HB2' ' O ' ' A' ' 10' ' ' ASP . . . 177.67 -31.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.182 -0.949 . . . . 0.0 109.533 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.415 ' ND2' ' H ' ' A' ' 35' ' ' ASN . 2.6 p30 -74.77 -0.91 19.79 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.171 -0.955 . . . . 0.0 109.619 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.05 -45.2 3.48 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.29 -54.79 31.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.158 -1.201 . . . . 0.0 109.514 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.605 ' HG2' HD11 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -71.24 -15.37 62.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.911 . . . . 0.0 109.617 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.814 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -70.6 -60.66 2.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.205 -0.935 . . . . 0.0 109.536 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.511 ' CD2' ' HB3' ' A' ' 68' ' ' ARG . 0.7 OUTLIER -69.85 -38.66 76.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.247 -0.908 . . . . 0.0 109.55 -179.974 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.461 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 14.8 m-20 -61.43 -60.79 3.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.332 -0.855 . . . . 0.0 109.547 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.785 HG21 HD23 ' A' ' 7' ' ' LEU . 41.5 mt -56.97 -31.05 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.248 -0.908 . . . . 0.0 109.513 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.814 HG23 ' O ' ' A' ' 39' ' ' ALA . 44.0 t -68.84 -31.69 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.204 -0.935 . . . . 0.0 109.485 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 79.8 m -90.02 -14.5 33.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.214 -0.929 . . . . 0.0 109.474 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 3.7 mmtt -84.61 -58.48 2.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.891 . . . . 0.0 109.545 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 47' ' ' ARG . 2.4 mm-40 -89.97 -25.38 20.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 109.628 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.507 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 6.5 mmm180 63.48 62.8 1.61 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.182 -0.949 . . . . 0.0 109.436 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.507 ' HD3' ' N ' ' A' ' 47' ' ' ARG . 35.3 Cg_endo -77.69 158.18 31.84 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.603 2.202 . . . . 0.0 110.49 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.405 ' HB2' ' CD1' ' A' ' 119' ' ' LEU . 4.4 m-20 -100.04 -10.9 21.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.246 -0.909 . . . . 0.0 109.508 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.695 HD23 ' HB2' ' A' ' 119' ' ' LEU . 1.7 mm? -116.62 122.89 45.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.221 -0.924 . . . . 0.0 109.499 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.887 HG11 ' CE ' ' A' ' 69' ' ' MET . 9.0 t -123.91 113.06 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.902 . . . . 0.0 109.529 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.633 HD12 ' O ' ' A' ' 7' ' ' LEU . 1.0 OUTLIER -90.75 120.31 31.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.883 . . . . 0.0 109.419 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.673 HD21 ' HB ' ' A' ' 65' ' ' ILE . 1.1 tp -110.75 121.98 46.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.337 -0.852 . . . . 0.0 109.534 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.471 ' OD2' ' HB2' ' A' ' 56' ' ' LYS . 8.9 t0 -104.45 109.14 20.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 0.0 109.366 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.45 ' HB2' ' HB ' ' A' ' 82' ' ' THR . 6.6 mmt -67.18 -9.59 41.7 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.144 -0.972 . . . . 0.0 109.512 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.471 ' HB2' ' OD2' ' A' ' 54' ' ' ASP . 6.3 mmtt -74.92 -19.13 60.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 0.0 109.383 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.668 HG21 ' HE2' ' A' ' 60' ' ' MET . 81.0 mt -43.11 103.15 0.3 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.324 -0.86 . . . . 0.0 109.519 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.44 ' HD2' ' CG ' ' A' ' 11' ' ' ASP . 35.5 Cg_endo -77.55 108.76 2.64 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.412 2.075 . . . . 0.0 110.421 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 128.93 -33.76 3.0 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.668 ' HE2' HG21 ' A' ' 57' ' ' ILE . 0.6 OUTLIER -138.82 133.34 31.94 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.276 -1.132 . . . . 0.0 109.458 -179.962 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.418 ' O ' ' HE3' ' A' ' 60' ' ' MET . 4.3 m-20 -83.52 157.94 22.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.161 -0.962 . . . . 0.0 109.477 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.526 ' HA2' ' CD1' ' A' ' 65' ' ' ILE . . . -102.89 9.17 55.0 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.7 mm -70.37 -57.68 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -1.191 . . . . 0.0 109.447 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -58.59 -29.13 66.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 0.0 109.432 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.673 ' HB ' HD21 ' A' ' 53' ' ' LEU . 10.1 mt -59.23 -52.15 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.277 -0.889 . . . . 0.0 109.412 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.777 ' CD2' HG11 ' A' ' 78' ' ' VAL . 25.8 mt -53.87 -51.5 63.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.357 -0.84 . . . . 0.0 109.486 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.522 ' O ' HG23 ' A' ' 71' ' ' VAL . 1.3 tttt -46.81 -49.39 20.03 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.262 -0.899 . . . . 0.0 109.483 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.511 ' HB3' ' CD2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -57.93 -38.54 76.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.278 -0.889 . . . . 0.0 109.463 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.887 ' CE ' HG11 ' A' ' 51' ' ' VAL . 7.0 mtt -67.94 -25.31 65.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 0.0 109.465 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 66' ' ' LEU . 0.8 OUTLIER -78.88 -30.32 44.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.271 -0.893 . . . . 0.0 109.452 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 67' ' ' LYS . 3.6 t -84.9 -20.85 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.274 -0.891 . . . . 0.0 109.435 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 68' ' ' ARG . 91.4 mt -89.92 -34.97 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -0.879 . . . . 0.0 109.432 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -166.31 134.05 2.77 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.261 -0.899 . . . . 0.0 109.433 -179.927 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -89.72 -10.48 45.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.514 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -103.23 12.45 35.6 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.226 -0.921 . . . . 0.0 109.552 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.632 ' O ' HG23 ' A' ' 76' ' ' ILE . 1.0 OUTLIER -78.62 115.26 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.262 -0.899 . . . . 0.0 109.496 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.792 ' HB3' HD11 ' A' ' 99' ' ' LEU . 59.0 mtt85 -69.85 126.97 31.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 109.513 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.777 HG11 ' CD2' ' A' ' 66' ' ' LEU . 2.9 t -133.23 110.44 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.269 -0.894 . . . . 0.0 109.458 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.547 HG22 ' N ' ' A' ' 80' ' ' ILE . 75.5 mt -92.59 165.02 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 109.384 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 1.016 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.3 OUTLIER -128.42 152.76 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.162 -0.962 . . . . 0.0 109.528 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.46 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 16.9 mtm -136.93 98.37 3.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.286 -0.884 . . . . 0.0 109.361 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 1.077 HG22 ' NE2' ' A' ' 101' ' ' HIS . 4.4 t -166.37 -147.23 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.153 -0.967 . . . . 0.0 109.64 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.787 ' N ' HG23 ' A' ' 82' ' ' THR . . . -40.93 108.19 0.09 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.464 -0.772 . . . . 0.0 110.052 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.559 ' CG ' ' O ' ' A' ' 84' ' ' TYR . 9.7 t80 -90.05 20.16 4.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 0.0 109.303 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 86' ' ' GLU . . . -136.08 -90.83 0.31 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.438 ' HG2' ' HB1' ' A' ' 83' ' ' ALA . 10.2 pt-20 -45.03 148.67 0.53 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.156 -1.202 . . . . 0.0 109.143 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.526 ' CD2' ' HB2' ' A' ' 91' ' ' GLN . 3.3 mp -134.02 87.21 2.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.161 -0.962 . . . . 0.0 109.748 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -94.5 -43.62 8.25 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.229 -0.92 . . . . 0.0 109.259 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.7 ptp -136.18 6.07 3.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.321 -0.862 . . . . 0.0 109.491 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.982 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.0 OUTLIER -90.95 -53.3 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.188 -0.945 . . . . 0.0 108.719 179.639 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.526 ' HB2' ' CD2' ' A' ' 87' ' ' LEU . 10.6 tt0 -47.66 -58.36 4.38 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.253 -0.905 . . . . 0.0 109.5 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.41 ' O ' ' C ' ' A' ' 93' ' ' SER . 11.2 tm-20 -58.81 -42.71 89.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.259 -0.901 . . . . 0.0 109.488 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.553 ' HA ' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -43.76 -30.77 0.69 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 0.0 109.457 179.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.757 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -55.64 -54.6 42.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 109.469 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -51.06 -47.17 61.85 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.281 -0.887 . . . . 0.0 109.502 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.553 HD12 ' HA ' ' A' ' 93' ' ' SER . 0.7 OUTLIER -49.37 -58.36 5.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.212 -0.93 . . . . 0.0 109.488 179.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 169.62 64.89 0.04 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.757 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -134.78 118.58 17.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.257 -1.143 . . . . 0.0 109.485 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.792 HD11 ' HB3' ' A' ' 77' ' ' ARG . 0.5 OUTLIER -71.11 -71.16 0.27 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.188 -0.945 . . . . 0.0 109.426 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.463 HG23 HG23 ' A' ' 79' ' ' ILE . 14.5 t -122.24 173.16 7.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.247 -0.908 . . . . 0.0 109.453 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 1.077 ' NE2' HG22 ' A' ' 82' ' ' THR . 5.4 t-160 -139.88 90.89 2.42 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.224 -0.923 . . . . 0.0 109.582 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.848 ' CE2' HD13 ' A' ' 111' ' ' ILE . 38.2 m-85 -73.21 -168.31 0.5 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.303 -0.873 . . . . 0.0 109.42 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.589 ' HB2' ' O ' ' A' ' 82' ' ' THR . . . -168.94 -147.39 0.07 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.224 -0.923 . . . . 0.0 109.294 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 7.6 ptmt -137.2 135.87 20.14 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.139 -0.976 . . . . 0.0 109.4 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.86 138.61 52.7 Favored 'Cis proline' 0 C--N 1.31 -1.459 0 C-N-CA 123.437 -1.485 . . . . 0.0 110.281 0.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.448 ' HB3' ' O ' ' A' ' 103' ' ' ALA . 26.9 p90 -99.43 172.45 7.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.28 -0.888 . . . . 0.0 109.656 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -114.81 111.96 22.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.271 -0.893 . . . . 0.0 109.348 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.445 HD13 ' HA ' ' A' ' 108' ' ' ILE . 10.7 mm -54.74 -18.76 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 109.38 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -72.96 -46.98 49.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 109.167 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -67.0 -33.73 76.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.302 -0.874 . . . . 0.0 109.215 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.848 HD13 ' CE2' ' A' ' 102' ' ' PHE . 16.7 mm -71.45 -35.19 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.322 -0.861 . . . . 0.0 109.116 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.532 ' CG ' ' CG1' ' A' ' 22' ' ' VAL . 5.3 mtp85 -63.69 -50.58 68.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.334 -0.854 . . . . 0.0 109.513 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 114' ' ' ALA . 61.8 m-20 -67.15 -62.54 1.38 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.223 -0.923 . . . . 0.0 109.766 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.56 ' O ' ' CD2' ' A' ' 118' ' ' TYR . . . -43.82 -39.77 4.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.113 -0.992 . . . . 0.0 109.684 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.759 HG21 ' CZ ' ' A' ' 23' ' ' PHE . 41.2 t -66.6 -42.97 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.909 . . . . 0.0 109.614 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 4.2 mtpp -61.81 -59.41 5.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 0.0 109.558 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -47.18 -56.31 6.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.197 -0.939 . . . . 0.0 109.566 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.56 ' CD2' ' O ' ' A' ' 114' ' ' ALA . 17.8 m-30 -51.96 -72.2 0.06 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.284 -0.885 . . . . 0.0 109.524 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.725 HD23 ' CE1' ' A' ' 28' ' ' TYR . 1.9 tp -90.19 112.49 52.86 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.324 -0.86 . . . . 0.0 109.534 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 118' ' ' TYR . 35.7 Cg_endo -78.16 152.94 27.96 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.318 2.012 . . . . 0.0 110.408 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.633 HD12 ' OH ' ' A' ' 28' ' ' TYR . 1.0 OUTLIER -115.43 79.93 1.36 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 109.439 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.1 mttm -55.8 165.65 0.86 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.282 -0.886 . . . . 0.0 109.463 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 4.2 t 59.86 -151.4 0.41 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.299 -0.876 . . . . 0.0 109.469 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 54.0 m-20 . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.557 179.982 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 mmt . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER 61.83 31.06 18.41 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.282 -0.886 . . . . 0.0 109.453 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -143.15 81.42 1.72 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.886 . . . . 0.0 109.396 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.612 ' HG3' HD11 ' A' ' 121' ' ' LEU . 16.8 mm-40 -113.36 124.63 52.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.267 -0.895 . . . . 0.0 109.456 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.47 ' O ' HG12 ' A' ' 6' ' ' ILE . 1.2 mtmp? -138.15 144.11 40.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.256 -0.902 . . . . 0.0 109.442 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.86 HD12 HG22 ' A' ' 30' ' ' THR . 3.5 mt -150.04 159.4 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.194 -0.941 . . . . 0.0 109.516 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.914 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.7 OUTLIER -131.18 128.14 39.39 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.333 -0.854 . . . . 0.0 109.492 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.914 ' N ' HD13 ' A' ' 7' ' ' LEU . 7.7 mt -109.68 106.81 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.287 -0.883 . . . . 0.0 109.494 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.666 HG12 ' HA ' ' A' ' 34' ' ' ALA . 2.6 t -104.46 89.01 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.32 -0.862 . . . . 0.0 109.473 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.54 ' CB ' ' HD2' ' A' ' 16' ' ' ARG . 2.2 t70 -87.51 -155.98 0.32 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.202 -0.936 . . . . 0.0 109.392 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.512 ' CB ' ' HA ' ' A' ' 57' ' ' ILE . 0.7 OUTLIER -109.6 -45.52 3.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.91 . . . . 0.0 109.564 -179.977 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.501 ' HG2' ' N ' ' A' ' 13' ' ' TYR . 7.4 tt0 -132.52 -90.13 0.41 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.17 -0.956 . . . . 0.0 109.482 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 1.147 ' CE2' HD11 ' A' ' 17' ' ' ILE . 2.8 t80 -149.83 167.92 25.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.302 -0.874 . . . . 0.0 109.489 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.01 -66.75 0.24 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.528 HD13 ' OD1' ' A' ' 10' ' ' ASP . 9.8 mt -68.04 -28.01 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.254 -1.145 . . . . 0.0 109.48 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.54 ' HD2' ' CB ' ' A' ' 10' ' ' ASP . 0.3 OUTLIER -66.51 -25.87 66.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.302 -0.874 . . . . 0.0 109.444 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 1.147 HD11 ' CE2' ' A' ' 13' ' ' TYR . 4.5 mt -90.04 -51.85 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.221 -0.925 . . . . 0.0 109.533 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.785 ' O ' HG23 ' A' ' 22' ' ' VAL . 4.8 mp -59.29 -58.04 10.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.241 -0.912 . . . . 0.0 109.554 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.728 ' HB3' HD13 ' A' ' 8' ' ' ILE . 1.9 tp -56.6 -22.54 34.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.891 . . . . 0.0 109.464 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 28.1 t30 -74.87 -72.77 0.27 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.244 -0.91 . . . . 0.0 109.528 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.427 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 17.4 tt0 -44.12 -35.52 2.21 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -0.895 . . . . 0.0 109.488 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.785 HG23 ' O ' ' A' ' 18' ' ' LEU . 58.3 t -62.84 -56.99 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.903 . . . . 0.0 109.461 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.545 ' CB ' HG21 ' A' ' 30' ' ' THR . 18.8 m-85 -73.28 -2.49 22.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.342 -0.849 . . . . 0.0 109.618 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.427 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 0.7 OUTLIER -85.65 -55.14 4.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.145 -0.972 . . . . 0.0 109.45 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.8 mttt -69.54 -19.81 63.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.311 -0.868 . . . . 0.0 109.457 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.487 ' HB3' ' CD2' ' A' ' 28' ' ' TYR . 1.4 tt0 -78.55 -30.97 47.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.258 -0.901 . . . . 0.0 109.45 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.443 ' O ' ' CG ' ' A' ' 28' ' ' TYR . . . 110.07 64.48 0.53 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.487 ' CD2' ' HB3' ' A' ' 26' ' ' GLU . 93.7 m-85 -154.76 134.73 13.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.225 -1.162 . . . . 0.0 109.503 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 22.5 mm-40 -91.67 81.8 5.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.286 -0.884 . . . . 0.0 109.409 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.86 HG22 HD12 ' A' ' 6' ' ' ILE . 5.9 p -89.88 152.58 21.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.275 -0.89 . . . . 0.0 109.56 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.837 ' HB2' HD22 ' A' ' 7' ' ' LEU . 58.8 m-85 -116.48 -170.23 1.78 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.301 -0.875 . . . . 0.0 109.402 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.427 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 22.1 mp0 -124.17 161.26 26.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.241 -0.912 . . . . 0.0 109.547 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.463 ' HB3' HG22 ' A' ' 9' ' ' VAL . . . 178.49 177.52 0.44 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 109.437 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.666 ' HA ' HG12 ' A' ' 9' ' ' VAL . . . 178.73 -41.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.217 -0.927 . . . . 0.0 109.466 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.41 ' OD1' ' CB ' ' A' ' 38' ' ' GLN . 30.9 p-10 -65.18 -10.58 32.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.923 . . . . 0.0 109.459 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.416 ' O ' ' C ' ' A' ' 37' ' ' LEU . . . 87.9 -71.42 2.58 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 40' ' ' LEU . 1.9 tt -44.46 -42.21 6.89 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -1.147 . . . . 0.0 109.395 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.517 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 6.6 tp-100 -58.72 -53.87 53.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.264 -0.898 . . . . 0.0 109.504 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.597 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -55.69 -24.16 32.81 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.15 -0.969 . . . . 0.0 109.493 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 37' ' ' LEU . 54.9 mt -73.06 -45.46 57.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.91 . . . . 0.0 109.517 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 42' ' ' ILE . 1.7 p30 -64.81 -43.02 94.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.182 -0.949 . . . . 0.0 109.449 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.644 HG21 HD23 ' A' ' 7' ' ' LEU . 7.2 mt -64.23 -34.77 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.21 -0.931 . . . . 0.0 109.268 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 39' ' ' ALA . 54.2 t -74.32 -24.03 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.891 . . . . 0.0 109.453 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.2 m -89.7 -18.72 25.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.228 -0.92 . . . . 0.0 109.532 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.95 -55.65 3.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.285 -0.884 . . . . 0.0 109.483 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.438 ' O ' ' CB ' ' A' ' 47' ' ' ARG . 1.1 mt-10 -89.98 -39.04 13.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.268 -0.895 . . . . 0.0 109.458 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER 71.28 65.91 0.39 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.23 -0.919 . . . . 0.0 109.498 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.531 ' CD ' ' HA ' ' A' ' 43' ' ' VAL . 35.5 Cg_endo -78.14 167.99 22.52 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.589 2.192 . . . . 0.0 110.421 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.559 ' C ' HD22 ' A' ' 50' ' ' LEU . 29.0 t70 -109.43 -9.91 14.92 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.218 -0.926 . . . . 0.0 109.533 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.559 HD22 ' C ' ' A' ' 49' ' ' ASP . 3.8 mm? -117.84 121.51 40.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -0.937 . . . . 0.0 109.543 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.488 HG11 ' CE ' ' A' ' 69' ' ' MET . 72.9 t -127.33 140.93 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.257 -0.902 . . . . 0.0 109.471 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.648 HD12 ' O ' ' A' ' 7' ' ' LEU . 1.1 mp -115.27 112.17 22.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.309 -0.87 . . . . 0.0 109.423 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.632 HD22 ' CD2' ' A' ' 66' ' ' LEU . 1.7 mp -102.59 132.02 48.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.282 -0.886 . . . . 0.0 109.517 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.451 ' O ' HG13 ' A' ' 57' ' ' ILE . 17.7 t70 -112.76 130.14 56.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.319 -0.863 . . . . 0.0 109.453 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.729 ' HB2' HG21 ' A' ' 82' ' ' THR . 9.6 mmt -86.84 -6.98 58.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.322 -0.861 . . . . 0.0 109.555 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt -86.58 15.02 5.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.166 -0.959 . . . . 0.0 109.498 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.512 ' HA ' ' CB ' ' A' ' 11' ' ' ASP . 41.7 mt -80.97 138.78 49.57 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.128 -0.983 . . . . 0.0 109.309 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.493 ' HD3' ' HB2' ' A' ' 11' ' ' ASP . 36.2 Cg_endo -78.54 -36.15 0.96 Allowed 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.488 2.126 . . . . 0.0 110.549 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 58' ' ' PRO . . . -42.41 -53.79 4.91 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.502 ' N ' ' SD ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -169.47 -150.3 0.08 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.136 -1.214 . . . . 0.0 109.558 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.497 ' N ' ' HG2' ' A' ' 60' ' ' MET . 36.9 m-20 -90.19 -97.28 0.11 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.291 -0.881 . . . . 0.0 109.481 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.459 ' HA2' HG13 ' A' ' 65' ' ' ILE . . . 147.42 -14.76 1.44 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.466 HD13 ' HA ' ' A' ' 63' ' ' ILE . 14.4 mm -57.0 -18.72 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.314 -1.109 . . . . 0.0 109.238 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -87.47 -33.52 18.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.313 -0.867 . . . . 0.0 109.24 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.515 ' HB ' HD21 ' A' ' 53' ' ' LEU . 17.2 mt -56.15 -54.58 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.338 -0.851 . . . . 0.0 109.319 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.925 HD21 HG11 ' A' ' 78' ' ' VAL . 23.0 mt -51.02 -44.49 61.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 109.31 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.559 ' O ' HG23 ' A' ' 71' ' ' VAL . 3.2 tttp -52.38 -50.32 62.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.326 -0.859 . . . . 0.0 109.411 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.492 ' O ' HD12 ' A' ' 72' ' ' ILE . 0.3 OUTLIER -59.28 -31.5 69.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.286 -0.884 . . . . 0.0 109.431 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.488 ' CE ' HG11 ' A' ' 51' ' ' VAL . 2.7 mtt -74.47 -24.92 59.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.278 -0.889 . . . . 0.0 109.435 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -79.95 -28.93 39.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.379 -0.826 . . . . 0.0 109.264 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 67' ' ' LYS . 2.7 t -90.08 -22.04 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.306 -0.871 . . . . 0.0 109.549 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.492 HD12 ' O ' ' A' ' 68' ' ' ARG . 53.3 mt -87.43 -44.56 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -0.909 . . . . 0.0 109.459 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.507 ' O ' HG22 ' A' ' 76' ' ' ILE . 73.0 m-20 -150.49 122.69 8.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.331 -0.856 . . . . 0.0 109.404 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -81.99 -9.62 59.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.277 -0.889 . . . . 0.0 109.522 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -103.37 49.87 0.82 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.233 -0.917 . . . . 0.0 109.493 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.601 ' O ' HG23 ' A' ' 76' ' ' ILE . 1.1 tp -129.94 112.62 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.466 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.518 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 1.6 mtt180 -79.85 154.19 28.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 0.0 109.468 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.925 HG11 HD21 ' A' ' 66' ' ' LEU . 4.8 t -150.02 108.44 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.913 . . . . 0.0 109.572 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.692 HG23 HG23 ' A' ' 100' ' ' THR . 72.5 mt -90.5 140.81 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.247 -0.908 . . . . 0.0 109.449 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.898 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.0 OUTLIER -94.44 152.32 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.271 -0.893 . . . . 0.0 109.198 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.459 ' O ' ' HB ' ' A' ' 82' ' ' THR . 14.0 mtm -124.53 73.16 1.24 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.183 -0.948 . . . . 0.0 109.373 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.729 HG21 ' HB2' ' A' ' 55' ' ' MET . 9.6 t 177.29 56.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.31 -0.869 . . . . 0.0 109.397 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.88 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . . . -82.09 -15.39 53.62 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.281 -0.887 . . . . 0.0 109.528 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -89.98 84.31 6.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.211 -0.931 . . . . 0.0 109.525 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 142.23 -96.87 0.2 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.446 ' OE2' ' HB3' ' A' ' 55' ' ' MET . 0.4 OUTLIER -53.34 146.76 11.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.324 -1.104 . . . . 0.0 109.59 -179.94 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.624 ' HA ' HG23 ' A' ' 90' ' ' ILE . 0.3 OUTLIER -160.11 23.01 0.17 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.281 -0.887 . . . . 0.0 109.431 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -96.75 -77.92 0.48 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.204 -0.935 . . . . 0.0 109.513 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.506 ' O ' ' CB ' ' A' ' 93' ' ' SER . 1.8 mmt -79.23 3.82 16.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.27 -0.894 . . . . 0.0 109.57 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 1.068 HD12 ' CE1' ' A' ' 101' ' ' HIS . 0.1 OUTLIER -90.47 -53.22 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.231 -0.918 . . . . 0.0 108.862 179.533 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -51.35 -37.15 46.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.255 -0.903 . . . . 0.0 109.5 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 93' ' ' SER . 1.4 mt-10 -90.15 -36.28 14.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.226 -0.921 . . . . 0.0 109.625 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.506 ' CB ' ' O ' ' A' ' 89' ' ' MET . 0.4 OUTLIER -43.55 -44.92 6.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.312 -0.868 . . . . 0.0 109.649 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.928 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 2.5 ttpt -44.02 -51.79 7.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.282 -0.886 . . . . 0.0 109.445 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -59.5 -40.99 88.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 0.0 109.431 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.562 HD22 ' N ' ' A' ' 96' ' ' LEU . 4.2 mm? -53.31 -64.99 0.64 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.296 -0.878 . . . . 0.0 109.49 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -176.08 40.98 0.11 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.928 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -110.77 101.33 9.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -1.164 . . . . 0.0 109.49 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.518 ' CD1' ' HB3' ' A' ' 77' ' ' ARG . 18.6 mt -44.1 -68.32 0.21 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 109.47 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.692 HG23 HG23 ' A' ' 79' ' ' ILE . 15.1 t -134.9 -177.6 4.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.284 -0.885 . . . . 0.0 109.437 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 1.068 ' CE1' HD12 ' A' ' 90' ' ' ILE . 3.2 t-160 -140.48 88.35 2.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 109.339 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.717 ' CE1' HD13 ' A' ' 111' ' ' ILE . 65.5 m-85 -58.99 -164.35 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.236 -0.915 . . . . 0.0 109.579 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.88 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -177.27 155.31 1.12 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.199 -0.938 . . . . 0.0 109.361 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.519 ' HA ' ' N ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -93.41 142.14 24.84 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.211 -0.931 . . . . 0.0 109.387 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.91 117.1 4.9 Favored 'Cis proline' 0 C--N 1.31 -1.479 0 C-N-CA 123.335 -1.527 . . . . 0.0 110.353 -0.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.519 ' N ' ' HA ' ' A' ' 104' ' ' LYS . 11.1 p90 -79.84 169.6 17.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.248 -0.908 . . . . 0.0 109.574 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.472 ' O ' HG12 ' A' ' 111' ' ' ILE . 36.0 t0 -119.77 121.73 39.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.347 -0.846 . . . . 0.0 109.473 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.463 HG23 HG11 ' A' ' 22' ' ' VAL . 14.5 mm -54.63 -21.28 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -0.897 . . . . 0.0 109.509 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -76.24 -37.52 57.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.235 -0.916 . . . . 0.0 109.518 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -77.57 -25.31 49.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.184 -0.947 . . . . 0.0 109.436 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.717 HD13 ' CE1' ' A' ' 102' ' ' PHE . 19.2 mm -75.73 -45.85 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.313 -0.867 . . . . 0.0 109.516 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.467 ' HB2' ' OE1' ' A' ' 26' ' ' GLU . 7.6 ptt85 -72.51 -41.88 65.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.472 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -61.16 -53.43 57.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.928 . . . . 0.0 109.538 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.486 ' O ' ' HG2' ' A' ' 117' ' ' LYS . . . -59.18 -45.06 92.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.292 -0.88 . . . . 0.0 109.47 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 111' ' ' ILE . 54.7 t -60.48 -25.19 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.191 -0.943 . . . . 0.0 109.396 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -76.89 -45.66 27.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.179 -0.95 . . . . 0.0 109.451 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.524 ' HG3' ' N ' ' A' ' 118' ' ' TYR . 0.0 OUTLIER -63.49 -27.08 69.03 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 109.481 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.524 ' N ' ' HG3' ' A' ' 117' ' ' LYS . 38.9 m-85 -84.51 -72.84 0.45 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.24 -0.912 . . . . 0.0 109.423 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.8 tp -90.06 112.58 53.18 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.341 -0.849 . . . . 0.0 109.422 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 118' ' ' TYR . 35.6 Cg_endo -77.79 132.76 12.15 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.33 2.02 . . . . 0.0 110.418 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.612 HD11 ' HG3' ' A' ' 4' ' ' GLU . 0.6 OUTLIER -133.54 12.15 4.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.327 -0.858 . . . . 0.0 109.47 -179.917 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.57 26.22 0.23 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.213 -0.929 . . . . 0.0 109.507 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -142.62 -77.22 0.25 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.198 -0.939 . . . . 0.0 109.529 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.453 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptp . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 28.7 mtp -63.4 -150.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.175 -0.953 . . . . 0.0 109.408 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.31 149.31 31.6 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.252 -0.905 . . . . 0.0 109.473 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.567 ' OE1' ' CD2' ' A' ' 28' ' ' TYR . 1.6 mm-40 -82.91 111.6 18.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.173 -0.954 . . . . 0.0 109.47 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.495 ' HB2' ' HA ' ' A' ' 48' ' ' PRO . 42.3 mttt -121.96 120.52 34.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -0.916 . . . . 0.0 109.485 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.475 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 49.1 mt -148.51 150.93 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.157 -0.964 . . . . 0.0 109.483 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.633 HD11 HD13 ' A' ' 42' ' ' ILE . 0.6 OUTLIER -133.56 127.83 33.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.183 -0.948 . . . . 0.0 109.432 -179.999 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.403 HD13 ' CB ' ' A' ' 19' ' ' LEU . 8.4 mt -101.02 109.54 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.244 -0.91 . . . . 0.0 109.522 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.651 HG12 HD11 ' A' ' 57' ' ' ILE . 17.0 t -96.27 91.33 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.23 -0.919 . . . . 0.0 109.427 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.518 ' O ' ' CD ' ' A' ' 16' ' ' ARG . 16.7 t70 -145.27 146.01 31.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.264 -0.898 . . . . 0.0 109.45 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.477 ' OD2' ' HD2' ' A' ' 58' ' ' PRO . 9.1 p-10 -109.88 -37.75 5.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.185 -0.947 . . . . 0.0 109.501 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.414 ' O ' ' C ' ' A' ' 13' ' ' TYR . 1.8 tp60 -63.01 104.84 0.6 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.232 -0.918 . . . . 0.0 109.448 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.583 ' CZ ' HG13 ' A' ' 17' ' ' ILE . 9.2 t80 -44.73 132.3 6.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.243 -0.911 . . . . 0.0 109.447 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 18' ' ' LEU . . . 138.72 -47.11 0.94 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 1.021 HG23 HD13 ' A' ' 19' ' ' LEU . 4.5 mt -82.85 -43.62 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.174 -1.192 . . . . 0.0 109.491 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.518 ' CD ' ' O ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -63.0 -24.05 67.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.89 . . . . 0.0 109.505 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.583 HG13 ' CZ ' ' A' ' 13' ' ' TYR . 5.3 mm -90.1 -55.41 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.212 -0.93 . . . . 0.0 109.598 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.591 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.3 OUTLIER -56.61 -58.57 7.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 109.573 -179.853 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 1.021 HD13 HG23 ' A' ' 15' ' ' ILE . 5.0 mp -57.86 -21.23 41.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.905 . . . . 0.0 109.552 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 12.7 t30 -74.16 -71.11 0.35 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.316 -0.865 . . . . 0.0 109.469 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.451 ' N ' ' OE1' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -45.57 -44.18 12.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 0.0 109.522 -179.897 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.902 HG21 HD12 ' A' ' 108' ' ' ILE . 48.2 t -58.93 -53.18 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.218 -0.926 . . . . 0.0 109.431 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.771 ' HZ ' HG22 ' A' ' 111' ' ' ILE . 21.8 m-85 -78.13 2.33 18.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.372 -0.83 . . . . 0.0 109.622 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.457 ' ND2' ' OD1' ' A' ' 20' ' ' ASN . 0.6 OUTLIER -90.02 -50.32 6.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.139 -0.975 . . . . 0.0 109.532 179.896 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.5 tttp -79.57 -44.68 20.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.178 -0.951 . . . . 0.0 109.49 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.534 ' HB3' ' CD1' ' A' ' 28' ' ' TYR . 0.9 OUTLIER -49.09 -34.29 13.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 109.453 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.526 ' C ' ' CD1' ' A' ' 28' ' ' TYR . . . 110.26 66.26 0.55 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.751 ' CE2' HD21 ' A' ' 121' ' ' LEU . 70.1 m-85 -148.64 135.62 20.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.333 -1.099 . . . . 0.0 109.5 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.465 ' HG2' ' HB2' ' A' ' 4' ' ' GLU . 5.6 mm100 -92.39 83.02 4.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.306 -0.871 . . . . 0.0 109.266 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.671 HG21 ' CB ' ' A' ' 23' ' ' PHE . 5.7 p -89.98 158.63 17.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.914 . . . . 0.0 109.571 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.577 ' HB2' HD12 ' A' ' 7' ' ' LEU . 8.8 m-85 -118.18 -163.56 0.95 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.289 -0.882 . . . . 0.0 109.465 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -144.52 147.89 33.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.166 -0.959 . . . . 0.0 109.519 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -168.36 -176.24 2.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.903 . . . . 0.0 109.417 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.464 ' O ' ' HE1' ' A' ' 60' ' ' MET . . . 177.98 -31.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.214 -0.929 . . . . 0.0 109.498 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -76.42 -8.06 56.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.259 -0.9 . . . . 0.0 109.514 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.13 -47.44 3.77 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.463 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -59.16 -43.26 92.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -1.113 . . . . 0.0 109.435 -179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 1.062 ' O ' HD12 ' A' ' 42' ' ' ILE . 18.8 mm-40 -69.1 -24.31 64.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.324 -0.86 . . . . 0.0 109.436 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.669 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -70.98 -57.85 4.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -0.882 . . . . 0.0 109.515 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.427 HD22 ' HB3' ' A' ' 68' ' ' ARG . 12.7 mt -64.02 -31.41 72.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.188 -0.945 . . . . 0.0 109.531 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 37' ' ' LEU . 3.9 t0 -64.87 -49.88 68.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.27 -0.894 . . . . 0.0 109.459 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 1.062 HD12 ' O ' ' A' ' 38' ' ' GLN . 3.6 mt -70.21 -20.17 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.25 -0.906 . . . . 0.0 109.477 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 39' ' ' ALA . 55.5 t -77.67 -34.33 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.911 . . . . 0.0 109.489 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.3 m -90.02 -16.03 30.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.182 -0.949 . . . . 0.0 109.483 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.27 -51.44 5.76 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.252 -0.905 . . . . 0.0 109.552 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.478 ' HG3' HG23 ' A' ' 42' ' ' ILE . 0.9 OUTLIER -92.88 -26.03 17.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.236 -0.915 . . . . 0.0 109.518 -179.925 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.492 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 12.8 mtm180 61.02 63.16 2.6 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.254 -0.903 . . . . 0.0 109.452 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.594 ' O ' HD12 ' A' ' 76' ' ' ILE . 35.2 Cg_endo -77.81 -178.32 4.52 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.594 2.196 . . . . 0.0 110.388 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.862 ' O ' HD22 ' A' ' 50' ' ' LEU . 55.5 m-20 -128.06 -2.76 5.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.302 -0.874 . . . . 0.0 109.673 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.862 HD22 ' O ' ' A' ' 49' ' ' ASP . 3.8 mm? -131.49 106.06 7.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.176 -0.952 . . . . 0.0 109.502 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.853 HG11 ' CE ' ' A' ' 69' ' ' MET . 1.5 t -115.88 121.41 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.9 . . . . 0.0 109.45 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.468 ' HB3' ' CE ' ' A' ' 81' ' ' MET . 1.1 mp -94.99 110.53 22.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.262 -0.899 . . . . 0.0 109.437 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.814 HD23 ' CG1' ' A' ' 78' ' ' VAL . 2.9 mm? -104.41 133.11 49.84 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.189 -0.944 . . . . 0.0 109.547 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -118.0 129.35 55.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.908 . . . . 0.0 109.488 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.624 ' HB2' HG21 ' A' ' 82' ' ' THR . 27.7 mmt -78.75 3.35 16.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 109.562 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.434 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 2.0 mmmm -78.16 -28.19 48.23 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.149 -0.969 . . . . 0.0 109.424 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.839 HG21 ' CE ' ' A' ' 60' ' ' MET . 44.3 mt -43.06 103.15 0.3 Allowed Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.392 -0.818 . . . . 0.0 109.552 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.477 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 35.3 Cg_endo -77.76 71.74 6.41 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.497 2.131 . . . . 0.0 110.387 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -164.4 -47.67 0.02 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.839 ' CE ' HG21 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -153.21 135.09 14.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.262 -1.14 . . . . 0.0 109.454 179.897 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -56.65 136.47 54.78 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.205 -0.934 . . . . 0.0 109.482 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.452 ' HA2' HG13 ' A' ' 65' ' ' ILE . . . -83.69 9.69 61.67 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.586 HG23 ' SD ' ' A' ' 89' ' ' MET . 38.7 mm -67.62 -45.05 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.191 -1.182 . . . . 0.0 109.475 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -66.83 -25.48 66.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.235 -0.915 . . . . 0.0 109.449 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.452 HG13 ' HA2' ' A' ' 62' ' ' GLY . 7.2 mt -69.81 -68.24 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.34 -0.85 . . . . 0.0 109.434 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 1.045 HD21 HG11 ' A' ' 78' ' ' VAL . 3.1 mt -50.35 -39.37 46.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.267 -0.896 . . . . 0.0 109.528 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.505 ' O ' HG23 ' A' ' 71' ' ' VAL . 1.7 ttpp -60.68 -39.41 88.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -0.876 . . . . 0.0 109.505 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.427 ' HB3' HD22 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -68.25 -58.28 4.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.234 -0.916 . . . . 0.0 109.515 -179.894 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.853 ' CE ' HG11 ' A' ' 51' ' ' VAL . 2.2 ptp -60.71 -13.72 16.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.267 -0.896 . . . . 0.0 109.548 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 66' ' ' LEU . 0.6 OUTLIER -89.72 -31.58 17.39 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.836 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 67' ' ' LYS . 52.8 t -75.09 -28.97 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 109.195 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.5 mt -90.05 -44.52 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.363 -0.836 . . . . 0.0 109.419 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.758 ' O ' HG22 ' A' ' 76' ' ' ILE . 15.0 t0 -132.05 116.78 17.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.16 -0.962 . . . . 0.0 109.427 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.01 -40.45 12.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.248 -0.908 . . . . 0.0 109.544 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -61.23 -13.87 21.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.281 -0.887 . . . . 0.0 109.46 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.758 HG22 ' O ' ' A' ' 73' ' ' ASP . 1.0 OUTLIER -60.51 112.03 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.2 -0.937 . . . . 0.0 109.525 179.922 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.485 ' CB ' HD11 ' A' ' 99' ' ' LEU . 5.0 mtt85 -71.19 142.43 50.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.213 -0.929 . . . . 0.0 109.436 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 1.045 HG11 HD21 ' A' ' 66' ' ' LEU . 15.9 t -145.05 150.58 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.237 -0.915 . . . . 0.0 109.631 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.667 HG23 ' O ' ' A' ' 100' ' ' THR . 11.1 mt -134.19 141.33 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.266 -0.896 . . . . 0.0 109.433 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.885 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.1 OUTLIER -96.74 141.77 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.172 -0.955 . . . . 0.0 109.206 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.468 ' CE ' ' HB3' ' A' ' 52' ' ' LEU . 2.8 mtm -113.88 59.85 0.67 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.145 -0.972 . . . . 0.0 109.508 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.624 HG21 ' HB2' ' A' ' 55' ' ' MET . 14.2 t -172.43 43.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.176 -0.952 . . . . 0.0 109.521 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.732 ' N ' ' HB2' ' A' ' 103' ' ' ALA . . . -52.99 -74.5 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.266 -0.896 . . . . 0.0 109.526 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -56.52 104.42 0.15 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 109.522 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 175.16 -72.12 0.09 OUTLIER Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.482 ' O ' HG21 ' A' ' 90' ' ' ILE . 3.9 pt-20 -155.51 140.46 17.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.182 -1.187 . . . . 0.0 109.477 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.836 ' N ' HD22 ' A' ' 87' ' ' LEU . 2.4 mm? -103.71 68.55 0.93 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.338 -0.851 . . . . 0.0 109.435 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.531 ' O ' ' CB ' ' A' ' 89' ' ' MET . 21.3 m-20 -121.36 101.11 7.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.274 -0.891 . . . . 0.0 109.359 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.586 ' SD ' HG23 ' A' ' 63' ' ' ILE . 0.0 OUTLIER 77.67 -2.4 2.54 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.369 -0.832 . . . . 0.0 109.341 -179.49 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.656 HD12 ' CE1' ' A' ' 101' ' ' HIS . 0.2 OUTLIER -90.86 -50.16 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.353 -0.842 . . . . 0.0 108.905 179.619 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.78 -38.26 15.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.315 -0.865 . . . . 0.0 109.573 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -90.02 -40.73 12.13 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.227 -0.92 . . . . 0.0 109.619 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.534 ' O ' ' CA ' ' A' ' 97' ' ' GLY . 9.9 m -58.73 -15.22 11.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.202 -0.936 . . . . 0.0 109.644 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.872 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 1.7 ttpt -88.89 -45.86 9.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.155 -0.966 . . . . 0.0 109.506 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.993 ' C ' HD22 ' A' ' 96' ' ' LEU . 10.0 mm-40 -47.62 -44.24 26.52 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.515 -0.741 . . . . 0.0 110.542 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.993 HD22 ' C ' ' A' ' 95' ' ' GLU . 3.3 mm? -132.38 5.51 4.07 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.93 -1.106 . . . . 0.0 110.704 -179.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.534 ' CA ' ' O ' ' A' ' 93' ' ' SER . . . -124.39 -14.19 3.68 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.473 -1.346 . . . . 0.0 109.99 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.872 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -149.84 98.03 2.68 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.166 -1.196 . . . . 0.0 109.615 -179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.485 HD11 ' CB ' ' A' ' 77' ' ' ARG . 0.7 OUTLIER -48.79 -61.1 2.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.235 -0.915 . . . . 0.0 109.478 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.667 ' O ' HG23 ' A' ' 79' ' ' ILE . 16.7 m -113.53 157.68 21.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 109.476 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.885 ' ND1' HD12 ' A' ' 80' ' ' ILE . 3.4 t-160 -135.52 85.5 2.17 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.325 -0.859 . . . . 0.0 109.331 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.54 ' CE1' ' HG2' ' A' ' 110' ' ' GLU . 11.7 m-85 -73.13 158.27 35.62 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.198 -0.939 . . . . 0.0 109.575 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.732 ' HB2' ' N ' ' A' ' 83' ' ' ALA . . . -144.61 151.99 39.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.348 -0.845 . . . . 0.0 109.424 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 103' ' ' ALA . 0.6 OUTLIER -45.1 137.04 4.84 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.235 -0.916 . . . . 0.0 109.304 -179.937 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' A' ' 103' ' ' ALA . 35.7 Cg_endo -77.78 -172.6 11.47 Favored 'Cis proline' 0 C--N 1.312 -1.363 0 C-N-CA 123.365 -1.514 . . . . 0.0 110.403 -0.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.759 ' HE2' HD21 ' A' ' 19' ' ' LEU . 0.4 OUTLIER -118.66 111.52 18.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.212 -0.93 . . . . 0.0 109.492 -179.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.468 ' O ' HG12 ' A' ' 111' ' ' ILE . 22.1 t0 -89.94 105.79 18.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.262 -0.899 . . . . 0.0 109.36 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.902 HD12 HG21 ' A' ' 22' ' ' VAL . 13.7 mm -45.92 -24.63 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.226 -0.921 . . . . 0.0 109.772 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.431 ' O ' ' HG2' ' A' ' 112' ' ' ARG . 9.6 m-20 -69.75 -47.55 62.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.904 . . . . 0.0 109.542 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.54 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 0.9 OUTLIER -69.19 -30.23 68.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -0.901 . . . . 0.0 109.475 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.771 HG22 ' HZ ' ' A' ' 23' ' ' PHE . 14.7 mm -68.01 -46.31 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.234 -0.916 . . . . 0.0 109.399 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.472 ' O ' ' HG3' ' A' ' 116' ' ' LYS . 3.2 ptt180 -74.06 -20.76 60.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.354 -0.841 . . . . 0.0 109.572 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -73.54 -51.38 17.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.157 -0.965 . . . . 0.0 109.495 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.544 ' O ' ' CD2' ' A' ' 118' ' ' TYR . . . -70.06 -31.63 69.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 109.535 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.569 HG21 ' CZ ' ' A' ' 23' ' ' PHE . 72.4 t -74.95 -31.45 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -0.923 . . . . 0.0 109.57 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 112' ' ' ARG . 0.1 OUTLIER -74.55 -42.55 58.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.21 -0.931 . . . . 0.0 109.583 179.957 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.454 ' HE2' ' HA ' ' A' ' 117' ' ' LYS . 0.0 OUTLIER -64.15 -50.42 68.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.921 . . . . 0.0 109.519 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.544 ' CD2' ' O ' ' A' ' 114' ' ' ALA . 14.8 m-85 -65.62 -63.71 1.03 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.207 -0.933 . . . . 0.0 109.486 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.52 HD21 ' OE2' ' A' ' 4' ' ' GLU . 2.9 tt -87.91 113.2 53.62 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.161 -0.962 . . . . 0.0 109.405 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 118' ' ' TYR . 35.7 Cg_endo -77.87 139.93 17.92 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.353 2.035 . . . . 0.0 110.401 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.751 HD21 ' CE2' ' A' ' 28' ' ' TYR . 2.8 mm? -113.33 -166.51 1.09 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.251 -0.906 . . . . 0.0 109.51 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 121' ' ' LEU . 13.2 mttt -43.4 125.83 4.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.388 -0.82 . . . . 0.0 109.556 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 28.1 t -48.07 102.69 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.889 . . . . 0.0 109.451 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.9 m120 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.39 179.914 . . . . . . . . 0 0 . 1 stop_ save_